

  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Amino-4,6-dichloropyrimidine
C4H3Cl2N3
5413-85-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6674 0.0000 0.0 0
M  V30 2 Cl 0.0000 1.5400 0.0 0
M  V30 3 Cl 5.3349 1.5400 0.0 0
M  V30 4 C 2.6674 1.5400 0.0 0
M  V30 5 C 1.3338 2.3100 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 N 1.3338 3.8500 0.0 0
M  V30 8 N 4.0011 3.8500 0.0 0
M  V30 9 C 2.6674 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 5
M  V30 3 1 3 6
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-N4-methyl-4,5-pyrimidinediamine
C5H7ClN4
52602-68-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 1.5400 0.0 0
M  V30 2 C 6.6686 2.3100 0.0 0
M  V30 3 N 2.6675 0.0000 0.0 0
M  V30 4 Cl 0.0000 1.5400 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 2.6675 1.5400 0.0 0
M  V30 7 N 4.0011 3.8500 0.0 0
M  V30 8 C 1.3338 2.3100 0.0 0
M  V30 9 C 2.6675 4.6201 0.0 0
M  V30 10 N 1.3338 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 3 6
M  V30 4 1 4 8
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5413-85-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 52602-68-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-18639921
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM steel vial used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM New potent and selective A1 adenosine receptor antagonists as potential
tools for the treatment of gastrointestinal diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lambertucci, Catia; Marucci, Gabriella; Dal Ben, Diego; Buccioni,
Michela; Spinaci, Andrea; Kachler, Sonja; Klotz, Karl-Norbert; Volpini,
Rosaria
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2018), 151199-213

$RFMT $RIREG SCHEME2 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Nitrobenzaldehyde
C7H5NO3
552-89-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 1.3338 0.0 0
M  V30 2 O 6.1600 1.3338 0.0 0
M  V30 3 N 1.5400 1.3338 0.0 0 VAL=5
M  V30 4 O 2.3100 0.0000 0.0 0
M  V30 5 O 0.0000 1.3338 0.0 0
M  V30 6 C 3.8500 2.6674 0.0 0
M  V30 7 C 2.3100 2.6674 0.0 0
M  V30 8 C 4.6200 4.0011 0.0 0
M  V30 9 C 1.5400 4.0011 0.0 0
M  V30 10 C 3.8500 5.3349 0.0 0
M  V30 11 C 2.3100 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(2-Nitrophenyl)methylene]methanamine
C8H8N2O2
57707-11-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.5400 4.0011 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0011 0.0 0
M  V30 3 O 2.3100 5.3349 0.0 0
M  V30 4 C 4.6200 4.0011 0.0 0
M  V30 5 N 6.1600 4.0011 0.0 0
M  V30 6 C 6.9300 5.3349 0.0 0
M  V30 7 C 2.3100 2.6674 0.0 0
M  V30 8 C 3.8500 2.6674 0.0 0
M  V30 9 C 1.5400 1.3338 0.0 0
M  V30 10 C 4.6200 1.3338 0.0 0
M  V30 11 C 2.3100 0.0000 0.0 0
M  V30 12 C 3.8500 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 2 4 5 CFG=2
M  V30 5 1 4 8
M  V30 6 1 5 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 552-89-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 57707-11-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31477782
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 16898-52-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-catalyst, green chemistry-solvent, recyclable catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 4,4'-Trimethylenedipiperidine, a safe and greener alternative for
piperidine, catalyzed the synthesis of N-methyl imines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gorjian, Hayedeh; Khaligh, Nader Ghaffari
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Research on Chemical Intermediates (2022), 48(5), 2035-2045

$RFMT $RIREG SCHEME3 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Dichloronitrobenzene
C6H3Cl2NO2
611-06-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 Cl 2.3101 0.0000 0.0 0
M  V30 5 Cl 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Chloro-N-methyl-2-nitrobenzenamine
C7H7ClN2O2
35966-84-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 N 0.7700 4.0011 0.0 0 VAL=5
M  V30 4 O 0.0000 2.6674 0.0 0
M  V30 5 O 0.0000 5.3349 0.0 0
M  V30 6 Cl 6.9300 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 8
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 611-06-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 35966-84-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-271224
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-68-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 5: SNAr reaction of (5-chloro-2-nitrophenyl)-methylamine. To a
solution of (5-chloro-2-nitrophenyl)-methylamine (40 g, 208.3 mmol, 1
equiv) in DMSO (160 mL) was added 40% MeNH2 solution in water (100mL,
1145.6 mmol, 5.5 eq) slowly keeping the temperature below 35° C. The
reaction was stirred at r.t. until the complete consumption of the
starting material (> 10 h). Water (400 mL) was added to the resulting
orange slurry and stirred at r.t. for additional 2 h. The solid was
filtered, rinsed with water (200 mL) and dried under reduced pressure at
40° C. (5-chloro-2-nitrophenyl)-methylamine (36.2 g, 93% yield, 94 A %
purity) was isolated as a solid.
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Oral combination therapy for treating HCV infection in specific patient
subgenotype populations
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mensa, Federico; Nehmiz, Gerhard
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20130288957 A1 2013-10-31

$RFMT $RIREG SCHEME3 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Dichloronitrobenzene
C6H3Cl2NO2
611-06-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 Cl 2.3101 0.0000 0.0 0
M  V30 5 Cl 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Chloro-N-methyl-2-nitrobenzenamine
C7H7ClN2O2
35966-84-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 N 0.7700 4.0011 0.0 0 VAL=5
M  V30 4 O 0.0000 2.6674 0.0 0
M  V30 5 O 0.0000 5.3349 0.0 0
M  V30 6 Cl 6.9300 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 8
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 611-06-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 35966-84-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-12661552
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-68-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 5: SNAr reaction of (5-chloro-2-nitrophenyl)-methylamine. To a
solution of (5-chloro-2-nitrophenyl)-methylamine (40 g, 208.3 mmol, 1
equiv) in DMSO (160 mL) was added 40% MeNH2 solution in water (100 mL,
1145. 6 mmol, 5.5 eq) slowly keeping the temperature below 35 °C. The
reaction was stirred at r.t. until the complete consumption of the
starting material (>10 h). Water (400 mL) was added to the resulting
orange slurry and stirred at r.t. for additional 2 h. The solid was
filtered, rinsed with water (200 mL) and dried under reduced pressure at
40 °C. (5-chloro-2-nitrophenyl)-methylamine. (36.2 g, 93% yield, 94 A%
purity), solid.
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Oral combination therapy for treating HCV infection in specific patient
subgenotype populations
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mensa, Federico; Nehmiz, Gerhard
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2013147749 A1 2013-10-03

$RFMT $RIREG SCHEME3 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Dichloronitrobenzene
C6H3Cl2NO2
611-06-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 Cl 2.3101 0.0000 0.0 0
M  V30 5 Cl 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Chloro-N-methyl-2-nitrobenzenamine
C7H7ClN2O2
35966-84-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 N 0.7700 4.0011 0.0 0 VAL=5
M  V30 4 O 0.0000 2.6674 0.0 0
M  V30 5 O 0.0000 5.3349 0.0 0
M  V30 6 Cl 6.9300 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 8
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 611-06-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 35966-84-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-10774381
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-68-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 5: SNAr reaction of (5-chloro-2-nitrophenyl)-methylamine To a
solution of (5-chloro-2-nitrophenyl)-methylamine (40 g, 208.3 mmol, 1
equiv) in DMSO (160 mL) was added 40% MeNH2 solution in water (100 mL,
1145. 6 mmol, 5.5 eq) slowly keeping the temperature below 35 °C. The
reaction was stirred at r.t. until the complete consumption of the
starting material (>10 h). Water (400 mL) was added to the resulting
orange slurry and stirred at r.t. for additional 2 h. The solid was
filtered, rinsed with water (200 mL) and dried under reduced pressure at
40 °C. (5-chloro-2-nitrophenyl)-methylamine (36.2 g, 93% yield, 94 A%
purity) was isolated as a solid.
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Oral combination therapy for treating HCV infection in specific patient
sub-population
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mensa, Federico
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2013147750 A1 2013-10-03

$RFMT $RIREG SCHEME3 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Dichloronitrobenzene
C6H3Cl2NO2
611-06-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 Cl 2.3101 0.0000 0.0 0
M  V30 5 Cl 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Chloro-N-methyl-2-nitrobenzenamine
C7H7ClN2O2
35966-84-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 N 0.7700 4.0011 0.0 0 VAL=5
M  V30 4 O 0.0000 2.6674 0.0 0
M  V30 5 O 0.0000 5.3349 0.0 0
M  V30 6 Cl 6.9300 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 8
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 611-06-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 35966-84-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-5845780
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-68-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 5: SNAr reaction of (5-chloro-2-nitrophenvl)-methylamine To a
solution of (5-chloro-2-nitrophenyl)-methylamine (40 g, 208.3 mmol, I
equiv) in DMSO (160 mL) was added 40% MeNID solution in water (100 mL,
1145. 6 mmol, 5.5 eq) slowly keeping the temperature below 35 °C. The
reaction was stirred at r.t. until the complete consumption of the
starting material (>10 h). Water (400 mL) was added to the resulting
orange slurry and stirred at r.t. for additional 2 h. The solid was
filtered, rinsed with water (200 mL) and dried under reduced pressure at
40°C. (5-chloro-2-nitrophenyl)-methylamine, yield:93% (36.2 g), a solid,
purity: 94 A%.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of
bromopyrimidinylcyclopentylmethylindolecarboxamidocyclobutylmethylbenzoimidazolylacrylic
acid and its mesylate salt for use as HCV inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Zhibin; Yang, Bing-Shiou; Yip, Kazuhiko
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2013149147 A1 2013-10-03

$RFMT $RIREG SCHEME3 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Dichloronitrobenzene
C6H3Cl2NO2
611-06-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 Cl 2.3101 0.0000 0.0 0
M  V30 5 Cl 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Chloro-N-methyl-2-nitrobenzenamine
C7H7ClN2O2
35966-84-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 N 0.7700 4.0011 0.0 0 VAL=5
M  V30 4 O 0.0000 2.6674 0.0 0
M  V30 5 O 0.0000 5.3349 0.0 0
M  V30 6 Cl 6.9300 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 8
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 611-06-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 35966-84-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-2266144
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-68-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM To a solution of (5-chloro-2-nitrophenyl)-methylamine (40 g, 208.3 mmol,
1 equiv) in DMSO (160 mL) was added 40% MeNH2 solution in water (100 mL,
1145.6 mmol, 5.5 eq) slowly keeping the temperature below 35°C. The
reaction was stirred at r.t. until the complete consumption of the
starting material (10 h). Water (400 mL) was added to the resulting
orange slurry and stirred at r.t. for additional 2 h. The solid was
filtered, rinsed NEt3, DMSO, 65°C 90% with water (200 mL) and dried under
reduced pressure at 40°C. (5-chloro-2-nitrophenyl)-methylamine as a
solid, yield 36.2 g, 93%, 94 A% purity.
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, scalable
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Combination therapy for treating HCV infection
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Boecher, Wulf; Haefner, Carla; Kukolj, George
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012041771 A1 2012-04-05

$RFMT $RIREG SCHEME3 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Dichloronitrobenzene
C6H3Cl2NO2
611-06-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 Cl 2.3101 0.0000 0.0 0
M  V30 5 Cl 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Chloro-N-methyl-2-nitrobenzenamine
C7H7ClN2O2
35966-84-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 N 0.7700 4.0011 0.0 0 VAL=5
M  V30 4 O 0.0000 2.6674 0.0 0
M  V30 5 O 0.0000 5.3349 0.0 0
M  V30 6 Cl 6.9300 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 8
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 611-06-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 35966-84-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-12519689
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-68-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 5: SNAr reaction of (5-chloro-2-nitrophenyl)-methylamine. To a
solution of (5-chloro-2-nitrophenyl)-methylamine (40 g, 208.3 mmol, 1
equiv) in DMSO (160 mL) was added 40% MeNH2 solution in water (100 mL,
1145. 6 mmol, 5.5 eq) slowly keeping the temperature below 35°C. The
reaction was stirred at r.t. until the complete consumption of the
starting material (greater than 10 h). Water (400 mL) was added to the
resulting orange slurry and stirred at r.t. for additional 2 h. The solid
was filtered, rinsed with water (200 mL) and dried under reduced pressure
at 40°C. (5-chloro-2-nitrophenyl)-methylamine as a solid, yield 36.2 g,
93% (94 A% purity).
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of sodium salt forms of the potent HCV inhibitor,
(E)-3-[2-[1-[[2-(5-Bromopyrimidin-2-yl)-3-cyclopentyl-1-methyl-1H-indole-6-carbonyl]amino]cyclobutyl]-3-methyl-3H-benzimidazol-5-yl]acrylic
acid and pharmaceutical formulations thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Brickl, Rolf-Stefan; Chen, Shirlynn; Chung, Jihchin; Dudhedia, Mayur
Suryakant; Li, Danping; Lu, Zhi Hiu; Mujumdar, Siddharthya; Telang,
Chitra; Varsolona, Richard; Wang, Zeren
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012044520 A1 2012-04-05

$RFMT $RIREG SCHEME3 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Dichloronitrobenzene
C6H3Cl2NO2
611-06-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 Cl 2.3101 0.0000 0.0 0
M  V30 5 Cl 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Chloro-N-methyl-2-nitrobenzenamine
C7H7ClN2O2
35966-84-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 N 0.7700 4.0011 0.0 0 VAL=5
M  V30 4 O 0.0000 2.6674 0.0 0
M  V30 5 O 0.0000 5.3349 0.0 0
M  V30 6 Cl 6.9300 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 8
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 611-06-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 35966-84-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-9689941
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-68-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM To a clean flask was charged 176.0 g of DMSO and 40.0 g of
2,4-dichloronitrobenzene. After the batch temperature was adjusted to
29-35 °C, 89.0 g of methyl amine (40% in water) was added in over at
least 4 h while maintaining the content between 27 to 37 °C. After being
stirred for 2 h, the batch was cooled to 25 °C. 400 g of water was added
at a rate to maintain the batch temperature at 26 ±4 °C. After at least 2
h at 25 ±2 °C, the solid was collected and washed with 2 x 100 g of
water. After dried under vacuum, of the product was isolated.
5-Chloro-N-methy2-nitroaniline 22, yield 31.5 g, 80%. 1H NMR (400 MHz,
CDCl3): δ 8.11 (d, J = 9.08 Hz, 1H), 8.06 (bs, 1H), 6.82 (d, J = 1.68 Hz,
1H), 6.61 (dd, J = 1.88, 9.12 Hz, 1H), 3.02 (d, J = 5.08 Hz, 3H); 13C NMR
(100 MHz, CDCl3): δ 146.7, 142.9, 130.6, 128.2, 115.8, 112.9, 29.8. HRMS
(ES pos.): m/z calcd for C7H7ClN2O2 + (M + H+): 187.0269, found:
187.0268.
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A Highly Concise and Convergent Synthesis of HCV Polymerase Inhibitor
Deleobuvir (BI 207127): Application of a One-Pot Borylation-Suzuki
Coupling Reaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Yongda; Lu, Bruce Z.; Li, Guisheng; Rodriguez, Sonia; Tan,
Jonathan; Wei, Han-Xun; Liu, Jianxiu; Roschangar, Frank; Ding, Fei; Zhao,
Wenyi; Qu, Bo; Reeves, Diana; Grinberg, Nelu; Lee, Heewon; Heckmann,
Golo; Niemeier, Oliver; Brenner, Michael; Tsantrizos, Youla; Beaulieu,
Pierre L.; Hossain, Azad; Yee, Nathan; Farina, Vittorio; Senanayake,
Chris H.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2014), 16(17), 4558-4561

$RFMT $RIREG SCHEME4 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(3,4-Dichlorophenyl)-3,4-dihydro-1(2H)-naphthalenone
C16H12Cl2O
79560-19-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 4.0011 0.0 0
M  V30 2 Cl 9.2400 6.6685 0.0 0
M  V30 3 Cl 10.7800 4.0011 0.0 0
M  V30 4 C 3.8500 2.6674 0.0 0
M  V30 5 C 4.6200 4.0011 0.0 0
M  V30 6 C 2.3100 2.6674 0.0 0
M  V30 7 C 4.6200 1.3338 0.0 0
M  V30 8 C 3.8500 5.3347 0.0 0
M  V30 9 C 1.5400 4.0011 0.0 0
M  V30 10 C 1.5400 1.3338 0.0 0
M  V30 11 C 3.8500 0.0000 0.0 0
M  V30 12 C 2.3100 5.3347 0.0 0
M  V30 13 C 2.3100 0.0000 0.0 0
M  V30 14 C 6.1600 4.0011 0.0 0
M  V30 15 C 6.9300 5.3347 0.0 0
M  V30 16 C 6.9300 2.6674 0.0 0
M  V30 17 C 8.4700 5.3347 0.0 0
M  V30 18 C 8.4700 2.6674 0.0 0
M  V30 19 C 9.2400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 1 2 17
M  V30 3 1 3 19
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 5 14
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 1 9 12
M  V30 14 1 10 13
M  V30 15 2 11 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[4-(3,4-Dichlorophenyl)-3,4-dihydro-1(2H)-naphthalenylidene]methanamine
C17H15Cl2N
79560-20-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 4.0011 0.0 0
M  V30 2 C 0.0000 5.3348 0.0 0
M  V30 3 Cl 10.0101 6.6686 0.0 0
M  V30 4 Cl 11.5501 4.0011 0.0 0
M  V30 5 C 4.6201 2.6675 0.0 0
M  V30 6 C 5.3901 4.0011 0.0 0
M  V30 7 C 3.0800 2.6675 0.0 0
M  V30 8 C 5.3901 1.3338 0.0 0
M  V30 9 C 4.6201 5.3348 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 2.3100 1.3338 0.0 0
M  V30 12 C 4.6201 0.0000 0.0 0
M  V30 13 C 3.0800 5.3348 0.0 0
M  V30 14 C 3.0800 0.0000 0.0 0
M  V30 15 C 6.9301 4.0011 0.0 0
M  V30 16 C 7.7001 5.3348 0.0 0
M  V30 17 C 7.7001 2.6675 0.0 0
M  V30 18 C 9.2401 5.3348 0.0 0
M  V30 19 C 9.2401 2.6675 0.0 0
M  V30 20 C 10.0101 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 10 CFG=2
M  V30 3 1 3 18
M  V30 4 1 4 20
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 6 15
M  V30 10 1 7 10
M  V30 11 2 7 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 10 13
M  V30 15 1 11 14
M  V30 16 2 12 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 79560-19-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 79560-20-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-11679300
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7446-70-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example-1: (using aluminum chloride as a dehydrating agent). In a round
bottom flask, sertralone (100gm, 0.34mole) was dissolved in toluene
(1000ml) and then cooled to 0°C-5°C. The monomethyl amine gas (53.3gm,
1.72mole) was slowly passed through the reaction mixture at 0°C-5°C. Then
anhydrous aluminum chloride (22.9gm, 0.17mole) was slowly added at
0°C-5°C. Exotherm was observed during the addition of aluminum chloride
and the temperature of the reaction rose to 30°C. The flask was slowly
heated to 65°C-70°C for 1 hour and the temperature of the flask was
maintained for 5-6 hours. The reaction mixture was allowed to cool to
room temperature and the inorganic salts precipitated were filtered out.
The cake was washed with toluene (100ml) and then the toluene was removed
completely under vacuum to obtain ketimine (96.6gm). Yield 92.9%, purity
98% (GC analysis).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Improved process for preparing an intermediate of sertraline
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pandit, Vilas Vasant; Naik, Rajesh; Karnik, Pravin; Pawar, Nitin; Shah,
Pranay
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010084459 A2 2010-07-29

$RFMT $RIREG SCHEME4 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(3,4-Dichlorophenyl)-3,4-dihydro-1(2H)-naphthalenone
C16H12Cl2O
79560-19-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 4.0011 0.0 0
M  V30 2 Cl 9.2400 6.6685 0.0 0
M  V30 3 Cl 10.7800 4.0011 0.0 0
M  V30 4 C 3.8500 2.6674 0.0 0
M  V30 5 C 4.6200 4.0011 0.0 0
M  V30 6 C 2.3100 2.6674 0.0 0
M  V30 7 C 4.6200 1.3338 0.0 0
M  V30 8 C 3.8500 5.3347 0.0 0
M  V30 9 C 1.5400 4.0011 0.0 0
M  V30 10 C 1.5400 1.3338 0.0 0
M  V30 11 C 3.8500 0.0000 0.0 0
M  V30 12 C 2.3100 5.3347 0.0 0
M  V30 13 C 2.3100 0.0000 0.0 0
M  V30 14 C 6.1600 4.0011 0.0 0
M  V30 15 C 6.9300 5.3347 0.0 0
M  V30 16 C 6.9300 2.6674 0.0 0
M  V30 17 C 8.4700 5.3347 0.0 0
M  V30 18 C 8.4700 2.6674 0.0 0
M  V30 19 C 9.2400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 1 2 17
M  V30 3 1 3 19
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 5 14
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 1 9 12
M  V30 14 1 10 13
M  V30 15 2 11 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[4-(3,4-Dichlorophenyl)-3,4-dihydro-1(2H)-naphthalenylidene]methanamine
C17H15Cl2N
79560-20-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 4.0011 0.0 0
M  V30 2 C 0.0000 5.3348 0.0 0
M  V30 3 Cl 10.0101 6.6686 0.0 0
M  V30 4 Cl 11.5501 4.0011 0.0 0
M  V30 5 C 4.6201 2.6675 0.0 0
M  V30 6 C 5.3901 4.0011 0.0 0
M  V30 7 C 3.0800 2.6675 0.0 0
M  V30 8 C 5.3901 1.3338 0.0 0
M  V30 9 C 4.6201 5.3348 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 2.3100 1.3338 0.0 0
M  V30 12 C 4.6201 0.0000 0.0 0
M  V30 13 C 3.0800 5.3348 0.0 0
M  V30 14 C 3.0800 0.0000 0.0 0
M  V30 15 C 6.9301 4.0011 0.0 0
M  V30 16 C 7.7001 5.3348 0.0 0
M  V30 17 C 7.7001 2.6675 0.0 0
M  V30 18 C 9.2401 5.3348 0.0 0
M  V30 19 C 9.2401 2.6675 0.0 0
M  V30 20 C 10.0101 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 10 CFG=2
M  V30 3 1 3 18
M  V30 4 1 4 20
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 6 15
M  V30 10 1 7 10
M  V30 11 2 7 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 10 13
M  V30 15 1 11 14
M  V30 16 2 12 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 79560-19-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 79560-20-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-10525352
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 1 Process for the preparation of
[4(S,R)~(3,4-dichlorophenyl)-3,4-dihydro-1(2H)-naphthalene-1-ylidene]
-methyl-amine 9 g (30.8 mM) of
4-(3,4-dichlorophenyl)-3,4-dihydro-1(2H)-naphthalene-1-one are dissolved
in 140 ml of tetrahydrofurane. The solution is cooled to -10°C and 12.6 g
(400 mM) of gaseous methyl amine are introduced. To the reaction mixture
at -10°C 4.2 ml (60 mM) of thionyl chloride are added under stirring. The
addition having been completed the reaction mixture is stirred at room
temperature. The reaction is monitored by GC. The reaction mixture is
worked up when the amount of the starting material is decreased below 0.3
%. The tetrahydrofurane phase is separated from the precipitated methyl
amine hydrochloride, evaporated and the residue is suspended in 20 ml of
cold methanol. The crystals obtained are dried under an infra lamp. Thus
8.7 g of the desired compound are obtained, yield 93 %. Mp.: 147-148°C.IR
(KBr): 1625, 1468, 1056, 764. 1H-NMR (CDCl3, i400): 8.20 (1H, dd, J2=7.3
Hz, J2=1.9 Hz),7.3 m (2H), 7.19J (1H, d, J=2.0 Hz), 6.89 m (2H), 4.15
(1H, dd, Jl=4.5 Hz, J2=6.8 Hz), 3.17 s (3H), 2.52 m (2H), 2.28 m (1H),
2.13 m (1H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Imination process for the preparation of
[4(S,R)-(3,4-dichlorophenyl)-3,4-dihydro-1(2H)-naphthalen-1-ylidene]methylamine
from 4-(3,4-dichlorophenyl)-3,4-dihydro-1(2H)naphthalen-1-one and
methylamine in the presence of thionyl chloride in an ether-type solvent
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Barkoczy, Jozsef; Kotay Nagy, Peter; Simig, Gyula; Jakfalvi, Elemer;
Gregorne Boros, Livia; Krasznai, Gyoergy; Vereczkeyne Donath, Gyoergyi;
Nagy, Kalman; Memeth, Norbert
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2005007611 A2 2005-01-27

$RFMT $RIREG SCHEME4 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(3,4-Dichlorophenyl)-3,4-dihydro-1(2H)-naphthalenone
C16H12Cl2O
79560-19-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 4.0011 0.0 0
M  V30 2 Cl 9.2400 6.6685 0.0 0
M  V30 3 Cl 10.7800 4.0011 0.0 0
M  V30 4 C 3.8500 2.6674 0.0 0
M  V30 5 C 4.6200 4.0011 0.0 0
M  V30 6 C 2.3100 2.6674 0.0 0
M  V30 7 C 4.6200 1.3338 0.0 0
M  V30 8 C 3.8500 5.3347 0.0 0
M  V30 9 C 1.5400 4.0011 0.0 0
M  V30 10 C 1.5400 1.3338 0.0 0
M  V30 11 C 3.8500 0.0000 0.0 0
M  V30 12 C 2.3100 5.3347 0.0 0
M  V30 13 C 2.3100 0.0000 0.0 0
M  V30 14 C 6.1600 4.0011 0.0 0
M  V30 15 C 6.9300 5.3347 0.0 0
M  V30 16 C 6.9300 2.6674 0.0 0
M  V30 17 C 8.4700 5.3347 0.0 0
M  V30 18 C 8.4700 2.6674 0.0 0
M  V30 19 C 9.2400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 1 2 17
M  V30 3 1 3 19
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 5 14
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 1 9 12
M  V30 14 1 10 13
M  V30 15 2 11 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[4-(3,4-Dichlorophenyl)-3,4-dihydro-1(2H)-naphthalenylidene]methanamine
C17H15Cl2N
79560-20-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 4.0011 0.0 0
M  V30 2 C 0.0000 5.3348 0.0 0
M  V30 3 Cl 10.0101 6.6686 0.0 0
M  V30 4 Cl 11.5501 4.0011 0.0 0
M  V30 5 C 4.6201 2.6675 0.0 0
M  V30 6 C 5.3901 4.0011 0.0 0
M  V30 7 C 3.0800 2.6675 0.0 0
M  V30 8 C 5.3901 1.3338 0.0 0
M  V30 9 C 4.6201 5.3348 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 2.3100 1.3338 0.0 0
M  V30 12 C 4.6201 0.0000 0.0 0
M  V30 13 C 3.0800 5.3348 0.0 0
M  V30 14 C 3.0800 0.0000 0.0 0
M  V30 15 C 6.9301 4.0011 0.0 0
M  V30 16 C 7.7001 5.3348 0.0 0
M  V30 17 C 7.7001 2.6675 0.0 0
M  V30 18 C 9.2401 5.3348 0.0 0
M  V30 19 C 9.2401 2.6675 0.0 0
M  V30 20 C 10.0101 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 10 CFG=2
M  V30 3 1 3 18
M  V30 4 1 4 20
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 6 15
M  V30 10 1 7 10
M  V30 11 2 7 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 10 13
M  V30 15 1 11 14
M  V30 16 2 12 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 79560-19-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 79560-20-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-11532149
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Preparation of N-[4-(3,4-dichlorophenyl)-3,4-dihydro-1-(2H)-
naphthalenylidene]-methanamine
4-(3,4-Dichlorophenyl)-3,4-dihydro-1-(2H)-naphtalenone (100 g), N,N-
dimethylformamide (300 ml) and formic acid (6.5 ml) are charged.
Methylamine (56.0 g) is added at about 0 °C. The mixture is stirred for
20 hours at room temperature. The mixture is cooled to 10 °C and stirred
for 1 hour. The crystalline compound is filtered and washed with
methanol. The yield is 97.7 g (93.5 %) as dried. The same process was
performed using N-methylformamide as a solvent in the imination step.
Yield was 90.1 %.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Process for preparing sertraline intermediates
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Laitinen, Ilpo; Pietikaeinen, Pekka
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2002096860 A1 2002-12-05

$RFMT $RIREG SCHEME4 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(3,4-Dichlorophenyl)-3,4-dihydro-1(2H)-naphthalenone
C16H12Cl2O
79560-19-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 4.0011 0.0 0
M  V30 2 Cl 9.2400 6.6685 0.0 0
M  V30 3 Cl 10.7800 4.0011 0.0 0
M  V30 4 C 3.8500 2.6674 0.0 0
M  V30 5 C 4.6200 4.0011 0.0 0
M  V30 6 C 2.3100 2.6674 0.0 0
M  V30 7 C 4.6200 1.3338 0.0 0
M  V30 8 C 3.8500 5.3347 0.0 0
M  V30 9 C 1.5400 4.0011 0.0 0
M  V30 10 C 1.5400 1.3338 0.0 0
M  V30 11 C 3.8500 0.0000 0.0 0
M  V30 12 C 2.3100 5.3347 0.0 0
M  V30 13 C 2.3100 0.0000 0.0 0
M  V30 14 C 6.1600 4.0011 0.0 0
M  V30 15 C 6.9300 5.3347 0.0 0
M  V30 16 C 6.9300 2.6674 0.0 0
M  V30 17 C 8.4700 5.3347 0.0 0
M  V30 18 C 8.4700 2.6674 0.0 0
M  V30 19 C 9.2400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 1 2 17
M  V30 3 1 3 19
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 5 14
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 1 9 12
M  V30 14 1 10 13
M  V30 15 2 11 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[4-(3,4-Dichlorophenyl)-3,4-dihydro-1(2H)-naphthalenylidene]methanamine
C17H15Cl2N
79560-20-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 4.0011 0.0 0
M  V30 2 C 0.0000 5.3348 0.0 0
M  V30 3 Cl 10.0101 6.6686 0.0 0
M  V30 4 Cl 11.5501 4.0011 0.0 0
M  V30 5 C 4.6201 2.6675 0.0 0
M  V30 6 C 5.3901 4.0011 0.0 0
M  V30 7 C 3.0800 2.6675 0.0 0
M  V30 8 C 5.3901 1.3338 0.0 0
M  V30 9 C 4.6201 5.3348 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 2.3100 1.3338 0.0 0
M  V30 12 C 4.6201 0.0000 0.0 0
M  V30 13 C 3.0800 5.3348 0.0 0
M  V30 14 C 3.0800 0.0000 0.0 0
M  V30 15 C 6.9301 4.0011 0.0 0
M  V30 16 C 7.7001 5.3348 0.0 0
M  V30 17 C 7.7001 2.6675 0.0 0
M  V30 18 C 9.2401 5.3348 0.0 0
M  V30 19 C 9.2401 2.6675 0.0 0
M  V30 20 C 10.0101 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 10 CFG=2
M  V30 3 1 3 18
M  V30 4 1 4 20
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 6 15
M  V30 10 1 7 10
M  V30 11 2 7 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 10 13
M  V30 15 1 11 14
M  V30 16 2 12 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 79560-19-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 79560-20-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-7526631
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7705-08-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example-2: (using ferric chloride as a dehydrating agent). In a round
bottom flask, sertralone (25gm, 0.086mole) was dissolved in toluene
(250ml) and then cooled to 0°C-5°C. The monomethyl amine gas (18gm,
0.58mole) was slowly passed through the reaction mixture at 0°C-5°C. Then
ferric chloride (13.8gm, 0.08mole) was slowly added at 0°C-5°C. Exotherm
was observed during the addition of ferric chloride and the temperature
of the reaction rose to 30°C. The flask was slowly heated to 65°C-70°C
for 1 hour and the temperature of the flask was maintained for 5-6 hours.
The reaction mixture was allowed to cool to room temperature and the
inorganic salts precipitated were filtered out. The cake was washed with
toluene (25ml) and then the toluene was removed completely under vacuum
to obtain ketimine (24gm). Yield 92%, Purity 98% (GC analysis).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Improved process for preparing an intermediate of sertraline
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pandit, Vilas Vasant; Naik, Rajesh; Karnik, Pravin; Pawar, Nitin; Shah,
Pranay
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010084459 A2 2010-07-29

$RFMT $RIREG SCHEME4 STEP1
$RXN



  2  1
$MOL
4-(3,4-Dichlorophenyl)-3,4-dihydro-1(2H)-naphthalenone
C16H12Cl2O
79560-19-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 4.0011 0.0 0
M  V30 2 Cl 9.2400 6.6685 0.0 0
M  V30 3 Cl 10.7800 4.0011 0.0 0
M  V30 4 C 3.8500 2.6674 0.0 0
M  V30 5 C 4.6200 4.0011 0.0 0
M  V30 6 C 2.3100 2.6674 0.0 0
M  V30 7 C 4.6200 1.3338 0.0 0
M  V30 8 C 3.8500 5.3347 0.0 0
M  V30 9 C 1.5400 4.0011 0.0 0
M  V30 10 C 1.5400 1.3338 0.0 0
M  V30 11 C 3.8500 0.0000 0.0 0
M  V30 12 C 2.3100 5.3347 0.0 0
M  V30 13 C 2.3100 0.0000 0.0 0
M  V30 14 C 6.1600 4.0011 0.0 0
M  V30 15 C 6.9300 5.3347 0.0 0
M  V30 16 C 6.9300 2.6674 0.0 0
M  V30 17 C 8.4700 5.3347 0.0 0
M  V30 18 C 8.4700 2.6674 0.0 0
M  V30 19 C 9.2400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 1 2 17
M  V30 3 1 3 19
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 5 14
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 1 9 12
M  V30 14 1 10 13
M  V30 15 2 11 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[4-(3,4-Dichlorophenyl)-3,4-dihydro-1(2H)-naphthalenylidene]methanamine
C17H15Cl2N
79560-20-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 4.0011 0.0 0
M  V30 2 C 0.0000 5.3348 0.0 0
M  V30 3 Cl 10.0101 6.6686 0.0 0
M  V30 4 Cl 11.5501 4.0011 0.0 0
M  V30 5 C 4.6201 2.6675 0.0 0
M  V30 6 C 5.3901 4.0011 0.0 0
M  V30 7 C 3.0800 2.6675 0.0 0
M  V30 8 C 5.3901 1.3338 0.0 0
M  V30 9 C 4.6201 5.3348 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 2.3100 1.3338 0.0 0
M  V30 12 C 4.6201 0.0000 0.0 0
M  V30 13 C 3.0800 5.3348 0.0 0
M  V30 14 C 3.0800 0.0000 0.0 0
M  V30 15 C 6.9301 4.0011 0.0 0
M  V30 16 C 7.7001 5.3348 0.0 0
M  V30 17 C 7.7001 2.6675 0.0 0
M  V30 18 C 9.2401 5.3348 0.0 0
M  V30 19 C 9.2401 2.6675 0.0 0
M  V30 20 C 10.0101 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 10 CFG=2
M  V30 3 1 3 18
M  V30 4 1 4 20
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 6 15
M  V30 10 1 7 10
M  V30 11 2 7 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 10 13
M  V30 15 1 11 14
M  V30 16 2 12 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 79560-19-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 79560-20-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-12636075
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-63-0
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM N-[4-(3,4-Dichlorophenyl)-3,4-dihydro-1(2H)-naphthalenylidene]methanamine
(3) in Isopropyl Alcohol. Sertraline tetralone 2 (165 g, 1 mol equiv) is
combined with isopropyl alcohol (700 mL) in a suitable pressurerated
vessel and the mixture cooled to -5 to -10°C. Monomethylamine (60.2 g,
3.4 mol equiv) is added and the mixture heated to 85-100°C for 16 h,
whereupon 95% imine conversion is typically seen. The mixture is then
cooled to -15°C for 24 h and the product isolated by filtration in
approximately 92% yield and 95% purity.
$DTYPE RXN:VAR(1):NOTES
$DATUM other metnod gave similar yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A New and Simplified Process for Preparing
N-[4-(3,4-Dichlorophenyl)-3,4-dihydro-1(2H)-naphthalenylidene]methanamine
and a Telescoped Process for the Synthesis of
(1S-cis)-4-(3,4-Dichlorophenol)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine
Mandelate: Key Intermediates in the Synthesis of Sertraline Hydrochloride
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Taber, Geraldine P.; Pfisterer, David M.; Colberg, Juan C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Process Research & Development (2004), 8(3), 385-388

$RFMT $RIREG SCHEME5 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chlorobenzaldehyde
C7H5ClO
89-98-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 O 5.3901 4.0010 0.0 0
M  V30 3 Cl 3.0801 0.0000 0.0 0
M  V30 4 C 3.0801 2.6673 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 2.3101 4.0010 0.0 0
M  V30 7 C 0.7700 1.3337 0.0 0
M  V30 8 C 0.7700 4.0010 0.0 0
M  V30 9 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 5
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(2-Chlorophenyl)methylene]methanamine
C8H8ClN
1020073-49-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 N 5.3901 4.0010 0.0 0
M  V30 3 C 6.9302 4.0010 0.0 0
M  V30 4 Cl 3.0801 0.0000 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 2.3101 1.3337 0.0 0
M  V30 7 C 2.3101 4.0010 0.0 0
M  V30 8 C 0.7700 1.3337 0.0 0
M  V30 9 C 0.7700 4.0010 0.0 0
M  V30 10 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 89-98-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1020073-49-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-10528841
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for the Synthesis of the
Alkyl Imines The imines were prepared by a modified protocol of Hachiya
and coworkers. In an oven-dried flask equipped with a magnetic stirring
bar and molecular sieve (4 Å, 1 g) a solution of the aldehyde (3 mmol) in
5 mL DCM was added. Then an amine solution e.g. methylamine solution (2 M
in MeOH, 6 mmol, 2.0 equiv.) was added slowly and the stirring continued
for additional 18 hours. The mixture was filtered and the clear filtrate
was washed with saturated NaHCO3 solution and dried over magnesium
sulfate. By concentration under reduced pressure and drying in vacuo the
product were obtained without further purification. Alkyl Imine: 3i,
yield:93%.
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, molecular sieves used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Asymmetric Synthesis of Tetrahydropyridines via an Organocatalytic
One-Pot Multicomponent Michael/Aza-Henry/Cyclization Triple Domino
Reaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bluemel, Marcus; Chauhan, Pankaj; Hahn, Robert; Raabe, Gerhard; Enders,
Dieter
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2014), 16(22), 6012-6015

$RFMT $RIREG SCHEME6 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Chloro-2,4-dinitrobenzene
C6H3ClN2O4
97-00-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3336 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3336 0.0000 0.0 0
M  V30 4 Cl 1.3336 4.6200 0.0 0
M  V30 5 N 6.6685 1.5400 0.0 0 VAL=5
M  V30 6 O 6.6685 0.0000 0.0 0
M  V30 7 O 8.0021 2.3100 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 C 4.0011 1.5400 0.0 0
M  V30 10 C 2.6674 3.8500 0.0 0
M  V30 11 C 5.3347 2.3100 0.0 0
M  V30 12 C 4.0011 4.6200 0.0 0
M  V30 13 C 5.3347 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2,4-dinitroaniline
C7H7N3O4
2044-88-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0012 6.1601 0.0 0 VAL=5
M  V30 2 O 5.3348 6.9302 0.0 0
M  V30 3 O 2.6675 6.9302 0.0 0
M  V30 4 N 6.6687 4.6201 0.0 0
M  V30 5 C 8.0023 3.8501 0.0 0
M  V30 6 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 3.8501 0.0 0
M  V30 11 C 2.6675 3.8501 0.0 0
M  V30 12 C 5.3348 2.3101 0.0 0
M  V30 13 C 2.6675 2.3101 0.0 0
M  V30 14 C 4.0012 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 4 5
M  V30 5 1 4 10
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 13
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 97-00-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2044-88-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-18478806
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and synthesis of novel protein kinase R (PKR) inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Weintraub, Sagiv; Yarnitzky, Tali; Kahremany, Shirin; Barrera, Iliana;
Viskind, Olga; Rosenblum, Kobi; Niv, Masha Y.; Gruzman, Arie
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molecular Diversity (2016), 20(4), 805-819

$RFMT $RIREG SCHEME6 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Chloro-2,4-dinitrobenzene
C6H3ClN2O4
97-00-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3336 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3336 0.0000 0.0 0
M  V30 4 Cl 1.3336 4.6200 0.0 0
M  V30 5 N 6.6685 1.5400 0.0 0 VAL=5
M  V30 6 O 6.6685 0.0000 0.0 0
M  V30 7 O 8.0021 2.3100 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 C 4.0011 1.5400 0.0 0
M  V30 10 C 2.6674 3.8500 0.0 0
M  V30 11 C 5.3347 2.3100 0.0 0
M  V30 12 C 4.0011 4.6200 0.0 0
M  V30 13 C 5.3347 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2,4-dinitroaniline
C7H7N3O4
2044-88-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0012 6.1601 0.0 0 VAL=5
M  V30 2 O 5.3348 6.9302 0.0 0
M  V30 3 O 2.6675 6.9302 0.0 0
M  V30 4 N 6.6687 4.6201 0.0 0
M  V30 5 C 8.0023 3.8501 0.0 0
M  V30 6 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 3.8501 0.0 0
M  V30 11 C 2.6675 3.8501 0.0 0
M  V30 12 C 5.3348 2.3101 0.0 0
M  V30 13 C 2.6675 2.3101 0.0 0
M  V30 14 C 4.0012 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 4 5
M  V30 5 1 4 10
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 13
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 97-00-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2044-88-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-4381086
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Synthesis of (2,4-Dinitro-phenyl)-methyl-amine. Procedure: To a solution
of 1-Chloro-2,4-dinitro-benzene (3g, 0.0148mol) in ethanol (30ml) at 0°C,
was added Methylamine (8.22ml) and was stirred at RT for 15hrs. The
reaction was monitored by the TLC (20% EtOAc in hexane). The reaction
flask was concentrated, hot water was added and the solid precipitate
obtained was filtered, washed with hexane. 2.7g (93% yield) of
(2,4-Dinitro-phenyl)-methyl-amine.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 2,4-diaminopyrimidine derivatives as protein kinase
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sengupta, Saumitra; Rajagopalan, Srinivasan; Belavagi, Ningaraddi;
Ramachandra, Muralidhara
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012059932 A1 2012-05-10

$RFMT $RIREG SCHEME6 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Chloro-2,4-dinitrobenzene
C6H3ClN2O4
97-00-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3336 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3336 0.0000 0.0 0
M  V30 4 Cl 1.3336 4.6200 0.0 0
M  V30 5 N 6.6685 1.5400 0.0 0 VAL=5
M  V30 6 O 6.6685 0.0000 0.0 0
M  V30 7 O 8.0021 2.3100 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 C 4.0011 1.5400 0.0 0
M  V30 10 C 2.6674 3.8500 0.0 0
M  V30 11 C 5.3347 2.3100 0.0 0
M  V30 12 C 4.0011 4.6200 0.0 0
M  V30 13 C 5.3347 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2,4-dinitroaniline
C7H7N3O4
2044-88-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0012 6.1601 0.0 0 VAL=5
M  V30 2 O 5.3348 6.9302 0.0 0
M  V30 3 O 2.6675 6.9302 0.0 0
M  V30 4 N 6.6687 4.6201 0.0 0
M  V30 5 C 8.0023 3.8501 0.0 0
M  V30 6 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 3.8501 0.0 0
M  V30 11 C 2.6675 3.8501 0.0 0
M  V30 12 C 5.3348 2.3101 0.0 0
M  V30 13 C 2.6675 2.3101 0.0 0
M  V30 14 C 4.0012 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 4 5
M  V30 5 1 4 10
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 13
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 97-00-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2044-88-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-6776594
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM (Adamantanylamino)pyrimidinamine derivatives as protein kinase inhibitors
and their preparation and use for the treatment of diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sengupta, Saumitra; Rajagopalan, Srinivasan; Belavagi, Ningaraddi;
Ramachandra, Muralidhara
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM India, IN2009CH00628 A 2012-04-13

$RFMT $RIREG SCHEME7 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Nitrobenzenesulfonyl chloride
C6H4ClNO4S
98-74-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.9300 1.5400 0.0 0 VAL=6
M  V30 2 Cl 8.4700 1.5400 0.0 0
M  V30 3 O 6.9300 3.0800 0.0 0
M  V30 4 O 6.9300 0.0000 0.0 0
M  V30 5 N 0.7700 1.5400 0.0 0 VAL=5
M  V30 6 O 0.0000 0.2064 0.0 0
M  V30 7 O 0.0000 2.8736 0.0 0
M  V30 8 C 5.3900 1.5400 0.0 0
M  V30 9 C 4.6200 0.2064 0.0 0
M  V30 10 C 4.6200 2.8736 0.0 0
M  V30 11 C 3.0800 0.2064 0.0 0
M  V30 12 C 3.0800 2.8736 0.0 0
M  V30 13 C 2.3100 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-nitrobenzenesulfonamide
C7H8N2O4S
6319-45-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.6685 4.6201 0.0 0 VAL=6
M  V30 2 N 8.0023 5.3901 0.0 0
M  V30 3 O 5.8985 5.9538 0.0 0
M  V30 4 O 7.4385 3.2864 0.0 0
M  V30 5 C 9.3360 4.6201 0.0 0
M  V30 6 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 7 O 0.0000 2.3101 0.0 0
M  V30 8 O 1.3337 0.0000 0.0 0
M  V30 9 C 5.3348 3.8501 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 2.6675 3.8501 0.0 0
M  V30 13 C 4.0012 1.5400 0.0 0
M  V30 14 C 2.6675 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 1 2 5
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 98-74-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 6319-45-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24611762
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 110-86-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Controlled Anchoring of (Phenylureido)sulfonamide-Based Receptor
Moieties: An Impact of Binding Site Multiplication on Complexation
Properties
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Salvadori, Karolina; Krupkova, Alena; Stastna, Lucie Cervenkova;
Mullerova, Monika; Eigner, Vaclav; Strasak, Tomas; Curinova, Petra
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molecules (2021), 26(18), 5670

$RFMT $RIREG SCHEME8 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl acrylate
C4H6O2
96-33-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 1.5400 0.0 0
M  V30 2 C 1.3338 2.3100 0.0 0
M  V30 3 O 4.0011 2.3100 0.0 0
M  V30 4 O 2.6674 0.0000 0.0 0
M  V30 5 C 0.0000 1.5400 0.0 0
M  V30 6 C 5.3349 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
β-Alanine, N-(3-methoxy-3-oxopropyl)-N-methyl-, methyl ester
C9H17NO4
105-71-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 C 8.0022 2.3101 0.0 0
M  V30 4 C 6.6685 0.0000 0.0 0
M  V30 5 C 4.0010 1.5400 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 2.6673 2.3101 0.0 0
M  V30 8 C 10.6697 2.3101 0.0 0
M  V30 9 O 1.3337 1.5400 0.0 0
M  V30 10 O 2.6673 3.8501 0.0 0
M  V30 11 O 12.0033 1.5400 0.0 0
M  V30 12 O 10.6697 3.8501 0.0 0
M  V30 13 C 0.0000 2.3101 0.0 0
M  V30 14 C 13.3370 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 11 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 96-33-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 105-71-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-22844453
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM key step, key intermediate, Michael addition
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, surface activity and antielectrostatic properties of new soft
dichain cationic surfactants
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zielinski, Wojciech; Wilk, Kazimiera A.; Para, Grazyna; Jarek, Ewelina;
Ciszewski, Krzysztof; Palus, Jerzy; Warszynski, Piotr
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Colloids and Surfaces, A: Physicochemical and Engineering Aspects (2015),
48063-70

$RFMT $RIREG SCHEME9 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chlorobenzenesulfonyl chloride
C6H4Cl2O2S
98-60-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.5400 1.5400 0.0 0 VAL=6
M  V30 2 Cl 0.0000 1.5400 0.0 0
M  V30 3 O 1.5400 3.0800 0.0 0
M  V30 4 O 1.5400 0.0000 0.0 0
M  V30 5 Cl 7.7000 1.5400 0.0 0
M  V30 6 C 3.0800 1.5400 0.0 0
M  V30 7 C 3.8500 0.2064 0.0 0
M  V30 8 C 3.8500 2.8736 0.0 0
M  V30 9 C 5.3900 0.2064 0.0 0
M  V30 10 C 5.3900 2.8736 0.0 0
M  V30 11 C 6.1600 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 6
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-N-methylbenzenesulfonamide
C7H8ClNO2S
6333-79-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 2.3100 1.5400 0.0 0 VAL=6
M  V30 2 N 0.7700 1.5400 0.0 0
M  V30 3 O 2.3100 3.0800 0.0 0
M  V30 4 O 2.3100 0.0000 0.0 0
M  V30 5 C 0.0000 2.8736 0.0 0
M  V30 6 Cl 8.4700 1.5400 0.0 0
M  V30 7 C 3.8500 1.5400 0.0 0
M  V30 8 C 4.6200 0.2064 0.0 0
M  V30 9 C 4.6200 2.8736 0.0 0
M  V30 10 C 6.1600 0.2064 0.0 0
M  V30 11 C 6.1600 2.8736 0.0 0
M  V30 12 C 6.9300 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 7
M  V30 5 1 2 5
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 98-60-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 6333-79-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-19901214
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Transition-Metal-Free One-Step Synthesis of Ynamides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zeng, Xianzhu; Tu, Yongliang; Zhang, Zhenming; You, Changming; Wu, Jiao;
Ye, Zhiying; Zhao, Junfeng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2019), 84(7), 4458-4466

$RFMT $RIREG SCHEME10 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-2-fluoro-1-nitrobenzene
C6H3ClFNO2
700-37-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 F 2.3101 0.0000 0.0 0
M  V30 5 Cl 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Chloro-N-methyl-2-nitrobenzenamine
C7H7ClN2O2
35966-84-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 N 0.7700 4.0011 0.0 0 VAL=5
M  V30 4 O 0.0000 2.6674 0.0 0
M  V30 5 O 0.0000 5.3349 0.0 0
M  V30 6 Cl 6.9300 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 8
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 700-37-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 35966-84-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-21696508
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of novel oxoquinolizine compounds for the treatment and
prophylaxis of bacterial infection
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dey, Fabian; Ding, Xiao; Hu, Yimin; Liu, Yongqiang; Shen, Hong; Shi,
Houguang; Tan, Xuefei; Zhou, Chengang; Zhou, Mingwei
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019228940 A1 2019-12-05

$RFMT $RIREG SCHEME11 STEP1
$RXN



  2  1
$MOL
2-Iodobenzoic acid
C7H5IO2
88-67-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 I 2.3101 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 7 C 3.0801 4.0010 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 4.6201 4.0010 0.0 0
M  V30 10 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Iodo-N-methylbenzamide
C8H8INO
58084-22-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 N 5.3901 4.0010 0.0 0
M  V30 3 O 5.3901 1.3337 0.0 0
M  V30 4 C 6.9302 4.0010 0.0 0
M  V30 5 I 3.0801 0.0000 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 2.3101 1.3337 0.0 0
M  V30 8 C 2.3101 4.0010 0.0 0
M  V30 9 C 0.7700 1.3337 0.0 0
M  V30 10 C 0.7700 4.0010 0.0 0
M  V30 11 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 88-67-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 58084-22-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-20020046
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Phosphazene Superbase-Mediated Regio- and Stereoselective
Iodoaminocyclization of 2-(1-Alkynyl)benzamides for the Synthesis of
Isoindolin-1-ones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mehta, Saurabh; Brahmchari, Dhirendra
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2019), 84(9), 5492-5503

$RFMT $RIREG SCHEME11 STEP1
$RXN



  2  1
$MOL
2-Iodobenzoic acid
C7H5IO2
88-67-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 I 2.3101 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 7 C 3.0801 4.0010 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 4.6201 4.0010 0.0 0
M  V30 10 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Iodo-N-methylbenzamide
C8H8INO
58084-22-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 N 5.3901 4.0010 0.0 0
M  V30 3 O 5.3901 1.3337 0.0 0
M  V30 4 C 6.9302 4.0010 0.0 0
M  V30 5 I 3.0801 0.0000 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 2.3101 1.3337 0.0 0
M  V30 8 C 2.3101 4.0010 0.0 0
M  V30 9 C 0.7700 1.3337 0.0 0
M  V30 10 C 0.7700 4.0010 0.0 0
M  V30 11 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 88-67-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 58084-22-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-19897204
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM PPh3/I2/HCOOH: An efficient CO source for the synthesis of phthalimides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Yingying; Zhou, Yang; Lei, Min; Hou, Jinjun; Jin, Qinghao; Guo,
Dean; Wu, Wanying
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2019), 75(9), 1180-1185

$RFMT $RIREG SCHEME12 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Dichloroquinazoline
C8H4Cl2N2
607-68-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 2.3100 0.0000 0.0 0
M  V30 2 Cl 6.9300 2.6674 0.0 0
M  V30 3 C 2.3100 2.6674 0.0 0
M  V30 4 C 3.0800 4.0011 0.0 0
M  V30 5 C 3.0800 1.3338 0.0 0
M  V30 6 C 0.7700 2.6674 0.0 0
M  V30 7 N 4.6200 4.0011 0.0 0
M  V30 8 C 2.3100 5.3349 0.0 0
M  V30 9 N 4.6200 1.3338 0.0 0
M  V30 10 C 0.0000 4.0011 0.0 0
M  V30 11 C 5.3900 2.6674 0.0 0
M  V30 12 C 0.7700 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 11
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 4 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N-methyl-4-quinazolinamine
C9H8ClN3
83260-68-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3900 5.3349 0.0 0
M  V30 2 C 6.9300 5.3349 0.0 0
M  V30 3 Cl 5.3900 0.0000 0.0 0
M  V30 4 C 3.0800 4.0011 0.0 0
M  V30 5 C 2.3100 2.6674 0.0 0
M  V30 6 C 4.6200 4.0011 0.0 0
M  V30 7 C 2.3100 5.3349 0.0 0
M  V30 8 N 3.0800 1.3338 0.0 0
M  V30 9 C 0.7700 2.6674 0.0 0
M  V30 10 N 5.3900 2.6674 0.0 0
M  V30 11 C 0.7700 5.3349 0.0 0
M  V30 12 C 4.6200 1.3338 0.0 0
M  V30 13 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 3 12
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 607-68-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 83260-68-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-19564718
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Amine-substituted aryl or heteroaryl compounds as EHMT1 and EHMT2
inhibitors and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Campbell, John Emmerson; Duncan, Kenneth William; Foley, Megan Alene;
Harvey, Darren Martin; Kuntz, Kevin Wayne; Mills, James Edward John;
Munchhof, Michael John
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2017181177 A1 2017-10-19

$RFMT $RIREG SCHEME12 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Dichloroquinazoline
C8H4Cl2N2
607-68-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 2.3100 0.0000 0.0 0
M  V30 2 Cl 6.9300 2.6674 0.0 0
M  V30 3 C 2.3100 2.6674 0.0 0
M  V30 4 C 3.0800 4.0011 0.0 0
M  V30 5 C 3.0800 1.3338 0.0 0
M  V30 6 C 0.7700 2.6674 0.0 0
M  V30 7 N 4.6200 4.0011 0.0 0
M  V30 8 C 2.3100 5.3349 0.0 0
M  V30 9 N 4.6200 1.3338 0.0 0
M  V30 10 C 0.0000 4.0011 0.0 0
M  V30 11 C 5.3900 2.6674 0.0 0
M  V30 12 C 0.7700 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 11
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 4 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N-methyl-4-quinazolinamine
C9H8ClN3
83260-68-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3900 5.3349 0.0 0
M  V30 2 C 6.9300 5.3349 0.0 0
M  V30 3 Cl 5.3900 0.0000 0.0 0
M  V30 4 C 3.0800 4.0011 0.0 0
M  V30 5 C 2.3100 2.6674 0.0 0
M  V30 6 C 4.6200 4.0011 0.0 0
M  V30 7 C 2.3100 5.3349 0.0 0
M  V30 8 N 3.0800 1.3338 0.0 0
M  V30 9 C 0.7700 2.6674 0.0 0
M  V30 10 N 5.3900 2.6674 0.0 0
M  V30 11 C 0.7700 5.3349 0.0 0
M  V30 12 C 4.6200 1.3338 0.0 0
M  V30 13 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 3 12
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 607-68-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 83260-68-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-5641092
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 127-09-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure C: Amine Substitution of
2,4-Dichloroquinazolines to Yield 4-Amino-Substituted
2-Chloroquinazolines. 1.1 equiv of amine and sodium acetate were mixed
with 1 equiv of 2,4-dichloroquinazoline at 0.1 M concentration in a 3 to
1 mix of tetrahydrofuran and water and heated to 65 °C. When the reaction
was observed to be finished by TLC, the solution was diluted with ethyl
acetate, the layers were separated, and the organic phase was washed
three times with an equal amount of water and dried over Na2SO4. The
crude was then purified by either method Ca: Purification Method Ca. The
compound was recrystallized with ethanol and water, filtered, and rinsed
with cold ethanol to yield pure product.
N-Methy2-chloroquinazolin-4-amine (15d). 1.0 g (5.0 mmol) of 1c was
reacted with methylamine and purified according to method Ca to furnish
0.89 g (4.6 mmol) of the title compound in 92% yield. 1H NMR (400 MHz,
CDCl3) δ 7.74−7.66 (m, 3H), 7.41 (t, J = 6.9 Hz, 1H), 6.28 (s, NH), 3.20
(d, J = 4.7 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ 161.82, 158.02, 150.80,
133.64, 127.90, 126.41, 121.02, 113.60, 28.74. Mass (ESI): [M + H]+ 194;
found 194. Rf = 0.12 (hexanes to ethyl acetate 4:1).
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Antileishmanial Activity of a Series of N2,N4-Disubstituted
Quinazoline-2,4-diamines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Van Horn, Kurt S.; Zhu, Xiaohua; Pandharkar, Trupti; Yang, Sihyung;
Vesely, Brian; Vanaerschot, Manu; Dujardin, Jean-Claude; Rijal, Suman;
Kyle, Dennis E.; Wang, Michael Zhuo; Werbovetz, Karl A.; Manetsch, Roman
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2014), 57(12), 5141-5156

$RFMT $RIREG SCHEME12 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Dichloroquinazoline
C8H4Cl2N2
607-68-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 2.3100 0.0000 0.0 0
M  V30 2 Cl 6.9300 2.6674 0.0 0
M  V30 3 C 2.3100 2.6674 0.0 0
M  V30 4 C 3.0800 4.0011 0.0 0
M  V30 5 C 3.0800 1.3338 0.0 0
M  V30 6 C 0.7700 2.6674 0.0 0
M  V30 7 N 4.6200 4.0011 0.0 0
M  V30 8 C 2.3100 5.3349 0.0 0
M  V30 9 N 4.6200 1.3338 0.0 0
M  V30 10 C 0.0000 4.0011 0.0 0
M  V30 11 C 5.3900 2.6674 0.0 0
M  V30 12 C 0.7700 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 11
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 4 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N-methyl-4-quinazolinamine
C9H8ClN3
83260-68-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3900 5.3349 0.0 0
M  V30 2 C 6.9300 5.3349 0.0 0
M  V30 3 Cl 5.3900 0.0000 0.0 0
M  V30 4 C 3.0800 4.0011 0.0 0
M  V30 5 C 2.3100 2.6674 0.0 0
M  V30 6 C 4.6200 4.0011 0.0 0
M  V30 7 C 2.3100 5.3349 0.0 0
M  V30 8 N 3.0800 1.3338 0.0 0
M  V30 9 C 0.7700 2.6674 0.0 0
M  V30 10 N 5.3900 2.6674 0.0 0
M  V30 11 C 0.7700 5.3349 0.0 0
M  V30 12 C 4.6200 1.3338 0.0 0
M  V30 13 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 3 12
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 607-68-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 83260-68-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-2588182
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 127-09-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Synthetic Procedure C: Amine
Substitution of 2,4-Dichloroquinazolines to Yield 4-Amino-substituted
2-Chloroquinazolines. Amine (1.1 equivalent) and sodium acetate were
mixed with 1 equivalent of 2,4-dichloroquinazoline at 0.1 M concentration
in a 3:1 mix of tetrahydrofuran and water and heated to 65 °C. When the
reaction was observed to be finished by TLC, the solution was diluted
with ethyl acetate, the layers were separated, and the organic phase
washed three times with an equal amount of water and dried over Na2SO4.
The crude was then purified by either method Ca or Cb: Purification
Method Ca. The compound was recrystallized with ethanol and water,
filtered, and rinsed with cold ethanol to pure product.
N-Methy2-chloroquinazolin-4-amine (11d). 1c (1.0 g, 5.0 mmol) was reacted
with methylamine and purified according to method Ca to furnish 0.89 g
(4.6 mmol) of the title compound in 92% yield. 1H NMR (400 MHz, CDCl3) δ
7.74-7.66 (m, 3H), 7.41 (t, J = 6.9 Hz, 1H), 6.28 (s, NH), 3.20 (d, J =
4.7 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ 161.82, 158.02, 150.80, 133.64,
127.90, 126.41, 121.02, 113.60, 28.74. MS (ESI): [M + H]+ 194; found 194.
Rf = 0.12 (hexanes to ethyl acetate 4:1).
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Antibacterial Activity of a Series of N2,N4-Disubstituted
Quinazoline-2,4-diamines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Van Horn, Kurt S.; Burda, Whittney N.; Fleeman, Renee; Shaw, Lindsey N.;
Manetsch, Roman
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2014), 57(7), 3075-3093

$RFMT $RIREG SCHEME13 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromo-4-chloro-3-nitroquinoline
C9H4BrClN2O2
723281-72-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 4.0011 0.0000 0.0 0
M  V30 2 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 3 O 0.0000 2.3100 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 5 Br 9.3359 1.5400 0.0 0
M  V30 6 C 5.3348 2.3100 0.0 0
M  V30 7 C 5.3348 3.8500 0.0 0
M  V30 8 C 4.0011 1.5400 0.0 0
M  V30 9 C 6.6684 1.5400 0.0 0
M  V30 10 N 4.0011 4.6201 0.0 0
M  V30 11 C 6.6684 4.6201 0.0 0
M  V30 12 C 2.6675 2.3100 0.0 0
M  V30 13 C 8.0022 2.3100 0.0 0
M  V30 14 C 2.6675 3.8500 0.0 0
M  V30 15 C 8.0022 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 2 2 3
M  V30 3 2 2 4
M  V30 4 1 2 12
M  V30 5 1 5 13
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromo-N-methyl-3-nitro-4-quinolinamine
C10H8BrN3O2
1289187-99-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 0.7700 0.0 0
M  V30 2 C 4.0012 0.0000 0.0 0
M  V30 3 N 8.0023 2.3101 0.0 0 VAL=5
M  V30 4 O 8.0023 0.7700 0.0 0
M  V30 5 O 9.3360 3.0801 0.0 0
M  V30 6 Br 0.0000 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 5.3348 2.3101 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 2.6675 2.3101 0.0 0
M  V30 11 C 6.6685 3.0801 0.0 0
M  V30 12 N 5.3348 5.3901 0.0 0
M  V30 13 C 2.6675 5.3901 0.0 0
M  V30 14 C 1.3337 3.0801 0.0 0
M  V30 15 C 6.6685 4.6201 0.0 0
M  V30 16 C 1.3337 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 11
M  V30 6 1 6 14
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 2 12 15
M  V30 16 2 13 16
M  V30 17 1 14 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 723281-72-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1289187-99-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-8011318
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Synthesis of 6-bromo-N-methyl-3-nitroquinolin-4-amine: To a solution of
6-bromo-4-chloro-3-nitroquinoline (4.5 g, 15.65 mmol, prepared according
to the procedure reported in Bioorganic & Medicinal Chemistry Letters,
18(3), 1027-1030; 2008.) in Et2O (20 ml), was added methanamine (0.58 g,
18.8 mmol, 1.2 equiv) slowly at rt. The resulted mixture was stirred at
rt for 0.5 h, until TLC showed the starting material disappeared. The
solution was concentrated in vacuo and purified by silica gel column. The
desired product (4.1 g, 93%). ESI-MS (M+H+): 282.0; 1H NMR (400 MHz,
CDCl3) δ: 9.35 (s, 1H), 8.54 (d, 1H), 7.82-7.89 (m, 2H), 9.85 (br, 1H),
3.64 (d, 3H).
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocyclic compounds useful as PDK1 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Arndt, Joseph; Chan, Timothy; Guckian, Kevin; Kumaravel, Gnanasambandam;
Lee, Wen-Cherng; Lin, Edward Yin-Shiang; Scott, Daniel; Sun, Lihong;
Thomas, Jermaine; Van Vloten, Kurt; Wang, Deping; Zhang, Lei; Erlanson,
Daniel
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011044157 A1 2011-04-14

$RFMT $RIREG SCHEME14 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-4-fluorobenzoic acid
C7H6FNO2
446-32-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 N 2.3101 0.0000 0.0 0
M  V30 5 F 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-4-fluoro-N-methylbenzamide
C8H9FN2O
917343-25-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 2.6673 0.0 0
M  V30 2 N 1.5400 4.0010 0.0 0
M  V30 3 O 1.5400 1.3337 0.0 0
M  V30 4 C 0.0000 4.0010 0.0 0
M  V30 5 N 3.8501 0.0000 0.0 0
M  V30 6 F 8.4702 2.6673 0.0 0
M  V30 7 C 3.8501 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 4.6201 4.0010 0.0 0
M  V30 10 C 6.1601 1.3337 0.0 0
M  V30 11 C 6.1601 4.0010 0.0 0
M  V30 12 C 6.9302 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 8
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 446-32-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 917343-25-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-23197167
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 71849-58-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Importance of fluorine in 2,3-dihydroquinazolinone and its interaction
study with lysozyme
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hemalatha, K.; Madhumitha, G.; AbdullahAl-Dhabi, Naif; Arasu, Mariadhas
Valan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Photochemistry and Photobiology, B: Biology (2016), 162176-188

$RFMT $RIREG SCHEME15 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Dibromo-5-nitropyridine
C5H2Br2N2O2
4487-57-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 Br 2.3101 0.0000 0.0 0
M  V30 5 Br 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 N 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-N-methyl-5-nitro-4-pyridinamine
C6H6BrN3O2
1234014-33-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 N 0.7700 4.0011 0.0 0 VAL=5
M  V30 4 O 0.0000 2.6674 0.0 0
M  V30 5 O 0.0000 5.3349 0.0 0
M  V30 6 Br 6.9300 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 N 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 8
M  V30 6 1 6 11
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4487-57-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1234014-33-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-14575974
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-14-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heteroaryl compounds useful as Raf kinase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chuaqui, Claudio; Cossrow, Jennifer; Dowling, James; Guan, Bing; Hoemann,
Michael; Ishchenko, Alexey; Jones, John Howard; Kabigting, Lori;
Kumaravel, Gnanasambandam; Peng, Hairuo; Powell, Noel; Raimundo, Brian;
Tanaka, Hiroko; Van Vloten, Kurt; Vessels, Jeffrey; Xin, Zhili
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010078408 A1 2010-07-08

$RFMT $RIREG SCHEME16 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-(2-methoxyphenoxy)benzeneacetate
C16H16O4
476691-10-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6201 4.0012 0.0 0
M  V30 2 C 7.7002 4.0012 0.0 0
M  V30 3 C 9.2402 4.0012 0.0 0
M  V30 4 O 10.0102 2.6675 0.0 0
M  V30 5 O 10.0102 5.3348 0.0 0
M  V30 6 C 11.5503 2.6675 0.0 0
M  V30 7 O 3.0801 1.3337 0.0 0
M  V30 8 C 2.3101 0.0000 0.0 0
M  V30 9 C 5.3901 5.3348 0.0 0
M  V30 10 C 6.9302 5.3348 0.0 0
M  V30 11 C 4.6201 6.6687 0.0 0
M  V30 12 C 7.7002 6.6687 0.0 0
M  V30 13 C 5.3901 8.0023 0.0 0
M  V30 14 C 6.9302 8.0023 0.0 0
M  V30 15 C 3.0801 4.0012 0.0 0
M  V30 16 C 2.3101 2.6675 0.0 0
M  V30 17 C 2.3101 5.3348 0.0 0
M  V30 18 C 0.7700 2.6675 0.0 0
M  V30 19 C 0.7700 5.3348 0.0 0
M  V30 20 C 0.0000 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 1 2 10
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 1 4 6
M  V30 8 1 7 8
M  V30 9 1 7 16
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(2-Methoxyphenoxy)-N-methylbenzeneacetamide
C16H17NO3
476691-12-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6201 4.0012 0.0 0
M  V30 2 C 7.7002 4.0012 0.0 0
M  V30 3 C 9.2402 4.0012 0.0 0
M  V30 4 N 10.0102 2.6675 0.0 0
M  V30 5 O 10.0102 5.3348 0.0 0
M  V30 6 C 11.5503 2.6675 0.0 0
M  V30 7 O 3.0801 1.3337 0.0 0
M  V30 8 C 2.3101 0.0000 0.0 0
M  V30 9 C 5.3901 5.3348 0.0 0
M  V30 10 C 6.9302 5.3348 0.0 0
M  V30 11 C 4.6201 6.6687 0.0 0
M  V30 12 C 7.7002 6.6687 0.0 0
M  V30 13 C 5.3901 8.0023 0.0 0
M  V30 14 C 6.9302 8.0023 0.0 0
M  V30 15 C 3.0801 4.0012 0.0 0
M  V30 16 C 2.3101 2.6675 0.0 0
M  V30 17 C 2.3101 5.3348 0.0 0
M  V30 18 C 0.7700 2.6675 0.0 0
M  V30 19 C 0.7700 5.3348 0.0 0
M  V30 20 C 0.0000 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 1 2 10
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 1 4 6
M  V30 8 1 7 8
M  V30 9 1 7 16
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 476691-10-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 476691-12-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-13518465
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 143-33-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of 3,4-dioxocularine and aristocularine alkaloids in a
convergent route from aryloxyphenyl acetamides involving oxalyl
chloride-Lewis acid
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Suau, Rafael; Rico, Rodrigo; Lopez-Romero, Juan Manuel; Najera,
Francisco; Ruiz, Antonio; Ortiz-Lopez, Francisco Javier
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ARKIVOC (Gainesville, FL, United States) [online computer file] (2002),
(5), 62-72

$RFMT $RIREG SCHEME17 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1′-Bis(phenylmethyl) 2,2′-[carbonylbis(oxy)]bis[benzoate]
C29H22O7
479206-96-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 39 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 5.3901 0.0 0
M  V30 2 O 4.0012 4.6201 0.0 0
M  V30 3 O 6.6685 4.6201 0.0 0
M  V30 4 C 4.0012 3.0801 0.0 0
M  V30 5 O 8.0023 6.9302 0.0 0
M  V30 6 C 9.3360 7.7002 0.0 0
M  V30 7 O 10.6697 6.9302 0.0 0
M  V30 8 O 9.3360 9.2402 0.0 0
M  V30 9 C 13.3372 5.3901 0.0 0
M  V30 10 O 14.6708 4.6201 0.0 0
M  V30 11 O 12.0035 4.6201 0.0 0
M  V30 12 C 14.6708 3.0801 0.0 0
M  V30 13 C 5.3348 6.9302 0.0 0
M  V30 14 C 6.6685 7.7002 0.0 0
M  V30 15 C 4.0012 7.7002 0.0 0
M  V30 16 C 6.6685 9.2402 0.0 0
M  V30 17 C 4.0012 9.2402 0.0 0
M  V30 18 C 5.3348 10.0102 0.0 0
M  V30 19 C 2.6675 2.3101 0.0 0
M  V30 20 C 1.3337 3.0801 0.0 0
M  V30 21 C 2.6675 0.7700 0.0 0
M  V30 22 C 0.0000 2.3101 0.0 0
M  V30 23 C 1.3337 0.0000 0.0 0
M  V30 24 C 0.0000 0.7700 0.0 0
M  V30 25 C 12.0035 7.7002 0.0 0
M  V30 26 C 13.3372 6.9302 0.0 0
M  V30 27 C 12.0035 9.2402 0.0 0
M  V30 28 C 14.6708 7.7002 0.0 0
M  V30 29 C 13.3372 10.0102 0.0 0
M  V30 30 C 14.6708 9.2402 0.0 0
M  V30 31 C 16.0045 2.3101 0.0 0
M  V30 32 C 16.0045 0.7700 0.0 0
M  V30 33 C 17.3383 3.0801 0.0 0
M  V30 34 C 17.3383 0.0000 0.0 0
M  V30 35 C 18.6720 2.3101 0.0 0
M  V30 36 C 18.6720 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 4 19
M  V30 6 1 5 6
M  V30 7 1 5 14
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 7 25
M  V30 11 1 9 10
M  V30 12 2 9 11
M  V30 13 1 9 26
M  V30 14 1 10 12
M  V30 15 1 12 31
M  V30 16 2 13 14
M  V30 17 1 13 15
M  V30 18 1 14 16
M  V30 19 2 15 17
M  V30 20 2 16 18
M  V30 21 1 17 18
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 34 2 31 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 2 33 35
M  V30 38 2 34 36
M  V30 39 1 35 36
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylmethyl 2-[[(methylamino)carbonyl]oxy]benzoate
C16H15NO4
1643696-52-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 4.0011 0.0 0
M  V30 2 O 5.3900 4.0011 0.0 0
M  V30 3 O 7.7000 5.3347 0.0 0
M  V30 4 C 4.6200 5.3347 0.0 0
M  V30 5 O 10.0100 4.0011 0.0 0
M  V30 6 C 11.5500 4.0011 0.0 0
M  V30 7 N 12.3200 5.3347 0.0 0
M  V30 8 O 12.3200 2.6674 0.0 0
M  V30 9 C 13.8600 5.3347 0.0 0
M  V30 10 C 7.7000 2.6674 0.0 0
M  V30 11 C 9.2400 2.6674 0.0 0
M  V30 12 C 6.9300 1.3338 0.0 0
M  V30 13 C 10.0100 1.3338 0.0 0
M  V30 14 C 7.7000 0.0000 0.0 0
M  V30 15 C 9.2400 0.0000 0.0 0
M  V30 16 C 3.0800 5.3347 0.0 0
M  V30 17 C 2.3100 6.6685 0.0 0
M  V30 18 C 2.3100 4.0011 0.0 0
M  V30 19 C 0.7700 6.6685 0.0 0
M  V30 20 C 0.7700 4.0011 0.0 0
M  V30 21 C 0.0000 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 4 16
M  V30 6 1 5 6
M  V30 7 1 5 11
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 7 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 479206-96-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1643696-52-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-1838140
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Protonation Switching to the Least-Basic Heteroatom of Carbamate through
Cationic Hydrogen Bonding Promotes the Formation of Isocyanate Cations
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kurouchi, Hiroaki; Sumita, Akinari; Otani, Yuko; Ohwada, Tomohiko
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2014), 20(28), 8682-8690

$RFMT $RIREG SCHEME18 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(4-Bromophenyl)-1-butanone
C10H11BrO
4981-64-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 1.5400 0.0 0
M  V30 2 C 6.6684 2.3100 0.0 0
M  V30 3 O 5.3348 0.0000 0.0 0
M  V30 4 C 8.0022 1.5400 0.0 0
M  V30 5 C 9.3359 2.3100 0.0 0
M  V30 6 Br 0.0000 4.6201 0.0 0
M  V30 7 C 4.0011 2.3100 0.0 0
M  V30 8 C 4.0011 3.8500 0.0 0
M  V30 9 C 2.6675 1.5400 0.0 0
M  V30 10 C 2.6675 4.6201 0.0 0
M  V30 11 C 1.3337 2.3100 0.0 0
M  V30 12 C 1.3337 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-N-methyl-α-propylbenzenemethanamine
C11H16BrN
912907-06-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 2.3101 0.0 0
M  V30 2 C 6.6685 3.0801 0.0 0
M  V30 3 N 5.3348 0.7700 0.0 0
M  V30 4 C 8.0023 2.3101 0.0 0
M  V30 5 C 6.6685 0.0000 0.0 0
M  V30 6 C 9.3360 3.0801 0.0 0
M  V30 7 Br 0.0000 5.3901 0.0 0
M  V30 8 C 4.0012 3.0801 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 2.6675 2.3101 0.0 0
M  V30 11 C 2.6675 5.3901 0.0 0
M  V30 12 C 1.3337 3.0801 0.0 0
M  V30 13 C 1.3337 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4981-64-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 912907-06-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-33340138
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 3087-36-3
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 1634-04-4
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of novel bifunctional molecules for targeted protein
degradation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Testa, Andrea; Macgregor, Callum; Mcgarry, David; Meier, Gregor;
Churcher, Ian; Mathieson, Michael
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022129925 A1 2022-06-23

$RFMT $RIREG SCHEME19 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylmethyl (2R)-2-(hydroxymethyl)-4-morpholinecarboxylate
C13H17NO4
500702-97-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 O 5.3348 2.3101 0.0 0
M  V30 3 O 6.6685 0.0000 0.0 0
M  V30 4 C 4.0010 1.5400 0.0 0
M  V30 5 C 12.0033 1.5400 0.0 0
M  V30 6 O 13.3370 2.3101 0.0 0
M  V30 7 N 8.0022 2.3101 0.0 0
M  V30 8 C 9.3360 1.5400 0.0 0
M  V30 9 C 8.0022 3.8501 0.0 0
M  V30 10 C 10.6697 2.3101 0.0 0 CFG=2
M  V30 11 C 9.3360 4.6201 0.0 0
M  V30 12 O 10.6697 3.8501 0.0 0
M  V30 13 C 2.6673 2.3101 0.0 0
M  V30 14 C 1.3337 1.5400 0.0 0
M  V30 15 C 2.6673 3.8501 0.0 0
M  V30 16 C 0.0000 2.3101 0.0 0
M  V30 17 C 1.3337 4.6201 0.0 0
M  V30 18 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 4 13
M  V30 6 1 5 6
M  V30 7 1 10 5 CFG=1
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Phenylmethyl (2S)-2-[(methylamino)methyl]-4-morpholinecarboxylate
C14H20N2O3
2360518-62-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 O 5.3348 2.3101 0.0 0
M  V30 3 O 6.6685 0.0000 0.0 0
M  V30 4 C 4.0010 1.5400 0.0 0
M  V30 5 C 12.0033 1.5400 0.0 0
M  V30 6 N 13.3370 2.3101 0.0 0
M  V30 7 C 14.6707 1.5400 0.0 0
M  V30 8 N 8.0022 2.3101 0.0 0
M  V30 9 C 9.3358 1.5400 0.0 0
M  V30 10 C 8.0022 3.8501 0.0 0
M  V30 11 C 10.6697 2.3101 0.0 0 CFG=2
M  V30 12 C 9.3358 4.6201 0.0 0
M  V30 13 O 10.6697 3.8501 0.0 0
M  V30 14 C 2.6673 2.3101 0.0 0
M  V30 15 C 1.3337 1.5400 0.0 0
M  V30 16 C 2.6673 3.8501 0.0 0
M  V30 17 C 0.0000 2.3101 0.0 0
M  V30 18 C 1.3337 4.6201 0.0 0
M  V30 19 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 4 14
M  V30 6 1 5 6
M  V30 7 1 11 5 CFG=1
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 500702-97-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2360518-62-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-33484130
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of bifunctional pyridopyrimidinone derivatives for degrading
cyclin-dependent kinase 2 via ubiquitin proteasome pathway
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fu, Jiping; Lou, Yan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022140472 A1 2022-06-30

$RFMT $RIREG SCHEME20 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-6-chloro-9H-purine
C5H2BrClN4
500797-85-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 3.7036 0.0000 0.0 0
M  V30 2 Br 6.3710 4.6200 0.0 0
M  V30 3 C 2.3699 3.8500 0.0 0
M  V30 4 C 2.3699 2.3100 0.0 0
M  V30 5 N 3.7036 4.6200 0.0 0
M  V30 6 N 0.9052 4.3259 0.0 0
M  V30 7 C 3.7036 1.5400 0.0 0
M  V30 8 N 0.9052 1.8341 0.0 0
M  V30 9 C 5.0372 3.8500 0.0 0
M  V30 10 C 0.0000 3.0800 0.0 0
M  V30 11 N 5.0372 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 2 9
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 2 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-N-methyl-9H-purin-6-amine
C6H6BrN5
630103-43-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.1456 4.6201 0.0 0
M  V30 2 C 6.4792 3.8501 0.0 0
M  V30 3 Br 2.4781 0.0000 0.0 0
M  V30 4 C 2.4781 4.6201 0.0 0
M  V30 5 C 1.1444 3.8501 0.0 0
M  V30 6 C 3.8119 3.8501 0.0 0
M  V30 7 N 2.1579 6.1264 0.0 0
M  V30 8 N 1.1444 2.3101 0.0 0
M  V30 9 N 0.0000 4.8805 0.0 0
M  V30 10 N 3.8119 2.3101 0.0 0
M  V30 11 C 0.6263 6.2873 0.0 0
M  V30 12 C 2.4781 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 3 12
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 11
M  V30 13 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 500797-85-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 630103-43-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-13814688
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 2-Bromo-6-methylamino-9H-purine (38). The mixture of 35 (130 mg, 0.557
mmol) in CH3NH2 (40% in H2O, 2 mL) was heated to 70 °C and stirred at
this temperature for 6 h. The reaction mixture was cooled to room
temperature, and the formed white precipitate was filtered and washed
with a small amount of water/MeOH. The precipitate was dried in a vacuum
to give 38 (118 mg, 93%). 1H NMR (DMSO-d 6) δ 8.08 (s, 1H), 8.06 (bs,
1H), 3.30 (s, 1H), 2.91 (s, 3H); MS (m/e) (positive- FAB) 228 (M+ + H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 2-Substitution of Adenine Nucleotide Analogues Containing a
Bicyclo[3.1.0]hexane Ring System Locked in a Northern Conformation:
Enhanced Potency as P2Y1 Receptor Antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kim, Hak Sung; Ohno, Michihiro; Xu, Bin; Kim, Hea Ok; Choi, Yongseok; Ji,
Xiao D.; Maddileti, Savitri; Marquez, Victor E.; Harden, T. Kendall;
Jacobson, Kenneth A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2003), 46(23), 4974-4987

$RFMT $RIREG SCHEME21 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Iodo-6-methoxybenzaldehyde
C8H7IO2
5025-59-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 2.3101 0.0 0
M  V30 2 C 6.6687 3.0801 0.0 0
M  V30 3 C 2.6675 0.7700 0.0 0
M  V30 4 O 1.3338 0.0000 0.0 0
M  V30 5 I 0.0000 2.3101 0.0 0
M  V30 6 C 4.0012 3.0801 0.0 0
M  V30 7 C 2.6675 2.3101 0.0 0
M  V30 8 C 4.0012 4.6201 0.0 0
M  V30 9 C 1.3338 3.0801 0.0 0
M  V30 10 C 2.6675 5.3901 0.0 0
M  V30 11 C 1.3338 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 3 4
M  V30 4 1 3 7
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Iodo-6-methoxy-N-methylbenzenemethanamine
C9H12INO
877264-41-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 1.3338 0.0 0
M  V30 2 N 0.7700 1.3338 0.0 0
M  V30 3 C 0.0000 0.0000 0.0 0
M  V30 4 O 5.3900 1.3338 0.0 0
M  V30 5 C 6.9300 1.3338 0.0 0
M  V30 6 I 0.7700 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 4.6200 2.6674 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 5.3900 4.0011 0.0 0
M  V30 11 C 3.0800 5.3349 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 8
M  V30 6 1 6 9
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5025-59-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 877264-41-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-13599373
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM The product from Step A (0.43 g, 1.64 mmol), and methylamine (40% aqueous
solution in water, 0.14 mL, 1.67 mmol) was stirred in methanol (2.5 mL)
at room temperature for 30 minutes. The reaction mixture was then cooled
to 0°C and treated with sodium borohydride (90 mg, 2.46 mmol). The
reaction mixture was stirred at 0°C for 1 hour, warmed to room
temperature and stirred for an additional 3.5 hours. The reaction mixture
was diluted with water, extracted with methylene chloride three times,
dried over sodium sulfate, filtered, and the solvent was evaporated to
afford the desired product (0.42 g, 93%) as a yellow oil: 1H NMR (CDCl3,
500 MHz) δ 7.42 (d, J= 7.9 Hz, 1H), 6.92 (t, J= 8.1 Hz, 1H), 6.84 (d, J=
7.8 Hz, 1H), 3.85 (s, 2H), 3.80 (s, 3H), 2.43 (s, 3H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Aryl- and heteroaryl-substituted tetrahydroisoquinolines and their
preparation, pharmaceutical compositions and use thereof to block
reuptake of norepinephrine, dopamine, and serotonin for the treatment of
neurological and psychological disorders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Molino, Bruce F.; Liu, Shuang; Berkowitz, Barry A.; Guzzo, Peter R.;
Beck, James P.; Cohen, Marlene
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2006020049 A2 2006-02-23

$RFMT $RIREG SCHEME22 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(4-Methylphenyl)methyl β-oxobenzenepropanoate
C17H16O3
505092-97-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 O 4.0010 0.0000 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 O 8.0022 2.3101 0.0 0
M  V30 6 O 6.6685 0.0000 0.0 0
M  V30 7 C 9.3358 1.5400 0.0 0
M  V30 8 C 14.6707 4.6201 0.0 0
M  V30 9 C 2.6673 2.3101 0.0 0
M  V30 10 C 2.6673 3.8501 0.0 0
M  V30 11 C 1.3337 1.5400 0.0 0
M  V30 12 C 1.3337 4.6201 0.0 0
M  V30 13 C 0.0000 2.3101 0.0 0
M  V30 14 C 0.0000 3.8501 0.0 0
M  V30 15 C 10.6697 2.3101 0.0 0
M  V30 16 C 12.0033 1.5400 0.0 0
M  V30 17 C 10.6697 3.8501 0.0 0
M  V30 18 C 13.3370 2.3101 0.0 0
M  V30 19 C 12.0033 4.6201 0.0 0
M  V30 20 C 13.3370 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 7 15
M  V30 9 1 8 20
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(4-Methylphenyl)methyl (2Z)-3-(methylamino)-3-phenyl-2-propenoate
C18H19NO2
2304416-25-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 2.3101 0.0 0
M  V30 2 C 5.3348 3.0801 0.0 0
M  V30 3 N 4.0010 0.7700 0.0 0
M  V30 4 C 6.6685 2.3101 0.0 0
M  V30 5 C 2.6673 0.0000 0.0 0
M  V30 6 O 8.0022 3.0801 0.0 0
M  V30 7 O 6.6685 0.7700 0.0 0
M  V30 8 C 9.3358 2.3101 0.0 0
M  V30 9 C 14.6707 5.3901 0.0 0
M  V30 10 C 2.6673 3.0801 0.0 0
M  V30 11 C 1.3337 2.3101 0.0 0
M  V30 12 C 2.6673 4.6201 0.0 0
M  V30 13 C 0.0000 3.0801 0.0 0
M  V30 14 C 1.3337 5.3901 0.0 0
M  V30 15 C 0.0000 4.6201 0.0 0
M  V30 16 C 10.6697 3.0801 0.0 0
M  V30 17 C 10.6697 4.6201 0.0 0
M  V30 18 C 12.0033 2.3101 0.0 0
M  V30 19 C 12.0033 5.3901 0.0 0
M  V30 20 C 13.3370 3.0801 0.0 0
M  V30 21 C 13.3370 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 6 8
M  V30 9 1 8 16
M  V30 10 1 9 21
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 505092-97-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2304416-25-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-19946817
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of Functionalized Imidazolium Salts via Iodine-Mediated
Annulations of Enamines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xia, Biao; Chen, Wenjun; Zhao, Qiongli; Yu, Wenquan; Chang, Junbiao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2019), 21(8), 2583-2587

$RFMT $RIREG SCHEME23 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Benzyloxy-4-hydroxybenzaldehyde
C14H12O3
50773-56-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.1600 2.6674 0.0 0
M  V30 2 C 6.9300 4.0011 0.0 0
M  V30 3 O 4.6200 0.0000 0.0 0
M  V30 4 C 1.5400 5.3349 0.0 0
M  V30 5 O 0.0000 5.3349 0.0 0
M  V30 6 C 4.6200 2.6674 0.0 0
M  V30 7 C 3.8500 4.0011 0.0 0
M  V30 8 C 3.8500 1.3338 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 2.3100 1.3338 0.0 0
M  V30 11 C 1.5400 2.6674 0.0 0
M  V30 12 C 8.4700 4.0011 0.0 0
M  V30 13 C 9.2400 5.3349 0.0 0
M  V30 14 C 9.2400 2.6674 0.0 0
M  V30 15 C 10.7800 5.3349 0.0 0
M  V30 16 C 10.7800 2.6674 0.0 0
M  V30 17 C 11.5500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 12
M  V30 4 1 3 8
M  V30 5 2 4 5
M  V30 6 1 4 9
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[(Methylamino)methyl]-2-(phenylmethoxy)phenol
C15H17NO2
179616-32-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.9302 2.6675 0.0 0
M  V30 2 C 7.7002 4.0012 0.0 0
M  V30 3 O 5.3901 0.0000 0.0 0
M  V30 4 C 2.3101 5.3348 0.0 0
M  V30 5 N 0.7700 5.3348 0.0 0
M  V30 6 C 0.0000 6.6687 0.0 0
M  V30 7 C 5.3901 2.6675 0.0 0
M  V30 8 C 4.6201 1.3338 0.0 0
M  V30 9 C 4.6201 4.0012 0.0 0
M  V30 10 C 3.0801 1.3338 0.0 0
M  V30 11 C 3.0801 4.0012 0.0 0
M  V30 12 C 2.3101 2.6675 0.0 0
M  V30 13 C 9.2402 4.0012 0.0 0
M  V30 14 C 10.0102 5.3348 0.0 0
M  V30 15 C 10.0102 2.6675 0.0 0
M  V30 16 C 11.5503 5.3348 0.0 0
M  V30 17 C 11.5503 2.6675 0.0 0
M  V30 18 C 12.3203 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 13
M  V30 4 1 3 8
M  V30 5 1 4 5
M  V30 6 1 4 11
M  V30 7 1 5 6
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 50773-56-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 179616-32-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-5820828
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM MeOH, r.t./1 h., NaBH4, 10 C/1 h., Amination, C-Amination, Condensation,
Reduction, Reductive amination
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Reductive aminations of carbonyl compounds with borohydride and borane
reducing agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Baxter, Ellen W.; Reitz, Allen B.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Reactions (Hoboken, NJ, United States) (2002), 59No pp. given

$RFMT $RIREG SCHEME24 STEP1
$RXN



  3  1
$MOL
trans-4-Bromo-β-nitrostyrene
C8H6BrNO2
5153-71-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 1.5400 0.0 0
M  V30 2 C 6.6684 2.3100 0.0 0
M  V30 3 N 8.0022 1.5400 0.0 0 VAL=5
M  V30 4 O 9.3359 2.3100 0.0 0
M  V30 5 O 8.0022 0.0000 0.0 0
M  V30 6 Br 0.0000 4.6201 0.0 0
M  V30 7 C 4.0011 2.3100 0.0 0
M  V30 8 C 2.6675 1.5400 0.0 0
M  V30 9 C 4.0011 3.8500 0.0 0
M  V30 10 C 1.3337 2.3100 0.0 0
M  V30 11 C 2.6675 4.6201 0.0 0
M  V30 12 C 1.3337 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 2 3 5
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dimethyl P-(2-phenylacetyl)phosphonate
C10H13O4P
51463-66-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 2.3100 2.3100 0.0 0 VAL=5
M  V30 2 C 3.8500 2.3100 0.0 0
M  V30 3 O 0.7700 2.3100 0.0 0
M  V30 4 O 2.3100 0.7700 0.0 0
M  V30 5 O 2.3100 3.8500 0.0 0
M  V30 6 C 4.6200 3.6436 0.0 0
M  V30 7 O 4.6200 0.9762 0.0 0
M  V30 8 C 0.0000 3.6436 0.0 0
M  V30 9 C 0.9764 0.0000 0.0 0
M  V30 10 C 6.1600 3.6436 0.0 0
M  V30 11 C 6.9300 4.9773 0.0 0
M  V30 12 C 6.9300 2.3100 0.0 0
M  V30 13 C 8.4700 4.9773 0.0 0
M  V30 14 C 8.4700 2.3100 0.0 0
M  V30 15 C 9.2400 3.6436 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 1 5
M  V30 5 1 2 6
M  V30 6 2 2 7
M  V30 7 1 3 8
M  V30 8 1 4 9
M  V30 9 1 6 10
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αR,βS)-4-Bromo-N-methyl-β-(nitromethyl)-α-phenylbenzenepropanamide
C17H17BrN2O3
1457935-42-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3901 5.3348 0.0 0 CFG=1
M  V30 2 C 4.6201 4.0012 0.0 0 CFG=2
M  V30 3 C 4.6201 6.6685 0.0 0
M  V30 4 C 5.3901 2.6675 0.0 0
M  V30 5 N 5.3901 8.0023 0.0 0 VAL=5
M  V30 6 N 4.6201 1.3337 0.0 0
M  V30 7 O 6.9302 2.6675 0.0 0
M  V30 8 O 4.6201 9.3360 0.0 0
M  V30 9 O 6.9302 8.0023 0.0 0
M  V30 10 C 5.3901 0.0000 0.0 0
M  V30 11 Br 11.5503 5.3348 0.0 0
M  V30 12 C 6.9302 5.3348 0.0 0
M  V30 13 C 7.7002 6.6685 0.0 0
M  V30 14 C 7.7002 4.0012 0.0 0
M  V30 15 C 9.2402 6.6685 0.0 0
M  V30 16 C 9.2402 4.0012 0.0 0
M  V30 17 C 10.0102 5.3348 0.0 0
M  V30 18 C 3.0801 4.0012 0.0 0
M  V30 19 C 2.3101 5.3348 0.0 0
M  V30 20 C 2.3101 2.6675 0.0 0
M  V30 21 C 0.7700 5.3348 0.0 0
M  V30 22 C 0.7700 2.6675 0.0 0
M  V30 23 C 0.0000 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 12
M  V30 4 1 2 4 CFG=1
M  V30 5 1 2 18
M  V30 6 1 3 5
M  V30 7 1 4 6
M  V30 8 2 4 7
M  V30 9 2 5 8
M  V30 10 2 5 9
M  V30 11 1 6 10
M  V30 12 1 11 17
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 5153-71-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 51463-66-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1457935-42-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-8994210
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1457935-39-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, dr=>95:5, 78% ee, Michael addition
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Organocatalyzed asymmetric Michael reaction of β-aryl-α-ketophosphonates
and nitroalkenes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Guang, Jie; Zhao, John Cong-Gui
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2013), 54(42), 5703-5706

$RFMT $RIREG SCHEME25 STEP1
$RXN



  3  1
$MOL
1-Methoxy-4-[(1E)-2-nitroethenyl]benzene
C9H9NO3
5576-97-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6673 2.3101 0.0 0
M  V30 3 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 4 O 0.0000 2.3101 0.0 0
M  V30 5 O 1.3337 0.0000 0.0 0
M  V30 6 O 9.3360 4.6201 0.0 0
M  V30 7 C 10.6697 3.8501 0.0 0
M  V30 8 C 5.3348 2.3101 0.0 0
M  V30 9 C 6.6685 1.5400 0.0 0
M  V30 10 C 5.3348 3.8501 0.0 0
M  V30 11 C 8.0022 2.3101 0.0 0
M  V30 12 C 6.6685 4.6201 0.0 0
M  V30 13 C 8.0022 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 2 3 5
M  V30 6 1 6 7
M  V30 7 1 6 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dimethyl P-(2-phenylacetyl)phosphonate
C10H13O4P
51463-66-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 2.3100 2.3100 0.0 0 VAL=5
M  V30 2 C 3.8500 2.3100 0.0 0
M  V30 3 O 0.7700 2.3100 0.0 0
M  V30 4 O 2.3100 0.7700 0.0 0
M  V30 5 O 2.3100 3.8500 0.0 0
M  V30 6 C 4.6200 3.6436 0.0 0
M  V30 7 O 4.6200 0.9762 0.0 0
M  V30 8 C 0.0000 3.6436 0.0 0
M  V30 9 C 0.9764 0.0000 0.0 0
M  V30 10 C 6.1600 3.6436 0.0 0
M  V30 11 C 6.9300 4.9773 0.0 0
M  V30 12 C 6.9300 2.3100 0.0 0
M  V30 13 C 8.4700 4.9773 0.0 0
M  V30 14 C 8.4700 2.3100 0.0 0
M  V30 15 C 9.2400 3.6436 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 1 5
M  V30 5 1 2 6
M  V30 6 2 2 7
M  V30 7 1 3 8
M  V30 8 1 4 9
M  V30 9 1 6 10
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αR,βS)-4-Methoxy-N-methyl-β-(nitromethyl)-α-phenylbenzenepropanamide
C18H20N2O4
1457935-40-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 4.0012 0.0 0 CFG=2
M  V30 2 C 5.3901 5.3348 0.0 0 CFG=1
M  V30 3 C 5.3901 2.6675 0.0 0
M  V30 4 C 4.6201 6.6685 0.0 0
M  V30 5 N 4.6201 1.3337 0.0 0
M  V30 6 O 6.9302 2.6675 0.0 0
M  V30 7 N 5.3901 8.0023 0.0 0 VAL=5
M  V30 8 C 5.3901 0.0000 0.0 0
M  V30 9 O 4.6201 9.3360 0.0 0
M  V30 10 O 6.9302 8.0023 0.0 0
M  V30 11 O 11.5503 5.3348 0.0 0
M  V30 12 C 12.3203 6.6685 0.0 0
M  V30 13 C 3.0801 4.0012 0.0 0
M  V30 14 C 2.3101 5.3348 0.0 0
M  V30 15 C 2.3101 2.6675 0.0 0
M  V30 16 C 0.7700 5.3348 0.0 0
M  V30 17 C 0.7700 2.6675 0.0 0
M  V30 18 C 0.0000 4.0012 0.0 0
M  V30 19 C 6.9302 5.3348 0.0 0
M  V30 20 C 7.7002 6.6685 0.0 0
M  V30 21 C 7.7002 4.0012 0.0 0
M  V30 22 C 9.2402 6.6685 0.0 0
M  V30 23 C 9.2402 4.0012 0.0 0
M  V30 24 C 10.0102 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 13
M  V30 4 1 2 4 CFG=3
M  V30 5 1 2 19
M  V30 6 1 3 5
M  V30 7 2 3 6
M  V30 8 1 4 7
M  V30 9 1 5 8
M  V30 10 2 7 9
M  V30 11 2 7 10
M  V30 12 1 11 12
M  V30 13 1 11 24
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 5576-97-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 51463-66-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1457935-40-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-4747500
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1457935-39-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, dr=>95:5, 81% ee, Michael addition
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Organocatalyzed asymmetric Michael reaction of β-aryl-α-ketophosphonates
and nitroalkenes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Guang, Jie; Zhao, John Cong-Gui
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2013), 54(42), 5703-5706

$RFMT $RIREG SCHEME26 STEP1
$RXN



  3  1
$MOL
trans-β-Nitrostyrene
C8H7NO2
5153-67-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 N 6.6685 1.5400 0.0 0 VAL=5
M  V30 4 O 8.0021 2.3100 0.0 0
M  V30 5 O 6.6685 0.0000 0.0 0
M  V30 6 C 2.6674 2.3100 0.0 0
M  V30 7 C 2.6674 3.8500 0.0 0
M  V30 8 C 1.3336 1.5400 0.0 0
M  V30 9 C 1.3336 4.6200 0.0 0
M  V30 10 C 0.0000 2.3100 0.0 0
M  V30 11 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 2 3 5
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phosphonic acid, [(4-methylphenyl)acetyl]-, dimethyl ester
C11H15O4P
87600-64-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 3.6436 0.0 0
M  V30 2 C 3.8500 2.3100 0.0 0
M  V30 3 P 2.3100 2.3100 0.0 0 VAL=5
M  V30 4 O 4.6200 0.9762 0.0 0
M  V30 5 O 0.7700 2.3100 0.0 0
M  V30 6 O 2.3100 0.7700 0.0 0
M  V30 7 O 2.3100 3.8500 0.0 0
M  V30 8 C 0.0000 3.6436 0.0 0
M  V30 9 C 0.9764 0.0000 0.0 0
M  V30 10 C 10.7800 3.6436 0.0 0
M  V30 11 C 6.1600 3.6436 0.0 0
M  V30 12 C 6.9300 4.9773 0.0 0
M  V30 13 C 6.9300 2.3100 0.0 0
M  V30 14 C 8.4700 4.9773 0.0 0
M  V30 15 C 8.4700 2.3100 0.0 0
M  V30 16 C 9.2400 3.6436 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 3 6
M  V30 7 2 3 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 10 16
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αR,βS)-N-Methyl-α-(4-methylphenyl)-β-(nitromethyl)benzenepropanamide
C18H20N2O3
1457935-48-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 5.3348 0.0 0 CFG=1
M  V30 2 C 5.3901 4.0012 0.0 0 CFG=2
M  V30 3 C 5.3901 6.6685 0.0 0
M  V30 4 C 4.6201 2.6675 0.0 0
M  V30 5 N 4.6201 8.0023 0.0 0 VAL=5
M  V30 6 N 5.3901 1.3337 0.0 0
M  V30 7 O 3.0801 2.6675 0.0 0
M  V30 8 O 5.3901 9.3360 0.0 0
M  V30 9 O 3.0801 8.0023 0.0 0
M  V30 10 C 4.6201 0.0000 0.0 0
M  V30 11 C 11.5503 4.0012 0.0 0
M  V30 12 C 3.0801 5.3348 0.0 0
M  V30 13 C 2.3101 6.6685 0.0 0
M  V30 14 C 2.3101 4.0012 0.0 0
M  V30 15 C 0.7700 6.6685 0.0 0
M  V30 16 C 0.7700 4.0012 0.0 0
M  V30 17 C 0.0000 5.3348 0.0 0
M  V30 18 C 6.9302 4.0012 0.0 0
M  V30 19 C 7.7002 5.3348 0.0 0
M  V30 20 C 7.7002 2.6675 0.0 0
M  V30 21 C 9.2402 5.3348 0.0 0
M  V30 22 C 9.2402 2.6675 0.0 0
M  V30 23 C 10.0102 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 12
M  V30 4 1 2 4 CFG=3
M  V30 5 1 2 18
M  V30 6 1 3 5
M  V30 7 1 4 6
M  V30 8 2 4 7
M  V30 9 2 5 8
M  V30 10 2 5 9
M  V30 11 1 6 10
M  V30 12 1 11 23
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 5153-67-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 87600-64-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1457935-48-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-13543227
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1457935-39-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, dr=>95:5, 79% ee, Michael addition
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Organocatalyzed asymmetric Michael reaction of β-aryl-α-ketophosphonates
and nitroalkenes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Guang, Jie; Zhao, John Cong-Gui
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2013), 54(42), 5703-5706

$RFMT $RIREG SCHEME27 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Chlorophenyl)-2-[(dimethylamino)methylene]-3-oxobutanamide
C13H15ClN2O2
517907-16-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 2.6674 0.0 0
M  V30 2 C 4.6200 2.6674 0.0 0
M  V30 3 C 2.3100 4.0011 0.0 0
M  V30 4 C 2.3100 1.3338 0.0 0
M  V30 5 N 5.3900 4.0011 0.0 0
M  V30 6 O 5.3900 1.3338 0.0 0
M  V30 7 N 0.7700 4.0011 0.0 0
M  V30 8 C 3.0800 0.0000 0.0 0
M  V30 9 O 0.7700 1.3338 0.0 0
M  V30 10 C 0.0000 2.6674 0.0 0
M  V30 11 C 0.0000 5.3349 0.0 0
M  V30 12 Cl 11.5500 4.0011 0.0 0
M  V30 13 C 6.9300 4.0011 0.0 0
M  V30 14 C 7.7000 2.6674 0.0 0
M  V30 15 C 7.7000 5.3349 0.0 0
M  V30 16 C 9.2400 2.6674 0.0 0
M  V30 17 C 9.2400 5.3349 0.0 0
M  V30 18 C 10.0100 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 2 4 9
M  V30 9 1 5 13
M  V30 10 1 7 10
M  V30 11 1 7 11
M  V30 12 1 12 18
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Butanamide, N-(4-chlorophenyl)-2-[(methylamino)methylene]-3-oxo-
C12H13ClN2O2
2197964-17-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3900 4.0011 0.0 0
M  V30 2 C 4.6200 2.6674 0.0 0
M  V30 3 C 3.0800 2.6674 0.0 0
M  V30 4 O 5.3900 1.3338 0.0 0
M  V30 5 C 2.3100 4.0011 0.0 0
M  V30 6 C 2.3100 1.3338 0.0 0
M  V30 7 N 0.7700 4.0011 0.0 0
M  V30 8 C 3.0800 0.0000 0.0 0
M  V30 9 O 0.7700 1.3338 0.0 0
M  V30 10 C 0.0000 5.3349 0.0 0
M  V30 11 Cl 11.5500 4.0011 0.0 0
M  V30 12 C 6.9300 4.0011 0.0 0
M  V30 13 C 7.7000 2.6674 0.0 0
M  V30 14 C 7.7000 5.3349 0.0 0
M  V30 15 C 9.2400 2.6674 0.0 0
M  V30 16 C 9.2400 5.3349 0.0 0
M  V30 17 C 10.0100 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 3 5 CFG=2
M  V30 6 1 3 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 7 10
M  V30 11 1 11 17
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 517907-16-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2197964-17-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-18916607
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-14-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM PIFA-Mediated Oxidative Cyclization Reactions of α-Acyl Acrylamides: A
Synthetic Route to Substituted Isoxazol-3(2H)-ones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yuan, Jingwen; Rao, Chitturi Bhujanga; Zhang, Qian; Zhang, Rui; Liang,
Yongjiu; Zhang, Ning; Dong, Dewen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2018), 50(9), 1875-1882

$RFMT $RIREG SCHEME28 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-4-thiazolecarboxaldehyde
C4H2BrNOS
5198-80-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3026 2.6218 0.0 0
M  V30 2 O 6.6363 1.8517 0.0 0
M  V30 3 Br 0.0000 1.4946 0.0 0
M  V30 4 C 3.9690 1.8517 0.0 0
M  V30 5 N 2.5620 2.4782 0.0 0
M  V30 6 C 3.8079 0.3202 0.0 0
M  V30 7 C 1.5316 1.3337 0.0 0
M  V30 8 S 2.3016 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 7
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-N-methyl-4-thiazolemethanamine
C5H7BrN2S
933692-77-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3026 2.6218 0.0 0
M  V30 2 N 6.6363 1.8517 0.0 0
M  V30 3 C 7.9700 2.6218 0.0 0
M  V30 4 Br 0.0000 1.4946 0.0 0
M  V30 5 C 3.9690 1.8517 0.0 0
M  V30 6 N 2.5620 2.4782 0.0 0
M  V30 7 C 3.8079 0.3202 0.0 0
M  V30 8 C 1.5316 1.3337 0.0 0
M  V30 9 S 2.3016 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 4 8
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5198-80-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 933692-77-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-16350622
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 546-68-9
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Application of Isayama-Mukaiyama cobalt catalyzed hydroperoxysilylation
for the preparation of ritonavir hydroperoxide
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gazal, Sharon; Gupta, Priya; Gunturu, Siva Ramakrishna; Isherwood,
Matthew; Voss, Matthew E.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2016), 57(46), 5099-5102

$RFMT $RIREG SCHEME29 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl β-oxobenzenepropanoate
C13H16O3
54441-66-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 4.2073 0.0 0
M  V30 2 C 5.3901 2.8737 0.0 0
M  V30 3 O 5.3901 5.5410 0.0 0
M  V30 4 C 6.9301 2.8737 0.0 0
M  V30 5 O 7.7001 1.5400 0.0 0
M  V30 6 O 7.7001 4.2073 0.0 0
M  V30 7 C 9.2401 1.5400 0.0 0
M  V30 8 C 9.2401 3.0800 0.0 0
M  V30 9 C 10.7801 1.5400 0.0 0
M  V30 10 C 9.2401 0.0000 0.0 0
M  V30 11 C 3.0800 4.2073 0.0 0
M  V30 12 C 2.3100 2.8737 0.0 0
M  V30 13 C 2.3100 5.5410 0.0 0
M  V30 14 C 0.7700 2.8737 0.0 0
M  V30 15 C 0.7700 5.5410 0.0 0
M  V30 16 C 0.0000 4.2073 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (2Z)-3-(methylamino)-3-phenyl-2-propenoate
C14H19NO2
2304416-33-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.2074 0.0 0
M  V30 2 C 5.3900 2.8738 0.0 0
M  V30 3 N 5.3900 5.5411 0.0 0
M  V30 4 C 6.9300 2.8738 0.0 0
M  V30 5 C 4.6200 6.8749 0.0 0
M  V30 6 O 7.7000 1.5400 0.0 0
M  V30 7 O 7.7000 4.2074 0.0 0
M  V30 8 C 9.2400 1.5400 0.0 0
M  V30 9 C 9.2400 3.0800 0.0 0
M  V30 10 C 10.7800 1.5400 0.0 0
M  V30 11 C 9.2400 0.0000 0.0 0
M  V30 12 C 3.0800 4.2074 0.0 0
M  V30 13 C 2.3100 2.8738 0.0 0
M  V30 14 C 2.3100 5.5411 0.0 0
M  V30 15 C 0.7700 2.8738 0.0 0
M  V30 16 C 0.7700 5.5411 0.0 0
M  V30 17 C 0.0000 4.2074 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 54441-66-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2304416-33-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-19946825
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-65-0
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of Functionalized Imidazolium Salts via Iodine-Mediated
Annulations of Enamines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xia, Biao; Chen, Wenjun; Zhao, Qiongli; Yu, Wenquan; Chang, Junbiao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2019), 21(8), 2583-2587

$RFMT $RIREG SCHEME30 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Bis(benzyloxy)benzaldehyde
C21H18O3
5447-02-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6201 6.6685 0.0 0
M  V30 2 C 3.0801 6.6685 0.0 0
M  V30 3 O 7.7002 6.6685 0.0 0
M  V30 4 C 9.2402 6.6685 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 O 5.3901 0.0000 0.0 0
M  V30 7 C 5.3901 5.3348 0.0 0
M  V30 8 C 6.9302 5.3348 0.0 0
M  V30 9 C 4.6201 4.0012 0.0 0
M  V30 10 C 7.7002 4.0012 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 12 C 6.9302 2.6673 0.0 0
M  V30 13 C 2.3101 8.0023 0.0 0
M  V30 14 C 3.0801 9.3360 0.0 0
M  V30 15 C 0.7700 8.0023 0.0 0
M  V30 16 C 2.3101 10.6697 0.0 0
M  V30 17 C 0.0000 9.3360 0.0 0
M  V30 18 C 0.7700 10.6697 0.0 0
M  V30 19 C 10.0102 8.0023 0.0 0
M  V30 20 C 11.5503 8.0023 0.0 0
M  V30 21 C 9.2402 9.3360 0.0 0
M  V30 22 C 12.3203 9.3360 0.0 0
M  V30 23 C 10.0102 10.6697 0.0 0
M  V30 24 C 11.5503 10.6697 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 13
M  V30 4 1 3 4
M  V30 5 1 3 8
M  V30 6 1 4 19
M  V30 7 2 5 6
M  V30 8 1 5 11
M  V30 9 2 7 8
M  V30 10 1 7 9
M  V30 11 1 8 10
M  V30 12 2 9 11
M  V30 13 2 10 12
M  V30 14 1 11 12
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-3,4-bis(phenylmethoxy)benzenemethanamine
C22H23NO2
214424-25-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.9302 5.3348 0.0 0
M  V30 2 C 7.7002 4.0012 0.0 0
M  V30 3 O 5.3901 8.0023 0.0 0
M  V30 4 C 4.6201 9.3360 0.0 0
M  V30 5 C 11.5503 8.0023 0.0 0
M  V30 6 N 12.3203 9.3360 0.0 0
M  V30 7 C 13.8603 9.3360 0.0 0
M  V30 8 C 7.7002 6.6685 0.0 0
M  V30 9 C 6.9302 8.0023 0.0 0
M  V30 10 C 9.2402 6.6685 0.0 0
M  V30 11 C 7.7002 9.3360 0.0 0
M  V30 12 C 10.0102 8.0023 0.0 0
M  V30 13 C 9.2402 9.3360 0.0 0
M  V30 14 C 6.9302 2.6673 0.0 0
M  V30 15 C 5.3901 2.6673 0.0 0
M  V30 16 C 7.7002 1.3337 0.0 0
M  V30 17 C 4.6201 1.3337 0.0 0
M  V30 18 C 6.9302 0.0000 0.0 0
M  V30 19 C 5.3901 0.0000 0.0 0
M  V30 20 C 3.0801 9.3360 0.0 0
M  V30 21 C 2.3101 10.6697 0.0 0
M  V30 22 C 2.3101 8.0023 0.0 0
M  V30 23 C 0.7700 10.6697 0.0 0
M  V30 24 C 0.7700 8.0023 0.0 0
M  V30 25 C 0.0000 9.3360 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 14
M  V30 4 1 3 4
M  V30 5 1 3 9
M  V30 6 1 4 20
M  V30 7 1 5 6
M  V30 8 1 5 12
M  V30 9 1 6 7
M  V30 10 2 8 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5447-02-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 214424-25-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-6268607
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for the Reductive Amination
of Aldehydes with Methylamine Titanium(IV) isopropoxide (2 mL, 6.6 mmol)
was added to a commercially available solution of methylamine in methanol
(2M, 7.5 mL) followed by the addition of the starting aldehyde (5 mmol).
The reaction mixture was stirred at ambient temperature for 5 h, after
which sodium borohydride (0.2 g, 5 mmol) was added and the resulting
mixture was further stirred for another period of 2 h. The reaction was
then quenched by the addition of water (1 mL), the resulting inorganic
precipitate was filtered and washed with diethyl ether (20 mL). The
organic layer was separated and the aqueous part was further extracted
with diethyl ether (20 mL x 2). The combined ether extracts were dried
(K2CO3) and concentrated in vacuo to give N-methyl secondary amines in
high purity. Table I, Entry 12, yield 93%.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of N-methyl secondary amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kumpaty, Hephzibah J.; Williamson, John S.; Bhattacharyya, Sukanta
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthetic Communications (2003), 33(8), 1411-1416

$RFMT $RIREG SCHEME31 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,2-Dimethylpropanedioyl dichloride
C5H6Cl2O2
5659-93-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 1.3337 0.0 0
M  V30 2 C 3.4374 2.6673 0.0 0
M  V30 3 C 1.3337 2.1037 0.0 0
M  V30 4 C 4.0012 0.5637 0.0 0
M  V30 5 C 1.8973 0.0000 0.0 0
M  V30 6 Cl 4.9774 2.6673 0.0 0
M  V30 7 O 2.6673 4.0010 0.0 0
M  V30 8 Cl 1.3337 3.6437 0.0 0
M  V30 9 O 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 2 2 7
M  V30 7 1 3 8
M  V30 8 2 3 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Dodecylpiperazine
C16H34N2
54722-40-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.0801 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 C 6.6685 3.0801 0.0 0
M  V30 4 C 8.0023 2.3101 0.0 0
M  V30 5 C 9.3360 3.0801 0.0 0
M  V30 6 C 10.6697 2.3101 0.0 0
M  V30 7 C 12.0035 3.0801 0.0 0
M  V30 8 C 13.3372 2.3101 0.0 0
M  V30 9 C 14.6708 3.0801 0.0 0
M  V30 10 C 16.0045 2.3101 0.0 0
M  V30 11 C 17.3383 3.0801 0.0 0
M  V30 12 C 18.6720 2.3101 0.0 0
M  V30 13 N 2.6675 2.3101 0.0 0
M  V30 14 C 1.3337 3.0801 0.0 0
M  V30 15 C 2.6675 0.7700 0.0 0
M  V30 16 C 0.0000 2.3101 0.0 0
M  V30 17 C 1.3337 0.0000 0.0 0
M  V30 18 N 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Dodecyl-N,α,α-trimethyl-β-oxo-1-piperazinepropanamide
C22H43N3O2
850404-57-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.4137 1.8973 0.0 0
M  V30 2 C 3.0801 2.6673 0.0 0
M  V30 3 O 4.4137 0.3573 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 1.7464 3.4374 0.0 0
M  V30 6 C 3.8501 4.0012 0.0 0
M  V30 7 N 0.7700 1.3337 0.0 0
M  V30 8 O 3.0801 0.0000 0.0 0
M  V30 9 C 0.0000 0.0000 0.0 0
M  V30 10 C 9.7486 4.9774 0.0 0
M  V30 11 C 11.0824 4.2074 0.0 0
M  V30 12 C 12.4161 4.9774 0.0 0
M  V30 13 C 13.7497 4.2074 0.0 0
M  V30 14 C 15.0834 4.9774 0.0 0
M  V30 15 C 16.4172 4.2074 0.0 0
M  V30 16 C 17.7509 4.9774 0.0 0
M  V30 17 C 19.0846 4.2074 0.0 0
M  V30 18 C 20.4182 4.9774 0.0 0
M  V30 19 C 21.7521 4.2074 0.0 0
M  V30 20 C 23.0857 4.9774 0.0 0
M  V30 21 C 24.4194 4.2074 0.0 0
M  V30 22 N 5.7474 2.6673 0.0 0
M  V30 23 C 5.7474 4.2074 0.0 0
M  V30 24 C 7.0812 1.8973 0.0 0
M  V30 25 C 7.0812 4.9774 0.0 0
M  V30 26 C 8.4149 2.6673 0.0 0
M  V30 27 N 8.4149 4.2074 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 22
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 4 7
M  V30 8 2 4 8
M  V30 9 1 7 9
M  V30 10 1 10 11
M  V30 11 1 10 27
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 14 15
M  V30 16 1 15 16
M  V30 17 1 16 17
M  V30 18 1 17 18
M  V30 19 1 18 19
M  V30 20 1 19 20
M  V30 21 1 20 21
M  V30 22 1 22 23
M  V30 23 1 22 24
M  V30 24 1 23 25
M  V30 25 1 24 26
M  V30 26 1 25 27
M  V30 27 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5659-93-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 54722-40-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 850404-57-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-5329749
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure BAL-resin (200 mg) was
washed with CH2Cl2-DIPEA 5:1. Then the dialkyl malonyldichloride (5-10
equiv) was added in 3 mL CH2Cl2-DIPEA (5:1) and shaken for 6 h. The resin
was washed three times with CH2Cl2-DIPEA (5:1), then the amine (10-20
equiv) in 3 mL CH2Cl2-DIPEA (5:1) was added and shaken at r.t. overnight.
The resin was washed several times with CH2Cl2, DMA and finally MeOH. The
dried resin was then treated with TFA (95%)-CH2Cl2 (2:8) twice.
Evaporation of the solvents then yielded the product. 18: Yield 93%.
Formula: C22H43N3O2; exact mass: 381.36; Massa: 382.6.
$DTYPE RXN:VAR(1):NOTES
$DATUM solid-supported reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A short and efficient protocol for the solid-phase synthesis of
retro-inverso surrogates
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Voegtle, Markus M.; Marzinzik, Andreas L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synlett (2005), (3), 496-500

$RFMT $RIREG SCHEME32 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Bromomethyl)-3-nitrobenzoic acid
C8H6BrNO4
55715-03-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0012 6.1601 0.0 0 VAL=5
M  V30 2 O 5.3348 6.9302 0.0 0
M  V30 3 O 2.6675 6.9302 0.0 0
M  V30 4 C 6.6687 4.6201 0.0 0
M  V30 5 Br 8.0023 3.8501 0.0 0
M  V30 6 C 1.3337 1.5400 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 3.8501 0.0 0
M  V30 11 C 2.6675 3.8501 0.0 0
M  V30 12 C 5.3348 2.3101 0.0 0
M  V30 13 C 2.6675 2.3101 0.0 0
M  V30 14 C 4.0012 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 4 5
M  V30 5 1 4 10
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 13
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methanol
CH4O
67-56-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methoxy-2-methyl-2H-indazole-6-carboxylic acid
C10H10N2O3
919106-89-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.0410 3.3320 0.0 0
M  V30 2 C 9.5057 2.8561 0.0 0
M  V30 3 C 8.3912 0.0000 0.0 0
M  V30 4 C 0.7700 2.6218 0.0 0
M  V30 5 O 0.0000 1.2881 0.0 0
M  V30 6 O 0.0000 3.9554 0.0 0
M  V30 7 C 5.3901 2.6218 0.0 0
M  V30 8 C 4.6201 1.2881 0.0 0
M  V30 9 C 6.8966 2.3016 0.0 0
M  V30 10 C 4.6201 3.9554 0.0 0
M  V30 11 C 3.0801 1.2881 0.0 0
M  V30 12 N 5.6507 0.1435 0.0 0
M  V30 13 N 7.0575 0.7700 0.0 0
M  V30 14 C 3.0801 3.9554 0.0 0
M  V30 15 C 2.3101 2.6218 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 3 13
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 15
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 1 12 13
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 55715-03-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 919106-89-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-30553850
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-58-3
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for the Synthesis of the
2-Alkyl-3-alkoxy-2H-indazole-6-carboxylic Acids.
4-(Bromomethyl)-3-nitrobenzoic acid (5.00 g, 19.3 mmol) was dissolved in
THF (20 mL) and added dropwise to a 40% (w/w) solution of diversity amine
(A-E, 675 mmol) in water. The reaction was allowed to stir for 4 h, then
concentrated. The ammonium salt was precipitated by the addition of
ether, followed by trituration with methanol. This salt was transferred
to a 100-mL, round-bottom flask fitted with a reflux condenser, followed
by the addition of diversity alcohol (w or x, 38 g), water (10% by weight
for MeOH, 20% by weight for EtOH), and 10% KOH (w/w). The resulting
mixture was refluxed for 12 h and then allowed to cool to room
temperature. The solution was neutralized with 6 N aq HCl to pH 4-5,
which caused the neutral 2-alkyl-3-alkoxy-2H-indazole to precipitate from
the alcohol solvent. The supernate was concentrated, and the remaining
precipitate was combined with the original. The solid was collected by
filtration and dried to afford the 2H-indazole carboxylic acid.
2-Butyl-3-methoxy-2H-indazole-6-carboxylic Acid (Aw).
3-Methoxy-2-methyl-2H-indazole-6-carboxylic Acid (Bw). yield 93%. 1H NMR
(300 MHz, CD3OD): δ 8.14 (s, 1H), 7.89 (d, J = 8.7 Hz, 1H), 7.51 (dd, J =
9.0 Hz, J = 0.9, 1H), 4.38 (s, 3H), 3.95 (s, 3H). LC/MS: m/z 207.01 [M +
H]+ (Nova-Pak C18 column, 93%, 200-400 nm).
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of a library of 2-alkyl-3-alkyloxy-2H-indazole-6-carboxamides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mills, Aaron D.; Maloney, Patrick; Hassanein, Elsayed; Haddadin, Makhluf
J.; Kurth, Mark J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Combinatorial Chemistry (2007), 9(1), 171-177

$RFMT $RIREG SCHEME33 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Indole-3-carboxylic acid, 1-methyl-, ethyl ester
C12H13NO2
56559-60-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7534 4.0286 0.0 0
M  V30 2 O 7.0871 3.2585 0.0 0
M  V30 3 O 5.7534 5.5686 0.0 0
M  V30 4 C 8.4207 4.0286 0.0 0
M  V30 5 C 9.7545 3.2585 0.0 0
M  V30 6 C 2.1260 0.0000 0.0 0
M  V30 7 C 3.0128 3.8850 0.0 0
M  V30 8 C 4.4197 3.2585 0.0 0
M  V30 9 C 1.9823 2.7405 0.0 0
M  V30 10 C 2.5369 5.3496 0.0 0
M  V30 11 C 4.2586 1.7270 0.0 0
M  V30 12 N 2.7523 1.4068 0.0 0
M  V30 13 C 0.4759 3.0607 0.0 0
M  V30 14 C 1.0306 5.6698 0.0 0
M  V30 15 C 0.0000 4.5254 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 12
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 12
M  V30 15 1 13 15
M  V30 16 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,1-Dimethyl-1H-indole-3-carboxamide
C11H12N2O
85729-22-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7308 4.6948 0.0 0
M  V30 2 N 7.1955 4.2189 0.0 0
M  V30 3 O 5.4106 6.2011 0.0 0
M  V30 4 C 8.3399 5.2494 0.0 0
M  V30 5 C 3.0203 0.0000 0.0 0
M  V30 6 C 3.0801 3.9845 0.0 0
M  V30 7 C 4.5864 3.6644 0.0 0
M  V30 8 C 2.3101 2.6509 0.0 0
M  V30 9 C 2.3101 5.3182 0.0 0
M  V30 10 C 4.7473 2.1326 0.0 0
M  V30 11 N 3.3405 1.5063 0.0 0
M  V30 12 C 0.7700 2.6509 0.0 0
M  V30 13 C 0.7700 5.3182 0.0 0
M  V30 14 C 0.0000 3.9845 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 11
M  V30 14 1 12 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 56559-60-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 85729-22-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-19228792
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of N-(indolylmethyl) benzamides as Fab I inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Miller, William H.; Newlander, Kenneth A.; Seefeld, Mark A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2001026654 A1 2001-04-19

$RFMT $RIREG SCHEME34 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 3-aminobenzoate
C9H11NO2
582-33-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 1.5400 0.0 0
M  V30 2 O 6.6684 2.3100 0.0 0
M  V30 3 O 5.3348 0.0000 0.0 0
M  V30 4 C 8.0022 1.5400 0.0 0
M  V30 5 C 9.3359 2.3100 0.0 0
M  V30 6 N 0.0000 1.5400 0.0 0
M  V30 7 C 4.0011 2.3100 0.0 0
M  V30 8 C 2.6675 1.5400 0.0 0
M  V30 9 C 4.0011 3.8500 0.0 0
M  V30 10 C 1.3337 2.3100 0.0 0
M  V30 11 C 2.6675 4.6201 0.0 0
M  V30 12 C 1.3337 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Amino-N-methylbenzamide
C8H10N2O
25900-61-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 1.5400 0.0 0
M  V30 2 N 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 0.0000 0.0 0
M  V30 4 C 8.0021 1.5400 0.0 0
M  V30 5 N 0.0000 1.5400 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 1.5400 0.0 0
M  V30 8 C 4.0011 3.8500 0.0 0
M  V30 9 C 1.3336 2.3100 0.0 0
M  V30 10 C 2.6674 4.6200 0.0 0
M  V30 11 C 1.3336 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 582-33-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 25900-61-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-15965075
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 124-41-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 1,4,6-triaza-1H-indene compounds as colony stimulating
factor 1 receptor modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Armer, Richard; Belfield, Andrew; Bingham, Matilda; Johnson, Alice;
Margathe, Jean-Francois; Avery, Craig; Hughes, Shaun; Morrison, Angus
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2016051193 A1 2016-04-07

$RFMT $RIREG SCHEME35 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Bromo-3-nitrobenzene
C6H4BrNO2
585-79-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3338 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3338 0.0000 0.0 0
M  V30 4 Br 6.6686 1.5400 0.0 0
M  V30 5 C 2.6675 2.3100 0.0 0
M  V30 6 C 4.0011 1.5400 0.0 0
M  V30 7 C 2.6675 3.8500 0.0 0
M  V30 8 C 5.3348 2.3100 0.0 0
M  V30 9 C 4.0011 4.6201 0.0 0
M  V30 10 C 5.3348 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 8
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-3-nitrobenzenamine
C7H8N2O2
619-26-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 2 O 1.3337 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 N 6.6687 1.5400 0.0 0
M  V30 5 C 8.0023 2.3101 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 1.5400 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 5
M  V30 5 1 4 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 585-79-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 619-26-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-4203408
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7782-44-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-50-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for the Copper-Catalyzed on
Water Ullmann Reaction. A mixture of an aryl halide (10.0 mmol), 30%
aqueous methylamine solution (5.4mL, 50 mmol), copper powder (0.032 g,
0.5 mmol), and a stirring bar was sealed in a 30 mL screwed tube and
stirred electromagnetically in an oil bath at 100 °C. During the
reaction, most of the copper powder was dissolved. After the reaction was
completed or proceeded to the times in Tables 1-3, the reaction mixture
was cooled to room temperature and ethyl acetate (20 mL) was added to
extract the aryl amine. The organic layer was separated and the aqueous
layer was extracted by ethyl acetate (3 x 10 mL). The combined extracts
were dried by anhydrous sodium sulfate and the solvent was removed under
reduced pressure to give crude product that was purified by silica gel
column chromatography (eluent: petroleum ether/ethyl acetate). The pure
product. N-Methyl-3-nitroaniline (Table 2-8) The reaction of
3-nitrobromobenzene (2.020 g, 10 mmol), aqueous methylamine (5.4 mL, 5
eq), copper powder (0.032 g, 5 mol%) produced 1.416 g (93.1 %) of
N-methyl-3-nitroaniline as a orange crystal. 1H NMR (300 MHz, d 6-DMSO) δ
(ppm): 2.73(s, 3H), 6.41(s, 1H), 6.94(s, 1H), 7.28-7.33(d, J = 14.7 Hz,
2H); 13C NMR (75 MHz, d 6-DMSO) δ (ppm): 29.9, 105.0, 110.0, 118.5,
130.4, 151.3.
$DTYPE RXN:VAR(1):NOTES
$DATUM Ullmann amination, sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A Facile and Practical Copper Powder-Catalyzed, Organic Solvent- and
Ligand-Free Ullmann Amination of Aryl Halides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jiao, Jiao; Zhang, Xi-Ru; Chang, Ning-Hui; Wang, Jie; Wei, Jun-Fa; Shi,
Xian-Ying; Chen, Zhan-Guo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2011), 76(4), 1180-1183

$RFMT $RIREG SCHEME36 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 1,4,5,6-tetrahydro-1-[4-(methylsulfonyl)phenyl]benzo[1,2-c:3,4-c′]dipyr...
C18H18N4O4S
586353-12-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.6375 4.6889 0.0 0
M  V30 2 O 11.2638 6.0957 0.0 0
M  V30 3 O 11.5427 3.4429 0.0 0
M  V30 4 C 12.7954 6.2566 0.0 0
M  V30 5 C 13.4219 7.6636 0.0 0
M  V30 6 S 1.3338 8.1259 0.0 0 VAL=6
M  V30 7 C 0.0000 8.8959 0.0 0
M  V30 8 O 2.1038 9.4597 0.0 0
M  V30 9 O 0.5638 6.7922 0.0 0
M  V30 10 C 6.8295 3.5143 0.0 0
M  V30 11 N 6.6686 5.0459 0.0 0
M  V30 12 C 8.3358 3.1941 0.0 0
M  V30 13 C 5.7991 2.3699 0.0 0
M  V30 14 N 8.0754 5.6723 0.0 0
M  V30 15 C 9.1058 4.5278 0.0 0
M  V30 16 C 8.8118 1.7296 0.0 0
M  V30 17 C 6.2749 0.9052 0.0 0
M  V30 18 C 4.2591 2.3699 0.0 0
M  V30 19 C 7.7812 0.5851 0.0 0
M  V30 20 N 5.0291 0.0000 0.0 0
M  V30 21 N 3.7830 0.9052 0.0 0
M  V30 22 C 5.3348 5.8159 0.0 0
M  V30 23 C 4.0011 5.0459 0.0 0
M  V30 24 C 5.3348 7.3559 0.0 0
M  V30 25 C 2.6675 5.8159 0.0 0
M  V30 26 C 4.0011 8.1259 0.0 0
M  V30 27 C 2.6675 7.3559 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 6 9
M  V30 9 1 6 27
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 13
M  V30 13 1 11 14
M  V30 14 1 11 22
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 2 13 17
M  V30 18 1 13 18
M  V30 19 2 14 15
M  V30 20 1 16 19
M  V30 21 1 17 19
M  V30 22 1 17 20
M  V30 23 2 18 21
M  V30 24 1 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,4,5,6-Tetrahydro-N-methyl-1-[4-(methylsulfonyl)phenyl]benzo[1,2-c:3,4-c′]di...
C17H17N5O3S
586354-65-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.6373 4.6889 0.0 0
M  V30 2 N 11.2638 6.0957 0.0 0
M  V30 3 O 11.5425 3.4428 0.0 0
M  V30 4 C 12.7953 6.2566 0.0 0
M  V30 5 S 1.3336 8.1259 0.0 0 VAL=6
M  V30 6 C 0.0000 8.8959 0.0 0
M  V30 7 O 0.5636 6.7922 0.0 0
M  V30 8 O 2.1037 9.4597 0.0 0
M  V30 9 C 6.8295 3.5143 0.0 0
M  V30 10 N 6.6684 5.0458 0.0 0
M  V30 11 C 8.3358 3.1941 0.0 0
M  V30 12 C 5.7989 2.3699 0.0 0
M  V30 13 N 8.0753 5.6723 0.0 0
M  V30 14 C 9.1058 4.5278 0.0 0
M  V30 15 C 8.8116 1.7296 0.0 0
M  V30 16 C 6.2748 0.9052 0.0 0
M  V30 17 C 4.2589 2.3699 0.0 0
M  V30 18 C 7.7812 0.5850 0.0 0
M  V30 19 N 5.0289 0.0000 0.0 0
M  V30 20 N 3.7830 0.9052 0.0 0
M  V30 21 C 5.3347 5.8158 0.0 0
M  V30 22 C 4.0011 5.0458 0.0 0
M  V30 23 C 5.3347 7.3558 0.0 0
M  V30 24 C 2.6674 5.8158 0.0 0
M  V30 25 C 4.0011 8.1259 0.0 0
M  V30 26 C 2.6674 7.3558 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 5 8
M  V30 8 1 5 26
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 1 10 21
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 2 12 16
M  V30 17 1 12 17
M  V30 18 2 13 14
M  V30 19 1 15 18
M  V30 20 1 16 18
M  V30 21 1 16 19
M  V30 22 2 17 20
M  V30 23 1 19 20
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 586353-12-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 586354-65-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-12935593
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Tricyclic pyrazole derivatives as protein kinase inhibitors, process for
their preparation and their use as antitumor agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM D'Alessio, Roberto; Bargiotti, Alberto; Brasca, Maria Gabriella; Ermoli,
Antonella; Pevarello, Paolo; Tibolla, Marcellino
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2003070236 A2 2003-08-28

$RFMT $RIREG SCHEME37 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromobenzoic acid
C7H5BrO2
586-76-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 Br 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Methylamino)benzoic acid
C8H9NO2
10541-83-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 N 6.6687 4.6201 0.0 0
M  V30 5 C 8.0023 3.8501 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 1.5400 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 586-76-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 10541-83-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-14820327
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7782-44-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-50-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for the Copper-Catalyzed on
Water Ullmann Reaction. A mixture of an aryl halide (10.0 mmol), 30%
aqueous methylamine solution (5.4mL, 50 mmol), copper powder (0.032 g,
0.5 mmol), and a stirring bar was sealed in a 30 mL screwed tube and
stirred electromagnetically in an oil bath at 100 °C. During the
reaction, most of the copper powder was dissolved. After the reaction was
completed or proceeded to the times in Tables 1-3, the reaction mixture
was cooled to room temperature and ethyl acetate (20 mL) was added to
extract the aryl amine. The organic layer was separated and the aqueous
layer was extracted by ethyl acetate (3 x 10 mL). The combined extracts
were dried by anhydrous sodium sulfate and the solvent was removed under
reduced pressure to give crude product that was purified by silica gel
column chromatography (eluent: petroleum ether/ethyl acetate). The pure
product. 4-Methylaminobenzoic acid (Table 2-13) The reaction of
4-bromobenzoic acid (2.012 g, 10 mmol), aqueous methylamine (5.4 mL, 5
eq), copper powder (0.032 g, 5 mol%) produced 1.410 g (93.3 %) of
4-methylaminobenzoic acid as a white solid. 1H NMR (300 MHz, d 6-DMSO) δ
(ppm): 2.71-2.73(d, J = 4.8 Hz, 3H), 6.43-6.54(q, 3H), 7.66-7.69(d, J =
8.4 Hz, 3H), 11.97(s, 1H); 13C NMR (75 MHz, d 6-DMSO) δ (ppm): 28.7,
110.0, 116.3, 130.6, 153.0, 167.1.
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation shown, Ullmann amination, sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A Facile and Practical Copper Powder-Catalyzed, Organic Solvent- and
Ligand-Free Ullmann Amination of Aryl Halides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jiao, Jiao; Zhang, Xi-Ru; Chang, Ning-Hui; Wang, Jie; Wei, Jun-Fa; Shi,
Xian-Ying; Chen, Zhan-Guo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2011), 76(4), 1180-1183

$RFMT $RIREG SCHEME38 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Bromo-4-nitrobenzene
C6H4BrNO2
586-78-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 1.3337 0.0 0 VAL=5
M  V30 2 O 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 Br 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-nitroaniline
C7H8N2O2
100-15-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 N 6.6687 4.6201 0.0 0
M  V30 5 C 8.0023 3.8501 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 1.5400 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 586-78-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 100-15-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-15469452
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7782-44-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-50-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for the Copper-Catalyzed on
Water Ullmann Reaction. A mixture of an aryl halide (10.0 mmol), 30%
aqueous methylamine solution (5.4mL, 50 mmol), copper powder (0.032 g,
0.5 mmol), and a stirring bar was sealed in a 30 mL screwed tube and
stirred electromagnetically in an oil bath at 100 °C. During the
reaction, most of the copper powder was dissolved. After the reaction was
completed or proceeded to the times in Tables 1-3, the reaction mixture
was cooled to room temperature and ethyl acetate (20 mL) was added to
extract the aryl amine. The organic layer was separated and the aqueous
layer was extracted by ethyl acetate (3 x 10 mL). The combined extracts
were dried by anhydrous sodium sulfate and the solvent was removed under
reduced pressure to give crude product that was purified by silica gel
column chromatography (eluent: petroleum ether/ethyl acetate). The pure
product. N-Methyl-4-nitroaniline (Table 2-6) The reaction of
4-nitrobromobenzene (2.020 g, 10 mmol), aqueous methylamine (5.4 mL, 5
eq), copper powder (5 mol%) produced 1.421 g (93.4 %) of
N-methyl-4-nitroaniline as yellow crystal. 1H NMR (300 MHz, d 6-DMSO) δ
(ppm): 2.78-2.90(d, J = 4.5 Hz , 3H), 6.60(s, 2H), 7.26(s, 1H),
7.97-7.99(d, J = 7.5 Hz, 2H); 13C NMR (75 MHz, d 6-DMSO) δ (ppm): 29.7,
110.9, 126.7, 136.0, 155.8.
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation shown, Ullmann amination, sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A Facile and Practical Copper Powder-Catalyzed, Organic Solvent- and
Ligand-Free Ullmann Amination of Aryl Halides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jiao, Jiao; Zhang, Xi-Ru; Chang, Ning-Hui; Wang, Jie; Wei, Jun-Fa; Shi,
Xian-Ying; Chen, Zhan-Guo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2011), 76(4), 1180-1183

$RFMT $RIREG SCHEME39 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromobenzyl bromide
C7H6Br2
589-15-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 Br 0.0000 2.6673 0.0 0
M  V30 3 Br 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-N-methylbenzenemethanamine
C8H10BrN
699-03-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 1.3337 0.0 0
M  V30 2 N 6.9301 2.6673 0.0 0
M  V30 3 C 8.4701 2.6673 0.0 0
M  V30 4 Br 0.0000 1.3337 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 3.8500 2.6673 0.0 0
M  V30 7 C 3.8500 0.0000 0.0 0
M  V30 8 C 2.3100 2.6673 0.0 0
M  V30 9 C 2.3100 0.0000 0.0 0
M  V30 10 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 589-15-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 699-03-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-11403362
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: N-(4-Bromobenzyl)propan-2-amine A solution of
1-bromo-4-(bromomethyl)benzene (2.0 g, 8.0 mmol), isopropylamine (950 mg,
16 mmol) and potassium carbonate (2.2 g, 16 mmol) in acetonitrile (40 mL)
was stirred at room temperature for 18 h. The reaction mixture was
quenched with water and extracted with ethyl acetate. The combined
organic layers were washed with brine, dried over anhydrous sodium
sulfate, filtered, and concentrated. The residue was purified by column
chromatography (silica, 0-100% methylene chloride/methanol) to afford the
desired product. 1-(4-Bromophenyl)-N-methylmethanamine Following the
procedure outlined for Example 488, 1-bromo-4-(bromomethyl)benzene (1.0
g, 4.0 mmol) was reacted with methanamine (620 mg, 20 mmol) to afford the
desired product (750 mg, 93%) as a brown solid. ESI MS m/z 201 [C8H10BrN
+ H]+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of thieno[2,3-c]quinoline derivatives as PKB inhibitors for
treating cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nakamura, Yusuke; Matsuo, Yo; Hisada, Shoji; Ahmed, Feryan; Huntley,
Raymond; Sajjadi-Hashemi, Zohreh; Jenkins, David M.; Kargbo, Robert B.;
Cui, Wenge; Gauuan, Polivina Jolicia F.; Walker, Joel R.; Decornez,
Helene; Gurram, Mahender
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011123419 A1 2011-10-06

$RFMT $RIREG SCHEME40 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methoxybenzaldehyde
C8H8O2
591-31-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 6.6687 3.0801 0.0 0
M  V30 4 C 8.0023 2.3101 0.0 0
M  V30 5 C 4.0012 3.0801 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 5.3348 2.3101 0.0 0
M  V30 8 C 2.6675 0.7700 0.0 0
M  V30 9 C 5.3348 0.7700 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 1 3 4
M  V30 4 1 3 7
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αS)-N-[(3-Methoxyphenyl)methyl]-α-methylbenzenemethanamine
C16H19NO
620598-71-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 N 5.3348 2.3101 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0 CFG=2
M  V30 4 C 4.0010 0.0000 0.0 0
M  V30 5 O 12.0033 1.5400 0.0 0
M  V30 6 C 13.3370 2.3101 0.0 0
M  V30 7 C 8.0022 2.3101 0.0 0
M  V30 8 C 9.3360 1.5400 0.0 0
M  V30 9 C 8.0022 3.8501 0.0 0
M  V30 10 C 10.6697 2.3101 0.0 0
M  V30 11 C 9.3360 4.6201 0.0 0
M  V30 12 C 10.6697 3.8501 0.0 0
M  V30 13 C 2.6673 2.3101 0.0 0
M  V30 14 C 1.3337 1.5400 0.0 0
M  V30 15 C 2.6673 3.8501 0.0 0
M  V30 16 C 0.0000 2.3101 0.0 0
M  V30 17 C 1.3337 4.6201 0.0 0
M  V30 18 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 3 4 CFG=1
M  V30 5 1 3 13
M  V30 6 1 5 6
M  V30 7 1 5 10
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 591-31-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 620598-71-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-111-CAS-11866187
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Highly stereoselective Friedel-Crafts type cyclization. Facile access to
enantiopure 1,4-dihydro-4-phenyl isoquinolinones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Philippe, Nicolas; Denivet, Francois; Vasse, Jean-Luc; Sopkova-de Olivera
Santos, Jana; Levacher, Vincent; Dupas, Georges
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2003), 59(40), 8049-8056

$RFMT $RIREG SCHEME41 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2′-Hydroxypropiophenone
C9H10O2
610-99-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 C 5.3901 4.0010 0.0 0
M  V30 3 O 5.3901 1.3337 0.0 0
M  V30 4 C 6.9302 4.0010 0.0 0
M  V30 5 O 3.0801 0.0000 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 2.3101 1.3337 0.0 0
M  V30 8 C 2.3101 4.0010 0.0 0
M  V30 9 C 0.7700 1.3337 0.0 0
M  V30 10 C 0.7700 4.0010 0.0 0
M  V30 11 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[(2E)-1-(Methylimino)propyl]phenol
C10H13NO
365276-82-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 C 5.3901 1.3337 0.0 0
M  V30 3 N 5.3901 4.0010 0.0 0
M  V30 4 C 6.9302 1.3337 0.0 0
M  V30 5 C 6.9302 4.0010 0.0 0
M  V30 6 O 3.0801 0.0000 0.0 0
M  V30 7 C 3.0801 2.6673 0.0 0
M  V30 8 C 2.3101 1.3337 0.0 0
M  V30 9 C 2.3101 4.0010 0.0 0
M  V30 10 C 0.7700 1.3337 0.0 0
M  V30 11 C 0.7700 4.0010 0.0 0
M  V30 12 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 6 8
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 610-99-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 365276-82-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-14578135
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An improved solvent-free preparation of 2-imidoylphenols
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cimarelli, Cristina; Palmieri, Gianni; Volpini, Emanuela
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Preparations and Procedures International (2001), 33(4), 369-371

$RFMT $RIREG SCHEME42 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Chloro-1-methyl-1H-indole-3-carboxaldehyde
C10H8ClNO
620175-79-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6520 3.0203 0.0 0
M  V30 2 O 7.6826 4.1647 0.0 0
M  V30 3 C 1.9572 5.7308 0.0 0
M  V30 4 Cl 0.0000 3.0801 0.0 0
M  V30 5 C 4.0012 2.3101 0.0 0
M  V30 6 C 2.6675 3.0801 0.0 0
M  V30 7 C 5.1457 3.3405 0.0 0
M  V30 8 C 4.0012 0.7700 0.0 0
M  V30 9 N 2.9877 4.5864 0.0 0
M  V30 10 C 1.3338 2.3101 0.0 0
M  V30 11 C 4.5192 4.7473 0.0 0
M  V30 12 C 2.6675 0.0000 0.0 0
M  V30 13 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 3 9
M  V30 4 1 4 10
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 1 10 13
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Chloro-N,1-dimethyl-1H-indole-3-methanamine
C11H13ClN2
620175-80-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6519 3.0203 0.0 0
M  V30 2 N 7.6825 4.1647 0.0 0
M  V30 3 C 9.1888 3.8445 0.0 0
M  V30 4 C 1.9571 5.7308 0.0 0
M  V30 5 Cl 0.0000 3.0801 0.0 0
M  V30 6 C 4.0012 2.3101 0.0 0
M  V30 7 C 2.6673 3.0801 0.0 0
M  V30 8 C 5.1456 3.3405 0.0 0
M  V30 9 C 4.0012 0.7700 0.0 0
M  V30 10 N 2.9875 4.5864 0.0 0
M  V30 11 C 1.3337 2.3101 0.0 0
M  V30 12 C 4.5192 4.7473 0.0 0
M  V30 13 C 2.6673 0.0000 0.0 0
M  V30 14 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 4 10
M  V30 5 1 5 11
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 1 11 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 620175-79-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 620175-80-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-6713038
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-66-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: c)
1,3-Dimethyl-2-(methylaminomethyl)-1H-indole c)
7-Chloro-1-methyl-3-(methylaminomethyl)-1H-indole [0758] According to the
procedure of Preparation 13 (c), except substituting
7-chloro-1-methyl-1H-indole-3-carboxaldehyde for the
1,3-dimethyl-1H-indole-2-carboxaldehyde, the title compound (2.0 g, 93%)
was obtained as an amber oil. MS (ES) m/e 209.2 (M+H)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20060142265 A1 2006-06-29

$RFMT $RIREG SCHEME42 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Chloro-1-methyl-1H-indole-3-carboxaldehyde
C10H8ClNO
620175-79-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6520 3.0203 0.0 0
M  V30 2 O 7.6826 4.1647 0.0 0
M  V30 3 C 1.9572 5.7308 0.0 0
M  V30 4 Cl 0.0000 3.0801 0.0 0
M  V30 5 C 4.0012 2.3101 0.0 0
M  V30 6 C 2.6675 3.0801 0.0 0
M  V30 7 C 5.1457 3.3405 0.0 0
M  V30 8 C 4.0012 0.7700 0.0 0
M  V30 9 N 2.9877 4.5864 0.0 0
M  V30 10 C 1.3338 2.3101 0.0 0
M  V30 11 C 4.5192 4.7473 0.0 0
M  V30 12 C 2.6675 0.0000 0.0 0
M  V30 13 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 3 9
M  V30 4 1 4 10
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 1 10 13
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Chloro-N,1-dimethyl-1H-indole-3-methanamine
C11H13ClN2
620175-80-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6519 3.0203 0.0 0
M  V30 2 N 7.6825 4.1647 0.0 0
M  V30 3 C 9.1888 3.8445 0.0 0
M  V30 4 C 1.9571 5.7308 0.0 0
M  V30 5 Cl 0.0000 3.0801 0.0 0
M  V30 6 C 4.0012 2.3101 0.0 0
M  V30 7 C 2.6673 3.0801 0.0 0
M  V30 8 C 5.1456 3.3405 0.0 0
M  V30 9 C 4.0012 0.7700 0.0 0
M  V30 10 N 2.9875 4.5864 0.0 0
M  V30 11 C 1.3337 2.3101 0.0 0
M  V30 12 C 4.5192 4.7473 0.0 0
M  V30 13 C 2.6673 0.0000 0.0 0
M  V30 14 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 4 10
M  V30 5 1 5 11
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 1 11 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 620175-79-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 620175-80-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-13816318
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-66-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004082586 A2 2004-09-30

$RFMT $RIREG SCHEME42 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Chloro-1-methyl-1H-indole-3-carboxaldehyde
C10H8ClNO
620175-79-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6520 3.0203 0.0 0
M  V30 2 O 7.6826 4.1647 0.0 0
M  V30 3 C 1.9572 5.7308 0.0 0
M  V30 4 Cl 0.0000 3.0801 0.0 0
M  V30 5 C 4.0012 2.3101 0.0 0
M  V30 6 C 2.6675 3.0801 0.0 0
M  V30 7 C 5.1457 3.3405 0.0 0
M  V30 8 C 4.0012 0.7700 0.0 0
M  V30 9 N 2.9877 4.5864 0.0 0
M  V30 10 C 1.3338 2.3101 0.0 0
M  V30 11 C 4.5192 4.7473 0.0 0
M  V30 12 C 2.6675 0.0000 0.0 0
M  V30 13 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 3 9
M  V30 4 1 4 10
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 1 10 13
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Chloro-N,1-dimethyl-1H-indole-3-methanamine
C11H13ClN2
620175-80-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6519 3.0203 0.0 0
M  V30 2 N 7.6825 4.1647 0.0 0
M  V30 3 C 9.1888 3.8445 0.0 0
M  V30 4 C 1.9571 5.7308 0.0 0
M  V30 5 Cl 0.0000 3.0801 0.0 0
M  V30 6 C 4.0012 2.3101 0.0 0
M  V30 7 C 2.6673 3.0801 0.0 0
M  V30 8 C 5.1456 3.3405 0.0 0
M  V30 9 C 4.0012 0.7700 0.0 0
M  V30 10 N 2.9875 4.5864 0.0 0
M  V30 11 C 1.3337 2.3101 0.0 0
M  V30 12 C 4.5192 4.7473 0.0 0
M  V30 13 C 2.6673 0.0000 0.0 0
M  V30 14 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 4 10
M  V30 5 1 5 11
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 1 11 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 620175-79-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 620175-80-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-11808383
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25895-60-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of N-(heteroaryl)methylacrylamides as Fab I inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Burgess, Walter J.; Jakas, Dalia; Huffman, William F.; Miller, William
H.; Newlander, Kenneth A.; Seefeld, Mark A.; Uzinskas, Irene N.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2003088897 A2 2003-10-30

$RFMT $RIREG SCHEME43 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-1-methyl-1H-indole-3-carboxaldehyde
C10H8ClNO
620175-81-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.2708 4.6948 0.0 0
M  V30 2 O 8.7354 4.2188 0.0 0
M  V30 3 C 4.5602 0.0000 0.0 0
M  V30 4 Cl 0.0000 3.9844 0.0 0
M  V30 5 C 4.6200 3.9844 0.0 0
M  V30 6 C 3.8500 2.6508 0.0 0
M  V30 7 C 6.1264 3.6643 0.0 0
M  V30 8 C 3.8500 5.3182 0.0 0
M  V30 9 N 4.8805 1.5064 0.0 0
M  V30 10 C 2.3100 2.6508 0.0 0
M  V30 11 C 6.2873 2.1327 0.0 0
M  V30 12 C 2.3100 5.3182 0.0 0
M  V30 13 C 1.5400 3.9844 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 3 9
M  V30 4 1 4 13
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 1 10 13
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-N,1-dimethyl-1H-indole-3-methanamine
C11H13ClN2
620175-82-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.2706 4.6948 0.0 0
M  V30 2 N 8.7353 4.2188 0.0 0
M  V30 3 C 9.8797 5.2494 0.0 0
M  V30 4 C 4.5602 0.0000 0.0 0
M  V30 5 Cl 0.0000 3.9844 0.0 0
M  V30 6 C 4.6200 3.9844 0.0 0
M  V30 7 C 3.8500 2.6508 0.0 0
M  V30 8 C 6.1263 3.6643 0.0 0
M  V30 9 C 3.8500 5.3182 0.0 0
M  V30 10 N 4.8804 1.5064 0.0 0
M  V30 11 C 2.3100 2.6508 0.0 0
M  V30 12 C 6.2872 2.1327 0.0 0
M  V30 13 C 2.3100 5.3182 0.0 0
M  V30 14 C 1.5400 3.9844 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 4 10
M  V30 5 1 5 14
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 1 11 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 620175-81-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 620175-82-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-13102455
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-66-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: c)
1,3-Dimethyl-2-(methylaminomethyl)-1H-indole c)
6-Chloro-1-methyl-3-(methylaminomethyl)-1H-indole [0761] According to the
procedure of Preparation 13 (c), except substituting
6-chloro-1-methyl-1H-indole-3-carboxaldehyde for the
1,3-dimethyl-1H-indole-2-carboxaldehyde, the title compound (2.1 g, 93%)
was obtained as an amber oil. MS (ES) m/e 209.2 (M+H)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20060142265 A1 2006-06-29

$RFMT $RIREG SCHEME43 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-1-methyl-1H-indole-3-carboxaldehyde
C10H8ClNO
620175-81-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.2708 4.6948 0.0 0
M  V30 2 O 8.7354 4.2188 0.0 0
M  V30 3 C 4.5602 0.0000 0.0 0
M  V30 4 Cl 0.0000 3.9844 0.0 0
M  V30 5 C 4.6200 3.9844 0.0 0
M  V30 6 C 3.8500 2.6508 0.0 0
M  V30 7 C 6.1264 3.6643 0.0 0
M  V30 8 C 3.8500 5.3182 0.0 0
M  V30 9 N 4.8805 1.5064 0.0 0
M  V30 10 C 2.3100 2.6508 0.0 0
M  V30 11 C 6.2873 2.1327 0.0 0
M  V30 12 C 2.3100 5.3182 0.0 0
M  V30 13 C 1.5400 3.9844 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 3 9
M  V30 4 1 4 13
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 1 10 13
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-N,1-dimethyl-1H-indole-3-methanamine
C11H13ClN2
620175-82-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.2706 4.6948 0.0 0
M  V30 2 N 8.7353 4.2188 0.0 0
M  V30 3 C 9.8797 5.2494 0.0 0
M  V30 4 C 4.5602 0.0000 0.0 0
M  V30 5 Cl 0.0000 3.9844 0.0 0
M  V30 6 C 4.6200 3.9844 0.0 0
M  V30 7 C 3.8500 2.6508 0.0 0
M  V30 8 C 6.1263 3.6643 0.0 0
M  V30 9 C 3.8500 5.3182 0.0 0
M  V30 10 N 4.8804 1.5064 0.0 0
M  V30 11 C 2.3100 2.6508 0.0 0
M  V30 12 C 6.2872 2.1327 0.0 0
M  V30 13 C 2.3100 5.3182 0.0 0
M  V30 14 C 1.5400 3.9844 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 4 10
M  V30 5 1 5 14
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 1 11 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 620175-81-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 620175-82-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-11967903
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-66-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004082586 A2 2004-09-30

$RFMT $RIREG SCHEME43 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-1-methyl-1H-indole-3-carboxaldehyde
C10H8ClNO
620175-81-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.2708 4.6948 0.0 0
M  V30 2 O 8.7354 4.2188 0.0 0
M  V30 3 C 4.5602 0.0000 0.0 0
M  V30 4 Cl 0.0000 3.9844 0.0 0
M  V30 5 C 4.6200 3.9844 0.0 0
M  V30 6 C 3.8500 2.6508 0.0 0
M  V30 7 C 6.1264 3.6643 0.0 0
M  V30 8 C 3.8500 5.3182 0.0 0
M  V30 9 N 4.8805 1.5064 0.0 0
M  V30 10 C 2.3100 2.6508 0.0 0
M  V30 11 C 6.2873 2.1327 0.0 0
M  V30 12 C 2.3100 5.3182 0.0 0
M  V30 13 C 1.5400 3.9844 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 3 9
M  V30 4 1 4 13
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 1 10 13
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-N,1-dimethyl-1H-indole-3-methanamine
C11H13ClN2
620175-82-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.2706 4.6948 0.0 0
M  V30 2 N 8.7353 4.2188 0.0 0
M  V30 3 C 9.8797 5.2494 0.0 0
M  V30 4 C 4.5602 0.0000 0.0 0
M  V30 5 Cl 0.0000 3.9844 0.0 0
M  V30 6 C 4.6200 3.9844 0.0 0
M  V30 7 C 3.8500 2.6508 0.0 0
M  V30 8 C 6.1263 3.6643 0.0 0
M  V30 9 C 3.8500 5.3182 0.0 0
M  V30 10 N 4.8804 1.5064 0.0 0
M  V30 11 C 2.3100 2.6508 0.0 0
M  V30 12 C 6.2872 2.1327 0.0 0
M  V30 13 C 2.3100 5.3182 0.0 0
M  V30 14 C 1.5400 3.9844 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 4 10
M  V30 5 1 5 14
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 1 11 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 620175-81-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 620175-82-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-2948259
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25895-60-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of N-(heteroaryl)methylacrylamides as Fab I inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Burgess, Walter J.; Jakas, Dalia; Huffman, William F.; Miller, William
H.; Newlander, Kenneth A.; Seefeld, Mark A.; Uzinskas, Irene N.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2003088897 A2 2003-10-30

$RFMT $RIREG SCHEME44 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
D-Galactonimidic-15N acid, N-[(methylsulfonyl)oxy]-2,3,4,6-tetrakis-O-(phenyl...
C35H37NO8S
620946-71-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  45 49 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 6.9302 9.3358 0.0 0
M  V30 2 C 5.3901 9.3358 0.0 0
M  V30 3 O 10.0102 9.3358 0.0 0
M  V30 4 C 9.2402 10.6697 0.0 0
M  V30 5 O 5.3901 6.6685 0.0 0
M  V30 6 C 4.6201 5.3348 0.0 0
M  V30 7 C 11.5503 6.6685 0.0 0
M  V30 8 O 12.3203 8.0022 0.0 0
M  V30 9 C 13.8603 8.0022 0.0 0
M  V30 10 N 6.9302 4.0010 0.0 0 MASS=15
M  V30 11 O 7.7002 2.6673 0.0 0
M  V30 12 S 6.9302 1.3337 0.0 0 VAL=6
M  V30 13 C 5.5965 2.1037 0.0 0
M  V30 14 O 6.1601 0.0000 0.0 0
M  V30 15 O 8.2638 0.5637 0.0 0
M  V30 16 C 7.7002 8.0022 0.0 0 CFG=2
M  V30 17 C 9.2402 8.0022 0.0 0 CFG=1
M  V30 18 C 6.9302 6.6685 0.0 0 CFG=1
M  V30 19 C 10.0102 6.6685 0.0 0 CFG=1
M  V30 20 C 7.7002 5.3348 0.0 0
M  V30 21 O 9.2402 5.3348 0.0 0
M  V30 22 C 4.6201 10.6697 0.0 0
M  V30 23 C 5.3901 12.0033 0.0 0
M  V30 24 C 3.0801 10.6697 0.0 0
M  V30 25 C 4.6201 13.3370 0.0 0
M  V30 26 C 2.3101 12.0033 0.0 0
M  V30 27 C 3.0801 13.3370 0.0 0
M  V30 28 C 10.0102 12.0033 0.0 0
M  V30 29 C 9.2402 13.3370 0.0 0
M  V30 30 C 11.5503 12.0033 0.0 0
M  V30 31 C 10.0102 14.6707 0.0 0
M  V30 32 C 12.3203 13.3370 0.0 0
M  V30 33 C 11.5503 14.6707 0.0 0
M  V30 34 C 3.0801 5.3348 0.0 0
M  V30 35 C 2.3101 6.6685 0.0 0
M  V30 36 C 2.3101 4.0010 0.0 0
M  V30 37 C 0.7700 6.6685 0.0 0
M  V30 38 C 0.7700 4.0010 0.0 0
M  V30 39 C 0.0000 5.3348 0.0 0
M  V30 40 C 14.6303 6.6685 0.0 0
M  V30 41 C 13.8603 5.3348 0.0 0
M  V30 42 C 16.1704 6.6685 0.0 0
M  V30 43 C 14.6303 4.0010 0.0 0
M  V30 44 C 16.9404 5.3348 0.0 0
M  V30 45 C 16.1704 4.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 16 1 CFG=1
M  V30 3 1 2 22
M  V30 4 1 3 4
M  V30 5 1 17 3 CFG=1
M  V30 6 1 4 28
M  V30 7 1 5 6
M  V30 8 1 18 5 CFG=3
M  V30 9 1 6 34
M  V30 10 1 7 8
M  V30 11 1 19 7 CFG=1
M  V30 12 1 8 9
M  V30 13 1 9 40
M  V30 14 1 10 11
M  V30 15 2 10 20 CFG=2
M  V30 16 1 11 12
M  V30 17 1 12 13
M  V30 18 2 12 14
M  V30 19 2 12 15
M  V30 20 1 16 17
M  V30 21 1 16 18
M  V30 22 1 17 19
M  V30 23 1 18 20
M  V30 24 1 19 21
M  V30 25 1 20 21
M  V30 26 2 22 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 2 24 26
M  V30 30 2 25 27
M  V30 31 1 26 27
M  V30 32 2 28 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 2 30 32
M  V30 36 2 31 33
M  V30 37 1 32 33
M  V30 38 2 34 35
M  V30 39 1 34 36
M  V30 40 1 35 37
M  V30 41 2 36 38
M  V30 42 2 37 39
M  V30 43 1 38 39
M  V30 44 2 40 41
M  V30 45 1 40 42
M  V30 46 1 41 43
M  V30 47 2 42 44
M  V30 48 2 43 45
M  V30 49 1 44 45
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 16 17 18 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
4-Oxa-1,2-diazaspiro[2.5]octane-1-15N, 1-methyl-6,7,8-tris(phenylmethoxy)-5-[...
C35H38N2O5
620946-91-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  42 47 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 10.0102 0.0 0
M  V30 2 C 5.3348 11.5503 0.0 0
M  V30 3 C 10.1060 12.1139 0.0 0
M  V30 4 O 5.3348 6.9302 0.0 0
M  V30 5 C 4.0012 7.7002 0.0 0
M  V30 6 C 10.6697 6.9302 0.0 0
M  V30 7 O 12.0035 7.7002 0.0 0
M  V30 8 C 13.3372 6.9302 0.0 0
M  V30 9 O 8.0023 5.3901 0.0 0
M  V30 10 C 9.3360 4.6201 0.0 0
M  V30 11 C 8.0023 10.0102 0.0 0 CFG=2
M  V30 12 C 6.6687 9.2402 0.0 0 CFG=2
M  V30 13 N 8.7723 11.3439 0.0 0
M  V30 14 N 7.2323 11.3439 0.0 0 MASS=15
M  V30 15 O 9.3360 9.2402 0.0 0
M  V30 16 C 6.6687 7.7002 0.0 0 CFG=1
M  V30 17 C 9.3360 7.7002 0.0 0 CFG=2
M  V30 18 C 8.0023 6.9302 0.0 0 CFG=1
M  V30 19 C 4.0012 12.3203 0.0 0
M  V30 20 C 4.0012 13.8603 0.0 0
M  V30 21 C 2.6675 11.5503 0.0 0
M  V30 22 C 2.6675 14.6303 0.0 0
M  V30 23 C 1.3338 12.3203 0.0 0
M  V30 24 C 1.3338 13.8603 0.0 0
M  V30 25 C 2.6675 6.9302 0.0 0
M  V30 26 C 2.6675 5.3901 0.0 0
M  V30 27 C 1.3338 7.7002 0.0 0
M  V30 28 C 1.3338 4.6201 0.0 0
M  V30 29 C 0.0000 6.9302 0.0 0
M  V30 30 C 0.0000 5.3901 0.0 0
M  V30 31 C 9.3360 3.0801 0.0 0
M  V30 32 C 8.0023 2.3101 0.0 0
M  V30 33 C 10.6697 2.3101 0.0 0
M  V30 34 C 8.0023 0.7700 0.0 0
M  V30 35 C 10.6697 0.7700 0.0 0
M  V30 36 C 9.3360 0.0000 0.0 0
M  V30 37 C 14.6708 7.7002 0.0 0
M  V30 38 C 16.0045 6.9302 0.0 0
M  V30 39 C 14.6708 9.2402 0.0 0
M  V30 40 C 17.3383 7.7002 0.0 0
M  V30 41 C 16.0045 10.0102 0.0 0
M  V30 42 C 17.3383 9.2402 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 12 1 CFG=1
M  V30 3 1 2 19
M  V30 4 1 3 13
M  V30 5 1 4 5
M  V30 6 1 16 4 CFG=3
M  V30 7 1 5 25
M  V30 8 1 6 7
M  V30 9 1 17 6 CFG=3
M  V30 10 1 7 8
M  V30 11 1 8 37
M  V30 12 1 9 10
M  V30 13 1 18 9 CFG=3
M  V30 14 1 10 31
M  V30 15 1 11 12
M  V30 16 1 11 13
M  V30 17 1 11 14 CFG=1
M  V30 18 1 11 15
M  V30 19 1 12 16
M  V30 20 1 13 14
M  V30 21 1 15 17
M  V30 22 1 16 18
M  V30 23 1 17 18
M  V30 24 2 19 20
M  V30 25 1 19 21
M  V30 26 1 20 22
M  V30 27 2 21 23
M  V30 28 2 22 24
M  V30 29 1 23 24
M  V30 30 2 25 26
M  V30 31 1 25 27
M  V30 32 1 26 28
M  V30 33 2 27 29
M  V30 34 2 28 30
M  V30 35 1 29 30
M  V30 36 2 31 32
M  V30 37 1 31 33
M  V30 38 1 32 34
M  V30 39 2 33 35
M  V30 40 2 34 36
M  V30 41 1 35 36
M  V30 42 2 37 38
M  V30 43 1 37 39
M  V30 44 1 38 40
M  V30 45 2 39 41
M  V30 46 2 40 42
M  V30 47 1 41 42
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 11 12 16 17 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 620946-71-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 620946-91-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29980209
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM isomer mix.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Glycosylidene carbenes: Part 31: Glycosylidene diaziridines:
Stereoselective addition of ammonia and methylamine to lactone oxime
sulfonates
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bernet, Bruno; Mangholz, Sissi E.; Briner, Karin; Vasella, Andrea
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Helvetica Chimica Acta (2003), 86(5), 1488-1521

$RFMT $RIREG SCHEME45 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,4-Dicyanobenzene
C8H4N2
623-26-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.3336 0.0 0
M  V30 2 N 0.0000 1.3336 0.0 0
M  V30 3 C 7.7000 1.3336 0.0 0
M  V30 4 N 9.2400 1.3336 0.0 0
M  V30 5 C 3.0800 1.3336 0.0 0
M  V30 6 C 3.8500 2.6673 0.0 0
M  V30 7 C 3.8500 0.0000 0.0 0
M  V30 8 C 5.3900 2.6673 0.0 0
M  V30 9 C 5.3900 0.0000 0.0 0
M  V30 10 C 6.1600 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 5
M  V30 3 3 3 4
M  V30 4 1 3 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,5-Dimethyl-2,4-hexadiene
C8H14
764-13-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 C 4.0011 1.5400 0.0 0
M  V30 3 C 1.3338 1.5400 0.0 0
M  V30 4 C 5.3347 2.3100 0.0 0
M  V30 5 C 0.0000 2.3100 0.0 0
M  V30 6 C 1.3338 0.0000 0.0 0
M  V30 7 C 6.6685 1.5400 0.0 0
M  V30 8 C 5.3347 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 2 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 4 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[(2E)-1,1,4-Trimethyl-4-(methylamino)-2-penten-1-yl]benzonitrile
C16H22N2
1379458-81-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7476 1.3338 0.0 0
M  V30 2 C 4.9775 2.6675 0.0 0
M  V30 3 C 4.4137 0.5638 0.0 0
M  V30 4 C 6.5176 0.0000 0.0 0
M  V30 5 C 3.4375 2.6675 0.0 0
M  V30 6 C 2.6675 4.0012 0.0 0
M  V30 7 N 1.3337 3.2311 0.0 0
M  V30 8 C 1.8975 5.3350 0.0 0
M  V30 9 C 4.0012 4.7712 0.0 0
M  V30 10 C 0.0000 4.0012 0.0 0
M  V30 11 C 11.0824 4.4139 0.0 0
M  V30 12 N 12.4161 5.1839 0.0 0
M  V30 13 C 7.0812 2.1038 0.0 0
M  V30 14 C 8.4149 1.3338 0.0 0
M  V30 15 C 7.0812 3.6439 0.0 0
M  V30 16 C 9.7486 2.1038 0.0 0
M  V30 17 C 8.4149 4.4139 0.0 0
M  V30 18 C 9.7486 3.6439 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 13
M  V30 5 2 2 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 3 11 12
M  V30 12 1 11 18
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 623-26-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 764-13-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1379458-81-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-239-CAS-4043613
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 85-01-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM photochemical, stereoselective, high-pressure mercury lamp (>290 nm) used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Temperature dependence of photosensitized nucleophilic addition to
alkenes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Matsumoto, Jin; Yoshinaga, Yusuke; Hamasaki, Akiko; Kawasaki, Tomohiro;
Yamashita, Toshiaki; Shiragami, Tsutomu; Yasuda, Masahide
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bulletin of the Chemical Society of Japan (2011), 84(10), 1130-1132

$RFMT $RIREG SCHEME46 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylmethyl β-oxobenzenepropanoate
C16H14O3
63888-22-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 O 4.0010 0.0000 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 O 8.0022 2.3101 0.0 0
M  V30 6 O 6.6685 0.0000 0.0 0
M  V30 7 C 9.3360 1.5400 0.0 0
M  V30 8 C 2.6673 2.3101 0.0 0
M  V30 9 C 1.3337 1.5400 0.0 0
M  V30 10 C 2.6673 3.8501 0.0 0
M  V30 11 C 0.0000 2.3101 0.0 0
M  V30 12 C 1.3337 4.6201 0.0 0
M  V30 13 C 0.0000 3.8501 0.0 0
M  V30 14 C 10.6697 2.3101 0.0 0
M  V30 15 C 12.0033 1.5400 0.0 0
M  V30 16 C 10.6697 3.8501 0.0 0
M  V30 17 C 13.3370 2.3101 0.0 0
M  V30 18 C 12.0033 4.6201 0.0 0
M  V30 19 C 13.3370 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 7 14
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylmethyl (2Z)-3-(methylamino)-3-phenyl-2-propenoate
C17H17NO2
2304416-24-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 2.3101 0.0 0
M  V30 2 C 5.3348 3.0801 0.0 0
M  V30 3 N 4.0010 0.7700 0.0 0
M  V30 4 C 6.6685 2.3101 0.0 0
M  V30 5 C 2.6673 0.0000 0.0 0
M  V30 6 O 8.0022 3.0801 0.0 0
M  V30 7 O 6.6685 0.7700 0.0 0
M  V30 8 C 9.3360 2.3101 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 1.3337 2.3101 0.0 0
M  V30 11 C 2.6673 4.6201 0.0 0
M  V30 12 C 0.0000 3.0801 0.0 0
M  V30 13 C 1.3337 5.3901 0.0 0
M  V30 14 C 0.0000 4.6201 0.0 0
M  V30 15 C 10.6697 3.0801 0.0 0
M  V30 16 C 10.6697 4.6201 0.0 0
M  V30 17 C 12.0033 2.3101 0.0 0
M  V30 18 C 12.0033 5.3901 0.0 0
M  V30 19 C 13.3370 3.0801 0.0 0
M  V30 20 C 13.3370 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 6 8
M  V30 9 1 8 15
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 63888-22-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2304416-24-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-19946816
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of Functionalized Imidazolium Salts via Iodine-Mediated
Annulations of Enamines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xia, Biao; Chen, Wenjun; Zhao, Qiongli; Yu, Wenquan; Chang, Junbiao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2019), 21(8), 2583-2587

$RFMT $RIREG SCHEME47 STEP1
$RXN



  2  1
$MOL
L-Phenylalanine
C9H11NO2
63-91-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 3.0800 0.0 0
M  V30 2 C 2.6674 4.6200 0.0 0 CFG=2
M  V30 3 C 1.3338 5.3900 0.0 0
M  V30 4 N 4.0011 5.3900 0.0 0
M  V30 5 O 0.0000 4.6200 0.0 0
M  V30 6 O 1.3338 6.9300 0.0 0
M  V30 7 C 4.0011 2.3100 0.0 0
M  V30 8 C 4.0011 0.7700 0.0 0
M  V30 9 C 5.3347 3.0800 0.0 0
M  V30 10 C 5.3347 0.0000 0.0 0
M  V30 11 C 6.6685 2.3100 0.0 0
M  V30 12 C 6.6685 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=1
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αS)-α-Amino-N-methylbenzenepropanamide
C10H14N2O
35373-92-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0 CFG=2
M  V30 3 C 6.6684 1.5400 0.0 0
M  V30 4 N 5.3347 3.8500 0.0 0
M  V30 5 N 8.0021 2.3100 0.0 0
M  V30 6 O 6.6684 0.0000 0.0 0
M  V30 7 C 9.3358 1.5400 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 C 1.3336 1.5400 0.0 0
M  V30 10 C 2.6674 3.8500 0.0 0
M  V30 11 C 0.0000 2.3100 0.0 0
M  V30 12 C 1.3336 4.6200 0.0 0
M  V30 13 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=3
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 63-91-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 35373-92-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-11345382
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Synthesis of catalyst 1e: To a solution of L-phenylalanine 16.5 g (100
mmol) in 250 mL MeOH was added SOCl2 25 mL slowly, then the solution was
refluxing for 2 h. After cooling to room temperature, the solvent was
removed. MeNH2 (in MeOH) 100 mL was added and the solution was stirred
for 24 h under room temperature, then the solvent and excess MeNH2 was
removed. 150 mL CH2Cl2 and 80 mL H2O was added, and the pH value was
adjusted to 12 by K2CO3. The aqueous phase was extracted with 20 mL
CH2Cl2. The organics were combined and dried with anhydrous Na2SO4. 16.6
g 1i was afforded by removing the solvent and dried in vacuo, yield 93 %.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Chiral Primary-Tertiary Diamine Catalysts Derived From Natural Amino
Acids for syn-Aldol Reactions of Hydroxy Ketones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Jiuyuan; Luo, Sanzhong; Cheng, Jin-Pei
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2009), 74(4), 1747-1750

$RFMT $RIREG SCHEME48 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(-)-Sophocarpine
C15H22N2O
6483-15-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 0.0000 0.0 0
M  V30 2 C 2.6674 3.8500 0.0 0 CFG=1
M  V30 3 C 4.0011 4.6200 0.0 0 CFG=2
M  V30 4 C 2.6674 2.3100 0.0 0 CFG=1
M  V30 5 N 1.3336 4.6200 0.0 0
M  V30 6 C 5.3347 3.8500 0.0 0 CFG=1
M  V30 7 C 4.0011 6.1600 0.0 0
M  V30 8 C 4.0011 1.5400 0.0 0
M  V30 9 C 1.3336 1.5400 0.0 0
M  V30 10 C 1.3338 6.1600 0.0 0
M  V30 11 C 0.0000 3.8500 0.0 0
M  V30 12 N 5.3347 2.3100 0.0 0
M  V30 13 C 6.6685 4.6200 0.0 0
M  V30 14 C 2.6674 6.9300 0.0 0
M  V30 15 C 0.0000 2.3100 0.0 0
M  V30 16 C 6.6685 1.5400 0.0 0
M  V30 17 C 8.0021 3.8500 0.0 0
M  V30 18 C 8.0021 2.3100 0.0 0
M  V30 19 H 1.3336 3.0800 0.0 0
M  V30 20 H 4.8844 5.8816 0.0 0
M  V30 21 H 2.6674 0.7700 0.0 0
M  V30 22 H 5.9855 5.2457 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 16
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 19 CFG=1
M  V30 6 1 3 6
M  V30 7 1 3 7
M  V30 8 1 3 20 CFG=1
M  V30 9 1 4 8
M  V30 10 1 4 9
M  V30 11 1 4 21 CFG=1
M  V30 12 1 5 10
M  V30 13 1 5 11
M  V30 14 1 6 12
M  V30 15 1 6 13
M  V30 16 1 6 22 CFG=3
M  V30 17 1 7 14
M  V30 18 1 8 12
M  V30 19 1 9 15
M  V30 20 1 10 14
M  V30 21 1 11 15
M  V30 22 1 12 16
M  V30 23 1 13 17
M  V30 24 1 16 18
M  V30 25 2 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 2 3 4 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(7aS,12S,13aR,13bR,13cS)-Dodecahydro-12-(methylamino)-1H,5H,10H-dipyrido[2,1-...
C16H27N3O
2413398-28-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 6.6684 0.0000 0.0 0
M  V30 2 N 9.3358 4.6200 0.0 0
M  V30 3 C 10.6694 3.8500 0.0 0
M  V30 4 C 2.6673 3.8500 0.0 0 CFG=1
M  V30 5 C 4.0011 4.6200 0.0 0 CFG=2
M  V30 6 C 2.6673 2.3100 0.0 0 CFG=1
M  V30 7 N 1.3336 4.6200 0.0 0
M  V30 8 C 5.3347 3.8500 0.0 0 CFG=1
M  V30 9 C 4.0011 6.1600 0.0 0
M  V30 10 C 4.0011 1.5400 0.0 0
M  V30 11 C 1.3336 1.5400 0.0 0
M  V30 12 C 1.3336 6.1600 0.0 0
M  V30 13 C 0.0000 3.8500 0.0 0
M  V30 14 N 5.3347 2.3100 0.0 0
M  V30 15 C 6.6684 4.6200 0.0 0
M  V30 16 C 2.6673 6.9300 0.0 0
M  V30 17 C 0.0000 2.3100 0.0 0
M  V30 18 C 6.6684 1.5400 0.0 0
M  V30 19 C 8.0021 3.8500 0.0 0 CFG=2
M  V30 20 C 8.0021 2.3100 0.0 0
M  V30 21 H 1.3336 3.0800 0.0 0
M  V30 22 H 4.8844 5.8816 0.0 0
M  V30 23 H 2.6673 0.7700 0.0 0
M  V30 24 H 5.9855 5.2457 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 18
M  V30 2 1 2 3
M  V30 3 1 19 2 CFG=3
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 4 21 CFG=1
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 1 5 22 CFG=1
M  V30 11 1 6 10
M  V30 12 1 6 11
M  V30 13 1 6 23 CFG=1
M  V30 14 1 7 12
M  V30 15 1 7 13
M  V30 16 1 8 14
M  V30 17 1 8 15
M  V30 18 1 8 24 CFG=3
M  V30 19 1 9 16
M  V30 20 1 10 14
M  V30 21 1 11 17
M  V30 22 1 12 16
M  V30 23 1 13 17
M  V30 24 1 14 18
M  V30 25 1 15 19
M  V30 26 1 18 20
M  V30 27 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 4 5 6 8 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 6483-15-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2413398-28-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-21774333
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, stereoselective, Michael addition
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of new matrine derivatives in aqueous phase and their crystal
structures
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Wei; Lu, Mengjiao; Zhao, Lixia; Zhang, Yaling; Li, Benhao; Li,
Baolin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Youji Huaxue (2018), 38(4), 883-889

$RFMT $RIREG SCHEME49 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
β-D-threo-Hex-3-enopyranose, 1,6-anhydro-3,4-dideoxy-, 4-methylbenzenesulfonate
C13H14O5S
66762-52-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.4041 2.6675 0.0 0
M  V30 2 S 6.1741 1.3337 0.0 0 VAL=6
M  V30 3 O 6.9442 0.0000 0.0 0
M  V30 4 O 4.8403 0.5637 0.0 0
M  V30 5 C 11.5090 4.4137 0.0 0
M  V30 6 C 3.8641 2.6675 0.0 0 CFG=1
M  V30 7 C 2.7182 4.0007 0.0 0 CFG=2
M  V30 8 C 2.8414 1.4777 0.0 0
M  V30 9 O 2.6803 5.3488 0.0 0
M  V30 10 O 1.2990 3.6101 0.0 0
M  V30 11 C 2.8411 2.7477 0.0 0
M  V30 12 C 1.6657 4.1621 0.0 0 CFG=2
M  V30 13 C 0.0000 4.0572 0.0 0
M  V30 14 C 7.5078 2.1037 0.0 0
M  V30 15 C 7.5078 3.6437 0.0 0
M  V30 16 C 8.8415 1.3337 0.0 0
M  V30 17 C 8.8415 4.4137 0.0 0
M  V30 18 C 10.1752 2.1037 0.0 0
M  V30 19 C 10.1752 3.6437 0.0 0
M  V30 20 H 4.1544 4.5562 0.0 0
M  V30 21 H 0.9776 5.5398 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 6 1 CFG=1
M  V30 3 2 2 3
M  V30 4 2 2 4
M  V30 5 1 2 14
M  V30 6 1 5 19
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 7 20 CFG=1
M  V30 12 2 8 11
M  V30 13 1 9 12
M  V30 14 1 10 13
M  V30 15 1 11 12
M  V30 16 1 12 13
M  V30 17 1 12 21 CFG=3
M  V30 18 2 14 15
M  V30 19 1 14 16
M  V30 20 1 15 17
M  V30 21 2 16 18
M  V30 22 2 17 19
M  V30 23 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 6 7 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
β-D-erythro-Hex-3-enopyranose, 1,6-anhydro-2,3,4-trideoxy-2-(methylamino)-
C7H11NO2
873957-94-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 6.0773 2.6008 0.0 0
M  V30 2 C 6.8473 3.9345 0.0 0
M  V30 3 C 3.8619 1.2166 0.0 0 CFG=2
M  V30 4 C 4.5372 2.6008 0.0 0 CFG=2
M  V30 5 O 2.9245 2.6906 0.0 0
M  V30 6 O 2.5284 0.9420 0.0 0
M  V30 7 C 3.9374 3.8301 0.0 0
M  V30 8 C 1.3851 3.2818 0.0 0 CFG=1
M  V30 9 C 1.3525 1.9269 0.0 0
M  V30 10 C 2.4374 4.1507 0.0 0
M  V30 11 H 4.8061 0.0000 0.0 0
M  V30 12 H 0.0000 3.9550 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 4 1 CFG=1
M  V30 3 1 3 4
M  V30 4 1 3 5 CFG=1
M  V30 5 1 3 6
M  V30 6 1 3 11
M  V30 7 1 4 7
M  V30 8 1 8 5 CFG=1
M  V30 9 1 6 9
M  V30 10 2 7 10
M  V30 11 1 8 9
M  V30 12 1 8 10
M  V30 13 1 8 12
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 3 4 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 66762-52-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 873957-94-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-2642291
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Aminolysis in Liquid Ammonia and Methylamine.
Compound 7 (0.28 g, 1 mmol) and liquid ammonia (5 mL) were placed into
two thick-walled ampuls; 7 (0.28 g) and liquid methylamine (5 mL), into
two others. The ampuls were sealed. One of each pair was held for 60 d at
room temperature; the other, heated at 100°C for 10 h. After each period
had expired, the ampuls were opened and volatile compounds were removed.
The solid was chromatographed over silica gel. The reaction mixture from
the heated ampuls. The reaction mixture from the long-term stored ampul.
1,6-Anhydro-2-aminomethyl-2,3,4-trideoxy-β -D-erythro-hex-3-enopyranose
(11), yield (0.130 g, 93%). Rf 0.2 (petroleum ether:ethylacetate, 1:1),
[α]D20 -89° (c 1.0, CHCl3). PMR spectrum (CDCl3, δ, ppm, J/Hz): 2.53 (3H,
s, CH3), 2.89 (1H, d, J = 3.7, H-2), 3.6 (1H, br.s, NHCH3), 3.7 (1H, dd,
J = 6.2, J= 4.3, Hexo-6), 3.8 (1H, d, J = 6.2, Hendo-6), 4.68 (1H, t, J =
4.3, H-5), 5.6 (1H, s, H-1), 5.78 (1H, dd, J = 9.9, J = 3.7, H-3), 6.1
(1H, dd, J = 4.3, J = 3.9, H-4). 13C NMR spectrum (δ , ppm): 33.78
(NCH3), 51.78 (C-2), 70.15 (C-6), 70.65 (C-5), 101.08 (C-1), 126.28
(C-4), 129.05 (C-3).
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, alternative reaction conditions gave lower yield, sealed
ampoule used, yield depends on temperature and time
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of 2-amino derivatives of levoglucosenone
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Valeev, F. A.; Kalimullina, L. Kh.; Salikhov, Sh. M.; Shitikova, O. V.;
Tsypysheva, I. P.; Safarov, M. G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry of Natural Compounds (2004), 40(6), 521-525

$RFMT $RIREG SCHEME50 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Ethoxy-3-methoxybenzaldehyde
C10H12O3
66799-97-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 2.3101 0.0 0
M  V30 2 C 2.6675 1.5400 0.0 0
M  V30 3 C 2.6675 0.0000 0.0 0
M  V30 4 C 6.6687 3.8501 0.0 0
M  V30 5 O 8.0023 4.6201 0.0 0
M  V30 6 O 1.3337 3.8501 0.0 0
M  V30 7 C 0.0000 4.6201 0.0 0
M  V30 8 C 4.0012 3.8501 0.0 0
M  V30 9 C 5.3348 4.6201 0.0 0
M  V30 10 C 2.6675 4.6201 0.0 0
M  V30 11 C 5.3348 6.1601 0.0 0
M  V30 12 C 2.6675 6.1601 0.0 0
M  V30 13 C 4.0012 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 4 5
M  V30 5 1 4 9
M  V30 6 1 6 7
M  V30 7 1 6 10
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2-Ethoxy-3-methoxybenzyl)methylamine
C11H17NO2
709649-59-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 2.3101 0.0 0
M  V30 2 C 2.6675 1.5400 0.0 0
M  V30 3 C 2.6675 0.0000 0.0 0
M  V30 4 C 6.6685 3.8501 0.0 0
M  V30 5 N 8.0023 4.6201 0.0 0
M  V30 6 C 9.3360 3.8501 0.0 0
M  V30 7 O 1.3337 3.8501 0.0 0
M  V30 8 C 0.0000 4.6201 0.0 0
M  V30 9 C 4.0012 3.8501 0.0 0
M  V30 10 C 5.3348 4.6201 0.0 0
M  V30 11 C 2.6675 4.6201 0.0 0
M  V30 12 C 5.3348 6.1601 0.0 0
M  V30 13 C 2.6675 6.1601 0.0 0
M  V30 14 C 4.0012 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 10
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 1 7 11
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 66799-97-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 709649-59-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-5217373
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Preparation 67 Preparation of
Methyl-(1-propyl-naphthalen-2-ylmethyl)amine Preparation 87 Preparation
of (2-Ethoxy-3-methoxy-benzyl)methylamine [0842] According to the
procedure of Preparation 67, except substituting
2-ethoxy-3-methoxy-benzaldehyde for 1-propyl-naphthalene-2-carbaldehyde,
the title compound (2.03 g, 93%) was prepared as a yellow oil. 1H NMR
(300 MHz, DMSO-d6) δ 6.99-6.88 (m, 3H), 3.92 (q, J=6.9 Hz, 2H), 3.77 (s,
3H), 3.61 (s, 2H), 2.25 (s, 3H), 1.87 (br s, 1H), 1.26 (t, J=6.3 Hz, 3H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20060142265 A1 2006-06-29

$RFMT $RIREG SCHEME50 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Ethoxy-3-methoxybenzaldehyde
C10H12O3
66799-97-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 2.3101 0.0 0
M  V30 2 C 2.6675 1.5400 0.0 0
M  V30 3 C 2.6675 0.0000 0.0 0
M  V30 4 C 6.6687 3.8501 0.0 0
M  V30 5 O 8.0023 4.6201 0.0 0
M  V30 6 O 1.3337 3.8501 0.0 0
M  V30 7 C 0.0000 4.6201 0.0 0
M  V30 8 C 4.0012 3.8501 0.0 0
M  V30 9 C 5.3348 4.6201 0.0 0
M  V30 10 C 2.6675 4.6201 0.0 0
M  V30 11 C 5.3348 6.1601 0.0 0
M  V30 12 C 2.6675 6.1601 0.0 0
M  V30 13 C 4.0012 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 4 5
M  V30 5 1 4 9
M  V30 6 1 6 7
M  V30 7 1 6 10
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2-Ethoxy-3-methoxybenzyl)methylamine
C11H17NO2
709649-59-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 2.3101 0.0 0
M  V30 2 C 2.6675 1.5400 0.0 0
M  V30 3 C 2.6675 0.0000 0.0 0
M  V30 4 C 6.6685 3.8501 0.0 0
M  V30 5 N 8.0023 4.6201 0.0 0
M  V30 6 C 9.3360 3.8501 0.0 0
M  V30 7 O 1.3337 3.8501 0.0 0
M  V30 8 C 0.0000 4.6201 0.0 0
M  V30 9 C 4.0012 3.8501 0.0 0
M  V30 10 C 5.3348 4.6201 0.0 0
M  V30 11 C 2.6675 4.6201 0.0 0
M  V30 12 C 5.3348 6.1601 0.0 0
M  V30 13 C 2.6675 6.1601 0.0 0
M  V30 14 C 4.0012 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 10
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 1 7 11
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 66799-97-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 709649-59-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-4062279
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004082586 A2 2004-09-30

$RFMT $RIREG SCHEME50 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Ethoxy-3-methoxybenzaldehyde
C10H12O3
66799-97-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 2.3101 0.0 0
M  V30 2 C 2.6675 1.5400 0.0 0
M  V30 3 C 2.6675 0.0000 0.0 0
M  V30 4 C 6.6687 3.8501 0.0 0
M  V30 5 O 8.0023 4.6201 0.0 0
M  V30 6 O 1.3337 3.8501 0.0 0
M  V30 7 C 0.0000 4.6201 0.0 0
M  V30 8 C 4.0012 3.8501 0.0 0
M  V30 9 C 5.3348 4.6201 0.0 0
M  V30 10 C 2.6675 4.6201 0.0 0
M  V30 11 C 5.3348 6.1601 0.0 0
M  V30 12 C 2.6675 6.1601 0.0 0
M  V30 13 C 4.0012 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 4 5
M  V30 5 1 4 9
M  V30 6 1 6 7
M  V30 7 1 6 10
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2-Ethoxy-3-methoxybenzyl)methylamine
C11H17NO2
709649-59-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 2.3101 0.0 0
M  V30 2 C 2.6675 1.5400 0.0 0
M  V30 3 C 2.6675 0.0000 0.0 0
M  V30 4 C 6.6685 3.8501 0.0 0
M  V30 5 N 8.0023 4.6201 0.0 0
M  V30 6 C 9.3360 3.8501 0.0 0
M  V30 7 O 1.3337 3.8501 0.0 0
M  V30 8 C 0.0000 4.6201 0.0 0
M  V30 9 C 4.0012 3.8501 0.0 0
M  V30 10 C 5.3348 4.6201 0.0 0
M  V30 11 C 2.6675 4.6201 0.0 0
M  V30 12 C 5.3348 6.1601 0.0 0
M  V30 13 C 2.6675 6.1601 0.0 0
M  V30 14 C 4.0012 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 10
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 1 7 11
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 66799-97-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 709649-59-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-12057161
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Preparation of
Methyl-(1-propyl-naphthalen-2-ylmethyl)amine A solution of 2.0 M
methylamine in methanol (20 mL) was added to
1-propylnaphthalene-2-carbaldehyde (0.983 g, 4.95 mmol) under N2 and
allowed to stir for 18 h. The solution was concentrated under reduced
pressure. Then the resulting dark yellow oil was solvated in EtOH (20 mL)
under N2. To the solution was added NaBH4 (0.187 g, 4.95 mmol) and the
mixture allowed to stir for 6.5 h. The reaction was concentrated under
reduced pressure, then solvated in 1 N NaOH (20 mL) and extracted with
Et2O (3 x 50 mL). The organics were combined, washed with brine (2 x 100
mL), dried over Na2SO4, filtered and concentrated to yield the title
compound as a yellow oil. Preparation of
(2-Ethoxy-3-methoxy-benzyl)methylamine According to the procedure of
Preparation 1, except substituting 2-ethoxy-3-methoxy-benzaldehyde for
1-propyl-naphthalene-2-carbaldehyde, the title compound (2.03 g, 93%) was
prepared as a yellow oil. 1H NMR (300 MHz, DMSO-d6) δ 6.99-6.88 (m, 3H),
3.92 (q, J = 6.9 Hz, 2H), 3.77 (s, 3H), 3.61 (s, 2H), 2.25 (s, 3H), 1.87
(br s, 1H), 1.26 (t, J = 6.3 Hz, 3H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocyclic compounds as antibacterial agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd; Sampson, Peter; Pauls, Heinz W.; Ramnauth, Jailall;
Manning, David Douglas; Surman, Matthew David; Xie, Dejian; Decornez,
Helene Yvonne
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004052890 A1 2004-06-24

$RFMT $RIREG SCHEME51 STEP1
$RXN



  2  1
$MOL
(αS)-α-[1,1′-Biphenyl]-4-yl-1-piperidineethanol
C19H23NO
678197-51-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3901 2.6673 0.0 0 CFG=2
M  V30 2 C 4.6201 1.3337 0.0 0
M  V30 3 O 4.6201 4.0010 0.0 0
M  V30 4 C 10.0102 2.6673 0.0 0
M  V30 5 C 9.2402 1.3337 0.0 0
M  V30 6 C 9.2402 4.0010 0.0 0
M  V30 7 C 7.7002 1.3337 0.0 0
M  V30 8 C 7.7002 4.0010 0.0 0
M  V30 9 C 6.9302 2.6673 0.0 0
M  V30 10 C 11.5503 2.6673 0.0 0
M  V30 11 C 12.3203 1.3337 0.0 0
M  V30 12 C 12.3203 4.0010 0.0 0
M  V30 13 C 13.8603 1.3337 0.0 0
M  V30 14 C 13.8603 4.0010 0.0 0
M  V30 15 C 14.6303 2.6673 0.0 0
M  V30 16 N 3.0801 1.3337 0.0 0
M  V30 17 C 2.3101 2.6673 0.0 0
M  V30 18 C 2.3101 0.0000 0.0 0
M  V30 19 C 0.7700 2.6673 0.0 0
M  V30 20 C 0.7700 0.0000 0.0 0
M  V30 21 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 9
M  V30 4 1 2 16
M  V30 5 2 4 5
M  V30 6 1 4 6
M  V30 7 1 4 10
M  V30 8 1 5 7
M  V30 9 2 6 8
M  V30 10 2 7 9
M  V30 11 1 8 9
M  V30 12 2 10 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αS)-α-[1,1′-Biphenyl]-4-yl-N-methyl-1-piperidineethanamine
C20H26N2
678197-54-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3901 2.6675 0.0 0 CFG=2
M  V30 2 C 4.6201 4.0011 0.0 0
M  V30 3 N 4.6201 1.3338 0.0 0
M  V30 4 C 5.3901 0.0000 0.0 0
M  V30 5 C 10.0101 2.6675 0.0 0
M  V30 6 C 9.2401 1.3338 0.0 0
M  V30 7 C 9.2401 4.0011 0.0 0
M  V30 8 C 7.7001 1.3338 0.0 0
M  V30 9 C 7.7001 4.0011 0.0 0
M  V30 10 C 6.9301 2.6675 0.0 0
M  V30 11 C 11.5501 2.6675 0.0 0
M  V30 12 C 12.3201 1.3338 0.0 0
M  V30 13 C 12.3201 4.0011 0.0 0
M  V30 14 C 13.8602 1.3338 0.0 0
M  V30 15 C 13.8602 4.0011 0.0 0
M  V30 16 C 14.6302 2.6675 0.0 0
M  V30 17 N 3.0800 4.0011 0.0 0
M  V30 18 C 2.3100 5.3349 0.0 0
M  V30 19 C 2.3100 2.6675 0.0 0
M  V30 20 C 0.7700 5.3349 0.0 0
M  V30 21 C 0.7700 2.6675 0.0 0
M  V30 22 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 10
M  V30 4 1 2 17
M  V30 5 1 3 4
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 5 11
M  V30 9 1 6 8
M  V30 10 2 7 9
M  V30 11 2 8 10
M  V30 12 1 9 10
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 1 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 678197-51-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 678197-54-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-032-CAS-8261795
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, literature prepn.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An easy and convenient synthesis of optically active β-amino alcohols and
1,2-diamines. Applications in enantioselective deprotonation of
cyclohexene oxide
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shin, Sung Hye; Kang, Sang Kyu; Cho, Byung Tae
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bulletin of the Korean Chemical Society (2003), 24(11), 1695-1698

$RFMT $RIREG SCHEME52 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1′-Diethyl 2,2′-[(4,5-dimethyl-1,2-phenylene)diimino]bis[2-oxoacetate]
C16H20N2O6
690958-43-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.2401 5.3348 0.0 0
M  V30 2 C 10.7801 5.3348 0.0 0
M  V30 3 C 11.5501 6.6686 0.0 0
M  V30 4 O 11.5501 4.0011 0.0 0
M  V30 5 O 13.0901 6.6686 0.0 0
M  V30 6 O 10.7801 8.0022 0.0 0
M  V30 7 C 13.8602 8.0022 0.0 0
M  V30 8 C 15.4002 8.0022 0.0 0
M  V30 9 N 6.1601 5.3348 0.0 0
M  V30 10 C 4.6201 5.3348 0.0 0
M  V30 11 C 3.8500 6.6686 0.0 0
M  V30 12 O 3.8500 4.0011 0.0 0
M  V30 13 O 2.3100 6.6686 0.0 0
M  V30 14 O 4.6201 8.0022 0.0 0
M  V30 15 C 1.5400 8.0022 0.0 0
M  V30 16 C 0.0000 8.0022 0.0 0
M  V30 17 C 9.2401 0.0000 0.0 0
M  V30 18 C 6.1601 0.0000 0.0 0
M  V30 19 C 8.4701 4.0011 0.0 0
M  V30 20 C 6.9301 4.0011 0.0 0
M  V30 21 C 9.2401 2.6675 0.0 0
M  V30 22 C 6.1601 2.6675 0.0 0
M  V30 23 C 8.4701 1.3337 0.0 0
M  V30 24 C 6.9301 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 19
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 9 10
M  V30 10 1 9 20
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 13 15
M  V30 16 1 15 16
M  V30 17 1 17 23
M  V30 18 1 18 24
M  V30 19 2 19 20
M  V30 20 1 19 21
M  V30 21 1 20 22
M  V30 22 2 21 23
M  V30 23 2 22 24
M  V30 24 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethanediamide, N1,N1′-(4,5-dimethyl-1,2-phenylene)bis[N2-methyl-
C14H18N4O4
1779491-55-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 5.3348 0.0 0
M  V30 2 C 3.0801 5.3348 0.0 0
M  V30 3 C 2.3101 6.6687 0.0 0
M  V30 4 O 2.3101 4.0012 0.0 0
M  V30 5 N 0.7700 6.6687 0.0 0
M  V30 6 O 3.0801 8.0023 0.0 0
M  V30 7 C 0.0000 8.0023 0.0 0
M  V30 8 N 7.7002 5.3348 0.0 0
M  V30 9 C 9.2402 5.3348 0.0 0
M  V30 10 C 10.0102 6.6687 0.0 0
M  V30 11 O 10.0102 4.0012 0.0 0
M  V30 12 N 11.5503 6.6687 0.0 0
M  V30 13 O 9.2402 8.0023 0.0 0
M  V30 14 C 12.3203 8.0023 0.0 0
M  V30 15 C 4.6201 0.0000 0.0 0
M  V30 16 C 7.7002 0.0000 0.0 0
M  V30 17 C 5.3901 4.0012 0.0 0
M  V30 18 C 6.9302 4.0012 0.0 0
M  V30 19 C 4.6201 2.6675 0.0 0
M  V30 20 C 7.7002 2.6675 0.0 0
M  V30 21 C 5.3901 1.3337 0.0 0
M  V30 22 C 6.9302 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 1 8 9
M  V30 9 1 8 18
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 1 12 14
M  V30 15 1 15 21
M  V30 16 1 16 22
M  V30 17 2 17 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 2 19 21
M  V30 21 2 20 22
M  V30 22 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 690958-43-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1779491-55-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35689507
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Ligand Radical Mediated Water Oxidation by a Family of Copper o-Phenylene
Bis-oxamidate Complexes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chattopadhyay, Samir; Ghatak, Arnab; Ro, Youngju; Guillot, Regis; Halime,
Zakaria; Aukauloo, Ally; Dey, Abhishek
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Inorganic Chemistry (2021), 60(13), 9442-9455

$RFMT $RIREG SCHEME53 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1′-Diethyl 2,2′-[(4,5-dinitro-1,2-phenylene)diimino]bis[2-oxoacetate]
C14H14N4O10
690958-50-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.2401 6.6684 0.0 0
M  V30 2 C 10.7801 6.6684 0.0 0
M  V30 3 C 11.5501 8.0022 0.0 0
M  V30 4 O 11.5501 5.3348 0.0 0
M  V30 5 O 13.0901 8.0022 0.0 0
M  V30 6 O 10.7801 9.3359 0.0 0
M  V30 7 C 13.8602 9.3359 0.0 0
M  V30 8 C 15.4002 9.3359 0.0 0
M  V30 9 N 6.1601 6.6684 0.0 0
M  V30 10 C 4.6201 6.6684 0.0 0
M  V30 11 C 3.8500 8.0022 0.0 0
M  V30 12 O 3.8500 5.3348 0.0 0
M  V30 13 O 2.3100 8.0022 0.0 0
M  V30 14 O 4.6201 9.3359 0.0 0
M  V30 15 C 1.5400 9.3359 0.0 0
M  V30 16 C 0.0000 9.3359 0.0 0
M  V30 17 N 9.2401 1.3337 0.0 0 VAL=5
M  V30 18 O 8.4701 0.0000 0.0 0
M  V30 19 O 10.7801 1.3337 0.0 0
M  V30 20 N 6.1601 1.3337 0.0 0 VAL=5
M  V30 21 O 4.6201 1.3337 0.0 0
M  V30 22 O 6.9301 0.0000 0.0 0
M  V30 23 C 8.4701 5.3348 0.0 0
M  V30 24 C 6.9301 5.3348 0.0 0
M  V30 25 C 9.2401 4.0011 0.0 0
M  V30 26 C 6.1601 4.0011 0.0 0
M  V30 27 C 8.4701 2.6675 0.0 0
M  V30 28 C 6.9301 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 23
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 9 10
M  V30 10 1 9 24
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 13 15
M  V30 16 1 15 16
M  V30 17 2 17 18
M  V30 18 2 17 19
M  V30 19 1 17 27
M  V30 20 2 20 21
M  V30 21 2 20 22
M  V30 22 1 20 28
M  V30 23 2 23 24
M  V30 24 1 23 25
M  V30 25 1 24 26
M  V30 26 2 25 27
M  V30 27 2 26 28
M  V30 28 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C12H12N6O8
2788839-67-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 7.7002 6.6685 0.0 0
M  V30 2 C 9.2402 6.6685 0.0 0
M  V30 3 C 10.0102 8.0023 0.0 0
M  V30 4 O 10.0102 5.3348 0.0 0
M  V30 5 N 11.5503 8.0023 0.0 0
M  V30 6 O 9.2402 9.3360 0.0 0
M  V30 7 C 12.3203 9.3360 0.0 0
M  V30 8 N 4.6201 6.6685 0.0 0
M  V30 9 C 3.0801 6.6685 0.0 0
M  V30 10 C 2.3101 8.0023 0.0 0
M  V30 11 O 2.3101 5.3348 0.0 0
M  V30 12 N 0.7700 8.0023 0.0 0
M  V30 13 O 3.0801 9.3360 0.0 0
M  V30 14 C 0.0000 9.3360 0.0 0
M  V30 15 N 7.7002 1.3337 0.0 0 VAL=5
M  V30 16 O 6.9302 0.0000 0.0 0
M  V30 17 O 9.2402 1.3337 0.0 0
M  V30 18 N 4.6201 1.3337 0.0 0 VAL=5
M  V30 19 O 3.0801 1.3337 0.0 0
M  V30 20 O 5.3901 0.0000 0.0 0
M  V30 21 C 6.9302 5.3348 0.0 0
M  V30 22 C 5.3901 5.3348 0.0 0
M  V30 23 C 7.7002 4.0012 0.0 0
M  V30 24 C 4.6201 4.0012 0.0 0
M  V30 25 C 6.9302 2.6675 0.0 0
M  V30 26 C 5.3901 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 21
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 1 8 9
M  V30 9 1 8 22
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 1 12 14
M  V30 15 2 15 16
M  V30 16 2 15 17
M  V30 17 1 15 25
M  V30 18 2 18 19
M  V30 19 2 18 20
M  V30 20 1 18 26
M  V30 21 2 21 22
M  V30 22 1 21 23
M  V30 23 1 22 24
M  V30 24 2 23 25
M  V30 25 2 24 26
M  V30 26 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 690958-50-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2788839-67-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35689505
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Ligand Radical Mediated Water Oxidation by a Family of Copper o-Phenylene
Bis-oxamidate Complexes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chattopadhyay, Samir; Ghatak, Arnab; Ro, Youngju; Guillot, Regis; Halime,
Zakaria; Aukauloo, Ally; Dey, Abhishek
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Inorganic Chemistry (2021), 60(13), 9442-9455

$RFMT $RIREG SCHEME54 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[2-[4-(Trifluoromethyl)phenyl]hydrazinylidene]propanedinitrile
C10H5F3N4
7089-17-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 6.1601 0.0 0
M  V30 2 F 0.5637 4.8265 0.0 0
M  V30 3 F 0.0000 6.9302 0.0 0
M  V30 4 F 2.1037 7.4938 0.0 0
M  V30 5 N 6.6685 3.0801 0.0 0
M  V30 6 N 8.0022 3.8501 0.0 0
M  V30 7 C 9.3360 3.0801 0.0 0
M  V30 8 C 9.3360 1.5400 0.0 0
M  V30 9 C 10.6697 3.8501 0.0 0
M  V30 10 N 9.3360 0.0000 0.0 0
M  V30 11 N 12.0033 4.6201 0.0 0
M  V30 12 C 2.6673 5.3901 0.0 0
M  V30 13 C 4.0012 6.1601 0.0 0
M  V30 14 C 2.6673 3.8501 0.0 0
M  V30 15 C 5.3348 5.3901 0.0 0
M  V30 16 C 4.0012 3.0801 0.0 0
M  V30 17 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 12
M  V30 5 1 5 6
M  V30 6 1 5 17
M  V30 7 2 6 7
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 3 8 10
M  V30 11 3 9 11
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(Methylamino)-2-[4-(trifluoromethyl)phenyl]-2H-1,2,3-triazole-4-carbonitrile
C11H8F3N5
2414943-17-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.2459 4.8820 0.0 0
M  V30 2 N 0.0000 5.7870 0.0 0
M  V30 3 N 1.2459 1.5315 0.0 0
M  V30 4 C 1.4068 0.0000 0.0 0
M  V30 5 C 11.0215 3.2067 0.0 0
M  V30 6 F 11.0215 1.6667 0.0 0
M  V30 7 F 12.5615 3.2067 0.0 0
M  V30 8 F 11.0215 4.7467 0.0 0
M  V30 9 N 4.8615 3.2067 0.0 0
M  V30 10 N 3.9564 4.4526 0.0 0
M  V30 11 N 3.9564 1.9609 0.0 0
M  V30 12 C 2.4917 3.9767 0.0 0
M  V30 13 C 2.4917 2.4367 0.0 0
M  V30 14 C 6.4015 3.2067 0.0 0
M  V30 15 C 7.1715 1.8729 0.0 0
M  V30 16 C 7.1715 4.5404 0.0 0
M  V30 17 C 8.7115 1.8729 0.0 0
M  V30 18 C 8.7115 4.5404 0.0 0
M  V30 19 C 9.4815 3.2067 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 12
M  V30 3 1 3 4
M  V30 4 1 3 13
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 19
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 14
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 7089-17-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2414943-17-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-30074544
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7782-44-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 142-71-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 110-86-1
$DTYPE RXN:VAR(1):NOTES
$DATUM aerobic (stage 2)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 5-Amino-2-aryl-1,2,3-triazol-4-carboxylic acids: Synthesis, photophysical
properties, and application prospects
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Safronov, Nikita E.; Fomin, Timur O.; Minin, Artem S.; Todorov, Lozan;
Kostova, Irena; Benassi, Enrico; Belskaya, Nataliya P.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Dyes and Pigments (2020), 178108343

$RFMT $RIREG SCHEME55 STEP1
$RXN



  2  1
$MOL
1-(1,1-Dimethylethyl) (3R)-1,3-pyrrolidinedicarboxylate
C10H17NO4
72925-16-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 3.2067 0.0 0
M  V30 2 O 3.0800 4.5405 0.0 0
M  V30 3 O 3.0800 1.8731 0.0 0
M  V30 4 C 1.5400 4.5405 0.0 0
M  V30 5 C 1.5400 3.0005 0.0 0
M  V30 6 C 0.0000 4.5405 0.0 0
M  V30 7 C 1.5400 6.0805 0.0 0
M  V30 8 C 9.0058 1.5317 0.0 0
M  V30 9 O 8.8447 0.0000 0.0 0
M  V30 10 O 10.4126 2.1580 0.0 0
M  V30 11 N 5.3900 3.2067 0.0 0
M  V30 12 C 6.2952 1.9609 0.0 0
M  V30 13 C 6.2952 4.4528 0.0 0
M  V30 14 C 7.7598 2.4367 0.0 0 CFG=2
M  V30 15 C 7.7598 3.9767 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 14 8 CFG=1
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (3R)-3-[(methylamino)carbonyl]-1-pyrrolidinecarboxylate
C11H20N2O3
1160161-51-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 O 2.6673 2.3101 0.0 0
M  V30 3 O 4.0012 0.0000 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 2.1037 0.2064 0.0 0
M  V30 6 C 0.0000 0.7700 0.0 0
M  V30 7 C 0.5637 2.8737 0.0 0
M  V30 8 C 9.3038 2.6672 0.0 0
M  V30 9 N 10.2090 3.9131 0.0 0
M  V30 10 O 9.9301 1.2602 0.0 0
M  V30 11 C 11.7406 3.7521 0.0 0
M  V30 12 N 5.3348 2.3101 0.0 0
M  V30 13 C 6.7417 1.6836 0.0 0
M  V30 14 C 5.4958 3.8416 0.0 0
M  V30 15 C 7.7722 2.8281 0.0 0 CFG=2
M  V30 16 C 7.0022 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 15 8 CFG=1
M  V30 11 1 9 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 72925-16-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1160161-51-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-1573106
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-02-4
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 543-27-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 1: Preparation of
(R)-tert-butyl-3-(methylcarbamoyl)pyrrolidine-1-carboxylic acid
(Intermediate 72A) To a solution of
(R)-1-(tert-butoxycarbonyl)pyrrolidine-3-carboxylic acid (215 mg, 1.0
mmol) in DCM (5 mL) was added 4-methylmorpholine (0.11 mL, 1.00 mmol) and
the mixture was then cooled in an ice water bath. Isobutyl chloroformate
(0.013 mL, 1.00 mmol) was added and reaction was stirred 2 hours. Methyl
amine (0.35 mL of a 40% aqueous solution) was added drop wise and the
mixture was stirred for 2 hours at ice bath temperature. Water (5 mL) was
added and the two layers were separated. The aqueous phase was extracted
with 5 mL of DCM and the combined organic phases were extracted with 10
mL of 1M aqueous H3PO4, dried over anhydrous Na2SO4, filtered and
concentrated in vacuo. The residue was dried in a vacuum oven (-40°C.) to
provide the title compound (212 mg, 0.93 mmol, 93% yield) as a foam that
was used without further purification.
(R)-tert-butyl-3-(methylcarbamoyl)pyrrolidine-1-carboxylic acid
(Intermediate 72A), yield 93% (212 mg, 0.93 mmol) LCMS (+ESI) m/z=173.0
[(M-56)+H]+; 1H-NMR (DMSO d6) δ 7.75 (bs, 1H), 3.23-3.18 (m, 2H),
3.16-3.01 (m, 2H), 2.74 (m, 1H), 2.46 (d, 3H), 1.90-1.69 (m, 2H), 1.27
(s, 9H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Substituted imidazoheterocycle derivatives as cannabinoid receptor
modulators and their preparation, pharmaceutical compositions and use in
the treatment of pain
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Beckett, R. Paul; Foster, Richard; Henault, Christelle; Ralbovsky, Janet
L.; Gauss, Carla M.; Gustafson, Gary R.; Luo, Robert Zhiyong; Campbell,
Ann-Marie; Shelekhin, Tatiana E.; Zablocki, Mary-Margaret E.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20090149450 A1 2009-06-11

$RFMT $RIREG SCHEME56 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Phenyl-5-(2,3,4,5-tetrafluorophenyl)-1,2,4-oxadiazole
C14H6F4N2O
740817-43-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 2.6674 6.1600 0.0 0
M  V30 2 F 0.0000 4.6200 0.0 0
M  V30 3 F 2.6674 0.0000 0.0 0
M  V30 4 F 0.0000 1.5400 0.0 0
M  V30 5 C 5.3347 4.6200 0.0 0
M  V30 6 N 6.7417 3.9935 0.0 0
M  V30 7 O 5.4958 6.1516 0.0 0
M  V30 8 C 7.7721 5.1381 0.0 0
M  V30 9 N 7.0021 6.4717 0.0 0
M  V30 10 C 4.0011 3.8500 0.0 0
M  V30 11 C 2.6674 4.6200 0.0 0
M  V30 12 C 4.0011 2.3100 0.0 0
M  V30 13 C 1.3338 3.8500 0.0 0
M  V30 14 C 2.6674 1.5400 0.0 0
M  V30 15 C 1.3338 2.3100 0.0 0
M  V30 16 C 9.3036 4.9772 0.0 0
M  V30 17 C 9.9301 3.5702 0.0 0
M  V30 18 C 10.2089 6.2230 0.0 0
M  V30 19 C 11.4617 3.4093 0.0 0
M  V30 20 C 11.7404 6.0621 0.0 0
M  V30 21 C 12.3669 4.6551 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 13
M  V30 3 1 3 14
M  V30 4 1 4 15
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 10
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 9
M  V30 11 1 8 16
M  V30 12 2 10 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3,6-Trifluoro-N-methyl-4-(3-phenyl-1,2,4-oxadiazol-5-yl)benzenamine
C15H10F3N3O
1103667-35-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 7.8085 6.7794 0.0 0
M  V30 2 F 10.8885 6.7794 0.0 0
M  V30 3 F 10.8885 1.4447 0.0 0
M  V30 4 N 12.4285 4.1120 0.0 0
M  V30 5 C 13.1985 2.7783 0.0 0
M  V30 6 C 6.2684 4.1120 0.0 0
M  V30 7 N 5.3632 2.8661 0.0 0
M  V30 8 O 5.3632 5.3578 0.0 0
M  V30 9 C 3.8987 3.3420 0.0 0
M  V30 10 N 3.8987 4.8820 0.0 0
M  V30 11 C 7.8085 4.1120 0.0 0
M  V30 12 C 8.5785 5.4456 0.0 0
M  V30 13 C 8.5785 2.7783 0.0 0
M  V30 14 C 10.1185 5.4456 0.0 0
M  V30 15 C 10.1185 2.7783 0.0 0
M  V30 16 C 10.8885 4.1120 0.0 0
M  V30 17 C 2.6528 2.4368 0.0 0
M  V30 18 C 1.2459 3.0632 0.0 0
M  V30 19 C 2.8137 0.9052 0.0 0
M  V30 20 C 0.0000 2.1580 0.0 0
M  V30 21 C 1.5679 0.0000 0.0 0
M  V30 22 C 0.1609 0.6265 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 2 14
M  V30 3 1 3 15
M  V30 4 1 4 5
M  V30 5 1 4 16
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 11
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 10
M  V30 12 1 9 17
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 740817-43-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1103667-35-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-14275622
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective, regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM On the reaction of some 5-polyfluoroaryl-1,2,4-oxadiazoles with
methylhydrazine: synthesis of fluorinated indazoles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Palumbo Piccionello, Antonio; Pace, Andrea; Pierro, Paola; Pibiri, Ivana;
Buscemi, Silvestre; Vivona, Nicolo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2009), 65(1), 119-127

$RFMT $RIREG SCHEME57 STEP1
$RXN



  2  1
$MOL
4-Chlorobenzoic acid
C7H5ClO2
74-11-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 Cl 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-chlorobenzoate
C8H7ClO2
1126-46-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 O 1.5400 2.6673 0.0 0
M  V30 3 O 1.5400 0.0000 0.0 0
M  V30 4 C 0.0000 2.6673 0.0 0
M  V30 5 Cl 8.4702 1.3337 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 4.6201 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 6.1601 0.0000 0.0 0
M  V30 10 C 6.1601 2.6673 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-11-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):AMD
$DATUM reaction products with divinylbenzene-styrene copolymer diazonium salt
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1126-46-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-017-CAS-299055
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 110-71-4
$DTYPE RXN:VAR(1):NOTES
$DATUM solid-supported reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Polymer-supported triazenes as smart reagents for the alkylation of
carboxylic acids
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Erb, Bernhard; Kucma, Jean-Philippe; Mourey, Sandrine; Struber, Fritz
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2003), 9(11), 2582-2588

$RFMT $RIREG SCHEME58 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Diphenylamino)-2-oxoacetyl chloride
C14H10ClNO2
75385-92-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 4.6200 0.0 0
M  V30 2 C 5.3347 5.3900 0.0 0
M  V30 3 C 6.6685 4.6200 0.0 0
M  V30 4 O 5.3347 6.9300 0.0 0
M  V30 5 Cl 6.6685 3.0800 0.0 0
M  V30 6 O 8.0021 5.3900 0.0 0
M  V30 7 C 4.0011 3.0800 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 C 5.3347 2.3100 0.0 0
M  V30 10 C 2.6674 0.7700 0.0 0
M  V30 11 C 5.3347 0.7700 0.0 0
M  V30 12 C 4.0011 0.0000 0.0 0
M  V30 13 C 2.6674 5.3900 0.0 0
M  V30 14 C 1.3336 4.6200 0.0 0
M  V30 15 C 2.6674 6.9300 0.0 0
M  V30 16 C 0.0000 5.3900 0.0 0
M  V30 17 C 1.3336 7.7000 0.0 0
M  V30 18 C 0.0000 6.9300 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 1 13
M  V30 4 1 2 3
M  V30 5 2 2 4
M  V30 6 1 3 5
M  V30 7 2 3 6
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N2-Methyl-N1,N1-diphenylethanediamide
C15H14N2O2
1359824-02-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 4.6201 0.0 0
M  V30 2 C 5.3348 5.3901 0.0 0
M  V30 3 C 6.6684 4.6201 0.0 0
M  V30 4 O 5.3348 6.9301 0.0 0
M  V30 5 N 8.0022 5.3901 0.0 0
M  V30 6 O 6.6684 3.0800 0.0 0
M  V30 7 C 9.3359 4.6201 0.0 0
M  V30 8 C 2.6675 5.3901 0.0 0
M  V30 9 C 2.6675 6.9301 0.0 0
M  V30 10 C 1.3337 4.6201 0.0 0
M  V30 11 C 1.3337 7.7001 0.0 0
M  V30 12 C 0.0000 5.3901 0.0 0
M  V30 13 C 0.0000 6.9301 0.0 0
M  V30 14 C 4.0011 3.0800 0.0 0
M  V30 15 C 5.3348 2.3100 0.0 0
M  V30 16 C 2.6675 2.3100 0.0 0
M  V30 17 C 5.3348 0.7700 0.0 0
M  V30 18 C 2.6675 0.7700 0.0 0
M  V30 19 C 4.0011 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 1 14
M  V30 4 1 2 3
M  V30 5 2 2 4
M  V30 6 1 3 5
M  V30 7 2 3 6
M  V30 8 1 5 7
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75385-92-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1359824-02-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-1233417
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and Synthesis of Novel Diphenyl Oxalamide and Diphenyl Acetamide
Derivatives as Anticonvulsants
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nikalje, Anna Pratima G.; Ghodke, Mangesh; Girbane, Amol
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Archiv der Pharmazie (Weinheim, Germany) (2012), 345(1), 57-64

$RFMT $RIREG SCHEME59 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methoxy-2-(1-methylethoxy)benzaldehyde
C11H14O3
75792-35-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0011 2.3100 0.0 0
M  V30 2 C 2.6675 1.5400 0.0 0
M  V30 3 C 2.6675 0.0000 0.0 0
M  V30 4 C 1.3337 2.3100 0.0 0
M  V30 5 C 1.3337 3.8500 0.0 0
M  V30 6 O 0.0000 4.6201 0.0 0
M  V30 7 O 6.6686 3.8500 0.0 0
M  V30 8 C 8.0022 4.6201 0.0 0
M  V30 9 C 4.0011 3.8500 0.0 0
M  V30 10 C 2.6675 4.6201 0.0 0
M  V30 11 C 5.3348 4.6201 0.0 0
M  V30 12 C 2.6675 6.1601 0.0 0
M  V30 13 C 5.3348 6.1601 0.0 0
M  V30 14 C 4.0011 6.9301 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 1 5 10
M  V30 7 1 7 8
M  V30 8 1 7 11
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methoxy-N-methyl-2-(1-methylethoxy)benzenemethanamine
C12H19NO2
709649-54-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 2.3101 0.0 0
M  V30 2 C 2.6675 1.5400 0.0 0
M  V30 3 C 2.6675 0.0000 0.0 0
M  V30 4 C 1.3337 2.3101 0.0 0
M  V30 5 C 6.6685 3.8501 0.0 0
M  V30 6 N 8.0023 4.6201 0.0 0
M  V30 7 C 9.3360 3.8501 0.0 0
M  V30 8 O 1.3337 3.8501 0.0 0
M  V30 9 C 0.0000 4.6201 0.0 0
M  V30 10 C 4.0012 3.8501 0.0 0
M  V30 11 C 5.3348 4.6201 0.0 0
M  V30 12 C 2.6675 4.6201 0.0 0
M  V30 13 C 5.3348 6.1601 0.0 0
M  V30 14 C 2.6675 6.1601 0.0 0
M  V30 15 C 4.0012 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 11
M  V30 7 1 6 7
M  V30 8 1 8 9
M  V30 9 1 8 12
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75792-35-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 709649-54-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-4031515
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Preparation 67 Preparation of
Methyl-(1-propyl-naphthalen-2-ylmethyl)amine b)
(2-Isopropoxy-3-methoxy-benzyl)methylamine [0830] According to the
procedure of Preparation 67, except substituting
2-isopropoxy-3-methoxy-benzaldehyde for
1-propyl-naphthalene-2-carbaldehyde, the title compound (6.39 g, 93%) was
prepared as a yellow oil. MS (ESI) m/e 210 (M+H)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20060142265 A1 2006-06-29

$RFMT $RIREG SCHEME59 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methoxy-2-(1-methylethoxy)benzaldehyde
C11H14O3
75792-35-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0011 2.3100 0.0 0
M  V30 2 C 2.6675 1.5400 0.0 0
M  V30 3 C 2.6675 0.0000 0.0 0
M  V30 4 C 1.3337 2.3100 0.0 0
M  V30 5 C 1.3337 3.8500 0.0 0
M  V30 6 O 0.0000 4.6201 0.0 0
M  V30 7 O 6.6686 3.8500 0.0 0
M  V30 8 C 8.0022 4.6201 0.0 0
M  V30 9 C 4.0011 3.8500 0.0 0
M  V30 10 C 2.6675 4.6201 0.0 0
M  V30 11 C 5.3348 4.6201 0.0 0
M  V30 12 C 2.6675 6.1601 0.0 0
M  V30 13 C 5.3348 6.1601 0.0 0
M  V30 14 C 4.0011 6.9301 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 1 5 10
M  V30 7 1 7 8
M  V30 8 1 7 11
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methoxy-N-methyl-2-(1-methylethoxy)benzenemethanamine
C12H19NO2
709649-54-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 2.3101 0.0 0
M  V30 2 C 2.6675 1.5400 0.0 0
M  V30 3 C 2.6675 0.0000 0.0 0
M  V30 4 C 1.3337 2.3101 0.0 0
M  V30 5 C 6.6685 3.8501 0.0 0
M  V30 6 N 8.0023 4.6201 0.0 0
M  V30 7 C 9.3360 3.8501 0.0 0
M  V30 8 O 1.3337 3.8501 0.0 0
M  V30 9 C 0.0000 4.6201 0.0 0
M  V30 10 C 4.0012 3.8501 0.0 0
M  V30 11 C 5.3348 4.6201 0.0 0
M  V30 12 C 2.6675 4.6201 0.0 0
M  V30 13 C 5.3348 6.1601 0.0 0
M  V30 14 C 2.6675 6.1601 0.0 0
M  V30 15 C 4.0012 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 11
M  V30 7 1 6 7
M  V30 8 1 8 9
M  V30 9 1 8 12
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75792-35-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 709649-54-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-2910920
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004082586 A2 2004-09-30

$RFMT $RIREG SCHEME59 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methoxy-2-(1-methylethoxy)benzaldehyde
C11H14O3
75792-35-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0011 2.3100 0.0 0
M  V30 2 C 2.6675 1.5400 0.0 0
M  V30 3 C 2.6675 0.0000 0.0 0
M  V30 4 C 1.3337 2.3100 0.0 0
M  V30 5 C 1.3337 3.8500 0.0 0
M  V30 6 O 0.0000 4.6201 0.0 0
M  V30 7 O 6.6686 3.8500 0.0 0
M  V30 8 C 8.0022 4.6201 0.0 0
M  V30 9 C 4.0011 3.8500 0.0 0
M  V30 10 C 2.6675 4.6201 0.0 0
M  V30 11 C 5.3348 4.6201 0.0 0
M  V30 12 C 2.6675 6.1601 0.0 0
M  V30 13 C 5.3348 6.1601 0.0 0
M  V30 14 C 4.0011 6.9301 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 1 5 10
M  V30 7 1 7 8
M  V30 8 1 7 11
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methoxy-N-methyl-2-(1-methylethoxy)benzenemethanamine
C12H19NO2
709649-54-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 2.3101 0.0 0
M  V30 2 C 2.6675 1.5400 0.0 0
M  V30 3 C 2.6675 0.0000 0.0 0
M  V30 4 C 1.3337 2.3101 0.0 0
M  V30 5 C 6.6685 3.8501 0.0 0
M  V30 6 N 8.0023 4.6201 0.0 0
M  V30 7 C 9.3360 3.8501 0.0 0
M  V30 8 O 1.3337 3.8501 0.0 0
M  V30 9 C 0.0000 4.6201 0.0 0
M  V30 10 C 4.0012 3.8501 0.0 0
M  V30 11 C 5.3348 4.6201 0.0 0
M  V30 12 C 2.6675 4.6201 0.0 0
M  V30 13 C 5.3348 6.1601 0.0 0
M  V30 14 C 2.6675 6.1601 0.0 0
M  V30 15 C 4.0012 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 11
M  V30 7 1 6 7
M  V30 8 1 8 9
M  V30 9 1 8 12
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75792-35-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 709649-54-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-8131300
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Preparation of
Methyl-(1-propyl-naphthalen-2-ylmethyl)amine A solution of 2.0 M
methylamine in methanol (20 mL) was added to
1-propylnaphthalene-2-carbaldehyde (0.983 g, 4.95 mmol) under N2 and
allowed to stir for 18 h. The solution was concentrated under reduced
pressure. Then the resulting dark yellow oil was solvated in EtOH (20 mL)
under N2. To the solution was added NaBH4 (0.187 g, 4.95 mmol) and the
mixture allowed to stir for 6.5 h. The reaction was concentrated under
reduced pressure, then solvated in 1 N NaOH (20 mL) and extracted with
Et2O (3 x 50 mL). The organics were combined, washed with brine (2 x 100
mL), dried over Na2SO4, filtered and concentrated to yield the title
compound as a yellow oil. b) (2-Isopropoxy-3-methoxy-benzyl)methylamine
According to the procedure of Preparation 1, except substituting
2-isopropoxy-3-methoxy-benzaldehyde for
1-propyl-naphthalene-2-carbaldehyde, the title compound (6.39 g, 93%) was
prepared as a yellow oil. MS (ESI) m/e 210 (M + H)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocyclic compounds as antibacterial agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd; Sampson, Peter; Pauls, Heinz W.; Ramnauth, Jailall;
Manning, David Douglas; Surman, Matthew David; Xie, Dejian; Decornez,
Helene Yvonne
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004052890 A1 2004-06-24

$RFMT $RIREG SCHEME60 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dimethyl acetylenedicarboxylate
C6H6O4
762-42-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 O 8.0023 2.3101 0.0 0
M  V30 4 O 6.6685 0.0000 0.0 0
M  V30 5 C 4.0012 3.0801 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 O 1.3337 3.0801 0.0 0
M  V30 9 O 2.6675 5.3901 0.0 0
M  V30 10 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 3 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,2-Dimethylpropanoyl isothiocyanate
C6H9NOS
93700-38-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 1.5400 0.0 0
M  V30 2 C 1.5400 1.5400 0.0 0
M  V30 3 N 3.8500 2.8736 0.0 0
M  V30 4 O 3.8500 0.2064 0.0 0
M  V30 5 C 1.5400 3.0800 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 1.5400 0.0000 0.0 0
M  V30 8 C 5.3900 2.8736 0.0 0
M  V30 9 S 6.9300 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 2 7
M  V30 7 2 3 8
M  V30 8 2 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,5-Dimethyl 2-(methylamino)-4,5-thiazoledicarboxylate
C8H10N2O4S
59026-88-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.3450 2.6675 0.0 0
M  V30 2 O 4.1150 1.3338 0.0 0
M  V30 3 O 1.8049 2.6675 0.0 0
M  V30 4 C 3.3450 0.0000 0.0 0
M  V30 5 C 1.9822 5.7283 0.0 0
M  V30 6 O 1.5063 7.1929 0.0 0
M  V30 7 O 0.9517 4.5838 0.0 0
M  V30 8 C 0.0000 7.5132 0.0 0
M  V30 9 N 7.3737 6.2949 0.0 0
M  V30 10 C 8.6196 5.3898 0.0 0
M  V30 11 C 4.1150 4.0012 0.0 0
M  V30 12 C 3.4886 5.4081 0.0 0
M  V30 13 N 5.6465 4.1622 0.0 0
M  V30 14 S 4.6330 6.4386 0.0 0
M  V30 15 C 5.9669 5.6686 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 12
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 15
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 762-42-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 93700-38-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 59026-88-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25333207
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-45-9
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1314-13-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-solvent, optimization study, optimized on catalyst,
optimized on stoichiometry of catalyst, optimized on solvent, optimized
on time
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM ZnO-NR as the efficient catalyst for the synthesis of new thiazole and
cyclopentadienone phosphonate derivatives in water
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hossaini, Zinatossadat; Zareyee, Daryoush; Sheikholeslami-Farahani,
Fatemeh; Vaseghi, Samaneh; Zamani, Afshin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Heteroatom Chemistry (2017), 28(2), n/a

$RFMT $RIREG SCHEME61 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,5-Dihydro-1-methyl-8-(phenylamino)-1H-pyrazolo[4,3-h]quinazoline-3-carboxyl...
C17H15N5O2
802535-83-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7254 0.0000 0.0 0
M  V30 2 N 10.3498 2.6507 0.0 0
M  V30 3 C 1.0304 2.7105 0.0 0
M  V30 4 O 0.5546 4.1752 0.0 0
M  V30 5 O 0.0000 1.5661 0.0 0
M  V30 6 C 6.3488 3.4207 0.0 0
M  V30 7 C 5.0150 2.6507 0.0 0
M  V30 8 C 6.3488 4.9608 0.0 0
M  V30 9 N 7.6825 2.6507 0.0 0
M  V30 10 C 3.6813 3.4207 0.0 0
M  V30 11 N 4.6948 1.1444 0.0 0
M  V30 12 C 5.0150 5.7308 0.0 0
M  V30 13 C 7.6825 5.7308 0.0 0
M  V30 14 C 9.0161 3.4207 0.0 0
M  V30 15 C 2.5369 2.3903 0.0 0
M  V30 16 C 3.6813 4.9608 0.0 0
M  V30 17 N 3.1632 0.9835 0.0 0
M  V30 18 N 9.0161 4.9608 0.0 0
M  V30 19 C 11.6836 3.4207 0.0 0
M  V30 20 C 13.0173 2.6507 0.0 0
M  V30 21 C 11.6836 4.9608 0.0 0
M  V30 22 C 14.3510 3.4207 0.0 0
M  V30 23 C 13.0173 5.7308 0.0 0
M  V30 24 C 14.3510 4.9608 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 14
M  V30 3 1 2 19
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 15
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 2 7 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 2 8 13
M  V30 14 1 9 14
M  V30 15 1 10 15
M  V30 16 1 10 16
M  V30 17 1 11 17
M  V30 18 1 12 16
M  V30 19 1 13 18
M  V30 20 2 14 18
M  V30 21 2 15 17
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,5-Dihydro-N,1-dimethyl-8-(phenylamino)-1H-pyrazolo[4,3-h]quinazoline-3-carb...
C18H18N6O
802537-65-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.6257 0.0000 0.0 0
M  V30 2 C 13.3205 2.7105 0.0 0
M  V30 3 N 14.3510 1.5661 0.0 0
M  V30 4 O 13.7964 4.1752 0.0 0
M  V30 5 C 15.8574 1.8862 0.0 0
M  V30 6 N 4.0012 2.6507 0.0 0
M  V30 7 C 9.3360 2.6507 0.0 0
M  V30 8 C 8.0023 3.4207 0.0 0
M  V30 9 C 10.6697 3.4207 0.0 0
M  V30 10 N 9.6562 1.1444 0.0 0
M  V30 11 C 8.0023 4.9608 0.0 0
M  V30 12 N 6.6685 2.6507 0.0 0
M  V30 13 C 11.8142 2.3903 0.0 0
M  V30 14 C 10.6697 4.9608 0.0 0
M  V30 15 N 11.1877 0.9835 0.0 0
M  V30 16 C 9.3360 5.7308 0.0 0
M  V30 17 C 6.6685 5.7308 0.0 0
M  V30 18 C 5.3348 3.4207 0.0 0
M  V30 19 N 5.3348 4.9608 0.0 0
M  V30 20 C 2.6675 3.4207 0.0 0
M  V30 21 C 1.3337 2.6507 0.0 0
M  V30 22 C 2.6675 4.9608 0.0 0
M  V30 23 C 0.0000 3.4207 0.0 0
M  V30 24 C 1.3337 5.7308 0.0 0
M  V30 25 C 0.0000 4.9608 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 13
M  V30 5 1 3 5
M  V30 6 1 6 18
M  V30 7 1 6 20
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 2 8 12
M  V30 13 1 9 13
M  V30 14 1 9 14
M  V30 15 1 10 15
M  V30 16 1 11 16
M  V30 17 2 11 17
M  V30 18 1 12 18
M  V30 19 2 13 15
M  V30 20 1 14 16
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 802535-83-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 802537-65-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-10873907
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1892-57-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):NOTES
$DATUM 60-93% yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and SAR of new pyrazolo[4,3-h]quinazoline-3-carboxamide
derivatives as potent and selective MPS1 kinase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Caldarelli, Marina; Angiolini, Mauro; Disingrini, Teresa; Donati,
Daniele; Guanci, Marco; Nuvoloni, Stefano; Posteri, Helena; Quartieri,
Francesca; Silvagni, Marco; Colombo, Riccardo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2011), 21(15), 4507-4511

$RFMT $RIREG SCHEME61 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,5-Dihydro-1-methyl-8-(phenylamino)-1H-pyrazolo[4,3-h]quinazoline-3-carboxyl...
C17H15N5O2
802535-83-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7254 0.0000 0.0 0
M  V30 2 N 10.3498 2.6507 0.0 0
M  V30 3 C 1.0304 2.7105 0.0 0
M  V30 4 O 0.5546 4.1752 0.0 0
M  V30 5 O 0.0000 1.5661 0.0 0
M  V30 6 C 6.3488 3.4207 0.0 0
M  V30 7 C 5.0150 2.6507 0.0 0
M  V30 8 C 6.3488 4.9608 0.0 0
M  V30 9 N 7.6825 2.6507 0.0 0
M  V30 10 C 3.6813 3.4207 0.0 0
M  V30 11 N 4.6948 1.1444 0.0 0
M  V30 12 C 5.0150 5.7308 0.0 0
M  V30 13 C 7.6825 5.7308 0.0 0
M  V30 14 C 9.0161 3.4207 0.0 0
M  V30 15 C 2.5369 2.3903 0.0 0
M  V30 16 C 3.6813 4.9608 0.0 0
M  V30 17 N 3.1632 0.9835 0.0 0
M  V30 18 N 9.0161 4.9608 0.0 0
M  V30 19 C 11.6836 3.4207 0.0 0
M  V30 20 C 13.0173 2.6507 0.0 0
M  V30 21 C 11.6836 4.9608 0.0 0
M  V30 22 C 14.3510 3.4207 0.0 0
M  V30 23 C 13.0173 5.7308 0.0 0
M  V30 24 C 14.3510 4.9608 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 14
M  V30 3 1 2 19
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 15
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 2 7 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 2 8 13
M  V30 14 1 9 14
M  V30 15 1 10 15
M  V30 16 1 10 16
M  V30 17 1 11 17
M  V30 18 1 12 16
M  V30 19 1 13 18
M  V30 20 2 14 18
M  V30 21 2 15 17
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,5-Dihydro-N,1-dimethyl-8-(phenylamino)-1H-pyrazolo[4,3-h]quinazoline-3-carb...
C18H18N6O
802537-65-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.6257 0.0000 0.0 0
M  V30 2 C 13.3205 2.7105 0.0 0
M  V30 3 N 14.3510 1.5661 0.0 0
M  V30 4 O 13.7964 4.1752 0.0 0
M  V30 5 C 15.8574 1.8862 0.0 0
M  V30 6 N 4.0012 2.6507 0.0 0
M  V30 7 C 9.3360 2.6507 0.0 0
M  V30 8 C 8.0023 3.4207 0.0 0
M  V30 9 C 10.6697 3.4207 0.0 0
M  V30 10 N 9.6562 1.1444 0.0 0
M  V30 11 C 8.0023 4.9608 0.0 0
M  V30 12 N 6.6685 2.6507 0.0 0
M  V30 13 C 11.8142 2.3903 0.0 0
M  V30 14 C 10.6697 4.9608 0.0 0
M  V30 15 N 11.1877 0.9835 0.0 0
M  V30 16 C 9.3360 5.7308 0.0 0
M  V30 17 C 6.6685 5.7308 0.0 0
M  V30 18 C 5.3348 3.4207 0.0 0
M  V30 19 N 5.3348 4.9608 0.0 0
M  V30 20 C 2.6675 3.4207 0.0 0
M  V30 21 C 1.3337 2.6507 0.0 0
M  V30 22 C 2.6675 4.9608 0.0 0
M  V30 23 C 0.0000 3.4207 0.0 0
M  V30 24 C 1.3337 5.7308 0.0 0
M  V30 25 C 0.0000 4.9608 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 13
M  V30 5 1 3 5
M  V30 6 1 6 18
M  V30 7 1 6 20
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 2 8 12
M  V30 13 1 9 13
M  V30 14 1 9 14
M  V30 15 1 10 15
M  V30 16 1 11 16
M  V30 17 2 11 17
M  V30 18 1 12 18
M  V30 19 2 13 15
M  V30 20 1 14 16
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 802535-83-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 802537-65-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-1741767
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM N,1-Dimethyl-8-(phenylamino)-4,5-dihydro-1H-pyrazolo[4,3-h]-quinazoline-3-carboxamide
(16). To a solution of 2 (150 mg, 0.46 mmol) in anhydrous DMF (5 mL) were
added N,N-diisopropylethylamine (0.12 mL, 0.69 mmol), HOBT (93 mg, 0.69
mmol), EDC (131 mg, 0.69 mmol), 2M methylamine in THF (0.345 mL, 0.69
mmol), and the reaction mixture was stirred at room temperature
overnight. The reaction mixture was poured into water (25 mL) and
extracted with dichloromethane (4 × 25 mL). The combined organic extracts
were washed with water and dried over Na2SO4, and the solvent was removed
under reduced pressure. The crude was purified by flash chromatography on
silica gel (dichloromethane/methanol, 98/2) to afford 16 (141 mg, 92%).
mp>250 °C; 1H NMR (400 MHz, DMSO-d 6) δ 9.50 (s, 1H), 8.40 (s, 1H), 8.07
(q, J = 4.9 Hz, 1H), 7.69-7.71 (m, 2H), 7.30 (m, 2H), 6.96 (m, 1H), 4.33
(s, 3H), 2.99 (t, J = 7.9 Hz, 2H), 2.81 (t, J = 7.9 Hz, 2H), 2.73 (d, J =
4.9Hz, 3H); LCMS (ESI) m/z 335 (M + H) + ; HRMS (ESI) calcd for C18H18N6O
+ H + 335.1615, found 335.1627.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Identification of
N,1,4,4-Tetramethyl-8-{[4-(4-methylpiperazin-1-yl)phenyl]amino}-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide
(PHA-848125), a Potent, Orally Available Cyclin Dependent Kinase
Inhibitor
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Brasca, Maria Gabriella; Amboldi, Nadia; Ballinari, Dario; Cameron,
Alexander; Casale, Elena; Cervi, Giovanni; Colombo, Maristella; Colotta,
Francesco; Croci, Valter; D'Alessio, Roberto; Fiorentini, Francesco;
Isacchi, Antonella; Mercurio, Ciro; Moretti, Walter; Panzeri, Achille;
Pastori, Wilma; Pevarello, Paolo; Quartieri, Francesca; Roletto, Fulvia;
Traquandi, Gabriella; Vianello, Paola; Vulpetti, Anna; Ciomei, Marina
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2009), 52(16), 5152-5163

$RFMT $RIREG SCHEME62 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1′-Dimethyl 2,2′-[carbonylbis(oxy)]bis[benzoate]
C17H14O7
82091-12-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.0102 6.6685 0.0 0
M  V30 2 O 11.5503 6.6685 0.0 0
M  V30 3 O 9.2402 5.3348 0.0 0
M  V30 4 C 12.3203 5.3348 0.0 0
M  V30 5 O 6.9302 6.6685 0.0 0
M  V30 6 C 5.3901 6.6685 0.0 0
M  V30 7 O 4.6201 5.3348 0.0 0
M  V30 8 O 4.6201 8.0023 0.0 0
M  V30 9 C 3.0801 2.6673 0.0 0
M  V30 10 O 2.3101 1.3337 0.0 0
M  V30 11 O 4.6201 2.6673 0.0 0
M  V30 12 C 3.0801 0.0000 0.0 0
M  V30 13 C 9.2402 8.0023 0.0 0
M  V30 14 C 7.7002 8.0023 0.0 0
M  V30 15 C 10.0102 9.3360 0.0 0
M  V30 16 C 6.9302 9.3360 0.0 0
M  V30 17 C 9.2402 10.6697 0.0 0
M  V30 18 C 7.7002 10.6697 0.0 0
M  V30 19 C 3.0801 5.3348 0.0 0
M  V30 20 C 2.3101 4.0012 0.0 0
M  V30 21 C 2.3101 6.6685 0.0 0
M  V30 22 C 0.7700 4.0012 0.0 0
M  V30 23 C 0.7700 6.6685 0.0 0
M  V30 24 C 0.0000 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 14
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 7 19
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 9 20
M  V30 13 1 10 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-[[(methylamino)carbonyl]oxy]benzoate
C10H11NO4
76353-78-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 4.0011 0.0 0
M  V30 2 O 0.7700 4.0011 0.0 0
M  V30 3 O 3.0800 5.3349 0.0 0
M  V30 4 C 0.0000 5.3349 0.0 0
M  V30 5 O 5.3900 4.0011 0.0 0
M  V30 6 C 6.9300 4.0011 0.0 0
M  V30 7 N 7.7000 5.3349 0.0 0
M  V30 8 O 7.7000 2.6674 0.0 0
M  V30 9 C 9.2400 5.3349 0.0 0
M  V30 10 C 3.0800 2.6674 0.0 0
M  V30 11 C 4.6200 2.6674 0.0 0
M  V30 12 C 2.3100 1.3338 0.0 0
M  V30 13 C 5.3900 1.3338 0.0 0
M  V30 14 C 3.0800 0.0000 0.0 0
M  V30 15 C 4.6200 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 11
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 82091-12-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 76353-78-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-1731137
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Protonation Switching to the Least-Basic Heteroatom of Carbamate through
Cationic Hydrogen Bonding Promotes the Formation of Isocyanate Cations
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kurouchi, Hiroaki; Sumita, Akinari; Otani, Yuko; Ohwada, Tomohiko
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2014), 20(28), 8682-8690

$RFMT $RIREG SCHEME63 STEP1
$RXN



  2  1
$MOL
Benzoic acid, 2-[2-(2-methoxyphenyl)ethenyl]-, (E)-
C16H14O3
85164-33-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.0011 0.0 0
M  V30 2 C 6.1600 4.0011 0.0 0
M  V30 3 C 1.5400 4.0011 0.0 0
M  V30 4 O 0.0000 4.0011 0.0 0
M  V30 5 O 2.3100 5.3347 0.0 0
M  V30 6 O 9.2400 4.0011 0.0 0
M  V30 7 C 10.7800 4.0011 0.0 0
M  V30 8 C 3.8500 2.6674 0.0 0
M  V30 9 C 2.3100 2.6674 0.0 0
M  V30 10 C 4.6200 1.3336 0.0 0
M  V30 11 C 1.5400 1.3336 0.0 0
M  V30 12 C 3.8500 0.0000 0.0 0
M  V30 13 C 2.3100 0.0000 0.0 0
M  V30 14 C 6.9300 5.3347 0.0 0
M  V30 15 C 8.4700 5.3347 0.0 0
M  V30 16 C 6.1600 6.6685 0.0 0
M  V30 17 C 9.2400 6.6685 0.0 0
M  V30 18 C 6.9300 8.0021 0.0 0
M  V30 19 C 8.4700 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 8
M  V30 3 1 2 14
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 9
M  V30 7 1 6 7
M  V30 8 1 6 15
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[(1E)-2-(2-Methoxyphenyl)ethenyl]-N-methylbenzamide
C17H17NO2
2874204-21-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 4.0011 0.0 0
M  V30 2 C 6.9300 4.0011 0.0 0
M  V30 3 C 2.3100 4.0011 0.0 0
M  V30 4 N 0.7700 4.0011 0.0 0
M  V30 5 O 3.0800 5.3347 0.0 0
M  V30 6 C 0.0000 5.3347 0.0 0
M  V30 7 O 10.0100 4.0011 0.0 0
M  V30 8 C 11.5500 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 2.6674 0.0 0
M  V30 11 C 5.3900 1.3336 0.0 0
M  V30 12 C 2.3100 1.3336 0.0 0
M  V30 13 C 4.6200 0.0000 0.0 0
M  V30 14 C 3.0800 0.0000 0.0 0
M  V30 15 C 7.7000 5.3347 0.0 0
M  V30 16 C 9.2400 5.3347 0.0 0
M  V30 17 C 6.9300 6.6685 0.0 0
M  V30 18 C 10.0100 6.6685 0.0 0
M  V30 19 C 7.7000 8.0021 0.0 0
M  V30 20 C 9.2400 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 9
M  V30 3 1 2 15
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 10
M  V30 7 1 4 6
M  V30 8 1 7 8
M  V30 9 1 7 16
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 85164-33-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2874204-21-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35010596
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM 1.08 mmol scale used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Metal- and Oxidant-Free Electrosynthesis of Heterocycles from
1,2-Diarylalkene Derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yu, Eunsoo; Kim, Hyungguk; Park, Cheol-Min
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Advanced Synthesis & Catalysis (2022), 364(23), 4088-4096

$RFMT $RIREG SCHEME64 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[2-(2-Iodoethoxy)ethyl]-3-methoxy-5-nitro-1H-indazole
C12H14IN3O4
852378-47-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3304 1.0304 0.0 0
M  V30 2 C 6.4749 0.0000 0.0 0
M  V30 3 C 8.0410 5.7252 0.0 0
M  V30 4 C 9.5057 5.2494 0.0 0
M  V30 5 O 10.6501 6.2798 0.0 0
M  V30 6 C 12.1148 5.8039 0.0 0
M  V30 7 C 13.2592 6.8344 0.0 0
M  V30 8 I 14.7240 6.3585 0.0 0
M  V30 9 N 0.7700 5.0150 0.0 0 VAL=5
M  V30 10 O 0.0000 3.6813 0.0 0
M  V30 11 O 0.0000 6.3486 0.0 0
M  V30 12 C 4.6201 3.6813 0.0 0
M  V30 13 C 5.3901 5.0150 0.0 0
M  V30 14 C 5.6507 2.5367 0.0 0
M  V30 15 C 3.0801 3.6813 0.0 0
M  V30 16 N 6.8966 4.6948 0.0 0
M  V30 17 C 4.6201 6.3486 0.0 0
M  V30 18 N 7.0575 3.1632 0.0 0
M  V30 19 C 2.3101 5.0150 0.0 0
M  V30 20 C 3.0801 6.3486 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 3 4
M  V30 4 1 3 16
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 2 9 10
M  V30 10 2 9 11
M  V30 11 1 9 19
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 2 12 15
M  V30 15 1 13 16
M  V30 16 2 13 17
M  V30 17 2 14 18
M  V30 18 1 15 19
M  V30 19 1 16 18
M  V30 20 1 17 20
M  V30 21 2 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[2-(3-Methoxy-5-nitro-1H-indazol-1-yl)ethoxy]-N-methylethanamine
C13H18N4O4
1575505-19-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3302 1.0304 0.0 0
M  V30 2 C 6.4746 0.0000 0.0 0
M  V30 3 C 8.0406 5.7253 0.0 0
M  V30 4 C 9.5053 5.2492 0.0 0
M  V30 5 O 10.6497 6.2798 0.0 0
M  V30 6 C 12.1144 5.8040 0.0 0
M  V30 7 C 13.2588 6.8344 0.0 0
M  V30 8 N 14.7235 6.3585 0.0 0
M  V30 9 C 15.8679 7.3889 0.0 0
M  V30 10 N 0.7700 5.0149 0.0 0 VAL=5
M  V30 11 O 0.0000 3.6812 0.0 0
M  V30 12 O 0.0000 6.3487 0.0 0
M  V30 13 C 4.6200 3.6812 0.0 0
M  V30 14 C 5.3900 5.0149 0.0 0
M  V30 15 C 5.6504 2.5368 0.0 0
M  V30 16 C 3.0800 3.6812 0.0 0
M  V30 17 N 6.8963 4.6947 0.0 0
M  V30 18 C 4.6200 6.3487 0.0 0
M  V30 19 N 7.0572 3.1632 0.0 0
M  V30 20 C 2.3100 5.0149 0.0 0
M  V30 21 C 3.0800 6.3487 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 3 4
M  V30 4 1 3 17
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 2 10 11
M  V30 11 2 10 12
M  V30 12 1 10 20
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 2 13 16
M  V30 16 1 14 17
M  V30 17 2 14 18
M  V30 18 2 15 19
M  V30 19 1 16 20
M  V30 20 1 17 19
M  V30 21 1 18 21
M  V30 22 2 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 852378-47-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1575505-19-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-4749708
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM New perspectives on the synthesis and antichagasic activity of
3-alkoxy-1-alkyl-5-nitroindazoles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Muro, Beatriz; Reviriego, Felipe; Navarro, Pilar; Marin, Clotilde;
Ramirez-Macias, Inmaculada; Rosales, Maria Jose; Sanchez-Moreno, Manuel;
Aran, Vicente J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2014), 74124-134

$RFMT $RIREG SCHEME65 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methanone, (3-chlorophenyl)(2-fluoro-5-methyl-3-pyridinyl)-
C13H9ClFNO
852510-34-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 4.6200 0.0 0
M  V30 2 O 4.0011 6.1600 0.0 0
M  V30 3 F 1.3336 6.1600 0.0 0
M  V30 4 C 1.3336 0.0000 0.0 0
M  V30 5 Cl 9.3358 4.6200 0.0 0
M  V30 6 C 2.6674 3.8500 0.0 0
M  V30 7 C 1.3336 4.6200 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 N 0.0000 3.8500 0.0 0
M  V30 10 C 1.3336 1.5400 0.0 0
M  V30 11 C 0.0000 2.3100 0.0 0
M  V30 12 C 5.3347 3.8500 0.0 0
M  V30 13 C 6.6684 4.6200 0.0 0
M  V30 14 C 5.3347 2.3100 0.0 0
M  V30 15 C 8.0021 3.8500 0.0 0
M  V30 16 C 6.6684 1.5400 0.0 0
M  V30 17 C 8.0021 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 1 1 12
M  V30 4 1 3 7
M  V30 5 1 4 10
M  V30 6 1 5 15
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methanone, (3-chlorophenyl)[5-methyl-2-(methylamino)-3-pyridinyl]-
C14H13ClN2O
852510-35-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 4.6200 0.0 0
M  V30 2 O 4.0011 6.1600 0.0 0
M  V30 3 N 1.3336 6.1600 0.0 0
M  V30 4 C 0.0000 6.9300 0.0 0
M  V30 5 C 1.3336 0.0000 0.0 0
M  V30 6 Cl 9.3358 4.6200 0.0 0
M  V30 7 C 2.6674 3.8500 0.0 0
M  V30 8 C 1.3336 4.6200 0.0 0
M  V30 9 C 2.6674 2.3100 0.0 0
M  V30 10 N 0.0000 3.8500 0.0 0
M  V30 11 C 1.3336 1.5400 0.0 0
M  V30 12 C 0.0000 2.3100 0.0 0
M  V30 13 C 5.3347 3.8500 0.0 0
M  V30 14 C 6.6684 4.6200 0.0 0
M  V30 15 C 5.3347 2.3100 0.0 0
M  V30 16 C 8.0021 3.8500 0.0 0
M  V30 17 C 6.6684 1.5400 0.0 0
M  V30 18 C 8.0021 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 1 13
M  V30 4 1 3 4
M  V30 5 1 3 8
M  V30 6 1 5 11
M  V30 7 1 6 16
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 852510-34-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 852510-35-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-2234354
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis, and activity of achiral analogs of 2-quinolones and
indoles as non-thiol farnesyltransferase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Qun; Woods, Keith W.; Wang, Weibo; Lin, Nan-Horng; Claiborne, Akiyo;
Gu, Wen-zhen; Cohen, Jerry; Stoll, Vincent S.; Hutchins, Charles; Frost,
David; Rosenberg, Saul H.; Sham, Hing L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2005), 15(8), 2033-2039

$RFMT $RIREG SCHEME66 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamic acid, [9H-fluorene-2,7-diylbis(iminocarbonothioyl)]bis-, diethyl ester
C21H22N4O4S2
853579-43-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.9300 4.0011 0.0 0
M  V30 2 C 6.1600 2.6673 0.0 0
M  V30 3 N 4.6200 2.6673 0.0 0
M  V30 4 S 6.9300 1.3336 0.0 0
M  V30 5 C 3.8500 1.3336 0.0 0
M  V30 6 O 2.3100 1.3336 0.0 0
M  V30 7 O 4.6200 0.0000 0.0 0
M  V30 8 C 1.5400 0.0000 0.0 0
M  V30 9 C 0.0000 0.0000 0.0 0
M  V30 10 N 17.2769 6.2004 0.0 0
M  V30 11 C 18.5229 5.2952 0.0 0
M  V30 12 N 19.9297 5.9215 0.0 0
M  V30 13 S 18.3618 3.7636 0.0 0
M  V30 14 C 21.1756 5.0163 0.0 0
M  V30 15 O 22.5825 5.6427 0.0 0
M  V30 16 O 21.0146 3.4847 0.0 0
M  V30 17 C 23.8284 4.7375 0.0 0
M  V30 18 C 25.2352 5.3638 0.0 0
M  V30 19 C 11.5501 4.0011 0.0 0
M  V30 20 C 13.0563 4.3213 0.0 0
M  V30 21 C 10.7801 5.3347 0.0 0
M  V30 22 C 10.7801 2.6673 0.0 0
M  V30 23 C 13.2173 5.8528 0.0 0
M  V30 24 C 14.3022 3.4160 0.0 0
M  V30 25 C 11.8105 6.4791 0.0 0
M  V30 26 C 9.2400 5.3347 0.0 0
M  V30 27 C 9.2400 2.6673 0.0 0
M  V30 28 C 14.6242 6.4791 0.0 0
M  V30 29 C 15.7092 4.0424 0.0 0
M  V30 30 C 8.4700 4.0011 0.0 0
M  V30 31 C 15.8701 5.5739 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 30
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 10 11
M  V30 11 1 10 31
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 12 14
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 1 15 17
M  V30 18 1 17 18
M  V30 19 1 19 20
M  V30 20 1 19 21
M  V30 21 2 19 22
M  V30 22 1 20 23
M  V30 23 2 20 24
M  V30 24 1 21 25
M  V30 25 2 21 26
M  V30 26 1 22 27
M  V30 27 1 23 25
M  V30 28 2 23 28
M  V30 29 1 24 29
M  V30 30 1 26 30
M  V30 31 2 27 30
M  V30 32 1 28 31
M  V30 33 2 29 31
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamic acid, [9H-fluorene-2,7-diylbis[imino(methylcarbonimidoyl)]]bis-, die...
C23H28N6O4
853579-25-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 16.1353 6.2364 0.0 0
M  V30 2 C 16.9053 7.5701 0.0 0
M  V30 3 N 18.4453 7.5701 0.0 0
M  V30 4 N 16.1353 8.9037 0.0 0
M  V30 5 C 19.2153 6.2364 0.0 0
M  V30 6 C 16.9053 10.2374 0.0 0
M  V30 7 O 20.7553 6.2364 0.0 0
M  V30 8 O 18.4453 4.9026 0.0 0
M  V30 9 C 21.5253 4.9026 0.0 0
M  V30 10 C 23.0653 4.9026 0.0 0
M  V30 11 N 5.7884 4.0370 0.0 0
M  V30 12 C 4.5424 4.9422 0.0 0
M  V30 13 N 3.1356 4.3159 0.0 0
M  V30 14 N 4.7035 6.4737 0.0 0
M  V30 15 C 2.9747 2.7843 0.0 0
M  V30 16 C 3.4576 7.3789 0.0 0
M  V30 17 O 1.5677 2.1579 0.0 0
M  V30 18 O 4.2205 1.8791 0.0 0
M  V30 19 C 1.4068 0.6263 0.0 0
M  V30 20 C 0.0000 0.0000 0.0 0
M  V30 21 C 11.5153 6.2364 0.0 0
M  V30 22 C 10.0090 5.9161 0.0 0
M  V30 23 C 12.2853 4.9026 0.0 0
M  V30 24 C 12.2853 7.5701 0.0 0
M  V30 25 C 9.8480 4.3846 0.0 0
M  V30 26 C 8.7631 6.8213 0.0 0
M  V30 27 C 11.2548 3.7582 0.0 0
M  V30 28 C 13.8253 4.9026 0.0 0
M  V30 29 C 13.8253 7.5701 0.0 0
M  V30 30 C 8.4411 3.7582 0.0 0
M  V30 31 C 7.3562 6.1950 0.0 0
M  V30 32 C 14.5953 6.2364 0.0 0
M  V30 33 C 7.1952 4.6635 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 32
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 2 11 12 CFG=2
M  V30 12 1 11 33
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 15 18
M  V30 19 1 17 19
M  V30 20 1 19 20
M  V30 21 1 21 22
M  V30 22 1 21 23
M  V30 23 2 21 24
M  V30 24 1 22 25
M  V30 25 2 22 26
M  V30 26 1 23 27
M  V30 27 2 23 28
M  V30 28 1 24 29
M  V30 29 1 25 27
M  V30 30 2 25 30
M  V30 31 1 26 31
M  V30 32 1 28 32
M  V30 33 2 29 32
M  V30 34 1 30 33
M  V30 35 2 31 33
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 853579-43-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 853579-25-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-10011546
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Preparation of N-Substituted Carbamoyl
Guanidines (General Procedure) (Scheme 2). 2,7-Bis(N'-ethoxycarbonyl)
guanidino-9H-fluorene (11a). A stirred solution of carbamoyl thiourea
(10a) (0.58 g, 1.26 mmol), ammonia (0.5 M solution in dioxane) (10 mL,
5.05 mmol), and diisopropylethylamine (0.98 g, 7.56 mmol) in anhydrous
CH2Cl2 (10 mL) was cooled to 0 °C. EDCI
(N-ethyl-N'-(3-dimethylaminopropyl)- carbodiimide hydrochloride) (0.96 g,
5.05 mmol) was added, and the solution was stirred at room temperature
overnight. The reaction mixture was washed with water (3) followed by
brine and dried over anhydrous Na2SO4. The residue remaining after
removal of the solvent was crystallized from EtOH/water (0.45 g, 84%)
2,7-Bis(N'-ethoxycarbonyl-N''-methyl)guanidino-9H-fluorene (11c). With
the same procedure for preparation of 11a, methylamine (2 M solution in
THF) was used for the transformation of the thiourea compound (10a) into
the N-substituted guanidine 11c. The reaction yielded an off-white solid
(0.53 g, 93%) mp 157-8 °C; 1H NMR (DMSO-d6) δ 1.15 (t, J = 7.2 Hz, 6H),
2.83 (s, 6H), 3.90 (s, 2H), 3.94 (q, J = 7.2 Hz, 4H), 7.32 (d, J = 8.1
Hz, 2H), 7.54 (s, 2H), 7.83 (d, J = 8.1 Hz, 2H); 13C NMR (DMSO-d6) δ
161.9, 157.9, 143.7, 137.7, 135.9, 123.1, 121.1, 119.9, 59.9, 36.5, 28.3,
14.5; MS (ESI) m/z (rel intens) 453 (M+ + 1, 100), 407 (39), 323 (15).
Anal. Calcd for C23H28N6O4•H2O (470.52): C, 58.71; H, 6.42; N, 17.86.
Found: C, 58.81; H, 6.39; N, 17.71.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, DNA Affinity, and Antiprotozoal Activity of Fused Ring
Dicationic Compounds and Their Prodrugs
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Arafa, Reem K.; Brun, Reto; Wenzler, Tanja; Tanious, Farial A.; Wilson,
W. David; Stephens, Chad E.; Boykin, David W.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2005), 48(17), 5480-5488

$RFMT $RIREG SCHEME67 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2E)-2-Cyano-3-(4-ethyl-5-propyl-1H-pyrrol-2-yl)-3-(ethylthio)-2-propenamide
C15H21N3OS
854275-20-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.8501 0.0 0
M  V30 2 C 2.6675 4.6201 0.0 0
M  V30 3 S 4.0012 2.3101 0.0 0
M  V30 4 C 2.6675 6.1601 0.0 0
M  V30 5 C 1.3337 3.8501 0.0 0
M  V30 6 C 2.6675 1.5400 0.0 0
M  V30 7 N 1.3337 6.9302 0.0 0
M  V30 8 O 4.0012 6.9302 0.0 0
M  V30 9 N 0.0000 3.0801 0.0 0
M  V30 10 C 2.6675 0.0000 0.0 0
M  V30 11 C 9.3038 4.9772 0.0 0
M  V30 12 C 9.9303 3.5703 0.0 0
M  V30 13 C 11.4619 3.4093 0.0 0
M  V30 14 C 7.6286 7.8788 0.0 0
M  V30 15 C 6.7235 9.1247 0.0 0
M  V30 16 C 5.3348 4.6201 0.0 0
M  V30 17 N 6.7418 3.9938 0.0 0
M  V30 18 C 5.4959 6.1517 0.0 0
M  V30 19 C 7.7722 5.1382 0.0 0
M  V30 20 C 7.0022 6.4718 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 2 4 8
M  V30 9 3 5 9
M  V30 10 1 6 10
M  V30 11 1 11 12
M  V30 12 1 11 19
M  V30 13 1 12 13
M  V30 14 1 14 15
M  V30 15 1 14 20
M  V30 16 1 16 17
M  V30 17 2 16 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 2 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Ethyl-3-imino-1-(methylamino)-5-propyl-3H-pyrrolizine-2-carboxamide
C14H20N4O
943825-94-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.6261 4.8385 0.0 0
M  V30 2 C 8.9599 4.0684 0.0 0
M  V30 3 C 10.2936 4.8385 0.0 0
M  V30 4 N 4.7419 7.4354 0.0 0
M  V30 5 N 1.1145 3.4069 0.0 0
M  V30 6 C 1.1145 1.8668 0.0 0
M  V30 7 C 7.2759 1.5065 0.0 0
M  V30 8 C 6.9557 0.0000 0.0 0
M  V30 9 C 1.4647 6.7389 0.0 0
M  V30 10 N 1.7849 8.2453 0.0 0
M  V30 11 O 0.0000 6.2630 0.0 0
M  V30 12 N 4.8856 4.6949 0.0 0
M  V30 13 C 3.8550 3.5504 0.0 0
M  V30 14 C 6.2924 4.0684 0.0 0
M  V30 15 C 4.1156 6.0286 0.0 0
M  V30 16 C 2.4482 4.1769 0.0 0
M  V30 17 C 4.6250 2.2167 0.0 0
M  V30 18 C 6.1315 2.5369 0.0 0
M  V30 19 C 2.6091 5.7084 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 2 4 15
M  V30 5 1 5 6
M  V30 6 1 5 16
M  V30 7 1 7 8
M  V30 8 1 7 18
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 19
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 15 1 13 16
M  V30 16 2 13 17
M  V30 17 2 14 18
M  V30 18 1 15 19
M  V30 19 2 16 19
M  V30 20 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 854275-20-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 943825-94-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-14746801
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Facile coupling of 2-(1-ethylthioethenyl)pyrroles with amines: a route to
2-(1-aminoethenyl)pyrroles and 1-amino-3-iminopyrrolizines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Trofimov, Boris A.; Sobenina, Lyubov' N.; Mikhaleva, Al'bina I.; Petrova,
Ol'ga V.; Drichkov, Vladislav N.; Ushakov, Igor A.; Tarasova, Ol'ga A.;
Toryashinova, Darya-Suren D.; Rusakov, Yuriy Yu.; Krivdin, Leonid B.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Heterocyclic Chemistry (2007), 44(3), 505-513

$RFMT $RIREG SCHEME68 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3S,4S)-1-[[4-[(3-Methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methy...
C28H30N6O5
859855-42-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 43 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.6990 5.0543 0.0 0
M  V30 2 N 5.4709 4.3939 0.0 0
M  V30 3 C 11.3664 9.6743 0.0 0
M  V30 4 O 10.0326 10.4443 0.0 0
M  V30 5 O 12.7001 10.4443 0.0 0
M  V30 6 O 1.5064 7.9635 0.0 0
M  V30 7 C 0.0000 8.2837 0.0 0
M  V30 8 N 14.0337 8.1343 0.0 0
M  V30 9 C 15.3674 7.3643 0.0 0
M  V30 10 O 16.7011 8.1343 0.0 0
M  V30 11 O 15.3674 5.8243 0.0 0
M  V30 12 C 18.0348 7.3643 0.0 0
M  V30 13 C 7.4531 2.6091 0.0 0
M  V30 14 C 8.6990 3.5143 0.0 0
M  V30 15 C 5.9467 2.9292 0.0 0
M  V30 16 N 7.9290 1.1445 0.0 0
M  V30 17 C 9.9449 2.6091 0.0 0
M  V30 18 N 4.9163 1.7849 0.0 0
M  V30 19 C 9.4690 1.1445 0.0 0
M  V30 20 N 6.8986 0.0000 0.0 0
M  V30 21 C 5.3922 0.3202 0.0 0
M  V30 22 N 10.0326 5.8243 0.0 0
M  V30 23 C 10.0326 7.3643 0.0 0
M  V30 24 C 11.3664 5.0543 0.0 0
M  V30 25 C 11.3664 8.1343 0.0 0 CFG=2
M  V30 26 C 12.7001 5.8243 0.0 0
M  V30 27 C 12.7001 7.3643 0.0 0 CFG=1
M  V30 28 C 3.9646 4.7141 0.0 0
M  V30 29 C 3.4887 6.1786 0.0 0
M  V30 30 C 2.9340 3.5696 0.0 0
M  V30 31 C 1.9823 6.4990 0.0 0
M  V30 32 C 1.4277 3.8899 0.0 0
M  V30 33 C 0.9519 5.3544 0.0 0
M  V30 34 C 19.3684 8.1343 0.0 0
M  V30 35 C 20.7021 7.3643 0.0 0
M  V30 36 C 19.3684 9.6743 0.0 0
M  V30 37 C 22.0359 8.1343 0.0 0
M  V30 38 C 20.7021 10.4443 0.0 0
M  V30 39 C 22.0359 9.6743 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 1 22
M  V30 3 1 2 15
M  V30 4 1 2 28
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 1 25 3 CFG=3
M  V30 8 1 6 7
M  V30 9 1 6 31
M  V30 10 1 8 9
M  V30 11 1 27 8 CFG=1
M  V30 12 1 9 10
M  V30 13 2 9 11
M  V30 14 1 10 12
M  V30 15 1 12 34
M  V30 16 2 13 14
M  V30 17 1 13 15
M  V30 18 1 13 16
M  V30 19 1 14 17
M  V30 20 2 15 18
M  V30 21 1 16 19
M  V30 22 1 16 20
M  V30 23 2 17 19
M  V30 24 1 18 21
M  V30 25 2 20 21
M  V30 26 1 22 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 1 26 27
M  V30 32 2 28 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 2 30 32
M  V30 36 2 31 33
M  V30 37 1 32 33
M  V30 38 2 34 35
M  V30 39 1 34 36
M  V30 40 1 35 37
M  V30 41 2 36 38
M  V30 42 2 37 39
M  V30 43 1 38 39
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 25 27)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Carbamic acid, [(3S,4S)-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]tr...
C29H33N7O4
859855-43-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 44 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.6990 5.0543 0.0 0
M  V30 2 N 5.4709 4.3939 0.0 0
M  V30 3 C 11.3664 9.6743 0.0 0
M  V30 4 N 10.0326 10.4443 0.0 0
M  V30 5 O 12.7001 10.4443 0.0 0
M  V30 6 C 10.0326 11.9843 0.0 0
M  V30 7 O 1.5064 7.9635 0.0 0
M  V30 8 C 0.0000 8.2837 0.0 0
M  V30 9 N 14.0337 8.1343 0.0 0
M  V30 10 C 15.3674 7.3643 0.0 0
M  V30 11 O 16.7011 8.1343 0.0 0
M  V30 12 O 15.3674 5.8243 0.0 0
M  V30 13 C 18.0348 7.3643 0.0 0
M  V30 14 C 7.4531 2.6091 0.0 0
M  V30 15 C 8.6990 3.5143 0.0 0
M  V30 16 C 5.9467 2.9292 0.0 0
M  V30 17 N 7.9290 1.1445 0.0 0
M  V30 18 C 9.9449 2.6091 0.0 0
M  V30 19 N 4.9163 1.7849 0.0 0
M  V30 20 C 9.4690 1.1445 0.0 0
M  V30 21 N 6.8986 0.0000 0.0 0
M  V30 22 C 5.3922 0.3202 0.0 0
M  V30 23 N 10.0326 5.8243 0.0 0
M  V30 24 C 10.0326 7.3643 0.0 0
M  V30 25 C 11.3664 5.0543 0.0 0
M  V30 26 C 11.3664 8.1343 0.0 0 CFG=2
M  V30 27 C 12.7001 5.8243 0.0 0
M  V30 28 C 12.7001 7.3643 0.0 0 CFG=1
M  V30 29 C 3.9646 4.7141 0.0 0
M  V30 30 C 3.4887 6.1786 0.0 0
M  V30 31 C 2.9340 3.5696 0.0 0
M  V30 32 C 1.9823 6.4990 0.0 0
M  V30 33 C 1.4277 3.8899 0.0 0
M  V30 34 C 0.9519 5.3544 0.0 0
M  V30 35 C 19.3684 8.1343 0.0 0
M  V30 36 C 20.7021 7.3643 0.0 0
M  V30 37 C 19.3684 9.6743 0.0 0
M  V30 38 C 22.0359 8.1343 0.0 0
M  V30 39 C 20.7021 10.4443 0.0 0
M  V30 40 C 22.0359 9.6743 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 15
M  V30 2 1 1 23
M  V30 3 1 2 16
M  V30 4 1 2 29
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 1 26 3 CFG=3
M  V30 8 1 4 6
M  V30 9 1 7 8
M  V30 10 1 7 32
M  V30 11 1 9 10
M  V30 12 1 28 9 CFG=1
M  V30 13 1 10 11
M  V30 14 2 10 12
M  V30 15 1 11 13
M  V30 16 1 13 35
M  V30 17 2 14 15
M  V30 18 1 14 16
M  V30 19 1 14 17
M  V30 20 1 15 18
M  V30 21 2 16 19
M  V30 22 1 17 20
M  V30 23 1 17 21
M  V30 24 2 18 20
M  V30 25 1 19 22
M  V30 26 2 21 22
M  V30 27 1 23 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 1 27 28
M  V30 33 2 29 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 31 33
M  V30 37 2 32 34
M  V30 38 1 33 34
M  V30 39 2 35 36
M  V30 40 1 35 37
M  V30 41 1 36 38
M  V30 42 2 37 39
M  V30 43 2 38 40
M  V30 44 1 39 40
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 26 28)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 859855-42-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 859855-43-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-12897807
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 56602-33-6
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 260G. Preparation of benzyl
(3S,4S)-1-((4-(3-methoxyphenylamino)pyrrolo[1,2-f][1,2,4]triazin-5-yl)methyl)-3-(methylcarbamoyl)piperidine-4-ylcarbamate
A solution of 260F (40 mg, 0.075 mmol) in DMF (0.8 mL) at room
temperature was treated with diisopropylethylamine (10 mg, 0.075 mmol),
Bop Reagent (59 mg, 0.11 mmol), then 2N methylamine in THF (0.12 mL, 0.23
mmol). The reaction mixture was stirred for 16 hours, quenched with
water, and concentrated. The resulting suspension was dissolved in MeOH,
and purified by preparative HPLC (YMC ODS-A 50m, 20 x 100 mm, solvent A
10% MeOH-90% H20-0.1% TFA, solvent B 90% MeOH-10% H20-0.1% TFA, gradient
0-100%B, 12 minutes). The desired fractions were concentrated to remove
most of the MeOH, neutralized by saturated NaHCO3 to pH 10 and extracted
with EtOAc (2×50 mL). The combined organic layers were dried over Na2SO4
and concentrated in vacuo to give 38 mg (yield: 93%) of 260G as a solid.
benzyl
(3S,4S)-1-((4-(3-methoxyphenylamino)pyrrolo[1,2-f][1,2,4]triazin-5-yl)methyl)-3-(methylcarbamoyl)piperidine-4-ylcarbamate,
38 mg (yield: 93%) Mass (M+H)+= 544.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrrolo[2,1-f][1,2,4]triazine derivatives as HER1, HER2,
and HER4 kinase inhibitors, and antiproliferative agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fink, Brian E.; Gavai, Ashvinikumar V.; Vite, Gregory D.; Chen, Ping;
Mastalerz, Harold; Norris, Derek J.; Tokarski, John S.; Zhao, Yufen; Han,
Wen-Ching
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2005066176 A1 2005-07-21

$RFMT $RIREG SCHEME69 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(1,1-Dimethylethyl) 6-[[(4-carboxyphenyl)methyl]amino]-7-chloro-1,2,4,5-tet...
C23H27ClN2O4
864262-93-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.4349 6.5378 0.0 0
M  V30 2 C 10.7687 7.3078 0.0 0
M  V30 3 Cl 9.4349 9.6178 0.0 0
M  V30 4 C 3.6437 2.6673 0.0 0
M  V30 5 O 2.1037 2.6673 0.0 0
M  V30 6 O 4.4137 1.3337 0.0 0
M  V30 7 C 1.3337 1.3337 0.0 0
M  V30 8 C 2.6675 0.5637 0.0 0
M  V30 9 C 0.5637 0.0000 0.0 0
M  V30 10 C 0.0000 2.1037 0.0 0
M  V30 11 C 16.1035 4.2277 0.0 0
M  V30 12 O 16.1035 2.6877 0.0 0
M  V30 13 O 17.4372 4.9977 0.0 0
M  V30 14 C 6.7675 6.5378 0.0 0
M  V30 15 C 8.1012 7.3078 0.0 0
M  V30 16 C 5.4339 7.3078 0.0 0
M  V30 17 C 6.9970 5.0150 0.0 0
M  V30 18 C 8.1012 8.8478 0.0 0
M  V30 19 C 4.0002 6.7452 0.0 0
M  V30 20 C 5.4339 8.8478 0.0 0
M  V30 21 C 5.9495 3.8860 0.0 0
M  V30 22 C 6.7675 9.6178 0.0 0
M  V30 23 C 3.5462 5.2735 0.0 0
M  V30 24 N 4.4137 4.0012 0.0 0
M  V30 25 C 12.1024 6.5378 0.0 0
M  V30 26 C 12.1024 4.9977 0.0 0
M  V30 27 C 13.4360 7.3078 0.0 0
M  V30 28 C 13.4360 4.2277 0.0 0
M  V30 29 C 14.7697 6.5378 0.0 0
M  V30 30 C 14.7697 4.9977 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 25
M  V30 4 1 3 18
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 24
M  V30 8 1 5 7
M  V30 9 1 7 8
M  V30 10 1 7 9
M  V30 11 1 7 10
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 11 30
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 14 17
M  V30 18 1 15 18
M  V30 19 1 16 19
M  V30 20 2 16 20
M  V30 21 1 17 21
M  V30 22 2 18 22
M  V30 23 1 19 23
M  V30 24 1 20 22
M  V30 25 1 21 24
M  V30 26 1 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 7-chloro-1,2,4,5-tetrahydro-6-[[[4-[(methylamino)carbonyl]p...
C24H30ClN3O3
864264-42-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.4349 6.5378 0.0 0
M  V30 2 C 10.7685 7.3078 0.0 0
M  V30 3 Cl 9.4349 9.6178 0.0 0
M  V30 4 C 3.6437 2.6673 0.0 0
M  V30 5 O 2.1037 2.6673 0.0 0
M  V30 6 O 4.4137 1.3337 0.0 0
M  V30 7 C 1.3337 1.3337 0.0 0
M  V30 8 C 0.0000 2.1037 0.0 0
M  V30 9 C 0.5637 0.0000 0.0 0
M  V30 10 C 2.6675 0.5637 0.0 0
M  V30 11 C 16.1034 4.2277 0.0 0
M  V30 12 N 17.4372 4.9977 0.0 0
M  V30 13 O 16.1034 2.6877 0.0 0
M  V30 14 C 18.7709 4.2277 0.0 0
M  V30 15 C 6.7675 6.5378 0.0 0
M  V30 16 C 8.1012 7.3078 0.0 0
M  V30 17 C 5.4337 7.3078 0.0 0
M  V30 18 C 6.9970 5.0150 0.0 0
M  V30 19 C 8.1012 8.8478 0.0 0
M  V30 20 C 4.0002 6.7452 0.0 0
M  V30 21 C 5.4337 8.8478 0.0 0
M  V30 22 C 5.9495 3.8860 0.0 0
M  V30 23 C 6.7675 9.6178 0.0 0
M  V30 24 C 3.5462 5.2735 0.0 0
M  V30 25 N 4.4137 4.0012 0.0 0
M  V30 26 C 12.1024 6.5378 0.0 0
M  V30 27 C 12.1024 4.9977 0.0 0
M  V30 28 C 13.4360 7.3078 0.0 0
M  V30 29 C 13.4360 4.2277 0.0 0
M  V30 30 C 14.7697 6.5378 0.0 0
M  V30 31 C 14.7697 4.9977 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 2 26
M  V30 4 1 3 19
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 25
M  V30 8 1 5 7
M  V30 9 1 7 8
M  V30 10 1 7 9
M  V30 11 1 7 10
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 11 31
M  V30 15 1 12 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 15 18
M  V30 19 1 16 19
M  V30 20 1 17 20
M  V30 21 2 17 21
M  V30 22 1 18 22
M  V30 23 2 19 23
M  V30 24 1 20 24
M  V30 25 1 21 23
M  V30 26 1 22 25
M  V30 27 1 24 25
M  V30 28 2 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 864262-93-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 864264-42-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-1081613
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 7-Chloro-6-(4-methylcarbamoyl-benzylamino)-2,3,4,5-tetrahydro-1H-benzo[d]azepine
Hydrochloride Combine
3-(tert-butoxycarbonyl)-6-(4-carboxy-benzylamino)-7-chloro-2,3,4,5-tetrahydro-1H-benzo[d]azepine
(0.1 g, 0.3 mmol), methylamine hydrochloride (31 mg, 0.46 mmol),
triethylamine (0.1 g, 0.9 mmol), HATU (0.2 g, 0.5 mmol), anhydrous DMF (3
mL) and stir at ambient temperature for 17 h. Partition the reaction
mixture between brine (5 mL) and diethyl ether (5 mL), separate the
organic layer and dry over anhydrous Na2SO4. Evaporate the solvent to
obtain
3-(tert-butoxycarbonyl)-7-chloro-6-(4-methylcarbamoyl-benzylamino)-2,3,4,5-tetrahydro-1H-benzo[d]azepine
as a yellow oil (0.1 g, 93%).
3-(tert-butoxycarbonyl)-7-chloro-6-(4-methylcarbamoyl-benzylamino)-2,3,4,5-tetrahydro-1H-benzo[d]azepine,
yield 0.1 g, 93%. MS (ES+) m/z: 344 (M+H-Boc)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 6-substituted 2,3,4,5-tetrahydro-1H-benzo[d]azepines as
5-HT2c receptor agonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Allen, John Gordon; Briner, Karin; Cohen, Michael Philip; Galka,
Christopher Stanley; Hellman, Sarah Lynne; Martinez-Grau, Maria Angeles;
Reinhard, Matthew Robert; Rodriguez, Michael John; Rothhaar, Roger Ryan;
Tidwell, Michael Wade; Victor, Frantz; Williams, Andrew Caerwyn; Zhang,
Deyi; Boyd, Steven Armen; Conway, Richard Gerard; Deo, Arundhati S.; Lee,
Wai-Man; Siedem, Christopher Stephen; Singh, Ajay
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2005082859 A1 2005-09-09

$RFMT $RIREG SCHEME70 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[2-[(1S)-1-[[[trans-4-[[[(1,1-Dimethylethoxy)carbonyl]amino]methyl]cyclohex...
C31H38N4O5
872017-46-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 43 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.4952 5.3348 0.0 0 CFG=1
M  V30 2 C 8.7252 4.0010 0.0 0
M  V30 3 N 11.0352 5.3348 0.0 0
M  V30 4 C 11.8052 6.6685 0.0 0
M  V30 5 O 11.0352 8.0021 0.0 0
M  V30 6 C 17.9653 6.6685 0.0 0
M  V30 7 N 18.7353 8.0021 0.0 0
M  V30 8 C 20.2753 8.0021 0.0 0
M  V30 9 O 21.0454 9.3358 0.0 0
M  V30 10 O 21.0454 6.6685 0.0 0
M  V30 11 C 22.5854 9.3358 0.0 0
M  V30 12 C 22.5854 7.7958 0.0 0
M  V30 13 C 24.1254 9.3358 0.0 0
M  V30 14 C 22.5854 10.8758 0.0 0
M  V30 15 C 1.2459 10.8413 0.0 0
M  V30 16 O 0.0000 9.9361 0.0 0
M  V30 17 O 1.0849 12.3729 0.0 0
M  V30 18 C 8.7252 6.6685 0.0 0
M  V30 19 N 7.1936 6.8294 0.0 0
M  V30 20 N 9.3516 8.0753 0.0 0
M  V30 21 C 6.8734 8.3358 0.0 0
M  V30 22 C 8.2071 9.1059 0.0 0
M  V30 23 C 9.4952 2.6673 0.0 0
M  V30 24 C 8.7252 1.3337 0.0 0
M  V30 25 C 11.0352 2.6673 0.0 0
M  V30 26 C 9.4952 0.0000 0.0 0
M  V30 27 C 11.8052 1.3337 0.0 0
M  V30 28 C 11.0352 0.0000 0.0 0
M  V30 29 C 13.3452 6.6685 0.0 0 CFG=2
M  V30 30 C 14.1152 8.0021 0.0 0
M  V30 31 C 14.1152 5.3348 0.0 0
M  V30 32 C 15.6553 8.0021 0.0 0
M  V30 33 C 15.6553 5.3348 0.0 0
M  V30 34 C 16.4253 6.6685 0.0 0 CFG=2
M  V30 35 C 5.4665 8.9622 0.0 0
M  V30 36 C 4.2206 8.0569 0.0 0
M  V30 37 C 5.3055 10.4937 0.0 0
M  V30 38 C 2.8138 8.6834 0.0 0
M  V30 39 C 3.8987 11.1202 0.0 0
M  V30 40 C 2.6527 10.2150 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 18
M  V30 4 1 2 23
M  V30 5 1 3 4
M  V30 6 2 4 5
M  V30 7 1 29 4 CFG=1
M  V30 8 1 6 7
M  V30 9 1 34 6 CFG=3
M  V30 10 1 7 8
M  V30 11 1 8 9
M  V30 12 2 8 10
M  V30 13 1 9 11
M  V30 14 1 11 12
M  V30 15 1 11 13
M  V30 16 1 11 14
M  V30 17 1 15 16
M  V30 18 2 15 17
M  V30 19 1 15 40
M  V30 20 1 18 19
M  V30 21 2 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 22
M  V30 25 1 21 35
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 32 1 29 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 1 33 34
M  V30 38 2 35 36
M  V30 39 1 35 37
M  V30 40 1 36 38
M  V30 41 2 37 39
M  V30 42 2 38 40
M  V30 43 1 39 40
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 1 29 34)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[[trans-4-[[[(1S)-1-[5-[4-[(methylamino)carbonyl]phenyl]-...
C32H41N5O4
872017-47-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 44 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.8171 5.3348 0.0 0 CFG=1
M  V30 2 C 9.0470 4.0011 0.0 0
M  V30 3 N 11.3571 5.3348 0.0 0
M  V30 4 C 12.1271 6.6685 0.0 0
M  V30 5 O 11.3571 8.0021 0.0 0
M  V30 6 C 18.2872 6.6685 0.0 0
M  V30 7 N 19.0572 8.0021 0.0 0
M  V30 8 C 20.5973 8.0021 0.0 0
M  V30 9 O 21.3673 9.3360 0.0 0
M  V30 10 O 21.3673 6.6685 0.0 0
M  V30 11 C 22.9073 9.3360 0.0 0
M  V30 12 C 22.9073 10.8760 0.0 0
M  V30 13 C 24.4473 9.3360 0.0 0
M  V30 14 C 22.9073 7.7959 0.0 0
M  V30 15 C 1.5677 10.8413 0.0 0
M  V30 16 N 1.4068 12.3730 0.0 0
M  V30 17 O 0.3219 9.9363 0.0 0
M  V30 18 C 0.0000 12.9994 0.0 0
M  V30 19 C 9.0470 6.6685 0.0 0
M  V30 20 N 7.5155 6.8296 0.0 0
M  V30 21 N 9.6735 8.0754 0.0 0
M  V30 22 C 7.1953 8.3359 0.0 0
M  V30 23 C 8.5290 9.1059 0.0 0
M  V30 24 C 9.8171 2.6673 0.0 0
M  V30 25 C 9.0470 1.3337 0.0 0
M  V30 26 C 11.3571 2.6673 0.0 0
M  V30 27 C 9.8171 0.0000 0.0 0
M  V30 28 C 12.1271 1.3337 0.0 0
M  V30 29 C 11.3571 0.0000 0.0 0
M  V30 30 C 13.6671 6.6685 0.0 0 CFG=2
M  V30 31 C 14.4371 5.3348 0.0 0
M  V30 32 C 14.4371 8.0021 0.0 0
M  V30 33 C 15.9772 5.3348 0.0 0
M  V30 34 C 15.9772 8.0021 0.0 0
M  V30 35 C 16.7472 6.6685 0.0 0 CFG=2
M  V30 36 C 5.7885 8.9622 0.0 0
M  V30 37 C 5.6274 10.4939 0.0 0
M  V30 38 C 4.5425 8.0571 0.0 0
M  V30 39 C 4.2206 11.1202 0.0 0
M  V30 40 C 3.1357 8.6834 0.0 0
M  V30 41 C 2.9747 10.2150 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 19
M  V30 4 1 2 24
M  V30 5 1 3 4
M  V30 6 2 4 5
M  V30 7 1 30 4 CFG=3
M  V30 8 1 6 7
M  V30 9 1 35 6 CFG=1
M  V30 10 1 7 8
M  V30 11 1 8 9
M  V30 12 2 8 10
M  V30 13 1 9 11
M  V30 14 1 11 12
M  V30 15 1 11 13
M  V30 16 1 11 14
M  V30 17 1 15 16
M  V30 18 2 15 17
M  V30 19 1 15 41
M  V30 20 1 16 18
M  V30 21 1 19 20
M  V30 22 2 19 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 23
M  V30 26 1 22 36
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 33 1 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 1 34 35
M  V30 39 2 36 37
M  V30 40 1 36 38
M  V30 41 1 37 39
M  V30 42 2 38 40
M  V30 43 2 39 41
M  V30 44 1 40 41
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 1 30 35)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 872017-46-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 872017-47-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-14286137
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 56602-33-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 110-86-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: To a solution of I-2 (75 mg, 0.15 mmol) and
N-Boc-tranexamic acid (75 mg, 0.29 mmol) in pyridine (1.7 mL) was added
BOP reagent (152 mg, 0.34 mmol). The reaction mixture was stirred at rt
for 12 h. The mixture was diluted with H2O and extracted with EtOAc. The
combined organic extracts were washed with brine, dried over Na2SO4,
filtered, and evaporated in vacuo. 10a (100 mg, 71%). 10a was carried
onto the next step without purification. tert-Butyl
((trans-4-(((S)-1-(4-(4-(Methylcarbamoyl)phenyl)-1H-imidazol-2-yl)-2-phenylethyl)carbamoyl)cyclohexyl)-methyl)carbamate
(10m). 10l (45 mg, 0.08 mmol) and methylamine (0.2 mL, 0.09 mmol) were
converted to 10m (44.0. mg, 93%) using the alternative procedure
described for conversion of I-2 to 10a. 10m was carried to the next step
without purification. m/z 560 [M + H]+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Phenylimidazoles as Potent and Selective Inhibitors of Coagulation Factor
XIa with in Vivo Antithrombotic Activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hangeland, Jon J.; Friends, Todd J.; Rossi, Karen A.; Smallheer, Joanne
M.; Wang, Cailan; Sun, Zhong; Corte, James R.; Fang, Tianan; Wong,
Pancras C.; Rendina, Alan R.; Barbera, Frank A.; Bozarth, Jeffrey M.;
Luettgen, Joseph M.; Watson, Carol A.; Zhang, Ge; Wei, Anzhi; Ramamurthy,
Vidhyashankar; Morin, Paul E.; Bisacchi, Gregory S.; Subramaniam,
Srinath; Arunachalam, Piramanayagam; Mathur, Arvind; Seiffert, Dietmar
A.; Wexler, Ruth R.; Quan, Mimi L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2014), 57(23), 9915-9932

$RFMT $RIREG SCHEME71 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Oxo-N-(phenylmethyl)butanamide
C11H13NO2
882-36-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.0801 0.0 0
M  V30 2 N 5.3348 2.3101 0.0 0
M  V30 3 C 6.6685 3.0801 0.0 0
M  V30 4 C 8.0023 2.3101 0.0 0
M  V30 5 O 6.6685 4.6201 0.0 0
M  V30 6 C 9.3360 3.0801 0.0 0
M  V30 7 C 9.3360 4.6201 0.0 0
M  V30 8 O 10.6697 2.3101 0.0 0
M  V30 9 C 2.6673 2.3101 0.0 0
M  V30 10 C 1.3337 3.0801 0.0 0
M  V30 11 C 2.6673 0.7700 0.0 0
M  V30 12 C 0.0000 2.3101 0.0 0
M  V30 13 C 1.3337 0.0000 0.0 0
M  V30 14 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(Methylimino)-N-(phenylmethyl)butanamide
C12H16N2O
74276-53-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.0801 0.0 0
M  V30 2 N 5.3348 2.3101 0.0 0
M  V30 3 C 6.6685 3.0801 0.0 0
M  V30 4 C 8.0022 2.3101 0.0 0
M  V30 5 O 6.6685 4.6201 0.0 0
M  V30 6 C 9.3360 3.0801 0.0 0
M  V30 7 N 10.6697 2.3101 0.0 0
M  V30 8 C 9.3360 4.6201 0.0 0
M  V30 9 C 12.0033 3.0801 0.0 0
M  V30 10 C 2.6673 2.3101 0.0 0
M  V30 11 C 2.6673 0.7700 0.0 0
M  V30 12 C 1.3337 3.0801 0.0 0
M  V30 13 C 1.3337 0.0000 0.0 0
M  V30 14 C 0.0000 2.3101 0.0 0
M  V30 15 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 2 6 7 CFG=2
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 882-36-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 74276-53-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24906875
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1643-19-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM PIFA-Mediated Tandem Hofmann-Type Rearrangement and Cyclization Reaction
of α-Acyl-β-aminoacrylamides: Access to Polysubstituted Oxazol-2(3H)-ones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Baibin; Yuan, Jingwen; Ye, Xuebei; Zhang, Rui; Li, Jiacheng; Wang,
Yu; Hu, Jiana; Dong, Dewen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2021), 86(24), 17944-17954

$RFMT $RIREG SCHEME72 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,6-Dichloro-1-methyl-1H-imidazo[4,5-c]pyridine
C7H5Cl2N3
887147-19-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 4.6201 0.0 0
M  V30 2 C 6.6520 4.5603 0.0 0
M  V30 3 Cl 2.6675 0.0000 0.0 0
M  V30 4 C 2.6675 4.6201 0.0 0
M  V30 5 C 4.0012 3.8501 0.0 0
M  V30 6 C 1.3337 3.8501 0.0 0
M  V30 7 N 2.9877 6.1264 0.0 0
M  V30 8 C 4.0012 2.3101 0.0 0
M  V30 9 N 5.1456 4.8805 0.0 0
M  V30 10 N 1.3337 2.3101 0.0 0
M  V30 11 C 4.5192 6.2873 0.0 0
M  V30 12 C 2.6675 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 2 9
M  V30 3 1 3 12
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-N,1-dimethyl-1H-imidazo[4,5-c]pyridin-4-amine
C8H9ClN4
887147-21-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6520 4.6201 0.0 0
M  V30 2 C 7.9857 3.8501 0.0 0
M  V30 3 C 0.0000 4.5603 0.0 0
M  V30 4 Cl 3.9845 0.0000 0.0 0
M  V30 5 C 3.9845 4.6201 0.0 0
M  V30 6 C 2.6509 3.8501 0.0 0
M  V30 7 C 5.3182 3.8501 0.0 0
M  V30 8 N 3.6644 6.1264 0.0 0
M  V30 9 N 1.5065 4.8805 0.0 0
M  V30 10 C 2.6509 2.3101 0.0 0
M  V30 11 N 5.3182 2.3101 0.0 0
M  V30 12 C 2.1328 6.2873 0.0 0
M  V30 13 C 3.9845 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 3 9
M  V30 4 1 4 13
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 2 8 12
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 2 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 887147-19-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 887147-21-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-8010127
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM A1.8: 4-Methylamino-6-chloro-1-methyl-1H-imidazo[4,5-c]pyridine A mixture
of A1.5 (9.9 g; 49 mmol) and methylamine (8M solution in ethanol, 80
mmol, 100 ml) was heated to 82°C. for 24 hr. After removing the volatiles
in vacuo, the residue was triturated with water (30 mL), filtered and
dried to afford A1.8. Yield 8.89 g, 93%, tan solid. HPLC (A): 99%, ret.
time=0.98 min., LC/MS (M+H)+=197.16 (199.06).
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, alternate reaction conditions gave 90% yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 1,6-Dihydro-1,3,5,6-tetraaza-as-indacene based tricyclic compounds and
pharmaceutical compositions comprising same as inhibitors of IKK enzyme
activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pitts, William J.; Kempson, James; Guo, Junqing; Das, Jagabandhu;
Langevine, Charles M.; Spergel, Steven H.; Watterson, Scott Hunter
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US7737279 B2 2010-06-15

$RFMT $RIREG SCHEME72 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,6-Dichloro-1-methyl-1H-imidazo[4,5-c]pyridine
C7H5Cl2N3
887147-19-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 4.6201 0.0 0
M  V30 2 C 6.6520 4.5603 0.0 0
M  V30 3 Cl 2.6675 0.0000 0.0 0
M  V30 4 C 2.6675 4.6201 0.0 0
M  V30 5 C 4.0012 3.8501 0.0 0
M  V30 6 C 1.3337 3.8501 0.0 0
M  V30 7 N 2.9877 6.1264 0.0 0
M  V30 8 C 4.0012 2.3101 0.0 0
M  V30 9 N 5.1456 4.8805 0.0 0
M  V30 10 N 1.3337 2.3101 0.0 0
M  V30 11 C 4.5192 6.2873 0.0 0
M  V30 12 C 2.6675 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 2 9
M  V30 3 1 3 12
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-N,1-dimethyl-1H-imidazo[4,5-c]pyridin-4-amine
C8H9ClN4
887147-21-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6520 4.6201 0.0 0
M  V30 2 C 7.9857 3.8501 0.0 0
M  V30 3 C 0.0000 4.5603 0.0 0
M  V30 4 Cl 3.9845 0.0000 0.0 0
M  V30 5 C 3.9845 4.6201 0.0 0
M  V30 6 C 2.6509 3.8501 0.0 0
M  V30 7 C 5.3182 3.8501 0.0 0
M  V30 8 N 3.6644 6.1264 0.0 0
M  V30 9 N 1.5065 4.8805 0.0 0
M  V30 10 C 2.6509 2.3101 0.0 0
M  V30 11 N 5.3182 2.3101 0.0 0
M  V30 12 C 2.1328 6.2873 0.0 0
M  V30 13 C 3.9845 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 3 9
M  V30 4 1 4 13
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 2 8 12
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 2 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 887147-19-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 887147-21-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-11824534
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM A1.8: 4-Methylamino-6-chloro-1-methyl-1H-imidazo[4,5-c]pyridine A mixture
of A1.5 (9.9 g; 49 mmol) and methylamine (8M solution in ethanol, 80
mmol, 100 ml) was heated to 82°C for 24 hr. After removing the volatiles
in vacuo, the residue was triturated with water (30 mL), filtered and
dried. 8.89 g (93%) of A1.8 as a tan solid. HPLC (A): 99%, ret. time =
0.98 min., LC/MS (M+H)+ = 197.16 (199.06).
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, alternate reaction conditions gave 90% yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 1,6-Dihydro-1,3,5,6-tetraaza-as-indacene based tricyclic compounds and
pharmaceutical compositions comprising same as inhibitors of IKK enzyme
activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pitts, William J.; Kempson, James; Guo, Junqing; Das, Jagabandhu;
Langevine, Charles M.; Spergel, Steven H.; Watterson, Scott H.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2006122137 A1 2006-11-16

$RFMT $RIREG SCHEME73 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chloro-2-(1-methylethoxy)benzaldehyde
C10H11ClO2
894851-27-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3100 1.3338 0.0 0
M  V30 2 C 0.7700 1.3338 0.0 0
M  V30 3 C 0.0000 0.0000 0.0 0
M  V30 4 C 0.0000 2.6674 0.0 0
M  V30 5 C 5.3900 1.3338 0.0 0
M  V30 6 O 6.9300 1.3338 0.0 0
M  V30 7 Cl 0.7700 4.0011 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 3.0800 5.3349 0.0 0
M  V30 13 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 1 5 9
M  V30 7 1 7 10
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chloro-N-methyl-2-(1-methylethoxy)benzenemethanamine
C11H16ClNO
894851-28-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6674 2.3100 0.0 0
M  V30 2 C 1.3336 1.5400 0.0 0
M  V30 3 C 1.3336 0.0000 0.0 0
M  V30 4 C 0.0000 2.3100 0.0 0
M  V30 5 C 5.3347 3.8500 0.0 0
M  V30 6 N 6.6685 4.6200 0.0 0
M  V30 7 C 8.0021 3.8500 0.0 0
M  V30 8 Cl 0.0000 3.8500 0.0 0
M  V30 9 C 2.6674 3.8500 0.0 0
M  V30 10 C 4.0011 4.6200 0.0 0
M  V30 11 C 1.3336 4.6200 0.0 0
M  V30 12 C 4.0011 6.1600 0.0 0
M  V30 13 C 1.3336 6.1600 0.0 0
M  V30 14 C 2.6674 6.9300 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 10
M  V30 7 1 6 7
M  V30 8 1 8 11
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 894851-27-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 894851-28-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-2962695
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM d) (3-chloro-2-isopropoxybenzyl)methylamine [1283] Methylamine (10.3 mL
of a 2.0 M solution in MeOH, 20.6 mmol) was added to
3-chloro-2-isopropoxybenzaldehyde (0.500 g, 2.52 mmol) and the mixture
was stirred for 72 h. The solution was concentrated under reduced
pressure. The resulting light yellow oil was dissolved in EtOH (10.3 mL)
and treated with NaBH 4 (0.095 g, 2.52 mmol). After stirring for 18 h,
the reaction mixture was concentrated under reduced pressure, dissolved
in 1 N NaOH (20 mL) and extracted with Et2 O (3×50 mL). The combined
organics were washed with brine (2×75 mL), dried (Na2SO4) and
concentrated to give the title compound (0.50 g, 93%) as a yellow oil. 1H
NMR (300 MHz, DMSO-d6) δ 7.40-7.31 (m, 2H), 7.08 (t, J=7.8 Hz, 1H), 4.42
(q, J=6.1 Hz, 1H), 3.66 (s, 2H), 2.25 (s, 3H), 2.02 (br s, 1H), 1.25 (d,
J=6.1 Hz, 6H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20060142265 A1 2006-06-29

$RFMT $RIREG SCHEME73 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chloro-2-(1-methylethoxy)benzaldehyde
C10H11ClO2
894851-27-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3100 1.3338 0.0 0
M  V30 2 C 0.7700 1.3338 0.0 0
M  V30 3 C 0.0000 0.0000 0.0 0
M  V30 4 C 0.0000 2.6674 0.0 0
M  V30 5 C 5.3900 1.3338 0.0 0
M  V30 6 O 6.9300 1.3338 0.0 0
M  V30 7 Cl 0.7700 4.0011 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 3.0800 5.3349 0.0 0
M  V30 13 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 1 5 9
M  V30 7 1 7 10
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chloro-N-methyl-2-(1-methylethoxy)benzenemethanamine
C11H16ClNO
894851-28-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6674 2.3100 0.0 0
M  V30 2 C 1.3336 1.5400 0.0 0
M  V30 3 C 1.3336 0.0000 0.0 0
M  V30 4 C 0.0000 2.3100 0.0 0
M  V30 5 C 5.3347 3.8500 0.0 0
M  V30 6 N 6.6685 4.6200 0.0 0
M  V30 7 C 8.0021 3.8500 0.0 0
M  V30 8 Cl 0.0000 3.8500 0.0 0
M  V30 9 C 2.6674 3.8500 0.0 0
M  V30 10 C 4.0011 4.6200 0.0 0
M  V30 11 C 1.3336 4.6200 0.0 0
M  V30 12 C 4.0011 6.1600 0.0 0
M  V30 13 C 1.3336 6.1600 0.0 0
M  V30 14 C 2.6674 6.9300 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 10
M  V30 7 1 6 7
M  V30 8 1 8 11
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 894851-27-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 894851-28-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-442074
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM d) (3-chloro-2-isopropoxybenzyl)methylamine Methylamine (10.3 mL of a 2.0
M solution in MeOH, 20.6 mmol) was added to
3-chloro-2-isopropoxybenzaldehyde (0.500 g, 2.52 mmol) and the mixture
was stirred for 72 h. The solution was concentrated under reduced
pressure. The resulting light yellow oil was dissolved in EtOH (10.3 mL)
and treated with NaBH4 (0.095 g, 2.52 mmol). After stirring for 18 h, the
reaction mixture was concentrated under reduced pressure, dissolved in 1
N NaOH (20 mL) and extracted with Et2O (3×50 mL). The combined organics
were washed with brine (2×75 mL), dried (Na2SO4) and concentrated to give
the title compound (0.50 g, 93%) as a yellow oil: 1H NMR (300 MHz,
DMSO-d6 ) δ 7.40-7.31 (m, 2H), 7.08 (t, J = 7.8 Hz, 1H), 4.42 (q, J = 6.1
Hz, 1H), 3.66 (s, 2H), 2.25 (s, 3H), 2.02 (br s, 1H), 1.25 (d, J = 6.1
Hz, 6H). C11H16ClNO Exact Mass: 213.09.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocyclyl acrylamide compounds as FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Manning, David Douglas; Decornez, Helene Yvonne; Surman, Matthew David;
Martin, Fernando J. L.; Ramnauth, Jailall; Toro, Andras; Berman, Judd M.;
Sampson, Peter; Pauls, Henry; Sargent, Bruce Jeremy
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Canada, CA2568914 A1 2005-12-04

$RFMT $RIREG SCHEME74 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylmethyl 1′-[(1,1-dimethylethoxy)carbonyl]-1,5-dihydro-3-oxospiro[4H-2-be...
C27H32N2O5
908590-02-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.9891 2.6664 0.0 0
M  V30 2 O 2.6439 1.9164 0.0 0
M  V30 3 O 4.0121 4.2061 0.0 0
M  V30 4 C 1.3220 2.7063 0.0 0
M  V30 5 C 0.5321 1.3842 0.0 0
M  V30 6 C 0.0000 3.4962 0.0 0
M  V30 7 C 2.1118 4.0283 0.0 0
M  V30 8 O 9.1889 1.6204 0.0 0
M  V30 9 C 10.4368 4.2120 0.0 0
M  V30 10 C 11.2068 5.5456 0.0 0
M  V30 11 O 12.7468 5.5456 0.0 0
M  V30 12 O 10.4368 6.8793 0.0 0
M  V30 13 C 13.5168 6.8793 0.0 0
M  V30 14 C 6.7272 2.4818 0.0 0
M  V30 15 N 5.3111 1.8765 0.0 0
M  V30 16 C 8.2287 2.8244 0.0 0
M  V30 17 C 5.5232 3.4420 0.0 0
M  V30 18 C 7.7405 1.3220 0.0 0
M  V30 19 C 5.4491 0.3427 0.0 0
M  V30 20 N 8.8967 4.2120 0.0 0
M  V30 21 C 5.5232 4.9820 0.0 0
M  V30 22 C 6.9506 0.0000 0.0 0
M  V30 23 C 8.2287 5.5994 0.0 0
M  V30 24 C 6.7272 5.9422 0.0 0
M  V30 25 C 4.0895 5.5446 0.0 0
M  V30 26 C 6.4977 7.4650 0.0 0
M  V30 27 C 3.8601 7.0673 0.0 0
M  V30 28 C 5.0641 8.0276 0.0 0
M  V30 29 C 15.0569 6.8793 0.0 0
M  V30 30 C 15.8269 5.5456 0.0 0
M  V30 31 C 15.8269 8.2130 0.0 0
M  V30 32 C 17.3669 5.5456 0.0 0
M  V30 33 C 17.3669 8.2130 0.0 0
M  V30 34 C 18.1369 6.8793 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 2 8 16
M  V30 9 1 9 10
M  V30 10 1 9 20
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 11 13
M  V30 14 1 13 29
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 14 17
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 1 16 20
M  V30 21 1 17 21
M  V30 22 1 18 22
M  V30 23 1 19 22
M  V30 24 1 20 23
M  V30 25 1 21 24
M  V30 26 2 21 25
M  V30 27 1 23 24
M  V30 28 2 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 28
M  V30 32 2 29 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 2 31 33
M  V30 36 2 32 34
M  V30 37 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 1,2,3,5-tetrahydro-2-[2-(methylamino)-2-oxoethyl]-3-oxospir...
C21H29N3O4
908590-03-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.6437 4.1591 0.0 0
M  V30 2 O 2.1037 4.1591 0.0 0
M  V30 3 O 4.4137 2.8253 0.0 0
M  V30 4 C 1.3336 2.8253 0.0 0
M  V30 5 C 0.0000 3.5953 0.0 0
M  V30 6 C 0.5636 1.4917 0.0 0
M  V30 7 C 2.6673 2.0553 0.0 0
M  V30 8 O 7.6757 7.6047 0.0 0
M  V30 9 C 10.0278 5.9491 0.0 0
M  V30 10 C 11.3499 5.1592 0.0 0
M  V30 11 N 12.6949 5.9092 0.0 0
M  V30 12 O 11.3268 3.6193 0.0 0
M  V30 13 C 14.0169 5.1193 0.0 0
M  V30 14 C 5.9452 5.6537 0.0 0
M  V30 15 N 4.4137 5.4928 0.0 0
M  V30 16 C 5.3612 4.2287 0.0 0
M  V30 17 C 7.4235 6.0855 0.0 0
M  V30 18 C 6.2654 7.1601 0.0 0
M  V30 19 C 3.7873 6.8996 0.0 0
M  V30 20 C 6.1112 2.8837 0.0 0
M  V30 21 N 8.6827 5.1991 0.0 0
M  V30 22 C 4.9317 7.9301 0.0 0
M  V30 23 C 7.6304 2.6314 0.0 0
M  V30 24 C 5.1332 1.6942 0.0 0
M  V30 25 C 8.7748 3.6618 0.0 0
M  V30 26 C 8.1714 1.1897 0.0 0
M  V30 27 C 5.6742 0.2524 0.0 0
M  V30 28 C 7.1934 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 2 8 17
M  V30 9 1 9 10
M  V30 10 1 9 21
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 11 13
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 14 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 1 17 21
M  V30 21 1 18 22
M  V30 22 1 19 22
M  V30 23 1 20 23
M  V30 24 2 20 24
M  V30 25 1 21 25
M  V30 26 1 23 25
M  V30 27 2 23 26
M  V30 28 1 24 27
M  V30 29 1 26 28
M  V30 30 2 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 908590-02-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 908590-03-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-10289767
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and evaluation of the β-turn properties of
4-amino-1,2,4,5-tetrahydro-2-benzazepin-3-ones and of their spirocyclic
derivative
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Van Rompaey, Karolien; Ballet, Steven; Tomboly, Csaba; De Wachter, Rien;
Vanommeslaeghe, Kenno; Biesemans, Monique; Willem, Rudolph; Tourwe, Dirk
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2006), (13), 2899-2911

$RFMT $RIREG SCHEME75 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methyl (3R)-2,3-dihydro-7-(1-naphthalenylmethyl)-5-oxo-8-phenyl-5H-thiazolo...
C27H21NO5S
916314-97-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 38 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 5.3347 0.0 0
M  V30 2 C 12.6606 6.0450 0.0 0
M  V30 3 O 14.1253 5.5691 0.0 0
M  V30 4 O 12.3405 7.5514 0.0 0
M  V30 5 C 15.2697 6.5995 0.0 0
M  V30 6 O 10.0100 8.0021 0.0 0
M  V30 7 C 7.5657 8.2025 0.0 0
M  V30 8 O 8.8273 9.0858 0.0 0
M  V30 9 O 6.1700 8.8535 0.0 0
M  V30 10 C 9.2400 4.0011 0.0 0
M  V30 11 C 7.7000 4.0011 0.0 0
M  V30 12 N 10.0100 5.3347 0.0 0
M  V30 13 S 10.2704 2.8565 0.0 0
M  V30 14 C 6.9300 5.3347 0.0 0
M  V30 15 C 11.5163 5.0145 0.0 0 CFG=2
M  V30 16 C 9.2400 6.6684 0.0 0
M  V30 17 C 11.6772 3.4830 0.0 0
M  V30 18 C 7.7000 6.6684 0.0 0
M  V30 19 C 6.9300 2.6674 0.0 0
M  V30 20 C 5.3900 2.6674 0.0 0
M  V30 21 C 7.7000 1.3336 0.0 0
M  V30 22 C 4.6200 1.3336 0.0 0
M  V30 23 C 6.9300 0.0000 0.0 0
M  V30 24 C 5.3900 0.0000 0.0 0
M  V30 25 C 4.6200 6.6684 0.0 0
M  V30 26 C 3.0800 6.6684 0.0 0
M  V30 27 C 5.3900 8.0021 0.0 0
M  V30 28 C 2.3100 8.0021 0.0 0
M  V30 29 C 2.3100 5.3347 0.0 0
M  V30 30 C 4.6200 9.3358 0.0 0
M  V30 31 C 3.0800 9.3358 0.0 0
M  V30 32 C 0.7700 8.0021 0.0 0
M  V30 33 C 0.7700 5.3347 0.0 0
M  V30 34 C 0.0000 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 1 25
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 15 2 CFG=3
M  V30 6 1 3 5
M  V30 7 2 6 16
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 18
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 1 11 19
M  V30 16 1 12 15
M  V30 17 1 12 16
M  V30 18 1 13 17
M  V30 19 2 14 18
M  V30 20 1 15 17
M  V30 21 1 16 18
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 28 1 25 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 26 29
M  V30 32 1 27 30
M  V30 33 1 28 31
M  V30 34 1 28 32
M  V30 35 2 29 33
M  V30 36 2 30 31
M  V30 37 2 32 34
M  V30 38 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methyl (3R)-2,3-dihydro-6-[(methylamino)carbonyl]-7-(1-naphthalenylmethyl)-5-...
C28H24N2O4S
916314-99-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 39 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3901 5.3348 0.0 0
M  V30 2 C 7.5659 8.2027 0.0 0
M  V30 3 N 8.8273 9.0860 0.0 0
M  V30 4 O 6.1701 8.8535 0.0 0
M  V30 5 C 8.6932 10.6201 0.0 0
M  V30 6 C 12.6609 6.0451 0.0 0
M  V30 7 O 14.1257 5.5692 0.0 0
M  V30 8 O 12.3408 7.5514 0.0 0
M  V30 9 C 15.2701 6.5997 0.0 0
M  V30 10 O 10.0102 8.0022 0.0 0
M  V30 11 C 7.7002 4.0010 0.0 0
M  V30 12 C 9.2402 4.0010 0.0 0
M  V30 13 C 6.9302 5.3348 0.0 0
M  V30 14 N 10.0102 5.3348 0.0 0
M  V30 15 S 10.2706 2.8566 0.0 0
M  V30 16 C 7.7002 6.6685 0.0 0
M  V30 17 C 11.5165 5.0145 0.0 0 CFG=2
M  V30 18 C 9.2402 6.6685 0.0 0
M  V30 19 C 11.6775 3.4829 0.0 0
M  V30 20 C 6.9302 2.6673 0.0 0
M  V30 21 C 5.3901 2.6673 0.0 0
M  V30 22 C 7.7002 1.3337 0.0 0
M  V30 23 C 4.6201 1.3337 0.0 0
M  V30 24 C 6.9302 0.0000 0.0 0
M  V30 25 C 5.3901 0.0000 0.0 0
M  V30 26 C 4.6201 6.6685 0.0 0
M  V30 27 C 3.0801 6.6685 0.0 0
M  V30 28 C 5.3901 8.0022 0.0 0
M  V30 29 C 2.3101 8.0022 0.0 0
M  V30 30 C 2.3101 5.3348 0.0 0
M  V30 31 C 4.6201 9.3358 0.0 0
M  V30 32 C 3.0801 9.3358 0.0 0
M  V30 33 C 0.7700 8.0022 0.0 0
M  V30 34 C 0.7700 5.3348 0.0 0
M  V30 35 C 0.0000 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 1 26
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 16
M  V30 6 1 3 5
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 17 6 CFG=3
M  V30 10 1 7 9
M  V30 11 2 10 18
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 11 20
M  V30 15 1 12 14
M  V30 16 1 12 15
M  V30 17 2 13 16
M  V30 18 1 14 17
M  V30 19 1 14 18
M  V30 20 1 15 19
M  V30 21 1 16 18
M  V30 22 1 17 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 29 1 26 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 27 30
M  V30 33 1 28 31
M  V30 34 1 29 32
M  V30 35 1 29 33
M  V30 36 2 30 34
M  V30 37 2 31 32
M  V30 38 2 33 35
M  V30 39 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 916314-97-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 916314-99-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-14638067
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 538-75-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 39968-33-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM inert, 84% overall yield in 3 steps from
8-phenyl-2,3-dihydro-7-(1-naphthalenylmethyl)-5-pyridone methyl ester
derivative
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and evaluation of peptidomimetics based on substituted
bicyclic 2-pyridones-Targeting virulence of uropathogenic E. coli
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Aaberg, Veronica; Sellstedt, Magnus; Hedenstroem, Mattias; Pinkner,
Jerome S.; Hultgren, Scott J.; Almqvist, Fredrik
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2006), 14(22), 7563-7581

$RFMT $RIREG SCHEME76 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,5-Dichlorophthalic anhydride
C8H2Cl2O3
942-06-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 4.6949 0.0 0
M  V30 2 O 2.7104 0.0000 0.0 0
M  V30 3 Cl 5.7307 6.6519 0.0 0
M  V30 4 Cl 7.2707 3.9845 0.0 0
M  V30 5 C 2.6507 3.9845 0.0 0
M  V30 6 C 3.4207 2.6508 0.0 0
M  V30 7 C 1.1444 3.6643 0.0 0
M  V30 8 C 3.4207 5.3183 0.0 0
M  V30 9 C 2.3903 1.5064 0.0 0
M  V30 10 C 4.9607 2.6508 0.0 0
M  V30 11 O 0.9835 2.1328 0.0 0
M  V30 12 C 4.9607 5.3183 0.0 0
M  V30 13 C 5.7307 3.9845 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 2 2 9
M  V30 3 1 3 12
M  V30 4 1 4 13
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 1 10 13
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5,6-Dichloro-2-methyl-1H-isoindole-1,3(2H)-dione
C9H5Cl2NO2
86611-81-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.9416 0.0000 0.0 0
M  V30 2 O 5.9416 5.4211 0.0 0
M  V30 3 C 7.9110 2.7106 0.0 0
M  V30 4 Cl 0.0000 1.1706 0.0 0
M  V30 5 Cl 0.0000 4.2506 0.0 0
M  V30 6 C 4.0011 1.9406 0.0 0
M  V30 7 C 4.0011 3.4806 0.0 0
M  V30 8 C 5.4658 1.4647 0.0 0
M  V30 9 C 2.6674 1.1706 0.0 0
M  V30 10 C 5.4658 3.9564 0.0 0
M  V30 11 C 2.6674 4.2506 0.0 0
M  V30 12 N 6.3710 2.7106 0.0 0
M  V30 13 C 1.3338 1.9406 0.0 0
M  V30 14 C 1.3338 3.4806 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 2 2 10
M  V30 3 1 3 12
M  V30 4 1 4 13
M  V30 5 1 5 14
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 1 11 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 942-06-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 86611-81-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-42639426
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 127-08-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Building lactams by a driven highly selective and general deoxygenative
hydrogenation of cyclic imides using an alumina-supported AgRe bimetallic
nanocatalyst
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lluna-Galan, Carles; Arango-Daza, Juan Camilo; Gomez, Daviel; Concepcion,
Patricia; Sun, Rong; Calvino, Jose J.; Simonelli, Laura; Adam, Rosa;
Cabrero-Antonino, Jose R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemRxiv (2024), 1-48

$RFMT $RIREG SCHEME77 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (3R)-3-[(2S)-2-(3-chlorophenyl)tetrahydro-6-oxo-2H-pyran-2-...
C21H28ClNO4
942142-87-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 3.8817 0.0000 0.0 0
M  V30 2 C 9.8627 4.4837 0.0 0
M  V30 3 O 11.1964 5.2537 0.0 0
M  V30 4 O 9.8627 2.9436 0.0 0
M  V30 5 C 12.5300 4.4837 0.0 0
M  V30 6 C 11.7600 3.1500 0.0 0
M  V30 7 C 13.8637 3.7136 0.0 0
M  V30 8 C 13.3000 5.8175 0.0 0
M  V30 9 Cl 0.0000 3.8065 0.0 0
M  V30 10 C 5.3348 3.8065 0.0 0 CFG=2
M  V30 11 O 4.3449 2.6268 0.0 0
M  V30 12 C 6.8515 3.5392 0.0 0
M  V30 13 C 4.8716 1.1797 0.0 0
M  V30 14 C 7.3781 2.0920 0.0 0
M  V30 15 C 6.3882 0.9123 0.0 0
M  V30 16 C 5.8615 5.2537 0.0 0 CFG=2
M  V30 17 C 7.1952 4.4837 0.0 0
M  V30 18 C 5.8615 6.7937 0.0 0
M  V30 19 N 8.5289 5.2537 0.0 0
M  V30 20 C 7.1952 7.5637 0.0 0
M  V30 21 C 8.5289 6.7937 0.0 0
M  V30 22 C 4.0010 4.5765 0.0 0
M  V30 23 C 2.6673 3.8065 0.0 0
M  V30 24 C 4.0010 6.1166 0.0 0
M  V30 25 C 1.3337 4.5765 0.0 0
M  V30 26 C 2.6673 6.8866 0.0 0
M  V30 27 C 1.3337 6.1166 0.0 0
M  V30 28 H 4.3449 5.5212 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 13
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 19
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 25
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 16
M  V30 13 1 10 22 CFG=1
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 1 14 15
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 16 28 CFG=1
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 1 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 10 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (3R)-3-[(1S)-1-(3-chlorophenyl)-1-hydroxy-5-(methylamino)-5...
C22H33ClN2O4
942142-88-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 31 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 8.0021 0.0 0 CFG=1
M  V30 2 C 4.5648 6.6685 0.0 0
M  V30 3 O 6.6685 7.2321 0.0 0
M  V30 4 C 5.3348 5.3348 0.0 0
M  V30 5 C 4.5648 4.0011 0.0 0
M  V30 6 C 5.3348 2.6673 0.0 0
M  V30 7 N 4.5648 1.3337 0.0 0
M  V30 8 O 6.8748 2.6673 0.0 0
M  V30 9 C 5.3348 0.0000 0.0 0
M  V30 10 C 9.9114 7.8828 0.0 0
M  V30 11 O 11.3585 8.4095 0.0 0
M  V30 12 O 9.6439 6.3662 0.0 0
M  V30 13 C 12.5383 7.4197 0.0 0
M  V30 14 C 13.5282 8.5993 0.0 0
M  V30 15 C 13.7179 6.4298 0.0 0
M  V30 16 C 11.5483 6.2399 0.0 0
M  V30 17 Cl 0.0000 8.0021 0.0 0
M  V30 18 C 6.1048 9.3359 0.0 0 CFG=2
M  V30 19 C 7.2845 8.3460 0.0 0
M  V30 20 C 6.3722 10.8526 0.0 0
M  V30 21 N 8.7316 8.8727 0.0 0
M  V30 22 C 7.8193 11.3792 0.0 0
M  V30 23 C 8.9991 10.3893 0.0 0
M  V30 24 C 4.0010 8.7721 0.0 0
M  V30 25 C 2.6673 8.0021 0.0 0
M  V30 26 C 4.0010 10.3122 0.0 0
M  V30 27 C 1.3337 8.7721 0.0 0
M  V30 28 C 2.6673 11.0822 0.0 0
M  V30 29 C 1.3337 10.3122 0.0 0
M  V30 30 H 4.6577 9.8626 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 18
M  V30 4 1 1 24
M  V30 5 1 2 4
M  V30 6 1 4 5
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 7 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 10 21
M  V30 14 1 11 13
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 13 16
M  V30 18 1 17 27
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 18 30 CFG=1
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 942142-87-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 942142-88-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-3184231
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 4. (R)-tert-butyl
3-((S)-1-(3-chlorophenyl)-1-hydroxy-5-(methylamino)-5-oxopentyl)piperidine-1-carboxylate.
(R)-tert-butyl
3-((S)-2-(3-chlorophenyl)-6-oxotetrahydro-2H-pyran-2-yl)piperidine-1-carboxylate
(60 mg, 0.153 mmol) was dissolved in a ca 30% solution of methylamine in
methanol (3 mL). The mixture was stirred at rt for 2 h then concentrated
under reduced pressure to give (R)-tert-butyl
3-((S)-1-(3-chlorophenyl)-1-hydroxy-5-(methylamino)-5-oxopentyl)piperidine-1-carboxylate
(60 mg, 93%), which was used directly without purification. 1H NMR
(400MHz, CDCl3): 1.12-1.45 (m, 3H), 1.46 (s, 9H), 1.58-1.81 (m, 6H),
2.05-2.17 (m, 2H), 2.50-2.58 (m, 2H), 2.69 (m, 3H), 4.06 (m, 1H),
4.12-4.28 (m, 2H), 7.22-7.32 (m, 3H), 7.43 (s, 1H). MS (E/Z): 425 (M+H+).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Piperidine derivatives as aspartic protease inhibitors and their
preparation, pharmaceutical compositions and use in the treatment of
aspartic protease mediated diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Baldwin, John J.; Claremon, David A.; Tice, Colin; Cacatian, Salvation;
Dillard, Lawrence W.; Ishchenko, Alexey V.; Yuan, Jing; Xu, Zhenrong;
McGeehan, Gerard; Simpson, Robert D.; Singh, Suresh B.; Zhao, Wei;
Flaherty, Patrick T.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2007070201 A1 2007-06-21

$RFMT $RIREG SCHEME78 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-5-fluorobenzaldehyde
C7H4BrFO
94569-84-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.3338 0.0 0
M  V30 2 O 2.3100 0.0000 0.0 0
M  V30 3 Br 0.0000 4.0011 0.0 0
M  V30 4 F 6.1600 4.0011 0.0 0
M  V30 5 C 2.3100 2.6674 0.0 0
M  V30 6 C 1.5400 4.0011 0.0 0
M  V30 7 C 3.8500 2.6674 0.0 0
M  V30 8 C 2.3100 5.3349 0.0 0
M  V30 9 C 4.6200 4.0011 0.0 0
M  V30 10 C 3.8500 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 6
M  V30 4 1 4 9
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-5-fluoro-N-methylbenzenemethanamine
C8H9BrFN
887139-05-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 2.6674 0.0 0
M  V30 2 N 5.3900 4.0011 0.0 0
M  V30 3 C 6.9300 4.0011 0.0 0
M  V30 4 Br 3.0800 0.0000 0.0 0
M  V30 5 F 0.0000 5.3349 0.0 0
M  V30 6 C 3.0800 2.6674 0.0 0
M  V30 7 C 2.3100 1.3338 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 0.7700 1.3338 0.0 0
M  V30 10 C 0.7700 4.0011 0.0 0
M  V30 11 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 4 7
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 94569-84-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 887139-05-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-23522594
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocyclic compounds useful in the treatment of
disorders that lead to accumulation of oxalate
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Ying; Lee, Esther C. Y.; McRiner, Andrew J.; Hupp, Christopher D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021050555 A1 2021-03-18

$RFMT $RIREG SCHEME79 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (5R)-3-(1-ethyl-1H-indazol-5-yl)-2-oxo-5-oxazolidinecarboxylate
C14H15N3O4
945928-53-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 1.4647 2.0003 0.0 0
M  V30 2 C 0.0000 2.4762 0.0 0
M  V30 3 O 9.1647 0.0000 0.0 0
M  V30 4 C 12.3512 4.3858 0.0 0
M  V30 5 O 13.7581 3.7593 0.0 0
M  V30 6 O 12.1902 5.9173 0.0 0
M  V30 7 C 15.0040 4.6645 0.0 0
M  V30 8 C 4.1155 2.7106 0.0 0
M  V30 9 C 4.8855 4.0442 0.0 0
M  V30 10 N 2.6091 3.0307 0.0 0
M  V30 11 C 4.8855 1.3769 0.0 0
M  V30 12 C 6.4255 4.0442 0.0 0
M  V30 13 C 3.8549 5.1887 0.0 0
M  V30 14 N 2.4482 4.5623 0.0 0
M  V30 15 C 6.4255 1.3769 0.0 0
M  V30 16 C 7.1955 2.7106 0.0 0
M  V30 17 N 8.7355 2.7106 0.0 0
M  V30 18 C 9.6406 3.9564 0.0 0
M  V30 19 C 9.6406 1.4647 0.0 0
M  V30 20 C 11.1053 3.4806 0.0 0 CFG=2
M  V30 21 O 11.1053 1.9406 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 2 3 19
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 20 4 CFG=3
M  V30 7 1 5 7
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 2 8 11
M  V30 11 2 9 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 2 13 14
M  V30 17 2 15 16
M  V30 18 1 16 17
M  V30 19 1 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(5R)-3-(1-Ethyl-1H-indazol-5-yl)-N-methyl-2-oxo-5-oxazolidinecarboxamide
C14H16N4O3
945928-33-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 1.4647 2.0003 0.0 0
M  V30 2 C 0.0000 2.4762 0.0 0
M  V30 3 O 9.1647 0.0000 0.0 0
M  V30 4 C 12.3512 4.3858 0.0 0
M  V30 5 N 13.7581 3.7593 0.0 0
M  V30 6 O 12.1902 5.9173 0.0 0
M  V30 7 C 15.0040 4.6645 0.0 0
M  V30 8 C 4.1155 2.7106 0.0 0
M  V30 9 C 4.8855 4.0442 0.0 0
M  V30 10 N 2.6091 3.0307 0.0 0
M  V30 11 C 4.8855 1.3769 0.0 0
M  V30 12 C 6.4255 4.0442 0.0 0
M  V30 13 C 3.8549 5.1887 0.0 0
M  V30 14 N 2.4482 4.5623 0.0 0
M  V30 15 C 6.4255 1.3769 0.0 0
M  V30 16 C 7.1955 2.7106 0.0 0
M  V30 17 N 8.7355 2.7106 0.0 0
M  V30 18 C 9.6406 3.9564 0.0 0
M  V30 19 C 9.6406 1.4647 0.0 0
M  V30 20 C 11.1053 3.4806 0.0 0 CFG=2
M  V30 21 O 11.1053 1.9406 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 2 3 19
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 20 4 CFG=3
M  V30 7 1 5 7
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 2 8 11
M  V30 11 2 9 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 2 13 14
M  V30 17 2 15 16
M  V30 18 1 16 17
M  V30 19 1 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 945928-53-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 945928-33-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-7809539
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 6 Preparation of (R)-3-(1-ethyl-1H-indazol-5
-yl)-N-methyl-2-oxooxazolidine-5-carboxamide Methylamine (2M solution in
methanol,2mL) is added to solid (R)-methyl
3-(1-ethyl-1H-indazol-5-yl)-2-oxooxazolidine-5-carboxylate (0.1184 g,
0.000409 mol) and the mixture stirred at room temperature for 1h. The
solvent is then removed in vacuo, the residue triturated with a minimum
amount of methanol, and filtered to afford the title compound (0.109 g,
93%). HPLC (SYMMETRY C18 3.5 μM, 4.6 x 30 mm column; gradient elution
2%-98% MeCN with 0.1% TFA over 10 min; 2 mL/min rate): retention time =
3.50 min; 1H NMR (300 MHz, CDCl3) 7.96 (s, 1H), 7.67 (m, 1H), 7.63(d, J=
2.2Hz, 1H), 7.41 (dd, J = 0.8, 9.9Hz,1H), 6.65 (bs, 1H), 4.98 (dd, J=
5.8, 9.6Hz, 1H), 4.41 (q, J= 7.1Hz, 2H), 4.36-4.25 (dd, J= 3.6, 9.3Hz,
2H), 2.91 (d, J= 5.0Hz, 3H), 1.50(t, J= 7.3Hz, 3H); MS for C14H16N4O3m/z
289.3 (M+H)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 5-(2-oxooxazolidine-3-yl)-1H-indazole derivatives as
antibacterial agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gordeev, Mikhail Fedorovich; Josyula, Vara Prasad Venkata Nagendra;
Luehr, Gary Wayne
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2007088478 A1 2007-08-09

$RFMT $RIREG SCHEME80 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Imidazo[5,1-c]naphtho[2,1-e][1,2,4]triazine-1-carbonyl azide
C14H7N7O
951315-61-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.3508 3.3777 0.0 0
M  V30 2 N 11.8153 2.9018 0.0 0
M  V30 3 O 10.0306 4.8841 0.0 0
M  V30 4 N 12.9599 3.9322 0.0 0 CHG=1 VAL=4
M  V30 5 N 14.1042 4.9628 0.0 0 CHG=-1
M  V30 6 C 5.3900 1.3338 0.0 0
M  V30 7 N 6.9300 1.3338 0.0 0
M  V30 8 C 4.6200 2.6674 0.0 0
M  V30 9 C 4.6200 0.0000 0.0 0
M  V30 10 C 7.7000 2.6674 0.0 0
M  V30 11 C 7.9604 0.1893 0.0 0
M  V30 12 C 3.0800 2.6674 0.0 0
M  V30 13 N 5.3900 4.0011 0.0 0
M  V30 14 C 3.0800 0.0000 0.0 0
M  V30 15 C 9.2063 2.3473 0.0 0
M  V30 16 N 6.9300 4.0011 0.0 0
M  V30 17 N 9.3674 0.8157 0.0 0
M  V30 18 C 2.3100 1.3338 0.0 0
M  V30 19 C 2.3100 4.0011 0.0 0
M  V30 20 C 0.7700 1.3338 0.0 0
M  V30 21 C 0.7700 4.0011 0.0 0
M  V30 22 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 2 2 4
M  V30 5 2 4 5
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 2 8 12
M  V30 12 1 8 13
M  V30 13 1 9 14
M  V30 14 2 10 15
M  V30 15 1 10 16
M  V30 16 2 11 17
M  V30 17 1 12 18
M  V30 18 1 12 19
M  V30 19 2 13 16
M  V30 20 2 14 18
M  V30 21 1 15 17
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methylimidazo[5,1-c]naphtho[2,1-e][1,2,4]triazine-1-carboxamide
C15H11N5O
308321-18-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.3506 1.5063 0.0 0
M  V30 2 N 11.8153 1.9823 0.0 0
M  V30 3 O 10.0305 0.0000 0.0 0
M  V30 4 C 12.9597 0.9517 0.0 0
M  V30 5 C 5.3900 3.5503 0.0 0
M  V30 6 N 6.9300 3.5503 0.0 0
M  V30 7 C 4.6200 2.2167 0.0 0
M  V30 8 C 4.6200 4.8840 0.0 0
M  V30 9 C 7.7000 2.2167 0.0 0
M  V30 10 C 7.9604 4.6947 0.0 0
M  V30 11 C 3.0800 2.2167 0.0 0
M  V30 12 N 5.3900 0.8829 0.0 0
M  V30 13 C 3.0800 4.8840 0.0 0
M  V30 14 C 9.2063 2.5368 0.0 0
M  V30 15 N 6.9300 0.8829 0.0 0
M  V30 16 N 9.3672 4.0684 0.0 0
M  V30 17 C 2.3100 3.5503 0.0 0
M  V30 18 C 2.3100 0.8829 0.0 0
M  V30 19 C 0.7700 3.5503 0.0 0
M  V30 20 C 0.7700 0.8829 0.0 0
M  V30 21 C 0.0000 2.2167 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 1 7 12
M  V30 12 1 8 13
M  V30 13 2 9 14
M  V30 14 1 9 15
M  V30 15 2 10 16
M  V30 16 1 11 17
M  V30 17 1 11 18
M  V30 18 2 12 15
M  V30 19 2 13 17
M  V30 20 1 14 16
M  V30 21 1 17 19
M  V30 22 2 18 20
M  V30 23 2 19 21
M  V30 24 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951315-61-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 308321-18-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-15004126
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM B. Methylamine (1.5 mL, 17.3 mmol) was added to a solution of carboxazide
5l (1 g, 3.46 mmol) in DMF (10 mL), and the mixture was kept for 1 h at
70°C, cooled, and treated with CCl4 (10 mL). The yellow precipitate was
filtered off, recrystallized from a DMF-ethanol mixture, and dried.
1-Methylcarbamoylnaphtho[2,1-e]imidazo[5,1-c][1,2,4]triazine (5f): Yield:
93%. M.p: 286-289°C; C15H11N5O; 1H NMR, δ (J/Hz): 3.87 (d, 3 H, NHMe, J =
4.9,); 7.78-7.97 (m, 3 H, H(7), H(8), H(9)); 8.31 (d, 1 H, H(6), J =
9.0); 8.40 (d, 1 H, H(5), J = 9.0); 9.24 (q, 1 H, NHMe, J = 4.9); 9.38
(d, 1 H, H(10), J = 8.3); 9.43 (s, 1 H, H(3))
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative reaction conditions gave lower yield, alternative reaction
conditions shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of 4-arylcarbamoyl-5-(2-hydroxynaphthylazo)imidazoles and
1-substituted naphtho[2,1-e]imidazo[5,1-c][1,2,4]triazines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sadchikova, E. V.; Mokrushin, V. S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Russian Chemical Bulletin (2006), 55(7), 1255-1261

$RFMT $RIREG SCHEME81 STEP1
$RXN



  2  1
$MOL
Ethyl (5aR,7S,9aR)-7-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-6,7-dihydro-4-me...
C23H34O5Si
951396-71-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.4617 6.1772 0.0 0
M  V30 2 C 9.3667 7.4231 0.0 0
M  V30 3 O 10.8984 7.2622 0.0 0
M  V30 4 O 8.7404 8.8299 0.0 0
M  V30 5 C 11.8035 8.5080 0.0 0
M  V30 6 C 13.3352 8.3470 0.0 0
M  V30 7 O 5.0751 1.5315 0.0 0
M  V30 8 C 5.2362 0.0000 0.0 0
M  V30 9 O 4.6200 10.3393 0.0 0
M  V30 10 Si 3.0800 10.3393 0.0 0
M  V30 11 C 1.5400 10.3393 0.0 0
M  V30 12 C 3.0800 8.7993 0.0 0
M  V30 13 C 3.0800 11.8793 0.0 0
M  V30 14 C 1.5400 11.8793 0.0 0
M  V30 15 C 0.0000 10.3393 0.0 0
M  V30 16 C 1.5400 8.7993 0.0 0
M  V30 17 C 6.9300 6.3382 0.0 0 CFG=2
M  V30 18 C 7.4059 4.8735 0.0 0
M  V30 19 C 5.3900 6.3382 0.0 0 CFG=1
M  V30 20 C 7.7000 7.6718 0.0 0
M  V30 21 C 6.1600 3.9684 0.0 0
M  V30 22 C 8.8128 4.2472 0.0 0
M  V30 23 O 4.9141 4.8735 0.0 0
M  V30 24 C 4.6200 7.6718 0.0 0
M  V30 25 C 6.9300 9.0055 0.0 0
M  V30 26 C 6.3211 2.4367 0.0 0
M  V30 27 C 8.9737 2.7156 0.0 0
M  V30 28 C 5.3900 9.0055 0.0 0 CFG=2
M  V30 29 C 7.7279 1.8104 0.0 0
M  V30 30 H 3.8585 6.1772 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 17 1 CFG=1
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 1 7 26
M  V30 9 1 9 10
M  V30 10 1 28 9 CFG=3
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 1 11 16
M  V30 17 1 17 18
M  V30 18 1 17 19
M  V30 19 1 17 20
M  V30 20 1 18 21
M  V30 21 2 18 22
M  V30 22 1 19 23
M  V30 23 1 19 24
M  V30 24 1 19 30 CFG=1
M  V30 25 2 20 25
M  V30 26 1 21 23
M  V30 27 2 21 26
M  V30 28 1 22 27
M  V30 29 1 24 28
M  V30 30 1 25 28
M  V30 31 1 26 29
M  V30 32 2 27 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 17 19 28)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(5aR,7S,9aR)-7-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]-6,7-dihydro-4-methoxy-...
C22H33NO4Si
951396-72-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.7368 4.0596 0.0 0
M  V30 2 C 4.3633 2.6528 0.0 0
M  V30 3 N 3.4581 1.4070 0.0 0
M  V30 4 O 5.8948 2.4919 0.0 0
M  V30 5 C 4.0844 0.0000 0.0 0
M  V30 6 O 1.4070 9.3152 0.0 0
M  V30 7 C 0.0000 9.9417 0.0 0
M  V30 8 O 9.2621 5.3055 0.0 0
M  V30 9 Si 10.0321 6.6393 0.0 0
M  V30 10 C 10.8021 7.9729 0.0 0
M  V30 11 C 11.3659 5.8693 0.0 0
M  V30 12 C 8.6984 7.4093 0.0 0
M  V30 13 C 12.1359 7.2029 0.0 0
M  V30 14 C 11.5721 9.3066 0.0 0
M  V30 15 C 9.4684 8.7429 0.0 0
M  V30 16 C 4.6420 5.3055 0.0 0 CFG=2
M  V30 17 C 3.1358 5.6258 0.0 0
M  V30 18 C 5.4120 6.6393 0.0 0 CFG=1
M  V30 19 C 5.4120 3.9718 0.0 0
M  V30 20 C 2.9748 7.1573 0.0 0
M  V30 21 C 1.8899 4.7206 0.0 0
M  V30 22 O 4.3816 7.7837 0.0 0
M  V30 23 C 6.9521 6.6393 0.0 0
M  V30 24 C 6.9521 3.9718 0.0 0
M  V30 25 C 1.5679 7.7837 0.0 0
M  V30 26 C 0.4829 5.3469 0.0 0
M  V30 27 C 7.7221 5.3055 0.0 0 CFG=2
M  V30 28 C 0.3220 6.8784 0.0 0
M  V30 29 H 6.0385 8.0461 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 16 1 CFG=1
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 25
M  V30 8 1 8 9
M  V30 9 1 27 8 CFG=3
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 1 10 14
M  V30 15 1 10 15
M  V30 16 1 16 17
M  V30 17 1 16 18
M  V30 18 1 16 19
M  V30 19 1 17 20
M  V30 20 2 17 21
M  V30 21 1 18 22
M  V30 22 1 18 23
M  V30 23 1 18 29 CFG=1
M  V30 24 2 19 24
M  V30 25 1 20 22
M  V30 26 2 20 25
M  V30 27 1 21 26
M  V30 28 1 23 27
M  V30 29 1 24 27
M  V30 30 1 25 28
M  V30 31 2 26 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 16 18 27)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 951396-71-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951396-72-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-12897646
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-65-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 2942-58-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Total synthesis of (+)-galanthamine starting from D-glucose
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tanimoto, Hiroki; Kato, Tomoaki; Chida, Noritaka
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2007), 48(36), 6267-6270

$RFMT $RIREG SCHEME82 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Fluoro-6-S-[(4-nitrophenyl)methyl]-6-thioinosine
C17H16FN5O6S
958889-59-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 33 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 3.7113 7.1224 0.0 0
M  V30 2 S 11.3467 4.6201 0.0 0
M  V30 3 C 12.6804 3.8501 0.0 0
M  V30 4 F 8.6793 0.0000 0.0 0
M  V30 5 C 1.5063 2.1700 0.0 0
M  V30 6 O 0.0000 2.4902 0.0 0
M  V30 7 O 0.8097 5.4472 0.0 0
M  V30 8 N 18.0152 6.9301 0.0 0 VAL=5
M  V30 9 O 18.0152 8.4701 0.0 0
M  V30 10 O 19.3488 6.1601 0.0 0
M  V30 11 N 6.2012 4.8805 0.0 0
M  V30 12 C 7.3456 3.8501 0.0 0
M  V30 13 C 6.8275 6.2874 0.0 0
M  V30 14 C 8.6793 4.6201 0.0 0
M  V30 15 N 7.3456 2.3100 0.0 0
M  V30 16 N 8.3591 6.1264 0.0 0
M  V30 17 C 10.0131 3.8501 0.0 0
M  V30 18 C 8.6793 1.5400 0.0 0
M  V30 19 N 10.0131 2.3100 0.0 0
M  V30 20 C 4.6948 4.5603 0.0 0 CFG=1
M  V30 21 O 4.0684 3.1535 0.0 0
M  V30 22 C 3.5504 5.5909 0.0 0 CFG=2
M  V30 23 C 2.5367 3.3144 0.0 0 CFG=2
M  V30 24 C 2.2166 4.8209 0.0 0 CFG=2
M  V30 25 C 14.0140 4.6201 0.0 0
M  V30 26 C 15.3479 3.8501 0.0 0
M  V30 27 C 14.0140 6.1601 0.0 0
M  V30 28 C 16.6815 4.6201 0.0 0
M  V30 29 C 15.3479 6.9301 0.0 0
M  V30 30 C 16.6815 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 22 1 CFG=1
M  V30 2 1 2 3
M  V30 3 1 2 17
M  V30 4 1 3 25
M  V30 5 1 4 18
M  V30 6 1 5 6
M  V30 7 1 23 5 CFG=3
M  V30 8 1 24 7 CFG=1
M  V30 9 2 8 9
M  V30 10 2 8 10
M  V30 11 1 8 30
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 20 11 CFG=3
M  V30 15 1 12 14
M  V30 16 2 12 15
M  V30 17 2 13 16
M  V30 18 1 14 16
M  V30 19 2 14 17
M  V30 20 1 15 18
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 23 1 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 24
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 20 22 23 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-Methyl-6-S-[(4-nitrophenyl)methyl]-6-thioguanosine
C18H20N6O6S
958889-65-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 34 0 0 1
M  V30 BEGIN ATOM
M  V30 1 S 11.3467 5.3901 0.0 0
M  V30 2 C 12.6804 4.6201 0.0 0
M  V30 3 N 8.6793 0.7700 0.0 0
M  V30 4 C 10.0131 0.0000 0.0 0
M  V30 5 O 3.7113 7.8925 0.0 0
M  V30 6 C 1.5063 2.9401 0.0 0
M  V30 7 O 0.0000 3.2602 0.0 0
M  V30 8 O 0.8097 6.2172 0.0 0
M  V30 9 N 18.0152 7.7001 0.0 0 VAL=5
M  V30 10 O 19.3489 6.9301 0.0 0
M  V30 11 O 18.0152 9.2401 0.0 0
M  V30 12 C 7.3456 4.6201 0.0 0
M  V30 13 N 6.2012 5.6505 0.0 0
M  V30 14 C 8.6793 5.3901 0.0 0
M  V30 15 N 7.3456 3.0800 0.0 0
M  V30 16 C 6.8275 7.0575 0.0 0
M  V30 17 C 10.0131 4.6201 0.0 0
M  V30 18 N 8.3591 6.8964 0.0 0
M  V30 19 C 8.6793 2.3100 0.0 0
M  V30 20 N 10.0131 3.0800 0.0 0
M  V30 21 C 4.6948 5.3303 0.0 0 CFG=1
M  V30 22 O 4.0684 3.9235 0.0 0
M  V30 23 C 3.5504 6.3608 0.0 0 CFG=2
M  V30 24 C 2.5367 4.0844 0.0 0 CFG=2
M  V30 25 C 2.2166 5.5907 0.0 0 CFG=2
M  V30 26 C 14.0141 5.3901 0.0 0
M  V30 27 C 14.0141 6.9301 0.0 0
M  V30 28 C 15.3479 4.6201 0.0 0
M  V30 29 C 15.3479 7.7001 0.0 0
M  V30 30 C 16.6815 5.3901 0.0 0
M  V30 31 C 16.6815 6.9301 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 2 26
M  V30 4 1 3 4
M  V30 5 1 3 19
M  V30 6 1 23 5 CFG=1
M  V30 7 1 6 7
M  V30 8 1 24 6 CFG=3
M  V30 9 1 25 8 CFG=1
M  V30 10 2 9 10
M  V30 11 2 9 11
M  V30 12 1 9 31
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 2 12 15
M  V30 16 1 13 16
M  V30 17 1 21 13 CFG=3
M  V30 18 2 14 17
M  V30 19 1 14 18
M  V30 20 1 15 19
M  V30 21 2 16 18
M  V30 22 1 17 20
M  V30 23 2 19 20
M  V30 24 1 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 25
M  V30 29 2 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 28 30
M  V30 33 2 29 31
M  V30 34 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 21 23 24 25)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 958889-59-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 958889-65-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-5901397
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel C2-purine position analogs of nitrobenzylmercaptopurine riboside as
human equilibrative nucleoside transporter 1 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gupte, Amol; Buolamwini, John K.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2007), 15(24), 7726-7737

$RFMT $RIREG SCHEME83 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Nitrosalicylaldehyde
C7H5NO4
97-51-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 4.0011 0.0 0
M  V30 2 O 6.9301 2.6675 0.0 0
M  V30 3 O 4.6201 6.6686 0.0 0
M  V30 4 N 1.5400 1.3338 0.0 0 VAL=5
M  V30 5 O 2.3100 0.0000 0.0 0
M  V30 6 O 0.0000 1.3338 0.0 0
M  V30 7 C 4.6201 4.0011 0.0 0
M  V30 8 C 3.8500 2.6675 0.0 0
M  V30 9 C 3.8500 5.3348 0.0 0
M  V30 10 C 2.3100 2.6675 0.0 0
M  V30 11 C 2.3100 5.3348 0.0 0
M  V30 12 C 1.5400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 2 4 6
M  V30 6 1 4 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[(Methylimino)methyl]-4-nitrophenol
C8H8N2O3
35082-69-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 2.6674 0.0 0
M  V30 2 N 6.9300 4.0011 0.0 0
M  V30 3 C 8.4700 4.0011 0.0 0
M  V30 4 O 4.6200 0.0000 0.0 0
M  V30 5 N 1.5400 5.3347 0.0 0 VAL=5
M  V30 6 O 2.3100 6.6685 0.0 0
M  V30 7 O 0.0000 5.3347 0.0 0
M  V30 8 C 4.6200 2.6674 0.0 0
M  V30 9 C 3.8500 4.0011 0.0 0
M  V30 10 C 3.8500 1.3338 0.0 0
M  V30 11 C 2.3100 4.0011 0.0 0
M  V30 12 C 2.3100 1.3338 0.0 0
M  V30 13 C 1.5400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 97-51-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 35082-69-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-1455189
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Metal carbene catalysts used in olefin metathesis, atom/group transfer
radical polymerization, addition reaction and vinylation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Verpoort, Francis Walter Cornelius; De Clercq, Bob
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2003062253 A1 2003-07-31

$RFMT $RIREG SCHEME83 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Nitrosalicylaldehyde
C7H5NO4
97-51-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 4.0011 0.0 0
M  V30 2 O 6.9301 2.6675 0.0 0
M  V30 3 O 4.6201 6.6686 0.0 0
M  V30 4 N 1.5400 1.3338 0.0 0 VAL=5
M  V30 5 O 2.3100 0.0000 0.0 0
M  V30 6 O 0.0000 1.3338 0.0 0
M  V30 7 C 4.6201 4.0011 0.0 0
M  V30 8 C 3.8500 2.6675 0.0 0
M  V30 9 C 3.8500 5.3348 0.0 0
M  V30 10 C 2.3100 2.6675 0.0 0
M  V30 11 C 2.3100 5.3348 0.0 0
M  V30 12 C 1.5400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 2 4 6
M  V30 6 1 4 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[(Methylimino)methyl]-4-nitrophenol
C8H8N2O3
35082-69-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 2.6674 0.0 0
M  V30 2 N 6.9300 4.0011 0.0 0
M  V30 3 C 8.4700 4.0011 0.0 0
M  V30 4 O 4.6200 0.0000 0.0 0
M  V30 5 N 1.5400 5.3347 0.0 0 VAL=5
M  V30 6 O 2.3100 6.6685 0.0 0
M  V30 7 O 0.0000 5.3347 0.0 0
M  V30 8 C 4.6200 2.6674 0.0 0
M  V30 9 C 3.8500 4.0011 0.0 0
M  V30 10 C 3.8500 1.3338 0.0 0
M  V30 11 C 2.3100 4.0011 0.0 0
M  V30 12 C 2.3100 1.3338 0.0 0
M  V30 13 C 1.5400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 97-51-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 35082-69-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-7304320
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Metal carbene complexes, methods and intermediates for making them and
their use in metathesis reactions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Verpoort, Francis Walter Cornelius; De Clercq, Bob
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Patent Organization, EP1329455 A1 2003-07-23

$RFMT $RIREG SCHEME84 STEP1
$RXN



  1  1
$MOL
3-Benzofuranacetic acid, 2-(1-hydrazinylideneethyl)-6-methyl-, compd. with hy...
C13H14N2O3.H4N2
864466-13-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.9416 4.1491 0.0 0
M  V30 2 C 4.9112 3.0045 0.0 0
M  V30 3 O 5.3871 1.5400 0.0 0
M  V30 4 O 3.4048 3.3247 0.0 0
M  V30 5 C 7.9110 6.8595 0.0 0
M  V30 6 N 8.6810 8.1933 0.0 0
M  V30 7 C 8.6810 5.5258 0.0 0
M  V30 8 N 10.2210 8.1933 0.0 0
M  V30 9 C 0.0000 8.3995 0.0 0
M  V30 10 C 5.4658 5.6136 0.0 0
M  V30 11 C 4.0011 6.0895 0.0 0
M  V30 12 C 6.3710 6.8595 0.0 0
M  V30 13 C 4.0011 7.6295 0.0 0
M  V30 14 C 2.6674 5.3195 0.0 0
M  V30 15 O 5.4658 8.1055 0.0 0
M  V30 16 C 2.6674 8.3995 0.0 0
M  V30 17 C 1.3338 6.0895 0.0 0
M  V30 18 C 1.3338 7.6295 0.0 0
M  V30 19 N 4.3405 0.0000 0.0 0
M  V30 20 N 5.8805 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 5 6 CFG=2
M  V30 6 1 5 7
M  V30 7 1 5 12
M  V30 8 1 6 8
M  V30 9 1 9 18
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 11 13
M  V30 13 2 11 14
M  V30 14 1 12 15
M  V30 15 1 13 15
M  V30 16 2 13 16
M  V30 17 1 14 17
M  V30 18 1 16 18
M  V30 19 2 17 18
M  V30 20 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(3,6-Dimethyl-2-benzofuranyl)ethanone 2-[1-(3,6-dimethyl-2-benzofuranyl)eth...
C24H24N2O2
864466-14-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.9415 9.4221 0.0 0
M  V30 2 C 7.9109 6.7115 0.0 0
M  V30 3 N 8.6809 5.3779 0.0 0
M  V30 4 C 8.6809 8.0453 0.0 0
M  V30 5 N 7.9109 4.0442 0.0 0
M  V30 6 C 8.6809 2.7106 0.0 0
M  V30 7 C 7.9109 1.3768 0.0 0
M  V30 8 C 0.0000 5.1715 0.0 0
M  V30 9 C 10.6502 0.0000 0.0 0
M  V30 10 C 16.5917 4.2506 0.0 0
M  V30 11 C 4.0011 5.9415 0.0 0
M  V30 12 C 4.0011 7.4815 0.0 0
M  V30 13 O 5.4656 5.4656 0.0 0
M  V30 14 C 2.6673 5.1715 0.0 0
M  V30 15 C 5.4656 7.9575 0.0 0
M  V30 16 C 2.6673 8.2515 0.0 0
M  V30 17 C 6.3709 6.7115 0.0 0
M  V30 18 C 1.3336 5.9415 0.0 0
M  V30 19 C 1.3336 7.4815 0.0 0
M  V30 20 C 10.2209 2.7106 0.0 0
M  V30 21 C 11.1261 1.4645 0.0 0
M  V30 22 O 11.1261 3.9564 0.0 0
M  V30 23 C 12.5906 1.9406 0.0 0
M  V30 24 C 12.5906 3.4806 0.0 0
M  V30 25 C 13.9244 1.1706 0.0 0
M  V30 26 C 13.9244 4.2506 0.0 0
M  V30 27 C 15.2581 1.9406 0.0 0
M  V30 28 C 15.2581 3.4806 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 15
M  V30 2 2 2 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 2 17
M  V30 5 1 3 5
M  V30 6 2 5 6 CFG=2
M  V30 7 1 6 7
M  V30 8 1 6 20
M  V30 9 1 8 18
M  V30 10 1 9 21
M  V30 11 1 10 28
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 12 15
M  V30 16 2 12 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 2 15 17
M  V30 20 1 16 19
M  V30 21 2 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 864466-13-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 864466-14-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-154-CAS-13030332
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Reaction of 2-acyl-6-methylbenzo[b]furan-3-acetic acid derivatives with
hydrazine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tolkunov, Valery S.; Perepichka, Igor F.; Dulenko, Vladimir I.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Heterocyclic Chemistry (2005), 42(5), 811-817

$RFMT $RIREG SCHEME85 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Dimethoxybenzaldehyde
C9H10O3
120-14-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 O 0.7700 4.0011 0.0 0
M  V30 4 C 0.0000 5.3349 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 O 7.7000 5.3349 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 3 4
M  V30 4 1 3 8
M  V30 5 2 5 6
M  V30 6 1 5 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Dimethoxy-N-methylbenzenemethanamine
C10H15NO2
63-64-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 O 0.7700 4.0011 0.0 0
M  V30 4 C 0.0000 5.3349 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 N 7.7000 5.3349 0.0 0
M  V30 7 C 9.2400 5.3349 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 11 C 3.0800 5.3349 0.0 0
M  V30 12 C 5.3900 4.0011 0.0 0
M  V30 13 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 3 4
M  V30 4 1 3 9
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 1 6 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 120-14-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 63-64-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-21791798
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7757-82-6
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Thiol-Ene Networks from Sequence-Defined Polyurethane Macromers
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hoff, Emily A.; De Hoe, Guilhem X.; Mulvaney, Christopher M.; Hillmyer,
Marc A.; Alabi, Christopher A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2020), 142(14), 6729-6736

$RFMT $RIREG SCHEME86 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[6-(methoxycarbonyl)-3-pyridinyl]-1-piperazinecarboxylate
C16H23N3O4
1354355-85-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.8737 0.0 0
M  V30 2 O 3.0800 1.5400 0.0 0
M  V30 3 O 3.0800 4.2073 0.0 0
M  V30 4 C 1.5400 1.5400 0.0 0
M  V30 5 C 1.5400 0.0000 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 1.5400 3.0800 0.0 0
M  V30 8 C 14.6302 2.8737 0.0 0
M  V30 9 O 15.4002 4.2073 0.0 0
M  V30 10 O 15.4002 1.5400 0.0 0
M  V30 11 C 16.9402 4.2073 0.0 0
M  V30 12 N 8.4701 2.8737 0.0 0
M  V30 13 C 7.7001 4.2073 0.0 0
M  V30 14 C 7.7001 1.5400 0.0 0
M  V30 15 C 6.1601 4.2073 0.0 0
M  V30 16 C 6.1601 1.5400 0.0 0
M  V30 17 N 5.3901 2.8737 0.0 0
M  V30 18 C 10.0101 2.8737 0.0 0
M  V30 19 C 10.7801 1.5400 0.0 0
M  V30 20 C 10.7801 4.2073 0.0 0
M  V30 21 C 12.3201 1.5400 0.0 0
M  V30 22 N 12.3201 4.2073 0.0 0
M  V30 23 C 13.0901 2.8737 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 23
M  V30 11 1 9 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 18
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 19 1 18 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[6-[(methylamino)carbonyl]-3-pyridinyl]-1-piperazinecarbo...
C16H24N4O3
2589532-06-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.8737 0.0 0
M  V30 2 O 3.0800 1.5400 0.0 0
M  V30 3 O 3.0800 4.2073 0.0 0
M  V30 4 C 1.5400 1.5400 0.0 0
M  V30 5 C 1.5400 3.0800 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 1.5400 0.0000 0.0 0
M  V30 8 C 14.6302 2.8737 0.0 0
M  V30 9 N 15.4002 4.2073 0.0 0
M  V30 10 O 15.4002 1.5400 0.0 0
M  V30 11 C 16.9402 4.2073 0.0 0
M  V30 12 N 8.4701 2.8737 0.0 0
M  V30 13 C 7.7001 4.2073 0.0 0
M  V30 14 C 7.7001 1.5400 0.0 0
M  V30 15 C 6.1601 4.2073 0.0 0
M  V30 16 C 6.1601 1.5400 0.0 0
M  V30 17 N 5.3901 2.8737 0.0 0
M  V30 18 C 10.0101 2.8737 0.0 0
M  V30 19 C 10.7801 4.2073 0.0 0
M  V30 20 C 10.7801 1.5400 0.0 0
M  V30 21 C 12.3201 4.2073 0.0 0
M  V30 22 N 12.3201 1.5400 0.0 0
M  V30 23 C 13.0901 2.8737 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 23
M  V30 11 1 9 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 18
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 19 1 18 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1354355-85-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2589532-06-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37242933
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocyclic compounds as PARP1 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pan, Jun; Bai, Yu; Zheng, Hewen; Li, Yu; Yang, Jeffrey; Wu, Liangxing;
Yao, Wenqing
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023122140 A1 2023-06-29

$RFMT $RIREG SCHEME87 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl acetoacetate
C6H10O3
141-97-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 2.3100 0.0 0
M  V30 2 C 4.0011 1.5400 0.0 0
M  V30 3 C 1.3337 1.5400 0.0 0
M  V30 4 O 5.3348 2.3100 0.0 0
M  V30 5 O 4.0011 0.0000 0.0 0
M  V30 6 C 0.0000 2.3100 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 6.6686 1.5400 0.0 0
M  V30 9 C 8.0022 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl (2Z)-3-(methylamino)-2-butenoate
C7H13NO2
21759-70-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8501 1.3337 0.0 0
M  V30 2 C 4.6201 2.6673 0.0 0
M  V30 3 C 2.3101 1.3337 0.0 0
M  V30 4 O 6.1601 2.6673 0.0 0
M  V30 5 O 3.8501 4.0010 0.0 0
M  V30 6 N 1.5400 2.6673 0.0 0
M  V30 7 C 1.5400 0.0000 0.0 0
M  V30 8 C 6.9302 4.0010 0.0 0
M  V30 9 C 0.0000 2.6673 0.0 0
M  V30 10 C 8.4702 4.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 6 9
M  V30 9 1 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 141-97-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 21759-70-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-15029435
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7553-56-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for the Formation of
Enaminones Iodine (20 mol%) was added to a mixture of ethyl acetoacetate
or acetylacetone (1.5 mmol) and amine (1.5 mmol) [but in the case of
aniline and ethylene diamine (entries 3, 6,9 and 12), iodine was first
added to the substrates, the mixture was cooled to 5°C, and then amine
was added dropwise]. When iodine was added, heat evolved (exothermic
reaction). Then, the reaction mixture was cooled under tap water. During
this period, the reaction completed, which was indicated by TLC. Then,
the reaction mixture was diluted with CH2Cl2 and washed with water. The
extract was dried (Na2SO4), filtered, and concentrated in vacuo. The
residue was purified by preparative TLC on silica gel using n-hexane/EtO
Ac (1 : 1), which gave the pure β -enaminones (79-99%). Ethyl
(2Z)-3-(Methylamino)-2-butenoate (entry 10), yield 92%[22] IR (thin flim,
CHCl3): 1651, 1610 cm-1. 1H NMR (300MHz, CDCl3) δ (ppm): 8.42 (br s, 1H,
NH), 4.41 (s, 1H), 4.01 (q, 2H, J = 7.0Hz), 2.85 (d, 3H, J = 5.5), 18.2
(s, 3R), 1.21 (t, 3H, J = 7.0Hz) 13C NMR (75 MHz, CDCl3) δ (ppm): 170.4,
162.5, 81.7, 58.21, 29.4, 19.0, 14.5. MS (ESI): m/z 166 (M+ + Na). Anal
calcd. for C7H13NO2: C, 58.67; H, 9.11; N, 9.69. Found: C, 58.72; H,
9.15; N, 9.78.
$DTYPE RXN:VAR(1):NOTES
$DATUM no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Iodine-catalyzed conversion of β-dicarbonyl compounds into β-enaminones
within a minute under solvent-free conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gogoi, Siddhartha; Bhuyan, Ranjana; Barua, Nabin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthetic Communications (2005), 35(21), 2811-2818

$RFMT $RIREG SCHEME88 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl acetoacetate
C6H10O3
141-97-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 2.3100 0.0 0
M  V30 2 C 4.0011 1.5400 0.0 0
M  V30 3 C 1.3337 1.5400 0.0 0
M  V30 4 O 5.3348 2.3100 0.0 0
M  V30 5 O 4.0011 0.0000 0.0 0
M  V30 6 C 0.0000 2.3100 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 6.6686 1.5400 0.0 0
M  V30 9 C 8.0022 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Butenoic acid, 3-(methylamino)-, ethyl ester
C7H13NO2
870-85-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 2.3101 0.0 0
M  V30 2 C 5.3348 1.5400 0.0 0
M  V30 3 C 2.6675 1.5400 0.0 0
M  V30 4 O 6.6685 2.3101 0.0 0
M  V30 5 O 5.3348 0.0000 0.0 0
M  V30 6 N 1.3337 2.3101 0.0 0
M  V30 7 C 2.6675 0.0000 0.0 0
M  V30 8 C 8.0023 1.5400 0.0 0
M  V30 9 C 0.0000 1.5400 0.0 0
M  V30 10 C 9.3360 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 6 9
M  V30 9 1 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 141-97-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 870-85-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-19946831
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of Functionalized Imidazolium Salts via Iodine-Mediated
Annulations of Enamines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xia, Biao; Chen, Wenjun; Zhao, Qiongli; Yu, Wenquan; Chang, Junbiao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2019), 21(8), 2583-2587

$RFMT $RIREG SCHEME89 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromobenzenesulfonyl chloride
C6H4BrClO2S
2905-25-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6673 0.0 0 VAL=6
M  V30 2 Cl 6.1600 2.6673 0.0 0
M  V30 3 O 4.6200 4.2073 0.0 0
M  V30 4 O 4.6200 1.1273 0.0 0
M  V30 5 Br 3.0800 0.0000 0.0 0
M  V30 6 C 3.0800 2.6673 0.0 0
M  V30 7 C 2.3100 1.3336 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 0.7700 1.3336 0.0 0
M  V30 10 C 0.7700 4.0011 0.0 0
M  V30 11 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 6
M  V30 5 1 5 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-N-methylbenzenesulfonamide
C7H8BrNO2S
98192-14-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6673 0.0 0 VAL=6
M  V30 2 N 6.1600 2.6673 0.0 0
M  V30 3 O 4.6200 4.2073 0.0 0
M  V30 4 O 4.6200 1.1273 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 Br 3.0800 0.0000 0.0 0
M  V30 7 C 3.0800 2.6673 0.0 0
M  V30 8 C 2.3100 1.3336 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 0.7700 1.3336 0.0 0
M  V30 11 C 0.7700 4.0011 0.0 0
M  V30 12 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 7
M  V30 5 1 2 5
M  V30 6 1 6 8
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2905-25-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 98192-14-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-6797935
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-66-3
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 2-Ethynyl-N-methylbenzenesulfonamide (14a). To a solution of
2-bromobenzenesulfonylchloride (3.00 g, 11.8 mmol) in CHCl3 (100 mL) was
added dropwise methanamine (40% in MeOH, 3.47 mL, 33.5 mmol) at 0 °C and
the reaction mixture was stirred at room temperature for 5 min. After
concentration under reduced pressure, the residue was dissolved in Et2O.
The solution was washed successively with 1 N HCl and brine, and dried
over MgSO4. The filtrate was concentrated under reduced pressure and the
residue was purified by column chromatography over silica gel with
hexane-EtOAc (3:1). Sulfonamide, yield 2.70 g, 92%. 1H NMR (400 MHz,
CDCl3) δ 1.53 (d, J = 6.6 Hz, 3H, CHCH3), 2.21 (br s, 1H, NH), 3.84 (d, J
= 14.1 Hz, 1H, NCHH), 3.90 (d, J = 14.1 Hz, 1H, NCHH), 4.70 (q, J = 6.6
Hz, 1H, NCH), 6.27 (s, 1H, 3-H), 7.05-7.09 (m, 1H, Ar), 7.12-7.16 (m, 1H,
Ar), 7.30 (d, J = 7.8 Hz, 1H, Ar), 7.46-7.54 (m, 4H, Ar), 7.68 (d, J =
7.1 Hz, 1H, Ar), 7.77 (d, J = 8.3 Hz, 1H, Ar), 7.86-7.96 (m, 1H, Ar),
8.10-8.13 (m, 1H, Ar), 8.44 (br s, 1H, 1-H); 13C NMR (100 MHz, CDCl3) δ
23.4, 44.8, 53.0, 100.1, 110.7, 119.6, 120.1, 121.4, 122.6, 122.9, 125.5,
125.7, 125.9, 127.5, 128.5, 129.0, 131.3, 134.0, 135.8, 137.8, 140.5; MS
(FAB) m/z (%): 401 (MH+, 100); HRMS (FAB) calcd for C21H21N2 (MH+):
301.1715; found: 301.1716.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Construction of Nitrogen Heterocycles Bearing an Aminomethyl Group by
Copper-Catalyzed Domino Three-Component Coupling-Cyclization
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ohta, Yusuke; Chiba, Hiroaki; Oishi, Shinya; Fujii, Nobutaka; Ohno,
Hiroaki
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2009), 74(18), 7052-7058

$RFMT $RIREG SCHEME90 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 3-oxopentanoate
C6H10O3
30414-53-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 2.3100 0.0 0
M  V30 2 C 5.3348 1.5400 0.0 0
M  V30 3 C 2.6675 1.5400 0.0 0
M  V30 4 C 6.6686 2.3100 0.0 0
M  V30 5 O 5.3348 0.0000 0.0 0
M  V30 6 O 1.3337 2.3100 0.0 0
M  V30 7 O 2.6675 0.0000 0.0 0
M  V30 8 C 8.0022 1.5400 0.0 0
M  V30 9 C 0.0000 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 1 6 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 3-(methylamino)-2-pentenoate
C7H13NO2
1280735-14-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6674 0.0 0
M  V30 2 C 3.0800 4.0011 0.0 0
M  V30 3 C 0.7700 2.6674 0.0 0
M  V30 4 N 3.0800 1.3338 0.0 0
M  V30 5 C 4.6200 4.0011 0.0 0
M  V30 6 C 0.0000 4.0011 0.0 0
M  V30 7 C 2.3100 0.0000 0.0 0
M  V30 8 O 5.3900 5.3349 0.0 0
M  V30 9 O 5.3900 2.6674 0.0 0
M  V30 10 C 6.9300 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 30414-53-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1280735-14-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-9198552
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7487-88-9
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 557-34-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General procedure for preparation of enaminoesters 1a-1c An appropriate β
-ketoester (30 mmol), 0.33 g zinc acetate dihydrate (1.5 mmol, 5 mol %),
and 0.72 g anhydrous MgSO4 (6 mmol, 20 mol %) were added into a flask
equipped with a calcium chloride drying tube and suspended in 40 cm3
dichloromethane. Acorresponding amine (30 mmol) was then added in one
portion, and the reaction mixture was stirred at room temperature for 16
h. Subsequently, another portion of 0.72 g MgSO4 was added into the
mixture and the suspension was stirred for 2 days. Solid compounds were
then filtered off, and the filtrate was evaporated in vacuo to give
products 1a-1c. All products were used in next steps without further
purification unless other wise stated. Methyl
3-(methylamino)pent-2-enoate (1a). Prepared from methyl 3-oxopentanoate
and 8 M ethanolic solution of methylamine. Yellow oily compound, 92 %
yield. 1H NMR (400.13 MHz): δ = 8.51 (br s, 1H), 4.48 (s, 1H), 3.62 (s,
3H), 2.91 (d, J= 5.3 Hz, 3H), 2.23 (q, J= 7.5 Hz, 2H), 1.14 (t, J= 7.5
Hz, 3H) ppm.
$DTYPE RXN:VAR(1):NOTES
$DATUM incremental addition of MgSO4, literature preparation
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A simple new hydrazine-free synthesis of methyl 1,4,5-trisubstituted
1H-pyrazole-3-carboxylates
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Broz, Bretislav; Padelkova, Zdenka; Bertolasi, Valerio; Simunek, Petr
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Monatshefte fuer Chemie (2013), 144(7), 1013-1019

$RFMT $RIREG SCHEME91 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Fluoro-4-methoxy-1-nitrobenzene
C7H6FNO3
446-38-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 F 1.3337 4.6201 0.0 0
M  V30 5 O 6.6686 4.6201 0.0 0
M  V30 6 C 8.0022 3.8500 0.0 0
M  V30 7 C 2.6675 2.3100 0.0 0
M  V30 8 C 2.6675 3.8500 0.0 0
M  V30 9 C 4.0011 1.5400 0.0 0
M  V30 10 C 4.0011 4.6201 0.0 0
M  V30 11 C 5.3348 2.3100 0.0 0
M  V30 12 C 5.3348 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 8
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Methoxy-N-methyl-2-nitrobenzenamine
C8H10N2O3
69397-93-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3336 4.6200 0.0 0
M  V30 2 C 1.3336 6.1600 0.0 0
M  V30 3 N 1.3336 1.5400 0.0 0 VAL=5
M  V30 4 O 0.0000 2.3100 0.0 0
M  V30 5 O 1.3336 0.0000 0.0 0
M  V30 6 O 6.6685 4.6200 0.0 0
M  V30 7 C 8.0021 3.8500 0.0 0
M  V30 8 C 2.6674 3.8500 0.0 0
M  V30 9 C 2.6674 2.3100 0.0 0
M  V30 10 C 4.0011 4.6200 0.0 0
M  V30 11 C 4.0011 1.5400 0.0 0
M  V30 12 C 5.3347 3.8500 0.0 0
M  V30 13 C 5.3347 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 9
M  V30 6 1 6 7
M  V30 7 1 6 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 446-38-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 69397-93-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-39745633
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Arylazobenzimidazoles: versatile visible-light photoswitches with
tuneable Z-isomer stability
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Steinmueller, Sophie A. M.; Odaybat, Magdalena; Galli, Giulia; Prischich,
Davia; Fuchter, Matthew J.; Decker, Michael
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Science (2024), 15(14), 5360-5367

$RFMT $RIREG SCHEME92 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-chloro-3-nitrobenzoate
C8H6ClNO4
53553-14-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 3.0800 0.0 0
M  V30 2 O 8.0022 2.3100 0.0 0
M  V30 3 O 6.6684 4.6201 0.0 0
M  V30 4 C 9.3359 3.0800 0.0 0
M  V30 5 Cl 4.0011 4.6201 0.0 0
M  V30 6 N 1.3337 3.0800 0.0 0 VAL=5
M  V30 7 O 1.3337 4.6201 0.0 0
M  V30 8 O 0.0000 2.3100 0.0 0
M  V30 9 C 5.3348 2.3100 0.0 0
M  V30 10 C 4.0011 3.0800 0.0 0
M  V30 11 C 5.3348 0.7700 0.0 0
M  V30 12 C 2.6675 2.3100 0.0 0
M  V30 13 C 4.0011 0.0000 0.0 0
M  V30 14 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 12
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 2-(methylamino)-3-nitro-, methyl ester
C9H10N2O4
913297-15-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0012 4.6201 0.0 0
M  V30 2 C 2.6675 5.3901 0.0 0
M  V30 3 C 6.6685 3.0801 0.0 0
M  V30 4 O 8.0023 2.3101 0.0 0
M  V30 5 O 6.6685 4.6201 0.0 0
M  V30 6 C 9.3360 3.0801 0.0 0
M  V30 7 N 1.3337 3.0801 0.0 0 VAL=5
M  V30 8 O 1.3337 4.6201 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 C 4.0012 3.0801 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 2.6675 2.3101 0.0 0
M  V30 13 C 5.3348 0.7700 0.0 0
M  V30 14 C 2.6675 0.7700 0.0 0
M  V30 15 C 4.0012 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 11
M  V30 6 1 4 6
M  V30 7 2 7 8
M  V30 8 2 7 9
M  V30 9 1 7 12
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 53553-14-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 913297-15-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40749630
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of Tetrazolamide-benzimidazol-2-ones as novel
4-Hydroxyphenylpyruvate dioxygenase Inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cai, Zhuo-Mei; Huang, Guang-Yi; Dong, Jin; Chen, Li-Jun; Ye, Bao-Qing;
Lin, Hong-Yan; Wang, Da-Wei; Yang, Guang-Fu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Agricultural and Food Chemistry (2024), 72(8), 3884-3893

$RFMT $RIREG SCHEME93 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 4-chloro-2-(methylthio)-5-pyrimidinecarboxylate
C8H9ClN2O2S
5909-24-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 2.6675 0.0 0
M  V30 2 O 2.3100 4.0011 0.0 0
M  V30 3 O 2.3100 1.3338 0.0 0
M  V30 4 C 0.7700 4.0011 0.0 0
M  V30 5 C 0.0000 5.3349 0.0 0
M  V30 6 Cl 4.6201 0.0000 0.0 0
M  V30 7 S 9.2401 2.6675 0.0 0
M  V30 8 C 10.0101 4.0011 0.0 0
M  V30 9 C 4.6201 2.6675 0.0 0
M  V30 10 C 5.3901 1.3338 0.0 0
M  V30 11 C 5.3901 4.0011 0.0 0
M  V30 12 N 6.9301 1.3338 0.0 0
M  V30 13 N 6.9301 4.0011 0.0 0
M  V30 14 C 7.7001 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 10
M  V30 7 1 7 8
M  V30 8 1 7 14
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Pyrimidinecarboxylic acid, 4-(methylamino)-2-(methylthio)-, ethyl ester
C9H13N3O2S
76360-82-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 1.3338 0.0 0
M  V30 2 C 5.3901 0.0000 0.0 0
M  V30 3 C 3.0801 4.0012 0.0 0
M  V30 4 O 2.3101 5.3348 0.0 0
M  V30 5 O 2.3101 2.6675 0.0 0
M  V30 6 C 0.7700 5.3348 0.0 0
M  V30 7 C 0.0000 6.6687 0.0 0
M  V30 8 S 9.2402 4.0012 0.0 0
M  V30 9 C 10.0102 5.3348 0.0 0
M  V30 10 C 5.3901 2.6675 0.0 0
M  V30 11 C 4.6201 4.0012 0.0 0
M  V30 12 N 6.9302 2.6675 0.0 0
M  V30 13 C 5.3901 5.3348 0.0 0
M  V30 14 C 7.7002 4.0012 0.0 0
M  V30 15 N 6.9302 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 11
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 8 9
M  V30 9 1 8 14
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5909-24-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 76360-82-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-5069450
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 1. To a solution of ethyl
4-chloro-2-(methylthio)pyrimidine-5-carboxylate (10 g, 42.98 mmol, 1.0
eq) in THF (100 mL) at 0° C. was added methylamine (43 mL, 86.0 mmol, 2
eq, 2M in THF). The resulted mixture was stirred at room temperature for
1 h. The solvent was removed and the residue dissolved in EtOAc and then
washed with brine, dried and concentrated. Ethyl
4-(methylamino)-2-(methylthio)pyrimidine-5-carboxylate as a brown solid
(9.0 g, 92% in yield).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrazolo[3,4-d]pyrimidine derivatives as Btk kinase
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Taunton, John William, Jr.; Brameld, Kenneth Albert; Goldstein, David
Michael; McFarland, Jesse; Krishnan, Shyam; Choy, Jonathan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012158843 A2 2012-11-22

$RFMT $RIREG SCHEME94 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Dimethoxybenzaldehyde
C9H10O3
613-45-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 C 0.7700 4.0011 0.0 0
M  V30 4 O 0.0000 5.3349 0.0 0
M  V30 5 O 6.9300 4.0011 0.0 0
M  V30 6 C 7.7000 5.3349 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 1 3 8
M  V30 5 1 5 6
M  V30 6 1 5 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Dimethoxy-N-methylbenzenemethanamine
C10H15NO2
102503-23-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 4.0011 0.0 0
M  V30 2 N 7.7000 5.3349 0.0 0
M  V30 3 C 9.2400 5.3349 0.0 0
M  V30 4 O 5.3900 1.3338 0.0 0
M  V30 5 C 4.6200 0.0000 0.0 0
M  V30 6 O 0.7700 4.0011 0.0 0
M  V30 7 C 0.0000 5.3349 0.0 0
M  V30 8 C 5.3900 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 4.6200 5.3349 0.0 0
M  V30 11 C 3.0800 2.6674 0.0 0
M  V30 12 C 3.0800 5.3349 0.0 0
M  V30 13 C 2.3100 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 9
M  V30 6 1 6 7
M  V30 7 1 6 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 613-45-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 102503-23-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-20717808
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of oxadiazolylpyrimidine derivatives for use as metalloenzyme
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yates, Christopher M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018165520 A1 2018-09-13

$RFMT $RIREG SCHEME95 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Acetylacetone
C5H8O2
123-54-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 C 4.0011 1.5400 0.0 0
M  V30 3 C 1.3338 1.5400 0.0 0
M  V30 4 C 4.0011 0.0000 0.0 0
M  V30 5 O 5.3349 2.3100 0.0 0
M  V30 6 C 0.0000 2.3100 0.0 0
M  V30 7 O 1.3338 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Methylamino)-3-penten-2-one
C6H11NO
14092-14-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 2.6674 2.3100 0.0 0
M  V30 3 N 5.3347 2.3100 0.0 0
M  V30 4 C 4.0011 0.0000 0.0 0
M  V30 5 C 1.3338 1.5400 0.0 0
M  V30 6 C 6.6685 1.5400 0.0 0
M  V30 7 C 0.0000 2.3100 0.0 0
M  V30 8 O 1.3338 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-54-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 14092-14-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-13144913
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-50-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, mechanism studied
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A novel method for the synthesis of β-enaminones using Cu-nanoparticles
as catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kidwai, Mazaahir; Bhardwaj, Saurav; Mishra, Neeraj Kumar; Bansal, Vikas;
Kumar, Ajeet; Mozumdar, Subho
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Catalysis Communications (2009), 10(11), 1514-1517

$RFMT $RIREG SCHEME96 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-3-nitropyridine
C5H3ClN2O2
13091-23-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 Cl 2.3101 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 7 C 3.0801 4.0010 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 N 4.6201 4.0010 0.0 0
M  V30 10 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 6
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-3-nitro-4-pyridinamine
C6H7N3O2
1633-41-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 1.3338 0.0 0
M  V30 2 C 6.1600 1.3338 0.0 0
M  V30 3 N 1.5400 1.3338 0.0 0 VAL=5
M  V30 4 O 2.3100 0.0000 0.0 0
M  V30 5 O 0.0000 1.3338 0.0 0
M  V30 6 C 3.8500 2.6674 0.0 0
M  V30 7 C 2.3100 2.6674 0.0 0
M  V30 8 C 4.6200 4.0011 0.0 0
M  V30 9 C 1.5400 4.0011 0.0 0
M  V30 10 C 3.8500 5.3349 0.0 0
M  V30 11 N 2.3100 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 7
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 13091-23-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1633-41-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-15815882
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pyridinones as antifibrotic agents and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ramphal, Johnnie Y.; Buckman, Brad Owen; Emayan, Kumaraswamy; Nicholas,
John Beamond; Seiwert, Scott D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2015153683 A1 2015-10-08

$RFMT $RIREG SCHEME97 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Fluoro-3-nitrobenzoic acid
C7H4FNO4
317-46-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3336 3.0800 0.0 0
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3336 4.6200 0.0 0
M  V30 4 F 4.0011 4.6200 0.0 0
M  V30 5 N 6.6685 3.0800 0.0 0 VAL=5
M  V30 6 O 6.6685 4.6200 0.0 0
M  V30 7 O 8.0021 2.3100 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 C 4.0011 3.0800 0.0 0
M  V30 10 C 2.6674 0.7700 0.0 0
M  V30 11 C 5.3347 2.3100 0.0 0
M  V30 12 C 4.0011 0.0000 0.0 0
M  V30 13 C 5.3347 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 9
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Methylamino)-3-nitrobenzoic acid
C8H8N2O4
124341-38-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 4.6201 0.0 0
M  V30 2 C 2.6675 5.3901 0.0 0
M  V30 3 C 6.6686 3.0800 0.0 0
M  V30 4 O 6.6686 4.6201 0.0 0
M  V30 5 O 8.0022 2.3100 0.0 0
M  V30 6 N 1.3337 3.0800 0.0 0 VAL=5
M  V30 7 O 0.0000 2.3100 0.0 0
M  V30 8 O 1.3337 4.6201 0.0 0
M  V30 9 C 4.0011 3.0800 0.0 0
M  V30 10 C 5.3348 2.3100 0.0 0
M  V30 11 C 2.6675 2.3100 0.0 0
M  V30 12 C 5.3348 0.7700 0.0 0
M  V30 13 C 2.6675 0.7700 0.0 0
M  V30 14 C 4.0011 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 10
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 11
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 317-46-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 124341-38-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-21571606
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of novel bifunctional compounds as MerTK degraders and uses
thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ji, Nan; Mainolfi, Nello; Weiss, Matthew
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020010210 A1 2020-01-09

$RFMT $RIREG SCHEME97 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Fluoro-3-nitrobenzoic acid
C7H4FNO4
317-46-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3336 3.0800 0.0 0
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3336 4.6200 0.0 0
M  V30 4 F 4.0011 4.6200 0.0 0
M  V30 5 N 6.6685 3.0800 0.0 0 VAL=5
M  V30 6 O 6.6685 4.6200 0.0 0
M  V30 7 O 8.0021 2.3100 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 C 4.0011 3.0800 0.0 0
M  V30 10 C 2.6674 0.7700 0.0 0
M  V30 11 C 5.3347 2.3100 0.0 0
M  V30 12 C 4.0011 0.0000 0.0 0
M  V30 13 C 5.3347 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 9
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Methylamino)-3-nitrobenzoic acid
C8H8N2O4
124341-38-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 4.6201 0.0 0
M  V30 2 C 2.6675 5.3901 0.0 0
M  V30 3 C 6.6686 3.0800 0.0 0
M  V30 4 O 6.6686 4.6201 0.0 0
M  V30 5 O 8.0022 2.3100 0.0 0
M  V30 6 N 1.3337 3.0800 0.0 0 VAL=5
M  V30 7 O 0.0000 2.3100 0.0 0
M  V30 8 O 1.3337 4.6201 0.0 0
M  V30 9 C 4.0011 3.0800 0.0 0
M  V30 10 C 5.3348 2.3100 0.0 0
M  V30 11 C 2.6675 2.3100 0.0 0
M  V30 12 C 5.3348 0.7700 0.0 0
M  V30 13 C 2.6675 0.7700 0.0 0
M  V30 14 C 4.0011 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 10
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 11
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 317-46-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 124341-38-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-20149730
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of lactams, imides and related nitrogen heterocycles as CRBN
ligands for the treatment of CRBN-mediated diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mainolfi, Nello; Ji, Nan; Zhang, Yi; Weiss, Matthew M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019060693 A1 2019-03-28

$RFMT $RIREG SCHEME98 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-2-fluoro-1-nitrobenzene
C6H3BrFNO2
321-23-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 F 2.3101 0.0000 0.0 0
M  V30 5 Br 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-N-methyl-2-nitrobenzenamine
C7H7BrN2O2
302800-13-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 N 0.7700 4.0011 0.0 0 VAL=5
M  V30 4 O 0.0000 2.6674 0.0 0
M  V30 5 O 0.0000 5.3349 0.0 0
M  V30 6 Br 6.9300 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 8
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 321-23-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 302800-13-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35684954
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Bifunctional compounds for degrading Bruton's tyrosine kinases for
treatment of cancer, inflammation and autoimmune diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Guiducci, Cristiana; Noviski, Mark; Powers, Janine; Rountree, Ryan; Tan,
Ying Siow
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023287928 A1 2023-01-19

$RFMT $RIREG SCHEME98 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-2-fluoro-1-nitrobenzene
C6H3BrFNO2
321-23-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 F 2.3101 0.0000 0.0 0
M  V30 5 Br 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-N-methyl-2-nitrobenzenamine
C7H7BrN2O2
302800-13-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 N 0.7700 4.0011 0.0 0 VAL=5
M  V30 4 O 0.0000 2.6674 0.0 0
M  V30 5 O 0.0000 5.3349 0.0 0
M  V30 6 Br 6.9300 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 8
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 321-23-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 302800-13-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34996392
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Heterocyclic compounds for inhibiting or degrading ITK, compositions,
comprising the same methods of their making and methods of their use
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM McIntosh, Joel; Kato, Daisuke; Mihalic, Jeffrey; Peng, Ge
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022235715 A1 2022-11-10

$RFMT $RIREG SCHEME98 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-2-fluoro-1-nitrobenzene
C6H3BrFNO2
321-23-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 F 2.3101 0.0000 0.0 0
M  V30 5 Br 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-N-methyl-2-nitrobenzenamine
C7H7BrN2O2
302800-13-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 N 0.7700 4.0011 0.0 0 VAL=5
M  V30 4 O 0.0000 2.6674 0.0 0
M  V30 5 O 0.0000 5.3349 0.0 0
M  V30 6 Br 6.9300 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 8
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 321-23-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 302800-13-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24261626
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of bifunctional degraders of interleukin-1
receptor-associated kinases and therapeutic use thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Palmer, Wylie Solang; Wu, Jeffrey; Zipfel, Sheila; Ozboya, Kerem; Weiss,
Dahlia
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021168197 A1 2021-08-26

$RFMT $RIREG SCHEME98 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-2-fluoro-1-nitrobenzene
C6H3BrFNO2
321-23-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 F 2.3101 0.0000 0.0 0
M  V30 5 Br 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-N-methyl-2-nitrobenzenamine
C7H7BrN2O2
302800-13-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 N 0.7700 4.0011 0.0 0 VAL=5
M  V30 4 O 0.0000 2.6674 0.0 0
M  V30 5 O 0.0000 5.3349 0.0 0
M  V30 6 Br 6.9300 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 8
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 321-23-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 302800-13-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-20149746
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of lactams, imides and related nitrogen heterocycles as CRBN
ligands for the treatment of CRBN-mediated diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mainolfi, Nello; Ji, Nan; Zhang, Yi; Weiss, Matthew M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019060693 A1 2019-03-28

$RFMT $RIREG SCHEME99 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Bromo-2-chloro-3-nitrobenzene
C6H3BrClNO2
3970-37-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3347 3.0800 0.0 0 VAL=5
M  V30 2 O 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 4.6200 0.0 0
M  V30 4 Cl 2.6674 4.6200 0.0 0
M  V30 5 Br 0.0000 3.0800 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 3.0800 0.0 0
M  V30 8 C 4.0011 0.7700 0.0 0
M  V30 9 C 1.3338 2.3100 0.0 0
M  V30 10 C 2.6674 0.0000 0.0 0
M  V30 11 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-N-methyl-6-nitrobenzenamine
C7H7BrN2O2
1004618-77-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6675 4.6201 0.0 0
M  V30 2 C 1.3338 5.3901 0.0 0
M  V30 3 N 5.3348 3.0800 0.0 0 VAL=5
M  V30 4 O 5.3348 4.6201 0.0 0
M  V30 5 O 6.6686 2.3100 0.0 0
M  V30 6 Br 0.0000 3.0800 0.0 0
M  V30 7 C 2.6675 3.0800 0.0 0
M  V30 8 C 4.0011 2.3100 0.0 0
M  V30 9 C 1.3338 2.3100 0.0 0
M  V30 10 C 4.0011 0.7700 0.0 0
M  V30 11 C 1.3338 0.7700 0.0 0
M  V30 12 C 2.6675 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 8
M  V30 6 1 6 9
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3970-37-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1004618-77-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-2312651
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM To a stirred solution of 1-bromo-2-chloro-3-nitrobenzene in 50 mL of
ethanol was added methyl amine solution (40% in methanol, 50 mL) at room
temperature. The mixture was then heated to 85°C under N2 for 1h. LC-MS
showed small amount of starting material. Additional methylamine solution
(10 mL) was added and the reaction mixture was heated for another hour
and then cooled to room temperature. The mixture was extracted with
CH2Cl2 and the organic layer was washed with water, brine and dried with
Na2SO4. The solvent was removed in vacuo to give 4.5 g of
2-bromo-N-methyl-6-nitrobenzenamine (92%). 400 MHz 1H NMR (CDCl3) δ 7.84
(d, 1H), 7.65 (d, 1H), 6.65 (dd, 1H), 3.0 (s, 3H); MS (M+1) 231, 233,
234.
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective, incremental addition of methyl amine solution
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Benzimidazolyl compounds as potentiators of mGluR2 subtype of glutamate
receptor and their preparation, pharmaceutical compositions and use in
the treatment of diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Efremov, Ivan Viktorovich; Rogers, Bruce Nelsen; Duplantier, Allen Jacob;
Zhang, Lei; Zhang, Qian; Maklad, Noha Serour; Evrard, Edelweiss Virginie;
Brodney, Michael A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008012623 A1 2008-01-31

$RFMT $RIREG SCHEME100 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Cyanobenzenesulfonyl chloride
C7H4ClNO2S
56542-67-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.3337 3.0801 0.0 0 VAL=6
M  V30 2 Cl 0.0000 3.8501 0.0 0
M  V30 3 O 0.5637 1.7464 0.0 0
M  V30 4 O 2.1037 4.4137 0.0 0
M  V30 5 C 6.6687 3.0801 0.0 0
M  V30 6 N 8.0023 3.8501 0.0 0
M  V30 7 C 2.6675 2.3101 0.0 0
M  V30 8 C 4.0012 3.0801 0.0 0
M  V30 9 C 2.6675 0.7700 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 4.0012 0.0000 0.0 0
M  V30 12 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 7
M  V30 5 3 5 6
M  V30 6 1 5 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Cyano-N-methylbenzenesulfonamide
C8H8N2O2S
56542-62-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 2.6675 3.0801 0.0 0 VAL=6
M  V30 2 N 1.3337 3.8501 0.0 0
M  V30 3 O 3.4375 4.4137 0.0 0
M  V30 4 O 1.8975 1.7464 0.0 0
M  V30 5 C 0.0000 3.0801 0.0 0
M  V30 6 C 8.0023 3.0801 0.0 0
M  V30 7 N 9.3360 3.8501 0.0 0
M  V30 8 C 4.0012 2.3101 0.0 0
M  V30 9 C 5.3348 3.0801 0.0 0
M  V30 10 C 4.0012 0.7700 0.0 0
M  V30 11 C 6.6685 2.3101 0.0 0
M  V30 12 C 5.3348 0.0000 0.0 0
M  V30 13 C 6.6685 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 1 2 5
M  V30 6 3 6 7
M  V30 7 1 6 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 56542-67-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 56542-62-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-19144483
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of adenine derivatives as protein kinase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Surleraux, Dominique; Amiable, Claire; Guillon, Remi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2017191297 A1 2017-11-09

$RFMT $RIREG SCHEME101 STEP1
$RXN



  2  1
$MOL
4-Bromo-2-methylbenzoic acid
C8H7BrO2
68837-59-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 C 2.3101 0.0000 0.0 0
M  V30 5 Br 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-N,2-dimethylbenzamide
C9H10BrNO
893420-18-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 2.6673 0.0 0
M  V30 2 N 1.5400 4.0010 0.0 0
M  V30 3 O 1.5400 1.3337 0.0 0
M  V30 4 C 0.0000 4.0010 0.0 0
M  V30 5 C 3.8501 0.0000 0.0 0
M  V30 6 Br 8.4702 2.6673 0.0 0
M  V30 7 C 3.8501 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 4.6201 4.0010 0.0 0
M  V30 10 C 6.1601 1.3337 0.0 0
M  V30 11 C 6.1601 4.0010 0.0 0
M  V30 12 C 6.9302 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 8
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 68837-59-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 893420-18-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-14926076
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 497-19-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 1: 4-Bromo-N,2-dimethylbenzamide. N,N-Dimethylformamide (10 μL) was
added to a mixture of 4-bromo-2-methylbenzoic acid (1.0 g, 4.6 mmol) in
oxalyl chloride (2.0 mL, 23 mmol). The mixture was stirred at room
temperature overnight. The mixture was concentrated to afford a crude
carbonyl chloride which was dissolved in methylene chloride (2 mL). The
solution was added slowly to a mixture of methylamine in tetrahydrofuran
(THF) (2.0 M, 0.465 mL, 9.3 mmol) and triethylamine (1.3 mL, 9.3 mmol) in
DCM (10 ml). After 30 min, the reaction mixture was quenched with sat.
sodium carbonate (10 mL) and extracted with DCM (3×20 mL). The combined
organic layers were washed with brine, dried over Na2SO4, filtered,
concentrated under reduced pressure. 4-Bromo-N,2-dimethylbenzamide (980
mg, 92%). LCMS (M+H)+: m/z=228.1/230.2.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Imidazo[1,2-b][1,2,4]triazines as c-met inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhuo, Jincong; He, Chunhong; Yao, Wenqing
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20110212967 A1 2011-09-01

$RFMT $RIREG SCHEME101 STEP1
$RXN



  2  1
$MOL
4-Bromo-2-methylbenzoic acid
C8H7BrO2
68837-59-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 C 2.3101 0.0000 0.0 0
M  V30 5 Br 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-N,2-dimethylbenzamide
C9H10BrNO
893420-18-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 2.6673 0.0 0
M  V30 2 N 1.5400 4.0010 0.0 0
M  V30 3 O 1.5400 1.3337 0.0 0
M  V30 4 C 0.0000 4.0010 0.0 0
M  V30 5 C 3.8501 0.0000 0.0 0
M  V30 6 Br 8.4702 2.6673 0.0 0
M  V30 7 C 3.8501 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 4.6201 4.0010 0.0 0
M  V30 10 C 6.1601 1.3337 0.0 0
M  V30 11 C 6.1601 4.0010 0.0 0
M  V30 12 C 6.9302 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 8
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 68837-59-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 893420-18-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-11189208
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 497-19-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 130
4-{2-[2-Amino-6-(4-methylpiperazin-1-yl)pyrimidin-4-yl]-3-methyl-1,2,3,4-tetrahydroisoquinolin-7-yl}-N,2-dimethylbenzamide
Step 1: 4-bromo-N,2-dimethylbenzamide N,N-Dimethylformamide (10 uL) was
added to a mixture of 4-bromo-2-methylbenzoic acid (1.0 g, 0.0046 mol) in
oxalyl chloride (2.0 mL, 0.023 mol). The mixture was stirred at r.t.
overnight. The volatiles were removed under reduced pressure. The residue
was dissolved in methylene chloride (2 mL). To the solution was added to
a mixture of methylamine (0.41 mL, 0.0093 mol) and triethylamine (1.3 mL,
0.0093 mol) in DCM (10 ml). After 30 min, the reaction mixture was
quenched with aqueous sodium carbonate (10 mL) and extracted with DCM
(3×20 mL). The organic layers were washed with brine, dried over Na2SO4,
filtered. The solvents were removed under reduced pressure to give a
crude product (980 mg, 92.4%). LCMS (M+H)+: m/z=228.1/230.2.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 4,6-disubstituted 2-amino-pyrimidines as histamine H4
receptor modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Colin; Qian, Ding-Quan; Zhuo, Jincong; Yao, Wenqing
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010075270 A1 2010-07-01

$RFMT $RIREG SCHEME102 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-2-(2,2-difluoroethoxy)-5-nitro-N-[trans-4-(trifluoromethyl)cyclohexy...
C15H15ClF5N3O4
1218944-88-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 6.6684 0.0 0
M  V30 2 N 6.9300 8.0021 0.0 0
M  V30 3 O 6.9300 5.3347 0.0 0
M  V30 4 O 4.6200 4.0011 0.0 0
M  V30 5 C 3.8500 2.6673 0.0 0
M  V30 6 C 4.6200 1.3336 0.0 0
M  V30 7 F 3.8500 0.0000 0.0 0
M  V30 8 F 6.1600 1.3336 0.0 0
M  V30 9 N 1.5400 9.3358 0.0 0 VAL=5
M  V30 10 O 2.3100 10.6694 0.0 0
M  V30 11 O 0.0000 9.3358 0.0 0
M  V30 12 Cl 0.0000 6.6684 0.0 0
M  V30 13 C 13.0900 8.0021 0.0 0
M  V30 14 F 13.0900 6.4621 0.0 0
M  V30 15 F 14.6300 8.0021 0.0 0
M  V30 16 F 13.0900 9.5421 0.0 0
M  V30 17 C 4.6200 6.6684 0.0 0
M  V30 18 C 3.8500 5.3347 0.0 0
M  V30 19 C 3.8500 8.0021 0.0 0
M  V30 20 N 2.3100 5.3347 0.0 0
M  V30 21 C 2.3100 8.0021 0.0 0
M  V30 22 C 1.5400 6.6684 0.0 0
M  V30 23 C 8.4700 8.0021 0.0 0 CFG=2
M  V30 24 C 9.2400 6.6684 0.0 0
M  V30 25 C 9.2400 9.3358 0.0 0
M  V30 26 C 10.7800 6.6684 0.0 0
M  V30 27 C 10.7800 9.3358 0.0 0
M  V30 28 C 11.5500 8.0021 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 23 2 CFG=3
M  V30 5 1 4 5
M  V30 6 1 4 18
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 6 8
M  V30 10 2 9 10
M  V30 11 2 9 11
M  V30 12 1 9 21
M  V30 13 1 12 22
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 13 16
M  V30 17 1 28 13 CFG=1
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 24 1 23 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 1 26 28
M  V30 29 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 23 28)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
2-(2,2-Difluoroethoxy)-6-(methylamino)-5-nitro-N-[trans-4-(trifluoromethyl)cy...
C16H19F5N4O4
1218944-89-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 6.6684 0.0 0
M  V30 2 N 7.7000 8.0021 0.0 0
M  V30 3 O 7.7000 5.3347 0.0 0
M  V30 4 O 5.3900 4.0011 0.0 0
M  V30 5 C 4.6200 2.6673 0.0 0
M  V30 6 C 5.3900 1.3336 0.0 0
M  V30 7 F 4.6200 0.0000 0.0 0
M  V30 8 F 6.9300 1.3336 0.0 0
M  V30 9 N 2.3100 9.3358 0.0 0 VAL=5
M  V30 10 O 3.0800 10.6694 0.0 0
M  V30 11 O 0.7700 9.3358 0.0 0
M  V30 12 N 0.7700 6.6684 0.0 0
M  V30 13 C 0.0000 5.3347 0.0 0
M  V30 14 C 13.8600 8.0021 0.0 0
M  V30 15 F 13.8600 9.5421 0.0 0
M  V30 16 F 15.4000 8.0021 0.0 0
M  V30 17 F 13.8600 6.4621 0.0 0
M  V30 18 C 5.3900 6.6684 0.0 0
M  V30 19 C 4.6200 5.3347 0.0 0
M  V30 20 C 4.6200 8.0021 0.0 0
M  V30 21 N 3.0800 5.3347 0.0 0
M  V30 22 C 3.0800 8.0021 0.0 0
M  V30 23 C 2.3100 6.6684 0.0 0
M  V30 24 C 9.2400 8.0021 0.0 0 CFG=2
M  V30 25 C 10.0100 6.6684 0.0 0
M  V30 26 C 10.0100 9.3358 0.0 0
M  V30 27 C 11.5500 6.6684 0.0 0
M  V30 28 C 11.5500 9.3358 0.0 0
M  V30 29 C 12.3200 8.0021 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 24 2 CFG=3
M  V30 5 1 4 5
M  V30 6 1 4 19
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 6 8
M  V30 10 2 9 10
M  V30 11 2 9 11
M  V30 12 1 9 22
M  V30 13 1 12 13
M  V30 14 1 12 23
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 14 17
M  V30 18 1 29 14 CFG=1
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 25 1 24 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 1 26 28
M  V30 29 1 27 29
M  V30 30 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 24 29)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1218944-88-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1218944-89-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-975200
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: (154a) 6-Amino-5-nitro-nicotinic acid
6-Chloro-5-nitro-nicotinic acid (3.00 g, 14.8 mmol) in 100 mL conc.
ammonia was stirred for 16 h. The mixture was concentrated, the residue
mixed with 50 mL water, acidified with hydrochloric acid and stirred for
10 min. The precipitate was filtered off and washed with water. The solid
was dried and taken up in refluxing THF. The mixture was filtered and
concentrated. Yield: 1.90 g (70%) (777d)
2-(2,2-Difluoroethoxy)-6-methylamino-5-nitro-N-(trans-4-trifluoromethyl-cyclohexyl)-nicotinamide
Prepared analogously to example 154a from the product obtained in (777c)
and 2 N methylamine (solution in THF) in THF. Yield: 92% mass spectrum:
(M+H)+ = 427 Rf value: 0.58 (silica gel; eluens: petrolether/ethyl
acetate = 1:1)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 3H-imidazo[4,5-b]pyridine-6-carboxamides as therapeutic
inhibitors of enzymes belonging to the MAPEG family
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pfau, Roland; Arndt, Kirsten; Doods, Henri; Hauel, Norbert; Klinder,
Klaus; Kuelzer, Raimund
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010034799 A1 2010-04-01

$RFMT $RIREG SCHEME103 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Chloropretadalafil
C22H19ClN2O5
171489-59-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 34 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.7046 8.9402 0.0 0
M  V30 2 C 9.0383 9.7102 0.0 0
M  V30 3 O 6.3709 9.7102 0.0 0
M  V30 4 Cl 9.0383 11.2502 0.0 0
M  V30 5 C 10.3721 7.4001 0.0 0
M  V30 6 O 11.7058 6.6301 0.0 0
M  V30 7 O 10.3721 8.9402 0.0 0
M  V30 8 C 13.0394 7.4001 0.0 0
M  V30 9 C 6.3709 6.6301 0.0 0 CFG=1
M  V30 10 C 6.3709 5.0901 0.0 0
M  V30 11 N 7.7046 7.4001 0.0 0
M  V30 12 C 7.7046 4.3201 0.0 0
M  V30 13 N 5.2265 4.0597 0.0 0
M  V30 14 C 9.0383 6.6301 0.0 0 CFG=1
M  V30 15 C 7.3844 2.8138 0.0 0
M  V30 16 C 9.0383 5.0901 0.0 0
M  V30 17 C 5.8529 2.6527 0.0 0
M  V30 18 C 8.2897 1.5679 0.0 0
M  V30 19 C 5.2265 1.2459 0.0 0
M  V30 20 C 7.6633 0.1609 0.0 0
M  V30 21 C 6.1316 0.0000 0.0 0
M  V30 22 C 5.0373 7.4001 0.0 0
M  V30 23 C 3.7035 6.6301 0.0 0
M  V30 24 C 5.0373 8.9402 0.0 0
M  V30 25 C 2.3698 7.4001 0.0 0
M  V30 26 C 3.7035 9.7102 0.0 0
M  V30 27 C 2.3698 8.9402 0.0 0
M  V30 28 O 0.9052 6.9243 0.0 0
M  V30 29 O 0.9052 9.4160 0.0 0
M  V30 30 C 0.0000 8.1702 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 14 5 CFG=1
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 22 CFG=1
M  V30 12 2 10 12
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 2 15 18
M  V30 21 2 17 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 21
M  V30 25 1 22 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 25 28
M  V30 31 2 26 27
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 9 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Tadalafil
C22H19N3O4
171596-29-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 35 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 9.7101 0.0 0
M  V30 2 O 0.0000 6.6301 0.0 0
M  V30 3 C 0.0000 9.7101 0.0 0
M  V30 4 C 5.3348 6.6301 0.0 0 CFG=1
M  V30 5 C 5.3348 5.0901 0.0 0
M  V30 6 N 4.0011 7.4001 0.0 0
M  V30 7 C 4.0011 4.3201 0.0 0
M  V30 8 N 6.4792 4.0597 0.0 0
M  V30 9 C 2.6673 6.6301 0.0 0 CFG=1
M  V30 10 C 4.0011 8.9401 0.0 0
M  V30 11 C 4.3213 2.8138 0.0 0
M  V30 12 C 2.6673 5.0901 0.0 0
M  V30 13 C 5.8529 2.6527 0.0 0
M  V30 14 C 1.3337 7.4001 0.0 0
M  V30 15 C 2.6673 9.7101 0.0 0
M  V30 16 C 3.4161 1.5679 0.0 0
M  V30 17 C 6.4792 1.2459 0.0 0
M  V30 18 N 1.3337 8.9401 0.0 0
M  V30 19 C 4.0424 0.1609 0.0 0
M  V30 20 C 5.5741 0.0000 0.0 0
M  V30 21 C 6.6684 7.4001 0.0 0
M  V30 22 C 8.0021 6.6301 0.0 0
M  V30 23 C 6.6684 8.9401 0.0 0
M  V30 24 C 9.3359 7.4001 0.0 0
M  V30 25 C 8.0021 9.7101 0.0 0
M  V30 26 C 9.3359 8.9401 0.0 0
M  V30 27 O 10.8005 6.9242 0.0 0
M  V30 28 O 10.8005 9.4160 0.0 0
M  V30 29 C 11.7057 8.1701 0.0 0
M  V30 30 H 1.3337 5.8601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 2 2 14
M  V30 3 1 3 18
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 21 CFG=3
M  V30 7 2 5 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 6 10
M  V30 11 1 7 11
M  V30 12 1 7 12
M  V30 13 1 8 13
M  V30 14 1 9 12
M  V30 15 1 9 14
M  V30 16 1 9 30 CFG=1
M  V30 17 1 10 15
M  V30 18 1 11 13
M  V30 19 2 11 16
M  V30 20 2 13 17
M  V30 21 1 14 18
M  V30 22 1 15 18
M  V30 23 1 16 19
M  V30 24 1 17 20
M  V30 25 2 19 20
M  V30 26 1 21 22
M  V30 27 2 21 23
M  V30 28 2 22 24
M  V30 29 1 23 25
M  V30 30 1 24 26
M  V30 31 1 24 27
M  V30 32 2 25 26
M  V30 33 1 26 28
M  V30 34 1 27 29
M  V30 35 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 4 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 171489-59-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 171596-29-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-17554689
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Chloroacetyl chloride
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Olah, George A.; Parkash, G. K. Surya; Wang, Qi; Li, Xing-ya; Ziegler,
Thomas
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM e-EROS Encyclopedia of Reagents for Organic Synthesis (2005), 1-7

$RFMT $RIREG SCHEME103 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Chloropretadalafil
C22H19ClN2O5
171489-59-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 34 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.7046 8.9402 0.0 0
M  V30 2 C 9.0383 9.7102 0.0 0
M  V30 3 O 6.3709 9.7102 0.0 0
M  V30 4 Cl 9.0383 11.2502 0.0 0
M  V30 5 C 10.3721 7.4001 0.0 0
M  V30 6 O 11.7058 6.6301 0.0 0
M  V30 7 O 10.3721 8.9402 0.0 0
M  V30 8 C 13.0394 7.4001 0.0 0
M  V30 9 C 6.3709 6.6301 0.0 0 CFG=1
M  V30 10 C 6.3709 5.0901 0.0 0
M  V30 11 N 7.7046 7.4001 0.0 0
M  V30 12 C 7.7046 4.3201 0.0 0
M  V30 13 N 5.2265 4.0597 0.0 0
M  V30 14 C 9.0383 6.6301 0.0 0 CFG=1
M  V30 15 C 7.3844 2.8138 0.0 0
M  V30 16 C 9.0383 5.0901 0.0 0
M  V30 17 C 5.8529 2.6527 0.0 0
M  V30 18 C 8.2897 1.5679 0.0 0
M  V30 19 C 5.2265 1.2459 0.0 0
M  V30 20 C 7.6633 0.1609 0.0 0
M  V30 21 C 6.1316 0.0000 0.0 0
M  V30 22 C 5.0373 7.4001 0.0 0
M  V30 23 C 3.7035 6.6301 0.0 0
M  V30 24 C 5.0373 8.9402 0.0 0
M  V30 25 C 2.3698 7.4001 0.0 0
M  V30 26 C 3.7035 9.7102 0.0 0
M  V30 27 C 2.3698 8.9402 0.0 0
M  V30 28 O 0.9052 6.9243 0.0 0
M  V30 29 O 0.9052 9.4160 0.0 0
M  V30 30 C 0.0000 8.1702 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 14 5 CFG=1
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 22 CFG=1
M  V30 12 2 10 12
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 2 15 18
M  V30 21 2 17 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 21
M  V30 25 1 22 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 25 28
M  V30 31 2 26 27
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 9 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Tadalafil
C22H19N3O4
171596-29-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 35 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 9.7101 0.0 0
M  V30 2 O 0.0000 6.6301 0.0 0
M  V30 3 C 0.0000 9.7101 0.0 0
M  V30 4 C 5.3348 6.6301 0.0 0 CFG=1
M  V30 5 C 5.3348 5.0901 0.0 0
M  V30 6 N 4.0011 7.4001 0.0 0
M  V30 7 C 4.0011 4.3201 0.0 0
M  V30 8 N 6.4792 4.0597 0.0 0
M  V30 9 C 2.6673 6.6301 0.0 0 CFG=1
M  V30 10 C 4.0011 8.9401 0.0 0
M  V30 11 C 4.3213 2.8138 0.0 0
M  V30 12 C 2.6673 5.0901 0.0 0
M  V30 13 C 5.8529 2.6527 0.0 0
M  V30 14 C 1.3337 7.4001 0.0 0
M  V30 15 C 2.6673 9.7101 0.0 0
M  V30 16 C 3.4161 1.5679 0.0 0
M  V30 17 C 6.4792 1.2459 0.0 0
M  V30 18 N 1.3337 8.9401 0.0 0
M  V30 19 C 4.0424 0.1609 0.0 0
M  V30 20 C 5.5741 0.0000 0.0 0
M  V30 21 C 6.6684 7.4001 0.0 0
M  V30 22 C 8.0021 6.6301 0.0 0
M  V30 23 C 6.6684 8.9401 0.0 0
M  V30 24 C 9.3359 7.4001 0.0 0
M  V30 25 C 8.0021 9.7101 0.0 0
M  V30 26 C 9.3359 8.9401 0.0 0
M  V30 27 O 10.8005 6.9242 0.0 0
M  V30 28 O 10.8005 9.4160 0.0 0
M  V30 29 C 11.7057 8.1701 0.0 0
M  V30 30 H 1.3337 5.8601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 2 2 14
M  V30 3 1 3 18
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 21 CFG=3
M  V30 7 2 5 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 6 10
M  V30 11 1 7 11
M  V30 12 1 7 12
M  V30 13 1 8 13
M  V30 14 1 9 12
M  V30 15 1 9 14
M  V30 16 1 9 30 CFG=1
M  V30 17 1 10 15
M  V30 18 1 11 13
M  V30 19 2 11 16
M  V30 20 2 13 17
M  V30 21 1 14 18
M  V30 22 1 15 18
M  V30 23 1 16 19
M  V30 24 1 17 20
M  V30 25 2 19 20
M  V30 26 1 21 22
M  V30 27 2 21 23
M  V30 28 2 22 24
M  V30 29 1 23 25
M  V30 30 1 24 26
M  V30 31 1 24 27
M  V30 32 2 25 26
M  V30 33 1 26 28
M  V30 34 1 27 29
M  V30 35 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 4 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 171489-59-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 171596-29-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-2129025
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM The cis tetrahydro-b-carboline product 3 now intersects the Icos
synthesis (although obtained in one less step), and reaction with
methylamine gave Cialis in high yield. Yield 92%.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Two concise syntheses of Cialis via the N-acyliminium Pictet-Spengler
reaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Revell, Jefferson D.; Srinivasan, Natarajan; Ganesan, A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synlett (2004), (8), 1428-1430

$RFMT $RIREG SCHEME104 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,6-Dichloropyrimidine
C4H2Cl2N2
1193-21-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 3.0800 0.0 0
M  V30 2 Cl 5.3349 3.0800 0.0 0
M  V30 3 C 2.6675 3.0800 0.0 0
M  V30 4 C 1.3338 2.3100 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 N 1.3338 0.7700 0.0 0
M  V30 7 N 4.0011 0.7700 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 5
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 2 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-N-methylpyrimidin-4-amine
C5H6ClN3
65766-32-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 3.0801 0.0 0
M  V30 2 C 6.6687 2.3101 0.0 0
M  V30 3 Cl 0.0000 3.0801 0.0 0
M  V30 4 C 4.0012 2.3101 0.0 0
M  V30 5 C 2.6675 3.0801 0.0 0
M  V30 6 N 4.0012 0.7700 0.0 0
M  V30 7 C 1.3338 2.3101 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 9 N 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 7
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1193-21-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 65766-32-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-32156157
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-63-0
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of 4,6-Disubstituted Pyrimidine Derivatives as Novel Dual
VEGFR2/FGFR1 Inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Jin-Yang; Xue, Wen-Jun; Wang, Min; Li, Wen; Dong, Ru; Li,
Ming-Tao; Sun, Li-Ping
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry & Biodiversity (2021), 18(5), e2100095

$RFMT $RIREG SCHEME105 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(2-Bromoethyl)-5-(bromomethyl)-3-nitro-1H-pyrazole
C6H7Br2N3O2
1227210-31-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.5626 3.8551 0.0 0
M  V30 2 C 7.3326 5.1887 0.0 0
M  V30 3 Br 8.8726 5.1887 0.0 0
M  V30 4 C 4.5932 1.1445 0.0 0
M  V30 5 Br 3.5628 0.0000 0.0 0
M  V30 6 N 1.4068 5.5301 0.0 0 VAL=5
M  V30 7 O 0.0000 4.9038 0.0 0
M  V30 8 O 1.5679 7.0618 0.0 0
M  V30 9 N 5.0226 3.8551 0.0 0
M  V30 10 C 4.1173 2.6091 0.0 0
M  V30 11 N 4.1173 5.1009 0.0 0
M  V30 12 C 2.6528 3.0851 0.0 0
M  V30 13 C 2.6528 4.6251 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 10
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 13
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,5,6,7-Tetrahydro-5-methyl-2-nitropyrazolo[1,5-a]pyrazine
C7H10N4O2
1227210-32-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3338 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3338 0.0000 0.0 0
M  V30 4 C 8.9549 4.1617 0.0 0
M  V30 5 N 4.3348 4.1617 0.0 0
M  V30 6 C 5.1048 2.8281 0.0 0
M  V30 7 N 2.8284 3.8416 0.0 0
M  V30 8 C 5.1048 5.4954 0.0 0
M  V30 9 C 4.0743 1.6835 0.0 0
M  V30 10 C 6.6448 2.8281 0.0 0
M  V30 11 C 2.6675 2.3100 0.0 0
M  V30 12 C 6.6448 5.4954 0.0 0
M  V30 13 N 7.4149 4.1617 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 4 13
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 2 6 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 1 10 13
M  V30 14 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1227210-31-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1227210-32-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24175781
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Substituted pyrimidine compounds, compositions and medicinal applications
thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Venkateshappa, Chandregowda; Sivanandhan, Dhanalakshmi; Bakthavatchalam,
Rajagopal
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM India, IN2013CH03726 A 2016-06-17

$RFMT $RIREG SCHEME105 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(2-Bromoethyl)-5-(bromomethyl)-3-nitro-1H-pyrazole
C6H7Br2N3O2
1227210-31-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.5626 3.8551 0.0 0
M  V30 2 C 7.3326 5.1887 0.0 0
M  V30 3 Br 8.8726 5.1887 0.0 0
M  V30 4 C 4.5932 1.1445 0.0 0
M  V30 5 Br 3.5628 0.0000 0.0 0
M  V30 6 N 1.4068 5.5301 0.0 0 VAL=5
M  V30 7 O 0.0000 4.9038 0.0 0
M  V30 8 O 1.5679 7.0618 0.0 0
M  V30 9 N 5.0226 3.8551 0.0 0
M  V30 10 C 4.1173 2.6091 0.0 0
M  V30 11 N 4.1173 5.1009 0.0 0
M  V30 12 C 2.6528 3.0851 0.0 0
M  V30 13 C 2.6528 4.6251 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 10
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 13
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,5,6,7-Tetrahydro-5-methyl-2-nitropyrazolo[1,5-a]pyrazine
C7H10N4O2
1227210-32-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3338 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3338 0.0000 0.0 0
M  V30 4 C 8.9549 4.1617 0.0 0
M  V30 5 N 4.3348 4.1617 0.0 0
M  V30 6 C 5.1048 2.8281 0.0 0
M  V30 7 N 2.8284 3.8416 0.0 0
M  V30 8 C 5.1048 5.4954 0.0 0
M  V30 9 C 4.0743 1.6835 0.0 0
M  V30 10 C 6.6448 2.8281 0.0 0
M  V30 11 C 2.6675 2.3100 0.0 0
M  V30 12 C 6.6448 5.4954 0.0 0
M  V30 13 N 7.4149 4.1617 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 4 13
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 2 6 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 1 10 13
M  V30 14 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1227210-31-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1227210-32-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-8961553
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted pyrimidine compounds as inhibitors of
epidermal growth factor receptor (EGFR) kinases for treating cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Venkateshappa, Chandregowda; Sivanandhan, Dhanalakshmi; Bakthavatchalam,
Rajagopal; Kethiri, Raghava Reddy; Viswanadhan, Vellarkad Narayana; Giri,
Sanjeev
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2015025197 A1 2015-02-26

$RFMT $RIREG SCHEME106 STEP1
$RXN



  2  1
$MOL
4-Iodobenzoic acid
C7H5IO2
619-58-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 I 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Iodo-N-methylbenzamide
C8H8INO
89976-43-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 N 1.5400 2.6673 0.0 0
M  V30 3 O 1.5400 0.0000 0.0 0
M  V30 4 C 0.0000 2.6673 0.0 0
M  V30 5 I 8.4702 1.3337 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 6.1601 2.6673 0.0 0
M  V30 10 C 6.1601 0.0000 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 619-58-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 89976-43-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-7763293
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and redistribution reactions of asymmetric σ-arylplatinum(II)
complexes containing 4,7-phenanthroline
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gallasch, David P.; Woodhouse, Susan L.; Rendina, Louis M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organometallic Chemistry (2004), 689(7), 1288-1294

$RFMT $RIREG SCHEME107 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methyl-8-(4-morpholinylsulfonyl)furo[3,4-c]quinoline-1,3-dione
C16H14N2O6S
753482-69-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6948 0.4292 0.0 0
M  V30 2 S 9.3194 3.0801 0.0 0 VAL=6
M  V30 3 O 8.5493 1.7464 0.0 0
M  V30 4 O 10.0894 4.4137 0.0 0
M  V30 5 C 1.3170 6.1601 0.0 0
M  V30 6 O 0.0000 3.1398 0.0 0
M  V30 7 C 5.3182 3.8501 0.0 0
M  V30 8 C 3.9845 3.0801 0.0 0
M  V30 9 C 5.3182 5.3901 0.0 0
M  V30 10 C 6.6519 3.0801 0.0 0
M  V30 11 C 2.6507 3.8501 0.0 0
M  V30 12 C 3.6644 1.5738 0.0 0
M  V30 13 N 3.9845 6.1601 0.0 0
M  V30 14 C 6.6519 6.1601 0.0 0
M  V30 15 C 7.9855 3.8501 0.0 0
M  V30 16 C 2.6507 5.3901 0.0 0
M  V30 17 C 1.5063 2.8196 0.0 0
M  V30 18 O 2.1326 1.4127 0.0 0
M  V30 19 C 7.9855 5.3901 0.0 0
M  V30 20 N 10.6530 2.3101 0.0 0
M  V30 21 C 10.6530 0.7700 0.0 0
M  V30 22 C 11.9867 3.0801 0.0 0
M  V30 23 C 11.9867 0.0000 0.0 0
M  V30 24 C 13.3204 2.3101 0.0 0
M  V30 25 O 13.3204 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 12
M  V30 2 2 2 3
M  V30 3 2 2 4
M  V30 4 1 2 15
M  V30 5 1 2 20
M  V30 6 1 5 16
M  V30 7 2 6 17
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 2 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 2 9 14
M  V30 15 1 10 15
M  V30 16 1 11 16
M  V30 17 1 11 17
M  V30 18 1 12 18
M  V30 19 2 13 16
M  V30 20 1 14 19
M  V30 21 2 15 19
M  V30 22 1 17 18
M  V30 23 1 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Dimethyl-8-(4-morpholinylsulfonyl)-1H-pyrrolo[3,4-c]quinoline-1,3(2H)-dione
C17H17N3O5S
745046-20-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6948 0.4292 0.0 0
M  V30 2 O 0.0000 3.1398 0.0 0
M  V30 3 C 1.3170 6.1601 0.0 0
M  V30 4 C 1.3626 0.0790 0.0 0
M  V30 5 S 9.3194 3.0801 0.0 0 VAL=6
M  V30 6 O 8.5493 1.7464 0.0 0
M  V30 7 O 10.0894 4.4137 0.0 0
M  V30 8 C 3.9845 3.0801 0.0 0
M  V30 9 C 5.3182 3.8501 0.0 0
M  V30 10 C 2.6507 3.8501 0.0 0
M  V30 11 C 3.6644 1.5738 0.0 0
M  V30 12 C 5.3182 5.3901 0.0 0
M  V30 13 C 6.6519 3.0801 0.0 0
M  V30 14 C 1.5063 2.8196 0.0 0
M  V30 15 C 2.6507 5.3901 0.0 0
M  V30 16 N 2.1326 1.4127 0.0 0
M  V30 17 N 3.9845 6.1601 0.0 0
M  V30 18 C 6.6519 6.1601 0.0 0
M  V30 19 C 7.9855 3.8501 0.0 0
M  V30 20 C 7.9855 5.3901 0.0 0
M  V30 21 N 10.6530 2.3101 0.0 0
M  V30 22 C 10.6530 0.7700 0.0 0
M  V30 23 C 11.9867 3.0801 0.0 0
M  V30 24 C 11.9867 0.0000 0.0 0
M  V30 25 C 13.3204 2.3101 0.0 0
M  V30 26 O 13.3204 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 2 2 14
M  V30 3 1 3 15
M  V30 4 1 4 16
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 19
M  V30 8 1 5 21
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 1 10 14
M  V30 15 1 10 15
M  V30 16 1 11 16
M  V30 17 1 12 17
M  V30 18 2 12 18
M  V30 19 1 13 19
M  V30 20 1 14 16
M  V30 21 2 15 17
M  V30 22 1 18 20
M  V30 23 2 19 20
M  V30 24 1 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 753482-69-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 745046-20-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-366-CAS-8567440
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 110-86-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 1,3-Dioxo-4-methyl-2,3-dihydro-1H-pyrrolo[3,4-c]quinolines as potent
caspase-3 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kravchenko, Dmitri V.; Kysil, Vladimir V.; Ilyn, Alexey P.; Tkachenko,
Sergey E.; Maliarchouk, Sergey; Okun, Ilya M.; Ivachtchenko, Alexandre V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2005), 15(7), 1841-1845

$RFMT $RIREG SCHEME108 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-1,8-naphthalic anhydride
C12H5BrO3
81-86-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6674 0.0000 0.0 0
M  V30 2 O 0.0000 4.6200 0.0 0
M  V30 3 Br 8.0021 4.6200 0.0 0
M  V30 4 C 4.0011 3.8500 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 2.6674 4.6200 0.0 0
M  V30 7 C 5.3347 4.6200 0.0 0
M  V30 8 C 2.6674 1.5400 0.0 0
M  V30 9 C 5.3347 1.5400 0.0 0
M  V30 10 C 1.3336 3.8500 0.0 0
M  V30 11 C 2.6674 6.1600 0.0 0
M  V30 12 C 6.6685 3.8500 0.0 0
M  V30 13 C 5.3347 6.1600 0.0 0
M  V30 14 O 1.3336 2.3100 0.0 0
M  V30 15 C 6.6685 2.3100 0.0 0
M  V30 16 C 4.0011 6.9300 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 2 2 10
M  V30 3 1 3 12
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 2 6 11
M  V30 11 1 7 12
M  V30 12 1 7 13
M  V30 13 1 8 14
M  V30 14 1 9 15
M  V30 15 1 10 14
M  V30 16 1 11 16
M  V30 17 2 12 15
M  V30 18 2 13 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-N-methyl-1,8-naphthalimide
C13H8BrNO2
4116-90-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.5400 5.3349 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 3 Br 8.4700 4.0011 0.0 0
M  V30 4 C 0.0000 2.6674 0.0 0
M  V30 5 C 4.6200 2.6674 0.0 0
M  V30 6 C 3.8500 4.0011 0.0 0
M  V30 7 C 3.8500 1.3338 0.0 0
M  V30 8 C 6.1600 2.6674 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 4.6200 5.3349 0.0 0
M  V30 11 C 2.3100 1.3338 0.0 0
M  V30 12 C 4.6200 0.0000 0.0 0
M  V30 13 C 6.9300 4.0011 0.0 0
M  V30 14 C 6.9300 1.3338 0.0 0
M  V30 15 N 1.5400 2.6674 0.0 0
M  V30 16 C 6.1600 5.3349 0.0 0
M  V30 17 C 6.1600 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 2 2 11
M  V30 3 1 3 13
M  V30 4 1 4 15
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 2 7 12
M  V30 12 1 8 13
M  V30 13 1 8 14
M  V30 14 1 9 15
M  V30 15 1 10 16
M  V30 16 1 11 15
M  V30 17 1 12 17
M  V30 18 2 13 16
M  V30 19 2 14 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 81-86-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 4116-90-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-366-CAS-23673902
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Fluorescent cellulose nanocrystals with responsiveness to solvent
polarity and ionic strength
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wu, Weibing; Song, Ruyuan; Xu, Zhaoyang; Jing, Yi; Dai, Hongqi; Fang,
Guigan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Sensors and Actuators, B: Chemical (2018), 275490-498

$RFMT $RIREG SCHEME109 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-2,1,3-Benzothiadiazine, 3-(2-bromoethyl)-6-fluoro-1-(2-fluorophenyl)-3,4-d...
C15H13BrF2N2O2S
1034028-77-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.3248 8.1098 0.0 0
M  V30 2 O 4.3449 8.1098 0.0 0
M  V30 3 F 1.3337 4.6201 0.0 0
M  V30 4 C 8.0023 6.9302 0.0 0
M  V30 5 C 9.3360 6.1601 0.0 0
M  V30 6 Br 10.6697 6.9302 0.0 0
M  V30 7 F 4.0012 0.0000 0.0 0
M  V30 8 N 4.0012 6.1601 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 S 5.3348 6.9302 0.0 0 VAL=6
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 12 C 2.6673 3.8501 0.0 0
M  V30 13 N 6.6685 6.1601 0.0 0
M  V30 14 C 6.6685 4.6201 0.0 0
M  V30 15 C 5.3348 2.3101 0.0 0
M  V30 16 C 2.6673 2.3101 0.0 0
M  V30 17 C 4.0012 1.5400 0.0 0
M  V30 18 C 2.6673 6.9302 0.0 0
M  V30 19 C 1.3337 6.1601 0.0 0
M  V30 20 C 2.6673 8.4702 0.0 0
M  V30 21 C 0.0000 6.9302 0.0 0
M  V30 22 C 1.3337 9.2402 0.0 0
M  V30 23 C 0.0000 8.4702 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 2 2 10
M  V30 3 1 3 19
M  V30 4 1 4 5
M  V30 5 1 4 13
M  V30 6 1 5 6
M  V30 7 1 7 17
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 18
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 2 11 15
M  V30 16 1 12 16
M  V30 17 1 13 14
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3H-2,1,3-Benzothiadiazine-3-ethanamine, 6-fluoro-1-(2-fluorophenyl)-1,4-dihyd...
C16H17F2N3O2S
1034027-10-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.3248 8.1098 0.0 0
M  V30 2 O 4.3449 8.1098 0.0 0
M  V30 3 F 1.3337 4.6201 0.0 0
M  V30 4 C 8.0022 6.9302 0.0 0
M  V30 5 C 9.3360 6.1601 0.0 0
M  V30 6 N 10.6697 6.9302 0.0 0
M  V30 7 C 12.0033 6.1601 0.0 0
M  V30 8 F 4.0012 0.0000 0.0 0
M  V30 9 N 4.0012 6.1601 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 S 5.3348 6.9302 0.0 0 VAL=6
M  V30 12 C 5.3348 3.8501 0.0 0
M  V30 13 C 2.6673 3.8501 0.0 0
M  V30 14 N 6.6685 6.1601 0.0 0
M  V30 15 C 6.6685 4.6201 0.0 0
M  V30 16 C 5.3348 2.3101 0.0 0
M  V30 17 C 2.6673 2.3101 0.0 0
M  V30 18 C 4.0012 1.5400 0.0 0
M  V30 19 C 2.6673 6.9302 0.0 0
M  V30 20 C 1.3337 6.1601 0.0 0
M  V30 21 C 2.6673 8.4702 0.0 0
M  V30 22 C 0.0000 6.9302 0.0 0
M  V30 23 C 1.3337 9.2402 0.0 0
M  V30 24 C 0.0000 8.4702 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 2 2 11
M  V30 3 1 3 20
M  V30 4 1 4 5
M  V30 5 1 4 14
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 8 18
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 19
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 2 12 16
M  V30 17 1 13 17
M  V30 18 1 14 15
M  V30 19 1 16 18
M  V30 20 2 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1034028-77-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1034027-10-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-9106242
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Example 11:
2-[1-(2-fluorophenyl)-2,2-dioxido-1,4-dihydro-3H-2,1,3-benzothiadiazin-3-yl]-N-methylethanamine
Example 17:
2-[6-fluoro-1-(2-fluorophenyl)-2,2-dioxido-1,4-dihydro-3H-2,1,3-benzothiadiazin-3-yl]-N-methylethanamine
Step 2: In an analogous manner to Example 11 step 5,
3-(2-bromoethyl)-6-fluoro-1-(2-fluorophenyl)-3,4-dihydro-1H-2,1,3-benzothiadiazine
2,2-dioxide (0.1 g, 0.25 mmol) was reacted to methylamine and then
treated with HCl to provide
2-[6-fluoro-1-(2-fluorophenyl)-2,2-dioxido-1,4-dihydro-3H-2,1,3-benzothiadiazin-3-yl]-N-methylethanamine
(0.081 g, 92%) as a white solid. HPLC purity 96.3% at 210-370 nm, 6.8
min.; Xterra RP18, 3.5μ, 150 x 4.6 mm column, 1.2 mL/min, 85/15-5/95
(ammonium formate buffer pH 3.5/acetonitrile) gradient for 10 min, then
hold for 4 min. HRMS: calcd for C16H17F2N3O2S + H+, 354.10823; found
(ESI, [M+H]+ Obs'd), 354.1078.
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Substituted benzothiadiazine dioxide derivatives and methods of their use
and preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Goldberg, Joel; Fensome, Andrew; McComas, Casey Cameron; Zhang, Puwen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008073958 A2 2008-06-19

$RFMT $RIREG SCHEME110 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Diethoxymethyl)benzaldehyde
C12H16O3
81172-89-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.8500 0.0 0
M  V30 2 O 2.6673 4.6200 0.0 0
M  V30 3 O 4.0011 2.3100 0.0 0
M  V30 4 C 1.3336 3.8500 0.0 0
M  V30 5 C 2.6673 1.5400 0.0 0
M  V30 6 C 0.0000 4.6200 0.0 0
M  V30 7 C 2.6673 0.0000 0.0 0
M  V30 8 C 9.3358 6.9300 0.0 0
M  V30 9 O 10.6694 6.1600 0.0 0
M  V30 10 C 5.3347 4.6200 0.0 0
M  V30 11 C 6.6684 3.8500 0.0 0
M  V30 12 C 5.3347 6.1600 0.0 0
M  V30 13 C 8.0021 4.6200 0.0 0
M  V30 14 C 6.6684 6.9300 0.0 0
M  V30 15 C 8.0021 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 8 9
M  V30 9 1 8 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Diethoxymethyl)-N-methylbenzenemethanamine
C13H21NO2
214424-26-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.8501 0.0 0
M  V30 2 O 2.6673 4.6201 0.0 0
M  V30 3 O 4.0012 2.3101 0.0 0
M  V30 4 C 1.3337 3.8501 0.0 0
M  V30 5 C 2.6673 1.5400 0.0 0
M  V30 6 C 0.0000 4.6201 0.0 0
M  V30 7 C 2.6673 0.0000 0.0 0
M  V30 8 C 9.3360 6.9302 0.0 0
M  V30 9 N 10.6697 6.1601 0.0 0
M  V30 10 C 12.0033 6.9302 0.0 0
M  V30 11 C 5.3348 4.6201 0.0 0
M  V30 12 C 5.3348 6.1601 0.0 0
M  V30 13 C 6.6685 3.8501 0.0 0
M  V30 14 C 6.6685 6.9302 0.0 0
M  V30 15 C 8.0022 4.6201 0.0 0
M  V30 16 C 8.0022 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 8 9
M  V30 9 1 8 16
M  V30 10 1 9 10
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 81172-89-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 214424-26-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-15396008
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for the Reductive Amination
of Aldehydes with Methylamine Titanium(IV) isopropoxide (2 mL, 6.6 mmol)
was added to a commercially available solution of methylamine in methanol
(2M, 7.5 mL) followed by the addition of the starting aldehyde (5 mmol).
The reaction mixture was stirred at ambient temperature for 5 h, after
which sodium borohydride (0.2 g, 5 mmol) was added and the resulting
mixture was further stirred for another period of 2 h. The reaction was
then quenched by the addition of water (1 mL), the resulting inorganic
precipitate was filtered and washed with diethyl ether (20 mL). The
organic layer was separated and the aqueous part was further extracted
with diethyl ether (20 mL x 2). The combined ether extracts were dried
(K2CO3) and concentrated in vacuo to give N-methyl secondary amines in
high purity. Table I, Entry 11, yield 92%.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of N-methyl secondary amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kumpaty, Hephzibah J.; Williamson, John S.; Bhattacharyya, Sukanta
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthetic Communications (2003), 33(8), 1411-1416

$RFMT $RIREG SCHEME111 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzil
C14H10O2
134-81-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 C 5.3901 1.3337 0.0 0
M  V30 3 O 5.3901 4.0010 0.0 0
M  V30 4 O 4.6201 0.0000 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 2.3101 4.0010 0.0 0
M  V30 7 C 2.3101 1.3337 0.0 0
M  V30 8 C 0.7700 4.0010 0.0 0
M  V30 9 C 0.7700 1.3337 0.0 0
M  V30 10 C 0.0000 2.6673 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 12 C 7.7002 2.6673 0.0 0
M  V30 13 C 7.7002 0.0000 0.0 0
M  V30 14 C 9.2402 2.6673 0.0 0
M  V30 15 C 9.2402 0.0000 0.0 0
M  V30 16 C 10.0102 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 2 2 4
M  V30 5 1 2 11
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromobenzaldehyde
C7H5BrO
1122-91-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 Br 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(4-Bromophenyl)-1-methyl-4,5-diphenyl-1H-imidazole
C22H17BrN2
36750-83-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0157 3.5103 0.0 0
M  V30 2 Br 12.3670 9.1524 0.0 0
M  V30 3 C 5.3648 4.2206 0.0 0
M  V30 4 C 4.5948 5.5542 0.0 0
M  V30 5 N 6.8711 4.5408 0.0 0
M  V30 6 N 5.6252 6.6988 0.0 0
M  V30 7 C 7.0322 6.0723 0.0 0
M  V30 8 C 4.7385 2.8138 0.0 0
M  V30 9 C 5.6436 1.5677 0.0 0
M  V30 10 C 3.2068 2.6527 0.0 0
M  V30 11 C 5.0172 0.1609 0.0 0
M  V30 12 C 2.5805 1.2459 0.0 0
M  V30 13 C 3.4857 0.0000 0.0 0
M  V30 14 C 3.0633 5.7153 0.0 0
M  V30 15 C 2.1580 4.4693 0.0 0
M  V30 16 C 2.4368 7.1221 0.0 0
M  V30 17 C 0.6265 4.6304 0.0 0
M  V30 18 C 0.9052 7.2831 0.0 0
M  V30 19 C 0.0000 6.0372 0.0 0
M  V30 20 C 8.3659 6.8423 0.0 0
M  V30 21 C 8.3659 8.3823 0.0 0
M  V30 22 C 9.6995 6.0723 0.0 0
M  V30 23 C 9.6995 9.1524 0.0 0
M  V30 24 C 11.0332 6.8423 0.0 0
M  V30 25 C 11.0332 8.3823 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 25
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 8
M  V30 6 1 4 6
M  V30 7 1 4 14
M  V30 8 1 5 7
M  V30 9 2 6 7
M  V30 10 1 7 20
M  V30 11 2 8 9
M  V30 12 1 8 10
M  V30 13 1 9 11
M  V30 14 2 10 12
M  V30 15 2 11 13
M  V30 16 1 12 13
M  V30 17 2 14 15
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 2 16 18
M  V30 21 2 17 19
M  V30 22 1 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 134-81-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 1122-91-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 36750-83-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-27071
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 631-61-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7558-80-7
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: A mixture of the benzil of choice (5 mmol),
methylamine (5 mmol), aldehyde (5 mmol), ammonium acetate (5 mmol) and
NaH2PO4 (1.5 mmol) was added to a thick-walled test-tube with a screw-on
Teflon top. The reaction mixture was heated to 150 °C and maintained at
the temperature for 2-5 hours; the reaction mixture was stirred
throughout. Then the reaction mixture was cooled to room temperature.
Acetone was added to dissolve the mixture and the undissolved residue was
removed by filtration. After evaporation of the solvent under reduced
pressure, the resulting solid residue was recrystallized from
acetone-water to obtain pure products.
2-(4-Bromophenyl)-1-methyl-4,5-diphenyl-1H-imidazole (3a) Yield: 92%;
Yellow needle. M.p.: 201-202 °C; 1H NMR (400 MHz, CDCl3): δ 3.50 (s, 3H,
CH3), 7.16 (t, 1H, J = 7.2 Hz, Ar-H), 7.22 (t, 2H, J = 7.2 Hz, Ar-H),
7.39-7.41 (m, 2H, Ar-H), 7.45-7.48 (m, 3H, Ar-H), 7.52-7.54 (m, 2H,
Ar-H), 7.63 (d, 2H, J = 8.8 Hz, Ar-H), 7.65 (d, 2H, J = 8.8 Hz, Ar-H).
$DTYPE RXN:VAR(1):NOTES
$DATUM no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel triarylimidazole redox catalysts: Synthesis, electrochemical
properties, and applicability to electrooxidative C-H activation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zeng, Cheng-chu; Zhang, Ni-tao; Lam, Chiu Marco; Little, R. Daniel
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2012), 14(5), 1314-1317

$RFMT $RIREG SCHEME112 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Nitrobenzenesulfonyl chloride
C6H4ClNO4S
1694-92-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 4.0009 0.0 0 VAL=6
M  V30 2 Cl 6.1600 4.0009 0.0 0
M  V30 3 O 4.6200 2.4609 0.0 0
M  V30 4 O 4.6200 5.5409 0.0 0
M  V30 5 N 3.0800 1.3336 0.0 0 VAL=5
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 O 4.6200 1.3336 0.0 0
M  V30 8 C 3.0800 4.0009 0.0 0
M  V30 9 C 2.3100 2.6673 0.0 0
M  V30 10 C 2.3100 5.3347 0.0 0
M  V30 11 C 0.7700 2.6673 0.0 0
M  V30 12 C 0.7700 5.3347 0.0 0
M  V30 13 C 0.0000 4.0009 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 9
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2-nitrobenzenesulfonamide
C7H8N2O4S
23530-40-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 4.0011 0.0 0 VAL=6
M  V30 2 N 5.3900 5.3349 0.0 0
M  V30 3 O 5.9536 3.2311 0.0 0
M  V30 4 O 3.2864 4.7711 0.0 0
M  V30 5 C 6.9300 5.3349 0.0 0
M  V30 6 N 1.5400 4.0011 0.0 0 VAL=5
M  V30 7 O 2.3100 5.3349 0.0 0
M  V30 8 O 0.0000 4.0011 0.0 0
M  V30 9 C 3.8500 2.6674 0.0 0
M  V30 10 C 2.3100 2.6674 0.0 0
M  V30 11 C 4.6200 1.3338 0.0 0
M  V30 12 C 1.5400 1.3338 0.0 0
M  V30 13 C 3.8500 0.0000 0.0 0
M  V30 14 C 2.3100 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 1 2 5
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 10
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1694-92-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 23530-40-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-11331155
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM N-Methyl-2-nitro-benzenesulfonamide (18) 2-Nitrobenzenesulfonyl chloride
(10.5 g, 47.5 mmol) in DCM (150 mL) was slowly added methyl amine in EtOH
(33%, 15 mL, 121 mmol). After stirring for 30 minutes. the solution was
washed with HCl (1M), sat. Na2CO3, dried (MgSO4) and evaporated.
Recrystallization (EtOH) gave N-methyl-2-nitro-benzenesulfonamide. White
solid (9.40 g, 92 %).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Selective mGAT2 (BGT-1) GABA Uptake Inhibitors: Design, Synthesis, and
Pharmacological Characterization
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Vogensen, Stine B.; Joergensen, Lars; Madsen, Karsten K.; Borkar, Nrupa;
Wellendorph, Petrine; Skovgaard-Petersen, Jonas; Schousboe, Arne; White,
H. Steve; Krogsgaard-Larsen, Povl; Clausen, Rasmus P.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2013), 56(5), 2160-2164

$RFMT $RIREG SCHEME113 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methoxy-4-nitrobenzonitrile
C8H6N2O3
177476-75-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 N 0.7700 4.0011 0.0 0 VAL=5
M  V30 4 O 0.0000 5.3349 0.0 0
M  V30 5 O 0.0000 2.6674 0.0 0
M  V30 6 C 6.9300 4.0011 0.0 0
M  V30 7 N 8.4700 4.0011 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 11 C 3.0800 5.3349 0.0 0
M  V30 12 C 5.3900 4.0011 0.0 0
M  V30 13 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 9
M  V30 6 3 6 7
M  V30 7 1 6 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzonitrile, 3-(methylamino)-4-nitro-
C8H7N3O2
64910-48-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 N 0.7700 4.0011 0.0 0 VAL=5
M  V30 4 O 0.0000 2.6674 0.0 0
M  V30 5 O 0.0000 5.3349 0.0 0
M  V30 6 C 6.9300 4.0011 0.0 0
M  V30 7 N 8.4700 4.0011 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 11 C 3.0800 5.3349 0.0 0
M  V30 12 C 5.3900 4.0011 0.0 0
M  V30 13 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 9
M  V30 6 3 6 7
M  V30 7 1 6 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 177476-75-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 64910-48-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-4958732
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-68-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 3-Methylamino-4-nitrobenzonitrile (44). The crude
3-methoxy-4-nitrobenzonitrile 43 (1.0 g, 5.6 mmol) was stirred in DMSO (7
mL) and heated to 75 °C. A 40% solution of methylamine in water (1 mL)
was added and the mixture heated at 75 °C for 2 h. The solution was
allowed to cool, and then EtOAc (200 mL) was added. The solution was
washed with 10% NaHCO3 (3 ×100 mL) followed by brine. The organic
solution was dried over Na2SO4, filtered, and concentrated under reduced
pressure. 44 (0.91 g, 92%) as an orange solid. 1H NMR (DMSO-d 6)) δ 8.24
(br q, J = 5.1 Hz, 1H), 8.17 (d, J = 8.8 Hz, 1H), 7.51 (s, 1H), 7.00 (d,
J = 8.8 Hz, 1H), 2.96 (d, J = 5.1 Hz, 3H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Development of serine protease inhibitors displaying a multicentered
short (<2.3 Å) hydrogen bond binding mode: Inhibitors of urokinase-type
plasminogen activator and factor Xa
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Verner, Erik; Katz, Bradley A.; Spencer, Jeffrey R.; Allen, Darin;
Hataye, Jason; Hruzewicz, Witold; Hui, Hon C.; Kolesnikov, Aleksandr; Li,
Yong; Luong, Christine; Martelli, Arnold; Radika, Kesavan; Rai, Roopa;
She, Miles; Shrader, William; Sprengeler, Paul A.; Trapp, Sean; Wang,
Jing; Young, Wendy B.; Mackman, Richard L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2001), 44(17), 2753-2771

$RFMT $RIREG SCHEME114 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1,2,2,3,3,4,4,4-Nonafluoro-1-butanesulfonyl fluoride
C4F10O2S
375-72-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 1.5400 0.0 0
M  V30 2 C 3.0800 1.5400 0.0 0
M  V30 3 C 6.1600 1.5400 0.0 0
M  V30 4 F 4.6200 3.0800 0.0 0
M  V30 5 F 4.6200 0.0000 0.0 0
M  V30 6 C 1.5400 1.5400 0.0 0
M  V30 7 F 3.0800 3.0800 0.0 0
M  V30 8 F 3.0800 0.0000 0.0 0
M  V30 9 S 7.7000 1.5400 0.0 0 VAL=6
M  V30 10 F 6.1600 3.0800 0.0 0
M  V30 11 F 6.1600 0.0000 0.0 0
M  V30 12 F 0.0000 1.5400 0.0 0
M  V30 13 F 1.5400 3.0800 0.0 0
M  V30 14 F 1.5400 0.0000 0.0 0
M  V30 15 F 9.2400 1.5400 0.0 0
M  V30 16 O 7.7000 0.0000 0.0 0
M  V30 17 O 7.7000 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 1 2 7
M  V30 7 1 2 8
M  V30 8 1 3 9
M  V30 9 1 3 10
M  V30 10 1 3 11
M  V30 11 1 6 12
M  V30 12 1 6 13
M  V30 13 1 6 14
M  V30 14 1 9 15
M  V30 15 2 9 16
M  V30 16 2 9 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methylperfluorobutanesulfonamide
C5H4F9NO2S
68298-12-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 1.5400 0.0 0
M  V30 2 C 6.1600 1.5400 0.0 0
M  V30 3 C 3.0800 1.5400 0.0 0
M  V30 4 F 4.6200 3.0800 0.0 0
M  V30 5 F 4.6200 0.0000 0.0 0
M  V30 6 S 7.7000 1.5400 0.0 0 VAL=6
M  V30 7 F 6.1600 3.0800 0.0 0
M  V30 8 F 6.1600 0.0000 0.0 0
M  V30 9 C 1.5400 1.5400 0.0 0
M  V30 10 F 3.0800 3.0800 0.0 0
M  V30 11 F 3.0800 0.0000 0.0 0
M  V30 12 N 9.2400 1.5400 0.0 0
M  V30 13 O 7.7000 0.0000 0.0 0
M  V30 14 O 7.7000 3.0800 0.0 0
M  V30 15 F 0.0000 1.5400 0.0 0
M  V30 16 F 1.5400 3.0800 0.0 0
M  V30 17 F 1.5400 0.0000 0.0 0
M  V30 18 C 10.0100 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 1 2 7
M  V30 7 1 2 8
M  V30 8 1 3 9
M  V30 9 1 3 10
M  V30 10 1 3 11
M  V30 11 1 6 12
M  V30 12 2 6 13
M  V30 13 2 6 14
M  V30 14 1 9 15
M  V30 15 1 9 16
M  V30 16 1 9 17
M  V30 17 1 12 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 375-72-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 68298-12-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-20468775
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM incremental addition of methanamine (stage 1)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Ink-jet ink compositions containing fluorochemical surfactants
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ylitalo, Caroline M.; Thery, Ronald K.; Severance, Richard L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2003010249 A1 2003-02-06

$RFMT $RIREG SCHEME114 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1,2,2,3,3,4,4,4-Nonafluoro-1-butanesulfonyl fluoride
C4F10O2S
375-72-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 1.5400 0.0 0
M  V30 2 C 3.0800 1.5400 0.0 0
M  V30 3 C 6.1600 1.5400 0.0 0
M  V30 4 F 4.6200 3.0800 0.0 0
M  V30 5 F 4.6200 0.0000 0.0 0
M  V30 6 C 1.5400 1.5400 0.0 0
M  V30 7 F 3.0800 3.0800 0.0 0
M  V30 8 F 3.0800 0.0000 0.0 0
M  V30 9 S 7.7000 1.5400 0.0 0 VAL=6
M  V30 10 F 6.1600 3.0800 0.0 0
M  V30 11 F 6.1600 0.0000 0.0 0
M  V30 12 F 0.0000 1.5400 0.0 0
M  V30 13 F 1.5400 3.0800 0.0 0
M  V30 14 F 1.5400 0.0000 0.0 0
M  V30 15 F 9.2400 1.5400 0.0 0
M  V30 16 O 7.7000 0.0000 0.0 0
M  V30 17 O 7.7000 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 1 2 7
M  V30 7 1 2 8
M  V30 8 1 3 9
M  V30 9 1 3 10
M  V30 10 1 3 11
M  V30 11 1 6 12
M  V30 12 1 6 13
M  V30 13 1 6 14
M  V30 14 1 9 15
M  V30 15 2 9 16
M  V30 16 2 9 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methylperfluorobutanesulfonamide
C5H4F9NO2S
68298-12-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 1.5400 0.0 0
M  V30 2 C 6.1600 1.5400 0.0 0
M  V30 3 C 3.0800 1.5400 0.0 0
M  V30 4 F 4.6200 3.0800 0.0 0
M  V30 5 F 4.6200 0.0000 0.0 0
M  V30 6 S 7.7000 1.5400 0.0 0 VAL=6
M  V30 7 F 6.1600 3.0800 0.0 0
M  V30 8 F 6.1600 0.0000 0.0 0
M  V30 9 C 1.5400 1.5400 0.0 0
M  V30 10 F 3.0800 3.0800 0.0 0
M  V30 11 F 3.0800 0.0000 0.0 0
M  V30 12 N 9.2400 1.5400 0.0 0
M  V30 13 O 7.7000 0.0000 0.0 0
M  V30 14 O 7.7000 3.0800 0.0 0
M  V30 15 F 0.0000 1.5400 0.0 0
M  V30 16 F 1.5400 3.0800 0.0 0
M  V30 17 F 1.5400 0.0000 0.0 0
M  V30 18 C 10.0100 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 1 2 7
M  V30 7 1 2 8
M  V30 8 1 3 9
M  V30 9 1 3 10
M  V30 10 1 3 11
M  V30 11 1 6 12
M  V30 12 2 6 13
M  V30 13 2 6 14
M  V30 14 1 9 15
M  V30 15 1 9 16
M  V30 16 1 9 17
M  V30 17 1 12 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 375-72-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 68298-12-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-110149
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 1. Preparation of C4F9SO2N(CH3)(CH2CH2O)7.5CH3. In this example
the adduct of MeFBSA (N-methyl-perfluorobutanesulfonamide) and a
polyoxyethylene monomethyl ether was prepared. A. Preparation of MeFBSA
(N-methyl-perfluorobutanesulfonamide). CHARGES: A. 200 g PBSF
(perfluorobutanesulfonyl fluoride) distilled (est 95%, MW = 302, 190 g
active = 0.63 mole), B. 43 g NH2CH3 (MW = 31, 1.38 moles), C. 300 ml
water (2 times), D. 300 ml 3% H2SO4 E. 300 ml water (3 times). PROCEDURE:
1. In a 100 ml flask fitted with a-78°C cold finger condenser, an
overhead stirrer, thermocouple, and a plastic gas inlet tube, Charge A
was added. The flask was placed in a water bath, and with stirring the
gas addition (Charge B) was started. 2. After 10 minutes of gas addition,
the temperature rose only 3°C. The internal temperature was raised by the
addition of warm water to the bath to 50°C and the gas addition rate was
increased. 3. The internal temperature was kept at 53-45°C and the
addition of Charge B took approximately 40 minutes. The batch was allowed
to stir at room temperature overnight and was still a liquid in the
morning. 4. In the morning, the batch was heated to 50°C with a heating
mantle. Charge C was added slowly to maintain the temperature. The batch
was agitated for 15 minutes 20 then allowed to split. The upper water
layer was removed by vacuum decant (sucking off the top phase with the
aspirator). This operation was repeated w ith an additional 300 ml of
water. 5. After washing 2× with water, the batch was washed with Charge
D, split and vacuum decanted. 6. The acid washed fluorochemical (FC)
bottom layer was washed 3× with 300 ml of water, split and vacuum
decanted each time. 7. After the third wash the unused openings in the
flask were stopped up, and a vacuum pump was attached to the flask. With
stirring and at 45°C, the vacuum was slowly pulled on the flask to
prevent spitting when residual water boils off too 30 rapidly. The vacuum
leveled off at 5 torr. 8. The batch was heated to 60°C at 5 torr vacuum
for 30 min then at 85°C for 15 min. The batch was cooled to 45° and
vacuum was broken. 9. The yellow liquid was poured out into a
crystallizing dish and weighed. A thermocouple was inserted into the
liquid. The liquid crystallized at 37°C. Yield: 181 g (theoretical = 197
g, yield = 181/197 = 92%). pale yellow solid.
$DTYPE RXN:VAR(1):NOTES
$DATUM other products also detected
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Fluorochemical sulfonamide surfactants
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Savu, Patricia M.; Etienne, Sandra A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2001030873 A1 2001-05-03

$RFMT $RIREG SCHEME115 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,6-Dichloropurine
C5H2Cl2N4
5451-40-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 3.7036 0.0000 0.0 0
M  V30 2 Cl 6.3710 4.6200 0.0 0
M  V30 3 C 2.3699 3.8500 0.0 0
M  V30 4 C 2.3699 2.3100 0.0 0
M  V30 5 N 3.7036 4.6200 0.0 0
M  V30 6 N 0.9052 4.3259 0.0 0
M  V30 7 C 3.7036 1.5400 0.0 0
M  V30 8 N 0.9052 1.8341 0.0 0
M  V30 9 C 5.0372 3.8500 0.0 0
M  V30 10 C 0.0000 3.0800 0.0 0
M  V30 11 N 5.0372 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 2 9
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 2 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N-methyl-9H-purin-6-amine
C6H6ClN5
82499-02-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.1456 4.6201 0.0 0
M  V30 2 C 6.4792 3.8501 0.0 0
M  V30 3 Cl 2.4781 0.0000 0.0 0
M  V30 4 C 2.4781 4.6201 0.0 0
M  V30 5 C 1.1444 3.8501 0.0 0
M  V30 6 C 3.8119 3.8501 0.0 0
M  V30 7 N 2.1579 6.1264 0.0 0
M  V30 8 N 1.1444 2.3101 0.0 0
M  V30 9 N 0.0000 4.8805 0.0 0
M  V30 10 N 3.8119 2.3101 0.0 0
M  V30 11 C 0.6263 6.2873 0.0 0
M  V30 12 C 2.4781 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 3 12
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 11
M  V30 13 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5451-40-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 82499-02-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-16401498
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM LRRK2 inhibitors and methods of making and using the same
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gray, Nathanael S.; Hatcher, John; Choi, Hwan Geun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2016130920 A2 2016-08-18

$RFMT $RIREG SCHEME115 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,6-Dichloropurine
C5H2Cl2N4
5451-40-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 3.7036 0.0000 0.0 0
M  V30 2 Cl 6.3710 4.6200 0.0 0
M  V30 3 C 2.3699 3.8500 0.0 0
M  V30 4 C 2.3699 2.3100 0.0 0
M  V30 5 N 3.7036 4.6200 0.0 0
M  V30 6 N 0.9052 4.3259 0.0 0
M  V30 7 C 3.7036 1.5400 0.0 0
M  V30 8 N 0.9052 1.8341 0.0 0
M  V30 9 C 5.0372 3.8500 0.0 0
M  V30 10 C 0.0000 3.0800 0.0 0
M  V30 11 N 5.0372 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 2 9
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 2 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N-methyl-9H-purin-6-amine
C6H6ClN5
82499-02-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.1456 4.6201 0.0 0
M  V30 2 C 6.4792 3.8501 0.0 0
M  V30 3 Cl 2.4781 0.0000 0.0 0
M  V30 4 C 2.4781 4.6201 0.0 0
M  V30 5 C 1.1444 3.8501 0.0 0
M  V30 6 C 3.8119 3.8501 0.0 0
M  V30 7 N 2.1579 6.1264 0.0 0
M  V30 8 N 1.1444 2.3101 0.0 0
M  V30 9 N 0.0000 4.8805 0.0 0
M  V30 10 N 3.8119 2.3101 0.0 0
M  V30 11 C 0.6263 6.2873 0.0 0
M  V30 12 C 2.4781 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 3 12
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 11
M  V30 13 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5451-40-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 82499-02-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-15419330
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of a Pyrrolopyrimidine (JH-II-127), a Highly Potent, Selective,
and Brain Penetrant LRRK2 Inhibitor
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hatcher, John M.; Zhang, Jinwei; Choi, Hwan Geun; Ito, Genta; Alessi,
Dario R.; Gray, Nathanael S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Medicinal Chemistry Letters (2015), 6(5), 584-589

$RFMT $RIREG SCHEME116 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloroanisole
C7H7ClO
623-12-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 2.6673 0.0 0
M  V30 3 Cl 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxy-N-methylbenzenamine
C8H11NO
5961-59-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 3.0801 0.0 0
M  V30 2 C 0.0000 2.3101 0.0 0
M  V30 3 O 6.6687 0.0000 0.0 0
M  V30 4 C 8.0023 0.7700 0.0 0
M  V30 5 C 2.6675 2.3101 0.0 0
M  V30 6 C 2.6675 0.7700 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 4.0012 0.0000 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 623-12-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 5961-59-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-14284539
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 865-48-5
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1148148-01-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-65-0
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM EXAMPLE TWENTY-FOUR: Synthesis of 4-Methoxy-N-methylaniline (Figure 11,
Table 7, entry 1) Following general procedure A, a mixture of
4-chloroanisole (123 μL, 1.0 mmol), 2M methylamine (1 mL, 2.0 mmol), NaO
t-Bu (120 mg, 1.2 mmol), BrettPhos precatalyst 10 (8 mg, 0.01 mmol), and
E-BuOH (1 mL) was stirred at room temperature for 2 h. The crude product
was purified via column chromatography (20:1 CH2Cl2/MeOH) to provide the
title compound as a yellow liquid that turned into a tan solid upon
standing (126 mg, 92%). 4-Methoxy-N-methylaniline, yield (126 mg, 92%) 1H
NMR (400 MHz, CDCl3) δ: 6.80 (dt, J = 9.0, 2.3 Hz, 2H), 6.59 (dt, J =
9.0, 2.3 Hz, 2H), 3.76 (s, 3H), 3.46 (bs, 1H), 2.81 (s, 3H) ppm. 13C NMR
(75 MHz, CDCl3) δ: 152.2, 143.9, 115.1, 113.8, 56.1, 31.8 ppm. All, H.
I.; Tomita, K.; Akaho, E.; Kambara, H.; Miura, S.; Hayakawa, H.; Ashida,
N.; Kawashima, Y.; Yamagishi, T.; Ikeya, H.; Yoneda, F.; Nagamatsu, T.
Bioorg. Med. Chem. 2007,15, 242.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Ligands for transition-metal-catalyzed cross-couplings, and methods of
use thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Buchwald, Stephen L.; Fors, Brett P.; Surry, David S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009076622 A2 2009-06-18

$RFMT $RIREG SCHEME117 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pentafluoropyridine
C5F5N
700-16-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 0.0000 2.6674 0.0 0
M  V30 2 F 1.5400 5.3349 0.0 0
M  V30 3 F 1.5400 0.0000 0.0 0
M  V30 4 F 4.6200 5.3349 0.0 0
M  V30 5 F 6.1600 2.6674 0.0 0
M  V30 6 C 1.5400 2.6674 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 C 2.3100 1.3338 0.0 0
M  V30 9 C 3.8500 4.0011 0.0 0
M  V30 10 N 3.8500 1.3338 0.0 0
M  V30 11 C 4.6200 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 2 7
M  V30 3 1 3 8
M  V30 4 1 4 9
M  V30 5 1 5 11
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Pyridinamine, 2,3,5,6-tetrafluoro-N-methyl-
C6H4F4N2
65171-12-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 4.6201 0.0 0
M  V30 2 C 6.6686 3.8500 0.0 0
M  V30 3 F 5.3348 1.5400 0.0 0
M  V30 4 F 2.6675 6.1601 0.0 0
M  V30 5 F 2.6675 0.0000 0.0 0
M  V30 6 F 0.0000 4.6201 0.0 0
M  V30 7 C 4.0011 3.8500 0.0 0
M  V30 8 C 4.0011 2.3100 0.0 0
M  V30 9 C 2.6675 4.6201 0.0 0
M  V30 10 C 2.6675 1.5400 0.0 0
M  V30 11 C 1.3338 3.8500 0.0 0
M  V30 12 N 1.3338 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 3 8
M  V30 4 1 4 9
M  V30 5 1 5 10
M  V30 6 1 6 11
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 700-16-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 65171-12-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-12556926
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, alternative preparation shown, ultrasonic irradiation (45
kHz)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Ultrasound-promoted facile synthesis of some pentafluoropyridine
derivatives at ambient conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ranjbar-Karimi, Reza; Mashak-Shoshtari, Mahtab; Darehkordi, Ali
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Ultrasonics Sonochemistry (2010), 18(1), 258-263

$RFMT $RIREG SCHEME118 STEP1
$RXN



  2  1
$MOL
6-Methoxy-2-methylbenzo[b]thiophene-3-carboxylic acid
C11H10O3S
854515-01-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.4647 3.3321 0.0 0
M  V30 2 O 1.7849 4.8384 0.0 0
M  V30 3 O 0.0000 2.8561 0.0 0
M  V30 4 C 1.1145 0.0000 0.0 0
M  V30 5 O 8.7355 2.6217 0.0 0
M  V30 6 C 9.5055 3.9555 0.0 0
M  V30 7 C 4.1155 2.6217 0.0 0
M  V30 8 C 2.6091 2.3015 0.0 0
M  V30 9 C 4.8855 1.2881 0.0 0
M  V30 10 C 4.8855 3.9555 0.0 0
M  V30 11 C 2.4481 0.7700 0.0 0
M  V30 12 S 3.8549 0.1437 0.0 0
M  V30 13 C 6.4255 1.2881 0.0 0
M  V30 14 C 6.4255 3.9555 0.0 0
M  V30 15 C 7.1955 2.6217 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 11
M  V30 5 1 5 6
M  V30 6 1 5 15
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 12
M  V30 15 1 13 15
M  V30 16 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Methoxy-N,2-dimethylbenzo[b]thiophene-3-carboxamide
C12H13NO2S
638216-86-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6091 3.3321 0.0 0
M  V30 2 N 1.1444 2.8561 0.0 0
M  V30 3 O 2.9292 4.8384 0.0 0
M  V30 4 C 0.0000 3.8867 0.0 0
M  V30 5 C 2.2587 0.0000 0.0 0
M  V30 6 O 9.8797 2.6217 0.0 0
M  V30 7 C 10.6497 3.9555 0.0 0
M  V30 8 C 5.2597 2.6217 0.0 0
M  V30 9 C 3.7534 2.3015 0.0 0
M  V30 10 C 6.0297 1.2881 0.0 0
M  V30 11 C 6.0297 3.9555 0.0 0
M  V30 12 C 3.5925 0.7700 0.0 0
M  V30 13 S 4.9993 0.1437 0.0 0
M  V30 14 C 7.5697 1.2881 0.0 0
M  V30 15 C 7.5697 3.9555 0.0 0
M  V30 16 C 8.3397 2.6217 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 12
M  V30 6 1 6 7
M  V30 7 1 6 16
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 2 8 11
M  V30 11 2 9 12
M  V30 12 1 10 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 1 12 13
M  V30 16 1 14 16
M  V30 17 2 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 854515-01-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 638216-86-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-2463001
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 6-Methoxy-N,2-dimethylbenzo[b]thiophene-3-carboxamide (9). A 75-L
Hastelloy reactor was sequentially charged with THF (27 L) and 13 (3010
g, 13.54 mol) at room temperature. To the slurry was added
1,1'-carbonyldiimidazole (CDI, 2632 g, 16.23 mol) in one portion. After 1
h, the reaction solution was cooled to 10 °C. The CH3NH2 solution (2.34
L, 40% by wt in H2O, 67.6 mol) was slowly added to the reaction. After
complete addition of the CH3NH2 solution, the reaction solution was
warmed to room temperature. After a reaction time of 3 h (post-amine
addition), water (27 L) was added to the reaction solution. The mixture
was distilled under atmospheric pressure down to an approximate volume of
30 L and a distillation head temperature of 71 °C. The reaction mixture
was seeded with 9 at 60 °C, then the heat was turned off and the solution
allowed to cool to room temperature overnight with continued stirring.
After 18 h, the solution was filtered, and the solids were rinsed with a
5:1 H2O/THF mixure (27 L). The white solids were dried to provide 2919 g
(92%) of 9. Mp = 157.9-159.0 °C. 1H NMR (300 MHz, CDCl3): 2.66 (s, 3H),
3.07 (d, 3H, J = 4.9), 3.88 (s, 3H), 5.93 (br s, 1H), 6.99 (dd, 1H, J =
2.4, 8.9), 7.23 (d, 1H, J = 2.4), 7.75 (d, 1H, J = 8.9). 13C NMR (75 MHz,
d 6-DMSO): 14.7, 26.0, 55.4, 104.8, 114.2, 123.3, 129.6, 132.1, 137.6,
138.6, 156.8, 164.5. Anal. Calcd for C12H13NO2S: C, 61.25; H, 5.57; N,
5.95. Found: C, 61.25; H, 5.50; N, 5.92.
$DTYPE RXN:VAR(1):NOTES
$DATUM kilogram scale
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Development of a scalable synthesis to VEGFR Inhibitor AG-28262
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Scott, Robert W.; Neville, Sean N.; Urbina, Armando; Camp, David;
Stankovic, Nebojsa
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Process Research & Development (2006), 10(2), 296-303

$RFMT $RIREG SCHEME119 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Chloro-4-nitrobenzene
C6H4ClNO2
100-00-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 1.3337 0.0 0 VAL=5
M  V30 2 O 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 Cl 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-nitroaniline
C7H8N2O2
100-15-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 N 6.6687 4.6201 0.0 0
M  V30 5 C 8.0023 3.8501 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 1.5400 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 100-00-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 100-15-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-1927340
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7782-44-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-50-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for the Copper-Catalyzed on
Water Ullmann Reaction. A mixture of an aryl halide (10.0 mmol), 30%
aqueous methylamine solution (5.4mL, 50 mmol), copper powder (0.032 g,
0.5 mmol), and a stirring bar was sealed in a 30 mL screwed tube and
stirred electromagnetically in an oil bath at 100 °C. During the
reaction, most of the copper powder was dissolved. After the reaction was
completed or proceeded to the times in Tables 1-3, the reaction mixture
was cooled to room temperature and ethyl acetate (20 mL) was added to
extract the aryl amine. The organic layer was separated and the aqueous
layer was extracted by ethyl acetate (3 x 10 mL). The combined extracts
were dried by anhydrous sodium sulfate and the solvent was removed under
reduced pressure to give crude product that was purified by silica gel
column chromatography (eluent: petroleum ether/ethyl acetate). The pure
product. N-Methyl-4-nitroaniline (Table 2-29) The reaction of
4-nitrochlorobenzene (1.576 g, 10 mmol), aqueous methylamine (5.4 mL, 5
eq), copper powder (5 mol%), produced 1.392 g (91.5 %) product. 1H NMR
(300 MHz, d 6-DMSO) δ (ppm): 2.78–2.90(d, J = 4.5 Hz , 3H), 6.60(s, 2H),
7.26(s, 1H), 7.97–7.99(d, J = 7.5 Hz, 2H); 13C NMR (75 MHz, d 6-DMSO) δ
(ppm): 29.7, 110.9, 126.7, 136.0, 155.8.
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation shown, Ullmann amination, sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A Facile and Practical Copper Powder-Catalyzed, Organic Solvent- and
Ligand-Free Ullmann Amination of Aryl Halides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jiao, Jiao; Zhang, Xi-Ru; Chang, Ning-Hui; Wang, Jie; Wei, Jun-Fa; Shi,
Xian-Ying; Chen, Zhan-Guo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2011), 76(4), 1180-1183

$RFMT $RIREG SCHEME120 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloroimidazo[1,2-a]quinoxaline
C10H6ClN3
191349-69-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 1.6672 0.0000 0.0 0
M  V30 2 C 3.9772 4.0011 0.0 0
M  V30 3 N 2.4372 4.0011 0.0 0
M  V30 4 C 4.7472 2.6675 0.0 0
M  V30 5 C 4.7472 5.3349 0.0 0
M  V30 6 C 1.6672 2.6675 0.0 0
M  V30 7 C 1.4068 5.1456 0.0 0
M  V30 8 N 3.9772 1.3338 0.0 0
M  V30 9 C 6.2873 2.6675 0.0 0
M  V30 10 C 6.2873 5.3349 0.0 0
M  V30 11 C 2.4372 1.3338 0.0 0
M  V30 12 N 0.1609 2.9876 0.0 0
M  V30 13 C 0.0000 4.5192 0.0 0
M  V30 14 C 7.0573 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 2 4 9
M  V30 9 1 5 10
M  V30 10 1 6 11
M  V30 11 2 6 12
M  V30 12 2 7 13
M  V30 13 2 8 11
M  V30 14 1 9 14
M  V30 15 2 10 14
M  V30 16 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methylimidazo[1,2-a]quinoxalin-4-amine
C11H10N4
452311-39-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.9300 3.7035 0.0 0
M  V30 2 C 7.7000 5.0372 0.0 0
M  V30 3 N 3.0800 2.3699 0.0 0
M  V30 4 C 2.3100 3.7035 0.0 0
M  V30 5 C 4.6200 2.3699 0.0 0
M  V30 6 C 2.6041 0.9052 0.0 0
M  V30 7 C 3.0800 5.0372 0.0 0
M  V30 8 C 0.7700 3.7035 0.0 0
M  V30 9 C 5.3900 3.7035 0.0 0
M  V30 10 N 5.0959 0.9052 0.0 0
M  V30 11 C 3.8500 0.0000 0.0 0
M  V30 12 N 4.6200 5.0372 0.0 0
M  V30 13 C 2.3100 6.3710 0.0 0
M  V30 14 C 0.0000 5.0372 0.0 0
M  V30 15 C 0.7700 6.3710 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 2 5 10
M  V30 10 2 6 11
M  V30 11 1 7 12
M  V30 12 2 7 13
M  V30 13 1 8 14
M  V30 14 2 9 12
M  V30 15 1 10 11
M  V30 16 1 13 15
M  V30 17 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 191349-69-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 452311-39-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38133990
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and evaluation of imidazo[1,2-a]quinoxaline derivatives as
potential antifungal agents against phytopathogenic fungi
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ma, Taigui; Zhong, Xu; Yang, Ya; Liu, Wenjing; Guo, Bing; Fan, Judi;
Tang, Lei; Fan, Lingling; Li, Yong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molecular Diversity (2024), 28(5), 3153-3163

$RFMT $RIREG SCHEME121 STEP1
$RXN



  3  1
$MOL
1,1′-Carbonyldiimidazole
C7H6N4O
530-62-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 O 3.7711 0.0000 0.0 0
M  V30 3 N 2.4374 2.3100 0.0 0
M  V30 4 C 2.2763 3.8416 0.0 0
M  V30 5 C 1.0304 1.6836 0.0 0
M  V30 6 C 0.7700 4.1618 0.0 0
M  V30 7 N 0.0000 2.8281 0.0 0
M  V30 8 N 5.1047 2.3100 0.0 0
M  V30 9 C 5.2658 3.8416 0.0 0
M  V30 10 C 6.5117 1.6836 0.0 0
M  V30 11 C 6.7721 4.1618 0.0 0
M  V30 12 N 7.5421 2.8281 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 2 4 6
M  V30 7 2 5 7
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Fluoro-4-iodoaniline
C6H5FIN
29632-74-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 1.5400 0.0000 0.0 0
M  V30 2 N 0.0000 2.6673 0.0 0
M  V30 3 I 6.1601 2.6673 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 1.5400 2.6673 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 2.3101 4.0010 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 3.8501 4.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 5
M  V30 3 1 3 8
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(2-Fluoro-4-iodophenyl)-N′-methylurea
C8H8FIN2O
871700-37-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3347 1.5400 0.0 0
M  V30 2 C 6.6684 2.3100 0.0 0
M  V30 3 N 8.0021 1.5400 0.0 0
M  V30 4 O 6.6684 3.8500 0.0 0
M  V30 5 C 9.3358 2.3100 0.0 0
M  V30 6 F 2.6674 0.0000 0.0 0
M  V30 7 I 0.0000 4.6200 0.0 0
M  V30 8 C 4.0011 2.3100 0.0 0
M  V30 9 C 2.6674 1.5400 0.0 0
M  V30 10 C 4.0011 3.8500 0.0 0
M  V30 11 C 1.3336 2.3100 0.0 0
M  V30 12 C 2.6674 4.6200 0.0 0
M  V30 13 C 1.3336 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 9
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 29632-74-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 871700-37-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-5956972
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step B: 1-(2-fluoro-4-iodophenyl)-3-methylurea To N,N-carbonyldiimidazole
(30 g) in 150 ml N,N-dimethylformamide was added triethylamine (26 ml),
followed by the dropwise addition of 2-fluoro-4-iodoaniline (38 g) in 30
ml N,N-dimethylformamide at 0°C. After complete addition, the mixture was
stirred at rt for 5 h, followed by the addition of 30 ml 30% methylamine
in methanol dropwise at 0°C. After stirring at rt overnight, the white
precipitate was diluted with water-toluene, then filtered and dried to
give the desired product as a white solid (92%).
1-(2-fluoro-4-iodophenyl)-3-methylurea, yield (92%). 1H NMR (400 MHz,
DMSO-D6) δ 8.39 (s, 1H), 7.90- 7.94 (t, J= 8.6 Hz, 1H), 7.52-7.55 (dd, J=
1.8 & 10.6 Hz, 1H), 7.38-7.40 (d, J= 10.4 Hz, 1H), 6.46-6.48 (d, J= 4.8
Hz, 1H), 2.62 (s, 3H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of N-arylamino(oxo)pyridinyl sulfonamides and
N-arylamino(oxo)pyrazinyl sulfonamides as MEK inhibitors and useful in
the treatment of inflammatory diseases, cancer and other
hyperproliferative diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xiao, Dengming; Zhu, Li; Wang, Shixin; Liang, Zhi; Hu, Wei
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010145197 A1 2010-12-23

$RFMT $RIREG SCHEME122 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (2R,3S)-3-phenyl-2-oxiranecarboperoxoate
C13H16O4
370084-23-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.8749 2.3101 0.0 0
M  V30 2 O 8.2085 3.0801 0.0 0
M  V30 3 O 6.8749 0.7700 0.0 0
M  V30 4 O 9.5424 2.3101 0.0 0
M  V30 5 C 10.8760 3.0801 0.0 0
M  V30 6 C 11.6460 1.7464 0.0 0
M  V30 7 C 12.2097 3.8501 0.0 0
M  V30 8 C 10.1060 4.4137 0.0 0
M  V30 9 C 4.0012 3.0801 0.0 0 CFG=2
M  V30 10 C 5.5412 3.0801 0.0 0 CFG=2
M  V30 11 O 4.7712 4.4137 0.0 0
M  V30 12 C 2.6673 2.3101 0.0 0
M  V30 13 C 2.6673 0.7700 0.0 0
M  V30 14 C 1.3337 3.0801 0.0 0
M  V30 15 C 1.3337 0.0000 0.0 0
M  V30 16 C 0.0000 2.3101 0.0 0
M  V30 17 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 10 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12 CFG=3
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 9 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(2R,3S)-N-Methyl-3-phenyl-2-oxiranecarboxamide
C10H11NO2
486413-41-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.8748 2.1037 0.0 0
M  V30 2 N 8.2086 1.3337 0.0 0
M  V30 3 O 6.8748 3.6437 0.0 0
M  V30 4 C 9.5423 2.1037 0.0 0
M  V30 5 C 4.0011 1.3337 0.0 0 CFG=2
M  V30 6 C 5.5411 1.3337 0.0 0 CFG=2
M  V30 7 O 4.7711 0.0000 0.0 0
M  V30 8 C 2.6675 2.1037 0.0 0
M  V30 9 C 1.3337 1.3337 0.0 0
M  V30 10 C 2.6675 3.6437 0.0 0
M  V30 11 C 0.0000 2.1037 0.0 0
M  V30 12 C 1.3337 4.4137 0.0 0
M  V30 13 C 0.0000 3.6437 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 6 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8 CFG=1
M  V30 8 1 6 7
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 5 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 370084-23-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 486413-41-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28179983
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Catalytic asymmetric epoxidation of α,β-unsaturated carboxylic acid
imidazolides and amides by lanthanide-BINOL complexes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ohshima, Takashi; Nemoto, Tetsuhiro; Tosaki, Shin-ya; Kakei, Hiroyuki;
Gnanadesikan, Vijay; Shibasaki, Masakatsu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2003), 59(52), 10485-10497

$RFMT $RIREG SCHEME123 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Dimethylamino)benzaldehyde
C9H11NO
100-10-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0
M  V30 2 C 0.0000 2.3101 0.0 0
M  V30 3 C 1.3337 0.0000 0.0 0
M  V30 4 C 6.6687 4.6201 0.0 0
M  V30 5 O 8.0023 3.8501 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 1.5400 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 6
M  V30 4 2 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Isatoic anhydride
C8H5NO3
118-48-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3100 0.0000 0.0 0
M  V30 2 O 6.9300 2.6674 0.0 0
M  V30 3 C 2.3100 2.6674 0.0 0
M  V30 4 C 3.0800 4.0011 0.0 0
M  V30 5 C 3.0800 1.3338 0.0 0
M  V30 6 C 0.7700 2.6674 0.0 0
M  V30 7 N 4.6200 4.0011 0.0 0
M  V30 8 C 2.3100 5.3349 0.0 0
M  V30 9 O 4.6200 1.3338 0.0 0
M  V30 10 C 0.0000 4.0011 0.0 0
M  V30 11 C 5.3900 2.6674 0.0 0
M  V30 12 C 0.7700 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 2 2 11
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[4-(Dimethylamino)phenyl]-2,3-dihydro-3-methyl-4(1H)-quinazolinone
C17H19N3O
81144-95-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 0.0000 0.0 0
M  V30 2 O 2.3100 0.0000 0.0 0
M  V30 3 N 11.5500 2.6674 0.0 0
M  V30 4 C 12.3200 1.3338 0.0 0
M  V30 5 C 12.3200 4.0011 0.0 0
M  V30 6 C 5.3900 2.6674 0.0 0
M  V30 7 N 4.6200 4.0011 0.0 0
M  V30 8 N 4.6200 1.3338 0.0 0
M  V30 9 C 3.0800 4.0011 0.0 0
M  V30 10 C 3.0800 1.3338 0.0 0
M  V30 11 C 2.3100 2.6674 0.0 0
M  V30 12 C 2.3100 5.3349 0.0 0
M  V30 13 C 0.7700 2.6674 0.0 0
M  V30 14 C 0.7700 5.3349 0.0 0
M  V30 15 C 0.0000 4.0011 0.0 0
M  V30 16 C 6.9300 2.6674 0.0 0
M  V30 17 C 7.7000 4.0011 0.0 0
M  V30 18 C 7.7000 1.3338 0.0 0
M  V30 19 C 9.2400 4.0011 0.0 0
M  V30 20 C 9.2400 1.3338 0.0 0
M  V30 21 C 10.0100 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 2 2 10
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 21
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 16
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 1 10 11
M  V30 14 2 11 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 100-10-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 118-48-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 81144-95-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-21404217
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 13463-67-7
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-catalyst, no solvent, optimization study (based on
catalyst loading and solvents)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Catalytic activity of TiO2 nanoparticles in the synthesis of some
2,3-disubstituted dihydroquinazolin-4(1H)-ones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bharathi, A.; Roopan, Selvaraj Mohana; Kajbafvala, Amir; Padmaja, R. D.;
Darsana, M. S.; Nandhini Kumari, G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chinese Chemical Letters (2014), 25(2), 324-326

$RFMT $RIREG SCHEME124 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Dimethylamino)benzaldehyde
C9H11NO
100-10-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0
M  V30 2 C 0.0000 2.3101 0.0 0
M  V30 3 C 1.3337 0.0000 0.0 0
M  V30 4 C 6.6687 4.6201 0.0 0
M  V30 5 O 8.0023 3.8501 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 1.5400 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 6
M  V30 4 2 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzil
C14H10O2
134-81-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 C 5.3901 1.3337 0.0 0
M  V30 3 O 5.3901 4.0010 0.0 0
M  V30 4 O 4.6201 0.0000 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 2.3101 4.0010 0.0 0
M  V30 7 C 2.3101 1.3337 0.0 0
M  V30 8 C 0.7700 4.0010 0.0 0
M  V30 9 C 0.7700 1.3337 0.0 0
M  V30 10 C 0.0000 2.6673 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 12 C 7.7002 2.6673 0.0 0
M  V30 13 C 7.7002 0.0000 0.0 0
M  V30 14 C 9.2402 2.6673 0.0 0
M  V30 15 C 9.2402 0.0000 0.0 0
M  V30 16 C 10.0102 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 2 2 4
M  V30 5 1 2 11
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,N-Dimethyl-4-(1-methyl-4,5-diphenyl-1H-imidazol-2-yl)benzenamine
C24H23N3
85059-15-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3051 8.2051 0.0 0
M  V30 2 N 12.3670 9.1524 0.0 0
M  V30 3 C 13.7007 8.3824 0.0 0
M  V30 4 C 12.3670 10.6924 0.0 0
M  V30 5 C 4.5948 5.5543 0.0 0
M  V30 6 C 5.3648 4.2206 0.0 0
M  V30 7 N 5.6252 6.6988 0.0 0
M  V30 8 N 6.8711 4.5408 0.0 0
M  V30 9 C 7.0322 6.0723 0.0 0
M  V30 10 C 3.0633 5.7153 0.0 0
M  V30 11 C 2.1580 4.4693 0.0 0
M  V30 12 C 2.4368 7.1221 0.0 0
M  V30 13 C 0.6265 4.6304 0.0 0
M  V30 14 C 0.9052 7.2831 0.0 0
M  V30 15 C 0.0000 6.0372 0.0 0
M  V30 16 C 4.7383 2.8138 0.0 0
M  V30 17 C 5.6436 1.5677 0.0 0
M  V30 18 C 3.2068 2.6527 0.0 0
M  V30 19 C 5.0172 0.1609 0.0 0
M  V30 20 C 2.5805 1.2459 0.0 0
M  V30 21 C 3.4857 0.0000 0.0 0
M  V30 22 C 8.3659 6.8423 0.0 0
M  V30 23 C 8.3659 8.3824 0.0 0
M  V30 24 C 9.6995 6.0723 0.0 0
M  V30 25 C 9.6995 9.1524 0.0 0
M  V30 26 C 11.0332 6.8423 0.0 0
M  V30 27 C 11.0332 8.3824 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 27
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 10
M  V30 8 1 6 8
M  V30 9 1 6 16
M  V30 10 1 7 9
M  V30 11 2 8 9
M  V30 12 1 9 22
M  V30 13 2 10 11
M  V30 14 1 10 12
M  V30 15 1 11 13
M  V30 16 2 12 14
M  V30 17 2 13 15
M  V30 18 1 14 15
M  V30 19 2 16 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 2 18 20
M  V30 23 2 19 21
M  V30 24 1 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 100-10-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 134-81-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 85059-15-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-36064
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 631-61-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7558-80-7
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General Procedure for the Synthesis of Triarylimidazoles. A mixture of
the benzil of choice (5 mmol), methylamine (5 mmol; or another amine of
interest), aldehyde (5 mmol), ammonium acetate (5 mmol) and NaH2PO4 (1.5
mmol) was added to a thick-walled test tube with a screw-on Teflon top.
The reaction mixture was heated to 150 °C and maintained at the
temperature for 2−5 h; the reaction mixture was stirred throughout. Then
the reaction mixture was cooled to room temperature. Acetone was added to
dissolve the mixture and the undissolved residue was removed by
filtration. After evaporation of the solvent under reduced pressure, the
resulting solid residue was recrystallized from acetone−water to obtain
pure products 3.
N,N-Dimethyl-4-(1-methyl-4,5-diphenyl-1H-imidazol-2-yl)-aniline (3aa):16
325.2 mg, 92% yield; brown powder. mp: 227−229 °C; 1H NMR (400 MHz,
CDCl3): δ 3.02 (s, 6H), 3.49 (s, 3H), 6.80 (d, J = 8.8 Hz, 2H), 7.11−7.15
(m, 1H), 7.19−7.22 (m, 2H), 7.40− 7.48 (m, 5H), 7.56 (d, J = 7.2 Hz, 2H),
7.63 (d, J = 8.8 Hz, 2H).
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Triarylimidazole Redox Catalysts: Electrochemical Analysis and Empirical
Correlations
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Ni-tao; Zeng, Cheng-chu; Lam, Chiu Marco; Gbur, Randi K.; Little,
R. Daniel
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2013), 78(5), 2104-2110

$RFMT $RIREG SCHEME125 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Diethyl P-(6-bromohexyl)phosphonate
C10H22BrO3P
100462-72-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 3.8500 3.8500 0.0 0 VAL=5
M  V30 2 C 5.3900 3.8500 0.0 0
M  V30 3 O 2.3100 3.8500 0.0 0
M  V30 4 O 3.8500 2.3100 0.0 0
M  V30 5 O 3.8500 5.3900 0.0 0
M  V30 6 C 6.1600 5.1836 0.0 0
M  V30 7 C 1.5400 5.1836 0.0 0
M  V30 8 C 2.5164 1.5400 0.0 0
M  V30 9 C 7.7000 5.1836 0.0 0
M  V30 10 C 0.0000 5.1836 0.0 0
M  V30 11 C 2.5164 0.0000 0.0 0
M  V30 12 C 8.4700 6.5173 0.0 0
M  V30 13 C 10.0100 6.5173 0.0 0
M  V30 14 C 10.7800 7.8509 0.0 0
M  V30 15 Br 12.3200 7.8509 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 1 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 1 12 13
M  V30 13 1 13 14
M  V30 14 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Diethyl P-[6-(methylamino)hexyl]phosphonate
C11H26NO3P
1101178-24-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 3.0801 3.0801 0.0 0 VAL=5
M  V30 2 C 4.4137 3.8501 0.0 0
M  V30 3 O 1.7464 2.3101 0.0 0
M  V30 4 O 2.3101 4.4137 0.0 0
M  V30 5 O 3.8501 1.7462 0.0 0
M  V30 6 C 5.7474 3.0801 0.0 0
M  V30 7 C 1.7464 0.7700 0.0 0
M  V30 8 C 0.7700 4.4137 0.0 0
M  V30 9 C 7.0812 3.8501 0.0 0
M  V30 10 C 0.4126 0.0000 0.0 0
M  V30 11 C 0.0000 5.7474 0.0 0
M  V30 12 C 8.4149 3.0801 0.0 0
M  V30 13 C 9.7486 3.8501 0.0 0
M  V30 14 C 11.0824 3.0801 0.0 0
M  V30 15 N 12.4161 3.8501 0.0 0
M  V30 16 C 13.7497 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 1 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 1 12 13
M  V30 13 1 13 14
M  V30 14 1 14 15
M  V30 15 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 100462-72-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1101178-24-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-8307114
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, photopolymerization and adhesive properties of new
hydrolytically stable phosphonic acids for dental applications
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Catel, Yohann; Degrange, Michel; Le Pluart, Loic; Madec, Pierre-Jean;
Pham, Thi-Nhan; Picton, Luc
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Polymer Science, Part A: Polymer Chemistry (2008), 46(21),
7074-7090

$RFMT $RIREG SCHEME126 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Chloro-1H-indole-3-carboxaldehyde
C9H6ClNO
1008-07-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6520 3.0203 0.0 0
M  V30 2 O 7.6826 4.1647 0.0 0
M  V30 3 Cl 0.0000 3.0801 0.0 0
M  V30 4 C 4.0012 2.3101 0.0 0
M  V30 5 C 2.6675 3.0801 0.0 0
M  V30 6 C 5.1457 3.3405 0.0 0
M  V30 7 C 4.0012 0.7700 0.0 0
M  V30 8 C 1.3338 2.3101 0.0 0
M  V30 9 N 2.9877 4.5864 0.0 0
M  V30 10 C 4.5192 4.7473 0.0 0
M  V30 11 C 2.6675 0.0000 0.0 0
M  V30 12 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 1 3 8
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 10
M  V30 13 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Chloro-N-methyl-1H-indole-3-methanamine
C10H11ClN2
620175-91-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6519 3.0203 0.0 0
M  V30 2 N 7.6825 4.1647 0.0 0
M  V30 3 C 9.1888 3.8445 0.0 0
M  V30 4 Cl 0.0000 3.0801 0.0 0
M  V30 5 C 4.0012 2.3101 0.0 0
M  V30 6 C 2.6673 3.0801 0.0 0
M  V30 7 C 5.1456 3.3405 0.0 0
M  V30 8 C 4.0012 0.7700 0.0 0
M  V30 9 C 1.3337 2.3101 0.0 0
M  V30 10 N 2.9875 4.5864 0.0 0
M  V30 11 C 4.5192 4.7473 0.0 0
M  V30 12 C 2.6673 0.0000 0.0 0
M  V30 13 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 4 9
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 2 6 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 11
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1008-07-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 620175-91-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-225289
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-66-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: c)
1,3-Dimethyl-2-(methylaminomethyl)-1H-indole b)
7-Chloro-3-(methylaminomethyl)-1H-indole [0778] According to the
procedure of Preparation 13 (c), except substituting
7-chloro-1H-indole-3-carboxaldehyde for the
1,3-dimethyl-1H-indole-2-carboxaldehyde, the title compound (440 mg, 92%)
was obtained as an off white solid. MS (ES) m/e 195.2 (M+H)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20060142265 A1 2006-06-29

$RFMT $RIREG SCHEME126 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Chloro-1H-indole-3-carboxaldehyde
C9H6ClNO
1008-07-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6520 3.0203 0.0 0
M  V30 2 O 7.6826 4.1647 0.0 0
M  V30 3 Cl 0.0000 3.0801 0.0 0
M  V30 4 C 4.0012 2.3101 0.0 0
M  V30 5 C 2.6675 3.0801 0.0 0
M  V30 6 C 5.1457 3.3405 0.0 0
M  V30 7 C 4.0012 0.7700 0.0 0
M  V30 8 C 1.3338 2.3101 0.0 0
M  V30 9 N 2.9877 4.5864 0.0 0
M  V30 10 C 4.5192 4.7473 0.0 0
M  V30 11 C 2.6675 0.0000 0.0 0
M  V30 12 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 1 3 8
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 10
M  V30 13 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Chloro-N-methyl-1H-indole-3-methanamine
C10H11ClN2
620175-91-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6519 3.0203 0.0 0
M  V30 2 N 7.6825 4.1647 0.0 0
M  V30 3 C 9.1888 3.8445 0.0 0
M  V30 4 Cl 0.0000 3.0801 0.0 0
M  V30 5 C 4.0012 2.3101 0.0 0
M  V30 6 C 2.6673 3.0801 0.0 0
M  V30 7 C 5.1456 3.3405 0.0 0
M  V30 8 C 4.0012 0.7700 0.0 0
M  V30 9 C 1.3337 2.3101 0.0 0
M  V30 10 N 2.9875 4.5864 0.0 0
M  V30 11 C 4.5192 4.7473 0.0 0
M  V30 12 C 2.6673 0.0000 0.0 0
M  V30 13 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 4 9
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 2 6 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 11
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1008-07-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 620175-91-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-8900075
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-66-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004082586 A2 2004-09-30

$RFMT $RIREG SCHEME126 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Chloro-1H-indole-3-carboxaldehyde
C9H6ClNO
1008-07-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6520 3.0203 0.0 0
M  V30 2 O 7.6826 4.1647 0.0 0
M  V30 3 Cl 0.0000 3.0801 0.0 0
M  V30 4 C 4.0012 2.3101 0.0 0
M  V30 5 C 2.6675 3.0801 0.0 0
M  V30 6 C 5.1457 3.3405 0.0 0
M  V30 7 C 4.0012 0.7700 0.0 0
M  V30 8 C 1.3338 2.3101 0.0 0
M  V30 9 N 2.9877 4.5864 0.0 0
M  V30 10 C 4.5192 4.7473 0.0 0
M  V30 11 C 2.6675 0.0000 0.0 0
M  V30 12 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 1 3 8
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 10
M  V30 13 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Chloro-N-methyl-1H-indole-3-methanamine
C10H11ClN2
620175-91-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6519 3.0203 0.0 0
M  V30 2 N 7.6825 4.1647 0.0 0
M  V30 3 C 9.1888 3.8445 0.0 0
M  V30 4 Cl 0.0000 3.0801 0.0 0
M  V30 5 C 4.0012 2.3101 0.0 0
M  V30 6 C 2.6673 3.0801 0.0 0
M  V30 7 C 5.1456 3.3405 0.0 0
M  V30 8 C 4.0012 0.7700 0.0 0
M  V30 9 C 1.3337 2.3101 0.0 0
M  V30 10 N 2.9875 4.5864 0.0 0
M  V30 11 C 4.5192 4.7473 0.0 0
M  V30 12 C 2.6673 0.0000 0.0 0
M  V30 13 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 4 9
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 2 6 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 11
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1008-07-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 620175-91-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-9253798
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25895-60-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of N-(heteroaryl)methylacrylamides as Fab I inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Burgess, Walter J.; Jakas, Dalia; Huffman, William F.; Miller, William
H.; Newlander, Kenneth A.; Seefeld, Mark A.; Uzinskas, Irene N.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2003088897 A2 2003-10-30

$RFMT $RIREG SCHEME127 STEP1
$RXN



  3  1
$MOL
Thiocarbonyldiimidazole
C7H6N4S
6160-65-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 S 3.7711 0.0000 0.0 0
M  V30 3 N 2.4374 2.3100 0.0 0
M  V30 4 C 2.2763 3.8416 0.0 0
M  V30 5 C 1.0304 1.6836 0.0 0
M  V30 6 C 0.7700 4.1618 0.0 0
M  V30 7 N 0.0000 2.8281 0.0 0
M  V30 8 N 5.1047 2.3100 0.0 0
M  V30 9 C 5.2658 3.8416 0.0 0
M  V30 10 C 6.5117 1.6836 0.0 0
M  V30 11 C 6.7721 4.1618 0.0 0
M  V30 12 N 7.5421 2.8281 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 2 4 6
M  V30 7 2 5 7
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N-cyclopentyl-2′-C-methyl-2′,3′-O-(1-methylethylidene)adenosine
C19H26ClN5O4
1010382-31-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 34 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.7138 6.3487 0.0 0
M  V30 2 C 3.8841 1.0304 0.0 0
M  V30 3 O 5.0284 0.0000 0.0 0
M  V30 4 C 1.0306 6.9976 0.0 0
M  V30 5 C 0.0000 5.2128 0.0 0
M  V30 6 N 11.1809 8.0724 0.0 0
M  V30 7 Cl 11.1809 2.7377 0.0 0
M  V30 8 C 5.4501 4.6947 0.0 0 CFG=2
M  V30 9 C 3.9438 5.0149 0.0 0 CFG=1
M  V30 10 O 5.6110 3.1632 0.0 0
M  V30 11 C 3.1738 3.6812 0.0 0 CFG=2
M  V30 12 O 2.9132 6.1594 0.0 0
M  V30 13 C 4.2042 2.5369 0.0 0 CFG=2
M  V30 14 O 1.6674 4.0014 0.0 0
M  V30 15 C 1.5064 5.5329 0.0 0
M  V30 16 N 6.5946 5.7253 0.0 0
M  V30 17 C 8.1009 5.4050 0.0 0
M  V30 18 C 6.4335 7.2568 0.0 0
M  V30 19 C 8.8709 6.7388 0.0 0
M  V30 20 N 8.8709 4.0713 0.0 0
M  V30 21 N 7.8405 7.8831 0.0 0
M  V30 22 C 10.4109 6.7388 0.0 0
M  V30 23 C 10.4109 4.0713 0.0 0
M  V30 24 N 11.1809 5.4050 0.0 0
M  V30 25 C 12.7209 8.0724 0.0 0
M  V30 26 C 13.6261 9.3183 0.0 0
M  V30 27 C 13.6261 6.8265 0.0 0
M  V30 28 C 15.0908 8.8424 0.0 0
M  V30 29 C 15.0908 7.3024 0.0 0
M  V30 30 H 2.4038 2.3476 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 9 1 CFG=3
M  V30 2 1 2 3
M  V30 3 1 13 2 CFG=3
M  V30 4 1 4 15
M  V30 5 1 5 15
M  V30 6 1 6 22
M  V30 7 1 6 25
M  V30 8 1 7 23
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 16 CFG=3
M  V30 12 1 9 11
M  V30 13 1 9 12
M  V30 14 1 10 13
M  V30 15 1 11 13
M  V30 16 1 11 14
M  V30 17 1 11 30 CFG=3
M  V30 18 1 12 15
M  V30 19 1 14 15
M  V30 20 1 16 17
M  V30 21 1 16 18
M  V30 22 1 17 19
M  V30 23 2 17 20
M  V30 24 2 18 21
M  V30 25 1 19 21
M  V30 26 2 19 22
M  V30 27 1 20 23
M  V30 28 1 22 24
M  V30 29 2 23 24
M  V30 30 1 25 26
M  V30 31 1 25 27
M  V30 32 1 26 28
M  V30 33 1 27 29
M  V30 34 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 8 9 11 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Adenosine, 2-chloro-N-cyclopentyl-2′-C-methyl-2′,3′-O-(1-methylethylidene)-, ...
C21H29ClN6O4S
1010382-37-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 38 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.4388 9.4091 0.0 0
M  V30 2 C 2.0610 5.2182 0.0 0
M  V30 3 O 2.5369 3.7537 0.0 0
M  V30 4 C 1.5065 2.6091 0.0 0
M  V30 5 N 1.9823 1.1445 0.0 0
M  V30 6 S 0.0000 2.9294 0.0 0
M  V30 7 C 0.9519 0.0000 0.0 0
M  V30 8 C 2.5734 11.8129 0.0 0
M  V30 9 C 0.7886 10.7824 0.0 0
M  V30 10 N 11.9015 7.6684 0.0 0
M  V30 11 Cl 9.2340 3.0483 0.0 0
M  V30 12 C 5.2495 7.6087 0.0 0 CFG=2
M  V30 13 C 4.1049 8.6391 0.0 0 CFG=1
M  V30 14 O 4.6232 6.2018 0.0 0
M  V30 15 C 2.7713 7.8691 0.0 0 CFG=2
M  V30 16 O 3.7848 10.1455 0.0 0
M  V30 17 C 3.0915 6.3628 0.0 0 CFG=2
M  V30 18 O 1.6269 8.8997 0.0 0
M  V30 19 C 2.2532 10.3065 0.0 0
M  V30 20 N 6.7558 7.9288 0.0 0
M  V30 21 C 7.9003 6.8984 0.0 0
M  V30 22 C 7.3823 9.3358 0.0 0
M  V30 23 C 9.2340 7.6684 0.0 0
M  V30 24 N 7.9003 5.3584 0.0 0
M  V30 25 N 8.9138 9.1747 0.0 0
M  V30 26 C 10.5677 6.8984 0.0 0
M  V30 27 C 9.2340 4.5884 0.0 0
M  V30 28 N 10.5677 5.3584 0.0 0
M  V30 29 C 13.2352 6.8984 0.0 0
M  V30 30 C 14.6420 7.5247 0.0 0
M  V30 31 C 13.3961 5.3668 0.0 0
M  V30 32 C 15.6726 6.3803 0.0 0
M  V30 33 C 14.9025 5.0467 0.0 0
M  V30 34 H 1.4376 7.0991 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 13 1 CFG=3
M  V30 2 1 2 3
M  V30 3 1 17 2 CFG=3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 8 19
M  V30 9 1 9 19
M  V30 10 1 10 26
M  V30 11 1 10 29
M  V30 12 1 11 27
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 12 20 CFG=3
M  V30 16 1 13 15
M  V30 17 1 13 16
M  V30 18 1 14 17
M  V30 19 1 15 17
M  V30 20 1 15 18
M  V30 21 1 15 34 CFG=3
M  V30 22 1 16 19
M  V30 23 1 18 19
M  V30 24 1 20 21
M  V30 25 1 20 22
M  V30 26 1 21 23
M  V30 27 2 21 24
M  V30 28 2 22 25
M  V30 29 1 23 25
M  V30 30 2 23 26
M  V30 31 1 24 27
M  V30 32 1 26 28
M  V30 33 2 27 28
M  V30 34 1 29 30
M  V30 35 1 29 31
M  V30 36 1 30 32
M  V30 37 1 31 33
M  V30 38 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 12 13 15 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 6160-65-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1010382-31-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1010382-37-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-358-CAS-986366
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 5'-Carbamoyl derivatives of 2'-C-methyl-purine nucleosides as selective
A1 adenosine receptor agonists: Affinity, efficacy, and selectivity for
A1 receptor from different species
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cappellacci, Loredana; Franchetti, Palmarisa; Vita, Patrizia; Petrelli,
Riccardo; Lavecchia, Antonio; Costa, Barbara; Spinetti, Francesca;
Martini, Claudia; Klotz, Karl-Norbert; Grifantini, Mario
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2008), 16(1), 336-353

$RFMT $RIREG SCHEME128 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Borono-5-nitrobenzoic acid
C7H6BNO6
101084-81-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 B 1.3337 5.3901 0.0 0
M  V30 2 O 0.0000 4.6201 0.0 0
M  V30 3 O 1.3337 6.9302 0.0 0
M  V30 4 C 4.0012 0.7700 0.0 0
M  V30 5 O 5.3348 0.0000 0.0 0
M  V30 6 O 2.6675 0.0000 0.0 0
M  V30 7 N 6.6687 5.3901 0.0 0 VAL=5
M  V30 8 O 6.6687 6.9302 0.0 0
M  V30 9 O 8.0023 4.6201 0.0 0
M  V30 10 C 2.6675 4.6201 0.0 0
M  V30 11 C 2.6675 3.0801 0.0 0
M  V30 12 C 4.0012 5.3901 0.0 0
M  V30 13 C 4.0012 2.3101 0.0 0
M  V30 14 C 5.3348 4.6201 0.0 0
M  V30 15 C 5.3348 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 10
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 13
M  V30 7 2 7 8
M  V30 8 2 7 9
M  V30 9 1 7 14
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Methyl 3-borono-5-nitrobenzoate
C8H8BNO6
117342-20-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 5.3901 0.0 0
M  V30 2 O 8.0023 4.6201 0.0 0
M  V30 3 O 6.6685 6.9302 0.0 0
M  V30 4 C 9.3360 5.3901 0.0 0
M  V30 5 B 1.3337 5.3901 0.0 0
M  V30 6 O 1.3337 6.9302 0.0 0
M  V30 7 O 0.0000 4.6201 0.0 0
M  V30 8 N 4.0012 0.7700 0.0 0 VAL=5
M  V30 9 O 2.6675 0.0000 0.0 0
M  V30 10 O 5.3348 0.0000 0.0 0
M  V30 11 C 5.3348 4.6201 0.0 0
M  V30 12 C 4.0012 5.3901 0.0 0
M  V30 13 C 5.3348 3.0801 0.0 0
M  V30 14 C 2.6675 4.6201 0.0 0
M  V30 15 C 4.0012 2.3101 0.0 0
M  V30 16 C 2.6675 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 14
M  V30 8 2 8 9
M  V30 9 2 8 10
M  V30 10 1 8 15
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 101084-81-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 117342-20-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-27395697
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 32589-78-9
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Mild Esterification of Carboxylic Acids via Continuous Flow Diazotization
of Amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Audubert, Clement; Lebel, Helene
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2017), 19(16), 4407-4410

$RFMT $RIREG SCHEME129 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3aR,4S,6S,6aS)-4-(6-Chloro-9H-purin-9-yl)-3a,5,6,6a-tetrahydro-3-phenyl-...
C18H16ClN5O2
1023322-76-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.1788 9.1158 0.0 0
M  V30 2 O 10.5126 8.3458 0.0 0
M  V30 3 Cl 4.7365 0.0000 0.0 0
M  V30 4 C 5.4078 7.8278 0.0 0 CFG=1
M  V30 5 C 6.1778 6.4941 0.0 0 CFG=2
M  V30 6 C 6.4384 8.9721 0.0 0 CFG=1
M  V30 7 C 4.0010 8.4541 0.0 0
M  V30 8 C 7.6842 6.8143 0.0 0
M  V30 9 C 7.8452 8.3458 0.0 0 CFG=1
M  V30 10 O 5.6684 10.3059 0.0 0
M  V30 11 N 4.1620 9.9856 0.0 0
M  V30 12 N 5.5515 5.0872 0.0 0
M  V30 13 C 6.3215 3.7536 0.0 0
M  V30 14 C 4.0452 4.7670 0.0 0
M  V30 15 C 5.2911 2.6091 0.0 0
M  V30 16 N 7.8279 3.4334 0.0 0
M  V30 17 N 3.8842 3.2355 0.0 0
M  V30 18 C 5.7670 1.1445 0.0 0
M  V30 19 C 8.3038 1.9687 0.0 0
M  V30 20 N 7.2732 0.8244 0.0 0
M  V30 21 C 2.6674 7.6841 0.0 0
M  V30 22 C 2.6674 6.1441 0.0 0
M  V30 23 C 1.3338 8.4541 0.0 0
M  V30 24 C 1.3338 5.3741 0.0 0
M  V30 25 C 0.0000 7.6841 0.0 0
M  V30 26 C 0.0000 6.1441 0.0 0
M  V30 27 H 4.3774 6.6832 0.0 0
M  V30 28 H 7.4688 10.1167 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 9 1 CFG=1
M  V30 3 1 3 18
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 4 27 CFG=3
M  V30 8 1 5 8
M  V30 9 1 5 12 CFG=1
M  V30 10 1 6 9
M  V30 11 1 6 10
M  V30 12 1 6 28 CFG=3
M  V30 13 2 7 11
M  V30 14 1 7 21
M  V30 15 1 8 9
M  V30 16 1 10 11
M  V30 17 1 12 13
M  V30 18 1 12 14
M  V30 19 1 13 15
M  V30 20 2 13 16
M  V30 21 2 14 17
M  V30 22 1 15 17
M  V30 23 2 15 18
M  V30 24 1 16 19
M  V30 25 1 18 20
M  V30 26 2 19 20
M  V30 27 2 21 22
M  V30 28 1 21 23
M  V30 29 1 22 24
M  V30 30 2 23 25
M  V30 31 2 24 26
M  V30 32 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 4 5 6 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-(3aR,4S,6S,6aS)-3a,5,6,6a-Tetrahydro-4-[6-(methylamino)-9H-purin-9-yl]-3-...
C19H20N6O2
1023322-84-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.1901 1.3338 0.0 0
M  V30 2 O 1.9601 0.0000 0.0 0
M  V30 3 N 10.3060 5.7762 0.0 0
M  V30 4 C 11.7707 5.3003 0.0 0
M  V30 5 C 2.4782 5.1049 0.0 0 CFG=1
M  V30 6 C 3.8119 4.3349 0.0 0 CFG=2
M  V30 7 C 1.3337 4.0743 0.0 0 CFG=1
M  V30 8 C 1.8517 6.5117 0.0 0
M  V30 9 C 3.4917 2.8284 0.0 0
M  V30 10 C 1.9601 2.6675 0.0 0 CFG=1
M  V30 11 O 0.0000 4.8443 0.0 0
M  V30 12 N 0.3202 6.3508 0.0 0
M  V30 13 N 5.2188 4.9612 0.0 0
M  V30 14 C 6.5525 4.1912 0.0 0
M  V30 15 C 5.5390 6.4675 0.0 0
M  V30 16 C 7.6969 5.2216 0.0 0
M  V30 17 N 6.8727 2.6847 0.0 0
M  V30 18 N 7.0706 6.6286 0.0 0
M  V30 19 C 9.1616 4.7457 0.0 0
M  V30 20 C 8.3372 2.2089 0.0 0
M  V30 21 N 9.4818 3.2394 0.0 0
M  V30 22 C 2.6217 7.8453 0.0 0
M  V30 23 C 1.8517 9.1790 0.0 0
M  V30 24 C 4.1618 7.8453 0.0 0
M  V30 25 C 2.6217 10.5128 0.0 0
M  V30 26 C 4.9318 9.1790 0.0 0
M  V30 27 C 4.1618 10.5128 0.0 0
M  V30 28 H 3.6226 6.1353 0.0 0
M  V30 29 H 0.1893 3.0439 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 10 1 CFG=3
M  V30 3 1 3 4
M  V30 4 1 3 19
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 28 CFG=1
M  V30 9 1 6 9
M  V30 10 1 6 13 CFG=3
M  V30 11 1 7 10
M  V30 12 1 7 11
M  V30 13 1 7 29 CFG=1
M  V30 14 2 8 12
M  V30 15 1 8 22
M  V30 16 1 9 10
M  V30 17 1 11 12
M  V30 18 1 13 14
M  V30 19 1 13 15
M  V30 20 1 14 16
M  V30 21 2 14 17
M  V30 22 2 15 18
M  V30 23 1 16 18
M  V30 24 2 16 19
M  V30 25 1 17 20
M  V30 26 1 19 21
M  V30 27 2 20 21
M  V30 28 2 22 23
M  V30 29 1 22 24
M  V30 30 1 23 25
M  V30 31 2 24 26
M  V30 32 2 25 27
M  V30 33 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 5 6 7 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1023322-76-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1023322-84-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-6312358
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM From cyclopentadiene to isoxazoline-carbocyclic nucleosides: a rapid
access to biological molecules through aza-Diels-Alder reactions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Quadrelli, Paolo; Piccanello, Andrea; Mella, Mariella; Corsaro, Antonino;
Pistara, Venerando
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2008), 64(16), 3541-3547

$RFMT $RIREG SCHEME130 STEP1
$RXN



  2  1
$MOL
(βS)-β-[[(1,1-Dimethylethoxy)carbonyl]amino]benzenepropanoic acid
C14H19NO4
103365-47-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.0011 0.0 0 CFG=2
M  V30 2 N 5.3900 5.3347 0.0 0
M  V30 3 C 5.3900 2.6674 0.0 0
M  V30 4 C 6.9300 5.3347 0.0 0
M  V30 5 C 4.6200 1.3338 0.0 0
M  V30 6 O 7.7000 6.6685 0.0 0
M  V30 7 O 7.7000 4.0011 0.0 0
M  V30 8 O 5.3900 0.0000 0.0 0
M  V30 9 O 3.0800 1.3338 0.0 0
M  V30 10 C 9.2400 6.6685 0.0 0
M  V30 11 C 9.2400 5.1285 0.0 0
M  V30 12 C 10.7800 6.6685 0.0 0
M  V30 13 C 9.2400 8.2085 0.0 0
M  V30 14 C 3.0800 4.0011 0.0 0
M  V30 15 C 2.3100 2.6674 0.0 0
M  V30 16 C 2.3100 5.3347 0.0 0
M  V30 17 C 0.7700 2.6674 0.0 0
M  V30 18 C 0.7700 5.3347 0.0 0
M  V30 19 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C15H22N2O3
2734274-03-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 5.3347 0.0 0 CFG=2
M  V30 2 N 5.3900 6.6685 0.0 0
M  V30 3 C 5.3900 4.0011 0.0 0
M  V30 4 C 6.9300 6.6685 0.0 0
M  V30 5 C 4.6200 2.6674 0.0 0
M  V30 6 O 7.7000 8.0021 0.0 0
M  V30 7 O 7.7000 5.3347 0.0 0
M  V30 8 N 5.3900 1.3336 0.0 0
M  V30 9 O 3.0800 2.6674 0.0 0
M  V30 10 C 9.2400 8.0021 0.0 0
M  V30 11 C 4.6200 0.0000 0.0 0
M  V30 12 C 9.2400 6.4621 0.0 0
M  V30 13 C 10.7800 8.0021 0.0 0
M  V30 14 C 9.2400 9.5421 0.0 0
M  V30 15 C 3.0800 5.3347 0.0 0
M  V30 16 C 2.3100 4.0011 0.0 0
M  V30 17 C 2.3100 6.6685 0.0 0
M  V30 18 C 0.7700 4.0011 0.0 0
M  V30 19 C 0.7700 6.6685 0.0 0
M  V30 20 C 0.0000 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 1 8 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 10 14
M  V30 15 2 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 2 17 19
M  V30 19 2 18 20
M  V30 20 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 103365-47-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2734274-03-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38476171
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of Nanomolar DCAF1 Small Molecule Ligands
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Alice Shi Ming; Kimani, Serah; Wilson, Brian; Noureldin, Mahmoud;
Gonzalez-Alvarez, Hector; Mamai, Ahmed; Hoffer, Laurent; Guilinger, John
P.; Zhang, Ying; von Rechenberg, Moritz; Disch, Jeremy S.; Mulhern,
Christopher J.; Slakman, Belinda L.; Cuozzo, John W.; Dong, Aiping; Poda,
Gennady; Mohammed, Mohammed; Saraon, Punit; Mittal, Manish; Modh, Pratik;
Rathod, Vaibhavi; Patel, Bhashant; Ackloo, Suzanne; Santhakumar,
Vijayaratnam; Szewczyk, Magdalena M.; Barsyte-Lovejoy, Dalia; Arrowsmith,
Cheryl H.; Marcellus, Richard; Guie, Marie-Aude; Keefe, Anthony D.;
Brown, Peter J.; Halabelian, Levon; Al-awar, Rima; Vedadi, Masoud
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(7), 5041-5060

$RFMT $RIREG SCHEME131 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[6,11-Dihydro-2-(trifluoromethyl)-6-[[4-(trifluoromethoxy)phenyl]sulfonyl]-...
C25H19F6N3O5S
1034048-19-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 44 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 8.5800 6.1654 0.0 0 VAL=6
M  V30 2 O 8.1814 7.6531 0.0 0
M  V30 3 O 8.9786 4.6779 0.0 0
M  V30 4 C 7.8750 1.2160 0.0 0
M  V30 5 O 6.3495 1.0055 0.0 0
M  V30 6 O 8.8201 0.0000 0.0 0
M  V30 7 C 1.3141 10.2566 0.0 0
M  V30 8 F 2.1170 11.5707 0.0 0
M  V30 9 F 0.0000 11.0596 0.0 0
M  V30 10 F 0.5111 8.9425 0.0 0
M  V30 11 O 13.9147 9.2454 0.0 0
M  V30 12 C 15.2485 8.4754 0.0 0
M  V30 13 F 16.5822 9.2454 0.0 0
M  V30 14 F 16.5822 7.7054 0.0 0
M  V30 15 F 15.2485 6.9354 0.0 0
M  V30 16 C 6.1936 4.5165 0.0 0
M  V30 17 C 7.0291 3.2228 0.0 0
M  V30 18 N 7.0925 5.7669 0.0 0
M  V30 19 C 4.6554 4.4397 0.0 0
M  V30 20 C 6.3265 1.8525 0.0 0
M  V30 21 C 6.6755 7.2493 0.0 0
M  V30 22 N 3.6364 5.5944 0.0 0
M  V30 23 C 3.9529 3.0694 0.0 0
M  V30 24 C 4.7883 1.7756 0.0 0
M  V30 25 C 5.2564 7.8476 0.0 0
M  V30 26 C 3.9039 7.1110 0.0 0
M  V30 27 C 5.2947 9.3871 0.0 0
M  V30 28 N 2.5898 7.9139 0.0 0
M  V30 29 C 3.9806 10.1901 0.0 0
M  V30 30 C 2.6282 9.4535 0.0 0
M  V30 31 C 8.4554 2.6423 0.0 0
M  V30 32 C 9.0360 4.0689 0.0 0
M  V30 33 C 9.8819 2.0619 0.0 0
M  V30 34 C 10.4624 3.4884 0.0 0
M  V30 35 C 9.9138 6.9354 0.0 0
M  V30 36 C 9.9138 8.4754 0.0 0
M  V30 37 C 11.2474 6.1654 0.0 0
M  V30 38 C 11.2474 9.2454 0.0 0
M  V30 39 C 12.5811 6.9354 0.0 0
M  V30 40 C 12.5811 8.4754 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 1 35
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 31
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 7 30
M  V30 12 1 11 12
M  V30 13 1 11 40
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 1 12 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 16 19
M  V30 20 1 17 20
M  V30 21 1 17 31
M  V30 22 1 18 21
M  V30 23 1 19 22
M  V30 24 2 19 23
M  V30 25 2 20 24
M  V30 26 1 21 25
M  V30 27 1 22 26
M  V30 28 1 23 24
M  V30 29 1 25 26
M  V30 30 2 25 27
M  V30 31 2 26 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 2 29 30
M  V30 35 1 31 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 1 33 34
M  V30 39 2 35 36
M  V30 40 1 35 37
M  V30 41 1 36 38
M  V30 42 2 37 39
M  V30 43 2 38 40
M  V30 44 1 39 40
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(6R)-6,11-Dihydro-6-[[4-(trifluoromethoxy)phenyl]sulfonyl]-2-(trifluoromet...
C26H22F6N4O4S
1034158-58-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 45 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 8.5800 7.5920 0.0 0 VAL=6
M  V30 2 O 8.9788 6.1043 0.0 0
M  V30 3 O 8.1815 9.0795 0.0 0
M  V30 4 C 7.8750 2.6424 0.0 0
M  V30 5 N 8.8201 1.4265 0.0 0
M  V30 6 O 6.3495 2.4318 0.0 0
M  V30 7 C 8.2397 0.0000 0.0 0
M  V30 8 C 1.3141 11.6830 0.0 0
M  V30 9 F 2.1172 12.9971 0.0 0
M  V30 10 F 0.0000 12.4861 0.0 0
M  V30 11 F 0.5111 10.3689 0.0 0
M  V30 12 O 13.9148 10.6720 0.0 0
M  V30 13 C 13.9148 12.2120 0.0 0
M  V30 14 F 15.2486 12.9820 0.0 0
M  V30 15 F 13.9148 13.7520 0.0 0
M  V30 16 F 12.5812 12.9820 0.0 0
M  V30 17 C 6.1936 5.9429 0.0 0
M  V30 18 C 7.0291 4.6493 0.0 0
M  V30 19 N 7.0925 7.1933 0.0 0
M  V30 20 C 4.6555 5.8662 0.0 0
M  V30 21 C 6.3265 3.2788 0.0 0
M  V30 22 C 6.6755 8.6758 0.0 0
M  V30 23 N 3.6364 7.0208 0.0 0
M  V30 24 C 3.9529 4.4958 0.0 0
M  V30 25 C 4.7884 3.2022 0.0 0
M  V30 26 C 5.2564 9.2740 0.0 0
M  V30 27 C 3.9039 8.5375 0.0 0
M  V30 28 C 5.2947 10.8135 0.0 0
M  V30 29 N 2.5898 9.3405 0.0 0
M  V30 30 C 3.9806 11.6165 0.0 0
M  V30 31 C 2.6282 10.8801 0.0 0
M  V30 32 C 8.4556 4.0689 0.0 0
M  V30 33 C 9.0360 5.4952 0.0 0
M  V30 34 C 9.8820 3.4884 0.0 0
M  V30 35 C 10.4624 4.9148 0.0 0
M  V30 36 C 9.9139 8.3620 0.0 0
M  V30 37 C 9.9139 9.9020 0.0 0
M  V30 38 C 11.2475 7.5920 0.0 0
M  V30 39 C 11.2475 10.6720 0.0 0
M  V30 40 C 12.5812 8.3620 0.0 0
M  V30 41 C 12.5812 9.9020 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 1 36
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 32
M  V30 8 1 5 7
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 8 31
M  V30 13 1 12 13
M  V30 14 1 12 41
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 13 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 17 20
M  V30 21 1 18 21
M  V30 22 1 18 32
M  V30 23 1 19 22
M  V30 24 1 20 23
M  V30 25 2 20 24
M  V30 26 2 21 25
M  V30 27 1 22 26
M  V30 28 1 23 27
M  V30 29 1 24 25
M  V30 30 1 26 27
M  V30 31 2 26 28
M  V30 32 2 27 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 2 30 31
M  V30 36 1 32 33
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 1 34 35
M  V30 40 2 36 37
M  V30 41 1 36 38
M  V30 42 1 37 39
M  V30 43 2 38 40
M  V30 44 2 39 41
M  V30 45 1 40 41
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1034048-19-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1034158-58-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-15127753
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7664-41-7
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM no exptl. detail
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM The design and synthesis of potent, selective benzodiazepine sulfonamide
bombesin receptor subtype 3 (BRS-3) agonists with an increased barrier of
atropisomerization
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chobanian, Harry R.; Guo, Yan; Liu, Ping; Lanza, Thomas J. Jr.; Chioda,
Marc; Chang, Linda; Kelly, Theresa M.; Kan, Yanqing; Palyha, Oksana;
Guan, Xiao-Ming; Marsh, Donald J.; Metzger, Joseph M.; Raustad, Katie;
Wang, Sheng-Ping; Strack, Alison M.; Gorski, Judith N.; Miller, Randy;
Pang, Jianmei; Lyons, Kathy; Dragovic, Jasminka; Ning, Jian G.; Schafer,
Wes A.; Welch, Christopher J.; Gong, Xiaoyi; Gao, Ying-Duo; Hornak,
Viktor; Reitman, Marc L.; Nargund, Ravi P.; Lin, Linus S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2012), 20(9), 2845-2849

$RFMT $RIREG SCHEME132 STEP1
$RXN



  4  1
$MOL
Malononitrile
C3H2N2
109-77-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 0.0000 0.0 0
M  V30 2 C 1.3338 0.7700 0.0 0
M  V30 3 C 4.0010 0.7700 0.0 0
M  V30 4 N 0.0000 1.5400 0.0 0
M  V30 5 N 5.3348 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 3 2 4
M  V30 4 3 3 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Indene-1,2,3-trione
C9H4O3
938-24-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6078 0.0000 0.0 0
M  V30 2 O 4.6078 5.4211 0.0 0
M  V30 3 O 6.5770 2.7106 0.0 0
M  V30 4 C 2.6673 1.9406 0.0 0
M  V30 5 C 2.6673 3.4806 0.0 0
M  V30 6 C 4.1320 1.4647 0.0 0
M  V30 7 C 1.3336 1.1706 0.0 0
M  V30 8 C 4.1320 3.9564 0.0 0
M  V30 9 C 1.3336 4.2506 0.0 0
M  V30 10 C 5.0370 2.7106 0.0 0
M  V30 11 C 0.0000 1.9406 0.0 0
M  V30 12 C 0.0000 3.4806 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 2 2 8
M  V30 3 2 3 10
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 1 9 12
M  V30 13 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenyl isothiocyanate
C7H5NS
103-72-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 3.0800 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 S 6.6685 1.5400 0.0 0
M  V30 4 C 2.6674 2.3100 0.0 0
M  V30 5 C 2.6674 0.7700 0.0 0
M  V30 6 C 1.3338 3.0800 0.0 0
M  V30 7 C 1.3338 0.0000 0.0 0
M  V30 8 C 0.0000 2.3100 0.0 0
M  V30 9 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 2 2 3
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
10-Amino-2,3-dihydro-3-methyl-8-oxo-2-(phenylimino)-3a,8a-(epoxyetheno)-8H-in...
C20H14N4O2S
1416983-39-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.2806 6.8346 0.0 0
M  V30 2 C 3.1402 1.3201 0.0 0
M  V30 3 N 2.3469 0.0000 0.0 0
M  V30 4 O 0.6234 3.3471 0.0 0
M  V30 5 N 8.7055 3.5883 0.0 0
M  V30 6 N 7.4587 2.6164 0.0 0
M  V30 7 C 3.8118 5.7373 0.0 0
M  V30 8 C 3.1854 4.3306 0.0 0
M  V30 9 C 2.6674 6.7679 0.0 0
M  V30 10 N 5.4631 5.0773 0.0 0
M  V30 11 O 4.9999 5.1950 0.0 0
M  V30 12 C 3.9873 3.6824 0.0 0
M  V30 13 C 1.6538 4.4915 0.0 0
M  V30 14 S 4.3129 3.8131 0.0 0
M  V30 15 C 1.3336 5.9979 0.0 0
M  V30 16 C 2.6674 8.3079 0.0 0
M  V30 17 C 5.5700 4.5748 0.0 0
M  V30 18 C 5.2747 3.7349 0.0 0
M  V30 19 C 0.0000 6.7679 0.0 0
M  V30 20 C 1.3336 9.0779 0.0 0
M  V30 21 C 0.0000 8.3079 0.0 0
M  V30 22 C 11.4738 4.9384 0.0 0
M  V30 23 C 12.7504 4.0773 0.0 0
M  V30 24 C 11.5813 6.4747 0.0 0
M  V30 25 C 14.1346 4.7524 0.0 0
M  V30 26 C 12.9654 7.1498 0.0 0
M  V30 27 C 14.2420 6.2887 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 3 2 3
M  V30 3 1 2 12
M  V30 4 2 4 13
M  V30 5 2 5 17 CFG=2
M  V30 6 1 5 22
M  V30 7 1 6 18
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 1 8 13
M  V30 14 1 8 14
M  V30 15 1 9 15
M  V30 16 2 9 16
M  V30 17 1 10 17
M  V30 18 1 11 18
M  V30 19 2 12 18
M  V30 20 1 13 15
M  V30 21 1 14 17
M  V30 22 2 15 19
M  V30 23 1 16 20
M  V30 24 1 19 21
M  V30 25 2 20 21
M  V30 26 2 22 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 2 24 26
M  V30 30 2 25 27
M  V30 31 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 109-77-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 938-24-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 103-72-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1416983-39-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-11106378
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure: To a solution of ninhydrin
(1 mmol) and malononitrile (1 mmol) in EtOH (4 mL) was added Et3N (0.1
mmol), and the solution was stirred for 1 h at r.t. Then, aryl
isothiocyanate 1 (1 mmol) and primary amine 2 (1 mmol) were added at once
and dropwise over 15 min, respectively. Upon completion (7 h), monitored
by TLC, the mixture was filtered and the precipitate was washed with EtOH
(4 mL).
8c-Amino-3-methyl-8-oxo-2-phenylimino-2,3-dihydro-8H-8d-oxa-1-thia-3-azapentaleno[3a,6a-a]inden-8-yl
Cyanide (3g): white powder; yield: 0.34 g (92%). mp 181-183 °C. IR (KBr):
3380, 3271 (NH2), 2194 (CN), 1732 (C═O), 1666 (C═N), 1620, 1591, 1433
cm-1. 1H NMR (300 MHz, DMSO): δ = 3.33 (s, 3 H, Me), 6.82 (d, J= 7.7 Hz,
2 H, 2 × CH of Ph), 7.05 (t, J= 6.8 Hz, 1 H, CH of Ph), 7.26 (t, J= 6.8
Hz, 2 H, 2 × CH of Ph), 7.82 (t, J= 7.4 Hz, 1 H, CH of Ar), 7.95 (d, J=
7.4 Hz, 1 H, CH of Ar), 7.98 (d, J= 7.4 Hz, 1 H, CH of Ar), 8.09 (s, 2 H,
NH2), 8.17 (d, J= 7.7 Hz, 1 H, CH of Ar). 13C NMR (75 MHz, DMSO): δ =
30.81 (Me), 53.57 (CS), 70.75 (CCN), 107.51 (CN), 116.55 (OCN), 121.75 (2
× CH of Ph), 124.32 (CH of Ar), 125.92 (CH of Ar), 126.19 (CH of Ar),
129.60 (2 × CH of Ph), 132.86 (Cipso of Ph), 133.01 (CH of Ph), 137.82
(CH of Ar), 144.34 (Cipso of Ar), 150.24 (Cipso of Ar), 154.99 (SCN),
166.41 (CNH2), 193.32 (CO). MS: m/z = 374 [M+], 331, 299, 236, 185, 149,
123, 97, 69. Anal. Calcd for C20H14N4O2S: C, 64.16; H, 3.77; N, 14.96.
Found: C, 64.23; H, 3.73; N, 14.93.
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective, regioselective, mechanism studied
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Chemo- and regioselective 4CR synthesis of oxathiaaza[3.3.3]propellanes
via sequential C-S, C-N and C-O bond formation in a single pot
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rezvanian, Atieh; Alizadeh, Abdolali; Zhu, Long-Guan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synlett (2012), 23(17), 2526-2530

$RFMT $RIREG SCHEME133 STEP1
$RXN



  6  1
$MOL
Phenyl isothiocyanate
C7H5NS
103-72-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 3.0800 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 S 6.6685 1.5400 0.0 0
M  V30 4 C 2.6674 2.3100 0.0 0
M  V30 5 C 2.6674 0.7700 0.0 0
M  V30 6 C 1.3338 3.0800 0.0 0
M  V30 7 C 1.3338 0.0000 0.0 0
M  V30 8 C 0.0000 2.3100 0.0 0
M  V30 9 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 2 2 3
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Glycine ethyl ester
C4H9NO2
459-73-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 O 4.0011 2.3100 0.0 0
M  V30 3 C 1.3338 2.3100 0.0 0
M  V30 4 O 2.6675 0.0000 0.0 0
M  V30 5 C 5.3348 1.5400 0.0 0
M  V30 6 N 0.0000 1.5400 0.0 0
M  V30 7 C 6.6686 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methyl-1,2-benzenedicarboxaldehyde
C9H8O2
15158-36-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 4.0011 0.0 0
M  V30 2 O 0.0000 5.3349 0.0 0
M  V30 3 C 2.3100 1.3338 0.0 0
M  V30 4 O 3.0800 0.0000 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 C 2.3100 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 3.0800 5.3349 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 4.6200 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 2 3 4
M  V30 4 1 3 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methyl-1-buten-3-yne
C5H6
78-80-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 2.6673 2.3101 0.0 0
M  V30 3 C 0.0000 2.3101 0.0 0
M  V30 4 C 1.3337 0.0000 0.0 0
M  V30 5 C 4.0010 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 3 2 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2′,4′-Dihydroxyacetophenone
C8H8O3
89-84-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 C 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 O 2.3101 0.0000 0.0 0
M  V30 5 O 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 12-methyl-2-(1-methylethenyl)-5-[1-(methylimino)ethyl]-7-(phenylimino)-...
C34H31N3O4
2754289-91-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 46 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.1618 10.7802 0.0 0
M  V30 2 N 2.8281 11.5502 0.0 0
M  V30 3 C 5.4954 11.5502 0.0 0
M  V30 4 C 2.8281 13.0902 0.0 0
M  V30 5 N 9.4966 9.2402 0.0 0
M  V30 6 C 10.8302 6.9301 0.0 0
M  V30 7 O 12.1641 6.1601 0.0 0
M  V30 8 O 10.8302 8.4702 0.0 0
M  V30 9 C 13.4977 6.9301 0.0 0
M  V30 10 C 14.8314 6.1601 0.0 0
M  V30 11 C 1.5400 3.1591 0.0 0
M  V30 12 C 2.3100 1.8254 0.0 0
M  V30 13 C 0.0000 3.1591 0.0 0
M  V30 14 C 6.8293 0.0000 0.0 0
M  V30 15 C 5.4954 6.9301 0.0 0
M  V30 16 C 6.8293 6.1601 0.0 0
M  V30 17 C 5.4954 8.4702 0.0 0
M  V30 18 C 4.1618 6.1601 0.0 0
M  V30 19 N 8.1629 6.9301 0.0 0
M  V30 20 C 6.8293 4.6201 0.0 0
M  V30 21 C 4.1618 9.2402 0.0 0
M  V30 22 O 6.8293 9.2402 0.0 0
M  V30 23 C 2.8281 6.9301 0.0 0
M  V30 24 O 3.8416 4.6538 0.0 0
M  V30 25 C 8.1629 8.4702 0.0 0
M  V30 26 C 9.4966 6.1601 0.0 0
M  V30 27 C 8.1629 3.8501 0.0 0
M  V30 28 C 5.4954 3.8501 0.0 0
M  V30 29 C 2.8281 8.4702 0.0 0
M  V30 30 C 1.6836 5.8997 0.0 0
M  V30 31 C 2.3100 4.4927 0.0 0
M  V30 32 C 9.4966 4.6201 0.0 0
M  V30 33 C 8.1629 2.3100 0.0 0
M  V30 34 C 5.4954 2.3100 0.0 0
M  V30 35 C 6.8293 1.5400 0.0 0
M  V30 36 C 9.4966 10.7802 0.0 0
M  V30 37 C 10.8302 11.5502 0.0 0
M  V30 38 C 8.1629 11.5502 0.0 0
M  V30 39 C 10.8302 13.0902 0.0 0
M  V30 40 C 8.1629 13.0902 0.0 0
M  V30 41 C 9.4966 13.8603 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 21
M  V30 4 1 2 4
M  V30 5 2 5 25 CFG=2
M  V30 6 1 5 36
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 26
M  V30 10 1 7 9
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 11 31
M  V30 15 1 14 35
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 1 15 18
M  V30 19 1 16 19
M  V30 20 1 16 20
M  V30 21 1 17 21
M  V30 22 1 17 22
M  V30 23 2 18 23
M  V30 24 1 18 24
M  V30 25 1 19 25
M  V30 26 1 19 26
M  V30 27 1 20 27
M  V30 28 2 20 28
M  V30 29 2 21 29
M  V30 30 1 22 25
M  V30 31 1 23 29
M  V30 32 1 23 30
M  V30 33 1 24 31
M  V30 34 2 26 32
M  V30 35 1 27 32
M  V30 36 2 27 33
M  V30 37 1 28 34
M  V30 38 2 30 31
M  V30 39 1 33 35
M  V30 40 2 34 35
M  V30 41 2 36 37
M  V30 42 1 36 38
M  V30 43 1 37 39
M  V30 44 2 38 40
M  V30 45 2 39 41
M  V30 46 1 40 41
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 103-72-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 459-73-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 15158-36-8
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 78-80-8
$DTYPE RXN:RCT(5):CAS_RN
$DATUM 89-84-9
$DTYPE RXN:RCT(6):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2754289-91-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24903592
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-50-8
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 7789-23-3
$DTYPE RXN:VAR(1):CAT(3):CAS_RN
$DATUM 12173-10-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-catalyst, solid-supported catalyst, optimization study,
optimized on stoichiometric of catalyst, solvent and reaction condition,
catalyst can be recycled and reused, catalyst prepared and used, MWCNTs
nanocomposite support used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Biosynthesis of Cu/KF/Clinoptilolite@MWCNTs nanocomposite and its
application as a recyclable nanocatalyst for the synthesis of new Schiff
base of benzoxazine derivatives and reduction of organic pollutants
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hamedani, Naghmeh Faal; Hargalani, Fariba Zamani; Rostami-Charati,
Faramarz
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molecular Diversity (2022), 26(4), 2069-2083

$RFMT $RIREG SCHEME134 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(Bromomethyl)-6-chloro-2-iodo-5-methylpyridine
C7H6BrClIN
1043870-53-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 2.6674 0.0 0
M  V30 2 Br 6.9300 4.0011 0.0 0
M  V30 3 I 4.6200 0.0000 0.0 0
M  V30 4 C 1.5400 5.3349 0.0 0
M  V30 5 Cl 0.0000 2.6674 0.0 0
M  V30 6 C 4.6200 2.6674 0.0 0
M  V30 7 C 3.8500 1.3338 0.0 0
M  V30 8 C 3.8500 4.0011 0.0 0
M  V30 9 N 2.3100 1.3338 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 1.5400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 3 7
M  V30 4 1 4 10
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-2-iodo-N,5-dimethyl-3-pyridinemethanamine
C8H10ClIN2
1043870-54-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 2.6674 0.0 0
M  V30 2 N 6.9300 4.0011 0.0 0
M  V30 3 C 8.4700 4.0011 0.0 0
M  V30 4 I 4.6200 0.0000 0.0 0
M  V30 5 C 1.5400 5.3349 0.0 0
M  V30 6 Cl 0.0000 2.6674 0.0 0
M  V30 7 C 4.6200 2.6674 0.0 0
M  V30 8 C 3.8500 1.3338 0.0 0
M  V30 9 C 3.8500 4.0011 0.0 0
M  V30 10 N 2.3100 1.3338 0.0 0
M  V30 11 C 2.3100 4.0011 0.0 0
M  V30 12 C 1.5400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 4 8
M  V30 5 1 5 11
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1043870-53-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1043870-54-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-13480596
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Spirocyclic pyridoazepine analogues of galanthamine: synthesis, modelling
studies and evaluation as inhibitors of acetylcholinesterase
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Vanlaer, Sofie; De Borggraeve, Wim M.; Voet, Arnout; Gielens, Constant;
De Maeyer, Marc; Compernolle, Frans
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2008), (15), 2571-2581

$RFMT $RIREG SCHEME135 STEP1
$RXN



  4  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbon disulfide
CS2
75-15-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 0.0000 0.0 0
M  V30 2 S 0.0000 0.0000 0.0 0
M  V30 3 S 3.0800 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methylbenzaldehyde
C8H8O
104-87-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 C 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl chloroacetate
C4H7ClO2
105-39-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 O 4.0011 2.3100 0.0 0
M  V30 3 C 1.3338 2.3100 0.0 0
M  V30 4 O 2.6675 0.0000 0.0 0
M  V30 5 C 5.3348 1.5400 0.0 0
M  V30 6 Cl 0.0000 1.5400 0.0 0
M  V30 7 C 6.6686 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(5Z)-3-Methyl-5-[(4-methylphenyl)methylene]-2-thioxo-4-thiazolidinone
C12H11NOS2
1133954-03-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3028 1.3628 0.0 0
M  V30 2 O 2.2420 0.0000 0.0 0
M  V30 3 C 0.0000 2.4898 0.0 0
M  V30 4 S 1.6752 5.3914 0.0 0
M  V30 5 C 10.6376 4.4428 0.0 0
M  V30 6 C 3.9690 2.1328 0.0 0
M  V30 7 C 2.5622 1.5063 0.0 0
M  V30 8 S 3.8080 3.6644 0.0 0
M  V30 9 N 1.5317 2.6509 0.0 0
M  V30 10 C 2.3017 3.9845 0.0 0
M  V30 11 C 6.6365 2.1328 0.0 0
M  V30 12 C 6.6365 3.6728 0.0 0
M  V30 13 C 7.9701 1.3628 0.0 0
M  V30 14 C 7.9701 4.4428 0.0 0
M  V30 15 C 9.3038 2.1328 0.0 0
M  V30 16 C 9.3038 3.6728 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 1 1 11
M  V30 3 2 2 7
M  V30 4 1 3 9
M  V30 5 2 4 10
M  V30 6 1 5 16
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-15-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 104-87-0
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 105-39-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1133954-03-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-318-CAS-14430422
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 284049-75-8
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, stereoselective, no solvent, Knoevenagel condensation,
ionic liquid used as catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 1-Butyl-3-methylimidazolium acetate catalyzed synthesis of
N-substituted-5-arylidene-rhodanines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Singh, Sarangthem Joychandra; Ahmad, Sohail; Chauhan, S. M. S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Heterocyclic Chemistry (2014), 51(S1), E129-E139

$RFMT $RIREG SCHEME136 STEP1
$RXN



  4  1
$MOL
1-Phenyl-2-(triphenylphosphoranylidene)ethanone
C26H21OP
859-65-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 4.6200 4.6200 0.0 0 VAL=5
M  V30 2 C 6.1600 4.6200 0.0 0
M  V30 3 C 6.9300 5.9537 0.0 0
M  V30 4 O 6.1600 7.2875 0.0 0
M  V30 5 C 3.0800 4.6200 0.0 0
M  V30 6 C 2.3100 5.9537 0.0 0
M  V30 7 C 2.3100 3.2864 0.0 0
M  V30 8 C 0.7700 5.9537 0.0 0
M  V30 9 C 0.7700 3.2864 0.0 0
M  V30 10 C 0.0000 4.6200 0.0 0
M  V30 11 C 4.6200 3.0800 0.0 0
M  V30 12 C 5.9537 2.3100 0.0 0
M  V30 13 C 3.2864 2.3100 0.0 0
M  V30 14 C 5.9537 0.7700 0.0 0
M  V30 15 C 3.2864 0.7700 0.0 0
M  V30 16 C 4.6200 0.0000 0.0 0
M  V30 17 C 4.2215 6.1075 0.0 0
M  V30 18 C 2.7340 6.5062 0.0 0
M  V30 19 C 5.3104 7.1964 0.0 0
M  V30 20 C 2.3353 7.9937 0.0 0
M  V30 21 C 4.9118 8.6841 0.0 0
M  V30 22 C 3.4242 9.0826 0.0 0
M  V30 23 C 8.4700 5.9537 0.0 0
M  V30 24 C 9.2400 4.6200 0.0 0
M  V30 25 C 9.2400 7.2875 0.0 0
M  V30 26 C 10.7800 4.6200 0.0 0
M  V30 27 C 10.7800 7.2875 0.0 0
M  V30 28 C 11.5500 5.9537 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 5
M  V30 3 1 1 11
M  V30 4 1 1 17
M  V30 5 1 2 3
M  V30 6 2 3 4
M  V30 7 1 3 23
M  V30 8 2 5 6
M  V30 9 1 5 7
M  V30 10 1 6 8
M  V30 11 2 7 9
M  V30 12 2 8 10
M  V30 13 1 9 10
M  V30 14 2 11 12
M  V30 15 1 11 13
M  V30 16 1 12 14
M  V30 17 2 13 15
M  V30 18 2 14 16
M  V30 19 1 15 16
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Isopropylisatin
C11H11NO2
10487-31-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7309 4.6948 0.0 0
M  V30 2 C 7.1957 4.2189 0.0 0
M  V30 3 C 5.4108 6.2011 0.0 0
M  V30 4 O 3.0203 0.0000 0.0 0
M  V30 5 O 6.0811 1.3626 0.0 0
M  V30 6 C 3.0801 3.9845 0.0 0
M  V30 7 C 2.3101 2.6509 0.0 0
M  V30 8 N 4.5865 3.6644 0.0 0
M  V30 9 C 2.3101 5.3182 0.0 0
M  V30 10 C 3.3406 1.5063 0.0 0
M  V30 11 C 0.7700 2.6509 0.0 0
M  V30 12 C 4.7475 2.1326 0.0 0
M  V30 13 C 0.7700 5.3182 0.0 0
M  V30 14 C 0.0000 3.9845 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 2 4 10
M  V30 5 2 5 12
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 1 11 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbon disulfide
CS2
75-15-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 0.0000 0.0 0
M  V30 2 S 0.0000 0.0000 0.0 0
M  V30 3 S 3.0800 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2H-Indol-2-one, 1,3-dihydro-3-[(4R,5S)-4-hydroxy-3-methyl-4-phenyl-2-thioxo-5...
C21H22N2O2S2
3052403-84-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6218 3.5203 0.0 0
M  V30 2 O 7.3944 4.4300 0.0 0
M  V30 3 C 4.3800 1.0306 0.0 0
M  V30 4 C 5.8445 0.5547 0.0 0
M  V30 5 C 3.2354 0.0000 0.0 0
M  V30 6 C 8.7280 8.2633 0.0 0
M  V30 7 S 5.6673 9.6260 0.0 0
M  V30 8 C 4.3202 5.0151 0.0 0 CFG=2
M  V30 9 C 2.8138 4.6949 0.0 0
M  V30 10 C 5.0902 3.6814 0.0 0
M  V30 11 C 2.6528 3.1633 0.0 0
M  V30 12 C 1.5679 5.6001 0.0 0
M  V30 13 N 4.0596 2.5369 0.0 0
M  V30 14 C 1.2460 2.5369 0.0 0
M  V30 15 C 0.1611 4.9736 0.0 0
M  V30 16 C 0.0000 3.4421 0.0 0
M  V30 17 C 5.7270 5.6414 0.0 0 CFG=1
M  V30 18 C 7.2335 5.9616 0.0 0 CFG=2
M  V30 19 S 4.9570 6.9752 0.0 0
M  V30 20 N 7.3944 7.4933 0.0 0
M  V30 21 C 5.9874 8.1196 0.0 0
M  V30 22 C 8.7735 5.9616 0.0 0
M  V30 23 C 9.5435 4.6279 0.0 0
M  V30 24 C 9.5435 7.2954 0.0 0
M  V30 25 C 11.0835 4.6279 0.0 0
M  V30 26 C 11.0835 7.2954 0.0 0
M  V30 27 C 11.8535 5.9616 0.0 0
M  V30 28 H 3.8443 6.4798 0.0 0
M  V30 29 H 6.2029 4.1768 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 1 18 2 CFG=1
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 13
M  V30 6 1 6 20
M  V30 7 2 7 21
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 17
M  V30 11 1 8 28 CFG=1
M  V30 12 1 9 11
M  V30 13 2 9 12
M  V30 14 1 10 13
M  V30 15 1 11 13
M  V30 16 2 11 14
M  V30 17 1 12 15
M  V30 18 1 14 16
M  V30 19 2 15 16
M  V30 20 1 17 18
M  V30 21 1 17 19
M  V30 22 1 17 29 CFG=3
M  V30 23 1 18 20
M  V30 24 1 18 22 CFG=3
M  V30 25 1 19 21
M  V30 26 1 20 21
M  V30 27 2 22 23
M  V30 28 1 22 24
M  V30 29 1 23 25
M  V30 30 2 24 26
M  V30 31 2 25 27
M  V30 32 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 8 17 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 859-65-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 10487-31-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 75-15-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3052403-84-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41257935
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, regioselective, stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Regio- and diastereoselective synthesis of
thioxothiazolidin-indolin-2-ones, oxoindolin-carbamodithioate hybrids,
and their base-catalyzed conversion into dispirocyclopentanebisoxindoles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Aghamiri, Bagher; Moghaddam, F. Matloubi; Badpa, Sara; Kavoosi, Leila
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Scientific Reports (2024), 14(1), 14222

$RFMT $RIREG SCHEME137 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxybenzyl alcohol
C8H10O2
105-13-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 6.6687 0.0000 0.0 0
M  V30 4 C 8.0023 0.7700 0.0 0
M  V30 5 C 2.6675 2.3101 0.0 0
M  V30 6 C 2.6675 0.7700 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 4.0012 0.0000 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Isatoic anhydride
C8H5NO3
118-48-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3100 0.0000 0.0 0
M  V30 2 O 6.9300 2.6674 0.0 0
M  V30 3 C 2.3100 2.6674 0.0 0
M  V30 4 C 3.0800 4.0011 0.0 0
M  V30 5 C 3.0800 1.3338 0.0 0
M  V30 6 C 0.7700 2.6674 0.0 0
M  V30 7 N 4.6200 4.0011 0.0 0
M  V30 8 C 2.3100 5.3349 0.0 0
M  V30 9 O 4.6200 1.3338 0.0 0
M  V30 10 C 0.0000 4.0011 0.0 0
M  V30 11 C 5.3900 2.6674 0.0 0
M  V30 12 C 0.7700 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 2 2 11
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(4-Methoxyphenyl)-3-methyl-4(3H)-quinazolinone
C16H14N2O2
36567-89-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 0.0000 0.0 0
M  V30 2 O 2.3100 0.0000 0.0 0
M  V30 3 O 11.5500 2.6674 0.0 0
M  V30 4 C 12.3200 4.0011 0.0 0
M  V30 5 C 5.3900 2.6674 0.0 0
M  V30 6 N 4.6200 4.0011 0.0 0
M  V30 7 N 4.6200 1.3338 0.0 0
M  V30 8 C 3.0800 4.0011 0.0 0
M  V30 9 C 3.0800 1.3338 0.0 0
M  V30 10 C 2.3100 2.6674 0.0 0
M  V30 11 C 2.3100 5.3349 0.0 0
M  V30 12 C 0.7700 2.6674 0.0 0
M  V30 13 C 0.7700 5.3349 0.0 0
M  V30 14 C 0.0000 4.0011 0.0 0
M  V30 15 C 6.9300 2.6674 0.0 0
M  V30 16 C 7.7000 4.0011 0.0 0
M  V30 17 C 7.7000 1.3338 0.0 0
M  V30 18 C 9.2400 4.0011 0.0 0
M  V30 19 C 9.2400 1.3338 0.0 0
M  V30 20 C 10.0100 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 2 2 9
M  V30 3 1 3 4
M  V30 4 1 3 20
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 15
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 10
M  V30 13 2 10 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 105-13-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 118-48-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 36567-89-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-032-CAS-24182287
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 3375-31-3
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 63995-75-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used, reaction conducted in the presence of air, selective,
Tsuji-Trost N-benzylation/C-H activation/amination
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Direct Use of Benzylic Alcohols for Multicomponent Synthesis of 2-Aryl
Quinazolinones Utilizing the π-Benzylpalladium(II) System in Water
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hikawa, Hidemasa; Nakayama, Taku; Takahashi, Makiko; Kikkawa, Shoko;
Azumaya, Isao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Advanced Synthesis & Catalysis (2021), 363(16), 4075-4084

$RFMT $RIREG SCHEME138 STEP1
$RXN



  4  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dimethyl acetylenedicarboxylate
C6H6O4
762-42-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 O 8.0023 2.3101 0.0 0
M  V30 4 O 6.6685 0.0000 0.0 0
M  V30 5 C 4.0012 3.0801 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 O 1.3337 3.0801 0.0 0
M  V30 9 O 2.6675 5.3901 0.0 0
M  V30 10 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 3 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formaldehyde
CH2O
50-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloroaniline
C6H6ClN
106-47-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 1.3337 0.0 0
M  V30 2 N 6.1601 1.3337 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 8
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C13H13ClN2O3
3053160-55-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.3513 1.9424 0.0 0
M  V30 2 N 7.6285 1.2459 0.0 0
M  V30 3 C 6.7235 0.0000 0.0 0
M  V30 4 C 9.3038 4.1474 0.0 0
M  V30 5 O 9.9303 5.5544 0.0 0
M  V30 6 O 10.2090 2.9016 0.0 0
M  V30 7 C 11.4618 5.7154 0.0 0
M  V30 8 Cl 0.0000 7.5846 0.0 0
M  V30 9 N 5.3348 4.5046 0.0 0
M  V30 10 C 5.4959 2.9730 0.0 0
M  V30 11 C 6.7418 5.1309 0.0 0
M  V30 12 C 7.0022 2.6529 0.0 0
M  V30 13 C 7.7722 3.9865 0.0 0
M  V30 14 C 4.0011 5.2746 0.0 0
M  V30 15 C 4.0011 6.8146 0.0 0
M  V30 16 C 2.6675 4.5046 0.0 0
M  V30 17 C 2.6675 7.5846 0.0 0
M  V30 18 C 1.3337 5.2746 0.0 0
M  V30 19 C 1.3337 6.8146 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 1 2 3
M  V30 3 1 2 12
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 13
M  V30 7 1 5 7
M  V30 8 1 8 19
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 14
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 762-42-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 50-00-0
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 106-47-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3053160-55-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41265452
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 97-05-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, product formed via Michael addition and Mannich type
reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Exploring the versatility of 5-sulfosalicylic acid dihydrate as catalyst
in 3-pyrrolin-2-one Synthesis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gadge, Dhananjay D.; Kulkarni, Pramod S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Research on Chemical Intermediates (2024), 50(8), 3785-3801

$RFMT $RIREG SCHEME139 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzenesulfonyl chloride
C6H5ClO2S
98-09-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 1.5400 0.0 0 VAL=6
M  V30 2 Cl 6.1600 1.5400 0.0 0
M  V30 3 O 4.6200 3.0800 0.0 0
M  V30 4 O 4.6200 0.0000 0.0 0
M  V30 5 C 3.0800 1.5400 0.0 0
M  V30 6 C 2.3100 0.2064 0.0 0
M  V30 7 C 2.3100 2.8736 0.0 0
M  V30 8 C 0.7700 0.2064 0.0 0
M  V30 9 C 0.7700 2.8736 0.0 0
M  V30 10 C 0.0000 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 5
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Propargyl bromide
C3H3Br
106-96-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 0.0000 0.0 0
M  V30 2 C 1.3337 0.7700 0.0 0
M  V30 3 Br 4.0010 0.7700 0.0 0
M  V30 4 C 0.0000 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 3 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-N-2-propyn-1-ylbenzenesulfonamide
C10H11NO2S
20044-77-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 1.5400 0.0 0 VAL=6
M  V30 2 N 6.1600 1.5400 0.0 0
M  V30 3 O 4.6200 3.0800 0.0 0
M  V30 4 O 4.6200 0.0000 0.0 0
M  V30 5 C 6.9300 2.8736 0.0 0
M  V30 6 C 6.9300 0.2064 0.0 0
M  V30 7 C 8.4700 2.8736 0.0 0
M  V30 8 C 10.0100 2.8736 0.0 0
M  V30 9 C 3.0800 1.5400 0.0 0
M  V30 10 C 2.3100 2.8736 0.0 0
M  V30 11 C 2.3100 0.2064 0.0 0
M  V30 12 C 0.7700 2.8736 0.0 0
M  V30 13 C 0.7700 0.2064 0.0 0
M  V30 14 C 0.0000 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 5 7
M  V30 8 3 7 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 98-09-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 106-96-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 20044-77-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-17380963
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7681-82-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 78-93-3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of Indole-2-methylsulfonamides by Domino Sonogashira Coupling
and Hydroamination Reaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Debnath, Sudarshan; Malakar, Suniti; Mondal, Shovan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemistrySelect (2017), 2(10), 3147-3151

$RFMT $RIREG SCHEME140 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Butadiene
C4H6
106-99-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 C 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-N-2,7-octadien-1-yl-2,7-octadien-1-amine
C17H29N
68657-83-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 10.6697 1.5400 0.0 0
M  V30 2 C 12.0033 2.3101 0.0 0
M  V30 3 C 9.3360 2.3101 0.0 0
M  V30 4 C 10.6697 0.0000 0.0 0
M  V30 5 C 13.3370 1.5400 0.0 0
M  V30 6 C 8.0022 1.5400 0.0 0
M  V30 7 C 14.6708 2.3101 0.0 0
M  V30 8 C 6.6685 2.3101 0.0 0
M  V30 9 C 16.0045 1.5400 0.0 0
M  V30 10 C 5.3348 1.5400 0.0 0
M  V30 11 C 17.3382 2.3101 0.0 0
M  V30 12 C 4.0012 2.3101 0.0 0
M  V30 13 C 18.6720 1.5400 0.0 0
M  V30 14 C 2.6673 1.5400 0.0 0
M  V30 15 C 20.0057 2.3101 0.0 0
M  V30 16 C 1.3337 2.3101 0.0 0
M  V30 17 C 21.3393 1.5400 0.0 0
M  V30 18 C 0.0000 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 2 5 7 CFG=2
M  V30 7 2 6 8 CFG=2
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 106-99-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 68657-83-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-239-CAS-5911350
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 21324-39-0
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 478980-03-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Telomerization of amines and butadiene
reaction procedure: The Fisher-Porter vessel (200mL) was loaded with
catalyst precursor (lmol% 5.7mg), NaPF6 or NaBF4, NaBPh4 (2 mol%) and
purged with argon three times. Solvent (2mL) was added via a cannula
through the external valve. Amines (5mmol) were added using a syringe
through the external valve under positive argon pressure. The pressure
vessel was cooled to -78 °C and the system was connected to a butadiene
tank. An excess of butadiene was condensed in the reactor. The pressure
inside the vessel after warming up at room temperature was 20psi. The
vessel was shielded and heated to working temperature. The reaction times
were optimized. Work-up: The vessel was cooled to room temperature and
the excess butadiene was discharged by releasing the pressure. The
solution was mixed with silica gel, dried and the resulting powder was
placed on the top of flash column. Elution was performed with 100%
hexanes or 90/10% hexanes/EtOAc.
N-methyl-N-2,7-octadienyl-2,7-Octadien-1-amine8 (Table 2 Entry 7) The
general procedure afforded 1136 mg (92%) of the title compound.
$DTYPE RXN:VAR(1):NOTES
$DATUM In Fisher-Porter pressure vessel
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Telomerization of Amines Mediated by Cationic N-Heterocyclic Carbene
(NHC) Palladium Complexes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Viciu, Mihai S.; Zinn, Fabiano Kauer; Stevens, Edwin D.; Nolan, Steven P.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organometallics (2003), 22(16), 3175-3177

$RFMT $RIREG SCHEME141 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Indole-7-carboxaldehyde
C9H7NO
1074-88-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.1456 3.0801 0.0 0
M  V30 2 O 6.4792 2.3101 0.0 0
M  V30 3 C 2.4781 3.0801 0.0 0
M  V30 4 C 1.1444 2.3101 0.0 0
M  V30 5 C 3.8119 2.3101 0.0 0
M  V30 6 N 2.1579 4.5864 0.0 0
M  V30 7 C 0.0000 3.3405 0.0 0
M  V30 8 C 1.1444 0.7700 0.0 0
M  V30 9 C 3.8119 0.7700 0.0 0
M  V30 10 C 0.6263 4.7473 0.0 0
M  V30 11 C 2.4781 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 2 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-1H-indole-7-methanamine
C10H12N2
709649-74-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.1456 3.0801 0.0 0
M  V30 2 N 6.4792 2.3101 0.0 0
M  V30 3 C 7.8129 3.0801 0.0 0
M  V30 4 C 2.4781 3.0801 0.0 0
M  V30 5 C 1.1444 2.3101 0.0 0
M  V30 6 C 3.8119 2.3101 0.0 0
M  V30 7 N 2.1579 4.5864 0.0 0
M  V30 8 C 0.0000 3.3405 0.0 0
M  V30 9 C 1.1444 0.7700 0.0 0
M  V30 10 C 3.8119 0.7700 0.0 0
M  V30 11 C 0.6263 4.7473 0.0 0
M  V30 12 C 2.4781 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1074-88-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 709649-74-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-4580138
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Preparation 109 Preparation of (1H-Indol-7-ylmethyl)methylamine [0867]
Indole-7-carbaldehyde (500 mg, 3.4 mmol) was dissolved in anhydrous
methanol (10 mL). Methylamine (5.1 mL of 2M solution in methanol, 9.55
mmol) was added and the reaction was stirred for 3 hr. The solution was
concentrated to a yellow oil and then dissolved into anhydrous methanol
(10 mL). Sodium borohydride (131 mg, 3.45 mmol) was added and the mixture
was stirred overnight. Water (1 mL) was added and the solution was
concentrated. Sodium hydroxide (5 mL, 1N) was added and the indole was
extracted with ethyl acetate (3×20 mL), dried over MgSO4 and concentrated
to afford the tide compound as a yellow oil (484 mg, 92%). 1H NMR (300
MHz, CDCl3) δ 7.54 (s, 1H), 7.29-7.17 (m, 2H), 7.04 (d, J=3.1 Hz, 1H),
6.44 (d, J=3.1 Hz, 1H), 3.84 (s, 2H), 2.46 (s, 3H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20060142265 A1 2006-06-29

$RFMT $RIREG SCHEME141 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Indole-7-carboxaldehyde
C9H7NO
1074-88-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.1456 3.0801 0.0 0
M  V30 2 O 6.4792 2.3101 0.0 0
M  V30 3 C 2.4781 3.0801 0.0 0
M  V30 4 C 1.1444 2.3101 0.0 0
M  V30 5 C 3.8119 2.3101 0.0 0
M  V30 6 N 2.1579 4.5864 0.0 0
M  V30 7 C 0.0000 3.3405 0.0 0
M  V30 8 C 1.1444 0.7700 0.0 0
M  V30 9 C 3.8119 0.7700 0.0 0
M  V30 10 C 0.6263 4.7473 0.0 0
M  V30 11 C 2.4781 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 2 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-1H-indole-7-methanamine
C10H12N2
709649-74-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.1456 3.0801 0.0 0
M  V30 2 N 6.4792 2.3101 0.0 0
M  V30 3 C 7.8129 3.0801 0.0 0
M  V30 4 C 2.4781 3.0801 0.0 0
M  V30 5 C 1.1444 2.3101 0.0 0
M  V30 6 C 3.8119 2.3101 0.0 0
M  V30 7 N 2.1579 4.5864 0.0 0
M  V30 8 C 0.0000 3.3405 0.0 0
M  V30 9 C 1.1444 0.7700 0.0 0
M  V30 10 C 3.8119 0.7700 0.0 0
M  V30 11 C 0.6263 4.7473 0.0 0
M  V30 12 C 2.4781 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1074-88-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 709649-74-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-3458884
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004082586 A2 2004-09-30

$RFMT $RIREG SCHEME141 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Indole-7-carboxaldehyde
C9H7NO
1074-88-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.1456 3.0801 0.0 0
M  V30 2 O 6.4792 2.3101 0.0 0
M  V30 3 C 2.4781 3.0801 0.0 0
M  V30 4 C 1.1444 2.3101 0.0 0
M  V30 5 C 3.8119 2.3101 0.0 0
M  V30 6 N 2.1579 4.5864 0.0 0
M  V30 7 C 0.0000 3.3405 0.0 0
M  V30 8 C 1.1444 0.7700 0.0 0
M  V30 9 C 3.8119 0.7700 0.0 0
M  V30 10 C 0.6263 4.7473 0.0 0
M  V30 11 C 2.4781 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 2 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-1H-indole-7-methanamine
C10H12N2
709649-74-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.1456 3.0801 0.0 0
M  V30 2 N 6.4792 2.3101 0.0 0
M  V30 3 C 7.8129 3.0801 0.0 0
M  V30 4 C 2.4781 3.0801 0.0 0
M  V30 5 C 1.1444 2.3101 0.0 0
M  V30 6 C 3.8119 2.3101 0.0 0
M  V30 7 N 2.1579 4.5864 0.0 0
M  V30 8 C 0.0000 3.3405 0.0 0
M  V30 9 C 1.1444 0.7700 0.0 0
M  V30 10 C 3.8119 0.7700 0.0 0
M  V30 11 C 0.6263 4.7473 0.0 0
M  V30 12 C 2.4781 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1074-88-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 709649-74-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-7976806
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Preparation of (1H-Indol-7-ylmethyl)methylamine Indole-7-carbaldehyde
(500 mg, 3.4 mmol) was dissolved in anhydrous methanol (10 mL).
Methylamine (5.1 mL of 2M solution in methanol, 9.55 mmol) was added and
the reaction was stirred for 3 hr. The solution was concentrated to a
yellow oil and then dissolved into anhydrous methanol (10 mL). Sodium
borohydride (131 mg, 3.45 mmol) was added and the mixture was stirred
overnight. Water (1 mL) was added and the solution was concentrated.
Sodium hydroxide (5 mL, 1N) was added and the indole was extracted with
ethyl acetate (3 x 20 mL), dried over MgSO4 and concentrated to afford
the title compound as a yellow oil. (1H-Indol-7-ylmethyl)methylamine,
yield 484 mg, 92%. 1H NMR (300 MHz, CDCl3) δ 7.54 (s, 1H), 7.29- 7.17 (m,
2H), 7.04 (d, J = 3.1 Hz, 1H), 6.44 (d, J = 3.1 Hz, 1H), 3.84 (s, 2H),
2.46 (s, 3H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocyclic compounds as antibacterial agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd; Sampson, Peter; Pauls, Heinz W.; Ramnauth, Jailall;
Manning, David Douglas; Surman, Matthew David; Xie, Dejian; Decornez,
Helene Yvonne
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004052890 A1 2004-06-24

$RFMT $RIREG SCHEME142 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methoxybenzaldehyde
C8H8O2
591-31-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 6.6687 3.0801 0.0 0
M  V30 4 C 8.0023 2.3101 0.0 0
M  V30 5 C 4.0012 3.0801 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 5.3348 2.3101 0.0 0
M  V30 8 C 2.6675 0.7700 0.0 0
M  V30 9 C 5.3348 0.7700 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 1 3 4
M  V30 4 1 3 7
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Isopropyl chloroformate
C4H7ClO2
108-23-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6674 2.3100 0.0 0
M  V30 2 C 4.0011 1.5400 0.0 0
M  V30 3 C 1.3338 1.5400 0.0 0
M  V30 4 C 5.3349 2.3100 0.0 0
M  V30 5 C 4.0011 0.0000 0.0 0
M  V30 6 Cl 1.3338 0.0000 0.0 0
M  V30 7 O 0.0000 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Methylethyl N-[(3-methoxyphenyl)methyl]-N-methylcarbamate
C13H19NO3
1520080-20-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.0801 0.0 0
M  V30 2 N 5.3348 2.3101 0.0 0
M  V30 3 C 4.0010 3.0801 0.0 0
M  V30 4 C 5.3348 0.7700 0.0 0
M  V30 5 O 2.6673 2.3101 0.0 0
M  V30 6 O 4.0010 4.6201 0.0 0
M  V30 7 C 1.3337 3.0801 0.0 0
M  V30 8 C 1.3337 4.6201 0.0 0
M  V30 9 C 0.0000 2.3101 0.0 0
M  V30 10 O 12.0033 3.0801 0.0 0
M  V30 11 C 13.3370 2.3101 0.0 0
M  V30 12 C 8.0022 2.3101 0.0 0
M  V30 13 C 9.3360 3.0801 0.0 0
M  V30 14 C 8.0022 0.7700 0.0 0
M  V30 15 C 10.6697 2.3101 0.0 0
M  V30 16 C 9.3360 0.0000 0.0 0
M  V30 17 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 10 11
M  V30 11 1 10 15
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 591-31-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 108-23-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1520080-20-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-6144983
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 5
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-64-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General Procedures for Synthesis of Carbamates: Method B. Preparation of
carbamates 5b, 6b, 7b, S1, S4, 10b, 11b, 12b, 13b, 13c, 13f, 13g, 14b,
and 14g. To a stirred solution of aldehyde (2.10 mmol) in MeOH (10.5 mL)
was added at rt a 40% MeOH solution of MeNH2 (0.429 mL, 4.20 mmol). After
1 h at rt, NaBH4 (159 mg, 4.20 mmol) was added at 0°C and the mixture was
stirred at rt for 30 min. The reaction mixture was quenched with acetone
(20 mL) at 0°C and the new mixture was concentrated under reduced
pressure. The residual white solids were used for the next step without
purification. To a stirred solution of the residue in a mixture of 1:1:1
THF-acetone-H2O (10.0 mL) was added at 0°C ClCO2R (3.78 mmol) or FmocOSu
(1.28 g, 3.78 mmol, for 17g and S15). After 2 h at rt, saturated aqueous
NaHCO3 (10 mL) was added at 0°C and the mixture was extracted with EtOAc
(10 mL x 3). The extracts were washed with saturated aqueous NaCl (10
mL), dried over Na2SO4, and concentrated under reduced pressure. The
residue was purified by column chromatography on silica gel to afford
carbamates 5b, 6b, 7b, S1, S4, 10b, 11b, 12b, 13b, 13c, 13f, 13g, 14b,
and 14g. From 3-methoxybenzaldehyde. Isopropyl
3-methoxybenzyl(methyl)carbamate (5b) as a colorless syrup, yield 92%. Rf
= 0.34 (3:1 hexane-EtOAc); IR (neat, cm-1) 2980, 1698, 1602, 1490, 1457,
1400, 1262, 1234, 1151, 1113; 1H NMR (500 MHz, (CD3)2SO, 80°C, solvent
residual peak = 2.50) δ 1.21 (6H, d, J = 6.3 Hz), 2.80 (3H, s), 3.76 (3H,
s), 4.38 (2H, s), 4.84 (1H, sept, J = 6.3 Hz), 6.77-6.86 (3H, m), 7.26
(1H, dd, J = 7.8, 7.8 Hz); 13C NMR (125 MHz, 80°C, (CD3)2SO) δ 21.5,
33.4, 51.2, 54.7, 67.6, 112.3, 112.8, 119.1, 129.1, 139.2, 155.1, 159.2;
LRMS (EI) m/z (M)+ 237.1; HRMS (EI) m/z (M)+ calcd for C13H19NO3
237.1365, found 237.1361.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Smooth Isoindolinone Formation from Isopropyl Carbamates via
Bischler-Napieralski-Type Cyclization
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Adachi, Satoshi; Onozuka, Masao; Yoshida, Yuko; Ide, Mitsuaki; Saikawa,
Yoko; Nakata, Masaya
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2014), 16(2), 358-361

$RFMT $RIREG SCHEME143 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-5-methoxybenzaldehyde
C8H7BrO2
7507-86-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 2.6674 0.0 0
M  V30 2 O 6.9300 4.0011 0.0 0
M  V30 3 Br 4.6200 0.0000 0.0 0
M  V30 4 O 1.5400 5.3349 0.0 0
M  V30 5 C 0.0000 5.3349 0.0 0
M  V30 6 C 4.6200 2.6674 0.0 0
M  V30 7 C 3.8500 4.0011 0.0 0
M  V30 8 C 3.8500 1.3338 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 2.3100 1.3338 0.0 0
M  V30 11 C 1.5400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 1 3 8
M  V30 4 1 4 5
M  V30 5 1 4 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Isopropyl chloroformate
C4H7ClO2
108-23-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6674 2.3100 0.0 0
M  V30 2 C 4.0011 1.5400 0.0 0
M  V30 3 C 1.3338 1.5400 0.0 0
M  V30 4 C 5.3349 2.3100 0.0 0
M  V30 5 C 4.0011 0.0000 0.0 0
M  V30 6 Cl 1.3338 0.0000 0.0 0
M  V30 7 O 0.0000 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Methylethyl N-[(2-bromo-5-methoxyphenyl)methyl]-N-methylcarbamate
C13H18BrNO3
1520080-21-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3901 2.6675 0.0 0
M  V30 2 N 4.6201 4.0012 0.0 0
M  V30 3 C 3.0801 4.0012 0.0 0
M  V30 4 C 5.3901 5.3348 0.0 0
M  V30 5 O 2.3101 5.3348 0.0 0
M  V30 6 O 2.3101 2.6675 0.0 0
M  V30 7 C 0.7700 5.3348 0.0 0
M  V30 8 C 0.0000 4.0012 0.0 0
M  V30 9 C 0.0000 6.6687 0.0 0
M  V30 10 Br 6.9302 0.0000 0.0 0
M  V30 11 O 10.0102 5.3348 0.0 0
M  V30 12 C 11.5503 5.3348 0.0 0
M  V30 13 C 6.9302 2.6675 0.0 0
M  V30 14 C 7.7002 4.0012 0.0 0
M  V30 15 C 7.7002 1.3338 0.0 0
M  V30 16 C 9.2402 4.0012 0.0 0
M  V30 17 C 9.2402 1.3338 0.0 0
M  V30 18 C 10.0102 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 10 15
M  V30 11 1 11 12
M  V30 12 1 11 16
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 7507-86-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 108-23-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1520080-21-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-10413218
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 5
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-64-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedures for Synthesis of
Carbamates: Method B. Preparation of carbamates 5b, 6b, 7b, S1, S4, 10b,
11b, 12b, 13b, 13c, 13f, 13g, 14b, and 14g. To a stirred solution of
aldehyde (2.10 mmol) in MeOH (10.5 mL) was added at rt a 40% MeOH
solution of MeNH2 (0.429 mL, 4.20 mmol). After 1 h at rt, NaBH4 (159 mg,
4.20 mmol) was added at 0°C and the mixture was stirred at rt for 30 min.
The reaction mixture was quenched with acetone (20 mL) at 0°C and the new
mixture was concentrated under reduced pressure. The residual white
solids were used for the next step without purification. To a stirred
solution of the residue in a mixture of 1:1:1 THF-acetone-H2O (10.0 mL)
was added at 0°C ClCO2R (3.78 mmol) or FmocOSu (1.28 g, 3.78 mmol, for
17g and S15). After 2 h at rt, saturated aqueous NaHCO3 (10 mL) was added
at 0°C and the mixture was extracted with EtOAc (10 mL x 3). The extracts
were washed with saturated aqueous NaCl (10 mL), dried over Na2SO4, and
concentrated under reduced pressure. The residue was purified by column
chromatography on silica gel to afford carbamates 5b, 6b, 7b, S1, S4,
10b, 11b, 12b, 13b, 13c, 13f, 13g, 14b, and 14g. From
3-methoxybenzaldehyde. From 2-bromo-5-methoxybenzaldehyde. Isopropyl
2-bromo-5-methoxybenzyl(methyl)carbamate (6b) as a colorless syrup, yield
92%. Rf = 0.36 (3:1 hexane-EtOAc); IR (neat, cm-1) 2980, 1700, 1470,
1399, 1296, 1238, 1159, 1112, 1019; 1H NMR (500 MHz, (CD3)2SO, 80°C,
solvent residual peak = 2.50) δ 1.20 (6H, d, J = 6.3 Hz), 2.85 (3H, s),
3.76 (3H, s), 4.44 (2H, s), 4.83 (1H, sept, J = 6.3 Hz), 6.73 (1H, d, J =
2.9 Hz), 6.84 (1H, dd, J = 8.9, 2.9 Hz), 7.50 (1H, d, J = 8.9 Hz); 13C
NMR (125 MHz, 80°C, (CD3)2SO) δ 21.5, 33.8, 51.6, 55.0, 67.8, 112.2,
114.1, 114.2, 133.0, 137.3, 155.1, 158.8; LRMS (EI) m/z (M)+ 315.1; HRMS
(EI) m/z (M)+ calcd for C13H18NO3Br 315.0470, found 315.0493.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Smooth Isoindolinone Formation from Isopropyl Carbamates via
Bischler-Napieralski-Type Cyclization
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Adachi, Satoshi; Onozuka, Masao; Yoshida, Yuko; Ide, Mitsuaki; Saikawa,
Yoko; Nakata, Masaya
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2014), 16(2), 358-361

$RFMT $RIREG SCHEME144 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Indole-3-carboxylic acid, 1-methyl-, methyl ester
C11H11NO2
108438-43-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7308 4.6948 0.0 0
M  V30 2 O 7.1955 4.2189 0.0 0
M  V30 3 O 5.4106 6.2011 0.0 0
M  V30 4 C 8.3399 5.2494 0.0 0
M  V30 5 C 3.0203 0.0000 0.0 0
M  V30 6 C 3.0801 3.9845 0.0 0
M  V30 7 C 4.5864 3.6644 0.0 0
M  V30 8 C 2.3101 2.6509 0.0 0
M  V30 9 C 2.3101 5.3182 0.0 0
M  V30 10 C 4.7473 2.1326 0.0 0
M  V30 11 N 3.3405 1.5063 0.0 0
M  V30 12 C 0.7700 2.6509 0.0 0
M  V30 13 C 0.7700 5.3182 0.0 0
M  V30 14 C 0.0000 3.9845 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 11
M  V30 14 1 12 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,1-Dimethyl-1H-indole-3-carboxamide
C11H12N2O
85729-22-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7308 4.6948 0.0 0
M  V30 2 N 7.1955 4.2189 0.0 0
M  V30 3 O 5.4106 6.2011 0.0 0
M  V30 4 C 8.3399 5.2494 0.0 0
M  V30 5 C 3.0203 0.0000 0.0 0
M  V30 6 C 3.0801 3.9845 0.0 0
M  V30 7 C 4.5864 3.6644 0.0 0
M  V30 8 C 2.3101 2.6509 0.0 0
M  V30 9 C 2.3101 5.3182 0.0 0
M  V30 10 C 4.7473 2.1326 0.0 0
M  V30 11 N 3.3405 1.5063 0.0 0
M  V30 12 C 0.7700 2.6509 0.0 0
M  V30 13 C 0.7700 5.3182 0.0 0
M  V30 14 C 0.0000 3.9845 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 11
M  V30 14 1 12 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 108438-43-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 85729-22-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-12989730
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Preparation 11 Preparation of 1-methyl-3-(methylaminomethyl)-1H-indole
(Method B) [0680] To a solution of 1-methylindole-3-carboxaldehyde (10.0
g, 62.8 mmole) in MeOH (100 mL) was added a solution of 2.0 M CH3NH2 in
MeOH (126 mL, 252.0 mmole). The reaction was stirred at RT for 2 hrs,
then was concentrated to a light yellow oil. This oil was dissolved in
EtOH (300 mL), and NaBH4 (2.38 g, 62.8 mmole) was added. After 2 hrs the
reaction was concentrated to a slurry and dissolved in 1.0 N NaOH (75
mL). The aqueous solution was extracted with Et2O (2×200 mL) and the
combined organic fractions were dried over Na2SO4 and concentrated. Flash
chromatography on silica gel (9:1 CHCl3/MeOH containing 5% NH4OH) and
drying in high vacuum left the title compound (10.1 g, 92%) as a faintly
yellow oil. MS (ES) m/e 175 (M+H)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20060142265 A1 2006-06-29

$RFMT $RIREG SCHEME144 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Indole-3-carboxylic acid, 1-methyl-, methyl ester
C11H11NO2
108438-43-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7308 4.6948 0.0 0
M  V30 2 O 7.1955 4.2189 0.0 0
M  V30 3 O 5.4106 6.2011 0.0 0
M  V30 4 C 8.3399 5.2494 0.0 0
M  V30 5 C 3.0203 0.0000 0.0 0
M  V30 6 C 3.0801 3.9845 0.0 0
M  V30 7 C 4.5864 3.6644 0.0 0
M  V30 8 C 2.3101 2.6509 0.0 0
M  V30 9 C 2.3101 5.3182 0.0 0
M  V30 10 C 4.7473 2.1326 0.0 0
M  V30 11 N 3.3405 1.5063 0.0 0
M  V30 12 C 0.7700 2.6509 0.0 0
M  V30 13 C 0.7700 5.3182 0.0 0
M  V30 14 C 0.0000 3.9845 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 11
M  V30 14 1 12 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,1-Dimethyl-1H-indole-3-carboxamide
C11H12N2O
85729-22-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7308 4.6948 0.0 0
M  V30 2 N 7.1955 4.2189 0.0 0
M  V30 3 O 5.4106 6.2011 0.0 0
M  V30 4 C 8.3399 5.2494 0.0 0
M  V30 5 C 3.0203 0.0000 0.0 0
M  V30 6 C 3.0801 3.9845 0.0 0
M  V30 7 C 4.5864 3.6644 0.0 0
M  V30 8 C 2.3101 2.6509 0.0 0
M  V30 9 C 2.3101 5.3182 0.0 0
M  V30 10 C 4.7473 2.1326 0.0 0
M  V30 11 N 3.3405 1.5063 0.0 0
M  V30 12 C 0.7700 2.6509 0.0 0
M  V30 13 C 0.7700 5.3182 0.0 0
M  V30 14 C 0.0000 3.9845 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 11
M  V30 14 1 12 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 108438-43-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 85729-22-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-6170612
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004082586 A2 2004-09-30

$RFMT $RIREG SCHEME145 STEP1
$RXN



  4  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,2′-[(4-Fluoro-3-nitrophenyl)imino]bis[ethanol]
C10H13FN2O4
29705-38-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6684 3.8500 0.0 0
M  V30 2 C 8.0021 4.6200 0.0 0
M  V30 3 C 6.6684 2.3100 0.0 0
M  V30 4 C 9.3358 3.8500 0.0 0
M  V30 5 C 8.0021 1.5400 0.0 0
M  V30 6 O 10.6694 4.6200 0.0 0
M  V30 7 O 8.0021 0.0000 0.0 0
M  V30 8 N 1.3336 3.8500 0.0 0 VAL=5
M  V30 9 O 1.3336 2.3100 0.0 0
M  V30 10 O 0.0000 4.6200 0.0 0
M  V30 11 F 1.3336 6.9300 0.0 0
M  V30 12 C 5.3347 4.6200 0.0 0
M  V30 13 C 4.0011 3.8500 0.0 0
M  V30 14 C 5.3347 6.1600 0.0 0
M  V30 15 C 2.6673 4.6200 0.0 0
M  V30 16 C 4.0011 6.9300 0.0 0
M  V30 17 C 2.6673 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 8 9
M  V30 9 2 8 10
M  V30 10 1 8 15
M  V30 11 1 11 17
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Glutaric anhydride
C5H6O3
108-55-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 3.0800 0.0 0
M  V30 2 O 5.3349 3.0800 0.0 0
M  V30 3 O 2.6675 3.0800 0.0 0
M  V30 4 C 1.3338 2.3100 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 1.3338 0.7700 0.0 0
M  V30 7 C 4.0011 0.7700 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 4
M  V30 2 2 2 5
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methanol
CH4O
67-56-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 5-[bis(2-hydroxyethyl)amino]-1-methyl-1H-benzimidazole-2-butanoate
C17H25N3O4
109882-31-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.9426 8.1004 0.0 0
M  V30 2 N 4.0011 3.8500 0.0 0
M  V30 3 C 2.6674 4.6200 0.0 0
M  V30 4 C 4.0011 2.3100 0.0 0
M  V30 5 C 1.3336 3.8500 0.0 0
M  V30 6 C 2.6674 1.5400 0.0 0
M  V30 7 O 0.0000 4.6200 0.0 0
M  V30 8 O 2.6674 0.0000 0.0 0
M  V30 9 C 11.9120 5.3900 0.0 0
M  V30 10 C 12.6820 4.0562 0.0 0
M  V30 11 C 14.2220 4.0562 0.0 0
M  V30 12 C 14.9920 2.7226 0.0 0
M  V30 13 O 16.5320 2.7226 0.0 0
M  V30 14 O 14.2220 1.3889 0.0 0
M  V30 15 C 17.3020 1.3889 0.0 0
M  V30 16 C 8.0022 4.6200 0.0 0
M  V30 17 C 8.0022 6.1600 0.0 0
M  V30 18 C 6.6684 3.8500 0.0 0
M  V30 19 N 9.4667 4.1440 0.0 0
M  V30 20 N 9.4667 6.6359 0.0 0
M  V30 21 C 6.6684 6.9300 0.0 0
M  V30 22 C 5.3347 4.6200 0.0 0
M  V30 23 C 10.3720 5.3900 0.0 0
M  V30 24 C 5.3347 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 20
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 22
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 23
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 1 13 15
M  V30 16 1 16 17
M  V30 17 2 16 18
M  V30 18 1 16 19
M  V30 19 1 17 20
M  V30 20 2 17 21
M  V30 21 1 18 22
M  V30 22 2 19 23
M  V30 23 1 20 23
M  V30 24 1 21 24
M  V30 25 2 22 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 29705-38-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 108-55-4
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 109882-31-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-2662806
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 5
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 10043-35-3
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1333-74-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-05-3
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 79-20-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 2 A 300 ml, pressure reactor equipped with a magnetic stirring
bar was charged with the compound of formula [12] (19.54 g, 0.08 mol),
boric acid (1.48 g, 24 mmol), and methylamine aqueous solution (35 ml,
0.4 mol). The mixture was stirred at 800 rpm at 70°C in the sealed
reactor for 6.0 h. The mixture was concentrated on a rotary evaporator at
75°C at 700 mbar and co-evaporated with methanol (150) ml three times.
The evaporation residue was diluted with 150 ml of methanol and
transferred into a pressure reactor containing palladium on activated
carbon (4.37 g, 1.6 mmol, 3.9 % wet basis) moistened with water (I ml).
The reactor was flushed with nitrogen three times, with hydrogen four
times, and pressurized to 50 psi with hydrogen. The reaction mixture was
stirred at 900 rpm at 23°C for 2.5 h under hydrogen atmosphere of 50-55
psi. The reactor was charged with a solution of glutaric anhydride (12.36
g, 0.1 mol, 96 %) in methyl acetate (30 ml) via a syringe over 0.1 h and
the mixture was stirred at 1000 rpm at 23°C for 2.0 h under nitrogen
atmosphere. The mixture was filtered over a sintered glass filter and the
filtrate was collected in a 500 ml, round bottomed flask. The flask was
equipped with a magnetic stirring bar as well as a reflux condenser and
charged with hydrochloric acid (16.11 ml, 0.18 mol, 35 %). The reaction
mixture was stirred at 700 rpm at 73°C for 2.5 h and cooled to room
temperature over 1.0 h. The pH of the mixture was adjusted with
concentrated aqueous ammonia solution to the value of 6.0 and the mixture
was concentrated at 60°C at 350-100 mbar on the rotary evaporator. The
residue was diluted with water (150 ml) and washed with dichloromethane
(200 ml). The pH of the aqueous layer was adjusted with concentrated
aqueous ammonia solution to the value of 8.5 and the layer was extracted
with dichloromethane (200 ml). The extract was concentrated at 60°C at
950 mbar to one fifth of initial volume and diluted with ethyl acetate
(200 ml). The solution was filtered over a sintered glass filter and the
filtrate was evaporated at 60°C at 450-100 mbar. [11, R = Me] (24.6 g) in
an overall isolated yield of 92%. Characterization: 1H NMR (400 MHz,
DMSO-d6): δ (ppm) = 2.04 (q, J = 7.33 Hz, 2H), 2.48 (t, J = 7.33 Hz, 2H),
2.82 (t, J = 7.38 Hz, 2H), 3.41 (t, J = 6.32 Hz, 4H), 3.58 (t, J = 6.34
Hz, 4H), 3.61 (s, 3H), 3.64 (s, 3H), 4.57 (s, b, 2H), 6.75 (dd, J 1 =
2.35 Hz, J 2 = 8.81 Hz, 1H), 6.89 (d, J = 2.27 Hz, 1H), 7.22 (d, J = 8.80
Hz, 1H).
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used in stage 1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Process for making bendamustine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bartos, Petr; Benovsky, Petr; Bartl, Jiri
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2013150020 A1 2013-10-10

$RFMT $RIREG SCHEME146 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4H-1,3,2-Oxazaphosphorin-4-one, 2-chloro-5-(3-chloropropyl)-2,3-dihydro-6-met...
C13H14Cl2NO3P
1093777-40-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 5.2971 0.0 0
M  V30 2 Cl 3.4743 0.0000 0.0 0
M  V30 3 O 2.4845 1.7145 0.0 0
M  V30 4 C 8.0022 3.7571 0.0 0
M  V30 5 C 9.3360 2.9870 0.0 0
M  V30 6 C 10.6697 3.7571 0.0 0
M  V30 7 Cl 12.0033 2.9870 0.0 0
M  V30 8 C 8.0022 0.6770 0.0 0
M  V30 9 N 4.0012 2.9870 0.0 0
M  V30 10 C 5.3348 3.7571 0.0 0
M  V30 11 P 4.0012 1.4470 0.0 0 VAL=5
M  V30 12 C 6.6685 2.9870 0.0 0
M  V30 13 O 5.3348 0.6770 0.0 0
M  V30 14 C 6.6685 1.4470 0.0 0
M  V30 15 C 2.6673 3.7571 0.0 0
M  V30 16 C 1.3337 2.9870 0.0 0
M  V30 17 C 2.6673 5.2971 0.0 0
M  V30 18 C 0.0000 3.7571 0.0 0
M  V30 19 C 1.3337 6.0671 0.0 0
M  V30 20 C 0.0000 5.2971 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 1 2 11
M  V30 3 2 3 11
M  V30 4 1 4 5
M  V30 5 1 4 12
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 8 14
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 15
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4H-1,3,2-Oxazaphosphorin-4-one, 5-(3-chloropropyl)-2,3-dihydro-6-methyl-2-(me...
C14H18ClN2O3P
1104564-97-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.4845 4.3526 0.0 0
M  V30 2 C 1.4946 5.5323 0.0 0
M  V30 3 O 3.4743 6.0671 0.0 0
M  V30 4 O 5.3348 0.7700 0.0 0
M  V30 5 C 8.0022 2.3101 0.0 0
M  V30 6 C 9.3360 3.0801 0.0 0
M  V30 7 C 10.6697 2.3101 0.0 0
M  V30 8 Cl 12.0033 3.0801 0.0 0
M  V30 9 C 8.0022 5.3901 0.0 0
M  V30 10 N 4.0012 3.0801 0.0 0
M  V30 11 P 4.0012 4.6201 0.0 0 VAL=5
M  V30 12 C 5.3348 2.3101 0.0 0
M  V30 13 O 5.3348 5.3901 0.0 0
M  V30 14 C 6.6685 3.0801 0.0 0
M  V30 15 C 6.6685 4.6201 0.0 0
M  V30 16 C 2.6673 2.3101 0.0 0
M  V30 17 C 1.3337 3.0801 0.0 0
M  V30 18 C 2.6673 0.7700 0.0 0
M  V30 19 C 0.0000 2.3101 0.0 0
M  V30 20 C 1.3337 0.0000 0.0 0
M  V30 21 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 2 3 11
M  V30 4 2 4 12
M  V30 5 1 5 6
M  V30 6 1 5 14
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 9 15
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 16
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1093777-40-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1104564-97-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-569-CAS-4714308
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Efficient and divergent synthesis of cyclophosphamide analogues from
2-arylamino-3-acetyl-5,6-dihydro-4H-pyrans
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xiang, Dexuan; Huang, Peng; Wang, Kewei; Zhou, Guangyuan; Liang, Yongjiu;
Dong, Dewen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Communications (Cambridge, United Kingdom) (2008), (46),
6236-6238

$RFMT $RIREG SCHEME147 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N-methoxy-9-methyl-9H-purin-6-amine
C7H8ClN5O
1095281-95-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6520 4.6201 0.0 0
M  V30 2 O 7.9857 3.8501 0.0 0
M  V30 3 C 9.3194 4.6201 0.0 0
M  V30 4 C 0.0000 4.5603 0.0 0
M  V30 5 Cl 3.9845 0.0000 0.0 0
M  V30 6 C 3.9845 4.6201 0.0 0
M  V30 7 C 2.6509 3.8501 0.0 0
M  V30 8 C 5.3182 3.8501 0.0 0
M  V30 9 N 3.6644 6.1264 0.0 0
M  V30 10 N 1.5063 4.8805 0.0 0
M  V30 11 N 2.6509 2.3101 0.0 0
M  V30 12 N 5.3182 2.3101 0.0 0
M  V30 13 C 2.1328 6.2873 0.0 0
M  V30 14 C 3.9845 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 8 CFG=2
M  V30 3 1 2 3
M  V30 4 1 4 10
M  V30 5 1 5 14
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 13
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 2 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-(Methoxyamino)-9-methyl-9H-purine-2-methanamine
C8H12N6O
1322686-21-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6520 5.3901 0.0 0
M  V30 2 O 7.9857 4.6201 0.0 0
M  V30 3 C 9.3194 5.3901 0.0 0
M  V30 4 C 0.0000 5.3304 0.0 0
M  V30 5 C 3.9845 0.7700 0.0 0
M  V30 6 N 2.6509 0.0000 0.0 0
M  V30 7 C 3.9845 5.3901 0.0 0
M  V30 8 C 2.6509 4.6201 0.0 0
M  V30 9 C 5.3182 4.6201 0.0 0
M  V30 10 N 3.6644 6.8964 0.0 0
M  V30 11 N 2.6509 3.0801 0.0 0
M  V30 12 N 1.5063 5.6505 0.0 0
M  V30 13 N 5.3182 3.0801 0.0 0
M  V30 14 C 2.1328 7.0574 0.0 0
M  V30 15 C 3.9845 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 9 CFG=2
M  V30 3 1 2 3
M  V30 4 1 4 12
M  V30 5 1 5 6
M  V30 6 1 5 15
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1095281-95-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1322686-21-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28752107
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):NOTES
$DATUM no experimental detail, methylamine reactant assumed
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 2-substituted agelasine analogs: synthesis and biological activity, and
structure and reactivity of synthetic intermediates
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Roggen, Heidi; Bohlin, Lars; Burman, Robert; Charnock, Colin; Felth,
Jenny; Gorbitz, Carl Henrik; Larsson, Rolf; Tamm, Toomas; Gundersen,
Lise-LotteIUPAC Commission
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Pure and Applied Chemistry (2011), 83(3), 645-653

$RFMT $RIREG SCHEME148 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromobenzaldehyde
C7H5BrO
1122-91-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 Br 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Propyl chloroformate
C4H7ClO2
109-61-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6675 2.3100 0.0 0
M  V30 2 C 1.3338 1.5400 0.0 0
M  V30 3 C 4.0011 1.5400 0.0 0
M  V30 4 Cl 0.0000 2.3100 0.0 0
M  V30 5 O 1.3338 0.0000 0.0 0
M  V30 6 C 5.3348 2.3100 0.0 0
M  V30 7 C 6.6686 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 1 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Propyl N-[(4-bromophenyl)methyl]-N-methylcarbamate
C12H16BrNO2
1520080-31-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 1.5400 0.0 0
M  V30 2 N 6.6685 2.3101 0.0 0
M  V30 3 C 8.0022 1.5400 0.0 0
M  V30 4 C 6.6685 3.8501 0.0 0
M  V30 5 O 9.3360 2.3101 0.0 0
M  V30 6 O 8.0022 0.0000 0.0 0
M  V30 7 C 10.6697 1.5400 0.0 0
M  V30 8 C 12.0033 2.3101 0.0 0
M  V30 9 C 13.3370 1.5400 0.0 0
M  V30 10 Br 0.0000 4.6201 0.0 0
M  V30 11 C 4.0010 2.3101 0.0 0
M  V30 12 C 4.0010 3.8501 0.0 0
M  V30 13 C 2.6673 1.5400 0.0 0
M  V30 14 C 2.6673 4.6201 0.0 0
M  V30 15 C 1.3337 2.3101 0.0 0
M  V30 16 C 1.3337 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 10 16
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1122-91-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 109-61-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1520080-31-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-7792798
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 5
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-64-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedures for Synthesis of
Carbamates: Method B. Preparation of carbamates 5b, 6b, 7b, S1, S4, 10b,
11b, 12b, 13b, 13c, 13f, 13g, 14b, and 14g. To a stirred solution of
aldehyde (2.10 mmol) in MeOH (10.5 mL) was added at rt a 40% MeOH
solution of MeNH2 (0.429 mL, 4.20 mmol). After 1 h at rt, NaBH4 (159 mg,
4.20 mmol) was added at 0°C and the mixture was stirred at rt for 30 min.
The reaction mixture was quenched with acetone (20 mL) at 0°C and the new
mixture was concentrated under reduced pressure. The residual white
solids were used for the next step without purification. To a stirred
solution of the residue in a mixture of 1:1:1 THF-acetone-H2O (10.0 mL)
was added at 0°C ClCO2R (3.78 mmol) or FmocOSu (1.28 g, 3.78 mmol, for
17g and S15). After 2 h at rt, saturated aqueous NaHCO3 (10 mL) was added
at 0°C and the mixture was extracted with EtOAc (10 mL x 3). The extracts
were washed with saturated aqueous NaCl (10 mL), dried over Na2SO4, and
concentrated under reduced pressure. The residue was purified by column
chromatography on silica gel to afford carbamates 5b, 6b, 7b, S1, S4,
10b, 11b, 12b, 13b, 13c, 13f, 13g, 14b, and 14g. From
3-methoxybenzaldehyde. From 4-bromobenzaldehyde. n-Propyl
4-bromobenzyl(methyl)carbamate (13c) as a colorless syrup, yield 92%. Rf
= 0.34 (4:1 hexane-EtOAc); IR (neat, cm-1) 2968, 1701, 1488, 1403, 1380,
1221, 1146, 1071, 794; 1H NMR (500 MHz, (CD3)2SO, 80°C, solvent residual
peak = 2.50) δ 0.88 (3H, t, J = 7.5 Hz), 1.59 (2H, tq, J = 7.5, 6.6 Hz),
2.82 (3H, s), 4.00 (2H, t, J = 6.6 Hz), 4.40 (2H, s), 7.19 (2H, d, J =
8.3 Hz), 7.52 (2H, d, J = 8.3 Hz); 13C NMR (125 MHz, 80°C, (CD3)2SO) δ
9.7, 21.5, 33.5, 50.8, 66.1, 119.8, 129.1, 131.0, 137.0, 155.5; LRMS (EI)
m/z (M)+ 285.0; HRMS (EI) m/z (M)+ calcd for C12H16NO2Br 285.0364, found
285.0345.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Smooth Isoindolinone Formation from Isopropyl Carbamates via
Bischler-Napieralski-Type Cyclization
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Adachi, Satoshi; Onozuka, Masao; Yoshida, Yuko; Ide, Mitsuaki; Saikawa,
Yoko; Nakata, Masaya
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2014), 16(2), 358-361

$RFMT $RIREG SCHEME149 STEP1
$RXN



  4  1
$MOL
Bromoacetic acid
C2H3BrO2
79-08-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 2.6673 2.3101 0.0 0
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 O 0.0000 2.3101 0.0 0
M  V30 5 Br 4.0010 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-N-(phenylmethyl)-D-alanine
C25H23NO4
2137135-65-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 33 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 4.0011 0.0 0
M  V30 2 O 5.3900 4.0011 0.0 0
M  V30 3 C 4.6200 5.3347 0.0 0
M  V30 4 N 3.0800 5.3347 0.0 0
M  V30 5 O 5.3900 6.6685 0.0 0
M  V30 6 C 2.3100 4.0011 0.0 0
M  V30 7 C 2.3100 6.6685 0.0 0 CFG=2
M  V30 8 C 0.7700 6.6685 0.0 0
M  V30 9 C 3.0800 8.0021 0.0 0
M  V30 10 O 0.0000 8.0021 0.0 0
M  V30 11 O 0.0000 5.3347 0.0 0
M  V30 12 C 7.7000 5.3347 0.0 0
M  V30 13 C 9.2315 5.4958 0.0 0
M  V30 14 C 7.0735 6.7417 0.0 0
M  V30 15 C 9.5517 7.0021 0.0 0
M  V30 16 C 10.3759 4.4652 0.0 0
M  V30 17 C 8.2181 7.7721 0.0 0
M  V30 18 C 5.6090 7.2175 0.0 0
M  V30 19 C 11.0164 7.4779 0.0 0
M  V30 20 C 11.8406 4.9411 0.0 0
M  V30 21 C 7.8979 9.2785 0.0 0
M  V30 22 C 5.2888 8.7238 0.0 0
M  V30 23 C 12.1608 6.4475 0.0 0
M  V30 24 C 6.4332 9.7544 0.0 0
M  V30 25 C 3.0800 2.6674 0.0 0
M  V30 26 C 2.3100 1.3338 0.0 0
M  V30 27 C 4.6200 2.6674 0.0 0
M  V30 28 C 3.0800 0.0000 0.0 0
M  V30 29 C 5.3900 1.3338 0.0 0
M  V30 30 C 4.6200 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 6 25
M  V30 9 1 7 8
M  V30 10 1 7 9 CFG=1
M  V30 11 1 8 10
M  V30 12 2 8 11
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 13 16
M  V30 17 1 14 17
M  V30 18 2 14 18
M  V30 19 1 15 17
M  V30 20 2 15 19
M  V30 21 1 16 20
M  V30 22 2 17 21
M  V30 23 1 18 22
M  V30 24 1 19 23
M  V30 25 2 20 23
M  V30 26 1 21 24
M  V30 27 2 22 24
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 7)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
2-Methoxyethylamine
C3H9NO
109-85-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 0.7700 0.0 0
M  V30 2 C 1.3338 0.0000 0.0 0
M  V30 3 O 4.0010 0.0000 0.0 0
M  V30 4 N 0.0000 0.7700 0.0 0
M  V30 5 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C18H27N3O5
2172815-25-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 26 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 6.9301 5.3348 0.0 0
M  V30 2 C 6.1601 4.0011 0.0 0
M  V30 3 C 6.1601 6.6684 0.0 0 CFG=2
M  V30 4 C 8.4701 5.3348 0.0 0
M  V30 5 C 4.6201 6.6684 0.0 0
M  V30 6 C 6.9301 8.0022 0.0 0
M  V30 7 C 9.2401 6.6684 0.0 0
M  V30 8 O 9.2401 4.0011 0.0 0
M  V30 9 N 3.8500 8.0022 0.0 0
M  V30 10 O 3.8500 5.3348 0.0 0
M  V30 11 N 10.7801 6.6684 0.0 0
M  V30 12 C 2.3100 8.0022 0.0 0
M  V30 13 C 4.6201 9.3359 0.0 0
M  V30 14 C 11.5501 8.0022 0.0 0
M  V30 15 C 1.5400 9.3359 0.0 0
M  V30 16 C 13.0901 8.0022 0.0 0
M  V30 17 O 0.0000 9.3359 0.0 0
M  V30 18 O 2.3100 10.6695 0.0 0
M  V30 19 O 13.8602 9.3359 0.0 0
M  V30 20 C 15.4002 9.3359 0.0 0
M  V30 21 C 6.9301 2.6673 0.0 0
M  V30 22 C 8.4701 2.6673 0.0 0
M  V30 23 C 6.1601 1.3337 0.0 0
M  V30 24 C 9.2401 1.3337 0.0 0
M  V30 25 C 6.9301 0.0000 0.0 0
M  V30 26 C 8.4701 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 21
M  V30 5 1 3 5
M  V30 6 1 3 6 CFG=1
M  V30 7 1 4 7
M  V30 8 2 4 8
M  V30 9 1 5 9
M  V30 10 2 5 10
M  V30 11 1 7 11
M  V30 12 1 9 12
M  V30 13 1 9 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 15 18
M  V30 19 1 16 19
M  V30 20 1 19 20
M  V30 21 2 21 22
M  V30 22 1 21 23
M  V30 23 1 22 24
M  V30 24 2 23 25
M  V30 25 2 24 26
M  V30 26 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 79-08-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 2137135-65-8
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 109-85-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2172815-25-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-18429974
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 6
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 110-89-4
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 920-66-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):NOTES
$DATUM solid-supported reaction, attachment to 2-chlorotrityl resin in stage
1,solid phase peptoide synthesis,cleavage step repeated twice,further
bromoacetic acid-amine coupling carried out by DIC in DMF
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Cyclic peptoids as topological templates: Synthesis via central to
conformational chirality induction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM D'Amato, Assunta; Pierri, Giovanni; Costabile, Chiara; Della Sala,
Giorgio; Tedesco, Consiglia; Izzo, Irene; De Riccardis, Francesco
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2018), 20(3), 640-643

$RFMT $RIREG SCHEME150 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
trans-4-[[5-[2-[[[(3-Methoxyphenyl)methyl]amino]carbonyl]-6-methyl-4-pyridiny...
C24H28N6O4
1112173-02-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 14.4562 6.7475 0.0 0
M  V30 2 N 15.7898 7.5175 0.0 0
M  V30 3 O 14.4562 5.2074 0.0 0
M  V30 4 C 17.1235 6.7475 0.0 0
M  V30 5 C 11.7887 11.3675 0.0 0
M  V30 6 C 5.1525 6.3905 0.0 0
M  V30 7 C 1.5317 1.4068 0.0 0
M  V30 8 O 2.1580 0.0000 0.0 0
M  V30 9 O 0.0000 1.5677 0.0 0
M  V30 10 O 22.4583 6.7475 0.0 0
M  V30 11 C 23.7921 7.5175 0.0 0
M  V30 12 C 10.4551 7.5175 0.0 0
M  V30 13 C 11.7887 6.7475 0.0 0
M  V30 14 C 10.4551 9.0575 0.0 0
M  V30 15 C 13.1225 7.5175 0.0 0
M  V30 16 C 11.7887 9.8275 0.0 0
M  V30 17 N 13.1225 9.0575 0.0 0
M  V30 18 C 9.1214 6.7475 0.0 0
M  V30 19 N 7.7144 7.3739 0.0 0
M  V30 20 N 8.9605 5.2159 0.0 0
M  V30 21 N 6.6840 6.2294 0.0 0
M  V30 22 N 7.4540 4.8957 0.0 0
M  V30 23 C 4.2472 5.1444 0.0 0 CFG=1
M  V30 24 C 2.7157 5.3055 0.0 0
M  V30 25 C 4.8736 3.7376 0.0 0
M  V30 26 C 1.8104 4.0597 0.0 0
M  V30 27 C 3.9685 2.4918 0.0 0
M  V30 28 C 2.4368 2.6527 0.0 0 CFG=1
M  V30 29 C 18.4573 7.5175 0.0 0
M  V30 30 C 19.7910 6.7475 0.0 0
M  V30 31 C 18.4573 9.0575 0.0 0
M  V30 32 C 21.1246 7.5175 0.0 0
M  V30 33 C 19.7910 9.8275 0.0 0
M  V30 34 C 21.1246 9.0575 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 4 29
M  V30 6 1 5 16
M  V30 7 1 6 21
M  V30 8 1 23 6 CFG=1
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 1 28 7 CFG=3
M  V30 12 1 10 11
M  V30 13 1 10 32
M  V30 14 1 12 13
M  V30 15 2 12 14
M  V30 16 1 12 18
M  V30 17 2 13 15
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 2 16 17
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 1 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 1 27 28
M  V30 32 2 29 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 2 31 33
M  V30 36 2 32 34
M  V30 37 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 23 28)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[(3-Methoxyphenyl)methyl]-6-methyl-4-[2-[[trans-4-[(methylamino)carbonyl]cy...
C25H31N7O3
1112173-25-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 16.7059 8.3436 0.0 0
M  V30 2 C 8.4700 4.0011 0.0 0
M  V30 3 N 6.9300 4.0011 0.0 0
M  V30 4 O 9.2400 2.6674 0.0 0
M  V30 5 C 6.1600 2.6674 0.0 0
M  V30 6 C 8.4700 9.3358 0.0 0
M  V30 7 C 22.3332 5.8382 0.0 0
M  V30 8 N 23.5792 6.7434 0.0 0
M  V30 9 O 22.4943 4.3066 0.0 0
M  V30 10 C 24.9860 6.1169 0.0 0
M  V30 11 O 1.5400 0.0000 0.0 0
M  V30 12 C 0.0000 0.0000 0.0 0
M  V30 13 C 13.0901 6.6684 0.0 0
M  V30 14 N 13.9953 7.9144 0.0 0
M  V30 15 N 13.9953 5.4225 0.0 0
M  V30 16 N 15.4598 7.4384 0.0 0
M  V30 17 N 15.4598 5.8984 0.0 0
M  V30 18 C 11.5501 6.6684 0.0 0
M  V30 19 C 10.7801 5.3347 0.0 0
M  V30 20 C 10.7801 8.0022 0.0 0
M  V30 21 C 9.2400 5.3347 0.0 0
M  V30 22 C 9.2400 8.0022 0.0 0
M  V30 23 N 8.4700 6.6684 0.0 0
M  V30 24 C 18.1126 7.7173 0.0 0 CFG=2
M  V30 25 C 18.2736 6.1857 0.0 0
M  V30 26 C 19.3585 8.6225 0.0 0
M  V30 27 C 19.6805 5.5593 0.0 0
M  V30 28 C 20.7655 7.9960 0.0 0
M  V30 29 C 20.9264 6.4645 0.0 0 CFG=2
M  V30 30 C 4.6200 2.6674 0.0 0
M  V30 31 C 3.8500 1.3336 0.0 0
M  V30 32 C 3.8500 4.0011 0.0 0
M  V30 33 C 2.3100 1.3336 0.0 0
M  V30 34 C 2.3100 4.0011 0.0 0
M  V30 35 C 1.5400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 16
M  V30 2 1 24 1 CFG=3
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 21
M  V30 6 1 3 5
M  V30 7 1 5 30
M  V30 8 1 6 22
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 1 29 7 CFG=1
M  V30 12 1 8 10
M  V30 13 1 11 12
M  V30 14 1 11 33
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 13 18
M  V30 18 1 14 16
M  V30 19 2 15 17
M  V30 20 1 16 17
M  V30 21 1 18 19
M  V30 22 2 18 20
M  V30 23 2 19 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 23
M  V30 27 1 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 1 28 29
M  V30 33 2 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 2 32 34
M  V30 37 2 33 35
M  V30 38 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 24 29)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1112173-02-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1112173-25-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-14154594
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Example 275.
N-(3-Methoxybenzyl)-6-methyl-4-(2-(((trans)-4-(methylcarbamoyl)cyclohexyl)methyl)-2H-tetrazol-5-yl)picolinamide.
O-(7-Azabenzotriazole-1-yl)-N,NN'N'-tetramethyluronium
hexafluorophosphate (49.0 mg, 0.130 mmol), methylamine (0.054 mL of a 2M
solution in tetrahydrofuran, 0.108 mmol), and diisopropylethylamine
(0.038 mL, 0.216 mmol) was added to a solution of
(trans)-4-((5-(2-((3-methoxybenzyl)carbamoyl)-6-methylpyridin-4-yl)-2H-tetrazol-2-yl
)methyl)cyclohexanecarboxylic acid (prepared as described in Example 268)
(50.0 mg, 0.108 mmol) in N,N-dimethylformamide (1 mL), and the mixture
was stirred overnight at room temperature. The reaction mixture was
concentrated and the residue was purified by reverse phase preparative
HPLC (5%-95% CH3CN/H2O, 8 min.) as a solid (47.4 mg, 92%). LC/MS (5%-95%
CH3CN/H2O, 4.5 min.; 95% CH3CN, 1.5 min.): 2.996 min., m/z 478 (M+H). 1H
NMR (400 MHz, DMSO-d6) δ ppm 0.95 - 1.18 (m, 2 H), 1.21 - 1.43 (m, 2 H),
1.53 - 1.80 (m, 4 H), 1.87 - 2.13 (m, 1 H), 2.51 (d, J=4.39 Hz, 3 H),
2.65 (s, 3 H), 3.71 (s, 3 H), 4.49 (d, J=6.59 Hz, 2 H), 4.65 (d, J=732
Hz, 2 H), 6.74 - 6.83 (m, 1 H), 6.90 (m, 2 H), 7.15 - 7.29 (m, 1 H), 7.48
- 7.64 (m, 1 H), 8.05 (s, 1 H), 8.40 (s, 1 H), 9.11 - 9.29 (m, 1 H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrimidine and pyridine derivatives as antiinflammatory
agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Schnute, Mark E.; Carroll, Jeffery Neal; Hanau, Cathleen Elizabeth;
McReynolds, Matthew David; Scholten, Jeffrey Allen; McDonald, Joseph J.;
Grapperhaus, Margaret L.; Massa, Mark Alan; Ruminski, Peter G.; Schmidt,
Michelle Ann; Strohback, Joseph Walter; Hamper, Bruce Cameron; Fletcher,
Theresa R.; Rogers, Michael David; O'Brien, Patrick Michael; Nahra, Joe;
Morris, Mark Anthony; Roark, William Howard
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009016498 A1 2009-02-05

$RFMT $RIREG SCHEME151 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 7-chloro-6-fluoro-4-hydroxy-8-nitro-3-quinolinecarboxylate
C12H8ClFN2O5
112857-73-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6673 0.7700 0.0 0 VAL=5
M  V30 2 O 1.3337 0.0000 0.0 0
M  V30 3 O 4.0012 0.0000 0.0 0
M  V30 4 O 5.3348 6.9302 0.0 0
M  V30 5 Cl 0.0000 2.3101 0.0 0
M  V30 6 C 8.0022 5.3901 0.0 0
M  V30 7 O 9.3360 4.6201 0.0 0
M  V30 8 O 8.0022 6.9302 0.0 0
M  V30 9 C 10.6697 5.3901 0.0 0
M  V30 10 C 12.0033 4.6201 0.0 0
M  V30 11 F 0.0000 5.3901 0.0 0
M  V30 12 C 4.0012 3.0801 0.0 0
M  V30 13 C 4.0012 4.6201 0.0 0
M  V30 14 C 2.6673 2.3101 0.0 0
M  V30 15 N 5.3348 2.3101 0.0 0
M  V30 16 C 5.3348 5.3901 0.0 0
M  V30 17 C 2.6673 5.3901 0.0 0
M  V30 18 C 1.3337 3.0801 0.0 0
M  V30 19 C 6.6685 3.0801 0.0 0
M  V30 20 C 6.6685 4.6201 0.0 0
M  V30 21 C 1.3337 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 4 16
M  V30 5 1 5 18
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 20
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 11 21
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 15 1 13 16
M  V30 16 1 13 17
M  V30 17 2 14 18
M  V30 18 2 15 19
M  V30 19 2 16 20
M  V30 20 2 17 21
M  V30 21 1 18 21
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Fluoro-4-hydroxy-N-methyl-7-(methylamino)-8-nitro-3-quinolinecarboxamide
C12H11FN4O4
1147874-37-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0012 0.7700 0.0 0 VAL=5
M  V30 2 O 2.6673 0.0000 0.0 0
M  V30 3 O 5.3348 0.0000 0.0 0
M  V30 4 O 6.6685 6.9302 0.0 0
M  V30 5 N 1.3337 2.3101 0.0 0
M  V30 6 C 0.0000 3.0801 0.0 0
M  V30 7 C 9.3360 5.3901 0.0 0
M  V30 8 N 10.6697 4.6201 0.0 0
M  V30 9 O 9.3360 6.9302 0.0 0
M  V30 10 C 12.0033 5.3901 0.0 0
M  V30 11 F 1.3337 5.3901 0.0 0
M  V30 12 C 5.3348 3.0801 0.0 0
M  V30 13 C 5.3348 4.6201 0.0 0
M  V30 14 C 4.0012 2.3101 0.0 0
M  V30 15 N 6.6685 2.3101 0.0 0
M  V30 16 C 6.6685 5.3901 0.0 0
M  V30 17 C 4.0012 5.3901 0.0 0
M  V30 18 C 2.6673 3.0801 0.0 0
M  V30 19 C 8.0022 3.0801 0.0 0
M  V30 20 C 8.0022 4.6201 0.0 0
M  V30 21 C 2.6673 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 4 16
M  V30 5 1 5 6
M  V30 6 1 5 18
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 20
M  V30 10 1 8 10
M  V30 11 1 11 21
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 15 1 13 16
M  V30 16 1 13 17
M  V30 17 2 14 18
M  V30 18 2 15 19
M  V30 19 2 16 20
M  V30 20 2 17 21
M  V30 21 1 18 21
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 112857-73-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1147874-37-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-3285814
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of fused imidazoquinolone carboxamides as antibacterial
agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rao, Pamulaparthy Shanthan; Reddy, Ghojala Venkat; Narsaiah, Banda;
Rambabu, Yadla; Reddy, Sripathi Narayan; Maidraie, Dravidum; Rao, Vejju
V. V. N. S. Rama; Ravikanth, Sribhashyam; Harakishore, Kankipati;
Upadhyaula, Suryanarayana Murthy
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM India, IN2005DE02853 A 2009-10-02

$RFMT $RIREG SCHEME151 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 7-chloro-6-fluoro-4-hydroxy-8-nitro-3-quinolinecarboxylate
C12H8ClFN2O5
112857-73-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6673 0.7700 0.0 0 VAL=5
M  V30 2 O 1.3337 0.0000 0.0 0
M  V30 3 O 4.0012 0.0000 0.0 0
M  V30 4 O 5.3348 6.9302 0.0 0
M  V30 5 Cl 0.0000 2.3101 0.0 0
M  V30 6 C 8.0022 5.3901 0.0 0
M  V30 7 O 9.3360 4.6201 0.0 0
M  V30 8 O 8.0022 6.9302 0.0 0
M  V30 9 C 10.6697 5.3901 0.0 0
M  V30 10 C 12.0033 4.6201 0.0 0
M  V30 11 F 0.0000 5.3901 0.0 0
M  V30 12 C 4.0012 3.0801 0.0 0
M  V30 13 C 4.0012 4.6201 0.0 0
M  V30 14 C 2.6673 2.3101 0.0 0
M  V30 15 N 5.3348 2.3101 0.0 0
M  V30 16 C 5.3348 5.3901 0.0 0
M  V30 17 C 2.6673 5.3901 0.0 0
M  V30 18 C 1.3337 3.0801 0.0 0
M  V30 19 C 6.6685 3.0801 0.0 0
M  V30 20 C 6.6685 4.6201 0.0 0
M  V30 21 C 1.3337 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 4 16
M  V30 5 1 5 18
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 20
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 11 21
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 15 1 13 16
M  V30 16 1 13 17
M  V30 17 2 14 18
M  V30 18 2 15 19
M  V30 19 2 16 20
M  V30 20 2 17 21
M  V30 21 1 18 21
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Fluoro-4-hydroxy-N-methyl-7-(methylamino)-8-nitro-3-quinolinecarboxamide
C12H11FN4O4
1147874-37-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0012 0.7700 0.0 0 VAL=5
M  V30 2 O 2.6673 0.0000 0.0 0
M  V30 3 O 5.3348 0.0000 0.0 0
M  V30 4 O 6.6685 6.9302 0.0 0
M  V30 5 N 1.3337 2.3101 0.0 0
M  V30 6 C 0.0000 3.0801 0.0 0
M  V30 7 C 9.3360 5.3901 0.0 0
M  V30 8 N 10.6697 4.6201 0.0 0
M  V30 9 O 9.3360 6.9302 0.0 0
M  V30 10 C 12.0033 5.3901 0.0 0
M  V30 11 F 1.3337 5.3901 0.0 0
M  V30 12 C 5.3348 3.0801 0.0 0
M  V30 13 C 5.3348 4.6201 0.0 0
M  V30 14 C 4.0012 2.3101 0.0 0
M  V30 15 N 6.6685 2.3101 0.0 0
M  V30 16 C 6.6685 5.3901 0.0 0
M  V30 17 C 4.0012 5.3901 0.0 0
M  V30 18 C 2.6673 3.0801 0.0 0
M  V30 19 C 8.0022 3.0801 0.0 0
M  V30 20 C 8.0022 4.6201 0.0 0
M  V30 21 C 2.6673 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 4 16
M  V30 5 1 5 6
M  V30 6 1 5 18
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 20
M  V30 10 1 8 10
M  V30 11 1 11 21
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 15 1 13 16
M  V30 16 1 13 17
M  V30 17 2 14 18
M  V30 18 2 15 19
M  V30 19 2 16 20
M  V30 20 2 17 21
M  V30 21 1 18 21
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 112857-73-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1147874-37-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-5667103
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM solvent assumed (1st stage)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis, structure-activity relationship and antibacterial
activity series of novel imidazo fused quinolone carboxamides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Venkat Reddy, G.; Ravi Kanth, S.; Maitraie, D.; Narsaiah, B.; Shanthan
Rao, P.; Hara Kishore, K.; Murthy, U. S. N.; Ravi, B.; Ashok Kumar, B.;
Parthasarathy, T.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2009), 44(4), 1570-1578

$RFMT $RIREG SCHEME152 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Chloromethyl)-2-(4-fluorophenyl)thiazole
C10H7ClFNS
113264-13-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.7758 3.0089 0.0 0
M  V30 2 Cl 11.1826 2.3825 0.0 0
M  V30 3 F 0.0000 1.3336 0.0 0
M  V30 4 C 6.1600 1.3336 0.0 0
M  V30 5 N 7.0652 2.5795 0.0 0
M  V30 6 S 7.0652 0.0878 0.0 0
M  V30 7 C 8.5298 2.1037 0.0 0
M  V30 8 C 8.5298 0.5636 0.0 0
M  V30 9 C 4.6200 1.3336 0.0 0
M  V30 10 C 3.8500 0.0000 0.0 0
M  V30 11 C 3.8500 2.6673 0.0 0
M  V30 12 C 2.3100 0.0000 0.0 0
M  V30 13 C 2.3100 2.6673 0.0 0
M  V30 14 C 1.5400 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 3 14
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 9
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 8
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(4-Fluorophenyl)-N-methyl-4-thiazolemethanamine
C11H11FN2S
1153070-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.7757 3.0089 0.0 0
M  V30 2 N 11.1826 2.3824 0.0 0
M  V30 3 C 12.4285 3.2876 0.0 0
M  V30 4 F 0.0000 1.3336 0.0 0
M  V30 5 C 6.1600 1.3336 0.0 0
M  V30 6 N 7.0652 2.5795 0.0 0
M  V30 7 S 7.0652 0.0878 0.0 0
M  V30 8 C 8.5298 2.1037 0.0 0
M  V30 9 C 8.5298 0.5636 0.0 0
M  V30 10 C 4.6200 1.3336 0.0 0
M  V30 11 C 3.8500 2.6673 0.0 0
M  V30 12 C 3.8500 0.0000 0.0 0
M  V30 13 C 2.3100 2.6673 0.0 0
M  V30 14 C 2.3100 0.0000 0.0 0
M  V30 15 C 1.5400 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 4 15
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 10
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 113264-13-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1153070-05-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24398647
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structural and Activity Relationships of
6-Sulfonyl-8-Nitrobenzothiazinones as Antitubercular Agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fan, Dongguang; Wang, Bin; Stelitano, Giovanni; Savkova, Karin; Shi, Rui;
Huszar, Stanislav; Han, Quanquan; Mikusova, Katarina; Chiarelli, Laurent
R.; Lu, Yu; Qiao, Chunhua
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2021), 64(19), 14526-14539

$RFMT $RIREG SCHEME153 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Thiophenecarboxaldehyde, 5-[(6-chloro-3-pyridinyl)thio]-4-(2-fluoro-3-pyrid...
C15H8ClFN2OS2
1138034-39-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.8690 6.2078 0.0 0
M  V30 2 F 0.5546 4.0727 0.0 0
M  V30 3 C 4.7418 0.9052 0.0 0
M  V30 4 O 3.4960 0.0000 0.0 0
M  V30 5 Cl 12.0290 6.2078 0.0 0
M  V30 6 C 3.5673 4.7132 0.0 0
M  V30 7 C 5.0990 4.8741 0.0 0
M  V30 8 C 3.2471 3.2068 0.0 0
M  V30 9 S 5.7253 3.4672 0.0 0
M  V30 10 C 4.5809 2.4367 0.0 0
M  V30 11 C 2.5368 5.8576 0.0 0
M  V30 12 C 1.0306 5.5374 0.0 0
M  V30 13 C 3.0127 7.3223 0.0 0
M  V30 14 N 0.0000 6.6818 0.0 0
M  V30 15 C 1.9823 8.4666 0.0 0
M  V30 16 C 0.4760 8.1465 0.0 0
M  V30 17 C 7.4090 6.2078 0.0 0
M  V30 18 C 8.1790 7.5414 0.0 0
M  V30 19 C 8.1790 4.8741 0.0 0
M  V30 20 C 9.7190 7.5414 0.0 0
M  V30 21 N 9.7190 4.8741 0.0 0
M  V30 22 C 10.4890 6.2078 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 1 17
M  V30 3 1 2 12
M  V30 4 2 3 4
M  V30 5 1 3 10
M  V30 6 1 5 22
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 6 11
M  V30 10 1 7 9
M  V30 11 2 8 10
M  V30 12 1 9 10
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 1 17 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Di-tert-butyl dicarbonate
C10H18O5
24424-99-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6673 0.5637 0.0 0
M  V30 2 C 1.3337 1.3337 0.0 0
M  V30 3 C 4.0012 1.3337 0.0 0
M  V30 4 C 0.5637 0.0000 0.0 0
M  V30 5 C 0.0000 2.1037 0.0 0
M  V30 6 C 2.1037 2.6673 0.0 0
M  V30 7 O 5.3348 0.5637 0.0 0
M  V30 8 O 4.0012 2.8737 0.0 0
M  V30 9 C 6.6685 1.3337 0.0 0
M  V30 10 O 8.0023 0.5637 0.0 0
M  V30 11 O 6.6685 2.8737 0.0 0
M  V30 12 C 9.3360 1.3337 0.0 0
M  V30 13 C 10.1060 0.0000 0.0 0
M  V30 14 C 10.6697 2.1037 0.0 0
M  V30 15 C 8.5660 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 7 9
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[[5-[(6-chloro-3-pyridinyl)thio]-4-(2-fluoro-3-pyridinyl)...
C21H21ClFN3O2S2
1138034-90-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.9825 4.7385 0.0 0
M  V30 2 F 4.4281 3.3420 0.0 0
M  V30 3 C 5.9538 8.3659 0.0 0
M  V30 4 N 4.4137 8.3659 0.0 0
M  V30 5 C 3.6437 9.6996 0.0 0
M  V30 6 C 3.6437 7.0323 0.0 0
M  V30 7 O 2.1037 9.6996 0.0 0
M  V30 8 O 4.4137 11.0333 0.0 0
M  V30 9 C 1.3337 11.0333 0.0 0
M  V30 10 C 2.6673 11.8033 0.0 0
M  V30 11 C 0.5637 12.3671 0.0 0
M  V30 12 C 0.0000 10.2632 0.0 0
M  V30 13 Cl 14.9660 8.3593 0.0 0
M  V30 14 C 7.2419 4.5948 0.0 0
M  V30 15 C 8.5755 5.3649 0.0 0
M  V30 16 C 6.0975 5.6253 0.0 0
M  V30 17 S 8.2554 6.8712 0.0 0
M  V30 18 C 6.7238 7.0323 0.0 0
M  V30 19 C 7.0809 3.0633 0.0 0
M  V30 20 C 5.6739 2.4368 0.0 0
M  V30 21 C 8.3268 2.1580 0.0 0
M  V30 22 N 5.5130 0.9052 0.0 0
M  V30 23 C 8.1659 0.6265 0.0 0
M  V30 24 C 6.7589 0.0000 0.0 0
M  V30 25 C 11.2284 5.6436 0.0 0
M  V30 26 C 12.6352 5.0173 0.0 0
M  V30 27 C 11.0675 7.1753 0.0 0
M  V30 28 C 13.8811 5.9225 0.0 0
M  V30 29 N 12.3133 8.0804 0.0 0
M  V30 30 C 13.7202 7.4541 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 15
M  V30 2 1 1 25
M  V30 3 1 2 20
M  V30 4 1 3 4
M  V30 5 1 3 18
M  V30 6 1 4 5
M  V30 7 1 4 6
M  V30 8 1 5 7
M  V30 9 2 5 8
M  V30 10 1 7 9
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 1 9 12
M  V30 14 1 13 30
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 14 19
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 27 1 25 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1138034-39-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 24424-99-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1138034-90-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-10949692
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Reference Example 105 tert-butyl
({5-[(6-chloropyridin-3-yl)thio]-4-(2-fluoropyridin-3-yl)thiophen-2-yl}methyl)methylcarbamate
In the same manner as in Reference Example 99 and using
5-[(6-chloropyridin-3-yl)thio]-4-(2-fluoropyridin-3-yl)thiophene-2-carbaldehyde
(556 mg) as a starting material and 40% methylamine-methanol solution
(1.62 mL), sodium borohydride (300 mg) and di-tert-butyl bicarbonate
(0.498 mL), the title compound was obtained as a colorless oil (683 mg,
yield 92%). 1H-NMR (CDCl3) &#x03B4; : 1.49 (9H, s), 2.92 (3H, s), 4.54
(2H, brs), 7.06-7.09 (1H, m), 7.15-7.28 (2H, m), 7.33 (1H, dd, J=8.3, 2.7
Hz), 7.74-7.84 (1H, m), 8.11 (1H, d, J=2.3 Hz), 8.19-8.24 (1H, m).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of thiophene and pyrazole derivatives and related analogous
as acid secretion inhibitors and antiulcer agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nishida, Haruyuki; Arikawa, Yasuyoshi; Hirase, Keizo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009041705 A2 2009-04-02

$RFMT $RIREG SCHEME154 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Pyrazole-3-carboxaldehyde, 1-(2-chlorophenyl)-5-(3-pyridinylthio)-
C15H10ClN3OS
1138037-68-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.8690 6.2078 0.0 0
M  V30 2 Cl 0.5546 4.0727 0.0 0
M  V30 3 C 4.7418 0.9052 0.0 0
M  V30 4 O 3.4960 0.0000 0.0 0
M  V30 5 N 3.5673 4.7132 0.0 0
M  V30 6 C 5.0990 4.8741 0.0 0
M  V30 7 N 3.2471 3.2068 0.0 0
M  V30 8 C 5.7253 3.4672 0.0 0
M  V30 9 C 4.5809 2.4368 0.0 0
M  V30 10 C 2.5369 5.8576 0.0 0
M  V30 11 C 1.0306 5.5374 0.0 0
M  V30 12 C 3.0127 7.3223 0.0 0
M  V30 13 C 0.0000 6.6818 0.0 0
M  V30 14 C 1.9823 8.4667 0.0 0
M  V30 15 C 0.4760 8.1465 0.0 0
M  V30 16 C 7.4090 6.2078 0.0 0
M  V30 17 C 8.1790 7.5414 0.0 0
M  V30 18 C 8.1790 4.8741 0.0 0
M  V30 19 C 9.7190 7.5414 0.0 0
M  V30 20 N 9.7190 4.8741 0.0 0
M  V30 21 C 10.4890 6.2078 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 1 16
M  V30 3 1 2 11
M  V30 4 2 3 4
M  V30 5 1 3 9
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 10
M  V30 9 2 6 8
M  V30 10 2 7 9
M  V30 11 1 8 9
M  V30 12 2 10 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 18 1 16 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Di-tert-butyl dicarbonate
C10H18O5
24424-99-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6673 0.5637 0.0 0
M  V30 2 C 1.3337 1.3337 0.0 0
M  V30 3 C 4.0012 1.3337 0.0 0
M  V30 4 C 0.5637 0.0000 0.0 0
M  V30 5 C 0.0000 2.1037 0.0 0
M  V30 6 C 2.1037 2.6673 0.0 0
M  V30 7 O 5.3348 0.5637 0.0 0
M  V30 8 O 4.0012 2.8737 0.0 0
M  V30 9 C 6.6685 1.3337 0.0 0
M  V30 10 O 8.0023 0.5637 0.0 0
M  V30 11 O 6.6685 2.8737 0.0 0
M  V30 12 C 9.3360 1.3337 0.0 0
M  V30 13 C 10.1060 0.0000 0.0 0
M  V30 14 C 10.6697 2.1037 0.0 0
M  V30 15 C 8.5660 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 7 9
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[[1-(2-chlorophenyl)-5-(3-pyridinylthio)-1H-pyrazol-3-yl]...
C21H23ClN4O2S
1138038-18-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 2.7844 5.7153 0.0 0
M  V30 2 Cl 6.8964 1.7288 0.0 0
M  V30 3 C 8.0870 6.8425 0.0 0
M  V30 4 N 9.4208 6.0725 0.0 0
M  V30 5 C 10.7544 6.8425 0.0 0
M  V30 6 C 9.4208 4.5324 0.0 0
M  V30 7 O 12.0881 6.0725 0.0 0
M  V30 8 O 10.7544 8.3825 0.0 0
M  V30 9 C 13.4218 6.8425 0.0 0
M  V30 10 C 12.6517 8.1761 0.0 0
M  V30 11 C 14.7556 7.6125 0.0 0
M  V30 12 C 14.1918 5.5087 0.0 0
M  V30 13 N 5.0859 4.2206 0.0 0
M  V30 14 C 4.3159 5.5542 0.0 0
M  V30 15 N 6.5924 4.5408 0.0 0
M  V30 16 C 5.3465 6.6988 0.0 0
M  V30 17 C 6.7533 6.0725 0.0 0
M  V30 18 C 4.4596 2.8138 0.0 0
M  V30 19 C 5.3648 1.5679 0.0 0
M  V30 20 C 2.9280 2.6527 0.0 0
M  V30 21 C 4.7385 0.1609 0.0 0
M  V30 22 C 2.3017 1.2459 0.0 0
M  V30 23 C 3.2068 0.0000 0.0 0
M  V30 24 C 2.1580 7.1221 0.0 0
M  V30 25 C 0.6265 7.2832 0.0 0
M  V30 26 C 3.0633 8.3680 0.0 0
M  V30 27 C 0.0000 8.6900 0.0 0
M  V30 28 N 2.4368 9.7750 0.0 0
M  V30 29 C 0.9052 9.9359 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 1 24
M  V30 3 1 2 19
M  V30 4 1 3 4
M  V30 5 1 3 17
M  V30 6 1 4 5
M  V30 7 1 4 6
M  V30 8 1 5 7
M  V30 9 2 5 8
M  V30 10 1 7 9
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 1 9 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 13 18
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 26 1 24 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1138037-68-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 24424-99-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1138038-18-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-11719408
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Reference Example 322 tert-butyl
({1-(2-chlorophenyl)-5-[(pyridin-3-yl)thio]-1H-pyrazol-3-yl}methyl)methylcarbamate
1-(2-Chlorophenyl)-5-[(pyridin-3-yl)thio]-1H-pyrazole-3-carbaldehyde (152
mg) was dissolved in a mixed solvent of tetrahydrofuran (3 mL) and
methanol (1 mL), 40% methylamine-methanol solution (0.5 mL) was added,
and the mixture was stirred at room temperature for 1 hr. The reaction
mixture was concentrated under reduced pressure, the residue was
dissolved again in a mixed solvent of tetrahydrofuran (3 mL) and methanol
(1 mL), and sodium borohydride (55 mg) was added under ice-cooling. The
mixture was stirred at room temperature for 3 hr, water was added, and
the solvent was evaporated under reduced pressure. Ethyl acetate and
saturated aqueous sodium hydrogen carbonate solution were added to the
residue, di-tert-butyl bicarbonate (126 mg) was added, and the mixture
was stirred for 10 min. The ethyl acetate layer was washed with saturated
brine, dried over anhydrous sodium sulfate, and concentrated under
reduced pressure. The residue was purified by silica gel column
chromatography (eluent: hexane-ethyl acetate=4:1&#x2192;2:1) to give the
title compound as a pale-yellow oil (190 mg, yield 92%). 1H-NMR (CDCl3)
&#x03B4; : 1.49 (9H, s), 2.89 (3H, br), 4.45 (2H, br), 6.58 (1H, br),
7.10-7.15 (1H, m), 7.20-7.33 (2H, m), 7.35-7.47 (3H, m), 8.25-8.26 (1H,
m), 8.39-8.40 (1H, m).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of thiophene and pyrazole derivatives and related analogous
as acid secretion inhibitors and antiulcer agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nishida, Haruyuki; Arikawa, Yasuyoshi; Hirase, Keizo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009041705 A2 2009-04-02

$RFMT $RIREG SCHEME155 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5,8-Dichloro-2,3-quinoxalinedicarbonitrile
C10H2Cl2N4
1140899-25-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 2.6674 0.0 0
M  V30 2 Cl 3.0800 8.0021 0.0 0
M  V30 3 C 5.3900 1.3336 0.0 0
M  V30 4 N 6.1600 0.0000 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 N 8.4700 4.0011 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 C 3.0800 5.3347 0.0 0
M  V30 9 N 3.0800 2.6674 0.0 0
M  V30 10 C 0.7700 4.0011 0.0 0
M  V30 11 N 4.6200 5.3347 0.0 0
M  V30 12 C 2.3100 6.6685 0.0 0
M  V30 13 C 4.6200 2.6674 0.0 0
M  V30 14 C 0.0000 5.3347 0.0 0
M  V30 15 C 5.3900 4.0011 0.0 0
M  V30 16 C 0.7700 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 2 12
M  V30 3 3 3 4
M  V30 4 1 3 13
M  V30 5 3 5 6
M  V30 6 1 5 15
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 2 12 16
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5,8-Dichloro-3-(methylamino)-2-quinoxalinecarbonitrile
C10H6Cl2N4
1311965-15-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 3.0800 8.0021 0.0 0
M  V30 2 Cl 0.0000 2.6674 0.0 0
M  V30 3 C 6.9300 4.0011 0.0 0
M  V30 4 N 8.4700 4.0011 0.0 0
M  V30 5 N 5.3900 1.3336 0.0 0
M  V30 6 C 4.6200 0.0000 0.0 0
M  V30 7 C 3.0800 5.3347 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 N 4.6200 5.3347 0.0 0
M  V30 10 C 2.3100 6.6685 0.0 0
M  V30 11 N 3.0800 2.6674 0.0 0
M  V30 12 C 0.7700 4.0011 0.0 0
M  V30 13 C 5.3900 4.0011 0.0 0
M  V30 14 C 0.7700 6.6685 0.0 0
M  V30 15 C 4.6200 2.6674 0.0 0
M  V30 16 C 0.0000 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 2 12
M  V30 3 3 3 4
M  V30 4 1 3 13
M  V30 5 1 5 6
M  V30 6 1 5 15
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 2 12 16
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1140899-25-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1311965-15-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28550367
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Reactions of 5,8-dichloro-2,3-dicyanoquinoxaline with amines and
hydrazines. A new and efficient synthetic approach to
3-amino-5,8-dichloroflavazoles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Guirado, Antonio; Lopez Sanchez, Jose I.; Bautista, Delia
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2011), 67(22), 4123-4129

$RFMT $RIREG SCHEME156 STEP1
$RXN



  2  1
$MOL
4-(Methylthio)-2-oxo-6-phenyl-2H-pyran-3-carboxylic acid
C13H10O4S
115411-37-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 2.3101 1.3338 0.0 0
M  V30 2 C 3.0801 0.0000 0.0 0
M  V30 3 O 2.3101 6.6687 0.0 0
M  V30 4 C 0.7700 4.0012 0.0 0
M  V30 5 O 0.0000 5.3348 0.0 0
M  V30 6 O 0.0000 2.6675 0.0 0
M  V30 7 C 5.3901 4.0012 0.0 0
M  V30 8 C 4.6201 2.6675 0.0 0
M  V30 9 O 4.6201 5.3348 0.0 0
M  V30 10 C 3.0801 2.6675 0.0 0
M  V30 11 C 3.0801 5.3348 0.0 0
M  V30 12 C 2.3101 4.0012 0.0 0
M  V30 13 C 6.9302 4.0012 0.0 0
M  V30 14 C 7.7002 5.3348 0.0 0
M  V30 15 C 7.7002 2.6675 0.0 0
M  V30 16 C 9.2402 5.3348 0.0 0
M  V30 17 C 9.2402 2.6675 0.0 0
M  V30 18 C 10.0102 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 2 3 11
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 13
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-(methylthio)-2-oxo-6-phenyl-2H-pyran-3-carboxamide
C14H13NO3S
1512808-12-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.2402 4.0012 0.0 0
M  V30 2 N 10.0102 5.3348 0.0 0
M  V30 3 O 10.0102 2.6675 0.0 0
M  V30 4 C 11.5503 5.3348 0.0 0
M  V30 5 S 7.7002 1.3338 0.0 0
M  V30 6 C 6.9302 0.0000 0.0 0
M  V30 7 O 7.7002 6.6687 0.0 0
M  V30 8 C 7.7002 4.0012 0.0 0
M  V30 9 C 6.9302 2.6675 0.0 0
M  V30 10 C 6.9302 5.3348 0.0 0
M  V30 11 C 5.3901 2.6675 0.0 0
M  V30 12 O 5.3901 5.3348 0.0 0
M  V30 13 C 4.6201 4.0012 0.0 0
M  V30 14 C 3.0801 4.0012 0.0 0
M  V30 15 C 2.3101 5.3348 0.0 0
M  V30 16 C 2.3101 2.6675 0.0 0
M  V30 17 C 0.7700 5.3348 0.0 0
M  V30 18 C 0.7700 2.6675 0.0 0
M  V30 19 C 0.0000 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 9
M  V30 7 2 7 10
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 115411-37-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1512808-12-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-10567108
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General method for the preparation of
substituted 4-(methylthio)-2-oxo-6-phenyl-2H-pyran-3-carboxamides (11) To
a stirring solution of appropriately substituted 10 (0.76 mmoles) in DMF
at rt, HATU (0.83 mmoles) and diisopropylethylamine (2.29 mmoles) was
added. Appropriately substituted amine (0.76 mmoles) was added after 15
min and stirring continued for another 1h at rt. The reaction was
monitored by TLC and then poured into ice water with stirring. The so
formed precipitate was filtered off and recrystallized from a mixture of
ethyl acetate and n-hexane to get pure compound.
6-(4-fluorophenyl)-4-(methylthio)-2-oxo-N-phenyl-2H-pyran-3-carboxamide
N-methyl-4-(methylthio)-2-oxo-6-phenyl-2H-pyran-3-carboxamide Light
yellow powder; Yield 92 %. mp 212-213°C; Mass[M++1] = 277.0; 1H NMR: (400
MHz, DMSO-d6): δ 2.59 (S, 3H, Me), 2.75-2.76 (d, J = 4.4 Hz, 3H, Me),
7.15 (s, 1H, Pyrone), 7.55-7.60 (m, 3H, ArH), 7.99-8.01 (t, J = 7.6 Hz,
2H, ArH), 8.64-8.65 (q, J = 4.8 Hz, 1H, NH amide).
$DTYPE RXN:VAR(1):NOTES
$DATUM literature preparation
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and Anti-HCV Activity of 4-Hydroxyamino α-Pyranone Carboxamide
Analogues
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Konreddy, Ananda Kumar; Toyama, Massaki; Ito, Wataru; Bal, Chandralata;
Baba, Masanori; Sharon, Ashoke
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Medicinal Chemistry Letters (2014), 5(3), 259-263

$RFMT $RIREG SCHEME157 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (αE)-2-[[2-bromo-3-(2,2-dibromoethenyl)-6-methoxyphenoxy]methyl]-α-(me...
C20H18Br3NO5
1159342-68-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.3359 4.6201 0.0 0
M  V30 2 C 8.0021 3.8500 0.0 0
M  V30 3 N 10.6695 3.8500 0.0 0
M  V30 4 O 8.0021 2.3100 0.0 0
M  V30 5 O 6.6684 4.6201 0.0 0
M  V30 6 O 12.0032 4.6201 0.0 0
M  V30 7 C 9.3359 1.5400 0.0 0
M  V30 8 C 13.3369 3.8500 0.0 0
M  V30 9 C 6.6684 6.1601 0.0 0
M  V30 10 O 5.3348 6.9301 0.0 0
M  V30 11 O 2.6673 8.4701 0.0 0
M  V30 12 C 1.3337 9.2401 0.0 0
M  V30 13 Br 5.3348 3.8500 0.0 0
M  V30 14 C 2.6673 2.3100 0.0 0
M  V30 15 C 1.3337 1.5400 0.0 0
M  V30 16 Br 1.3337 0.0000 0.0 0
M  V30 17 Br 0.0000 2.3100 0.0 0
M  V30 18 C 9.3359 6.1601 0.0 0
M  V30 19 C 8.0021 6.9301 0.0 0
M  V30 20 C 10.6695 6.9301 0.0 0
M  V30 21 C 8.0021 8.4701 0.0 0
M  V30 22 C 10.6695 8.4701 0.0 0
M  V30 23 C 9.3359 9.2401 0.0 0
M  V30 24 C 4.0010 6.1601 0.0 0
M  V30 25 C 2.6673 6.9301 0.0 0
M  V30 26 C 4.0010 4.6201 0.0 0
M  V30 27 C 1.3337 6.1601 0.0 0
M  V30 28 C 2.6673 3.8500 0.0 0
M  V30 29 C 1.3337 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 19
M  V30 11 1 10 24
M  V30 12 1 11 12
M  V30 13 1 11 25
M  V30 14 1 13 26
M  V30 15 2 14 15
M  V30 16 1 14 28
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 25 2 24 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 2 26 28
M  V30 29 2 27 29
M  V30 30 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αE)-2-[[2-Bromo-3-(2,2-dibromoethenyl)-6-methoxyphenoxy]methyl]-α-(methoxyim...
C20H19Br3N2O4
1159342-69-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.3359 4.6201 0.0 0
M  V30 2 C 8.0021 3.8500 0.0 0
M  V30 3 N 10.6695 3.8500 0.0 0
M  V30 4 N 8.0021 2.3100 0.0 0
M  V30 5 O 6.6684 4.6201 0.0 0
M  V30 6 O 12.0032 4.6201 0.0 0
M  V30 7 C 9.3359 1.5400 0.0 0
M  V30 8 C 13.3369 3.8500 0.0 0
M  V30 9 C 6.6684 6.1601 0.0 0
M  V30 10 O 5.3348 6.9301 0.0 0
M  V30 11 O 2.6673 8.4701 0.0 0
M  V30 12 C 1.3337 9.2401 0.0 0
M  V30 13 Br 5.3348 3.8500 0.0 0
M  V30 14 C 2.6673 2.3100 0.0 0
M  V30 15 C 1.3337 1.5400 0.0 0
M  V30 16 Br 0.0000 2.3100 0.0 0
M  V30 17 Br 1.3337 0.0000 0.0 0
M  V30 18 C 9.3359 6.1601 0.0 0
M  V30 19 C 8.0021 6.9301 0.0 0
M  V30 20 C 10.6695 6.9301 0.0 0
M  V30 21 C 8.0021 8.4701 0.0 0
M  V30 22 C 10.6695 8.4701 0.0 0
M  V30 23 C 9.3359 9.2401 0.0 0
M  V30 24 C 4.0010 6.1601 0.0 0
M  V30 25 C 2.6673 6.9301 0.0 0
M  V30 26 C 4.0010 4.6201 0.0 0
M  V30 27 C 1.3337 6.1601 0.0 0
M  V30 28 C 2.6673 3.8500 0.0 0
M  V30 29 C 1.3337 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 19
M  V30 11 1 10 24
M  V30 12 1 11 12
M  V30 13 1 11 25
M  V30 14 1 13 26
M  V30 15 2 14 15
M  V30 16 1 14 28
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 25 2 24 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 2 26 28
M  V30 29 2 27 29
M  V30 30 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1159342-68-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1159342-69-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-3175424
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Example 40: Preparation of
(E)-2-(2-((2-chloro-4-(2,2-dichlorovinyl)phenoxy)methyl)phenyl)-2-methoxyimino-N-methylacetamide
Example 76: Preparation of
(E)-2-(2-((2-(2-bromo-3-(2,2-dibromovinyl)-6-methoxyphenoxy)methyl)phenyl)-2-methoxyimino-N-methylacetamide
The procedure of Example 40 was repeated except for using
methyl-(E)-2-(2-((2-bromo-3-(2,2-dibromovinyl)-6-methoxyphenoxy)methyl)phenyl)-2-methoxyiminoacetate(0.592g,
1mmol) obtained in Example 75 instead of
methyl-(E)-2-(2-((2-chloro-4-(2,2-dichlorovinyl)phenoxy)methyl)phenyl)-2-methoxyiminoacetate
to obtain the title compound (0.534g, 92%). 1H-NMR(CDCl3, TMS)δ(ppm):
2.84(d, 3H), 3.82(s, 3H), 3.96(s, 3H), 4.88(s, 2H), 6.72(s, 1H), 6.94(s,
1H), 6.99-7.82(m, 6H) MS : 587.9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of methoxyiminobenzene compounds as agrochemical fungicidal
agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kim, Joo-Kyung; Kim, Hyung-Ho; Hwang, In-Cheon; Nam, Ho-Tae
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009072837 A2 2009-06-11

$RFMT $RIREG SCHEME158 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Phenyl-2,4-piperidinedione
C11H11NO2
118264-04-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.0021 4.6200 0.0 0
M  V30 2 O 5.3347 0.0000 0.0 0
M  V30 3 C 4.0011 3.8500 0.0 0
M  V30 4 C 5.3347 4.6200 0.0 0
M  V30 5 N 4.0011 2.3100 0.0 0
M  V30 6 C 6.6685 3.8500 0.0 0
M  V30 7 C 5.3347 1.5400 0.0 0
M  V30 8 C 6.6685 2.3100 0.0 0
M  V30 9 C 2.6674 4.6200 0.0 0
M  V30 10 C 2.6674 6.1600 0.0 0
M  V30 11 C 1.3336 3.8500 0.0 0
M  V30 12 C 1.3336 6.9300 0.0 0
M  V30 13 C 0.0000 4.6200 0.0 0
M  V30 14 C 0.0000 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 2 2 7
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 9
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 8
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2(1H)-Pyridinone, 5,6-dihydro-4-(methylamino)-6-phenyl-
C12H14N2O
2957981-07-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 8.0022 4.6201 0.0 0
M  V30 2 C 9.3359 3.8500 0.0 0
M  V30 3 O 5.3348 0.0000 0.0 0
M  V30 4 C 4.0011 3.8500 0.0 0
M  V30 5 C 5.3348 4.6201 0.0 0
M  V30 6 N 4.0011 2.3100 0.0 0
M  V30 7 C 6.6684 3.8500 0.0 0
M  V30 8 C 5.3348 1.5400 0.0 0
M  V30 9 C 6.6684 2.3100 0.0 0
M  V30 10 C 2.6675 4.6201 0.0 0
M  V30 11 C 1.3337 3.8500 0.0 0
M  V30 12 C 2.6675 6.1601 0.0 0
M  V30 13 C 0.0000 4.6201 0.0 0
M  V30 14 C 1.3337 6.9301 0.0 0
M  V30 15 C 0.0000 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 8
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 10
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 118264-04-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2957981-07-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37393989
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Bilateral metalloheterocyclic systems based on palladacycle and
piperidine-2,4-dione pharmacophores
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bulygina, Ludmila A.; Khrushcheva, Natalya S.; Nelyubina, Yulia V.;
Dorovatovskii, Pavel; Strelkova, Tatiana V.; Alexeev, Michael S.;
Mandegani, Zeinab; Nabavizadeh, S. Masoud; Kuznetsov, Nikolai Yu.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2023), 21(11), 2337-2354

$RFMT $RIREG SCHEME159 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Isatoic anhydride
C8H5NO3
118-48-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3100 0.0000 0.0 0
M  V30 2 O 6.9300 2.6674 0.0 0
M  V30 3 C 2.3100 2.6674 0.0 0
M  V30 4 C 3.0800 4.0011 0.0 0
M  V30 5 C 3.0800 1.3338 0.0 0
M  V30 6 C 0.7700 2.6674 0.0 0
M  V30 7 N 4.6200 4.0011 0.0 0
M  V30 8 C 2.3100 5.3349 0.0 0
M  V30 9 O 4.6200 1.3338 0.0 0
M  V30 10 C 0.0000 4.0011 0.0 0
M  V30 11 C 5.3900 2.6674 0.0 0
M  V30 12 C 0.7700 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 2 2 11
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Benzodioxole-5-carboxaldehyde
C8H6O3
120-57-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3709 3.0800 0.0 0
M  V30 2 O 7.7047 2.3100 0.0 0
M  V30 3 C 2.3699 2.3100 0.0 0
M  V30 4 C 2.3699 0.7700 0.0 0
M  V30 5 C 3.7036 3.0800 0.0 0
M  V30 6 O 0.9052 2.7859 0.0 0
M  V30 7 C 3.7036 0.0000 0.0 0
M  V30 8 O 0.9052 0.2941 0.0 0
M  V30 9 C 5.0372 2.3100 0.0 0
M  V30 10 C 0.0000 1.5400 0.0 0
M  V30 11 C 5.0372 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 2 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(1,3-Benzodioxol-5-yl)-2,3-dihydro-3-methyl-4(1H)-quinazolinone
C16H14N2O3
1643332-56-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 0.0000 0.0 0
M  V30 2 O 2.3100 0.0000 0.0 0
M  V30 3 C 5.3900 2.6675 0.0 0
M  V30 4 N 4.6200 4.0011 0.0 0
M  V30 5 N 4.6200 1.3338 0.0 0
M  V30 6 C 3.0800 4.0011 0.0 0
M  V30 7 C 3.0800 1.3338 0.0 0
M  V30 8 C 2.3100 2.6675 0.0 0
M  V30 9 C 2.3100 5.3349 0.0 0
M  V30 10 C 0.7700 2.6675 0.0 0
M  V30 11 C 0.7700 5.3349 0.0 0
M  V30 12 C 0.0000 4.0011 0.0 0
M  V30 13 C 6.9301 2.6675 0.0 0
M  V30 14 C 7.7001 4.0011 0.0 0
M  V30 15 C 7.7001 1.3338 0.0 0
M  V30 16 C 9.2401 4.0011 0.0 0
M  V30 17 C 9.2401 1.3338 0.0 0
M  V30 18 C 10.0101 2.6675 0.0 0
M  V30 19 O 10.2705 5.1456 0.0 0
M  V30 20 O 11.5164 2.9876 0.0 0
M  V30 21 C 11.6773 4.5192 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 2 2 7
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 13
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 7 8
M  V30 11 2 8 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 2 11 12
M  V30 15 1 13 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 16 19
M  V30 21 2 17 18
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 118-48-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 120-57-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1643332-56-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-21394113
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 47221-31-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM ultrasound, alternative reaction conditions gave lower yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Efficient synthesis of 2,3-disubstituted-2,3-dihydroquinazolin-4(1H)-ones
catalyzed by dodecylbenzenesulfonic acid in aqueous media under
ultrasound irradiation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chen, Bao-Hua; Li, Ji-Tai; Chen, Guo-Feng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Ultrasonics Sonochemistry (2015), 2359-65

$RFMT $RIREG SCHEME160 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3S)-1,2,3,4-Tetrahydro-2-(phenylmethyl)-3-isoquinolinecarboxylic acid
C17H17NO2
1187927-66-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 4.0011 0.0 0
M  V30 2 C 4.6200 1.3336 0.0 0
M  V30 3 O 5.3900 0.0000 0.0 0
M  V30 4 O 3.0800 1.3336 0.0 0
M  V30 5 N 4.6200 4.0011 0.0 0
M  V30 6 C 5.3900 2.6674 0.0 0 CFG=2
M  V30 7 C 5.3900 5.3347 0.0 0
M  V30 8 C 6.9300 2.6674 0.0 0
M  V30 9 C 6.9300 5.3347 0.0 0
M  V30 10 C 7.7000 4.0011 0.0 0
M  V30 11 C 7.7000 6.6685 0.0 0
M  V30 12 C 9.2400 4.0011 0.0 0
M  V30 13 C 9.2400 6.6685 0.0 0
M  V30 14 C 10.0100 5.3347 0.0 0
M  V30 15 C 2.3100 5.3347 0.0 0
M  V30 16 C 0.7700 5.3347 0.0 0
M  V30 17 C 3.0800 6.6685 0.0 0
M  V30 18 C 0.0000 6.6685 0.0 0
M  V30 19 C 2.3100 8.0021 0.0 0
M  V30 20 C 0.7700 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 6 2 CFG=1
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 10
M  V30 12 2 9 11
M  V30 13 2 10 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(3S)-1,2,3,4-Tetrahydro-N-methyl-2-(phenylmethyl)-3-isoquinolinecarboxamide
C18H20N2O
1360606-56-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 5.3347 0.0 0
M  V30 2 C 4.6200 2.6674 0.0 0
M  V30 3 N 5.3900 1.3336 0.0 0
M  V30 4 O 3.0800 2.6674 0.0 0
M  V30 5 C 4.6200 0.0000 0.0 0
M  V30 6 N 4.6200 5.3347 0.0 0
M  V30 7 C 5.3900 4.0011 0.0 0 CFG=2
M  V30 8 C 5.3900 6.6684 0.0 0
M  V30 9 C 6.9300 4.0011 0.0 0
M  V30 10 C 6.9300 6.6684 0.0 0
M  V30 11 C 7.7000 5.3347 0.0 0
M  V30 12 C 7.7000 8.0021 0.0 0
M  V30 13 C 9.2400 5.3347 0.0 0
M  V30 14 C 9.2400 8.0021 0.0 0
M  V30 15 C 10.0100 6.6684 0.0 0
M  V30 16 C 2.3100 6.6684 0.0 0
M  V30 17 C 0.7700 6.6684 0.0 0
M  V30 18 C 3.0800 8.0021 0.0 0
M  V30 19 C 0.0000 8.0021 0.0 0
M  V30 20 C 2.3100 9.3358 0.0 0
M  V30 21 C 0.7700 9.3358 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 7 2 CFG=1
M  V30 6 1 3 5
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 11
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 7)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1187927-66-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1360606-56-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-5176284
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 94790-37-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Tetrahydroisoquinoline-Based N-Oxides as Chiral Organocatalysts for the
Asymmetric Allylation of Aldehydes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Naicker, Tricia; Arvidsson, Per I.; Kruger, Hendrik G.; Maguire, Glenn E.
M.; Govender, Thavendran
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2011), 2011(34), 6923-6932,
S6923/1-S6923/37

$RFMT $RIREG SCHEME161 STEP1
$RXN



 12  1
$MOL
BOC-L-leucine
C11H21NO4
13139-15-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 15 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 3.8501 0.0 0 CFG=2
M  V30 2 N 4.0012 4.6201 0.0 0
M  V30 3 C 2.6675 2.3101 0.0 0
M  V30 4 C 1.3337 4.6201 0.0 0
M  V30 5 C 5.3348 3.8501 0.0 0
M  V30 6 C 1.3337 1.5400 0.0 0
M  V30 7 O 0.0000 3.8501 0.0 0
M  V30 8 O 1.3337 6.1601 0.0 0
M  V30 9 O 6.6685 4.6201 0.0 0
M  V30 10 O 5.3348 2.3101 0.0 0
M  V30 11 C 1.3337 0.0000 0.0 0
M  V30 12 C 0.0000 2.3101 0.0 0
M  V30 13 C 8.0023 3.8501 0.0 0
M  V30 14 C 7.2323 2.5164 0.0 0
M  V30 15 C 9.3360 3.0801 0.0 0
M  V30 16 C 8.7723 5.1838 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 2 5 10
M  V30 10 1 6 11
M  V30 11 1 6 12
M  V30 12 1 9 13
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
BOC-L-Phenylalanine
C14H19NO4
13734-34-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3901 2.6675 0.0 0 CFG=1
M  V30 2 C 4.6201 4.0012 0.0 0
M  V30 3 N 6.9302 2.6675 0.0 0
M  V30 4 C 4.6201 1.3338 0.0 0
M  V30 5 C 7.7002 4.0012 0.0 0
M  V30 6 O 3.0801 1.3338 0.0 0
M  V30 7 O 5.3901 0.0000 0.0 0
M  V30 8 O 9.2402 4.0012 0.0 0
M  V30 9 O 6.9302 5.3348 0.0 0
M  V30 10 C 10.0102 5.3348 0.0 0
M  V30 11 C 11.3439 4.5648 0.0 0
M  V30 12 C 10.7802 6.6687 0.0 0
M  V30 13 C 8.6766 6.1048 0.0 0
M  V30 14 C 3.0801 4.0012 0.0 0
M  V30 15 C 2.3101 5.3348 0.0 0
M  V30 16 C 2.3101 2.6675 0.0 0
M  V30 17 C 0.7700 5.3348 0.0 0
M  V30 18 C 0.7700 2.6675 0.0 0
M  V30 19 C 0.0000 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 14
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
α-tert-Butoxycarbonyl-L-lysine
C11H22N2O4
13734-28-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 16 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.9537 2.6675 0.0 0 CFG=2
M  V30 2 N 4.4137 2.6675 0.0 0
M  V30 3 C 6.7237 4.0011 0.0 0
M  V30 4 C 6.7237 1.3338 0.0 0
M  V30 5 C 3.6437 4.0011 0.0 0
M  V30 6 C 8.2637 4.0011 0.0 0
M  V30 7 O 5.9537 0.0000 0.0 0
M  V30 8 O 8.2637 1.3338 0.0 0
M  V30 9 O 2.1037 4.0011 0.0 0
M  V30 10 O 4.4137 5.3348 0.0 0
M  V30 11 C 9.0337 5.3348 0.0 0
M  V30 12 C 1.3337 5.3348 0.0 0
M  V30 13 C 10.5738 5.3348 0.0 0
M  V30 14 C 0.0000 4.5648 0.0 0
M  V30 15 C 0.5636 6.6686 0.0 0
M  V30 16 C 2.6673 6.1048 0.0 0
M  V30 17 N 11.3438 6.6686 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 2 5 10
M  V30 10 1 6 11
M  V30 11 1 9 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
6-(Fmoc-amino)hexanoic acid
C21H23NO4
88574-06-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7533 5.2310 0.0 0
M  V30 2 O 7.0870 4.4610 0.0 0
M  V30 3 C 8.4208 5.2310 0.0 0
M  V30 4 N 9.7545 4.4610 0.0 0
M  V30 5 O 8.4208 6.7710 0.0 0
M  V30 6 C 11.0881 5.2310 0.0 0
M  V30 7 C 12.4218 4.4610 0.0 0
M  V30 8 C 13.7556 5.2310 0.0 0
M  V30 9 C 15.0892 4.4610 0.0 0
M  V30 10 C 16.4229 5.2310 0.0 0
M  V30 11 C 17.7565 4.4610 0.0 0
M  V30 12 O 19.0904 5.2310 0.0 0
M  V30 13 O 17.7565 2.9209 0.0 0
M  V30 14 C 4.4197 4.4610 0.0 0
M  V30 15 C 4.2588 2.9293 0.0 0
M  V30 16 C 3.0127 5.0873 0.0 0
M  V30 17 C 2.7523 2.6091 0.0 0
M  V30 18 C 5.2892 1.7849 0.0 0
M  V30 19 C 1.9823 3.9429 0.0 0
M  V30 20 C 2.5369 6.5520 0.0 0
M  V30 21 C 2.2765 1.1445 0.0 0
M  V30 22 C 4.8133 0.3202 0.0 0
M  V30 23 C 0.4760 4.2631 0.0 0
M  V30 24 C 1.0306 6.8722 0.0 0
M  V30 25 C 3.3069 0.0000 0.0 0
M  V30 26 C 0.0000 5.7276 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 15 18
M  V30 18 1 16 19
M  V30 19 2 16 20
M  V30 20 1 17 19
M  V30 21 2 17 21
M  V30 22 1 18 22
M  V30 23 2 19 23
M  V30 24 1 20 24
M  V30 25 1 21 25
M  V30 26 2 22 25
M  V30 27 1 23 26
M  V30 28 2 24 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
FMOC-L-glutamic acid
C20H19NO6
121343-82-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.0543 3.7827 0.0 0
M  V30 2 O 5.8243 5.1163 0.0 0
M  V30 3 C 7.3643 5.1163 0.0 0
M  V30 4 N 8.1343 6.4500 0.0 0
M  V30 5 O 8.1343 3.7827 0.0 0
M  V30 6 C 9.6743 6.4500 0.0 0 CFG=2
M  V30 7 C 10.4443 5.1163 0.0 0
M  V30 8 C 10.4443 7.7838 0.0 0
M  V30 9 C 11.9843 5.1163 0.0 0
M  V30 10 O 11.9843 7.7838 0.0 0
M  V30 11 O 9.6743 9.1174 0.0 0
M  V30 12 C 12.7543 3.7827 0.0 0
M  V30 13 O 14.2943 3.7827 0.0 0
M  V30 14 O 11.9843 2.4491 0.0 0
M  V30 15 C 3.5143 3.7827 0.0 0
M  V30 16 C 2.6091 5.0286 0.0 0
M  V30 17 C 2.6091 2.5368 0.0 0
M  V30 18 C 1.1445 4.5527 0.0 0
M  V30 19 C 2.9292 6.5350 0.0 0
M  V30 20 C 1.1445 3.0127 0.0 0
M  V30 21 C 2.9292 1.0304 0.0 0
M  V30 22 C 0.0000 5.5831 0.0 0
M  V30 23 C 1.7849 7.5654 0.0 0
M  V30 24 C 0.0000 1.9823 0.0 0
M  V30 25 C 1.7849 0.0000 0.0 0
M  V30 26 C 0.3202 7.0895 0.0 0
M  V30 27 C 0.3202 0.4759 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7 CFG=3
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 2 16 19
M  V30 19 1 17 20
M  V30 20 2 17 21
M  V30 21 1 18 20
M  V30 22 2 18 22
M  V30 23 1 19 23
M  V30 24 2 20 24
M  V30 25 1 21 25
M  V30 26 1 22 26
M  V30 27 2 23 26
M  V30 28 1 24 27
M  V30 29 2 25 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-L-aspartic acid
C19H17NO6
119062-05-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.7534 5.2309 0.0 0
M  V30 2 O 7.0871 4.4608 0.0 0
M  V30 3 C 8.4207 5.2309 0.0 0
M  V30 4 N 9.7544 4.4608 0.0 0
M  V30 5 O 8.4207 6.7709 0.0 0
M  V30 6 C 11.0882 5.2309 0.0 0 CFG=2
M  V30 7 C 11.0882 6.7709 0.0 0
M  V30 8 C 12.4219 4.4608 0.0 0
M  V30 9 C 12.4219 7.5409 0.0 0
M  V30 10 O 12.4219 2.9208 0.0 0
M  V30 11 O 13.7555 5.2309 0.0 0
M  V30 12 O 13.7555 6.7709 0.0 0
M  V30 13 O 12.4219 9.0809 0.0 0
M  V30 14 C 4.4196 4.4608 0.0 0
M  V30 15 C 4.2586 2.9293 0.0 0
M  V30 16 C 3.0128 5.0873 0.0 0
M  V30 17 C 2.7523 2.6091 0.0 0
M  V30 18 C 5.2891 1.7849 0.0 0
M  V30 19 C 1.9823 3.9428 0.0 0
M  V30 20 C 2.5369 6.5519 0.0 0
M  V30 21 C 2.2763 1.1444 0.0 0
M  V30 22 C 4.8132 0.3202 0.0 0
M  V30 23 C 0.4759 4.2630 0.0 0
M  V30 24 C 1.0304 6.8721 0.0 0
M  V30 25 C 3.3069 0.0000 0.0 0
M  V30 26 C 0.0000 5.7277 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7 CFG=1
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 15 18
M  V30 18 1 16 19
M  V30 19 2 16 20
M  V30 20 1 17 19
M  V30 21 2 17 21
M  V30 22 1 18 22
M  V30 23 2 19 23
M  V30 24 1 20 24
M  V30 25 1 21 25
M  V30 26 2 22 25
M  V30 27 1 23 26
M  V30 28 2 24 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Fmoc-leucine
C21H23NO4
35661-60-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.7534 5.2309 0.0 0
M  V30 2 O 7.0871 4.4608 0.0 0
M  V30 3 C 8.4207 5.2309 0.0 0
M  V30 4 N 9.7544 4.4608 0.0 0
M  V30 5 O 8.4207 6.7709 0.0 0
M  V30 6 C 11.0882 5.2309 0.0 0 CFG=2
M  V30 7 C 11.0882 6.7709 0.0 0
M  V30 8 C 12.4219 4.4608 0.0 0
M  V30 9 C 12.4219 7.5409 0.0 0
M  V30 10 O 12.4219 2.9208 0.0 0
M  V30 11 O 13.7555 5.2309 0.0 0
M  V30 12 C 13.7555 6.7709 0.0 0
M  V30 13 C 12.4219 9.0809 0.0 0
M  V30 14 C 4.4196 4.4608 0.0 0
M  V30 15 C 4.2586 2.9293 0.0 0
M  V30 16 C 3.0128 5.0873 0.0 0
M  V30 17 C 2.7523 2.6091 0.0 0
M  V30 18 C 5.2891 1.7849 0.0 0
M  V30 19 C 1.9823 3.9428 0.0 0
M  V30 20 C 2.5369 6.5519 0.0 0
M  V30 21 C 2.2763 1.1444 0.0 0
M  V30 22 C 4.8132 0.3202 0.0 0
M  V30 23 C 0.4759 4.2630 0.0 0
M  V30 24 C 1.0304 6.8721 0.0 0
M  V30 25 C 3.3069 0.0000 0.0 0
M  V30 26 C 0.0000 5.7277 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7 CFG=1
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 1 9 13
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 15 18
M  V30 18 1 16 19
M  V30 19 2 16 20
M  V30 20 1 17 19
M  V30 21 2 17 21
M  V30 22 1 18 22
M  V30 23 2 19 23
M  V30 24 1 20 24
M  V30 25 1 21 25
M  V30 26 2 22 25
M  V30 27 1 23 26
M  V30 28 2 24 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-L-methionine
C20H21NO4S
71989-28-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.0543 3.7827 0.0 0
M  V30 2 O 5.8243 5.1163 0.0 0
M  V30 3 C 7.3643 5.1163 0.0 0
M  V30 4 N 8.1343 6.4500 0.0 0
M  V30 5 O 8.1343 3.7827 0.0 0
M  V30 6 C 9.6743 6.4500 0.0 0 CFG=2
M  V30 7 C 10.4443 5.1163 0.0 0
M  V30 8 C 10.4443 7.7838 0.0 0
M  V30 9 C 11.9843 5.1163 0.0 0
M  V30 10 O 9.6743 9.1174 0.0 0
M  V30 11 O 11.9843 7.7838 0.0 0
M  V30 12 S 12.7543 3.7827 0.0 0
M  V30 13 C 14.2943 3.7827 0.0 0
M  V30 14 C 3.5143 3.7827 0.0 0
M  V30 15 C 2.6091 5.0286 0.0 0
M  V30 16 C 2.6091 2.5368 0.0 0
M  V30 17 C 1.1445 4.5527 0.0 0
M  V30 18 C 2.9292 6.5350 0.0 0
M  V30 19 C 1.1445 3.0127 0.0 0
M  V30 20 C 2.9292 1.0304 0.0 0
M  V30 21 C 0.0000 5.5831 0.0 0
M  V30 22 C 1.7849 7.5654 0.0 0
M  V30 23 C 0.0000 1.9823 0.0 0
M  V30 24 C 1.7849 0.0000 0.0 0
M  V30 25 C 0.3202 7.0895 0.0 0
M  V30 26 C 0.3202 0.4759 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7 CFG=3
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 1 12 13
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 15 18
M  V30 18 1 16 19
M  V30 19 2 16 20
M  V30 20 1 17 19
M  V30 21 2 17 21
M  V30 22 1 18 22
M  V30 23 2 19 23
M  V30 24 1 20 24
M  V30 25 1 21 25
M  V30 26 2 22 25
M  V30 27 1 23 26
M  V30 28 2 24 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
FMOC-L-phenylalanine
C24H21NO4
35661-40-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 32 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.3360 5.2309 0.0 0
M  V30 2 O 8.0021 4.4608 0.0 0
M  V30 3 C 6.6685 5.2309 0.0 0
M  V30 4 N 5.3348 4.4608 0.0 0
M  V30 5 O 6.6685 6.7709 0.0 0
M  V30 6 C 4.0011 5.2309 0.0 0 CFG=2
M  V30 7 C 4.0011 6.7709 0.0 0
M  V30 8 C 2.6673 4.4608 0.0 0
M  V30 9 O 1.3337 5.2309 0.0 0
M  V30 10 O 2.6673 2.9208 0.0 0
M  V30 11 C 10.6696 4.4608 0.0 0
M  V30 12 C 10.8306 2.9293 0.0 0
M  V30 13 C 12.0764 5.0873 0.0 0
M  V30 14 C 12.3370 2.6091 0.0 0
M  V30 15 C 9.8001 1.7849 0.0 0
M  V30 16 C 13.1070 3.9428 0.0 0
M  V30 17 C 12.5523 6.5519 0.0 0
M  V30 18 C 12.8129 1.1444 0.0 0
M  V30 19 C 10.2760 0.3202 0.0 0
M  V30 20 C 14.6133 4.2630 0.0 0
M  V30 21 C 14.0588 6.8721 0.0 0
M  V30 22 C 11.7823 0.0000 0.0 0
M  V30 23 C 15.0892 5.7277 0.0 0
M  V30 24 C 2.6673 7.5409 0.0 0
M  V30 25 C 1.3337 6.7709 0.0 0
M  V30 26 C 2.6673 9.0809 0.0 0
M  V30 27 C 0.0000 7.5409 0.0 0
M  V30 28 C 1.3337 9.8509 0.0 0
M  V30 29 C 0.0000 9.0809 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7 CFG=3
M  V30 8 1 6 8
M  V30 9 1 7 24
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 12 15
M  V30 16 1 13 16
M  V30 17 2 13 17
M  V30 18 1 14 16
M  V30 19 2 14 18
M  V30 20 1 15 19
M  V30 21 2 16 20
M  V30 22 1 17 21
M  V30 23 1 18 22
M  V30 24 2 19 22
M  V30 25 1 20 23
M  V30 26 2 21 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(S)-2-[[[(9H-Fluoren-9-yl)methoxy]carbonyl]amino]butanoic acid
C19H19NO4
135112-27-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.7534 5.2309 0.0 0
M  V30 2 O 7.0871 4.4608 0.0 0
M  V30 3 C 8.4207 5.2309 0.0 0
M  V30 4 N 9.7544 4.4608 0.0 0
M  V30 5 O 8.4207 6.7709 0.0 0
M  V30 6 C 11.0882 5.2309 0.0 0 CFG=1
M  V30 7 C 12.4219 4.4608 0.0 0
M  V30 8 C 11.0882 6.7709 0.0 0
M  V30 9 O 12.4219 2.9208 0.0 0
M  V30 10 O 13.7555 5.2309 0.0 0
M  V30 11 C 12.4219 7.5409 0.0 0
M  V30 12 C 4.4196 4.4608 0.0 0
M  V30 13 C 4.2586 2.9293 0.0 0
M  V30 14 C 3.0128 5.0873 0.0 0
M  V30 15 C 2.7523 2.6091 0.0 0
M  V30 16 C 5.2891 1.7849 0.0 0
M  V30 17 C 1.9823 3.9428 0.0 0
M  V30 18 C 2.5369 6.5519 0.0 0
M  V30 19 C 2.2763 1.1444 0.0 0
M  V30 20 C 4.8132 0.3202 0.0 0
M  V30 21 C 0.4759 4.2630 0.0 0
M  V30 22 C 1.0304 6.8721 0.0 0
M  V30 23 C 3.3069 0.0000 0.0 0
M  V30 24 C 0.0000 5.7277 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8 CFG=1
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 13 16
M  V30 16 1 14 17
M  V30 17 2 14 18
M  V30 18 1 15 17
M  V30 19 2 15 19
M  V30 20 1 16 20
M  V30 21 2 17 21
M  V30 22 1 18 22
M  V30 23 1 19 23
M  V30 24 2 20 23
M  V30 25 1 21 24
M  V30 26 2 22 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-L-tyrosine
C24H21NO5
92954-90-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 33 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.7533 5.2309 0.0 0
M  V30 2 O 7.0871 4.4609 0.0 0
M  V30 3 C 8.4207 5.2309 0.0 0
M  V30 4 N 9.7544 4.4609 0.0 0
M  V30 5 O 8.4207 6.7709 0.0 0
M  V30 6 C 11.0881 5.2309 0.0 0 CFG=2
M  V30 7 C 11.0881 6.7709 0.0 0
M  V30 8 C 12.4219 4.4609 0.0 0
M  V30 9 O 13.7556 5.2309 0.0 0
M  V30 10 O 12.4219 2.9208 0.0 0
M  V30 11 O 16.4229 9.8510 0.0 0
M  V30 12 C 4.4196 4.4609 0.0 0
M  V30 13 C 4.2587 2.9293 0.0 0
M  V30 14 C 3.0128 5.0873 0.0 0
M  V30 15 C 2.7522 2.6091 0.0 0
M  V30 16 C 5.2891 1.7849 0.0 0
M  V30 17 C 1.9822 3.9428 0.0 0
M  V30 18 C 2.5367 6.5519 0.0 0
M  V30 19 C 2.2763 1.1444 0.0 0
M  V30 20 C 4.8132 0.3202 0.0 0
M  V30 21 C 0.4759 4.2630 0.0 0
M  V30 22 C 1.0304 6.8721 0.0 0
M  V30 23 C 3.3068 0.0000 0.0 0
M  V30 24 C 0.0000 5.7277 0.0 0
M  V30 25 C 12.4219 7.5409 0.0 0
M  V30 26 C 13.7556 6.7709 0.0 0
M  V30 27 C 12.4219 9.0810 0.0 0
M  V30 28 C 15.0892 7.5409 0.0 0
M  V30 29 C 13.7556 9.8510 0.0 0
M  V30 30 C 15.0892 9.0810 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7 CFG=1
M  V30 8 1 6 8
M  V30 9 1 7 25
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 11 30
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 13 16
M  V30 17 1 14 17
M  V30 18 2 14 18
M  V30 19 1 15 17
M  V30 20 2 15 19
M  V30 21 1 16 20
M  V30 22 2 17 21
M  V30 23 1 18 22
M  V30 24 1 19 23
M  V30 25 2 20 23
M  V30 26 1 21 24
M  V30 27 2 22 24
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
L-Tyrosyl-(2S)-2-aminobutanoyl-L-phenylalanyl-L-methionyl-L-leucyl-L-α-aspart...
C70H105N13O16S
1380239-46-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  100 102 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 14.6707 0.0 0 CFG=2
M  V30 2 C 3.0801 14.6707 0.0 0
M  V30 3 C 5.3901 16.0045 0.0 0
M  V30 4 N 5.3901 13.3370 0.0 0
M  V30 5 N 6.9302 16.0045 0.0 0
M  V30 6 O 4.6201 17.3382 0.0 0
M  V30 7 C 4.6201 12.0033 0.0 0
M  V30 8 C 7.7002 17.3382 0.0 0 CFG=1
M  V30 9 C 5.3901 10.6697 0.0 0 CFG=2
M  V30 10 O 3.0801 12.0033 0.0 0
M  V30 11 C 9.2402 17.3382 0.0 0
M  V30 12 C 6.9302 18.6718 0.0 0
M  V30 13 N 4.6201 9.3358 0.0 0
M  V30 14 C 6.9302 10.6697 0.0 0
M  V30 15 N 10.0102 18.6718 0.0 0
M  V30 16 O 10.0102 16.0045 0.0 0
M  V30 17 C 7.7002 20.0055 0.0 0
M  V30 18 C 5.3901 8.0022 0.0 0
M  V30 19 C 7.7002 12.0033 0.0 0
M  V30 20 C 11.5503 18.6718 0.0 0 CFG=1
M  V30 21 S 6.9302 21.3393 0.0 0
M  V30 22 C 4.6201 6.6685 0.0 0 CFG=1
M  V30 23 O 6.9302 8.0022 0.0 0
M  V30 24 C 12.3203 20.0055 0.0 0
M  V30 25 C 12.3203 17.3382 0.0 0
M  V30 26 C 7.7002 22.6730 0.0 0
M  V30 27 C 5.3901 5.3348 0.0 0
M  V30 28 N 3.0801 6.6685 0.0 0
M  V30 29 N 13.8603 20.0055 0.0 0
M  V30 30 O 11.5503 21.3393 0.0 0
M  V30 31 C 13.8603 17.3382 0.0 0
M  V30 32 C 14.6303 21.3393 0.0 0 CFG=1
M  V30 33 C 14.6303 18.6718 0.0 0
M  V30 34 C 14.6303 16.0045 0.0 0
M  V30 35 C 16.1704 21.3393 0.0 0
M  V30 36 C 13.8603 22.6730 0.0 0
M  V30 37 N 16.9404 20.0055 0.0 0
M  V30 38 O 16.9404 22.6730 0.0 0
M  V30 39 C 14.6303 24.0067 0.0 0
M  V30 40 C 18.4804 20.0055 0.0 0 CFG=1
M  V30 41 O 16.1704 24.0067 0.0 0
M  V30 42 O 13.8603 25.3403 0.0 0
M  V30 43 C 19.2504 18.6718 0.0 0
M  V30 44 C 19.2504 21.3393 0.0 0
M  V30 45 N 20.7905 18.6718 0.0 0
M  V30 46 O 18.4804 17.3382 0.0 0
M  V30 47 C 20.7905 21.3393 0.0 0
M  V30 48 C 21.5605 17.3382 0.0 0
M  V30 49 C 21.5605 22.6730 0.0 0
M  V30 50 C 23.1005 17.3382 0.0 0
M  V30 51 O 23.1005 22.6730 0.0 0
M  V30 52 O 20.7905 24.0067 0.0 0
M  V30 53 C 23.8705 16.0045 0.0 0
M  V30 54 C 25.4106 16.0045 0.0 0
M  V30 55 C 26.1806 14.6707 0.0 0
M  V30 56 C 27.7206 14.6707 0.0 0
M  V30 57 N 28.4906 13.3370 0.0 0
M  V30 58 O 28.4906 16.0045 0.0 0
M  V30 59 C 30.0307 13.3370 0.0 0 CFG=1
M  V30 60 C 30.8007 12.0033 0.0 0
M  V30 61 C 30.8007 14.6707 0.0 0
M  V30 62 N 32.3407 12.0033 0.0 0
M  V30 63 O 30.0307 10.6697 0.0 0
M  V30 64 C 32.3407 14.6707 0.0 0
M  V30 65 C 33.1107 10.6697 0.0 0 CFG=2
M  V30 66 C 33.1107 16.0045 0.0 0
M  V30 67 C 32.3407 9.3358 0.0 0
M  V30 68 C 34.6508 10.6697 0.0 0
M  V30 69 C 34.6508 16.0045 0.0 0
M  V30 70 N 35.4208 9.3358 0.0 0
M  V30 71 O 35.4208 12.0033 0.0 0
M  V30 72 N 35.4208 17.3382 0.0 0
M  V30 73 C 36.9608 9.3358 0.0 0 CFG=1
M  V30 74 C 37.7308 10.6697 0.0 0
M  V30 75 C 37.7308 8.0022 0.0 0
M  V30 76 N 39.2709 10.6697 0.0 0
M  V30 77 O 36.9608 12.0033 0.0 0
M  V30 78 C 39.2709 8.0022 0.0 0
M  V30 79 C 40.0409 12.0033 0.0 0
M  V30 80 C 40.0409 6.6685 0.0 0
M  V30 81 C 40.0409 9.3358 0.0 0
M  V30 82 O 2.3101 0.0000 0.0 0
M  V30 83 C 2.3101 16.0045 0.0 0
M  V30 84 C 0.7700 16.0045 0.0 0
M  V30 85 C 3.0801 17.3382 0.0 0
M  V30 86 C 0.0000 17.3382 0.0 0
M  V30 87 C 2.3101 18.6718 0.0 0
M  V30 88 C 0.7700 18.6718 0.0 0
M  V30 89 C 4.6201 4.0010 0.0 0
M  V30 90 C 5.3901 2.6673 0.0 0
M  V30 91 C 3.0801 4.0010 0.0 0
M  V30 92 C 4.6201 1.3337 0.0 0
M  V30 93 C 2.3101 2.6673 0.0 0
M  V30 94 C 3.0801 1.3337 0.0 0
M  V30 95 C 33.1107 8.0022 0.0 0
M  V30 96 C 32.3407 6.6685 0.0 0
M  V30 97 C 34.6508 8.0022 0.0 0
M  V30 98 C 33.1107 5.3348 0.0 0
M  V30 99 C 35.4208 6.6685 0.0 0
M  V30 100 C 34.6508 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 83
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 8 12 CFG=1
M  V30 13 1 9 13
M  V30 14 1 9 14 CFG=3
M  V30 15 1 11 15
M  V30 16 2 11 16
M  V30 17 1 12 17
M  V30 18 1 13 18
M  V30 19 1 14 19
M  V30 20 1 15 20
M  V30 21 1 17 21
M  V30 22 1 18 22
M  V30 23 2 18 23
M  V30 24 1 20 24
M  V30 25 1 20 25 CFG=3
M  V30 26 1 21 26
M  V30 27 1 22 27
M  V30 28 1 22 28 CFG=3
M  V30 29 1 24 29
M  V30 30 2 24 30
M  V30 31 1 25 31
M  V30 32 1 27 89
M  V30 33 1 29 32
M  V30 34 1 31 33
M  V30 35 1 31 34
M  V30 36 1 32 35
M  V30 37 1 32 36 CFG=1
M  V30 38 1 35 37
M  V30 39 2 35 38
M  V30 40 1 36 39
M  V30 41 1 37 40
M  V30 42 1 39 41
M  V30 43 2 39 42
M  V30 44 1 40 43
M  V30 45 1 40 44 CFG=1
M  V30 46 1 43 45
M  V30 47 2 43 46
M  V30 48 1 44 47
M  V30 49 1 45 48
M  V30 50 1 47 49
M  V30 51 1 48 50
M  V30 52 1 49 51
M  V30 53 2 49 52
M  V30 54 1 50 53
M  V30 55 1 53 54
M  V30 56 1 54 55
M  V30 57 1 55 56
M  V30 58 1 56 57
M  V30 59 2 56 58
M  V30 60 1 57 59
M  V30 61 1 59 60
M  V30 62 1 59 61 CFG=1
M  V30 63 1 60 62
M  V30 64 2 60 63
M  V30 65 1 61 64
M  V30 66 1 62 65
M  V30 67 1 64 66
M  V30 68 1 65 67 CFG=3
M  V30 69 1 65 68
M  V30 70 1 66 69
M  V30 71 1 67 95
M  V30 72 1 68 70
M  V30 73 2 68 71
M  V30 74 1 69 72
M  V30 75 1 70 73
M  V30 76 1 73 74
M  V30 77 1 73 75 CFG=3
M  V30 78 1 74 76
M  V30 79 2 74 77
M  V30 80 1 75 78
M  V30 81 1 76 79
M  V30 82 1 78 80
M  V30 83 1 78 81
M  V30 84 1 82 94
M  V30 85 2 83 84
M  V30 86 1 83 85
M  V30 87 1 84 86
M  V30 88 2 85 87
M  V30 89 2 86 88
M  V30 90 1 87 88
M  V30 91 2 89 90
M  V30 92 1 89 91
M  V30 93 1 90 92
M  V30 94 2 91 93
M  V30 95 2 92 94
M  V30 96 1 93 94
M  V30 97 2 95 96
M  V30 98 1 95 97
M  V30 99 1 96 98
M  V30 100 2 97 99
M  V30 101 2 98 100
M  V30 102 1 99 100
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(10 1 8 9 20 22 32 40 59 65 73)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 13139-15-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 13734-34-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 13734-28-6
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 88574-06-5
$DTYPE RXN:RCT(5):CAS_RN
$DATUM 121343-82-6
$DTYPE RXN:RCT(6):CAS_RN
$DATUM 119062-05-4
$DTYPE RXN:RCT(7):CAS_RN
$DATUM 35661-60-0
$DTYPE RXN:RCT(8):CAS_RN
$DATUM 71989-28-1
$DTYPE RXN:RCT(9):CAS_RN
$DATUM 35661-40-6
$DTYPE RXN:RCT(10):CAS_RN
$DATUM 135112-27-5
$DTYPE RXN:RCT(11):CAS_RN
$DATUM 92954-90-0
$DTYPE RXN:RCT(12):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1380239-46-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-353-CAS-16586279
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 25
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 26198-19-6
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 94790-37-1
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 110-89-4
$DTYPE RXN:VAR(1):RGT(5):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM solid-supported reaction, attachment to resin stage 1 (Merrifield resin)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compatibility study of merrifield linker in Fmoc strategy peptide
synthesis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yang, Xiaoxiao; Lin, Hao; Lu, Wen; Wang, Dexin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Protein & Peptide Letters (2013), 20(2), 140-145

$RFMT $RIREG SCHEME162 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-1-[(2R,3R)-4-Oxo-3-phenoxy-1-(2-propen-1-yl)-2-azetidinyl]-1′-[(2S,3S)-4-...
C34H32FeN2O4
1196711-50-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 54 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.8714 16.7172 0.0 0
M  V30 2 C 10.8621 13.7623 0.0 0
M  V30 3 C 12.0894 14.4697 0.0 0
M  V30 4 C 13.3167 13.7623 0.0 0
M  V30 5 O 10.7878 3.2520 0.0 0
M  V30 6 C 6.7971 0.2931 0.0 0
M  V30 7 C 5.5698 1.0045 0.0 0
M  V30 8 C 4.3425 0.2931 0.0 0
M  V30 9 O 10.6393 17.0104 0.0 0
M  V30 10 O 10.5650 0.0000 0.0 0
M  V30 11 Fe 3.4435 8.4739 0.0 0 CHG=2 VAL=10
M  V30 12 C 6.8714 13.7623 0.0 0 CHG=-1 VAL=4
M  V30 13 C 6.7971 3.2520 0.0 0 CHG=-1 VAL=4
M  V30 14 C 4.6395 4.4988 0.0 0 VAL=5
M  V30 15 C 3.3653 1.0592 0.0 0 VAL=5
M  V30 16 C 4.7177 12.5154 0.0 0 VAL=5
M  V30 17 C 3.4435 15.9472 0.0 0 VAL=5
M  V30 18 C 0.0743 13.7623 0.0 0 VAL=5
M  V30 19 C 2.2240 12.5154 0.0 0 VAL=5
M  V30 20 C 0.0000 3.2520 0.0 0 VAL=5
M  V30 21 C 2.1458 4.4988 0.0 0 VAL=5
M  V30 22 C 8.0987 14.4697 0.0 0
M  V30 23 C 8.0987 16.0097 0.0 0
M  V30 24 N 9.6348 14.4697 0.0 0
M  V30 25 C 9.6348 16.0097 0.0 0
M  V30 26 C 8.0244 2.5445 0.0 0
M  V30 27 C 9.5605 2.5445 0.0 0
M  V30 28 N 8.0244 1.0045 0.0 0
M  V30 29 C 9.5605 1.0045 0.0 0
M  V30 30 C 6.8714 18.1360 0.0 0
M  V30 31 C 8.2003 18.9021 0.0 0
M  V30 32 C 5.5385 18.9021 0.0 0
M  V30 33 C 8.2042 20.4421 0.0 0
M  V30 34 C 5.5385 20.4421 0.0 0
M  V30 35 C 6.8714 21.2121 0.0 0
M  V30 36 C 12.0151 2.5445 0.0 0
M  V30 37 C 12.0151 1.0045 0.0 0
M  V30 38 C 13.3519 3.3106 0.0 0
M  V30 39 C 13.3519 0.2345 0.0 0
M  V30 40 C 14.6808 2.5445 0.0 0
M  V30 41 C 14.6808 1.0045 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 23
M  V30 2 1 1 30
M  V30 3 1 2 3
M  V30 4 1 2 24
M  V30 5 2 3 4
M  V30 6 1 5 27
M  V30 7 1 5 36
M  V30 8 1 6 7
M  V30 9 1 6 28
M  V30 10 2 7 8
M  V30 11 2 9 25
M  V30 12 2 10 29
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 11 14
M  V30 16 1 11 15
M  V30 17 1 11 16
M  V30 18 1 11 17
M  V30 19 1 11 18
M  V30 20 1 11 19
M  V30 21 1 11 20
M  V30 22 1 11 21
M  V30 23 1 12 16
M  V30 24 1 12 17
M  V30 25 1 12 22
M  V30 26 1 13 14
M  V30 27 1 13 15
M  V30 28 1 13 26
M  V30 29 2 14 21
M  V30 30 2 15 20
M  V30 31 2 16 19
M  V30 32 2 17 18
M  V30 33 1 18 19
M  V30 34 1 20 21
M  V30 35 1 22 23
M  V30 36 1 22 24
M  V30 37 1 23 25
M  V30 38 1 24 25
M  V30 39 1 26 27
M  V30 40 1 26 28
M  V30 41 1 27 29
M  V30 42 1 28 29
M  V30 43 2 30 31
M  V30 44 1 30 32
M  V30 45 1 31 33
M  V30 46 2 32 34
M  V30 47 2 33 35
M  V30 48 1 34 35
M  V30 49 2 36 37
M  V30 50 1 36 38
M  V30 51 1 37 39
M  V30 52 2 38 40
M  V30 53 2 39 41
M  V30 54 1 40 41
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-1-[(1R,2R)-3-(Methylamino)-3-oxo-2-phenoxy-1-(2-propen-1-ylamino)propyl]-...
C36H42FeN4O4
1196711-53-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  45 56 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.1090 14.0498 0.0 0
M  V30 2 C 9.3378 13.3375 0.0 0
M  V30 3 N 8.1090 15.4665 0.0 0
M  V30 4 O 9.3378 11.9208 0.0 0
M  V30 5 C 10.5667 14.0498 0.0 0
M  V30 6 C 6.8801 16.1788 0.0 0
M  V30 7 N 11.7956 13.3375 0.0 0
M  V30 8 O 10.5667 15.4665 0.0 0
M  V30 9 C 5.6395 15.4900 0.0 0
M  V30 10 C 13.1458 14.1203 0.0 0
M  V30 11 C 4.4106 16.1984 0.0 0
M  V30 12 C 8.0346 2.1055 0.0 0
M  V30 13 C 9.2635 2.8139 0.0 0
M  V30 14 N 8.0346 0.6849 0.0 0
M  V30 15 O 9.2635 4.2345 0.0 0
M  V30 16 C 10.4924 2.1055 0.0 0
M  V30 17 C 6.7940 0.0000 0.0 0
M  V30 18 N 11.7212 2.8139 0.0 0
M  V30 19 O 10.4924 0.6849 0.0 0
M  V30 20 C 5.5651 0.7084 0.0 0
M  V30 21 C 13.0753 2.0351 0.0 0
M  V30 22 C 4.3245 0.0196 0.0 0
M  V30 23 Fe 3.4479 8.0424 0.0 0 CHG=2 VAL=10
M  V30 24 C 6.8801 13.3375 0.0 0 CHG=-1 VAL=4
M  V30 25 C 6.8057 2.8139 0.0 0 CHG=-1 VAL=4
M  V30 26 C 4.6454 4.0662 0.0 0 VAL=5
M  V30 27 C 3.3735 0.6223 0.0 0 VAL=5
M  V30 28 C 4.7237 12.0891 0.0 0 VAL=5
M  V30 29 C 3.4479 15.5291 0.0 0 VAL=5
M  V30 30 C 0.0783 13.3375 0.0 0 VAL=5
M  V30 31 C 2.2307 12.0891 0.0 0 VAL=5
M  V30 32 C 0.0000 2.8139 0.0 0 VAL=5
M  V30 33 C 2.1486 4.0662 0.0 0 VAL=5
M  V30 34 C 10.5667 11.2085 0.0 0
M  V30 35 C 10.5667 9.6705 0.0 0
M  V30 36 C 11.9052 11.9795 0.0 0
M  V30 37 C 11.9052 8.8995 0.0 0
M  V30 38 C 13.2358 11.2085 0.0 0
M  V30 39 C 13.2358 9.6705 0.0 0
M  V30 40 C 10.4924 4.9429 0.0 0
M  V30 41 C 10.4924 6.4848 0.0 0
M  V30 42 C 11.8308 4.1758 0.0 0
M  V30 43 C 11.8308 7.2558 0.0 0
M  V30 44 C 13.1614 4.9429 0.0 0
M  V30 45 C 13.1614 6.4848 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 24
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 3 6
M  V30 7 1 4 34
M  V30 8 1 5 7
M  V30 9 2 5 8
M  V30 10 1 6 9
M  V30 11 1 7 10
M  V30 12 2 9 11
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 12 25
M  V30 16 1 13 15
M  V30 17 1 13 16
M  V30 18 1 14 17
M  V30 19 1 15 40
M  V30 20 1 16 18
M  V30 21 2 16 19
M  V30 22 1 17 20
M  V30 23 1 18 21
M  V30 24 2 20 22
M  V30 25 1 23 24
M  V30 26 1 23 25
M  V30 27 1 23 26
M  V30 28 1 23 27
M  V30 29 1 23 28
M  V30 30 1 23 29
M  V30 31 1 23 30
M  V30 32 1 23 31
M  V30 33 1 23 32
M  V30 34 1 23 33
M  V30 35 1 24 28
M  V30 36 1 24 29
M  V30 37 1 25 26
M  V30 38 1 25 27
M  V30 39 2 26 33
M  V30 40 2 27 32
M  V30 41 2 28 31
M  V30 42 2 29 30
M  V30 43 1 30 31
M  V30 44 1 32 33
M  V30 45 2 34 35
M  V30 46 1 34 36
M  V30 47 1 35 37
M  V30 48 2 36 38
M  V30 49 2 37 39
M  V30 50 1 38 39
M  V30 51 2 40 41
M  V30 52 1 40 42
M  V30 53 1 41 43
M  V30 54 2 42 44
M  V30 55 2 43 45
M  V30 56 1 44 45
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1196711-50-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1196711-53-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-363-CAS-5685356
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of ferrocene tethered open and macrocyclic bis-β-lactams and
bis-β-amino acid derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sierra, Miguel A.; Rodriguez-Fernandez, Mamen; Casarrubios, Luis;
Gomez-Gallego, Mar; Allen, Charles P.; Mancheno, Maria Jose
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Dalton Transactions (2009), (39), 8399-8405

$RFMT $RIREG SCHEME163 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(1S,2Z)-4-[[cis-4-[(2E,4E)-5-[(3R,5S)-7,7-Dimethyl-1,6-dioxaspiro[2.5]oct-5-y...
C32H42N2O8
1197054-30-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  42 45 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.5178 4.6201 0.0 0
M  V30 2 C 6.8514 3.8501 0.0 0
M  V30 3 C 8.1852 4.6201 0.0 0
M  V30 4 C 9.5189 3.8501 0.0 0
M  V30 5 C 8.1852 6.1601 0.0 0
M  V30 6 C 10.8526 4.6201 0.0 0
M  V30 7 C 0.9899 5.2972 0.0 0
M  V30 8 C 0.0000 3.5827 0.0 0
M  V30 9 N 16.1874 1.5400 0.0 0
M  V30 10 C 17.5210 2.3100 0.0 0
M  V30 11 C 17.5210 3.8501 0.0 0
M  V30 12 O 18.8548 1.5400 0.0 0
M  V30 13 C 18.8548 4.6201 0.0 0
M  V30 14 C 20.1885 3.8501 0.0 0 CFG=2
M  V30 15 O 21.5222 4.6201 0.0 0
M  V30 16 C 20.1885 2.3100 0.0 0
M  V30 17 C 22.8558 3.8501 0.0 0
M  V30 18 O 24.1896 4.6201 0.0 0
M  V30 19 O 22.8558 2.3100 0.0 0
M  V30 20 N 29.5244 1.5400 0.0 0 VAL=5
M  V30 21 O 30.8581 2.3100 0.0 0
M  V30 22 O 29.5244 0.0000 0.0 0
M  V30 23 C 2.8504 1.5400 0.0 0 CFG=2
M  V30 24 C 2.0804 0.2064 0.0 0
M  V30 25 O 3.6204 0.2064 0.0 0
M  V30 26 C 4.1841 2.3100 0.0 0
M  V30 27 C 1.5166 2.3100 0.0 0
M  V30 28 C 4.1841 3.8501 0.0 0 CFG=1
M  V30 29 C 1.5166 3.8501 0.0 0
M  V30 30 O 2.8504 4.6201 0.0 0
M  V30 31 C 12.1862 3.8501 0.0 0 CFG=2
M  V30 32 C 12.1862 2.3100 0.0 0
M  V30 33 C 13.5200 4.6201 0.0 0
M  V30 34 C 13.5200 1.5400 0.0 0
M  V30 35 C 14.8537 3.8501 0.0 0
M  V30 36 C 14.8537 2.3100 0.0 0 CFG=1
M  V30 37 C 25.5233 3.8501 0.0 0
M  V30 38 C 26.8570 4.6201 0.0 0
M  V30 39 C 25.5233 2.3100 0.0 0
M  V30 40 C 28.1906 3.8501 0.0 0
M  V30 41 C 26.8570 1.5400 0.0 0
M  V30 42 C 28.1906 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 28 1 CFG=3
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 31 6 CFG=3
M  V30 8 1 7 29
M  V30 9 1 8 29
M  V30 10 1 9 10
M  V30 11 1 36 9 CFG=3
M  V30 12 1 10 11
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 13 14
M  V30 16 1 14 15
M  V30 17 1 14 16 CFG=1
M  V30 18 1 15 17
M  V30 19 1 17 18
M  V30 20 2 17 19
M  V30 21 1 18 37
M  V30 22 2 20 21
M  V30 23 2 20 22
M  V30 24 1 20 42
M  V30 25 1 23 24 CFG=3
M  V30 26 1 23 25
M  V30 27 1 23 26
M  V30 28 1 23 27
M  V30 29 1 24 25
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 1 29 30
M  V30 34 1 31 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 1 35 36
M  V30 40 2 37 38
M  V30 41 1 37 39
M  V30 42 1 38 40
M  V30 43 2 39 41
M  V30 44 2 40 42
M  V30 45 1 41 42
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 14 23 28 31 36)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(2Z,4S)-N-[cis-4-[(2E,4E)-5-[(3R,5S)-7,7-Dimethyl-1,6-dioxaspiro[2.5]oct-5-yl...
C27H42N2O5
1510837-67-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.5178 4.4137 0.0 0
M  V30 2 C 6.8515 3.6437 0.0 0
M  V30 3 C 8.1851 4.4137 0.0 0
M  V30 4 C 9.5188 3.6437 0.0 0
M  V30 5 C 8.1851 5.9538 0.0 0
M  V30 6 C 10.8526 4.4137 0.0 0
M  V30 7 C 0.9899 5.0909 0.0 0
M  V30 8 C 0.0000 3.3764 0.0 0
M  V30 9 N 16.1874 1.3337 0.0 0
M  V30 10 C 17.5211 2.1037 0.0 0
M  V30 11 C 17.5211 3.6437 0.0 0
M  V30 12 O 18.8548 1.3337 0.0 0
M  V30 13 C 18.8548 4.4137 0.0 0
M  V30 14 C 20.1885 3.6437 0.0 0 CFG=2
M  V30 15 O 21.5223 4.4137 0.0 0
M  V30 16 C 20.1885 2.1037 0.0 0
M  V30 17 C 22.8559 3.6437 0.0 0
M  V30 18 N 24.1896 4.4137 0.0 0
M  V30 19 O 22.8559 2.1037 0.0 0
M  V30 20 C 25.5233 3.6437 0.0 0
M  V30 21 C 2.8503 1.3337 0.0 0 CFG=2
M  V30 22 C 2.0803 0.0000 0.0 0
M  V30 23 O 3.6203 0.0000 0.0 0
M  V30 24 C 4.1840 2.1037 0.0 0
M  V30 25 C 1.5166 2.1037 0.0 0
M  V30 26 C 4.1840 3.6437 0.0 0 CFG=1
M  V30 27 C 1.5166 3.6437 0.0 0
M  V30 28 O 2.8503 4.4137 0.0 0
M  V30 29 C 12.1863 3.6437 0.0 0 CFG=2
M  V30 30 C 13.5200 4.4137 0.0 0
M  V30 31 C 12.1863 2.1037 0.0 0
M  V30 32 C 14.8536 3.6437 0.0 0
M  V30 33 C 13.5200 1.3337 0.0 0
M  V30 34 C 14.8536 2.1037 0.0 0 CFG=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 26 1 CFG=3
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 29 6 CFG=1
M  V30 8 1 7 27
M  V30 9 1 8 27
M  V30 10 1 9 10
M  V30 11 1 34 9 CFG=1
M  V30 12 1 10 11
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 13 14
M  V30 16 1 14 15
M  V30 17 1 14 16 CFG=1
M  V30 18 1 15 17
M  V30 19 1 17 18
M  V30 20 2 17 19
M  V30 21 1 18 20
M  V30 22 1 21 22
M  V30 23 1 21 23 CFG=1
M  V30 24 1 21 24
M  V30 25 1 21 25
M  V30 26 1 22 23
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 1 27 28
M  V30 31 1 29 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 1 32 34
M  V30 36 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 14 21 26 29 34)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1197054-30-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1510837-67-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-5657198
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 107-06-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Anticancer compounds
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Webb, Thomas R.; Lagisetti, Chandraiah
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2014089571 A1 2014-06-12

$RFMT $RIREG SCHEME163 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(1S,2Z)-4-[[cis-4-[(2E,4E)-5-[(3R,5S)-7,7-Dimethyl-1,6-dioxaspiro[2.5]oct-5-y...
C32H42N2O8
1197054-30-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  42 45 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.5178 4.6201 0.0 0
M  V30 2 C 6.8514 3.8501 0.0 0
M  V30 3 C 8.1852 4.6201 0.0 0
M  V30 4 C 9.5189 3.8501 0.0 0
M  V30 5 C 8.1852 6.1601 0.0 0
M  V30 6 C 10.8526 4.6201 0.0 0
M  V30 7 C 0.9899 5.2972 0.0 0
M  V30 8 C 0.0000 3.5827 0.0 0
M  V30 9 N 16.1874 1.5400 0.0 0
M  V30 10 C 17.5210 2.3100 0.0 0
M  V30 11 C 17.5210 3.8501 0.0 0
M  V30 12 O 18.8548 1.5400 0.0 0
M  V30 13 C 18.8548 4.6201 0.0 0
M  V30 14 C 20.1885 3.8501 0.0 0 CFG=2
M  V30 15 O 21.5222 4.6201 0.0 0
M  V30 16 C 20.1885 2.3100 0.0 0
M  V30 17 C 22.8558 3.8501 0.0 0
M  V30 18 O 24.1896 4.6201 0.0 0
M  V30 19 O 22.8558 2.3100 0.0 0
M  V30 20 N 29.5244 1.5400 0.0 0 VAL=5
M  V30 21 O 30.8581 2.3100 0.0 0
M  V30 22 O 29.5244 0.0000 0.0 0
M  V30 23 C 2.8504 1.5400 0.0 0 CFG=2
M  V30 24 C 2.0804 0.2064 0.0 0
M  V30 25 O 3.6204 0.2064 0.0 0
M  V30 26 C 4.1841 2.3100 0.0 0
M  V30 27 C 1.5166 2.3100 0.0 0
M  V30 28 C 4.1841 3.8501 0.0 0 CFG=1
M  V30 29 C 1.5166 3.8501 0.0 0
M  V30 30 O 2.8504 4.6201 0.0 0
M  V30 31 C 12.1862 3.8501 0.0 0 CFG=2
M  V30 32 C 12.1862 2.3100 0.0 0
M  V30 33 C 13.5200 4.6201 0.0 0
M  V30 34 C 13.5200 1.5400 0.0 0
M  V30 35 C 14.8537 3.8501 0.0 0
M  V30 36 C 14.8537 2.3100 0.0 0 CFG=1
M  V30 37 C 25.5233 3.8501 0.0 0
M  V30 38 C 26.8570 4.6201 0.0 0
M  V30 39 C 25.5233 2.3100 0.0 0
M  V30 40 C 28.1906 3.8501 0.0 0
M  V30 41 C 26.8570 1.5400 0.0 0
M  V30 42 C 28.1906 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 28 1 CFG=3
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 31 6 CFG=3
M  V30 8 1 7 29
M  V30 9 1 8 29
M  V30 10 1 9 10
M  V30 11 1 36 9 CFG=3
M  V30 12 1 10 11
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 13 14
M  V30 16 1 14 15
M  V30 17 1 14 16 CFG=1
M  V30 18 1 15 17
M  V30 19 1 17 18
M  V30 20 2 17 19
M  V30 21 1 18 37
M  V30 22 2 20 21
M  V30 23 2 20 22
M  V30 24 1 20 42
M  V30 25 1 23 24 CFG=3
M  V30 26 1 23 25
M  V30 27 1 23 26
M  V30 28 1 23 27
M  V30 29 1 24 25
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 1 29 30
M  V30 34 1 31 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 1 35 36
M  V30 40 2 37 38
M  V30 41 1 37 39
M  V30 42 1 38 40
M  V30 43 2 39 41
M  V30 44 2 40 42
M  V30 45 1 41 42
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 14 23 28 31 36)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(2Z,4S)-N-[cis-4-[(2E,4E)-5-[(3R,5S)-7,7-Dimethyl-1,6-dioxaspiro[2.5]oct-5-yl...
C27H42N2O5
1510837-67-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.5178 4.4137 0.0 0
M  V30 2 C 6.8515 3.6437 0.0 0
M  V30 3 C 8.1851 4.4137 0.0 0
M  V30 4 C 9.5188 3.6437 0.0 0
M  V30 5 C 8.1851 5.9538 0.0 0
M  V30 6 C 10.8526 4.4137 0.0 0
M  V30 7 C 0.9899 5.0909 0.0 0
M  V30 8 C 0.0000 3.3764 0.0 0
M  V30 9 N 16.1874 1.3337 0.0 0
M  V30 10 C 17.5211 2.1037 0.0 0
M  V30 11 C 17.5211 3.6437 0.0 0
M  V30 12 O 18.8548 1.3337 0.0 0
M  V30 13 C 18.8548 4.4137 0.0 0
M  V30 14 C 20.1885 3.6437 0.0 0 CFG=2
M  V30 15 O 21.5223 4.4137 0.0 0
M  V30 16 C 20.1885 2.1037 0.0 0
M  V30 17 C 22.8559 3.6437 0.0 0
M  V30 18 N 24.1896 4.4137 0.0 0
M  V30 19 O 22.8559 2.1037 0.0 0
M  V30 20 C 25.5233 3.6437 0.0 0
M  V30 21 C 2.8503 1.3337 0.0 0 CFG=2
M  V30 22 C 2.0803 0.0000 0.0 0
M  V30 23 O 3.6203 0.0000 0.0 0
M  V30 24 C 4.1840 2.1037 0.0 0
M  V30 25 C 1.5166 2.1037 0.0 0
M  V30 26 C 4.1840 3.6437 0.0 0 CFG=1
M  V30 27 C 1.5166 3.6437 0.0 0
M  V30 28 O 2.8503 4.4137 0.0 0
M  V30 29 C 12.1863 3.6437 0.0 0 CFG=2
M  V30 30 C 13.5200 4.4137 0.0 0
M  V30 31 C 12.1863 2.1037 0.0 0
M  V30 32 C 14.8536 3.6437 0.0 0
M  V30 33 C 13.5200 1.3337 0.0 0
M  V30 34 C 14.8536 2.1037 0.0 0 CFG=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 26 1 CFG=3
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 29 6 CFG=1
M  V30 8 1 7 27
M  V30 9 1 8 27
M  V30 10 1 9 10
M  V30 11 1 34 9 CFG=1
M  V30 12 1 10 11
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 13 14
M  V30 16 1 14 15
M  V30 17 1 14 16 CFG=1
M  V30 18 1 15 17
M  V30 19 1 17 18
M  V30 20 2 17 19
M  V30 21 1 18 20
M  V30 22 1 21 22
M  V30 23 1 21 23 CFG=1
M  V30 24 1 21 24
M  V30 25 1 21 25
M  V30 26 1 22 23
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 1 27 28
M  V30 31 1 29 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 1 32 34
M  V30 36 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 14 21 26 29 34)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1197054-30-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1510837-67-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-2314995
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 107-06-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (S,Z)-5-(((1R,4R)-4-((2E,4E)-5-((3R,5S)-7,7-Dimethyl-1,6-dioxaspiro[2.5]octan-5-yl)-3-methylpenta-2,4-dien-1-yl)cyclohexyl)-amino)-5-oxopent-3-en-2-yl
Methylcarbamate (3). A stirred solution of activated carbonate 17 (100
mg, 0.17 mmol) in 1,2-dichloroethane (0.3 mL) was cooled in an ice bath
and slowly treated with methylamine (77 μL, 0.51 mmol, 2 M in THF). The
resulting yellow solution was stirred at 0 °C for 10 min. The solid
precipitate (pnitro phenol) was removed by filtration, and the residue
was washed with a mixture of methylene chloride and hexane. The combined
filtrates were concentrated, and the residue was purified on a silica
column (25g, 15-100% EtOAc in hexane). 75 mg (92%) of methyl carbamate 3
as a white viscous solid. 1H NMR (400 MHz, CDCl3) δ 7.94 (d, J = 7.7 Hz,
1H), 6.26 (d, J = 15.7 Hz, 1H), 5.82 (d, J = 10.8 Hz, 1H), 5.66-5.44 (m,
4H), 4.77 (s, 1H), 4.52-4.39 (m, 1H), 4.18-4.06 (m, 1H), 2.78 (d, J = 5.0
Hz, 3H), 2.57 (s, 2H), 2.09 (t, J = 7.1 Hz, 2H), 2.05-1.87 (m, 2H),
1.80-1.67 (m, 2H), 1.72 (s, 3H), 1.65-1.49 (m, 4H), 1.48-1.41 (m, 1H),
1.40 (s, 3H), 1.38-1.34 (m, 2H), 1.31 (d, J = 5.8 Hz, 3H), 1.28 (s, 3H),
1.24-1.12 (m, 2H). 13C NMR (101 MHz, CDCl3) δ 165.17, 157.03, 136.66,
136.16, 133.70, 132.10, 126.80, 126.06, 73.06, 69.52, 69.15, 55.68,
51.04, 45.36, 42.46, 38.57, 36.62, 34.42, 31.52, 29.57, 29.44, 27.68,
27.39, 27.33, 23.76, 20.60, 12.44. HRMS (ESI) m/z calcd for C27H43N2O5 (M
+ H)+, 475.3172; found, 475.3188.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Optimization of Antitumor Modulators of Pre-mRNA Splicing
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lagisetti, Chandraiah; Palacios, Gustavo; Goronga, Tinopiwa; Freeman,
Burgess; Caufield, William; Webb, Thomas R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2013), 56(24), 10033-10044

$RFMT $RIREG SCHEME164 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(Phenylmethoxy)carbonyl]-D-leucyl-L-phenylalanine methyl ester
C24H30N2O5
120342-23-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 32 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 6.9300 0.0 0 CFG=1
M  V30 2 C 4.0011 6.1600 0.0 0
M  V30 3 N 6.6685 6.1600 0.0 0
M  V30 4 C 5.3347 8.4700 0.0 0
M  V30 5 C 6.6685 4.6200 0.0 0
M  V30 6 O 6.6685 9.2400 0.0 0
M  V30 7 O 4.0011 9.2400 0.0 0
M  V30 8 C 8.0021 3.8500 0.0 0 CFG=1
M  V30 9 O 5.3347 3.8500 0.0 0
M  V30 10 C 6.6685 10.7800 0.0 0
M  V30 11 N 9.3358 4.6200 0.0 0
M  V30 12 C 8.0021 2.3100 0.0 0
M  V30 13 C 10.6694 3.8500 0.0 0
M  V30 14 C 6.6685 1.5400 0.0 0
M  V30 15 O 12.0032 4.6200 0.0 0
M  V30 16 O 10.6694 2.3100 0.0 0
M  V30 17 C 6.6685 0.0000 0.0 0
M  V30 18 C 5.3347 2.3100 0.0 0
M  V30 19 C 13.3369 3.8500 0.0 0
M  V30 20 C 2.6674 6.9300 0.0 0
M  V30 21 C 1.3338 6.1600 0.0 0
M  V30 22 C 2.6674 8.4700 0.0 0
M  V30 23 C 0.0000 6.9300 0.0 0
M  V30 24 C 1.3338 9.2400 0.0 0
M  V30 25 C 0.0000 8.4700 0.0 0
M  V30 26 C 14.6705 4.6200 0.0 0
M  V30 27 C 14.6705 6.1600 0.0 0
M  V30 28 C 16.0041 3.8500 0.0 0
M  V30 29 C 16.0041 6.9300 0.0 0
M  V30 30 C 17.3379 4.6200 0.0 0
M  V30 31 C 17.3379 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 20
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 1 8 11
M  V30 12 1 8 12 CFG=3
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 13 16
M  V30 17 1 14 17
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 1 19 26
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 27 2 26 27
M  V30 28 1 26 28
M  V30 29 1 27 29
M  V30 30 2 28 30
M  V30 31 2 29 31
M  V30 32 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[(Phenylmethoxy)carbonyl]-D-leucyl-N-methyl-L-phenylalaninamide
C24H31N3O4
1036388-72-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 32 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 6.9300 0.0 0 CFG=1
M  V30 2 C 4.0011 6.1600 0.0 0
M  V30 3 N 6.6685 6.1600 0.0 0
M  V30 4 C 5.3347 8.4700 0.0 0
M  V30 5 C 6.6685 4.6200 0.0 0
M  V30 6 N 6.6685 9.2400 0.0 0
M  V30 7 O 4.0011 9.2400 0.0 0
M  V30 8 C 8.0021 3.8500 0.0 0 CFG=1
M  V30 9 O 5.3347 3.8500 0.0 0
M  V30 10 C 6.6685 10.7800 0.0 0
M  V30 11 N 9.3358 4.6200 0.0 0
M  V30 12 C 8.0021 2.3100 0.0 0
M  V30 13 C 10.6694 3.8500 0.0 0
M  V30 14 C 6.6685 1.5400 0.0 0
M  V30 15 O 12.0032 4.6200 0.0 0
M  V30 16 O 10.6694 2.3100 0.0 0
M  V30 17 C 6.6685 0.0000 0.0 0
M  V30 18 C 5.3347 2.3100 0.0 0
M  V30 19 C 13.3369 3.8500 0.0 0
M  V30 20 C 2.6674 6.9300 0.0 0
M  V30 21 C 1.3338 6.1600 0.0 0
M  V30 22 C 2.6674 8.4700 0.0 0
M  V30 23 C 0.0000 6.9300 0.0 0
M  V30 24 C 1.3338 9.2400 0.0 0
M  V30 25 C 0.0000 8.4700 0.0 0
M  V30 26 C 14.6705 4.6200 0.0 0
M  V30 27 C 14.6705 6.1600 0.0 0
M  V30 28 C 16.0041 3.8500 0.0 0
M  V30 29 C 16.0041 6.9300 0.0 0
M  V30 30 C 17.3379 4.6200 0.0 0
M  V30 31 C 17.3379 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 20
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 1 8 11
M  V30 12 1 8 12 CFG=3
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 13 16
M  V30 17 1 14 17
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 1 19 26
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 27 2 26 27
M  V30 28 1 26 28
M  V30 29 1 27 29
M  V30 30 2 28 30
M  V30 31 2 29 31
M  V30 32 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 120342-23-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1036388-72-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-9600039
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Peptidyl 3-substituted 1-hydroxyureas as isosteric analogues of
succinylhydroxamate MMP inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Campestre, Cristina; Tortorella, Paolo; Agamennone, Mariangela; Preziuso,
Serena; Biasone, Alessandro; Nuti, Elisa; Rossello, Armando; Gallina,
Carlo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2008), 43(5), 1008-1014

$RFMT $RIREG SCHEME165 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(T-4)-[Ethyl 2-[(1E)-2-(acetyloxy)ethenyl]-5-[[4-(ethoxycarbonyl)-5-methyl-3-...
C32H29BF2N2O6
1206782-13-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  43 47 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.0619 5.0736 0.0 0
M  V30 2 C 5.9174 4.0432 0.0 0
M  V30 3 O 6.2376 2.5367 0.0 0
M  V30 4 C 5.0932 1.5063 0.0 0
M  V30 5 C 5.4133 0.0000 0.0 0
M  V30 6 O 3.6285 1.9822 0.0 0
M  V30 7 F 9.0449 6.2078 0.0 0 CHG=-1 VAL=1
M  V30 8 F 10.7594 7.1978 0.0 0 CHG=-1 VAL=1
M  V30 9 C 4.0011 6.4364 0.0 0
M  V30 10 O 2.6675 7.2064 0.0 0
M  V30 11 O 4.0011 4.8964 0.0 0
M  V30 12 C 1.3337 6.4364 0.0 0
M  V30 13 C 0.0000 7.2064 0.0 0
M  V30 14 C 12.7331 8.3479 0.0 0
M  V30 15 C 13.0833 11.6800 0.0 0
M  V30 16 O 14.4169 10.9100 0.0 0
M  V30 17 O 13.0833 13.2200 0.0 0
M  V30 18 C 15.7508 11.6800 0.0 0
M  V30 19 C 17.0844 10.9100 0.0 0
M  V30 20 N 7.7722 7.7245 0.0 0 CHG=-1 VAL=3
M  V30 21 C 7.0022 9.0581 0.0 0
M  V30 22 C 6.7418 6.5801 0.0 0
M  V30 23 B 9.3122 7.7245 0.0 0 CHG=3 VAL=4
M  V30 24 C 5.4959 8.7379 0.0 0
M  V30 25 C 7.7722 10.3919 0.0 0
M  V30 26 C 5.3348 7.2064 0.0 0
M  V30 27 N 10.0822 9.0581 0.0 0 VAL=4
M  V30 28 C 9.3122 10.3919 0.0 0
M  V30 29 C 11.5885 9.3783 0.0 0
M  V30 30 C 10.3427 11.5363 0.0 0
M  V30 31 C 11.7496 10.9100 0.0 0
M  V30 32 C 4.3513 9.7685 0.0 0
M  V30 33 C 2.8868 9.2925 0.0 0
M  V30 34 C 4.6715 11.2748 0.0 0
M  V30 35 C 1.7422 10.3231 0.0 0
M  V30 36 C 3.5271 12.3053 0.0 0
M  V30 37 C 2.0624 11.8294 0.0 0
M  V30 38 C 10.0225 13.0426 0.0 0
M  V30 39 C 11.1670 14.0732 0.0 0
M  V30 40 C 8.5579 13.5186 0.0 0
M  V30 41 C 10.8469 15.5795 0.0 0
M  V30 42 C 8.2377 15.0249 0.0 0
M  V30 43 C 9.3821 16.0554 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 22
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 7 23
M  V30 8 1 8 23
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 26
M  V30 12 1 10 12
M  V30 13 1 12 13
M  V30 14 1 14 29
M  V30 15 1 15 16
M  V30 16 2 15 17
M  V30 17 1 15 31
M  V30 18 1 16 18
M  V30 19 1 18 19
M  V30 20 1 20 21
M  V30 21 1 20 22
M  V30 22 1 20 23
M  V30 23 2 21 24
M  V30 24 1 21 25
M  V30 25 2 22 26
M  V30 26 1 23 27
M  V30 27 1 24 26
M  V30 28 1 24 32
M  V30 29 2 25 28
M  V30 30 1 27 28
M  V30 31 2 27 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 31
M  V30 35 1 30 38
M  V30 36 2 32 33
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 2 34 36
M  V30 40 2 35 37
M  V30 41 1 36 37
M  V30 42 2 38 39
M  V30 43 1 38 40
M  V30 44 1 39 41
M  V30 45 2 40 42
M  V30 46 2 41 43
M  V30 47 1 42 43
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(T-4)-[Ethyl 5-[(4,5-dihydro-5-methyl-4-oxo-3-phenyl-2H-pyrrolo[3,2-c]pyridin...
C29H24BF2N3O3
1206782-20-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 43 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 6.4032 8.3594 0.0 0 CHG=-1 VAL=1
M  V30 2 F 8.3830 8.3594 0.0 0 CHG=-1 VAL=1
M  V30 3 O 1.2528 4.5549 0.0 0
M  V30 4 C 10.6673 8.3502 0.0 0
M  V30 5 C 0.0000 7.3686 0.0 0
M  V30 6 C 12.6366 5.6396 0.0 0
M  V30 7 O 13.4066 6.9734 0.0 0
M  V30 8 O 13.4066 4.3060 0.0 0
M  V30 9 C 14.9466 6.9734 0.0 0
M  V30 10 C 15.7166 8.3071 0.0 0
M  V30 11 C 6.0594 4.8696 0.0 0
M  V30 12 N 6.0594 6.4096 0.0 0 VAL=4
M  V30 13 C 4.5947 4.3938 0.0 0
M  V30 14 C 7.3931 4.0996 0.0 0
M  V30 15 C 4.5947 6.8856 0.0 0
M  V30 16 B 7.3931 7.1796 0.0 0 CHG=3 VAL=4
M  V30 17 C 3.6895 5.6396 0.0 0
M  V30 18 C 8.7267 4.8696 0.0 0
M  V30 19 C 3.9684 8.2924 0.0 0
M  V30 20 N 8.7267 6.4096 0.0 0 CHG=-1 VAL=3
M  V30 21 C 2.1580 5.8007 0.0 0
M  V30 22 C 10.1914 4.3938 0.0 0
M  V30 23 C 2.4367 8.4534 0.0 0
M  V30 24 C 10.1914 6.8856 0.0 0
M  V30 25 N 1.5317 7.2075 0.0 0
M  V30 26 C 11.0966 5.6396 0.0 0
M  V30 27 C 4.1189 2.9292 0.0 0
M  V30 28 C 5.1493 1.7847 0.0 0
M  V30 29 C 2.6125 2.6091 0.0 0
M  V30 30 C 4.6734 0.3202 0.0 0
M  V30 31 C 2.1366 1.1444 0.0 0
M  V30 32 C 3.1672 0.0000 0.0 0
M  V30 33 C 10.6673 2.9292 0.0 0
M  V30 34 C 12.1735 2.6091 0.0 0
M  V30 35 C 9.6369 1.7847 0.0 0
M  V30 36 C 12.6496 1.1444 0.0 0
M  V30 37 C 10.1127 0.3202 0.0 0
M  V30 38 C 11.6190 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 16
M  V30 2 1 2 16
M  V30 3 2 3 21
M  V30 4 1 4 24
M  V30 5 1 5 25
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 26
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 2 11 14
M  V30 14 2 12 15
M  V30 15 1 12 16
M  V30 16 2 13 17
M  V30 17 1 13 27
M  V30 18 1 14 18
M  V30 19 1 15 17
M  V30 20 1 15 19
M  V30 21 1 16 20
M  V30 22 1 17 21
M  V30 23 1 18 20
M  V30 24 2 18 22
M  V30 25 2 19 23
M  V30 26 1 20 24
M  V30 27 1 21 25
M  V30 28 1 22 26
M  V30 29 1 22 33
M  V30 30 1 23 25
M  V30 31 2 24 26
M  V30 32 2 27 28
M  V30 33 1 27 29
M  V30 34 1 28 30
M  V30 35 2 29 31
M  V30 36 2 30 32
M  V30 37 1 31 32
M  V30 38 2 33 34
M  V30 39 1 33 35
M  V30 40 1 34 36
M  V30 41 2 35 37
M  V30 42 2 36 38
M  V30 43 1 37 38
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1206782-13-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1206782-20-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29128378
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 127-09-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-66-3
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 67-63-0
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An efficient method of chemical modification of BODIPY core
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zatsikha, Yuriy V.; Yakubovskyi, Viktor P.; Shandura, Mykola P.; Dubey,
Igor Ya; Kovtun, Yuriy P.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2013), 69(10), 2233-2238

$RFMT $RIREG SCHEME166 STEP1
$RXN



  2  1
$MOL
1,1-Dimethylethyl N-[(S)-[(4S)-4,5-dihydro-5-oxo-4-phenyl-2-(phenylmethoxy)-4...
C28H28N2O4S
1207728-21-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 38 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 4.6688 0.0 0 CFG=1
M  V30 2 N 5.3348 3.8987 0.0 0
M  V30 3 C 4.0010 4.6688 0.0 0
M  V30 4 O 2.6673 3.8987 0.0 0
M  V30 5 O 4.0010 6.2088 0.0 0
M  V30 6 C 1.3337 4.6688 0.0 0
M  V30 7 C 2.1037 6.0024 0.0 0
M  V30 8 C 0.0000 5.4388 0.0 0
M  V30 9 C 0.5637 3.3351 0.0 0
M  V30 10 O 8.9856 1.3366 0.0 0
M  V30 11 O 11.1907 6.2892 0.0 0
M  V30 12 C 12.6970 5.9689 0.0 0
M  V30 13 C 8.0022 3.8987 0.0 0 CFG=1
M  V30 14 N 8.6285 5.3056 0.0 0
M  V30 15 C 9.1466 2.8683 0.0 0
M  V30 16 C 10.1602 5.1446 0.0 0
M  V30 17 S 10.4804 3.6383 0.0 0
M  V30 18 C 7.0969 2.6529 0.0 0
M  V30 19 C 7.7234 1.2459 0.0 0
M  V30 20 C 5.5654 2.8138 0.0 0
M  V30 21 C 6.8182 0.0000 0.0 0
M  V30 22 C 4.6601 1.5679 0.0 0
M  V30 23 C 5.2865 0.1609 0.0 0
M  V30 24 C 6.6685 6.2088 0.0 0
M  V30 25 C 5.3348 6.9788 0.0 0
M  V30 26 C 8.0022 6.9788 0.0 0
M  V30 27 C 5.3348 8.5189 0.0 0
M  V30 28 C 8.0022 8.5189 0.0 0
M  V30 29 C 6.6685 9.2889 0.0 0
M  V30 30 C 13.7276 7.1134 0.0 0
M  V30 31 C 15.2339 6.7932 0.0 0
M  V30 32 C 13.2517 8.5780 0.0 0
M  V30 33 C 16.2643 7.9376 0.0 0
M  V30 34 C 14.2821 9.7225 0.0 0
M  V30 35 C 15.7884 9.4024 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 13
M  V30 3 1 1 24
M  V30 4 1 2 3
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 1 4 6
M  V30 8 1 6 7
M  V30 9 1 6 8
M  V30 10 1 6 9
M  V30 11 2 10 15
M  V30 12 1 11 12
M  V30 13 1 11 16
M  V30 14 1 12 30
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 13 18 CFG=1
M  V30 18 2 14 16
M  V30 19 1 15 17
M  V30 20 1 16 17
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 33 2 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 2 32 34
M  V30 37 2 33 35
M  V30 38 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(1S,2S)-2-amino-3-(methylamino)-3-oxo-1,2-diphenylpropyl...
C21H27N3O3
1207728-33-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.7000 4.0011 0.0 0 CFG=2
M  V30 2 C 6.1600 4.0011 0.0 0 CFG=2
M  V30 3 C 7.7000 5.5411 0.0 0
M  V30 4 N 7.7000 2.4611 0.0 0
M  V30 5 N 5.3900 5.3347 0.0 0
M  V30 6 N 9.0336 6.3111 0.0 0
M  V30 7 O 6.3664 6.3111 0.0 0
M  V30 8 C 3.8500 5.3347 0.0 0
M  V30 9 C 9.0336 7.8511 0.0 0
M  V30 10 O 3.0800 6.6685 0.0 0
M  V30 11 O 3.0800 4.0011 0.0 0
M  V30 12 C 1.5400 6.6685 0.0 0
M  V30 13 C 1.5400 5.1285 0.0 0
M  V30 14 C 0.0000 6.6685 0.0 0
M  V30 15 C 1.5400 8.2085 0.0 0
M  V30 16 C 9.2400 4.0011 0.0 0
M  V30 17 C 10.0100 5.3347 0.0 0
M  V30 18 C 10.0100 2.6674 0.0 0
M  V30 19 C 11.5500 5.3347 0.0 0
M  V30 20 C 11.5500 2.6674 0.0 0
M  V30 21 C 12.3200 4.0011 0.0 0
M  V30 22 C 5.3900 2.6674 0.0 0
M  V30 23 C 3.8500 2.6674 0.0 0
M  V30 24 C 6.1600 1.3338 0.0 0
M  V30 25 C 3.0800 1.3338 0.0 0
M  V30 26 C 5.3900 0.0000 0.0 0
M  V30 27 C 3.8500 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 4
M  V30 4 1 1 16 CFG=3
M  V30 5 1 2 5 CFG=3
M  V30 6 1 2 22
M  V30 7 1 3 6
M  V30 8 2 3 7
M  V30 9 1 5 8
M  V30 10 1 6 9
M  V30 11 1 8 10
M  V30 12 2 8 11
M  V30 13 1 10 12
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 1 12 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 23 2 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 2 24 26
M  V30 27 2 25 27
M  V30 28 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1207728-21-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1207728-33-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-27801812
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Flexible synthesis, structural determination, and synthetic application
of a new C1-symmetric chiral ammonium betaine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Uraguchi, Daisuke; Koshimoto, Kyohei; Ooi, Takashi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Communications (Cambridge, United Kingdom) (2010), 46(2),
300-302

$RFMT $RIREG SCHEME167 STEP1
$RXN



  4  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Cyclopentanone
C5H8O
120-92-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.9098 1.2459 0.0 0
M  V30 2 C 2.3698 1.2459 0.0 0
M  V30 3 C 1.4645 2.4917 0.0 0
M  V30 4 C 1.4645 0.0000 0.0 0
M  V30 5 C 0.0000 2.0159 0.0 0
M  V30 6 C 0.0000 0.4759 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dimedone
C8H12O2
126-81-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 3.5826 0.0 0
M  V30 2 C 0.9898 5.2971 0.0 0
M  V30 3 O 2.8503 0.0000 0.0 0
M  V30 4 O 5.5176 4.6201 0.0 0
M  V30 5 C 1.5166 3.8501 0.0 0
M  V30 6 C 1.5166 2.3101 0.0 0
M  V30 7 C 2.8503 4.6201 0.0 0
M  V30 8 C 2.8503 1.5400 0.0 0
M  V30 9 C 4.1840 3.8501 0.0 0
M  V30 10 C 4.1840 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 5
M  V30 3 2 3 8
M  V30 4 2 4 9
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,2-Dimethyl-1,3-dioxane-4,6-dione
C6H8O4
2033-24-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 3.5826 0.0 0
M  V30 2 C 0.9898 5.2971 0.0 0
M  V30 3 O 2.8503 0.0000 0.0 0
M  V30 4 O 5.5176 4.6201 0.0 0
M  V30 5 C 1.5166 3.8501 0.0 0
M  V30 6 O 1.5166 2.3101 0.0 0
M  V30 7 O 2.8503 4.6201 0.0 0
M  V30 8 C 2.8503 1.5400 0.0 0
M  V30 9 C 4.1840 3.8501 0.0 0
M  V30 10 C 4.1840 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 5
M  V30 3 2 3 8
M  V30 4 2 4 9
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7′,8′-Dihydro-1′,7′,7′-trimethylspiro[cyclopentane-1,4′(1′H)-quinoline]-2′,5′...
C16H23NO2
1800597-63-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3347 6.1600 0.0 0
M  V30 2 O 0.0000 1.5400 0.0 0
M  V30 3 C 2.6674 0.0000 0.0 0
M  V30 4 C 8.1851 2.5774 0.0 0
M  V30 5 C 7.1952 0.8629 0.0 0
M  V30 6 C 2.6674 4.6200 0.0 0
M  V30 7 C 4.0011 3.8500 0.0 0
M  V30 8 C 1.3338 3.8500 0.0 0
M  V30 9 C 1.4216 5.5252 0.0 0
M  V30 10 C 3.9133 5.5252 0.0 0
M  V30 11 C 4.0011 2.3100 0.0 0
M  V30 12 C 5.3347 4.6200 0.0 0
M  V30 13 C 1.3338 2.3100 0.0 0
M  V30 14 C 1.8974 6.9898 0.0 0
M  V30 15 C 3.4375 6.9898 0.0 0
M  V30 16 N 2.6674 1.5400 0.0 0
M  V30 17 C 5.3347 1.5400 0.0 0
M  V30 18 C 6.6685 3.8500 0.0 0
M  V30 19 C 6.6685 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 12
M  V30 2 2 2 13
M  V30 3 1 3 16
M  V30 4 1 4 19
M  V30 5 1 5 19
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 1 7 12
M  V30 12 1 8 13
M  V30 13 1 9 14
M  V30 14 1 10 15
M  V30 15 1 11 16
M  V30 16 1 11 17
M  V30 17 1 12 18
M  V30 18 1 13 16
M  V30 19 1 14 15
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 120-92-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 126-81-8
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 2033-24-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1800597-63-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-11217826
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1314-98-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, ultrasound, reusable catalyst, ZnS nanoparticles used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM ZnS Nanoparticle Catalysed Four Component Syntheses of Novel
Spiropolyhydroquinoline Derivatives in Aqueous Medium Under Ultrasonic
Irradiation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dandia, Anshu; Singh, Ruby; Gupta, Shyam L.; Rathore, Kuldeep S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Proceedings of the National Academy of Sciences, India, Section A:
Physical Sciences (2015), 85(1), 19-27

$RFMT $RIREG SCHEME168 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ferrocenecarboxaldehyde
C11H10FeO
12093-10-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0673 5.0777 0.0 0
M  V30 2 O 3.5322 4.8098 0.0 0
M  V30 3 Fe 1.3042 2.8068 0.0 0 CHG=2 VAL=10
M  V30 4 C 2.6025 4.8098 0.0 0 CHG=-1 VAL=4
M  V30 5 C 1.7868 4.3375 0.0 0 VAL=5
M  V30 6 C 1.3042 5.6373 0.0 0 VAL=5
M  V30 7 C 0.0296 4.8098 0.0 0 VAL=5
M  V30 8 C 0.8438 4.3375 0.0 0 VAL=5
M  V30 9 C 0.0000 0.8290 0.0 0 CHG=-1 VAL=4
M  V30 10 C 2.5744 0.8290 0.0 0 VAL=5
M  V30 11 C 1.7572 1.3013 0.0 0 VAL=5
M  V30 12 C 0.8127 1.3013 0.0 0 VAL=5
M  V30 13 C 1.2761 0.0000 0.0 0 VAL=5
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 3 8
M  V30 8 1 3 9
M  V30 9 1 3 10
M  V30 10 1 3 11
M  V30 11 1 3 12
M  V30 12 1 3 13
M  V30 13 1 4 5
M  V30 14 1 4 6
M  V30 15 2 5 8
M  V30 16 2 6 7
M  V30 17 1 7 8
M  V30 18 1 9 12
M  V30 19 1 9 13
M  V30 20 1 10 11
M  V30 21 2 10 13
M  V30 22 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C12H13FeN
2070910-61-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0681 5.0790 0.0 0
M  V30 2 N 3.5331 4.8110 0.0 0
M  V30 3 C 3.9981 5.0790 0.0 0
M  V30 4 Fe 1.3046 2.8075 0.0 0 CHG=2 VAL=10
M  V30 5 C 2.6032 4.8110 0.0 0 CHG=-1 VAL=4
M  V30 6 C 1.7873 4.3386 0.0 0 VAL=5
M  V30 7 C 1.3046 5.6387 0.0 0 VAL=5
M  V30 8 C 0.0281 4.8110 0.0 0 VAL=5
M  V30 9 C 0.8426 4.3386 0.0 0 VAL=5
M  V30 10 C 0.0000 0.8292 0.0 0 CHG=-1 VAL=4
M  V30 11 C 2.5750 0.8292 0.0 0 VAL=5
M  V30 12 C 1.7577 1.3016 0.0 0 VAL=5
M  V30 13 C 0.8129 1.3016 0.0 0 VAL=5
M  V30 14 C 1.2749 0.0000 0.0 0 VAL=5
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 4 8
M  V30 8 1 4 9
M  V30 9 1 4 10
M  V30 10 1 4 11
M  V30 11 1 4 12
M  V30 12 1 4 13
M  V30 13 1 4 14
M  V30 14 1 5 6
M  V30 15 1 5 7
M  V30 16 2 6 9
M  V30 17 2 7 8
M  V30 18 1 8 9
M  V30 19 1 10 13
M  V30 20 1 10 14
M  V30 21 1 11 12
M  V30 22 2 11 14
M  V30 23 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 12093-10-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2070910-61-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-16557430
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Three-component carboarylation of unactivated imines with arynes and
carbon nucleophiles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xu, Jing-Kun; Li, Sheng-Jun; Wang, Hai-Yang; Xu, Wen-Cong; Tian, Shi-Kai
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Communications (Cambridge, United Kingdom) (2017), 53(10),
1708-1711

$RFMT $RIREG SCHEME169 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-Heptadecafluorooctyl)[2]benzopyrano[6,5,...
C22H3F17O6
1224622-78-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  45 48 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.4700 5.3347 0.0 0
M  V30 2 C 10.0100 5.3347 0.0 0
M  V30 3 F 8.4700 3.7947 0.0 0
M  V30 4 F 8.4700 6.8747 0.0 0
M  V30 5 C 11.5500 5.3347 0.0 0
M  V30 6 F 10.0100 3.7947 0.0 0
M  V30 7 F 10.0100 6.8747 0.0 0
M  V30 8 C 13.0900 5.3347 0.0 0
M  V30 9 F 11.5500 3.7947 0.0 0
M  V30 10 F 11.5500 6.8747 0.0 0
M  V30 11 C 14.6300 5.3347 0.0 0
M  V30 12 F 13.0900 3.7947 0.0 0
M  V30 13 F 13.0900 6.8747 0.0 0
M  V30 14 C 16.1700 5.3347 0.0 0
M  V30 15 F 14.6300 3.7947 0.0 0
M  V30 16 F 14.6300 6.8747 0.0 0
M  V30 17 C 17.7100 5.3347 0.0 0
M  V30 18 F 16.1700 3.7947 0.0 0
M  V30 19 F 16.1700 6.8747 0.0 0
M  V30 20 C 19.2500 5.3347 0.0 0
M  V30 21 F 17.7100 3.7947 0.0 0
M  V30 22 F 17.7100 6.8747 0.0 0
M  V30 23 F 20.7900 5.3347 0.0 0
M  V30 24 F 19.2500 3.7947 0.0 0
M  V30 25 F 19.2500 6.8747 0.0 0
M  V30 26 O 8.4700 2.6674 0.0 0
M  V30 27 O 3.8500 0.0000 0.0 0
M  V30 28 O 4.6200 9.3358 0.0 0
M  V30 29 O 0.0000 6.6684 0.0 0
M  V30 30 C 4.6200 4.0011 0.0 0
M  V30 31 C 3.8500 5.3347 0.0 0
M  V30 32 C 6.1600 4.0011 0.0 0
M  V30 33 C 3.8500 2.6674 0.0 0
M  V30 34 C 4.6200 6.6684 0.0 0
M  V30 35 C 2.3100 5.3347 0.0 0
M  V30 36 C 6.9300 5.3347 0.0 0
M  V30 37 C 6.9300 2.6674 0.0 0
M  V30 38 C 2.3100 2.6674 0.0 0
M  V30 39 C 4.6200 1.3336 0.0 0
M  V30 40 C 6.1600 6.6684 0.0 0
M  V30 41 C 3.8500 8.0021 0.0 0
M  V30 42 C 1.5400 4.0011 0.0 0
M  V30 43 C 1.5400 6.6684 0.0 0
M  V30 44 O 6.1600 1.3336 0.0 0
M  V30 45 O 2.3100 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 36
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 2 7
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 1 5 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 8 13
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 1 11 16
M  V30 17 1 14 17
M  V30 18 1 14 18
M  V30 19 1 14 19
M  V30 20 1 17 20
M  V30 21 1 17 21
M  V30 22 1 17 22
M  V30 23 1 20 23
M  V30 24 1 20 24
M  V30 25 1 20 25
M  V30 26 2 26 37
M  V30 27 2 27 39
M  V30 28 2 28 41
M  V30 29 2 29 43
M  V30 30 2 30 31
M  V30 31 1 30 32
M  V30 32 1 30 33
M  V30 33 1 31 34
M  V30 34 1 31 35
M  V30 35 2 32 36
M  V30 36 1 32 37
M  V30 37 2 33 38
M  V30 38 1 33 39
M  V30 39 2 34 40
M  V30 40 1 34 41
M  V30 41 2 35 42
M  V30 42 1 35 43
M  V30 43 1 36 40
M  V30 44 1 37 44
M  V30 45 1 38 42
M  V30 46 1 39 44
M  V30 47 1 41 45
M  V30 48 1 43 45
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-Heptadecafluorooctyl)-2,7-dimethylbenzo[...
C24H9F17N2O4
1224622-89-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  47 50 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.4700 5.3347 0.0 0
M  V30 2 C 10.0100 5.3347 0.0 0
M  V30 3 F 8.4700 3.7947 0.0 0
M  V30 4 F 8.4700 6.8747 0.0 0
M  V30 5 C 11.5500 5.3347 0.0 0
M  V30 6 F 10.0100 3.7947 0.0 0
M  V30 7 F 10.0100 6.8747 0.0 0
M  V30 8 C 13.0900 5.3347 0.0 0
M  V30 9 F 11.5500 3.7947 0.0 0
M  V30 10 F 11.5500 6.8747 0.0 0
M  V30 11 C 14.6300 5.3347 0.0 0
M  V30 12 F 13.0900 3.7947 0.0 0
M  V30 13 F 13.0900 6.8747 0.0 0
M  V30 14 C 16.1700 5.3347 0.0 0
M  V30 15 F 14.6300 3.7947 0.0 0
M  V30 16 F 14.6300 6.8747 0.0 0
M  V30 17 C 17.7100 5.3347 0.0 0
M  V30 18 F 16.1700 3.7947 0.0 0
M  V30 19 F 16.1700 6.8747 0.0 0
M  V30 20 C 19.2500 5.3347 0.0 0
M  V30 21 F 17.7100 3.7947 0.0 0
M  V30 22 F 17.7100 6.8747 0.0 0
M  V30 23 F 20.7900 5.3347 0.0 0
M  V30 24 F 19.2500 3.7947 0.0 0
M  V30 25 F 19.2500 6.8747 0.0 0
M  V30 26 O 8.4700 2.6674 0.0 0
M  V30 27 O 3.8500 0.0000 0.0 0
M  V30 28 O 4.6200 9.3358 0.0 0
M  V30 29 O 0.0000 6.6684 0.0 0
M  V30 30 C 6.9300 0.0000 0.0 0
M  V30 31 C 1.5400 9.3358 0.0 0
M  V30 32 C 4.6200 4.0011 0.0 0
M  V30 33 C 3.8500 5.3347 0.0 0
M  V30 34 C 6.1600 4.0011 0.0 0
M  V30 35 C 3.8500 2.6674 0.0 0
M  V30 36 C 4.6200 6.6684 0.0 0
M  V30 37 C 2.3100 5.3347 0.0 0
M  V30 38 C 6.9300 5.3347 0.0 0
M  V30 39 C 6.9300 2.6674 0.0 0
M  V30 40 C 2.3100 2.6674 0.0 0
M  V30 41 C 4.6200 1.3336 0.0 0
M  V30 42 C 6.1600 6.6684 0.0 0
M  V30 43 C 3.8500 8.0021 0.0 0
M  V30 44 C 1.5400 4.0011 0.0 0
M  V30 45 C 1.5400 6.6684 0.0 0
M  V30 46 N 6.1600 1.3336 0.0 0
M  V30 47 N 2.3100 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 38
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 2 7
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 1 5 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 8 13
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 1 11 16
M  V30 17 1 14 17
M  V30 18 1 14 18
M  V30 19 1 14 19
M  V30 20 1 17 20
M  V30 21 1 17 21
M  V30 22 1 17 22
M  V30 23 1 20 23
M  V30 24 1 20 24
M  V30 25 1 20 25
M  V30 26 2 26 39
M  V30 27 2 27 41
M  V30 28 2 28 43
M  V30 29 2 29 45
M  V30 30 1 30 46
M  V30 31 1 31 47
M  V30 32 2 32 33
M  V30 33 1 32 34
M  V30 34 1 32 35
M  V30 35 1 33 36
M  V30 36 1 33 37
M  V30 37 2 34 38
M  V30 38 1 34 39
M  V30 39 2 35 40
M  V30 40 1 35 41
M  V30 41 2 36 42
M  V30 42 1 36 43
M  V30 43 2 37 44
M  V30 44 1 37 45
M  V30 45 1 38 42
M  V30 46 1 39 46
M  V30 47 1 40 44
M  V30 48 1 41 46
M  V30 49 1 43 47
M  V30 50 1 45 47
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1224622-78-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1224622-89-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-366-CAS-5189290
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 79-09-4
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General procedure for synthesis of 7c, 7e, 8b,
8c, 8e, 8f, 8g, mixture of 11d and 11'd, 20a, 20b, 20d, and 21a-21c.
Mixture of 5, 6, mixture of 10 and 10', 18, or 19, and primary amine was
stirred in propanoic acid at 100 °C or at boiling point of solvent for
2-3 h. After cooling down to room temperature, precipitations were
filtered for 8g. After adding water to the reaction mixture,
precipitations were also filtered for the other target compounds. For 8g,
filter cake was pure enough to be characterized by 1H NMR. The other
compounds were purified by silica gel column chromatography with CH2Cl2
as eluent. 20a. Compound 18 (200 mg, 0.29 mmol), 30% aqueous methylamine
(0.15 mL, 1.45 mmol), and 1 mL propanoic acid led to 20a as a white solid
(190 mg, 92%). mp: 197-199°C; HRMS: Calcd for C24H10N2O4F17 713.0369,
found: 713.0361 ([M+H]+, MALDI-TOF); 1H NMR (400 MHz, CDCl3): δ =
3.62-3.60 (m, 6H), 8.91 (s, 2H), 9.02 ppm (s, 1H); 19F NMR (376.5 MHz,
CDCl3) : δ = -126.04, -122.62, -121.76, -121.45, -114.93, -98.40, -80.74
ppm; 13C NMR (100 MHz, CDCl3): δ = 28.3, 29.7, 127.3, 127.5, 128.9,
131.5, 131.6, 131.7, 134.8, 135.0, 159.5, 160.9 ppm.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Core-perfluoroalkylated perylene diimides and naphthalene diimides:
Versatile synthesis, solubility, electrochemistry, and optical properties
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yuan, Zhongyi; Li, Jing; Xiao, Yi; Li, Zheng; Qian, Xuhong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2010), 75(9), 3007-3016

$RFMT $RIREG SCHEME170 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Acetamidobenzaldehyde
C9H9NO2
122-85-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6675 3.0801 0.0 0
M  V30 2 C 1.3337 2.3101 0.0 0
M  V30 3 C 1.3337 0.7700 0.0 0
M  V30 4 O 0.0000 3.0801 0.0 0
M  V30 5 C 8.0023 0.0000 0.0 0
M  V30 6 O 9.3360 0.7700 0.0 0
M  V30 7 C 4.0012 2.3101 0.0 0
M  V30 8 C 4.0012 0.7700 0.0 0
M  V30 9 C 5.3348 3.0801 0.0 0
M  V30 10 C 5.3348 0.0000 0.0 0
M  V30 11 C 6.6685 2.3101 0.0 0
M  V30 12 C 6.6685 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[4-[(Methylamino)methyl]phenyl]acetamide
C10H14N2O
65542-25-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3101 2.6673 0.0 0
M  V30 2 C 1.5400 1.3337 0.0 0
M  V30 3 C 2.3101 0.0000 0.0 0
M  V30 4 O 0.0000 1.3337 0.0 0
M  V30 5 C 8.4702 2.6673 0.0 0
M  V30 6 N 9.2402 4.0010 0.0 0
M  V30 7 C 10.7802 4.0010 0.0 0
M  V30 8 C 3.8501 2.6673 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 6.1601 1.3337 0.0 0
M  V30 12 C 6.1601 4.0010 0.0 0
M  V30 13 C 6.9302 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 6
M  V30 6 1 5 13
M  V30 7 1 6 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 122-85-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 65542-25-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-12926130
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for the Reductive Amination
of Aldehydes with Methylamine Titanium(IV) isopropoxide (2 mL, 6.6 mmol)
was added to a commercially available solution of methylamine in methanol
(2M, 7.5 mL) followed by the addition of the starting aldehyde (5 mmol).
The reaction mixture was stirred at ambient temperature for 5 h, after
which sodium borohydride (0.2 g, 5 mmol) was added and the resulting
mixture was further stirred for another period of 2 h. The reaction was
then quenched by the addition of water (1 mL), the resulting inorganic
precipitate was filtered and washed with diethyl ether (20 mL). The
organic layer was separated and the aqueous part was further extracted
with diethyl ether (20 mL x 2). The combined ether extracts were dried
(K2CO3) and concentrated in vacuo to give N-methyl secondary amines in
high purity. Table I, Entry 16, yield 92%.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of N-methyl secondary amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kumpaty, Hephzibah J.; Williamson, John S.; Bhattacharyya, Sukanta
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthetic Communications (2003), 33(8), 1411-1416

$RFMT $RIREG SCHEME171 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxybenzaldehyde
C8H8O2
123-11-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 6.6687 0.0000 0.0 0
M  V30 4 C 8.0023 0.7700 0.0 0
M  V30 5 C 2.6675 2.3101 0.0 0
M  V30 6 C 2.6675 0.7700 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 4.0012 0.0000 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Diphenylacetylene
C14H10
501-65-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 C 6.1601 1.3337 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 2.3101 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 0.7700 0.0000 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 9 C 7.7002 1.3337 0.0 0
M  V30 10 C 8.4702 0.0000 0.0 0
M  V30 11 C 8.4702 2.6673 0.0 0
M  V30 12 C 10.0102 0.0000 0.0 0
M  V30 13 C 10.0102 2.6673 0.0 0
M  V30 14 C 10.7802 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 3
M  V30 3 1 2 9
M  V30 4 2 3 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 5 7
M  V30 8 2 6 8
M  V30 9 1 7 8
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Isoquinolinium, 6-methoxy-2-methyl-3,4-diphenyl-, tetrafluoroborate(1-) (1:1)
C23H20NO.BF4
1356496-49-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 12.3202 0.0 0
M  V30 2 O 10.6697 9.2401 0.0 0
M  V30 3 C 12.0033 10.0101 0.0 0
M  V30 4 C 5.3348 9.2401 0.0 0
M  V30 5 C 6.6685 10.0101 0.0 0
M  V30 6 C 4.0012 10.0101 0.0 0
M  V30 7 C 6.6685 11.5502 0.0 0
M  V30 8 C 8.0022 9.2401 0.0 0
M  V30 9 N 4.0012 11.5502 0.0 0 CHG=1 VAL=4
M  V30 10 C 5.3348 12.3202 0.0 0
M  V30 11 C 8.0022 12.3202 0.0 0
M  V30 12 C 9.3360 10.0101 0.0 0
M  V30 13 C 9.3360 11.5502 0.0 0
M  V30 14 C 5.3348 7.7001 0.0 0
M  V30 15 C 6.6685 6.9301 0.0 0
M  V30 16 C 4.0012 6.9301 0.0 0
M  V30 17 C 6.6685 5.3900 0.0 0
M  V30 18 C 4.0012 5.3900 0.0 0
M  V30 19 C 5.3348 4.6200 0.0 0
M  V30 20 C 2.6673 9.2401 0.0 0
M  V30 21 C 2.6673 7.7001 0.0 0
M  V30 22 C 1.3337 10.0101 0.0 0
M  V30 23 C 1.3337 6.9301 0.0 0
M  V30 24 C 0.0000 9.2401 0.0 0
M  V30 25 C 0.0000 7.7001 0.0 0
M  V30 26 B 6.0017 1.5400 0.0 0 CHG=3 VAL=4
M  V30 27 F 4.4617 1.5400 0.0 0 CHG=-1 VAL=1
M  V30 28 F 7.5417 1.5400 0.0 0 CHG=-1 VAL=1
M  V30 29 F 6.0017 0.0000 0.0 0 CHG=-1 VAL=1
M  V30 30 F 6.0017 3.0800 0.0 0 CHG=-1 VAL=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 3
M  V30 3 1 2 12
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 14
M  V30 7 2 5 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 6 20
M  V30 11 1 7 10
M  V30 12 1 7 11
M  V30 13 2 8 12
M  V30 14 2 9 10
M  V30 15 2 11 13
M  V30 16 1 12 13
M  V30 17 2 14 15
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 2 16 18
M  V30 21 2 17 19
M  V30 22 1 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 29 1 26 27
M  V30 30 1 26 28
M  V30 31 1 26 29
M  V30 32 1 26 30
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-11-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 501-65-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1356496-49-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29585311
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 142-71-2
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 12354-85-7
$DTYPE RXN:VAR(1):CAT(3):CAS_RN
$DATUM 14104-20-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-85-4
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM One-Pot Synthesis of Isoquinolinium Salts by Rhodium-Catalyzed C-H Bond
Activation: Application to the Total Synthesis of Oxychelerythrine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jayakumar, Jayachandran; Parthasarathy, Kanniyappan; Cheng, Chien-Hong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2012), 51(1), 197-200

$RFMT $RIREG SCHEME172 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Acetylacetone
C5H8O2
123-54-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 C 4.0011 1.5400 0.0 0
M  V30 3 C 1.3338 1.5400 0.0 0
M  V30 4 C 4.0011 0.0000 0.0 0
M  V30 5 O 5.3349 2.3100 0.0 0
M  V30 6 C 0.0000 2.3100 0.0 0
M  V30 7 O 1.3338 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ninhydrin
C9H6O4
485-47-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.2334 0.0000 0.0 0
M  V30 2 O 0.5228 4.6949 0.0 0
M  V30 3 O 0.0000 2.4529 0.0 0
M  V30 4 O 1.0304 0.6682 0.0 0
M  V30 5 C 3.9437 2.6508 0.0 0
M  V30 6 C 3.1737 3.9845 0.0 0
M  V30 7 C 2.9132 1.5064 0.0 0
M  V30 8 C 5.4837 2.6508 0.0 0
M  V30 9 C 1.6674 3.6643 0.0 0
M  V30 10 C 3.9437 5.3183 0.0 0
M  V30 11 C 1.5063 2.1328 0.0 0
M  V30 12 C 6.2537 3.9845 0.0 0
M  V30 13 C 5.4837 5.3183 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 2 2 9
M  V30 3 1 3 11
M  V30 4 1 4 11
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 1 10 13
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Indeno[1,2-b]pyrrol-4(1H)-one, 3-acetyl-1,2-dimethyl-
C15H13NO2
2265220-37-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.7477 4.3858 0.0 0
M  V30 2 C 9.1547 3.7593 0.0 0
M  V30 3 O 7.5868 5.9173 0.0 0
M  V30 4 O 4.6080 6.6670 0.0 0
M  V30 5 C 4.5613 0.0000 0.0 0
M  V30 6 C 7.7477 1.0353 0.0 0
M  V30 7 C 5.0372 3.9564 0.0 0
M  V30 8 C 4.1321 2.7106 0.0 0
M  V30 9 C 6.5019 3.4806 0.0 0
M  V30 10 C 4.1321 5.2023 0.0 0
M  V30 11 C 2.6674 3.1864 0.0 0
M  V30 12 N 5.0372 1.4647 0.0 0
M  V30 13 C 6.5019 1.9406 0.0 0
M  V30 14 C 2.6674 4.7264 0.0 0
M  V30 15 C 1.3338 2.4164 0.0 0
M  V30 16 C 1.3338 5.4964 0.0 0
M  V30 17 C 0.0000 3.1864 0.0 0
M  V30 18 C 0.0000 4.7264 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 2 4 10
M  V30 5 1 5 12
M  V30 6 1 6 13
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 14
M  V30 15 2 11 15
M  V30 16 1 12 13
M  V30 17 2 14 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-54-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 485-47-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2265220-37-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-20118348
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):NOTES
$DATUM optimization study, optimized on solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM One-pot three-component reaction of ninhydrin, 1,3-dicarbonyl compounds,
and primary amines to afford indeno[1,2-b]pyrrol-4(1H)-ones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Karami, Hossein; Hossaini, Zinatossadat; Sabbaghan, Maryam;
Rostami-Charati, Faramarz
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry of Heterocyclic Compounds (New York, NY, United States) (2018),
54(11), 1040-1044

$RFMT $RIREG SCHEME173 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Acetylacetone
C5H8O2
123-54-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 C 4.0011 1.5400 0.0 0
M  V30 3 C 1.3338 1.5400 0.0 0
M  V30 4 C 4.0011 0.0000 0.0 0
M  V30 5 O 5.3349 2.3100 0.0 0
M  V30 6 C 0.0000 2.3100 0.0 0
M  V30 7 O 1.3338 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Indene-1,2,3-trione
C9H4O3
938-24-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6078 0.0000 0.0 0
M  V30 2 O 4.6078 5.4211 0.0 0
M  V30 3 O 6.5770 2.7106 0.0 0
M  V30 4 C 2.6673 1.9406 0.0 0
M  V30 5 C 2.6673 3.4806 0.0 0
M  V30 6 C 4.1320 1.4647 0.0 0
M  V30 7 C 1.3336 1.1706 0.0 0
M  V30 8 C 4.1320 3.9564 0.0 0
M  V30 9 C 1.3336 4.2506 0.0 0
M  V30 10 C 5.0370 2.7106 0.0 0
M  V30 11 C 0.0000 1.9406 0.0 0
M  V30 12 C 0.0000 3.4806 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 2 2 8
M  V30 3 2 3 10
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 1 9 12
M  V30 13 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Acetyl-3a,8b-dihydro-3a,8b-dihydroxy-1,2-dimethylindeno[1,2-b]pyrrol-4(1H)-one
C15H15NO4
1357480-48-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.2269 1.4647 0.0 0
M  V30 2 O 5.9424 5.2023 0.0 0
M  V30 3 C 4.5613 0.0000 0.0 0
M  V30 4 C 7.7477 4.3858 0.0 0
M  V30 5 C 7.5868 5.9173 0.0 0
M  V30 6 O 9.1547 3.7593 0.0 0
M  V30 7 O 4.6080 6.6670 0.0 0
M  V30 8 C 7.7477 1.0353 0.0 0
M  V30 9 C 4.1321 2.7106 0.0 0
M  V30 10 C 5.0372 3.9564 0.0 0
M  V30 11 C 2.6674 3.1864 0.0 0
M  V30 12 N 5.0372 1.4647 0.0 0
M  V30 13 C 6.5019 3.4806 0.0 0
M  V30 14 C 4.1321 5.2023 0.0 0
M  V30 15 C 2.6674 4.7264 0.0 0
M  V30 16 C 1.3338 2.4164 0.0 0
M  V30 17 C 6.5019 1.9406 0.0 0
M  V30 18 C 1.3338 5.4964 0.0 0
M  V30 19 C 0.0000 3.1864 0.0 0
M  V30 20 C 0.0000 4.7264 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 10
M  V30 3 1 3 12
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 13
M  V30 7 2 7 14
M  V30 8 1 8 17
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 2 11 16
M  V30 16 1 12 17
M  V30 17 2 13 17
M  V30 18 1 14 15
M  V30 19 2 15 18
M  V30 20 1 16 19
M  V30 21 1 18 20
M  V30 22 2 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-54-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 938-24-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1357480-48-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-329-CAS-63101
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):NOTES
$DATUM no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Solvent-free synthesis of pyrrole derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rostami-Charati, Faramarz; Hossaini, Zinatossadat; Khalilzadeh, Mohammad
A.; Jafaryan, Hojatollah
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Heterocyclic Chemistry (2012), 49(1), 217-220

$RFMT $RIREG SCHEME174 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
β-D-Galactopyranoside, methyl 3-[4,5-bis(methoxycarbonyl)-1H-1,2,3-triazol-1-...
C19H25N3O11S
1242965-18-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 35 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 9.0731 2.3101 0.0 0
M  V30 2 C 10.4068 1.5400 0.0 0
M  V30 3 C 10.4068 0.0000 0.0 0
M  V30 4 O 11.7406 2.3101 0.0 0
M  V30 5 O 6.4058 6.9302 0.0 0
M  V30 6 C 6.4058 8.4702 0.0 0
M  V30 7 C 5.0719 9.2402 0.0 0
M  V30 8 O 7.7394 9.2402 0.0 0
M  V30 9 C 4.6786 5.9829 0.0 0
M  V30 10 O 3.2139 6.4587 0.0 0
M  V30 11 O 5.8232 7.0133 0.0 0
M  V30 12 C 2.8937 7.9651 0.0 0
M  V30 13 C 11.7406 3.8501 0.0 0
M  V30 14 O 13.0743 4.6201 0.0 0
M  V30 15 C 14.4079 3.8501 0.0 0
M  V30 16 C 14.4079 2.3101 0.0 0
M  V30 17 O 15.7416 4.6201 0.0 0
M  V30 18 S 9.0731 8.4702 0.0 0
M  V30 19 C 10.4068 9.2402 0.0 0
M  V30 20 C 2.4368 3.4930 0.0 0
M  V30 21 O 1.5316 2.2471 0.0 0
M  V30 22 O 1.8103 4.8999 0.0 0
M  V30 23 C 0.0000 2.4080 0.0 0
M  V30 24 C 7.7394 4.6201 0.0 0 CFG=2
M  V30 25 C 9.0731 3.8501 0.0 0 CFG=1
M  V30 26 C 7.7394 6.1601 0.0 0 CFG=1
M  V30 27 C 10.4068 4.6201 0.0 0 CFG=1
M  V30 28 C 9.0731 6.9302 0.0 0 CFG=2
M  V30 29 O 10.4068 6.1601 0.0 0
M  V30 30 N 6.4058 3.8501 0.0 0
M  V30 31 C 4.9988 4.4764 0.0 0
M  V30 32 N 6.2447 2.3185 0.0 0
M  V30 33 C 3.9684 3.3320 0.0 0
M  V30 34 N 4.7384 1.9983 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 25 1 CFG=3
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 6
M  V30 6 1 26 5 CFG=1
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 31
M  V30 12 1 10 12
M  V30 13 1 13 14
M  V30 14 1 27 13 CFG=3
M  V30 15 1 14 15
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 1 18 19
M  V30 19 1 28 18 CFG=3
M  V30 20 1 20 21
M  V30 21 2 20 22
M  V30 22 1 20 33
M  V30 23 1 21 23
M  V30 24 1 24 25
M  V30 25 1 24 26
M  V30 26 1 24 30 CFG=3
M  V30 27 1 25 27
M  V30 28 1 26 28
M  V30 29 1 27 29
M  V30 30 1 28 29
M  V30 31 1 30 31
M  V30 32 1 30 32
M  V30 33 2 31 33
M  V30 34 2 32 34
M  V30 35 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 24 25 26 27 28)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methyl 3-[4,5-bis[(methylamino)carbonyl]-1H-1,2,3-triazol-1-yl]-3-deoxy-1-thi...
C13H21N5O6S
1242965-26-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6785 3.2573 0.0 0
M  V30 2 N 3.2140 2.7814 0.0 0
M  V30 3 O 5.8231 2.2268 0.0 0
M  V30 4 C 2.8938 1.2750 0.0 0
M  V30 5 O 9.0729 6.9300 0.0 0
M  V30 6 O 6.4056 2.3100 0.0 0
M  V30 7 C 2.4367 5.7471 0.0 0
M  V30 8 N 1.5315 6.9930 0.0 0
M  V30 9 O 1.8104 4.3402 0.0 0
M  V30 10 C 0.0000 6.8321 0.0 0
M  V30 11 C 11.7404 5.3900 0.0 0
M  V30 12 O 13.0740 4.6200 0.0 0
M  V30 13 S 9.0729 0.7700 0.0 0
M  V30 14 C 10.4067 0.0000 0.0 0
M  V30 15 N 6.4056 5.3900 0.0 0
M  V30 16 C 4.9987 4.7635 0.0 0
M  V30 17 N 6.2447 6.9215 0.0 0
M  V30 18 C 3.9683 5.9081 0.0 0
M  V30 19 N 4.7383 7.2417 0.0 0
M  V30 20 C 7.7393 4.6200 0.0 0 CFG=2
M  V30 21 C 9.0729 5.3900 0.0 0 CFG=1
M  V30 22 C 7.7393 3.0800 0.0 0 CFG=1
M  V30 23 C 10.4067 4.6200 0.0 0 CFG=1
M  V30 24 C 9.0729 2.3100 0.0 0 CFG=2
M  V30 25 O 10.4067 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 1 21 5 CFG=1
M  V30 6 1 22 6 CFG=3
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 18
M  V30 10 1 8 10
M  V30 11 1 11 12
M  V30 12 1 23 11 CFG=1
M  V30 13 1 13 14
M  V30 14 1 24 13 CFG=1
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 1 20 15 CFG=1
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 21 1 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 20 21 22 23 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1242965-18-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1242965-26-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-352-CAS-11806070
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 1H-1,2,3-Triazol-1-yl thiodigalactoside derivatives as high affinity
galectin-3 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Salameh, Bader A.; Cumpstey, Ian; Sundin, Anders; Leffler, Hakon;
Nilsson, Ulf J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2010), 18(14), 5367-5378

$RFMT $RIREG SCHEME175 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(S)-4-(3,4-Dichlorophenyl)-1-tetralone
C16H12Cl2O
124379-29-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 4.0011 0.0 0
M  V30 2 Cl 9.2400 6.6685 0.0 0
M  V30 3 Cl 10.7800 4.0011 0.0 0
M  V30 4 C 3.8500 2.6674 0.0 0
M  V30 5 C 4.6200 4.0011 0.0 0 CFG=2
M  V30 6 C 2.3100 2.6674 0.0 0
M  V30 7 C 4.6200 1.3338 0.0 0
M  V30 8 C 3.8500 5.3347 0.0 0
M  V30 9 C 1.5400 4.0011 0.0 0
M  V30 10 C 1.5400 1.3338 0.0 0
M  V30 11 C 3.8500 0.0000 0.0 0
M  V30 12 C 2.3100 5.3347 0.0 0
M  V30 13 C 2.3100 0.0000 0.0 0
M  V30 14 C 6.1600 4.0011 0.0 0
M  V30 15 C 6.9300 5.3347 0.0 0
M  V30 16 C 6.9300 2.6674 0.0 0
M  V30 17 C 8.4700 5.3347 0.0 0
M  V30 18 C 8.4700 2.6674 0.0 0
M  V30 19 C 9.2400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 1 2 17
M  V30 3 1 3 19
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 5 14 CFG=1
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 1 9 12
M  V30 14 1 10 13
M  V30 15 2 11 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 5)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Sertraline
C17H17Cl2N
79617-96-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 4.0011 0.0 0
M  V30 2 C 0.0000 5.3348 0.0 0
M  V30 3 Cl 10.0101 6.6686 0.0 0
M  V30 4 Cl 11.5501 4.0011 0.0 0
M  V30 5 C 4.6201 2.6675 0.0 0
M  V30 6 C 5.3901 4.0011 0.0 0 CFG=2
M  V30 7 C 3.0800 2.6675 0.0 0
M  V30 8 C 5.3901 1.3338 0.0 0
M  V30 9 C 4.6201 5.3348 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0 CFG=1
M  V30 11 C 2.3100 1.3338 0.0 0
M  V30 12 C 4.6201 0.0000 0.0 0
M  V30 13 C 3.0800 5.3348 0.0 0
M  V30 14 C 3.0800 0.0000 0.0 0
M  V30 15 C 6.9301 4.0011 0.0 0
M  V30 16 C 7.7001 5.3348 0.0 0
M  V30 17 C 7.7001 2.6675 0.0 0
M  V30 18 C 9.2401 5.3348 0.0 0
M  V30 19 C 9.2401 2.6675 0.0 0
M  V30 20 C 10.0101 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 10 1 CFG=1
M  V30 3 1 3 18
M  V30 4 1 4 20
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 6 15 CFG=1
M  V30 10 1 7 10
M  V30 11 2 7 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 10 13
M  V30 15 1 11 14
M  V30 16 2 12 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 6 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 124379-29-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 79617-96-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-21585150
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Chemoenzymatic Synthesis of Sertraline
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Marx, Lisa; Rios-Lombardia, Nicolas; Suess, Philipp; Hoehne, Matthias;
Moris, Francisco; Gonzalez-Sabin, Javier; Berglund, Per
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2020), 2020(4), 510-513

$RFMT $RIREG SCHEME176 STEP1
$RXN



  2  1
$MOL
6-[(5R)-1-(4-Cyano-3-methylphenyl)-5-cyclopentyl-4,5-dihydro-1H-pyrazol-3-yl]...
C23H24N4O3
1246765-54-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 33 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 13.4218 8.3545 0.0 0
M  V30 2 C 15.2322 5.8627 0.0 0
M  V30 3 N 16.7638 6.0237 0.0 0
M  V30 4 O 1.3337 5.7369 0.0 0
M  V30 5 C 1.3337 4.1969 0.0 0
M  V30 6 C 1.3337 8.8169 0.0 0
M  V30 7 O 0.0000 8.0469 0.0 0
M  V30 8 O 1.3337 10.3570 0.0 0
M  V30 9 N 9.1059 5.2188 0.0 0
M  V30 10 C 8.3358 3.8850 0.0 0 CFG=1
M  V30 11 N 8.0754 6.3632 0.0 0
M  V30 12 C 6.8294 4.2053 0.0 0
M  V30 13 C 6.6685 5.7369 0.0 0
M  V30 14 C 10.6374 5.3798 0.0 0
M  V30 15 C 11.2639 6.7866 0.0 0
M  V30 16 C 11.5426 4.1339 0.0 0
M  V30 17 C 12.7954 6.9477 0.0 0
M  V30 18 C 13.0742 4.2948 0.0 0
M  V30 19 C 13.7007 5.7016 0.0 0
M  V30 20 C 8.9622 2.4782 0.0 0
M  V30 21 C 8.1922 1.1445 0.0 0
M  V30 22 C 10.4686 2.1580 0.0 0
M  V30 23 C 9.2227 0.0000 0.0 0
M  V30 24 C 10.6296 0.6265 0.0 0
M  V30 25 C 5.3348 6.5069 0.0 0
M  V30 26 N 4.0011 5.7369 0.0 0
M  V30 27 C 5.3348 8.0469 0.0 0
M  V30 28 C 2.6673 6.5069 0.0 0
M  V30 29 C 4.0011 8.8169 0.0 0
M  V30 30 C 2.6673 8.0469 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 17
M  V30 2 3 2 3
M  V30 3 1 2 19
M  V30 4 1 4 5
M  V30 5 1 4 28
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 30
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 14
M  V30 12 1 10 12
M  V30 13 1 10 20 CFG=1
M  V30 14 2 11 13
M  V30 15 1 12 13
M  V30 16 1 13 25
M  V30 17 2 14 15
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 2 16 18
M  V30 21 2 17 19
M  V30 22 1 18 19
M  V30 23 1 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 24
M  V30 28 1 25 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-[(5R)-1-(4-Cyano-3-methylphenyl)-5-cyclopentyl-4,5-dihydro-1H-pyrazol-3-yl]...
C24H27N5O2
1246766-12-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 34 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0596 0.0000 0.0 0
M  V30 2 C 1.2460 1.2526 0.0 0
M  V30 3 N 0.0000 0.3474 0.0 0
M  V30 4 O 13.2194 8.3108 0.0 0
M  V30 5 C 12.4494 9.6444 0.0 0
M  V30 6 C 14.7594 5.6435 0.0 0
M  V30 7 N 15.5294 4.3097 0.0 0
M  V30 8 O 15.5294 6.9771 0.0 0
M  V30 9 C 17.0694 4.3097 0.0 0
M  V30 10 N 6.2295 4.8735 0.0 0
M  V30 11 C 6.2295 6.4135 0.0 0 CFG=1
M  V30 12 N 7.6942 4.3976 0.0 0
M  V30 13 C 7.6942 6.8894 0.0 0
M  V30 14 C 8.5994 5.6435 0.0 0
M  V30 15 C 4.9836 3.9683 0.0 0
M  V30 16 C 5.1445 2.4367 0.0 0
M  V30 17 C 3.5768 4.5946 0.0 0
M  V30 18 C 3.8987 1.5315 0.0 0
M  V30 19 C 2.3308 3.6894 0.0 0
M  V30 20 C 2.4919 2.1579 0.0 0
M  V30 21 C 4.9836 7.3187 0.0 0
M  V30 22 C 3.5189 6.8427 0.0 0
M  V30 23 C 4.9836 8.8587 0.0 0
M  V30 24 C 2.6138 8.0887 0.0 0
M  V30 25 C 3.5189 9.3346 0.0 0
M  V30 26 C 10.1394 5.6435 0.0 0
M  V30 27 N 10.9094 6.9771 0.0 0
M  V30 28 C 10.9094 4.3097 0.0 0
M  V30 29 C 12.4494 6.9771 0.0 0
M  V30 30 C 12.4494 4.3097 0.0 0
M  V30 31 C 13.2194 5.6435 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 18
M  V30 2 3 2 3
M  V30 3 1 2 20
M  V30 4 1 4 5
M  V30 5 1 4 29
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 31
M  V30 9 1 7 9
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 15
M  V30 13 1 11 13
M  V30 14 1 11 21 CFG=1
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 1 14 26
M  V30 18 2 15 16
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 2 17 19
M  V30 22 2 18 20
M  V30 23 1 19 20
M  V30 24 1 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 25
M  V30 29 1 26 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1246765-54-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1246766-12-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-7825174
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Synthesis of
(R)-6-(1-(4-Cyano-3-methylphenyl)-5-cyclopentyl-4,5-dihydro-1H-pyrazol-3-yl)-2-methoxy-N-methylnicotinamide
(R-16b). General Procedure D . To a solution of carboxylic acid R -14c
(0.10 g, 0.247 mmol) in DMF (0.5 mL) was added CDI (0.061 g, 0.370 mmol).
The mixture was stirred for 20 min, and then a 2 M solution of
methylamine in THF (1.24 mL, 2.47 mmol) was added. The reaction stirred
overnight at RT. The reaction was diluted with ethyl acetate and water,
and the layers were separated. The aqueous layer was washed an additional
ethyl acetate twice. The combined organic layers were washed with brine
and dried over magnesium sulfate, filtered, and concentrated. HPLC method
1: column, Waters Symmetry C18, 3.0 mm × 100 mm, 3.5 μm; mobile phase A,
0.1 M ammonium acetate/ acetic acid in water; mobile phase B,
acetonitrile; flow rate, 0.5 mL/ min; gradient, initial conditions, 0-4
min, 0-100% acetonitrile, 4-4.5 min, 100% acetonitrile, 4.5-5 min, 100-0%
acetonitrile, 5-6 min, 0% acetonitrile; injection volume, 4.3 μL;
detection, UV-260 nm. Pure R-16b as a yellow solid (0.094 g, 92%). HPLC
purity 100%, method 1. 1H NMR (DMSO-d 6, 500 MHz) δ 8.27-8.22 (m, 1 H),
8.20 (d, J = 7.8 Hz, 1 H), 7.73 (d, J = 7.8 Hz, 1 H), 7.59 (d, J = 8.8
Hz, 1 H), 7.24 (d, J = 1.7 Hz, 1 H), 7.16-7.06 (m, 1 H), 4.95-4.82 (m, 1
H), 4.04 (s, 3 H), 3.57-3.43 (m, 1 H), 3.29-3.19 (m, 1 H), 2.83 (d, J =
4.6 Hz, 3 H), 2.51 (m, 1 H), 2.44 (s, 3 H), 1.83-1.72 (m, 1 H), 1.65-1.56
(m, 1 H), 1.55-1.46 (m, 2 H), 1.44-1.35 (m, 1 H), 1.34-1.22 (m, 2 H),
1.13-1.02 (m, 1 H). ES-MS m/z 418.2 (M + H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Identification of
(R)-6-(1-(4-Cyano-3-methylphenyl)-5-cyclopentyl-4,5-dihydro-1H-pyrazol-3-yl)-2-methoxynicotinic
Acid, a Highly Potent and Selective Nonsteroidal Mineralocorticoid
Receptor Antagonist
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Casimiro-Garcia, Agustin; Piotrowski, David W.; Ambler, Catherine;
Arhancet, Graciela B.; Banker, Mary Ellen; Banks, Tereece; Boustany-Kari,
Carine M.; Cai, Cuiman; Chen, Xiangyang; Eudy, Rena; Hepworth, David;
Hulford, Catherine A.; Jennings, Sandra M.; Loria, Paula M.; Meyers,
Marvin J.; Petersen, Donna N.; Raheja, Neil K.; Sammons, Matthew; She,
Li; Song, Kun; Vrieze, Derek; Wei, Liuqing
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2014), 57(10), 4273-4288

$RFMT $RIREG SCHEME176 STEP1
$RXN



  2  1
$MOL
6-[(5R)-1-(4-Cyano-3-methylphenyl)-5-cyclopentyl-4,5-dihydro-1H-pyrazol-3-yl]...
C23H24N4O3
1246765-54-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 33 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 13.4218 8.3545 0.0 0
M  V30 2 C 15.2322 5.8627 0.0 0
M  V30 3 N 16.7638 6.0237 0.0 0
M  V30 4 O 1.3337 5.7369 0.0 0
M  V30 5 C 1.3337 4.1969 0.0 0
M  V30 6 C 1.3337 8.8169 0.0 0
M  V30 7 O 0.0000 8.0469 0.0 0
M  V30 8 O 1.3337 10.3570 0.0 0
M  V30 9 N 9.1059 5.2188 0.0 0
M  V30 10 C 8.3358 3.8850 0.0 0 CFG=1
M  V30 11 N 8.0754 6.3632 0.0 0
M  V30 12 C 6.8294 4.2053 0.0 0
M  V30 13 C 6.6685 5.7369 0.0 0
M  V30 14 C 10.6374 5.3798 0.0 0
M  V30 15 C 11.2639 6.7866 0.0 0
M  V30 16 C 11.5426 4.1339 0.0 0
M  V30 17 C 12.7954 6.9477 0.0 0
M  V30 18 C 13.0742 4.2948 0.0 0
M  V30 19 C 13.7007 5.7016 0.0 0
M  V30 20 C 8.9622 2.4782 0.0 0
M  V30 21 C 8.1922 1.1445 0.0 0
M  V30 22 C 10.4686 2.1580 0.0 0
M  V30 23 C 9.2227 0.0000 0.0 0
M  V30 24 C 10.6296 0.6265 0.0 0
M  V30 25 C 5.3348 6.5069 0.0 0
M  V30 26 N 4.0011 5.7369 0.0 0
M  V30 27 C 5.3348 8.0469 0.0 0
M  V30 28 C 2.6673 6.5069 0.0 0
M  V30 29 C 4.0011 8.8169 0.0 0
M  V30 30 C 2.6673 8.0469 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 17
M  V30 2 3 2 3
M  V30 3 1 2 19
M  V30 4 1 4 5
M  V30 5 1 4 28
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 30
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 14
M  V30 12 1 10 12
M  V30 13 1 10 20 CFG=1
M  V30 14 2 11 13
M  V30 15 1 12 13
M  V30 16 1 13 25
M  V30 17 2 14 15
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 2 16 18
M  V30 21 2 17 19
M  V30 22 1 18 19
M  V30 23 1 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 24
M  V30 28 1 25 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-[(5R)-1-(4-Cyano-3-methylphenyl)-5-cyclopentyl-4,5-dihydro-1H-pyrazol-3-yl]...
C24H27N5O2
1246766-12-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 34 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0596 0.0000 0.0 0
M  V30 2 C 1.2460 1.2526 0.0 0
M  V30 3 N 0.0000 0.3474 0.0 0
M  V30 4 O 13.2194 8.3108 0.0 0
M  V30 5 C 12.4494 9.6444 0.0 0
M  V30 6 C 14.7594 5.6435 0.0 0
M  V30 7 N 15.5294 4.3097 0.0 0
M  V30 8 O 15.5294 6.9771 0.0 0
M  V30 9 C 17.0694 4.3097 0.0 0
M  V30 10 N 6.2295 4.8735 0.0 0
M  V30 11 C 6.2295 6.4135 0.0 0 CFG=1
M  V30 12 N 7.6942 4.3976 0.0 0
M  V30 13 C 7.6942 6.8894 0.0 0
M  V30 14 C 8.5994 5.6435 0.0 0
M  V30 15 C 4.9836 3.9683 0.0 0
M  V30 16 C 5.1445 2.4367 0.0 0
M  V30 17 C 3.5768 4.5946 0.0 0
M  V30 18 C 3.8987 1.5315 0.0 0
M  V30 19 C 2.3308 3.6894 0.0 0
M  V30 20 C 2.4919 2.1579 0.0 0
M  V30 21 C 4.9836 7.3187 0.0 0
M  V30 22 C 3.5189 6.8427 0.0 0
M  V30 23 C 4.9836 8.8587 0.0 0
M  V30 24 C 2.6138 8.0887 0.0 0
M  V30 25 C 3.5189 9.3346 0.0 0
M  V30 26 C 10.1394 5.6435 0.0 0
M  V30 27 N 10.9094 6.9771 0.0 0
M  V30 28 C 10.9094 4.3097 0.0 0
M  V30 29 C 12.4494 6.9771 0.0 0
M  V30 30 C 12.4494 4.3097 0.0 0
M  V30 31 C 13.2194 5.6435 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 18
M  V30 2 3 2 3
M  V30 3 1 2 20
M  V30 4 1 4 5
M  V30 5 1 4 29
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 31
M  V30 9 1 7 9
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 15
M  V30 13 1 11 13
M  V30 14 1 11 21 CFG=1
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 1 14 26
M  V30 18 2 15 16
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 2 17 19
M  V30 22 2 18 20
M  V30 23 1 19 20
M  V30 24 1 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 25
M  V30 29 1 26 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1246765-54-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1246766-12-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-14717803
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Example 42:
(R)-4-(1-(5-cyano-6-methylpyridin-2-yl)-5-cyclopentyl-4,5-dihydro-1H-pyrazol-3-yl)-2-ethoxybenzamide
To a solution of
(R)-4-(1-(5-cyano-6-methylpyridin-2-yl)-5-cyclopentyl-4,5-dihydro-1H-pyrazol-3-yl)-2-ethoxybenzoic
acid (Example 41, 60 mg,0.14 mmol) in N,N-dimethylformamide (1.5 mL) was
added 1,1'-carbonyldiimidazole (29.0 mg, 0.179 mmol). The mixture was
stirred for 15 min before ammonium hydroxide (0.200 mL, 3.00 mmol) was
added. The reaction was stirred at room temperature for 12 h. The
reaction was added to water. The water was extracted 3 times with ethyl
acetate. The combined organic layers were washed with brine, dried over
magnesium sulfate, filtered, and concentrated. The residue was purified
by silica gel column chromatography eluting with a gradient of 25%-65%
ethyl acetate/ heptane. Example 56:
(R)-6-(1-(4-cyano-3-methylphenyl)-5-cyclopentyl-4,5-dihydro-1H-pyrazol-3-yl)-2-methoxy-N-methylnicotinamide
The title compound was prepared by the method used to prepare Example 42
from
(R)-6-(1-(4-cyano-3-methylphenyl)-5-cyclopentyl-4,5-dihydro-1H-pyrazol-3-yl)-2-
methoxynicotinic acid (Example 4, 0.10 g, 0.247 mmol) and 2M methylamine
in tetrahydrofuran (1.24 mL, 0.0767 g, 2.47 mmol). 94.3 mg of the title
compound was isolated (92 %) as a yellow solid. 1H NMR (500 MHz, DMSO-d
6) δ ppm 1.05 (1 H, dd, J = 12.2, 9.5 Hz), 1.33 (1 H, m), 1.44 (1 H, m),
1.50 (2 H, m), 1.77 (1 H, m), 2.44 (3 H, s), 2.52 (3 H, d, J = 7.6 Hz),
2.82 (3 H, d, J = 4.9 Hz), 3.22 (1 H, dd, J = 18.4, 4.0 Hz), 3.48 (1 H,
dd, J = 18.3, 11.7 Hz), 4.04 (3 H, s), 4.89 (1 H, dt, J = 11.6, 4.1 Hz),
7.13 (1 H, dd, J = 8.7, 2.1 Hz), 7.24 (1 H, d, J = 1.7 Hz), 7.59 (1 H, d,
J = 8.8 Hz), 7.73 (1 H, d, J = 8.8 Hz), 8.20 (1 H, d, J = 7.8 Hz), 8.22
(1 H, m).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 4,5-dihydro-1H-pyrazole compounds as mineralocorticoid
receptor antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Arhancet, Graciela Barbieri; Casimiro-Garcia, Agustin; Chen, Xiangyang;
Hepworth, David; Meyers, Marvin Jay; Piotrowski, David Walter; Raheja,
Raj Kumar
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010116282 A1 2010-10-14

$RFMT $RIREG SCHEME177 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Diethyl P-[(4-formylphenyl)methyl]phosphonate
C12H17O4P
125185-25-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.7709 5.3347 0.0 0
M  V30 2 P 4.0009 4.0011 0.0 0 VAL=5
M  V30 3 O 3.2309 2.6674 0.0 0
M  V30 4 O 2.6673 4.7711 0.0 0
M  V30 5 O 5.3347 3.2311 0.0 0
M  V30 6 C 4.0009 1.3338 0.0 0
M  V30 7 C 1.3336 4.0011 0.0 0
M  V30 8 C 3.2309 0.0000 0.0 0
M  V30 9 C 0.0000 4.7711 0.0 0
M  V30 10 C 10.9309 5.3347 0.0 0
M  V30 11 O 11.7009 6.6685 0.0 0
M  V30 12 C 6.3109 5.3347 0.0 0
M  V30 13 C 7.0809 4.0011 0.0 0
M  V30 14 C 7.0809 6.6685 0.0 0
M  V30 15 C 8.6209 4.0011 0.0 0
M  V30 16 C 8.6209 6.6685 0.0 0
M  V30 17 C 9.3909 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 10 11
M  V30 11 1 10 17
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Diethyl P-[[4-[(methylamino)methyl]phenyl]methyl]phosphonate
C13H22NO3P
1101178-28-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.7709 5.3347 0.0 0
M  V30 2 P 4.0009 4.0011 0.0 0 VAL=5
M  V30 3 O 3.2309 2.6674 0.0 0
M  V30 4 O 2.6673 4.7711 0.0 0
M  V30 5 O 5.3347 3.2311 0.0 0
M  V30 6 C 4.0009 1.3338 0.0 0
M  V30 7 C 1.3336 4.0011 0.0 0
M  V30 8 C 3.2309 0.0000 0.0 0
M  V30 9 C 0.0000 4.7711 0.0 0
M  V30 10 C 10.9309 5.3347 0.0 0
M  V30 11 N 11.7009 6.6685 0.0 0
M  V30 12 C 13.2409 6.6685 0.0 0
M  V30 13 C 6.3109 5.3347 0.0 0
M  V30 14 C 7.0809 4.0011 0.0 0
M  V30 15 C 7.0809 6.6685 0.0 0
M  V30 16 C 8.6209 4.0011 0.0 0
M  V30 17 C 8.6209 6.6685 0.0 0
M  V30 18 C 9.3909 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 10 11
M  V30 11 1 10 18
M  V30 12 1 11 12
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 125185-25-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1101178-28-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-7697905
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, photopolymerization and adhesive properties of new
hydrolytically stable phosphonic acids for dental applications
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Catel, Yohann; Degrange, Michel; Le Pluart, Loic; Madec, Pierre-Jean;
Pham, Thi-Nhan; Picton, Luc
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Polymer Science, Part A: Polymer Chemistry (2008), 46(21),
7074-7090

$RFMT $RIREG SCHEME178 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Bromo-8-chloro-1,7-naphthyridine
C8H4BrClN2
1260670-05-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 4.0010 0.0 0
M  V30 2 Br 6.9302 2.6673 0.0 0
M  V30 3 C 2.3101 2.6673 0.0 0
M  V30 4 C 3.0801 1.3337 0.0 0
M  V30 5 C 0.7700 2.6673 0.0 0
M  V30 6 N 3.0801 4.0010 0.0 0
M  V30 7 C 4.6201 1.3337 0.0 0
M  V30 8 C 2.3101 0.0000 0.0 0
M  V30 9 N 0.0000 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 12 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 11
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 4 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 12
M  V30 13 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Bromo-N-methyl-1,7-naphthyridin-8-amine
C9H8BrN3
2389137-06-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.5400 4.0010 0.0 0
M  V30 2 C 0.0000 4.0010 0.0 0
M  V30 3 Br 8.4702 2.6673 0.0 0
M  V30 4 C 3.8501 2.6673 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 N 4.6201 4.0010 0.0 0
M  V30 8 C 6.1601 1.3337 0.0 0
M  V30 9 C 3.8501 0.0000 0.0 0
M  V30 10 N 1.5400 1.3337 0.0 0
M  V30 11 C 6.1601 4.0010 0.0 0
M  V30 12 C 6.9302 2.6673 0.0 0
M  V30 13 C 2.3101 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 3 12
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 13
M  V30 14 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1260670-05-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2389137-06-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-42578721
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of piperazinyl picolinamide derivatives and methods of use
thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kankanala, Jayakanth; Pettigrew, Jeremy D.; Pham, Son Minh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2024178127 A1 2024-08-29

$RFMT $RIREG SCHEME178 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Bromo-8-chloro-1,7-naphthyridine
C8H4BrClN2
1260670-05-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 4.0010 0.0 0
M  V30 2 Br 6.9302 2.6673 0.0 0
M  V30 3 C 2.3101 2.6673 0.0 0
M  V30 4 C 3.0801 1.3337 0.0 0
M  V30 5 C 0.7700 2.6673 0.0 0
M  V30 6 N 3.0801 4.0010 0.0 0
M  V30 7 C 4.6201 1.3337 0.0 0
M  V30 8 C 2.3101 0.0000 0.0 0
M  V30 9 N 0.0000 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 12 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 11
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 4 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 12
M  V30 13 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Bromo-N-methyl-1,7-naphthyridin-8-amine
C9H8BrN3
2389137-06-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.5400 4.0010 0.0 0
M  V30 2 C 0.0000 4.0010 0.0 0
M  V30 3 Br 8.4702 2.6673 0.0 0
M  V30 4 C 3.8501 2.6673 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 N 4.6201 4.0010 0.0 0
M  V30 8 C 6.1601 1.3337 0.0 0
M  V30 9 C 3.8501 0.0000 0.0 0
M  V30 10 N 1.5400 1.3337 0.0 0
M  V30 11 C 6.1601 4.0010 0.0 0
M  V30 12 C 6.9302 2.6673 0.0 0
M  V30 13 C 2.3101 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 3 12
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 13
M  V30 14 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1260670-05-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2389137-06-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-42575108
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of piperazinyl picolinamide derivatives as PARP1 modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kankanala, Jayakanth; Pettigrew, Jeremy D.; Pham, Son Minh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2024178125 A1 2024-08-29

$RFMT $RIREG SCHEME179 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(1,1-Dimethylethyl) (3S,4R)-4-(4-methoxyphenyl)-1,3-pyrrolidinedicarboxylate
C17H23NO5
1269260-00-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.0851 1.1445 0.0 0
M  V30 2 O 6.0545 0.0000 0.0 0
M  V30 3 O 8.5914 0.8244 0.0 0
M  V30 4 C 3.8987 5.5302 0.0 0
M  V30 5 O 2.4917 4.9038 0.0 0
M  V30 6 O 4.0596 7.0619 0.0 0
M  V30 7 C 1.2459 5.8091 0.0 0
M  V30 8 C 2.1511 7.0549 0.0 0
M  V30 9 C 0.0000 6.7143 0.0 0
M  V30 10 C 0.3406 4.5632 0.0 0
M  V30 11 O 13.6743 3.8551 0.0 0
M  V30 12 C 14.4443 5.1887 0.0 0
M  V30 13 C 7.5143 3.8551 0.0 0 CFG=2
M  V30 14 C 6.6091 2.6091 0.0 0 CFG=2
M  V30 15 C 6.6091 5.1010 0.0 0
M  V30 16 C 5.1446 3.0851 0.0 0
M  V30 17 N 5.1446 4.6251 0.0 0
M  V30 18 C 9.0543 3.8551 0.0 0
M  V30 19 C 9.8243 5.1887 0.0 0
M  V30 20 C 9.8243 2.5213 0.0 0
M  V30 21 C 11.3643 5.1887 0.0 0
M  V30 22 C 11.3643 2.5213 0.0 0
M  V30 23 C 12.1343 3.8551 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 14 1 CFG=3
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 17
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 11 12
M  V30 12 1 11 23
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 18 CFG=1
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 13 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(3S,4R)-4-(4-Methoxyphenyl)-N-methyl-3-pyrrolidinecarboxamide
C13H18N2O2
2727170-40-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 1.7849 3.9845 0.0 0
M  V30 2 N 0.3202 4.4604 0.0 0
M  V30 3 O 2.9293 5.0150 0.0 0
M  V30 4 C 0.0000 5.9667 0.0 0
M  V30 5 O 8.8469 4.9318 0.0 0
M  V30 6 C 10.1805 4.1618 0.0 0
M  V30 7 C 3.5119 1.8517 0.0 0 CFG=2
M  V30 8 C 2.1051 2.4781 0.0 0 CFG=2
M  V30 9 C 3.3510 0.3202 0.0 0
M  V30 10 C 1.0746 1.3337 0.0 0
M  V30 11 N 1.8447 0.0000 0.0 0
M  V30 12 C 4.8457 2.6218 0.0 0
M  V30 13 C 4.8457 4.1618 0.0 0
M  V30 14 C 6.1794 1.8517 0.0 0
M  V30 15 C 6.1794 4.9318 0.0 0
M  V30 16 C 7.5131 2.6218 0.0 0
M  V30 17 C 7.5131 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 8 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 17
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 12 CFG=3
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1269260-00-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2727170-40-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24733385
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 39968-33-7
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of guanidine derivatives as direct thrombin inhibitors and
methods of use thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Matzuk, Martin; Dawadi, Surendra; Ucisik, Melek; Faver, John; Bohren,
Kurt; Li, Feng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021211913 A1 2021-10-21

$RFMT $RIREG SCHEME180 STEP1
$RXN



  3  1
$MOL
Carbamic acid, N-(3-hydroxy-2-phenylpropyl)-, 1,1-dimethylethyl ester
C14H21NO3
127087-62-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 2.3101 0.0 0
M  V30 2 C 5.3348 3.0801 0.0 0
M  V30 3 C 4.0012 0.7700 0.0 0
M  V30 4 N 6.6685 2.3101 0.0 0
M  V30 5 O 2.6673 0.0000 0.0 0
M  V30 6 C 8.0022 3.0801 0.0 0
M  V30 7 O 9.3360 2.3101 0.0 0
M  V30 8 O 8.0022 4.6201 0.0 0
M  V30 9 C 10.6697 3.0801 0.0 0
M  V30 10 C 11.4397 1.7464 0.0 0
M  V30 11 C 12.0033 3.8501 0.0 0
M  V30 12 C 9.8996 4.4137 0.0 0
M  V30 13 C 2.6673 3.0801 0.0 0
M  V30 14 C 1.3337 2.3101 0.0 0
M  V30 15 C 2.6673 4.6201 0.0 0
M  V30 16 C 0.0000 3.0801 0.0 0
M  V30 17 C 1.3337 5.3901 0.0 0
M  V30 18 C 0.0000 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbon disulfide
CS2
75-15-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 0.0000 0.0 0
M  V30 2 S 0.0000 0.0000 0.0 0
M  V30 3 S 3.0800 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamic acid, [3-[(methylamino)thioxomethoxy]-2-phenylpropyl]-, 1,1-dimethyl...
C16H24N2O3S
235439-52-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 4.0011 0.0 0
M  V30 2 C 6.9300 4.0011 0.0 0
M  V30 3 C 4.6200 5.3347 0.0 0
M  V30 4 N 7.7000 5.3347 0.0 0
M  V30 5 O 3.0800 5.3347 0.0 0
M  V30 6 C 9.2400 5.3347 0.0 0
M  V30 7 C 2.3100 6.6685 0.0 0
M  V30 8 O 10.0100 6.6685 0.0 0
M  V30 9 O 10.0100 4.0011 0.0 0
M  V30 10 N 0.7700 6.6685 0.0 0
M  V30 11 S 3.0800 8.0021 0.0 0
M  V30 12 C 11.5500 6.6685 0.0 0
M  V30 13 C 0.0000 8.0021 0.0 0
M  V30 14 C 11.5500 5.1285 0.0 0
M  V30 15 C 13.0900 6.6685 0.0 0
M  V30 16 C 11.5500 8.2085 0.0 0
M  V30 17 C 4.6200 2.6674 0.0 0
M  V30 18 C 5.3900 1.3338 0.0 0
M  V30 19 C 3.0800 2.6674 0.0 0
M  V30 20 C 4.6200 0.0000 0.0 0
M  V30 21 C 2.3100 1.3338 0.0 0
M  V30 22 C 3.0800 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 17
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 7 10
M  V30 11 2 7 11
M  V30 12 1 8 12
M  V30 13 1 10 13
M  V30 14 1 12 14
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 2 17 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 2 19 21
M  V30 21 2 20 22
M  V30 22 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 127087-62-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-15-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 235439-52-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28433022
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 5
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7646-69-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 74-88-4
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Example 1.
O-Thiocarbamoyl-N-(t-butyloxycarbonyl)-(DL)-phenylalaninol. In a 500mL
flask equipped with magnetic stirrer,
N-(t-butyloxycarbonyl)-(DL)-phenylalaninol(0.051 mole, 13.6g) was
dissolved in 200mL of THF and was added with NaH(0.061 mole, 1.47g) at
0°C. The reaction mixture was stirred at 0°C for 1 hour, followed by the
addition of CS2(0.061 mole, 4.66g). After being stirred for 40 min. at
0°C, MeI(0.061 mole, 8.69g) was added to the reaction mixture. The
reaction mixture was stirred at room temperature for 2 hours, followed by
the addition of 5N NH4OH (0.090 mole, 18.0mL) for 6 hours. The resulting
solution was quenched with water. The organic layer was extracted 3 times
with dichloromethane, dried over magnesium sulfate and distilled in
vacuo. This was recrystalized in a solution mixture of n-hexane and
diethyl ether.
3-N-(t-Butyloxycarbonyl)amino-2-phenyl-1-0-((N-methly)thiocarbamoyl)
propanol. The procedure given in Examplel was followed using
3-N-(t-butyloxycarbonyl)amino-2-phenyl-1-propanol as a starting material
and methyl amine as a reactant instead of
N-(t-butyloxycarbonyl)-(DL)-phenylalaninol and NH4OH to give
3-N-(t-butyloxycarbonyl)amino-2-phenyl-1-O-((N-methyl)thiocarbamoyl)
propanol. A yield of 92% was obtained. 1H-NMR(CDCl3, 200MHz), ppm(δ) ;
1.40 (9H), 2.89 (1H), 3.06 (H), 3.13-3.45(2H), 3.45-3.72 (1H ) 5
4.40-5.80 (2H), 6.30-6.70 (1H ) 7.10-7.40 (5H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 2-amino-2-phenylethyl thiocarbamates and analogs as
nervous system agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Choi, Yong Moon; Kim, Yong Kil
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2000046191 A1 2000-08-10

$RFMT $RIREG SCHEME181 STEP1
$RXN



  2  1
$MOL
6-(4-Methylphenyl)-4-(methylthio)-2-oxo-2H-pyran-3-carboxylic acid
C14H12O4S
127449-57-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 4.0012 0.0 0
M  V30 2 O 0.0000 2.6675 0.0 0
M  V30 3 O 0.0000 5.3348 0.0 0
M  V30 4 S 2.3101 1.3338 0.0 0
M  V30 5 C 3.0801 0.0000 0.0 0
M  V30 6 O 2.3101 6.6687 0.0 0
M  V30 7 C 11.5503 4.0012 0.0 0
M  V30 8 C 2.3101 4.0012 0.0 0
M  V30 9 C 3.0801 2.6675 0.0 0
M  V30 10 C 3.0801 5.3348 0.0 0
M  V30 11 C 4.6201 2.6675 0.0 0
M  V30 12 O 4.6201 5.3348 0.0 0
M  V30 13 C 5.3901 4.0012 0.0 0
M  V30 14 C 6.9302 4.0012 0.0 0
M  V30 15 C 7.7002 5.3348 0.0 0
M  V30 16 C 7.7002 2.6675 0.0 0
M  V30 17 C 9.2402 5.3348 0.0 0
M  V30 18 C 9.2402 2.6675 0.0 0
M  V30 19 C 10.0102 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 5
M  V30 5 1 4 9
M  V30 6 2 6 10
M  V30 7 1 7 19
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-6-(4-methylphenyl)-4-(methylthio)-2-oxo-2H-pyran-3-carboxamide
C15H15NO3S
1512808-18-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 4.0012 0.0 0
M  V30 2 N 1.5400 5.3348 0.0 0
M  V30 3 O 1.5400 2.6675 0.0 0
M  V30 4 C 0.0000 5.3348 0.0 0
M  V30 5 S 3.8501 1.3338 0.0 0
M  V30 6 C 4.6201 0.0000 0.0 0
M  V30 7 O 3.8501 6.6687 0.0 0
M  V30 8 C 13.0903 4.0012 0.0 0
M  V30 9 C 3.8501 4.0012 0.0 0
M  V30 10 C 4.6201 2.6675 0.0 0
M  V30 11 C 4.6201 5.3348 0.0 0
M  V30 12 C 6.1601 2.6675 0.0 0
M  V30 13 O 6.1601 5.3348 0.0 0
M  V30 14 C 6.9302 4.0012 0.0 0
M  V30 15 C 8.4702 4.0012 0.0 0
M  V30 16 C 9.2402 5.3348 0.0 0
M  V30 17 C 9.2402 2.6675 0.0 0
M  V30 18 C 10.7802 5.3348 0.0 0
M  V30 19 C 10.7802 2.6675 0.0 0
M  V30 20 C 11.5503 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 10
M  V30 7 2 7 11
M  V30 8 1 8 20
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 15 1 14 15
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 127449-57-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1512808-18-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-8104778
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General method for the preparation of
substituted 4-(methylthio)-2-oxo-6-phenyl-2H-pyran-3-carboxamides (11) To
a stirring solution of appropriately substituted 10 (0.76 mmoles) in DMF
at rt, HATU (0.83 mmoles) and diisopropylethylamine (2.29 mmoles) was
added. Appropriately substituted amine (0.76 mmoles) was added after 15
min and stirring continued for another 1h at rt. The reaction was
monitored by TLC and then poured into ice water with stirring. The so
formed precipitate was filtered off and recrystallized from a mixture of
ethyl acetate and n-hexane to get pure compound.
6-(4-fluorophenyl)-4-(methylthio)-2-oxo-N-phenyl-2H-pyran-3-carboxamide
N-methyl-4-(methylthio)-2-oxo-6-p-tolyl-2H-pyran-3-carboxamide Yellow
powder; Yield 92 %. mp 208-209°C; Mass [M++1] = 290.0; 1H NMR: (400 MHz,
DMSO-d6): δ 2.39 (s, 3H, CH3), 2.58 (s, 3H, Me), 2.75-2.76 (d, J = 4.4
Hz, 3H, Me), 7.09 (s, 1H, Pyrone), 7.37-7.39 (d, J = 8.0 Hz, 2H, ArH),
7.89-7.91 (d, J = 8.4 Hz, 2H, ArH), 8.66-8.67 (q, J = 4.4 Hz, 1H, NH
amide).
$DTYPE RXN:VAR(1):NOTES
$DATUM literature preparation
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and Anti-HCV Activity of 4-Hydroxyamino α-Pyranone Carboxamide
Analogues
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Konreddy, Ananda Kumar; Toyama, Massaki; Ito, Wataru; Bal, Chandralata;
Baba, Masanori; Sharon, Ashoke
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Medicinal Chemistry Letters (2014), 5(3), 259-263

$RFMT $RIREG SCHEME182 STEP1
$RXN



 12  1
$MOL
BOC-L-leucine
C11H21NO4
13139-15-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 15 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 3.8501 0.0 0 CFG=2
M  V30 2 N 4.0012 4.6201 0.0 0
M  V30 3 C 2.6675 2.3101 0.0 0
M  V30 4 C 1.3337 4.6201 0.0 0
M  V30 5 C 5.3348 3.8501 0.0 0
M  V30 6 C 1.3337 1.5400 0.0 0
M  V30 7 O 0.0000 3.8501 0.0 0
M  V30 8 O 1.3337 6.1601 0.0 0
M  V30 9 O 6.6685 4.6201 0.0 0
M  V30 10 O 5.3348 2.3101 0.0 0
M  V30 11 C 1.3337 0.0000 0.0 0
M  V30 12 C 0.0000 2.3101 0.0 0
M  V30 13 C 8.0023 3.8501 0.0 0
M  V30 14 C 7.2323 2.5164 0.0 0
M  V30 15 C 9.3360 3.0801 0.0 0
M  V30 16 C 8.7723 5.1838 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 2 5 10
M  V30 10 1 6 11
M  V30 11 1 6 12
M  V30 12 1 9 13
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
BOC-L-Phenylalanine
C14H19NO4
13734-34-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3901 2.6675 0.0 0 CFG=1
M  V30 2 C 4.6201 4.0012 0.0 0
M  V30 3 N 6.9302 2.6675 0.0 0
M  V30 4 C 4.6201 1.3338 0.0 0
M  V30 5 C 7.7002 4.0012 0.0 0
M  V30 6 O 3.0801 1.3338 0.0 0
M  V30 7 O 5.3901 0.0000 0.0 0
M  V30 8 O 9.2402 4.0012 0.0 0
M  V30 9 O 6.9302 5.3348 0.0 0
M  V30 10 C 10.0102 5.3348 0.0 0
M  V30 11 C 11.3439 4.5648 0.0 0
M  V30 12 C 10.7802 6.6687 0.0 0
M  V30 13 C 8.6766 6.1048 0.0 0
M  V30 14 C 3.0801 4.0012 0.0 0
M  V30 15 C 2.3101 5.3348 0.0 0
M  V30 16 C 2.3101 2.6675 0.0 0
M  V30 17 C 0.7700 5.3348 0.0 0
M  V30 18 C 0.7700 2.6675 0.0 0
M  V30 19 C 0.0000 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 14
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Fmoc-Lys(Boc)-OH
C26H32N2O6
71989-26-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.7533 5.2308 0.0 0
M  V30 2 O 5.7533 6.7708 0.0 0
M  V30 3 C 7.0870 7.5408 0.0 0
M  V30 4 N 7.0870 9.0808 0.0 0
M  V30 5 O 8.4206 6.7708 0.0 0
M  V30 6 C 8.4206 9.8508 0.0 0 CFG=2
M  V30 7 C 9.7544 9.0808 0.0 0
M  V30 8 C 8.4206 11.3908 0.0 0
M  V30 9 C 11.0881 9.8508 0.0 0
M  V30 10 O 7.0870 12.1609 0.0 0
M  V30 11 O 9.7544 12.1609 0.0 0
M  V30 12 C 12.4217 9.0808 0.0 0
M  V30 13 C 13.7554 9.8508 0.0 0
M  V30 14 N 15.0892 9.0808 0.0 0
M  V30 15 C 16.4228 9.8508 0.0 0
M  V30 16 O 17.7565 9.0808 0.0 0
M  V30 17 O 16.4228 11.3908 0.0 0
M  V30 18 C 19.0901 9.8508 0.0 0
M  V30 19 C 18.3201 11.1846 0.0 0
M  V30 20 C 20.4239 10.6208 0.0 0
M  V30 21 C 19.8603 8.5172 0.0 0
M  V30 22 C 4.4197 4.4608 0.0 0
M  V30 23 C 4.2586 2.9293 0.0 0
M  V30 24 C 3.0127 5.0873 0.0 0
M  V30 25 C 2.7523 2.6091 0.0 0
M  V30 26 C 5.2892 1.7847 0.0 0
M  V30 27 C 1.9823 3.9427 0.0 0
M  V30 28 C 2.5369 6.5518 0.0 0
M  V30 29 C 2.2764 1.1444 0.0 0
M  V30 30 C 4.8133 0.3202 0.0 0
M  V30 31 C 0.4759 4.2629 0.0 0
M  V30 32 C 1.0306 6.8720 0.0 0
M  V30 33 C 3.3069 0.0000 0.0 0
M  V30 34 C 0.0000 5.7276 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 22
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7 CFG=3
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 14 15
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 1 16 18
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 18 21
M  V30 22 1 22 23
M  V30 23 1 22 24
M  V30 24 1 23 25
M  V30 25 2 23 26
M  V30 26 1 24 27
M  V30 27 2 24 28
M  V30 28 1 25 27
M  V30 29 2 25 29
M  V30 30 1 26 30
M  V30 31 2 27 31
M  V30 32 1 28 32
M  V30 33 1 29 33
M  V30 34 2 30 33
M  V30 35 1 31 34
M  V30 36 2 32 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
6-(Fmoc-amino)hexanoic acid
C21H23NO4
88574-06-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7533 5.2310 0.0 0
M  V30 2 O 7.0870 4.4610 0.0 0
M  V30 3 C 8.4208 5.2310 0.0 0
M  V30 4 N 9.7545 4.4610 0.0 0
M  V30 5 O 8.4208 6.7710 0.0 0
M  V30 6 C 11.0881 5.2310 0.0 0
M  V30 7 C 12.4218 4.4610 0.0 0
M  V30 8 C 13.7556 5.2310 0.0 0
M  V30 9 C 15.0892 4.4610 0.0 0
M  V30 10 C 16.4229 5.2310 0.0 0
M  V30 11 C 17.7565 4.4610 0.0 0
M  V30 12 O 19.0904 5.2310 0.0 0
M  V30 13 O 17.7565 2.9209 0.0 0
M  V30 14 C 4.4197 4.4610 0.0 0
M  V30 15 C 4.2588 2.9293 0.0 0
M  V30 16 C 3.0127 5.0873 0.0 0
M  V30 17 C 2.7523 2.6091 0.0 0
M  V30 18 C 5.2892 1.7849 0.0 0
M  V30 19 C 1.9823 3.9429 0.0 0
M  V30 20 C 2.5369 6.5520 0.0 0
M  V30 21 C 2.2765 1.1445 0.0 0
M  V30 22 C 4.8133 0.3202 0.0 0
M  V30 23 C 0.4760 4.2631 0.0 0
M  V30 24 C 1.0306 6.8722 0.0 0
M  V30 25 C 3.3069 0.0000 0.0 0
M  V30 26 C 0.0000 5.7276 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 15 18
M  V30 18 1 16 19
M  V30 19 2 16 20
M  V30 20 1 17 19
M  V30 21 2 17 21
M  V30 22 1 18 22
M  V30 23 2 19 23
M  V30 24 1 20 24
M  V30 25 1 21 25
M  V30 26 2 22 25
M  V30 27 1 23 26
M  V30 28 2 24 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Fmoc-L-Asp(OtBu)-OH
C23H25NO6
71989-14-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.0543 3.7827 0.0 0
M  V30 2 O 5.8243 5.1163 0.0 0
M  V30 3 C 7.3643 5.1163 0.0 0
M  V30 4 N 8.1343 6.4500 0.0 0
M  V30 5 O 8.1343 3.7827 0.0 0
M  V30 6 C 9.6743 6.4500 0.0 0 CFG=2
M  V30 7 C 10.4443 5.1163 0.0 0
M  V30 8 C 10.4443 7.7838 0.0 0
M  V30 9 C 11.9843 5.1163 0.0 0
M  V30 10 O 11.9843 7.7838 0.0 0
M  V30 11 O 9.6743 9.1174 0.0 0
M  V30 12 O 12.7543 3.7827 0.0 0
M  V30 13 O 12.7543 6.4500 0.0 0
M  V30 14 C 14.2943 3.7827 0.0 0
M  V30 15 C 14.2943 5.3227 0.0 0
M  V30 16 C 15.8343 3.7827 0.0 0
M  V30 17 C 14.2943 2.2427 0.0 0
M  V30 18 C 3.5143 3.7827 0.0 0
M  V30 19 C 2.6091 5.0286 0.0 0
M  V30 20 C 2.6091 2.5368 0.0 0
M  V30 21 C 1.1445 4.5527 0.0 0
M  V30 22 C 2.9292 6.5350 0.0 0
M  V30 23 C 1.1445 3.0127 0.0 0
M  V30 24 C 2.9292 1.0304 0.0 0
M  V30 25 C 0.0000 5.5831 0.0 0
M  V30 26 C 1.7849 7.5654 0.0 0
M  V30 27 C 0.0000 1.9823 0.0 0
M  V30 28 C 1.7849 0.0000 0.0 0
M  V30 29 C 0.3202 7.0895 0.0 0
M  V30 30 C 0.3202 0.4759 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7 CFG=3
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 1 12 14
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 14 17
M  V30 18 1 18 19
M  V30 19 1 18 20
M  V30 20 1 19 21
M  V30 21 2 19 22
M  V30 22 1 20 23
M  V30 23 2 20 24
M  V30 24 1 21 23
M  V30 25 2 21 25
M  V30 26 1 22 26
M  V30 27 2 23 27
M  V30 28 1 24 28
M  V30 29 1 25 29
M  V30 30 2 26 29
M  V30 31 1 27 30
M  V30 32 2 28 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-(9-Fluorenylmethoxycarbonyl)-L-glutamic acid γ-tert-butyl ester
C24H27NO6
71989-18-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.7533 5.2309 0.0 0
M  V30 2 O 5.7533 6.7709 0.0 0
M  V30 3 C 7.0871 7.5409 0.0 0
M  V30 4 N 7.0871 9.0810 0.0 0
M  V30 5 O 8.4208 6.7709 0.0 0
M  V30 6 C 8.4208 9.8510 0.0 0 CFG=2
M  V30 7 C 9.7544 9.0810 0.0 0
M  V30 8 C 8.4208 11.3910 0.0 0
M  V30 9 C 11.0881 9.8510 0.0 0
M  V30 10 O 7.0871 12.1610 0.0 0
M  V30 11 O 9.7544 12.1610 0.0 0
M  V30 12 C 12.4219 9.0810 0.0 0
M  V30 13 O 13.7556 9.8510 0.0 0
M  V30 14 O 12.4219 7.5409 0.0 0
M  V30 15 C 15.0893 9.0810 0.0 0
M  V30 16 C 15.8593 10.4146 0.0 0
M  V30 17 C 16.4229 8.3109 0.0 0
M  V30 18 C 14.3192 7.7473 0.0 0
M  V30 19 C 3.0128 5.0873 0.0 0
M  V30 20 C 4.4196 4.4609 0.0 0
M  V30 21 C 1.9822 3.9428 0.0 0
M  V30 22 C 2.5367 6.5519 0.0 0
M  V30 23 C 4.2587 2.9293 0.0 0
M  V30 24 C 2.7522 2.6091 0.0 0
M  V30 25 C 0.4759 4.2630 0.0 0
M  V30 26 C 1.0304 6.8721 0.0 0
M  V30 27 C 5.2891 1.7849 0.0 0
M  V30 28 C 2.2763 1.1444 0.0 0
M  V30 29 C 0.0000 5.7277 0.0 0
M  V30 30 C 4.8132 0.3202 0.0 0
M  V30 31 C 3.3068 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 20
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7 CFG=3
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 1 13 15
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 15 18
M  V30 19 1 19 20
M  V30 20 1 19 21
M  V30 21 2 19 22
M  V30 22 1 20 23
M  V30 23 1 21 24
M  V30 24 2 21 25
M  V30 25 1 22 26
M  V30 26 1 23 24
M  V30 27 2 23 27
M  V30 28 2 24 28
M  V30 29 1 25 29
M  V30 30 2 26 29
M  V30 31 1 27 30
M  V30 32 1 28 31
M  V30 33 2 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Fmoc-leucine
C21H23NO4
35661-60-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.7534 5.2309 0.0 0
M  V30 2 O 7.0871 4.4608 0.0 0
M  V30 3 C 8.4207 5.2309 0.0 0
M  V30 4 N 9.7544 4.4608 0.0 0
M  V30 5 O 8.4207 6.7709 0.0 0
M  V30 6 C 11.0882 5.2309 0.0 0 CFG=2
M  V30 7 C 11.0882 6.7709 0.0 0
M  V30 8 C 12.4219 4.4608 0.0 0
M  V30 9 C 12.4219 7.5409 0.0 0
M  V30 10 O 12.4219 2.9208 0.0 0
M  V30 11 O 13.7555 5.2309 0.0 0
M  V30 12 C 13.7555 6.7709 0.0 0
M  V30 13 C 12.4219 9.0809 0.0 0
M  V30 14 C 4.4196 4.4608 0.0 0
M  V30 15 C 4.2586 2.9293 0.0 0
M  V30 16 C 3.0128 5.0873 0.0 0
M  V30 17 C 2.7523 2.6091 0.0 0
M  V30 18 C 5.2891 1.7849 0.0 0
M  V30 19 C 1.9823 3.9428 0.0 0
M  V30 20 C 2.5369 6.5519 0.0 0
M  V30 21 C 2.2763 1.1444 0.0 0
M  V30 22 C 4.8132 0.3202 0.0 0
M  V30 23 C 0.4759 4.2630 0.0 0
M  V30 24 C 1.0304 6.8721 0.0 0
M  V30 25 C 3.3069 0.0000 0.0 0
M  V30 26 C 0.0000 5.7277 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7 CFG=1
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 1 9 13
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 15 18
M  V30 18 1 16 19
M  V30 19 2 16 20
M  V30 20 1 17 19
M  V30 21 2 17 21
M  V30 22 1 18 22
M  V30 23 2 19 23
M  V30 24 1 20 24
M  V30 25 1 21 25
M  V30 26 2 22 25
M  V30 27 1 23 26
M  V30 28 2 24 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-L-methionine
C20H21NO4S
71989-28-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.0543 3.7827 0.0 0
M  V30 2 O 5.8243 5.1163 0.0 0
M  V30 3 C 7.3643 5.1163 0.0 0
M  V30 4 N 8.1343 6.4500 0.0 0
M  V30 5 O 8.1343 3.7827 0.0 0
M  V30 6 C 9.6743 6.4500 0.0 0 CFG=2
M  V30 7 C 10.4443 5.1163 0.0 0
M  V30 8 C 10.4443 7.7838 0.0 0
M  V30 9 C 11.9843 5.1163 0.0 0
M  V30 10 O 9.6743 9.1174 0.0 0
M  V30 11 O 11.9843 7.7838 0.0 0
M  V30 12 S 12.7543 3.7827 0.0 0
M  V30 13 C 14.2943 3.7827 0.0 0
M  V30 14 C 3.5143 3.7827 0.0 0
M  V30 15 C 2.6091 5.0286 0.0 0
M  V30 16 C 2.6091 2.5368 0.0 0
M  V30 17 C 1.1445 4.5527 0.0 0
M  V30 18 C 2.9292 6.5350 0.0 0
M  V30 19 C 1.1445 3.0127 0.0 0
M  V30 20 C 2.9292 1.0304 0.0 0
M  V30 21 C 0.0000 5.5831 0.0 0
M  V30 22 C 1.7849 7.5654 0.0 0
M  V30 23 C 0.0000 1.9823 0.0 0
M  V30 24 C 1.7849 0.0000 0.0 0
M  V30 25 C 0.3202 7.0895 0.0 0
M  V30 26 C 0.3202 0.4759 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7 CFG=3
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 1 12 13
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 15 18
M  V30 18 1 16 19
M  V30 19 2 16 20
M  V30 20 1 17 19
M  V30 21 2 17 21
M  V30 22 1 18 22
M  V30 23 2 19 23
M  V30 24 1 20 24
M  V30 25 1 21 25
M  V30 26 2 22 25
M  V30 27 1 23 26
M  V30 28 2 24 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
FMOC-L-phenylalanine
C24H21NO4
35661-40-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 32 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.3360 5.2309 0.0 0
M  V30 2 O 8.0021 4.4608 0.0 0
M  V30 3 C 6.6685 5.2309 0.0 0
M  V30 4 N 5.3348 4.4608 0.0 0
M  V30 5 O 6.6685 6.7709 0.0 0
M  V30 6 C 4.0011 5.2309 0.0 0 CFG=2
M  V30 7 C 4.0011 6.7709 0.0 0
M  V30 8 C 2.6673 4.4608 0.0 0
M  V30 9 O 1.3337 5.2309 0.0 0
M  V30 10 O 2.6673 2.9208 0.0 0
M  V30 11 C 10.6696 4.4608 0.0 0
M  V30 12 C 10.8306 2.9293 0.0 0
M  V30 13 C 12.0764 5.0873 0.0 0
M  V30 14 C 12.3370 2.6091 0.0 0
M  V30 15 C 9.8001 1.7849 0.0 0
M  V30 16 C 13.1070 3.9428 0.0 0
M  V30 17 C 12.5523 6.5519 0.0 0
M  V30 18 C 12.8129 1.1444 0.0 0
M  V30 19 C 10.2760 0.3202 0.0 0
M  V30 20 C 14.6133 4.2630 0.0 0
M  V30 21 C 14.0588 6.8721 0.0 0
M  V30 22 C 11.7823 0.0000 0.0 0
M  V30 23 C 15.0892 5.7277 0.0 0
M  V30 24 C 2.6673 7.5409 0.0 0
M  V30 25 C 1.3337 6.7709 0.0 0
M  V30 26 C 2.6673 9.0809 0.0 0
M  V30 27 C 0.0000 7.5409 0.0 0
M  V30 28 C 1.3337 9.8509 0.0 0
M  V30 29 C 0.0000 9.0809 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7 CFG=3
M  V30 8 1 6 8
M  V30 9 1 7 24
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 12 15
M  V30 16 1 13 16
M  V30 17 2 13 17
M  V30 18 1 14 16
M  V30 19 2 14 18
M  V30 20 1 15 19
M  V30 21 2 16 20
M  V30 22 1 17 21
M  V30 23 1 18 22
M  V30 24 2 19 22
M  V30 25 1 20 23
M  V30 26 2 21 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(S)-2-[[[(9H-Fluoren-9-yl)methoxy]carbonyl]amino]butanoic acid
C19H19NO4
135112-27-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.7534 5.2309 0.0 0
M  V30 2 O 7.0871 4.4608 0.0 0
M  V30 3 C 8.4207 5.2309 0.0 0
M  V30 4 N 9.7544 4.4608 0.0 0
M  V30 5 O 8.4207 6.7709 0.0 0
M  V30 6 C 11.0882 5.2309 0.0 0 CFG=1
M  V30 7 C 12.4219 4.4608 0.0 0
M  V30 8 C 11.0882 6.7709 0.0 0
M  V30 9 O 12.4219 2.9208 0.0 0
M  V30 10 O 13.7555 5.2309 0.0 0
M  V30 11 C 12.4219 7.5409 0.0 0
M  V30 12 C 4.4196 4.4608 0.0 0
M  V30 13 C 4.2586 2.9293 0.0 0
M  V30 14 C 3.0128 5.0873 0.0 0
M  V30 15 C 2.7523 2.6091 0.0 0
M  V30 16 C 5.2891 1.7849 0.0 0
M  V30 17 C 1.9823 3.9428 0.0 0
M  V30 18 C 2.5369 6.5519 0.0 0
M  V30 19 C 2.2763 1.1444 0.0 0
M  V30 20 C 4.8132 0.3202 0.0 0
M  V30 21 C 0.4759 4.2630 0.0 0
M  V30 22 C 1.0304 6.8721 0.0 0
M  V30 23 C 3.3069 0.0000 0.0 0
M  V30 24 C 0.0000 5.7277 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8 CFG=1
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 13 16
M  V30 16 1 14 17
M  V30 17 2 14 18
M  V30 18 1 15 17
M  V30 19 2 15 19
M  V30 20 1 16 20
M  V30 21 2 17 21
M  V30 22 1 18 22
M  V30 23 1 19 23
M  V30 24 2 20 23
M  V30 25 1 21 24
M  V30 26 2 22 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-L-tyrosine
C24H21NO5
92954-90-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 33 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.7533 5.2309 0.0 0
M  V30 2 O 7.0871 4.4609 0.0 0
M  V30 3 C 8.4207 5.2309 0.0 0
M  V30 4 N 9.7544 4.4609 0.0 0
M  V30 5 O 8.4207 6.7709 0.0 0
M  V30 6 C 11.0881 5.2309 0.0 0 CFG=2
M  V30 7 C 11.0881 6.7709 0.0 0
M  V30 8 C 12.4219 4.4609 0.0 0
M  V30 9 O 13.7556 5.2309 0.0 0
M  V30 10 O 12.4219 2.9208 0.0 0
M  V30 11 O 16.4229 9.8510 0.0 0
M  V30 12 C 4.4196 4.4609 0.0 0
M  V30 13 C 4.2587 2.9293 0.0 0
M  V30 14 C 3.0128 5.0873 0.0 0
M  V30 15 C 2.7522 2.6091 0.0 0
M  V30 16 C 5.2891 1.7849 0.0 0
M  V30 17 C 1.9822 3.9428 0.0 0
M  V30 18 C 2.5367 6.5519 0.0 0
M  V30 19 C 2.2763 1.1444 0.0 0
M  V30 20 C 4.8132 0.3202 0.0 0
M  V30 21 C 0.4759 4.2630 0.0 0
M  V30 22 C 1.0304 6.8721 0.0 0
M  V30 23 C 3.3068 0.0000 0.0 0
M  V30 24 C 0.0000 5.7277 0.0 0
M  V30 25 C 12.4219 7.5409 0.0 0
M  V30 26 C 13.7556 6.7709 0.0 0
M  V30 27 C 12.4219 9.0810 0.0 0
M  V30 28 C 15.0892 7.5409 0.0 0
M  V30 29 C 13.7556 9.8510 0.0 0
M  V30 30 C 15.0892 9.0810 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7 CFG=1
M  V30 8 1 6 8
M  V30 9 1 7 25
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 11 30
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 13 16
M  V30 17 1 14 17
M  V30 18 2 14 18
M  V30 19 1 15 17
M  V30 20 2 15 19
M  V30 21 1 16 20
M  V30 22 2 17 21
M  V30 23 1 18 22
M  V30 24 1 19 23
M  V30 25 2 20 23
M  V30 26 1 21 24
M  V30 27 2 22 24
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
L-Tyrosyl-(2S)-2-aminobutanoyl-L-phenylalanyl-L-methionyl-L-leucyl-L-α-glutam...
C70H105N13O16S
1374645-28-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  100 102 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3901 9.3358 0.0 0 CFG=2
M  V30 2 C 4.6201 8.0022 0.0 0
M  V30 3 C 4.6201 10.6697 0.0 0
M  V30 4 N 6.9302 9.3358 0.0 0
M  V30 5 N 5.3901 12.0033 0.0 0
M  V30 6 O 3.0801 10.6697 0.0 0
M  V30 7 C 7.7002 8.0022 0.0 0
M  V30 8 C 4.6201 13.3370 0.0 0 CFG=1
M  V30 9 C 9.2402 8.0022 0.0 0 CFG=2
M  V30 10 O 6.9302 6.6685 0.0 0
M  V30 11 C 5.3901 14.6707 0.0 0
M  V30 12 C 3.0801 13.3370 0.0 0
M  V30 13 N 10.0102 6.6685 0.0 0
M  V30 14 C 10.0102 9.3358 0.0 0
M  V30 15 N 6.9302 14.6707 0.0 0
M  V30 16 O 4.6201 16.0045 0.0 0
M  V30 17 C 2.3101 14.6707 0.0 0
M  V30 18 C 11.5503 6.6685 0.0 0
M  V30 19 C 9.2402 10.6697 0.0 0
M  V30 20 C 7.7002 16.0045 0.0 0 CFG=1
M  V30 21 S 0.7700 14.6707 0.0 0
M  V30 22 C 12.3203 5.3348 0.0 0 CFG=1
M  V30 23 O 12.3203 8.0022 0.0 0
M  V30 24 C 9.2402 16.0045 0.0 0
M  V30 25 C 6.9302 17.3382 0.0 0
M  V30 26 C 0.0000 13.3370 0.0 0
M  V30 27 C 13.8603 5.3348 0.0 0
M  V30 28 N 11.5503 4.0010 0.0 0
M  V30 29 N 10.0102 17.3382 0.0 0
M  V30 30 O 10.0102 14.6707 0.0 0
M  V30 31 C 7.7002 18.6718 0.0 0
M  V30 32 C 11.5503 17.3382 0.0 0 CFG=1
M  V30 33 C 9.2402 18.6718 0.0 0
M  V30 34 C 6.9302 20.0055 0.0 0
M  V30 35 C 12.3203 18.6718 0.0 0
M  V30 36 C 12.3203 16.0045 0.0 0
M  V30 37 N 13.8603 18.6718 0.0 0
M  V30 38 O 11.5503 20.0057 0.0 0
M  V30 39 C 13.8603 16.0045 0.0 0
M  V30 40 C 14.6303 20.0057 0.0 0 CFG=1
M  V30 41 C 14.6303 14.6708 0.0 0
M  V30 42 C 16.1704 20.0057 0.0 0
M  V30 43 C 13.8603 21.3393 0.0 0
M  V30 44 O 16.1704 14.6708 0.0 0
M  V30 45 O 13.8603 13.3370 0.0 0
M  V30 46 N 16.9404 18.6718 0.0 0
M  V30 47 O 16.9404 21.3393 0.0 0
M  V30 48 C 14.6303 22.6730 0.0 0
M  V30 49 C 18.4804 18.6718 0.0 0
M  V30 50 O 16.1704 22.6730 0.0 0
M  V30 51 O 13.8603 24.0067 0.0 0
M  V30 52 C 19.2504 17.3382 0.0 0
M  V30 53 C 20.7905 17.3382 0.0 0
M  V30 54 C 21.5605 16.0045 0.0 0
M  V30 55 C 23.1005 16.0045 0.0 0
M  V30 56 C 23.8705 14.6707 0.0 0
M  V30 57 N 25.4106 14.6707 0.0 0
M  V30 58 O 23.1005 13.3370 0.0 0
M  V30 59 C 26.1806 13.3370 0.0 0 CFG=1
M  V30 60 C 27.7206 13.3370 0.0 0
M  V30 61 C 25.4106 12.0033 0.0 0
M  V30 62 N 28.4906 12.0033 0.0 0
M  V30 63 O 28.4906 14.6707 0.0 0
M  V30 64 C 26.1806 10.6697 0.0 0
M  V30 65 C 30.0307 12.0033 0.0 0 CFG=2
M  V30 66 C 25.4106 9.3358 0.0 0
M  V30 67 C 30.8007 13.3370 0.0 0
M  V30 68 C 30.8007 10.6697 0.0 0
M  V30 69 C 26.1806 8.0022 0.0 0
M  V30 70 N 32.3407 10.6697 0.0 0
M  V30 71 O 30.0307 9.3358 0.0 0
M  V30 72 N 25.4106 6.6685 0.0 0
M  V30 73 C 33.1107 9.3358 0.0 0 CFG=1
M  V30 74 C 32.3407 8.0022 0.0 0
M  V30 75 C 34.6508 9.3358 0.0 0
M  V30 76 N 33.1107 6.6685 0.0 0
M  V30 77 O 30.8007 8.0022 0.0 0
M  V30 78 C 35.4208 8.0022 0.0 0
M  V30 79 C 32.3407 5.3348 0.0 0
M  V30 80 C 36.9608 8.0022 0.0 0
M  V30 81 C 34.6508 6.6685 0.0 0
M  V30 82 O 16.9404 0.0000 0.0 0
M  V30 83 C 3.0801 8.0022 0.0 0
M  V30 84 C 2.3101 9.3358 0.0 0
M  V30 85 C 2.3101 6.6685 0.0 0
M  V30 86 C 0.7700 9.3358 0.0 0
M  V30 87 C 0.7700 6.6685 0.0 0
M  V30 88 C 0.0000 8.0022 0.0 0
M  V30 89 C 14.6303 4.0010 0.0 0
M  V30 90 C 16.1704 4.0010 0.0 0
M  V30 91 C 13.8603 2.6673 0.0 0
M  V30 92 C 16.9404 2.6673 0.0 0
M  V30 93 C 14.6303 1.3337 0.0 0
M  V30 94 C 16.1704 1.3337 0.0 0
M  V30 95 C 32.3407 13.3370 0.0 0
M  V30 96 C 33.1107 12.0033 0.0 0
M  V30 97 C 33.1107 14.6707 0.0 0
M  V30 98 C 34.6508 12.0033 0.0 0
M  V30 99 C 34.6508 14.6707 0.0 0
M  V30 100 C 35.4208 13.3370 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 83
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 8 12 CFG=1
M  V30 13 1 9 13
M  V30 14 1 9 14 CFG=3
M  V30 15 1 11 15
M  V30 16 2 11 16
M  V30 17 1 12 17
M  V30 18 1 13 18
M  V30 19 1 14 19
M  V30 20 1 15 20
M  V30 21 1 17 21
M  V30 22 1 18 22
M  V30 23 2 18 23
M  V30 24 1 20 24
M  V30 25 1 20 25 CFG=1
M  V30 26 1 21 26
M  V30 27 1 22 27
M  V30 28 1 22 28 CFG=3
M  V30 29 1 24 29
M  V30 30 2 24 30
M  V30 31 1 25 31
M  V30 32 1 27 89
M  V30 33 1 29 32
M  V30 34 1 31 33
M  V30 35 1 31 34
M  V30 36 1 32 35
M  V30 37 1 32 36 CFG=3
M  V30 38 1 35 37
M  V30 39 2 35 38
M  V30 40 1 36 39
M  V30 41 1 37 40
M  V30 42 1 39 41
M  V30 43 1 40 42
M  V30 44 1 40 43 CFG=1
M  V30 45 1 41 44
M  V30 46 2 41 45
M  V30 47 1 42 46
M  V30 48 2 42 47
M  V30 49 1 43 48
M  V30 50 1 46 49
M  V30 51 1 48 50
M  V30 52 2 48 51
M  V30 53 1 49 52
M  V30 54 1 52 53
M  V30 55 1 53 54
M  V30 56 1 54 55
M  V30 57 1 55 56
M  V30 58 1 56 57
M  V30 59 2 56 58
M  V30 60 1 57 59
M  V30 61 1 59 60
M  V30 62 1 59 61 CFG=3
M  V30 63 1 60 62
M  V30 64 2 60 63
M  V30 65 1 61 64
M  V30 66 1 62 65
M  V30 67 1 64 66
M  V30 68 1 65 67 CFG=1
M  V30 69 1 65 68
M  V30 70 1 66 69
M  V30 71 1 67 95
M  V30 72 1 68 70
M  V30 73 2 68 71
M  V30 74 1 69 72
M  V30 75 1 70 73
M  V30 76 1 73 74
M  V30 77 1 73 75 CFG=1
M  V30 78 1 74 76
M  V30 79 2 74 77
M  V30 80 1 75 78
M  V30 81 1 76 79
M  V30 82 1 78 80
M  V30 83 1 78 81
M  V30 84 1 82 94
M  V30 85 2 83 84
M  V30 86 1 83 85
M  V30 87 1 84 86
M  V30 88 2 85 87
M  V30 89 2 86 88
M  V30 90 1 87 88
M  V30 91 2 89 90
M  V30 92 1 89 91
M  V30 93 1 90 92
M  V30 94 2 91 93
M  V30 95 2 92 94
M  V30 96 1 93 94
M  V30 97 2 95 96
M  V30 98 1 95 97
M  V30 99 1 96 98
M  V30 100 2 97 99
M  V30 101 2 98 100
M  V30 102 1 99 100
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(10 1 8 9 20 22 32 40 59 65 73)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 13139-15-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 13734-34-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 71989-26-9
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 88574-06-5
$DTYPE RXN:RCT(5):CAS_RN
$DATUM 71989-14-5
$DTYPE RXN:RCT(6):CAS_RN
$DATUM 71989-18-9
$DTYPE RXN:RCT(7):CAS_RN
$DATUM 35661-60-0
$DTYPE RXN:RCT(8):CAS_RN
$DATUM 71989-28-1
$DTYPE RXN:RCT(9):CAS_RN
$DATUM 35661-40-6
$DTYPE RXN:RCT(10):CAS_RN
$DATUM 135112-27-5
$DTYPE RXN:RCT(11):CAS_RN
$DATUM 92954-90-0
$DTYPE RXN:RCT(12):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1374645-28-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-352-CAS-8432834
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 16
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7681-11-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 109-02-4
$DTYPE RXN:VAR(1):RGT(5):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(6):CAS_RN
$DATUM 94790-37-1
$DTYPE RXN:VAR(1):RGT(7):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM solid-supported reaction, 74.5% purified yield, Fmoc deprotection with
DBU/DMF, attachment to Merrifield resin in stage 1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An expedient synthesis of peptidyl N-alkylamides by "HOPE" strategy
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lin, Hao; Yang, Xiao Xiao; Wang, De Xin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chinese Chemical Letters (2012), 23(5), 565-568

$RFMT $RIREG SCHEME183 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(3R)-1-(2-chloro-6-methyl-3-nitro-4-pyridinyl)-3-piperid...
C16H23ClN4O4
1314946-24-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 2.6673 6.1601 0.0 0 VAL=5
M  V30 2 O 4.0010 6.9302 0.0 0
M  V30 3 O 1.3337 6.9302 0.0 0
M  V30 4 Cl 0.0000 4.6201 0.0 0
M  V30 5 C 2.6673 0.0000 0.0 0
M  V30 6 N 9.3358 3.8501 0.0 0
M  V30 7 C 10.6697 4.6201 0.0 0
M  V30 8 O 12.0033 3.8501 0.0 0
M  V30 9 O 10.6697 6.1601 0.0 0
M  V30 10 C 13.3370 4.6201 0.0 0
M  V30 11 C 14.1070 3.2864 0.0 0
M  V30 12 C 14.6707 5.3901 0.0 0
M  V30 13 C 12.5670 5.9538 0.0 0
M  V30 14 C 4.0010 3.8501 0.0 0
M  V30 15 C 2.6673 4.6201 0.0 0
M  V30 16 C 4.0010 2.3101 0.0 0
M  V30 17 C 1.3337 3.8501 0.0 0
M  V30 18 C 2.6673 1.5400 0.0 0
M  V30 19 N 1.3337 2.3101 0.0 0
M  V30 20 N 5.3348 4.6201 0.0 0
M  V30 21 C 6.6685 3.8501 0.0 0
M  V30 22 C 5.3348 6.1601 0.0 0
M  V30 23 C 8.0022 4.6201 0.0 0 CFG=2
M  V30 24 C 6.6685 6.9302 0.0 0
M  V30 25 C 8.0022 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 4 17
M  V30 5 1 5 18
M  V30 6 1 6 7
M  V30 7 1 23 6 CFG=1
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 14 15
M  V30 15 2 14 16
M  V30 16 1 14 20
M  V30 17 2 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 19
M  V30 21 1 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(3R)-1-[6-methyl-2-(methylamino)-3-nitro-4-pyridinyl]-3-...
C17H27N5O4
1314946-26-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 4.0012 6.1601 0.0 0 VAL=5
M  V30 2 O 2.6675 6.9302 0.0 0
M  V30 3 O 5.3348 6.9302 0.0 0
M  V30 4 N 1.3338 4.6201 0.0 0
M  V30 5 C 0.0000 3.8501 0.0 0
M  V30 6 C 4.0012 0.0000 0.0 0
M  V30 7 N 10.6698 3.8501 0.0 0
M  V30 8 C 12.0035 4.6201 0.0 0
M  V30 9 O 13.3372 3.8501 0.0 0
M  V30 10 O 12.0035 6.1601 0.0 0
M  V30 11 C 14.6708 4.6201 0.0 0
M  V30 12 C 13.9008 5.9538 0.0 0
M  V30 13 C 16.0046 5.3901 0.0 0
M  V30 14 C 15.4408 3.2864 0.0 0
M  V30 15 C 4.0012 4.6201 0.0 0
M  V30 16 C 5.3348 3.8501 0.0 0
M  V30 17 C 2.6675 3.8501 0.0 0
M  V30 18 C 5.3348 2.3101 0.0 0
M  V30 19 N 2.6675 2.3101 0.0 0
M  V30 20 C 4.0012 1.5400 0.0 0
M  V30 21 N 6.6687 4.6201 0.0 0
M  V30 22 C 8.0023 3.8501 0.0 0
M  V30 23 C 6.6687 6.1601 0.0 0
M  V30 24 C 9.3360 4.6201 0.0 0 CFG=2
M  V30 25 C 8.0023 6.9302 0.0 0
M  V30 26 C 9.3360 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 4 5
M  V30 5 1 4 17
M  V30 6 1 6 20
M  V30 7 1 7 8
M  V30 8 1 24 7 CFG=1
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 15 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 16 21
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 20
M  V30 22 1 21 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1314946-24-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1314946-26-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-9637741
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 71-36-3
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM It was dissolved in butanol (10 mL) and to this solution was added methyl
amine in ethanol (27wt%, 10 mL) and heated at 110 °C for 24 h. The
reaction was concentrated in vacuum to afford. Yellow solid, yield (1.0
g, 92%).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of Imigliptin, a Novel Selective DPP-4 Inhibitor for the
Treatment of Type 2 Diabetes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shu, Chutian; Ge, Hu; Song, Michael; Chen, Jyun-hong; Zhou, Huimin; Qi,
Qu; Wang, Feng; Ma, Xifeng; Yang, Xiaolei; Zhang, Genyan; Ding, Yanwei;
Zhou, Dapeng; Peng, Peng; Shih, Cheng-kon; Xu, Jun; Wu, Frank
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Medicinal Chemistry Letters (2014), 5(8), 921-926

$RFMT $RIREG SCHEME184 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3aS,5aS,6R,9aS,9bS)-Dodecahydro-3a,6-dimethyl-3,7-dioxo-1H-benz[e]indene-6-a...
C17H24O4
1315357-69-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6268 2.5065 0.0 0
M  V30 2 C 1.4471 1.5166 0.0 0
M  V30 3 O 0.0000 2.0433 0.0 0
M  V30 4 O 1.7146 0.0000 0.0 0
M  V30 5 C 0.9123 3.4963 0.0 0
M  V30 6 C 7.8846 2.7771 0.0 0
M  V30 7 O 0.0494 5.3567 0.0 0
M  V30 8 O 9.6302 3.3127 0.0 0
M  V30 9 C 4.6694 5.3567 0.0 0 CFG=1
M  V30 10 C 3.8994 4.0231 0.0 0 CFG=2
M  V30 11 C 6.2094 5.3567 0.0 0 CFG=2
M  V30 12 C 3.8994 6.6904 0.0 0
M  V30 13 C 2.3594 4.0231 0.0 0 CFG=1
M  V30 14 C 4.6694 2.6893 0.0 0
M  V30 15 C 6.9794 4.0231 0.0 0 CFG=2
M  V30 16 C 7.2398 6.5011 0.0 0
M  V30 17 C 2.3594 6.6904 0.0 0
M  V30 18 C 1.5894 5.3567 0.0 0
M  V30 19 C 6.2094 2.6893 0.0 0
M  V30 20 C 8.4857 4.3433 0.0 0
M  V30 21 C 8.6468 5.8748 0.0 0
M  V30 22 H 5.0680 6.8442 0.0 0
M  V30 23 H 3.1294 2.6893 0.0 0
M  V30 24 H 6.2364 6.8964 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 13 1 CFG=1
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 13 5 CFG=3
M  V30 6 1 15 6 CFG=3
M  V30 7 2 7 18
M  V30 8 2 8 20
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 9 22 CFG=3
M  V30 13 1 10 13
M  V30 14 1 10 14
M  V30 15 1 10 23 CFG=1
M  V30 16 1 11 15
M  V30 17 1 11 16
M  V30 18 1 11 24 CFG=1
M  V30 19 1 12 17
M  V30 20 1 13 18
M  V30 21 1 14 19
M  V30 22 1 15 19
M  V30 23 1 15 20
M  V30 24 1 16 21
M  V30 25 1 17 18
M  V30 26 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 9 10 11 13 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(3aR,3bS,5aS,8aS,8bR)-1,3,3a,3b,4,5,5a,7,8,8a,8b,9-Dodecahydro-1,3a,5a-trimet...
C18H25NO2
1382475-16-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.2976 4.4133 0.0 0
M  V30 2 C 1.7456 4.1193 0.0 0
M  V30 3 C 10.6916 0.8296 0.0 0
M  V30 4 O 11.0418 4.1615 0.0 0
M  V30 5 O 0.0000 3.5837 0.0 0
M  V30 6 C 5.7308 2.8735 0.0 0 CFG=2
M  V30 7 C 4.9608 1.5398 0.0 0 CFG=1
M  V30 8 C 7.2708 2.8735 0.0 0 CFG=2
M  V30 9 C 4.9608 4.2071 0.0 0
M  V30 10 C 3.4208 1.5398 0.0 0 CFG=2
M  V30 11 C 5.7308 0.2062 0.0 0
M  V30 12 C 8.0408 1.5398 0.0 0
M  V30 13 C 8.3012 4.0180 0.0 0
M  V30 14 C 3.4208 4.2071 0.0 0
M  V30 15 C 2.6508 2.8735 0.0 0 CFG=2
M  V30 16 C 2.3904 0.3953 0.0 0
M  V30 17 C 7.2708 0.2062 0.0 0
M  V30 18 N 9.5471 1.8600 0.0 0
M  V30 19 C 9.7082 3.3915 0.0 0
M  V30 20 C 1.1444 2.5533 0.0 0
M  V30 21 C 0.9834 1.0218 0.0 0
M  V30 22 H 5.8651 4.4076 0.0 0
M  V30 23 H 4.8265 0.0057 0.0 0
M  V30 24 H 3.3939 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 8 1 CFG=3
M  V30 2 1 15 2 CFG=3
M  V30 3 1 3 18
M  V30 4 2 4 19
M  V30 5 2 5 20
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 6 22 CFG=1
M  V30 10 1 7 10
M  V30 11 1 7 11
M  V30 12 1 7 23 CFG=3
M  V30 13 1 8 12
M  V30 14 1 8 13
M  V30 15 1 9 14
M  V30 16 1 10 15
M  V30 17 1 10 16
M  V30 18 1 10 24 CFG=1
M  V30 19 1 11 17
M  V30 20 2 12 17
M  V30 21 1 12 18
M  V30 22 1 13 19
M  V30 23 1 14 15
M  V30 24 1 15 20
M  V30 25 1 16 21
M  V30 26 1 18 19
M  V30 27 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 6 7 8 10 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1315357-69-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1382475-16-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-8874385
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 1330-20-7
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Preparation of Compound (185a) To a solution of
2-((3aS,6R)-3a,6-dimethyl-3,7-dioxododecahydro-1H-cyclopenta[a]naphthalen-6-yl)acetic
acid (2.3 g, 7.9 imnol) in MeOH (50 mL), MeNH2 (11.5 mL) was added to the
mixture, heated to reflux for 2 h, then evaporated to remove MeOH and
MeNH2. The residue (2.4 g, 7.9 mmol) was dissolved in xylene (50 mL) and
the mixture was stirred at 140 °C for 2 h. Then cooled to room
temperature, the mixture was evaporated to remove xylene under the reduce
pressure. The crude product was purified by column chromatography
(petroleum ether/ethyl acetate/DCM =3/1/1, v/v/v) to give (185a). White
solid, yield 2.3 g, 92%. LC-MS (m/z): 288 [M+H]+. 1H NMR (CDCl3, 400 MHz)
peaks: δ (ppm) 0.92 (s, 3H), 1.14 (s, 3H), 2.92 (s, 3H), 4.74 (s, 1H).
$DTYPE RXN:VAR(1):NOTES
$DATUM xylenes used in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of steroidal CYP11B, CYP17, and/or CYP21 inhibitors for
treating androgen-dependent conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chu, Daniel; Wang, Bing; Ye, Tao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012083112 A2 2012-06-21

$RFMT $RIREG SCHEME185 STEP1
$RXN



  2  1
$MOL
2,6-Anhydro-4,5,7-trideoxy-1-O-[(1,1-dimethylethyl)diphenylsilyl]-3-O-methyl-...
C25H36O4Si
1318256-61-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 1
M  V30 BEGIN ATOM
M  V30 1 Si 4.6200 5.3349 0.0 0
M  V30 2 O 6.1600 5.3349 0.0 0
M  V30 3 C 4.6200 6.8749 0.0 0
M  V30 4 C 6.9300 4.0011 0.0 0
M  V30 5 C 3.0800 6.8749 0.0 0
M  V30 6 C 4.6200 8.4149 0.0 0
M  V30 7 C 6.1600 6.8749 0.0 0
M  V30 8 O 8.4700 1.3338 0.0 0
M  V30 9 C 9.2400 0.0000 0.0 0
M  V30 10 C 11.5500 6.6685 0.0 0
M  V30 11 C 13.0900 6.6685 0.0 0
M  V30 12 O 13.8600 8.0021 0.0 0
M  V30 13 C 3.0800 5.3349 0.0 0
M  V30 14 C 2.3100 6.6685 0.0 0
M  V30 15 C 2.3100 4.0011 0.0 0
M  V30 16 C 0.7700 6.6685 0.0 0
M  V30 17 C 0.7700 4.0011 0.0 0
M  V30 18 C 0.0000 5.3349 0.0 0
M  V30 19 C 4.6200 3.7949 0.0 0
M  V30 20 C 5.9536 3.0249 0.0 0
M  V30 21 C 3.2864 3.0249 0.0 0
M  V30 22 C 5.9536 1.4849 0.0 0
M  V30 23 C 3.2864 1.4849 0.0 0
M  V30 24 C 4.6200 0.7149 0.0 0
M  V30 25 C 8.4700 4.0011 0.0 0 CFG=2
M  V30 26 C 9.2400 2.6674 0.0 0 CFG=1
M  V30 27 O 9.2400 5.3349 0.0 0
M  V30 28 C 10.7800 2.6674 0.0 0
M  V30 29 C 10.7800 5.3349 0.0 0 CFG=1
M  V30 30 C 11.5500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 13
M  V30 4 1 1 19
M  V30 5 1 2 4
M  V30 6 1 3 5
M  V30 7 1 3 6
M  V30 8 1 3 7
M  V30 9 1 25 4 CFG=3
M  V30 10 1 8 9
M  V30 11 1 26 8 CFG=3
M  V30 12 1 10 11
M  V30 13 1 29 10 CFG=1
M  V30 14 1 11 12
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 27 1 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 25 26 29)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,6-Anhydro-4,5,7,8-tetradeoxy-1-O-[(1,1-dimethylethyl)diphenylsilyl]-3-O-met...
C26H39NO3Si
1318256-70-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 1
M  V30 BEGIN ATOM
M  V30 1 Si 4.6200 5.3349 0.0 0
M  V30 2 O 6.1600 5.3349 0.0 0
M  V30 3 C 4.6200 6.8749 0.0 0
M  V30 4 C 6.9300 4.0011 0.0 0
M  V30 5 C 3.0800 6.8749 0.0 0
M  V30 6 C 4.6200 8.4149 0.0 0
M  V30 7 C 6.1600 6.8749 0.0 0
M  V30 8 O 8.4700 1.3338 0.0 0
M  V30 9 C 9.2400 0.0000 0.0 0
M  V30 10 C 11.5500 6.6685 0.0 0
M  V30 11 C 13.0900 6.6685 0.0 0
M  V30 12 N 13.8600 8.0021 0.0 0
M  V30 13 C 15.4000 8.0021 0.0 0
M  V30 14 C 3.0800 5.3349 0.0 0
M  V30 15 C 2.3100 6.6685 0.0 0
M  V30 16 C 2.3100 4.0011 0.0 0
M  V30 17 C 0.7700 6.6685 0.0 0
M  V30 18 C 0.7700 4.0011 0.0 0
M  V30 19 C 0.0000 5.3349 0.0 0
M  V30 20 C 4.6200 3.7949 0.0 0
M  V30 21 C 5.9536 3.0249 0.0 0
M  V30 22 C 3.2864 3.0249 0.0 0
M  V30 23 C 5.9536 1.4849 0.0 0
M  V30 24 C 3.2864 1.4849 0.0 0
M  V30 25 C 4.6200 0.7149 0.0 0
M  V30 26 C 8.4700 4.0011 0.0 0 CFG=2
M  V30 27 C 9.2400 2.6674 0.0 0 CFG=1
M  V30 28 O 9.2400 5.3349 0.0 0
M  V30 29 C 10.7800 2.6674 0.0 0
M  V30 30 C 10.7800 5.3349 0.0 0 CFG=1
M  V30 31 C 11.5500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 14
M  V30 4 1 1 20
M  V30 5 1 2 4
M  V30 6 1 3 5
M  V30 7 1 3 6
M  V30 8 1 3 7
M  V30 9 1 26 4 CFG=3
M  V30 10 1 8 9
M  V30 11 1 27 8 CFG=3
M  V30 12 1 10 11
M  V30 13 1 30 10 CFG=1
M  V30 14 1 11 12
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 28 1 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 26 27 30)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1318256-61-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1318256-70-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-032-CAS-1949927
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 5
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 77-76-9
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7772-98-7
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Fragment-based domain shuffling approach for the synthesis of pyran-based
macrocyclic compounds
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Comer, Eamon; Liu, Haibo; Joliton, Adrien; Clabaut, Alexandre; Johnson,
Christopher; Akella, Lakshmi B.; Marcaurelle, Lisa A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Proceedings of the National Academy of Sciences of the United States of
America (2011), 108(17), 6751-6756, S6751/1-S6751/60

$RFMT $RIREG SCHEME186 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N2-[(1,1-Dimethylethoxy)carbonyl]-N-(triphenylmethyl)-L-asparagine
C28H30N2O5
132388-68-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.6200 0.0 0
M  V30 2 N 6.1600 4.6200 0.0 0
M  V30 3 C 6.9300 5.9538 0.0 0
M  V30 4 C 8.4700 5.9538 0.0 0
M  V30 5 O 6.1600 7.2874 0.0 0
M  V30 6 C 9.2400 7.2874 0.0 0 CFG=1
M  V30 7 N 10.7800 7.2874 0.0 0
M  V30 8 C 8.4700 8.6211 0.0 0
M  V30 9 C 11.5500 5.9538 0.0 0
M  V30 10 O 6.9300 8.6211 0.0 0
M  V30 11 O 9.2400 9.9549 0.0 0
M  V30 12 O 13.0900 5.9538 0.0 0
M  V30 13 O 10.7800 4.6200 0.0 0
M  V30 14 C 13.8600 4.6200 0.0 0
M  V30 15 C 12.5264 3.8500 0.0 0
M  V30 16 C 14.6300 3.2864 0.0 0
M  V30 17 C 15.1936 5.3900 0.0 0
M  V30 18 C 4.2214 6.1076 0.0 0
M  V30 19 C 5.3104 7.1966 0.0 0
M  V30 20 C 2.7338 6.5062 0.0 0
M  V30 21 C 4.9118 8.6841 0.0 0
M  V30 22 C 2.3353 7.9937 0.0 0
M  V30 23 C 3.4242 9.0826 0.0 0
M  V30 24 C 3.0800 4.6200 0.0 0
M  V30 25 C 2.3100 3.2864 0.0 0
M  V30 26 C 2.3100 5.9538 0.0 0
M  V30 27 C 0.7700 3.2864 0.0 0
M  V30 28 C 0.7700 5.9538 0.0 0
M  V30 29 C 0.0000 4.6200 0.0 0
M  V30 30 C 4.6200 3.0800 0.0 0
M  V30 31 C 5.9536 2.3100 0.0 0
M  V30 32 C 3.2864 2.3100 0.0 0
M  V30 33 C 5.9536 0.7700 0.0 0
M  V30 34 C 3.2864 0.7700 0.0 0
M  V30 35 C 4.6200 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 1 24
M  V30 4 1 1 30
M  V30 5 1 2 3
M  V30 6 1 3 4
M  V30 7 2 3 5
M  V30 8 1 4 6
M  V30 9 1 6 7 CFG=1
M  V30 10 1 6 8
M  V30 11 1 7 9
M  V30 12 1 8 10
M  V30 13 2 8 11
M  V30 14 1 9 12
M  V30 15 2 9 13
M  V30 16 1 12 14
M  V30 17 1 14 15
M  V30 18 1 14 16
M  V30 19 1 14 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Carbamic acid, [(1S)-1-[(methylamino)carbonyl]-3-oxo-3-[(triphenylmethyl)amin...
C29H33N3O4
424833-81-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 38 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 6.6685 0.0 0
M  V30 2 N 6.1600 6.6685 0.0 0
M  V30 3 C 6.9300 5.3347 0.0 0
M  V30 4 C 8.4700 5.3347 0.0 0
M  V30 5 O 6.1600 4.0011 0.0 0
M  V30 6 C 9.2400 4.0011 0.0 0 CFG=1
M  V30 7 N 10.7800 4.0011 0.0 0
M  V30 8 C 8.4700 2.6674 0.0 0
M  V30 9 C 11.5500 5.3347 0.0 0
M  V30 10 N 9.2400 1.3338 0.0 0
M  V30 11 O 6.9300 2.6674 0.0 0
M  V30 12 O 13.0900 5.3347 0.0 0
M  V30 13 O 10.7800 6.6685 0.0 0
M  V30 14 C 8.4700 0.0000 0.0 0
M  V30 15 C 13.8600 6.6685 0.0 0
M  V30 16 C 15.1936 5.8985 0.0 0
M  V30 17 C 14.6300 8.0021 0.0 0
M  V30 18 C 12.5264 7.4385 0.0 0
M  V30 19 C 4.2214 5.1809 0.0 0
M  V30 20 C 5.3104 4.0919 0.0 0
M  V30 21 C 2.7338 4.7823 0.0 0
M  V30 22 C 4.9118 2.6044 0.0 0
M  V30 23 C 2.3353 3.2948 0.0 0
M  V30 24 C 3.4242 2.2059 0.0 0
M  V30 25 C 3.0800 6.6685 0.0 0
M  V30 26 C 2.3100 8.0021 0.0 0
M  V30 27 C 2.3100 5.3347 0.0 0
M  V30 28 C 0.7700 8.0021 0.0 0
M  V30 29 C 0.7700 5.3347 0.0 0
M  V30 30 C 0.0000 6.6685 0.0 0
M  V30 31 C 4.6200 8.2085 0.0 0
M  V30 32 C 3.2864 8.9785 0.0 0
M  V30 33 C 5.9536 8.9785 0.0 0
M  V30 34 C 3.2864 10.5185 0.0 0
M  V30 35 C 5.9536 10.5185 0.0 0
M  V30 36 C 4.6200 11.2885 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 19
M  V30 3 1 1 25
M  V30 4 1 1 31
M  V30 5 1 2 3
M  V30 6 1 3 4
M  V30 7 2 3 5
M  V30 8 1 4 6
M  V30 9 1 6 7 CFG=3
M  V30 10 1 6 8
M  V30 11 1 7 9
M  V30 12 1 8 10
M  V30 13 2 8 11
M  V30 14 1 9 12
M  V30 15 2 9 13
M  V30 16 1 10 14
M  V30 17 1 12 15
M  V30 18 1 15 16
M  V30 19 1 15 17
M  V30 20 1 15 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 33 2 31 32
M  V30 34 1 31 33
M  V30 35 1 32 34
M  V30 36 2 33 35
M  V30 37 2 34 36
M  V30 38 1 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 132388-68-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 424833-81-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-10916083
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1892-57-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Conformational investigations on glycosylated asparagine-oligopeptides of
increasing chain length
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Biondi, Laura; Filira, Fernando; Gobbo, Marina; Rocchi, Raniero
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Peptide Science (2002), 8(2), 80-92

$RFMT $RIREG SCHEME187 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-(1-methylethyl)-4-thiazolecarboxylate
C9H13NO2S
133047-44-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.2079 1.5400 0.0 0
M  V30 2 O 7.5415 2.3101 0.0 0
M  V30 3 O 6.2079 0.0000 0.0 0
M  V30 4 C 8.8752 1.5400 0.0 0
M  V30 5 C 10.2089 2.3101 0.0 0
M  V30 6 C 0.9051 2.6672 0.0 0
M  V30 7 C 0.0000 3.9131 0.0 0
M  V30 8 C 0.2787 1.2602 0.0 0
M  V30 9 C 4.8741 2.3101 0.0 0
M  V30 10 N 3.4672 1.6836 0.0 0
M  V30 11 C 4.7131 3.8416 0.0 0
M  V30 12 C 2.4368 2.8281 0.0 0
M  V30 13 S 3.2068 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 12
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2-(1-methylethyl)-4-thiazolecarboxamide
C8H12N2OS
619330-29-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.2079 1.5400 0.0 0
M  V30 2 N 7.5415 2.3100 0.0 0
M  V30 3 O 6.2079 0.0000 0.0 0
M  V30 4 C 8.8752 1.5400 0.0 0
M  V30 5 C 0.9052 2.6672 0.0 0
M  V30 6 C 0.2787 1.2602 0.0 0
M  V30 7 C 0.0000 3.9131 0.0 0
M  V30 8 C 4.8742 2.3100 0.0 0
M  V30 9 N 3.4672 1.6836 0.0 0
M  V30 10 C 4.7131 3.8416 0.0 0
M  V30 11 C 2.4368 2.8281 0.0 0
M  V30 12 S 3.2068 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 11
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 133047-44-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 619330-29-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-6733587
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 2-isopropyl-N-methyl-1,3-thiazole-4-carboxamide (18). Thiazolester 7 (4.8
g, 24.1 mmol) was diluted in MeNH2 2.5M in MeOH (50 mL) and stirred for a
12 h period time and concentrated under reduced pressure. The crude
yellow oil was purified by column chromatography on silica gel; (35-50%
EtOAc/hexanes) to afforded amide 18 (4.1g, 92%) as a pale yellow oil. Rf
0.26 (35% EtOAc/hexanes); 1H NMR (300 MHz, CDCl3) δ 7.95 (s, 1H, CHS),
7.34 (br, 1H, NHMe), 3.27 (sept, J= 6.9 Hz, 1H, CH (CH3)2, 3.00 (d, J =
4.1 Hz, 3H, NHCH3), 1.40 (d, J= 6.9 Hz, 6H, (CH3)2); 13C NMR (75 MHz,
CDCl3) δ 177.8, 161.9, 149.3, 121.6, 33.1, 25.9, 22.9; IR (film) ν
3333,2965, 2932, 1649, 1545, 1493, 1408, 1248 cm-1; HRMS (MAB) calcd for
C8H12N2OS [M]+ : 184.0670, Found: 184.0677.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Total Synthesis of (+)-Cystothiazole A
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM DeRoy, Patrick L.; Charette, Andre B.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2003), 5(22), 4163-4165

$RFMT $RIREG SCHEME188 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromo-3-(2,5-dimethyl-1H-pyrrol-1-yl)-5-(trifluoromethyl)-2-pyridinecarboxy...
C13H10BrF3N2O2
1334547-16-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.4258 1.3957 0.0 0
M  V30 2 O 3.0766 0.0000 0.0 0
M  V30 3 O 0.8917 1.5299 0.0 0
M  V30 4 C 0.0000 3.6731 0.0 0
M  V30 5 C 3.8333 7.5063 0.0 0
M  V30 6 C 7.3101 4.9672 0.0 0
M  V30 7 F 8.0801 3.6335 0.0 0
M  V30 8 F 8.6438 5.7372 0.0 0
M  V30 9 F 6.5401 6.3010 0.0 0
M  V30 10 Br 7.3101 1.8871 0.0 0
M  V30 11 C 3.3090 4.1972 0.0 0
M  V30 12 C 3.3090 2.6571 0.0 0
M  V30 13 C 4.6428 4.9672 0.0 0
M  V30 14 N 4.6428 1.8871 0.0 0
M  V30 15 C 5.9765 4.1972 0.0 0
M  V30 16 C 5.9765 2.6571 0.0 0
M  V30 17 N 2.2201 5.2861 0.0 0
M  V30 18 C 0.6990 5.0452 0.0 0
M  V30 19 C 2.4611 6.8072 0.0 0
M  V30 20 C 0.0000 6.4174 0.0 0
M  V30 21 C 1.0889 7.5063 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 4 18
M  V30 5 1 5 19
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 6 15
M  V30 10 1 10 16
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 11 17
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(2,5-Dimethyl-1H-pyrrol-1-yl)-6-(methylamino)-5-(trifluoromethyl)-2-pyridin...
C14H14F3N3O2
2786825-28-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.7543 0.8832 0.0 0
M  V30 2 O 3.4927 0.0000 0.0 0
M  V30 3 O 6.1500 0.2324 0.0 0
M  V30 4 C 7.9938 1.6426 0.0 0
M  V30 5 C 6.5907 6.8789 0.0 0
M  V30 6 C 2.3100 6.4184 0.0 0
M  V30 7 F 0.9764 5.6484 0.0 0
M  V30 8 F 1.5400 7.7521 0.0 0
M  V30 9 F 3.6438 7.1884 0.0 0
M  V30 10 N 0.7700 3.7511 0.0 0
M  V30 11 C 0.0000 2.4173 0.0 0
M  V30 12 C 5.3900 3.7511 0.0 0
M  V30 13 C 4.6200 2.4173 0.0 0
M  V30 14 C 4.6200 5.0848 0.0 0
M  V30 15 N 3.0800 2.4173 0.0 0
M  V30 16 C 3.0800 5.0848 0.0 0
M  V30 17 C 2.3100 3.7511 0.0 0
M  V30 18 N 6.8776 4.1497 0.0 0
M  V30 19 C 8.0744 3.1806 0.0 0
M  V30 20 C 7.4294 5.5874 0.0 0
M  V30 21 C 9.3660 4.0192 0.0 0
M  V30 22 C 8.9674 5.5067 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 4 19
M  V30 5 1 5 20
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 6 16
M  V30 10 1 10 11
M  V30 11 1 10 17
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 12 18
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1334547-16-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2786825-28-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-32518670
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of Icenticaftor (QBW251), a Cystic Fibrosis Transmembrane
Conductance Regulator Potentiator with Clinical Efficacy in Cystic
Fibrosis and Chronic Obstructive Pulmonary Disease
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Grand, Darren Le; Gosling, Martin; Baettig, Urs; Bahra, Parmjit; Bala,
Kamlesh; Brocklehurst, Cara; Budd, Emma; Butler, Rebecca; Cheung, Atwood
K.; Choudhury, Hedaythul; Collingwood, Stephen P.; Cox, Brian; Danahay,
Henry; Edwards, Lee; Everatt, Brian; Glaenzel, Ulrike; Glotin, Anne-Lise;
Groot-Kormelink, Paul; Hall, Edward; Hatto, Julia; Howsham, Catherine;
Hughes, Glyn; King, Anna; Koehler, Julia; Kulkarni, Swarupa; Lightfoot,
Megan; Nicholls, Ian; Page, Christopher; Pergl-Wilson, Giles; Popa,
Mariana Oana; Robinson, Richard; Rowlands, David; Sharp, Tom; Spendiff,
Matthew; Stanley, Emily; Steward, Oliver; Taylor, Roger J.; Tranter,
Pamela; Wagner, Trixie; Watson, Hazel; Williams, Gareth; Wright, Penny;
Young, Alice; Sandham, David A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2021), 64(11), 7241-7260

$RFMT $RIREG SCHEME189 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Methyl-1H-indole-4-carboxaldehyde
C10H9NO
133994-99-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6520 3.0801 0.0 0
M  V30 2 O 7.9857 2.3101 0.0 0
M  V30 3 C 0.0000 3.0203 0.0 0
M  V30 4 C 3.9845 3.0801 0.0 0
M  V30 5 C 2.6509 2.3101 0.0 0
M  V30 6 C 5.3182 2.3101 0.0 0
M  V30 7 C 3.6644 4.5864 0.0 0
M  V30 8 N 1.5065 3.3405 0.0 0
M  V30 9 C 2.6509 0.7700 0.0 0
M  V30 10 C 5.3182 0.7700 0.0 0
M  V30 11 C 2.1328 4.7473 0.0 0
M  V30 12 C 3.9845 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 1 3 8
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,1-Dimethyl-1H-indole-4-methanamine
C11H14N2
864068-94-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6520 3.0801 0.0 0
M  V30 2 N 7.9857 2.3101 0.0 0
M  V30 3 C 9.3194 3.0801 0.0 0
M  V30 4 C 0.0000 3.0203 0.0 0
M  V30 5 C 3.9845 3.0801 0.0 0
M  V30 6 C 2.6509 2.3101 0.0 0
M  V30 7 C 5.3182 2.3101 0.0 0
M  V30 8 C 3.6644 4.5864 0.0 0
M  V30 9 N 1.5063 3.3405 0.0 0
M  V30 10 C 2.6509 0.7700 0.0 0
M  V30 11 C 5.3182 0.7700 0.0 0
M  V30 12 C 2.1328 4.7473 0.0 0
M  V30 13 C 3.9845 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 4 9
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 2 8 12
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 2 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 133994-99-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 864068-94-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-11616530
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM b) N-methyl(1-methyl-1H-indol-4-yl)methanamine [1462]
1-Methyl-1H-indole-4-carbaldehyde (427 mg, 2.68 mmol) was dissolved in
anhydrous methanol (12 mL). Methylamine (1.07 mL of 33% solution in
ethanol, 8.59 mmol) was added and the reaction was stirred for 3 h. The
solution was concentrated to a yellow oil and then dissolved in anhydrous
methanol (12 mL). Sodium borohydride (104 mg, 2.74 mmol) was added and
the mixture was stirred overnight at room temperature. Water (10 mL) was
added and the solution was concentrated. Sodium hydroxide (20 mL, 1N) was
added and the aqueous layer was extracted with ethyl acetate (3×30 mL).
Combined organic layers were dried over Na2SO4, filtered and concentrated
to afford N-methyl(1-methyl-1H-indol-4-yl)methanamine (432 mg, 92%) as a
yellow oil. 1H NMR (400 MHz, DMSO-d6) δ 7.29-7.26 (m, 2H), 7.10-7.06 (m,
1H), 7.00-6.98 (m, 1H), 6.51 (d, J=3.2 Hz, 1H), 3.87 (s, 2H), 3.76 (s,
3H), 2.29 (s, 3H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20060142265 A1 2006-06-29

$RFMT $RIREG SCHEME189 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Methyl-1H-indole-4-carboxaldehyde
C10H9NO
133994-99-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6520 3.0801 0.0 0
M  V30 2 O 7.9857 2.3101 0.0 0
M  V30 3 C 0.0000 3.0203 0.0 0
M  V30 4 C 3.9845 3.0801 0.0 0
M  V30 5 C 2.6509 2.3101 0.0 0
M  V30 6 C 5.3182 2.3101 0.0 0
M  V30 7 C 3.6644 4.5864 0.0 0
M  V30 8 N 1.5065 3.3405 0.0 0
M  V30 9 C 2.6509 0.7700 0.0 0
M  V30 10 C 5.3182 0.7700 0.0 0
M  V30 11 C 2.1328 4.7473 0.0 0
M  V30 12 C 3.9845 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 1 3 8
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,1-Dimethyl-1H-indole-4-methanamine
C11H14N2
864068-94-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6520 3.0801 0.0 0
M  V30 2 N 7.9857 2.3101 0.0 0
M  V30 3 C 9.3194 3.0801 0.0 0
M  V30 4 C 0.0000 3.0203 0.0 0
M  V30 5 C 3.9845 3.0801 0.0 0
M  V30 6 C 2.6509 2.3101 0.0 0
M  V30 7 C 5.3182 2.3101 0.0 0
M  V30 8 C 3.6644 4.5864 0.0 0
M  V30 9 N 1.5063 3.3405 0.0 0
M  V30 10 C 2.6509 0.7700 0.0 0
M  V30 11 C 5.3182 0.7700 0.0 0
M  V30 12 C 2.1328 4.7473 0.0 0
M  V30 13 C 3.9845 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 4 9
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 2 8 12
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 2 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 133994-99-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 864068-94-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-2968551
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM b) N-methyl(1-methyl-1H-indol-4-yl)methanamine
1-Methyl-1H-indole-4-carbaldehyde (427 mg, 2.68 mmol) was dissolved in
anhydrous methanol (12 mL). Methylamine (1.07 mL of 33% solution in
ethanol, 8.59 mmol) was added and the reaction was stirred for 3 h. The
solution was concentrated to a yellow oil and then dissolved in anhydrous
methanol (12 mL). Sodium borohydride (104 mg, 2.74 mmol) was added and
the mixture was stirred overnight at room temperature. Water (10 mL) was
added and the solution was concentrated. Sodium hydroxide (20 mL, 1N) was
added and the aqueous layer was extracted with ethyl acetate (3×30 mL).
Combined organic layers were dried over Na2SO4, filtered and concentrated
to afford N-methyl(1-methyl-1H-indol-4-yl)methanamine (432 mg, 92%) as a
yellow oil: 1H NMR (400 MHz, DMSO-d 6) δ 7.29-7.26 (m, 2H), 7.10-7.06 (m,
1H), 7.00-6.98 (m, 1H), 6.51 (d, J = 3.2 Hz, 1H), 3.87 (s, 2H), 3.76 (s,
3H), 2.29 (s, 3H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocyclyl acrylamide compounds as FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Manning, David Douglas; Decornez, Helene Yvonne; Surman, Matthew David;
Martin, Fernando J. L.; Ramnauth, Jailall; Toro, Andras; Berman, Judd M.;
Sampson, Peter; Pauls, Henry; Sargent, Bruce Jeremy
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Canada, CA2568914 A1 2005-12-04

$RFMT $RIREG SCHEME190 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 6,7,8-trifluoro-4-hydroxy-2-oxo-2H-1-benzopyran-3-carboxylate
C12H7F3O5
1347761-35-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 6.1601 0.0 0
M  V30 2 F 2.6673 0.0000 0.0 0
M  V30 3 C 8.0022 4.6201 0.0 0
M  V30 4 O 9.3360 3.8501 0.0 0
M  V30 5 O 8.0022 6.1601 0.0 0
M  V30 6 C 10.6697 4.6201 0.0 0
M  V30 7 C 12.0033 3.8501 0.0 0
M  V30 8 F 0.0000 4.6201 0.0 0
M  V30 9 O 8.0022 1.5400 0.0 0
M  V30 10 F 0.0000 1.5400 0.0 0
M  V30 11 C 4.0012 3.8501 0.0 0
M  V30 12 C 4.0012 2.3101 0.0 0
M  V30 13 C 5.3348 4.6201 0.0 0
M  V30 14 C 2.6673 4.6201 0.0 0
M  V30 15 O 5.3348 1.5400 0.0 0
M  V30 16 C 2.6673 1.5400 0.0 0
M  V30 17 C 6.6685 3.8501 0.0 0
M  V30 18 C 1.3337 3.8501 0.0 0
M  V30 19 C 6.6685 2.3101 0.0 0
M  V30 20 C 1.3337 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 2 16
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 17
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 8 18
M  V30 9 2 9 19
M  V30 10 1 10 20
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 2 11 14
M  V30 14 1 12 15
M  V30 15 2 12 16
M  V30 16 2 13 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2H-1-Benzopyran-3-carboxylic acid, 6,7,8-trifluoro-4-hydroxy-2-oxo-, ethyl es...
C12H7F3O5.CH5N
1566585-81-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 7.7001 0.0 0
M  V30 2 F 2.6673 1.5400 0.0 0
M  V30 3 C 8.0022 6.1601 0.0 0
M  V30 4 O 9.3360 5.3901 0.0 0
M  V30 5 O 8.0022 7.7001 0.0 0
M  V30 6 C 10.6697 6.1601 0.0 0
M  V30 7 C 12.0033 5.3901 0.0 0
M  V30 8 F 0.0000 6.1601 0.0 0
M  V30 9 O 8.0022 3.0800 0.0 0
M  V30 10 F 0.0000 3.0800 0.0 0
M  V30 11 C 4.0012 5.3901 0.0 0
M  V30 12 C 4.0012 3.8501 0.0 0
M  V30 13 C 5.3348 6.1601 0.0 0
M  V30 14 C 2.6673 6.1601 0.0 0
M  V30 15 O 5.3348 3.0800 0.0 0
M  V30 16 C 2.6673 3.0800 0.0 0
M  V30 17 C 6.6685 5.3901 0.0 0
M  V30 18 C 1.3337 5.3901 0.0 0
M  V30 19 C 6.6685 3.8501 0.0 0
M  V30 20 C 1.3337 3.8501 0.0 0
M  V30 21 C 5.2317 0.0000 0.0 0
M  V30 22 N 6.7717 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 2 16
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 17
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 8 18
M  V30 9 2 9 19
M  V30 10 1 10 20
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 2 11 14
M  V30 14 1 12 15
M  V30 15 2 12 16
M  V30 16 2 13 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1347761-35-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1566585-81-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25460750
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Ammonium
polyfluoro-3-(ethoxycarbonyl)-2-oxo-2H-chromen-4-olates IIIa-IIIe
(general proce- dure). Coumarin Ia-Ic, 1 mmol, was dissolved in 20 mL of
ethanol, 1 mmol of the corresponding amine was added, and the mixture was
stirred for 25°C until the reaction was complete (TLC). The solvent was
removed, and the solid residue was recrystallized from appropriate
solvent. Methylammonium
3-(ethoxycarbonyl)-6,7,8-tri-fluoro-2-oxo-2H-chromen-4-olate (IIIa).
Yield: 92%, yellow powder. mp >350°C (from Et2O). IR spectrum, ν, cm-1:
3084, 2985 (CH, H3N+), 1707 (C2═O), 1664, 1647 (C═O, ester), 1575, 1521,
1449, 1412 (C═C), 1050, 1030, 996 (C-F). 1H NMR spectrum, δ, ppm: 1.20 t
(3H, CH2CH3, J = 7.1 Hz), 2.38 s (3H, NCH3), 4.07 q (2H, CH2CH3, J = 7.1
Hz), 7.50 d.d.d (1H, 5-H, J = 10.7, 8.6, 2.2 Hz). 19F NMR spectrum, δF,
ppm: 5.54 m, 7.79 m, 19.47 m (1F each). Found, %: C 49.75; H 4.10; F
17.74; N 4.09. C13H12F3NO5. Calculated, %: C 48.91; H 3.79; F 17.85; N
4.39.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and anticorrosive properties of alkylammonium
polyfluoro-3-(ethoxycarbonyl)-2-oxo-2h-chromen-4-olates
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shcherbakov, K. V.; Gorbunova, T. I.; Burgart, Ya. V.; Saloutin, V. I.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Russian Journal of Organic Chemistry (2014), 50(1), 66-71

$RFMT $RIREG SCHEME191 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzil
C14H10O2
134-81-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 C 5.3901 1.3337 0.0 0
M  V30 3 O 5.3901 4.0010 0.0 0
M  V30 4 O 4.6201 0.0000 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 2.3101 4.0010 0.0 0
M  V30 7 C 2.3101 1.3337 0.0 0
M  V30 8 C 0.7700 4.0010 0.0 0
M  V30 9 C 0.7700 1.3337 0.0 0
M  V30 10 C 0.0000 2.6673 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 12 C 7.7002 2.6673 0.0 0
M  V30 13 C 7.7002 0.0000 0.0 0
M  V30 14 C 9.2402 2.6673 0.0 0
M  V30 15 C 9.2402 0.0000 0.0 0
M  V30 16 C 10.0102 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 2 2 4
M  V30 5 1 2 11
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromobenzaldehyde
C7H5BrO
6630-33-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 O 5.3901 4.0010 0.0 0
M  V30 3 Br 3.0801 0.0000 0.0 0
M  V30 4 C 3.0801 2.6673 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 2.3101 4.0010 0.0 0
M  V30 7 C 0.7700 1.3337 0.0 0
M  V30 8 C 0.7700 4.0010 0.0 0
M  V30 9 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 5
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(2-Bromophenyl)-1-methyl-4,5-diphenyl-1H-imidazole
C22H17BrN2
300657-96-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3051 8.2051 0.0 0
M  V30 2 Br 9.6995 4.5323 0.0 0
M  V30 3 C 5.3648 4.2206 0.0 0
M  V30 4 C 4.5948 5.5542 0.0 0
M  V30 5 N 6.8713 4.5408 0.0 0
M  V30 6 N 5.6252 6.6988 0.0 0
M  V30 7 C 7.0322 6.0723 0.0 0
M  V30 8 C 4.7385 2.8138 0.0 0
M  V30 9 C 3.2068 2.6527 0.0 0
M  V30 10 C 5.6437 1.5677 0.0 0
M  V30 11 C 2.5805 1.2459 0.0 0
M  V30 12 C 5.0172 0.1609 0.0 0
M  V30 13 C 3.4857 0.0000 0.0 0
M  V30 14 C 3.0633 5.7153 0.0 0
M  V30 15 C 2.4368 7.1221 0.0 0
M  V30 16 C 2.1580 4.4693 0.0 0
M  V30 17 C 0.9052 7.2831 0.0 0
M  V30 18 C 0.6265 4.6304 0.0 0
M  V30 19 C 0.0000 6.0372 0.0 0
M  V30 20 C 8.3659 6.8423 0.0 0
M  V30 21 C 9.6995 6.0723 0.0 0
M  V30 22 C 8.3659 8.3823 0.0 0
M  V30 23 C 11.0333 6.8423 0.0 0
M  V30 24 C 9.6995 9.1524 0.0 0
M  V30 25 C 11.0333 8.3823 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 2 21
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 8
M  V30 6 1 4 6
M  V30 7 1 4 14
M  V30 8 2 5 7
M  V30 9 1 6 7
M  V30 10 1 7 20
M  V30 11 2 8 9
M  V30 12 1 8 10
M  V30 13 1 9 11
M  V30 14 2 10 12
M  V30 15 2 11 13
M  V30 16 1 12 13
M  V30 17 2 14 15
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 2 16 18
M  V30 21 2 17 19
M  V30 22 1 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 134-81-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 6630-33-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 300657-96-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-17274428
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 631-61-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1306-38-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM catalyst prepared and used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and biological evaluation of 1,2,4,5-tetrasubstituted
imidazoles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fang, Yue; Yuan, Rui; Ge, Wen-hui; Wang, Yuan-jiang; Liu, Gui-xiang; Li,
Ming-qi; Xu, Jiang-biao; Wan, Yu; Zhou, Sheng-liang; Han, Xi-guang;
Zhang, Peng; Liu, Jin-juan; Wu, Hui
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Research on Chemical Intermediates (2017), 43(8), 4413-4421

$RFMT $RIREG SCHEME192 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzil
C14H10O2
134-81-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 C 5.3901 1.3337 0.0 0
M  V30 3 O 5.3901 4.0010 0.0 0
M  V30 4 O 4.6201 0.0000 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 2.3101 4.0010 0.0 0
M  V30 7 C 2.3101 1.3337 0.0 0
M  V30 8 C 0.7700 4.0010 0.0 0
M  V30 9 C 0.7700 1.3337 0.0 0
M  V30 10 C 0.0000 2.6673 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 12 C 7.7002 2.6673 0.0 0
M  V30 13 C 7.7002 0.0000 0.0 0
M  V30 14 C 9.2402 2.6673 0.0 0
M  V30 15 C 9.2402 0.0000 0.0 0
M  V30 16 C 10.0102 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 2 2 4
M  V30 5 1 2 11
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2Z)-2-(Methylimino)-1,2-diphenylethanone
C15H13NO
1471388-23-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3901 2.6673 0.0 0
M  V30 2 C 4.6201 1.3337 0.0 0
M  V30 3 N 4.6201 4.0010 0.0 0
M  V30 4 O 5.3901 0.0000 0.0 0
M  V30 5 C 3.0801 4.0010 0.0 0
M  V30 6 C 6.9302 2.6673 0.0 0
M  V30 7 C 7.7002 4.0010 0.0 0
M  V30 8 C 7.7002 1.3337 0.0 0
M  V30 9 C 9.2402 4.0010 0.0 0
M  V30 10 C 9.2402 1.3337 0.0 0
M  V30 11 C 10.0102 2.6673 0.0 0
M  V30 12 C 3.0801 1.3337 0.0 0
M  V30 13 C 2.3101 2.6673 0.0 0
M  V30 14 C 2.3101 0.0000 0.0 0
M  V30 15 C 0.7700 2.6673 0.0 0
M  V30 16 C 0.7700 0.0000 0.0 0
M  V30 17 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 2 2 4
M  V30 5 1 2 12
M  V30 6 1 3 5
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 134-81-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1471388-23-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-19734
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (Z)-2-(methylimino)-1,2-diphenylethanone (3) A 12-L four-neck
round-bottom flask was charged with benzil (600 g, 2.85 mol, 1.00 equiv)
and methanol (2.85 L) and the reaction vessel was immersed in an oil bath
at 23 ºC. One neck of the flask was equipped with a mechanical stirrer,
while the remaining necks of the flask were equipped with a thermometer,
a wide-mouth funnel, and a loose-fitting polyethylene cap, respectively.
The mechanical stirrer was set to stir at 180 rpm, producing a bright
yellow slurry. Methylamine solution (40 wt% in water, 741 mL, 8.56 mol,
3.00 equiv) was added to the slurry, which became dark orange in color.
The funnel was then replaced with a loose-fitting polyethylene cap, and
the mixture was warmed to 50 ºC. Prior to reaching the desired
temperature, all of the solid material dissolved to give a clear, orange
solution. Once the internal temperature of the solution reached 50 ºC,
the flask was removed from the oil bath, and the reaction solution was
transferred to a 4-L Erlenmeyer flask to cool. As the solution cooled,
the product began to crystallize. Once the temperature of the mother
liquor dropped below 30 ºC, the crystalline product was collected in a
large Büchner funnel. The collected off-white crystals were then washed
twice with water. Additional crystalline product formed in the filtrate,
and these crystals were collected separately and washed with water.
Formation of crystalline product in the filtrate was once again noted,
and the filtration process was repeated thrice more until no additional
crystalline product was observed in the filtrate. The solids were dried
via suction for three hours before being transferred to three round
bottom flasks (3-L and two 1-L flasks) and further dried under reduced
pressure (<1 torr, 72 h) to remove any remaining water. The crystalline
imine 3 (582 g, 91%.) thus obtained was used in subsequent reactions
without further purification. TLC (20% ethyl acetate-hexanes): Rf = 0.54
(UV, KMnO4). 1H NMR (500 MHz, CDCl3), δ: 7.95 - 7.88 (m, 2H), 7.73-7.66
(m, 2H), 7.67-7.57 (m, 1H), 7.53-7.44 (m, 2H), 7.46-7.31 (m, 3H), 3.35
(s, 3H). 13C NMR (125 MHz, CDCl3), δ: 198.96, 198.96, 168.08, 168.08,
135.16, 135.16, 134.62, 134.62, 134.51, 134.51, 130.77, 130.77, 129.25,
129.25, 129.08, 129.08, 128.59, 128.59, 127.04, 127.04, 41.01, 41.01.
FTIR (neat), cm-1: 3061 (w), 1670 (s), 1629 (m), 1446 (m), 1223 (s). HRMS
(ESI): Calcd for (C15H13NO + Na)+: 246.0889. Found: 246.0886. mp = 75-77
ºC
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, THF can also be used as a solvent, scalable
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A Simple, Scalable Synthetic Route to (+)- and (-)-Pseudoephenamine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mellem, Kevin T.; Myers, Andrew G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2013), 15(21), 5594-5597

$RFMT $RIREG SCHEME193 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-3-[5-[4-(bromomethyl)-2-methoxyphenyl]-1,3,4-oxadiazol-2-yl]-2-pyrazi...
C14H11Br2N5O2
1349733-83-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.8085 8.3108 0.0 0
M  V30 2 C 8.5785 9.6445 0.0 0
M  V30 3 C 12.4285 5.6435 0.0 0
M  V30 4 Br 13.1985 4.3097 0.0 0
M  V30 5 N 1.0849 6.1262 0.0 0
M  V30 6 Br 1.7288 0.0000 0.0 0
M  V30 7 C 6.2684 5.6435 0.0 0
M  V30 8 O 5.3632 4.3976 0.0 0
M  V30 9 N 5.3632 6.8894 0.0 0
M  V30 10 C 3.8987 4.8735 0.0 0
M  V30 11 N 3.8987 6.4135 0.0 0
M  V30 12 C 7.8085 5.6435 0.0 0
M  V30 13 C 8.5785 6.9772 0.0 0
M  V30 14 C 8.5785 4.3097 0.0 0
M  V30 15 C 10.1185 6.9772 0.0 0
M  V30 16 C 10.1185 4.3097 0.0 0
M  V30 17 C 10.8885 5.6435 0.0 0
M  V30 18 C 2.6528 3.9683 0.0 0
M  V30 19 C 1.2459 4.5946 0.0 0
M  V30 20 N 2.8137 2.4368 0.0 0
M  V30 21 N 0.0000 3.6894 0.0 0
M  V30 22 C 1.5679 1.5315 0.0 0
M  V30 23 C 0.1609 2.1579 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 3 4
M  V30 4 1 3 17
M  V30 5 1 5 19
M  V30 6 1 6 22
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 12
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 11
M  V30 13 1 10 18
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 20 1 18 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-3-[5-[2-methoxy-4-[(methylamino)methyl]phenyl]-1,3,4-oxadiazol-2-yl]-...
C15H15BrN6O2
1349734-25-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.8085 8.3108 0.0 0
M  V30 2 C 8.5785 9.6445 0.0 0
M  V30 3 C 12.4285 5.6435 0.0 0
M  V30 4 N 13.1985 4.3097 0.0 0
M  V30 5 C 14.7385 4.3097 0.0 0
M  V30 6 N 1.0849 6.1262 0.0 0
M  V30 7 Br 1.7288 0.0000 0.0 0
M  V30 8 C 6.2684 5.6435 0.0 0
M  V30 9 O 5.3632 4.3976 0.0 0
M  V30 10 N 5.3632 6.8894 0.0 0
M  V30 11 C 3.8987 4.8735 0.0 0
M  V30 12 N 3.8987 6.4135 0.0 0
M  V30 13 C 7.8085 5.6435 0.0 0
M  V30 14 C 8.5785 6.9772 0.0 0
M  V30 15 C 8.5785 4.3097 0.0 0
M  V30 16 C 10.1185 6.9772 0.0 0
M  V30 17 C 10.1185 4.3097 0.0 0
M  V30 18 C 10.8885 5.6435 0.0 0
M  V30 19 C 2.6528 3.9683 0.0 0
M  V30 20 C 1.2459 4.5946 0.0 0
M  V30 21 N 2.8137 2.4368 0.0 0
M  V30 22 N 0.0000 3.6894 0.0 0
M  V30 23 C 1.5679 1.5315 0.0 0
M  V30 24 C 0.1609 2.1579 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 3 4
M  V30 4 1 3 18
M  V30 5 1 4 5
M  V30 6 1 6 20
M  V30 7 1 7 23
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 13
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 12
M  V30 14 1 11 19
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 21 1 19 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1349733-83-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1349734-25-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-6149947
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 497-19-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 1: To a solution of
5-bromo-3-(5-(4-(bromomethyl)-2-methoxyphenyl)-1,3,4-oxadiazol-2-yl)pyrazin-2-amine
(5.0 g, 11.3 mmol) in THF (125 mL) was added sodium carbonate (3.6 g,
34.0 mmol) in one portion. Methylamine (28.3 ml, 2 M in methanol, 56.7
mmol) was then added dropwise over 10 min. The suspension was stirred for
30 min and then heated at 60 °C for 1 h. After cooling, the reaction
mixture was diluted with water and extracted with DCM. The combined
organics were washed with brine, dried over Na2SO4, filtered and
concentrated in vacuo. The solid was then triturated with ether to
provide 5-bromo-3-(5-(2-methoxy-4-((methylamino)methyl)
phenyl)-1,3,4-oxadiazol-2-yl)pyrazin-2-amine. Yield (4.1 g, 92%), light
yellow solid. LC/MS m/z 392.3 [M+H]+.
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrazine and pyridine compounds as ATR kinase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Charrier, Jean-Damien; Binch, Haley Marie; Hurley, Dennis James;
Cleveland, Thomas; Joshi, Pramod; Fanning, Lev Tyler Dewey; Pinder,
Joanne; O'Donnell, Michael; Virani, Anisa Nizarali; Knegtel, Ronald
Marcellus Alphonsus; Durrant, Steven John; Young, Stephen Clinton;
Pierre-Henri; Kay, David; Reaper, Philip Michael
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011143426 A1 2011-11-17

$RFMT $RIREG SCHEME194 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(2-Bromophenyl)-1-phenyl-1,3-pentanedione
C17H15BrO2
1358579-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 C 6.6685 1.5400 0.0 0
M  V30 4 C 8.0022 2.3101 0.0 0
M  V30 5 O 6.6685 0.0000 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 O 9.3360 0.0000 0.0 0
M  V30 8 Br 1.3337 0.0000 0.0 0
M  V30 9 C 2.6673 2.3101 0.0 0
M  V30 10 C 1.3337 1.5400 0.0 0
M  V30 11 C 2.6673 3.8501 0.0 0
M  V30 12 C 0.0000 2.3101 0.0 0
M  V30 13 C 1.3337 4.6201 0.0 0
M  V30 14 C 0.0000 3.8501 0.0 0
M  V30 15 C 10.6697 2.3101 0.0 0
M  V30 16 C 10.6697 3.8501 0.0 0
M  V30 17 C 12.0033 1.5400 0.0 0
M  V30 18 C 12.0033 4.6201 0.0 0
M  V30 19 C 13.3370 2.3101 0.0 0
M  V30 20 C 13.3370 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 2 6 7
M  V30 8 1 6 15
M  V30 9 1 8 10
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C18H18BrNO
2173253-80-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.3360 2.3101 0.0 0
M  V30 2 C 8.0022 3.0801 0.0 0
M  V30 3 O 9.3360 0.7700 0.0 0
M  V30 4 C 6.6685 2.3101 0.0 0
M  V30 5 C 5.3348 3.0801 0.0 0
M  V30 6 N 6.6685 0.7700 0.0 0
M  V30 7 C 4.0010 2.3101 0.0 0
M  V30 8 C 5.3348 0.0000 0.0 0
M  V30 9 Br 1.3337 0.7700 0.0 0
M  V30 10 C 10.6697 3.0801 0.0 0
M  V30 11 C 12.0033 2.3101 0.0 0
M  V30 12 C 10.6697 4.6201 0.0 0
M  V30 13 C 13.3370 3.0801 0.0 0
M  V30 14 C 12.0033 5.3901 0.0 0
M  V30 15 C 13.3370 4.6201 0.0 0
M  V30 16 C 2.6673 3.0801 0.0 0
M  V30 17 C 1.3337 2.3101 0.0 0
M  V30 18 C 2.6673 4.6201 0.0 0
M  V30 19 C 0.0000 3.0801 0.0 0
M  V30 20 C 1.3337 5.3901 0.0 0
M  V30 21 C 0.0000 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 2 2 4 CFG=2
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 16
M  V30 10 1 9 17
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1358579-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2173253-80-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-18703491
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of N-Substituted Condensed Tetrahydropyridine-Based Enaminones
via Palladium-Catalyzed Intramolecular C-N Cross-coupling
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dousova, Hana; Ruzickova, Zdenka; Simunek, Petr
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Heterocyclic Chemistry (2018), 55(3), 670-684

$RFMT $RIREG SCHEME195 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-2-(2-fluoroethoxy)-5-nitro-N-[trans-4-(trifluoromethyl)cyclohexyl]-3...
C15H16ClF4N3O4
1360702-40-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 6.6684 0.0 0
M  V30 2 N 6.9300 8.0021 0.0 0
M  V30 3 O 6.9300 5.3347 0.0 0
M  V30 4 O 4.6200 4.0011 0.0 0
M  V30 5 C 3.8500 2.6673 0.0 0
M  V30 6 C 4.6200 1.3336 0.0 0
M  V30 7 F 3.8500 0.0000 0.0 0
M  V30 8 N 1.5400 9.3358 0.0 0 VAL=5
M  V30 9 O 2.3100 10.6694 0.0 0
M  V30 10 O 0.0000 9.3358 0.0 0
M  V30 11 Cl 0.0000 6.6684 0.0 0
M  V30 12 C 13.0900 8.0021 0.0 0
M  V30 13 F 13.0900 6.4621 0.0 0
M  V30 14 F 14.6300 8.0021 0.0 0
M  V30 15 F 13.0900 9.5421 0.0 0
M  V30 16 C 4.6200 6.6684 0.0 0
M  V30 17 C 3.8500 5.3347 0.0 0
M  V30 18 C 3.8500 8.0021 0.0 0
M  V30 19 N 2.3100 5.3347 0.0 0
M  V30 20 C 2.3100 8.0021 0.0 0
M  V30 21 C 1.5400 6.6684 0.0 0
M  V30 22 C 8.4700 8.0021 0.0 0 CFG=1
M  V30 23 C 9.2400 6.6684 0.0 0
M  V30 24 C 9.2400 9.3358 0.0 0
M  V30 25 C 10.7800 6.6684 0.0 0
M  V30 26 C 10.7800 9.3358 0.0 0
M  V30 27 C 11.5500 8.0021 0.0 0 CFG=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 22 2 CFG=1
M  V30 5 1 4 5
M  V30 6 1 4 17
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 2 8 9
M  V30 10 2 8 10
M  V30 11 1 8 20
M  V30 12 1 11 21
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 12 15
M  V30 16 1 27 12 CFG=3
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 23 1 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 22 27)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
2-(2-Fluoroethoxy)-6-(methylamino)-5-nitro-N-[trans-4-(trifluoromethyl)cycloh...
C16H20F4N4O4
1360702-42-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 6.6684 0.0 0
M  V30 2 N 7.7000 8.0021 0.0 0
M  V30 3 O 7.7000 5.3347 0.0 0
M  V30 4 O 5.3900 4.0011 0.0 0
M  V30 5 C 4.6200 2.6673 0.0 0
M  V30 6 C 5.3900 1.3336 0.0 0
M  V30 7 F 4.6200 0.0000 0.0 0
M  V30 8 N 2.3100 9.3358 0.0 0 VAL=5
M  V30 9 O 0.7700 9.3358 0.0 0
M  V30 10 O 3.0800 10.6694 0.0 0
M  V30 11 N 0.7700 6.6684 0.0 0
M  V30 12 C 0.0000 5.3347 0.0 0
M  V30 13 C 13.8600 8.0021 0.0 0
M  V30 14 F 13.8600 6.4621 0.0 0
M  V30 15 F 15.4000 8.0021 0.0 0
M  V30 16 F 13.8600 9.5421 0.0 0
M  V30 17 C 5.3900 6.6684 0.0 0
M  V30 18 C 4.6200 5.3347 0.0 0
M  V30 19 C 4.6200 8.0021 0.0 0
M  V30 20 N 3.0800 5.3347 0.0 0
M  V30 21 C 3.0800 8.0021 0.0 0
M  V30 22 C 2.3100 6.6684 0.0 0
M  V30 23 C 9.2400 8.0021 0.0 0 CFG=1
M  V30 24 C 10.0100 6.6684 0.0 0
M  V30 25 C 10.0100 9.3358 0.0 0
M  V30 26 C 11.5500 6.6684 0.0 0
M  V30 27 C 11.5500 9.3358 0.0 0
M  V30 28 C 12.3200 8.0021 0.0 0 CFG=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 23 2 CFG=1
M  V30 5 1 4 5
M  V30 6 1 4 18
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 2 8 9
M  V30 10 2 8 10
M  V30 11 1 8 21
M  V30 12 1 11 12
M  V30 13 1 11 22
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 13 16
M  V30 17 1 28 13 CFG=3
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 24 1 23 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 1 26 28
M  V30 29 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 23 28)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1360702-40-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1360702-42-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-11589080
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: (d)
2-(2,2-Difluoro-ethoxy)-6-methylamino-5-nitro-nicotinic acid methyl ester
Methylamine (2 M in THF; 32.0 mL, 64.0 mmol) is added at 10° C. to
6-chloro-2-(2,2-difluoro-ethoxy)-5-nitro-nicotinic acid methyl ester (9.1
g, 30.7 mmol) in THF (50 mL). After 1 h at rt the reaction mixture is
concentrated, treated with water and filtered. The filtercake is washed
with water and dried to give the sub-title compound. (c)
2-(2-Fluoro-ethoxy)-6-methylamino-5-nitro-N-(trans-4-trifluoromethyl-cyclohexyl)-nicotinamide
The sub-title compound is prepared from
6-chloro-2-(2-fluoro-ethoxy)-5-nitro-N-(trans-4-trifluoromethyl-cyclohexyl)-nicotinamide
(1.00 g, 2.30 mmol) and methylamine (2 M in THF; 2.75 mL, 5.50 mmol) in
THF (15 mL) in analogy with method described in example 1d. Yield: 0.86 g
(92%). HPLC-method C: Rt=2.23 min. MS m/z: 409 [M+H]+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of arylaminoimidazopyridinecarboxamide derivatives for use as
mPGES-1 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Priepke, Henning; Doods, Henri; Kuelzer, Raimund; Pfau, Roland; Stenkamp,
Dirk; Pelcman, Benjamin; Roenn, Robert; Lubriks, Dimitrijs; Suna, Edgars
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012022792 A1 2012-02-23

$RFMT $RIREG SCHEME196 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 4-[6-(3-fluorophenoxy)-8-[(3,3,3-trifluoropropyl)amino]imidazo[...
C23H18F4N4O3
1365244-23-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 11.3289 8.0021 0.0 0
M  V30 2 C 12.0989 9.3358 0.0 0
M  V30 3 C 13.6389 9.3358 0.0 0
M  V30 4 C 14.4089 10.6694 0.0 0
M  V30 5 F 15.1789 12.0031 0.0 0
M  V30 6 F 13.0752 11.4394 0.0 0
M  V30 7 F 15.7425 9.8994 0.0 0
M  V30 8 O 6.7089 5.3347 0.0 0
M  V30 9 C 3.4333 14.7649 0.0 0
M  V30 10 C 1.1444 12.7039 0.0 0
M  V30 11 O 0.0000 11.6735 0.0 0
M  V30 12 O 0.8242 14.2104 0.0 0
M  V30 13 F 6.7089 0.0000 0.0 0
M  V30 14 N 7.4789 9.3358 0.0 0
M  V30 15 C 7.0030 10.8005 0.0 0
M  V30 16 C 9.0189 9.3358 0.0 0
M  V30 17 N 6.7089 8.0021 0.0 0
M  V30 18 C 8.2489 11.7055 0.0 0
M  V30 19 C 9.7889 8.0021 0.0 0
M  V30 20 N 9.4947 10.8005 0.0 0
M  V30 21 C 7.4789 6.6684 0.0 0
M  V30 22 C 9.0189 6.6684 0.0 0
M  V30 23 C 5.5383 11.2763 0.0 0
M  V30 24 C 5.2181 12.7826 0.0 0
M  V30 25 C 4.3939 10.2458 0.0 0
M  V30 26 C 3.7534 13.2585 0.0 0
M  V30 27 C 2.9292 10.7218 0.0 0
M  V30 28 C 2.6091 12.2281 0.0 0
M  V30 29 C 7.4789 4.0011 0.0 0
M  V30 30 C 6.7089 2.6674 0.0 0
M  V30 31 C 9.0189 4.0011 0.0 0
M  V30 32 C 7.4789 1.3336 0.0 0
M  V30 33 C 9.7889 2.6674 0.0 0
M  V30 34 C 9.0189 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 19
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 21
M  V30 9 1 8 29
M  V30 10 1 9 26
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 10 28
M  V30 14 1 13 32
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 14 17
M  V30 18 2 15 18
M  V30 19 1 15 23
M  V30 20 1 16 19
M  V30 21 2 16 20
M  V30 22 2 17 21
M  V30 23 1 18 20
M  V30 24 2 19 22
M  V30 25 1 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 32 2 29 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 2 31 33
M  V30 36 2 32 34
M  V30 37 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[6-(3-Fluorophenoxy)-8-[(3,3,3-trifluoropropyl)amino]imidazo[1,2-b]pyridazi...
C24H21F4N5O2
1365242-61-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.4137 8.0022 0.0 0
M  V30 2 C 3.6437 9.3359 0.0 0
M  V30 3 C 2.1037 9.3359 0.0 0
M  V30 4 C 1.3337 10.6695 0.0 0
M  V30 5 F 0.5636 12.0032 0.0 0
M  V30 6 F 0.0000 9.8995 0.0 0
M  V30 7 F 2.6673 11.4396 0.0 0
M  V30 8 O 9.0337 5.3348 0.0 0
M  V30 9 C 12.3092 14.7651 0.0 0
M  V30 10 C 14.5981 12.7041 0.0 0
M  V30 11 N 15.7427 11.6736 0.0 0
M  V30 12 O 14.9183 14.2105 0.0 0
M  V30 13 C 17.2072 12.1495 0.0 0
M  V30 14 F 9.0337 0.0000 0.0 0
M  V30 15 N 8.2637 9.3359 0.0 0
M  V30 16 C 8.7396 10.8006 0.0 0
M  V30 17 C 6.7237 9.3359 0.0 0
M  V30 18 N 9.0337 8.0022 0.0 0
M  V30 19 C 7.4937 11.7057 0.0 0
M  V30 20 C 5.9537 8.0022 0.0 0
M  V30 21 N 6.2478 10.8006 0.0 0
M  V30 22 C 8.2637 6.6684 0.0 0
M  V30 23 C 6.7237 6.6684 0.0 0
M  V30 24 C 10.2043 11.2765 0.0 0
M  V30 25 C 10.5245 12.7828 0.0 0
M  V30 26 C 11.3487 10.2459 0.0 0
M  V30 27 C 11.9890 13.2586 0.0 0
M  V30 28 C 12.8134 10.7219 0.0 0
M  V30 29 C 13.1336 12.2282 0.0 0
M  V30 30 C 8.2637 4.0011 0.0 0
M  V30 31 C 9.0337 2.6675 0.0 0
M  V30 32 C 6.7237 4.0011 0.0 0
M  V30 33 C 8.2637 1.3337 0.0 0
M  V30 34 C 5.9537 2.6675 0.0 0
M  V30 35 C 6.7237 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 20
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 22
M  V30 9 1 8 30
M  V30 10 1 9 27
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 10 29
M  V30 14 1 11 13
M  V30 15 1 14 33
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 15 18
M  V30 19 2 16 19
M  V30 20 1 16 24
M  V30 21 1 17 20
M  V30 22 2 17 21
M  V30 23 2 18 22
M  V30 24 1 19 21
M  V30 25 2 20 23
M  V30 26 1 22 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 33 2 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 2 32 34
M  V30 37 2 33 35
M  V30 38 1 34 35
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1365244-23-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1365242-61-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-14880844
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 4-{6-(3-fluorophenoxy)-8-[(3,3,3-trifluoropropyl)amino]imidazo[1,2-b]pyridazin-3-yl}-N,2-dimethylbenzamide:
A mixture comprising 30 mg (63 μmol)
4-{6-(3-fluorophenoxy)-8-[(3,3,3-trifluoropropyl)amino]imidazo[1,2-b]pyridazin-3-yl}-2-methylbenzoic
acid which was prepared according to example 550, 2.94 mg methanamine,
36.1 mg
N-[(dimethylamino)(3H-[1,2,3]triazolo[4,5-b]pyridin-3-yloxy)methylene]-N-methylmethanaminium
hexafluorophosphate, 11.6 mg N,N-dimethylpyridin-4-amine and 1.5 mL
N,N-dimethylformamide was stirred at 23 °C overnight. The solvent was
removed and the residue purified by chromatography to give title
compound. Yield 30.0 mg, 92%. 1H-NMR (DMSO-d6): δ= 2.16 (3H), 2.49-2.76
(2H), 2.69 (3H), 3.60 (2H), 6.13 (1H), 7.13 (2H), 7.20 (1H), 7.25 (1H),
7.48 (1H), 7.63-7.74 (2H), 7.76 (1H), 7.93 (1H), 8.08 (1H) ppm.
$DTYPE RXN:VAR(1):NOTES
$DATUM alternate reaction method also shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted imidazopyridazines as monopolar spindle 1
kinase inhibitors for treating hyperproliferative and angiogenesis
disorders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Klar, Ulrich; Koppitz, Marcus; Jautelat, Rolf; Kosemund, Dirk; Bohlmann,
Rolf; Lienau, Philip; Siemeister, Gerhard; Wengner, Antje Margret
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012032031 A1 2012-03-15

$RFMT $RIREG SCHEME197 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Boc-L-valine
C10H19NO4
13734-41-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 14 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 2.3101 0.0 0 CFG=2
M  V30 2 N 4.0012 1.5400 0.0 0
M  V30 3 C 1.3337 1.5400 0.0 0
M  V30 4 C 2.6675 3.8501 0.0 0
M  V30 5 C 5.3348 2.3101 0.0 0
M  V30 6 C 0.0000 2.3101 0.0 0
M  V30 7 C 1.3337 0.0000 0.0 0
M  V30 8 O 1.3337 4.6201 0.0 0
M  V30 9 O 4.0012 4.6201 0.0 0
M  V30 10 O 6.6685 1.5400 0.0 0
M  V30 11 O 5.3348 3.8501 0.0 0
M  V30 12 C 8.0023 2.3101 0.0 0
M  V30 13 C 8.7723 0.9764 0.0 0
M  V30 14 C 9.3360 3.0801 0.0 0
M  V30 15 C 7.2323 3.6437 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 2 4 9
M  V30 9 1 5 10
M  V30 10 2 5 11
M  V30 11 1 10 12
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(1S)-2-methyl-1-[(methylamino)carbonyl]propyl]carbamate
C11H22N2O3
71988-70-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 15 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 4.2074 0.0 0 CFG=2
M  V30 2 C 7.7000 4.2074 0.0 0
M  V30 3 N 5.3900 2.8738 0.0 0
M  V30 4 C 5.3900 5.5411 0.0 0
M  V30 5 N 8.4700 2.8738 0.0 0
M  V30 6 O 8.4700 5.5411 0.0 0
M  V30 7 C 3.8500 2.8738 0.0 0
M  V30 8 C 3.8500 5.5411 0.0 0
M  V30 9 C 6.1600 6.8749 0.0 0
M  V30 10 C 10.0100 2.8738 0.0 0
M  V30 11 O 3.0800 1.5400 0.0 0
M  V30 12 O 3.0800 4.2074 0.0 0
M  V30 13 C 1.5400 1.5400 0.0 0
M  V30 14 C 1.5400 0.0000 0.0 0
M  V30 15 C 0.0000 1.5400 0.0 0
M  V30 16 C 1.5400 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 4 9
M  V30 9 1 5 10
M  V30 10 1 7 11
M  V30 11 2 7 12
M  V30 12 1 11 13
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 13734-41-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 71988-70-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-12194585
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Boc-Val-NHMe (1.4) Boc-Val-OH (6.0 g, 27.6 mmol) was dissolved in CH2Cl2
(275 mL). EDCI-HCl (6.4 g, 33.13 mmol) and DMAP (cat.) were added to the
solution. MeNH2 2M in THF (17 mL, 33.13 mmol) was then added and the
reaction was stirred for 30 h under N2. The reaction mixture was washed
with 1 N HCl (2 x 100 mL), NaHCO sat (2 x 100 mL) and brine (1 x 100 mL),
dried over Na2SO4 and concentrated under reduced pressure to leave 6 g
(92 % yield) of compound 1.4. Boc-Val-NHMe (1.4), yield 6 g 92 % 1H NMR
(300 MHz, CDCl3) δ 0.89 (d, J = 6.6Hz, 3H), 0.95 (d, J = 6.9 Hz, 3H),
1.44 (s, 9H), 2.00-2.16 (m, 1H), 2.81 (d, J = 4.8 Hz, 3H), 3.92 (dd, J =
9.0 and 6.6 Hz, 1H), 5.08 (d, J = 9.0 Hz, 1H (minor rotamer)), 5.16 (d, J
= 9.0 Hz, 1H (major rotamer)), 6.36 (br s, 1H); 13C NMR (300 MHz, CDCl3)
δ 18.1, 19.5, 26.3, 28.5, 31.0, 60.3, 80.1, 156.1, 172.5; ESI-MS calc.
[C11H22N2O3Na]+= 253.1528 obsd. [C11H22N2O3Na]+= 253.1522
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Diacid Linkers That Promote Parallel β-Sheet Secondary Structure in Water
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Freire, Felix; Fisk, John D.; Peoples, Aaron J.; Ivancic, Monika; Guzei,
Ilia A.; Gellman, Samuel H.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2008), 130(25), 7839-7841

$RFMT $RIREG SCHEME198 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C58H68N8O11
1374822-20-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  77 84 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 17.5039 4.4427 0.0 0
M  V30 2 O 16.3594 5.4732 0.0 0
M  V30 3 C 14.4432 3.0800 0.0 0
M  V30 4 N 13.1096 2.3100 0.0 0
M  V30 5 O 14.4432 4.6200 0.0 0
M  V30 6 C 11.7759 3.0800 0.0 0
M  V30 7 C 18.1443 7.4553 0.0 0
M  V30 8 N 18.4644 8.9617 0.0 0
M  V30 9 C 19.9291 9.4376 0.0 0
M  V30 10 O 21.0735 8.4072 0.0 0
M  V30 11 C 9.1085 4.6200 0.0 0
M  V30 12 O 10.4421 5.3900 0.0 0
M  V30 13 C 22.9899 10.8003 0.0 0
M  V30 14 O 22.9899 9.2603 0.0 0
M  V30 15 C 8.7583 7.9519 0.0 0
M  V30 16 N 8.4381 9.4584 0.0 0
M  V30 17 O 10.2230 7.4761 0.0 0
M  V30 18 C 6.9734 9.9342 0.0 0
M  V30 19 C 25.6572 9.2603 0.0 0
M  V30 20 N 26.9910 8.4903 0.0 0
M  V30 21 C 26.9910 6.9503 0.0 0
M  V30 22 O 28.3246 6.1803 0.0 0
M  V30 23 O 25.6572 6.1803 0.0 0
M  V30 24 C 28.3246 4.6403 0.0 0
M  V30 25 C 29.8646 4.6403 0.0 0
M  V30 26 C 28.3246 3.1003 0.0 0
M  V30 27 C 26.7846 4.6403 0.0 0
M  V30 28 C 4.0442 10.8860 0.0 0
M  V30 29 O 4.3644 9.3797 0.0 0
M  V30 30 C 1.3336 8.9166 0.0 0
M  V30 31 O 0.0000 8.1466 0.0 0
M  V30 32 O 2.6674 8.1466 0.0 0
M  V30 33 C 0.0000 6.6066 0.0 0
M  V30 34 N 17.1838 2.9363 0.0 0
M  V30 35 C 15.7768 2.3100 0.0 0 CFG=2
M  V30 36 C 18.2142 1.7919 0.0 0
M  V30 37 C 15.9379 0.7783 0.0 0
M  V30 38 C 17.4442 0.4581 0.0 0
M  V30 39 C 18.9686 4.9186 0.0 0
M  V30 40 C 19.2888 6.4249 0.0 0
M  V30 41 C 20.1130 3.8880 0.0 0
M  V30 42 C 20.7533 6.9007 0.0 0
M  V30 43 C 21.5777 4.3641 0.0 0
M  V30 44 C 21.8979 5.8703 0.0 0
M  V30 45 C 10.4421 2.3100 0.0 0
M  V30 46 C 9.1085 3.0800 0.0 0
M  V30 47 C 10.4421 0.7700 0.0 0
M  V30 48 C 7.7748 2.3100 0.0 0
M  V30 49 C 9.1085 0.0000 0.0 0
M  V30 50 C 7.7748 0.7700 0.0 0
M  V30 51 C 20.2493 10.9440 0.0 0 CFG=2
M  V30 52 N 21.6561 11.5703 0.0 0
M  V30 53 C 19.2189 12.0884 0.0 0
M  V30 54 C 21.4952 13.1019 0.0 0
M  V30 55 C 19.9889 13.4220 0.0 0
M  V30 56 N 7.7748 5.3900 0.0 0
M  V30 57 C 7.6139 6.9215 0.0 0 CFG=2
M  V30 58 C 6.3679 4.7635 0.0 0
M  V30 59 C 6.1075 7.2417 0.0 0
M  V30 60 C 5.3375 5.9081 0.0 0
M  V30 61 C 24.3235 11.5703 0.0 0
M  V30 62 C 25.6572 10.8003 0.0 0
M  V30 63 C 24.3235 13.1103 0.0 0
M  V30 64 C 26.9910 11.5703 0.0 0
M  V30 65 C 25.6572 13.8803 0.0 0
M  V30 66 C 26.9910 13.1103 0.0 0
M  V30 67 C 6.6533 11.4405 0.0 0
M  V30 68 C 5.1887 11.9165 0.0 0
M  V30 69 C 7.7978 12.4711 0.0 0
M  V30 70 C 4.8686 13.4228 0.0 0
M  V30 71 C 7.4775 13.9773 0.0 0
M  V30 72 C 6.0129 14.4532 0.0 0
M  V30 73 N 2.5797 11.3618 0.0 0
M  V30 74 C 1.3336 10.4566 0.0 0 CFG=2
M  V30 75 C 2.1036 12.8265 0.0 0
M  V30 76 C 0.0878 11.3618 0.0 0
M  V30 77 C 0.5636 12.8265 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 34
M  V30 3 1 1 39
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 35 3 CFG=1
M  V30 7 1 4 6
M  V30 8 1 6 45
M  V30 9 1 7 8
M  V30 10 1 7 40
M  V30 11 1 8 9
M  V30 12 2 9 10
M  V30 13 1 51 9 CFG=3
M  V30 14 2 11 12
M  V30 15 1 11 46
M  V30 16 1 11 56
M  V30 17 2 13 14
M  V30 18 1 13 52
M  V30 19 1 13 61
M  V30 20 1 15 16
M  V30 21 2 15 17
M  V30 22 1 57 15 CFG=1
M  V30 23 1 16 18
M  V30 24 1 18 67
M  V30 25 1 19 20
M  V30 26 1 19 62
M  V30 27 1 20 21
M  V30 28 1 21 22
M  V30 29 2 21 23
M  V30 30 1 22 24
M  V30 31 1 24 25
M  V30 32 1 24 26
M  V30 33 1 24 27
M  V30 34 2 28 29
M  V30 35 1 28 68
M  V30 36 1 28 73
M  V30 37 1 30 31
M  V30 38 2 30 32
M  V30 39 1 74 30 CFG=3
M  V30 40 1 31 33
M  V30 41 1 34 35
M  V30 42 1 34 36
M  V30 43 1 35 37
M  V30 44 1 36 38
M  V30 45 1 37 38
M  V30 46 2 39 40
M  V30 47 1 39 41
M  V30 48 1 40 42
M  V30 49 2 41 43
M  V30 50 2 42 44
M  V30 51 1 43 44
M  V30 52 2 45 46
M  V30 53 1 45 47
M  V30 54 1 46 48
M  V30 55 2 47 49
M  V30 56 2 48 50
M  V30 57 1 49 50
M  V30 58 1 51 52
M  V30 59 1 51 53
M  V30 60 1 52 54
M  V30 61 1 53 55
M  V30 62 1 54 55
M  V30 63 1 56 57
M  V30 64 1 56 58
M  V30 65 1 57 59
M  V30 66 1 58 60
M  V30 67 1 59 60
M  V30 68 2 61 62
M  V30 69 1 61 63
M  V30 70 1 62 64
M  V30 71 2 63 65
M  V30 72 2 64 66
M  V30 73 1 65 66
M  V30 74 2 67 68
M  V30 75 1 67 69
M  V30 76 1 68 70
M  V30 77 2 69 71
M  V30 78 2 70 72
M  V30 79 1 71 72
M  V30 80 1 73 74
M  V30 81 1 73 75
M  V30 82 1 74 76
M  V30 83 1 75 77
M  V30 84 1 76 77
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 35 51 57 74)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C58H69N9O10
1374822-21-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  77 84 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 16.2285 4.4427 0.0 0
M  V30 2 O 15.0841 5.4732 0.0 0
M  V30 3 C 13.1678 3.0800 0.0 0
M  V30 4 N 11.8341 2.3100 0.0 0
M  V30 5 O 13.1678 4.6200 0.0 0
M  V30 6 C 10.5005 3.0800 0.0 0
M  V30 7 C 16.8689 7.4554 0.0 0
M  V30 8 N 17.1890 8.9617 0.0 0
M  V30 9 C 18.6537 9.4377 0.0 0
M  V30 10 O 19.7981 8.4072 0.0 0
M  V30 11 C 7.8331 4.6200 0.0 0
M  V30 12 O 9.1667 5.3900 0.0 0
M  V30 13 C 21.7145 10.8003 0.0 0
M  V30 14 O 21.7145 9.2603 0.0 0
M  V30 15 C 7.4829 7.9521 0.0 0
M  V30 16 N 7.1627 9.4584 0.0 0
M  V30 17 O 8.9476 7.4761 0.0 0
M  V30 18 C 8.3071 10.4888 0.0 0
M  V30 19 C 24.3817 9.2603 0.0 0
M  V30 20 N 25.7155 8.4905 0.0 0
M  V30 21 C 25.7155 6.9505 0.0 0
M  V30 22 O 27.0492 6.1805 0.0 0
M  V30 23 O 24.3817 6.1803 0.0 0
M  V30 24 C 27.0492 4.6405 0.0 0
M  V30 25 C 25.5092 4.6405 0.0 0
M  V30 26 C 27.0492 3.1005 0.0 0
M  V30 27 C 28.5892 4.6405 0.0 0
M  V30 28 C 5.3778 11.4407 0.0 0
M  V30 29 O 5.6980 9.9342 0.0 0
M  V30 30 C 2.6674 9.4713 0.0 0
M  V30 31 N 1.3336 8.7013 0.0 0
M  V30 32 O 4.0011 8.7013 0.0 0
M  V30 33 C 0.0000 9.4713 0.0 0
M  V30 34 N 15.9084 2.9365 0.0 0
M  V30 35 C 14.5014 2.3100 0.0 0 CFG=2
M  V30 36 C 16.9388 1.7919 0.0 0
M  V30 37 C 14.6625 0.7785 0.0 0
M  V30 38 C 16.1688 0.4583 0.0 0
M  V30 39 C 17.6932 4.9186 0.0 0
M  V30 40 C 18.0134 6.4250 0.0 0
M  V30 41 C 18.8376 3.8882 0.0 0
M  V30 42 C 19.4779 6.9009 0.0 0
M  V30 43 C 20.3023 4.3641 0.0 0
M  V30 44 C 20.6224 5.8703 0.0 0
M  V30 45 C 9.1667 2.3100 0.0 0
M  V30 46 C 7.8331 3.0800 0.0 0
M  V30 47 C 9.1667 0.7700 0.0 0
M  V30 48 C 6.4994 2.3100 0.0 0
M  V30 49 C 7.8331 0.0000 0.0 0
M  V30 50 C 6.4994 0.7700 0.0 0
M  V30 51 C 18.9739 10.9440 0.0 0 CFG=2
M  V30 52 N 20.3808 11.5703 0.0 0
M  V30 53 C 17.9435 12.0885 0.0 0
M  V30 54 C 20.2197 13.1020 0.0 0
M  V30 55 C 18.7135 13.4222 0.0 0
M  V30 56 N 6.4994 5.3900 0.0 0
M  V30 57 C 6.3385 6.9215 0.0 0 CFG=2
M  V30 58 C 5.0926 4.7637 0.0 0
M  V30 59 C 4.8321 7.2417 0.0 0
M  V30 60 C 4.0621 5.9081 0.0 0
M  V30 61 C 23.0481 11.5703 0.0 0
M  V30 62 C 24.3817 10.8003 0.0 0
M  V30 63 C 23.0481 13.1103 0.0 0
M  V30 64 C 25.7155 11.5705 0.0 0
M  V30 65 C 24.3817 13.8803 0.0 0
M  V30 66 C 25.7155 13.1105 0.0 0
M  V30 67 C 7.9869 11.9952 0.0 0
M  V30 68 C 6.5224 12.4711 0.0 0
M  V30 69 C 9.1314 13.0256 0.0 0
M  V30 70 C 6.2022 13.9775 0.0 0
M  V30 71 C 8.8113 14.5321 0.0 0
M  V30 72 C 7.3466 15.0079 0.0 0
M  V30 73 N 3.9133 11.9165 0.0 0
M  V30 74 C 2.6674 11.0113 0.0 0 CFG=2
M  V30 75 C 3.4374 13.3812 0.0 0
M  V30 76 C 1.4214 11.9165 0.0 0
M  V30 77 C 1.8974 13.3812 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 34
M  V30 3 1 1 39
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 35 3 CFG=1
M  V30 7 1 4 6
M  V30 8 1 6 45
M  V30 9 1 7 8
M  V30 10 1 7 40
M  V30 11 1 8 9
M  V30 12 2 9 10
M  V30 13 1 51 9 CFG=3
M  V30 14 2 11 12
M  V30 15 1 11 46
M  V30 16 1 11 56
M  V30 17 2 13 14
M  V30 18 1 13 52
M  V30 19 1 13 61
M  V30 20 1 15 16
M  V30 21 2 15 17
M  V30 22 1 57 15 CFG=1
M  V30 23 1 16 18
M  V30 24 1 18 67
M  V30 25 1 19 20
M  V30 26 1 19 62
M  V30 27 1 20 21
M  V30 28 1 21 22
M  V30 29 2 21 23
M  V30 30 1 22 24
M  V30 31 1 24 25
M  V30 32 1 24 26
M  V30 33 1 24 27
M  V30 34 2 28 29
M  V30 35 1 28 68
M  V30 36 1 28 73
M  V30 37 1 30 31
M  V30 38 2 30 32
M  V30 39 1 74 30 CFG=3
M  V30 40 1 31 33
M  V30 41 1 34 35
M  V30 42 1 34 36
M  V30 43 1 35 37
M  V30 44 1 36 38
M  V30 45 1 37 38
M  V30 46 2 39 40
M  V30 47 1 39 41
M  V30 48 1 40 42
M  V30 49 2 41 43
M  V30 50 2 42 44
M  V30 51 1 43 44
M  V30 52 2 45 46
M  V30 53 1 45 47
M  V30 54 1 46 48
M  V30 55 2 47 49
M  V30 56 2 48 50
M  V30 57 1 49 50
M  V30 58 1 51 52
M  V30 59 1 51 53
M  V30 60 1 52 54
M  V30 61 1 53 55
M  V30 62 1 54 55
M  V30 63 1 56 57
M  V30 64 1 56 58
M  V30 65 1 57 59
M  V30 66 1 58 60
M  V30 67 1 59 60
M  V30 68 2 61 62
M  V30 69 1 61 63
M  V30 70 1 62 64
M  V30 71 2 63 65
M  V30 72 2 64 66
M  V30 73 1 65 66
M  V30 74 2 67 68
M  V30 75 1 67 69
M  V30 76 1 68 70
M  V30 77 2 69 71
M  V30 78 2 70 72
M  V30 79 1 71 72
M  V30 80 1 73 74
M  V30 81 1 73 75
M  V30 82 1 74 76
M  V30 83 1 75 77
M  V30 84 1 76 77
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 35 51 57 74)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1374822-20-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1374822-21-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-15123221
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Expanding the structural repertoire of β/α Ant-Pro (anthranilic
acid-proline) oligomers into γ/α 2-Amb-Pro (2-aminomethyl benzoic
acid-proline) oligomers
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ramesh, Veera V. E.; Priya, Gowri; Rajamohanan, P. R.; Hofmann,
Hans-Jorg; Sanjayan, Gangadhar J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2012), 68(23), 4399-4405

$RFMT $RIREG SCHEME199 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(4-Nitrophenyl)sulfonyl]proline ethyl ester
C13H16N2O6S
1375313-84-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.3103 2.6218 0.0 0 VAL=6
M  V30 2 O 5.5403 3.9554 0.0 0
M  V30 3 O 7.0803 1.2881 0.0 0
M  V30 4 C 3.2495 3.9845 0.0 0
M  V30 5 O 1.7849 4.4604 0.0 0
M  V30 6 O 4.3940 5.0150 0.0 0
M  V30 7 C 1.4646 5.9669 0.0 0
M  V30 8 C 0.0000 6.4427 0.0 0
M  V30 9 N 11.6451 5.7018 0.0 0 VAL=5
M  V30 10 O 11.6451 7.2419 0.0 0
M  V30 11 O 12.9788 4.9318 0.0 0
M  V30 12 N 4.9766 1.8517 0.0 0
M  V30 13 C 3.5696 2.4782 0.0 0
M  V30 14 C 4.8155 0.3202 0.0 0
M  V30 15 C 2.5392 1.3337 0.0 0
M  V30 16 C 3.3092 0.0000 0.0 0
M  V30 17 C 7.6440 3.3918 0.0 0
M  V30 18 C 7.6440 4.9318 0.0 0
M  V30 19 C 8.9776 2.6218 0.0 0
M  V30 20 C 8.9776 5.7018 0.0 0
M  V30 21 C 10.3115 3.3918 0.0 0
M  V30 22 C 10.3115 4.9318 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 1 17
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 13
M  V30 8 1 5 7
M  V30 9 1 7 8
M  V30 10 2 9 10
M  V30 11 2 9 11
M  V30 12 1 9 22
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-1-[(4-nitrophenyl)sulfonyl]-2-pyrrolidinecarboxamide
C12H15N3O5S
1375313-88-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.8457 2.6218 0.0 0 VAL=6
M  V30 2 O 4.0757 3.9554 0.0 0
M  V30 3 O 5.6157 1.2881 0.0 0
M  V30 4 C 1.7849 3.9845 0.0 0
M  V30 5 N 0.3202 4.4604 0.0 0
M  V30 6 O 2.9293 5.0150 0.0 0
M  V30 7 C 0.0000 5.9669 0.0 0
M  V30 8 N 10.1805 5.7018 0.0 0 VAL=5
M  V30 9 O 10.1805 7.2419 0.0 0
M  V30 10 O 11.5142 4.9318 0.0 0
M  V30 11 N 3.5119 1.8517 0.0 0
M  V30 12 C 2.1051 2.4782 0.0 0
M  V30 13 C 3.3510 0.3202 0.0 0
M  V30 14 C 1.0746 1.3337 0.0 0
M  V30 15 C 1.8447 0.0000 0.0 0
M  V30 16 C 6.1794 3.3918 0.0 0
M  V30 17 C 7.5131 2.6218 0.0 0
M  V30 18 C 6.1794 4.9318 0.0 0
M  V30 19 C 8.8467 3.3918 0.0 0
M  V30 20 C 7.5131 5.7018 0.0 0
M  V30 21 C 8.8467 4.9318 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 1 16
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 12
M  V30 8 1 5 7
M  V30 9 2 8 9
M  V30 10 2 8 10
M  V30 11 1 8 21
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1375313-84-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1375313-88-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-5467621
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: N'-(Arylsulfonyl)-N-methylprolinamides 1a-f
(General Method). A mixture of N-arylsulfonyl-proline ethyl ester 8a-f
(30 mmol) and 40% aqueous MeNH2 (30 ml) was stirred at room temperature
for seven days. The precipitate formed was filtered off and dried in the
air. N-Methyl-N'-(4-nitrophenylsulfonyl)prolinamide (1f). Yield 8.7 g
(92%). mp 172-174°C (EtOH). IR spectrum (CHCl3), ν, cm-1: 1670 (NCO),
1600 (Ar), 1525 (NCO, NO2), 1360 (NO2, SO2), 1160 (SO2). 1H NMR spectrum
(CDCl3), δ, ppm (J, Hz): 1.48-2.00 and 2.15-2.34 (4H, m, 3, 4-CH2); 2.89
(3H, d, 3 J = 4.9, CH3N); 3.09-3.28 and 3.53-3.72 (2H, m, 5-CH2);
4.04-4.18 (1H, m, 2-CH); 6.76 (1H, br. s, NH); 8.05 (2H, d, 3 J = 8.7, H
Ar); 8.42 (2H, d, 3 J = 8.7, H Ar). 13C NMR spectrum (CDCl3), δ, ppm:
24.3 (C-4); 26.5 (CH3N); 30.3 (C-3); 49.9 (C-5); 62.7 (C-2); 124.6 (C-3,
5 Ar); 129.0 (C-2, 6 Ar); 141.6 (C-1 Ar); 150.5 (C-4 Ar); 170.9 (C=O).
Found, %: C 46.03; H 4.80; N 13.42. C12H15N3O5S. Calculated, %: C 46.00;
H 4.83; N 13.41.
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pentacoordinated chlorosilanes with C,O-chelate ligands derived from
N-methyl-N'-organosulfonyl-prolinamides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nikolin, A. A.; Arkhipov, D. E.; Shipov, A. G.; Kramarova, E. P.;
Koval'chuk, N. A.; Korlyukov, A. A.; Negrebetsky, V. V.; Baukov, Yu. I.;
Bassindale, A. R.; Taylor, P. G.; Bowden, A.; Bylikin, S. Yu.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry of Heterocyclic Compounds (New York, NY, United States) (2012),
47(12), 1565-1583

$RFMT $RIREG SCHEME200 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3aR,4R,6R,6aS)-6-(4-Chloro-7H-pyrrolo[2,3-d]pyrimidin-7-yl)tetrahydro-2,2-di...
C15H18ClN3O3
1379540-62-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.2969 1.0304 0.0 0
M  V30 2 O 6.1524 0.0000 0.0 0
M  V30 3 C 11.1809 5.2128 0.0 0
M  V30 4 C 10.1504 6.9977 0.0 0
M  V30 5 Cl 0.0000 8.0725 0.0 0
M  V30 6 C 5.7309 4.6948 0.0 0 CFG=2
M  V30 7 C 7.2372 5.0149 0.0 0 CFG=2
M  V30 8 C 5.5698 3.1632 0.0 0
M  V30 9 C 8.0072 3.6813 0.0 0 CFG=2
M  V30 10 O 8.2676 6.1595 0.0 0
M  V30 11 C 6.9768 2.5369 0.0 0 CFG=2
M  V30 12 O 9.5136 4.0014 0.0 0
M  V30 13 C 9.6746 5.5331 0.0 0
M  V30 14 N 4.5863 5.7253 0.0 0
M  V30 15 C 3.0800 5.4052 0.0 0
M  V30 16 C 4.7473 7.2569 0.0 0
M  V30 17 C 2.3100 6.7388 0.0 0
M  V30 18 N 2.3100 4.0714 0.0 0
M  V30 19 C 3.3405 7.8832 0.0 0
M  V30 20 C 0.7700 6.7388 0.0 0
M  V30 21 C 0.7700 4.0714 0.0 0
M  V30 22 N 0.0000 5.4052 0.0 0
M  V30 23 H 6.4672 6.3487 0.0 0
M  V30 24 H 8.7772 2.3476 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 11 1 CFG=1
M  V30 3 1 3 13
M  V30 4 1 4 13
M  V30 5 1 5 20
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 14 CFG=1
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 7 23 CFG=1
M  V30 12 1 8 11
M  V30 13 1 9 11
M  V30 14 1 9 12
M  V30 15 1 9 24 CFG=1
M  V30 16 1 10 13
M  V30 17 1 12 13
M  V30 18 1 14 15
M  V30 19 1 14 16
M  V30 20 1 15 17
M  V30 21 2 15 18
M  V30 22 2 16 19
M  V30 23 1 17 19
M  V30 24 2 17 20
M  V30 25 1 18 21
M  V30 26 1 20 22
M  V30 27 2 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 6 7 9 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(3aR,4R,6R,6aS)-Tetrahydro-2,2-dimethyl-6-[4-(methylamino)-7H-pyrrolo[2,3-d]p...
C16H22N4O3
2413634-40-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.8839 1.0304 0.0 0
M  V30 2 O 5.0284 0.0000 0.0 0
M  V30 3 C 0.0000 5.2128 0.0 0
M  V30 4 C 1.0304 6.9977 0.0 0
M  V30 5 N 11.1808 8.0724 0.0 0
M  V30 6 C 12.7208 8.0724 0.0 0
M  V30 7 C 5.4499 4.6947 0.0 0 CFG=2
M  V30 8 C 3.9437 5.0149 0.0 0 CFG=2
M  V30 9 C 5.6110 3.1632 0.0 0
M  V30 10 C 3.1737 3.6812 0.0 0 CFG=2
M  V30 11 O 2.9132 6.1594 0.0 0
M  V30 12 C 4.2041 2.5369 0.0 0 CFG=2
M  V30 13 O 1.6672 4.0014 0.0 0
M  V30 14 C 1.5063 5.5331 0.0 0
M  V30 15 N 6.5945 5.7253 0.0 0
M  V30 16 C 8.1008 5.4051 0.0 0
M  V30 17 C 6.4336 7.2568 0.0 0
M  V30 18 C 8.8708 6.7388 0.0 0
M  V30 19 N 8.8708 4.0713 0.0 0
M  V30 20 C 7.8404 7.8832 0.0 0
M  V30 21 C 10.4108 6.7388 0.0 0
M  V30 22 C 10.4108 4.0713 0.0 0
M  V30 23 N 11.1808 5.4051 0.0 0
M  V30 24 H 4.7137 6.3487 0.0 0
M  V30 25 H 2.4036 2.3476 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 12 1 CFG=3
M  V30 3 1 3 14
M  V30 4 1 4 14
M  V30 5 1 5 6
M  V30 6 1 5 21
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 15 CFG=3
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 8 24 CFG=3
M  V30 13 1 9 12
M  V30 14 1 10 12
M  V30 15 1 10 13
M  V30 16 1 10 25 CFG=3
M  V30 17 1 11 14
M  V30 18 1 13 14
M  V30 19 1 15 16
M  V30 20 1 15 17
M  V30 21 1 16 18
M  V30 22 2 16 19
M  V30 23 2 17 20
M  V30 24 1 18 20
M  V30 25 2 18 21
M  V30 26 1 19 22
M  V30 27 1 21 23
M  V30 28 2 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 7 8 10 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1379540-62-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2413634-40-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36041034
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM alternate reaction conditions gave 79% yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of carbocyclic nucleosides as specific small molecule
inhibitors that block KMT9 methyltransferase activity and function
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Schuele, Roland; Wang, Sheng; Metzger, Eric; Jung, Manfred; Klein,
Sebastian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023017152 A1 2023-02-16

$RFMT $RIREG SCHEME201 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[2-[[(1,1-Dimethylethyl)diphenylsilyl]oxy]ethyl]-5-methoxy-4-oxo-4H-pyran-2...
C25H29NO5Si
1394231-78-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Si 4.0011 2.6675 0.0 0
M  V30 2 O 5.3348 1.8975 0.0 0
M  V30 3 C 3.2311 1.3338 0.0 0
M  V30 4 C 6.6686 2.6675 0.0 0
M  V30 5 C 4.5648 0.5638 0.0 0
M  V30 6 C 2.4611 0.0000 0.0 0
M  V30 7 C 1.8975 2.1038 0.0 0
M  V30 8 C 8.0022 1.8975 0.0 0
M  V30 9 N 9.3359 2.6675 0.0 0
M  V30 10 C 10.6697 1.8975 0.0 0
M  V30 11 O 10.6697 0.3574 0.0 0
M  V30 12 O 16.0045 1.8975 0.0 0
M  V30 13 O 16.0045 4.9775 0.0 0
M  V30 14 C 16.0045 6.5175 0.0 0
M  V30 15 C 2.6675 3.4375 0.0 0
M  V30 16 C 2.6675 4.9775 0.0 0
M  V30 17 C 1.3338 2.6675 0.0 0
M  V30 18 C 1.3338 5.7475 0.0 0
M  V30 19 C 0.0000 3.4375 0.0 0
M  V30 20 C 0.0000 4.9775 0.0 0
M  V30 21 C 4.7711 4.0011 0.0 0
M  V30 22 C 4.0011 5.3348 0.0 0
M  V30 23 C 6.3111 4.0011 0.0 0
M  V30 24 C 4.7711 6.6686 0.0 0
M  V30 25 C 7.0812 5.3348 0.0 0
M  V30 26 C 6.3111 6.6686 0.0 0
M  V30 27 C 12.0034 2.6675 0.0 0
M  V30 28 C 13.3370 1.8975 0.0 0
M  V30 29 O 12.0034 4.2075 0.0 0
M  V30 30 C 14.6707 2.6675 0.0 0
M  V30 31 C 13.3370 4.9775 0.0 0
M  V30 32 C 14.6707 4.2075 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 15
M  V30 4 1 1 21
M  V30 5 1 2 4
M  V30 6 1 3 5
M  V30 7 1 3 6
M  V30 8 1 3 7
M  V30 9 1 4 8
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 2 10 11
M  V30 13 1 10 27
M  V30 14 2 12 30
M  V30 15 1 13 14
M  V30 16 1 13 32
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 2 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[2-[[(1,1-Dimethylethyl)diphenylsilyl]oxy]ethyl]-1,4-dihydro-5-methoxy-1-me...
C26H32N2O4Si
1394231-79-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Si 4.0012 2.6675 0.0 0
M  V30 2 O 5.3348 1.8975 0.0 0
M  V30 3 C 3.2311 1.3338 0.0 0
M  V30 4 C 6.6687 2.6675 0.0 0
M  V30 5 C 4.5648 0.5638 0.0 0
M  V30 6 C 2.4611 0.0000 0.0 0
M  V30 7 C 1.8975 2.1038 0.0 0
M  V30 8 C 8.0023 1.8975 0.0 0
M  V30 9 N 9.3360 2.6675 0.0 0
M  V30 10 C 10.6697 1.8975 0.0 0
M  V30 11 O 10.6697 0.3574 0.0 0
M  V30 12 C 13.3372 0.3574 0.0 0
M  V30 13 O 13.3372 6.5176 0.0 0
M  V30 14 O 16.0045 4.9775 0.0 0
M  V30 15 C 17.3383 4.2075 0.0 0
M  V30 16 C 2.6675 3.4375 0.0 0
M  V30 17 C 1.3338 2.6675 0.0 0
M  V30 18 C 2.6675 4.9775 0.0 0
M  V30 19 C 0.0000 3.4375 0.0 0
M  V30 20 C 1.3338 5.7476 0.0 0
M  V30 21 C 0.0000 4.9775 0.0 0
M  V30 22 C 4.7712 4.0012 0.0 0
M  V30 23 C 4.0012 5.3348 0.0 0
M  V30 24 C 6.3112 4.0012 0.0 0
M  V30 25 C 4.7712 6.6687 0.0 0
M  V30 26 C 7.0812 5.3348 0.0 0
M  V30 27 C 6.3112 6.6687 0.0 0
M  V30 28 C 12.0035 2.6675 0.0 0
M  V30 29 N 13.3372 1.8975 0.0 0
M  V30 30 C 12.0035 4.2075 0.0 0
M  V30 31 C 14.6708 2.6675 0.0 0
M  V30 32 C 13.3372 4.9775 0.0 0
M  V30 33 C 14.6708 4.2075 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 16
M  V30 4 1 1 22
M  V30 5 1 2 4
M  V30 6 1 3 5
M  V30 7 1 3 6
M  V30 8 1 3 7
M  V30 9 1 4 8
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 2 10 11
M  V30 13 1 10 28
M  V30 14 1 12 29
M  V30 15 2 13 32
M  V30 16 1 14 15
M  V30 17 1 14 33
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 1 28 29
M  V30 31 2 28 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1394231-78-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1394231-79-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-3844132
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (2-(tert-Butyldiphenylsilyloxy)ethyl)-5-methoxy-N-methyl-4-oxo-1,4-
dihydropyridine-2-carboxamide (9) Amide 8 (3.42 g, 7.57 mmol) was
dissolved in THF (70 mL). A solution of 40% aq. methylamine (7.95 g, 102
mmol) was added. The reaction mixture was stirred at rt for 4 h. It was
then poured into a mixture of sat. aq. NH4Cl (100 mL) and ethyl acetate
(100 mL). The organic layer was separated and the aqueous layer was
extracted with ethyl acetate (3 X 25 mL). The combined organic layers
were washed with brine (35 mL) and dried over Na2SO4. The solvents were
removed under reduced pressure. The remaining oil was purified by
chromatography on silica (CHCl3/MeOH 40:1 → CHCl3/MeOH 20:1) to give
pyridone 9. Yield 3.22g, 6.93mmol, 92%, pale yellow foam. Rf (silica) =
0.42 (CHCl3/MeOH 10:1); 1H-NMR (300 MHz, CDCl3) δ = 1.03 (s, 9H, SitBu),
3.57 (dt, J = 5.7, 5.7 Hz, 2H, H19), 3.68 (s, 3H, -NMe), 3.74 (s, 3H,
OMe), 3.85 (t, J = 5.7 Hz, 2H, H2O), 6.45 (s, 1H, H3), 6.85 (s, 1H, H6),
7.31-7.47 (m, 6H, Har), 7.58- 7.72 (m, 4H, Har), 8.13 (s, 1H, NH) ;
13C-NMR (75 MHz, CDCl3): δ = 19.2 (SiCMe3), 26.8 (3 × C, SiCMe3), 42.3
(C19), 42.3 (NMe), 56.4 (OMe), 62.2 (C20), 115.3 (C3), 124.3 (C6), 127.8
(4 × Car), 129.8 (2 × Car), 133.4 (2 × Car,q), 135.6 (4 × Car), 143.8
(C2), 150.2 (C5), 163.3 (C1), 171.8 (C4); IR (neat): ν = 2930 (m), 2855
(m), 1665 (m), 1618 (s), 1561 (s), 1427 (s), 1308 (m), 1264 (m), 1232
(m), 1105(s), 997 (m), 822 (m), 735 (s), 700 (vs), 611 (s), 502 (s), 486
(s) cm-1; HRMS (ESI): m/z calcd for C26H33N2O4Si [M + H]+: 465.2204;
found: 465.2201.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Total Synthesis of Lodopyridone
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Burckhardt, Tobias; Harms, Klaus; Koert, Ulrich
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2012), 14(17), 4674-4677

$RFMT $RIREG SCHEME202 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
D-Mannonic acid, 5-azido-5-deoxy-3,6-bis-O-(phenylmethyl)-, γ-lactone, 2-meth...
C21H23N3O7S
1395068-41-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 4.3159 4.3816 0.0 0
M  V30 2 C 2.7843 4.2207 0.0 0
M  V30 3 C 7.9886 6.1086 0.0 0 CFG=2
M  V30 4 C 8.7586 4.7749 0.0 0
M  V30 5 N 8.7586 7.4424 0.0 0
M  V30 6 O 10.2986 4.7749 0.0 0
M  V30 7 N 10.2986 7.4424 0.0 0 CHG=1 VAL=4
M  V30 8 C 11.0687 3.4413 0.0 0
M  V30 9 N 11.8387 7.4424 0.0 0 CHG=-1
M  V30 10 O 2.6407 7.2832 0.0 0
M  V30 11 S 2.0143 8.6900 0.0 0 VAL=6
M  V30 12 C 0.6074 8.0636 0.0 0
M  V30 13 O 1.3880 10.0969 0.0 0
M  V30 14 O 3.4211 9.3164 0.0 0
M  V30 15 O 4.8826 9.7730 0.0 0
M  V30 16 C 4.9423 5.7884 0.0 0 CFG=2
M  V30 17 C 6.4486 6.1086 0.0 0 CFG=1
M  V30 18 C 4.1723 7.1222 0.0 0 CFG=2
M  V30 19 O 6.6096 7.6403 0.0 0
M  V30 20 C 5.2028 8.2666 0.0 0
M  V30 21 C 2.1580 2.8137 0.0 0
M  V30 22 C 0.6263 2.6528 0.0 0
M  V30 23 C 3.0631 1.5679 0.0 0
M  V30 24 C 0.0000 1.2459 0.0 0
M  V30 25 C 2.4368 0.1611 0.0 0
M  V30 26 C 0.9052 0.0000 0.0 0
M  V30 27 C 12.6087 3.4413 0.0 0
M  V30 28 C 13.3787 2.1077 0.0 0
M  V30 29 C 13.3787 4.7749 0.0 0
M  V30 30 C 14.9187 2.1077 0.0 0
M  V30 31 C 14.9187 4.7749 0.0 0
M  V30 32 C 15.6887 3.4413 0.0 0
M  V30 33 H 6.6096 4.5771 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 16 1 CFG=3
M  V30 3 1 2 21
M  V30 4 1 3 4 CFG=3
M  V30 5 1 3 5
M  V30 6 1 3 17
M  V30 7 1 4 6
M  V30 8 2 5 7
M  V30 9 1 6 8
M  V30 10 2 7 9
M  V30 11 1 8 27
M  V30 12 1 10 11
M  V30 13 1 18 10 CFG=3
M  V30 14 1 11 12
M  V30 15 2 11 13
M  V30 16 2 11 14
M  V30 17 2 15 20
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 17 33 CFG=1
M  V30 22 1 18 20
M  V30 23 1 19 20
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 30 2 27 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 31
M  V30 34 2 30 32
M  V30 35 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 3 16 17 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
D-Mannonamide, 5-azido-5-deoxy-N-methyl-3,6-bis-O-(phenylmethyl)-, 2-methanes...
C22H28N4O7S
1591783-18-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 35 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 6.9302 0.0 0 CFG=1
M  V30 2 C 4.0012 7.7002 0.0 0 CFG=1
M  V30 3 C 6.6687 7.7002 0.0 0 CFG=2
M  V30 4 O 5.3348 5.3901 0.0 0
M  V30 5 O 2.6675 6.9302 0.0 0
M  V30 6 C 4.0012 9.2402 0.0 0
M  V30 7 C 8.0023 6.9302 0.0 0 CFG=2
M  V30 8 O 6.6687 9.2402 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 S 1.3338 7.7002 0.0 0 VAL=6
M  V30 11 N 2.6675 10.0102 0.0 0
M  V30 12 O 5.3348 10.0102 0.0 0
M  V30 13 C 9.3360 7.7002 0.0 0
M  V30 14 N 8.0023 5.3901 0.0 0
M  V30 15 C 2.1038 9.0338 0.0 0
M  V30 16 O 0.0000 8.4702 0.0 0
M  V30 17 O 0.5638 6.3665 0.0 0
M  V30 18 C 2.6675 11.5503 0.0 0
M  V30 19 O 10.6698 6.9302 0.0 0
M  V30 20 N 9.3360 4.6201 0.0 0 CHG=1 VAL=4
M  V30 21 C 12.0035 7.7002 0.0 0
M  V30 22 N 10.6698 3.8501 0.0 0 CHG=-1
M  V30 23 C 4.0012 3.0801 0.0 0
M  V30 24 C 2.6675 2.3101 0.0 0
M  V30 25 C 5.3348 2.3101 0.0 0
M  V30 26 C 2.6675 0.7700 0.0 0
M  V30 27 C 5.3348 0.7700 0.0 0
M  V30 28 C 4.0012 0.0000 0.0 0
M  V30 29 C 13.3372 6.9302 0.0 0
M  V30 30 C 13.3372 5.3901 0.0 0
M  V30 31 C 14.6708 7.7002 0.0 0
M  V30 32 C 14.6708 4.6201 0.0 0
M  V30 33 C 16.0046 6.9302 0.0 0
M  V30 34 C 16.0046 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=3
M  V30 4 1 2 5 CFG=3
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 3 8 CFG=3
M  V30 8 1 4 9
M  V30 9 1 5 10
M  V30 10 1 6 11
M  V30 11 2 6 12
M  V30 12 1 7 13 CFG=1
M  V30 13 1 7 14
M  V30 14 1 9 23
M  V30 15 1 10 15
M  V30 16 2 10 16
M  V30 17 2 10 17
M  V30 18 1 11 18
M  V30 19 1 13 19
M  V30 20 2 14 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 1 21 29
M  V30 24 2 23 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 2 25 27
M  V30 28 2 26 28
M  V30 29 1 27 28
M  V30 30 2 29 30
M  V30 31 1 29 31
M  V30 32 1 30 32
M  V30 33 2 31 33
M  V30 34 2 32 34
M  V30 35 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 1 2 3 7)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1395068-41-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1591783-18-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-6120624
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Methyl 5-Azido-3,6-di-O-benzyl-5-deoxy-2-O-methanesulfonyl-D-mannonamide
44D. Methylamine solution (33% in absolute ethanol, 0.24 mL, 1.90 mmol)
was added to a solution of the mesylate 43D (0.18 g, 0.38 mmol) in
1,4-dioxane (3 mL) at rt. The reaction was stirred for 16 h, after which
TLC analysis (1:1, ethyl acetate-cyclohexane) indicated the complete
consumption of the starting material and the formation of a major
product. The reaction was concentrated in vacuo, and the remaining
residue was purified by flash chromatography (1:4, ethyl
acetate-cyclohexane) to afford the product. amide 44D (170 mg, 92%) as a
colorless oil. (Rf 0.29). [α]20D -52.8 (c 0.71 in CHCl3). νmax (thin
film): 3394 (br s, OH, NH), 2101 (s, N3), 1668 (s, CO). δH (400 MHz,
CDCl3): 2.85 (3 H, d, N-Me, JH,NH 4.8), 3.06 (3 H, s, SO2-Me), 3.51 (1 H,
br s 4-OH), 3.58 (1 H, ddd, H-5, J5,6' 3.4, J5,6 6.4, J5,4 9.6), 3.71 (1
H, m, H-4), 3.72 (1 H, dd, H-6, J6,5 6.4, J6,6' 10.0), 3.89 (1 H, dd,
H-6', J6',5 3.4, J6',6 10.0), 4.25 (1 H, dd, H-3, J3,4 1.4, J3,2 4.0),
4.57 (2 H, s, OCH2Ph), 4.63 (1 H, d, OCH2Ph, Jgem 10.8), 4.75 (1 H, d,
OCH2Ph, Jgem 10.8), 5.25 (1 H, d, H-2, J2,3 4.0), 6.55 (1 H, q, N-H,
JNH,H 4.8), 7.28-7.40 (10 H, m, Ar-H). δC (100 MHz, CDCl3): 26.6 (N-Me),
39.1 (SO2-Me), 61.9 (C-5), 70.3 (C-6), 70.4 (C-4), 73.7, 74.3 (OCH2Ph),
77.1 (C-3), 79.7 (C-2), 127.8, 128.0, 128.6, 128.7, 128.7, 128.7, 128.8
(ArCH), 136.8, 137.7 (ArCC), 167.1 (C-1). m/z (ESI +ve): 493 (M + H+, 9),
515 (M + Na+, 30), 1007 (2M + Na+, 100). HRMS m/z (ESI +ve): found
515.1567 [M + Na+], C22H28N4NaO7S requires 515.1571.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Nine of 16 Stereoisomeric Polyhydroxylated Proline Amides Are Potent
β-N-Acetylhexosaminidase Inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ayers, Benjamin J.; Glawar, Andreas F. G.; Martinez, R. Fernando; Ngo,
Nigel; Liu, Zilei; Fleet, George W. J.; Butters, Terry D.; Nash, Robert
J.; Yu, Chu-Yi; Wormald, Mark R.; Nakagawa, Shinpei; Adachi, Isao; Kato,
Atsushi; Jenkinson, Sarah F.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2014), 79(8), 3398-3409

$RFMT $RIREG SCHEME203 STEP1
$RXN



  1  1
$MOL
2(1H)-Pyridinethione, 5-nitro-, compd. with hydrazine (1:1)
C5H4N2O2S.H4N2
1403743-13-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.8737 0.0 0 VAL=5
M  V30 2 O 0.0000 1.5400 0.0 0
M  V30 3 O 0.0000 4.2073 0.0 0
M  V30 4 S 6.9302 2.8737 0.0 0
M  V30 5 C 2.3101 2.8737 0.0 0
M  V30 6 C 3.0801 4.2073 0.0 0
M  V30 7 C 3.0801 1.5400 0.0 0
M  V30 8 C 4.6201 4.2073 0.0 0
M  V30 9 N 4.6201 1.5400 0.0 0
M  V30 10 C 5.3901 2.8737 0.0 0
M  V30 11 N 2.6951 0.0000 0.0 0
M  V30 12 N 4.2351 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 2 4 10
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 10
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Iron, bis[μ-(5-nitro-2(1H)-pyridinethionato-κS2:κS2)]tetranitrosyldi-, (Fe-Fe...
C10H6Fe2N8O8S2
1403743-12-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 10.5504 7.7271 0.0 0 VAL=4
M  V30 2 O 11.7783 8.4388 0.0 0 CHG=1 VAL=3
M  V30 3 N 8.0947 9.1466 0.0 0 VAL=4
M  V30 4 O 8.0947 10.5661 0.0 0 CHG=1 VAL=3
M  V30 5 N 4.5205 2.9524 0.0 0 VAL=4
M  V30 6 O 3.2926 2.2446 0.0 0 CHG=1 VAL=3
M  V30 7 N 6.9763 1.5329 0.0 0 VAL=4
M  V30 8 O 6.9763 0.1173 0.0 0 CHG=1 VAL=3
M  V30 9 N 13.9760 1.4156 0.0 0 VAL=5
M  V30 10 O 13.9760 0.0000 0.0 0
M  V30 11 O 15.2039 2.1273 0.0 0
M  V30 12 N 1.2279 9.2717 0.0 0 VAL=5
M  V30 13 O 1.2279 10.6873 0.0 0
M  V30 14 O 0.0000 8.5600 0.0 0
M  V30 15 Fe 8.0947 6.3115 0.0 0 CHG=-1 VAL=5
M  V30 16 Fe 6.9763 4.3719 0.0 0 CHG=-1 VAL=5
M  V30 17 S 8.8533 4.3758 0.0 0 VAL=4
M  V30 18 S 6.3506 6.3115 0.0 0 VAL=4
M  V30 19 C 10.0812 3.6680 0.0 0
M  V30 20 C 11.4147 4.4345 0.0 0
M  V30 21 N 10.0812 2.1273 0.0 0 CHG=-1
M  V30 22 C 12.7481 3.6680 0.0 0
M  V30 23 C 11.4147 1.3569 0.0 0
M  V30 24 C 12.7481 2.1273 0.0 0
M  V30 25 C 5.1227 7.0232 0.0 0
M  V30 26 C 3.7892 6.2528 0.0 0
M  V30 27 N 5.1227 8.5600 0.0 0 CHG=-1
M  V30 28 C 2.4558 7.0232 0.0 0
M  V30 29 C 3.7892 9.3304 0.0 0
M  V30 30 C 2.4558 8.5600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 15
M  V30 3 3 3 4
M  V30 4 1 3 15
M  V30 5 3 5 6
M  V30 6 1 5 16
M  V30 7 3 7 8
M  V30 8 1 7 16
M  V30 9 2 9 10
M  V30 10 2 9 11
M  V30 11 1 9 24
M  V30 12 2 12 13
M  V30 13 2 12 14
M  V30 14 1 12 30
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 1 15 18
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 25
M  V30 22 1 19 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 24
M  V30 28 1 25 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1403743-13-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1403743-12-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-562-CAS-17762874
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7772-98-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 125823-36-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, structure, and NO-donor activity of
bis(5-nitropyridine-2-thiolato)tetranitrosyliron
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kozub, G. I.; Sanina, N. A.; Kondrat'eva, T. A.; Shilov, G. V.;
Korchagin, D. V.; Ovanesyan, N. S.; Aldoshin, S. M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Russian Journal of Coordination Chemistry (2012), 38(10), 671-682

$RFMT $RIREG SCHEME204 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(2-chloro-5-thiazolyl)methyl]carbamate
C9H13ClN2O2S
1416712-48-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6687 2.6218 0.0 0
M  V30 2 N 5.3348 1.8517 0.0 0
M  V30 3 C 4.0012 2.6218 0.0 0
M  V30 4 O 2.6675 1.8517 0.0 0
M  V30 5 O 4.0012 4.1618 0.0 0
M  V30 6 C 1.3338 2.6218 0.0 0
M  V30 7 C 0.5638 1.2881 0.0 0
M  V30 8 C 0.0000 3.3918 0.0 0
M  V30 9 C 2.1038 3.9554 0.0 0
M  V30 10 Cl 11.9713 1.4946 0.0 0
M  V30 11 C 8.0023 1.8517 0.0 0
M  V30 12 S 9.4091 2.4782 0.0 0
M  V30 13 C 8.1633 0.3202 0.0 0
M  V30 14 C 10.4397 1.3337 0.0 0
M  V30 15 N 9.6697 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 10 14
M  V30 11 1 11 12
M  V30 12 2 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[[2-(methylamino)-5-thiazolyl]methyl]carbamate
C10H17N3O2S
2114301-98-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6687 1.5400 0.0 0
M  V30 2 N 5.3348 2.3101 0.0 0
M  V30 3 C 4.0012 1.5400 0.0 0
M  V30 4 O 2.6675 2.3101 0.0 0
M  V30 5 O 4.0012 0.0000 0.0 0
M  V30 6 C 1.3338 1.5400 0.0 0
M  V30 7 C 2.1038 0.2064 0.0 0
M  V30 8 C 0.0000 0.7700 0.0 0
M  V30 9 C 0.5638 2.8737 0.0 0
M  V30 10 N 11.9713 2.6672 0.0 0
M  V30 11 C 12.8765 3.9131 0.0 0
M  V30 12 C 8.0023 2.3101 0.0 0
M  V30 13 S 9.4091 1.6836 0.0 0
M  V30 14 C 8.1633 3.8416 0.0 0
M  V30 15 C 10.4397 2.8281 0.0 0
M  V30 16 N 9.6697 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 10 11
M  V30 11 1 10 15
M  V30 12 1 12 13
M  V30 13 2 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1416712-48-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2114301-98-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-17358888
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of tricyclic carboxamides as hepatitis B core protein
modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Turner, William; Arnold, Lee Daniel; Maag, Hans; Li, Leping; Bures, Mark;
Haydar, Simon; Francis, Samson
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2017048950 A1 2017-03-23

$RFMT $RIREG SCHEME205 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(2-Chlorophenyl)-4-methyl[1,2,4]triazolo[4,3-a]quinoxaline-8-carboxylic acid
C17H11ClN4O2
1417411-00-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.6646 6.9302 0.0 0
M  V30 2 C 2.9961 1.5400 0.0 0
M  V30 3 O 1.6625 2.3101 0.0 0
M  V30 4 O 2.9961 0.0000 0.0 0
M  V30 5 Cl 2.4580 9.4795 0.0 0
M  V30 6 N 5.6636 6.1601 0.0 0
M  V30 7 C 5.6636 4.6201 0.0 0
M  V30 8 C 4.5191 7.1906 0.0 0
M  V30 9 C 6.9973 6.9302 0.0 0
M  V30 10 C 6.9973 3.8501 0.0 0
M  V30 11 C 4.3298 3.8501 0.0 0
M  V30 12 N 5.1454 8.5975 0.0 0
M  V30 13 N 6.6771 8.4365 0.0 0
M  V30 14 C 8.3310 6.1601 0.0 0
M  V30 15 N 8.3310 4.6201 0.0 0
M  V30 16 C 6.9973 2.3101 0.0 0
M  V30 17 C 4.3298 2.3101 0.0 0
M  V30 18 C 5.6636 1.5400 0.0 0
M  V30 19 C 3.0128 6.8704 0.0 0
M  V30 20 C 1.9822 8.0150 0.0 0
M  V30 21 C 2.5367 5.4058 0.0 0
M  V30 22 C 0.4759 7.6946 0.0 0
M  V30 23 C 1.0304 5.0855 0.0 0
M  V30 24 C 0.0000 6.2301 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 17
M  V30 5 1 5 20
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 8 19
M  V30 13 2 9 13
M  V30 14 1 9 14
M  V30 15 1 10 15
M  V30 16 2 10 16
M  V30 17 1 11 17
M  V30 18 1 12 13
M  V30 19 2 14 15
M  V30 20 1 16 18
M  V30 21 2 17 18
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(2-Chlorophenyl)-N,4-dimethyl[1,2,4]triazolo[4,3-a]quinoxaline-8-carboxamide
C18H14ClN5O
1417409-40-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.7800 5.8110 0.0 0
M  V30 2 C 2.3100 7.1447 0.0 0
M  V30 3 N 1.5400 8.4783 0.0 0
M  V30 4 O 1.5400 5.8110 0.0 0
M  V30 5 C 0.0000 8.4783 0.0 0
M  V30 6 Cl 5.8138 0.0000 0.0 0
M  V30 7 N 6.9300 4.4772 0.0 0
M  V30 8 C 6.1600 5.8110 0.0 0
M  V30 9 C 6.4541 3.0127 0.0 0
M  V30 10 C 8.4700 4.4772 0.0 0
M  V30 11 C 6.9300 7.1447 0.0 0
M  V30 12 C 4.6200 5.8110 0.0 0
M  V30 13 N 7.7000 2.1075 0.0 0
M  V30 14 C 9.2400 5.8110 0.0 0
M  V30 15 N 8.9459 3.0127 0.0 0
M  V30 16 N 8.4700 7.1447 0.0 0
M  V30 17 C 6.1600 8.4783 0.0 0
M  V30 18 C 3.8500 7.1447 0.0 0
M  V30 19 C 4.6200 8.4783 0.0 0
M  V30 20 C 4.9894 2.5368 0.0 0
M  V30 21 C 4.6693 1.0304 0.0 0
M  V30 22 C 3.8451 3.5673 0.0 0
M  V30 23 C 3.2047 0.5546 0.0 0
M  V30 24 C 2.3804 3.0914 0.0 0
M  V30 25 C 2.0602 1.5850 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 18
M  V30 5 1 3 5
M  V30 6 1 6 21
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 9 20
M  V30 14 1 10 14
M  V30 15 2 10 15
M  V30 16 1 11 16
M  V30 17 2 11 17
M  V30 18 1 12 18
M  V30 19 1 13 15
M  V30 20 2 14 16
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1417411-00-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1417409-40-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-19362796
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Mathematical and Structural Characterization of Strong Nonadditive
Structure-Activity Relationship Caused by Protein Conformational Changes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gomez, Laurent; Xu, Rui; Sinko, William; Selfridge, Brandon; Vernier,
William; Ly, Kiev; Truong, Richard; Metz, Markus; Marrone, Tami; Sebring,
Kristen; Yan, Yingzhou; Appleton, Brent; Aertgeerts, Kathleen; Massari,
Mark Eben; Breitenbucher, J. Guy
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2018), 61(17), 7754-7766

$RFMT $RIREG SCHEME206 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5,8-Dibromo-2-chloroquinoxaline
C8H3Br2ClN2
1417568-90-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 3.0800 0.0000 0.0 0
M  V30 2 Br 0.0000 5.3349 0.0 0
M  V30 3 Cl 6.9300 4.0011 0.0 0
M  V30 4 C 3.0800 2.6674 0.0 0
M  V30 5 C 2.3100 4.0011 0.0 0
M  V30 6 C 2.3100 1.3338 0.0 0
M  V30 7 N 4.6200 2.6674 0.0 0
M  V30 8 C 0.7700 4.0011 0.0 0
M  V30 9 N 3.0800 5.3349 0.0 0
M  V30 10 C 0.7700 1.3338 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 0.0000 2.6674 0.0 0
M  V30 13 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 2 8
M  V30 3 1 3 11
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5,8-Dibromo-N-methyl-2-quinoxalinamine
C9H7Br2N3
1417568-94-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 1.3336 0.0000 0.0 0
M  V30 2 Br 1.3336 6.1600 0.0 0
M  V30 3 N 6.6685 4.6200 0.0 0
M  V30 4 C 8.0021 3.8500 0.0 0
M  V30 5 C 2.6674 2.3100 0.0 0
M  V30 6 C 2.6674 3.8500 0.0 0
M  V30 7 N 4.0011 1.5400 0.0 0
M  V30 8 C 1.3336 1.5400 0.0 0
M  V30 9 N 4.0011 4.6200 0.0 0
M  V30 10 C 1.3336 4.6200 0.0 0
M  V30 11 C 5.3347 2.3100 0.0 0
M  V30 12 C 0.0000 2.3100 0.0 0
M  V30 13 C 5.3347 3.8500 0.0 0
M  V30 14 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 10
M  V30 3 1 3 4
M  V30 4 1 3 13
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1417568-90-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1417568-94-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-080-CAS-2028582
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 1: 5,8-dibromo-N-methylquinoxalin-2-amine (26a).
5,8-dibromo-2-chloroquinoxaline (25b) (0.20 g, 0.62 mmol) was dissolved
in tetrahydrofuran (6 ml) to which a solution of methyl amine in
tetrahydrofuran (3 ml) was added at room temperature. The resulting
reaction mixture was refluxed for 2 hours. After completion of the
reaction, the volatiles were removed under vacuum and water (20 ml) was
added to the reaction mixture. The resulting aqueous layer was extracted
with ethyl acetate (3 x 15 ml). The combined organic layer so obtained
was washed with water (20 ml) and brine (20 ml), dried over Na2SO4 and
concentrated under vacuum. The crude product so obtained was purified by
flash column chromatography to afford
5,8-dibromo-N-methylquinoxalin-2-amine (26a). Yield (0.18 g, 92%). MS
(EI) m/z: = 317.9 (M+1). 1H NMR (400 MHz, DMSO-d6): 8.35 (s, 1H), 8.16
(bs, 1H), 7.81 (d, J= 8 Hz, 1H), 7.55 (d, J= 8 Hz, 1H), 2.99 (s, 3H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of sulfone derivatives and their use as PKM2 modulators for
the treatment of cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kukreja, Gagan; Phukan, Samiron; Kodam, Jawahar; More, Dattatray Maruti;
Uravane, Mahesh Vilas; Palle, Venkata P.; Kamboj, Rajender Kumar
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2013005157 A1 2013-01-10

$RFMT $RIREG SCHEME207 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,6-Bis(4-phenyl-1H-1,2,3-triazol-1-yl)-9-(2,3,5-tri-O-acetyl-β-D-ribofuranos...
C32H28N10O7
1420352-79-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  49 55 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.3196 12.5939 0.0 0
M  V30 2 C 3.9860 13.3639 0.0 0
M  V30 3 C 2.6522 12.5939 0.0 0
M  V30 4 O 3.9860 14.9039 0.0 0
M  V30 5 O 2.6091 10.6245 0.0 0
M  V30 6 C 1.4647 9.5941 0.0 0
M  V30 7 C 0.0000 10.0700 0.0 0
M  V30 8 O 1.7849 8.0878 0.0 0
M  V30 9 C 3.6444 7.4382 0.0 0
M  V30 10 O 4.2707 6.0313 0.0 0
M  V30 11 C 3.3655 4.7854 0.0 0
M  V30 12 C 3.9920 3.3785 0.0 0
M  V30 13 O 1.8340 4.9464 0.0 0
M  V30 14 C 9.2761 9.7195 0.0 0
M  V30 15 N 8.0302 10.6245 0.0 0
M  V30 16 C 10.5219 10.6245 0.0 0
M  V30 17 N 9.4370 8.1878 0.0 0
M  V30 18 C 8.5061 12.0892 0.0 0
M  V30 19 C 11.9287 9.9982 0.0 0
M  V30 20 N 10.0461 12.0892 0.0 0
M  V30 21 C 10.8438 7.5614 0.0 0
M  V30 22 N 12.0898 8.4667 0.0 0
M  V30 23 C 6.5655 10.1487 0.0 0 CFG=2
M  V30 24 C 5.3196 11.0539 0.0 0 CFG=2
M  V30 25 O 6.0897 8.6841 0.0 0
M  V30 26 C 4.0738 10.1487 0.0 0 CFG=2
M  V30 27 C 4.5496 8.6841 0.0 0 CFG=2
M  V30 28 N 13.1748 10.9034 0.0 0
M  V30 29 C 14.6393 10.4275 0.0 0
M  V30 30 N 13.1748 12.4434 0.0 0
M  V30 31 C 15.5445 11.6734 0.0 0
M  V30 32 N 14.6393 12.9193 0.0 0
M  V30 33 N 11.0049 6.0299 0.0 0
M  V30 34 C 12.3385 5.2599 0.0 0
M  V30 35 N 9.8604 4.9993 0.0 0
M  V30 36 C 12.0184 3.7535 0.0 0
M  V30 37 N 10.4868 3.5925 0.0 0
M  V30 38 C 17.0845 11.6734 0.0 0
M  V30 39 C 17.8545 13.0071 0.0 0
M  V30 40 C 17.8545 10.3398 0.0 0
M  V30 41 C 19.3945 13.0071 0.0 0
M  V30 42 C 19.3945 10.3398 0.0 0
M  V30 43 C 20.1646 11.6734 0.0 0
M  V30 44 C 13.0488 2.6091 0.0 0
M  V30 45 C 12.5729 1.1444 0.0 0
M  V30 46 C 14.5552 2.9292 0.0 0
M  V30 47 C 13.6034 0.0000 0.0 0
M  V30 48 C 15.5856 1.7849 0.0 0
M  V30 49 C 15.1098 0.3202 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 24 1 CFG=1
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 6
M  V30 6 1 26 5 CFG=1
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 9 10
M  V30 10 1 27 9 CFG=3
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 2 14 17
M  V30 17 1 15 18
M  V30 18 1 23 15 CFG=3
M  V30 19 2 16 19
M  V30 20 1 16 20
M  V30 21 1 17 21
M  V30 22 2 18 20
M  V30 23 1 19 22
M  V30 24 1 19 28
M  V30 25 2 21 22
M  V30 26 1 21 33
M  V30 27 1 23 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 1 26 27
M  V30 32 1 28 29
M  V30 33 1 28 30
M  V30 34 2 29 31
M  V30 35 2 30 32
M  V30 36 1 31 32
M  V30 37 1 31 38
M  V30 38 1 33 34
M  V30 39 1 33 35
M  V30 40 2 34 36
M  V30 41 2 35 37
M  V30 42 1 36 37
M  V30 43 1 36 44
M  V30 44 2 38 39
M  V30 45 1 38 40
M  V30 46 1 39 41
M  V30 47 2 40 42
M  V30 48 2 41 43
M  V30 49 1 42 43
M  V30 50 2 44 45
M  V30 51 1 44 46
M  V30 52 1 45 47
M  V30 53 2 46 48
M  V30 54 2 47 49
M  V30 55 1 48 49
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 23 24 26 27)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-Methyl-2-(4-phenyl-1H-1,2,3-triazol-1-yl)adenosine
C19H20N8O4
906670-49-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 35 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 5.9846 10.8916 0.0 0
M  V30 2 C 7.3184 11.6616 0.0 0
M  V30 3 O 0.0000 5.5302 0.0 0
M  V30 4 C 3.1864 1.1445 0.0 0
M  V30 5 O 2.1559 0.0000 0.0 0
M  V30 6 O 0.0000 2.1799 0.0 0
M  V30 7 C 4.6510 7.0415 0.0 0
M  V30 8 N 3.1864 6.5655 0.0 0
M  V30 9 C 4.6510 8.5815 0.0 0
M  V30 10 N 5.9846 6.2715 0.0 0
M  V30 11 C 2.2812 7.8115 0.0 0
M  V30 12 C 5.9846 9.3515 0.0 0
M  V30 13 N 3.1864 9.0574 0.0 0
M  V30 14 C 7.3184 7.0415 0.0 0
M  V30 15 N 7.3184 8.5815 0.0 0
M  V30 16 C 2.7104 5.1010 0.0 0 CFG=1
M  V30 17 O 3.6156 3.8551 0.0 0
M  V30 18 C 1.2459 4.6251 0.0 0 CFG=2
M  V30 19 C 2.7104 2.6091 0.0 0 CFG=2
M  V30 20 C 1.2459 3.0851 0.0 0 CFG=2
M  V30 21 N 8.6521 6.2715 0.0 0
M  V30 22 C 10.0589 6.8978 0.0 0
M  V30 23 N 8.8130 4.7398 0.0 0
M  V30 24 C 11.0894 5.7533 0.0 0
M  V30 25 N 10.3194 4.4197 0.0 0
M  V30 26 C 12.6210 5.9144 0.0 0
M  V30 27 C 13.2473 7.3212 0.0 0
M  V30 28 C 13.5262 4.6685 0.0 0
M  V30 29 C 14.7788 7.4821 0.0 0
M  V30 30 C 15.0577 4.8295 0.0 0
M  V30 31 C 15.6841 6.2363 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 18 3 CFG=1
M  V30 4 1 4 5
M  V30 5 1 19 4 CFG=3
M  V30 6 1 20 6 CFG=1
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 16 8 CFG=3
M  V30 12 2 9 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 2 11 13
M  V30 16 1 12 15
M  V30 17 2 14 15
M  V30 18 1 14 21
M  V30 19 1 16 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 1 19 20
M  V30 24 1 21 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 29 1 24 26
M  V30 30 2 26 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 2 28 30
M  V30 34 2 29 31
M  V30 35 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 16 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1420352-79-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 906670-49-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-352-CAS-4592010
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Application of 2,6-diazidopurine derivatives in the synthesis of
thiopurine nucleosides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Novosjolova, Irina; Bizdena, Erika; Turks, Maris
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2013), 54(48), 6557-6561

$RFMT $RIREG SCHEME207 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,6-Bis(4-phenyl-1H-1,2,3-triazol-1-yl)-9-(2,3,5-tri-O-acetyl-β-D-ribofuranos...
C32H28N10O7
1420352-79-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  49 55 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.3196 12.5939 0.0 0
M  V30 2 C 3.9860 13.3639 0.0 0
M  V30 3 C 2.6522 12.5939 0.0 0
M  V30 4 O 3.9860 14.9039 0.0 0
M  V30 5 O 2.6091 10.6245 0.0 0
M  V30 6 C 1.4647 9.5941 0.0 0
M  V30 7 C 0.0000 10.0700 0.0 0
M  V30 8 O 1.7849 8.0878 0.0 0
M  V30 9 C 3.6444 7.4382 0.0 0
M  V30 10 O 4.2707 6.0313 0.0 0
M  V30 11 C 3.3655 4.7854 0.0 0
M  V30 12 C 3.9920 3.3785 0.0 0
M  V30 13 O 1.8340 4.9464 0.0 0
M  V30 14 C 9.2761 9.7195 0.0 0
M  V30 15 N 8.0302 10.6245 0.0 0
M  V30 16 C 10.5219 10.6245 0.0 0
M  V30 17 N 9.4370 8.1878 0.0 0
M  V30 18 C 8.5061 12.0892 0.0 0
M  V30 19 C 11.9287 9.9982 0.0 0
M  V30 20 N 10.0461 12.0892 0.0 0
M  V30 21 C 10.8438 7.5614 0.0 0
M  V30 22 N 12.0898 8.4667 0.0 0
M  V30 23 C 6.5655 10.1487 0.0 0 CFG=2
M  V30 24 C 5.3196 11.0539 0.0 0 CFG=2
M  V30 25 O 6.0897 8.6841 0.0 0
M  V30 26 C 4.0738 10.1487 0.0 0 CFG=2
M  V30 27 C 4.5496 8.6841 0.0 0 CFG=2
M  V30 28 N 13.1748 10.9034 0.0 0
M  V30 29 C 14.6393 10.4275 0.0 0
M  V30 30 N 13.1748 12.4434 0.0 0
M  V30 31 C 15.5445 11.6734 0.0 0
M  V30 32 N 14.6393 12.9193 0.0 0
M  V30 33 N 11.0049 6.0299 0.0 0
M  V30 34 C 12.3385 5.2599 0.0 0
M  V30 35 N 9.8604 4.9993 0.0 0
M  V30 36 C 12.0184 3.7535 0.0 0
M  V30 37 N 10.4868 3.5925 0.0 0
M  V30 38 C 17.0845 11.6734 0.0 0
M  V30 39 C 17.8545 13.0071 0.0 0
M  V30 40 C 17.8545 10.3398 0.0 0
M  V30 41 C 19.3945 13.0071 0.0 0
M  V30 42 C 19.3945 10.3398 0.0 0
M  V30 43 C 20.1646 11.6734 0.0 0
M  V30 44 C 13.0488 2.6091 0.0 0
M  V30 45 C 12.5729 1.1444 0.0 0
M  V30 46 C 14.5552 2.9292 0.0 0
M  V30 47 C 13.6034 0.0000 0.0 0
M  V30 48 C 15.5856 1.7849 0.0 0
M  V30 49 C 15.1098 0.3202 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 24 1 CFG=1
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 6
M  V30 6 1 26 5 CFG=1
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 9 10
M  V30 10 1 27 9 CFG=3
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 2 14 17
M  V30 17 1 15 18
M  V30 18 1 23 15 CFG=3
M  V30 19 2 16 19
M  V30 20 1 16 20
M  V30 21 1 17 21
M  V30 22 2 18 20
M  V30 23 1 19 22
M  V30 24 1 19 28
M  V30 25 2 21 22
M  V30 26 1 21 33
M  V30 27 1 23 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 1 26 27
M  V30 32 1 28 29
M  V30 33 1 28 30
M  V30 34 2 29 31
M  V30 35 2 30 32
M  V30 36 1 31 32
M  V30 37 1 31 38
M  V30 38 1 33 34
M  V30 39 1 33 35
M  V30 40 2 34 36
M  V30 41 2 35 37
M  V30 42 1 36 37
M  V30 43 1 36 44
M  V30 44 2 38 39
M  V30 45 1 38 40
M  V30 46 1 39 41
M  V30 47 2 40 42
M  V30 48 2 41 43
M  V30 49 1 42 43
M  V30 50 2 44 45
M  V30 51 1 44 46
M  V30 52 1 45 47
M  V30 53 2 46 48
M  V30 54 2 47 49
M  V30 55 1 48 49
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 23 24 26 27)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-Methyl-2-(4-phenyl-1H-1,2,3-triazol-1-yl)adenosine
C19H20N8O4
906670-49-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 35 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 5.9846 10.8916 0.0 0
M  V30 2 C 7.3184 11.6616 0.0 0
M  V30 3 O 0.0000 5.5302 0.0 0
M  V30 4 C 3.1864 1.1445 0.0 0
M  V30 5 O 2.1559 0.0000 0.0 0
M  V30 6 O 0.0000 2.1799 0.0 0
M  V30 7 C 4.6510 7.0415 0.0 0
M  V30 8 N 3.1864 6.5655 0.0 0
M  V30 9 C 4.6510 8.5815 0.0 0
M  V30 10 N 5.9846 6.2715 0.0 0
M  V30 11 C 2.2812 7.8115 0.0 0
M  V30 12 C 5.9846 9.3515 0.0 0
M  V30 13 N 3.1864 9.0574 0.0 0
M  V30 14 C 7.3184 7.0415 0.0 0
M  V30 15 N 7.3184 8.5815 0.0 0
M  V30 16 C 2.7104 5.1010 0.0 0 CFG=1
M  V30 17 O 3.6156 3.8551 0.0 0
M  V30 18 C 1.2459 4.6251 0.0 0 CFG=2
M  V30 19 C 2.7104 2.6091 0.0 0 CFG=2
M  V30 20 C 1.2459 3.0851 0.0 0 CFG=2
M  V30 21 N 8.6521 6.2715 0.0 0
M  V30 22 C 10.0589 6.8978 0.0 0
M  V30 23 N 8.8130 4.7398 0.0 0
M  V30 24 C 11.0894 5.7533 0.0 0
M  V30 25 N 10.3194 4.4197 0.0 0
M  V30 26 C 12.6210 5.9144 0.0 0
M  V30 27 C 13.2473 7.3212 0.0 0
M  V30 28 C 13.5262 4.6685 0.0 0
M  V30 29 C 14.7788 7.4821 0.0 0
M  V30 30 C 15.0577 4.8295 0.0 0
M  V30 31 C 15.6841 6.2363 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 18 3 CFG=1
M  V30 4 1 4 5
M  V30 5 1 19 4 CFG=3
M  V30 6 1 20 6 CFG=1
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 16 8 CFG=3
M  V30 12 2 9 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 2 11 13
M  V30 16 1 12 15
M  V30 17 2 14 15
M  V30 18 1 14 21
M  V30 19 1 16 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 1 19 20
M  V30 24 1 21 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 29 1 24 26
M  V30 30 2 26 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 2 28 30
M  V30 34 2 29 31
M  V30 35 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 16 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1420352-79-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 906670-49-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-352-CAS-6628411
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 1,2,3-Triazoles as leaving groups in purine chemistry: a three-step
synthesis of N6-substituted-2-triazolyl-adenine nucleosides and
photophysical properties thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kovalovs, Armands; Novosjolova, Irina; Bizdena, Erika; Bizane, Inga;
Skardziute, Lina; Kazlauskas, Karolis; Jursenas, Saulius; Turks, Maris
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2013), 54(8), 850-853

$RFMT $RIREG SCHEME208 STEP1
$RXN



  2  1
$MOL
Methyl (5R,7R)-5,8,8-trimethyl-7-[[(2R)-2-methyl-1-oxo-6-(phenylmethoxy)hexyl...
C27H44O5
1424403-24-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 32 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 13.8602 9.3359 0.0 0 CFG=1
M  V30 2 O 12.3201 9.3359 0.0 0
M  V30 3 C 14.6302 8.0021 0.0 0
M  V30 4 C 14.6302 10.6695 0.0 0
M  V30 5 C 11.5501 8.0021 0.0 0
M  V30 6 C 16.1702 8.0021 0.0 0 CFG=2
M  V30 7 C 13.2965 11.4396 0.0 0
M  V30 8 C 15.4002 12.0032 0.0 0
M  V30 9 C 15.9638 9.8995 0.0 0
M  V30 10 C 10.0101 8.0021 0.0 0 CFG=2
M  V30 11 O 12.3201 6.6684 0.0 0
M  V30 12 C 16.9402 6.6684 0.0 0
M  V30 13 C 16.9402 9.3359 0.0 0
M  V30 14 C 9.2401 6.6684 0.0 0
M  V30 15 C 9.2401 9.3359 0.0 0
M  V30 16 C 18.4802 6.6684 0.0 0
M  V30 17 C 7.7001 6.6684 0.0 0
M  V30 18 C 19.2502 5.3348 0.0 0
M  V30 19 C 6.9301 5.3348 0.0 0
M  V30 20 C 20.7902 5.3348 0.0 0
M  V30 21 C 5.3901 5.3348 0.0 0
M  V30 22 O 21.5602 4.0011 0.0 0
M  V30 23 O 21.5602 6.6684 0.0 0
M  V30 24 O 4.6201 4.0011 0.0 0
M  V30 25 C 23.1003 4.0011 0.0 0
M  V30 26 C 3.0800 4.0011 0.0 0
M  V30 27 C 2.3100 2.6673 0.0 0
M  V30 28 C 0.7700 2.6673 0.0 0
M  V30 29 C 3.0800 1.3337 0.0 0
M  V30 30 C 0.0000 1.3337 0.0 0
M  V30 31 C 2.3100 0.0000 0.0 0
M  V30 32 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 4 8
M  V30 8 1 4 9
M  V30 9 1 5 10
M  V30 10 2 5 11
M  V30 11 1 6 12
M  V30 12 1 6 13 CFG=3
M  V30 13 1 10 14
M  V30 14 1 10 15 CFG=1
M  V30 15 1 12 16
M  V30 16 1 14 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 1 19 21
M  V30 21 1 20 22
M  V30 22 2 20 23
M  V30 23 1 21 24
M  V30 24 1 22 25
M  V30 25 1 24 26
M  V30 26 1 26 27
M  V30 27 2 27 28
M  V30 28 1 27 29
M  V30 29 1 28 30
M  V30 30 2 29 31
M  V30 31 2 30 32
M  V30 32 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 1 6 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(1R,3R)-1-(1,1-Dimethylethyl)-3-methyl-7-(methylamino)-7-oxoheptyl (2R)-2-met...
C27H45NO4
1424403-25-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 32 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 13.8602 9.3359 0.0 0 CFG=1
M  V30 2 O 12.3201 9.3359 0.0 0
M  V30 3 C 14.6302 8.0021 0.0 0
M  V30 4 C 14.6302 10.6695 0.0 0
M  V30 5 C 11.5501 8.0021 0.0 0
M  V30 6 C 16.1702 8.0021 0.0 0 CFG=2
M  V30 7 C 13.2965 11.4396 0.0 0
M  V30 8 C 15.4002 12.0032 0.0 0
M  V30 9 C 15.9638 9.8995 0.0 0
M  V30 10 C 10.0101 8.0021 0.0 0 CFG=2
M  V30 11 O 12.3201 6.6684 0.0 0
M  V30 12 C 16.9402 6.6684 0.0 0
M  V30 13 C 16.9402 9.3359 0.0 0
M  V30 14 C 9.2401 6.6684 0.0 0
M  V30 15 C 9.2401 9.3359 0.0 0
M  V30 16 C 18.4802 6.6684 0.0 0
M  V30 17 C 7.7001 6.6684 0.0 0
M  V30 18 C 19.2502 5.3348 0.0 0
M  V30 19 C 6.9301 5.3348 0.0 0
M  V30 20 C 20.7902 5.3348 0.0 0
M  V30 21 C 5.3901 5.3348 0.0 0
M  V30 22 N 21.5602 4.0011 0.0 0
M  V30 23 O 21.5602 6.6684 0.0 0
M  V30 24 O 4.6201 4.0011 0.0 0
M  V30 25 C 23.1003 4.0011 0.0 0
M  V30 26 C 3.0800 4.0011 0.0 0
M  V30 27 C 2.3100 2.6673 0.0 0
M  V30 28 C 0.7700 2.6673 0.0 0
M  V30 29 C 3.0800 1.3337 0.0 0
M  V30 30 C 0.0000 1.3337 0.0 0
M  V30 31 C 2.3100 0.0000 0.0 0
M  V30 32 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 4 8
M  V30 8 1 4 9
M  V30 9 1 5 10
M  V30 10 2 5 11
M  V30 11 1 6 12
M  V30 12 1 6 13 CFG=3
M  V30 13 1 10 14
M  V30 14 1 10 15 CFG=1
M  V30 15 1 12 16
M  V30 16 1 14 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 1 19 21
M  V30 21 1 20 22
M  V30 22 2 20 23
M  V30 23 1 21 24
M  V30 24 1 22 25
M  V30 25 1 24 26
M  V30 26 1 26 27
M  V30 27 2 27 28
M  V30 28 1 27 29
M  V30 29 1 28 30
M  V30 30 2 29 31
M  V30 31 2 30 32
M  V30 32 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 1 6 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1424403-24-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1424403-25-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-10443159
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-65-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 538-75-0
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(5):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Total synthesis of palmyrolide A and its 5,7-epi isomers
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sudhakar, Gangarajula; Reddy, Karla Janardhan; Nanubolu, Jagadeesh Babu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2013), 69(11), 2419-2429

$RFMT $RIREG SCHEME209 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3aR,8aR)-3,3a,8,8a-Tetrahydro-5-methoxy-3a,8-bis(phenylmethyl)-2H-furo[2...
C25H23NO3
1425499-16-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.6842 0.0 0
M  V30 2 C 8.8108 8.0619 0.0 0
M  V30 3 O 2.3890 8.6397 0.0 0
M  V30 4 O 7.3444 0.9052 0.0 0
M  V30 5 C 8.5903 0.0000 0.0 0
M  V30 6 C 5.3900 6.0180 0.0 0 CFG=1
M  V30 7 C 6.4204 4.8735 0.0 0
M  V30 8 C 6.1600 7.3517 0.0 0 CFG=2
M  V30 9 C 3.8836 6.3382 0.0 0
M  V30 10 C 7.8272 5.4998 0.0 0
M  V30 11 C 6.2595 3.3420 0.0 0
M  V30 12 N 7.6663 7.0315 0.0 0
M  V30 13 O 5.1294 8.4960 0.0 0
M  V30 14 C 3.7227 7.8697 0.0 0
M  V30 15 C 9.0732 4.5948 0.0 0
M  V30 16 C 7.5054 2.4367 0.0 0
M  V30 17 C 8.9122 3.0631 0.0 0
M  V30 18 C 3.0800 4.6842 0.0 0
M  V30 19 C 2.3100 6.0180 0.0 0
M  V30 20 C 2.3100 3.3506 0.0 0
M  V30 21 C 0.7700 6.0180 0.0 0
M  V30 22 C 0.7700 3.3506 0.0 0
M  V30 23 C 0.0000 4.6842 0.0 0
M  V30 24 C 10.2754 7.5861 0.0 0
M  V30 25 C 11.4199 8.6165 0.0 0
M  V30 26 C 10.5955 6.0796 0.0 0
M  V30 27 C 12.8844 8.1406 0.0 0
M  V30 28 C 12.0602 5.6038 0.0 0
M  V30 29 C 13.2046 6.6342 0.0 0
M  V30 30 H 6.9300 8.6853 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 6 1 CFG=1
M  V30 2 1 1 18
M  V30 3 1 2 12
M  V30 4 1 2 24
M  V30 5 2 3 14
M  V30 6 1 4 5
M  V30 7 1 4 16
M  V30 8 1 6 7
M  V30 9 1 6 8
M  V30 10 1 6 9
M  V30 11 1 7 10
M  V30 12 2 7 11
M  V30 13 1 8 12
M  V30 14 1 8 13
M  V30 15 1 8 30 CFG=1
M  V30 16 1 9 14
M  V30 17 1 10 12
M  V30 18 2 10 15
M  V30 19 1 11 16
M  V30 20 1 13 14
M  V30 21 1 15 17
M  V30 22 2 16 17
M  V30 23 2 18 19
M  V30 24 1 18 20
M  V30 25 1 19 21
M  V30 26 2 20 22
M  V30 27 2 21 23
M  V30 28 1 22 23
M  V30 29 2 24 25
M  V30 30 1 24 26
M  V30 31 1 25 27
M  V30 32 2 26 28
M  V30 33 2 27 29
M  V30 34 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 6 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-(3aR,8aR)-3,3a,8,8a-Tetrahydro-5-methoxy-1-methyl-3a,8-bis(phenylmethyl)p...
C26H26N2O2
1425499-19-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 4.6843 0.0 0
M  V30 2 C 8.8110 8.0621 0.0 0
M  V30 3 C 5.4499 10.0025 0.0 0
M  V30 4 O 2.3891 8.6399 0.0 0
M  V30 5 O 7.3446 0.9051 0.0 0
M  V30 6 C 8.5905 0.0000 0.0 0
M  V30 7 C 5.3901 6.0180 0.0 0 CFG=2
M  V30 8 C 6.1601 7.3517 0.0 0 CFG=2
M  V30 9 C 6.4206 4.8736 0.0 0
M  V30 10 C 3.8837 6.3382 0.0 0
M  V30 11 N 7.6664 7.0315 0.0 0
M  V30 12 N 5.1295 8.4962 0.0 0
M  V30 13 C 7.8274 5.4999 0.0 0
M  V30 14 C 6.2596 3.3420 0.0 0
M  V30 15 C 3.7227 7.8699 0.0 0
M  V30 16 C 9.0734 4.5947 0.0 0
M  V30 17 C 7.5055 2.4368 0.0 0
M  V30 18 C 8.9123 3.0631 0.0 0
M  V30 19 C 3.0801 4.6843 0.0 0
M  V30 20 C 2.3101 3.3507 0.0 0
M  V30 21 C 2.3101 6.0180 0.0 0
M  V30 22 C 0.7700 3.3507 0.0 0
M  V30 23 C 0.7700 6.0180 0.0 0
M  V30 24 C 0.0000 4.6843 0.0 0
M  V30 25 C 10.2756 7.5861 0.0 0
M  V30 26 C 10.5957 6.0797 0.0 0
M  V30 27 C 11.4201 8.6166 0.0 0
M  V30 28 C 12.0605 5.6039 0.0 0
M  V30 29 C 12.8847 8.1408 0.0 0
M  V30 30 C 13.2049 6.6343 0.0 0
M  V30 31 H 6.9302 8.6855 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 7 1 CFG=1
M  V30 2 1 1 19
M  V30 3 1 2 11
M  V30 4 1 2 25
M  V30 5 1 3 12
M  V30 6 2 4 15
M  V30 7 1 5 6
M  V30 8 1 5 17
M  V30 9 1 7 8
M  V30 10 1 7 9
M  V30 11 1 7 10
M  V30 12 1 8 11
M  V30 13 1 8 12
M  V30 14 1 8 31 CFG=1
M  V30 15 1 9 13
M  V30 16 2 9 14
M  V30 17 1 10 15
M  V30 18 1 11 13
M  V30 19 1 12 15
M  V30 20 2 13 16
M  V30 21 1 14 17
M  V30 22 1 16 18
M  V30 23 2 17 18
M  V30 24 2 19 20
M  V30 25 1 19 21
M  V30 26 1 20 22
M  V30 27 2 21 23
M  V30 28 2 22 24
M  V30 29 1 23 24
M  V30 30 2 25 26
M  V30 31 1 25 27
M  V30 32 1 26 28
M  V30 33 2 27 29
M  V30 34 2 28 30
M  V30 35 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 7 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1425499-16-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1425499-19-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-15348313
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of O-methyl substituted 2-oxofuro- and
2-oxopyrrolidinoindolines by reductive lactonization of oxindolylacetic
acids
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Morales-Rios, Martha S.; Rivera-Becerril, Ernesto; Lopez-Camacho, Perla
Y.; Perez-Rojas, Nadia A.; Suarez-Castillo, Oscar R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Natural Product Communications (2012), 7(11), 1445-1451

$RFMT $RIREG SCHEME210 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl (3aR,3bS,4aS,5R,5aS)-tetrahydro-5-[2-iodo-6-[(2-phenylethyl)amino]-9H-p...
C25H28IN5O4
1446996-82-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 43 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.1049 5.9260 0.0 0
M  V30 2 O 1.7847 7.4325 0.0 0
M  V30 3 O 0.9605 4.8956 0.0 0
M  V30 4 C 0.3202 7.9084 0.0 0
M  V30 5 C 0.0000 9.4148 0.0 0
M  V30 6 C 1.2667 1.0306 0.0 0
M  V30 7 C 3.0516 0.0000 0.0 0
M  V30 8 N 12.3796 4.1445 0.0 0
M  V30 9 C 13.7132 4.9146 0.0 0
M  V30 10 C 15.0471 4.1445 0.0 0
M  V30 11 I 9.7122 8.7646 0.0 0
M  V30 12 C 3.5696 5.4502 0.0 0 CFG=2
M  V30 13 C 5.1012 5.6111 0.0 0 CFG=1
M  V30 14 C 3.2495 3.9439 0.0 0 CFG=1
M  V30 15 C 4.1960 6.8572 0.0 0
M  V30 16 C 5.7275 4.2043 0.0 0 CFG=1
M  V30 17 C 4.5831 3.1739 0.0 0 CFG=1
M  V30 18 O 2.1049 2.9133 0.0 0
M  V30 19 O 4.2630 1.6674 0.0 0
M  V30 20 C 2.7314 1.5065 0.0 0
M  V30 21 N 7.2340 3.8841 0.0 0
M  V30 22 C 8.3784 4.9146 0.0 0
M  V30 23 C 7.8603 2.4771 0.0 0
M  V30 24 C 9.7122 4.1445 0.0 0
M  V30 25 N 8.3784 6.4546 0.0 0
M  V30 26 N 9.3920 2.6382 0.0 0
M  V30 27 C 11.0459 4.9146 0.0 0
M  V30 28 C 9.7122 7.2246 0.0 0
M  V30 29 N 11.0459 6.4546 0.0 0
M  V30 30 C 16.3807 4.9146 0.0 0
M  V30 31 C 16.3807 6.4546 0.0 0
M  V30 32 C 17.7144 4.1445 0.0 0
M  V30 33 C 17.7144 7.2246 0.0 0
M  V30 34 C 19.0481 4.9146 0.0 0
M  V30 35 C 19.0481 6.4546 0.0 0
M  V30 36 H 6.4349 6.3811 0.0 0
M  V30 37 H 1.9158 4.7139 0.0 0
M  V30 38 H 5.9168 2.4038 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 12 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 20
M  V30 7 1 7 20
M  V30 8 1 8 9
M  V30 9 1 8 27
M  V30 10 1 9 10
M  V30 11 1 10 30
M  V30 12 1 11 28
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 12 15
M  V30 16 1 13 15
M  V30 17 1 13 16
M  V30 18 1 13 36 CFG=1
M  V30 19 1 14 17
M  V30 20 1 14 18
M  V30 21 1 14 37 CFG=1
M  V30 22 1 16 17
M  V30 23 1 16 21 CFG=1
M  V30 24 1 17 19
M  V30 25 1 17 38 CFG=1
M  V30 26 1 18 20
M  V30 27 1 19 20
M  V30 28 1 21 22
M  V30 29 1 21 23
M  V30 30 1 22 24
M  V30 31 2 22 25
M  V30 32 2 23 26
M  V30 33 1 24 26
M  V30 34 2 24 27
M  V30 35 1 25 28
M  V30 36 1 27 29
M  V30 37 2 28 29
M  V30 38 2 30 31
M  V30 39 1 30 32
M  V30 40 1 31 33
M  V30 41 2 32 34
M  V30 42 2 33 35
M  V30 43 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 12 13 14 16 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(3aR,3bS,4aS,5R,5aS)-Tetrahydro-5-[2-iodo-6-[(2-phenylethyl)amino]-9H-purin-9...
C24H27IN6O3
1446996-79-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 42 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 1.7849 5.9260 0.0 0
M  V30 2 N 1.4647 7.4324 0.0 0
M  V30 3 O 0.6403 4.8956 0.0 0
M  V30 4 C 0.0000 7.9084 0.0 0
M  V30 5 C 0.9467 1.0304 0.0 0
M  V30 6 C 2.7314 0.0000 0.0 0
M  V30 7 N 12.0595 4.1445 0.0 0
M  V30 8 C 13.3932 4.9146 0.0 0
M  V30 9 C 14.7269 4.1445 0.0 0
M  V30 10 I 9.3920 8.7646 0.0 0
M  V30 11 C 3.2495 5.4502 0.0 0 CFG=2
M  V30 12 C 4.7812 5.6111 0.0 0 CFG=1
M  V30 13 C 2.9293 3.9437 0.0 0 CFG=1
M  V30 14 C 3.8760 6.8570 0.0 0
M  V30 15 C 5.4075 4.2043 0.0 0 CFG=1
M  V30 16 C 4.2630 3.1737 0.0 0 CFG=1
M  V30 17 O 1.7849 2.9133 0.0 0
M  V30 18 O 3.9428 1.6674 0.0 0
M  V30 19 C 2.4112 1.5065 0.0 0
M  V30 20 N 6.9138 3.8841 0.0 0
M  V30 21 C 8.0584 4.9146 0.0 0
M  V30 22 C 7.5403 2.4771 0.0 0
M  V30 23 C 9.3920 4.1445 0.0 0
M  V30 24 N 8.0584 6.4546 0.0 0
M  V30 25 N 9.0719 2.6381 0.0 0
M  V30 26 C 10.7257 4.9146 0.0 0
M  V30 27 C 9.3920 7.2246 0.0 0
M  V30 28 N 10.7257 6.4546 0.0 0
M  V30 29 C 16.0605 4.9146 0.0 0
M  V30 30 C 16.0605 6.4546 0.0 0
M  V30 31 C 17.3944 4.1445 0.0 0
M  V30 32 C 17.3944 7.2246 0.0 0
M  V30 33 C 18.7280 4.9146 0.0 0
M  V30 34 C 18.7280 6.4546 0.0 0
M  V30 35 H 6.1149 6.3811 0.0 0
M  V30 36 H 1.5956 4.7137 0.0 0
M  V30 37 H 5.5968 2.4037 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 11 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 5 19
M  V30 6 1 6 19
M  V30 7 1 7 8
M  V30 8 1 7 26
M  V30 9 1 8 9
M  V30 10 1 9 29
M  V30 11 1 10 27
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 12 14
M  V30 16 1 12 15
M  V30 17 1 12 35 CFG=1
M  V30 18 1 13 16
M  V30 19 1 13 17
M  V30 20 1 13 36 CFG=1
M  V30 21 1 15 16
M  V30 22 1 15 20 CFG=1
M  V30 23 1 16 18
M  V30 24 1 16 37 CFG=1
M  V30 25 1 17 19
M  V30 26 1 18 19
M  V30 27 1 20 21
M  V30 28 1 20 22
M  V30 29 1 21 23
M  V30 30 2 21 24
M  V30 31 2 22 25
M  V30 32 1 23 25
M  V30 33 2 23 26
M  V30 34 1 24 27
M  V30 35 1 26 28
M  V30 36 2 27 28
M  V30 37 2 29 30
M  V30 38 1 29 31
M  V30 39 1 30 32
M  V30 40 2 31 33
M  V30 41 2 32 34
M  V30 42 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 11 12 13 15 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1446996-82-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1446996-79-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31872765
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A3 adenosine receptor agonists containing dopamine moieties for enhanced
inter-species affinity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tosh, Dilip K.; Salmaso, Veronica; Campbell, Ryan G.; Rao, Harsha;
Bitant, Amelia; Pottie, Eline; Stove, Christophe P.; Liu, Naili;
Gavrilova, Oksana; Gao, Zhan-Guo; Auchampach, John A.; Jacobson, Kenneth
A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2022), 228113983

$RFMT $RIREG SCHEME211 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-3-(bromomethyl)-1-methyl-1H-pyrazole-5-carbonitrile
C6H5Br2N3
1454848-82-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.5626 2.7106 0.0 0
M  V30 2 N 8.1026 2.7106 0.0 0
M  V30 3 Br 4.5932 5.4211 0.0 0
M  V30 4 C 4.5932 0.0000 0.0 0
M  V30 5 C 1.4068 4.3858 0.0 0
M  V30 6 Br 0.0000 3.7593 0.0 0
M  V30 7 C 5.0226 2.7106 0.0 0
M  V30 8 C 4.1173 3.9564 0.0 0
M  V30 9 N 4.1173 1.4647 0.0 0
M  V30 10 C 2.6528 3.4806 0.0 0
M  V30 11 N 2.6528 1.9406 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 7
M  V30 3 1 3 8
M  V30 4 1 4 9
M  V30 5 1 5 6
M  V30 6 1 5 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-1-methyl-3-[(methylamino)methyl]-1H-pyrazole-5-carbonitrile
C7H9BrN4
1454848-54-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.8342 4.0286 0.0 0
M  V30 2 N 8.1680 3.2586 0.0 0
M  V30 3 C 9.5017 4.0286 0.0 0
M  V30 4 Br 3.7735 5.3914 0.0 0
M  V30 5 C 1.5316 2.9016 0.0 0
M  V30 6 N 0.0000 3.0625 0.0 0
M  V30 7 C 3.2068 0.0000 0.0 0
M  V30 8 C 5.5005 3.2586 0.0 0
M  V30 9 C 4.0937 3.8850 0.0 0
M  V30 10 N 5.3396 1.7270 0.0 0
M  V30 11 C 3.0631 2.7405 0.0 0
M  V30 12 N 3.8331 1.4068 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 4 9
M  V30 5 3 5 6
M  V30 6 1 5 11
M  V30 7 1 7 12
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1454848-82-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1454848-54-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-1151583
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM industrial methylated spirits used as co-solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Conformational Studies and Atropisomerism Kinetics of the ALK Clinical
Candidate Lorlatinib (PF-06463922) and Desmethyl Congeners
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Elleraas, Jeff; Ewanicki, Jason; Johnson, Ted W.; Sach, Neal W.; Collins,
Michael R.; Richardson, Paul F.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2016), 55(11), 3590-3595

$RFMT $RIREG SCHEME212 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Pyrazinecarboxylic acid, 3-amino-5,6-dichloro-, methyl ester
C6H5Cl2N3O2
1458-18-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 2.6674 0.0 0
M  V30 2 O 6.9300 4.0011 0.0 0
M  V30 3 O 6.9300 1.3338 0.0 0
M  V30 4 C 8.4700 4.0011 0.0 0
M  V30 5 N 4.6200 0.0000 0.0 0
M  V30 6 Cl 1.5400 5.3349 0.0 0
M  V30 7 Cl 0.0000 2.6674 0.0 0
M  V30 8 C 4.6200 2.6674 0.0 0
M  V30 9 C 3.8500 1.3338 0.0 0
M  V30 10 N 3.8500 4.0011 0.0 0
M  V30 11 N 2.3100 1.3338 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 9
M  V30 6 1 6 12
M  V30 7 1 7 13
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 3-amino-6-chloro-5-(methylamino)-2-pyrazinecarboxylate
C7H9ClN4O2
1503-34-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 4.6201 0.0 0
M  V30 2 O 8.0022 3.8500 0.0 0
M  V30 3 O 6.6684 6.1601 0.0 0
M  V30 4 C 9.3359 4.6201 0.0 0
M  V30 5 N 4.0011 6.1601 0.0 0
M  V30 6 Cl 4.0011 0.0000 0.0 0
M  V30 7 N 1.3337 1.5400 0.0 0
M  V30 8 C 0.0000 2.3100 0.0 0
M  V30 9 C 5.3348 3.8500 0.0 0
M  V30 10 C 4.0011 4.6201 0.0 0
M  V30 11 N 5.3348 2.3100 0.0 0
M  V30 12 N 2.6675 3.8500 0.0 0
M  V30 13 C 4.0011 1.5400 0.0 0
M  V30 14 C 2.6675 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 10
M  V30 6 1 6 13
M  V30 7 1 7 8
M  V30 8 1 7 14
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1458-18-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1503-34-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35864738
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, alternate reaction conditions gave 71% yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted pyrazine-2-carboxamides as HPK1 inhibitors for
the treatment of cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nilsson Lill, Sten; Giblin, Kathryn; Kettle, Jason Grant; Goldberg,
Frederick Woolf; Grimster, Neil Patrick; Morrill, Lucas; Escobar,
Randolph; Metrano, Anthony; Song, Kun; Sheppeck, James; Ziegler, Robert
Evans; Wu, Ye; Sha, Li; Wu, Dedong; Grebe, Tyler; Mfuh, Adelphe; Balazs,
Amber; Shields, Jason
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023001794 A1 2023-01-26

$RFMT $RIREG SCHEME213 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 3-amino-6-phenyl-4-(trifluoromethyl)-1H-pyrazolo[3,4-b]pyridine-1-acetate
C17H15F3N4O2
1469293-82-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0408 4.6246 0.0 0
M  V30 2 C 9.5056 5.1004 0.0 0
M  V30 3 O 10.6499 4.0700 0.0 0
M  V30 4 O 9.8257 6.6069 0.0 0
M  V30 5 C 12.1147 4.5459 0.0 0
M  V30 6 C 13.2591 3.5154 0.0 0
M  V30 7 C 2.3101 8.0023 0.0 0
M  V30 8 F 3.6437 8.7723 0.0 0
M  V30 9 F 1.5400 9.3360 0.0 0
M  V30 10 F 0.9762 7.2323 0.0 0
M  V30 11 N 5.3304 9.3194 0.0 0
M  V30 12 C 5.3901 5.3348 0.0 0
M  V30 13 C 4.6201 6.6685 0.0 0
M  V30 14 N 6.8964 5.6550 0.0 0
M  V30 15 N 4.6201 4.0012 0.0 0
M  V30 16 C 3.0801 6.6685 0.0 0
M  V30 17 C 5.6505 7.8131 0.0 0
M  V30 18 N 7.0574 7.1866 0.0 0
M  V30 19 C 3.0801 4.0012 0.0 0
M  V30 20 C 2.3101 5.3348 0.0 0
M  V30 21 C 2.3101 2.6675 0.0 0
M  V30 22 C 0.7700 2.6675 0.0 0
M  V30 23 C 3.0801 1.3337 0.0 0
M  V30 24 C 0.0000 1.3337 0.0 0
M  V30 25 C 2.3101 0.0000 0.0 0
M  V30 26 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 7 16
M  V30 11 1 11 17
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 2 12 15
M  V30 15 2 13 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 2 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Amino-N-methyl-6-phenyl-4-(trifluoromethyl)-1H-pyrazolo[3,4-b]pyridine-1-ac...
C16H14F3N5O
1469293-83-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0410 4.6246 0.0 0
M  V30 2 C 9.5057 5.1004 0.0 0
M  V30 3 N 10.6501 4.0700 0.0 0
M  V30 4 O 9.8259 6.6069 0.0 0
M  V30 5 C 12.1148 4.5459 0.0 0
M  V30 6 C 2.3101 8.0023 0.0 0
M  V30 7 F 0.9764 7.2323 0.0 0
M  V30 8 F 1.5400 9.3360 0.0 0
M  V30 9 F 3.6437 8.7723 0.0 0
M  V30 10 N 5.3304 9.3194 0.0 0
M  V30 11 C 5.3901 5.3348 0.0 0
M  V30 12 C 4.6201 6.6685 0.0 0
M  V30 13 N 6.8966 5.6550 0.0 0
M  V30 14 N 4.6201 4.0012 0.0 0
M  V30 15 C 3.0801 6.6685 0.0 0
M  V30 16 C 5.6507 7.8131 0.0 0
M  V30 17 N 7.0575 7.1866 0.0 0
M  V30 18 C 3.0801 4.0012 0.0 0
M  V30 19 C 2.3101 5.3348 0.0 0
M  V30 20 C 2.3101 2.6675 0.0 0
M  V30 21 C 3.0801 1.3337 0.0 0
M  V30 22 C 0.7700 2.6675 0.0 0
M  V30 23 C 2.3101 0.0000 0.0 0
M  V30 24 C 0.0000 1.3337 0.0 0
M  V30 25 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 6 15
M  V30 10 1 10 16
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 2 11 14
M  V30 14 2 12 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 2 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1469293-82-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1469293-83-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-9517185
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and biological evaluation of novel alkyl amide functionalized
trifluoromethyl substituted pyrazolo[3,4-b]pyridine derivatives as
potential anticancer agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chavva, K.; Pillalamarri, S.; Banda, V.; Gautham, S.; Gaddamedi, J.;
Yedla, P.; Kumar, C. G.; Banda, N.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2013), 23(21), 5893-5895

$RFMT $RIREG SCHEME214 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-fluoro-δ-oxobenzenepentanoate
C12H13FO3
149437-67-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0801 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 O 5.3348 4.6201 0.0 0
M  V30 4 C 8.0022 3.0801 0.0 0
M  V30 5 C 9.3360 2.3101 0.0 0
M  V30 6 C 10.6697 3.0801 0.0 0
M  V30 7 O 12.0033 2.3101 0.0 0
M  V30 8 O 10.6697 4.6201 0.0 0
M  V30 9 C 13.3370 3.0801 0.0 0
M  V30 10 F 0.0000 0.0000 0.0 0
M  V30 11 C 4.0010 2.3101 0.0 0
M  V30 12 C 2.6673 3.0801 0.0 0
M  V30 13 C 4.0010 0.7700 0.0 0
M  V30 14 C 1.3337 2.3101 0.0 0
M  V30 15 C 2.6673 0.0000 0.0 0
M  V30 16 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 10 16
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-(4-Fluorophenyl)-1-methyl-2-piperidinone
C12H14FNO
149437-68-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 4.6200 0.0 0
M  V30 2 O 0.0000 3.0800 0.0 0
M  V30 3 F 9.3358 5.3900 0.0 0
M  V30 4 C 4.0011 2.3100 0.0 0
M  V30 5 N 2.6674 3.0800 0.0 0
M  V30 6 C 4.0011 0.7700 0.0 0
M  V30 7 C 1.3336 2.3100 0.0 0
M  V30 8 C 2.6674 0.0000 0.0 0
M  V30 9 C 1.3336 0.7700 0.0 0
M  V30 10 C 5.3347 3.0800 0.0 0
M  V30 11 C 6.6684 2.3100 0.0 0
M  V30 12 C 5.3347 4.6200 0.0 0
M  V30 13 C 8.0021 3.0800 0.0 0
M  V30 14 C 6.6684 5.3900 0.0 0
M  V30 15 C 8.0021 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 2 2 7
M  V30 3 1 3 15
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 10
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 149437-67-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 149437-68-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-13119661
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25895-60-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM Na(CN)BH3/pH 6/HOAc, MeOH/Reflux 6 h., Acylation, Amination, C-Amination,
Condensation, Heterocyclization, Intramolecular, N-Acylation, Reduction,
Ring formation, Reductive amination
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Reductive aminations of carbonyl compounds with borohydride and borane
reducing agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Baxter, Ellen W.; Reitz, Allen B.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Reactions (Hoboken, NJ, United States) (2002), 59No pp. given

$RFMT $RIREG SCHEME215 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Fluoro-2-[(1-methylethyl)thio]-5-nitrobenzaldehyde
C10H10FNO3S
1508296-06-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.6685 2.3101 0.0 0
M  V30 2 C 8.0023 3.0801 0.0 0
M  V30 3 C 9.3360 2.3101 0.0 0
M  V30 4 C 8.0023 4.6201 0.0 0
M  V30 5 C 4.0012 0.7700 0.0 0
M  V30 6 O 2.6675 0.0000 0.0 0
M  V30 7 F 6.6685 5.3901 0.0 0
M  V30 8 N 1.3337 5.3901 0.0 0 VAL=5
M  V30 9 O 1.3337 6.9302 0.0 0
M  V30 10 O 0.0000 4.6201 0.0 0
M  V30 11 C 5.3348 3.0801 0.0 0
M  V30 12 C 4.0012 2.3101 0.0 0
M  V30 13 C 5.3348 4.6201 0.0 0
M  V30 14 C 2.6675 3.0801 0.0 0
M  V30 15 C 4.0012 5.3901 0.0 0
M  V30 16 C 2.6675 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 1 5 12
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 2 8 10
M  V30 10 1 8 16
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Di-tert-butyl dicarbonate
C10H18O5
24424-99-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6673 0.5637 0.0 0
M  V30 2 C 1.3337 1.3337 0.0 0
M  V30 3 C 4.0012 1.3337 0.0 0
M  V30 4 C 0.5637 0.0000 0.0 0
M  V30 5 C 0.0000 2.1037 0.0 0
M  V30 6 C 2.1037 2.6673 0.0 0
M  V30 7 O 5.3348 0.5637 0.0 0
M  V30 8 O 4.0012 2.8737 0.0 0
M  V30 9 C 6.6685 1.3337 0.0 0
M  V30 10 O 8.0023 0.5637 0.0 0
M  V30 11 O 6.6685 2.8737 0.0 0
M  V30 12 C 9.3360 1.3337 0.0 0
M  V30 13 C 10.1060 0.0000 0.0 0
M  V30 14 C 10.6697 2.1037 0.0 0
M  V30 15 C 8.5660 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 7 9
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[[3-fluoro-2-[(1-methylethyl)thio]-5-nitrophenyl]methyl]-...
C16H23FN2O4S
1508296-07-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 5.3347 0.0 0
M  V30 2 N 6.9300 6.6685 0.0 0
M  V30 3 C 8.4700 6.6685 0.0 0
M  V30 4 C 6.1600 8.0021 0.0 0
M  V30 5 O 9.2400 8.0021 0.0 0
M  V30 6 O 9.2400 5.3347 0.0 0
M  V30 7 C 10.7800 8.0021 0.0 0
M  V30 8 C 10.7800 6.4621 0.0 0
M  V30 9 C 12.3200 8.0021 0.0 0
M  V30 10 C 10.7800 9.5421 0.0 0
M  V30 11 S 4.6200 2.6674 0.0 0
M  V30 12 C 3.8500 1.3336 0.0 0
M  V30 13 C 2.3100 1.3336 0.0 0
M  V30 14 C 4.6200 0.0000 0.0 0
M  V30 15 F 1.5400 2.6674 0.0 0
M  V30 16 N 1.5400 8.0021 0.0 0 VAL=5
M  V30 17 O 0.0000 8.0021 0.0 0
M  V30 18 O 2.3100 9.3358 0.0 0
M  V30 19 C 4.6200 5.3347 0.0 0
M  V30 20 C 3.8500 4.0011 0.0 0
M  V30 21 C 3.8500 6.6685 0.0 0
M  V30 22 C 2.3100 4.0011 0.0 0
M  V30 23 C 2.3100 6.6685 0.0 0
M  V30 24 C 1.5400 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 19
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 11 12
M  V30 12 1 11 20
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 15 22
M  V30 16 2 16 17
M  V30 17 2 16 18
M  V30 18 1 16 23
M  V30 19 2 19 20
M  V30 20 1 19 21
M  V30 21 1 20 22
M  V30 22 2 21 23
M  V30 23 2 22 24
M  V30 24 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1508296-06-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 24424-99-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1508296-07-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-2348421
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Macrocyclic compounds as factor VIIa inhibitors and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Xiaojun; Glunz, Peter W.; Priestley, Eldon Scott; Johnson, James
A.; Wurtz, Nicholas Ronald; Ladziata, Vladimir
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2013184734 A1 2013-12-12

$RFMT $RIREG SCHEME216 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl N-[6-chloro-2-(methylthio)-5-nitro-4-pyrimidinyl]-N-[[3-[[(1,1-dimethyl...
C21H29ClN4O5SSi
1539304-14-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6687 4.6201 0.0 0
M  V30 2 C 8.0023 5.3901 0.0 0
M  V30 3 C 6.6687 3.0801 0.0 0
M  V30 4 O 5.3348 2.3101 0.0 0
M  V30 5 O 8.0023 2.3101 0.0 0
M  V30 6 C 5.3348 0.7700 0.0 0
M  V30 7 C 4.0012 0.0000 0.0 0
M  V30 8 N 6.6687 7.7002 0.0 0 VAL=5
M  V30 9 O 8.0023 6.9302 0.0 0
M  V30 10 O 6.6687 9.2402 0.0 0
M  V30 11 Cl 4.0012 9.2402 0.0 0
M  V30 12 S 1.3338 4.6201 0.0 0
M  V30 13 C 0.0000 5.3901 0.0 0
M  V30 14 O 13.3372 5.3901 0.0 0
M  V30 15 Si 14.6708 4.6201 0.0 0
M  V30 16 C 16.0045 3.8501 0.0 0
M  V30 17 C 13.9008 3.2864 0.0 0
M  V30 18 C 15.4408 5.9538 0.0 0
M  V30 19 C 16.7745 5.1838 0.0 0
M  V30 20 C 17.3383 3.0801 0.0 0
M  V30 21 C 15.2345 2.5164 0.0 0
M  V30 22 C 5.3348 5.3901 0.0 0
M  V30 23 C 5.3348 6.9302 0.0 0
M  V30 24 N 4.0012 4.6201 0.0 0
M  V30 25 C 4.0012 7.7002 0.0 0
M  V30 26 C 2.6675 5.3901 0.0 0
M  V30 27 N 2.6675 6.9302 0.0 0
M  V30 28 C 9.3360 4.6201 0.0 0
M  V30 29 C 10.6697 5.3901 0.0 0
M  V30 30 C 9.3360 3.0801 0.0 0
M  V30 31 C 12.0035 4.6201 0.0 0
M  V30 32 C 10.6697 2.3101 0.0 0
M  V30 33 C 12.0035 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 22
M  V30 4 1 2 28
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 1 4 6
M  V30 8 1 6 7
M  V30 9 2 8 9
M  V30 10 2 8 10
M  V30 11 1 8 23
M  V30 12 1 11 25
M  V30 13 1 12 13
M  V30 14 1 12 26
M  V30 15 1 14 15
M  V30 16 1 14 31
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 15 18
M  V30 20 1 16 19
M  V30 21 1 16 20
M  V30 22 1 16 21
M  V30 23 1 22 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 2 26 27
M  V30 29 2 28 29
M  V30 30 1 28 30
M  V30 31 1 29 31
M  V30 32 2 30 32
M  V30 33 2 31 33
M  V30 34 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl N-[[3-[[(1,1-dimethylethyl)dimethylsilyl]oxy]phenyl]methyl]-N-[6-(methy...
C22H33N5O5SSi
1870031-91-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6687 5.3901 0.0 0
M  V30 2 C 8.0023 4.6201 0.0 0
M  V30 3 C 6.6687 6.9302 0.0 0
M  V30 4 O 5.3348 7.7002 0.0 0
M  V30 5 O 8.0023 7.7002 0.0 0
M  V30 6 C 5.3348 9.2402 0.0 0
M  V30 7 C 4.0012 10.0102 0.0 0
M  V30 8 N 6.6687 2.3101 0.0 0 VAL=5
M  V30 9 O 6.6687 0.7700 0.0 0
M  V30 10 O 8.0023 3.0801 0.0 0
M  V30 11 N 4.0012 0.7700 0.0 0
M  V30 12 C 2.6675 0.0000 0.0 0
M  V30 13 S 1.3338 5.3901 0.0 0
M  V30 14 C 0.0000 4.6201 0.0 0
M  V30 15 O 13.3372 4.6201 0.0 0
M  V30 16 Si 14.6708 5.3901 0.0 0
M  V30 17 C 16.0045 6.1601 0.0 0
M  V30 18 C 13.9008 6.7238 0.0 0
M  V30 19 C 15.4408 4.0564 0.0 0
M  V30 20 C 15.2345 7.4938 0.0 0
M  V30 21 C 17.3383 6.9302 0.0 0
M  V30 22 C 16.7745 4.8265 0.0 0
M  V30 23 C 5.3348 4.6201 0.0 0
M  V30 24 C 5.3348 3.0801 0.0 0
M  V30 25 N 4.0012 5.3901 0.0 0
M  V30 26 C 4.0012 2.3101 0.0 0
M  V30 27 C 2.6675 4.6201 0.0 0
M  V30 28 N 2.6675 3.0801 0.0 0
M  V30 29 C 9.3360 5.3901 0.0 0
M  V30 30 C 10.6697 4.6201 0.0 0
M  V30 31 C 9.3360 6.9302 0.0 0
M  V30 32 C 12.0035 5.3901 0.0 0
M  V30 33 C 10.6697 7.7002 0.0 0
M  V30 34 C 12.0035 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 23
M  V30 4 1 2 29
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 1 4 6
M  V30 8 1 6 7
M  V30 9 2 8 9
M  V30 10 2 8 10
M  V30 11 1 8 24
M  V30 12 1 11 12
M  V30 13 1 11 26
M  V30 14 1 13 14
M  V30 15 1 13 27
M  V30 16 1 15 16
M  V30 17 1 15 32
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 16 19
M  V30 21 1 17 20
M  V30 22 1 17 21
M  V30 23 1 17 22
M  V30 24 1 23 24
M  V30 25 2 23 25
M  V30 26 2 24 26
M  V30 27 1 25 27
M  V30 28 1 26 28
M  V30 29 2 27 28
M  V30 30 2 29 30
M  V30 31 1 29 31
M  V30 32 1 30 32
M  V30 33 2 31 33
M  V30 34 2 32 34
M  V30 35 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1539304-14-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1870031-91-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-6805714
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Potent and Selective Inhibitors of MTH1 Probe Its Role in Cancer Cell
Survival
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kettle, Jason G.; Alwan, Husam; Bista, Michal; Breed, Jason; Davies,
Nichola L.; Eckersley, Kay; Fillery, Shaun; Foote, Kevin M.; Goodwin,
Louise; Jones, David R.; Kack, Helena; Lau, Alan; Nissink, J. Willem M.;
Read, Jon; Scott, James S.; Taylor, Ben; Walker, Graeme; Wissler, Lisa;
Wylot, Marta
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2016), 59(6), 2346-2361

$RFMT $RIREG SCHEME217 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C29H44N4O6
1539320-84-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 40 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.0022 3.0801 0.0 0
M  V30 2 O 8.0022 4.6201 0.0 0
M  V30 3 C 11.0630 4.4428 0.0 0
M  V30 4 N 12.5277 4.9187 0.0 0
M  V30 5 O 9.9186 5.4733 0.0 0
M  V30 6 C 12.8479 6.4250 0.0 0 CFG=1
M  V30 7 C 14.3125 6.9010 0.0 0
M  V30 8 C 11.7033 7.4556 0.0 0
M  V30 9 O 15.4570 5.8705 0.0 0
M  V30 10 O 14.6326 8.4074 0.0 0
M  V30 11 C 12.0235 8.9619 0.0 0
M  V30 12 C 16.9216 6.3463 0.0 0
M  V30 13 C 13.4882 9.4378 0.0 0
M  V30 14 C 10.8791 9.9924 0.0 0
M  V30 15 N 5.3348 4.6201 0.0 0
M  V30 16 C 4.0010 5.3901 0.0 0
M  V30 17 C 4.0010 6.9302 0.0 0 CFG=1
M  V30 18 O 2.6673 4.6201 0.0 0
M  V30 19 N 2.6673 7.7002 0.0 0
M  V30 20 C 5.3348 7.7002 0.0 0
M  V30 21 C 2.6673 9.2402 0.0 0
M  V30 22 C 6.6685 6.9302 0.0 0
M  V30 23 C 5.3348 9.2402 0.0 0
M  V30 24 C 1.3337 10.0102 0.0 0
M  V30 25 O 4.0010 10.0102 0.0 0
M  V30 26 C 2.1037 11.3439 0.0 0
M  V30 27 C 0.0000 10.7802 0.0 0
M  V30 28 C 0.5637 8.6765 0.0 0
M  V30 29 N 9.3358 2.3101 0.0 0
M  V30 30 C 10.7428 2.9364 0.0 0 CFG=2
M  V30 31 C 9.4969 0.7785 0.0 0
M  V30 32 C 11.7732 1.7920 0.0 0
M  V30 33 C 11.0032 0.4583 0.0 0
M  V30 34 C 6.6685 2.3101 0.0 0
M  V30 35 C 5.3348 3.0801 0.0 0
M  V30 36 C 6.6685 0.7700 0.0 0
M  V30 37 C 4.0010 2.3101 0.0 0
M  V30 38 C 5.3348 0.0000 0.0 0
M  V30 39 C 4.0010 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 29
M  V30 3 1 1 34
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 30 3 CFG=3
M  V30 7 1 4 6
M  V30 8 1 6 7
M  V30 9 1 6 8 CFG=1
M  V30 10 1 7 9
M  V30 11 2 7 10
M  V30 12 1 8 11
M  V30 13 1 9 12
M  V30 14 1 11 13
M  V30 15 1 11 14
M  V30 16 1 15 16
M  V30 17 1 15 35
M  V30 18 1 16 17
M  V30 19 2 16 18
M  V30 20 1 17 19
M  V30 21 1 17 20 CFG=3
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 20 23
M  V30 25 1 21 24
M  V30 26 2 21 25
M  V30 27 1 24 26
M  V30 28 1 24 27
M  V30 29 1 24 28
M  V30 30 1 29 30
M  V30 31 1 29 31
M  V30 32 1 30 32
M  V30 33 1 31 33
M  V30 34 1 32 33
M  V30 35 2 34 35
M  V30 36 1 34 36
M  V30 37 1 35 37
M  V30 38 2 36 38
M  V30 39 2 37 39
M  V30 40 1 38 39
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 6 17 30)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C29H45N5O5
1539320-45-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 40 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.0022 3.0801 0.0 0
M  V30 2 O 8.0022 4.6201 0.0 0
M  V30 3 C 11.0630 4.4428 0.0 0
M  V30 4 N 12.5277 4.9187 0.0 0
M  V30 5 O 9.9186 5.4733 0.0 0
M  V30 6 C 12.8479 6.4250 0.0 0 CFG=1
M  V30 7 C 14.3125 6.9010 0.0 0
M  V30 8 C 11.7033 7.4556 0.0 0
M  V30 9 N 15.4570 5.8705 0.0 0
M  V30 10 O 14.6326 8.4074 0.0 0
M  V30 11 C 12.0235 8.9619 0.0 0
M  V30 12 C 16.9216 6.3463 0.0 0
M  V30 13 C 13.4882 9.4378 0.0 0
M  V30 14 C 10.8791 9.9924 0.0 0
M  V30 15 N 5.3348 4.6201 0.0 0
M  V30 16 C 4.0010 5.3901 0.0 0
M  V30 17 C 4.0010 6.9302 0.0 0 CFG=1
M  V30 18 O 2.6673 4.6201 0.0 0
M  V30 19 N 2.6673 7.7002 0.0 0
M  V30 20 C 5.3348 7.7002 0.0 0
M  V30 21 C 2.6673 9.2402 0.0 0
M  V30 22 C 5.3348 9.2402 0.0 0
M  V30 23 C 6.6685 6.9302 0.0 0
M  V30 24 C 1.3337 10.0102 0.0 0
M  V30 25 O 4.0010 10.0102 0.0 0
M  V30 26 C 0.5637 8.6765 0.0 0
M  V30 27 C 0.0000 10.7802 0.0 0
M  V30 28 C 2.1037 11.3439 0.0 0
M  V30 29 N 9.3358 2.3101 0.0 0
M  V30 30 C 10.7428 2.9364 0.0 0 CFG=2
M  V30 31 C 9.4969 0.7785 0.0 0
M  V30 32 C 11.7732 1.7920 0.0 0
M  V30 33 C 11.0032 0.4583 0.0 0
M  V30 34 C 6.6685 2.3101 0.0 0
M  V30 35 C 5.3348 3.0801 0.0 0
M  V30 36 C 6.6685 0.7700 0.0 0
M  V30 37 C 4.0010 2.3101 0.0 0
M  V30 38 C 5.3348 0.0000 0.0 0
M  V30 39 C 4.0010 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 29
M  V30 3 1 1 34
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 30 3 CFG=3
M  V30 7 1 4 6
M  V30 8 1 6 7
M  V30 9 1 6 8 CFG=1
M  V30 10 1 7 9
M  V30 11 2 7 10
M  V30 12 1 8 11
M  V30 13 1 9 12
M  V30 14 1 11 13
M  V30 15 1 11 14
M  V30 16 1 15 16
M  V30 17 1 15 35
M  V30 18 1 16 17
M  V30 19 2 16 18
M  V30 20 1 17 19
M  V30 21 1 17 20 CFG=3
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 20 23
M  V30 25 1 21 24
M  V30 26 2 21 25
M  V30 27 1 24 26
M  V30 28 1 24 27
M  V30 29 1 24 28
M  V30 30 1 29 30
M  V30 31 1 29 31
M  V30 32 1 30 32
M  V30 33 1 31 33
M  V30 34 1 32 33
M  V30 35 2 34 35
M  V30 36 1 34 36
M  V30 37 1 35 37
M  V30 38 2 36 38
M  V30 39 2 37 39
M  V30 40 1 38 39
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 6 17 30)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1539320-84-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1539320-45-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-4449346
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Formation of a pseudo-β-hairpin motif utilizing the Ant-Pro reverse turn:
consequences of stereochemical reordering
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nair, Roshna V.; Kotmale, Amol S.; Dhokale, Snehal A.; Gawade, Rupesh L.;
Puranik, Vedavadi G.; Rajamohanan, Pattuparambil R.; Sanjayan, Gangadhar
J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2014), 12(5), 774-782

$RFMT $RIREG SCHEME218 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 5-ethynyl-3-pyridinecarboxylate
C9H7NO2
154498-29-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.0801 0.0 0
M  V30 2 O 8.0023 2.3101 0.0 0
M  V30 3 O 6.6685 4.6201 0.0 0
M  V30 4 C 9.3360 3.0801 0.0 0
M  V30 5 C 1.3337 3.0801 0.0 0
M  V30 6 C 0.0000 3.8501 0.0 0
M  V30 7 C 5.3348 2.3101 0.0 0
M  V30 8 C 4.0012 3.0801 0.0 0
M  V30 9 C 5.3348 0.7700 0.0 0
M  V30 10 C 2.6675 2.3101 0.0 0
M  V30 11 N 4.0012 0.0000 0.0 0
M  V30 12 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 3 5 6
M  V30 6 1 5 10
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Ethynyl-N-methyl-3-pyridinecarboxamide
C9H8N2O
1256804-18-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.0801 0.0 0
M  V30 2 N 8.0023 2.3101 0.0 0
M  V30 3 O 6.6685 4.6201 0.0 0
M  V30 4 C 9.3360 3.0801 0.0 0
M  V30 5 C 1.3337 3.0801 0.0 0
M  V30 6 C 0.0000 3.8501 0.0 0
M  V30 7 C 5.3348 2.3101 0.0 0
M  V30 8 C 4.0012 3.0801 0.0 0
M  V30 9 C 5.3348 0.7700 0.0 0
M  V30 10 C 2.6675 2.3101 0.0 0
M  V30 11 N 4.0012 0.0000 0.0 0
M  V30 12 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 3 5 6
M  V30 6 1 5 10
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 154498-29-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1256804-18-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41166797
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Enhancing the binding of calix[5]arene containers for ferrocenes by a
fluorophobic effect through the release of high-energy
perfluoro-1-iodoalkanes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xing, Jiabin; Lin, Qihan; Zhuang, Sheng-Yi; Wu, Gang; Zhang, Jiangshan;
Wang, Hui; Zhang, Dan-Wei; Li, Zhan-Ting
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Chemistry Frontiers (2024), 11(15), 4094-4100

$RFMT $RIREG SCHEME219 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Bromo-4-methyl-1-(phenylmethyl)-4-piperidinol
C13H18BrNO
1548270-31-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.5177 3.7570 0.0 0
M  V30 2 Br 0.1830 3.7570 0.0 0
M  V30 3 C 0.9899 0.0000 0.0 0
M  V30 4 O 0.0000 1.7145 0.0 0
M  V30 5 N 4.1840 2.9870 0.0 0
M  V30 6 C 2.8504 3.7570 0.0 0
M  V30 7 C 4.1840 1.4470 0.0 0
M  V30 8 C 1.5166 2.9870 0.0 0
M  V30 9 C 2.8504 0.6770 0.0 0
M  V30 10 C 1.5166 1.4470 0.0 0
M  V30 11 C 6.8513 2.9870 0.0 0
M  V30 12 C 8.1851 3.7570 0.0 0
M  V30 13 C 6.8513 1.4470 0.0 0
M  V30 14 C 9.5187 2.9870 0.0 0
M  V30 15 C 8.1851 0.6770 0.0 0
M  V30 16 C 9.5187 1.4470 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 1 11
M  V30 3 1 2 8
M  V30 4 1 3 10
M  V30 5 1 4 10
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methyl-3-(methylamino)-1-(phenylmethyl)-4-piperidinol
C14H22N2O
1548270-19-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 5.5177 0.0 0
M  V30 2 N 0.7700 2.8504 0.0 0
M  V30 3 C 0.0000 4.1840 0.0 0
M  V30 4 C 3.3473 0.0000 0.0 0
M  V30 5 O 1.6329 0.9899 0.0 0
M  V30 6 N 4.6200 4.1840 0.0 0
M  V30 7 C 3.0800 4.1840 0.0 0
M  V30 8 C 5.3900 2.8504 0.0 0
M  V30 9 C 2.3100 2.8504 0.0 0
M  V30 10 C 4.6200 1.5167 0.0 0
M  V30 11 C 3.0800 1.5167 0.0 0
M  V30 12 C 6.9300 5.5177 0.0 0
M  V30 13 C 7.7000 6.8515 0.0 0
M  V30 14 C 7.7000 4.1840 0.0 0
M  V30 15 C 9.2400 6.8515 0.0 0
M  V30 16 C 9.2400 4.1840 0.0 0
M  V30 17 C 10.0100 5.5177 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 2 9
M  V30 5 1 4 11
M  V30 6 1 5 11
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1548270-31-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1548270-19-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-12225878
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative reaction conditions gave lower yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Process for the preparation of 3-aminopiperidine compounds useful as
intermediates in synthesis of pharmaceutically active agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Stavber, Gaj; Cluzeau, Jerome
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2014016338 A1 2014-01-30

$RFMT $RIREG SCHEME220 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl γ,γ-difluoro-α-iodo-δ-oxobenzenepentanoate
C13H13F2IO3
155534-91-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 O 4.0010 0.0000 0.0 0
M  V30 4 C 6.6685 3.0801 0.0 0
M  V30 5 F 4.5648 3.6437 0.0 0
M  V30 6 F 6.1048 0.9764 0.0 0
M  V30 7 C 8.0022 2.3101 0.0 0
M  V30 8 C 9.3360 3.0801 0.0 0
M  V30 9 I 8.0022 0.7700 0.0 0
M  V30 10 O 10.6697 2.3101 0.0 0
M  V30 11 O 9.3360 4.6201 0.0 0
M  V30 12 C 12.0033 3.0801 0.0 0
M  V30 13 C 13.3370 2.3101 0.0 0
M  V30 14 C 2.6673 2.3101 0.0 0
M  V30 15 C 1.3337 1.5400 0.0 0
M  V30 16 C 2.6673 3.8501 0.0 0
M  V30 17 C 0.0000 2.3101 0.0 0
M  V30 18 C 1.3337 4.6201 0.0 0
M  V30 19 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 4 7
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 10 12
M  V30 13 1 12 13
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,4-Difluoro-5-hydroxy-1-methyl-5-phenylproline ethyl ester
C14H17F2NO3
1092475-38-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0958 1.0304 0.0 0
M  V30 2 C 3.8575 5.0169 0.0 0
M  V30 3 F 4.0010 0.2154 0.0 0
M  V30 4 F 6.0508 0.0000 0.0 0
M  V30 5 C 7.1894 4.6667 0.0 0
M  V30 6 O 8.6959 4.3466 0.0 0
M  V30 7 O 6.7136 6.1315 0.0 0
M  V30 8 C 9.7263 5.4911 0.0 0
M  V30 9 C 11.2326 5.1708 0.0 0
M  V30 10 C 4.0010 2.2765 0.0 0
M  V30 11 N 4.6275 3.6833 0.0 0
M  V30 12 C 5.1455 1.2459 0.0 0
M  V30 13 C 6.1590 3.5223 0.0 0
M  V30 14 C 6.4792 2.0159 0.0 0
M  V30 15 C 2.6673 3.0465 0.0 0
M  V30 16 C 1.3337 2.2765 0.0 0
M  V30 17 C 2.6673 4.5865 0.0 0
M  V30 18 C 0.0000 3.0465 0.0 0
M  V30 19 C 1.3337 5.3565 0.0 0
M  V30 20 C 0.0000 4.5865 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 2 11
M  V30 3 1 3 12
M  V30 4 1 4 12
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 13
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 15
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 155534-91-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1092475-38-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-6404280
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of N-alkylated 4-fluoro-5-phenylpyrrole-2-carboxylate via
isolable pyrroline ionic intermediates
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kim, Sung Kwan; Jun, Changsoo; Kwak, Kyungchell; Park, Kwangyong; Chai,
Kyuyun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bulletin of the Korean Chemical Society (2007), 28(12), 2324-2328

$RFMT $RIREG SCHEME221 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-formylbenzoate
C9H8O3
1571-08-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 O 1.3337 2.3101 0.0 0
M  V30 3 O 2.6675 0.0000 0.0 0
M  V30 4 C 0.0000 1.5400 0.0 0
M  V30 5 C 8.0023 4.6201 0.0 0
M  V30 6 O 9.3360 3.8501 0.0 0
M  V30 7 C 4.0012 2.3101 0.0 0
M  V30 8 C 4.0012 3.8501 0.0 0
M  V30 9 C 5.3348 1.5400 0.0 0
M  V30 10 C 5.3348 4.6201 0.0 0
M  V30 11 C 6.6685 2.3101 0.0 0
M  V30 12 C 6.6685 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 4-[(methylamino)methyl]-, methyl ester
C10H13NO2
70785-70-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 3 O 1.5400 2.6673 0.0 0
M  V30 4 C 0.0000 0.0000 0.0 0
M  V30 5 C 8.4702 1.3337 0.0 0
M  V30 6 N 9.2402 2.6673 0.0 0
M  V30 7 C 10.7802 2.6673 0.0 0
M  V30 8 C 3.8501 1.3337 0.0 0
M  V30 9 C 4.6201 2.6673 0.0 0
M  V30 10 C 4.6201 0.0000 0.0 0
M  V30 11 C 6.1601 2.6673 0.0 0
M  V30 12 C 6.1601 0.0000 0.0 0
M  V30 13 C 6.9302 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 13
M  V30 7 1 6 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1571-08-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 70785-70-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40950760
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Development of Hsp90 inhibitor to regulate cytokine storms in excessive
delayed- and acute inflammation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sim, Hyun Bo; Sang Son, Jun; Gupta, Sunil K.; Jeong, Seung-Hyun; Choi,
Yu-Jeong; Han, Ji Yeon; Ramos, Sonny C.; Kim, Hyeongyeong; Park, Dae-Han;
Yoo, Ho Jin; Yoo, Young Joo; Chang, Dong-Jo; Mun, Seul-Ki; Seo, Young Ho;
Kim, Jong-Jin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM International Immunopharmacology (2024), 137112470

$RFMT $RIREG SCHEME221 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-formylbenzoate
C9H8O3
1571-08-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 O 1.3337 2.3101 0.0 0
M  V30 3 O 2.6675 0.0000 0.0 0
M  V30 4 C 0.0000 1.5400 0.0 0
M  V30 5 C 8.0023 4.6201 0.0 0
M  V30 6 O 9.3360 3.8501 0.0 0
M  V30 7 C 4.0012 2.3101 0.0 0
M  V30 8 C 4.0012 3.8501 0.0 0
M  V30 9 C 5.3348 1.5400 0.0 0
M  V30 10 C 5.3348 4.6201 0.0 0
M  V30 11 C 6.6685 2.3101 0.0 0
M  V30 12 C 6.6685 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 4-[(methylamino)methyl]-, methyl ester
C10H13NO2
70785-70-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 3 O 1.5400 2.6673 0.0 0
M  V30 4 C 0.0000 0.0000 0.0 0
M  V30 5 C 8.4702 1.3337 0.0 0
M  V30 6 N 9.2402 2.6673 0.0 0
M  V30 7 C 10.7802 2.6673 0.0 0
M  V30 8 C 3.8501 1.3337 0.0 0
M  V30 9 C 4.6201 2.6673 0.0 0
M  V30 10 C 4.6201 0.0000 0.0 0
M  V30 11 C 6.1601 2.6673 0.0 0
M  V30 12 C 6.1601 0.0000 0.0 0
M  V30 13 C 6.9302 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 13
M  V30 7 1 6 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1571-08-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 70785-70-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36123154
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 25895-60-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Benzamide derivatives as dual inhibitor of histone deacetylase 6 and heat
shock protein 90 and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yen, Yun; Chuang, Kuo-Hsiang; Liou, Jing-Ping
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023035005 A2 2023-03-09

$RFMT $RIREG SCHEME222 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Boc-L-alanine
C8H15NO4
15761-38-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 12 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 1.5400 0.0 0
M  V30 2 C 4.0012 2.3101 0.0 0
M  V30 3 C 6.6685 2.3101 0.0 0 CFG=1
M  V30 4 O 2.6675 1.5400 0.0 0
M  V30 5 O 4.0012 3.8501 0.0 0
M  V30 6 C 8.0023 1.5400 0.0 0
M  V30 7 C 6.6685 3.8501 0.0 0
M  V30 8 C 1.3337 2.3101 0.0 0
M  V30 9 O 8.0023 0.0000 0.0 0
M  V30 10 O 9.3360 2.3101 0.0 0
M  V30 11 C 0.5637 0.9764 0.0 0
M  V30 12 C 0.0000 3.0801 0.0 0
M  V30 13 C 2.1037 3.6437 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7 CFG=1
M  V30 7 1 4 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 8 13
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Boc-Ala-OMe
C9H17NO4
28875-17-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 13 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 1.5400 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0 CFG=1
M  V30 3 C 4.0012 2.3101 0.0 0
M  V30 4 C 8.0023 1.5400 0.0 0
M  V30 5 C 6.6685 3.8501 0.0 0
M  V30 6 O 2.6673 1.5400 0.0 0
M  V30 7 O 4.0012 3.8501 0.0 0
M  V30 8 O 9.3360 2.3101 0.0 0
M  V30 9 O 8.0023 0.0000 0.0 0
M  V30 10 C 1.3337 2.3101 0.0 0
M  V30 11 C 10.6697 1.5400 0.0 0
M  V30 12 C 2.1037 3.6437 0.0 0
M  V30 13 C 0.0000 3.0801 0.0 0
M  V30 14 C 0.5637 0.9764 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5 CFG=1
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 2 4 9
M  V30 9 1 6 10
M  V30 10 1 8 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(1):AMD
$DATUM reaction products with divinylbenzene-styrene copolymer diazonium salt
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 15761-38-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 28875-17-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-019-CAS-3924656
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM solid-supported reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Polymer-supported triazenes as smart reagents for the alkylation of
carboxylic acids
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Erb, Bernhard; Kucma, Jean-Philippe; Mourey, Sandrine; Struber, Fritz
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2003), 9(11), 2582-2588

$RFMT $RIREG SCHEME223 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,6-Dichloro-3-nitropyridine
C5H2Cl2N2O2
16013-85-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 Cl 2.3101 0.0000 0.0 0
M  V30 5 Cl 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 N 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-N-methyl-3-nitro-2-pyridinamine
C6H6ClN3O2
33742-70-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 N 0.7700 4.0011 0.0 0 VAL=5
M  V30 4 O 0.0000 2.6674 0.0 0
M  V30 5 O 0.0000 5.3349 0.0 0
M  V30 6 Cl 6.9300 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 N 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 8
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 16013-85-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 33742-70-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-22539022
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 497-19-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Benzimidazole derivatives and aza-benzimidazole derivatives as janus
kinase 2 inhibitors and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gray, Nathanael S.; Zhang, Tinghu; Liu, Yao; Weinstock, David; Li,
Loretta Sze-Mun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020097396 A1 2020-05-14

$RFMT $RIREG SCHEME224 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Dibromo-6,7-dihydro-4H-pyrazino[2,1-a]isoquinolin-4-one
C12H8Br2N2O
1620230-93-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 4.6200 0.0000 0.0 0
M  V30 2 O 7.7000 5.3349 0.0 0
M  V30 3 Br 9.2400 2.6674 0.0 0
M  V30 4 C 4.6200 2.6674 0.0 0
M  V30 5 C 3.0800 2.6674 0.0 0
M  V30 6 N 5.3900 4.0011 0.0 0
M  V30 7 C 5.3900 1.3338 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 2.3100 1.3338 0.0 0
M  V30 10 C 4.6200 5.3349 0.0 0
M  V30 11 C 6.9300 4.0011 0.0 0
M  V30 12 N 6.9300 1.3338 0.0 0
M  V30 13 C 3.0800 5.3349 0.0 0
M  V30 14 C 0.7700 4.0011 0.0 0
M  V30 15 C 0.7700 1.3338 0.0 0
M  V30 16 C 7.7000 2.6674 0.0 0
M  V30 17 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 2 2 11
M  V30 3 1 3 16
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 6 11
M  V30 11 1 7 12
M  V30 12 1 8 13
M  V30 13 2 8 14
M  V30 14 1 9 15
M  V30 15 1 10 13
M  V30 16 1 11 16
M  V30 17 2 12 16
M  V30 18 1 14 17
M  V30 19 2 15 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Bromo-6,7-dihydro-3-(methylamino)-4H-pyrazino[2,1-a]isoquinolin-4-one
C13H12BrN3O
1620231-04-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 4.6200 0.0000 0.0 0
M  V30 2 O 7.7000 5.3349 0.0 0
M  V30 3 N 9.2400 2.6674 0.0 0
M  V30 4 C 10.0100 1.3338 0.0 0
M  V30 5 C 4.6200 2.6674 0.0 0
M  V30 6 C 3.0800 2.6674 0.0 0
M  V30 7 N 5.3900 4.0011 0.0 0
M  V30 8 C 5.3900 1.3338 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 2.3100 1.3338 0.0 0
M  V30 11 C 6.9300 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 13 N 6.9300 1.3338 0.0 0
M  V30 14 C 3.0800 5.3349 0.0 0
M  V30 15 C 0.7700 4.0011 0.0 0
M  V30 16 C 0.7700 1.3338 0.0 0
M  V30 17 C 7.7000 2.6674 0.0 0
M  V30 18 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 2 2 11
M  V30 3 1 3 4
M  V30 4 1 3 17
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 7 12
M  V30 12 1 8 13
M  V30 13 1 9 14
M  V30 14 2 9 15
M  V30 15 1 10 16
M  V30 16 1 11 17
M  V30 17 1 12 14
M  V30 18 2 13 17
M  V30 19 1 15 18
M  V30 20 2 16 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1620230-93-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1620231-04-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-8109322
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Tetrasubstituted pyrazinones derived from the reaction of praziquantel
with N-bromosuccinimide
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhao, Qingjie; Wang, Chunkai; Ezell, Edward L.; Dong, Yuxiang;
Vennerstrom, Jonathan L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2014), 55(32), 4463-4465

$RFMT $RIREG SCHEME225 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Hexynoic acid, ethyl ester
C8H12O2
16205-90-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 2.3101 0.0 0
M  V30 2 C 4.0012 1.5400 0.0 0
M  V30 3 C 6.6685 3.0801 0.0 0
M  V30 4 O 2.6673 2.3101 0.0 0
M  V30 5 O 4.0012 0.0000 0.0 0
M  V30 6 C 8.0023 3.8501 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 9.3360 3.0801 0.0 0
M  V30 9 C 0.0000 2.3101 0.0 0
M  V30 10 C 10.6697 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 3 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2-hexynamide
C7H11NO
1430798-79-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 C 4.0012 2.3101 0.0 0
M  V30 3 N 1.3337 2.3101 0.0 0
M  V30 4 O 2.6675 0.0000 0.0 0
M  V30 5 C 5.3348 3.0801 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 6.6685 3.8501 0.0 0
M  V30 8 C 8.0023 3.0801 0.0 0
M  V30 9 C 9.3360 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 3 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 7 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 16205-90-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1430798-79-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-15375619
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General protocol C: Hydroiodination. Alkynyl
amide (1 equiv.), NaI (2 equiv.), and acetic acid (10 equiv.) were
combined and heated to 115 °C for 8h. Reaction completion was determined
by removing aliquots for 1H-NMR analysis. The deep red reaction mixture
was diluted with water and CH2Cl2, treated with NaHSO3 until colorless,
and carefully neutralized with a saturated aqueous solution of NaHCO3.
This mixture was poured into a separatory funnel with CH2Cl2, shaken and
separated. The aqueous fraction was extracted with CH2Cl2. The combined
organic fractions were washed with brine, dried over MgSO4, and
evaporated to yield the desired iodoamide. Synthesized by General
Protocol A. 92% yield. 1H-NMR (CDCl3, 500 MHz): δ 6.04 (bs, 1H, major
rotamer NH), 5.89 (bs, 1H, minor rotamer), 2.99 (d, 3H, J= 5.0 Hz, minor
rotamer), 2.81 (d, 3H, J= 5.0 Hz, major rotamer), 2.33 (t, 2H, J= 7.0 Hz,
minor rotamer), 2.22 (t, 2H, J= 7.0 Hz, major rotamer), 1.59 (sext, 2H,
J= 7.0 Hz, minor rotamer), 1.54 (sext, 2H, J= 7.0 Hz, major rotamer),
0.99 (t, 3H, J= 7.5 Hz, minor rotamer), 0.96 (t, 3H, J= 7.5 Hz, major
rotamer). 13C-NMR (CDCl3, 125 MHz): δ 54.47 (major), 87.18 (major), 75.76
(major), 29.87 (minor), 26.58 (major), 21.43 (major), 20.97 (minor),
20.65 (major), 13.60 (major). HRMS (ESI) calcd for C7H12NO (M+H)+:
126.0919, found: 126.0920.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of antitumor NAD(P)H quinone oxidoreductase (NQO1) substrates
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hergenrother, Paul J.; Boothman, David A.; Bair, Joseph S.; Palchaudhuri,
Rahul; Parkinson, Elizabeth I.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2013056073 A1 2013-04-18

$RFMT $RIREG SCHEME226 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4,6-Trichlorophenyl 4-[(E)-(1,3-dihydro-5,6-dimethoxy-1-oxo-2H-inden-2-ylid...
C24H16Cl3NO5
1620646-39-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.0408 3.2908 0.0 0
M  V30 2 C 8.3910 6.6229 0.0 0
M  V30 3 O 2.3100 1.3338 0.0 0
M  V30 4 C 3.0800 0.0000 0.0 0
M  V30 5 O 0.7700 4.0011 0.0 0
M  V30 6 C 0.0000 5.3347 0.0 0
M  V30 7 C 11.0583 8.1629 0.0 0
M  V30 8 O 12.3919 8.9329 0.0 0
M  V30 9 O 11.0583 6.6229 0.0 0
M  V30 10 Cl 15.0594 10.4729 0.0 0
M  V30 11 Cl 12.3919 5.8529 0.0 0
M  V30 12 Cl 17.7266 5.8529 0.0 0
M  V30 13 C 5.3900 4.0011 0.0 0
M  V30 14 C 4.6200 5.3347 0.0 0
M  V30 15 C 6.8963 4.3212 0.0 0
M  V30 16 C 4.6200 2.6674 0.0 0
M  V30 17 C 5.6504 6.4792 0.0 0
M  V30 18 C 3.0800 5.3347 0.0 0
M  V30 19 C 7.0572 5.8529 0.0 0
M  V30 20 C 3.0800 2.6674 0.0 0
M  V30 21 C 2.3100 4.0011 0.0 0
M  V30 22 C 8.3910 8.1629 0.0 0
M  V30 23 C 9.7246 8.9329 0.0 0
M  V30 24 C 7.0572 8.9329 0.0 0
M  V30 25 C 9.7246 10.4729 0.0 0
M  V30 26 C 7.0572 10.4729 0.0 0
M  V30 27 N 8.3910 11.2429 0.0 0
M  V30 28 C 13.7257 8.1629 0.0 0
M  V30 29 C 15.0594 8.9329 0.0 0
M  V30 30 C 13.7257 6.6229 0.0 0
M  V30 31 C 16.3930 8.1629 0.0 0
M  V30 32 C 15.0594 5.8529 0.0 0
M  V30 33 C 16.3930 6.6229 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 15
M  V30 2 2 2 19
M  V30 3 1 2 22
M  V30 4 1 3 4
M  V30 5 1 3 20
M  V30 6 1 5 6
M  V30 7 1 5 21
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 23
M  V30 11 1 8 28
M  V30 12 1 10 29
M  V30 13 1 11 30
M  V30 14 1 12 33
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 2 13 16
M  V30 18 1 14 17
M  V30 19 2 14 18
M  V30 20 1 15 19
M  V30 21 1 16 20
M  V30 22 1 17 19
M  V30 23 1 18 21
M  V30 24 2 20 21
M  V30 25 1 22 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 27
M  V30 31 2 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 32
M  V30 35 2 31 33
M  V30 36 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[(E)-(1,3-Dihydro-5,6-dimethoxy-1-oxo-2H-inden-2-ylidene)methyl]-N-methyl-3...
C19H18N2O4
1620646-42-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.0410 3.2909 0.0 0
M  V30 2 C 8.3912 6.6231 0.0 0
M  V30 3 O 0.7700 4.0012 0.0 0
M  V30 4 C 0.0000 5.3348 0.0 0
M  V30 5 O 2.3101 1.3338 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 11.0587 8.1631 0.0 0
M  V30 8 N 12.3923 8.9331 0.0 0
M  V30 9 O 11.0587 6.6231 0.0 0
M  V30 10 C 13.7260 8.1631 0.0 0
M  V30 11 C 4.6201 5.3348 0.0 0
M  V30 12 C 5.3901 4.0012 0.0 0
M  V30 13 C 5.6505 6.4794 0.0 0
M  V30 14 C 3.0801 5.3348 0.0 0
M  V30 15 C 6.8964 4.3213 0.0 0
M  V30 16 C 4.6201 2.6675 0.0 0
M  V30 17 C 7.0575 5.8531 0.0 0
M  V30 18 C 2.3101 4.0012 0.0 0
M  V30 19 C 3.0801 2.6675 0.0 0
M  V30 20 C 8.3912 8.1631 0.0 0
M  V30 21 C 9.7249 8.9331 0.0 0
M  V30 22 C 7.0575 8.9331 0.0 0
M  V30 23 C 9.7249 10.4732 0.0 0
M  V30 24 C 7.0575 10.4732 0.0 0
M  V30 25 N 8.3912 11.2432 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 15
M  V30 2 2 2 17
M  V30 3 1 2 20
M  V30 4 1 3 4
M  V30 5 1 3 18
M  V30 6 1 5 6
M  V30 7 1 5 19
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 21
M  V30 11 1 8 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 12 15
M  V30 16 2 12 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 1 15 17
M  V30 20 1 16 19
M  V30 21 2 18 19
M  V30 22 1 20 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1620646-39-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1620646-42-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-7766684
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM Schlenk tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of oxidizable pyridine derivatives as prodrugs for
acetylcholinesterase inhibitors and potent anti-Alzheimer agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Marsais, Francis; Levacher, Vincent; Papamicael, Cyril; Bohn, Pierre;
Peauger, Ludovic; Gembus, Vincent; Le Fur, Nicolas; Dumartin-Lepine,
Marie-Laurence
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2014114742 A1 2014-07-31

$RFMT $RIREG SCHEME227 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-fluoro-4-formyl-5-methylbenzoate
C10H9FO3
1621165-17-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 4.6201 0.0 0
M  V30 2 O 8.0022 3.8500 0.0 0
M  V30 3 O 6.6684 6.1601 0.0 0
M  V30 4 C 9.3359 4.6201 0.0 0
M  V30 5 F 4.0011 6.1601 0.0 0
M  V30 6 C 4.0011 0.0000 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 O 0.0000 2.3100 0.0 0
M  V30 9 C 5.3348 3.8500 0.0 0
M  V30 10 C 4.0011 4.6201 0.0 0
M  V30 11 C 5.3348 2.3100 0.0 0
M  V30 12 C 2.6675 3.8500 0.0 0
M  V30 13 C 4.0011 1.5400 0.0 0
M  V30 14 C 2.6675 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 10
M  V30 6 1 6 13
M  V30 7 2 7 8
M  V30 8 1 7 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Fluoro-4-formyl-N,5-dimethylbenzamide
C10H10FNO2
1621165-18-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 4.6201 0.0 0
M  V30 2 N 8.0022 3.8500 0.0 0
M  V30 3 O 6.6684 6.1601 0.0 0
M  V30 4 C 9.3359 4.6201 0.0 0
M  V30 5 F 4.0011 6.1601 0.0 0
M  V30 6 C 4.0011 0.0000 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 O 0.0000 2.3100 0.0 0
M  V30 9 C 5.3348 3.8500 0.0 0
M  V30 10 C 4.0011 4.6201 0.0 0
M  V30 11 C 5.3348 2.3100 0.0 0
M  V30 12 C 2.6675 3.8500 0.0 0
M  V30 13 C 4.0011 1.5400 0.0 0
M  V30 14 C 2.6675 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 10
M  V30 6 1 6 13
M  V30 7 2 7 8
M  V30 8 1 7 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1621165-17-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1621165-18-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-6141142
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of imidazopyridine compounds and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Buon, Christophe; Cantin, Louis-David; Hu, Yun-Jin; Luo, Xuehong;
Tomaszewski, Miroslaw Jerzy
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2014117274 A1 2014-08-07

$RFMT $RIREG SCHEME228 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Azetidinemethanol, 1-(diphenylmethyl)-, 3-methanesulfonate
C18H21NO3S
162698-41-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 4.6201 0.0 0
M  V30 2 C 8.5547 7.2491 0.0 0
M  V30 3 O 9.8884 6.4791 0.0 0
M  V30 4 S 11.2221 7.2491 0.0 0 VAL=6
M  V30 5 C 11.9921 5.9154 0.0 0
M  V30 6 O 12.5559 8.0191 0.0 0
M  V30 7 O 10.4521 8.5829 0.0 0
M  V30 8 N 5.3348 5.3901 0.0 0
M  V30 9 C 5.7334 6.8778 0.0 0
M  V30 10 C 6.8225 4.9916 0.0 0
M  V30 11 C 7.2211 6.4791 0.0 0
M  V30 12 C 2.6675 5.3901 0.0 0
M  V30 13 C 2.6675 6.9302 0.0 0
M  V30 14 C 1.3338 4.6201 0.0 0
M  V30 15 C 1.3338 7.7002 0.0 0
M  V30 16 C 0.0000 5.3901 0.0 0
M  V30 17 C 0.0000 6.9302 0.0 0
M  V30 18 C 4.0012 3.0801 0.0 0
M  V30 19 C 2.6675 2.3101 0.0 0
M  V30 20 C 5.3348 2.3101 0.0 0
M  V30 21 C 2.6675 0.7700 0.0 0
M  V30 22 C 5.3348 0.7700 0.0 0
M  V30 23 C 4.0012 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 1 12
M  V30 3 1 1 18
M  V30 4 1 2 3
M  V30 5 1 2 11
M  V30 6 1 3 4
M  V30 7 1 4 5
M  V30 8 2 4 6
M  V30 9 2 4 7
M  V30 10 1 8 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 1 10 11
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(Diphenylmethyl)-N-methyl-3-azetidinemethanamine
C18H22N2
91189-20-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 4.6201 0.0 0
M  V30 2 C 8.5547 7.2491 0.0 0
M  V30 3 N 9.8884 6.4791 0.0 0
M  V30 4 C 11.2222 7.2491 0.0 0
M  V30 5 N 5.3348 5.3901 0.0 0
M  V30 6 C 5.7335 6.8776 0.0 0
M  V30 7 C 6.8225 4.9916 0.0 0
M  V30 8 C 7.2211 6.4791 0.0 0
M  V30 9 C 4.0012 3.0801 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 2.6675 2.3101 0.0 0
M  V30 12 C 5.3348 0.7700 0.0 0
M  V30 13 C 2.6675 0.7700 0.0 0
M  V30 14 C 4.0012 0.0000 0.0 0
M  V30 15 C 2.6675 5.3901 0.0 0
M  V30 16 C 2.6675 6.9302 0.0 0
M  V30 17 C 1.3338 4.6201 0.0 0
M  V30 18 C 1.3338 7.7002 0.0 0
M  V30 19 C 0.0000 5.3901 0.0 0
M  V30 20 C 0.0000 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 1 9
M  V30 3 1 1 15
M  V30 4 1 2 3
M  V30 5 1 2 8
M  V30 6 1 3 4
M  V30 7 1 5 6
M  V30 8 1 5 7
M  V30 9 1 6 8
M  V30 10 1 7 8
M  V30 11 2 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 162698-41-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 91189-20-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38956329
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of bicyclic-substituted glutarimides as cereblon binders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nasveschuk, Christopher G.; Lazarski, Kiel; Hird, Alexander W.; Yin,
Ning; Good, Andrew Charles; Huang, Hongwei; Eron, Scott Joseph; Veits,
Gesine Kerstin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023239750 A1 2023-12-14

$RFMT $RIREG SCHEME229 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-[1-cyano-2-(dimethylamino)ethenyl]-4-phenyl-3-quinolinecarboxylate
C23H21N3O2
1627598-50-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.0011 0.0 0
M  V30 2 O 3.0800 4.0011 0.0 0
M  V30 3 O 5.3900 2.6673 0.0 0
M  V30 4 C 2.3100 2.6673 0.0 0
M  V30 5 C 0.7700 2.6673 0.0 0
M  V30 6 C 7.7000 4.0011 0.0 0
M  V30 7 C 6.9300 2.6673 0.0 0
M  V30 8 C 9.2400 4.0011 0.0 0
M  V30 9 N 7.7000 1.3336 0.0 0
M  V30 10 N 10.7800 4.0011 0.0 0
M  V30 11 C 6.9300 0.0000 0.0 0
M  V30 12 C 9.2400 1.3336 0.0 0
M  V30 13 C 4.6200 6.6684 0.0 0
M  V30 14 C 5.3900 5.3347 0.0 0
M  V30 15 C 5.3900 8.0021 0.0 0
M  V30 16 C 6.9300 5.3347 0.0 0
M  V30 17 C 6.9300 8.0021 0.0 0
M  V30 18 C 4.6200 9.3358 0.0 0
M  V30 19 N 7.7000 6.6684 0.0 0
M  V30 20 C 7.7000 9.3358 0.0 0
M  V30 21 C 5.3900 10.6694 0.0 0
M  V30 22 C 6.9300 10.6694 0.0 0
M  V30 23 C 3.0800 6.6684 0.0 0
M  V30 24 C 2.3100 5.3347 0.0 0
M  V30 25 C 2.3100 8.0021 0.0 0
M  V30 26 C 0.7700 5.3347 0.0 0
M  V30 27 C 0.7700 8.0021 0.0 0
M  V30 28 C 0.0000 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 6 7 CFG=2
M  V30 7 1 6 8
M  V30 8 1 6 16
M  V30 9 1 7 9
M  V30 10 3 8 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 13 23
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 1 15 18
M  V30 19 2 16 19
M  V30 20 1 17 19
M  V30 21 1 17 20
M  V30 22 2 18 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,2-Dihydro-2-methyl-1-oxo-10-phenylbenzo[b][1,6]naphthyridine-4-carbonitrile
C20H13N3O
1627598-51-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0800 2.6674 0.0 0
M  V30 2 C 9.2400 2.6674 0.0 0
M  V30 3 N 10.7800 2.6674 0.0 0
M  V30 4 C 4.6200 0.0000 0.0 0
M  V30 5 C 4.6200 5.3347 0.0 0
M  V30 6 C 5.3900 4.0011 0.0 0
M  V30 7 C 5.3900 6.6684 0.0 0
M  V30 8 C 6.9300 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 6.9300 6.6684 0.0 0
M  V30 11 C 4.6200 8.0021 0.0 0
M  V30 12 C 7.7000 2.6674 0.0 0
M  V30 13 N 7.7000 5.3347 0.0 0
M  V30 14 N 5.3900 1.3336 0.0 0
M  V30 15 C 7.7000 8.0021 0.0 0
M  V30 16 C 5.3900 9.3358 0.0 0
M  V30 17 C 6.9300 1.3336 0.0 0
M  V30 18 C 6.9300 9.3358 0.0 0
M  V30 19 C 3.0800 5.3347 0.0 0
M  V30 20 C 2.3100 6.6684 0.0 0
M  V30 21 C 2.3100 4.0011 0.0 0
M  V30 22 C 0.7700 6.6684 0.0 0
M  V30 23 C 0.7700 4.0011 0.0 0
M  V30 24 C 0.0000 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 3 2 3
M  V30 3 1 2 12
M  V30 4 1 4 14
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 19
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 2 7 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 2 8 13
M  V30 14 1 9 14
M  V30 15 1 10 13
M  V30 16 1 10 15
M  V30 17 2 11 16
M  V30 18 2 12 17
M  V30 19 1 14 17
M  V30 20 2 15 18
M  V30 21 1 16 18
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1627598-50-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1627598-51-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-568228
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM optimization study, optimized on solvent, optimized on temperature,
optimized on time, optimized on stoichiometry of solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An efficient synthesis of
1-oxo-1,2-dihydrobenzo[b][1,6]naphthyridine-4-carbonitriles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Dao-Lin; Wu, Jian-Ying; Wu, Dan; Wang, Yong-Yang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chinese Chemical Letters (2014), 25(12), 1555-1558

$RFMT $RIREG SCHEME230 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzenemethanol, 2-nitro-, 1-methanesulfonate
C8H9NO5S
163915-96-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.0011 0.0 0
M  V30 2 O 5.3900 5.3349 0.0 0
M  V30 3 S 6.9300 5.3349 0.0 0 VAL=6
M  V30 4 C 6.9300 3.7949 0.0 0
M  V30 5 O 8.4700 5.3349 0.0 0
M  V30 6 O 6.9300 6.8749 0.0 0
M  V30 7 N 3.0800 1.3338 0.0 0 VAL=5
M  V30 8 O 2.3100 0.0000 0.0 0
M  V30 9 O 4.6200 1.3338 0.0 0
M  V30 10 C 3.0800 4.0011 0.0 0
M  V30 11 C 2.3100 2.6674 0.0 0
M  V30 12 C 2.3100 5.3349 0.0 0
M  V30 13 C 0.7700 2.6674 0.0 0
M  V30 14 C 0.7700 5.3349 0.0 0
M  V30 15 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 2 3 6
M  V30 7 2 7 8
M  V30 8 2 7 9
M  V30 9 1 7 11
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2-nitrobenzenemethanamine
C8H10N2O2
56222-08-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.5400 4.0011 0.0 0 VAL=5
M  V30 2 O 2.3100 5.3349 0.0 0
M  V30 3 O 0.0000 4.0011 0.0 0
M  V30 4 C 4.6200 4.0011 0.0 0
M  V30 5 N 6.1600 4.0011 0.0 0
M  V30 6 C 6.9300 5.3349 0.0 0
M  V30 7 C 2.3100 2.6674 0.0 0
M  V30 8 C 3.8500 2.6674 0.0 0
M  V30 9 C 1.5400 1.3338 0.0 0
M  V30 10 C 4.6200 1.3338 0.0 0
M  V30 11 C 2.3100 0.0000 0.0 0
M  V30 12 C 3.8500 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 5
M  V30 5 1 4 8
M  V30 6 1 5 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 163915-96-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 56222-08-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-495302
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM A sample of intermediate N-methyl-1-(2-nitrophenyl)-methanamine 5 was
isolated in the laboratory and characterised as the hydrochloride salt.
The data obtained was in accordance with the published data.9 Reagents
ii) aq MeNH2 92%
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM The Development of a Manufacturing Route for the GPIIb/IIIa Receptor
Antagonist SB-214857-A. Part 1: Synthesis of the Key Intermediate
2,3,4,5-Tetrahydro-4-methyl-3-oxo-1H-1,4-benzodiazepine-2-acetic Acid
Methyl Ester, SB-235349
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Andrews, Ian P.; Atkins, Richard J.; Breen, Gary F.; Carey, John S.;
Forth, Michael A.; Morgan, David O.; Shamji, Amin; Share, Andrew C.;
Smith, Stephen A. C.; Walsgrove, Timothy C.; Wells, Andrew S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Process Research & Development (2003), 7(5), 655-662

$RFMT $RIREG SCHEME231 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6,10-Dichloro-12H-[1]benzothiopyrano[2,3-c]quinolin-12-one
C16H7Cl2NOS
1643806-74-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 6.1601 0.0 0
M  V30 2 Cl 2.6673 0.0000 0.0 0
M  V30 3 Cl 10.6695 4.6201 0.0 0
M  V30 4 C 4.0011 3.8500 0.0 0
M  V30 5 C 2.6673 4.6201 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 5.3348 4.6201 0.0 0
M  V30 8 C 1.3337 3.8500 0.0 0
M  V30 9 C 2.6673 6.1601 0.0 0
M  V30 10 S 5.3348 1.5400 0.0 0
M  V30 11 C 2.6673 1.5400 0.0 0
M  V30 12 C 6.6684 3.8500 0.0 0
M  V30 13 N 1.3337 2.3100 0.0 0
M  V30 14 C 0.0000 4.6201 0.0 0
M  V30 15 C 1.3337 6.9301 0.0 0
M  V30 16 C 6.6684 2.3100 0.0 0
M  V30 17 C 8.0022 4.6201 0.0 0
M  V30 18 C 0.0000 6.1601 0.0 0
M  V30 19 C 8.0022 1.5400 0.0 0
M  V30 20 C 9.3359 3.8500 0.0 0
M  V30 21 C 9.3359 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 1 2 11
M  V30 3 1 3 20
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 6 11
M  V30 11 1 7 12
M  V30 12 1 8 13
M  V30 13 2 8 14
M  V30 14 1 9 15
M  V30 15 1 10 16
M  V30 16 2 11 13
M  V30 17 1 12 16
M  V30 18 2 12 17
M  V30 19 1 14 18
M  V30 20 2 15 18
M  V30 21 2 16 19
M  V30 22 1 17 20
M  V30 23 1 19 21
M  V30 24 2 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
10-Chloro-6-(methylamino)-12H-[1]benzothiopyrano[2,3-c]quinolin-12-one
C17H11ClN2OS
1643806-93-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.9300 2.6674 0.0 0
M  V30 2 N 1.5400 6.6685 0.0 0
M  V30 3 C 0.0000 6.6685 0.0 0
M  V30 4 Cl 10.7800 6.6685 0.0 0
M  V30 5 C 4.6200 4.0011 0.0 0
M  V30 6 C 3.8500 5.3347 0.0 0
M  V30 7 C 3.8500 2.6674 0.0 0
M  V30 8 C 6.1600 4.0011 0.0 0
M  V30 9 C 2.3100 5.3347 0.0 0
M  V30 10 S 4.6200 6.6685 0.0 0
M  V30 11 C 2.3100 2.6674 0.0 0
M  V30 12 C 4.6200 1.3336 0.0 0
M  V30 13 C 6.9300 5.3347 0.0 0
M  V30 14 N 1.5400 4.0011 0.0 0
M  V30 15 C 6.1600 6.6685 0.0 0
M  V30 16 C 1.5400 1.3336 0.0 0
M  V30 17 C 3.8500 0.0000 0.0 0
M  V30 18 C 8.4700 5.3347 0.0 0
M  V30 19 C 6.9300 8.0021 0.0 0
M  V30 20 C 2.3100 0.0000 0.0 0
M  V30 21 C 9.2400 6.6685 0.0 0
M  V30 22 C 8.4700 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 1 2 3
M  V30 3 1 2 9
M  V30 4 1 4 21
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 2 7 12
M  V30 12 1 8 13
M  V30 13 2 9 14
M  V30 14 1 10 15
M  V30 15 1 11 14
M  V30 16 2 11 16
M  V30 17 1 12 17
M  V30 18 1 13 15
M  V30 19 2 13 18
M  V30 20 2 15 19
M  V30 21 1 16 20
M  V30 22 2 17 20
M  V30 23 1 18 21
M  V30 24 1 19 22
M  V30 25 2 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1643806-74-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1643806-93-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-17276432
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-68-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of thiochromenoquinolinone derivatives for use as
topoisomerase activity inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM 
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Israel, IL235077 A 2016-04-21

$RFMT $RIREG SCHEME231 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6,10-Dichloro-12H-[1]benzothiopyrano[2,3-c]quinolin-12-one
C16H7Cl2NOS
1643806-74-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 6.1601 0.0 0
M  V30 2 Cl 2.6673 0.0000 0.0 0
M  V30 3 Cl 10.6695 4.6201 0.0 0
M  V30 4 C 4.0011 3.8500 0.0 0
M  V30 5 C 2.6673 4.6201 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 5.3348 4.6201 0.0 0
M  V30 8 C 1.3337 3.8500 0.0 0
M  V30 9 C 2.6673 6.1601 0.0 0
M  V30 10 S 5.3348 1.5400 0.0 0
M  V30 11 C 2.6673 1.5400 0.0 0
M  V30 12 C 6.6684 3.8500 0.0 0
M  V30 13 N 1.3337 2.3100 0.0 0
M  V30 14 C 0.0000 4.6201 0.0 0
M  V30 15 C 1.3337 6.9301 0.0 0
M  V30 16 C 6.6684 2.3100 0.0 0
M  V30 17 C 8.0022 4.6201 0.0 0
M  V30 18 C 0.0000 6.1601 0.0 0
M  V30 19 C 8.0022 1.5400 0.0 0
M  V30 20 C 9.3359 3.8500 0.0 0
M  V30 21 C 9.3359 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 1 2 11
M  V30 3 1 3 20
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 6 11
M  V30 11 1 7 12
M  V30 12 1 8 13
M  V30 13 2 8 14
M  V30 14 1 9 15
M  V30 15 1 10 16
M  V30 16 2 11 13
M  V30 17 1 12 16
M  V30 18 2 12 17
M  V30 19 1 14 18
M  V30 20 2 15 18
M  V30 21 2 16 19
M  V30 22 1 17 20
M  V30 23 1 19 21
M  V30 24 2 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
10-Chloro-6-(methylamino)-12H-[1]benzothiopyrano[2,3-c]quinolin-12-one
C17H11ClN2OS
1643806-93-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.9300 2.6674 0.0 0
M  V30 2 N 1.5400 6.6685 0.0 0
M  V30 3 C 0.0000 6.6685 0.0 0
M  V30 4 Cl 10.7800 6.6685 0.0 0
M  V30 5 C 4.6200 4.0011 0.0 0
M  V30 6 C 3.8500 5.3347 0.0 0
M  V30 7 C 3.8500 2.6674 0.0 0
M  V30 8 C 6.1600 4.0011 0.0 0
M  V30 9 C 2.3100 5.3347 0.0 0
M  V30 10 S 4.6200 6.6685 0.0 0
M  V30 11 C 2.3100 2.6674 0.0 0
M  V30 12 C 4.6200 1.3336 0.0 0
M  V30 13 C 6.9300 5.3347 0.0 0
M  V30 14 N 1.5400 4.0011 0.0 0
M  V30 15 C 6.1600 6.6685 0.0 0
M  V30 16 C 1.5400 1.3336 0.0 0
M  V30 17 C 3.8500 0.0000 0.0 0
M  V30 18 C 8.4700 5.3347 0.0 0
M  V30 19 C 6.9300 8.0021 0.0 0
M  V30 20 C 2.3100 0.0000 0.0 0
M  V30 21 C 9.2400 6.6685 0.0 0
M  V30 22 C 8.4700 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 1 2 3
M  V30 3 1 2 9
M  V30 4 1 4 21
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 2 7 12
M  V30 12 1 8 13
M  V30 13 2 9 14
M  V30 14 1 10 15
M  V30 15 1 11 14
M  V30 16 2 11 16
M  V30 17 1 12 17
M  V30 18 1 13 15
M  V30 19 2 13 18
M  V30 20 2 15 19
M  V30 21 1 16 20
M  V30 22 2 17 20
M  V30 23 1 18 21
M  V30 24 1 19 22
M  V30 25 2 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1643806-74-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1643806-93-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-15854279
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-68-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of thiochromeno[2,3-c]quinolin-12-one derivatives and their
use as topoisomerase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Huang, Hsu-Shan; Yu, Dah-Shyong; Chen, Tsung-Chih
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Patent Organization, EP3002287 A1 2016-04-06

$RFMT $RIREG SCHEME231 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6,10-Dichloro-12H-[1]benzothiopyrano[2,3-c]quinolin-12-one
C16H7Cl2NOS
1643806-74-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 6.1601 0.0 0
M  V30 2 Cl 2.6673 0.0000 0.0 0
M  V30 3 Cl 10.6695 4.6201 0.0 0
M  V30 4 C 4.0011 3.8500 0.0 0
M  V30 5 C 2.6673 4.6201 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 5.3348 4.6201 0.0 0
M  V30 8 C 1.3337 3.8500 0.0 0
M  V30 9 C 2.6673 6.1601 0.0 0
M  V30 10 S 5.3348 1.5400 0.0 0
M  V30 11 C 2.6673 1.5400 0.0 0
M  V30 12 C 6.6684 3.8500 0.0 0
M  V30 13 N 1.3337 2.3100 0.0 0
M  V30 14 C 0.0000 4.6201 0.0 0
M  V30 15 C 1.3337 6.9301 0.0 0
M  V30 16 C 6.6684 2.3100 0.0 0
M  V30 17 C 8.0022 4.6201 0.0 0
M  V30 18 C 0.0000 6.1601 0.0 0
M  V30 19 C 8.0022 1.5400 0.0 0
M  V30 20 C 9.3359 3.8500 0.0 0
M  V30 21 C 9.3359 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 1 2 11
M  V30 3 1 3 20
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 6 11
M  V30 11 1 7 12
M  V30 12 1 8 13
M  V30 13 2 8 14
M  V30 14 1 9 15
M  V30 15 1 10 16
M  V30 16 2 11 13
M  V30 17 1 12 16
M  V30 18 2 12 17
M  V30 19 1 14 18
M  V30 20 2 15 18
M  V30 21 2 16 19
M  V30 22 1 17 20
M  V30 23 1 19 21
M  V30 24 2 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
10-Chloro-6-(methylamino)-12H-[1]benzothiopyrano[2,3-c]quinolin-12-one
C17H11ClN2OS
1643806-93-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.9300 2.6674 0.0 0
M  V30 2 N 1.5400 6.6685 0.0 0
M  V30 3 C 0.0000 6.6685 0.0 0
M  V30 4 Cl 10.7800 6.6685 0.0 0
M  V30 5 C 4.6200 4.0011 0.0 0
M  V30 6 C 3.8500 5.3347 0.0 0
M  V30 7 C 3.8500 2.6674 0.0 0
M  V30 8 C 6.1600 4.0011 0.0 0
M  V30 9 C 2.3100 5.3347 0.0 0
M  V30 10 S 4.6200 6.6685 0.0 0
M  V30 11 C 2.3100 2.6674 0.0 0
M  V30 12 C 4.6200 1.3336 0.0 0
M  V30 13 C 6.9300 5.3347 0.0 0
M  V30 14 N 1.5400 4.0011 0.0 0
M  V30 15 C 6.1600 6.6685 0.0 0
M  V30 16 C 1.5400 1.3336 0.0 0
M  V30 17 C 3.8500 0.0000 0.0 0
M  V30 18 C 8.4700 5.3347 0.0 0
M  V30 19 C 6.9300 8.0021 0.0 0
M  V30 20 C 2.3100 0.0000 0.0 0
M  V30 21 C 9.2400 6.6685 0.0 0
M  V30 22 C 8.4700 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 1 2 3
M  V30 3 1 2 9
M  V30 4 1 4 21
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 2 7 12
M  V30 12 1 8 13
M  V30 13 2 9 14
M  V30 14 1 10 15
M  V30 15 1 11 14
M  V30 16 2 11 16
M  V30 17 1 12 17
M  V30 18 1 13 15
M  V30 19 2 13 18
M  V30 20 2 15 19
M  V30 21 1 16 20
M  V30 22 2 17 20
M  V30 23 1 18 21
M  V30 24 1 19 22
M  V30 25 2 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1643806-74-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1643806-93-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-15913160
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-68-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of novel thiochromeno[2,3-c]quinolin-12-one derivatives as
topoisomerase type I and II inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Huang, Hsu-Shan; Yu, Dah-Shyong; Chen, Tsung-Chih
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Canada, CA2866502 A1 2016-04-03

$RFMT $RIREG SCHEME231 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6,10-Dichloro-12H-[1]benzothiopyrano[2,3-c]quinolin-12-one
C16H7Cl2NOS
1643806-74-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 6.1601 0.0 0
M  V30 2 Cl 2.6673 0.0000 0.0 0
M  V30 3 Cl 10.6695 4.6201 0.0 0
M  V30 4 C 4.0011 3.8500 0.0 0
M  V30 5 C 2.6673 4.6201 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 5.3348 4.6201 0.0 0
M  V30 8 C 1.3337 3.8500 0.0 0
M  V30 9 C 2.6673 6.1601 0.0 0
M  V30 10 S 5.3348 1.5400 0.0 0
M  V30 11 C 2.6673 1.5400 0.0 0
M  V30 12 C 6.6684 3.8500 0.0 0
M  V30 13 N 1.3337 2.3100 0.0 0
M  V30 14 C 0.0000 4.6201 0.0 0
M  V30 15 C 1.3337 6.9301 0.0 0
M  V30 16 C 6.6684 2.3100 0.0 0
M  V30 17 C 8.0022 4.6201 0.0 0
M  V30 18 C 0.0000 6.1601 0.0 0
M  V30 19 C 8.0022 1.5400 0.0 0
M  V30 20 C 9.3359 3.8500 0.0 0
M  V30 21 C 9.3359 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 1 2 11
M  V30 3 1 3 20
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 6 11
M  V30 11 1 7 12
M  V30 12 1 8 13
M  V30 13 2 8 14
M  V30 14 1 9 15
M  V30 15 1 10 16
M  V30 16 2 11 13
M  V30 17 1 12 16
M  V30 18 2 12 17
M  V30 19 1 14 18
M  V30 20 2 15 18
M  V30 21 2 16 19
M  V30 22 1 17 20
M  V30 23 1 19 21
M  V30 24 2 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
10-Chloro-6-(methylamino)-12H-[1]benzothiopyrano[2,3-c]quinolin-12-one
C17H11ClN2OS
1643806-93-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.9300 2.6674 0.0 0
M  V30 2 N 1.5400 6.6685 0.0 0
M  V30 3 C 0.0000 6.6685 0.0 0
M  V30 4 Cl 10.7800 6.6685 0.0 0
M  V30 5 C 4.6200 4.0011 0.0 0
M  V30 6 C 3.8500 5.3347 0.0 0
M  V30 7 C 3.8500 2.6674 0.0 0
M  V30 8 C 6.1600 4.0011 0.0 0
M  V30 9 C 2.3100 5.3347 0.0 0
M  V30 10 S 4.6200 6.6685 0.0 0
M  V30 11 C 2.3100 2.6674 0.0 0
M  V30 12 C 4.6200 1.3336 0.0 0
M  V30 13 C 6.9300 5.3347 0.0 0
M  V30 14 N 1.5400 4.0011 0.0 0
M  V30 15 C 6.1600 6.6685 0.0 0
M  V30 16 C 1.5400 1.3336 0.0 0
M  V30 17 C 3.8500 0.0000 0.0 0
M  V30 18 C 8.4700 5.3347 0.0 0
M  V30 19 C 6.9300 8.0021 0.0 0
M  V30 20 C 2.3100 0.0000 0.0 0
M  V30 21 C 9.2400 6.6685 0.0 0
M  V30 22 C 8.4700 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 1 2 3
M  V30 3 1 2 9
M  V30 4 1 4 21
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 2 7 12
M  V30 12 1 8 13
M  V30 13 2 9 14
M  V30 14 1 10 15
M  V30 15 1 11 14
M  V30 16 2 11 16
M  V30 17 1 12 17
M  V30 18 1 13 15
M  V30 19 2 13 18
M  V30 20 2 15 19
M  V30 21 1 16 20
M  V30 22 2 17 20
M  V30 23 1 18 21
M  V30 24 1 19 22
M  V30 25 2 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1643806-74-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1643806-93-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-5714766
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 497-19-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-68-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Thiochromeno[2,3-c]quinolin-12-one derivatives as topoisomerase I and II
inhibitors and their preparation and use for the treatment of cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Huang, Hsu-Shan; Yu, Dah-Shyong; Chen, Tsung-Chih
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US8927717 B1 2015-01-06

$RFMT $RIREG SCHEME232 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[[2-[[2-Methyl-2-[(methylsulfonyl)amino]-1-oxopropyl]amino]phenyl]sulfonyl]...
C17H25N3O7S2
1648703-75-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 S 9.3913 4.0012 0.0 0 VAL=6
M  V30 2 O 8.0575 4.7712 0.0 0
M  V30 3 O 10.7249 3.2311 0.0 0
M  V30 4 N 6.3112 4.0012 0.0 0
M  V30 5 C 4.7712 4.0012 0.0 0
M  V30 6 C 4.0012 5.3348 0.0 0
M  V30 7 O 4.0012 2.6675 0.0 0
M  V30 8 N 2.6673 4.5648 0.0 0
M  V30 9 C 3.2311 6.6685 0.0 0
M  V30 10 C 5.3348 6.1048 0.0 0
M  V30 11 S 1.3337 5.3348 0.0 0 VAL=6
M  V30 12 C 0.0000 6.1048 0.0 0
M  V30 13 O 0.5637 4.0012 0.0 0
M  V30 14 O 2.1037 6.6685 0.0 0
M  V30 15 C 12.7233 4.3514 0.0 0
M  V30 16 O 14.2298 4.6715 0.0 0
M  V30 17 O 12.2474 2.8866 0.0 0
M  V30 18 C 15.2602 3.5271 0.0 0
M  V30 19 C 8.6213 2.6675 0.0 0
M  V30 20 C 7.0812 2.6675 0.0 0
M  V30 21 C 9.3913 1.3337 0.0 0
M  V30 22 C 6.3112 1.3337 0.0 0
M  V30 23 C 8.6213 0.0000 0.0 0
M  V30 24 C 7.0812 0.0000 0.0 0
M  V30 25 N 10.1613 5.3348 0.0 0
M  V30 26 C 11.6929 5.4958 0.0 0 CFG=2
M  V30 27 C 9.5348 6.7418 0.0 0
M  V30 28 C 12.0130 7.0022 0.0 0
M  V30 29 C 10.6794 7.7722 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 1 25
M  V30 5 1 4 5
M  V30 6 1 4 20
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 1 6 8
M  V30 10 1 6 9
M  V30 11 1 6 10
M  V30 12 1 8 11
M  V30 13 1 11 12
M  V30 14 2 11 13
M  V30 15 2 11 14
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 1 26 15 CFG=1
M  V30 19 1 16 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 26 1 25 26
M  V30 27 1 25 27
M  V30 28 1 26 28
M  V30 29 1 27 29
M  V30 30 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 26)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(2S)-N-Methyl-1-[[2-[[2-methyl-2-[(methylsulfonyl)amino]-1-oxopropyl]amino]ph...
C17H26N4O6S2
1648703-67-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 S 9.3913 4.0012 0.0 0 VAL=6
M  V30 2 O 10.7249 3.2311 0.0 0
M  V30 3 O 8.0575 4.7712 0.0 0
M  V30 4 N 6.3112 4.0012 0.0 0
M  V30 5 C 4.7712 4.0012 0.0 0
M  V30 6 C 4.0012 5.3348 0.0 0
M  V30 7 O 4.0012 2.6675 0.0 0
M  V30 8 N 2.6673 4.5648 0.0 0
M  V30 9 C 5.3348 6.1048 0.0 0
M  V30 10 C 3.2311 6.6685 0.0 0
M  V30 11 S 1.3337 5.3348 0.0 0 VAL=6
M  V30 12 C 0.0000 6.1048 0.0 0
M  V30 13 O 0.5637 4.0012 0.0 0
M  V30 14 O 2.1037 6.6685 0.0 0
M  V30 15 C 12.7233 4.3514 0.0 0
M  V30 16 N 14.2298 4.6715 0.0 0
M  V30 17 O 12.2474 2.8866 0.0 0
M  V30 18 C 15.2602 3.5271 0.0 0
M  V30 19 C 8.6213 2.6675 0.0 0
M  V30 20 C 7.0812 2.6675 0.0 0
M  V30 21 C 9.3913 1.3337 0.0 0
M  V30 22 C 6.3112 1.3337 0.0 0
M  V30 23 C 8.6213 0.0000 0.0 0
M  V30 24 C 7.0812 0.0000 0.0 0
M  V30 25 N 10.1613 5.3348 0.0 0
M  V30 26 C 11.6929 5.4958 0.0 0 CFG=2
M  V30 27 C 9.5348 6.7418 0.0 0
M  V30 28 C 12.0130 7.0022 0.0 0
M  V30 29 C 10.6794 7.7722 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 1 25
M  V30 5 1 4 5
M  V30 6 1 4 20
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 1 6 8
M  V30 10 1 6 9
M  V30 11 1 6 10
M  V30 12 1 8 11
M  V30 13 1 11 12
M  V30 14 2 11 13
M  V30 15 2 11 14
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 1 26 15 CFG=1
M  V30 19 1 16 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 26 1 25 26
M  V30 27 1 25 27
M  V30 28 1 26 28
M  V30 29 1 27 29
M  V30 30 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 26)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1648703-75-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1648703-67-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-8581644
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Reversal of H-bonding direction by N-sulfonation in a synthetic
reverse-turn peptide motif
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Vijayadas, Kuruppanthara N.; Kotmale, Amol S.; Thorat, Shridhar H.;
Gonnade, Rajesh G.; Nair, Roshna V.; Rajamohanan, Pattuparambil R.;
Sanjayan, Gangadhar J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2015), 13(10), 3064-3069

$RFMT $RIREG SCHEME233 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 4-chloro-3-nitro-, ethyl ester
C9H8ClNO4
16588-16-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 2 O 1.3337 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 Cl 1.3337 4.6201 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 8.0023 2.3101 0.0 0
M  V30 7 O 6.6685 0.0000 0.0 0
M  V30 8 C 9.3360 1.5400 0.0 0
M  V30 9 C 10.6697 2.3101 0.0 0
M  V30 10 C 2.6673 2.3101 0.0 0
M  V30 11 C 4.0012 1.5400 0.0 0
M  V30 12 C 2.6673 3.8501 0.0 0
M  V30 13 C 5.3348 2.3101 0.0 0
M  V30 14 C 4.0012 4.6201 0.0 0
M  V30 15 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 4 12
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 13
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 4-(methylamino)-3-nitro-, ethyl ester
C10H12N2O4
71254-71-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 4.6201 0.0 0 VAL=5
M  V30 2 O 0.0000 3.8500 0.0 0
M  V30 3 O 1.3337 6.1601 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 C 1.3337 0.0000 0.0 0
M  V30 6 C 6.6684 4.6201 0.0 0
M  V30 7 O 8.0022 3.8500 0.0 0
M  V30 8 O 6.6684 6.1601 0.0 0
M  V30 9 C 9.3359 4.6201 0.0 0
M  V30 10 C 10.6695 3.8500 0.0 0
M  V30 11 C 2.6673 3.8500 0.0 0
M  V30 12 C 2.6673 2.3100 0.0 0
M  V30 13 C 4.0011 4.6201 0.0 0
M  V30 14 C 4.0011 1.5400 0.0 0
M  V30 15 C 5.3348 3.8500 0.0 0
M  V30 16 C 5.3348 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 4 5
M  V30 5 1 4 12
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 15
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 16588-16-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 71254-71-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36614869
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and biological evaluation of some novel hydrazones carrying
benzimidazole and pyrene/vanillin moiety
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gebretekle, Desta; Kalluraya, Balakrishna; Manju, N.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Applicable Chemistry (Lumami, India) (2021), 10(1), 12-21

$RFMT $RIREG SCHEME234 STEP1
$RXN



  2  1
$MOL
6-Chloro-1H-indole-2-carboxylic acid
C9H6ClNO2
16732-75-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 1.5400 0.0 0
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3338 0.0000 0.0 0
M  V30 4 Cl 8.9549 4.1617 0.0 0
M  V30 5 C 4.3348 4.1617 0.0 0
M  V30 6 C 5.1048 2.8281 0.0 0
M  V30 7 C 2.8284 3.8416 0.0 0
M  V30 8 C 5.1048 5.4954 0.0 0
M  V30 9 N 4.0743 1.6835 0.0 0
M  V30 10 C 6.6448 2.8281 0.0 0
M  V30 11 C 2.6675 2.3100 0.0 0
M  V30 12 C 6.6448 5.4954 0.0 0
M  V30 13 C 7.4149 4.1617 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 4 13
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 1 10 13
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-N-methyl-1H-indole-2-carboxamide
C10H9ClN2O
2349374-43-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.6211 1.5400 0.0 0
M  V30 2 N 8.9549 2.3100 0.0 0
M  V30 3 O 7.6211 0.0000 0.0 0
M  V30 4 C 10.2886 1.5400 0.0 0
M  V30 5 Cl 0.0000 4.1618 0.0 0
M  V30 6 C 4.6201 4.1618 0.0 0
M  V30 7 C 3.8501 2.8281 0.0 0
M  V30 8 C 6.1265 3.8416 0.0 0
M  V30 9 C 3.8501 5.4954 0.0 0
M  V30 10 N 4.8806 1.6836 0.0 0
M  V30 11 C 2.3100 2.8281 0.0 0
M  V30 12 C 6.2875 2.3100 0.0 0
M  V30 13 C 2.3100 5.4954 0.0 0
M  V30 14 C 1.5400 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 5 14
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 1 11 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 16732-75-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2349374-43-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29799072
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel 15-Lipoxygenase-1 Inhibitor Protects Macrophages from
Lipopolysaccharide-Induced Cytotoxicity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Guo, Hao; Verhoek, Iris C.; Prins, Gerian G. H.; van der Vlag, Ramon; van
der Wouden, Petra E.; van Merkerk, Ronald; Quax, Wim J.; Olinga, Peter;
Hirsch, Anna K. H.; Dekker, Frank J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2019), 62(9), 4624-4637

$RFMT $RIREG SCHEME235 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,3-Difluoro-1-iodo-1-(trimethylsilyl)-4-octanone
C11H21F2IOSi
169385-19-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.0801 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 F 4.5648 0.9764 0.0 0
M  V30 6 F 6.1048 3.6437 0.0 0
M  V30 7 Si 1.3337 3.0801 0.0 0
M  V30 8 I 2.6673 0.7700 0.0 0
M  V30 9 C 8.0022 2.3101 0.0 0
M  V30 10 O 6.6685 0.0000 0.0 0
M  V30 11 C 0.0000 3.8501 0.0 0
M  V30 12 C 0.5637 1.7464 0.0 0
M  V30 13 C 2.1037 4.4137 0.0 0
M  V30 14 C 9.3360 1.5400 0.0 0
M  V30 15 C 10.6697 2.3101 0.0 0
M  V30 16 C 12.0033 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 3 8
M  V30 8 1 4 9
M  V30 9 2 4 10
M  V30 10 1 7 11
M  V30 11 1 7 12
M  V30 12 1 7 13
M  V30 13 1 9 14
M  V30 14 1 14 15
M  V30 15 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Butyl-3-fluoro-1-methyl-1H-pyrrole
C9H14FN
1190757-24-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 3.3322 0.0 0
M  V30 2 C 5.1048 2.5622 0.0 0
M  V30 3 C 6.4386 3.3322 0.0 0
M  V30 4 C 7.7722 2.5622 0.0 0
M  V30 5 F 3.4209 0.0000 0.0 0
M  V30 6 C 0.7103 4.6949 0.0 0
M  V30 7 C 2.4374 2.5622 0.0 0
M  V30 8 C 2.2765 1.0306 0.0 0
M  V30 9 N 1.0304 3.1885 0.0 0
M  V30 10 C 0.7700 0.7104 0.0 0
M  V30 11 C 0.0000 2.0441 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 5 8
M  V30 6 1 6 9
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 169385-19-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1190757-24-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-8551270
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM excess amine used, mechanism studied
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of 2-n-butyl-3-fluoropyrrole derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kim, Bo-Mi; San, Quan-Ze; Bhatt, Lok Ranjan; Jung, Dong-Woon; Lee,
Young-Hang; Chai, Kyu-Yun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bulletin of the Korean Chemical Society (2009), 30(6), 1293-1296

$RFMT $RIREG SCHEME236 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbon disulfide
CS2
75-15-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 0.0000 0.0 0
M  V30 2 S 0.0000 0.0000 0.0 0
M  V30 3 S 3.0800 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Dicyanomethylene)-1,3-indandione
C12H4N2O2
16954-74-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.0811 3.0801 0.0 0
M  V30 2 C 6.0811 1.5400 0.0 0
M  V30 3 C 7.4150 3.8501 0.0 0
M  V30 4 N 6.0811 0.0000 0.0 0
M  V30 5 N 8.7486 4.6201 0.0 0
M  V30 6 O 5.7309 6.4121 0.0 0
M  V30 7 O 3.0203 1.7173 0.0 0
M  V30 8 C 4.7475 3.8501 0.0 0
M  V30 9 C 4.5865 5.3816 0.0 0
M  V30 10 C 3.3406 3.2236 0.0 0
M  V30 11 C 3.0801 5.7018 0.0 0
M  V30 12 C 2.3101 4.3682 0.0 0
M  V30 13 C 2.3101 7.0355 0.0 0
M  V30 14 C 0.7700 4.3682 0.0 0
M  V30 15 C 0.7700 7.0355 0.0 0
M  V30 16 C 0.0000 5.7018 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 8
M  V30 4 3 2 4
M  V30 5 3 3 5
M  V30 6 2 6 9
M  V30 7 2 7 10
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C14H9N3O2S2
2135526-81-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7791 7.1398 0.0 0
M  V30 2 C 9.5253 2.5988 0.0 0
M  V30 3 N 11.0370 2.3049 0.0 0
M  V30 4 O 4.6079 0.0000 0.0 0
M  V30 5 S 7.6217 6.7470 0.0 0
M  V30 6 N 8.6585 5.5544 0.0 0
M  V30 7 C 4.1320 3.9565 0.0 0
M  V30 8 C 5.0373 2.7106 0.0 0
M  V30 9 C 2.6673 3.4806 0.0 0
M  V30 10 N 4.7248 4.7952 0.0 0
M  V30 11 O 5.1959 4.7142 0.0 0
M  V30 12 C 6.4706 3.6988 0.0 0
M  V30 13 C 4.1320 1.4647 0.0 0
M  V30 14 S 6.0474 3.4252 0.0 0
M  V30 15 C 2.6673 1.9406 0.0 0
M  V30 16 C 1.3337 4.2506 0.0 0
M  V30 17 C 6.0048 4.8551 0.0 0
M  V30 18 C 6.5978 4.2223 0.0 0
M  V30 19 C 1.3337 1.1706 0.0 0
M  V30 20 C 0.0000 3.4806 0.0 0
M  V30 21 C 0.0000 1.9406 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 3 2 3
M  V30 3 1 2 12
M  V30 4 2 4 13
M  V30 5 2 5 17
M  V30 6 1 6 18
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 8 13
M  V30 13 1 8 14
M  V30 14 1 9 15
M  V30 15 2 9 16
M  V30 16 1 10 17
M  V30 17 1 11 18
M  V30 18 2 12 18
M  V30 19 1 13 15
M  V30 20 1 14 17
M  V30 21 2 15 19
M  V30 22 1 16 20
M  V30 23 1 19 21
M  V30 24 2 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-15-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 16954-74-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2135526-81-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25959616
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective, regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A synthesis of oxo-thioxo[3.3.3]propellanes from dithiocarbamates and
ninhydrin-malononitrile adduct
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yavari, Issa; Khajeh-Khezri, Aliyeh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molecular Diversity (2017), 21(4), 849-854

$RFMT $RIREG SCHEME237 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5,6-Dihydro-2-methyl-7(4H)-benzothiazolone
C8H9NOS
17583-14-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.3337 0.0000 0.0 0
M  V30 2 C 6.5771 3.0800 0.0 0
M  V30 3 C 2.6673 3.8500 0.0 0
M  V30 4 C 2.6673 2.3100 0.0 0
M  V30 5 N 4.1320 4.3259 0.0 0
M  V30 6 C 1.3337 4.6201 0.0 0
M  V30 7 S 4.1320 1.8342 0.0 0
M  V30 8 C 1.3337 1.5400 0.0 0
M  V30 9 C 5.0371 3.0800 0.0 0
M  V30 10 C 0.0000 3.8500 0.0 0
M  V30 11 C 0.0000 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 1 2 9
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 4 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 9
M  V30 11 1 8 11
M  V30 12 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,5,6,7-Tetrahydro-N,2-dimethyl-7-benzothiazolamine
C9H14N2S
70590-61-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.5400 4.0010 0.0 0
M  V30 2 C 0.0000 4.0010 0.0 0
M  V30 3 C 7.6213 3.9554 0.0 0
M  V30 4 C 3.8501 2.6673 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 2.3100 2.6673 0.0 0
M  V30 7 S 4.8806 3.8119 0.0 0
M  V30 8 N 6.1265 1.6538 0.0 0
M  V30 9 C 3.8501 0.0000 0.0 0
M  V30 10 C 1.5400 1.3337 0.0 0
M  V30 11 C 6.2875 3.1854 0.0 0
M  V30 12 C 2.3100 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 3 11
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 1 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 17583-14-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 70590-61-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-22801891
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM methylamine reactant and reagent stoichiometry dependent product
formation, incremental addition of agent in 3 portions stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Versatile approaches to a library of building blocks based on
5-acylthiazole skeleton
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kulyk, Olesia G.; Biloborodov, Dmytro A.; Cherevatenko, Maksim A.;
Shyriakin, Yevhen Y.; Lyapunov, Alexander Yu.; Mazepa, Alexander V.;
Vashchenko, Valerii V.; Orlov, Valeriy D.; Kolosov, Maksim A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthetic Communications (2020), 50(23), 3616-3628

$RFMT $RIREG SCHEME238 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
tert-Butyl 3-formylazetidine-1-carboxylate
C9H15NO3
177947-96-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 1.5400 0.0 0
M  V30 2 O 2.6673 2.3101 0.0 0
M  V30 3 O 4.0010 0.0000 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 2.1037 0.2064 0.0 0
M  V30 6 C 0.0000 0.7700 0.0 0
M  V30 7 C 0.5637 2.8739 0.0 0
M  V30 8 C 8.5546 4.1692 0.0 0
M  V30 9 O 9.8882 3.3992 0.0 0
M  V30 10 N 5.3348 2.3101 0.0 0
M  V30 11 C 6.8223 1.9115 0.0 0
M  V30 12 C 5.7334 3.7977 0.0 0
M  V30 13 C 7.2209 3.3992 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 2 8 9
M  V30 9 1 8 13
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 3-[(methylamino)methyl]-1-azetidinecarboxylate
C10H20N2O2
1049730-81-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.8737 0.0 0
M  V30 2 O 3.0800 1.5400 0.0 0
M  V30 3 O 3.0800 4.2073 0.0 0
M  V30 4 C 1.5400 1.5400 0.0 0
M  V30 5 C 1.5400 0.0000 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 1.5400 3.0800 0.0 0
M  V30 8 C 9.1079 2.8737 0.0 0
M  V30 9 N 9.8779 4.2073 0.0 0
M  V30 10 C 11.4179 4.2073 0.0 0
M  V30 11 N 5.3900 2.8737 0.0 0
M  V30 12 C 6.4790 1.7847 0.0 0
M  V30 13 C 6.4790 3.9626 0.0 0
M  V30 14 C 7.5679 2.8737 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 8 14
M  V30 10 1 9 10
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 177947-96-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1049730-81-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-32434035
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted quinazoline and pyrrolotriazine compounds as
ectonucleotide pyrophosphatase-phosphodiesterase-1 (ENPP1) inhibitors and
uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pujala, Brahmam; Ansari, Amantullah; Sapra, Shreya; Jadhavar, Pradeep S.;
Pendharkar, Dhananjay; Ramachandran, Sreekanth A.; Saeed, Uzma; Danodia,
Abhinandan; Khan, Farha; Patni, Sagar; Soni, Sanjeev; Gupta, Ashu;
Chakravarty, Sarvajit; Sathe, Balaji Dashrath
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022091048 A1 2022-05-05

$RFMT $RIREG SCHEME239 STEP1
$RXN



  2  1
$MOL
(2E)-3-(4-Nitrophenyl)-2-butenoic acid
C10H9NO4
179174-16-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 4.6200 0.0 0
M  V30 2 C 8.0021 3.8500 0.0 0
M  V30 3 C 6.6684 6.1600 0.0 0
M  V30 4 C 9.3358 4.6200 0.0 0
M  V30 5 O 9.3358 6.1600 0.0 0
M  V30 6 O 10.6694 3.8500 0.0 0
M  V30 7 N 1.3336 1.5400 0.0 0 VAL=5
M  V30 8 O 1.3336 0.0000 0.0 0
M  V30 9 O 0.0000 2.3100 0.0 0
M  V30 10 C 5.3347 3.8500 0.0 0
M  V30 11 C 5.3347 2.3100 0.0 0
M  V30 12 C 4.0011 4.6200 0.0 0
M  V30 13 C 4.0011 1.5400 0.0 0
M  V30 14 C 2.6673 3.8500 0.0 0
M  V30 15 C 2.6673 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 2 7 8
M  V30 8 2 7 9
M  V30 9 1 7 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2E)-N-Methyl-3-(4-nitrophenyl)-2-butenamide
C11H12N2O3
1598408-75-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 4.6201 0.0 0
M  V30 2 C 8.0021 3.8500 0.0 0
M  V30 3 C 6.6684 6.1601 0.0 0
M  V30 4 C 9.3359 4.6201 0.0 0
M  V30 5 N 10.6695 3.8500 0.0 0
M  V30 6 O 9.3359 6.1601 0.0 0
M  V30 7 C 12.0032 4.6201 0.0 0
M  V30 8 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 9 O 0.0000 2.3100 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 5.3348 3.8500 0.0 0
M  V30 12 C 5.3348 2.3100 0.0 0
M  V30 13 C 4.0011 4.6201 0.0 0
M  V30 14 C 4.0011 1.5400 0.0 0
M  V30 15 C 2.6673 3.8500 0.0 0
M  V30 16 C 2.6673 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 2 8 9
M  V30 9 2 8 10
M  V30 10 1 8 16
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 179174-16-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1598408-75-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-4600350
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and evaluation of novel diaryl urea derivatives as
potential antitumor agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lu, Chenshu; Tang, Ke; Li, Yan; Li, Peng; Lin, Ziyun; Yin, Dali; Chen,
Xiaoguang; Huang, Haihong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2014), 77351-360

$RFMT $RIREG SCHEME240 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylmethyl N-[(1S)-1-[[(2S)-2-[[[2-[bis(phenylmethyl)amino]-2-oxoethyl]amin...
C32H36N4O5
1801588-33-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 44 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 13.6536 2.6674 0.0 0
M  V30 2 C 15.1936 2.6674 0.0 0 CFG=2
M  V30 3 O 12.8836 1.3336 0.0 0
M  V30 4 N 15.9636 4.0011 0.0 0
M  V30 5 C 15.9636 1.3336 0.0 0
M  V30 6 C 17.5036 4.0011 0.0 0
M  V30 7 C 15.1936 0.0000 0.0 0
M  V30 8 C 17.5036 1.3336 0.0 0
M  V30 9 O 18.2736 5.3347 0.0 0
M  V30 10 O 18.2736 2.6674 0.0 0
M  V30 11 C 19.8136 5.3347 0.0 0
M  V30 12 C 10.0100 4.7711 0.0 0
M  V30 13 N 9.2400 6.1047 0.0 0
M  V30 14 O 9.2400 3.4374 0.0 0
M  V30 15 C 7.7000 6.1047 0.0 0
M  V30 16 C 6.9300 4.7711 0.0 0
M  V30 17 N 5.3900 4.7711 0.0 0
M  V30 18 O 7.7000 3.4374 0.0 0
M  V30 19 C 4.6200 6.1047 0.0 0
M  V30 20 C 4.6200 3.4374 0.0 0
M  V30 21 N 12.8836 4.0011 0.0 0
M  V30 22 C 11.5500 4.7711 0.0 0 CFG=2
M  V30 23 C 12.8836 5.5411 0.0 0
M  V30 24 C 20.5836 6.6684 0.0 0
M  V30 25 C 22.1236 6.6684 0.0 0
M  V30 26 C 19.8136 8.0021 0.0 0
M  V30 27 C 22.8936 8.0021 0.0 0
M  V30 28 C 20.5836 9.3358 0.0 0
M  V30 29 C 22.1236 9.3358 0.0 0
M  V30 30 C 5.3900 7.4384 0.0 0
M  V30 31 C 4.6200 8.7721 0.0 0
M  V30 32 C 6.9300 7.4384 0.0 0
M  V30 33 C 5.3900 10.1058 0.0 0
M  V30 34 C 7.7000 8.7721 0.0 0
M  V30 35 C 6.9300 10.1058 0.0 0
M  V30 36 C 3.0800 3.4374 0.0 0
M  V30 37 C 2.3100 2.1036 0.0 0
M  V30 38 C 2.3100 4.7711 0.0 0
M  V30 39 C 0.7700 2.1036 0.0 0
M  V30 40 C 0.7700 4.7711 0.0 0
M  V30 41 C 0.0000 3.4374 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 21
M  V30 4 1 2 4
M  V30 5 1 2 5 CFG=1
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 9 11
M  V30 12 1 11 24
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 1 22 12 CFG=3
M  V30 16 1 13 15
M  V30 17 1 15 16
M  V30 18 1 16 17
M  V30 19 2 16 18
M  V30 20 1 17 19
M  V30 21 1 17 20
M  V30 22 1 19 30
M  V30 23 1 20 36
M  V30 24 1 21 22
M  V30 25 1 21 23
M  V30 26 1 22 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 33 2 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 2 32 34
M  V30 37 2 33 35
M  V30 38 1 34 35
M  V30 39 2 36 37
M  V30 40 1 36 38
M  V30 41 1 37 39
M  V30 42 2 38 40
M  V30 43 2 39 41
M  V30 44 1 40 41
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 2 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
23,2′3-(Methylimino)bis[N-[(phenylmethoxy)carbonyl]-L-valyl-L-alanyl-N,N-bis(...
C65H77N9O10
1801588-76-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  84 89 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 11.5500 21.3389 0.0 0
M  V30 2 C 10.0100 21.3389 0.0 0
M  V30 3 C 12.3200 22.6725 0.0 0
M  V30 4 C 12.3200 20.0051 0.0 0
M  V30 5 C 11.5500 18.6714 0.0 0
M  V30 6 O 13.8600 20.0051 0.0 0
M  V30 7 N 12.3200 17.3378 0.0 0
M  V30 8 C 13.8600 17.3378 0.0 0
M  V30 9 C 14.6300 16.0041 0.0 0 CFG=2
M  V30 10 O 14.6300 18.6714 0.0 0
M  V30 11 N 16.1700 16.0041 0.0 0
M  V30 12 C 13.8600 14.6703 0.0 0
M  V30 13 C 16.9400 14.6703 0.0 0
M  V30 14 N 12.3200 14.6703 0.0 0
M  V30 15 C 18.4800 14.6703 0.0 0 CFG=2
M  V30 16 O 16.1700 13.3367 0.0 0
M  V30 17 C 11.5500 13.3367 0.0 0
M  V30 18 C 11.5500 16.0041 0.0 0
M  V30 19 N 19.2500 13.3367 0.0 0
M  V30 20 C 19.2500 16.0041 0.0 0
M  V30 21 C 10.0100 13.3367 0.0 0 CFG=1
M  V30 22 C 20.7900 13.3367 0.0 0
M  V30 23 C 18.4800 17.3378 0.0 0
M  V30 24 C 20.7900 16.0041 0.0 0
M  V30 25 N 9.2400 12.0031 0.0 0
M  V30 26 C 9.2400 14.6703 0.0 0
M  V30 27 O 21.5600 12.0031 0.0 0
M  V30 28 O 21.5600 14.6703 0.0 0
M  V30 29 C 10.0100 10.6694 0.0 0
M  V30 30 N 7.7000 14.6703 0.0 0
M  V30 31 O 10.0100 16.0041 0.0 0
M  V30 32 C 23.1000 12.0031 0.0 0
M  V30 33 C 9.2400 9.3356 0.0 0 CFG=2
M  V30 34 O 11.5500 10.6694 0.0 0
M  V30 35 C 6.9300 16.0041 0.0 0
M  V30 36 N 10.0100 8.0020 0.0 0
M  V30 37 C 7.7000 9.3356 0.0 0
M  V30 38 C 5.3900 16.0041 0.0 0
M  V30 39 C 9.2400 6.6684 0.0 0
M  V30 40 C 6.9300 10.6694 0.0 0
M  V30 41 C 6.9300 8.0020 0.0 0
M  V30 42 N 4.6200 17.3378 0.0 0
M  V30 43 O 4.6200 14.6703 0.0 0
M  V30 44 O 10.0100 5.3347 0.0 0
M  V30 45 O 7.7000 6.6684 0.0 0
M  V30 46 C 3.0800 17.3378 0.0 0
M  V30 47 C 5.3900 18.6714 0.0 0
M  V30 48 C 9.2400 4.0009 0.0 0
M  V30 49 C 9.2400 22.6725 0.0 0
M  V30 50 C 10.0100 24.0061 0.0 0
M  V30 51 C 7.7000 22.6725 0.0 0
M  V30 52 C 9.2400 25.3398 0.0 0
M  V30 53 C 6.9300 24.0061 0.0 0
M  V30 54 C 7.7000 25.3398 0.0 0
M  V30 55 C 13.8600 22.6725 0.0 0
M  V30 56 C 14.6300 24.0061 0.0 0
M  V30 57 C 14.6300 21.3389 0.0 0
M  V30 58 C 16.1700 24.0061 0.0 0
M  V30 59 C 16.1700 21.3389 0.0 0
M  V30 60 C 16.9400 22.6725 0.0 0
M  V30 61 C 23.8700 10.6694 0.0 0
M  V30 62 C 23.1000 9.3356 0.0 0
M  V30 63 C 25.4100 10.6694 0.0 0
M  V30 64 C 23.8700 8.0020 0.0 0
M  V30 65 C 26.1800 9.3358 0.0 0
M  V30 66 C 25.4100 8.0020 0.0 0
M  V30 67 C 2.3100 16.0041 0.0 0
M  V30 68 C 3.0800 14.6703 0.0 0
M  V30 69 C 0.7700 16.0041 0.0 0
M  V30 70 C 2.3100 13.3367 0.0 0
M  V30 71 C 0.0000 14.6703 0.0 0
M  V30 72 C 0.7700 13.3367 0.0 0
M  V30 73 C 4.6200 20.0051 0.0 0
M  V30 74 C 5.3900 21.3389 0.0 0
M  V30 75 C 3.0800 20.0051 0.0 0
M  V30 76 C 4.6200 22.6725 0.0 0
M  V30 77 C 2.3100 21.3389 0.0 0
M  V30 78 C 3.0800 22.6725 0.0 0
M  V30 79 C 10.0100 2.6673 0.0 0
M  V30 80 C 9.2400 1.3336 0.0 0
M  V30 81 C 11.5500 2.6673 0.0 0
M  V30 82 C 10.0100 0.0000 0.0 0
M  V30 83 C 12.3200 1.3336 0.0 0
M  V30 84 C 11.5500 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 49
M  V30 5 1 3 55
M  V30 6 1 4 5
M  V30 7 2 4 6
M  V30 8 1 5 7
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 9 11 CFG=1
M  V30 13 1 9 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 13 16
M  V30 18 1 14 17
M  V30 19 1 14 18
M  V30 20 1 15 19
M  V30 21 1 15 20 CFG=3
M  V30 22 1 17 21
M  V30 23 1 19 22
M  V30 24 1 20 23
M  V30 25 1 20 24
M  V30 26 1 21 25 CFG=3
M  V30 27 1 21 26
M  V30 28 1 22 27
M  V30 29 2 22 28
M  V30 30 1 25 29
M  V30 31 1 26 30
M  V30 32 2 26 31
M  V30 33 1 27 32
M  V30 34 1 29 33
M  V30 35 2 29 34
M  V30 36 1 30 35
M  V30 37 1 32 61
M  V30 38 1 33 36
M  V30 39 1 33 37 CFG=1
M  V30 40 1 35 38
M  V30 41 1 36 39
M  V30 42 1 37 40
M  V30 43 1 37 41
M  V30 44 1 38 42
M  V30 45 2 38 43
M  V30 46 1 39 44
M  V30 47 2 39 45
M  V30 48 1 42 46
M  V30 49 1 42 47
M  V30 50 1 44 48
M  V30 51 1 46 67
M  V30 52 1 47 73
M  V30 53 1 48 79
M  V30 54 2 49 50
M  V30 55 1 49 51
M  V30 56 1 50 52
M  V30 57 2 51 53
M  V30 58 2 52 54
M  V30 59 1 53 54
M  V30 60 2 55 56
M  V30 61 1 55 57
M  V30 62 1 56 58
M  V30 63 2 57 59
M  V30 64 2 58 60
M  V30 65 1 59 60
M  V30 66 2 61 62
M  V30 67 1 61 63
M  V30 68 1 62 64
M  V30 69 2 63 65
M  V30 70 2 64 66
M  V30 71 1 65 66
M  V30 72 2 67 68
M  V30 73 1 67 69
M  V30 74 1 68 70
M  V30 75 2 69 71
M  V30 76 2 70 72
M  V30 77 1 71 72
M  V30 78 2 73 74
M  V30 79 1 73 75
M  V30 80 1 74 76
M  V30 81 2 75 77
M  V30 82 2 76 78
M  V30 83 1 77 78
M  V30 84 2 79 80
M  V30 85 1 79 81
M  V30 86 1 80 82
M  V30 87 2 81 83
M  V30 88 2 82 84
M  V30 89 1 83 84
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 9 15 21 33)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1801588-33-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1801588-76-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-038-CAS-743497
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-66-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Aziridine electrophiles in the functionalization of peptide chains with
amine nucleophiles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Spork, Anatol P.; Donohoe, Timothy J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2015), 13(31), 8545-8549

$RFMT $RIREG SCHEME241 STEP1
$RXN



  2  1
$MOL
6-[1,1-Difluoro-2-(4-methoxyphenyl)-2-oxoethyl]-6-hydroxyindolo[2,1-b]quinazo...
C24H16F2N2O4
1802600-90-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.4364 4.5947 0.0 0
M  V30 2 C 9.2064 5.9284 0.0 0
M  V30 3 F 8.4364 3.0547 0.0 0
M  V30 4 F 9.7701 3.8247 0.0 0
M  V30 5 O 8.4364 7.2622 0.0 0
M  V30 6 O 7.0574 6.1263 0.0 0
M  V30 7 O 2.3100 2.2476 0.0 0
M  V30 8 O 15.3664 5.9284 0.0 0
M  V30 9 C 16.1364 7.2622 0.0 0
M  V30 10 C 6.8964 4.5947 0.0 0
M  V30 11 C 5.3900 4.9149 0.0 0
M  V30 12 C 7.0574 3.0632 0.0 0
M  V30 13 N 4.6200 3.5813 0.0 0
M  V30 14 N 4.6200 6.2486 0.0 0
M  V30 15 C 5.6506 2.4367 0.0 0
M  V30 16 C 8.3032 2.1580 0.0 0
M  V30 17 C 3.0800 3.5813 0.0 0
M  V30 18 C 3.0800 6.2486 0.0 0
M  V30 19 C 5.4895 0.9052 0.0 0
M  V30 20 C 8.1423 0.6265 0.0 0
M  V30 21 C 2.3100 4.9149 0.0 0
M  V30 22 C 2.3100 7.5823 0.0 0
M  V30 23 C 6.7353 0.0000 0.0 0
M  V30 24 C 0.7700 4.9149 0.0 0
M  V30 25 C 0.7700 7.5823 0.0 0
M  V30 26 C 0.0000 6.2486 0.0 0
M  V30 27 C 10.7464 5.9284 0.0 0
M  V30 28 C 11.5164 7.2622 0.0 0
M  V30 29 C 11.5164 4.5947 0.0 0
M  V30 30 C 13.0564 7.2622 0.0 0
M  V30 31 C 13.0564 4.5947 0.0 0
M  V30 32 C 13.8264 5.9284 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 10
M  V30 5 2 2 5
M  V30 6 1 2 27
M  V30 7 1 6 10
M  V30 8 2 7 17
M  V30 9 1 8 9
M  V30 10 1 8 32
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 12 15
M  V30 16 2 12 16
M  V30 17 1 13 15
M  V30 18 1 13 17
M  V30 19 1 14 18
M  V30 20 2 15 19
M  V30 21 1 16 20
M  V30 22 1 17 21
M  V30 23 1 18 21
M  V30 24 2 18 22
M  V30 25 1 19 23
M  V30 26 2 20 23
M  V30 27 2 21 24
M  V30 28 1 22 25
M  V30 29 1 24 26
M  V30 30 2 25 26
M  V30 31 2 27 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 2 29 31
M  V30 35 2 30 32
M  V30 36 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
α,α-Difluoro-6,12-dihydro-6-hydroxy-N-methyl-12-oxoindolo[2,1-b]quinazoline-6...
C18H13F2N3O3
1802600-57-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 4.5948 0.0 0
M  V30 2 C 2.3100 5.9284 0.0 0
M  V30 3 F 3.0800 3.0548 0.0 0
M  V30 4 F 1.7464 3.8248 0.0 0
M  V30 5 N 0.7700 5.9284 0.0 0
M  V30 6 O 3.0800 7.2622 0.0 0
M  V30 7 C 0.0000 7.2622 0.0 0
M  V30 8 O 4.4591 6.1263 0.0 0
M  V30 9 O 9.2065 2.2476 0.0 0
M  V30 10 C 6.1265 4.9149 0.0 0
M  V30 11 C 4.6200 4.5948 0.0 0
M  V30 12 N 6.8965 3.5813 0.0 0
M  V30 13 N 6.8965 6.2486 0.0 0
M  V30 14 C 4.4591 3.0632 0.0 0
M  V30 15 C 5.8659 2.4368 0.0 0
M  V30 16 C 8.4365 3.5813 0.0 0
M  V30 17 C 8.4365 6.2486 0.0 0
M  V30 18 C 3.2132 2.1580 0.0 0
M  V30 19 C 6.0270 0.9052 0.0 0
M  V30 20 C 9.2065 4.9149 0.0 0
M  V30 21 C 9.2065 7.5824 0.0 0
M  V30 22 C 3.3742 0.6265 0.0 0
M  V30 23 C 4.7811 0.0000 0.0 0
M  V30 24 C 10.7465 4.9149 0.0 0
M  V30 25 C 10.7465 7.5824 0.0 0
M  V30 26 C 11.5165 6.2486 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 11
M  V30 5 1 2 5
M  V30 6 2 2 6
M  V30 7 1 5 7
M  V30 8 1 8 11
M  V30 9 2 9 16
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 2 10 13
M  V30 13 1 11 14
M  V30 14 1 12 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 15
M  V30 18 2 14 18
M  V30 19 2 15 19
M  V30 20 1 16 20
M  V30 21 1 17 20
M  V30 22 2 17 21
M  V30 23 1 18 22
M  V30 24 1 19 23
M  V30 25 2 20 24
M  V30 26 1 21 25
M  V30 27 2 22 23
M  V30 28 1 24 26
M  V30 29 2 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1802600-90-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1802600-57-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25027414
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 937-14-4
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7772-98-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 920-66-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM Baeyer-Villiger oxidation, phosphate buffered solution used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An efficient catalyst-free Mukaiyama-aldol reaction of fluorinated enol
silyl ethers with tryptanthrin
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liao, Fu-Min; Liu, Yun-Lin; Yu, Jin-Sheng; Zhou, Feng; Zhou, Jian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2015), 13(33), 8906-8911

$RFMT $RIREG SCHEME242 STEP1
$RXN



  2  1
$MOL
8-[(1,1-Dimethylethoxy)carbonyl]-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decane-...
C20H27N3O5
180386-35-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.8391 8.3504 0.0 0
M  V30 2 C 2.6528 7.3150 0.0 0
M  V30 3 C 1.2459 6.6885 0.0 0
M  V30 4 O 0.0000 7.5938 0.0 0
M  V30 5 O 1.0849 5.1570 0.0 0
M  V30 6 C 10.8884 5.6398 0.0 0
M  V30 7 O 11.6584 6.9734 0.0 0
M  V30 8 O 11.6584 4.3062 0.0 0
M  V30 9 C 13.1985 6.9734 0.0 0
M  V30 10 C 13.1985 8.5134 0.0 0
M  V30 11 C 14.7385 6.9734 0.0 0
M  V30 12 C 13.1985 5.4334 0.0 0
M  V30 13 C 6.2684 5.6398 0.0 0
M  V30 14 N 5.3632 4.3939 0.0 0
M  V30 15 C 5.3632 6.8857 0.0 0
M  V30 16 C 7.0384 4.3062 0.0 0
M  V30 17 C 7.0384 6.9734 0.0 0
M  V30 18 C 3.8987 4.8698 0.0 0
M  V30 19 N 3.8987 6.4098 0.0 0
M  V30 20 C 8.5784 4.3062 0.0 0
M  V30 21 C 8.5784 6.9734 0.0 0
M  V30 22 N 9.3484 5.6398 0.0 0
M  V30 23 C 5.8391 2.9292 0.0 0
M  V30 24 C 7.3455 2.6091 0.0 0
M  V30 25 C 4.8087 1.7849 0.0 0
M  V30 26 C 7.8214 1.1444 0.0 0
M  V30 27 C 5.2845 0.3202 0.0 0
M  V30 28 C 6.7910 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 15
M  V30 2 1 2 3
M  V30 3 1 2 19
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 22
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 14 23
M  V30 19 1 15 19
M  V30 20 1 16 20
M  V30 21 1 17 21
M  V30 22 1 18 19
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 3-[2-(methylamino)-2-oxoethyl]-4-oxo-1-phenyl-1,3,8-triazas...
C21H30N4O4
2061924-80-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.8994 8.3503 0.0 0
M  V30 2 C 12.0858 7.3150 0.0 0
M  V30 3 C 13.4926 6.6885 0.0 0
M  V30 4 N 14.7384 7.5937 0.0 0
M  V30 5 O 13.6535 5.1570 0.0 0
M  V30 6 C 16.1454 6.9674 0.0 0
M  V30 7 C 3.8500 5.6398 0.0 0
M  V30 8 O 3.0800 6.9734 0.0 0
M  V30 9 O 3.0800 4.3061 0.0 0
M  V30 10 C 1.5400 6.9734 0.0 0
M  V30 11 C 1.5400 5.4334 0.0 0
M  V30 12 C 0.0000 6.9734 0.0 0
M  V30 13 C 1.5400 8.5134 0.0 0
M  V30 14 C 8.4700 5.6398 0.0 0
M  V30 15 N 9.3752 4.3939 0.0 0
M  V30 16 C 9.3752 6.8856 0.0 0
M  V30 17 C 7.7000 6.9734 0.0 0
M  V30 18 C 7.7000 4.3061 0.0 0
M  V30 19 C 10.8399 4.8698 0.0 0
M  V30 20 N 10.8399 6.4098 0.0 0
M  V30 21 C 6.1600 6.9734 0.0 0
M  V30 22 C 6.1600 4.3061 0.0 0
M  V30 23 N 5.3900 5.6398 0.0 0
M  V30 24 C 8.8994 2.9292 0.0 0
M  V30 25 C 9.9298 1.7849 0.0 0
M  V30 26 C 7.3929 2.6091 0.0 0
M  V30 27 C 9.4539 0.3202 0.0 0
M  V30 28 C 6.9171 1.1444 0.0 0
M  V30 29 C 7.9475 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 16
M  V30 2 1 2 3
M  V30 3 1 2 20
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 23
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 14 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 15 24
M  V30 20 1 16 20
M  V30 21 1 17 21
M  V30 22 1 18 22
M  V30 23 1 19 20
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 180386-35-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2061924-80-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-22793648
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel Autotaxin Inhibitor for the Treatment of Idiopathic Pulmonary
Fibrosis: A Clinical Candidate Discovered Using DNA-Encoded Chemistry
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cuozzo, John W.; Clark, Matthew A.; Keefe, Anthony D.; Kohlmann, Anna;
Mulvihill, Mark; Ni, Haihong; Renzetti, Louis M.; Resnicow, Daniel I.;
Ruebsam, Frank; Sigel, Eric A.; Thomson, Heather A.; Wang, Ce; Xie,
Zhifeng; Zhang, Ying
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2020), 63(14), 7840-7856

$RFMT $RIREG SCHEME243 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Bromo-4-chloro-3-fluoro-2-nitrobenzene
C6H2BrClFNO2
1804382-30-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3338 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3338 0.0000 0.0 0
M  V30 4 F 4.0011 0.0000 0.0 0
M  V30 5 Br 1.3338 4.6201 0.0 0
M  V30 6 Cl 6.6686 1.5400 0.0 0
M  V30 7 C 2.6675 2.3100 0.0 0
M  V30 8 C 4.0011 1.5400 0.0 0
M  V30 9 C 2.6675 3.8500 0.0 0
M  V30 10 C 5.3348 2.3100 0.0 0
M  V30 11 C 4.0011 4.6201 0.0 0
M  V30 12 C 5.3348 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 8
M  V30 5 1 5 9
M  V30 6 1 6 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzenamine, 3-bromo-6-chloro-N-methyl-2-nitro-
C7H6BrClN2O2
2925554-63-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 2.3101 0.0 0 VAL=5
M  V30 2 O 5.3348 0.7700 0.0 0
M  V30 3 O 6.6687 3.0801 0.0 0
M  V30 4 N 2.6675 0.7700 0.0 0
M  V30 5 C 1.3338 0.0000 0.0 0
M  V30 6 Br 5.3348 5.3901 0.0 0
M  V30 7 Cl 0.0000 2.3101 0.0 0
M  V30 8 C 4.0012 3.0801 0.0 0
M  V30 9 C 2.6675 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 1.3338 3.0801 0.0 0
M  V30 12 C 2.6675 5.3901 0.0 0
M  V30 13 C 1.3338 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 5
M  V30 5 1 4 9
M  V30 6 1 6 10
M  V30 7 1 7 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1804382-30-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2925554-63-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36859147
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 2-Aminoimidazole derivatives as PRMT5 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kulyk, Svitlana; Smith, Christopher Ronald; Ivetac, Anthony; Lawson, John
David
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023081367 A2 2023-05-11

$RFMT $RIREG SCHEME244 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(1,1-Dimethylethyl) 5-[[(phenylmethoxy)carbonyl]amino]-1,3-piperidinedicarb...
C19H26N2O6
1823790-63-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.3359 5.3901 0.0 0
M  V30 2 C 10.6695 4.6201 0.0 0
M  V30 3 O 12.0034 5.3901 0.0 0
M  V30 4 O 10.6695 3.0800 0.0 0
M  V30 5 C 13.3370 4.6201 0.0 0
M  V30 6 C 4.0011 5.3901 0.0 0
M  V30 7 O 2.6675 4.6201 0.0 0
M  V30 8 O 4.0011 6.9301 0.0 0
M  V30 9 C 1.3338 5.3901 0.0 0
M  V30 10 C 2.1038 6.7237 0.0 0
M  V30 11 C 0.0000 6.1601 0.0 0
M  V30 12 C 0.5638 4.0564 0.0 0
M  V30 13 C 6.6686 0.7700 0.0 0
M  V30 14 O 5.3348 0.0000 0.0 0
M  V30 15 O 8.0022 0.0000 0.0 0
M  V30 16 C 8.0022 4.6201 0.0 0
M  V30 17 C 6.6686 5.3901 0.0 0
M  V30 18 C 8.0022 3.0800 0.0 0
M  V30 19 N 5.3348 4.6201 0.0 0
M  V30 20 C 6.6686 2.3100 0.0 0
M  V30 21 C 5.3348 3.0800 0.0 0
M  V30 22 C 14.6707 5.3901 0.0 0
M  V30 23 C 14.6707 6.9301 0.0 0
M  V30 24 C 16.0043 4.6201 0.0 0
M  V30 25 C 16.0043 7.7001 0.0 0
M  V30 26 C 17.3381 5.3901 0.0 0
M  V30 27 C 17.3381 6.9301 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 22
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 19
M  V30 10 1 7 9
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 1 9 12
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 1 13 20
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 21
M  V30 23 2 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 2 24 26
M  V30 27 2 25 27
M  V30 28 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 3-[(methylamino)carbonyl]-5-[[(phenylmethoxy)carbonyl]amino...
C20H29N3O5
2173192-97-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 6.9300 0.0 0
M  V30 2 O 2.6674 8.4700 0.0 0
M  V30 3 O 1.3338 6.1600 0.0 0
M  V30 4 C 1.3338 9.2400 0.0 0
M  V30 5 C 0.5638 7.9064 0.0 0
M  V30 6 C 0.0000 10.0100 0.0 0
M  V30 7 C 2.1038 10.5736 0.0 0
M  V30 8 N 8.0021 6.9300 0.0 0
M  V30 9 C 9.3358 6.1600 0.0 0
M  V30 10 O 10.6696 6.9300 0.0 0
M  V30 11 O 9.3358 4.6200 0.0 0
M  V30 12 C 12.0032 6.1600 0.0 0
M  V30 13 C 5.3347 2.3100 0.0 0
M  V30 14 N 4.0011 1.5400 0.0 0
M  V30 15 O 6.6685 1.5400 0.0 0
M  V30 16 C 4.0011 0.0000 0.0 0
M  V30 17 N 4.0011 6.1600 0.0 0
M  V30 18 C 5.3347 6.9300 0.0 0
M  V30 19 C 4.0011 4.6200 0.0 0
M  V30 20 C 6.6685 6.1600 0.0 0
M  V30 21 C 5.3347 3.8500 0.0 0
M  V30 22 C 6.6685 4.6200 0.0 0
M  V30 23 C 13.3369 6.9300 0.0 0
M  V30 24 C 14.6705 6.1600 0.0 0
M  V30 25 C 13.3369 8.4700 0.0 0
M  V30 26 C 16.0043 6.9300 0.0 0
M  V30 27 C 14.6705 9.2400 0.0 0
M  V30 28 C 16.0043 8.4700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 8 20
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 1 12 23
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 1 13 21
M  V30 17 1 14 16
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 22
M  V30 24 2 23 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 2 25 27
M  V30 28 2 26 28
M  V30 29 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1823790-63-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2173192-97-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-20102480
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 94790-37-1
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of inhibitors of cyclin dependent kinase 7 (CDK7)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Marineau, Jason J.; Zahler, Robert; Ciblat, Stephane; Winter, Dana K.;
Kabro, Anzhelika; Roy, Stephanie; Schmidt, Darby; Chuaqui, Claudio;
Malojcic, Goran; Piras, Henri; Whitmore, Kenneth Matthew; Lund, Kate-Iyn;
Sinko, Bill; Sprott, Kevin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018013867 A1 2018-01-18

$RFMT $RIREG SCHEME245 STEP1
$RXN



  2  1
$MOL
2-Chlorobenzenepropanamine
C9H12ClN
18655-48-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 C 6.6685 1.5400 0.0 0
M  V30 4 N 8.0021 2.3100 0.0 0
M  V30 5 Cl 1.3336 0.0000 0.0 0
M  V30 6 C 2.6674 2.3100 0.0 0
M  V30 7 C 1.3336 1.5400 0.0 0
M  V30 8 C 2.6674 3.8500 0.0 0
M  V30 9 C 0.0000 2.3100 0.0 0
M  V30 10 C 1.3336 4.6200 0.0 0
M  V30 11 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 5 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N-methylbenzenepropanamine
C10H14ClN
103273-66-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 5.3348 2.3100 0.0 0
M  V30 3 C 6.6684 1.5400 0.0 0
M  V30 4 N 8.0022 2.3100 0.0 0
M  V30 5 C 9.3359 1.5400 0.0 0
M  V30 6 Cl 1.3337 0.0000 0.0 0
M  V30 7 C 2.6675 2.3100 0.0 0
M  V30 8 C 1.3337 1.5400 0.0 0
M  V30 9 C 2.6675 3.8500 0.0 0
M  V30 10 C 0.0000 2.3100 0.0 0
M  V30 11 C 1.3337 4.6201 0.0 0
M  V30 12 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 6 8
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 18655-48-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 103273-66-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-033-CAS-6646446
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 5
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 16853-85-3
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for the synthesis of
phenylpropylamines. A stirred solution of the appropriately substituted
phenylpropionic acid in 20 mL of DCM (ca. 0.5-1.0 M total cone.) was
reacted with 1.2 equiv. of 1,1’-carbonyldiimidazole by addition of 500 mg
portions over a 15 min period, during which time significant evolution of
CO was observed. The resulting solution was stirred 90 min at RT, then
cooled to 0 °C and treated with 8 mL of a cold (0 °C) 40% aqueous
solution of methylamine. The resulting mixture was allowed to warm to RT
and stirred vigorously for 14 h. The reaction mixture was then acidified
to pH =1 by careful addition of cone. HCl, diluted with 70 mL of
chloroform and extracted with H2O (1 x 100 mL). The organic layer was
separated, dried (MgSO4), and concentrated in vacuo to afford a white
solid. This material was immediately dissolved in 80 mL of THF, and 1.2
equiv. (assuming 100% conversion) of a 1.0 M solution of LiAlH4 in THF
was added dropwise over 10 min. After the addition was complete, the
resulting solution was stirred 10 min at RT and then was heated to 60 °C
for 6 h. The reaction mixture was then cooled to 0 °C and the reaction
was quenched by careful addition of 0.76 mL of H2O, followed by 0.76 mL
of 15% NaOH and then 2.7 mL of H2O. The resulting slurry was stirred
vigorously for 10 min. and then filtered through a pad of Celite to
remove the salts. The salts were isolated, triturated with EtOAc, and
refiltered through a pad of Celite. The filtrates were combined, dried
(MgSO4), and concentrated in vacuo. The material was used without further
purification unless otherwise noted.
N-[3-(2-chlorophenyl)propyl]-N-methylamine. Concentration in vacuo
afforded 92% of the title compound as a clear colorless oil, which was
used without further purification. 1H NMR (CDCl3, 400 MHz) δ 7.37-7.15
(m, 4 H), 2.81 (t, 2 H, J = 7.8), 2.65 (t, 2 H, J = 7.6), 2.48 (s, 3 H),
1.84 (m, 2 H), 1.59 (s, br, 1 H); TLC (chloroform/MeOH 9:1) Rf = 0.10.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A new series of estrogen receptor modulators that display selectivity for
estrogen receptor β
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Henke, Brad R.; Consler, Thomas G.; Go, Ning; Hale, Ron L.; Hohman, Dana
R.; Jones, Stacey A.; Lu, Amy T.; Moore, Linda B.; Moore, John T.;
Orband-Miller, Lisa A.; Robinett, R. Graham; Shearin, Jean; Spearing,
Paul K.; Stewart, Eugene L.; Turnbull, Philip S.; Weaver, Susan L.;
Williams, Shawn P.; Wisely, G. Bruce; Lambert, Millard H.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2002), 45(25), 5492-5505

$RFMT $RIREG SCHEME246 STEP1
$RXN



  3  1
$MOL
1,1′-Carbonyldiimidazole
C7H6N4O
530-62-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 O 3.7711 0.0000 0.0 0
M  V30 3 N 2.4374 2.3100 0.0 0
M  V30 4 C 2.2763 3.8416 0.0 0
M  V30 5 C 1.0304 1.6836 0.0 0
M  V30 6 C 0.7700 4.1618 0.0 0
M  V30 7 N 0.0000 2.8281 0.0 0
M  V30 8 N 5.1047 2.3100 0.0 0
M  V30 9 C 5.2658 3.8416 0.0 0
M  V30 10 C 6.5117 1.6836 0.0 0
M  V30 11 C 6.7721 4.1618 0.0 0
M  V30 12 N 7.5421 2.8281 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 2 4 6
M  V30 7 2 5 7
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
γ-(Dimethylamino)-ζ-[(tetrahydro-2H-pyran-2-yl)oxy]benzenehexanol
C19H31NO3
1884353-39-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 4.6201 0.0 0
M  V30 2 O 4.0011 3.0800 0.0 0
M  V30 3 C 5.3348 5.3901 0.0 0
M  V30 4 C 5.3348 6.9301 0.0 0
M  V30 5 C 6.6684 7.7001 0.0 0
M  V30 6 C 8.0022 6.9301 0.0 0
M  V30 7 N 6.6684 9.2401 0.0 0
M  V30 8 C 9.3359 7.7001 0.0 0
M  V30 9 C 8.0022 10.0101 0.0 0
M  V30 10 C 5.3348 10.0101 0.0 0
M  V30 11 O 10.6695 6.9301 0.0 0
M  V30 12 C 2.6673 5.3901 0.0 0
M  V30 13 C 2.6673 6.9301 0.0 0
M  V30 14 C 1.3337 4.6201 0.0 0
M  V30 15 C 1.3337 7.7001 0.0 0
M  V30 16 C 0.0000 5.3901 0.0 0
M  V30 17 C 0.0000 6.9301 0.0 0
M  V30 18 C 5.3348 2.3100 0.0 0
M  V30 19 C 5.3348 0.7700 0.0 0
M  V30 20 O 6.6684 3.0800 0.0 0
M  V30 21 C 6.6684 0.0000 0.0 0
M  V30 22 C 8.0022 2.3100 0.0 0
M  V30 23 C 8.0022 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 12
M  V30 4 1 2 18
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 1 5 6
M  V30 8 1 5 7
M  V30 9 1 6 8
M  V30 10 1 7 9
M  V30 11 1 7 10
M  V30 12 1 8 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C21H34N2O4
1808285-01-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 4.6201 0.0 0
M  V30 2 O 4.0010 3.0801 0.0 0
M  V30 3 C 5.3348 5.3901 0.0 0
M  V30 4 C 5.3348 6.9302 0.0 0
M  V30 5 C 6.6685 7.7002 0.0 0
M  V30 6 C 8.0022 6.9302 0.0 0
M  V30 7 N 6.6685 9.2402 0.0 0
M  V30 8 C 9.3358 7.7002 0.0 0
M  V30 9 C 8.0022 10.0102 0.0 0
M  V30 10 C 5.3348 10.0102 0.0 0
M  V30 11 O 10.6697 6.9302 0.0 0
M  V30 12 C 12.0033 7.7002 0.0 0
M  V30 13 N 13.3370 6.9302 0.0 0
M  V30 14 O 12.0033 9.2402 0.0 0
M  V30 15 C 14.6707 7.7002 0.0 0
M  V30 16 C 2.6673 5.3901 0.0 0
M  V30 17 C 2.6673 6.9302 0.0 0
M  V30 18 C 1.3337 4.6201 0.0 0
M  V30 19 C 1.3337 7.7002 0.0 0
M  V30 20 C 0.0000 5.3901 0.0 0
M  V30 21 C 0.0000 6.9302 0.0 0
M  V30 22 C 5.3348 2.3101 0.0 0
M  V30 23 C 5.3348 0.7700 0.0 0
M  V30 24 O 6.6685 3.0801 0.0 0
M  V30 25 C 6.6685 0.0000 0.0 0
M  V30 26 C 8.0022 2.3101 0.0 0
M  V30 27 C 8.0022 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 16
M  V30 4 1 2 22
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 1 5 6
M  V30 8 1 5 7
M  V30 9 1 6 8
M  V30 10 1 7 9
M  V30 11 1 7 10
M  V30 12 1 8 11
M  V30 13 1 11 12
M  V30 14 1 12 13
M  V30 15 2 12 14
M  V30 16 1 13 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 23 1 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1884353-39-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1808285-01-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-30017138
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM product further converted into oxalate salt in 59% yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Exploration of the molecular architecture of the orthosteric binding site
in the α4β2 nicotinic acetylcholine receptor with analogs of
3-(dimethylamino)butyl dimethylcarbamate (DMABC) and
1-(pyridin-3-yl)-1,4-diazepane
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bach, Tinna B.; Jensen, Anders A.; Petersen, Jette G.; Soerensen, Troels
E.; Della Volpe, Serena; Liu, Jun; Blaazer, Antoni R.; van
Muijlwijk-Koezen, Jacqueline E.; Balle, Thomas; Froelund, Bente
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2015), 102425-444

$RFMT $RIREG SCHEME247 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(4-Fluoro-5-benzofuranyl)-2-propanone
C11H9FO2
1891370-70-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 3.7036 0.0000 0.0 0
M  V30 2 C 6.3709 1.5400 0.0 0
M  V30 3 C 7.7047 2.3100 0.0 0
M  V30 4 C 9.0383 1.5400 0.0 0
M  V30 5 O 7.7047 3.8500 0.0 0
M  V30 6 C 2.3699 2.3100 0.0 0
M  V30 7 C 2.3699 3.8500 0.0 0
M  V30 8 C 3.7036 1.5400 0.0 0
M  V30 9 C 0.9052 1.8341 0.0 0
M  V30 10 C 3.7036 4.6200 0.0 0
M  V30 11 O 0.9052 4.3259 0.0 0
M  V30 12 C 5.0372 2.3100 0.0 0
M  V30 13 C 0.0000 3.0800 0.0 0
M  V30 14 C 5.0372 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 3
M  V30 3 1 2 12
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 2 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Benzofuranethanamine, 4-fluoro-N,α-dimethyl-
C12H14FNO
3057895-28-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 3.7036 0.0000 0.0 0
M  V30 2 C 6.3709 1.5400 0.0 0
M  V30 3 C 7.7045 2.3100 0.0 0
M  V30 4 N 9.0383 1.5400 0.0 0
M  V30 5 C 7.7045 3.8500 0.0 0
M  V30 6 C 10.3720 2.3100 0.0 0
M  V30 7 C 2.3698 2.3100 0.0 0
M  V30 8 C 2.3698 3.8500 0.0 0
M  V30 9 C 3.7036 1.5400 0.0 0
M  V30 10 C 0.9052 1.8341 0.0 0
M  V30 11 C 3.7036 4.6200 0.0 0
M  V30 12 O 0.9052 4.3259 0.0 0
M  V30 13 C 5.0372 2.3100 0.0 0
M  V30 14 C 0.0000 3.0800 0.0 0
M  V30 15 C 5.0372 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 3
M  V30 3 1 2 13
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 10
M  V30 10 2 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1891370-70-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3057895-28-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-43117106
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25895-60-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of advantageous fluorobenzofurans for the treatment of mental
disorders or enhancement
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Baggott, Matthew J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2024206712 A1 2024-10-03

$RFMT $RIREG SCHEME248 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(6-Fluoro-5-benzofuranyl)-2-propanone
C11H9FO2
1897019-40-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.2873 2.6675 0.0 0
M  V30 2 C 7.0573 4.0011 0.0 0
M  V30 3 C 6.2873 5.3350 0.0 0
M  V30 4 O 8.5973 4.0011 0.0 0
M  V30 5 F 4.7473 0.0000 0.0 0
M  V30 6 C 2.4372 4.0011 0.0 0
M  V30 7 C 1.6672 2.6675 0.0 0
M  V30 8 C 3.9773 4.0011 0.0 0
M  V30 9 C 1.4068 5.1457 0.0 0
M  V30 10 C 2.4372 1.3338 0.0 0
M  V30 11 O 0.1609 2.9876 0.0 0
M  V30 12 C 4.7473 2.6675 0.0 0
M  V30 13 C 0.0000 4.5192 0.0 0
M  V30 14 C 3.9773 1.3338 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 14
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 2 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Benzofuranethanamine, 6-fluoro-N,α-dimethyl-
C12H14FNO
3057895-34-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.2873 2.6675 0.0 0
M  V30 2 C 7.0573 4.0011 0.0 0
M  V30 3 N 8.5973 4.0011 0.0 0
M  V30 4 C 6.2873 5.3349 0.0 0
M  V30 5 C 9.3673 5.3349 0.0 0
M  V30 6 F 4.7472 0.0000 0.0 0
M  V30 7 C 2.4372 4.0011 0.0 0
M  V30 8 C 1.6672 2.6675 0.0 0
M  V30 9 C 3.9772 4.0011 0.0 0
M  V30 10 C 1.4068 5.1456 0.0 0
M  V30 11 C 2.4372 1.3338 0.0 0
M  V30 12 O 0.1609 2.9876 0.0 0
M  V30 13 C 4.7472 2.6675 0.0 0
M  V30 14 C 0.0000 4.5192 0.0 0
M  V30 15 C 3.9772 1.3338 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 6 15
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 10
M  V30 10 2 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1897019-40-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3057895-34-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-43117118
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25895-60-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of advantageous fluorobenzofurans for the treatment of mental
disorders or enhancement
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Baggott, Matthew J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2024206712 A1 2024-10-03

$RFMT $RIREG SCHEME249 STEP1
$RXN



  4  1
$MOL
1,1′-Carbonyldiimidazole
C7H6N4O
530-62-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 O 3.7711 0.0000 0.0 0
M  V30 3 N 2.4374 2.3100 0.0 0
M  V30 4 C 2.2763 3.8416 0.0 0
M  V30 5 C 1.0304 1.6836 0.0 0
M  V30 6 C 0.7700 4.1618 0.0 0
M  V30 7 N 0.0000 2.8281 0.0 0
M  V30 8 N 5.1047 2.3100 0.0 0
M  V30 9 C 5.2658 3.8416 0.0 0
M  V30 10 C 6.5117 1.6836 0.0 0
M  V30 11 C 6.7721 4.1618 0.0 0
M  V30 12 N 7.5421 2.8281 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 2 4 6
M  V30 7 2 5 7
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(1R,2S)-2-[5-[[(2S)-1-Methyl-2-pyrrolidinyl]methoxy]-3-pyridinyl]cyclopropane...
C16H24N2O2
1897438-87-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 13.3134 2.3101 0.0 0
M  V30 2 C 14.6471 3.0801 0.0 0
M  V30 3 O 15.9809 2.3101 0.0 0
M  V30 4 O 5.1049 3.0801 0.0 0
M  V30 5 C 3.7711 2.3101 0.0 0
M  V30 6 C 0.7104 0.9473 0.0 0
M  V30 7 C 10.4397 3.0801 0.0 0 CFG=1
M  V30 8 C 11.9798 3.0801 0.0 0 CFG=1
M  V30 9 C 11.2098 4.4137 0.0 0
M  V30 10 C 9.1059 2.3101 0.0 0
M  V30 11 C 7.7722 3.0801 0.0 0
M  V30 12 C 9.1059 0.7700 0.0 0
M  V30 13 C 6.4386 2.3101 0.0 0
M  V30 14 N 7.7722 0.0000 0.0 0
M  V30 15 C 6.4386 0.7700 0.0 0
M  V30 16 C 2.4374 3.0801 0.0 0 CFG=2
M  V30 17 N 1.0306 2.4536 0.0 0
M  V30 18 C 2.2765 4.6116 0.0 0
M  V30 19 C 0.0000 3.5981 0.0 0
M  V30 20 C 0.7700 4.9318 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 8 1 CFG=3
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 13
M  V30 6 1 16 5 CFG=1
M  V30 7 1 6 17
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10 CFG=1
M  V30 11 1 8 9
M  V30 12 1 10 11
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 15
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 7 8 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Trifluoroacetic acid
C2HF3O2
76-05-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 2.3101 0.0 0
M  V30 2 C 2.6673 1.5400 0.0 0
M  V30 3 F 2.1037 3.6437 0.0 0
M  V30 4 F 0.0000 3.0801 0.0 0
M  V30 5 F 0.5637 0.9764 0.0 0
M  V30 6 O 4.0010 2.3101 0.0 0
M  V30 7 O 2.6673 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 2 2 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C18H27N3O3.33/20C2HF3O2
1897438-93-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 13.3134 7.4938 0.0 0
M  V30 2 C 14.6471 8.2638 0.0 0
M  V30 3 O 15.9808 7.4938 0.0 0
M  V30 4 C 17.3144 8.2638 0.0 0
M  V30 5 N 18.6483 7.4938 0.0 0
M  V30 6 O 17.3144 9.8038 0.0 0
M  V30 7 C 19.9819 8.2638 0.0 0
M  V30 8 O 5.1047 8.2638 0.0 0
M  V30 9 C 3.7711 7.4938 0.0 0
M  V30 10 C 0.7103 6.1310 0.0 0
M  V30 11 C 10.4396 8.2638 0.0 0 CFG=1
M  V30 12 C 11.9796 8.2638 0.0 0 CFG=1
M  V30 13 C 11.2096 9.5975 0.0 0
M  V30 14 C 9.1059 7.4938 0.0 0
M  V30 15 C 7.7722 8.2638 0.0 0
M  V30 16 C 9.1059 5.9537 0.0 0
M  V30 17 C 6.4386 7.4938 0.0 0
M  V30 18 N 7.7722 5.1837 0.0 0
M  V30 19 C 6.4386 5.9537 0.0 0
M  V30 20 C 2.4374 8.2638 0.0 0 CFG=2
M  V30 21 N 1.0304 7.6373 0.0 0
M  V30 22 C 2.2765 9.7954 0.0 0
M  V30 23 C 0.0000 8.7819 0.0 0
M  V30 24 C 0.7700 10.1155 0.0 0
M  V30 25 C 9.3241 2.3101 0.0 0
M  V30 26 C 10.6578 1.5400 0.0 0
M  V30 27 F 10.0942 3.6437 0.0 0
M  V30 28 F 7.9905 3.0801 0.0 0
M  V30 29 F 8.5541 0.9764 0.0 0
M  V30 30 O 11.9915 2.3101 0.0 0
M  V30 31 O 10.6578 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 12 1 CFG=3
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 8 9
M  V30 9 1 8 17
M  V30 10 1 20 9 CFG=1
M  V30 11 1 10 21
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14 CFG=1
M  V30 15 1 12 13
M  V30 16 1 14 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 19
M  V30 22 1 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 24
M  V30 27 1 25 26
M  V30 28 1 25 27
M  V30 29 1 25 28
M  V30 30 1 25 29
M  V30 31 1 26 30
M  V30 32 2 26 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 11 12 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1897438-87-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1897438-93-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-26558384
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM product purified by HPLC and obtained as TFA salt
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and Behavioral Studies of Chiral Cyclopropanes as Selective
α4β2-Nicotinic Acetylcholine Receptor Partial Agonists Exhibiting an
Antidepressant Profile. Part III
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Onajole, Oluseye K.; Vallerini, Gian Paolo; Eaton, J. Brek; Lukas, Ronald
J.; Brunner, Dani; Caldarone, Barbara J.; Kozikowski, Alan P.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Chemical Neuroscience (2016), 7(6), 811-822

$RFMT $RIREG SCHEME250 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Methylindole-3-carboxaldehyde
C10H9NO
19012-03-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7307 4.6948 0.0 0
M  V30 2 O 7.1954 4.2188 0.0 0
M  V30 3 C 3.0202 0.0000 0.0 0
M  V30 4 C 3.0800 3.9844 0.0 0
M  V30 5 C 2.3100 2.6508 0.0 0
M  V30 6 C 4.5864 3.6642 0.0 0
M  V30 7 C 2.3100 5.3182 0.0 0
M  V30 8 N 3.3405 1.5064 0.0 0
M  V30 9 C 0.7700 2.6508 0.0 0
M  V30 10 C 4.7473 2.1327 0.0 0
M  V30 11 C 0.7700 5.3182 0.0 0
M  V30 12 C 0.0000 3.9844 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 1 3 8
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 1 9 12
M  V30 13 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,1-Dimethyl-1H-indole-3-methanamine
C11H14N2
56972-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7306 4.6948 0.0 0
M  V30 2 N 7.1953 4.2188 0.0 0
M  V30 3 C 8.3397 5.2494 0.0 0
M  V30 4 C 3.0202 0.0000 0.0 0
M  V30 5 C 3.0800 3.9844 0.0 0
M  V30 6 C 2.3100 2.6508 0.0 0
M  V30 7 C 4.5863 3.6643 0.0 0
M  V30 8 C 2.3100 5.3182 0.0 0
M  V30 9 N 3.3404 1.5064 0.0 0
M  V30 10 C 0.7700 2.6508 0.0 0
M  V30 11 C 4.7472 2.1327 0.0 0
M  V30 12 C 0.7700 5.3182 0.0 0
M  V30 13 C 0.0000 3.9844 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 4 9
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 1 10 13
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 19012-03-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 56972-00-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-13670708
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of N-(heteroaryl)methylacrylamides as Fab I inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Burgess, Walter J.; Jakas, Dalia; Huffman, William F.; Miller, William
H.; Newlander, Kenneth A.; Seefeld, Mark A.; Uzinskas, Irene N.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2003088897 A2 2003-10-30

$RFMT $RIREG SCHEME250 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Methylindole-3-carboxaldehyde
C10H9NO
19012-03-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7307 4.6948 0.0 0
M  V30 2 O 7.1954 4.2188 0.0 0
M  V30 3 C 3.0202 0.0000 0.0 0
M  V30 4 C 3.0800 3.9844 0.0 0
M  V30 5 C 2.3100 2.6508 0.0 0
M  V30 6 C 4.5864 3.6642 0.0 0
M  V30 7 C 2.3100 5.3182 0.0 0
M  V30 8 N 3.3405 1.5064 0.0 0
M  V30 9 C 0.7700 2.6508 0.0 0
M  V30 10 C 4.7473 2.1327 0.0 0
M  V30 11 C 0.7700 5.3182 0.0 0
M  V30 12 C 0.0000 3.9844 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 1 3 8
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 1 9 12
M  V30 13 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,1-Dimethyl-1H-indole-3-methanamine
C11H14N2
56972-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7306 4.6948 0.0 0
M  V30 2 N 7.1953 4.2188 0.0 0
M  V30 3 C 8.3397 5.2494 0.0 0
M  V30 4 C 3.0202 0.0000 0.0 0
M  V30 5 C 3.0800 3.9844 0.0 0
M  V30 6 C 2.3100 2.6508 0.0 0
M  V30 7 C 4.5863 3.6643 0.0 0
M  V30 8 C 2.3100 5.3182 0.0 0
M  V30 9 N 3.3404 1.5064 0.0 0
M  V30 10 C 0.7700 2.6508 0.0 0
M  V30 11 C 4.7472 2.1327 0.0 0
M  V30 12 C 0.7700 5.3182 0.0 0
M  V30 13 C 0.0000 3.9844 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 4 9
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 1 10 13
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 19012-03-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 56972-00-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-14989462
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: 1,2-Dimethyl-3-(methylaminomethyl)-1H-indole
(25). To a solution of 1,2-dimethyl-1H-indole-3-carboxaldehyde (24) (13.0
g, 75.0 mmol) in MeOH (200 mL) was added a solution of 2.0 M CH3NH2 in
MeOH (113 mL, 225.0 mmol). The reaction was stirred at RT for 3 h, then
was concentrated to a light yellow oil. This oil was dissolved in EtOH
(300 mL), and NaBH4 (2.84 g, 75.0 mmol) was added. After 6 h the reaction
was concentrated to a slurry and dissolved in 1 N NaOH (75 mL). The
aqueous solution was extracted with Et2O (2 × 200 mL), and the combined
organic fractions were dried over Na2SO4 and concentrated. Flash
chromatography on silica gel (9:1 CHCl3/MeOH containing 5% NH4OH) and
drying in high vacuum. 1-Methyl-3-(methylaminomethyl)-1H-indole (26).
According to the procedure for compound 25, except substituting
1-methylindole-3-carboxaldehyde (10.0 g, 62.8 mmol) for
1,2-dimethylindole-3-carboxaldehyde (24), the title compound (10.1 g,
92%) was prepared as a faintly yellow oil. 1H NMR (400 MHz, CDCl3) δ 7.63
(d, J = 6.8 Hz, 1H), 7.29 (m, 1), 7.21 (t, J = 6.4 Hz, 1H), 7.12 (t, J =
6.5 Hz, 1H), 6.95 (s, 1H), 3.90 (s, 2H), 3.71 (s, 3H), 2.48 (s, 3H). LCMS
(ES) m/e 175 (M + H)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Indole Naphthyridinones as Inhibitors of Bacterial Enoyl-ACP Reductases
FabI and FabK
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Seefeld, Mark A.; Miller, William H.; Newlander, Kenneth A.; Burgess,
Walter J.; DeWolf, Walter E. Jr.; Elkins, Patricia A.; Head, Martha S.;
Jakas, Dalia R.; Janson, Cheryl A.; Keller, Paul M.; Manley, Peter J.;
Moore, Terrance D.; Payne, David J.; Pearson, Stewart; Polizzi, Brian J.;
Qiu, Xiayang; Rittenhouse, Stephen F.; Uzinskas, Irene N.; Wallis, Nicola
G.; Huffman, William F.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2003), 46(9), 1627-1635

$RFMT $RIREG SCHEME250 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Methylindole-3-carboxaldehyde
C10H9NO
19012-03-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7307 4.6948 0.0 0
M  V30 2 O 7.1954 4.2188 0.0 0
M  V30 3 C 3.0202 0.0000 0.0 0
M  V30 4 C 3.0800 3.9844 0.0 0
M  V30 5 C 2.3100 2.6508 0.0 0
M  V30 6 C 4.5864 3.6642 0.0 0
M  V30 7 C 2.3100 5.3182 0.0 0
M  V30 8 N 3.3405 1.5064 0.0 0
M  V30 9 C 0.7700 2.6508 0.0 0
M  V30 10 C 4.7473 2.1327 0.0 0
M  V30 11 C 0.7700 5.3182 0.0 0
M  V30 12 C 0.0000 3.9844 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 1 3 8
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 1 9 12
M  V30 13 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,1-Dimethyl-1H-indole-3-methanamine
C11H14N2
56972-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7306 4.6948 0.0 0
M  V30 2 N 7.1953 4.2188 0.0 0
M  V30 3 C 8.3397 5.2494 0.0 0
M  V30 4 C 3.0202 0.0000 0.0 0
M  V30 5 C 3.0800 3.9844 0.0 0
M  V30 6 C 2.3100 2.6508 0.0 0
M  V30 7 C 4.5863 3.6643 0.0 0
M  V30 8 C 2.3100 5.3182 0.0 0
M  V30 9 N 3.3404 1.5064 0.0 0
M  V30 10 C 0.7700 2.6508 0.0 0
M  V30 11 C 4.7472 2.1327 0.0 0
M  V30 12 C 0.7700 5.3182 0.0 0
M  V30 13 C 0.0000 3.9844 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 4 9
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 1 10 13
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 19012-03-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 56972-00-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-15144605
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Preparation 36. Preparation of
1-methyl-3-(methylaminomethyl)-1H-indole (Method B). To a solution of
1-methylindole-3-carboxaldehyde (10.0 g, 62.8 mmole) in MeOH (100 mL) was
added a solution of 2.0 M CH3NH2 in MeOH (126 mL, 252.0 mmole). The
reaction was stirred at RT for 2 hrs, then was concentrated to a light
yellow oil. This oil was dissolved in EtOH (300 mL), and NaBH4 (2.38 g,
62.8 mmole) was added. After 2 hrs the reaction was concentrated to a
slurry and dissolved in 1.0 N NaOH (75 mL). The aqueous solution was
extracted with Et2O (2 × 200 mL) and the combined organic fractions were
dried over Na2SO4 and concentrated. Flash chromatography on silica gel
(9:1 CHCl3/MeOH containing 5% NH4OH) and drying in high vacuum left the
title compound. Yield: (10.1 g, 92%) as a faintly yellow oil. MS (ES) m/e
175 (M + H)+.
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of N-heteroarylmethyl acrylamides as Fab I inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Miller, William H.; Newlander, Kenneth A.; Seefeld, Mark A.; Uzinskas,
Irene N.; Dewolf, Walter E., Jr.; Jakas, Dalia R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2001027103 A1 2001-04-19

$RFMT $RIREG SCHEME251 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl (1S,3S)-6,7-dichloro-1-(2,4-dichlorophenyl)-2,3,4,9-tetrahydro-1H-pyrid...
C20H16Cl4N2O2
1918181-99-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.3359 8.8071 0.0 0
M  V30 2 O 10.6696 8.0371 0.0 0
M  V30 3 O 9.3359 10.3471 0.0 0
M  V30 4 C 12.0033 8.8071 0.0 0
M  V30 5 C 13.3369 8.0371 0.0 0
M  V30 6 Cl 5.3348 11.1171 0.0 0
M  V30 7 Cl 7.5323 0.3220 0.0 0
M  V30 8 Cl 4.4692 0.0000 0.0 0
M  V30 9 Cl 0.0000 11.1171 0.0 0
M  V30 10 C 5.3348 6.4971 0.0 0
M  V30 11 C 6.6685 5.7270 0.0 0
M  V30 12 C 5.3348 8.0371 0.0 0 CFG=2
M  V30 13 N 4.1903 5.4666 0.0 0
M  V30 14 C 6.3483 4.2206 0.0 0
M  V30 15 C 8.0021 6.4971 0.0 0
M  V30 16 N 6.6685 8.8071 0.0 0
M  V30 17 C 4.8167 4.0597 0.0 0
M  V30 18 C 7.2535 2.9747 0.0 0
M  V30 19 C 8.0021 8.0371 0.0 0 CFG=1
M  V30 20 C 4.1903 2.6528 0.0 0
M  V30 21 C 6.6270 1.5679 0.0 0
M  V30 22 C 5.0955 1.4070 0.0 0
M  V30 23 C 4.0010 8.8071 0.0 0
M  V30 24 C 4.0010 10.3471 0.0 0
M  V30 25 C 2.6673 8.0371 0.0 0
M  V30 26 C 2.6673 11.1171 0.0 0
M  V30 27 C 1.3337 8.8071 0.0 0
M  V30 28 C 1.3337 10.3471 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 19 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 24
M  V30 7 1 7 21
M  V30 8 1 8 22
M  V30 9 1 9 28
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 11 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 12 23 CFG=3
M  V30 17 1 13 17
M  V30 18 1 14 17
M  V30 19 2 14 18
M  V30 20 1 15 19
M  V30 21 1 16 19
M  V30 22 2 17 20
M  V30 23 1 18 21
M  V30 24 1 20 22
M  V30 25 2 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 12 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(1S,3S)-6,7-Dichloro-1-(2,4-dichlorophenyl)-2,3,4,9-tetrahydro-N-methyl-1H-py...
C19H15Cl4N3O
1918182-24-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.4464 2.3100 0.0 0
M  V30 2 N 5.1128 1.5400 0.0 0
M  V30 3 O 7.7802 1.5400 0.0 0
M  V30 4 C 5.1128 0.0000 0.0 0
M  V30 5 Cl 10.4475 4.6200 0.0 0
M  V30 6 Cl 0.0000 8.1144 0.0 0
M  V30 7 Cl 1.2528 10.9281 0.0 0
M  V30 8 Cl 13.1149 9.2400 0.0 0
M  V30 9 C 6.4464 6.9300 0.0 0
M  V30 10 C 5.1128 6.1600 0.0 0
M  V30 11 C 7.7802 6.1600 0.0 0 CFG=2
M  V30 12 N 6.1263 8.4364 0.0 0
M  V30 13 C 3.9684 7.1904 0.0 0
M  V30 14 C 5.1128 4.6200 0.0 0
M  V30 15 N 7.7802 4.6200 0.0 0
M  V30 16 C 4.5947 8.5974 0.0 0
M  V30 17 C 2.4367 7.0295 0.0 0
M  V30 18 C 6.4464 3.8500 0.0 0 CFG=1
M  V30 19 C 3.6895 9.8432 0.0 0
M  V30 20 C 1.5317 8.2753 0.0 0
M  V30 21 C 2.1580 9.6823 0.0 0
M  V30 22 C 9.1139 6.9300 0.0 0
M  V30 23 C 10.4475 6.1600 0.0 0
M  V30 24 C 9.1139 8.4700 0.0 0
M  V30 25 C 11.7812 6.9300 0.0 0
M  V30 26 C 10.4475 9.2400 0.0 0
M  V30 27 C 11.7812 8.4700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 18 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 5 23
M  V30 6 1 6 20
M  V30 7 1 7 21
M  V30 8 1 8 27
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 11 22 CFG=3
M  V30 16 1 12 16
M  V30 17 1 13 16
M  V30 18 2 13 17
M  V30 19 1 14 18
M  V30 20 1 15 18
M  V30 21 2 16 19
M  V30 22 1 17 20
M  V30 23 1 19 21
M  V30 24 2 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 11 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1918181-99-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1918182-24-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-15871989
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM closed vial used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions and formulations of methylerthritol phosphate pathway
inhibitors and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Carlier, Paul R.; Cassera, Maria Belen; Merino, Emilio Fernando; Yao,
Zhong-Ke; Ghavami, Maryam
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2016069949 A1 2016-05-06

$RFMT $RIREG SCHEME252 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloroethyl isocyanate
C3H4ClNO
1943-83-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 0.7700 0.0 0
M  V30 2 N 2.6675 1.5400 0.0 0
M  V30 3 C 5.3348 1.5400 0.0 0
M  V30 4 C 1.3338 0.7700 0.0 0
M  V30 5 Cl 6.6687 0.7700 0.0 0
M  V30 6 O 0.0000 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 2 4
M  V30 4 1 3 5
M  V30 5 2 4 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(2-Chloroethyl)-N′-methylurea
C4H9ClN2O
74378-14-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 N 4.0012 2.3101 0.0 0
M  V30 3 N 1.3337 2.3101 0.0 0
M  V30 4 O 2.6675 0.0000 0.0 0
M  V30 5 C 5.3348 1.5400 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 6.6687 2.3101 0.0 0
M  V30 8 Cl 8.0023 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1943-83-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 74378-14-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-316-CAS-15135941
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 1 - Synthesis of 1-(2-chloroethyl)-3-methylurea To a solution of
1-chloro-2-isocyanatoethane (5 g, 47 mmol) in THF (120 mL) was added 2M
CH3NH2 (38 mL) in THF at 0 °C. The reaction mixture was stirred at room
temperature overnight, concentrated in vacuo to provide
1-(2-chloroethyl)-3-methylurea and used to the next step without
purified. Yield 6 g, 92%. 1H-NMR (CDCl3, 400 MHz) δ 5.48 (s, 1H), 5.21
(s, 1H), 3.56~3.59 (m, 2H), 3.47~3.52 (m, 2H), 2.74 (s, 3H). MS (M+H)+:
137.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyridooxazinoindole derivatives and analogs for use as
antiviral agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM McComas, Casey Cameron; Liverton, Nigel J.; Habermann, Joerg; Koch, Uwe;
Narjes, Frank; Li, Peng; Peng, Xuanjia; Soll, Richard; Wu, Hao; Palani,
Anandan; He, Shuwen; Dai, Xing; Liu, Hong; Lai, Zhong; London, Clare;
Xiao, Dong; Zorn, Nicolas; Nargund, Ravi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2013033971 A1 2013-03-14

$RFMT $RIREG SCHEME253 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Dihydro-5-methyl-2,4-dioxo-1(2H)-pyrimidineethanethioamide
C7H9N3O2S
195819-57-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 2.6674 0.0 0
M  V30 2 C 6.9300 4.0011 0.0 0
M  V30 3 N 6.1600 5.3349 0.0 0
M  V30 4 S 8.4700 4.0011 0.0 0
M  V30 5 O 4.6200 0.0000 0.0 0
M  V30 6 C 1.5400 5.3349 0.0 0
M  V30 7 O 0.0000 2.6674 0.0 0
M  V30 8 N 4.6200 2.6674 0.0 0
M  V30 9 C 3.8500 1.3338 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 N 2.3100 1.3338 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 5 9
M  V30 6 1 6 12
M  V30 7 2 7 13
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 1 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Dihydro-N,5-dimethyl-2,4-dioxo-1(2H)-pyrimidineacetamide
C8H11N3O3
897392-78-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 4.6200 0.0 0
M  V30 2 C 6.6684 3.8500 0.0 0
M  V30 3 N 8.0021 4.6200 0.0 0
M  V30 4 O 6.6684 2.3100 0.0 0
M  V30 5 C 9.3358 3.8500 0.0 0
M  V30 6 O 2.6674 6.1600 0.0 0
M  V30 7 C 2.6674 0.0000 0.0 0
M  V30 8 O 0.0000 1.5400 0.0 0
M  V30 9 N 4.0011 3.8500 0.0 0
M  V30 10 C 2.6674 4.6200 0.0 0
M  V30 11 C 4.0011 2.3100 0.0 0
M  V30 12 N 1.3336 3.8500 0.0 0
M  V30 13 C 2.6674 1.5400 0.0 0
M  V30 14 C 1.3336 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 2 6 10
M  V30 7 1 7 13
M  V30 8 2 8 14
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 1 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 195819-57-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 897392-78-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-033-CAS-9013344
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7646-85-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: 1.1. Reaction of thioamide 1 with anhydrous
methylamine or dimethylamine Primary thioamide 1 (0.9962 g, 0.005 mol)
was added to a mixture of anhydrous zinc chloride (0.8177 g, 0.006 mol)
and 33% methylamine or 33% dimethylamine solution in absolute ethanol (20
cm3). A precipitate was formed immediately and some heat was evolved. The
reaction mixture was then stirred for 1 h at room temperature in a
stoppered flask. After evaporation of the solvent, the white residue was
mixed with 1 N hydrochloric acid (30 cm3) and warmed until the solid had
dissolved. The mixture was filtered to remove a small amount of the
precipitate, and the filtrate evaporated under diminished pressure.
Purification of the crude product was performed by crystallization from
methanol-water. After cooling, the respective hydrochloride salt 2 or 3
was separated out as white crystals. 1.2. Reaction of thioacetamide 1a
with aqueous methylamine or ammonium hydroxide A mixture of 1a (0.9962 g,
0.005 mol), ZnCl2 (0.8177 g, 0.006 mol), and 40% methylamine in water (20
cm3) was left to react as described for 2. Product 4 was purified by
crystallization from methanol-water. N-Methyl(1-thyminyl)acetamide (4):
92%. mp 291- 292 °C; ν max 3523, 3331, 3152, 3088, 2995, 2957, 2903,
2834, 1676, 1561, 1484, 1429, 1389, 1379, 1360, 1267, 1236, 1169, 1155,
1017 cm-1; δ H 1.75 (d, 3H, J = 1.1 Hz, CH 3), 2.61 (d, 3H, J = 4.7 Hz,
NCH 3), 4.25 (s, 2H, N1CH 2), 7.43 (d, 1H, J = 1.1 Hz, C6H), 8.03 (br q,
1H, J = 4.4 Hz, CONH), 11.25 (br s, 1H, N3H); δ C 11.8, 25.5, 49.7,
108.0, 142.3, 151.0, 164.5, 167.4; LRMS (EI): 197(24), 140(100), 111(3),
96(65), 69(43); HRMS (EI): M+·, found 197.0805. C8H11N3O3 requires
197.0801.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A Reaction of Thioamides with Zinc Ammoniates Leading to Simple Amidines.
Discovery of a New Zwitterionic Monomethylamidine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Spychala, Jaroslaw
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Catalysis Letters (2006), 109(1-2), 55-60

$RFMT $RIREG SCHEME254 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(4-Bromobutyl)-3-methyl-5-(phenylmethoxy)-2-[4-(phenylmethoxy)phenyl]-1H-in...
C33H32BrNO2
1967829-47-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 41 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 11.2762 5.2181 0.0 0
M  V30 2 C 10.2458 4.0736 0.0 0
M  V30 3 C 10.7216 2.6091 0.0 0
M  V30 4 C 9.6912 1.4645 0.0 0
M  V30 5 Br 10.1671 0.0000 0.0 0
M  V30 6 C 11.2762 10.6391 0.0 0
M  V30 7 O 5.3347 9.4685 0.0 0
M  V30 8 C 4.0011 8.6985 0.0 0
M  V30 9 O 17.8655 7.9285 0.0 0
M  V30 10 C 18.6355 9.2623 0.0 0
M  V30 11 N 10.8003 6.6827 0.0 0
M  V30 12 C 11.7055 7.9285 0.0 0
M  V30 13 C 9.3358 7.1585 0.0 0
M  V30 14 C 10.8003 9.1746 0.0 0
M  V30 15 C 9.3358 8.6985 0.0 0
M  V30 16 C 8.0020 6.3885 0.0 0
M  V30 17 C 8.0020 9.4685 0.0 0
M  V30 18 C 6.6684 7.1585 0.0 0
M  V30 19 C 6.6684 8.6985 0.0 0
M  V30 20 C 13.2455 7.9285 0.0 0
M  V30 21 C 14.0155 6.5949 0.0 0
M  V30 22 C 14.0155 9.2623 0.0 0
M  V30 23 C 15.5555 6.5949 0.0 0
M  V30 24 C 15.5555 9.2623 0.0 0
M  V30 25 C 16.3255 7.9285 0.0 0
M  V30 26 C 2.6673 9.4685 0.0 0
M  V30 27 C 2.6673 11.0085 0.0 0
M  V30 28 C 1.3336 8.6985 0.0 0
M  V30 29 C 1.3336 11.7785 0.0 0
M  V30 30 C 0.0000 9.4685 0.0 0
M  V30 31 C 0.0000 11.0085 0.0 0
M  V30 32 C 20.1755 9.2623 0.0 0
M  V30 33 C 20.9455 7.9285 0.0 0
M  V30 34 C 20.9455 10.5960 0.0 0
M  V30 35 C 22.4855 7.9285 0.0 0
M  V30 36 C 22.4855 10.5960 0.0 0
M  V30 37 C 23.2555 9.2623 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 6 14
M  V30 7 1 7 8
M  V30 8 1 7 19
M  V30 9 1 8 26
M  V30 10 1 9 10
M  V30 11 1 9 25
M  V30 12 1 10 32
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 16 1 12 20
M  V30 17 1 13 15
M  V30 18 2 13 16
M  V30 19 1 14 15
M  V30 20 2 15 17
M  V30 21 1 16 18
M  V30 22 1 17 19
M  V30 23 2 18 19
M  V30 24 2 20 21
M  V30 25 1 20 22
M  V30 26 1 21 23
M  V30 27 2 22 24
M  V30 28 2 23 25
M  V30 29 1 24 25
M  V30 30 2 26 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 2 28 30
M  V30 34 2 29 31
M  V30 35 1 30 31
M  V30 36 2 32 33
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 2 34 36
M  V30 40 2 35 37
M  V30 41 1 36 37
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,3-Dimethyl-5-(phenylmethoxy)-2-[4-(phenylmethoxy)phenyl]-1H-indole-1-butana...
C34H36N2O2
1973474-28-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 42 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 11.2762 6.3625 0.0 0
M  V30 2 C 10.2458 5.2182 0.0 0
M  V30 3 C 10.7217 3.7535 0.0 0
M  V30 4 C 9.6913 2.6091 0.0 0
M  V30 5 N 10.1671 1.1444 0.0 0
M  V30 6 C 9.1367 0.0000 0.0 0
M  V30 7 C 11.2762 11.7837 0.0 0
M  V30 8 O 5.3347 10.6131 0.0 0
M  V30 9 C 4.0011 9.8431 0.0 0
M  V30 10 O 17.8656 9.0731 0.0 0
M  V30 11 C 18.6356 10.4068 0.0 0
M  V30 12 N 10.8004 7.8272 0.0 0
M  V30 13 C 11.7056 9.0731 0.0 0
M  V30 14 C 9.3358 8.3031 0.0 0
M  V30 15 C 10.8004 10.3190 0.0 0
M  V30 16 C 9.3358 9.8431 0.0 0
M  V30 17 C 8.0020 7.5331 0.0 0
M  V30 18 C 8.0020 10.6131 0.0 0
M  V30 19 C 6.6684 8.3031 0.0 0
M  V30 20 C 6.6684 9.8431 0.0 0
M  V30 21 C 13.2456 9.0731 0.0 0
M  V30 22 C 14.0156 7.7395 0.0 0
M  V30 23 C 14.0156 10.4068 0.0 0
M  V30 24 C 15.5556 7.7395 0.0 0
M  V30 25 C 15.5556 10.4068 0.0 0
M  V30 26 C 16.3256 9.0731 0.0 0
M  V30 27 C 2.6673 10.6131 0.0 0
M  V30 28 C 1.3336 9.8431 0.0 0
M  V30 29 C 2.6673 12.1531 0.0 0
M  V30 30 C 0.0000 10.6131 0.0 0
M  V30 31 C 1.3336 12.9231 0.0 0
M  V30 32 C 0.0000 12.1531 0.0 0
M  V30 33 C 20.1756 10.4068 0.0 0
M  V30 34 C 20.9456 9.0731 0.0 0
M  V30 35 C 20.9456 11.7406 0.0 0
M  V30 36 C 22.4857 9.0731 0.0 0
M  V30 37 C 22.4857 11.7406 0.0 0
M  V30 38 C 23.2557 10.4068 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 7 15
M  V30 8 1 8 9
M  V30 9 1 8 20
M  V30 10 1 9 27
M  V30 11 1 10 11
M  V30 12 1 10 26
M  V30 13 1 11 33
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 1 13 21
M  V30 18 1 14 16
M  V30 19 2 14 17
M  V30 20 1 15 16
M  V30 21 2 16 18
M  V30 22 1 17 19
M  V30 23 1 18 20
M  V30 24 2 19 20
M  V30 25 2 21 22
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 2 23 25
M  V30 29 2 24 26
M  V30 30 1 25 26
M  V30 31 2 27 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 2 29 31
M  V30 35 2 30 32
M  V30 36 1 31 32
M  V30 37 2 33 34
M  V30 38 1 33 35
M  V30 39 1 34 36
M  V30 40 2 35 37
M  V30 41 2 36 38
M  V30 42 1 37 38
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1967829-47-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1973474-28-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-15986111
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed pressure tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, antiproliferative and pro-apoptotic activity of
2-phenylindoles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kelly, Patrick M.; Bright, Sandra A.; Fayne, Darren; Pollock, Jade K.;
Zisterer, Daniela M.; Williams, D. Clive; Meegan, Mary J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2016), 24(18), 4075-4099

$RFMT $RIREG SCHEME255 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-9-[(2R)-2-deoxy-2-fluoro-2-methyl-3,5-O-[1,1,3,3-tetrakis(1-methylet...
C23H39ClFN5O4Si2
1998706-13-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 41 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.3317 7.9181 0.0 0
M  V30 2 C 2.3317 9.4581 0.0 0
M  V30 3 C 0.9981 7.1481 0.0 0
M  V30 4 C 4.0641 8.6356 0.0 0
M  V30 5 C 2.9751 9.7245 0.0 0
M  V30 6 C 5.5515 9.0341 0.0 0
M  V30 7 C 1.0889 4.9177 0.0 0
M  V30 8 C 0.0000 3.8287 0.0 0
M  V30 9 C 0.6904 6.4052 0.0 0
M  V30 10 C 1.8066 3.1853 0.0 0
M  V30 11 C 0.2666 3.1853 0.0 0
M  V30 12 C 2.5766 1.8517 0.0 0
M  V30 13 C 7.1327 7.9418 0.0 0
M  V30 14 F 9.0928 7.3050 0.0 0
M  V30 15 Cl 15.1832 3.9644 0.0 0
M  V30 16 N 11.6134 0.0000 0.0 0
M  V30 17 Si 3.6655 7.1481 0.0 0
M  V30 18 O 2.5766 6.0591 0.0 0
M  V30 19 O 5.2055 7.1481 0.0 0
M  V30 20 Si 2.5766 4.5191 0.0 0
M  V30 21 C 6.2944 6.0591 0.0 0 CFG=1
M  V30 22 O 3.6655 3.4300 0.0 0
M  V30 23 C 6.2944 4.5191 0.0 0 CFG=2
M  V30 24 C 7.7590 6.5350 0.0 0 CFG=2
M  V30 25 C 5.2055 3.4300 0.0 0
M  V30 26 O 7.7590 4.0431 0.0 0
M  V30 27 C 8.6642 5.2891 0.0 0 CFG=2
M  V30 28 N 10.2042 5.2891 0.0 0
M  V30 29 C 11.1094 4.0431 0.0 0
M  V30 30 C 11.1094 6.5350 0.0 0
M  V30 31 C 12.5741 4.5191 0.0 0
M  V30 32 N 10.7892 2.5368 0.0 0
M  V30 33 N 12.5741 6.0591 0.0 0
M  V30 34 C 13.7185 3.4886 0.0 0
M  V30 35 C 11.9336 1.5064 0.0 0
M  V30 36 N 13.3983 1.9823 0.0 0
M  V30 37 H 6.6539 7.5565 0.0 0
M  V30 38 H 6.6539 3.0216 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 17
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 17
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 20
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 20
M  V30 13 1 24 13 CFG=3
M  V30 14 1 24 14 CFG=1
M  V30 15 1 15 34
M  V30 16 1 16 35
M  V30 17 1 17 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 1 19 21
M  V30 21 1 20 22
M  V30 22 1 21 23
M  V30 23 1 21 24
M  V30 24 1 21 37 CFG=3
M  V30 25 1 22 25
M  V30 26 1 23 25
M  V30 27 1 23 26
M  V30 28 1 23 38 CFG=1
M  V30 29 1 24 27
M  V30 30 1 26 27
M  V30 31 1 27 28 CFG=3
M  V30 32 1 28 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 2 29 32
M  V30 36 2 30 33
M  V30 37 1 31 33
M  V30 38 2 31 34
M  V30 39 1 32 35
M  V30 40 1 34 36
M  V30 41 2 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 21 23 24 27)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(2′R)-2-Amino-2′-deoxy-2′-fluoro-N,2′-dimethyl-3′,5′-O-[1,1,3,3-tetrakis(1-me...
C24H43FN6O4Si2
1998705-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 42 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.3317 7.9181 0.0 0
M  V30 2 C 2.3317 9.4581 0.0 0
M  V30 3 C 0.9981 7.1481 0.0 0
M  V30 4 C 4.0639 8.6356 0.0 0
M  V30 5 C 2.9750 9.7245 0.0 0
M  V30 6 C 5.5514 9.0341 0.0 0
M  V30 7 C 1.8064 3.1853 0.0 0
M  V30 8 C 2.5764 1.8517 0.0 0
M  V30 9 C 0.2664 3.1853 0.0 0
M  V30 10 C 1.0889 4.9177 0.0 0
M  V30 11 C 0.6902 6.4052 0.0 0
M  V30 12 C 0.0000 3.8287 0.0 0
M  V30 13 C 7.1325 7.9418 0.0 0
M  V30 14 F 9.0926 7.3050 0.0 0
M  V30 15 N 15.1830 3.9644 0.0 0
M  V30 16 C 16.3274 2.9340 0.0 0
M  V30 17 N 11.6134 0.0000 0.0 0
M  V30 18 Si 3.6654 7.1481 0.0 0
M  V30 19 O 2.5764 6.0591 0.0 0
M  V30 20 O 5.2054 7.1481 0.0 0
M  V30 21 Si 2.5764 4.5191 0.0 0
M  V30 22 C 6.2943 6.0591 0.0 0 CFG=1
M  V30 23 O 3.6654 3.4300 0.0 0
M  V30 24 C 6.2943 4.5191 0.0 0 CFG=2
M  V30 25 C 7.7590 6.5350 0.0 0 CFG=2
M  V30 26 C 5.2054 3.4300 0.0 0
M  V30 27 O 7.7590 4.0431 0.0 0
M  V30 28 C 8.6640 5.2891 0.0 0 CFG=2
M  V30 29 N 10.2042 5.2891 0.0 0
M  V30 30 C 11.1093 4.0431 0.0 0
M  V30 31 C 11.1093 6.5350 0.0 0
M  V30 32 C 12.5739 4.5191 0.0 0
M  V30 33 N 10.7891 2.5368 0.0 0
M  V30 34 N 12.5739 6.0591 0.0 0
M  V30 35 C 13.7183 3.4886 0.0 0
M  V30 36 C 11.9336 1.5064 0.0 0
M  V30 37 N 13.3982 1.9823 0.0 0
M  V30 38 H 6.6539 7.5565 0.0 0
M  V30 39 H 6.6539 3.0216 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 18
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 18
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 21
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 21
M  V30 13 1 25 13 CFG=3
M  V30 14 1 25 14 CFG=1
M  V30 15 1 15 16
M  V30 16 1 15 35
M  V30 17 1 17 36
M  V30 18 1 18 19
M  V30 19 1 18 20
M  V30 20 1 19 21
M  V30 21 1 20 22
M  V30 22 1 21 23
M  V30 23 1 22 24
M  V30 24 1 22 25
M  V30 25 1 22 38 CFG=3
M  V30 26 1 23 26
M  V30 27 1 24 26
M  V30 28 1 24 27
M  V30 29 1 24 39 CFG=1
M  V30 30 1 25 28
M  V30 31 1 27 28
M  V30 32 1 28 29 CFG=3
M  V30 33 1 29 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 30 33
M  V30 37 2 31 34
M  V30 38 1 32 34
M  V30 39 2 32 35
M  V30 40 1 33 36
M  V30 41 1 35 37
M  V30 42 2 36 37
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 22 24 25 28)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1998706-13-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1998705-75-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-16348841
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of
β-D-2'-deoxy-2'-α-fluoro-2'-β-C-substituted-2-modified-N6-substituted
purine nucleotides for HCV treatment
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sommadossi, Jean-Pierre; Moussa, Adel
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20160257706 A1 2016-09-08

$RFMT $RIREG SCHEME256 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4,6-Trichloroquinazoline
C8H3Cl3N2
20028-68-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 3.8500 0.0000 0.0 0
M  V30 2 Cl 8.4700 2.6674 0.0 0
M  V30 3 Cl 0.0000 4.0011 0.0 0
M  V30 4 C 4.6200 4.0011 0.0 0
M  V30 5 C 3.8500 2.6674 0.0 0
M  V30 6 N 6.1600 4.0011 0.0 0
M  V30 7 C 3.8500 5.3349 0.0 0
M  V30 8 C 4.6200 1.3338 0.0 0
M  V30 9 C 2.3100 2.6674 0.0 0
M  V30 10 C 6.9300 2.6674 0.0 0
M  V30 11 C 2.3100 5.3349 0.0 0
M  V30 12 N 6.1600 1.3338 0.0 0
M  V30 13 C 1.5400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 10
M  V30 3 1 3 13
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,6-Dichloro-N-methyl-4-quinazolinamine
C9H7Cl2N3
1001065-84-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.8500 1.3338 0.0 0
M  V30 2 C 4.6200 0.0000 0.0 0
M  V30 3 Cl 0.0000 5.3347 0.0 0
M  V30 4 Cl 8.4700 4.0011 0.0 0
M  V30 5 C 3.8500 4.0011 0.0 0
M  V30 6 C 4.6200 5.3347 0.0 0
M  V30 7 C 4.6200 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 N 6.1600 5.3347 0.0 0
M  V30 10 C 3.8500 6.6685 0.0 0
M  V30 11 N 6.1600 2.6674 0.0 0
M  V30 12 C 1.5400 5.3347 0.0 0
M  V30 13 C 6.9300 4.0011 0.0 0
M  V30 14 C 2.3100 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 3 12
M  V30 4 1 4 13
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 20028-68-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1001065-84-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-20834433
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 127-09-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of quinazolinediamine derivatives for use as antibiotics
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Manetsch, Roman; Van Horn, Kurt S.; Burda, Whittney; Shaw, Lindsey N.;
Fleeman, Renee; Barber, Megan; Flanigan, David Lawrence
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US10323007 B1 2019-06-18

$RFMT $RIREG SCHEME256 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4,6-Trichloroquinazoline
C8H3Cl3N2
20028-68-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 3.8500 0.0000 0.0 0
M  V30 2 Cl 8.4700 2.6674 0.0 0
M  V30 3 Cl 0.0000 4.0011 0.0 0
M  V30 4 C 4.6200 4.0011 0.0 0
M  V30 5 C 3.8500 2.6674 0.0 0
M  V30 6 N 6.1600 4.0011 0.0 0
M  V30 7 C 3.8500 5.3349 0.0 0
M  V30 8 C 4.6200 1.3338 0.0 0
M  V30 9 C 2.3100 2.6674 0.0 0
M  V30 10 C 6.9300 2.6674 0.0 0
M  V30 11 C 2.3100 5.3349 0.0 0
M  V30 12 N 6.1600 1.3338 0.0 0
M  V30 13 C 1.5400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 10
M  V30 3 1 3 13
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,6-Dichloro-N-methyl-4-quinazolinamine
C9H7Cl2N3
1001065-84-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.8500 1.3338 0.0 0
M  V30 2 C 4.6200 0.0000 0.0 0
M  V30 3 Cl 0.0000 5.3347 0.0 0
M  V30 4 Cl 8.4700 4.0011 0.0 0
M  V30 5 C 3.8500 4.0011 0.0 0
M  V30 6 C 4.6200 5.3347 0.0 0
M  V30 7 C 4.6200 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 N 6.1600 5.3347 0.0 0
M  V30 10 C 3.8500 6.6685 0.0 0
M  V30 11 N 6.1600 2.6674 0.0 0
M  V30 12 C 1.5400 5.3347 0.0 0
M  V30 13 C 6.9300 4.0011 0.0 0
M  V30 14 C 2.3100 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 3 12
M  V30 4 1 4 13
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 20028-68-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1001065-84-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-17729941
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 127-09-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Characterizing the antimicrobial activity of N2,N4-disubstituted
quinazoline-2,4-diamines toward multidrug-resistant Acinetobacter
baumannii
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fleeman, Renee; Van Horn, Kurt S.; Barber, Megan M.; Burda, Whittney N.;
Flanigan, David L.; Manetsch, Roman; Shaw, Lindsey N.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Antimicrobial Agents and Chemotherapy (2017), 61(6), e00059/1-e00059/11

$RFMT $RIREG SCHEME257 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Chloro-4-[(dibromochloromethyl)sulfonyl]-2-nitrobenzene
C7H3Br2Cl2NO4S
200619-55-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 2.6675 2.3101 0.0 0 VAL=6
M  V30 2 C 1.3337 1.5400 0.0 0
M  V30 3 O 3.4375 0.9764 0.0 0
M  V30 4 O 1.8975 3.6437 0.0 0
M  V30 5 Br 0.0000 2.3101 0.0 0
M  V30 6 Br 0.0000 0.7700 0.0 0
M  V30 7 Cl 1.3337 0.0000 0.0 0
M  V30 8 N 8.0023 2.3101 0.0 0 VAL=5
M  V30 9 O 8.0023 0.7700 0.0 0
M  V30 10 O 9.3360 3.0801 0.0 0
M  V30 11 Cl 8.0023 5.3901 0.0 0
M  V30 12 C 4.0012 3.0801 0.0 0
M  V30 13 C 5.3348 2.3101 0.0 0
M  V30 14 C 4.0012 4.6201 0.0 0
M  V30 15 C 6.6685 3.0801 0.0 0
M  V30 16 C 5.3348 5.3901 0.0 0
M  V30 17 C 6.6685 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 12
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 2 7
M  V30 8 2 8 9
M  V30 9 2 8 10
M  V30 10 1 8 15
M  V30 11 1 11 17
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[(Dibromochloromethyl)sulfonyl]-N-methyl-2-nitrobenzenamine
C8H7Br2ClN2O4S
1105572-37-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.9300 4.0009 0.0 0 VAL=6
M  V30 2 C 8.4700 4.0009 0.0 0
M  V30 3 O 6.9300 5.5409 0.0 0
M  V30 4 O 6.9300 2.4609 0.0 0
M  V30 5 Br 9.2400 5.3347 0.0 0
M  V30 6 Br 10.0100 4.0009 0.0 0
M  V30 7 Cl 9.2400 2.6673 0.0 0
M  V30 8 N 2.3100 1.3336 0.0 0 VAL=5
M  V30 9 O 0.7700 1.3336 0.0 0
M  V30 10 O 3.0800 0.0000 0.0 0
M  V30 11 N 0.7700 4.0009 0.0 0
M  V30 12 C 0.0000 5.3347 0.0 0
M  V30 13 C 5.3900 4.0009 0.0 0
M  V30 14 C 4.6200 2.6673 0.0 0
M  V30 15 C 4.6200 5.3347 0.0 0
M  V30 16 C 3.0800 2.6673 0.0 0
M  V30 17 C 3.0800 5.3347 0.0 0
M  V30 18 C 2.3100 4.0009 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 13
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 2 7
M  V30 8 2 8 9
M  V30 9 2 8 10
M  V30 10 1 8 16
M  V30 11 1 11 12
M  V30 12 1 11 18
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 200619-55-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1105572-37-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-13248995
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Transformation of chlorodibromomethyl-4-chlorophenyl sulfone into new
compounds with potential pesticidal activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ochal, Zbigniew; Wojcicki, Jakub
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Polish Journal of Applied Chemistry (2007), 51(1-2), 29-41

$RFMT $RIREG SCHEME258 STEP1
$RXN



  2  1
$MOL
(αS)-3-Nitro-α-[[(phenylmethoxy)carbonyl]amino]benzeneacetic acid
C16H14N2O6
202338-30-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.7000 6.6684 0.0 0 CFG=1
M  V30 2 N 6.9300 5.3347 0.0 0
M  V30 3 C 6.9300 8.0021 0.0 0
M  V30 4 C 5.3900 5.3347 0.0 0
M  V30 5 O 7.7000 9.3358 0.0 0
M  V30 6 O 5.3900 8.0021 0.0 0
M  V30 7 O 4.6200 4.0011 0.0 0
M  V30 8 O 4.6200 6.6684 0.0 0
M  V30 9 C 3.0800 4.0011 0.0 0
M  V30 10 N 12.3200 4.0011 0.0 0 VAL=5
M  V30 11 O 13.8600 4.0011 0.0 0
M  V30 12 O 11.5500 2.6674 0.0 0
M  V30 13 C 9.2400 6.6684 0.0 0
M  V30 14 C 10.0100 5.3347 0.0 0
M  V30 15 C 10.0100 8.0021 0.0 0
M  V30 16 C 11.5500 5.3347 0.0 0
M  V30 17 C 11.5500 8.0021 0.0 0
M  V30 18 C 12.3200 6.6684 0.0 0
M  V30 19 C 2.3100 2.6674 0.0 0
M  V30 20 C 0.7700 2.6674 0.0 0
M  V30 21 C 3.0800 1.3336 0.0 0
M  V30 22 C 0.0000 1.3336 0.0 0
M  V30 23 C 2.3100 0.0000 0.0 0
M  V30 24 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 2 4 8
M  V30 9 1 7 9
M  V30 10 1 9 19
M  V30 11 2 10 11
M  V30 12 2 10 12
M  V30 13 1 10 16
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylmethyl N-[(1S)-2-(methylamino)-1-(3-nitrophenyl)-2-oxoethyl]carbamate
C17H17N3O5
1421059-57-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.7000 4.0011 0.0 0 CFG=1
M  V30 2 N 6.9300 5.3347 0.0 0
M  V30 3 C 6.9300 2.6673 0.0 0
M  V30 4 C 5.3900 5.3347 0.0 0
M  V30 5 N 7.7000 1.3336 0.0 0
M  V30 6 O 5.3900 2.6673 0.0 0
M  V30 7 O 4.6200 6.6684 0.0 0
M  V30 8 O 4.6200 4.0011 0.0 0
M  V30 9 C 6.9300 0.0000 0.0 0
M  V30 10 C 3.0800 6.6684 0.0 0
M  V30 11 N 12.3200 6.6684 0.0 0 VAL=5
M  V30 12 O 11.5500 8.0021 0.0 0
M  V30 13 O 13.8600 6.6684 0.0 0
M  V30 14 C 9.2400 4.0011 0.0 0
M  V30 15 C 10.0100 5.3347 0.0 0
M  V30 16 C 10.0100 2.6673 0.0 0
M  V30 17 C 11.5500 5.3347 0.0 0
M  V30 18 C 11.5500 2.6673 0.0 0
M  V30 19 C 12.3200 4.0011 0.0 0
M  V30 20 C 2.3100 8.0021 0.0 0
M  V30 21 C 3.0800 9.3358 0.0 0
M  V30 22 C 0.7700 8.0021 0.0 0
M  V30 23 C 2.3100 10.6694 0.0 0
M  V30 24 C 0.0000 9.3358 0.0 0
M  V30 25 C 0.7700 10.6694 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 2 4 8
M  V30 9 1 5 9
M  V30 10 1 7 10
M  V30 11 1 10 20
M  V30 12 2 11 12
M  V30 13 2 11 13
M  V30 14 1 11 17
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 202338-30-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1421059-57-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-19329095
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 538-75-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM key step
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis, and evaluation of novel L-phenylglycine derivatives as
potential PPARγ lead compounds
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liu, Jinyu; Su, Xiaoyan; Li, Huachong; Fan, Li; Li, Yuanyuan; Tang,
Xuemei; Yan, Jufang; Chen, Xin; Chen, Feifei; Liu, Jie; Yang, Dacheng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2018), 26(14), 4153-4167

$RFMT $RIREG SCHEME259 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Chloromethyl)-2-cyclohexyloxazole
C10H14ClNO
202594-70-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.2359 3.0089 0.0 0
M  V30 2 Cl 9.6427 2.3826 0.0 0
M  V30 3 C 4.6201 1.3337 0.0 0
M  V30 4 N 5.5253 2.5795 0.0 0
M  V30 5 O 5.5253 0.0878 0.0 0
M  V30 6 C 6.9898 2.1037 0.0 0
M  V30 7 C 6.9898 0.5636 0.0 0
M  V30 8 C 3.0800 1.3337 0.0 0
M  V30 9 C 2.3100 0.0000 0.0 0
M  V30 10 C 2.3100 2.6673 0.0 0
M  V30 11 C 0.7700 0.0000 0.0 0
M  V30 12 C 0.7700 2.6673 0.0 0
M  V30 13 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 8
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 6 7
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Oxazolemethanamine, 2-cyclohexyl-N-methyl-
C11H18N2O
1894348-04-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.2357 3.0089 0.0 0
M  V30 2 N 9.6426 2.3824 0.0 0
M  V30 3 C 10.8885 3.2876 0.0 0
M  V30 4 C 4.6200 1.3336 0.0 0
M  V30 5 N 5.5252 2.5795 0.0 0
M  V30 6 O 5.5252 0.0878 0.0 0
M  V30 7 C 6.9898 2.1037 0.0 0
M  V30 8 C 6.9898 0.5636 0.0 0
M  V30 9 C 3.0800 1.3336 0.0 0
M  V30 10 C 2.3100 2.6673 0.0 0
M  V30 11 C 2.3100 0.0000 0.0 0
M  V30 12 C 0.7700 2.6673 0.0 0
M  V30 13 C 0.7700 0.0000 0.0 0
M  V30 14 C 0.0000 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 9
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 8
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 202594-70-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1894348-04-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24398640
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structural and Activity Relationships of
6-Sulfonyl-8-Nitrobenzothiazinones as Antitubercular Agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fan, Dongguang; Wang, Bin; Stelitano, Giovanni; Savkova, Karin; Shi, Rui;
Huszar, Stanislav; Han, Quanquan; Mikusova, Katarina; Chiarelli, Laurent
R.; Lu, Yu; Qiao, Chunhua
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2021), 64(19), 14526-14539

$RFMT $RIREG SCHEME260 STEP1
$RXN



  2  1
$MOL

C16H12D3N3O4
2055157-85-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 1.2593 4.0301 0.0 0
M  V30 2 O 1.1213 2.4962 0.0 0
M  V30 3 O 0.0000 4.9165 0.0 0
M  V30 4 O 7.9084 0.8492 0.0 0
M  V30 5 O 11.2736 4.7454 0.0 0
M  V30 6 C 12.0436 6.0791 0.0 0
M  V30 7 C 4.0018 3.9275 0.0 0
M  V30 8 N 5.1308 4.9749 0.0 0
M  V30 9 C 4.1168 2.3918 0.0 0 CFG=2
M  V30 10 C 2.6567 4.6775 0.0 0
M  V30 11 C 6.6535 4.7454 0.0 0
M  V30 12 C 4.4833 6.3723 0.0 0
M  V30 13 N 5.3893 1.5242 0.0 0
M  V30 14 C 2.8986 1.4496 0.0 0
M  V30 15 N 2.9542 6.1884 0.0 0
M  V30 16 C 7.4236 3.4118 0.0 0
M  V30 17 C 7.4236 6.0791 0.0 0
M  V30 18 C 6.8608 1.9782 0.0 0
M  V30 19 C 4.9573 0.0460 0.0 0
M  V30 20 C 3.4181 0.0000 0.0 0
M  V30 21 C 8.9636 3.4118 0.0 0
M  V30 22 C 8.9636 6.0791 0.0 0
M  V30 23 C 9.7336 4.7454 0.0 0
M  V30 24 H 11.2736 7.4128 0.0 0 MASS=2
M  V30 25 H 12.8136 7.4128 0.0 0 MASS=2
M  V30 26 H 13.5837 6.0791 0.0 0 MASS=2
M  V30 27 H 2.7100 3.0181 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 2 4 18
M  V30 5 1 5 6
M  V30 6 1 5 23
M  V30 7 1 6 24
M  V30 8 1 6 25
M  V30 9 1 6 26
M  V30 10 1 7 8
M  V30 11 1 7 9
M  V30 12 2 7 10
M  V30 13 1 8 11
M  V30 14 1 8 12
M  V30 15 1 9 13
M  V30 16 1 9 14
M  V30 17 1 9 27 CFG=3
M  V30 18 1 10 15
M  V30 19 1 11 16
M  V30 20 2 11 17
M  V30 21 2 12 15
M  V30 22 1 13 18
M  V30 23 1 13 19
M  V30 24 1 14 20
M  V30 25 1 16 18
M  V30 26 2 16 21
M  V30 27 1 17 22
M  V30 28 1 19 20
M  V30 29 1 21 23
M  V30 30 2 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C17H15D3N4O3
2055157-96-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6567 4.0300 0.0 0
M  V30 2 N 1.3974 4.9165 0.0 0
M  V30 3 O 2.5187 2.4962 0.0 0
M  V30 4 C 0.0000 4.2692 0.0 0
M  V30 5 O 9.3056 0.8492 0.0 0
M  V30 6 O 12.6708 4.7454 0.0 0
M  V30 7 C 13.4408 6.0790 0.0 0
M  V30 8 C 5.3991 3.9275 0.0 0
M  V30 9 N 6.5279 4.9748 0.0 0
M  V30 10 C 5.5141 2.3918 0.0 0 CFG=2
M  V30 11 C 4.0541 4.6775 0.0 0
M  V30 12 C 8.0508 4.7454 0.0 0
M  V30 13 C 5.8807 6.3722 0.0 0
M  V30 14 N 6.7865 1.5241 0.0 0
M  V30 15 C 4.2958 1.4496 0.0 0
M  V30 16 N 4.3516 6.1883 0.0 0
M  V30 17 C 8.8208 3.4117 0.0 0
M  V30 18 C 8.8208 6.0790 0.0 0
M  V30 19 C 8.2581 1.9781 0.0 0
M  V30 20 C 6.3547 0.0460 0.0 0
M  V30 21 C 4.8154 0.0000 0.0 0
M  V30 22 C 10.3608 3.4117 0.0 0
M  V30 23 C 10.3608 6.0790 0.0 0
M  V30 24 C 11.1308 4.7454 0.0 0
M  V30 25 H 12.6708 7.4126 0.0 0 MASS=2
M  V30 26 H 14.2108 7.4126 0.0 0 MASS=2
M  V30 27 H 14.9808 6.0790 0.0 0 MASS=2
M  V30 28 H 4.1073 3.0181 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 2 5 19
M  V30 6 1 6 7
M  V30 7 1 6 24
M  V30 8 1 7 25
M  V30 9 1 7 26
M  V30 10 1 7 27
M  V30 11 1 8 9
M  V30 12 1 8 10
M  V30 13 2 8 11
M  V30 14 1 9 12
M  V30 15 1 9 13
M  V30 16 1 10 14
M  V30 17 1 10 15
M  V30 18 1 10 28 CFG=3
M  V30 19 1 11 16
M  V30 20 1 12 17
M  V30 21 2 12 18
M  V30 22 2 13 16
M  V30 23 1 14 19
M  V30 24 1 14 20
M  V30 25 1 15 21
M  V30 26 1 17 19
M  V30 27 2 17 22
M  V30 28 1 18 23
M  V30 29 1 20 21
M  V30 30 1 22 24
M  V30 31 2 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2055157-85-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2055157-96-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-16531128
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Optimization of substituted imidazobenzodiazepines as novel asthma
treatments
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jahan, Rajwana; Stephen, Michael Rajesh; Forkuo, Gloria S.; Kodali,
Revathi; Guthrie, Margaret L.; Nieman, Amanda N.; Yuan, Nina Y.; Zahn,
Nicolas M.; Poe, Michael M.; Li, Guanguan; Yu, Olivia B.; Yocum, Gene T.;
Emala, Charles W.; Stafford, Douglas C.; Cook, James M.; Arnold, Leggy A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2017), 126550-560

$RFMT $RIREG SCHEME261 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[3-Chloro-1-(4-fluorophenyl)propoxy]-4-phenoxybenzene
C21H18ClFO2
2069939-57-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.0102 4.0012 0.0 0
M  V30 2 O 9.2402 5.3348 0.0 0
M  V30 3 C 9.2402 2.6675 0.0 0
M  V30 4 C 10.0102 1.3337 0.0 0
M  V30 5 Cl 9.2402 0.0000 0.0 0
M  V30 6 F 16.1704 4.0012 0.0 0
M  V30 7 O 3.0801 5.3348 0.0 0
M  V30 8 C 11.5503 4.0012 0.0 0
M  V30 9 C 12.3203 2.6675 0.0 0
M  V30 10 C 12.3203 5.3348 0.0 0
M  V30 11 C 13.8603 2.6675 0.0 0
M  V30 12 C 13.8603 5.3348 0.0 0
M  V30 13 C 14.6303 4.0012 0.0 0
M  V30 14 C 7.7002 5.3348 0.0 0
M  V30 15 C 6.9302 6.6685 0.0 0
M  V30 16 C 6.9302 4.0012 0.0 0
M  V30 17 C 5.3901 6.6685 0.0 0
M  V30 18 C 5.3901 4.0012 0.0 0
M  V30 19 C 4.6201 5.3348 0.0 0
M  V30 20 C 2.3101 6.6685 0.0 0
M  V30 21 C 3.0801 8.0023 0.0 0
M  V30 22 C 0.7700 6.6685 0.0 0
M  V30 23 C 2.3101 9.3360 0.0 0
M  V30 24 C 0.0000 8.0023 0.0 0
M  V30 25 C 0.7700 9.3360 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 1 2 14
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 1 6 13
M  V30 8 1 7 19
M  V30 9 1 7 20
M  V30 10 2 8 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Fluoro-N-methyl-γ-(4-phenoxyphenoxy)benzenepropanamine
C22H22FNO2
2069939-55-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.0101 5.3348 0.0 0
M  V30 2 O 9.2401 6.6684 0.0 0
M  V30 3 C 9.2401 4.0011 0.0 0
M  V30 4 C 10.0101 2.6673 0.0 0
M  V30 5 N 9.2401 1.3337 0.0 0
M  V30 6 C 10.0101 0.0000 0.0 0
M  V30 7 F 16.1702 5.3348 0.0 0
M  V30 8 O 3.0800 6.6684 0.0 0
M  V30 9 C 11.5501 5.3348 0.0 0
M  V30 10 C 12.3201 6.6684 0.0 0
M  V30 11 C 12.3201 4.0011 0.0 0
M  V30 12 C 13.8602 6.6684 0.0 0
M  V30 13 C 13.8602 4.0011 0.0 0
M  V30 14 C 14.6302 5.3348 0.0 0
M  V30 15 C 7.7001 6.6684 0.0 0
M  V30 16 C 6.9301 5.3348 0.0 0
M  V30 17 C 6.9301 8.0022 0.0 0
M  V30 18 C 5.3901 5.3348 0.0 0
M  V30 19 C 5.3901 8.0022 0.0 0
M  V30 20 C 4.6201 6.6684 0.0 0
M  V30 21 C 2.3100 8.0022 0.0 0
M  V30 22 C 0.7700 8.0022 0.0 0
M  V30 23 C 3.0800 9.3359 0.0 0
M  V30 24 C 0.0000 9.3359 0.0 0
M  V30 25 C 2.3100 10.6695 0.0 0
M  V30 26 C 0.7700 10.6695 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 9
M  V30 4 1 2 15
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 1 5 6
M  V30 8 1 7 14
M  V30 9 1 8 20
M  V30 10 1 8 21
M  V30 11 2 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2069939-57-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2069939-55-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-16773296
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM autoclave used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Sarcosine-Based Glycine Transporter Type-1 (GlyT-1) Inhibitors Containing
Pyridazine Moiety: A Further Search for Drugs with Potential to Influence
Schizophrenia Negative Symptoms
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Harsing, Laszlo G. Jr.; Timar, Julia; Szabo, Geza; Udvari, Szabolcs;
Nagy, Katalin M.; Marko, Bernadett; Zsilla, Gabriella; Czompa, Andrea;
Tapolcsanyi, Pal; Kocsis, Akos; Matyus, Peter
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Current Pharmaceutical Design (2015), 21(17), 2291-2303

$RFMT $RIREG SCHEME262 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-3-bromobenzoic acid
C7H6BrNO2
20776-51-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 3.0800 0.0 0
M  V30 2 O 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 4.6200 0.0 0
M  V30 4 N 2.6674 4.6200 0.0 0
M  V30 5 Br 0.0000 3.0800 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 3.0800 0.0 0
M  V30 8 C 4.0011 0.7700 0.0 0
M  V30 9 C 1.3338 2.3100 0.0 0
M  V30 10 C 2.6674 0.0000 0.0 0
M  V30 11 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-3-bromo-N-methylbenzamide
C8H9BrN2O
1022960-45-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 3.0800 0.0 0
M  V30 2 N 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 4.6200 0.0 0
M  V30 4 C 8.0021 3.0800 0.0 0
M  V30 5 N 2.6674 4.6200 0.0 0
M  V30 6 Br 0.0000 3.0800 0.0 0
M  V30 7 C 4.0011 2.3100 0.0 0
M  V30 8 C 2.6674 3.0800 0.0 0
M  V30 9 C 4.0011 0.7700 0.0 0
M  V30 10 C 1.3336 2.3100 0.0 0
M  V30 11 C 2.6674 0.0000 0.0 0
M  V30 12 C 1.3336 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 8
M  V30 6 1 6 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 20776-51-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1022960-45-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-15842147
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 68957-94-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery and Optimization of Quinazolinone-pyrrolopyrrolones as Potent
and Orally Bioavailable Pan-Pim Kinase Inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pettus, Liping H.; Andrews, Kristin L.; Booker, Shon K.; Chen, Jie; Cee,
Victor J.; Chavez, Frank Jr.; Chen, Yuping; Eastwood, Heather; Guerrero,
Nadia; Herberich, Bradley; Hickman, Dean; Lanman, Brian A.; Laszlo, Jimmy
III; Lee, Matthew R.; Lipford, J. Russell; Mattson, Bethany; Mohr,
Christopher; Nguyen, Yen; Norman, Mark H.; Powers, David; Reed, Anthony
B.; Rex, Karen; Sastri, Christine; Tamayo, Nuria; Wang, Paul; Winston,
Jeffrey T.; Wu, Bin; Wu, Tian; Wurz, Ryan P.; Xu, Yang; Zhou, Yihong;
Tasker, Andrew S.; Wang, Hui-Ling
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2016), 59(13), 6407-6430

$RFMT $RIREG SCHEME263 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2E)-3-[4-Chloro-6-(methylamino)-5-pyrimidinyl]-2-propenenitrile
C8H7ClN4
2101751-51-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.0011 0.0 0
M  V30 2 C 5.3900 5.3347 0.0 0
M  V30 3 C 6.9300 5.3347 0.0 0
M  V30 4 N 8.4700 5.3347 0.0 0
M  V30 5 N 3.0800 1.3338 0.0 0
M  V30 6 C 2.3100 0.0000 0.0 0
M  V30 7 Cl 3.0800 6.6685 0.0 0
M  V30 8 C 3.0800 4.0011 0.0 0
M  V30 9 C 2.3100 2.6674 0.0 0
M  V30 10 C 2.3100 5.3347 0.0 0
M  V30 11 N 0.7700 2.6674 0.0 0
M  V30 12 N 0.7700 5.3347 0.0 0
M  V30 13 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 3 3 4
M  V30 5 1 5 6
M  V30 6 1 5 9
M  V30 7 1 7 10
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2E)-3-[4,6-Bis(methylamino)-5-pyrimidinyl]-2-propenenitrile
C9H11N5
2101751-56-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 4.0011 0.0 0
M  V30 2 C 5.3901 5.3348 0.0 0
M  V30 3 C 6.9301 5.3348 0.0 0
M  V30 4 N 8.4701 5.3348 0.0 0
M  V30 5 N 3.0800 1.3337 0.0 0
M  V30 6 C 2.3100 0.0000 0.0 0
M  V30 7 N 3.0800 6.6686 0.0 0
M  V30 8 C 2.3100 8.0022 0.0 0
M  V30 9 C 3.0800 4.0011 0.0 0
M  V30 10 C 2.3100 2.6675 0.0 0
M  V30 11 C 2.3100 5.3348 0.0 0
M  V30 12 N 0.7700 2.6675 0.0 0
M  V30 13 N 0.7700 5.3348 0.0 0
M  V30 14 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 3 3 4
M  V30 5 1 5 6
M  V30 6 1 5 10
M  V30 7 1 7 8
M  V30 8 1 7 11
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2101751-51-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2101751-56-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-17180760
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of new 4-amino-substituted 7-iminopyrido[2,3-d]pyrimidines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zinchenko, Anna N.; Muzychka, Lyubov V.; Biletskii, Igor I.; Smolii, Oleg
B.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry of Heterocyclic Compounds (New York, NY, United States) (2017),
53(5), 589-596

$RFMT $RIREG SCHEME264 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 9-amino-1,2,3,4-tetrahydro-6-(1-methyl-1H-pyrazol-4-yl)-2-acridinecarbo...
C20H22N4O2
2127162-43-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.3038 6.4718 0.0 0
M  V30 2 C 14.6386 4.9318 0.0 0
M  V30 3 O 15.9723 4.1618 0.0 0
M  V30 4 O 14.6386 6.4718 0.0 0
M  V30 5 C 17.3060 4.9318 0.0 0
M  V30 6 C 18.6396 4.1618 0.0 0
M  V30 7 C 0.0000 1.4946 0.0 0
M  V30 8 C 10.6375 4.1618 0.0 0
M  V30 9 C 10.6375 2.6218 0.0 0
M  V30 10 C 9.3038 4.9318 0.0 0
M  V30 11 C 11.9711 4.9318 0.0 0
M  V30 12 N 9.3038 1.8517 0.0 0
M  V30 13 C 11.9711 1.8517 0.0 0
M  V30 14 C 7.9700 4.1618 0.0 0
M  V30 15 C 13.3048 4.1618 0.0 0
M  V30 16 C 7.9700 2.6218 0.0 0
M  V30 17 C 13.3048 2.6218 0.0 0
M  V30 18 C 6.6363 4.9318 0.0 0
M  V30 19 C 6.6363 1.8517 0.0 0
M  V30 20 C 5.3026 4.1618 0.0 0
M  V30 21 C 5.3026 2.6218 0.0 0
M  V30 22 C 3.9690 1.8517 0.0 0
M  V30 23 C 2.5620 2.4782 0.0 0
M  V30 24 C 3.8079 0.3202 0.0 0
M  V30 25 N 1.5316 1.3337 0.0 0
M  V30 26 N 2.3016 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 15
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 7 25
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 11
M  V30 11 2 9 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 16
M  V30 18 2 14 18
M  V30 19 1 15 17
M  V30 20 2 16 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 21
M  V30 24 1 21 22
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
9-Amino-1,2,3,4-tetrahydro-N-methyl-6-(1-methyl-1H-pyrazol-4-yl)-2-acridineca...
C19H21N5O
2379794-20-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.3038 6.4718 0.0 0
M  V30 2 C 14.6386 4.9318 0.0 0
M  V30 3 N 15.9723 4.1618 0.0 0
M  V30 4 O 14.6386 6.4718 0.0 0
M  V30 5 C 17.3060 4.9318 0.0 0
M  V30 6 C 0.0000 1.4946 0.0 0
M  V30 7 C 10.6375 4.1618 0.0 0
M  V30 8 C 10.6375 2.6218 0.0 0
M  V30 9 C 9.3038 4.9318 0.0 0
M  V30 10 C 11.9711 4.9318 0.0 0
M  V30 11 N 9.3038 1.8517 0.0 0
M  V30 12 C 11.9711 1.8517 0.0 0
M  V30 13 C 7.9700 4.1618 0.0 0
M  V30 14 C 13.3048 4.1618 0.0 0
M  V30 15 C 7.9700 2.6218 0.0 0
M  V30 16 C 13.3048 2.6218 0.0 0
M  V30 17 C 6.6363 4.9318 0.0 0
M  V30 18 C 6.6363 1.8517 0.0 0
M  V30 19 C 5.3026 4.1618 0.0 0
M  V30 20 C 5.3026 2.6218 0.0 0
M  V30 21 C 3.9690 1.8517 0.0 0
M  V30 22 C 2.5620 2.4782 0.0 0
M  V30 23 C 3.8079 0.3202 0.0 0
M  V30 24 N 1.5316 1.3337 0.0 0
M  V30 25 N 2.3016 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 14
M  V30 5 1 3 5
M  V30 6 1 6 24
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 10
M  V30 10 2 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 15
M  V30 17 2 13 17
M  V30 18 1 14 16
M  V30 19 2 15 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 20
M  V30 23 1 20 21
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2127162-43-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2379794-20-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25850400
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Neuroprotective derivatives of tacrine that target NMDA receptor and
acetyl cholinesterase - Design, synthesis and biological evaluation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Remya, Chandran; Dileep, K. V.; Koti Reddy, Eeda; Mantosh, Kumar;
Lakshmi, Kesavan; Sarah Jacob, Reena; Sajith, Ayyiliyath M.; Jayadevi
Variyar, E.; Anwar, Shaik; Zhang, Kam Y. J.; Sadasivan, C.; Omkumar, R.
V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Computational and Structural Biotechnology Journal (2021), 194517-4537

$RFMT $RIREG SCHEME264 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 9-amino-1,2,3,4-tetrahydro-6-(1-methyl-1H-pyrazol-4-yl)-2-acridinecarbo...
C20H22N4O2
2127162-43-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.3038 6.4718 0.0 0
M  V30 2 C 14.6386 4.9318 0.0 0
M  V30 3 O 15.9723 4.1618 0.0 0
M  V30 4 O 14.6386 6.4718 0.0 0
M  V30 5 C 17.3060 4.9318 0.0 0
M  V30 6 C 18.6396 4.1618 0.0 0
M  V30 7 C 0.0000 1.4946 0.0 0
M  V30 8 C 10.6375 4.1618 0.0 0
M  V30 9 C 10.6375 2.6218 0.0 0
M  V30 10 C 9.3038 4.9318 0.0 0
M  V30 11 C 11.9711 4.9318 0.0 0
M  V30 12 N 9.3038 1.8517 0.0 0
M  V30 13 C 11.9711 1.8517 0.0 0
M  V30 14 C 7.9700 4.1618 0.0 0
M  V30 15 C 13.3048 4.1618 0.0 0
M  V30 16 C 7.9700 2.6218 0.0 0
M  V30 17 C 13.3048 2.6218 0.0 0
M  V30 18 C 6.6363 4.9318 0.0 0
M  V30 19 C 6.6363 1.8517 0.0 0
M  V30 20 C 5.3026 4.1618 0.0 0
M  V30 21 C 5.3026 2.6218 0.0 0
M  V30 22 C 3.9690 1.8517 0.0 0
M  V30 23 C 2.5620 2.4782 0.0 0
M  V30 24 C 3.8079 0.3202 0.0 0
M  V30 25 N 1.5316 1.3337 0.0 0
M  V30 26 N 2.3016 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 15
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 7 25
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 11
M  V30 11 2 9 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 16
M  V30 18 2 14 18
M  V30 19 1 15 17
M  V30 20 2 16 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 21
M  V30 24 1 21 22
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
9-Amino-1,2,3,4-tetrahydro-N-methyl-6-(1-methyl-1H-pyrazol-4-yl)-2-acridineca...
C19H21N5O
2379794-20-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.3038 6.4718 0.0 0
M  V30 2 C 14.6386 4.9318 0.0 0
M  V30 3 N 15.9723 4.1618 0.0 0
M  V30 4 O 14.6386 6.4718 0.0 0
M  V30 5 C 17.3060 4.9318 0.0 0
M  V30 6 C 0.0000 1.4946 0.0 0
M  V30 7 C 10.6375 4.1618 0.0 0
M  V30 8 C 10.6375 2.6218 0.0 0
M  V30 9 C 9.3038 4.9318 0.0 0
M  V30 10 C 11.9711 4.9318 0.0 0
M  V30 11 N 9.3038 1.8517 0.0 0
M  V30 12 C 11.9711 1.8517 0.0 0
M  V30 13 C 7.9700 4.1618 0.0 0
M  V30 14 C 13.3048 4.1618 0.0 0
M  V30 15 C 7.9700 2.6218 0.0 0
M  V30 16 C 13.3048 2.6218 0.0 0
M  V30 17 C 6.6363 4.9318 0.0 0
M  V30 18 C 6.6363 1.8517 0.0 0
M  V30 19 C 5.3026 4.1618 0.0 0
M  V30 20 C 5.3026 2.6218 0.0 0
M  V30 21 C 3.9690 1.8517 0.0 0
M  V30 22 C 2.5620 2.4782 0.0 0
M  V30 23 C 3.8079 0.3202 0.0 0
M  V30 24 N 1.5316 1.3337 0.0 0
M  V30 25 N 2.3016 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 14
M  V30 5 1 3 5
M  V30 6 1 6 24
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 10
M  V30 10 2 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 15
M  V30 17 2 13 17
M  V30 18 1 14 16
M  V30 19 2 15 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 20
M  V30 23 1 20 21
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2127162-43-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2379794-20-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-20754091
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of tacrine derivatives targeting NMDA receptor,
acetylcholinesterase, butyrylcholinesterase and beta secretase activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Omkumar, Ramakrishnapillai Vyomakesannair; Chittalakkottu, Sadasivan;
Anwar, Shaik; Elessery, Jayadevi Variyar; Chandran, Remya; Reddy, Eeda
Koti
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM India, IN201841015699 A 2019-11-01

$RFMT $RIREG SCHEME264 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 9-amino-1,2,3,4-tetrahydro-6-(1-methyl-1H-pyrazol-4-yl)-2-acridinecarbo...
C20H22N4O2
2127162-43-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.3038 6.4718 0.0 0
M  V30 2 C 14.6386 4.9318 0.0 0
M  V30 3 O 15.9723 4.1618 0.0 0
M  V30 4 O 14.6386 6.4718 0.0 0
M  V30 5 C 17.3060 4.9318 0.0 0
M  V30 6 C 18.6396 4.1618 0.0 0
M  V30 7 C 0.0000 1.4946 0.0 0
M  V30 8 C 10.6375 4.1618 0.0 0
M  V30 9 C 10.6375 2.6218 0.0 0
M  V30 10 C 9.3038 4.9318 0.0 0
M  V30 11 C 11.9711 4.9318 0.0 0
M  V30 12 N 9.3038 1.8517 0.0 0
M  V30 13 C 11.9711 1.8517 0.0 0
M  V30 14 C 7.9700 4.1618 0.0 0
M  V30 15 C 13.3048 4.1618 0.0 0
M  V30 16 C 7.9700 2.6218 0.0 0
M  V30 17 C 13.3048 2.6218 0.0 0
M  V30 18 C 6.6363 4.9318 0.0 0
M  V30 19 C 6.6363 1.8517 0.0 0
M  V30 20 C 5.3026 4.1618 0.0 0
M  V30 21 C 5.3026 2.6218 0.0 0
M  V30 22 C 3.9690 1.8517 0.0 0
M  V30 23 C 2.5620 2.4782 0.0 0
M  V30 24 C 3.8079 0.3202 0.0 0
M  V30 25 N 1.5316 1.3337 0.0 0
M  V30 26 N 2.3016 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 15
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 7 25
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 11
M  V30 11 2 9 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 16
M  V30 18 2 14 18
M  V30 19 1 15 17
M  V30 20 2 16 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 21
M  V30 24 1 21 22
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
9-Amino-1,2,3,4-tetrahydro-N-methyl-6-(1-methyl-1H-pyrazol-4-yl)-2-acridineca...
C19H21N5O
2379794-20-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.3038 6.4718 0.0 0
M  V30 2 C 14.6386 4.9318 0.0 0
M  V30 3 N 15.9723 4.1618 0.0 0
M  V30 4 O 14.6386 6.4718 0.0 0
M  V30 5 C 17.3060 4.9318 0.0 0
M  V30 6 C 0.0000 1.4946 0.0 0
M  V30 7 C 10.6375 4.1618 0.0 0
M  V30 8 C 10.6375 2.6218 0.0 0
M  V30 9 C 9.3038 4.9318 0.0 0
M  V30 10 C 11.9711 4.9318 0.0 0
M  V30 11 N 9.3038 1.8517 0.0 0
M  V30 12 C 11.9711 1.8517 0.0 0
M  V30 13 C 7.9700 4.1618 0.0 0
M  V30 14 C 13.3048 4.1618 0.0 0
M  V30 15 C 7.9700 2.6218 0.0 0
M  V30 16 C 13.3048 2.6218 0.0 0
M  V30 17 C 6.6363 4.9318 0.0 0
M  V30 18 C 6.6363 1.8517 0.0 0
M  V30 19 C 5.3026 4.1618 0.0 0
M  V30 20 C 5.3026 2.6218 0.0 0
M  V30 21 C 3.9690 1.8517 0.0 0
M  V30 22 C 2.5620 2.4782 0.0 0
M  V30 23 C 3.8079 0.3202 0.0 0
M  V30 24 N 1.5316 1.3337 0.0 0
M  V30 25 N 2.3016 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 14
M  V30 5 1 3 5
M  V30 6 1 6 24
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 10
M  V30 10 2 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 15
M  V30 17 2 13 17
M  V30 18 1 14 16
M  V30 19 2 15 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 20
M  V30 23 1 20 21
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2127162-43-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2379794-20-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-22040558
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of tacrine derivatives targeting NMDA receptor,
acetylcholinesterase, butyrylcholinesterase and beta secretase activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Omkumar, Ramakrishnapillai Vyomakesannair; Chittalakkottu, Sadasivan;
Anwar, Shaik; Elessery, Jayadevi Variyar; Chandran, Remya; Reddy, Eeda
Koti
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019207604 A1 2019-10-31

$RFMT $RIREG SCHEME265 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl (3R,6′R)-1,2,5′,6′-tetrahydro-6′-(2-hydroxyphenyl)-1-methyl-2-oxospiro[...
C22H21NO5
2133827-14-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 2.2419 4.7973 0.0 0
M  V30 2 C 7.9700 7.7000 0.0 0
M  V30 3 O 9.3036 6.9300 0.0 0
M  V30 4 O 7.9700 9.2400 0.0 0
M  V30 5 C 10.6372 7.7000 0.0 0
M  V30 6 C 11.9710 6.9300 0.0 0
M  V30 7 C 0.0000 7.2871 0.0 0
M  V30 8 O 7.9700 3.0800 0.0 0
M  V30 9 C 3.9689 6.9300 0.0 0 CFG=2
M  V30 10 C 3.8080 8.4615 0.0 0
M  V30 11 C 3.9689 5.3900 0.0 0
M  V30 12 C 5.3025 7.7000 0.0 0
M  V30 13 C 2.5621 6.3035 0.0 0
M  V30 14 C 2.3015 8.7817 0.0 0
M  V30 15 C 4.8384 9.6059 0.0 0
M  V30 16 C 5.3025 4.6200 0.0 0 CFG=2
M  V30 17 C 6.6363 6.9300 0.0 0
M  V30 18 N 1.5315 7.4481 0.0 0
M  V30 19 C 1.8257 10.2464 0.0 0
M  V30 20 C 4.3625 11.0706 0.0 0
M  V30 21 O 6.6363 5.3900 0.0 0
M  V30 22 C 2.8562 11.3908 0.0 0
M  V30 23 C 5.3025 3.0800 0.0 0
M  V30 24 C 6.6363 2.3100 0.0 0
M  V30 25 C 3.9689 2.3100 0.0 0
M  V30 26 C 6.6363 0.7700 0.0 0
M  V30 27 C 3.9689 0.7700 0.0 0
M  V30 28 C 5.3025 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 13
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 17
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 7 18
M  V30 8 1 8 24
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 9 13 CFG=1
M  V30 13 1 10 14
M  V30 14 2 10 15
M  V30 15 1 11 16
M  V30 16 2 12 17
M  V30 17 1 13 18
M  V30 18 1 14 18
M  V30 19 2 14 19
M  V30 20 1 15 20
M  V30 21 1 16 21
M  V30 22 1 16 23 CFG=1
M  V30 23 1 17 21
M  V30 24 1 19 22
M  V30 25 2 20 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 9 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(3R,6′R)-1,2,5′,6′-Tetrahydro-6′-(2-hydroxyphenyl)-N,1-dimethyl-2-oxospiro[3H...
C21H20N2O4
2636793-58-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 6.5935 8.3955 0.0 0
M  V30 2 C 3.6908 2.6674 0.0 0
M  V30 3 N 4.4608 1.3338 0.0 0
M  V30 4 O 2.1508 2.6674 0.0 0
M  V30 5 C 3.6908 0.0000 0.0 0
M  V30 6 C 4.1036 10.6374 0.0 0
M  V30 7 O 8.3108 2.6674 0.0 0
M  V30 8 C 4.4608 6.6685 0.0 0 CFG=2
M  V30 9 C 2.9292 6.8294 0.0 0
M  V30 10 C 6.0008 6.6685 0.0 0
M  V30 11 C 3.6908 5.3347 0.0 0
M  V30 12 C 5.0872 8.0753 0.0 0
M  V30 13 C 2.6091 8.3357 0.0 0
M  V30 14 C 1.7849 5.7990 0.0 0
M  V30 15 C 6.7708 5.3347 0.0 0 CFG=2
M  V30 16 C 4.4608 4.0011 0.0 0
M  V30 17 N 3.9427 9.1057 0.0 0
M  V30 18 C 1.1444 8.8117 0.0 0
M  V30 19 C 0.3202 6.2749 0.0 0
M  V30 20 O 6.0008 4.0011 0.0 0
M  V30 21 C 0.0000 7.7812 0.0 0
M  V30 22 C 8.3108 5.3347 0.0 0
M  V30 23 C 9.0808 4.0011 0.0 0
M  V30 24 C 9.0808 6.6685 0.0 0
M  V30 25 C 10.6208 4.0011 0.0 0
M  V30 26 C 10.6208 6.6685 0.0 0
M  V30 27 C 11.3908 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 12
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 16
M  V30 5 1 3 5
M  V30 6 1 6 17
M  V30 7 1 7 23
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 8 12 CFG=3
M  V30 12 1 9 13
M  V30 13 2 9 14
M  V30 14 1 10 15
M  V30 15 2 11 16
M  V30 16 1 12 17
M  V30 17 1 13 17
M  V30 18 2 13 18
M  V30 19 1 14 19
M  V30 20 1 15 20
M  V30 21 1 15 22 CFG=3
M  V30 22 1 16 20
M  V30 23 1 18 21
M  V30 24 2 19 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 8 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2133827-14-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2636793-58-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-23383416
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, ee 93%, dr = 99:1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Box-copper catalyzed asymmetric inverse-electron-demand
oxa-hetero-Diels-Alder reaction for efficient synthesis of spiro
pyranyl-oxindole derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Nai-Kai; Sun, Bing-Bing; Chen, Jun-Bo; Yang, Hao-Di; Wang, Bai-Lin;
Yu, Jie-Qiang; Wang, Xing-Wang; Wang, Zheng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Chemistry Frontiers (2021), 8(9), 2009-2018

$RFMT $RIREG SCHEME266 STEP1
$RXN



  2  1
$MOL
N-[[1-(2,4-Difluorophenyl)-3-(4-fluorophenyl)-4,5-dihydro-5-methyl-4-(2-thien...
C23H18F3N3O3S
2171017-47-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 4.3159 0.0 0
M  V30 2 N 3.9278 3.6896 0.0 0
M  V30 3 O 6.5807 3.4108 0.0 0
M  V30 4 C 3.7669 2.1580 0.0 0
M  V30 5 C 2.3599 1.5316 0.0 0
M  V30 6 O 2.1990 0.0000 0.0 0
M  V30 7 O 1.1141 2.4368 0.0 0
M  V30 8 C 3.9557 5.8476 0.0 0
M  V30 9 F 5.3348 10.4592 0.0 0
M  V30 10 F 13.8984 7.5050 0.0 0
M  V30 11 F 0.0000 10.4592 0.0 0
M  V30 12 C 7.0020 5.5273 0.0 0
M  V30 13 C 5.4957 5.8476 0.0 0
M  V30 14 C 7.7720 6.8611 0.0 0
M  V30 15 N 5.3348 7.3792 0.0 0
M  V30 16 N 6.7416 8.0055 0.0 0
M  V30 17 C 7.6285 4.1205 0.0 0
M  V30 18 C 6.8585 2.7868 0.0 0
M  V30 19 S 9.1348 3.8003 0.0 0
M  V30 20 C 7.8889 1.6423 0.0 0
M  V30 21 C 9.2959 2.2688 0.0 0
M  V30 22 C 9.3037 7.0220 0.0 0
M  V30 23 C 10.2090 5.7762 0.0 0
M  V30 24 C 9.9301 8.4289 0.0 0
M  V30 25 C 11.7405 5.9371 0.0 0
M  V30 26 C 11.4616 8.5899 0.0 0
M  V30 27 C 12.3668 7.3441 0.0 0
M  V30 28 C 4.0010 8.1492 0.0 0
M  V30 29 C 4.0010 9.6892 0.0 0
M  V30 30 C 2.6673 7.3792 0.0 0
M  V30 31 C 2.6673 10.4592 0.0 0
M  V30 32 C 1.3337 8.1492 0.0 0
M  V30 33 C 1.3337 9.6892 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 8 13
M  V30 9 1 9 29
M  V30 10 1 10 27
M  V30 11 1 11 33
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 17
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 1 14 22
M  V30 18 1 15 16
M  V30 19 1 15 28
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 31 2 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 32
M  V30 35 2 31 33
M  V30 36 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(2,4-Difluorophenyl)-3-(4-fluorophenyl)-4,5-dihydro-5-methyl-N-[2-(methylam...
C24H21F3N4O2S
2171015-58-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.4051 7.9876 0.0 0
M  V30 2 N 4.8736 7.8265 0.0 0
M  V30 3 O 7.0314 9.3944 0.0 0
M  V30 4 C 3.9683 9.0726 0.0 0
M  V30 5 C 2.4368 8.9115 0.0 0
M  V30 6 N 1.5316 10.1575 0.0 0
M  V30 7 O 1.8103 7.5047 0.0 0
M  V30 8 C 0.0000 9.9964 0.0 0
M  V30 9 C 5.9767 5.9717 0.0 0
M  V30 10 F 9.4767 2.6675 0.0 0
M  V30 11 F 15.4159 9.5076 0.0 0
M  V30 12 F 4.8566 0.0000 0.0 0
M  V30 13 C 8.4547 7.7722 0.0 0
M  V30 14 C 7.3103 6.7418 0.0 0
M  V30 15 C 9.7885 7.0022 0.0 0
M  V30 16 N 7.9367 5.3348 0.0 0
M  V30 17 N 9.4682 5.4957 0.0 0
M  V30 18 C 8.2938 9.3037 0.0 0
M  V30 19 C 6.9601 10.0737 0.0 0
M  V30 20 S 9.4382 10.3342 0.0 0
M  V30 21 C 7.2803 11.5802 0.0 0
M  V30 22 C 8.8119 11.7411 0.0 0
M  V30 23 C 11.1953 7.6285 0.0 0
M  V30 24 C 11.3563 9.1601 0.0 0
M  V30 25 C 12.4412 6.7233 0.0 0
M  V30 26 C 12.7632 9.7865 0.0 0
M  V30 27 C 13.8482 7.3498 0.0 0
M  V30 28 C 14.0091 8.8813 0.0 0
M  V30 29 C 7.1666 4.0011 0.0 0
M  V30 30 C 7.9367 2.6675 0.0 0
M  V30 31 C 5.6266 4.0011 0.0 0
M  V30 32 C 7.1666 1.3337 0.0 0
M  V30 33 C 4.8566 2.6675 0.0 0
M  V30 34 C 5.6266 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 1 9 14
M  V30 10 1 10 30
M  V30 11 1 11 28
M  V30 12 1 12 34
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 18
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 1 15 23
M  V30 19 1 16 17
M  V30 20 1 16 29
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 32 2 29 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 2 31 33
M  V30 36 2 32 34
M  V30 37 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2171017-47-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2171015-58-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-19906916
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-02-4
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of dihydropyrazolecarboxamide derivatives useful for the
treatment of cancer and fibrosis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Peto, Csaba; Tolani, Bhairavi; Woodard, Gavitt; Tsang, Tsze; Mann,
Michael; Jablons, David M.; He, Biao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018005678 A1 2018-01-04

$RFMT $RIREG SCHEME267 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Phenoxymethyl)benzoyl chloride
C14H11ClO2
21733-94-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.0011 0.0 0
M  V30 2 O 5.3900 5.3347 0.0 0
M  V30 3 C 3.0800 1.3338 0.0 0
M  V30 4 Cl 2.3100 0.0000 0.0 0
M  V30 5 O 4.6200 1.3338 0.0 0
M  V30 6 C 3.0800 4.0011 0.0 0
M  V30 7 C 2.3100 2.6674 0.0 0
M  V30 8 C 2.3100 5.3347 0.0 0
M  V30 9 C 0.7700 2.6674 0.0 0
M  V30 10 C 0.7700 5.3347 0.0 0
M  V30 11 C 0.0000 4.0011 0.0 0
M  V30 12 C 6.9300 5.3347 0.0 0
M  V30 13 C 7.7000 6.6685 0.0 0
M  V30 14 C 7.7000 4.0011 0.0 0
M  V30 15 C 9.2400 6.6685 0.0 0
M  V30 16 C 9.2400 4.0011 0.0 0
M  V30 17 C 10.0100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 12
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 7
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2-(phenoxymethyl)benzamide
C15H15NO2
1197766-63-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.0011 0.0 0
M  V30 2 O 3.0800 4.0011 0.0 0
M  V30 3 C 7.7000 4.0011 0.0 0
M  V30 4 N 9.2400 4.0011 0.0 0
M  V30 5 O 6.9300 5.3347 0.0 0
M  V30 6 C 10.0100 5.3347 0.0 0
M  V30 7 C 5.3900 2.6674 0.0 0
M  V30 8 C 6.9300 2.6674 0.0 0
M  V30 9 C 4.6200 1.3336 0.0 0
M  V30 10 C 7.7000 1.3336 0.0 0
M  V30 11 C 5.3900 0.0000 0.0 0
M  V30 12 C 6.9300 0.0000 0.0 0
M  V30 13 C 2.3100 5.3347 0.0 0
M  V30 14 C 3.0800 6.6685 0.0 0
M  V30 15 C 0.7700 5.3347 0.0 0
M  V30 16 C 2.3100 8.0021 0.0 0
M  V30 17 C 0.0000 6.6685 0.0 0
M  V30 18 C 0.7700 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 13
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 8
M  V30 7 1 4 6
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 21733-94-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1197766-63-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-20231789
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Chromium-catalyzed para-selective formation of quaternary carbon centers
by alkylation of benzamide derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liu, Pei; Chen, Changpeng; Cong, Xuefeng; Tang, Jinghua; Zeng, Xiaoming
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Nature Communications (2018), 9(1), 1-8

$RFMT $RIREG SCHEME268 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Chlorophenyl)-2-[(dimethylamino)methylene]-3-oxohexanamide
C15H19ClN2O2
2197964-36-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 5.3347 0.0 0
M  V30 2 C 4.6200 5.3347 0.0 0
M  V30 3 C 2.3100 4.0011 0.0 0
M  V30 4 C 2.3100 6.6685 0.0 0
M  V30 5 N 5.3900 6.6685 0.0 0
M  V30 6 O 5.3900 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 O 0.7700 4.0011 0.0 0
M  V30 9 N 0.7700 6.6685 0.0 0
M  V30 10 C 2.3100 1.3336 0.0 0
M  V30 11 C 0.0000 5.3347 0.0 0
M  V30 12 C 0.0000 8.0021 0.0 0
M  V30 13 C 3.0800 0.0000 0.0 0
M  V30 14 Cl 11.5500 6.6685 0.0 0
M  V30 15 C 6.9300 6.6685 0.0 0
M  V30 16 C 7.7000 8.0021 0.0 0
M  V30 17 C 7.7000 5.3347 0.0 0
M  V30 18 C 9.2400 8.0021 0.0 0
M  V30 19 C 9.2400 5.3347 0.0 0
M  V30 20 C 10.0100 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4 CFG=2
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 4 9
M  V30 9 1 5 15
M  V30 10 1 7 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 1 14 20
M  V30 15 2 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 2 17 19
M  V30 19 2 18 20
M  V30 20 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Hexanamide, N-(4-chlorophenyl)-2-[(methylamino)methylene]-3-oxo-
C14H17ClN2O2
2197964-25-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0022 3.8501 0.0 0
M  V30 2 C 6.6685 4.6201 0.0 0
M  V30 3 C 9.3360 4.6201 0.0 0
M  V30 4 C 8.0022 2.3101 0.0 0
M  V30 5 N 5.3348 3.8501 0.0 0
M  V30 6 O 6.6685 6.1601 0.0 0
M  V30 7 C 10.6697 3.8501 0.0 0
M  V30 8 O 9.3360 6.1601 0.0 0
M  V30 9 N 9.3360 1.5400 0.0 0
M  V30 10 C 12.0033 4.6201 0.0 0
M  V30 11 C 9.3360 0.0000 0.0 0
M  V30 12 C 13.3370 3.8501 0.0 0
M  V30 13 Cl 0.0000 6.9302 0.0 0
M  V30 14 C 4.0010 4.6201 0.0 0
M  V30 15 C 2.6673 3.8501 0.0 0
M  V30 16 C 4.0010 6.1601 0.0 0
M  V30 17 C 1.3337 4.6201 0.0 0
M  V30 18 C 2.6673 6.9302 0.0 0
M  V30 19 C 1.3337 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4 CFG=2
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 4 9
M  V30 9 1 5 14
M  V30 10 1 7 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 13 19
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2197964-36-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2197964-25-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-18916614
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-14-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM PIFA-Mediated Oxidative Cyclization Reactions of α-Acyl Acrylamides: A
Synthetic Route to Substituted Isoxazol-3(2H)-ones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yuan, Jingwen; Rao, Chitturi Bhujanga; Zhang, Qian; Zhang, Rui; Liang,
Yongjiu; Zhang, Ning; Dong, Dewen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2018), 50(9), 1875-1882

$RFMT $RIREG SCHEME269 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Chloromethyl)-2-(4-fluorophenyl)oxazole
C10H7ClFNO
22091-39-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.7758 3.0089 0.0 0
M  V30 2 Cl 11.1826 2.3825 0.0 0
M  V30 3 F 0.0000 1.3336 0.0 0
M  V30 4 C 6.1600 1.3336 0.0 0
M  V30 5 N 7.0652 2.5795 0.0 0
M  V30 6 O 7.0652 0.0878 0.0 0
M  V30 7 C 8.5298 2.1037 0.0 0
M  V30 8 C 8.5298 0.5636 0.0 0
M  V30 9 C 4.6200 1.3336 0.0 0
M  V30 10 C 3.8500 0.0000 0.0 0
M  V30 11 C 3.8500 2.6673 0.0 0
M  V30 12 C 2.3100 0.0000 0.0 0
M  V30 13 C 2.3100 2.6673 0.0 0
M  V30 14 C 1.5400 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 3 14
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 9
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 8
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(4-Fluorophenyl)-N-methyl-4-oxazolemethanamine
C11H11FN2O
1482124-84-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.7757 3.0089 0.0 0
M  V30 2 N 11.1826 2.3824 0.0 0
M  V30 3 C 12.4285 3.2876 0.0 0
M  V30 4 F 0.0000 1.3336 0.0 0
M  V30 5 C 6.1600 1.3336 0.0 0
M  V30 6 N 7.0652 2.5795 0.0 0
M  V30 7 O 7.0652 0.0878 0.0 0
M  V30 8 C 8.5298 2.1037 0.0 0
M  V30 9 C 8.5298 0.5636 0.0 0
M  V30 10 C 4.6200 1.3336 0.0 0
M  V30 11 C 3.8500 2.6673 0.0 0
M  V30 12 C 3.8500 0.0000 0.0 0
M  V30 13 C 2.3100 2.6673 0.0 0
M  V30 14 C 2.3100 0.0000 0.0 0
M  V30 15 C 1.5400 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 4 15
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 10
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 22091-39-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1482124-84-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24398634
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structural and Activity Relationships of
6-Sulfonyl-8-Nitrobenzothiazinones as Antitubercular Agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fan, Dongguang; Wang, Bin; Stelitano, Giovanni; Savkova, Karin; Shi, Rui;
Huszar, Stanislav; Han, Quanquan; Mikusova, Katarina; Chiarelli, Laurent
R.; Lu, Yu; Qiao, Chunhua
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2021), 64(19), 14526-14539

$RFMT $RIREG SCHEME270 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3aR,8aR)-3,3a,8,8a-Tetrahydro-3a,8-bis(3-methyl-2-buten-1-yl)-2H-furo[2,...
C20H25NO2
221230-14-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 4.5411 0.0 0
M  V30 2 C 2.6673 3.7711 0.0 0
M  V30 3 C 1.3337 4.5411 0.0 0
M  V30 4 C 1.3337 6.0811 0.0 0
M  V30 5 C 0.0000 3.7711 0.0 0
M  V30 6 C 9.3193 3.7113 0.0 0
M  V30 7 C 10.3497 4.8558 0.0 0
M  V30 8 C 11.8562 4.5357 0.0 0
M  V30 9 C 12.8866 5.6801 0.0 0
M  V30 10 C 12.3320 3.0710 0.0 0
M  V30 11 O 4.0467 0.0000 0.0 0
M  V30 12 C 5.3348 3.7711 0.0 0 CFG=2
M  V30 13 C 6.6685 3.0010 0.0 0 CFG=2
M  V30 14 C 5.6550 5.2775 0.0 0
M  V30 15 C 4.1902 2.7406 0.0 0
M  V30 16 N 7.8130 4.0316 0.0 0
M  V30 17 O 6.3483 1.4947 0.0 0
M  V30 18 C 7.1865 5.4384 0.0 0
M  V30 19 C 4.7497 6.5234 0.0 0
M  V30 20 C 4.8167 1.3338 0.0 0
M  V30 21 C 7.8130 6.8454 0.0 0
M  V30 22 C 5.3762 7.9302 0.0 0
M  V30 23 C 6.9078 8.0913 0.0 0
M  V30 24 H 8.0021 2.2310 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 12 1 CFG=3
M  V30 3 2 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 16
M  V30 8 2 7 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 11 20
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 15 1 13 16
M  V30 16 1 13 17
M  V30 17 1 13 24 CFG=3
M  V30 18 1 14 18
M  V30 19 2 14 19
M  V30 20 1 15 20
M  V30 21 1 16 18
M  V30 22 1 17 20
M  V30 23 2 18 21
M  V30 24 1 19 22
M  V30 25 1 21 23
M  V30 26 2 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 12 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-(3aR,8aR)-3,3a,8,8a-Tetrahydro-1-methyl-3a,8-bis(3-methyl-2-buten-1-yl)py...
C21H28N2O
161991-18-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 4.5411 0.0 0
M  V30 2 C 2.6673 3.7711 0.0 0
M  V30 3 C 1.3337 4.5411 0.0 0
M  V30 4 C 1.3337 6.0811 0.0 0
M  V30 5 C 0.0000 3.7711 0.0 0
M  V30 6 C 9.3193 3.7115 0.0 0
M  V30 7 C 10.3497 4.8559 0.0 0
M  V30 8 C 11.8562 4.5357 0.0 0
M  V30 9 C 12.8866 5.6801 0.0 0
M  V30 10 C 12.3321 3.0710 0.0 0
M  V30 11 C 7.3787 0.3502 0.0 0
M  V30 12 O 4.0467 0.0000 0.0 0
M  V30 13 C 5.3348 3.7711 0.0 0 CFG=2
M  V30 14 C 6.6685 3.0010 0.0 0 CFG=2
M  V30 15 C 5.6550 5.2775 0.0 0
M  V30 16 C 4.1903 2.7406 0.0 0
M  V30 17 N 7.8130 4.0316 0.0 0
M  V30 18 N 6.3483 1.4947 0.0 0
M  V30 19 C 7.1865 5.4384 0.0 0
M  V30 20 C 4.7497 6.5234 0.0 0
M  V30 21 C 4.8167 1.3338 0.0 0
M  V30 22 C 7.8130 6.8454 0.0 0
M  V30 23 C 5.3762 7.9302 0.0 0
M  V30 24 C 6.9078 8.0913 0.0 0
M  V30 25 H 8.0021 2.2310 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 13 1 CFG=3
M  V30 3 2 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 17
M  V30 8 2 7 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 11 18
M  V30 12 2 12 21
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 16 1 14 17
M  V30 17 1 14 18
M  V30 18 1 14 25 CFG=3
M  V30 19 1 15 19
M  V30 20 2 15 20
M  V30 21 1 16 21
M  V30 22 1 17 19
M  V30 23 1 18 21
M  V30 24 2 19 22
M  V30 25 1 20 23
M  V30 26 1 22 24
M  V30 27 2 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 13 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 221230-14-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 161991-18-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-13904138
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for Lactamization. To a
solution of the appropriate lactone 16a (0.32 mmol), 17a (0.32 mmol), 16b
(0.23 mmol), or 17b (0.23 mmol) in MeOH (10 mL) was added NH2Me (2 mL of
a 2.0 M solution in MeOH, 4 mmol). The reaction mixture was stirred for
5, 2, 24, or 15 h, respectively, at rt. The mixture was evaporated, and
the resultant crude lactam 18, 3, 19, or 4 was purified by silica gel
flash column chromatography (1:1 EtOAc/hexane).
1-Methyl-3a,8-bis(3-methyl-2-buten-1-yl)-2-oxo-2,3,3a,-8a-tetrahydro-8H-pyrrolo[2,3-b]indole,
Debromoflustramide B (19). Prepared from 17a as a colorless oil (96 mg,
92% yield): Rf 0.43 (1:1 EtOAc/hexane); IR (CHCl3) νmax 2930, 1678, 1604,
1488 cm-1; 1H NMR (DMSO-d6) δ 7.08 (1H, br d, J = 8.0 Hz), 7.06 (1H, td,
J = 7.9, 1.3 Hz), 6.68 (1H, td, J = 7.8, 0.8 Hz), 6.53 (1H, br d, J = 7.8
Hz), 5.20 (1H, br t, J = 6.8 Hz), 4.98 (1H, br t, J = 7.4 Hz), 4.80 (1H,
s), 4.07 (1H, dd, J = 15.7, 6.7 Hz), 3.91 (1H, dd, J = 16.1, 7.1 Hz),
2.75 (3H, s), 2.68 (1H, d, J = 17.1 Hz), 2.47 (1H, d, J = 17.1 Hz), 2.38
(1H, dd, J = 14.6, 7.8 Hz), 2.30 (1H, dd, J = 14.8, 6.8 Hz), 1.72 (3H,
s), 1.70 (3H, s), 1.65 (3H, s), 1.51 (3H, s); 13C NMR (DMSO-d6) δ 171.5,
149.0, 135.2, 134.4, 134.3, 128.3, 123.2, 121.0, 119.1, 118.3, 108.5,
86.2, 49.4, 45.9, 41.4, 36.9, 27.2, 25.7, 25.4, 17.8 (2C); EIMS m/z
(relative intensity) 324 (M+, 38), 187 (100); HRMS (FAB) m/e 324.2201
(M+, C21H28N2O requires 324.2202).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Total syntheses of five indole alkaloids from the marine bryozoan Flustra
foliacea
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Morales-Rios, Martha S.; Suarez-Castillo, Oscar R.; Trujillo-Serrato,
Joel J.; Joseph-Nathan, Pedro
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2001), 66(4), 1186-1192

$RFMT $RIREG SCHEME271 STEP1
$RXN



  2  1
$MOL
(2S)-3-[[(1R)-4-(Methoxymethoxy)-1-[[(4-methylphenyl)sulfonyl]amino]butyl]dip...
C29H37NO6SSi
2222584-87-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 40 0 0 1
M  V30 BEGIN ATOM
M  V30 1 Si 5.3348 9.2402 0.0 0
M  V30 2 C 6.6685 8.4702 0.0 0 CFG=2
M  V30 3 C 4.0010 10.0102 0.0 0
M  V30 4 N 8.0022 9.2402 0.0 0
M  V30 5 C 6.6685 6.9302 0.0 0
M  V30 6 C 2.6673 9.2402 0.0 0 CFG=1
M  V30 7 S 9.3358 8.4702 0.0 0 VAL=6
M  V30 8 C 8.0022 6.1601 0.0 0
M  V30 9 C 1.3337 10.0102 0.0 0
M  V30 10 C 2.6673 7.7002 0.0 0
M  V30 11 O 10.1059 9.8039 0.0 0
M  V30 12 O 8.5658 7.1364 0.0 0
M  V30 13 C 8.0022 4.6201 0.0 0
M  V30 14 O 0.0000 9.2402 0.0 0
M  V30 15 O 1.3337 11.5503 0.0 0
M  V30 16 O 9.3358 3.8501 0.0 0
M  V30 17 C 9.3358 2.3101 0.0 0
M  V30 18 O 10.6697 1.5400 0.0 0
M  V30 19 C 10.6697 0.0000 0.0 0
M  V30 20 C 14.6707 5.3901 0.0 0
M  V30 21 C 4.9361 7.7525 0.0 0
M  V30 22 C 3.4486 7.3540 0.0 0
M  V30 23 C 6.0251 6.6636 0.0 0
M  V30 24 C 3.0500 5.8664 0.0 0
M  V30 25 C 5.6265 5.1761 0.0 0
M  V30 26 C 4.1390 4.7775 0.0 0
M  V30 27 C 6.1048 10.5739 0.0 0
M  V30 28 C 5.3348 11.9075 0.0 0
M  V30 29 C 7.6449 10.5739 0.0 0
M  V30 30 C 6.1048 13.2412 0.0 0
M  V30 31 C 8.4149 11.9075 0.0 0
M  V30 32 C 7.6449 13.2412 0.0 0
M  V30 33 C 10.6697 7.7002 0.0 0
M  V30 34 C 12.0033 8.4702 0.0 0
M  V30 35 C 10.6697 6.1601 0.0 0
M  V30 36 C 13.3370 7.7002 0.0 0
M  V30 37 C 12.0033 5.3901 0.0 0
M  V30 38 C 13.3370 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 21
M  V30 4 1 1 27
M  V30 5 1 2 4
M  V30 6 1 2 5 CFG=1
M  V30 7 1 3 6
M  V30 8 1 4 7
M  V30 9 1 5 8
M  V30 10 1 6 9
M  V30 11 1 6 10 CFG=1
M  V30 12 2 7 11
M  V30 13 2 7 12
M  V30 14 1 7 33
M  V30 15 1 8 13
M  V30 16 1 9 14
M  V30 17 2 9 15
M  V30 18 1 13 16
M  V30 19 1 16 17
M  V30 20 1 17 18
M  V30 21 1 18 19
M  V30 22 1 20 38
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 35 2 33 34
M  V30 36 1 33 35
M  V30 37 1 34 36
M  V30 38 2 35 37
M  V30 39 2 36 38
M  V30 40 1 37 38
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 2 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2S)-3-[[(1R)-4-(Methoxymethoxy)-1-[[(4-methylphenyl)sulfonyl]amino]butyl]dip...
C30H40N2O5SSi
2222584-88-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 41 0 0 1
M  V30 BEGIN ATOM
M  V30 1 Si 10.0100 4.6200 0.0 0
M  V30 2 C 8.4700 4.6200 0.0 0 CFG=2
M  V30 3 C 11.5500 4.6200 0.0 0
M  V30 4 N 7.7000 3.2864 0.0 0
M  V30 5 C 7.7000 5.9538 0.0 0
M  V30 6 C 12.3200 5.9538 0.0 0 CFG=1
M  V30 7 S 6.1600 3.2864 0.0 0 VAL=6
M  V30 8 C 6.1600 5.9538 0.0 0
M  V30 9 C 13.8600 5.9538 0.0 0
M  V30 10 C 11.5500 7.2874 0.0 0
M  V30 11 O 6.1600 4.8264 0.0 0
M  V30 12 O 6.1600 1.7464 0.0 0
M  V30 13 C 5.3900 7.2874 0.0 0
M  V30 14 N 14.6300 7.2874 0.0 0
M  V30 15 O 14.6300 4.6200 0.0 0
M  V30 16 O 3.8500 7.2874 0.0 0
M  V30 17 C 16.1700 7.2874 0.0 0
M  V30 18 C 3.0800 8.6211 0.0 0
M  V30 19 O 1.5400 8.6211 0.0 0
M  V30 20 C 0.7700 9.9549 0.0 0
M  V30 21 C 0.0000 3.2864 0.0 0
M  V30 22 C 9.6114 6.1076 0.0 0
M  V30 23 C 10.7004 7.1966 0.0 0
M  V30 24 C 8.1240 6.5062 0.0 0
M  V30 25 C 10.3018 8.6841 0.0 0
M  V30 26 C 7.7253 7.9937 0.0 0
M  V30 27 C 8.8142 9.0826 0.0 0
M  V30 28 C 10.0100 3.0800 0.0 0
M  V30 29 C 11.3436 2.3100 0.0 0
M  V30 30 C 8.6764 2.3100 0.0 0
M  V30 31 C 11.3436 0.7700 0.0 0
M  V30 32 C 8.6764 0.7700 0.0 0
M  V30 33 C 10.0100 0.0000 0.0 0
M  V30 34 C 4.6200 3.2864 0.0 0
M  V30 35 C 3.8500 4.6200 0.0 0
M  V30 36 C 3.8500 1.9527 0.0 0
M  V30 37 C 2.3100 4.6200 0.0 0
M  V30 38 C 2.3100 1.9527 0.0 0
M  V30 39 C 1.5400 3.2864 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 22
M  V30 4 1 1 28
M  V30 5 1 2 4
M  V30 6 1 2 5 CFG=1
M  V30 7 1 3 6
M  V30 8 1 4 7
M  V30 9 1 5 8
M  V30 10 1 6 9
M  V30 11 1 6 10 CFG=1
M  V30 12 2 7 11
M  V30 13 2 7 12
M  V30 14 1 7 34
M  V30 15 1 8 13
M  V30 16 1 9 14
M  V30 17 2 9 15
M  V30 18 1 13 16
M  V30 19 1 14 17
M  V30 20 1 16 18
M  V30 21 1 18 19
M  V30 22 1 19 20
M  V30 23 1 21 39
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 36 2 34 35
M  V30 37 1 34 36
M  V30 38 1 35 37
M  V30 39 2 36 38
M  V30 40 2 37 39
M  V30 41 1 38 39
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 2 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2222584-87-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2222584-88-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-18795900
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-02-4
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 543-27-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Asymmetric synthesis of silanediol inhibitors for the serine protease
coagulation cascade enzyme FXIa
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Duong, Hoan Q.; Sieburth, Scott McN.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2018), 83(10), 5398-5409

$RFMT $RIREG SCHEME272 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Thiobenzamide
C7H7NS
2227-79-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 N 0.0000 2.6673 0.0 0
M  V30 3 S 0.0000 0.0000 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 0.0000 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 4.6201 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methylbenzenecarbothioamide
C8H9NS
5310-14-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 N 5.3901 2.6673 0.0 0
M  V30 3 S 5.3901 0.0000 0.0 0
M  V30 4 C 6.9302 2.6673 0.0 0
M  V30 5 C 3.0801 1.3337 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 2.3101 0.0000 0.0 0
M  V30 8 C 0.7700 2.6673 0.0 0
M  V30 9 C 0.7700 0.0000 0.0 0
M  V30 10 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2227-79-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 5310-14-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-033-CAS-6626413
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General procedure for the synthesis of N-methylthioamide 6. Primary
thioamide 5 (0.005 mol) was dissolved in 33% methylamine in absolute
ethanol (10 mL) and the solution allowed to stand for three days at room
temperature until the substrate was consumed, as followed by TLC, and
then the solution was concentrated in vacuo. The oily residue was
solidified upon treatment of ice-water or keeping the flask in the
refrigerator until encrustation occurred to give pure sample 6. It can be
also purified by column chromatography on silica gel (100-200 mesh, 18:1
chloroform-methanol) and recrystallized from aqueous isopropanol.
Considerable recovery of starting material 5a was observed when the
reaction was carried out in 33% dimethylamine in absolute ethanol under
conditions analogous to those used above. N-Methyl(thiobenzamide) (6a).
92%. mp 77-78 °C (lit. [26] 79 °C); IR v (cm-1): 3315, 3063, 2997, 2950,
2923, 1539, 1489, 1457, 1437, 1394, 1358, 1317, 1287,1240,1045; 1H NMRδ
(ppm): 3.15 (d, 3H, J = 4.7 Hz, CH3), 7.36-7.53 (m,3H), 7.78 (d,2H, J =
8.2 Hz), 10.29 (brs, 1H, NH); 13C NMR δ (ppm): 33.6, 127.2, 128.1, 130.7,
141.0, 197.6; LRMS (EI): 151 (100), 150 (72), 121 (68), 118 (20),
117(16); HRMS (EI): M+•, found 151.0447. C8H9NS requires 151.0456.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Convenient syntheses of N-methylthioamides: a migration of the H2S
molecule in the thioamide-nitrile system
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Spychala, Jaroslaw
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Sulfur Chemistry (2006), 27(3), 203-212

$RFMT $RIREG SCHEME273 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
trans-4-[6-Chloro-2-[(1R)-1-hydroxyethyl]-1H-imidazo[4,5-c]pyridin-1-yl]cyclo...
C16H19ClN4O
2235403-93-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.0849 7.9996 0.0 0 CFG=2
M  V30 2 C 2.0545 9.1440 0.0 0
M  V30 3 O 4.5914 8.3197 0.0 0
M  V30 4 Cl 2.1050 0.0000 0.0 0
M  V30 5 C 9.6743 5.2890 0.0 0
M  V30 6 C 10.4443 3.9554 0.0 0
M  V30 7 N 11.2143 2.6217 0.0 0
M  V30 8 N 3.5143 5.2890 0.0 0
M  V30 9 C 2.6091 4.0431 0.0 0
M  V30 10 C 2.6091 6.5349 0.0 0
M  V30 11 C 1.1445 4.5190 0.0 0
M  V30 12 C 2.9292 2.5367 0.0 0
M  V30 13 N 1.1445 6.0590 0.0 0
M  V30 14 C 0.0000 3.4886 0.0 0
M  V30 15 C 1.7849 1.5063 0.0 0
M  V30 16 N 0.3202 1.9821 0.0 0
M  V30 17 C 5.0543 5.2890 0.0 0 CFG=2
M  V30 18 C 5.8243 6.6226 0.0 0
M  V30 19 C 5.8243 3.9554 0.0 0
M  V30 20 C 7.3643 6.6226 0.0 0
M  V30 21 C 7.3643 3.9554 0.0 0
M  V30 22 C 8.1343 5.2890 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 10
M  V30 4 1 4 15
M  V30 5 1 5 6
M  V30 6 1 22 5 CFG=3
M  V30 7 3 6 7
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 17 8 CFG=1
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 2 10 13
M  V30 14 1 11 13
M  V30 15 2 11 14
M  V30 16 1 12 15
M  V30 17 1 14 16
M  V30 18 2 15 16
M  V30 19 1 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 1 17 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
trans-4-[2-[(1R)-1-Hydroxyethyl]-6-(methylamino)-1H-imidazo[4,5-c]pyridin-1-y...
C17H23N5O
2235403-69-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 9.2446 0.0 0 CFG=2
M  V30 2 C 0.2064 10.0146 0.0 0
M  V30 3 O 2.8738 10.0146 0.0 0
M  V30 4 N 3.0800 1.3338 0.0 0
M  V30 5 C 2.3100 0.0000 0.0 0
M  V30 6 C 8.6445 8.7030 0.0 0
M  V30 7 C 9.7889 7.6724 0.0 0
M  V30 8 N 10.9334 6.6420 0.0 0
M  V30 9 N 2.7860 6.7994 0.0 0
M  V30 10 C 2.3100 5.3347 0.0 0
M  V30 11 C 1.5400 7.7046 0.0 0
M  V30 12 C 0.7700 5.3347 0.0 0
M  V30 13 C 3.0800 4.0011 0.0 0
M  V30 14 N 0.2941 6.7994 0.0 0
M  V30 15 C 0.0000 4.0011 0.0 0
M  V30 16 C 2.3100 2.6674 0.0 0
M  V30 17 N 0.7700 2.6674 0.0 0
M  V30 18 C 4.2506 7.2753 0.0 0 CFG=2
M  V30 19 C 5.3951 6.2449 0.0 0
M  V30 20 C 4.5707 8.7817 0.0 0
M  V30 21 C 6.8596 6.7207 0.0 0
M  V30 22 C 6.0354 9.2576 0.0 0
M  V30 23 C 7.1798 8.2270 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 11
M  V30 4 1 4 5
M  V30 5 1 4 16
M  V30 6 1 6 7
M  V30 7 1 23 6 CFG=1
M  V30 8 3 7 8
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 18 9 CFG=3
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 2 11 14
M  V30 15 1 12 14
M  V30 16 2 12 15
M  V30 17 1 13 16
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 20 1 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 1 18 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2235403-93-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2235403-69-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-20358622
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 865-48-5
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1536473-72-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM alternate method gave lower yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of novel amino-imidazopyridine derivatives as Janus kinase
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Larsen, Jens; Larsen, Mogens; Rasmussen, Lars Kyhn; Ritzen, Andreas;
Duus, Tine Marianne
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018130563 A1 2018-07-19

$RFMT $RIREG SCHEME274 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C19H18O6
2251807-36-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.2624 2.7246 0.0 0
M  V30 2 O 7.8871 5.2389 0.0 0
M  V30 3 C 9.4269 5.2171 0.0 0
M  V30 4 C 3.3920 2.7979 0.0 0 CFG=1
M  V30 5 C 2.4198 1.6036 0.0 0 CFG=2
M  V30 6 C 2.9918 4.2458 0.0 0 CFG=1
M  V30 7 C 4.8325 2.6365 0.0 0
M  V30 8 C 2.5566 4.0916 0.0 0
M  V30 9 C 0.6827 1.2332 0.0 0
M  V30 10 C 3.0484 0.1723 0.0 0
M  V30 11 O 0.9836 2.1591 0.0 0
M  V30 12 C 1.4658 4.5473 0.0 0
M  V30 13 O 4.3714 5.0306 0.0 0
M  V30 14 C 5.5432 3.9600 0.0 0
M  V30 15 C 5.5058 1.2779 0.0 0
M  V30 16 C 1.0680 3.6968 0.0 0
M  V30 17 C 0.4226 3.4193 0.0 0
M  V30 18 C 4.5867 0.0000 0.0 0
M  V30 19 O 2.3702 5.7936 0.0 0
M  V30 20 O 0.0009 5.0224 0.0 0
M  V30 21 C 7.0982 3.9164 0.0 0
M  V30 22 C 7.0584 1.2779 0.0 0
M  V30 23 C 1.4644 7.0390 0.0 0
M  V30 24 C 0.0000 6.5624 0.0 0
M  V30 25 C 7.8659 2.5855 0.0 0
M  V30 26 H 3.4103 5.7279 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 16
M  V30 2 1 2 3
M  V30 3 1 2 21
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 4 8 CFG=1
M  V30 8 1 5 9
M  V30 9 1 5 10
M  V30 10 1 5 11 CFG=1
M  V30 11 1 6 12
M  V30 12 1 6 13
M  V30 13 1 6 26 CFG=1
M  V30 14 1 7 14
M  V30 15 2 7 15
M  V30 16 1 8 16
M  V30 17 1 9 17
M  V30 18 2 10 18
M  V30 19 1 11 16
M  V30 20 1 12 17
M  V30 21 1 12 19
M  V30 22 1 12 20
M  V30 23 1 13 14
M  V30 24 2 14 21
M  V30 25 1 15 18
M  V30 26 1 15 22
M  V30 27 1 19 23
M  V30 28 1 20 24
M  V30 29 1 21 25
M  V30 30 2 22 25
M  V30 31 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 4 5 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C19H17BrO6
2251807-37-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.4547 7.4507 0.0 0
M  V30 2 Br 9.5078 6.9627 0.0 0
M  V30 3 O 5.0896 1.3225 0.0 0
M  V30 4 C 5.8784 0.0000 0.0 0
M  V30 5 C 4.9561 6.4359 0.0 0 CFG=2
M  V30 6 C 5.5043 7.8750 0.0 0 CFG=2
M  V30 7 C 5.8160 5.2690 0.0 0
M  V30 8 C 3.5021 6.0584 0.0 0 CFG=1
M  V30 9 C 3.4180 6.5126 0.0 0
M  V30 10 C 4.9564 9.5645 0.0 0
M  V30 11 C 7.0580 8.0462 0.0 0
M  V30 12 O 4.3050 8.8410 0.0 0
M  V30 13 C 5.0253 3.9918 0.0 0
M  V30 14 C 7.3292 5.3653 0.0 0
M  V30 15 C 2.4780 7.2293 0.0 0
M  V30 16 O 3.5122 4.4713 0.0 0
M  V30 17 C 3.0156 7.9989 0.0 0
M  V30 18 C 2.9332 8.6967 0.0 0
M  V30 19 C 7.9765 6.8002 0.0 0
M  V30 20 C 5.8405 2.6671 0.0 0
M  V30 21 C 8.1055 4.0206 0.0 0
M  V30 22 O 1.8507 5.8228 0.0 0
M  V30 23 O 1.3341 8.2604 0.0 0
M  V30 24 C 7.3769 2.6675 0.0 0
M  V30 25 C 0.3194 5.9847 0.0 0
M  V30 26 C 0.0000 7.4911 0.0 0
M  V30 27 H 2.4279 4.9550 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 17
M  V30 2 1 2 19
M  V30 3 1 3 4
M  V30 4 1 3 20
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 9 CFG=3
M  V30 9 1 6 10
M  V30 10 1 6 11
M  V30 11 1 6 12 CFG=3
M  V30 12 1 7 13
M  V30 13 2 7 14
M  V30 14 1 8 15
M  V30 15 1 8 16
M  V30 16 1 8 27 CFG=3
M  V30 17 1 9 17
M  V30 18 1 10 18
M  V30 19 2 11 19
M  V30 20 1 12 17
M  V30 21 1 13 16
M  V30 22 2 13 20
M  V30 23 1 14 19
M  V30 24 1 14 21
M  V30 25 1 15 18
M  V30 26 1 15 22
M  V30 27 1 15 23
M  V30 28 1 20 24
M  V30 29 2 21 24
M  V30 30 1 22 25
M  V30 31 1 23 26
M  V30 32 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 5 6 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C20H23NO6
2251807-38-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7071 3.5225 0.0 0
M  V30 2 C 7.0409 4.2925 0.0 0
M  V30 3 N 8.3746 3.5225 0.0 0
M  V30 4 O 7.0409 5.8325 0.0 0
M  V30 5 C 9.7082 4.2925 0.0 0
M  V30 6 O 0.0000 5.3783 0.0 0
M  V30 7 O 7.9562 6.4747 0.0 0
M  V30 8 C 9.0385 7.5701 0.0 0
M  V30 9 C 3.0398 5.0625 0.0 0 CFG=2
M  V30 10 C 3.7700 3.7496 0.0 0 CFG=1
M  V30 11 C 3.9535 6.1878 0.0 0
M  V30 12 C 1.5328 5.2296 0.0 0 CFG=1
M  V30 13 C 2.8934 2.4645 0.0 0
M  V30 14 O 5.3038 4.1577 0.0 0
M  V30 15 C 5.3884 5.7427 0.0 0
M  V30 16 C 3.4807 7.6285 0.0 0
M  V30 17 C 0.6942 3.9227 0.0 0
M  V30 18 C 0.9536 6.6934 0.0 0
M  V30 19 C 1.3588 2.5370 0.0 0
M  V30 20 O 4.4123 2.2102 0.0 0
M  V30 21 O 2.1824 1.0985 0.0 0
M  V30 22 C 6.4662 6.8643 0.0 0
M  V30 23 C 1.9293 7.8950 0.0 0
M  V30 24 C 4.5877 8.7174 0.0 0
M  V30 25 C 4.6399 0.6872 0.0 0
M  V30 26 C 3.2617 0.0000 0.0 0
M  V30 27 C 6.0803 8.3515 0.0 0
M  V30 28 H 5.5473 2.2741 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 9 1 CFG=3
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 12 6 CFG=3
M  V30 7 1 7 8
M  V30 8 1 7 22
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 14 1 10 28 CFG=3
M  V30 15 1 11 15
M  V30 16 2 11 16
M  V30 17 1 12 17
M  V30 18 1 12 18
M  V30 19 1 13 19
M  V30 20 1 13 20
M  V30 21 1 13 21
M  V30 22 1 14 15
M  V30 23 2 15 22
M  V30 24 1 16 23
M  V30 25 1 16 24
M  V30 26 1 17 19
M  V30 27 2 18 23
M  V30 28 1 20 25
M  V30 29 1 21 26
M  V30 30 1 22 27
M  V30 31 2 24 27
M  V30 32 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 9 10 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2251807-36-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 2251807-37-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2251807-38-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-22173762
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A desymmetrization-based approach to morphinans: application in the total
synthesis of oxycodone
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Park, Kun Ho; Chen, David Y.-K.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Communications (Cambridge, United Kingdom) (2018), 54(92),
13018-13021

$RFMT $RIREG SCHEME275 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(4-Chlorophenyl)methyl β-oxobenzenepropanoate
C16H13ClO3
2304416-41-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 O 4.0010 0.0000 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 O 8.0022 2.3101 0.0 0
M  V30 6 O 6.6685 0.0000 0.0 0
M  V30 7 C 9.3358 1.5400 0.0 0
M  V30 8 Cl 14.6707 4.6201 0.0 0
M  V30 9 C 2.6673 2.3101 0.0 0
M  V30 10 C 2.6673 3.8501 0.0 0
M  V30 11 C 1.3337 1.5400 0.0 0
M  V30 12 C 1.3337 4.6201 0.0 0
M  V30 13 C 0.0000 2.3101 0.0 0
M  V30 14 C 0.0000 3.8501 0.0 0
M  V30 15 C 10.6697 2.3101 0.0 0
M  V30 16 C 12.0033 1.5400 0.0 0
M  V30 17 C 10.6697 3.8501 0.0 0
M  V30 18 C 13.3370 2.3101 0.0 0
M  V30 19 C 12.0033 4.6201 0.0 0
M  V30 20 C 13.3370 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 7 15
M  V30 9 1 8 20
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(4-Chlorophenyl)methyl (2Z)-3-(methylamino)-3-phenyl-2-propenoate
C17H16ClNO2
2304416-27-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 2.3101 0.0 0
M  V30 2 C 5.3348 3.0801 0.0 0
M  V30 3 N 4.0010 0.7700 0.0 0
M  V30 4 C 6.6685 2.3101 0.0 0
M  V30 5 C 2.6673 0.0000 0.0 0
M  V30 6 O 8.0022 3.0801 0.0 0
M  V30 7 O 6.6685 0.7700 0.0 0
M  V30 8 C 9.3358 2.3101 0.0 0
M  V30 9 Cl 14.6707 5.3901 0.0 0
M  V30 10 C 2.6673 3.0801 0.0 0
M  V30 11 C 1.3337 2.3101 0.0 0
M  V30 12 C 2.6673 4.6201 0.0 0
M  V30 13 C 0.0000 3.0801 0.0 0
M  V30 14 C 1.3337 5.3901 0.0 0
M  V30 15 C 0.0000 4.6201 0.0 0
M  V30 16 C 10.6697 3.0801 0.0 0
M  V30 17 C 10.6697 4.6201 0.0 0
M  V30 18 C 12.0033 2.3101 0.0 0
M  V30 19 C 12.0033 5.3901 0.0 0
M  V30 20 C 13.3370 3.0801 0.0 0
M  V30 21 C 13.3370 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 6 8
M  V30 9 1 8 16
M  V30 10 1 9 21
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2304416-41-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2304416-27-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-19946819
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of Functionalized Imidazolium Salts via Iodine-Mediated
Annulations of Enamines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xia, Biao; Chen, Wenjun; Zhao, Qiongli; Yu, Wenquan; Chang, Junbiao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2019), 21(8), 2583-2587

$RFMT $RIREG SCHEME276 STEP1
$RXN



  2  1
$MOL
2-[3-[[4-(1,1-Dimethylethyl)benzoyl]amino]phenyl]-4-[[4-(4-morpholinyl)phenyl...
C31H32N4O4S
2306045-94-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 44 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 7.6363 2.5803 0.0 0
M  V30 2 C 10.5378 0.9052 0.0 0
M  V30 3 O 9.2919 0.0000 0.0 0
M  V30 4 O 11.9448 0.2787 0.0 0
M  V30 5 N 15.5150 7.5414 0.0 0
M  V30 6 C 16.2850 8.8751 0.0 0
M  V30 7 O 15.5150 10.2089 0.0 0
M  V30 8 C 22.4450 8.8751 0.0 0
M  V30 9 C 22.4450 10.4151 0.0 0
M  V30 10 C 23.9850 8.8751 0.0 0
M  V30 11 C 22.4450 7.3351 0.0 0
M  V30 12 C 10.8949 4.8741 0.0 0
M  V30 13 N 9.3634 4.7130 0.0 0
M  V30 14 S 11.5213 3.4672 0.0 0
M  V30 15 C 9.0432 3.2068 0.0 0
M  V30 16 C 10.3769 2.4368 0.0 0
M  V30 17 C 11.6649 6.2078 0.0 0
M  V30 18 C 13.2050 6.2078 0.0 0
M  V30 19 C 10.8949 7.5414 0.0 0
M  V30 20 C 13.9750 7.5414 0.0 0
M  V30 21 C 11.6649 8.8751 0.0 0
M  V30 22 C 13.2050 8.8751 0.0 0
M  V30 23 C 6.3904 3.4855 0.0 0
M  V30 24 C 6.5513 5.0170 0.0 0
M  V30 25 C 4.9836 2.8592 0.0 0
M  V30 26 C 5.3055 5.9223 0.0 0
M  V30 27 C 3.7376 3.7644 0.0 0
M  V30 28 C 3.8987 5.2959 0.0 0
M  V30 29 C 17.8250 8.8751 0.0 0
M  V30 30 C 18.5950 7.5414 0.0 0
M  V30 31 C 18.5950 10.2089 0.0 0
M  V30 32 C 20.1350 7.5414 0.0 0
M  V30 33 C 20.1350 10.2089 0.0 0
M  V30 34 C 20.9050 8.8751 0.0 0
M  V30 35 N 2.6528 6.2011 0.0 0
M  V30 36 C 1.2459 5.5747 0.0 0
M  V30 37 C 2.8137 7.7327 0.0 0
M  V30 38 C 0.0000 6.4799 0.0 0
M  V30 39 C 1.5679 8.6379 0.0 0
M  V30 40 O 0.1609 8.0116 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 15
M  V30 2 1 1 23
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 16
M  V30 6 1 5 6
M  V30 7 1 5 20
M  V30 8 2 6 7
M  V30 9 1 6 29
M  V30 10 1 8 9
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 1 8 34
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 12 17
M  V30 17 1 13 15
M  V30 18 1 14 16
M  V30 19 2 15 16
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 32 1 28 35
M  V30 33 2 29 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 31 33
M  V30 37 2 32 34
M  V30 38 1 33 34
M  V30 39 1 35 36
M  V30 40 1 35 37
M  V30 41 1 36 38
M  V30 42 1 37 39
M  V30 43 1 38 40
M  V30 44 1 39 40
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[3-[[4-(1,1-Dimethylethyl)benzoyl]amino]phenyl]-N-methyl-4-[[4-(4-morpholin...
C32H35N5O3S
2306046-24-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 45 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 7.6363 3.8332 0.0 0
M  V30 2 C 10.5378 2.1580 0.0 0
M  V30 3 N 11.9448 1.5315 0.0 0
M  V30 4 O 9.2919 1.2528 0.0 0
M  V30 5 C 12.1057 0.0000 0.0 0
M  V30 6 N 15.5150 8.7942 0.0 0
M  V30 7 C 16.2850 10.1280 0.0 0
M  V30 8 O 15.5150 11.4617 0.0 0
M  V30 9 C 22.4450 10.1280 0.0 0
M  V30 10 C 23.2150 8.7942 0.0 0
M  V30 11 C 23.9850 10.1280 0.0 0
M  V30 12 C 23.2150 11.4617 0.0 0
M  V30 13 C 9.0432 4.4596 0.0 0
M  V30 14 C 10.3769 3.6896 0.0 0
M  V30 15 N 9.3634 5.9660 0.0 0
M  V30 16 S 11.5213 4.7200 0.0 0
M  V30 17 C 10.8949 6.1269 0.0 0
M  V30 18 C 6.3904 4.7384 0.0 0
M  V30 19 C 6.5513 6.2700 0.0 0
M  V30 20 C 4.9836 4.1120 0.0 0
M  V30 21 C 5.3055 7.1752 0.0 0
M  V30 22 C 3.7376 5.0172 0.0 0
M  V30 23 C 3.8987 6.5487 0.0 0
M  V30 24 C 11.6649 7.4606 0.0 0
M  V30 25 C 13.2050 7.4606 0.0 0
M  V30 26 C 10.8949 8.7942 0.0 0
M  V30 27 C 13.9750 8.7942 0.0 0
M  V30 28 C 11.6649 10.1280 0.0 0
M  V30 29 C 13.2050 10.1280 0.0 0
M  V30 30 N 2.6528 7.4539 0.0 0
M  V30 31 C 2.8137 8.9855 0.0 0
M  V30 32 C 1.2459 6.8276 0.0 0
M  V30 33 C 1.5679 9.8907 0.0 0
M  V30 34 C 0.0000 7.7328 0.0 0
M  V30 35 O 0.1609 9.2644 0.0 0
M  V30 36 C 17.8250 10.1280 0.0 0
M  V30 37 C 18.5950 8.7942 0.0 0
M  V30 38 C 18.5950 11.4617 0.0 0
M  V30 39 C 20.1350 8.7942 0.0 0
M  V30 40 C 20.1350 11.4617 0.0 0
M  V30 41 C 20.9050 10.1280 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 14
M  V30 6 1 3 5
M  V30 7 1 6 7
M  V30 8 1 6 27
M  V30 9 2 7 8
M  V30 10 1 7 36
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 1 9 12
M  V30 14 1 9 41
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 20 1 17 24
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 27 1 23 30
M  V30 28 2 24 25
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 2 26 28
M  V30 32 2 27 29
M  V30 33 1 28 29
M  V30 34 1 30 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 1 34 35
M  V30 40 2 36 37
M  V30 41 1 36 38
M  V30 42 1 37 39
M  V30 43 2 38 40
M  V30 44 2 39 41
M  V30 45 1 40 41
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2306045-94-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2306046-24-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-20309554
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 156311-83-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery and structure-activity relationship of novel diphenylthiazole
derivatives as BTK inhibitor with potent activity against B cell lymphoma
cell lines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Guo, Xiaofeng; Yang, Dongyan; Fan, Zhijin; Zhang, Nailou; Zhao, Bin;
Huang, Chun; Wang, Fangjie; Ma, Rongji; Meng, Meng; Deng, Youcai
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2019), 178767-781

$RFMT $RIREG SCHEME277 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 2-chloro-3-pyridinecarboxylate
C10H12ClNO2
232951-83-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 O 5.3901 4.0010 0.0 0
M  V30 3 O 5.3901 1.3337 0.0 0
M  V30 4 C 6.9301 4.0010 0.0 0
M  V30 5 C 6.9301 5.5410 0.0 0
M  V30 6 C 8.4701 4.0010 0.0 0
M  V30 7 C 6.9301 2.4609 0.0 0
M  V30 8 Cl 3.0800 0.0000 0.0 0
M  V30 9 C 3.0800 2.6673 0.0 0
M  V30 10 C 2.3100 1.3337 0.0 0
M  V30 11 C 2.3100 4.0010 0.0 0
M  V30 12 N 0.7700 1.3337 0.0 0
M  V30 13 C 0.7700 4.0010 0.0 0
M  V30 14 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 10
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 2-(methylamino)-3-pyridinecarboxylate
C11H16N2O2
338990-70-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.0011 0.0 0
M  V30 2 O 5.3900 5.3349 0.0 0
M  V30 3 O 5.3900 2.6674 0.0 0
M  V30 4 C 6.9300 5.3349 0.0 0
M  V30 5 C 6.9300 3.7949 0.0 0
M  V30 6 C 8.4700 5.3349 0.0 0
M  V30 7 C 6.9300 6.8749 0.0 0
M  V30 8 N 3.0800 1.3338 0.0 0
M  V30 9 C 2.3100 0.0000 0.0 0
M  V30 10 C 3.0800 4.0011 0.0 0
M  V30 11 C 2.3100 2.6674 0.0 0
M  V30 12 C 2.3100 5.3349 0.0 0
M  V30 13 N 0.7700 2.6674 0.0 0
M  V30 14 C 0.7700 5.3349 0.0 0
M  V30 15 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 8 11
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 232951-83-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 338990-70-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-11783741
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Preparation of t-Butyl 2-(N-methylamino)nicotinate t-Butyl
2-chloronicotinate(k) (50.0 g, 0.234 mol) was 15 dissolved in a 40%
methylamine-methanol solution (300 mL) and the mixture was stirred at
room temperature for 30 h. The mixture was evaporated under reduced
pressure and the resulting residue was dissolved in EtOAc (750 mL). The
EtOAc solution was washed with water, dried over MgSO4 and evaporated
under reduced pressure. The obtaining oily crude product was purified by
a short silica gel column chromatography (ca. 300 g of silica gel,
eluent: EtOAc/ hexane=1/3) to give t-butyl 2-(N-methylamino)nicotinate(1)
contaminated by starting material. Yield (45.0 g, ca. 92%) . 1H NMR
(CDCl3): δ 1.57 (s, 9H), 3.05 (d, J =5.0 Hz, 3H), 6.49 (dd, J=4.6 and 7.6
Hz, 1H), 7.96 (bs, 1H), 8.04 (dd, J =2.0 and 7.6 Hz, 1H), 8.28 (dd, J
=2.0 and 4.6 Hz, 1H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of N-substituted carbamoyloxyalkyl-azolium derivatives as
antifungal agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fukuda, Hiroshi; Hayase, Tadakatsu; Mizuguchi, Eisaku; Shimma, Nobuo;
Ohwada, Jun; Oikawa, Nobuhiro; Sakaitani, Masahiro; Tsukazaki, Masao;
Umeda, Isao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US6812238 B1 2004-11-02

$RFMT $RIREG SCHEME277 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 2-chloro-3-pyridinecarboxylate
C10H12ClNO2
232951-83-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 O 5.3901 4.0010 0.0 0
M  V30 3 O 5.3901 1.3337 0.0 0
M  V30 4 C 6.9301 4.0010 0.0 0
M  V30 5 C 6.9301 5.5410 0.0 0
M  V30 6 C 8.4701 4.0010 0.0 0
M  V30 7 C 6.9301 2.4609 0.0 0
M  V30 8 Cl 3.0800 0.0000 0.0 0
M  V30 9 C 3.0800 2.6673 0.0 0
M  V30 10 C 2.3100 1.3337 0.0 0
M  V30 11 C 2.3100 4.0010 0.0 0
M  V30 12 N 0.7700 1.3337 0.0 0
M  V30 13 C 0.7700 4.0010 0.0 0
M  V30 14 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 10
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 2-(methylamino)-3-pyridinecarboxylate
C11H16N2O2
338990-70-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.0011 0.0 0
M  V30 2 O 5.3900 5.3349 0.0 0
M  V30 3 O 5.3900 2.6674 0.0 0
M  V30 4 C 6.9300 5.3349 0.0 0
M  V30 5 C 6.9300 3.7949 0.0 0
M  V30 6 C 8.4700 5.3349 0.0 0
M  V30 7 C 6.9300 6.8749 0.0 0
M  V30 8 N 3.0800 1.3338 0.0 0
M  V30 9 C 2.3100 0.0000 0.0 0
M  V30 10 C 3.0800 4.0011 0.0 0
M  V30 11 C 2.3100 2.6674 0.0 0
M  V30 12 C 2.3100 5.3349 0.0 0
M  V30 13 N 0.7700 2.6674 0.0 0
M  V30 14 C 0.7700 5.3349 0.0 0
M  V30 15 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 8 11
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 232951-83-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 338990-70-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-8249927
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM c) Preparation of t-butyl 2-(N-methylamino)nicotinate. t-Butyl
2-chloronicotinate(k) (50.0 g, 0.234 mol) was dissolved in a 40%
methylamine-methanol solution (300 mL) and the mixture was stirred at
room temperature for 30 h. The mixture was evaporated under reduced
pressure and the resulting residue was dissolved in EtOAc (750 mL). The
EtOAc solution was washed with water, dried over MgSO4 and evaporated
under reduced pressure. The obtaining oily crude product was purified by
a short silica gel column chromatography (ca. 300 g of silica gel,
eluent: EtOAc/hexane = 1/3) to give product contaminated by starting
meterial. t-butyl 2-(N-methylamino)nicotinate(1) (45.0 g, ca. 92%). 1H
NMR (CDCl3): δ 1.57 (s, 9H), 3.05 (d, J= 5.0 Hz, 3H), 6.49 (dd, J= 4.6
and 7.6 Hz, 1H), 7.96 (bs, 1H), 8.04 (dd, J= 2.0 and 7.6 Hz, 1H), 8.28
(dd, J= 2.0 and 4.6 Hz, 1H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and formulation of N-substituted carbamoyloxyalkyl-azolium
derivatives and their use as antifungal agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fukuda, Hiroshi; Hayase, Tadakatsu; Mizuguchi, Eisaku; Shimma, Nobuo;
Ohwada, Jun; Oikawa, Nobuhiro; Sakaitani, Masahiro; Tsukazaki, Masao;
Umeda, Isao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2001032652 A2 2001-05-10

$RFMT $RIREG SCHEME278 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(6aR,12aS)-5,6,6a,7,12,12a-Hexahydro-2-methoxy-7,7,9,12a-tetramethylnapht...
C22H26N2O3
2338792-96-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 2.6674 0.0 0
M  V30 2 C 10.6871 5.8615 0.0 0
M  V30 3 C 8.9727 6.8515 0.0 0
M  V30 4 O 2.3100 1.3338 0.0 0
M  V30 5 C 3.0800 0.0000 0.0 0
M  V30 6 C 0.7700 4.0011 0.0 0
M  V30 7 O 0.0000 5.3347 0.0 0
M  V30 8 O 0.0000 2.6674 0.0 0
M  V30 9 C 13.8600 2.6674 0.0 0
M  V30 10 C 6.9300 4.0011 0.0 0 CFG=2
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 7.7000 5.3347 0.0 0 CFG=1
M  V30 13 C 7.7000 2.6674 0.0 0
M  V30 14 C 4.6200 5.3347 0.0 0
M  V30 15 C 4.6200 2.6674 0.0 0
M  V30 16 C 9.2400 5.3347 0.0 0
M  V30 17 C 6.9300 6.6685 0.0 0
M  V30 18 C 9.2400 2.6674 0.0 0
M  V30 19 C 3.0800 5.3347 0.0 0
M  V30 20 C 5.3900 6.6685 0.0 0
M  V30 21 C 3.0800 2.6674 0.0 0
M  V30 22 C 10.0100 4.0011 0.0 0
M  V30 23 C 10.0100 1.3338 0.0 0
M  V30 24 C 2.3100 4.0011 0.0 0
M  V30 25 N 11.5500 4.0011 0.0 0
M  V30 26 N 11.5500 1.3338 0.0 0
M  V30 27 C 12.3200 2.6674 0.0 0
M  V30 28 H 8.4700 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 10 1 CFG=1
M  V30 2 1 2 16
M  V30 3 1 3 16
M  V30 4 1 4 5
M  V30 5 1 4 21
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 24
M  V30 9 1 9 27
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 11 14
M  V30 14 2 11 15
M  V30 15 1 12 16
M  V30 16 1 12 17
M  V30 17 1 12 28 CFG=3
M  V30 18 1 13 18
M  V30 19 2 14 19
M  V30 20 1 14 20
M  V30 21 1 15 21
M  V30 22 1 16 22
M  V30 23 1 17 20
M  V30 24 1 18 22
M  V30 25 2 18 23
M  V30 26 1 19 24
M  V30 27 2 21 24
M  V30 28 2 22 25
M  V30 29 1 23 26
M  V30 30 1 25 27
M  V30 31 2 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 10 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-(6aR,12aS)-5,6,6a,7,12,12a-Hexahydro-2-methoxy-N,7,7,9,12a-pentamethylnap...
C23H29N3O2
2338793-00-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.7000 2.6674 0.0 0
M  V30 2 C 3.1729 5.8615 0.0 0
M  V30 3 C 4.8873 6.8515 0.0 0
M  V30 4 O 11.5500 1.3338 0.0 0
M  V30 5 C 10.7800 0.0000 0.0 0
M  V30 6 C 13.0900 4.0011 0.0 0
M  V30 7 N 13.8600 5.3347 0.0 0
M  V30 8 O 13.8600 2.6674 0.0 0
M  V30 9 C 15.4000 5.3347 0.0 0
M  V30 10 C 0.0000 2.6674 0.0 0
M  V30 11 C 6.9300 4.0011 0.0 0 CFG=2
M  V30 12 C 8.4700 4.0011 0.0 0
M  V30 13 C 6.1600 5.3347 0.0 0 CFG=1
M  V30 14 C 6.1600 2.6674 0.0 0
M  V30 15 C 9.2400 5.3347 0.0 0
M  V30 16 C 9.2400 2.6674 0.0 0
M  V30 17 C 4.6200 5.3347 0.0 0
M  V30 18 C 6.9300 6.6685 0.0 0
M  V30 19 C 4.6200 2.6674 0.0 0
M  V30 20 C 10.7800 5.3347 0.0 0
M  V30 21 C 8.4700 6.6685 0.0 0
M  V30 22 C 10.7800 2.6674 0.0 0
M  V30 23 C 3.8500 4.0011 0.0 0
M  V30 24 C 3.8500 1.3338 0.0 0
M  V30 25 C 11.5500 4.0011 0.0 0
M  V30 26 N 2.3100 4.0011 0.0 0
M  V30 27 N 2.3100 1.3338 0.0 0
M  V30 28 C 1.5400 2.6674 0.0 0
M  V30 29 H 5.3900 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 11 1 CFG=3
M  V30 2 1 2 17
M  V30 3 1 3 17
M  V30 4 1 4 5
M  V30 5 1 4 22
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 25
M  V30 9 1 7 9
M  V30 10 1 10 28
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 12 15
M  V30 15 2 12 16
M  V30 16 1 13 17
M  V30 17 1 13 18
M  V30 18 1 13 29 CFG=1
M  V30 19 1 14 19
M  V30 20 2 15 20
M  V30 21 1 15 21
M  V30 22 1 16 22
M  V30 23 1 17 23
M  V30 24 1 18 21
M  V30 25 1 19 23
M  V30 26 2 19 24
M  V30 27 1 20 25
M  V30 28 2 22 25
M  V30 29 2 23 26
M  V30 30 1 24 27
M  V30 31 1 26 28
M  V30 32 2 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 11 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2338792-96-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2338793-00-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-20296456
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and biological evaluation of methylpyrimidine-fused tricyclic
diterpene analogs as novel oral anti-late-onset hypogonadism agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bai, Jie; Xie, Jia; Xing, Yajing; Wang, Li-Ting; Xie, Jiuqing; Yang, Fan;
Liu, Ting; Liu, Mingyao; Tang, Jie; Yi, Zhengfang; Qiu, Wen-Wei
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2019), 17621-40

$RFMT $RIREG SCHEME279 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Azido-6-bromohexane
C6H12BrN3
235095-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0012 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 0.7700 0.0 0
M  V30 6 N 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 N 10.6697 0.7700 0.0 0 CHG=1 VAL=4
M  V30 9 Br 0.0000 0.7700 0.0 0
M  V30 10 N 12.0033 0.0000 0.0 0 CHG=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Azido-N-methyl-1-hexanamine
C7H16N4
905715-02-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 0.7700 0.0 0
M  V30 2 C 8.0022 1.5400 0.0 0
M  V30 3 C 5.3348 1.5400 0.0 0
M  V30 4 C 9.3360 0.7700 0.0 0
M  V30 5 C 4.0010 0.7700 0.0 0
M  V30 6 C 10.6697 1.5400 0.0 0
M  V30 7 N 2.6673 1.5400 0.0 0
M  V30 8 N 12.0033 0.7700 0.0 0
M  V30 9 N 1.3337 0.7700 0.0 0 CHG=1 VAL=4
M  V30 10 C 13.3370 1.5400 0.0 0
M  V30 11 N 0.0000 0.0000 0.0 0 CHG=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 235095-05-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 905715-02-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-3107502
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 2.5. Preparation of the 6-azido-N-methylhexan-1-amine 10b. To a solution
of methylamine (12 mL, 138.7 mmol, 20 equiv, 40% in water) in THF (10 mL)
was added dropwise a solution of 1-azido-6-bromohexane 9 (1.429 g, 6.9
mmol, 1 equiv) in THF (5 mL). The mixture was stirred overnight. Then,
dichloromethane (50 mL) and NaOH 1M (50 mL) were added and the two layers
were separated. The aqueous layer was extracted with dichloromethane (2 ×
50 mL). The organic layers were combined, dried over MgSO4 and evaporated
under vacuo to give the pure 6-azido-N-methylhexan-1-amine (967 mg, 92%)
as a colorless oil. Rf (CH2Cl2/Acetone 1:1) 0.16 1H NMR (400 MHz, CDCl3,
298 K): δ (ppm) = 3.26 (t, 2H, 3JH6-H5 = 6.9 Hz, H6), 2.57 (t, 2H,
3JH1-H2 = 6.8 Hz, H1), 2.43 (s, 3H, H7), 1.66-1.55 (m, 2H, H5), 1.55-1.44
(m, 2H, H2), 1.43-1.29 (m, 4H, H3 H4). JMOD 13C NMR (100 MHz, CDCl3, 298
K): δ (ppm) = 52.0 (C1), 51.4 (C6), 36.5 (C7), 29.8 (C2), 28.8 (C5), 26.9
& 26.6 (C3 C4). MS (ESI):[M+H]+ calcd for C7H17N4+ : 157.14, found:
157.13.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Very Contracted to Extended co-Conformations with or without Oscillations
in Two- and Three-Station [c2]Daisy Chains
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Romuald, Camille; Busseron, Eric; Coutrot, Frederic
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2010), 75(19), 6516-6531

$RFMT $RIREG SCHEME279 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Azido-6-bromohexane
C6H12BrN3
235095-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0012 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 0.7700 0.0 0
M  V30 6 N 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 N 10.6697 0.7700 0.0 0 CHG=1 VAL=4
M  V30 9 Br 0.0000 0.7700 0.0 0
M  V30 10 N 12.0033 0.0000 0.0 0 CHG=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Azido-N-methyl-1-hexanamine
C7H16N4
905715-02-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 0.7700 0.0 0
M  V30 2 C 8.0022 1.5400 0.0 0
M  V30 3 C 5.3348 1.5400 0.0 0
M  V30 4 C 9.3360 0.7700 0.0 0
M  V30 5 C 4.0010 0.7700 0.0 0
M  V30 6 C 10.6697 1.5400 0.0 0
M  V30 7 N 2.6673 1.5400 0.0 0
M  V30 8 N 12.0033 0.7700 0.0 0
M  V30 9 N 1.3337 0.7700 0.0 0 CHG=1 VAL=4
M  V30 10 C 13.3370 1.5400 0.0 0
M  V30 11 N 0.0000 0.0000 0.0 0 CHG=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 235095-05-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 905715-02-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-15011183
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Controlling the Chair Conformation of a Mannopyranose in a
Large-Amplitude [2]Rotaxane Molecular Machine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Coutrot, Frederic; Busseron, Eric
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2009), 15(21), 5186-5190,
S5186/1-S5186/48

$RFMT $RIREG SCHEME280 STEP1
$RXN



  2  1
$MOL
Cyclopropanol, 2-(4-bromo-3-fluorophenyl)-, 1-carbamate, (1S,2R)-
C10H9BrFNO2
2369645-62-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 8.2085 2.3101 0.0 0
M  V30 2 C 9.5424 3.0801 0.0 0
M  V30 3 N 10.8760 2.3101 0.0 0
M  V30 4 O 9.5424 4.6201 0.0 0
M  V30 5 F 0.0000 3.0801 0.0 0
M  V30 6 Br 0.0000 0.0000 0.0 0
M  V30 7 C 5.3348 3.0801 0.0 0 CFG=1
M  V30 8 C 6.8749 3.0801 0.0 0 CFG=1
M  V30 9 C 6.1048 4.4137 0.0 0
M  V30 10 C 4.0012 2.3101 0.0 0
M  V30 11 C 2.6675 3.0801 0.0 0
M  V30 12 C 4.0012 0.7700 0.0 0
M  V30 13 C 1.3337 2.3101 0.0 0
M  V30 14 C 2.6675 0.0000 0.0 0
M  V30 15 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 8 1 CFG=3
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 13
M  V30 6 1 6 15
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10 CFG=1
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C11H11BrFNO2
2369645-63-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 8.2085 2.3101 0.0 0
M  V30 2 C 9.5424 3.0801 0.0 0
M  V30 3 N 10.8760 2.3101 0.0 0
M  V30 4 O 9.5424 4.6201 0.0 0
M  V30 5 C 12.2097 3.0801 0.0 0
M  V30 6 F 0.0000 3.0801 0.0 0
M  V30 7 Br 0.0000 0.0000 0.0 0
M  V30 8 C 5.3348 3.0801 0.0 0 CFG=1
M  V30 9 C 6.8749 3.0801 0.0 0 CFG=1
M  V30 10 C 6.1048 4.4137 0.0 0
M  V30 11 C 4.0012 2.3101 0.0 0
M  V30 12 C 2.6673 3.0801 0.0 0
M  V30 13 C 4.0012 0.7700 0.0 0
M  V30 14 C 1.3337 2.3101 0.0 0
M  V30 15 C 2.6673 0.0000 0.0 0
M  V30 16 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 9 1 CFG=3
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 14
M  V30 7 1 7 16
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11 CFG=1
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 8 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2369645-62-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2369645-63-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-26618337
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of cycloalkyl substituted pyrazolopyrimidines having activity
against RSV
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lancois, David Francis Alain; Guillemont, Jerome Emile Georges;
Raboisson, Pierre Jean-Marie Bernard; Roymans, Dirk Andre Emmy; Rigaux,
Peter; Michaut, Antoine Benjamin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019149734 A1 2019-08-08

$RFMT $RIREG SCHEME281 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 5-(2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)-2-pyridinecarboxylate
C14H11N3O3
2378816-30-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.4032 0.0000 0.0 0
M  V30 2 C 9.7544 5.6421 0.0 0
M  V30 3 O 11.0882 4.8720 0.0 0
M  V30 4 O 9.7544 7.1821 0.0 0
M  V30 5 C 12.4219 5.6421 0.0 0
M  V30 6 N 4.4196 2.5620 0.0 0
M  V30 7 C 3.0128 3.1885 0.0 0
M  V30 8 C 4.2586 1.0304 0.0 0
M  V30 9 C 1.9823 2.0439 0.0 0
M  V30 10 C 2.5369 4.6530 0.0 0
M  V30 11 N 2.7523 0.7103 0.0 0
M  V30 12 C 0.4759 2.3641 0.0 0
M  V30 13 C 1.0304 4.9732 0.0 0
M  V30 14 C 0.0000 3.8288 0.0 0
M  V30 15 C 5.7534 3.3320 0.0 0
M  V30 16 C 5.7534 4.8720 0.0 0
M  V30 17 C 7.0871 2.5620 0.0 0
M  V30 18 C 7.0871 5.6421 0.0 0
M  V30 19 N 8.4207 3.3320 0.0 0
M  V30 20 C 8.4207 4.8720 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 20
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 15
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 9 11
M  V30 13 2 9 12
M  V30 14 1 10 13
M  V30 15 1 12 14
M  V30 16 2 13 14
M  V30 17 1 15 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(2,3-Dihydro-2-oxo-1H-benzimidazol-1-yl)-N-methyl-2-pyridinecarboxamide
C14H12N4O2
2378817-67-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.4032 0.0000 0.0 0
M  V30 2 C 9.7544 5.6421 0.0 0
M  V30 3 N 11.0882 4.8720 0.0 0
M  V30 4 O 9.7544 7.1821 0.0 0
M  V30 5 C 12.4219 5.6421 0.0 0
M  V30 6 N 4.4196 2.5620 0.0 0
M  V30 7 C 3.0128 3.1885 0.0 0
M  V30 8 C 4.2586 1.0304 0.0 0
M  V30 9 C 1.9823 2.0439 0.0 0
M  V30 10 C 2.5369 4.6530 0.0 0
M  V30 11 N 2.7523 0.7103 0.0 0
M  V30 12 C 0.4759 2.3641 0.0 0
M  V30 13 C 1.0304 4.9732 0.0 0
M  V30 14 C 0.0000 3.8288 0.0 0
M  V30 15 C 5.7534 3.3320 0.0 0
M  V30 16 C 5.7534 4.8720 0.0 0
M  V30 17 C 7.0871 2.5620 0.0 0
M  V30 18 C 7.0871 5.6421 0.0 0
M  V30 19 N 8.4207 3.3320 0.0 0
M  V30 20 C 8.4207 4.8720 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 20
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 15
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 9 11
M  V30 13 2 9 12
M  V30 14 1 10 13
M  V30 15 1 12 14
M  V30 16 2 13 14
M  V30 17 1 15 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2378816-30-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2378817-67-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-20860264
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of fused cyclic urea derivatives as CRHR2 antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ohmi, Masashi; Matsushita, Takeshi; Ando, Kazuo; Yamaguchi, Ryuichi;
Fukumoto, Yutaka; Magara, Ryohei; Yamagishi, Tatsuya; Takefuji, Mikito
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019198692 A1 2019-10-17

$RFMT $RIREG SCHEME282 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Ethyl 4-(phenylmethyl) 10-bromo-1,2,3,6-tetrahydro-6-oxo[1]benzopyrano[4,3-...
C24H20BrNO6
2400914-02-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.0023 11.0070 0.0 0
M  V30 2 C 5.5901 3.8416 0.0 0
M  V30 3 O 6.5504 2.6376 0.0 0
M  V30 4 O 4.0674 3.6121 0.0 0
M  V30 5 C 5.9878 1.2040 0.0 0
M  V30 6 C 6.9480 0.0000 0.0 0
M  V30 7 Br 0.0000 7.9270 0.0 0
M  V30 8 C 10.0789 6.4332 0.0 0
M  V30 9 O 11.0391 7.6372 0.0 0
M  V30 10 O 10.6416 4.9995 0.0 0
M  V30 11 C 12.5619 7.4077 0.0 0
M  V30 12 C 5.3348 7.9270 0.0 0
M  V30 13 C 4.0011 8.6970 0.0 0
M  V30 14 C 6.6686 8.6970 0.0 0
M  V30 15 N 5.1053 6.4041 0.0 0
M  V30 16 C 4.0011 10.2370 0.0 0
M  V30 17 C 2.6675 7.9270 0.0 0
M  V30 18 C 8.1021 8.1343 0.0 0
M  V30 19 C 6.6686 10.2370 0.0 0
M  V30 20 C 6.1529 5.2752 0.0 0
M  V30 21 O 5.3348 11.0070 0.0 0
M  V30 22 C 2.6675 11.0070 0.0 0
M  V30 23 C 1.3338 8.6970 0.0 0
M  V30 24 C 8.5561 6.6626 0.0 0
M  V30 25 C 7.6886 5.3903 0.0 0
M  V30 26 C 1.3338 10.2370 0.0 0
M  V30 27 C 13.5221 8.6117 0.0 0
M  V30 28 C 15.0450 8.3822 0.0 0
M  V30 29 C 12.9595 10.0453 0.0 0
M  V30 30 C 16.0052 9.5862 0.0 0
M  V30 31 C 13.9197 11.2493 0.0 0
M  V30 32 C 15.4425 11.0198 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 19
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 20
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 7 23
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 24
M  V30 11 1 9 11
M  V30 12 1 11 27
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 1 12 15
M  V30 16 1 13 16
M  V30 17 2 13 17
M  V30 18 1 14 18
M  V30 19 1 14 19
M  V30 20 1 15 20
M  V30 21 1 16 21
M  V30 22 2 16 22
M  V30 23 1 17 23
M  V30 24 2 18 24
M  V30 25 1 19 21
M  V30 26 1 20 25
M  V30 27 1 22 26
M  V30 28 2 23 26
M  V30 29 1 24 25
M  V30 30 2 27 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 31
M  V30 34 2 30 32
M  V30 35 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylmethyl 10-bromo-1,2,3,6-tetrahydro-2-[(methylamino)carbonyl]-6-oxo[1]be...
C23H19BrN2O5
2400914-26-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3901 9.8944 0.0 0
M  V30 2 C 6.8839 2.4830 0.0 0
M  V30 3 N 5.6798 1.5228 0.0 0
M  V30 4 O 8.3174 1.9204 0.0 0
M  V30 5 C 5.9094 0.0000 0.0 0
M  V30 6 Br 0.0000 3.2259 0.0 0
M  V30 7 C 9.4755 6.9717 0.0 0
M  V30 8 O 10.6795 6.0115 0.0 0
M  V30 9 O 9.7049 8.4945 0.0 0
M  V30 10 C 12.1131 6.5741 0.0 0
M  V30 11 C 4.6201 5.8934 0.0 0
M  V30 12 C 3.0801 5.8934 0.0 0
M  V30 13 C 5.3901 7.2270 0.0 0
M  V30 14 N 5.1827 4.4598 0.0 0
M  V30 15 C 2.3100 7.2270 0.0 0
M  V30 16 C 2.3100 4.5596 0.0 0
M  V30 17 C 6.9129 7.4565 0.0 0
M  V30 18 C 4.6201 8.5607 0.0 0
M  V30 19 C 6.6543 4.0058 0.0 0
M  V30 20 O 3.0801 8.5607 0.0 0
M  V30 21 C 0.7700 7.2270 0.0 0
M  V30 22 C 0.7700 4.5596 0.0 0
M  V30 23 C 8.0419 6.4090 0.0 0
M  V30 24 C 7.9268 4.8733 0.0 0
M  V30 25 C 0.0000 5.8934 0.0 0
M  V30 26 C 13.3171 5.6139 0.0 0
M  V30 27 C 13.0876 4.0911 0.0 0
M  V30 28 C 14.7507 6.1766 0.0 0
M  V30 29 C 14.2916 3.1309 0.0 0
M  V30 30 C 15.9547 5.2164 0.0 0
M  V30 31 C 15.7252 3.6936 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 18
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 19
M  V30 5 1 3 5
M  V30 6 1 6 22
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 23
M  V30 10 1 8 10
M  V30 11 1 10 26
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 2 12 16
M  V30 17 1 13 17
M  V30 18 1 13 18
M  V30 19 1 14 19
M  V30 20 1 15 20
M  V30 21 2 15 21
M  V30 22 1 16 22
M  V30 23 2 17 23
M  V30 24 1 18 20
M  V30 25 1 19 24
M  V30 26 1 21 25
M  V30 27 2 22 25
M  V30 28 1 23 24
M  V30 29 2 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 28 30
M  V30 33 2 29 31
M  V30 34 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2400914-02-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2400914-26-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-21439719
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Phosphine-Catalyzed Chemoselective [4+3] Cycloaddition of Aldimine Esters
and β'-acetoxy Allenoates for Divergent Synthesis of Azepines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dai, Zonghao; Zhu, Jin; Wang, Jiahua; Su, Wenbo; Yang, Fulai; Zhou,
Qingfa
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Advanced Synthesis & Catalysis (2020), 362(3), 545-551

$RFMT $RIREG SCHEME283 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
L-Prolinamide, N-(8-bromo-1-oxooctyl)-3-methyl-L-valyl-4-hydroxy-N-[[4-(4-met...
C30H43BrN4O4S
2408342-03-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 42 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 14.3723 6.6684 0.0 0
M  V30 2 C 15.9123 6.6684 0.0 0 CFG=2
M  V30 3 O 13.6023 8.0022 0.0 0
M  V30 4 N 16.6823 5.3348 0.0 0
M  V30 5 C 16.6823 8.0022 0.0 0
M  V30 6 C 18.2223 5.3348 0.0 0
M  V30 7 C 15.3487 8.7722 0.0 0
M  V30 8 C 17.4523 9.3359 0.0 0
M  V30 9 C 18.0161 7.2322 0.0 0
M  V30 10 C 18.9923 4.0011 0.0 0
M  V30 11 O 18.9923 6.6684 0.0 0
M  V30 12 C 20.5324 4.0011 0.0 0
M  V30 13 C 21.3024 2.6675 0.0 0
M  V30 14 C 22.8424 2.6675 0.0 0
M  V30 15 C 23.6124 1.3336 0.0 0
M  V30 16 C 25.1524 1.3336 0.0 0
M  V30 17 C 25.9224 0.0000 0.0 0
M  V30 18 Br 27.4624 0.0000 0.0 0
M  V30 19 C 11.0403 6.3182 0.0 0
M  V30 20 N 9.5339 5.9980 0.0 0
M  V30 21 O 11.5162 7.7829 0.0 0
M  V30 22 C 8.5035 7.1426 0.0 0
M  V30 23 O 13.2453 1.3658 0.0 0
M  V30 24 C 1.4946 8.4239 0.0 0
M  V30 25 N 13.6023 5.3348 0.0 0
M  V30 26 C 12.0708 5.1738 0.0 0 CFG=2
M  V30 27 C 14.2288 3.9280 0.0 0
M  V30 28 C 11.7506 3.6674 0.0 0
M  V30 29 C 13.0842 2.8974 0.0 0 CFG=2
M  V30 30 C 6.9972 6.8224 0.0 0
M  V30 31 C 6.5213 5.3577 0.0 0
M  V30 32 C 5.9666 7.9668 0.0 0
M  V30 33 C 5.0149 5.0375 0.0 0
M  V30 34 C 4.4603 7.6466 0.0 0
M  V30 35 C 3.9845 6.1819 0.0 0
M  V30 36 C 2.4780 5.8617 0.0 0
M  V30 37 C 1.3336 6.8922 0.0 0
M  V30 38 S 1.8517 4.4549 0.0 0
M  V30 39 N 0.0000 6.1222 0.0 0
M  V30 40 C 0.3202 4.6159 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 25
M  V30 4 1 2 4
M  V30 5 1 2 5 CFG=3
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 1 6 10
M  V30 11 2 6 11
M  V30 12 1 10 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 14 15
M  V30 16 1 15 16
M  V30 17 1 16 17
M  V30 18 1 17 18
M  V30 19 1 19 20
M  V30 20 2 19 21
M  V30 21 1 26 19 CFG=1
M  V30 22 1 20 22
M  V30 23 1 22 30
M  V30 24 1 29 23 CFG=3
M  V30 25 1 24 37
M  V30 26 1 25 26
M  V30 27 1 25 27
M  V30 28 1 26 28
M  V30 29 1 27 29
M  V30 30 1 28 29
M  V30 31 2 30 31
M  V30 32 1 30 32
M  V30 33 1 31 33
M  V30 34 2 32 34
M  V30 35 2 33 35
M  V30 36 1 34 35
M  V30 37 1 35 36
M  V30 38 2 36 37
M  V30 39 1 36 38
M  V30 40 1 37 39
M  V30 41 1 38 40
M  V30 42 2 39 40
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 2 26 29)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C31H47N5O4S
2768472-44-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 43 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 14.3722 8.0021 0.0 0
M  V30 2 C 15.9122 8.0021 0.0 0 CFG=2
M  V30 3 O 13.6022 9.3358 0.0 0
M  V30 4 N 16.6822 6.6684 0.0 0
M  V30 5 C 16.6822 9.3358 0.0 0
M  V30 6 C 18.2222 6.6684 0.0 0
M  V30 7 C 15.3486 10.1058 0.0 0
M  V30 8 C 17.4522 10.6694 0.0 0
M  V30 9 C 18.0160 8.5658 0.0 0
M  V30 10 C 18.9922 5.3347 0.0 0
M  V30 11 O 18.9922 8.0021 0.0 0
M  V30 12 C 20.5322 5.3347 0.0 0
M  V30 13 C 21.3022 4.0011 0.0 0
M  V30 14 C 22.8422 4.0011 0.0 0
M  V30 15 C 23.6122 2.6673 0.0 0
M  V30 16 C 25.1522 2.6673 0.0 0
M  V30 17 C 25.9222 1.3336 0.0 0
M  V30 18 N 27.4622 1.3336 0.0 0
M  V30 19 C 28.2322 0.0000 0.0 0
M  V30 20 C 11.0403 7.6518 0.0 0
M  V30 21 N 9.5338 7.3316 0.0 0
M  V30 22 O 11.5161 9.1165 0.0 0
M  V30 23 C 8.5034 8.4762 0.0 0
M  V30 24 O 13.2452 2.6995 0.0 0
M  V30 25 C 1.4946 9.7574 0.0 0
M  V30 26 N 13.6022 6.6684 0.0 0
M  V30 27 C 12.0707 6.5074 0.0 0 CFG=2
M  V30 28 C 14.2287 5.2616 0.0 0
M  V30 29 C 11.7505 5.0010 0.0 0
M  V30 30 C 13.0841 4.2310 0.0 0 CFG=2
M  V30 31 C 6.9971 8.1560 0.0 0
M  V30 32 C 6.5213 6.6913 0.0 0
M  V30 33 C 5.9666 9.3004 0.0 0
M  V30 34 C 5.0149 6.3711 0.0 0
M  V30 35 C 4.4603 8.9802 0.0 0
M  V30 36 C 3.9844 7.5155 0.0 0
M  V30 37 C 2.4780 7.1953 0.0 0
M  V30 38 C 1.3336 8.2259 0.0 0
M  V30 39 S 1.8517 5.7886 0.0 0
M  V30 40 N 0.0000 7.4559 0.0 0
M  V30 41 C 0.3202 5.9495 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 26
M  V30 4 1 2 4
M  V30 5 1 2 5 CFG=3
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 1 6 10
M  V30 11 2 6 11
M  V30 12 1 10 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 14 15
M  V30 16 1 15 16
M  V30 17 1 16 17
M  V30 18 1 17 18
M  V30 19 1 18 19
M  V30 20 1 20 21
M  V30 21 2 20 22
M  V30 22 1 27 20 CFG=1
M  V30 23 1 21 23
M  V30 24 1 23 31
M  V30 25 1 30 24 CFG=3
M  V30 26 1 25 38
M  V30 27 1 26 27
M  V30 28 1 26 28
M  V30 29 1 27 29
M  V30 30 1 28 30
M  V30 31 1 29 30
M  V30 32 2 31 32
M  V30 33 1 31 33
M  V30 34 1 32 34
M  V30 35 2 33 35
M  V30 36 2 34 36
M  V30 37 1 35 36
M  V30 38 1 36 37
M  V30 39 2 37 38
M  V30 40 1 37 39
M  V30 41 1 38 40
M  V30 42 1 39 41
M  V30 43 2 40 41
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 2 27 30)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2408342-03-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2768472-44-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31906310
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7681-82-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of Potent PROTACs Targeting EGFR Mutants through the
Optimization of Covalent EGFR Ligands
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhao, Hong-Yi; Wang, Hai-Peng; Mao, Yu-Ze; Zhang, Hao; Xin, Minhang; Xi,
Xiao-Xiao; Lei, Hao; Mao, Shuai; Li, Dong-Hui; Zhang, San-Qi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2022), 65(6), 4709-4726

$RFMT $RIREG SCHEME284 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[4-[[(2,4-Dimethoxyphenyl)methyl]amino]-6-(hydroxymethyl)-7-(1-methylethyl)...
C28H29N5O5
2413300-69-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 42 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3932 6.4452 0.0 0
M  V30 2 O 0.8532 6.4452 0.0 0
M  V30 3 N 7.6825 9.4463 0.0 0
M  V30 4 C 9.0161 10.2163 0.0 0
M  V30 5 C 1.0304 9.5060 0.0 0
M  V30 6 C 0.0000 8.3616 0.0 0
M  V30 7 C 0.5546 10.9707 0.0 0
M  V30 8 C 8.8438 1.0304 0.0 0
M  V30 9 O 10.3085 0.5546 0.0 0
M  V30 10 O 7.6994 0.0000 0.0 0
M  V30 11 O 11.6835 11.7563 0.0 0
M  V30 12 C 13.0173 12.5263 0.0 0
M  V30 13 O 14.3510 7.1362 0.0 0
M  V30 14 C 15.6846 7.9062 0.0 0
M  V30 15 C 4.6948 7.9400 0.0 0
M  V30 16 C 5.0150 9.4463 0.0 0
M  V30 17 C 3.1632 7.7790 0.0 0
M  V30 18 C 3.6813 10.2163 0.0 0
M  V30 19 C 6.3486 10.2163 0.0 0
M  V30 20 N 2.5369 9.1858 0.0 0
M  V30 21 N 3.6813 11.7563 0.0 0
M  V30 22 N 6.3486 11.7563 0.0 0
M  V30 23 C 5.0150 12.5263 0.0 0
M  V30 24 C 5.7252 6.7954 0.0 0
M  V30 25 N 5.4051 5.2891 0.0 0
M  V30 26 C 7.2569 6.9565 0.0 0
M  V30 27 C 6.7389 4.5191 0.0 0
M  V30 28 C 7.8833 5.5495 0.0 0
M  V30 29 C 7.0591 3.0128 0.0 0
M  V30 30 C 9.3480 5.0736 0.0 0
M  V30 31 C 8.5236 2.5367 0.0 0
M  V30 32 C 9.6682 3.5673 0.0 0
M  V30 33 C 10.3498 9.4463 0.0 0
M  V30 34 C 11.6835 10.2163 0.0 0
M  V30 35 C 10.3498 7.9062 0.0 0
M  V30 36 C 13.0173 9.4463 0.0 0
M  V30 37 C 11.6836 7.1362 0.0 0
M  V30 38 C 13.0173 7.9062 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 3 4
M  V30 4 1 3 19
M  V30 5 1 4 33
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 20
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 8 31
M  V30 12 1 11 12
M  V30 13 1 11 34
M  V30 14 1 13 14
M  V30 15 1 13 38
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 1 15 24
M  V30 19 1 16 18
M  V30 20 2 16 19
M  V30 21 1 17 20
M  V30 22 1 18 20
M  V30 23 2 18 21
M  V30 24 1 19 22
M  V30 25 1 21 23
M  V30 26 2 22 23
M  V30 27 1 24 25
M  V30 28 2 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 1 27 28
M  V30 32 2 27 29
M  V30 33 2 28 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 31 32
M  V30 37 2 33 34
M  V30 38 1 33 35
M  V30 39 1 34 36
M  V30 40 2 35 37
M  V30 41 2 36 38
M  V30 42 1 37 38
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Bis(4-nitrophenyl) carbonate
C13H8N2O7
5070-13-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 9.3360 4.6201 0.0 0
M  V30 2 C 8.0023 3.8501 0.0 0
M  V30 3 O 6.6687 4.6201 0.0 0
M  V30 4 O 8.0023 2.3101 0.0 0
M  V30 5 N 14.6708 1.5400 0.0 0 VAL=5
M  V30 6 O 14.6708 0.0000 0.0 0
M  V30 7 O 16.0046 2.3101 0.0 0
M  V30 8 N 1.3338 1.5400 0.0 0 VAL=5
M  V30 9 O 1.3338 0.0000 0.0 0
M  V30 10 O 0.0000 2.3101 0.0 0
M  V30 11 C 10.6698 3.8501 0.0 0
M  V30 12 C 12.0035 4.6201 0.0 0
M  V30 13 C 10.6698 2.3101 0.0 0
M  V30 14 C 13.3372 3.8501 0.0 0
M  V30 15 C 12.0035 1.5400 0.0 0
M  V30 16 C 13.3372 2.3101 0.0 0
M  V30 17 C 5.3348 3.8501 0.0 0
M  V30 18 C 5.3348 2.3101 0.0 0
M  V30 19 C 4.0012 4.6201 0.0 0
M  V30 20 C 4.0012 1.5400 0.0 0
M  V30 21 C 2.6675 3.8501 0.0 0
M  V30 22 C 2.6675 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 17
M  V30 6 2 5 6
M  V30 7 2 5 7
M  V30 8 1 5 16
M  V30 9 2 8 9
M  V30 10 2 8 10
M  V30 11 1 8 22
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Amino-5,6,7,8-tetrahydro-N-methyl-5-(1-methylethyl)-8-oxopyrimido[5′′,4′′:4...
C21H21N7O2
2413299-29-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.2618 0.7862 0.0 0
M  V30 2 C 1.3450 5.2668 0.0 0
M  V30 3 C 1.3680 6.8067 0.0 0
M  V30 4 C 0.0000 4.5168 0.0 0
M  V30 5 O 8.2900 7.7351 0.0 0
M  V30 6 C 13.0057 5.5316 0.0 0
M  V30 7 N 14.3393 4.7615 0.0 0
M  V30 8 O 13.0057 7.0716 0.0 0
M  V30 9 C 15.6730 5.5316 0.0 0
M  V30 10 C 5.0963 3.9224 0.0 0
M  V30 11 C 6.6348 3.9915 0.0 0
M  V30 12 C 4.3065 2.6005 0.0 0
M  V30 13 C 4.0830 5.0822 0.0 0
M  V30 14 N 7.5400 5.2374 0.0 0
M  V30 15 C 7.5400 2.7457 0.0 0
M  V30 16 C 2.8051 2.9431 0.0 0
M  V30 17 C 4.7603 1.1288 0.0 0
M  V30 18 N 2.6670 4.4770 0.0 0
M  V30 19 C 4.3581 6.5974 0.0 0
M  V30 20 C 9.0046 4.7615 0.0 0
M  V30 21 C 7.1302 6.7220 0.0 0
M  V30 22 C 9.0046 3.2215 0.0 0
M  V30 23 N 1.7576 1.8143 0.0 0
M  V30 24 N 3.7130 0.0000 0.0 0
M  V30 25 N 5.7142 7.3272 0.0 0
M  V30 26 C 10.3382 5.5316 0.0 0
M  V30 27 C 10.3382 2.4515 0.0 0
M  V30 28 C 2.2115 0.3427 0.0 0
M  V30 29 C 11.6720 4.7615 0.0 0
M  V30 30 C 11.6720 3.2215 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 17
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 18
M  V30 5 2 5 21
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 29
M  V30 9 1 7 9
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 2 10 13
M  V30 13 1 11 14
M  V30 14 2 11 15
M  V30 15 1 12 16
M  V30 16 2 12 17
M  V30 17 1 13 18
M  V30 18 1 13 19
M  V30 19 1 14 20
M  V30 20 1 14 21
M  V30 21 1 15 22
M  V30 22 1 16 18
M  V30 23 2 16 23
M  V30 24 1 17 24
M  V30 25 1 19 25
M  V30 26 1 20 22
M  V30 27 2 20 26
M  V30 28 1 21 25
M  V30 29 2 22 27
M  V30 30 1 23 28
M  V30 31 2 24 28
M  V30 32 1 26 29
M  V30 33 1 27 30
M  V30 34 2 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2413300-69-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 5070-13-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2413299-29-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-21968839
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 6
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 6674-22-2
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 26386-88-9
$DTYPE RXN:VAR(1):RGT(5):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):RGT(6):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):RGT(7):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):RGT(8):CAS_RN
$DATUM 617-86-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):NOTES
$DATUM incremental addition of DBU and DPPA in three portions within 18 hours in
stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Fused heterocyclic compounds as RET kinase inhibitors and their
preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Blake, James F.; Dai, Donghua; Haas, Julia; Jiang, Yutong; Kahn, Dean;
Kolakowski, Gabrielle R.; McFaddin, Elizabeth A.; McKenney, Megan L.;
Metcalf, Andrew T.; Moreno, David A.; Prigaro, Brett; Ramann, Ginelle A.;
Ren, Li; Walls, Shane M.; Zhang, Hailong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020055672 A1 2020-03-19

$RFMT $RIREG SCHEME285 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[(1S)-3-Chloro-1-phenylpropoxy]-1-[[[(1,1-dimethylethyl)dimethylsilyl]oxy]m...
C22H30ClFO2Si
2416740-10-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.0011 0.0 0 CFG=2
M  V30 2 O 5.3900 5.3347 0.0 0
M  V30 3 C 5.3900 2.6674 0.0 0
M  V30 4 C 4.6200 1.3336 0.0 0
M  V30 5 Cl 5.3900 0.0000 0.0 0
M  V30 6 F 10.0100 8.0021 0.0 0
M  V30 7 C 11.5500 5.3347 0.0 0
M  V30 8 O 12.3200 4.0011 0.0 0
M  V30 9 Si 13.8600 4.0011 0.0 0
M  V30 10 C 15.4000 4.0011 0.0 0
M  V30 11 C 13.8600 5.5411 0.0 0
M  V30 12 C 13.8600 2.4611 0.0 0
M  V30 13 C 15.4000 5.5411 0.0 0
M  V30 14 C 16.9400 4.0011 0.0 0
M  V30 15 C 15.4000 2.4611 0.0 0
M  V30 16 C 3.0800 4.0011 0.0 0
M  V30 17 C 2.3100 2.6674 0.0 0
M  V30 18 C 2.3100 5.3347 0.0 0
M  V30 19 C 0.7700 2.6674 0.0 0
M  V30 20 C 0.7700 5.3347 0.0 0
M  V30 21 C 0.0000 4.0011 0.0 0
M  V30 22 C 6.9300 5.3347 0.0 0
M  V30 23 C 7.7000 6.6685 0.0 0
M  V30 24 C 7.7000 4.0011 0.0 0
M  V30 25 C 9.2400 6.6685 0.0 0
M  V30 26 C 9.2400 4.0011 0.0 0
M  V30 27 C 10.0100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 16
M  V30 4 1 2 22
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 1 6 25
M  V30 8 1 7 8
M  V30 9 1 7 27
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 1 9 12
M  V30 14 1 10 13
M  V30 15 1 10 14
M  V30 16 1 10 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 23 2 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 2 24 26
M  V30 27 2 25 27
M  V30 28 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(γS)-γ-[4-[[[(1,1-Dimethylethyl)dimethylsilyl]oxy]methyl]-3-fluorophenoxy]-N-...
C23H34FNO2Si
2416740-12-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 29 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 5.3347 0.0 0 CFG=2
M  V30 2 O 5.3900 6.6684 0.0 0
M  V30 3 C 5.3900 4.0011 0.0 0
M  V30 4 C 4.6200 2.6674 0.0 0
M  V30 5 N 5.3900 1.3336 0.0 0
M  V30 6 C 4.6200 0.0000 0.0 0
M  V30 7 F 10.0100 9.3358 0.0 0
M  V30 8 C 11.5500 6.6684 0.0 0
M  V30 9 O 12.3200 5.3347 0.0 0
M  V30 10 Si 13.8600 5.3347 0.0 0
M  V30 11 C 15.4000 5.3347 0.0 0
M  V30 12 C 13.8600 3.7947 0.0 0
M  V30 13 C 13.8600 6.8747 0.0 0
M  V30 14 C 15.4000 6.8747 0.0 0
M  V30 15 C 16.9400 5.3347 0.0 0
M  V30 16 C 15.4000 3.7947 0.0 0
M  V30 17 C 3.0800 5.3347 0.0 0
M  V30 18 C 2.3100 4.0011 0.0 0
M  V30 19 C 2.3100 6.6684 0.0 0
M  V30 20 C 0.7700 4.0011 0.0 0
M  V30 21 C 0.7700 6.6684 0.0 0
M  V30 22 C 0.0000 5.3347 0.0 0
M  V30 23 C 6.9300 6.6684 0.0 0
M  V30 24 C 7.7000 8.0021 0.0 0
M  V30 25 C 7.7000 5.3347 0.0 0
M  V30 26 C 9.2400 8.0021 0.0 0
M  V30 27 C 9.2400 5.3347 0.0 0
M  V30 28 C 10.0100 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 17
M  V30 4 1 2 23
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 1 5 6
M  V30 8 1 7 26
M  V30 9 1 8 9
M  V30 10 1 8 28
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 1 10 12
M  V30 14 1 10 13
M  V30 15 1 11 14
M  V30 16 1 11 15
M  V30 17 1 11 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 24 2 23 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 2 25 27
M  V30 28 2 26 28
M  V30 29 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2416740-10-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2416740-12-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-22447860
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of tetrahydropyrimidodiazepin and tetrahydropyridodiazepin
compounds for treating pain and pain related conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cuevas-Cordobes, Felix; Almansa-Rosales, Carme
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020089478 A1 2020-05-07

$RFMT $RIREG SCHEME286 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Glycine, N-(3′-azido-3′-deoxy-5′-thymidylyl)-, 1-methyl ester
C13H19N6O8P
244284-05-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 29 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 2.1699 4.5167 0.0 0
M  V30 2 C 8.8935 4.9995 0.0 0
M  V30 3 O 9.6635 6.3331 0.0 0
M  V30 4 P 11.2035 6.3331 0.0 0 VAL=5
M  V30 5 N 12.7435 6.3331 0.0 0
M  V30 6 O 11.2035 4.7931 0.0 0
M  V30 7 O 11.2035 7.8731 0.0 0
M  V30 8 C 13.5135 7.6667 0.0 0
M  V30 9 C 15.0535 7.6667 0.0 0
M  V30 10 O 15.8235 9.0005 0.0 0
M  V30 11 O 15.8235 6.3331 0.0 0
M  V30 12 C 17.3635 9.0005 0.0 0
M  V30 13 N 6.9241 2.2889 0.0 0
M  V30 14 N 5.8937 1.1445 0.0 0 CHG=1 VAL=4
M  V30 15 N 4.8632 0.0000 0.0 0 CHG=-1
M  V30 16 C 2.8137 10.6429 0.0 0
M  V30 17 O 0.0000 9.3902 0.0 0
M  V30 18 C 4.9836 5.7695 0.0 0 CFG=1
M  V30 19 O 6.4483 6.2453 0.0 0
M  V30 20 C 4.9836 4.2295 0.0 0
M  V30 21 C 7.3535 4.9995 0.0 0 CFG=2
M  V30 22 C 6.4483 3.7536 0.0 0 CFG=2
M  V30 23 N 3.7377 6.6747 0.0 0
M  V30 24 C 2.3309 6.0482 0.0 0
M  V30 25 C 3.8987 8.2062 0.0 0
M  V30 26 N 1.0849 6.9534 0.0 0
M  V30 27 C 2.6528 9.1114 0.0 0
M  V30 28 C 1.2460 8.4849 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 24
M  V30 2 1 2 3
M  V30 3 1 21 2 CFG=3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 2 13 14
M  V30 14 1 22 13 CFG=1
M  V30 15 2 14 15
M  V30 16 1 16 27
M  V30 17 2 17 28
M  V30 18 1 18 19
M  V30 19 1 18 20
M  V30 20 1 18 23 CFG=3
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 22
M  V30 24 1 23 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 2 25 27
M  V30 28 1 26 28
M  V30 29 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 18 21 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Thymidine, 3′-azido-3′-deoxy-, 5′-[hydrogen [2-(methylamino)-2-oxoethyl]phosp...
C13H20N7O7P
245321-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 29 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 2.1699 4.5167 0.0 0
M  V30 2 C 8.8935 4.9995 0.0 0
M  V30 3 O 9.6635 6.3331 0.0 0
M  V30 4 P 11.2035 6.3331 0.0 0 VAL=5
M  V30 5 N 12.7435 6.3331 0.0 0
M  V30 6 O 11.2035 4.7931 0.0 0
M  V30 7 O 11.2035 7.8731 0.0 0
M  V30 8 C 13.5135 7.6667 0.0 0
M  V30 9 C 15.0535 7.6667 0.0 0
M  V30 10 N 15.8235 9.0005 0.0 0
M  V30 11 O 15.8235 6.3331 0.0 0
M  V30 12 C 17.3635 9.0005 0.0 0
M  V30 13 N 6.9241 2.2889 0.0 0
M  V30 14 N 5.8937 1.1445 0.0 0 CHG=1 VAL=4
M  V30 15 N 4.8632 0.0000 0.0 0 CHG=-1
M  V30 16 C 2.8137 10.6429 0.0 0
M  V30 17 O 0.0000 9.3902 0.0 0
M  V30 18 C 4.9836 5.7695 0.0 0 CFG=1
M  V30 19 O 6.4483 6.2453 0.0 0
M  V30 20 C 4.9836 4.2295 0.0 0
M  V30 21 C 7.3535 4.9995 0.0 0 CFG=2
M  V30 22 C 6.4483 3.7536 0.0 0 CFG=2
M  V30 23 N 3.7377 6.6747 0.0 0
M  V30 24 C 2.3309 6.0482 0.0 0
M  V30 25 C 3.8987 8.2062 0.0 0
M  V30 26 N 1.0849 6.9534 0.0 0
M  V30 27 C 2.6528 9.1114 0.0 0
M  V30 28 C 1.2460 8.4849 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 24
M  V30 2 1 2 3
M  V30 3 1 21 2 CFG=3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 2 13 14
M  V30 14 1 22 13 CFG=1
M  V30 15 2 14 15
M  V30 16 1 16 27
M  V30 17 2 17 28
M  V30 18 1 18 19
M  V30 19 1 18 20
M  V30 20 1 18 23 CFG=3
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 22
M  V30 24 1 23 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 2 25 27
M  V30 28 1 26 28
M  V30 29 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 18 21 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 244284-05-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 245321-01-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-16778766
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed vial used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, in Vitro Anti-Breast Cancer Activity, and Intracellular
Decomposition of Amino Acid Methyl Ester and Alkyl Amide Phosphoramidate
Monoesters of 3'-Azido-3'-deoxythymidine (AZT)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Iyer, Vidhya V.; Griesgraber, George W.; Radmer, Matthew R.; McIntee,
Edward J.; Wagner, Carston R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2000), 43(11), 2266-2274

$RFMT $RIREG SCHEME287 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C44H65N5O8
2447201-67-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  57 59 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.7533 5.2308 0.0 0
M  V30 2 O 7.0869 4.4608 0.0 0
M  V30 3 C 8.4206 5.2308 0.0 0
M  V30 4 N 9.7544 4.4608 0.0 0
M  V30 5 O 8.4206 6.7708 0.0 0
M  V30 6 C 11.0880 5.2308 0.0 0 CFG=1
M  V30 7 C 9.7544 2.9208 0.0 0
M  V30 8 C 12.4216 4.4608 0.0 0
M  V30 9 C 11.0880 6.7708 0.0 0
M  V30 10 N 13.7553 5.2308 0.0 0
M  V30 11 O 12.4216 2.9208 0.0 0
M  V30 12 C 15.0891 4.4608 0.0 0 CFG=1
M  V30 13 C 13.7553 6.7708 0.0 0
M  V30 14 C 16.4227 5.2308 0.0 0
M  V30 15 C 15.0891 2.9208 0.0 0 CFG=1
M  V30 16 N 17.7564 4.4608 0.0 0
M  V30 17 O 16.4227 6.7708 0.0 0
M  V30 18 C 13.7553 2.1508 0.0 0
M  V30 19 C 16.4227 2.1508 0.0 0
M  V30 20 C 19.0900 5.2308 0.0 0 CFG=1
M  V30 21 C 17.7564 2.9208 0.0 0
M  V30 22 C 13.7553 0.6108 0.0 0
M  V30 23 C 20.4238 4.4608 0.0 0
M  V30 24 C 19.0900 6.7708 0.0 0
M  V30 25 N 21.7574 5.2308 0.0 0
M  V30 26 O 20.4238 2.9208 0.0 0
M  V30 27 C 17.7564 7.5408 0.0 0
M  V30 28 C 20.4238 7.5408 0.0 0
M  V30 29 C 23.0911 4.4608 0.0 0 CFG=1
M  V30 30 C 24.4247 5.2308 0.0 0
M  V30 31 C 23.0911 2.9208 0.0 0
M  V30 32 N 25.7585 4.4608 0.0 0
M  V30 33 O 24.4247 6.7708 0.0 0
M  V30 34 C 24.4247 2.1508 0.0 0
M  V30 35 C 21.7574 2.1508 0.0 0
M  V30 36 C 27.0921 5.2308 0.0 0 CFG=2
M  V30 37 C 25.7585 2.9208 0.0 0
M  V30 38 C 28.4258 4.4608 0.0 0 CFG=1
M  V30 39 C 27.0921 6.7708 0.0 0
M  V30 40 C 29.7594 5.2308 0.0 0
M  V30 41 C 28.4258 2.9208 0.0 0
M  V30 42 O 25.7585 7.5408 0.0 0
M  V30 43 O 28.4258 7.5408 0.0 0
M  V30 44 C 31.0932 4.4608 0.0 0
M  V30 45 C 4.4196 4.4608 0.0 0
M  V30 46 C 4.2586 2.9292 0.0 0
M  V30 47 C 3.0127 5.0872 0.0 0
M  V30 48 C 2.7523 2.6091 0.0 0
M  V30 49 C 5.2891 1.7847 0.0 0
M  V30 50 C 1.9823 3.9427 0.0 0
M  V30 51 C 2.5368 6.5518 0.0 0
M  V30 52 C 2.2764 1.1444 0.0 0
M  V30 53 C 4.8133 0.3202 0.0 0
M  V30 54 C 0.4759 4.2629 0.0 0
M  V30 55 C 1.0306 6.8719 0.0 0
M  V30 56 C 3.3068 0.0000 0.0 0
M  V30 57 C 0.0000 5.7276 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 45
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 6 9 CFG=1
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 12 10 CFG=3
M  V30 13 1 10 13
M  V30 14 1 12 14
M  V30 15 1 12 15
M  V30 16 1 14 16
M  V30 17 2 14 17
M  V30 18 1 15 18
M  V30 19 1 15 19 CFG=1
M  V30 20 1 16 20
M  V30 21 1 16 21
M  V30 22 1 18 22
M  V30 23 1 20 23
M  V30 24 1 20 24 CFG=1
M  V30 25 1 23 25
M  V30 26 2 23 26
M  V30 27 1 24 27
M  V30 28 1 24 28
M  V30 29 1 25 29
M  V30 30 1 29 30
M  V30 31 1 29 31 CFG=3
M  V30 32 1 30 32
M  V30 33 2 30 33
M  V30 34 1 31 34
M  V30 35 1 31 35
M  V30 36 1 36 32 CFG=3
M  V30 37 1 32 37
M  V30 38 1 36 38
M  V30 39 1 36 39
M  V30 40 1 38 40
M  V30 41 1 38 41 CFG=3
M  V30 42 1 39 42
M  V30 43 2 39 43
M  V30 44 1 40 44
M  V30 45 1 45 46
M  V30 46 1 45 47
M  V30 47 1 46 48
M  V30 48 2 46 49
M  V30 49 1 47 50
M  V30 50 2 47 51
M  V30 51 1 48 50
M  V30 52 2 48 52
M  V30 53 1 49 53
M  V30 54 2 50 54
M  V30 55 1 51 55
M  V30 56 1 52 56
M  V30 57 2 53 56
M  V30 58 1 54 57
M  V30 59 2 55 57
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(7 6 12 15 20 29 36 38)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C30H58N6O5
2447201-33-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 40 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 16.0041 4.6200 0.0 0 CFG=2
M  V30 2 C 14.6705 3.8500 0.0 0
M  V30 3 N 17.3378 3.8500 0.0 0
M  V30 4 C 16.0041 6.1600 0.0 0 CFG=1
M  V30 5 N 13.3367 4.6200 0.0 0
M  V30 6 O 14.6705 2.3100 0.0 0
M  V30 7 C 18.6714 4.6200 0.0 0
M  V30 8 C 17.3378 2.3100 0.0 0
M  V30 9 C 17.3378 6.9300 0.0 0
M  V30 10 C 14.6705 6.9300 0.0 0
M  V30 11 C 12.0031 3.8500 0.0 0 CFG=1
M  V30 12 C 13.3367 6.1600 0.0 0
M  V30 13 C 20.0052 3.8500 0.0 0 CFG=2
M  V30 14 O 18.6714 6.1600 0.0 0
M  V30 15 C 17.3378 8.4700 0.0 0
M  V30 16 C 10.6694 4.6200 0.0 0
M  V30 17 C 12.0031 2.3100 0.0 0
M  V30 18 N 21.3389 4.6200 0.0 0
M  V30 19 C 20.0052 2.3100 0.0 0
M  V30 20 N 9.3358 3.8500 0.0 0
M  V30 21 O 10.6694 6.1600 0.0 0
M  V30 22 C 13.3367 1.5400 0.0 0
M  V30 23 C 10.6694 1.5400 0.0 0
M  V30 24 C 22.6725 3.8500 0.0 0
M  V30 25 C 8.0020 4.6200 0.0 0 CFG=1
M  V30 26 C 6.6684 3.8500 0.0 0
M  V30 27 C 8.0020 6.1600 0.0 0
M  V30 28 N 5.3347 4.6200 0.0 0
M  V30 29 O 6.6684 2.3100 0.0 0
M  V30 30 C 9.3358 6.9300 0.0 0
M  V30 31 C 6.6684 6.9300 0.0 0
M  V30 32 C 4.0011 3.8500 0.0 0 CFG=2
M  V30 33 C 5.3347 6.1600 0.0 0
M  V30 34 C 4.0011 2.3100 0.0 0 CFG=1
M  V30 35 C 2.6673 4.6200 0.0 0
M  V30 36 C 2.6673 1.5400 0.0 0
M  V30 37 C 5.3347 1.5400 0.0 0
M  V30 38 N 1.3336 3.8500 0.0 0
M  V30 39 O 2.6673 6.1600 0.0 0
M  V30 40 C 2.6673 0.0000 0.0 0
M  V30 41 C 0.0000 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 1 3 8
M  V30 8 1 4 9
M  V30 9 1 4 10 CFG=1
M  V30 10 1 5 11
M  V30 11 1 5 12
M  V30 12 1 7 13
M  V30 13 2 7 14
M  V30 14 1 9 15
M  V30 15 1 11 16
M  V30 16 1 11 17 CFG=1
M  V30 17 1 13 18
M  V30 18 1 13 19 CFG=1
M  V30 19 1 16 20
M  V30 20 2 16 21
M  V30 21 1 17 22
M  V30 22 1 17 23
M  V30 23 1 18 24
M  V30 24 1 20 25
M  V30 25 1 25 26
M  V30 26 1 25 27 CFG=3
M  V30 27 1 26 28
M  V30 28 2 26 29
M  V30 29 1 27 30
M  V30 30 1 27 31
M  V30 31 1 32 28 CFG=1
M  V30 32 1 28 33
M  V30 33 1 32 34
M  V30 34 1 32 35
M  V30 35 1 34 36
M  V30 36 1 34 37 CFG=1
M  V30 37 1 35 38
M  V30 38 2 35 39
M  V30 39 1 36 40
M  V30 40 1 38 41
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(7 1 4 11 13 25 32 34)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2447201-67-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2447201-33-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-353-CAS-22279748
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 111-96-6
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(5):CAS_RN
$DATUM 6674-22-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM N-methylated peptide synthesis via generation of an acyl
N-methylimidazolium cation accelerated by a Broensted acid
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Otake, Yuma; Shibata, Yusuke; Hayashi, Yoshihiro; Kawauchi, Susumu;
Nakamura, Hiroyuki; Fuse, Shinichiro
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2020), 59(31), 12925-12930

$RFMT $RIREG SCHEME288 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dimethylformamide dimethyl acetal
C5H13NO2
4637-24-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 N 1.3338 1.5400 0.0 0
M  V30 3 O 4.0011 1.5400 0.0 0
M  V30 4 O 2.6674 3.8500 0.0 0
M  V30 5 C 0.0000 2.3100 0.0 0
M  V30 6 C 1.3338 0.0000 0.0 0
M  V30 7 C 5.3349 2.3100 0.0 0
M  V30 8 C 4.0011 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 3-amino-6-(4-methoxyphenyl)-4-(2-thienyl)thieno[2,3-b]pyridine-2-carbox...
C21H18N2O3S2
2476398-40-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.9426 2.7392 0.0 0
M  V30 2 C 11.9120 5.4498 0.0 0
M  V30 3 O 12.6820 6.7834 0.0 0
M  V30 4 O 12.6820 4.1161 0.0 0
M  V30 5 C 14.2220 6.7834 0.0 0
M  V30 6 C 14.9920 8.1172 0.0 0
M  V30 7 O 0.0000 9.2998 0.0 0
M  V30 8 C 0.0000 10.8398 0.0 0
M  V30 9 C 8.0022 4.6798 0.0 0
M  V30 10 C 6.6684 3.9098 0.0 0
M  V30 11 C 8.0022 6.2198 0.0 0
M  V30 12 C 9.4667 4.2039 0.0 0
M  V30 13 C 5.3347 4.6798 0.0 0
M  V30 14 N 6.6684 6.9898 0.0 0
M  V30 15 S 9.4667 6.6956 0.0 0
M  V30 16 C 10.3720 5.4498 0.0 0
M  V30 17 C 5.3347 6.2198 0.0 0
M  V30 18 C 6.6684 2.3698 0.0 0
M  V30 19 C 7.9143 1.4645 0.0 0
M  V30 20 S 5.4225 1.4645 0.0 0
M  V30 21 C 7.4384 0.0000 0.0 0
M  V30 22 C 5.8984 0.0000 0.0 0
M  V30 23 C 4.0011 6.9898 0.0 0
M  V30 24 C 2.6674 6.2198 0.0 0
M  V30 25 C 4.0011 8.5298 0.0 0
M  V30 26 C 1.3336 6.9898 0.0 0
M  V30 27 C 2.6674 9.2998 0.0 0
M  V30 28 C 1.3336 8.5298 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 16
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 1 7 28
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 1 10 18
M  V30 14 2 11 14
M  V30 15 1 11 15
M  V30 16 2 12 16
M  V30 17 2 13 17
M  V30 18 1 14 17
M  V30 19 1 15 16
M  V30 20 1 17 23
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-(4-Methoxyphenyl)-3-methyl-9-(2-thienyl)pyrido[3′,2′:4,5]thieno[3,2-d]pyrim...
C21H15N3O2S2
2659292-57-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.4918 9.1145 0.0 0
M  V30 2 C 0.0000 7.3040 0.0 0
M  V30 3 O 14.9672 5.1047 0.0 0
M  V30 4 C 15.7372 6.4384 0.0 0
M  V30 5 C 5.7270 5.1047 0.0 0
M  V30 6 C 4.2206 5.4249 0.0 0
M  V30 7 C 6.4970 3.7711 0.0 0
M  V30 8 C 6.4970 6.4384 0.0 0
M  V30 9 C 4.0597 6.9566 0.0 0
M  V30 10 N 2.9747 4.5197 0.0 0
M  V30 11 C 8.0371 3.7711 0.0 0
M  V30 12 S 5.4666 7.5829 0.0 0
M  V30 13 N 8.0371 6.4384 0.0 0
M  V30 14 C 2.6528 7.5829 0.0 0
M  V30 15 C 1.5679 5.1461 0.0 0
M  V30 16 C 8.8071 5.1047 0.0 0
M  V30 17 N 1.4070 6.6777 0.0 0
M  V30 18 C 5.7270 2.4374 0.0 0
M  V30 19 C 6.3534 1.0304 0.0 0
M  V30 20 S 4.1955 2.2763 0.0 0
M  V30 21 C 5.2090 0.0000 0.0 0
M  V30 22 C 3.8753 0.7700 0.0 0
M  V30 23 C 10.3471 5.1047 0.0 0
M  V30 24 C 11.1171 6.4384 0.0 0
M  V30 25 C 11.1171 3.7711 0.0 0
M  V30 26 C 12.6571 6.4384 0.0 0
M  V30 27 C 12.6571 3.7711 0.0 0
M  V30 28 C 13.4272 5.1047 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 14
M  V30 2 1 2 17
M  V30 3 1 3 4
M  V30 4 1 3 28
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 2 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 7 18
M  V30 12 1 8 12
M  V30 13 2 8 13
M  V30 14 1 9 12
M  V30 15 1 9 14
M  V30 16 2 10 15
M  V30 17 2 11 16
M  V30 18 1 13 16
M  V30 19 1 14 17
M  V30 20 1 15 17
M  V30 21 1 16 23
M  V30 22 2 18 19
M  V30 23 1 18 20
M  V30 24 1 19 21
M  V30 25 1 20 22
M  V30 26 2 21 22
M  V30 27 2 23 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 2 25 27
M  V30 31 2 26 28
M  V30 32 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4637-24-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 2476398-40-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2659292-57-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24323741
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):NOTES
$DATUM microwave irradiation (300W)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 3-Aminothieno [2,3-b]pyridine-2-carboxylate: Effective precursor for
microwave-assisted three components synthesis of new
pyrido[3',2':4,5]thieno[3,2-d]pyrimidin-4( 3H )-one hybrids
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mohamed Teleb, Mohamed A.; Mekky, Ahmed E. M.; Sanad, Sherif M. H.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Heterocyclic Chemistry (2021), 58(9), 1825-1835

$RFMT $RIREG SCHEME289 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Cyanobenzaldehyde
C8H5NO
24964-64-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 C 6.6687 3.0801 0.0 0
M  V30 4 O 8.0023 2.3101 0.0 0
M  V30 5 C 4.0012 3.0801 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 5.3348 2.3101 0.0 0
M  V30 8 C 2.6675 0.7700 0.0 0
M  V30 9 C 5.3348 0.7700 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 6
M  V30 3 2 3 4
M  V30 4 1 3 7
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[(Methylamino)methyl]benzonitrile
C9H10N2
90389-96-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.0801 0.0 0
M  V30 2 N 8.0023 2.3101 0.0 0
M  V30 3 C 9.3360 3.0801 0.0 0
M  V30 4 C 1.3337 3.0801 0.0 0
M  V30 5 N 0.0000 3.8501 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 5.3348 0.7700 0.0 0
M  V30 9 C 2.6675 2.3101 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 3 4 5
M  V30 5 1 4 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 24964-64-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 90389-96-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-2072460
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Boronic acid based photoinduced electron transfer (PET) fluorescence
sensors for saccharides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Larkin, Joseph D.; Frimat, Karine A.; Fyles, Thomas M.; Flower, Stephen
E.; James, Tony D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM New Journal of Chemistry (2010), 34(12), 2922-2931

$RFMT $RIREG SCHEME290 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Quinolinecarboxaldehyde, 4-(1-naphthalenyl)-2-phenyl-, (4S)-
C26H17NO
2594952-38-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.7000 2.6674 0.0 0
M  V30 2 O 9.2400 2.6674 0.0 0
M  V30 3 C 5.3900 4.0011 0.0 0
M  V30 4 C 4.6200 5.3347 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 C 5.3900 6.6685 0.0 0
M  V30 7 C 3.0800 5.3347 0.0 0
M  V30 8 C 7.7000 5.3347 0.0 0
M  V30 9 N 6.9300 6.6685 0.0 0
M  V30 10 C 4.6200 8.0021 0.0 0
M  V30 11 C 2.3100 6.6685 0.0 0
M  V30 12 C 3.0800 8.0021 0.0 0
M  V30 13 C 4.6200 2.6674 0.0 0
M  V30 14 C 3.0800 2.6674 0.0 0
M  V30 15 C 5.3900 1.3336 0.0 0
M  V30 16 C 2.3100 1.3336 0.0 0
M  V30 17 C 2.3100 4.0011 0.0 0
M  V30 18 C 4.6200 0.0000 0.0 0
M  V30 19 C 3.0800 0.0000 0.0 0
M  V30 20 C 0.7700 1.3336 0.0 0
M  V30 21 C 0.7700 4.0011 0.0 0
M  V30 22 C 0.0000 2.6674 0.0 0
M  V30 23 C 9.2400 5.3347 0.0 0
M  V30 24 C 10.0100 4.0011 0.0 0
M  V30 25 C 10.0100 6.6685 0.0 0
M  V30 26 C 11.5500 4.0011 0.0 0
M  V30 27 C 11.5500 6.6685 0.0 0
M  V30 28 C 12.3200 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 13
M  V30 6 2 4 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 6 10
M  V30 11 2 7 11
M  V30 12 2 8 9
M  V30 13 1 8 23
M  V30 14 2 10 12
M  V30 15 1 11 12
M  V30 16 1 13 14
M  V30 17 2 13 15
M  V30 18 2 14 16
M  V30 19 1 14 17
M  V30 20 1 15 18
M  V30 21 1 16 19
M  V30 22 1 16 20
M  V30 23 2 17 21
M  V30 24 2 18 19
M  V30 25 2 20 22
M  V30 26 1 21 22
M  V30 27 2 23 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 2 25 27
M  V30 31 2 26 28
M  V30 32 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Tosyl chloride
C7H7ClO2S
98-59-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.5400 1.5400 0.0 0 VAL=6
M  V30 2 Cl 0.0000 1.5400 0.0 0
M  V30 3 O 1.5400 3.0800 0.0 0
M  V30 4 O 1.5400 0.0000 0.0 0
M  V30 5 C 7.7000 1.5400 0.0 0
M  V30 6 C 3.0800 1.5400 0.0 0
M  V30 7 C 3.8500 0.2064 0.0 0
M  V30 8 C 3.8500 2.8736 0.0 0
M  V30 9 C 5.3900 0.2064 0.0 0
M  V30 10 C 5.3900 2.8736 0.0 0
M  V30 11 C 6.1600 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 6
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C34H28N2O2S
2624061-74-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 44 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 5.3347 0.0 0
M  V30 2 N 7.7000 6.6684 0.0 0
M  V30 3 S 9.2400 6.6684 0.0 0 VAL=6
M  V30 4 C 6.9300 8.0021 0.0 0
M  V30 5 O 9.2400 8.2084 0.0 0
M  V30 6 O 9.2400 5.1284 0.0 0
M  V30 7 C 15.4000 6.6684 0.0 0
M  V30 8 C 4.6200 6.6684 0.0 0
M  V30 9 C 5.3900 5.3347 0.0 0
M  V30 10 C 3.0800 6.6684 0.0 0
M  V30 11 C 4.6200 4.0011 0.0 0
M  V30 12 C 2.3100 5.3347 0.0 0
M  V30 13 C 2.3100 8.0021 0.0 0
M  V30 14 N 3.0800 4.0011 0.0 0
M  V30 15 C 0.7700 5.3347 0.0 0
M  V30 16 C 0.7700 8.0021 0.0 0
M  V30 17 C 0.0000 6.6684 0.0 0
M  V30 18 C 5.0186 8.1560 0.0 0
M  V30 19 C 3.9296 9.2449 0.0 0
M  V30 20 C 6.5060 8.5545 0.0 0
M  V30 21 C 4.3282 10.7324 0.0 0
M  V30 22 C 2.4421 8.8462 0.0 0
M  V30 23 C 6.9047 10.0420 0.0 0
M  V30 24 C 5.8158 11.1310 0.0 0
M  V30 25 C 3.2392 11.8213 0.0 0
M  V30 26 C 1.3532 9.9353 0.0 0
M  V30 27 C 1.7518 11.4228 0.0 0
M  V30 28 C 5.3900 2.6674 0.0 0
M  V30 29 C 4.6200 1.3336 0.0 0
M  V30 30 C 6.9300 2.6674 0.0 0
M  V30 31 C 5.3900 0.0000 0.0 0
M  V30 32 C 7.7000 1.3336 0.0 0
M  V30 33 C 6.9300 0.0000 0.0 0
M  V30 34 C 10.7800 6.6684 0.0 0
M  V30 35 C 11.5500 5.3347 0.0 0
M  V30 36 C 11.5500 8.0021 0.0 0
M  V30 37 C 13.0900 5.3347 0.0 0
M  V30 38 C 13.0900 8.0021 0.0 0
M  V30 39 C 13.8600 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 2 3 5
M  V30 6 2 3 6
M  V30 7 1 3 34
M  V30 8 1 7 39
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 8 18
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 14 1 10 13
M  V30 15 2 11 14
M  V30 16 1 11 28
M  V30 17 1 12 14
M  V30 18 1 12 15
M  V30 19 2 13 16
M  V30 20 2 15 17
M  V30 21 1 16 17
M  V30 22 1 18 19
M  V30 23 2 18 20
M  V30 24 2 19 21
M  V30 25 1 19 22
M  V30 26 1 20 23
M  V30 27 1 21 24
M  V30 28 1 21 25
M  V30 29 2 22 26
M  V30 30 2 23 24
M  V30 31 2 25 27
M  V30 32 1 26 27
M  V30 33 2 28 29
M  V30 34 1 28 30
M  V30 35 1 29 31
M  V30 36 2 30 32
M  V30 37 2 31 33
M  V30 38 1 32 33
M  V30 39 2 34 35
M  V30 40 1 34 36
M  V30 41 1 35 37
M  V30 42 2 36 38
M  V30 43 2 37 39
M  V30 44 1 38 39
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2594952-38-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 98-59-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2624061-74-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-23280677
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 110-86-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 107-06-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM 95% ee
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Organocatalyzed Cascade Aza-Michael/Aldol Reaction for Atroposelective
Construction of 4-Naphthylquinoline-3-carbaldehydes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Jing; Xu, Yong; Wang, Zhiming; Zhong, Rong; Wang, Yurong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2021), 86(5), 4262-4273

$RFMT $RIREG SCHEME291 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(OC-6-21)-Pentacarbonyl(ethoxyphenylmethylene)chromium
C14H10CrO6
26160-57-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cr 3.8909 7.2148 0.0 0 CHG=2 VAL=7
M  V30 2 C 3.8909 3.0189 0.0 0 CHG=-2 VAL=4
M  V30 3 C 2.5183 9.6941 0.0 0
M  V30 4 C 5.2674 4.7317 0.0 0
M  V30 5 C 6.3741 8.5874 0.0 0
M  V30 6 C 3.8909 10.0499 0.0 0
M  V30 7 C 1.4117 5.8383 0.0 0
M  V30 8 O 5.1188 2.3111 0.0 0
M  V30 9 O 1.2905 10.4018 0.0 0 VAL=3
M  V30 10 O 6.4953 4.0239 0.0 0 VAL=3
M  V30 11 O 7.6020 7.8796 0.0 0 VAL=3
M  V30 12 O 2.6669 10.7577 0.0 0 VAL=3
M  V30 13 O 0.1838 6.5461 0.0 0 VAL=3
M  V30 14 C 6.3467 3.0189 0.0 0
M  V30 15 C 7.5902 2.3306 0.0 0
M  V30 16 C 2.6669 2.3111 0.0 0
M  V30 17 C 1.3335 3.0814 0.0 0
M  V30 18 C 2.6669 0.7704 0.0 0
M  V30 19 C 0.0000 2.3111 0.0 0
M  V30 20 C 1.3335 0.0000 0.0 0
M  V30 21 C 0.0000 0.7704 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 1 6
M  V30 6 1 1 7
M  V30 7 1 2 8
M  V30 8 1 2 16
M  V30 9 3 3 9
M  V30 10 3 4 10
M  V30 11 3 5 11
M  V30 12 3 6 12
M  V30 13 3 7 13
M  V30 14 1 8 14
M  V30 15 1 14 15
M  V30 16 2 16 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 2 18 20
M  V30 20 2 19 21
M  V30 21 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(OC-6-21)-Pentacarbonyl[(methylamino)phenylmethylene]chromium
C13H9CrNO5
35797-14-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cr 3.8930 7.2114 0.0 0 CHG=2 VAL=7
M  V30 2 C 3.8930 3.0175 0.0 0 CHG=-2 VAL=4
M  V30 3 C 2.5211 9.6895 0.0 0
M  V30 4 C 5.2649 4.7294 0.0 0
M  V30 5 C 6.3711 8.5834 0.0 0
M  V30 6 C 3.8930 10.0452 0.0 0
M  V30 7 C 1.4149 5.8356 0.0 0
M  V30 8 N 5.1203 2.3100 0.0 0
M  V30 9 O 1.2938 10.3970 0.0 0 VAL=3
M  V30 10 O 6.4961 4.0220 0.0 0 VAL=3
M  V30 11 O 7.5984 7.8759 0.0 0 VAL=3
M  V30 12 O 2.6657 10.7526 0.0 0 VAL=3
M  V30 13 O 0.1876 6.5430 0.0 0 VAL=3
M  V30 14 C 6.5157 3.1152 0.0 0
M  V30 15 C 2.6657 2.3100 0.0 0
M  V30 16 C 1.3368 3.0800 0.0 0
M  V30 17 C 2.6657 0.7700 0.0 0
M  V30 18 C 0.0000 2.3100 0.0 0
M  V30 19 C 1.3368 0.0000 0.0 0
M  V30 20 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 1 6
M  V30 6 1 1 7
M  V30 7 1 2 8
M  V30 8 1 2 15
M  V30 9 3 3 9
M  V30 10 3 4 10
M  V30 11 3 5 11
M  V30 12 3 6 12
M  V30 13 3 7 13
M  V30 14 1 8 14
M  V30 15 2 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 2 17 19
M  V30 19 2 18 20
M  V30 20 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 26160-57-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 35797-14-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-032-CAS-4309878
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, 30:70 syn:anti
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Solution and solid state conformation of Fischer carbene complexes
vis-a-vis conformation of aryl carboxamides: complexation of the aromatic
ring by tricarbonylchromium makes a difference
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jayaprakash, K. N.; Hazra, Debasis; Hagen, Karl S.; Samanta, Uttamkumar;
Bhadbhade, Mohan M.; Puranik, Vedavati G.; Sarkar, Amitabha
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organometallic Chemistry (2001), 617-618709-722

$RFMT $RIREG SCHEME292 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromobenzenecarbothioamide
C7H6BrNS
26197-93-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 N 0.0000 0.0000 0.0 0
M  V30 3 S 0.0000 2.6673 0.0 0
M  V30 4 Br 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-N-methylbenzenecarbothioamide
C8H8BrNS
920510-22-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 N 1.5400 2.6673 0.0 0
M  V30 3 S 1.5400 0.0000 0.0 0
M  V30 4 C 0.0000 2.6673 0.0 0
M  V30 5 Br 8.4702 1.3337 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 6.1601 2.6673 0.0 0
M  V30 10 C 6.1601 0.0000 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 26197-93-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 920510-22-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-033-CAS-10884581
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General procedure for the synthesis of
N-methylthioamide 6. Primary thioamide 5 (0.005 mol) was dissolved in 33%
methylamine in absolute ethanol (10 mL) and the solution allowed to stand
for three days at room temperature until the substrate was consumed, as
followed by TLC, and then the solution was concentrated in vacuo. The
oily residue was solidified upon treatment of ice-water or keeping the
flask in the refrigerator until encrustation occurred to give pure sample
6. It can be also purified by column chromatography on silica gel
(100-200 mesh, 18:1 chloroform-methanol) and recrystallized from aqueous
isopropanol. Considerable recovery of starting material 5a was observed
when the reaction was carried out in 33% dimethylamine in absolute
ethanol under conditions analogous to those used above. 3.3.3
N-Methyl(thio-4-bromobenzamide) (6c). 92%. mp 135-136 °C; IR v (cm-1):
3334, 3012, 2965, 2925, 1585, 1564, 1537, 1483, 1446, 1394, 1360, 1352,
1302, 1273, 1255, 593; 1H NMR δ (ppm): 3.14 (d, 3H, J = 4.4 Hz, CH3),
7.64 (d, 2H, J = 8.8 Hz), 7.73 (d 2H, J = 8.8Hz), 10.38 (brs, 1H, NH) 13C
NMR δ (ppm): 33.5, 124.3, 129.1, 131.0, 139.8 195.9; LRMS (EI): 232 (14),
231 (100), 230 (94), 229 (97), 228 (82). HRMS (EI): M+•, found 228.9550
and 230.9556. C8H8 79BrNS and C8H8 81BrNS require 228.9561 and 230.9540
appropriately.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Convenient syntheses of N-methylthioamides: a migration of the H2S
molecule in the thioamide-nitrile system
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Spychala, Jaroslaw
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Sulfur Chemistry (2006), 27(3), 203-212

$RFMT $RIREG SCHEME293 STEP1
$RXN



  4  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phthalaldehyde
C8H6O2
643-79-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 4.0010 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 C 4.6201 4.0010 0.0 0
M  V30 4 O 6.1601 4.0010 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.8501 2.6673 0.0 0
M  V30 7 C 1.5400 1.3337 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 2.3101 0.0000 0.0 0
M  V30 10 C 3.8501 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 2 3 4
M  V30 4 1 3 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Diethyl acetylenedicarboxylate
C8H10O4
762-21-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.8501 0.0 0
M  V30 2 C 5.3348 3.0801 0.0 0
M  V30 3 O 2.6673 3.0801 0.0 0
M  V30 4 O 4.0012 5.3901 0.0 0
M  V30 5 C 6.6685 2.3101 0.0 0
M  V30 6 C 1.3337 3.8501 0.0 0
M  V30 7 C 8.0022 1.5400 0.0 0
M  V30 8 C 0.0000 3.0801 0.0 0
M  V30 9 O 9.3360 2.3101 0.0 0
M  V30 10 O 8.0022 0.0000 0.0 0
M  V30 11 C 10.6697 1.5400 0.0 0
M  V30 12 C 12.0033 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 3 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 9 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxyphenacyl bromide
C9H9BrO2
2632-13-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 C 1.3337 2.3101 0.0 0
M  V30 3 O 2.6675 0.0000 0.0 0
M  V30 4 Br 0.0000 1.5400 0.0 0
M  V30 5 O 8.0023 4.6201 0.0 0
M  V30 6 C 9.3360 3.8501 0.0 0
M  V30 7 C 4.0012 2.3101 0.0 0
M  V30 8 C 4.0012 3.8501 0.0 0
M  V30 9 C 5.3348 1.5400 0.0 0
M  V30 10 C 5.3348 4.6201 0.0 0
M  V30 11 C 6.6685 2.3101 0.0 0
M  V30 12 C 6.6685 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4,6-Triethyl 4a-ethoxy-1-(4-methoxyphenyl)-4aH,13bH-benzo[a]pyrano[4,3-h]qu...
C34H35NO9
2624254-46-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  44 48 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.0021 3.8500 0.0 0
M  V30 2 C 9.3358 3.0800 0.0 0
M  V30 3 C 9.3358 1.5400 0.0 0
M  V30 4 C 6.6685 3.0800 0.0 0
M  V30 5 O 5.3347 2.3100 0.0 0
M  V30 6 O 8.0021 2.3100 0.0 0
M  V30 7 C 5.3347 0.7700 0.0 0
M  V30 8 C 4.0011 0.0000 0.0 0
M  V30 9 C 4.0011 4.6200 0.0 0
M  V30 10 O 2.6674 5.3900 0.0 0
M  V30 11 O 4.0011 3.0800 0.0 0
M  V30 12 C 1.3338 4.6200 0.0 0
M  V30 13 C 0.0000 5.3900 0.0 0
M  V30 14 C 12.0032 4.6200 0.0 0
M  V30 15 O 13.3369 5.3900 0.0 0
M  V30 16 O 12.0032 3.0800 0.0 0
M  V30 17 C 14.6705 4.6200 0.0 0
M  V30 18 C 16.0043 5.3900 0.0 0
M  V30 19 O 4.0651 13.2828 0.0 0
M  V30 20 C 2.5310 13.4171 0.0 0
M  V30 21 C 8.0021 6.9300 0.0 0
M  V30 22 C 8.0021 5.3900 0.0 0
M  V30 23 C 9.3358 7.7000 0.0 0
M  V30 24 C 6.6685 7.7000 0.0 0
M  V30 25 C 6.6685 4.6200 0.0 0
M  V30 26 C 9.3358 4.6200 0.0 0
M  V30 27 N 10.6696 6.9300 0.0 0
M  V30 28 C 9.3358 9.2400 0.0 0
M  V30 29 O 5.3347 6.9300 0.0 0
M  V30 30 C 5.3347 5.3900 0.0 0
M  V30 31 C 10.6696 5.3900 0.0 0
M  V30 32 C 12.0032 7.7000 0.0 0
M  V30 33 C 10.6696 10.0100 0.0 0
M  V30 34 C 8.0021 10.0100 0.0 0
M  V30 35 C 12.0032 9.2400 0.0 0
M  V30 36 C 10.6696 11.5500 0.0 0
M  V30 37 C 8.0021 11.5500 0.0 0
M  V30 38 C 9.3358 12.3200 0.0 0
M  V30 39 C 6.0177 9.0957 0.0 0
M  V30 40 C 6.9009 10.3573 0.0 0
M  V30 41 C 4.4836 9.2300 0.0 0
M  V30 42 C 6.2501 11.7530 0.0 0
M  V30 43 C 3.8326 10.6257 0.0 0
M  V30 44 C 4.7159 11.8871 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 22
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 25
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 30
M  V30 12 1 10 12
M  V30 13 1 12 13
M  V30 14 1 14 15
M  V30 15 2 14 16
M  V30 16 1 14 31
M  V30 17 1 15 17
M  V30 18 1 17 18
M  V30 19 1 19 20
M  V30 20 1 19 44
M  V30 21 1 21 22
M  V30 22 1 21 23
M  V30 23 2 21 24
M  V30 24 1 22 25
M  V30 25 1 22 26
M  V30 26 1 23 27
M  V30 27 1 23 28
M  V30 28 1 24 29
M  V30 29 1 24 39
M  V30 30 2 25 30
M  V30 31 2 26 31
M  V30 32 1 27 31
M  V30 33 1 27 32
M  V30 34 1 28 33
M  V30 35 2 28 34
M  V30 36 1 29 30
M  V30 37 2 32 35
M  V30 38 1 33 35
M  V30 39 2 33 36
M  V30 40 1 34 37
M  V30 41 1 36 38
M  V30 42 2 37 38
M  V30 43 2 39 40
M  V30 44 1 39 41
M  V30 45 1 40 42
M  V30 46 2 41 43
M  V30 47 2 42 44
M  V30 48 1 43 44
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 643-79-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 762-21-0
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 2632-13-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2624254-46-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25586552
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, ultrasound, phosphonium salt prepared in stage 3 was
added in stage 4 to isoquinolinium intermediate prepared in stages 1-2,
alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Ultrasound-promoted Green Synthesis of Pyrido[2,1-a]isoquinoline
Derivatives and Studies on their Antioxidant Activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sharafian, Shirin; Hossaini, Zinatossadat; Rostami-Charati, Faramarz;
Khalilzadeh, Mohammad A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Combinatorial Chemistry & High Throughput Screening (2021), 24(1),
119-128

$RFMT $RIREG SCHEME294 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,6-Dichloro-N-[3-methoxy-4-(5-oxazolyl)phenyl]-1,3,5-triazin-2-amine
C13H9Cl2N5O2
267648-08-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.9098 1.3336 0.0 0
M  V30 2 C 4.6798 0.0000 0.0 0
M  V30 3 N 8.5298 4.0011 0.0 0
M  V30 4 Cl 13.1498 6.6684 0.0 0
M  V30 5 Cl 8.5298 9.3358 0.0 0
M  V30 6 C 3.9098 4.0011 0.0 0
M  V30 7 C 4.6798 2.6674 0.0 0
M  V30 8 C 4.6798 5.3347 0.0 0
M  V30 9 C 6.2198 2.6674 0.0 0
M  V30 10 C 6.2198 5.3347 0.0 0
M  V30 11 C 6.9898 4.0011 0.0 0
M  V30 12 C 2.3698 4.0011 0.0 0
M  V30 13 C 1.4645 5.2470 0.0 0
M  V30 14 O 1.4645 2.7552 0.0 0
M  V30 15 N 0.0000 4.7711 0.0 0
M  V30 16 C 0.0000 3.2311 0.0 0
M  V30 17 C 9.2998 5.3347 0.0 0
M  V30 18 N 10.8398 5.3347 0.0 0
M  V30 19 N 8.5298 6.6684 0.0 0
M  V30 20 C 11.6098 6.6684 0.0 0
M  V30 21 C 9.2998 8.0022 0.0 0
M  V30 22 N 10.8398 8.0022 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 3 11
M  V30 4 1 3 17
M  V30 5 1 4 20
M  V30 6 1 5 21
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 6 12
M  V30 10 1 7 9
M  V30 11 2 8 10
M  V30 12 2 9 11
M  V30 13 1 10 11
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 16
M  V30 19 1 17 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-N2-[3-methoxy-4-(5-oxazolyl)phenyl]-N4-methyl-1,3,5-triazine-2,4-dia...
C14H13ClN6O2
267648-09-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.4374 1.5400 0.0 0
M  V30 2 C 2.4374 0.0000 0.0 0
M  V30 3 N 7.7722 1.5400 0.0 0
M  V30 4 N 13.1070 1.5400 0.0 0
M  V30 5 C 14.4408 2.3100 0.0 0
M  V30 6 Cl 10.4397 6.1601 0.0 0
M  V30 7 C 3.7711 3.8501 0.0 0
M  V30 8 C 3.7711 2.3100 0.0 0
M  V30 9 C 5.1049 4.6201 0.0 0
M  V30 10 C 5.1049 1.5400 0.0 0
M  V30 11 C 6.4385 3.8501 0.0 0
M  V30 12 C 6.4385 2.3100 0.0 0
M  V30 13 C 2.4374 4.6201 0.0 0
M  V30 14 C 1.0306 3.9936 0.0 0
M  V30 15 O 2.2765 6.1516 0.0 0
M  V30 16 N 0.0000 5.1381 0.0 0
M  V30 17 C 0.7700 6.4718 0.0 0
M  V30 18 C 9.1060 2.3100 0.0 0
M  V30 19 N 10.4397 1.5400 0.0 0
M  V30 20 N 9.1060 3.8501 0.0 0
M  V30 21 C 11.7733 2.3100 0.0 0
M  V30 22 C 10.4397 4.6201 0.0 0
M  V30 23 N 11.7733 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 3 12
M  V30 4 1 3 18
M  V30 5 1 4 5
M  V30 6 1 4 21
M  V30 7 1 6 22
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 7 13
M  V30 11 1 8 10
M  V30 12 2 9 11
M  V30 13 2 10 12
M  V30 14 1 11 12
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 20 1 18 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 267648-08-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 267648-09-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-3335079
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Rapid synthesis of triazine inhibitors of inosine monophosphate
dehydrogenase
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pitts, William J.; Guo, Junqing; Dhar, T. G. Murali; Shen, Zhongqi; Gu,
Henry H.; Watterson, Scott H.; Bednarz, Mark S.; Chen, Bang-Chi; Barrish,
Joel C.; Bassolino, Donna; Cheney, Daniel; Fleener, Catherine A.;
Rouleau, Katherine A.; Hollenbaugh, Diane L.; Iwanowicz, Edwin J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2002), 12(16), 2137-2140

$RFMT $RIREG SCHEME295 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C41H70N6O10
2678593-43-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  57 57 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 12.2649 5.6747 0.0 0
M  V30 2 N 10.9312 6.4447 0.0 0
M  V30 3 N 13.5986 6.4447 0.0 0
M  V30 4 C 10.9312 7.9847 0.0 0 CFG=1
M  V30 5 C 14.9322 5.6747 0.0 0 CFG=1
M  V30 6 C 9.5974 8.7547 0.0 0
M  V30 7 C 12.2649 8.7547 0.0 0
M  V30 8 C 16.2660 6.4447 0.0 0
M  V30 9 C 14.9322 4.1347 0.0 0
M  V30 10 N 8.2638 7.9847 0.0 0
M  V30 11 O 9.5974 10.2947 0.0 0
M  V30 12 C 12.2649 10.2947 0.0 0
M  V30 13 N 17.5997 5.6747 0.0 0
M  V30 14 O 16.2660 7.9847 0.0 0
M  V30 15 C 16.2660 3.3646 0.0 0
M  V30 16 C 6.9301 8.7547 0.0 0
M  V30 17 C 10.9312 11.0648 0.0 0
M  V30 18 C 13.5986 11.0648 0.0 0
M  V30 19 C 18.9333 6.4447 0.0 0
M  V30 20 C 17.5997 4.1347 0.0 0
M  V30 21 C 16.2660 1.8246 0.0 0
M  V30 22 C 6.1601 7.4211 0.0 0
M  V30 23 C 5.5964 9.5247 0.0 0
M  V30 24 C 7.7001 10.0885 0.0 0
M  V30 25 C 19.7034 5.1110 0.0 0
M  V30 26 C 20.2670 7.2147 0.0 0
M  V30 27 C 18.1633 7.7783 0.0 0
M  V30 28 N 4.6201 7.4211 0.0 0
M  V30 29 O 6.9301 6.0874 0.0 0
M  V30 30 N 21.2434 5.1110 0.0 0
M  V30 31 O 18.9333 3.7774 0.0 0
M  V30 32 C 3.8501 6.0874 0.0 0 CFG=1
M  V30 33 C 22.0134 3.7774 0.0 0 CFG=1
M  V30 34 C 2.3100 6.0874 0.0 0
M  V30 35 C 4.6201 4.7536 0.0 0
M  V30 36 C 23.5534 3.7774 0.0 0
M  V30 37 C 21.2434 2.4436 0.0 0
M  V30 38 O 1.5400 7.4211 0.0 0
M  V30 39 O 1.5400 4.7536 0.0 0
M  V30 40 C 6.1601 4.7536 0.0 0
M  V30 41 C 3.8501 3.4199 0.0 0
M  V30 42 O 24.3234 5.1110 0.0 0
M  V30 43 O 24.3234 2.4436 0.0 0
M  V30 44 C 22.0134 1.1099 0.0 0
M  V30 45 C 19.7034 2.4436 0.0 0
M  V30 46 C 0.0000 7.4211 0.0 0
M  V30 47 C 25.8635 5.1110 0.0 0
M  V30 48 O 9.1966 5.4063 0.0 0
M  V30 49 O 14.0315 3.1517 0.0 0
M  V30 50 C 10.7110 0.0000 0.0 0
M  V30 51 C 8.9166 0.8367 0.0 0
M  V30 52 C 11.6141 4.2790 0.0 0
M  V30 53 C 10.0799 4.1448 0.0 0
M  V30 54 C 12.4973 3.0175 0.0 0
M  V30 55 C 9.4291 2.7491 0.0 0
M  V30 56 C 11.8465 1.6218 0.0 0
M  V30 57 C 10.3123 1.4875 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 52
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 4 7 CFG=3
M  V30 8 1 5 8
M  V30 9 1 5 9 CFG=3
M  V30 10 1 6 10
M  V30 11 2 6 11
M  V30 12 1 7 12
M  V30 13 1 8 13
M  V30 14 2 8 14
M  V30 15 1 9 15
M  V30 16 1 10 16
M  V30 17 1 12 17
M  V30 18 1 12 18
M  V30 19 1 13 19
M  V30 20 1 15 20
M  V30 21 1 15 21
M  V30 22 1 16 22
M  V30 23 1 16 23
M  V30 24 1 16 24
M  V30 25 1 19 25
M  V30 26 1 19 26
M  V30 27 1 19 27
M  V30 28 1 22 28
M  V30 29 2 22 29
M  V30 30 1 25 30
M  V30 31 2 25 31
M  V30 32 1 28 32
M  V30 33 1 30 33
M  V30 34 1 32 34
M  V30 35 1 32 35 CFG=1
M  V30 36 1 33 36
M  V30 37 1 33 37 CFG=3
M  V30 38 1 34 38
M  V30 39 2 34 39
M  V30 40 1 35 40
M  V30 41 1 35 41
M  V30 42 1 36 42
M  V30 43 2 36 43
M  V30 44 1 37 44
M  V30 45 1 37 45
M  V30 46 1 38 46
M  V30 47 1 42 47
M  V30 48 2 48 53
M  V30 49 2 49 54
M  V30 50 1 50 57
M  V30 51 1 51 57
M  V30 52 1 52 53
M  V30 53 1 52 54
M  V30 54 1 53 55
M  V30 55 1 54 56
M  V30 56 1 55 57
M  V30 57 1 56 57
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 4 5 32 33)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C41H72N8O8
2678593-44-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  57 57 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 12.2649 5.6747 0.0 0
M  V30 2 N 10.9312 6.4447 0.0 0
M  V30 3 N 13.5986 6.4447 0.0 0
M  V30 4 C 10.9312 7.9847 0.0 0 CFG=1
M  V30 5 C 14.9322 5.6747 0.0 0 CFG=1
M  V30 6 C 9.5974 8.7547 0.0 0
M  V30 7 C 12.2649 8.7547 0.0 0
M  V30 8 C 16.2660 6.4447 0.0 0
M  V30 9 C 14.9322 4.1347 0.0 0
M  V30 10 N 8.2638 7.9847 0.0 0
M  V30 11 O 9.5974 10.2947 0.0 0
M  V30 12 C 12.2649 10.2947 0.0 0
M  V30 13 N 17.5997 5.6747 0.0 0
M  V30 14 O 16.2660 7.9847 0.0 0
M  V30 15 C 16.2660 3.3646 0.0 0
M  V30 16 C 6.9301 8.7547 0.0 0
M  V30 17 C 10.9312 11.0648 0.0 0
M  V30 18 C 13.5986 11.0648 0.0 0
M  V30 19 C 18.9333 6.4447 0.0 0
M  V30 20 C 17.5997 4.1347 0.0 0
M  V30 21 C 16.2660 1.8246 0.0 0
M  V30 22 C 6.1601 7.4211 0.0 0
M  V30 23 C 5.5964 9.5247 0.0 0
M  V30 24 C 7.7001 10.0885 0.0 0
M  V30 25 C 19.7034 5.1110 0.0 0
M  V30 26 C 18.1633 7.7785 0.0 0
M  V30 27 C 20.2670 7.2147 0.0 0
M  V30 28 N 4.6201 7.4211 0.0 0
M  V30 29 O 6.9301 6.0874 0.0 0
M  V30 30 N 21.2434 5.1110 0.0 0
M  V30 31 O 18.9333 3.7774 0.0 0
M  V30 32 C 3.8501 6.0874 0.0 0 CFG=1
M  V30 33 C 22.0134 3.7774 0.0 0 CFG=1
M  V30 34 C 2.3100 6.0874 0.0 0
M  V30 35 C 4.6201 4.7536 0.0 0
M  V30 36 C 23.5534 3.7774 0.0 0
M  V30 37 C 21.2434 2.4437 0.0 0
M  V30 38 N 1.5400 7.4211 0.0 0
M  V30 39 O 1.5400 4.7537 0.0 0
M  V30 40 C 6.1601 4.7536 0.0 0
M  V30 41 C 3.8501 3.4199 0.0 0
M  V30 42 N 24.3234 5.1110 0.0 0
M  V30 43 O 24.3234 2.4437 0.0 0
M  V30 44 C 22.0134 1.1099 0.0 0
M  V30 45 C 19.7034 2.4437 0.0 0
M  V30 46 C 0.0000 7.4211 0.0 0
M  V30 47 C 25.8635 5.1110 0.0 0
M  V30 48 O 14.0315 3.1517 0.0 0
M  V30 49 O 9.1966 5.4063 0.0 0
M  V30 50 C 8.9166 0.8367 0.0 0
M  V30 51 C 10.7110 0.0000 0.0 0
M  V30 52 C 11.6141 4.2790 0.0 0
M  V30 53 C 12.4973 3.0175 0.0 0
M  V30 54 C 10.0799 4.1448 0.0 0
M  V30 55 C 11.8465 1.6218 0.0 0
M  V30 56 C 9.4291 2.7491 0.0 0
M  V30 57 C 10.3123 1.4875 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 52
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 4 7 CFG=3
M  V30 8 1 5 8
M  V30 9 1 5 9 CFG=3
M  V30 10 1 6 10
M  V30 11 2 6 11
M  V30 12 1 7 12
M  V30 13 1 8 13
M  V30 14 2 8 14
M  V30 15 1 9 15
M  V30 16 1 10 16
M  V30 17 1 12 17
M  V30 18 1 12 18
M  V30 19 1 13 19
M  V30 20 1 15 20
M  V30 21 1 15 21
M  V30 22 1 16 22
M  V30 23 1 16 23
M  V30 24 1 16 24
M  V30 25 1 19 25
M  V30 26 1 19 26
M  V30 27 1 19 27
M  V30 28 1 22 28
M  V30 29 2 22 29
M  V30 30 1 25 30
M  V30 31 2 25 31
M  V30 32 1 28 32
M  V30 33 1 30 33
M  V30 34 1 32 34
M  V30 35 1 32 35 CFG=1
M  V30 36 1 33 36
M  V30 37 1 33 37 CFG=3
M  V30 38 1 34 38
M  V30 39 2 34 39
M  V30 40 1 35 40
M  V30 41 1 35 41
M  V30 42 1 36 42
M  V30 43 2 36 43
M  V30 44 1 37 44
M  V30 45 1 37 45
M  V30 46 1 38 46
M  V30 47 1 42 47
M  V30 48 2 48 53
M  V30 49 2 49 54
M  V30 50 1 50 57
M  V30 51 1 51 57
M  V30 52 1 52 53
M  V30 53 1 52 54
M  V30 54 1 53 55
M  V30 55 1 54 56
M  V30 56 1 55 57
M  V30 57 1 56 57
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 4 5 32 33)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2678593-43-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2678593-44-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-24170730
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Dimedone-Based Rigid Organic Scaffold for Organizing Symmetrical Helical
Peptide Chains.
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Madica, Krishnaprasad; Lakshmi, Jerripothula K.; Madhu, Suresh;
Nadimpally, Krishna Chaitanya; Gonnade, Rajesh; Jagadeesh, Bharatam;
Sanjayan, Gangadhar J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemistrySelect (2019), 4(39), 11518-11522

$RFMT $RIREG SCHEME296 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-N-phenyl-2-propyl-8-(2-thienylmethyl)pyrazolo[1,5-a]-1,3,5-triazin-4...
C20H21N5S
2712477-42-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 8.0022 0.0 0
M  V30 2 C 5.3900 9.3358 0.0 0
M  V30 3 C 10.3508 4.6245 0.0 0
M  V30 4 C 4.6200 2.6674 0.0 0
M  V30 5 C 5.3900 1.3336 0.0 0
M  V30 6 C 4.6200 0.0000 0.0 0
M  V30 7 N 6.9300 6.6684 0.0 0
M  V30 8 C 7.7000 5.3347 0.0 0
M  V30 9 C 5.3900 6.6684 0.0 0
M  V30 10 N 7.9604 7.8129 0.0 0
M  V30 11 C 9.2064 5.6549 0.0 0
M  V30 12 N 6.9300 4.0011 0.0 0
M  V30 13 N 4.6200 5.3347 0.0 0
M  V30 14 C 9.3674 7.1864 0.0 0
M  V30 15 C 5.3900 4.0011 0.0 0
M  V30 16 C 3.0800 8.0022 0.0 0
M  V30 17 C 2.3100 6.6684 0.0 0
M  V30 18 C 2.3100 9.3358 0.0 0
M  V30 19 C 0.7700 6.6684 0.0 0
M  V30 20 C 0.7700 9.3358 0.0 0
M  V30 21 C 0.0000 8.0022 0.0 0
M  V30 22 C 11.8155 5.1003 0.0 0
M  V30 23 C 12.2914 6.5650 0.0 0
M  V30 24 S 13.0614 4.1951 0.0 0
M  V30 25 C 13.8314 6.5650 0.0 0
M  V30 26 C 14.3072 5.1003 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 1 16
M  V30 4 1 3 11
M  V30 5 1 3 22
M  V30 6 1 4 5
M  V30 7 1 4 15
M  V30 8 1 5 6
M  V30 9 1 7 8
M  V30 10 1 7 9
M  V30 11 1 7 10
M  V30 12 2 8 11
M  V30 13 1 8 12
M  V30 14 2 9 13
M  V30 15 2 10 14
M  V30 16 1 11 14
M  V30 17 2 12 15
M  V30 18 1 13 15
M  V30 19 2 16 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 2 18 20
M  V30 23 2 19 21
M  V30 24 1 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2-propyl-8-(2-thienylmethyl)pyrazolo[1,5-a]-1,3,5-triazin-4-amine
C14H17N5S
1209873-79-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.9846 6.5606 0.0 0
M  V30 2 N 7.2589 0.7700 0.0 0
M  V30 3 C 8.5925 0.0000 0.0 0
M  V30 4 C 9.9262 5.3901 0.0 0
M  V30 5 C 11.2598 4.6200 0.0 0
M  V30 6 C 12.5936 5.3901 0.0 0
M  V30 7 C 5.9251 4.6200 0.0 0
M  V30 8 N 5.9251 3.0800 0.0 0
M  V30 9 C 4.4605 5.0961 0.0 0
M  V30 10 N 7.2589 5.3901 0.0 0
M  V30 11 C 7.2589 2.3100 0.0 0
M  V30 12 N 4.4605 2.6042 0.0 0
M  V30 13 C 3.5553 3.8500 0.0 0
M  V30 14 C 8.5925 4.6200 0.0 0
M  V30 15 N 8.5925 3.0800 0.0 0
M  V30 16 C 2.4782 6.8808 0.0 0
M  V30 17 C 1.8519 8.2877 0.0 0
M  V30 18 S 1.3338 5.8504 0.0 0
M  V30 19 C 0.3203 8.1267 0.0 0
M  V30 20 C 0.0000 6.6204 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 1 2 11
M  V30 5 1 4 5
M  V30 6 1 4 14
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 2 10 14
M  V30 15 2 11 15
M  V30 16 2 12 13
M  V30 17 1 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2712477-42-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1209873-79-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24592380
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted pyrazolo[1,5-a]-1,3,5-triazine derivatives and
their analogues, as selective PDE2 and PDE4 inhibitors and therapeutic
uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bernard, Philippe
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20060106019 A1 2006-05-18

$RFMT $RIREG SCHEME297 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 3-[[6-ethoxy-1,4-dihydro-7-(2-methoxy-2-oxoethoxy)-1-methylindeno[1,2-...
C24H25N3O6
2733598-14-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.5170 10.3750 0.0 0
M  V30 2 N 13.4694 8.1700 0.0 0
M  V30 3 O 4.6200 5.3347 0.0 0
M  V30 4 C 3.8500 6.6685 0.0 0
M  V30 5 C 2.3100 6.6685 0.0 0
M  V30 6 O 1.5400 8.0022 0.0 0
M  V30 7 O 1.5400 5.3347 0.0 0
M  V30 8 C 0.0000 8.0022 0.0 0
M  V30 9 O 6.1600 2.6674 0.0 0
M  V30 10 C 6.9300 1.3338 0.0 0
M  V30 11 C 6.1600 0.0000 0.0 0
M  V30 12 C 18.3429 10.3399 0.0 0
M  V30 13 O 19.2481 11.5858 0.0 0
M  V30 14 O 18.9694 8.9330 0.0 0
M  V30 15 C 20.7796 11.4249 0.0 0
M  V30 16 C 9.5005 7.8129 0.0 0
M  V30 17 C 8.4700 6.6685 0.0 0
M  V30 18 C 10.9074 7.1866 0.0 0
M  V30 19 N 9.6614 9.3445 0.0 0
M  V30 20 C 9.2400 5.3347 0.0 0
M  V30 21 C 6.9300 6.6685 0.0 0
M  V30 22 C 11.9378 8.3310 0.0 0
M  V30 23 C 10.7463 5.6549 0.0 0
M  V30 24 N 11.1678 9.6646 0.0 0
M  V30 25 C 8.4700 4.0011 0.0 0
M  V30 26 C 6.1600 5.3347 0.0 0
M  V30 27 C 6.9300 4.0011 0.0 0
M  V30 28 C 14.3746 9.4159 0.0 0
M  V30 29 C 15.9061 9.2550 0.0 0
M  V30 30 C 13.7483 10.8227 0.0 0
M  V30 31 C 16.8113 10.5009 0.0 0
M  V30 32 C 14.6533 12.0687 0.0 0
M  V30 33 C 16.1850 11.9076 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 19
M  V30 2 1 2 22
M  V30 3 1 2 28
M  V30 4 1 3 4
M  V30 5 1 3 26
M  V30 6 1 4 5
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 1 6 8
M  V30 10 1 9 10
M  V30 11 1 9 27
M  V30 12 1 10 11
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 1 12 31
M  V30 16 1 13 15
M  V30 17 1 16 17
M  V30 18 2 16 18
M  V30 19 1 16 19
M  V30 20 1 17 20
M  V30 21 2 17 21
M  V30 22 1 18 22
M  V30 23 1 18 23
M  V30 24 1 19 24
M  V30 25 1 20 23
M  V30 26 2 20 25
M  V30 27 1 21 26
M  V30 28 2 22 24
M  V30 29 1 25 27
M  V30 30 2 26 27
M  V30 31 2 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 32
M  V30 35 2 31 33
M  V30 36 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 3-[[6-ethoxy-1,4-dihydro-1-methyl-7-[2-(methylamino)-2-oxoethoxy]inden...
C24H26N4O5
2733597-60-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.5170 10.3750 0.0 0
M  V30 2 N 13.4694 8.1700 0.0 0
M  V30 3 O 4.6200 5.3347 0.0 0
M  V30 4 C 3.8500 6.6685 0.0 0
M  V30 5 C 2.3100 6.6685 0.0 0
M  V30 6 N 1.5400 8.0022 0.0 0
M  V30 7 O 1.5400 5.3347 0.0 0
M  V30 8 C 0.0000 8.0022 0.0 0
M  V30 9 O 6.1600 2.6674 0.0 0
M  V30 10 C 6.9300 1.3338 0.0 0
M  V30 11 C 6.1600 0.0000 0.0 0
M  V30 12 C 18.3429 10.3399 0.0 0
M  V30 13 O 19.2481 11.5858 0.0 0
M  V30 14 O 18.9694 8.9330 0.0 0
M  V30 15 C 20.7796 11.4249 0.0 0
M  V30 16 C 9.5005 7.8129 0.0 0
M  V30 17 C 8.4700 6.6685 0.0 0
M  V30 18 C 10.9074 7.1866 0.0 0
M  V30 19 N 9.6614 9.3445 0.0 0
M  V30 20 C 9.2400 5.3347 0.0 0
M  V30 21 C 6.9300 6.6685 0.0 0
M  V30 22 C 11.9378 8.3310 0.0 0
M  V30 23 C 10.7463 5.6549 0.0 0
M  V30 24 N 11.1678 9.6646 0.0 0
M  V30 25 C 8.4700 4.0011 0.0 0
M  V30 26 C 6.1600 5.3347 0.0 0
M  V30 27 C 6.9300 4.0011 0.0 0
M  V30 28 C 14.3746 9.4159 0.0 0
M  V30 29 C 15.9061 9.2550 0.0 0
M  V30 30 C 13.7483 10.8227 0.0 0
M  V30 31 C 16.8113 10.5009 0.0 0
M  V30 32 C 14.6533 12.0687 0.0 0
M  V30 33 C 16.1850 11.9076 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 19
M  V30 2 1 2 22
M  V30 3 1 2 28
M  V30 4 1 3 4
M  V30 5 1 3 26
M  V30 6 1 4 5
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 1 6 8
M  V30 10 1 9 10
M  V30 11 1 9 27
M  V30 12 1 10 11
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 1 12 31
M  V30 16 1 13 15
M  V30 17 1 16 17
M  V30 18 2 16 18
M  V30 19 1 16 19
M  V30 20 1 17 20
M  V30 21 2 17 21
M  V30 22 1 18 22
M  V30 23 1 18 23
M  V30 24 1 19 24
M  V30 25 1 20 23
M  V30 26 2 20 25
M  V30 27 1 21 26
M  V30 28 2 22 24
M  V30 29 1 25 27
M  V30 30 2 26 27
M  V30 31 2 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 32
M  V30 35 2 31 33
M  V30 36 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2733598-14-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2733597-60-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24775640
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM SAR Investigation and Discovery of Water-Soluble
1-Methyl-1,4-dihydroindeno[1,2-c]pyrazoles as Potent Tubulin
Polymerization Inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cui, Ying-Jie; Liu, Chao; Ma, Chen-Chen; Ji, Ya-Ting; Yao, Yi-Li; Tang,
Long-Qian; Zhang, Cheng-Mei; Wu, Jing-De; Liu, Zhao-Peng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2020), 63(23), 14840-14866

$RFMT $RIREG SCHEME298 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-N2,N4-di-2-propyn-1-yl-1,3,5-triazine-2,4-diamine
C9H8ClN5
27469-59-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0010 4.6201 0.0 0
M  V30 2 C 2.6673 3.8501 0.0 0
M  V30 3 C 1.3337 4.6201 0.0 0
M  V30 4 C 0.0000 5.3901 0.0 0
M  V30 5 N 9.3360 4.6201 0.0 0
M  V30 6 C 10.6697 3.8501 0.0 0
M  V30 7 C 12.0033 4.6201 0.0 0
M  V30 8 C 13.3370 5.3901 0.0 0
M  V30 9 Cl 6.6685 0.0000 0.0 0
M  V30 10 C 5.3348 3.8501 0.0 0
M  V30 11 N 6.6685 4.6201 0.0 0
M  V30 12 N 5.3348 2.3101 0.0 0
M  V30 13 C 8.0022 3.8501 0.0 0
M  V30 14 C 6.6685 1.5400 0.0 0
M  V30 15 N 8.0022 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 3 3 4
M  V30 5 1 5 6
M  V30 6 1 5 13
M  V30 7 1 6 7
M  V30 8 3 7 8
M  V30 9 1 9 14
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N2-Methyl-N4,N6-di-2-propyn-1-yl-1,3,5-triazine-2,4,6-triamine
C10H12N6
1610533-87-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6673 5.3901 0.0 0
M  V30 2 C 2.6673 6.9302 0.0 0
M  V30 3 C 1.3337 7.7002 0.0 0
M  V30 4 C 0.0000 8.4702 0.0 0
M  V30 5 N 8.0022 5.3901 0.0 0
M  V30 6 C 9.3360 4.6201 0.0 0
M  V30 7 C 10.6697 5.3901 0.0 0
M  V30 8 C 12.0033 6.1601 0.0 0
M  V30 9 N 5.3348 0.7700 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 4.0012 4.6201 0.0 0
M  V30 12 N 5.3348 5.3901 0.0 0
M  V30 13 N 4.0012 3.0801 0.0 0
M  V30 14 C 6.6685 4.6201 0.0 0
M  V30 15 C 5.3348 2.3101 0.0 0
M  V30 16 N 6.6685 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 3 3 4
M  V30 5 1 5 6
M  V30 6 1 5 14
M  V30 7 1 6 7
M  V30 8 3 7 8
M  V30 9 1 9 10
M  V30 10 1 9 15
M  V30 11 1 11 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 27469-59-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1610533-87-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-4475847
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):NOTES
$DATUM product further converted into HCl salt, closed vial used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of triazinamine derivatives as oral bioavailable breathing
control modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mannion, James C.; Dax, Scott L.; Golder, Francis John; Macintyre, Duncan
Euan; McLeod, James; Ozola, Vita; Suna, Edgars; Shubin, Kirill; Mencel,
James Joseph; Peng, Sean X.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2014078575 A2 2014-05-22

$RFMT $RIREG SCHEME299 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[6-(methoxycarbonyl)-2-methyl-3-pyridinyl]-1-piperazineca...
C17H25N3O4
2756333-90-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.0102 0.0000 0.0 0
M  V30 2 C 14.6303 2.6673 0.0 0
M  V30 3 O 15.4003 4.0010 0.0 0
M  V30 4 O 15.4003 1.3337 0.0 0
M  V30 5 C 16.9404 4.0010 0.0 0
M  V30 6 C 3.8501 2.6673 0.0 0
M  V30 7 O 3.0801 4.0010 0.0 0
M  V30 8 O 3.0801 1.3337 0.0 0
M  V30 9 C 1.5400 4.0010 0.0 0
M  V30 10 C 1.5400 2.4610 0.0 0
M  V30 11 C 0.0000 4.0010 0.0 0
M  V30 12 C 1.5400 5.5410 0.0 0
M  V30 13 C 10.0102 2.6673 0.0 0
M  V30 14 C 10.7802 1.3337 0.0 0
M  V30 15 C 10.7802 4.0010 0.0 0
M  V30 16 N 12.3203 1.3337 0.0 0
M  V30 17 C 12.3203 4.0010 0.0 0
M  V30 18 C 13.0903 2.6673 0.0 0
M  V30 19 N 8.4702 2.6673 0.0 0
M  V30 20 C 7.7002 4.0010 0.0 0
M  V30 21 C 7.7002 1.3337 0.0 0
M  V30 22 C 6.1601 4.0010 0.0 0
M  V30 23 C 6.1601 1.3337 0.0 0
M  V30 24 N 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 18
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 24
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 13 19
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[2-methyl-6-[(methylamino)carbonyl]-3-pyridinyl]-1-pipera...
C17H26N4O3
2589532-70-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.0102 0.0000 0.0 0
M  V30 2 C 14.6303 2.6673 0.0 0
M  V30 3 N 15.4003 4.0010 0.0 0
M  V30 4 O 15.4003 1.3337 0.0 0
M  V30 5 C 16.9404 4.0010 0.0 0
M  V30 6 C 3.8501 2.6673 0.0 0
M  V30 7 O 3.0801 4.0010 0.0 0
M  V30 8 O 3.0801 1.3337 0.0 0
M  V30 9 C 1.5400 4.0010 0.0 0
M  V30 10 C 1.5400 2.4610 0.0 0
M  V30 11 C 0.0000 4.0010 0.0 0
M  V30 12 C 1.5400 5.5410 0.0 0
M  V30 13 C 10.0102 2.6673 0.0 0
M  V30 14 C 10.7802 1.3337 0.0 0
M  V30 15 C 10.7802 4.0010 0.0 0
M  V30 16 N 12.3203 1.3337 0.0 0
M  V30 17 C 12.3203 4.0010 0.0 0
M  V30 18 C 13.0903 2.6673 0.0 0
M  V30 19 N 8.4702 2.6673 0.0 0
M  V30 20 C 7.7002 1.3337 0.0 0
M  V30 21 C 7.7002 4.0010 0.0 0
M  V30 22 C 6.1601 1.3337 0.0 0
M  V30 23 C 6.1601 4.0010 0.0 0
M  V30 24 N 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 18
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 24
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 13 19
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2756333-90-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2589532-70-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-42578732
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of piperazinyl picolinamide derivatives and methods of use
thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kankanala, Jayakanth; Pettigrew, Jeremy D.; Pham, Son Minh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2024178127 A1 2024-08-29

$RFMT $RIREG SCHEME299 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[6-(methoxycarbonyl)-2-methyl-3-pyridinyl]-1-piperazineca...
C17H25N3O4
2756333-90-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.0102 0.0000 0.0 0
M  V30 2 C 14.6303 2.6673 0.0 0
M  V30 3 O 15.4003 4.0010 0.0 0
M  V30 4 O 15.4003 1.3337 0.0 0
M  V30 5 C 16.9404 4.0010 0.0 0
M  V30 6 C 3.8501 2.6673 0.0 0
M  V30 7 O 3.0801 4.0010 0.0 0
M  V30 8 O 3.0801 1.3337 0.0 0
M  V30 9 C 1.5400 4.0010 0.0 0
M  V30 10 C 1.5400 2.4610 0.0 0
M  V30 11 C 0.0000 4.0010 0.0 0
M  V30 12 C 1.5400 5.5410 0.0 0
M  V30 13 C 10.0102 2.6673 0.0 0
M  V30 14 C 10.7802 1.3337 0.0 0
M  V30 15 C 10.7802 4.0010 0.0 0
M  V30 16 N 12.3203 1.3337 0.0 0
M  V30 17 C 12.3203 4.0010 0.0 0
M  V30 18 C 13.0903 2.6673 0.0 0
M  V30 19 N 8.4702 2.6673 0.0 0
M  V30 20 C 7.7002 4.0010 0.0 0
M  V30 21 C 7.7002 1.3337 0.0 0
M  V30 22 C 6.1601 4.0010 0.0 0
M  V30 23 C 6.1601 1.3337 0.0 0
M  V30 24 N 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 18
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 24
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 13 19
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[2-methyl-6-[(methylamino)carbonyl]-3-pyridinyl]-1-pipera...
C17H26N4O3
2589532-70-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.0102 0.0000 0.0 0
M  V30 2 C 14.6303 2.6673 0.0 0
M  V30 3 N 15.4003 4.0010 0.0 0
M  V30 4 O 15.4003 1.3337 0.0 0
M  V30 5 C 16.9404 4.0010 0.0 0
M  V30 6 C 3.8501 2.6673 0.0 0
M  V30 7 O 3.0801 4.0010 0.0 0
M  V30 8 O 3.0801 1.3337 0.0 0
M  V30 9 C 1.5400 4.0010 0.0 0
M  V30 10 C 1.5400 2.4610 0.0 0
M  V30 11 C 0.0000 4.0010 0.0 0
M  V30 12 C 1.5400 5.5410 0.0 0
M  V30 13 C 10.0102 2.6673 0.0 0
M  V30 14 C 10.7802 1.3337 0.0 0
M  V30 15 C 10.7802 4.0010 0.0 0
M  V30 16 N 12.3203 1.3337 0.0 0
M  V30 17 C 12.3203 4.0010 0.0 0
M  V30 18 C 13.0903 2.6673 0.0 0
M  V30 19 N 8.4702 2.6673 0.0 0
M  V30 20 C 7.7002 1.3337 0.0 0
M  V30 21 C 7.7002 4.0010 0.0 0
M  V30 22 C 6.1601 1.3337 0.0 0
M  V30 23 C 6.1601 4.0010 0.0 0
M  V30 24 N 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 18
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 24
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 13 19
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2756333-90-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2589532-70-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-42575103
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of piperazinyl picolinamide derivatives as PARP1 modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kankanala, Jayakanth; Pettigrew, Jeremy D.; Pham, Son Minh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2024178125 A1 2024-08-29

$RFMT $RIREG SCHEME300 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-(4-Bromo-2-chlorophenyl)-8,9-dihydro-2-(methylsulfonyl)imidazo[1′,2′:1,6]py...
C16H12BrClN4O2S
2761069-64-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 10.0100 6.3708 0.0 0
M  V30 2 Br 14.6300 3.7034 0.0 0
M  V30 3 S 1.5400 5.0370 0.0 0 VAL=6
M  V30 4 C 0.0000 5.0370 0.0 0
M  V30 5 O 1.5400 3.4970 0.0 0
M  V30 6 O 1.5400 6.5770 0.0 0
M  V30 7 C 8.4700 3.7034 0.0 0
M  V30 8 C 7.7000 2.3698 0.0 0
M  V30 9 C 7.7000 5.0370 0.0 0
M  V30 10 N 6.1600 2.3698 0.0 0
M  V30 11 N 8.1759 0.9051 0.0 0
M  V30 12 C 6.1600 5.0370 0.0 0
M  V30 13 C 5.3900 3.7034 0.0 0
M  V30 14 C 5.6841 0.9051 0.0 0
M  V30 15 C 6.9300 0.0000 0.0 0
M  V30 16 C 5.3900 6.3708 0.0 0
M  V30 17 N 3.8500 3.7034 0.0 0
M  V30 18 N 3.8500 6.3708 0.0 0
M  V30 19 C 3.0800 5.0370 0.0 0
M  V30 20 C 10.0100 3.7034 0.0 0
M  V30 21 C 10.7800 5.0370 0.0 0
M  V30 22 C 10.7800 2.3698 0.0 0
M  V30 23 C 12.3200 5.0370 0.0 0
M  V30 24 C 12.3200 2.3698 0.0 0
M  V30 25 C 13.0900 3.7034 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 21
M  V30 2 1 2 25
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 2 3 6
M  V30 6 1 3 19
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 20
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 13
M  V30 17 2 12 16
M  V30 18 2 13 17
M  V30 19 1 14 15
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-(4-Bromo-2-chlorophenyl)-8,9-dihydro-N-methylimidazo[1′,2′:1,6]pyrido[2,3-d...
C16H13BrClN5
2761069-65-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 9.2400 6.3710 0.0 0
M  V30 2 Br 13.8600 3.7035 0.0 0
M  V30 3 N 0.7700 5.0372 0.0 0
M  V30 4 C 0.0000 6.3710 0.0 0
M  V30 5 C 7.7000 3.7035 0.0 0
M  V30 6 C 6.9300 2.3699 0.0 0
M  V30 7 C 6.9300 5.0372 0.0 0
M  V30 8 N 5.3900 2.3699 0.0 0
M  V30 9 N 7.4059 0.9052 0.0 0
M  V30 10 C 5.3900 5.0372 0.0 0
M  V30 11 C 4.6200 3.7035 0.0 0
M  V30 12 C 4.9141 0.9052 0.0 0
M  V30 13 C 6.1600 0.0000 0.0 0
M  V30 14 C 4.6200 6.3710 0.0 0
M  V30 15 N 3.0800 3.7035 0.0 0
M  V30 16 N 3.0800 6.3710 0.0 0
M  V30 17 C 2.3100 5.0372 0.0 0
M  V30 18 C 9.2400 3.7035 0.0 0
M  V30 19 C 10.0100 5.0372 0.0 0
M  V30 20 C 10.0100 2.3699 0.0 0
M  V30 21 C 11.5500 5.0372 0.0 0
M  V30 22 C 11.5500 2.3699 0.0 0
M  V30 23 C 12.3200 3.7035 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 19
M  V30 2 1 2 23
M  V30 3 1 3 4
M  V30 4 1 3 17
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 18
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 10 11
M  V30 15 2 10 14
M  V30 16 2 11 15
M  V30 17 1 12 13
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 2 16 17
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2761069-64-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2761069-65-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31617437
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of cyclic iminopyridimdine compounds and their bicyclic
derivatives as kinase inhibitors and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chen, Chen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022032071 A1 2022-02-10

$RFMT $RIREG SCHEME301 STEP1
$RXN



  2  1
$MOL
3-Pyridazinecarboxylic acid, 6-chloro-4-[[2-methoxy-3-(1-methyl-1H-1,2,4-tria...
C17H17ClN6O3
2761695-60-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.3388 8.0022 0.0 0
M  V30 2 C 7.8788 8.0022 0.0 0
M  V30 3 N 7.8788 5.3348 0.0 0
M  V30 4 C 0.0000 10.2960 0.0 0
M  V30 5 C 10.9589 5.3348 0.0 0
M  V30 6 O 12.4989 5.3348 0.0 0
M  V30 7 O 10.1889 6.6685 0.0 0
M  V30 8 C 13.2689 6.6685 0.0 0
M  V30 9 C 14.8090 6.6685 0.0 0
M  V30 10 Cl 7.8788 0.0000 0.0 0
M  V30 11 C 4.0287 6.6685 0.0 0
M  V30 12 C 5.5688 6.6685 0.0 0
M  V30 13 C 3.2587 5.3348 0.0 0
M  V30 14 C 6.3388 5.3348 0.0 0
M  V30 15 C 4.0287 4.0012 0.0 0
M  V30 16 C 5.5688 4.0012 0.0 0
M  V30 17 C 3.2587 8.0022 0.0 0
M  V30 18 N 1.7271 8.1633 0.0 0
M  V30 19 N 3.8850 9.4091 0.0 0
M  V30 20 N 1.4070 9.6696 0.0 0
M  V30 21 C 2.7406 10.4396 0.0 0
M  V30 22 C 8.6488 4.0012 0.0 0
M  V30 23 C 10.1889 4.0012 0.0 0
M  V30 24 C 7.8788 2.6673 0.0 0
M  V30 25 N 10.9589 2.6673 0.0 0
M  V30 26 C 8.6488 1.3337 0.0 0
M  V30 27 N 10.1889 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 3 14
M  V30 4 1 3 22
M  V30 5 1 4 20
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 23
M  V30 9 1 6 8
M  V30 10 1 8 9
M  V30 11 1 10 26
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 11 17
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Pyridazinecarboxamide, 6-chloro-4-[[2-methoxy-3-(1-methyl-1H-1,2,4-triazol-...
C16H16ClN7O2
2417138-49-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6684 6.1600 0.0 0
M  V30 2 C 5.3347 6.9300 0.0 0
M  V30 3 N 4.0011 4.6200 0.0 0
M  V30 4 C 13.3047 4.9771 0.0 0
M  V30 5 C 1.3336 6.1600 0.0 0
M  V30 6 N 0.0000 6.9300 0.0 0
M  V30 7 O 2.6674 6.9300 0.0 0
M  V30 8 C 0.0000 8.4700 0.0 0
M  V30 9 Cl 1.3336 0.0000 0.0 0
M  V30 10 C 8.0021 3.8500 0.0 0
M  V30 11 C 6.6684 4.6200 0.0 0
M  V30 12 C 8.0021 2.3100 0.0 0
M  V30 13 C 5.3347 3.8500 0.0 0
M  V30 14 C 6.6684 1.5400 0.0 0
M  V30 15 C 5.3347 2.3100 0.0 0
M  V30 16 C 9.3358 4.6200 0.0 0
M  V30 17 N 9.4967 6.1515 0.0 0
M  V30 18 N 10.7426 3.9937 0.0 0
M  V30 19 C 11.0031 6.4717 0.0 0
M  V30 20 N 11.7731 5.1381 0.0 0
M  V30 21 C 2.6674 3.8500 0.0 0
M  V30 22 C 1.3336 4.6200 0.0 0
M  V30 23 C 2.6674 2.3100 0.0 0
M  V30 24 N 0.0000 3.8500 0.0 0
M  V30 25 C 1.3336 1.5400 0.0 0
M  V30 26 N 0.0000 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 3 13
M  V30 4 1 3 21
M  V30 5 1 4 20
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 22
M  V30 9 1 6 8
M  V30 10 1 9 25
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 10 16
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 18 1 16 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2761695-60-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2417138-49-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-32460664
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7786-30-3
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of bifunctional PROTAC tyrosine kinase 2 (TYK2)degradation
compounds and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liu, Jing; Chen, Liqun; Wang, Jialiang; Han, Xiaoran; Wu, Zhaohui; Yang,
Ting; Zhang, Chengwei
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022100710 A1 2022-05-19

$RFMT $RIREG SCHEME302 STEP1
$RXN



  3  1
$MOL
(βS)-β-(Dimethylamino)benzenepropanol
C11H17NO
27720-03-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0 CFG=1
M  V30 3 N 6.6685 1.5400 0.0 0
M  V30 4 C 5.3347 3.8500 0.0 0
M  V30 5 C 6.6685 0.0000 0.0 0
M  V30 6 C 8.0021 2.3100 0.0 0
M  V30 7 O 6.6685 4.6200 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 C 1.3336 1.5400 0.0 0
M  V30 10 C 2.6674 3.8500 0.0 0
M  V30 11 C 0.0000 2.3100 0.0 0
M  V30 12 C 1.3336 4.6200 0.0 0
M  V30 13 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=1
M  V30 5 1 3 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Carbon disulfide
CS2
75-15-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 0.0000 0.0 0
M  V30 2 S 0.0000 0.0000 0.0 0
M  V30 3 S 3.0800 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamothioic acid, methyl-, O-[(2R)-2-(dimethylamino)-3-phenylpropyl] ester
C13H20N2OS
235439-11-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 2.6674 0.0 0 CFG=1
M  V30 2 C 3.0800 2.6674 0.0 0
M  V30 3 C 5.3900 4.0011 0.0 0
M  V30 4 N 5.3900 1.3338 0.0 0
M  V30 5 O 6.9300 4.0011 0.0 0
M  V30 6 C 4.6200 0.0000 0.0 0
M  V30 7 C 6.9300 1.3338 0.0 0
M  V30 8 C 7.7000 5.3347 0.0 0
M  V30 9 N 9.2400 5.3347 0.0 0
M  V30 10 S 6.9300 6.6685 0.0 0
M  V30 11 C 10.0100 6.6685 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 3.0800 5.3347 0.0 0
M  V30 14 C 0.7700 4.0011 0.0 0
M  V30 15 C 2.3100 6.6685 0.0 0
M  V30 16 C 0.0000 5.3347 0.0 0
M  V30 17 C 0.7700 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=3
M  V30 4 1 2 12
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27720-03-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-15-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 235439-11-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-26408047
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 5
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7646-69-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 74-88-4
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Example 3.
O-Thiocarbamoyl-N-(t-butyloxycarbonyl)-(D)-phenylalaninol. In a 500mL
flask equipped with magnetic stirrer,
N-(t-butyloxycarbonyl)-(D)-phenylalaninol(0.040 mole, 10.05g) was
dissolved in 200mL of THF and was added with NaH(0.048 mole, 1. 15g) at
0°C. The reaction mixture was stirred at 0°C for 15 hour, followed by the
addition of CS2(0.048 mole, 3.65g). After being stirred for min. at 0°C,
MeI(0.048 mole, 6.81g) was added to the reaction mixture. The reaction
mixture was stirred at room temperature for 2 hours, followed by the
addition of 5N NH4OH (0.090 mole, 18.0mL) for 6 hours. The resulting
solution was quenched with water. The organic layer was extracted 3 times
with dichloromethane, dried over magnesium sulfate and distilled in
vacuo. This was recrystalized in a solution mixture of n-hexane and
diethyl ether. O-(N-Methyl)thiocarbamoyl-N-dimethyl-(D)-phenylalaninol.
The procedure given in Example 3 was followed using
N-dimethyl-D-phenylalaninol as a starting material and methylamine as a
reactant, instead of N-(t-butyloxycarbonyl)-(D)-phenylalaninol and NH4OH,
to give 3.52g of the title compound. A yield of 92% was obtained.
1H-NMR(CDCl3, 200MHz), ppm(δ) ; 2.35(s,7.6H), 2.65-2.82(m,1.4H),
2.85-3.18(m,3H), 4.25-4.59(m,2H), 6.55(br,0.76H), 6.75(br,0.14H),
6.98-7.32(m,5H), ED50 = 31.5, 82.5.
$DTYPE RXN:VAR(1):NOTES
$DATUM product further converted into HCl salt
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 2-amino-2-phenylethyl thiocarbamates and analogs as
nervous system agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Choi, Yong Moon; Kim, Yong Kil
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2000046191 A1 2000-08-10

$RFMT $RIREG SCHEME303 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Acetic acid, 2-cyclobutylidene-, ethyl ester
C8H12O2
27741-65-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.2197 2.3101 0.0 0
M  V30 2 C 4.5536 1.5400 0.0 0
M  V30 3 O 5.8872 2.3101 0.0 0
M  V30 4 O 4.5536 0.0000 0.0 0
M  V30 5 C 7.2209 1.5400 0.0 0
M  V30 6 C 8.5546 2.3101 0.0 0
M  V30 7 C 1.8861 1.5400 0.0 0
M  V30 8 C 0.3986 1.9386 0.0 0
M  V30 9 C 1.4875 0.0525 0.0 0
M  V30 10 C 0.0000 0.4511 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 7
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 1-(methylamino)cyclobutaneacetate
C9H17NO2
1520977-83-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.6439 2.8737 0.0 0
M  V30 2 C 4.9775 2.1037 0.0 0
M  V30 3 O 6.3112 2.8737 0.0 0
M  V30 4 O 4.9775 0.5637 0.0 0
M  V30 5 C 7.6449 2.1037 0.0 0
M  V30 6 C 8.9787 2.8737 0.0 0
M  V30 7 N 1.5400 3.4374 0.0 0
M  V30 8 C 0.0000 3.4374 0.0 0
M  V30 9 C 2.3101 2.1037 0.0 0
M  V30 10 C 0.9764 1.3337 0.0 0
M  V30 11 C 3.0801 0.7700 0.0 0
M  V30 12 C 1.7464 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 27741-65-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1520977-83-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-18485718
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM The α-tertiary amine motif drives remarkable selectivity for Pd-catalyzed
carbonylation of β-methylene C-H bonds
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hogg, Kirsten F.; Trowbridge, Aaron; Alvarez-Perez, Andrea; Gaunt,
Matthew J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Science (2017), 8(12), 8198-8203

$RFMT $RIREG SCHEME304 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Methoxy-2-[(1R,2R)-2-methyl-4-oxocyclohexyl]-N-pyrazolo[1,5-a]pyrimidin-3-y...
C22H22N6O3
2787498-48-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 35 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.8243 4.0011 0.0 0
M  V30 2 N 5.0543 5.3347 0.0 0
M  V30 3 O 5.0543 2.6674 0.0 0
M  V30 4 O 7.3643 1.3336 0.0 0
M  V30 5 C 8.1343 0.0000 0.0 0
M  V30 6 C 14.7790 4.3128 0.0 0
M  V30 7 O 17.4464 8.9328 0.0 0
M  V30 8 C 9.6743 5.3347 0.0 0
M  V30 9 C 10.4443 4.0011 0.0 0
M  V30 10 C 10.7047 6.4791 0.0 0
M  V30 11 C 8.1343 5.3347 0.0 0
M  V30 12 N 11.9508 4.3213 0.0 0
M  V30 13 C 9.6743 2.6674 0.0 0
M  V30 14 N 12.1117 5.8528 0.0 0
M  V30 15 C 7.3643 4.0011 0.0 0
M  V30 16 C 8.1343 2.6674 0.0 0
M  V30 17 C 13.4453 6.6228 0.0 0 CFG=2
M  V30 18 C 14.7790 5.8528 0.0 0 CFG=2
M  V30 19 C 13.4453 8.1628 0.0 0
M  V30 20 C 16.1128 6.6228 0.0 0
M  V30 21 C 14.7790 8.9328 0.0 0
M  V30 22 C 16.1128 8.1628 0.0 0
M  V30 23 C 3.5143 5.3347 0.0 0
M  V30 24 C 2.6091 6.5806 0.0 0
M  V30 25 C 2.6091 4.0889 0.0 0
M  V30 26 N 1.1445 6.1047 0.0 0
M  V30 27 N 2.9292 8.0870 0.0 0
M  V30 28 N 1.1445 4.5647 0.0 0
M  V30 29 C 0.0000 7.1352 0.0 0
M  V30 30 C 1.7849 9.1175 0.0 0
M  V30 31 C 0.3202 8.6416 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 23
M  V30 5 1 4 5
M  V30 6 1 4 16
M  V30 7 1 18 6 CFG=1
M  V30 8 2 7 22
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 8 11
M  V30 12 2 9 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 2 11 15
M  V30 16 1 12 14
M  V30 17 2 13 16
M  V30 18 1 17 14 CFG=3
M  V30 19 1 15 16
M  V30 20 1 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 1 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 24 27
M  V30 30 2 25 28
M  V30 31 1 26 28
M  V30 32 1 26 29
M  V30 33 2 27 30
M  V30 34 2 29 31
M  V30 35 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 17 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
6-Methoxy-2-[(1R,2R)-2-methyl-4-(methylamino)cyclohexyl]-N-pyrazolo[1,5-a]pyr...
C23H27N7O2
2787498-49-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 36 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.8243 4.0011 0.0 0
M  V30 2 N 5.0543 5.3347 0.0 0
M  V30 3 O 5.0543 2.6674 0.0 0
M  V30 4 O 7.3643 1.3338 0.0 0
M  V30 5 C 8.1343 0.0000 0.0 0
M  V30 6 C 14.7789 4.3129 0.0 0
M  V30 7 N 17.4464 8.9329 0.0 0
M  V30 8 C 17.4464 10.4729 0.0 0
M  V30 9 C 9.6743 5.3347 0.0 0
M  V30 10 C 10.4443 4.0011 0.0 0
M  V30 11 C 10.7047 6.4792 0.0 0
M  V30 12 C 8.1343 5.3347 0.0 0
M  V30 13 N 11.9507 4.3212 0.0 0
M  V30 14 C 9.6743 2.6674 0.0 0
M  V30 15 N 12.1116 5.8529 0.0 0
M  V30 16 C 7.3643 4.0011 0.0 0
M  V30 17 C 8.1343 2.6674 0.0 0
M  V30 18 C 13.4453 6.6229 0.0 0 CFG=2
M  V30 19 C 14.7789 5.8529 0.0 0 CFG=2
M  V30 20 C 13.4453 8.1629 0.0 0
M  V30 21 C 16.1127 6.6229 0.0 0
M  V30 22 C 14.7789 8.9329 0.0 0
M  V30 23 C 16.1127 8.1629 0.0 0 CFG=3
M  V30 24 C 3.5143 5.3347 0.0 0
M  V30 25 C 2.6091 6.5807 0.0 0
M  V30 26 C 2.6091 4.0889 0.0 0
M  V30 27 N 1.1445 6.1047 0.0 0
M  V30 28 N 2.9292 8.0870 0.0 0
M  V30 29 N 1.1445 4.5647 0.0 0
M  V30 30 C 0.0000 7.1353 0.0 0
M  V30 31 C 1.7849 9.1174 0.0 0
M  V30 32 C 0.3202 8.6416 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 2 24
M  V30 5 1 4 5
M  V30 6 1 4 17
M  V30 7 1 19 6 CFG=1
M  V30 8 1 7 8
M  V30 9 1 7 23
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 9 12
M  V30 13 2 10 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 2 12 16
M  V30 17 1 13 15
M  V30 18 2 14 17
M  V30 19 1 18 15 CFG=3
M  V30 20 1 16 17
M  V30 21 1 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 1 22 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 25 28
M  V30 31 2 26 29
M  V30 32 1 27 29
M  V30 33 1 27 30
M  V30 34 2 28 31
M  V30 35 2 30 32
M  V30 36 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 18 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2787498-48-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2787498-49-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-33428180
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 56553-60-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 107-06-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM N-(imidazo[1,2-b]pyridazin-3-yl)-1-cyclohexyl-2H-indazole-5-carboxamide
and
N-(pyrazolo[1,5-a]pyrimidin-3-yl)-1-cyclohexyl-2H-indazole-5-carboxamide
derivatives as IRAK4 inhibitors for the treatment of asthma
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Terstiege, Ina; Schiesser, Stefan; Xue, Yafeng; Chang, Hui-Fang;
Berggren, Anna Ingrid Kristina
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022122876 A1 2022-06-16

$RFMT $RIREG SCHEME305 STEP1
$RXN



  2  1
$MOL
3-[(1R)-1-[[(4-Amino-6-bromo-3-pyridinyl)carbonyl]amino]ethyl]benzoic acid
C15H14BrN3O3
2800894-62-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 1.5400 0.0 0
M  V30 2 N 6.6685 2.3101 0.0 0
M  V30 3 O 5.3348 0.0000 0.0 0
M  V30 4 C 8.0022 1.5400 0.0 0 CFG=1
M  V30 5 C 8.0022 0.0000 0.0 0
M  V30 6 N 2.6673 0.0000 0.0 0
M  V30 7 Br 0.0000 4.6201 0.0 0
M  V30 8 C 13.3370 1.5400 0.0 0
M  V30 9 O 13.3370 0.0000 0.0 0
M  V30 10 O 14.6707 2.3101 0.0 0
M  V30 11 C 4.0010 2.3101 0.0 0
M  V30 12 C 2.6673 1.5400 0.0 0
M  V30 13 C 4.0010 3.8501 0.0 0
M  V30 14 C 1.3337 2.3101 0.0 0
M  V30 15 N 2.6673 4.6201 0.0 0
M  V30 16 C 1.3337 3.8501 0.0 0
M  V30 17 C 9.3358 2.3101 0.0 0
M  V30 18 C 10.6697 1.5400 0.0 0
M  V30 19 C 9.3358 3.8501 0.0 0
M  V30 20 C 12.0033 2.3101 0.0 0
M  V30 21 C 10.6697 4.6201 0.0 0
M  V30 22 C 12.0033 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 4 5 CFG=1
M  V30 6 1 4 17
M  V30 7 1 6 12
M  V30 8 1 7 16
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 8 20
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 4)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Amino-6-bromo-N-[(1R)-1-[3-[(methylamino)carbonyl]phenyl]ethyl]-3-pyridinec...
C16H17BrN4O2
2800894-63-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 3.0800 0.0 0
M  V30 2 N 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 4.6200 0.0 0
M  V30 4 C 8.0021 3.0800 0.0 0 CFG=1
M  V30 5 C 8.0021 4.6200 0.0 0
M  V30 6 N 2.6674 4.6200 0.0 0
M  V30 7 Br 0.0000 0.0000 0.0 0
M  V30 8 C 13.3369 3.0800 0.0 0
M  V30 9 N 14.6705 2.3100 0.0 0
M  V30 10 O 13.3369 4.6200 0.0 0
M  V30 11 C 16.0043 3.0800 0.0 0
M  V30 12 C 4.0011 2.3100 0.0 0
M  V30 13 C 2.6674 3.0800 0.0 0
M  V30 14 C 4.0011 0.7700 0.0 0
M  V30 15 C 1.3338 2.3100 0.0 0
M  V30 16 N 2.6674 0.0000 0.0 0
M  V30 17 C 1.3338 0.7700 0.0 0
M  V30 18 C 9.3358 2.3100 0.0 0
M  V30 19 C 10.6696 3.0800 0.0 0
M  V30 20 C 9.3358 0.7700 0.0 0
M  V30 21 C 12.0032 2.3100 0.0 0
M  V30 22 C 10.6696 0.0000 0.0 0
M  V30 23 C 12.0032 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 4 5 CFG=3
M  V30 6 1 4 18
M  V30 7 1 6 13
M  V30 8 1 7 17
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 8 21
M  V30 12 1 9 11
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 4)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2800894-62-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2800894-63-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-33622918
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 94790-37-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of novel substituted bicyclic derivatives as selective
inhibitors of ROCK1 and ROCK2 protein kinases and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lee, Wongil; Devine, William G.; Diebold, R. Bruce; Hwang, So Young;
Choi, Yunggeun; Liu, Yan; Seung, Sang-Ae; Yong, Miyong; Kim, Sewon; Lee,
Jaekyoo; Koh, Jong Sung
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022150381 A1 2022-07-14

$RFMT $RIREG SCHEME306 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[[4-[Bis[(2,4-dimethoxyphenyl)methyl]amino]-2-butyl-7-(1-methylethoxy)-1H-i...
C38H45N5O6
2817602-84-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  49 53 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1600 8.0021 0.0 0
M  V30 2 C 6.9300 6.6685 0.0 0
M  V30 3 C 4.6200 8.0021 0.0 0
M  V30 4 C 11.8908 11.3798 0.0 0
M  V30 5 O 9.2400 13.3369 0.0 0
M  V30 6 C 8.4700 14.6705 0.0 0
M  V30 7 C 6.9300 14.6705 0.0 0
M  V30 8 C 9.2400 16.0043 0.0 0
M  V30 9 C 12.2410 8.0477 0.0 0
M  V30 10 C 12.2410 6.5077 0.0 0
M  V30 11 C 13.5746 5.7377 0.0 0
M  V30 12 C 13.5746 4.1977 0.0 0
M  V30 13 O 8.4700 4.0011 0.0 0
M  V30 14 C 9.2400 2.6674 0.0 0
M  V30 15 O 1.5400 8.0021 0.0 0
M  V30 16 C 0.0000 8.0021 0.0 0
M  V30 17 C 17.1089 12.4889 0.0 0
M  V30 18 O 18.5736 12.0131 0.0 0
M  V30 19 O 3.8500 1.3338 0.0 0
M  V30 20 C 4.6200 0.0000 0.0 0
M  V30 21 O 1.5400 13.3369 0.0 0
M  V30 22 C 0.0000 13.3369 0.0 0
M  V30 23 C 8.4700 9.3358 0.0 0
M  V30 24 C 9.2400 10.6696 0.0 0
M  V30 25 C 6.9300 9.3358 0.0 0
M  V30 26 N 9.5006 8.1914 0.0 0
M  V30 27 N 10.7464 10.3493 0.0 0
M  V30 28 C 8.4700 12.0032 0.0 0
M  V30 29 N 6.1600 10.6696 0.0 0
M  V30 30 C 10.9074 8.8177 0.0 0
M  V30 31 N 6.9300 12.0032 0.0 0
M  V30 32 C 13.3555 10.9040 0.0 0
M  V30 33 C 14.4999 11.9344 0.0 0
M  V30 34 C 13.6757 9.3975 0.0 0
M  V30 35 C 15.9646 11.4585 0.0 0
M  V30 36 C 15.1402 8.9217 0.0 0
M  V30 37 C 16.2847 9.9521 0.0 0
M  V30 38 C 6.1600 5.3349 0.0 0
M  V30 39 C 6.9300 4.0011 0.0 0
M  V30 40 C 4.6200 5.3349 0.0 0
M  V30 41 C 6.1600 2.6674 0.0 0
M  V30 42 C 3.8500 4.0011 0.0 0
M  V30 43 C 4.6200 2.6674 0.0 0
M  V30 44 C 3.8500 9.3358 0.0 0
M  V30 45 C 2.3100 9.3358 0.0 0
M  V30 46 C 4.6200 10.6696 0.0 0
M  V30 47 C 1.5400 10.6696 0.0 0
M  V30 48 C 3.8500 12.0032 0.0 0
M  V30 49 C 2.3100 12.0032 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 25
M  V30 4 1 2 38
M  V30 5 1 3 44
M  V30 6 1 4 27
M  V30 7 1 4 32
M  V30 8 1 5 6
M  V30 9 1 5 28
M  V30 10 1 6 7
M  V30 11 1 6 8
M  V30 12 1 9 10
M  V30 13 1 9 30
M  V30 14 1 10 11
M  V30 15 1 11 12
M  V30 16 1 13 14
M  V30 17 1 13 39
M  V30 18 1 15 16
M  V30 19 1 15 45
M  V30 20 2 17 18
M  V30 21 1 17 35
M  V30 22 1 19 20
M  V30 23 1 19 43
M  V30 24 1 21 22
M  V30 25 1 21 49
M  V30 26 1 23 24
M  V30 27 2 23 25
M  V30 28 1 23 26
M  V30 29 1 24 27
M  V30 30 2 24 28
M  V30 31 1 25 29
M  V30 32 2 26 30
M  V30 33 1 27 30
M  V30 34 1 28 31
M  V30 35 2 29 31
M  V30 36 2 32 33
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 2 34 36
M  V30 40 2 35 37
M  V30 41 1 36 37
M  V30 42 2 38 39
M  V30 43 1 38 40
M  V30 44 1 39 41
M  V30 45 2 40 42
M  V30 46 2 41 43
M  V30 47 1 42 43
M  V30 48 2 44 45
M  V30 49 1 44 46
M  V30 50 1 45 47
M  V30 51 2 46 48
M  V30 52 2 47 49
M  V30 53 1 48 49
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Imidazo[4,5-d]pyridazin-4-amine, 2-butyl-N,N-bis[(2,4-dimethoxyphenyl)meth...
C39H50N6O5
2920744-02-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  50 54 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1600 8.0021 0.0 0
M  V30 2 C 6.9300 6.6685 0.0 0
M  V30 3 C 4.6200 8.0021 0.0 0
M  V30 4 C 11.8907 11.3798 0.0 0
M  V30 5 O 9.2400 13.3369 0.0 0
M  V30 6 C 8.4700 14.6705 0.0 0
M  V30 7 C 9.2400 16.0043 0.0 0
M  V30 8 C 6.9300 14.6705 0.0 0
M  V30 9 C 12.2410 8.0477 0.0 0
M  V30 10 C 12.2410 6.5077 0.0 0
M  V30 11 C 13.5746 5.7377 0.0 0
M  V30 12 C 13.5746 4.1977 0.0 0
M  V30 13 O 8.4700 4.0011 0.0 0
M  V30 14 C 9.2400 2.6674 0.0 0
M  V30 15 O 1.5400 8.0021 0.0 0
M  V30 16 C 0.0000 8.0021 0.0 0
M  V30 17 C 17.1088 12.4889 0.0 0
M  V30 18 N 18.5735 12.0131 0.0 0
M  V30 19 C 19.7179 13.0435 0.0 0
M  V30 20 O 3.8500 1.3338 0.0 0
M  V30 21 C 4.6200 0.0000 0.0 0
M  V30 22 O 1.5400 13.3369 0.0 0
M  V30 23 C 0.0000 13.3369 0.0 0
M  V30 24 C 8.4700 9.3358 0.0 0
M  V30 25 C 9.2400 10.6694 0.0 0
M  V30 26 C 6.9300 9.3358 0.0 0
M  V30 27 N 9.5004 8.1914 0.0 0
M  V30 28 N 10.7463 10.3493 0.0 0
M  V30 29 C 8.4700 12.0032 0.0 0
M  V30 30 N 6.1600 10.6694 0.0 0
M  V30 31 C 10.9072 8.8177 0.0 0
M  V30 32 N 6.9300 12.0032 0.0 0
M  V30 33 C 13.3553 10.9040 0.0 0
M  V30 34 C 14.4997 11.9344 0.0 0
M  V30 35 C 13.6755 9.3975 0.0 0
M  V30 36 C 15.9644 11.4585 0.0 0
M  V30 37 C 15.1402 8.9217 0.0 0
M  V30 38 C 16.2846 9.9521 0.0 0
M  V30 39 C 6.1600 5.3347 0.0 0
M  V30 40 C 6.9300 4.0011 0.0 0
M  V30 41 C 4.6200 5.3347 0.0 0
M  V30 42 C 6.1600 2.6674 0.0 0
M  V30 43 C 3.8500 4.0011 0.0 0
M  V30 44 C 4.6200 2.6674 0.0 0
M  V30 45 C 3.8500 9.3358 0.0 0
M  V30 46 C 2.3100 9.3358 0.0 0
M  V30 47 C 4.6200 10.6696 0.0 0
M  V30 48 C 1.5400 10.6696 0.0 0
M  V30 49 C 3.8500 12.0032 0.0 0
M  V30 50 C 2.3100 12.0032 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 26
M  V30 4 1 2 39
M  V30 5 1 3 45
M  V30 6 1 4 28
M  V30 7 1 4 33
M  V30 8 1 5 6
M  V30 9 1 5 29
M  V30 10 1 6 7
M  V30 11 1 6 8
M  V30 12 1 9 10
M  V30 13 1 9 31
M  V30 14 1 10 11
M  V30 15 1 11 12
M  V30 16 1 13 14
M  V30 17 1 13 40
M  V30 18 1 15 16
M  V30 19 1 15 46
M  V30 20 1 17 18
M  V30 21 1 17 36
M  V30 22 1 18 19
M  V30 23 1 20 21
M  V30 24 1 20 44
M  V30 25 1 22 23
M  V30 26 1 22 50
M  V30 27 1 24 25
M  V30 28 2 24 26
M  V30 29 1 24 27
M  V30 30 1 25 28
M  V30 31 2 25 29
M  V30 32 1 26 30
M  V30 33 2 27 31
M  V30 34 1 28 31
M  V30 35 1 29 32
M  V30 36 2 30 32
M  V30 37 2 33 34
M  V30 38 1 33 35
M  V30 39 1 34 36
M  V30 40 2 35 37
M  V30 41 2 36 38
M  V30 42 1 37 38
M  V30 43 2 39 40
M  V30 44 1 39 41
M  V30 45 1 40 42
M  V30 46 2 41 43
M  V30 47 2 42 44
M  V30 48 1 43 44
M  V30 49 2 45 46
M  V30 50 1 45 47
M  V30 51 1 46 48
M  V30 52 2 47 49
M  V30 53 2 48 50
M  V30 54 1 49 50
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2817602-84-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2920744-02-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34132698
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of imidazopyridazine TLR7 and/or TLR8 agonists treating cancers
and as vaccines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Jidong; Benedetti, Yannick; Arranz, Esther; Karlsson, Andreas;
Brun, Marie-Priscille; Bretin, Francois
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022167438 A1 2022-08-11

$RFMT $RIREG SCHEME307 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(2-Butyn-1-yloxy)benzenesulfonyl chloride
C10H9ClO3S
286459-94-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.5400 1.5400 0.0 0 VAL=6
M  V30 2 Cl 0.0000 1.5400 0.0 0
M  V30 3 O 1.5400 3.0800 0.0 0
M  V30 4 O 1.5400 0.0000 0.0 0
M  V30 5 O 7.7000 1.5400 0.0 0
M  V30 6 C 8.4700 2.8736 0.0 0
M  V30 7 C 10.0100 2.8736 0.0 0
M  V30 8 C 11.5500 2.8736 0.0 0
M  V30 9 C 13.0900 2.8736 0.0 0
M  V30 10 C 3.0800 1.5400 0.0 0
M  V30 11 C 3.8500 0.2064 0.0 0
M  V30 12 C 3.8500 2.8736 0.0 0
M  V30 13 C 5.3900 0.2064 0.0 0
M  V30 14 C 5.3900 2.8736 0.0 0
M  V30 15 C 6.1600 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 10
M  V30 5 1 5 6
M  V30 6 1 5 15
M  V30 7 1 6 7
M  V30 8 3 7 8
M  V30 9 1 8 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(2-Butyn-1-yloxy)-N-methylbenzenesulfonamide
C11H13NO3S
287379-32-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 2.3100 1.5400 0.0 0 VAL=6
M  V30 2 N 0.7700 1.5400 0.0 0
M  V30 3 O 2.3100 0.0000 0.0 0
M  V30 4 O 2.3100 3.0800 0.0 0
M  V30 5 C 0.0000 0.2064 0.0 0
M  V30 6 O 8.4700 1.5400 0.0 0
M  V30 7 C 9.2400 2.8736 0.0 0
M  V30 8 C 10.7800 2.8736 0.0 0
M  V30 9 C 12.3200 2.8736 0.0 0
M  V30 10 C 13.8600 2.8736 0.0 0
M  V30 11 C 3.8500 1.5400 0.0 0
M  V30 12 C 4.6200 0.2064 0.0 0
M  V30 13 C 4.6200 2.8736 0.0 0
M  V30 14 C 6.1600 0.2064 0.0 0
M  V30 15 C 6.1600 2.8736 0.0 0
M  V30 16 C 6.9300 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 11
M  V30 5 1 2 5
M  V30 6 1 6 7
M  V30 7 1 6 16
M  V30 8 1 7 8
M  V30 9 3 8 9
M  V30 10 1 9 10
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 286459-94-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 287379-32-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-6788095
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of acetylenic ortho-sulfonamido and phosphinic acid amido
bicyclic heteroaryl hydroxamic acids as TACE inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Levin, Jeremy I.; Chen, James Ming; Du, Xue-mei; Albright, Jay D.; Zask,
Arie
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20030208066 A1 2003-11-06

$RFMT $RIREG SCHEME307 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(2-Butyn-1-yloxy)benzenesulfonyl chloride
C10H9ClO3S
286459-94-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.5400 1.5400 0.0 0 VAL=6
M  V30 2 Cl 0.0000 1.5400 0.0 0
M  V30 3 O 1.5400 3.0800 0.0 0
M  V30 4 O 1.5400 0.0000 0.0 0
M  V30 5 O 7.7000 1.5400 0.0 0
M  V30 6 C 8.4700 2.8736 0.0 0
M  V30 7 C 10.0100 2.8736 0.0 0
M  V30 8 C 11.5500 2.8736 0.0 0
M  V30 9 C 13.0900 2.8736 0.0 0
M  V30 10 C 3.0800 1.5400 0.0 0
M  V30 11 C 3.8500 0.2064 0.0 0
M  V30 12 C 3.8500 2.8736 0.0 0
M  V30 13 C 5.3900 0.2064 0.0 0
M  V30 14 C 5.3900 2.8736 0.0 0
M  V30 15 C 6.1600 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 10
M  V30 5 1 5 6
M  V30 6 1 5 15
M  V30 7 1 6 7
M  V30 8 3 7 8
M  V30 9 1 8 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(2-Butyn-1-yloxy)-N-methylbenzenesulfonamide
C11H13NO3S
287379-32-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 2.3100 1.5400 0.0 0 VAL=6
M  V30 2 N 0.7700 1.5400 0.0 0
M  V30 3 O 2.3100 0.0000 0.0 0
M  V30 4 O 2.3100 3.0800 0.0 0
M  V30 5 C 0.0000 0.2064 0.0 0
M  V30 6 O 8.4700 1.5400 0.0 0
M  V30 7 C 9.2400 2.8736 0.0 0
M  V30 8 C 10.7800 2.8736 0.0 0
M  V30 9 C 12.3200 2.8736 0.0 0
M  V30 10 C 13.8600 2.8736 0.0 0
M  V30 11 C 3.8500 1.5400 0.0 0
M  V30 12 C 4.6200 0.2064 0.0 0
M  V30 13 C 4.6200 2.8736 0.0 0
M  V30 14 C 6.1600 0.2064 0.0 0
M  V30 15 C 6.1600 2.8736 0.0 0
M  V30 16 C 6.9300 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 11
M  V30 5 1 2 5
M  V30 6 1 6 7
M  V30 7 1 6 16
M  V30 8 1 7 8
M  V30 9 3 8 9
M  V30 10 1 9 10
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 286459-94-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 287379-32-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-13219651
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 5. 4-But-2-ynyloxy-N-methyl-benzenesulfonamide. To 22.5 mL (0.045
mol) of a 2M solution of methylamine in dichloromethane, cooled to 0°C,
was added a solution of 3.67g (0.015 mol) of
4-but-2-ynyloxy-benzenesulfonyl chloride in 45 mL of dichloromethane. The
reaction was allowed to warm to room temperature and stirred for 48h. The
resulting solution was poured into water and extracted with
dichloromethane. The combined organics were washed with 2N citric acid
solution, water and brine, dried over Na2SO4, filtered through Magnesol®
and concentrated in vacuo to provide compound. Yield: 3.23g (92%), white
solid. m.p.78-80°C. Anal. For C11H13NO3S. Calc: C, 55.21; H, 5.88; N,
5.85. Found: C, 55.49; H, 5.65; N, 5.80.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of acetylenic ortho-sulfonamido and phosphinic acid amido
bicyclic heteroaryl hydroxamic acids as TACE inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Levin, Jeremy Ian; Chen, James Ming; Du, Xue-Mei; Albright, Jay Donald;
Zask, Arie
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2000044749 A1 2000-08-03

$RFMT $RIREG SCHEME308 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(5-Benzofuranyl)-2-propanone
C11H10O2
286836-32-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3709 3.0800 0.0 0
M  V30 2 C 7.7047 2.3100 0.0 0
M  V30 3 C 7.7047 0.7700 0.0 0
M  V30 4 O 9.0383 3.0800 0.0 0
M  V30 5 C 2.3699 2.3100 0.0 0
M  V30 6 C 2.3699 0.7700 0.0 0
M  V30 7 C 3.7036 3.0800 0.0 0
M  V30 8 C 0.9052 2.7859 0.0 0
M  V30 9 C 3.7036 0.0000 0.0 0
M  V30 10 O 0.9052 0.2941 0.0 0
M  V30 11 C 5.0372 2.3100 0.0 0
M  V30 12 C 0.0000 1.5400 0.0 0
M  V30 13 C 5.0372 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 2 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(Benzofuran-5-yl)-N-methylpropan-2-amine
C12H15NO
1354631-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3709 3.0800 0.0 0
M  V30 2 C 7.7045 2.3100 0.0 0
M  V30 3 N 9.0383 3.0800 0.0 0
M  V30 4 C 7.7045 0.7700 0.0 0
M  V30 5 C 10.3720 2.3100 0.0 0
M  V30 6 C 2.3698 2.3100 0.0 0
M  V30 7 C 2.3698 0.7700 0.0 0
M  V30 8 C 3.7036 3.0800 0.0 0
M  V30 9 C 0.9052 2.7859 0.0 0
M  V30 10 C 3.7036 0.0000 0.0 0
M  V30 11 O 0.9052 0.2941 0.0 0
M  V30 12 C 5.0372 2.3100 0.0 0
M  V30 13 C 0.0000 1.5400 0.0 0
M  V30 14 C 5.0372 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 2 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 286836-32-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1354631-77-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37063915
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 56553-60-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM acetic acid also acts as solvent in stage 1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Specialized combinations for mental disorders or mental enhancement
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Baggott, Matthew J.; Dalziel, Sean
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023107715 A1 2023-06-15

$RFMT $RIREG SCHEME308 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(5-Benzofuranyl)-2-propanone
C11H10O2
286836-32-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3709 3.0800 0.0 0
M  V30 2 C 7.7047 2.3100 0.0 0
M  V30 3 C 7.7047 0.7700 0.0 0
M  V30 4 O 9.0383 3.0800 0.0 0
M  V30 5 C 2.3699 2.3100 0.0 0
M  V30 6 C 2.3699 0.7700 0.0 0
M  V30 7 C 3.7036 3.0800 0.0 0
M  V30 8 C 0.9052 2.7859 0.0 0
M  V30 9 C 3.7036 0.0000 0.0 0
M  V30 10 O 0.9052 0.2941 0.0 0
M  V30 11 C 5.0372 2.3100 0.0 0
M  V30 12 C 0.0000 1.5400 0.0 0
M  V30 13 C 5.0372 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 2 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(Benzofuran-5-yl)-N-methylpropan-2-amine
C12H15NO
1354631-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3709 3.0800 0.0 0
M  V30 2 C 7.7045 2.3100 0.0 0
M  V30 3 N 9.0383 3.0800 0.0 0
M  V30 4 C 7.7045 0.7700 0.0 0
M  V30 5 C 10.3720 2.3100 0.0 0
M  V30 6 C 2.3698 2.3100 0.0 0
M  V30 7 C 2.3698 0.7700 0.0 0
M  V30 8 C 3.7036 3.0800 0.0 0
M  V30 9 C 0.9052 2.7859 0.0 0
M  V30 10 C 3.7036 0.0000 0.0 0
M  V30 11 O 0.9052 0.2941 0.0 0
M  V30 12 C 5.0372 2.3100 0.0 0
M  V30 13 C 0.0000 1.5400 0.0 0
M  V30 14 C 5.0372 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 2 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 286836-32-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1354631-77-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37132004
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 56553-60-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Benzofuran salt morphic forms and mixtures for the treatment of mental
disorders or mental enhancement
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Baggott, Matthew J.; Lofthus, Sean Jeffrey; De Leon, Xanthe Marie
Renomeron; Singh, Aniruddh; Hudgins, Connor James
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023107653 A2 2023-06-15

$RFMT $RIREG SCHEME308 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(5-Benzofuranyl)-2-propanone
C11H10O2
286836-32-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3709 3.0800 0.0 0
M  V30 2 C 7.7047 2.3100 0.0 0
M  V30 3 C 7.7047 0.7700 0.0 0
M  V30 4 O 9.0383 3.0800 0.0 0
M  V30 5 C 2.3699 2.3100 0.0 0
M  V30 6 C 2.3699 0.7700 0.0 0
M  V30 7 C 3.7036 3.0800 0.0 0
M  V30 8 C 0.9052 2.7859 0.0 0
M  V30 9 C 3.7036 0.0000 0.0 0
M  V30 10 O 0.9052 0.2941 0.0 0
M  V30 11 C 5.0372 2.3100 0.0 0
M  V30 12 C 0.0000 1.5400 0.0 0
M  V30 13 C 5.0372 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 2 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(Benzofuran-5-yl)-N-methylpropan-2-amine
C12H15NO
1354631-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3709 3.0800 0.0 0
M  V30 2 C 7.7045 2.3100 0.0 0
M  V30 3 N 9.0383 3.0800 0.0 0
M  V30 4 C 7.7045 0.7700 0.0 0
M  V30 5 C 10.3720 2.3100 0.0 0
M  V30 6 C 2.3698 2.3100 0.0 0
M  V30 7 C 2.3698 0.7700 0.0 0
M  V30 8 C 3.7036 3.0800 0.0 0
M  V30 9 C 0.9052 2.7859 0.0 0
M  V30 10 C 3.7036 0.0000 0.0 0
M  V30 11 O 0.9052 0.2941 0.0 0
M  V30 12 C 5.0372 2.3100 0.0 0
M  V30 13 C 0.0000 1.5400 0.0 0
M  V30 14 C 5.0372 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 2 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 286836-32-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1354631-77-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31073428
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 56553-60-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Advantageous enantiomerically enriched mixtures of benzofurans and
compositions for mental disorders or enhancement
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Baggott, Matthew
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021252538 A2 2021-12-16

$RFMT $RIREG SCHEME309 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,2,3-Oxadiazolium, 5-hydroxy-3-[2-(2,2,2-tribromoacetyl)phenyl]-, inner salt
C10H5Br3N2O3
286960-86-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 4.0011 0.0 0
M  V30 2 C 1.5400 4.0011 0.0 0
M  V30 3 O 3.8500 5.3347 0.0 0
M  V30 4 Br 1.5400 2.4611 0.0 0
M  V30 5 Br 0.0000 4.0011 0.0 0
M  V30 6 Br 1.5400 5.5411 0.0 0
M  V30 7 O 9.4186 6.2947 0.0 0 CHG=-1
M  V30 8 C 5.3900 2.6674 0.0 0
M  V30 9 C 3.8500 2.6674 0.0 0
M  V30 10 C 6.1600 1.3336 0.0 0
M  V30 11 C 3.0800 1.3336 0.0 0
M  V30 12 C 5.3900 0.0000 0.0 0
M  V30 13 C 3.8500 0.0000 0.0 0
M  V30 14 N 6.1600 4.0011 0.0 0 CHG=1 VAL=4
M  V30 15 N 5.5337 5.4079 0.0 0
M  V30 16 C 7.6915 4.1620 0.0 0
M  V30 17 O 6.6781 6.4384 0.0 0
M  V30 18 C 8.0117 5.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 7 18
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 8 14
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,2,3-Oxadiazolium, 5-hydroxy-3-[2-[(methylamino)carbonyl]phenyl]-, inner salt
C10H9N3O3
108005-63-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 4.0012 0.0 0
M  V30 2 N 0.7700 4.0012 0.0 0
M  V30 3 O 3.0801 5.3348 0.0 0
M  V30 4 C 0.0000 5.3348 0.0 0
M  V30 5 O 8.6488 6.2949 0.0 0 CHG=-1
M  V30 6 C 4.6201 2.6675 0.0 0
M  V30 7 C 3.0801 2.6675 0.0 0
M  V30 8 C 5.3901 1.3337 0.0 0
M  V30 9 C 2.3101 1.3337 0.0 0
M  V30 10 C 4.6201 0.0000 0.0 0
M  V30 11 C 3.0801 0.0000 0.0 0
M  V30 12 N 5.3901 4.0012 0.0 0 CHG=1 VAL=4
M  V30 13 N 4.7638 5.4080 0.0 0
M  V30 14 C 6.9217 4.1621 0.0 0
M  V30 15 O 5.9082 6.4386 0.0 0
M  V30 16 C 7.2419 5.6686 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 16
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 12
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 286960-86-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 108005-63-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-6855918
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Activated carbonyl species for the preparation of ortho-acylarylsydnones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Turnbull, Kenneth; Beladakere, Ravindra N.; McCall, Neal D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Heterocyclic Chemistry (2000), 37(2), 383-388

$RFMT $RIREG SCHEME310 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Phenyl-4H-pyrano[3,4-c]quinoline-4,5(6H)-dione
C18H11NO3
2882178-27-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 0.0000 0.0 0
M  V30 2 O 2.6673 0.0000 0.0 0
M  V30 3 C 4.0012 3.8501 0.0 0
M  V30 4 C 2.6673 4.6201 0.0 0
M  V30 5 C 4.0012 2.3101 0.0 0
M  V30 6 C 5.3348 4.6201 0.0 0
M  V30 7 C 1.3337 3.8501 0.0 0
M  V30 8 C 2.6673 6.1601 0.0 0
M  V30 9 C 5.3348 1.5400 0.0 0
M  V30 10 C 2.6673 1.5400 0.0 0
M  V30 11 C 6.6685 3.8501 0.0 0
M  V30 12 N 1.3337 2.3101 0.0 0
M  V30 13 C 0.0000 4.6201 0.0 0
M  V30 14 C 1.3337 6.9302 0.0 0
M  V30 15 O 6.6685 2.3101 0.0 0
M  V30 16 C 0.0000 6.1601 0.0 0
M  V30 17 C 8.0023 4.6201 0.0 0
M  V30 18 C 9.3360 3.8501 0.0 0
M  V30 19 C 8.0023 6.1601 0.0 0
M  V30 20 C 10.6697 4.6201 0.0 0
M  V30 21 C 9.3360 6.9302 0.0 0
M  V30 22 C 10.6697 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 2 2 10
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 1 5 10
M  V30 10 2 6 11
M  V30 11 1 7 12
M  V30 12 2 7 13
M  V30 13 1 8 14
M  V30 14 1 9 15
M  V30 15 1 10 12
M  V30 16 1 11 15
M  V30 17 1 11 17
M  V30 18 1 13 16
M  V30 19 2 14 16
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methyl-2-phenylbenzo[c][2,7]naphthyridine-4,5(3H,6H)-dione
C19H14N2O2
2882178-48-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 0.0000 0.0 0
M  V30 2 O 2.6673 0.0000 0.0 0
M  V30 3 C 8.0022 1.5400 0.0 0
M  V30 4 C 4.0011 3.8500 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 2.6673 4.6201 0.0 0
M  V30 7 C 5.3348 4.6201 0.0 0
M  V30 8 C 5.3348 1.5400 0.0 0
M  V30 9 C 2.6673 1.5400 0.0 0
M  V30 10 C 1.3337 3.8500 0.0 0
M  V30 11 C 2.6673 6.1601 0.0 0
M  V30 12 C 6.6684 3.8500 0.0 0
M  V30 13 N 6.6684 2.3100 0.0 0
M  V30 14 N 1.3337 2.3100 0.0 0
M  V30 15 C 0.0000 4.6201 0.0 0
M  V30 16 C 1.3337 6.9301 0.0 0
M  V30 17 C 0.0000 6.1601 0.0 0
M  V30 18 C 8.0022 4.6201 0.0 0
M  V30 19 C 9.3359 3.8500 0.0 0
M  V30 20 C 8.0022 6.1601 0.0 0
M  V30 21 C 10.6695 4.6201 0.0 0
M  V30 22 C 9.3359 6.9301 0.0 0
M  V30 23 C 10.6695 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 2 2 9
M  V30 3 1 3 13
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 2 6 11
M  V30 11 2 7 12
M  V30 12 1 8 13
M  V30 13 1 9 14
M  V30 14 1 10 14
M  V30 15 2 10 15
M  V30 16 1 11 16
M  V30 17 1 12 13
M  V30 18 1 12 18
M  V30 19 1 15 17
M  V30 20 2 16 17
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2882178-27-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2882178-48-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35111774
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Divergent Sequential Reactions of β-(2-Aminophenyl)-α,β-ynones with
Malonyl Chloride
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Marsicano, Vincenzo; Marraffa, Gianpaolo; Chiarini, Marco; Palombi,
Laura; Arcadi, Antonio
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2022), 2022(45), e202201187

$RFMT $RIREG SCHEME311 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 2-[2-(methylsulfonyl)-4-pyrimidinyl]-1-azetidinecarboxylate
C13H19N3O4S
2882198-83-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.9813 2.2575 0.0 0
M  V30 2 O 10.3151 1.4875 0.0 0
M  V30 3 O 8.9813 3.7976 0.0 0
M  V30 4 C 11.6488 2.2575 0.0 0
M  V30 5 C 10.8788 3.5914 0.0 0
M  V30 6 C 12.9825 3.0276 0.0 0
M  V30 7 C 12.4188 0.9239 0.0 0
M  V30 8 S 1.5400 4.5536 0.0 0 VAL=6
M  V30 9 C 0.0000 4.5536 0.0 0
M  V30 10 O 1.5400 6.0936 0.0 0
M  V30 11 O 1.5400 3.0135 0.0 0
M  V30 12 C 6.1601 1.8861 0.0 0
M  V30 13 N 7.6477 1.4875 0.0 0
M  V30 14 C 5.7616 0.3986 0.0 0
M  V30 15 C 7.2491 0.0000 0.0 0
M  V30 16 C 5.3901 3.2199 0.0 0
M  V30 17 N 3.8501 3.2199 0.0 0
M  V30 18 C 6.1601 4.5536 0.0 0
M  V30 19 C 3.0801 4.5536 0.0 0
M  V30 20 C 5.3901 5.8872 0.0 0
M  V30 21 N 3.8501 5.8872 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 2 8 11
M  V30 11 1 8 19
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 16
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 2-[2-(methylamino)-4-pyrimidinyl]-1-azetidinecarboxylate
C13H20N4O2
2882198-78-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.6437 3.2199 0.0 0
M  V30 2 O 2.1037 3.2199 0.0 0
M  V30 3 O 4.4137 4.5536 0.0 0
M  V30 4 C 1.3337 4.5536 0.0 0
M  V30 5 C 0.0000 3.7836 0.0 0
M  V30 6 C 0.5637 5.8872 0.0 0
M  V30 7 C 2.6673 5.3236 0.0 0
M  V30 8 N 11.2361 1.4875 0.0 0
M  V30 9 C 12.5698 2.2575 0.0 0
M  V30 10 C 5.9013 1.4875 0.0 0
M  V30 11 N 4.4137 1.8861 0.0 0
M  V30 12 C 5.5027 0.0000 0.0 0
M  V30 13 C 4.0152 0.3986 0.0 0
M  V30 14 C 7.2349 2.2575 0.0 0
M  V30 15 N 8.5687 1.4875 0.0 0
M  V30 16 C 7.2349 3.7976 0.0 0
M  V30 17 C 9.9024 2.2575 0.0 0
M  V30 18 C 8.5687 4.5676 0.0 0
M  V30 19 N 9.9024 3.7976 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 8 17
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 14
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2882198-83-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2882198-78-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35100822
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A Decarboxylative Cross-Coupling Platform To Access 2-Heteroaryl
Azetidines: Building Blocks with Application in Medicinal Chemistry
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Brewster, James T.; Randall, Samuel D.; Kowalski, John; Cruz, Cole;
Shoemaker, Richard; Tarlton, Eugene; Hinklin, Ronald J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2022), 24(49), 9123-9129

$RFMT $RIREG SCHEME312 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C22H19O2.ClO4
2904546-49-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 10.0100 7.2874 0.0 0
M  V30 2 C 11.5500 7.2874 0.0 0
M  V30 3 C 5.3900 9.9547 0.0 0
M  V30 4 C 6.9300 9.9547 0.0 0
M  V30 5 C 4.6200 11.2885 0.0 0
M  V30 6 O 4.6200 8.6211 0.0 0 CHG=1 VAL=3
M  V30 7 C 7.7000 11.2885 0.0 0
M  V30 8 C 7.7000 8.6211 0.0 0
M  V30 9 C 3.0800 11.2885 0.0 0
M  V30 10 C 5.3900 12.6221 0.0 0
M  V30 11 C 3.0800 8.6211 0.0 0
M  V30 12 C 6.9300 12.6221 0.0 0
M  V30 13 C 9.2400 11.2885 0.0 0
M  V30 14 C 9.2400 8.6211 0.0 0
M  V30 15 C 2.3100 9.9547 0.0 0
M  V30 16 C 2.3100 7.2874 0.0 0
M  V30 17 C 10.0100 9.9547 0.0 0
M  V30 18 C 0.7700 9.9547 0.0 0
M  V30 19 C 0.7700 7.2874 0.0 0
M  V30 20 C 3.0800 5.9536 0.0 0
M  V30 21 C 0.0000 8.6211 0.0 0
M  V30 22 C 0.0000 5.9536 0.0 0
M  V30 23 C 2.3100 4.6200 0.0 0
M  V30 24 C 0.7700 4.6200 0.0 0
M  V30 25 Cl 5.7750 1.5400 0.0 0 VAL=7
M  V30 26 O 4.2350 1.5400 0.0 0
M  V30 27 O 7.3150 1.5400 0.0 0
M  V30 28 O 5.7750 0.0000 0.0 0
M  V30 29 O 5.7750 3.0800 0.0 0 CHG=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 2 5 9
M  V30 9 1 5 10
M  V30 10 1 6 11
M  V30 11 1 7 12
M  V30 12 2 7 13
M  V30 13 1 8 14
M  V30 14 1 9 15
M  V30 15 1 10 12
M  V30 16 2 11 15
M  V30 17 1 11 16
M  V30 18 1 13 17
M  V30 19 2 14 17
M  V30 20 1 15 18
M  V30 21 1 16 19
M  V30 22 2 16 20
M  V30 23 1 18 21
M  V30 24 1 19 21
M  V30 25 2 19 22
M  V30 26 1 20 23
M  V30 27 1 22 24
M  V30 28 2 23 24
M  V30 29 2 25 26
M  V30 30 2 25 27
M  V30 31 2 25 28
M  V30 32 1 25 29
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dibenz[c,h]acridinium, 5,6,8,9-tetrahydro-2-methoxy-14-methyl-, perchlorate (...
C23H22NO.ClO4
2904546-62-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 7.2874 0.0 0
M  V30 2 O 10.0100 7.2874 0.0 0
M  V30 3 C 11.5500 7.2874 0.0 0
M  V30 4 C 5.3900 9.9547 0.0 0
M  V30 5 C 6.9300 9.9547 0.0 0
M  V30 6 C 4.6200 11.2885 0.0 0
M  V30 7 N 4.6200 8.6211 0.0 0 CHG=1 VAL=4
M  V30 8 C 7.7000 11.2885 0.0 0
M  V30 9 C 7.7000 8.6211 0.0 0
M  V30 10 C 3.0800 11.2885 0.0 0
M  V30 11 C 5.3900 12.6221 0.0 0
M  V30 12 C 3.0800 8.6211 0.0 0
M  V30 13 C 6.9300 12.6221 0.0 0
M  V30 14 C 9.2400 11.2885 0.0 0
M  V30 15 C 9.2400 8.6211 0.0 0
M  V30 16 C 2.3100 9.9547 0.0 0
M  V30 17 C 2.3100 7.2874 0.0 0
M  V30 18 C 10.0100 9.9547 0.0 0
M  V30 19 C 0.7700 9.9547 0.0 0
M  V30 20 C 0.7700 7.2874 0.0 0
M  V30 21 C 3.0800 5.9536 0.0 0
M  V30 22 C 0.0000 8.6211 0.0 0
M  V30 23 C 0.0000 5.9536 0.0 0
M  V30 24 C 2.3100 4.6200 0.0 0
M  V30 25 C 0.7700 4.6200 0.0 0
M  V30 26 Cl 5.7750 1.5400 0.0 0 VAL=7
M  V30 27 O 4.2350 1.5400 0.0 0
M  V30 28 O 7.3150 1.5400 0.0 0
M  V30 29 O 5.7750 0.0000 0.0 0
M  V30 30 O 5.7750 3.0800 0.0 0 CHG=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 2 3
M  V30 3 1 2 15
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 1 6 11
M  V30 11 1 7 12
M  V30 12 1 8 13
M  V30 13 2 8 14
M  V30 14 1 9 15
M  V30 15 1 10 16
M  V30 16 1 11 13
M  V30 17 2 12 16
M  V30 18 1 12 17
M  V30 19 1 14 18
M  V30 20 2 15 18
M  V30 21 1 16 19
M  V30 22 1 17 20
M  V30 23 2 17 21
M  V30 24 1 19 22
M  V30 25 1 20 22
M  V30 26 2 20 23
M  V30 27 1 21 24
M  V30 28 1 23 25
M  V30 29 2 24 25
M  V30 30 2 26 27
M  V30 31 2 26 28
M  V30 32 2 26 29
M  V30 33 1 26 30
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2904546-49-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2904546-62-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35001827
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM IndiFluors: A New Full-Visible Color-Tunable Donor-Acceptor-Donor
(D1-A-D2) Fluorophore Family for Ratiometric pH Imaging during Mitophagy
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Munan, Subrata; Kottarathil, Shamna; Joseph, Manu M.; Jana, Anal; Ali,
Mudassar; Mapa, Koyeli; Maiti, Kaustabh Kumar; Samanta, Animesh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Sensors (2024), 9(7), 3502-3510

$RFMT $RIREG SCHEME313 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C23H21O3.ClO4
2904546-53-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 11.5500 12.6221 0.0 0
M  V30 2 C 12.3200 11.2884 0.0 0
M  V30 3 O 3.0800 5.9536 0.0 0
M  V30 4 C 2.3100 4.6200 0.0 0
M  V30 5 C 5.3900 12.6221 0.0 0
M  V30 6 C 6.9300 12.6221 0.0 0
M  V30 7 C 4.6200 13.9558 0.0 0
M  V30 8 O 4.6200 11.2884 0.0 0 CHG=1 VAL=3
M  V30 9 C 7.7000 13.9558 0.0 0
M  V30 10 C 7.7000 11.2884 0.0 0
M  V30 11 C 3.0800 13.9558 0.0 0
M  V30 12 C 5.3900 15.2894 0.0 0
M  V30 13 C 3.0800 11.2884 0.0 0
M  V30 14 C 6.9300 15.2894 0.0 0
M  V30 15 C 9.2400 13.9558 0.0 0
M  V30 16 C 9.2400 11.2884 0.0 0
M  V30 17 C 2.3100 12.6221 0.0 0
M  V30 18 C 2.3100 9.9547 0.0 0
M  V30 19 C 10.0100 12.6221 0.0 0
M  V30 20 C 0.7700 12.6221 0.0 0
M  V30 21 C 0.7700 9.9547 0.0 0
M  V30 22 C 3.0800 8.6211 0.0 0
M  V30 23 C 0.0000 11.2884 0.0 0
M  V30 24 C 0.0000 8.6211 0.0 0
M  V30 25 C 2.3100 7.2873 0.0 0
M  V30 26 C 0.7700 7.2873 0.0 0
M  V30 27 Cl 6.1600 1.5400 0.0 0 VAL=7
M  V30 28 O 4.6200 1.5400 0.0 0
M  V30 29 O 7.7000 1.5400 0.0 0
M  V30 30 O 6.1600 0.0000 0.0 0
M  V30 31 O 6.1600 3.0800 0.0 0 CHG=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 19
M  V30 3 1 3 4
M  V30 4 1 3 25
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 1 7 12
M  V30 12 1 8 13
M  V30 13 1 9 14
M  V30 14 2 9 15
M  V30 15 1 10 16
M  V30 16 1 11 17
M  V30 17 1 12 14
M  V30 18 2 13 17
M  V30 19 1 13 18
M  V30 20 1 15 19
M  V30 21 2 16 19
M  V30 22 1 17 20
M  V30 23 1 18 21
M  V30 24 2 18 22
M  V30 25 1 20 23
M  V30 26 1 21 23
M  V30 27 2 21 24
M  V30 28 1 22 25
M  V30 29 1 24 26
M  V30 30 2 25 26
M  V30 31 2 27 28
M  V30 32 2 27 29
M  V30 33 2 27 30
M  V30 34 1 27 31
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dibenz[c,h]acridinium, 5,6,8,9-tetrahydro-2,11-dimethoxy-14-methyl-, perchlor...
C24H24NO2.ClO4
2904546-68-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 7.7001 0.0 0
M  V30 2 O 12.0033 6.9301 0.0 0
M  V30 3 C 13.3370 7.7001 0.0 0
M  V30 4 O 1.3337 5.3900 0.0 0
M  V30 5 C 0.0000 4.6200 0.0 0
M  V30 6 C 6.6685 10.0101 0.0 0
M  V30 7 C 8.0022 9.2401 0.0 0
M  V30 8 C 6.6685 11.5502 0.0 0
M  V30 9 N 5.3348 9.2401 0.0 0 CHG=1 VAL=4
M  V30 10 C 9.3360 10.0101 0.0 0
M  V30 11 C 8.0022 7.7001 0.0 0
M  V30 12 C 5.3348 12.3202 0.0 0
M  V30 13 C 8.0022 12.3202 0.0 0
M  V30 14 C 4.0010 10.0101 0.0 0
M  V30 15 C 9.3360 11.5502 0.0 0
M  V30 16 C 10.6697 9.2401 0.0 0
M  V30 17 C 9.3360 6.9301 0.0 0
M  V30 18 C 4.0010 11.5502 0.0 0
M  V30 19 C 2.6673 9.2401 0.0 0
M  V30 20 C 10.6697 7.7001 0.0 0
M  V30 21 C 2.6673 12.3202 0.0 0
M  V30 22 C 1.3337 10.0101 0.0 0
M  V30 23 C 2.6673 7.7001 0.0 0
M  V30 24 C 1.3337 11.5502 0.0 0
M  V30 25 C 0.0000 9.2401 0.0 0
M  V30 26 C 1.3337 6.9301 0.0 0
M  V30 27 C 0.0000 7.7001 0.0 0
M  V30 28 Cl 6.6685 1.5400 0.0 0 VAL=7
M  V30 29 O 5.1285 1.5400 0.0 0
M  V30 30 O 8.2085 1.5400 0.0 0
M  V30 31 O 6.6685 0.0000 0.0 0
M  V30 32 O 6.6685 3.0800 0.0 0 CHG=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 3
M  V30 3 1 2 20
M  V30 4 1 4 5
M  V30 5 1 4 26
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 8 13
M  V30 13 1 9 14
M  V30 14 1 10 15
M  V30 15 2 10 16
M  V30 16 1 11 17
M  V30 17 1 12 18
M  V30 18 1 13 15
M  V30 19 2 14 18
M  V30 20 1 14 19
M  V30 21 1 16 20
M  V30 22 2 17 20
M  V30 23 1 18 21
M  V30 24 1 19 22
M  V30 25 2 19 23
M  V30 26 1 21 24
M  V30 27 1 22 24
M  V30 28 2 22 25
M  V30 29 1 23 26
M  V30 30 1 25 27
M  V30 31 2 26 27
M  V30 32 2 28 29
M  V30 33 2 28 30
M  V30 34 2 28 31
M  V30 35 1 28 32
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2904546-53-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2904546-68-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35001836
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM IndiFluors: A New Full-Visible Color-Tunable Donor-Acceptor-Donor
(D1-A-D2) Fluorophore Family for Ratiometric pH Imaging during Mitophagy
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Munan, Subrata; Kottarathil, Shamna; Joseph, Manu M.; Jana, Anal; Ali,
Mudassar; Mapa, Koyeli; Maiti, Kaustabh Kumar; Samanta, Animesh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Sensors (2024), 9(7), 3502-3510

$RFMT $RIREG SCHEME314 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C28H30N6O5
2911640-80-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 45 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 11.8092 0.0 0
M  V30 2 O 2.3100 11.8092 0.0 0
M  V30 3 O 4.6200 13.1430 0.0 0
M  V30 4 C 1.5400 13.1430 0.0 0
M  V30 5 C 0.0000 13.1430 0.0 0
M  V30 6 N 11.5807 11.3474 0.0 0
M  V30 7 C 16.2754 14.0580 0.0 0
M  V30 8 O 15.7996 15.5227 0.0 0
M  V30 9 N 7.6163 7.7778 0.0 0
M  V30 10 C 6.4717 8.8082 0.0 0
M  V30 11 C 6.9898 6.3710 0.0 0
M  V30 12 C 5.1381 8.0382 0.0 0
M  V30 13 C 6.1516 10.3147 0.0 0
M  V30 14 N 5.4582 6.5319 0.0 0
M  V30 15 C 3.9935 9.0688 0.0 0
M  V30 16 C 4.6200 10.4756 0.0 0 CFG=3
M  V30 17 C 9.1225 8.0980 0.0 0
M  V30 18 N 9.5984 9.5627 0.0 0
M  V30 19 C 10.1530 6.9536 0.0 0
M  V30 20 C 11.1048 9.8828 0.0 0
M  V30 21 C 11.6594 7.2738 0.0 0
M  V30 22 N 12.1353 8.7383 0.0 0
M  V30 23 C 7.7598 5.0372 0.0 0
M  V30 24 C 6.9898 3.7036 0.0 0
M  V30 25 C 9.2998 5.0372 0.0 0
M  V30 26 C 7.7598 2.3699 0.0 0
M  V30 27 C 10.0698 3.7036 0.0 0
M  V30 28 C 9.2998 2.3699 0.0 0
M  V30 29 O 7.2839 0.9052 0.0 0
M  V30 30 O 9.7757 0.9052 0.0 0
M  V30 31 C 8.5298 0.0000 0.0 0
M  V30 32 C 13.0870 11.6676 0.0 0 CFG=2
M  V30 33 C 13.7135 13.0745 0.0 0
M  V30 34 C 14.2315 10.6371 0.0 0
M  V30 35 N 15.2450 12.9136 0.0 0
M  V30 36 C 15.5652 11.4071 0.0 0
M  V30 37 C 17.7819 13.7378 0.0 0
M  V30 38 C 18.9262 12.7074 0.0 0
M  V30 39 C 19.2464 14.2137 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 20
M  V30 7 1 32 6 CFG=1
M  V30 8 2 7 8
M  V30 9 1 7 35
M  V30 10 1 7 37
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 1 9 17
M  V30 14 2 10 12
M  V30 15 1 10 13
M  V30 16 2 11 14
M  V30 17 1 11 23
M  V30 18 1 12 14
M  V30 19 1 12 15
M  V30 20 1 13 16
M  V30 21 1 15 16
M  V30 22 2 17 18
M  V30 23 1 17 19
M  V30 24 1 18 20
M  V30 25 2 19 21
M  V30 26 2 20 22
M  V30 27 1 21 22
M  V30 28 1 23 24
M  V30 29 2 23 25
M  V30 30 2 24 26
M  V30 31 1 25 27
M  V30 32 1 26 28
M  V30 33 1 26 29
M  V30 34 2 27 28
M  V30 35 1 28 30
M  V30 36 1 29 31
M  V30 37 1 30 31
M  V30 38 1 32 33
M  V30 39 1 32 34
M  V30 40 1 33 35
M  V30 41 1 34 36
M  V30 42 1 35 36
M  V30 43 1 37 38
M  V30 44 1 37 39
M  V30 45 1 38 39
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 32)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C27H29N7O4
2911640-88-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 44 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.8873 2.6673 0.0 0
M  V30 2 N 7.1173 1.3337 0.0 0
M  V30 3 O 9.4273 2.6673 0.0 0
M  V30 4 C 7.8873 0.0000 0.0 0
M  V30 5 N 11.3527 9.5933 0.0 0
M  V30 6 C 16.0476 12.3040 0.0 0
M  V30 7 O 17.0781 11.1596 0.0 0
M  V30 8 N 6.2790 7.9449 0.0 0
M  V30 9 C 6.5992 6.4384 0.0 0
M  V30 10 C 4.7473 8.1058 0.0 0
M  V30 11 C 5.2655 5.6684 0.0 0
M  V30 12 C 7.7436 5.4080 0.0 0
M  V30 13 N 4.1210 6.6990 0.0 0
M  V30 14 C 5.5857 4.1621 0.0 0
M  V30 15 C 7.1173 4.0012 0.0 0 CFG=3
M  V30 16 C 7.3095 9.0893 0.0 0
M  V30 17 N 8.8158 8.7691 0.0 0
M  V30 18 C 6.8336 10.5540 0.0 0
M  V30 19 C 9.8464 9.9137 0.0 0
M  V30 20 C 7.8640 11.6984 0.0 0
M  V30 21 N 9.3705 11.3782 0.0 0
M  V30 22 C 3.9773 9.4395 0.0 0
M  V30 23 C 2.4373 9.4395 0.0 0
M  V30 24 C 4.7473 10.7733 0.0 0
M  V30 25 C 1.6672 10.7733 0.0 0
M  V30 26 C 3.9773 12.1070 0.0 0
M  V30 27 C 2.4373 12.1070 0.0 0
M  V30 28 O 0.1609 11.0935 0.0 0
M  V30 29 O 1.4068 13.2514 0.0 0
M  V30 30 C 0.0000 12.6251 0.0 0
M  V30 31 C 12.3833 10.7379 0.0 0 CFG=2
M  V30 32 C 13.9148 10.5770 0.0 0
M  V30 33 C 12.0629 12.2442 0.0 0
M  V30 34 N 14.5412 11.9838 0.0 0
M  V30 35 C 13.3968 13.0142 0.0 0
M  V30 36 C 16.5235 13.7687 0.0 0
M  V30 37 C 17.6679 14.7991 0.0 0
M  V30 38 C 16.2033 15.2750 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 5 19
M  V30 6 1 31 5 CFG=3
M  V30 7 2 6 7
M  V30 8 1 6 34
M  V30 9 1 6 36
M  V30 10 1 8 9
M  V30 11 1 8 10
M  V30 12 1 8 16
M  V30 13 2 9 11
M  V30 14 1 9 12
M  V30 15 2 10 13
M  V30 16 1 10 22
M  V30 17 1 11 13
M  V30 18 1 11 14
M  V30 19 1 12 15
M  V30 20 1 14 15
M  V30 21 2 16 17
M  V30 22 1 16 18
M  V30 23 1 17 19
M  V30 24 2 18 20
M  V30 25 2 19 21
M  V30 26 1 20 21
M  V30 27 1 22 23
M  V30 28 2 22 24
M  V30 29 2 23 25
M  V30 30 1 24 26
M  V30 31 1 25 27
M  V30 32 1 25 28
M  V30 33 2 26 27
M  V30 34 1 27 29
M  V30 35 1 28 30
M  V30 36 1 29 30
M  V30 37 1 31 32
M  V30 38 1 31 33
M  V30 39 1 32 34
M  V30 40 1 33 35
M  V30 41 1 34 35
M  V30 42 1 36 37
M  V30 43 1 36 38
M  V30 44 1 37 38
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 31)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2911640-80-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2911640-88-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34862277
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel 1,4,5,6-tetrahydrocyclopenta[d]imidazole-5-carboxamide-based JNK3
inhibitors: Design, synthesis, molecular docking, and therapeutic
potential in neurodegenerative diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jun, Joonhong; Baek, Jihyun; Kang, Dahyun; Moon, Hyungwoo; Kim, Hyejin;
Cho, Hyunwook; Hah, Jung-Mi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2023), 245(Part_1), 114917

$RFMT $RIREG SCHEME315 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C34H38Cl2FN5O7
2913153-29-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  49 53 0 0 1
M  V30 BEGIN ATOM
M  V30 1 Cl 15.0387 11.4822 0.0 0
M  V30 2 N 15.0387 6.1475 0.0 0
M  V30 3 C 14.2687 4.8139 0.0 0
M  V30 4 C 16.5787 6.1475 0.0 0
M  V30 5 O 15.0387 3.4802 0.0 0
M  V30 6 O 12.7287 4.8139 0.0 0
M  V30 7 O 17.3487 7.4812 0.0 0
M  V30 8 O 17.3487 4.8139 0.0 0
M  V30 9 C 14.2687 2.1465 0.0 0
M  V30 10 C 18.8887 7.4812 0.0 0
M  V30 11 C 15.6024 1.3765 0.0 0
M  V30 12 C 13.4987 0.8128 0.0 0
M  V30 13 C 12.9349 2.9165 0.0 0
M  V30 14 C 18.8887 5.9412 0.0 0
M  V30 15 C 20.4287 7.4812 0.0 0
M  V30 16 C 18.8887 9.0212 0.0 0
M  V30 17 Cl 6.3947 9.0512 0.0 0
M  V30 18 F 8.2773 9.8894 0.0 0
M  V30 19 O 5.5000 6.9302 0.0 0
M  V30 20 C 4.5947 8.1760 0.0 0
M  V30 21 C 7.7417 4.4403 0.0 0
M  V30 22 O 6.2772 3.9644 0.0 0
M  V30 23 C 5.9570 2.4581 0.0 0
M  V30 24 C 11.9587 8.8150 0.0 0
M  V30 25 N 10.4523 9.1351 0.0 0
M  V30 26 C 12.7287 10.1486 0.0 0
M  V30 27 N 12.7287 7.4812 0.0 0
M  V30 28 C 10.2914 10.6667 0.0 0
M  V30 29 C 14.2687 10.1486 0.0 0
M  V30 30 N 11.6981 11.2930 0.0 0
M  V30 31 C 14.2687 7.4812 0.0 0
M  V30 32 N 15.0387 8.8150 0.0 0
M  V30 33 C 9.3079 8.1046 0.0 0 CFG=2
M  V30 34 C 7.8015 8.4249 0.0 0 CFG=1
M  V30 35 O 9.4688 6.5730 0.0 0
M  V30 36 C 7.0315 7.0911 0.0 0 CFG=2
M  V30 37 C 8.0619 5.9467 0.0 0 CFG=2
M  V30 38 C 3.0632 8.0151 0.0 0
M  V30 39 C 2.1580 9.2609 0.0 0
M  V30 40 C 2.4369 6.6081 0.0 0
M  V30 41 C 0.6265 9.1000 0.0 0
M  V30 42 C 0.9052 6.4472 0.0 0
M  V30 43 C 0.0000 7.6931 0.0 0
M  V30 44 C 4.4923 1.9823 0.0 0
M  V30 45 C 3.3480 3.0127 0.0 0
M  V30 46 C 4.1722 0.4759 0.0 0
M  V30 47 C 1.8833 2.5368 0.0 0
M  V30 48 C 2.7075 0.0000 0.0 0
M  V30 49 C 1.5631 1.0304 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 29
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 31
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 2 4 8
M  V30 9 1 5 9
M  V30 10 1 7 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 10 15
M  V30 16 1 10 16
M  V30 17 1 34 17 CFG=3
M  V30 18 1 34 18 CFG=1
M  V30 19 1 19 20
M  V30 20 1 36 19 CFG=1
M  V30 21 1 20 38
M  V30 22 1 21 22
M  V30 23 1 37 21 CFG=3
M  V30 24 1 22 23
M  V30 25 1 23 44
M  V30 26 1 24 25
M  V30 27 1 24 26
M  V30 28 2 24 27
M  V30 29 1 25 28
M  V30 30 1 33 25 CFG=3
M  V30 31 2 26 29
M  V30 32 1 26 30
M  V30 33 1 27 31
M  V30 34 2 28 30
M  V30 35 1 29 32
M  V30 36 2 31 32
M  V30 37 1 33 34
M  V30 38 1 33 35
M  V30 39 1 34 36
M  V30 40 1 35 37
M  V30 41 1 36 37
M  V30 42 2 38 39
M  V30 43 1 38 40
M  V30 44 1 39 41
M  V30 45 2 40 42
M  V30 46 2 41 43
M  V30 47 1 42 43
M  V30 48 2 44 45
M  V30 49 1 44 46
M  V30 50 1 45 47
M  V30 51 2 46 48
M  V30 52 2 47 49
M  V30 53 1 48 49
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 33 34 36 37)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C25H26ClFN6O3
2913153-30-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 40 0 0 1
M  V30 BEGIN ATOM
M  V30 1 Cl 9.3212 11.1496 0.0 0
M  V30 2 F 7.3054 11.5780 0.0 0
M  V30 3 N 15.7276 8.4641 0.0 0
M  V30 4 C 16.9734 7.5589 0.0 0
M  V30 5 N 12.5918 4.1480 0.0 0
M  V30 6 O 5.3348 10.3880 0.0 0
M  V30 7 C 4.0011 9.6180 0.0 0
M  V30 8 C 5.6850 7.0559 0.0 0
M  V30 9 O 6.0051 5.5496 0.0 0
M  V30 10 C 4.8607 4.5192 0.0 0
M  V30 11 N 10.6373 9.2609 0.0 0
M  V30 12 C 11.6679 8.1165 0.0 0
M  V30 13 C 11.4074 10.5945 0.0 0
M  V30 14 C 13.0747 8.7428 0.0 0
M  V30 15 N 11.5068 6.5848 0.0 0
M  V30 16 N 12.9138 10.2744 0.0 0
M  V30 17 C 14.3206 7.8376 0.0 0
M  V30 18 C 12.7529 5.6797 0.0 0
M  V30 19 N 14.1597 6.3061 0.0 0
M  V30 20 C 9.1058 9.0999 0.0 0 CFG=2
M  V30 21 C 8.0754 10.2443 0.0 0 CFG=1
M  V30 22 O 8.3358 7.7663 0.0 0
M  V30 23 C 6.6684 9.6180 0.0 0 CFG=2
M  V30 24 C 6.8295 8.0865 0.0 0 CFG=2
M  V30 25 C 2.6675 10.3880 0.0 0
M  V30 26 C 1.3337 9.6180 0.0 0
M  V30 27 C 2.6675 11.9280 0.0 0
M  V30 28 C 0.0000 10.3880 0.0 0
M  V30 29 C 1.3337 12.6980 0.0 0
M  V30 30 C 0.0000 11.9280 0.0 0
M  V30 31 C 5.1809 3.0127 0.0 0
M  V30 32 C 6.6456 2.5369 0.0 0
M  V30 33 C 4.0365 1.9823 0.0 0
M  V30 34 C 6.9658 1.0304 0.0 0
M  V30 35 C 4.3567 0.4759 0.0 0
M  V30 36 C 5.8213 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 21 1 CFG=3
M  V30 2 1 21 2 CFG=1
M  V30 3 1 3 4
M  V30 4 1 3 17
M  V30 5 1 5 18
M  V30 6 1 6 7
M  V30 7 1 23 6 CFG=1
M  V30 8 1 7 25
M  V30 9 1 8 9
M  V30 10 1 24 8 CFG=3
M  V30 11 1 9 10
M  V30 12 1 10 31
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 20 11 CFG=3
M  V30 16 1 12 14
M  V30 17 2 12 15
M  V30 18 2 13 16
M  V30 19 1 14 16
M  V30 20 2 14 17
M  V30 21 1 15 18
M  V30 22 1 17 19
M  V30 23 2 18 19
M  V30 24 1 20 21
M  V30 25 1 20 22
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 1 23 24
M  V30 29 2 25 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 2 27 29
M  V30 33 2 28 30
M  V30 34 1 29 30
M  V30 35 2 31 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 2 33 35
M  V30 39 2 34 36
M  V30 40 1 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 20 21 23 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2913153-29-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2913153-30-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36046611
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used (stage 1)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 2'-chloro-2'-fluoro-N2-amino-N6-methylamino purine
nucleotide phosphoramidate prodrugs and methods of use thereof for
treating flavivirus infection
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sommadossi, Jean-Pierre; Moussa, Adel
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Canada, CA3174107 A1 2023-03-03

$RFMT $RIREG SCHEME316 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Pyridinecarboxylic acid, 5-[[(3R)-1-[(1,1-dimethylethoxy)carbonyl]-3-pyrrol...
C17H25N3O4
2921726-85-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 9.2712 1.5400 0.0 0
M  V30 2 C 9.2712 0.0000 0.0 0
M  V30 3 C 3.9684 2.6672 0.0 0
M  V30 4 O 3.0631 3.9131 0.0 0
M  V30 5 O 3.3420 1.2602 0.0 0
M  V30 6 C 1.5316 3.7521 0.0 0
M  V30 7 C 1.3706 5.2837 0.0 0
M  V30 8 C 0.0000 3.5911 0.0 0
M  V30 9 C 1.6925 2.2204 0.0 0
M  V30 10 C 14.6060 4.6201 0.0 0
M  V30 11 O 15.9397 3.8501 0.0 0
M  V30 12 O 14.6060 6.1601 0.0 0
M  V30 13 C 17.2733 4.6201 0.0 0
M  V30 14 C 7.9373 2.3101 0.0 0 CFG=2
M  V30 15 C 6.5305 1.6837 0.0 0
M  V30 16 C 7.7764 3.8416 0.0 0
M  V30 17 N 5.4999 2.8281 0.0 0
M  V30 18 C 6.2699 4.1618 0.0 0
M  V30 19 C 10.6048 2.3101 0.0 0
M  V30 20 C 11.9385 1.5400 0.0 0
M  V30 21 C 10.6048 3.8501 0.0 0
M  V30 22 C 13.2722 2.3101 0.0 0
M  V30 23 N 11.9385 4.6201 0.0 0
M  V30 24 C 13.2722 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 14 1 CFG=1
M  V30 3 1 1 19
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 17
M  V30 7 1 4 6
M  V30 8 1 6 7
M  V30 9 1 6 8
M  V30 10 1 6 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 10 24
M  V30 14 1 11 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 20 1 19 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 2 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1-Pyrrolidinecarboxylic acid, 3-[methyl[6-[(methylamino)carbonyl]-3-pyridinyl...
C17H26N4O3
2921726-86-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 9.2712 1.5400 0.0 0
M  V30 2 C 9.2712 0.0000 0.0 0
M  V30 3 C 3.9684 2.6672 0.0 0
M  V30 4 O 3.0631 3.9131 0.0 0
M  V30 5 O 3.3420 1.2602 0.0 0
M  V30 6 C 1.5316 3.7521 0.0 0
M  V30 7 C 1.3706 5.2837 0.0 0
M  V30 8 C 0.0000 3.5911 0.0 0
M  V30 9 C 1.6925 2.2204 0.0 0
M  V30 10 C 14.6060 4.6201 0.0 0
M  V30 11 N 15.9397 3.8501 0.0 0
M  V30 12 O 14.6060 6.1601 0.0 0
M  V30 13 C 17.2733 4.6201 0.0 0
M  V30 14 C 7.9373 2.3101 0.0 0 CFG=2
M  V30 15 C 6.5305 1.6837 0.0 0
M  V30 16 C 7.7764 3.8416 0.0 0
M  V30 17 N 5.4999 2.8281 0.0 0
M  V30 18 C 6.2699 4.1618 0.0 0
M  V30 19 C 10.6048 2.3101 0.0 0
M  V30 20 C 11.9385 1.5400 0.0 0
M  V30 21 C 10.6048 3.8501 0.0 0
M  V30 22 C 13.2722 2.3101 0.0 0
M  V30 23 N 11.9385 4.6201 0.0 0
M  V30 24 C 13.2722 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 14 1 CFG=1
M  V30 3 1 1 19
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 17
M  V30 7 1 4 6
M  V30 8 1 6 7
M  V30 9 1 6 8
M  V30 10 1 6 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 10 24
M  V30 14 1 11 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 20 1 19 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 2 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2921726-85-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2921726-86-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36115900
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Azetidine for treating cancer and pharmaceutical composition thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hoffman, Robert L.; Dong, Qing; Trzoss, Lynnie; Va, Porino Jinjo; Kaldor,
Stephen W.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023056039 A1 2023-04-06

$RFMT $RIREG SCHEME317 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Pyridinecarboxamide, N-[3-[3-chloro-2-(4-formyl-3-methoxyphenyl)-4-pyridiny...
C27H20ClN3O4
2924115-58-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 6.9300 6.6684 0.0 0
M  V30 2 C 12.3200 5.3347 0.0 0
M  V30 3 N 13.8600 8.0020 0.0 0
M  V30 4 C 14.6300 9.3358 0.0 0
M  V30 5 O 13.8600 10.6694 0.0 0
M  V30 6 O 2.3100 1.3336 0.0 0
M  V30 7 C 3.0800 0.0000 0.0 0
M  V30 8 C 0.7700 4.0011 0.0 0
M  V30 9 O 0.0000 5.3347 0.0 0
M  V30 10 C 20.7900 9.3358 0.0 0
M  V30 11 O 21.5600 10.6694 0.0 0
M  V30 12 C 9.2400 5.3347 0.0 0
M  V30 13 C 7.7000 5.3347 0.0 0
M  V30 14 C 10.0100 4.0011 0.0 0
M  V30 15 C 6.9300 4.0011 0.0 0
M  V30 16 C 9.2400 2.6673 0.0 0
M  V30 17 N 7.7000 2.6673 0.0 0
M  V30 18 C 10.0100 6.6684 0.0 0
M  V30 19 C 11.5500 6.6684 0.0 0
M  V30 20 C 9.2400 8.0021 0.0 0
M  V30 21 C 12.3200 8.0020 0.0 0
M  V30 22 C 10.0100 9.3358 0.0 0
M  V30 23 C 11.5500 9.3358 0.0 0
M  V30 24 C 5.3900 4.0011 0.0 0
M  V30 25 C 4.6200 2.6673 0.0 0
M  V30 26 C 4.6200 5.3347 0.0 0
M  V30 27 C 3.0800 2.6674 0.0 0
M  V30 28 C 3.0800 5.3347 0.0 0
M  V30 29 C 2.3100 4.0011 0.0 0
M  V30 30 C 16.1700 9.3358 0.0 0
M  V30 31 C 16.9400 8.0020 0.0 0
M  V30 32 N 16.9400 10.6694 0.0 0
M  V30 33 C 18.4800 8.0020 0.0 0
M  V30 34 C 18.4800 10.6694 0.0 0
M  V30 35 C 19.2500 9.3358 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 2 19
M  V30 3 1 3 4
M  V30 4 1 3 21
M  V30 5 2 4 5
M  V30 6 1 4 30
M  V30 7 1 6 7
M  V30 8 1 6 27
M  V30 9 2 8 9
M  V30 10 1 8 29
M  V30 11 2 10 11
M  V30 12 1 10 35
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 1 12 18
M  V30 16 2 13 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 15 24
M  V30 20 2 16 17
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 33 2 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 2 32 34
M  V30 37 2 33 35
M  V30 38 1 34 35
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[3-[3-Chloro-2-[3-methoxy-4-[(methylamino)methyl]phenyl]-4-pyridinyl]-2-met...
C29H30ClN5O2
2845301-36-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 40 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 8.4700 6.6684 0.0 0
M  V30 2 C 13.8600 5.3347 0.0 0
M  V30 3 N 15.4000 8.0021 0.0 0
M  V30 4 C 16.1700 9.3358 0.0 0
M  V30 5 O 15.4000 10.6694 0.0 0
M  V30 6 O 3.8500 1.3336 0.0 0
M  V30 7 C 4.6200 0.0000 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 N 1.5400 5.3347 0.0 0
M  V30 10 C 0.0000 5.3347 0.0 0
M  V30 11 C 22.3300 9.3358 0.0 0
M  V30 12 N 23.1000 10.6694 0.0 0
M  V30 13 C 24.6400 10.6694 0.0 0
M  V30 14 C 10.7800 5.3347 0.0 0
M  V30 15 C 9.2400 5.3347 0.0 0
M  V30 16 C 11.5500 4.0011 0.0 0
M  V30 17 C 8.4700 4.0011 0.0 0
M  V30 18 C 10.7800 2.6673 0.0 0
M  V30 19 N 9.2400 2.6673 0.0 0
M  V30 20 C 11.5500 6.6684 0.0 0
M  V30 21 C 13.0900 6.6684 0.0 0
M  V30 22 C 10.7800 8.0021 0.0 0
M  V30 23 C 13.8600 8.0021 0.0 0
M  V30 24 C 11.5500 9.3358 0.0 0
M  V30 25 C 13.0900 9.3358 0.0 0
M  V30 26 C 6.9300 4.0011 0.0 0
M  V30 27 C 6.1600 2.6673 0.0 0
M  V30 28 C 6.1600 5.3347 0.0 0
M  V30 29 C 4.6200 2.6673 0.0 0
M  V30 30 C 4.6200 5.3347 0.0 0
M  V30 31 C 3.8500 4.0011 0.0 0
M  V30 32 C 17.7100 9.3358 0.0 0
M  V30 33 C 18.4800 10.6694 0.0 0
M  V30 34 N 18.4800 8.0021 0.0 0
M  V30 35 C 20.0200 10.6694 0.0 0
M  V30 36 C 20.0200 8.0021 0.0 0
M  V30 37 C 20.7900 9.3358 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 15
M  V30 2 1 2 21
M  V30 3 1 3 4
M  V30 4 1 3 23
M  V30 5 2 4 5
M  V30 6 1 4 32
M  V30 7 1 6 7
M  V30 8 1 6 29
M  V30 9 1 8 9
M  V30 10 1 8 31
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 1 11 37
M  V30 14 1 12 13
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 1 14 20
M  V30 18 2 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 17 26
M  V30 22 2 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 29 2 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 28 30
M  V30 33 2 29 31
M  V30 34 1 30 31
M  V30 35 2 32 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 2 34 36
M  V30 39 2 35 37
M  V30 40 1 36 37
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2924115-58-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2845301-36-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34742091
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25895-60-7
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM product isolated as formic acid salt by using reverse phase HPLC
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted 1-aryl-1'-heteroaryl compounds, substituted
1,1'-biheteroaryl compounds, and methods using same in the treatment of
cancer and hepatitis B and D
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ahuja, Vijay; Cole, Andrew G.; Dorsey, Bruce D.; Fan, Yi; Heffernan,
Gavin D.; Kakarla, Ramesh; Kultgen, Steven G.; Nguyen, Duyan; Ozturk,
Seyma; Quintero, Jorge; Sofia, Michael J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022208269 A2 2022-10-06

$RFMT $RIREG SCHEME318 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzeneacetic acid, 2-[[(5-acetyl-2,3-dihydro-2,2-dimethyl-7-benzofuranyl)oxy...
C23H25NO6
2925227-04-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.2536 6.6684 0.0 0
M  V30 2 C 7.7936 6.6684 0.0 0
M  V30 3 C 0.0000 5.5326 0.0 0
M  V30 4 C 1.0304 7.3175 0.0 0
M  V30 5 C 6.2536 1.3336 0.0 0
M  V30 6 C 5.4836 0.0000 0.0 0
M  V30 7 O 7.7936 1.3336 0.0 0
M  V30 8 C 10.8736 6.6684 0.0 0
M  V30 9 C 10.1036 5.3347 0.0 0
M  V30 10 N 12.4136 6.6684 0.0 0
M  V30 11 O 10.8736 4.0011 0.0 0
M  V30 12 O 8.5636 5.3347 0.0 0
M  V30 13 O 13.1836 8.0021 0.0 0
M  V30 14 C 12.4136 4.0011 0.0 0
M  V30 15 C 14.7236 8.0021 0.0 0
M  V30 16 C 3.9436 5.3347 0.0 0
M  V30 17 C 3.1736 4.0011 0.0 0
M  V30 18 C 5.4836 5.3347 0.0 0
M  V30 19 O 2.9132 6.4791 0.0 0
M  V30 20 C 3.9436 2.6673 0.0 0
M  V30 21 C 1.6674 4.3212 0.0 0
M  V30 22 C 6.2536 4.0011 0.0 0
M  V30 23 C 1.5063 5.8528 0.0 0
M  V30 24 C 5.4836 2.6673 0.0 0
M  V30 25 C 8.5636 8.0021 0.0 0
M  V30 26 C 10.1036 8.0021 0.0 0
M  V30 27 C 7.7936 9.3358 0.0 0
M  V30 28 C 10.8736 9.3358 0.0 0
M  V30 29 C 8.5636 10.6694 0.0 0
M  V30 30 C 10.1036 10.6694 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 2 25
M  V30 4 1 3 23
M  V30 5 1 4 23
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 24
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 8 26
M  V30 12 1 9 11
M  V30 13 2 9 12
M  V30 14 1 10 13
M  V30 15 1 11 14
M  V30 16 1 13 15
M  V30 17 1 16 17
M  V30 18 2 16 18
M  V30 19 1 16 19
M  V30 20 2 17 20
M  V30 21 1 17 21
M  V30 22 1 18 22
M  V30 23 1 19 23
M  V30 24 1 20 24
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzeneacetamide, 2-[[(5-acetyl-2,3-dihydro-2,2-dimethyl-7-benzofuranyl)oxy]m...
C23H26N2O5
2925227-09-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.2536 6.6684 0.0 0
M  V30 2 C 7.7936 6.6684 0.0 0
M  V30 3 C 0.0000 5.5326 0.0 0
M  V30 4 C 1.0304 7.3175 0.0 0
M  V30 5 C 6.2536 1.3336 0.0 0
M  V30 6 C 5.4836 0.0000 0.0 0
M  V30 7 O 7.7936 1.3336 0.0 0
M  V30 8 C 10.8736 6.6684 0.0 0
M  V30 9 C 10.1036 5.3347 0.0 0
M  V30 10 N 12.4136 6.6684 0.0 0
M  V30 11 N 10.8736 4.0011 0.0 0
M  V30 12 O 8.5636 5.3347 0.0 0
M  V30 13 O 13.1836 8.0021 0.0 0
M  V30 14 C 12.4136 4.0011 0.0 0
M  V30 15 C 14.7236 8.0021 0.0 0
M  V30 16 C 3.9436 5.3347 0.0 0
M  V30 17 C 3.1736 4.0011 0.0 0
M  V30 18 C 5.4836 5.3347 0.0 0
M  V30 19 O 2.9132 6.4791 0.0 0
M  V30 20 C 3.9436 2.6673 0.0 0
M  V30 21 C 1.6674 4.3212 0.0 0
M  V30 22 C 6.2536 4.0011 0.0 0
M  V30 23 C 1.5063 5.8528 0.0 0
M  V30 24 C 5.4836 2.6673 0.0 0
M  V30 25 C 8.5636 8.0021 0.0 0
M  V30 26 C 10.1036 8.0021 0.0 0
M  V30 27 C 7.7936 9.3358 0.0 0
M  V30 28 C 10.8736 9.3358 0.0 0
M  V30 29 C 8.5636 10.6694 0.0 0
M  V30 30 C 10.1036 10.6694 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 2 25
M  V30 4 1 3 23
M  V30 5 1 4 23
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 24
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 8 26
M  V30 12 1 9 11
M  V30 13 2 9 12
M  V30 14 1 10 13
M  V30 15 1 11 14
M  V30 16 1 13 15
M  V30 17 1 16 17
M  V30 18 2 16 18
M  V30 19 1 16 19
M  V30 20 2 17 20
M  V30 21 1 17 21
M  V30 22 1 18 22
M  V30 23 1 19 23
M  V30 24 1 20 24
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2925227-04-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2925227-09-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36471936
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, crystal structure, biological evaluation, docking study and
DFT calculation of novel strobilurins containing oxime ether phenyl ring
or dihydrobenzofuran moiety
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Mingfang; Li, Kangming; Yi, Yangjie; Luo, Xianfu; Qiu, Longjian;
Zhang, Lijuan; Wang, Man; Ye, Jiao; Ou, Xiaoming; Li, Jianming; Chen,
Yun; Hu, Aixi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Molecular Structure (2023), 1286135636

$RFMT $RIREG SCHEME319 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Nitro-1H,3H-naphtho[1,8-cd]pyran-1,3-dione
C12H5NO5
3027-38-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6675 6.9301 0.0 0
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 N 8.0022 5.3901 0.0 0 VAL=5
M  V30 4 O 9.3359 4.6201 0.0 0
M  V30 5 O 8.0022 6.9301 0.0 0
M  V30 6 C 4.0011 3.0800 0.0 0
M  V30 7 C 4.0011 4.6201 0.0 0
M  V30 8 C 5.3348 2.3100 0.0 0
M  V30 9 C 2.6675 2.3100 0.0 0
M  V30 10 C 5.3348 5.3901 0.0 0
M  V30 11 C 2.6675 5.3901 0.0 0
M  V30 12 C 6.6684 3.0800 0.0 0
M  V30 13 C 5.3348 0.7700 0.0 0
M  V30 14 C 1.3337 3.0800 0.0 0
M  V30 15 C 2.6675 0.7700 0.0 0
M  V30 16 C 6.6684 4.6201 0.0 0
M  V30 17 O 1.3337 4.6201 0.0 0
M  V30 18 C 4.0011 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 2 2 14
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 16
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 2 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 8 13
M  V30 13 1 9 14
M  V30 14 2 9 15
M  V30 15 1 10 16
M  V30 16 1 11 17
M  V30 17 2 12 16
M  V30 18 2 13 18
M  V30 19 1 14 17
M  V30 20 1 15 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methyl-5-nitro-1H-benz[de]isoquinoline-1,3(2H)-dione
C13H8N2O4
66266-37-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6675 6.9302 0.0 0
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 C 0.0000 5.3901 0.0 0
M  V30 4 N 8.0023 5.3901 0.0 0 VAL=5
M  V30 5 O 8.0023 6.9302 0.0 0
M  V30 6 O 9.3360 4.6201 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 4.0012 4.6201 0.0 0
M  V30 9 C 2.6675 2.3101 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 2.6675 5.3901 0.0 0
M  V30 12 C 5.3348 5.3901 0.0 0
M  V30 13 C 1.3337 3.0801 0.0 0
M  V30 14 C 2.6675 0.7700 0.0 0
M  V30 15 C 6.6685 3.0801 0.0 0
M  V30 16 C 5.3348 0.7700 0.0 0
M  V30 17 N 1.3337 4.6201 0.0 0
M  V30 18 C 6.6685 4.6201 0.0 0
M  V30 19 C 4.0012 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 2 2 13
M  V30 3 1 3 17
M  V30 4 2 4 5
M  V30 5 2 4 6
M  V30 6 1 4 18
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 2 9 14
M  V30 14 1 10 15
M  V30 15 1 10 16
M  V30 16 1 11 17
M  V30 17 1 12 18
M  V30 18 1 13 17
M  V30 19 1 14 19
M  V30 20 2 15 18
M  V30 21 2 16 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3027-38-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 66266-37-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41649872
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-86-4
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Colorful 3-amino-1,8-naphthalimide alkyl-substituted fluorescent
derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Johnson, Alex D.; Szacilowski, Konrad; Magri, David C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Dyes and Pigments (2024), 231112424

$RFMT $RIREG SCHEME320 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,6-Diazaspiro[3.3]heptane-2-carboxylic acid, 6-[[2-(methoxycarbonyl)phenyl]m...
C19H26N2O4
3033469-87-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 12.8257 4.0011 0.0 0
M  V30 2 O 13.5957 5.3349 0.0 0
M  V30 3 O 13.5957 2.6674 0.0 0
M  V30 4 C 15.1357 5.3349 0.0 0
M  V30 5 C 15.1357 3.7949 0.0 0
M  V30 6 C 16.6757 5.3349 0.0 0
M  V30 7 C 15.1357 6.8749 0.0 0
M  V30 8 C 5.3900 4.0011 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 O 0.7700 4.0011 0.0 0
M  V30 11 O 3.0800 5.3349 0.0 0
M  V30 12 C 0.0000 5.3349 0.0 0
M  V30 13 C 9.1079 4.0011 0.0 0
M  V30 14 C 10.1968 5.0900 0.0 0
M  V30 15 C 10.1968 2.9121 0.0 0
M  V30 16 C 8.0189 2.9121 0.0 0
M  V30 17 C 8.0189 5.0900 0.0 0
M  V30 18 N 11.2857 4.0011 0.0 0
M  V30 19 N 6.9300 4.0011 0.0 0
M  V30 20 C 4.6200 2.6674 0.0 0
M  V30 21 C 3.0800 2.6674 0.0 0
M  V30 22 C 5.3900 1.3338 0.0 0
M  V30 23 C 2.3100 1.3338 0.0 0
M  V30 24 C 4.6200 0.0000 0.0 0
M  V30 25 C 3.0800 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 19
M  V30 9 1 8 20
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 9 21
M  V30 13 1 10 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 13 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 1 15 18
M  V30 20 1 16 19
M  V30 21 1 17 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,6-Diazaspiro[3.3]heptane-2-carboxylic acid, 6-[[2-[(methylamino)carbonyl]ph...
C19H27N3O3
2923305-92-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 12.8257 4.0011 0.0 0
M  V30 2 O 13.5957 5.3349 0.0 0
M  V30 3 O 13.5957 2.6674 0.0 0
M  V30 4 C 15.1357 5.3349 0.0 0
M  V30 5 C 15.1357 6.8749 0.0 0
M  V30 6 C 16.6757 5.3349 0.0 0
M  V30 7 C 15.1357 3.7949 0.0 0
M  V30 8 C 5.3900 4.0011 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 N 0.7700 4.0011 0.0 0
M  V30 11 O 3.0800 5.3349 0.0 0
M  V30 12 C 0.0000 5.3349 0.0 0
M  V30 13 C 9.1079 4.0011 0.0 0
M  V30 14 C 10.1968 2.9121 0.0 0
M  V30 15 C 10.1968 5.0900 0.0 0
M  V30 16 C 8.0189 5.0900 0.0 0
M  V30 17 C 8.0189 2.9121 0.0 0
M  V30 18 N 11.2857 4.0011 0.0 0
M  V30 19 N 6.9300 4.0011 0.0 0
M  V30 20 C 4.6200 2.6674 0.0 0
M  V30 21 C 3.0800 2.6674 0.0 0
M  V30 22 C 5.3900 1.3338 0.0 0
M  V30 23 C 2.3100 1.3338 0.0 0
M  V30 24 C 4.6200 0.0000 0.0 0
M  V30 25 C 3.0800 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 19
M  V30 9 1 8 20
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 9 21
M  V30 13 1 10 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 13 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 1 15 18
M  V30 20 1 16 19
M  V30 21 1 17 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3033469-87-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2923305-92-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37663709
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed vial used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM New heterocyclic compounds as MAGL inhibitors and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Amoussa, Machoud; Benz, Joerg; Blaising, Julie Elisabeth Francoise;
Denizot, Jason Jacques; Friston, Kallie; Ganzoni, Rudolf Liun Zaccaria;
Giroud, Maude; Grether, Uwe; Hornsperger, Benoit; Kaufmann, Isabelle;
Kuhn, Bernd; Leake, Camiel John; Margarini, Jacopo; Martin, Rainer Eugen;
O'Hara, Fionn Susannah; Puellmann, Bernd; Ritter, Martin; Rombach,
Didier; Runtz-Schmitt, Valerie; Schmid, Philipp Claudio; Wittwer,
Matthias Beat
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023144160 A1 2023-08-03

$RFMT $RIREG SCHEME320 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,6-Diazaspiro[3.3]heptane-2-carboxylic acid, 6-[[2-(methoxycarbonyl)phenyl]m...
C19H26N2O4
3033469-87-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 12.8257 4.0011 0.0 0
M  V30 2 O 13.5957 5.3349 0.0 0
M  V30 3 O 13.5957 2.6674 0.0 0
M  V30 4 C 15.1357 5.3349 0.0 0
M  V30 5 C 15.1357 3.7949 0.0 0
M  V30 6 C 16.6757 5.3349 0.0 0
M  V30 7 C 15.1357 6.8749 0.0 0
M  V30 8 C 5.3900 4.0011 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 O 0.7700 4.0011 0.0 0
M  V30 11 O 3.0800 5.3349 0.0 0
M  V30 12 C 0.0000 5.3349 0.0 0
M  V30 13 C 9.1079 4.0011 0.0 0
M  V30 14 C 10.1968 5.0900 0.0 0
M  V30 15 C 10.1968 2.9121 0.0 0
M  V30 16 C 8.0189 2.9121 0.0 0
M  V30 17 C 8.0189 5.0900 0.0 0
M  V30 18 N 11.2857 4.0011 0.0 0
M  V30 19 N 6.9300 4.0011 0.0 0
M  V30 20 C 4.6200 2.6674 0.0 0
M  V30 21 C 3.0800 2.6674 0.0 0
M  V30 22 C 5.3900 1.3338 0.0 0
M  V30 23 C 2.3100 1.3338 0.0 0
M  V30 24 C 4.6200 0.0000 0.0 0
M  V30 25 C 3.0800 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 19
M  V30 9 1 8 20
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 9 21
M  V30 13 1 10 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 13 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 1 15 18
M  V30 20 1 16 19
M  V30 21 1 17 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,6-Diazaspiro[3.3]heptane-2-carboxylic acid, 6-[[2-[(methylamino)carbonyl]ph...
C19H27N3O3
2923305-92-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 12.8257 4.0011 0.0 0
M  V30 2 O 13.5957 5.3349 0.0 0
M  V30 3 O 13.5957 2.6674 0.0 0
M  V30 4 C 15.1357 5.3349 0.0 0
M  V30 5 C 15.1357 6.8749 0.0 0
M  V30 6 C 16.6757 5.3349 0.0 0
M  V30 7 C 15.1357 3.7949 0.0 0
M  V30 8 C 5.3900 4.0011 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 N 0.7700 4.0011 0.0 0
M  V30 11 O 3.0800 5.3349 0.0 0
M  V30 12 C 0.0000 5.3349 0.0 0
M  V30 13 C 9.1079 4.0011 0.0 0
M  V30 14 C 10.1968 2.9121 0.0 0
M  V30 15 C 10.1968 5.0900 0.0 0
M  V30 16 C 8.0189 5.0900 0.0 0
M  V30 17 C 8.0189 2.9121 0.0 0
M  V30 18 N 11.2857 4.0011 0.0 0
M  V30 19 N 6.9300 4.0011 0.0 0
M  V30 20 C 4.6200 2.6674 0.0 0
M  V30 21 C 3.0800 2.6674 0.0 0
M  V30 22 C 5.3900 1.3338 0.0 0
M  V30 23 C 2.3100 1.3338 0.0 0
M  V30 24 C 4.6200 0.0000 0.0 0
M  V30 25 C 3.0800 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 19
M  V30 9 1 8 20
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 9 21
M  V30 13 1 10 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 13 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 1 15 18
M  V30 20 1 16 19
M  V30 21 1 17 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3033469-87-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2923305-92-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36730865
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM reaction in a sealed vial
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocyclic compounds as monoacylglycerol lipase
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Amoussa, Machoud; Benz, Joerg; Blaising, Julie Elisabeth Francoise;
Giroud, Maude; Grether, Uwe; Kroll, Carsten; Kuhn, Bernd; Martin, Rainer
E.; O'Hara, Fionn Susannah; Puellmann, Bernd; Ritter, Martin; Rombach,
Didier; Schmid, Philipp Claudio; Wittwer, Matthias Beat
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023062049 A1 2023-04-20

$RFMT $RIREG SCHEME321 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzenemethanol, 4-[(2,6-dichloro-9H-purin-9-yl)methyl]-
C13H10Cl2N4O
3038727-03-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.0551 4.9832 0.0 0
M  V30 2 Cl 1.6485 0.0000 0.0 0
M  V30 3 Cl 0.0000 5.0736 0.0 0
M  V30 4 C 12.2152 4.9832 0.0 0
M  V30 5 O 12.9853 6.3169 0.0 0
M  V30 6 C 3.7535 3.4886 0.0 0
M  V30 7 C 3.4334 1.9822 0.0 0
M  V30 8 N 5.2851 3.6496 0.0 0
M  V30 9 N 2.6091 4.5191 0.0 0
M  V30 10 N 4.7670 1.2122 0.0 0
M  V30 11 C 1.9686 1.5063 0.0 0
M  V30 12 C 5.9116 2.2426 0.0 0
M  V30 13 C 1.1444 4.0432 0.0 0
M  V30 14 N 0.8242 2.5367 0.0 0
M  V30 15 C 7.5951 4.9832 0.0 0
M  V30 16 C 8.3652 3.6496 0.0 0
M  V30 17 C 8.3652 6.3169 0.0 0
M  V30 18 C 9.9052 3.6496 0.0 0
M  V30 19 C 9.9052 6.3169 0.0 0
M  V30 20 C 10.6752 4.9832 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 1 15
M  V30 3 1 2 11
M  V30 4 1 3 13
M  V30 5 1 4 5
M  V30 6 1 4 20
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 7 10
M  V30 11 2 7 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 2 10 12
M  V30 15 1 11 14
M  V30 16 2 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzenemethanol, 4-[[2-chloro-6-(methylamino)-9H-purin-9-yl]methyl]-
C14H14ClN5O
3038726-83-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.8143 3.1059 0.0 0
M  V30 2 N 1.5063 5.2182 0.0 0
M  V30 3 C 0.0000 4.8981 0.0 0
M  V30 4 Cl 2.6154 0.0000 0.0 0
M  V30 5 C 13.1491 6.1860 0.0 0
M  V30 6 O 14.4828 5.4160 0.0 0
M  V30 7 C 5.0736 3.2495 0.0 0
M  V30 8 C 4.0432 4.3940 0.0 0
M  V30 9 N 6.4806 3.8760 0.0 0
M  V30 10 N 4.5978 1.7849 0.0 0
M  V30 11 C 2.5369 4.0739 0.0 0
M  V30 12 N 4.8132 5.7277 0.0 0
M  V30 13 C 6.3195 5.4075 0.0 0
M  V30 14 C 3.0915 1.4647 0.0 0
M  V30 15 N 2.0609 2.6091 0.0 0
M  V30 16 C 9.1480 3.8760 0.0 0
M  V30 17 C 9.1480 5.4160 0.0 0
M  V30 18 C 10.4818 3.1059 0.0 0
M  V30 19 C 10.4818 6.1860 0.0 0
M  V30 20 C 11.8154 3.8760 0.0 0
M  V30 21 C 11.8154 5.4160 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 1 2 11
M  V30 5 1 4 14
M  V30 6 1 5 6
M  V30 7 1 5 21
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 2 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 2 12 13
M  V30 17 2 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3038727-03-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3038726-83-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40947872
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structure-Based Design of a Potent and Selective YTHDC1 Ligand
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zalesak, Frantisek; Nai, Francesco; Herok, Marcin; Bochenkova, Elena;
Bedi, Rajiv K.; Li, Yaozong; Errani, Francesco; Caflisch, Amedeo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2024), 67(11), 9516-9535

$RFMT $RIREG SCHEME322 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Chloromethyl)-2-phenyloxazole
C10H8ClNO
30494-97-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.2359 3.0089 0.0 0
M  V30 2 Cl 9.6427 2.3826 0.0 0
M  V30 3 C 4.6201 1.3337 0.0 0
M  V30 4 N 5.5253 2.5795 0.0 0
M  V30 5 O 5.5253 0.0878 0.0 0
M  V30 6 C 6.9898 2.1037 0.0 0
M  V30 7 C 6.9898 0.5636 0.0 0
M  V30 8 C 3.0800 1.3337 0.0 0
M  V30 9 C 2.3100 0.0000 0.0 0
M  V30 10 C 2.3100 2.6673 0.0 0
M  V30 11 C 0.7700 0.0000 0.0 0
M  V30 12 C 0.7700 2.6673 0.0 0
M  V30 13 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 8
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 6 7
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2-phenyl-4-oxazolemethanamine
C11H12N2O
1491509-07-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.2357 3.0089 0.0 0
M  V30 2 N 9.6426 2.3824 0.0 0
M  V30 3 C 10.8885 3.2876 0.0 0
M  V30 4 C 4.6200 1.3336 0.0 0
M  V30 5 N 5.5252 2.5795 0.0 0
M  V30 6 O 5.5252 0.0878 0.0 0
M  V30 7 C 6.9898 2.1037 0.0 0
M  V30 8 C 6.9898 0.5636 0.0 0
M  V30 9 C 3.0800 1.3336 0.0 0
M  V30 10 C 2.3100 2.6673 0.0 0
M  V30 11 C 2.3100 0.0000 0.0 0
M  V30 12 C 0.7700 2.6673 0.0 0
M  V30 13 C 0.7700 0.0000 0.0 0
M  V30 14 C 0.0000 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 9
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 8
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 30494-97-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1491509-07-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24398631
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structural and Activity Relationships of
6-Sulfonyl-8-Nitrobenzothiazinones as Antitubercular Agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fan, Dongguang; Wang, Bin; Stelitano, Giovanni; Savkova, Karin; Shi, Rui;
Huszar, Stanislav; Han, Quanquan; Mikusova, Katarina; Chiarelli, Laurent
R.; Lu, Yu; Qiao, Chunhua
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2021), 64(19), 14526-14539

$RFMT $RIREG SCHEME323 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C26H26N2O7S
3052324-14-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 39 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.5932 6.0559 0.0 0
M  V30 2 N 6.0665 4.6088 0.0 0
M  V30 3 C 4.5499 4.3414 0.0 0
M  V30 4 O 3.5600 5.5211 0.0 0
M  V30 5 O 12.1109 4.0134 0.0 0
M  V30 6 C 13.4445 4.7834 0.0 0
M  V30 7 O 14.7781 4.0134 0.0 0
M  V30 8 O 13.4445 6.3234 0.0 0
M  V30 9 O 1.5167 3.8066 0.0 0
M  V30 10 C 0.0000 3.5391 0.0 0
M  V30 11 N 20.1129 7.0934 0.0 0 VAL=5
M  V30 12 O 20.1129 8.6334 0.0 0
M  V30 13 O 21.4467 6.3234 0.0 0
M  V30 14 C 8.1098 6.3234 0.0 0 CFG=1
M  V30 15 C 8.1098 4.7834 0.0 0
M  V30 16 C 9.4434 7.0934 0.0 0
M  V30 17 C 9.4434 4.0134 0.0 0
M  V30 18 C 10.7772 6.3234 0.0 0
M  V30 19 C 10.7772 4.7834 0.0 0 CFG=1
M  V30 20 C 7.5831 7.7705 0.0 0
M  V30 21 C 8.4443 9.0472 0.0 0
M  V30 22 S 6.1027 8.1950 0.0 0
M  V30 23 C 7.4961 10.2607 0.0 0
M  V30 24 C 6.0490 9.7340 0.0 0
M  V30 25 C 4.0231 2.8943 0.0 0
M  V30 26 C 2.5065 2.6268 0.0 0
M  V30 27 C 5.0130 1.7145 0.0 0
M  V30 28 C 1.9798 1.1796 0.0 0
M  V30 29 C 4.4863 0.2673 0.0 0
M  V30 30 C 2.9697 0.0000 0.0 0
M  V30 31 C 16.1119 4.7834 0.0 0
M  V30 32 C 16.1119 6.3234 0.0 0
M  V30 33 C 17.4456 4.0134 0.0 0
M  V30 34 C 17.4456 7.0934 0.0 0
M  V30 35 C 18.7792 4.7834 0.0 0
M  V30 36 C 18.7792 6.3234 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 14 1 CFG=1
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 1 3 25
M  V30 6 1 5 6
M  V30 7 1 19 5 CFG=3
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 7 31
M  V30 11 1 9 10
M  V30 12 1 9 26
M  V30 13 2 11 12
M  V30 14 2 11 13
M  V30 15 1 11 36
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 14 20 CFG=3
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 1 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 24
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 34 2 31 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 2 33 35
M  V30 38 2 34 36
M  V30 39 1 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 14 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Benzamide, 2-methoxy-N-[[cis-4-[[(methylamino)carbonyl]oxy]-1-(2-thienyl)cycl...
C21H26N2O4S
3052323-97-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 3.9841 0.0 0
M  V30 2 N 6.1600 5.3178 0.0 0
M  V30 3 C 4.6200 5.3178 0.0 0
M  V30 4 O 3.8500 3.9841 0.0 0
M  V30 5 O 12.0092 6.9539 0.0 0
M  V30 6 C 13.4562 6.4270 0.0 0
M  V30 7 N 14.6360 7.4169 0.0 0
M  V30 8 O 13.7237 4.9104 0.0 0
M  V30 9 C 16.0831 6.8903 0.0 0
M  V30 10 O 1.5400 5.3178 0.0 0
M  V30 11 C 0.0000 5.3178 0.0 0
M  V30 12 C 8.4700 3.9841 0.0 0 CFG=1
M  V30 13 C 8.2027 5.5007 0.0 0
M  V30 14 C 9.9171 3.4575 0.0 0
M  V30 15 C 9.3823 6.4906 0.0 0
M  V30 16 C 11.0969 4.4474 0.0 0
M  V30 17 C 10.8294 5.9640 0.0 0 CFG=1
M  V30 18 C 8.2027 2.4675 0.0 0
M  V30 19 C 9.2723 1.3597 0.0 0
M  V30 20 S 6.8185 1.7924 0.0 0
M  V30 21 C 8.5495 0.0000 0.0 0
M  V30 22 C 7.0327 0.2673 0.0 0
M  V30 23 C 3.8500 6.6514 0.0 0
M  V30 24 C 2.3100 6.6514 0.0 0
M  V30 25 C 4.6200 7.9852 0.0 0
M  V30 26 C 1.5400 7.9852 0.0 0
M  V30 27 C 3.8500 9.3188 0.0 0
M  V30 28 C 2.3100 9.3188 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 12 1 CFG=3
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 1 3 23
M  V30 6 1 5 6
M  V30 7 1 17 5 CFG=1
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 7 9
M  V30 11 1 10 11
M  V30 12 1 10 24
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 12 18 CFG=1
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 12 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3052324-14-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3052323-97-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37330985
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM overall yield 48% over two steps
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Immunosuppressive effects of new thiophene-based KV1.3 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gubic, Spela; Montalbano, Alberto; Sala, Cesare; Becchetti, Andrea;
Hendrickx, Louise Antonia; Van Theemsche, Kenny M.; Pinheiro-Junior,
Ernesto Lopes; Altadonna, Ginevra Chioccioli; Peigneur, Steve; Ilas,
Janez; Labro, Alain J.; Pardo, Luis A.; Tytgat, Jan; Tomasic, Tihomir;
Arcangeli, Annarosa; Peterlin Masic, Lucija
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2023), 259115561

$RFMT $RIREG SCHEME324 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Piperazinecarboxylic acid, 4-[1,6-dihydro-5-(methoxycarbonyl)-1-methyl-6-ox...
C17H25N3O5
3053821-83-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.0102 5.5410 0.0 0
M  V30 2 O 13.0903 5.5410 0.0 0
M  V30 3 C 14.6303 2.8737 0.0 0
M  V30 4 O 15.4003 1.5400 0.0 0
M  V30 5 O 15.4003 4.2074 0.0 0
M  V30 6 C 16.9404 1.5400 0.0 0
M  V30 7 C 3.8501 2.8737 0.0 0
M  V30 8 O 3.0801 1.5400 0.0 0
M  V30 9 O 3.0801 4.2074 0.0 0
M  V30 10 C 1.5400 1.5400 0.0 0
M  V30 11 C 1.5400 3.0801 0.0 0
M  V30 12 C 0.0000 1.5400 0.0 0
M  V30 13 C 1.5400 0.0000 0.0 0
M  V30 14 C 10.0102 2.8737 0.0 0
M  V30 15 N 10.7802 4.2074 0.0 0
M  V30 16 C 10.7802 1.5400 0.0 0
M  V30 17 C 12.3203 4.2074 0.0 0
M  V30 18 C 12.3203 1.5400 0.0 0
M  V30 19 C 13.0903 2.8737 0.0 0
M  V30 20 N 8.4702 2.8737 0.0 0
M  V30 21 C 7.7002 1.5400 0.0 0
M  V30 22 C 7.7002 4.2074 0.0 0
M  V30 23 C 6.1601 1.5400 0.0 0
M  V30 24 C 6.1601 4.2074 0.0 0
M  V30 25 N 5.3901 2.8737 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 15
M  V30 2 2 2 17
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 19
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 25
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 14 15
M  V30 15 2 14 16
M  V30 16 1 14 20
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 19
M  V30 21 1 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Piperazinecarboxylic acid, 4-[1,6-dihydro-1-methyl-5-[(methylamino)carbonyl...
C17H26N4O4
3053821-85-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.0102 5.5410 0.0 0
M  V30 2 O 13.0903 5.5410 0.0 0
M  V30 3 C 14.6303 2.8737 0.0 0
M  V30 4 N 15.4003 1.5400 0.0 0
M  V30 5 O 15.4003 4.2074 0.0 0
M  V30 6 C 16.9404 1.5400 0.0 0
M  V30 7 C 3.8501 2.8737 0.0 0
M  V30 8 O 3.0801 1.5400 0.0 0
M  V30 9 O 3.0801 4.2074 0.0 0
M  V30 10 C 1.5400 1.5400 0.0 0
M  V30 11 C 1.5400 0.0000 0.0 0
M  V30 12 C 0.0000 1.5400 0.0 0
M  V30 13 C 1.5400 3.0801 0.0 0
M  V30 14 C 10.0102 2.8737 0.0 0
M  V30 15 N 10.7802 4.2074 0.0 0
M  V30 16 C 10.7802 1.5400 0.0 0
M  V30 17 C 12.3203 4.2074 0.0 0
M  V30 18 C 12.3203 1.5400 0.0 0
M  V30 19 C 13.0903 2.8737 0.0 0
M  V30 20 N 8.4702 2.8737 0.0 0
M  V30 21 C 7.7002 1.5400 0.0 0
M  V30 22 C 7.7002 4.2074 0.0 0
M  V30 23 C 6.1601 1.5400 0.0 0
M  V30 24 C 6.1601 4.2074 0.0 0
M  V30 25 N 5.3901 2.8737 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 15
M  V30 2 2 2 17
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 19
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 25
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 14 15
M  V30 15 2 14 16
M  V30 16 1 14 20
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 19
M  V30 21 1 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3053821-83-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3053821-85-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-42578840
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of piperazinyl picolinamide derivatives and methods of use
thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kankanala, Jayakanth; Pettigrew, Jeremy D.; Pham, Son Minh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2024178127 A1 2024-08-29

$RFMT $RIREG SCHEME325 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Piperidinol, 4-(3-chloro-1-propyn-1-yl)-1-methyl-
C9H14ClNO
3053841-96-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7996 1.9798 0.0 0
M  V30 2 C 6.9794 0.9899 0.0 0
M  V30 3 C 8.1591 0.0000 0.0 0
M  V30 4 Cl 9.6062 0.5267 0.0 0
M  V30 5 O 5.7996 3.9596 0.0 0
M  V30 6 C 0.0000 2.9697 0.0 0
M  V30 7 C 4.6200 2.9697 0.0 0
M  V30 8 C 3.8500 1.6359 0.0 0
M  V30 9 C 3.8500 4.3034 0.0 0
M  V30 10 C 2.3100 1.6359 0.0 0
M  V30 11 C 2.3100 4.3034 0.0 0
M  V30 12 N 1.5400 2.9697 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 5 7
M  V30 6 1 6 12
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Piperidinol, 1-methyl-4-[3-(methylamino)-1-propyn-1-yl]-
C10H18N2O
3053841-75-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.5176 1.7145 0.0 0
M  V30 2 C 7.0342 1.9819 0.0 0
M  V30 3 C 8.5510 2.2494 0.0 0
M  V30 4 N 9.5408 1.0695 0.0 0
M  V30 5 C 11.0574 1.3370 0.0 0
M  V30 6 O 4.5277 0.0000 0.0 0
M  V30 7 C 0.0000 3.7570 0.0 0
M  V30 8 C 4.0010 1.4470 0.0 0
M  V30 9 C 4.0010 2.9870 0.0 0
M  V30 10 C 2.6673 0.6770 0.0 0
M  V30 11 C 2.6673 3.7570 0.0 0
M  V30 12 C 1.3337 1.4470 0.0 0
M  V30 13 N 1.3337 2.9870 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 6 8
M  V30 7 1 7 13
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3053841-96-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3053841-75-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38843385
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Benzothiozinone derivatives with anti-tubercular Activity-Further side
chain investigation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wu, Xiaomei; Wang, Wenxin; Stelitano, Giovanni; Riabova, Olga; Wang, Bin;
Niu, Wei; Cocorullo, Mario; Shi, Rui; Chiarelli, Laurent R.; Makarov,
Vadim; Lu, Yu; Li, Chuan; Qiao, Chunhua
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2024), 264115976

$RFMT $RIREG SCHEME326 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Nitro-2-(1-piperidinyl)benzaldehyde
C12H14N2O3
30742-60-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 1.3338 0.0 0
M  V30 2 O 4.6200 0.0000 0.0 0
M  V30 3 N 0.7700 4.0011 0.0 0 VAL=5
M  V30 4 O 0.0000 5.3349 0.0 0
M  V30 5 O 0.0000 2.6674 0.0 0
M  V30 6 C 5.3900 4.0011 0.0 0
M  V30 7 C 4.6200 2.6674 0.0 0
M  V30 8 C 4.6200 5.3349 0.0 0
M  V30 9 C 3.0800 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 2.3100 4.0011 0.0 0
M  V30 12 N 6.9300 4.0011 0.0 0
M  V30 13 C 7.7000 2.6674 0.0 0
M  V30 14 C 7.7000 5.3349 0.0 0
M  V30 15 C 9.2400 2.6674 0.0 0
M  V30 16 C 9.2400 5.3349 0.0 0
M  V30 17 C 10.0100 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 12
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-5-nitro-2-(1-piperidinyl)benzenemethanamine
C13H19N3O2
1799563-24-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 2.6674 0.0 0
M  V30 2 N 4.6200 1.3338 0.0 0
M  V30 3 C 5.3900 0.0000 0.0 0
M  V30 4 N 0.7700 5.3347 0.0 0 VAL=5
M  V30 5 O 0.0000 6.6685 0.0 0
M  V30 6 O 0.0000 4.0011 0.0 0
M  V30 7 C 5.3900 5.3347 0.0 0
M  V30 8 C 4.6200 4.0011 0.0 0
M  V30 9 C 4.6200 6.6685 0.0 0
M  V30 10 C 3.0800 4.0011 0.0 0
M  V30 11 C 3.0800 6.6685 0.0 0
M  V30 12 C 2.3100 5.3347 0.0 0
M  V30 13 N 6.9300 5.3347 0.0 0
M  V30 14 C 7.7000 6.6685 0.0 0
M  V30 15 C 7.7000 4.0011 0.0 0
M  V30 16 C 9.2400 6.6685 0.0 0
M  V30 17 C 9.2400 4.0011 0.0 0
M  V30 18 C 10.0100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 4 5
M  V30 5 2 4 6
M  V30 6 1 4 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 13
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 30742-60-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1799563-24-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-1671876
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pyrimidopyrimidinones useful as Wee-1 kinase inhibitors and their
preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Harrison, Timothy; Trevitt, Graham; Hewitt, Peter Robin; O'Dowd, Colin
Roderick; Burkamp, Frank; Wilkinson, Andrew John; Shepherd, Steven D.;
Miel, Hugues
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2015092431 A1 2015-06-25

$RFMT $RIREG SCHEME327 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Octafluoronaphthalene
C10F8
313-72-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 1.5400 1.3338 0.0 0
M  V30 2 F 3.8500 0.0000 0.0 0
M  V30 3 F 6.9300 5.3347 0.0 0
M  V30 4 F 4.6200 6.6685 0.0 0
M  V30 5 F 0.0000 4.0011 0.0 0
M  V30 6 F 6.9300 0.0000 0.0 0
M  V30 7 F 8.4700 2.6674 0.0 0
M  V30 8 F 1.5400 6.6685 0.0 0
M  V30 9 C 3.8500 2.6674 0.0 0
M  V30 10 C 4.6200 4.0011 0.0 0
M  V30 11 C 2.3100 2.6674 0.0 0
M  V30 12 C 4.6200 1.3338 0.0 0
M  V30 13 C 6.1600 4.0011 0.0 0
M  V30 14 C 3.8500 5.3347 0.0 0
M  V30 15 C 1.5400 4.0011 0.0 0
M  V30 16 C 6.1600 1.3338 0.0 0
M  V30 17 C 6.9300 2.6674 0.0 0
M  V30 18 C 2.3100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 12
M  V30 3 1 3 13
M  V30 4 1 4 14
M  V30 5 1 5 15
M  V30 6 1 6 16
M  V30 7 1 7 17
M  V30 8 1 8 18
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 14 2 11 15
M  V30 15 2 12 16
M  V30 16 2 13 17
M  V30 17 2 14 18
M  V30 18 1 15 18
M  V30 19 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3,4,5,6,7,8-Heptafluoro-N-methyl-2-naphthalenamine
C11H4F7N
370556-50-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 5.3347 6.1600 0.0 0
M  V30 2 F 2.6674 6.1600 0.0 0
M  V30 3 F 5.3347 0.0000 0.0 0
M  V30 4 F 2.6674 0.0000 0.0 0
M  V30 5 N 8.0021 4.6200 0.0 0
M  V30 6 C 9.3358 3.8500 0.0 0
M  V30 7 F 0.0000 4.6200 0.0 0
M  V30 8 F 8.0021 1.5400 0.0 0
M  V30 9 F 0.0000 1.5400 0.0 0
M  V30 10 C 4.0011 3.8500 0.0 0
M  V30 11 C 4.0011 2.3100 0.0 0
M  V30 12 C 5.3347 4.6200 0.0 0
M  V30 13 C 2.6674 4.6200 0.0 0
M  V30 14 C 5.3347 1.5400 0.0 0
M  V30 15 C 2.6674 1.5400 0.0 0
M  V30 16 C 6.6684 3.8500 0.0 0
M  V30 17 C 1.3336 3.8500 0.0 0
M  V30 18 C 6.6684 2.3100 0.0 0
M  V30 19 C 1.3336 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 2 13
M  V30 3 1 3 14
M  V30 4 1 4 15
M  V30 5 1 5 6
M  V30 6 1 5 16
M  V30 7 1 7 17
M  V30 8 1 8 18
M  V30 9 1 9 19
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 11 14
M  V30 14 1 11 15
M  V30 15 2 12 16
M  V30 16 2 13 17
M  V30 17 2 14 18
M  V30 18 2 15 19
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 313-72-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 370556-50-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-11570755
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-63-0
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Polyfluorinated arylnitramines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Platonov, V. E.; Haas, A.; Schelvis, M.; Lieb, M.; Dvornikova, K. V.;
Osina, O. I.; Gatilov, Y. V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Fluorine Chemistry (2001), 109(2), 131-139

$RFMT $RIREG SCHEME328 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Benzyl-4-methylpiperidin-3-one
C13H17NO
32018-96-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0800 0.0 0
M  V30 2 O 0.0000 3.0800 0.0 0
M  V30 3 C 0.0000 0.0000 0.0 0
M  V30 4 N 4.0011 2.3100 0.0 0
M  V30 5 C 2.6675 3.0800 0.0 0
M  V30 6 C 4.0011 0.7700 0.0 0
M  V30 7 C 1.3337 2.3100 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 9 C 1.3337 0.7700 0.0 0
M  V30 10 C 6.6684 2.3100 0.0 0
M  V30 11 C 8.0022 3.0800 0.0 0
M  V30 12 C 6.6684 0.7700 0.0 0
M  V30 13 C 9.3359 2.3100 0.0 0
M  V30 14 C 8.0022 0.0000 0.0 0
M  V30 15 C 9.3359 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 1 10
M  V30 3 2 2 7
M  V30 4 1 3 9
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
cis-1-Benzyl-N-methyl-4-methylpiperidin-3-amine
C14H22N2
477600-69-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 5.3347 0.0 0
M  V30 2 N 9.2400 2.6674 0.0 0
M  V30 3 C 10.0100 4.0011 0.0 0
M  V30 4 C 7.7000 0.0000 0.0 0
M  V30 5 N 5.3900 4.0011 0.0 0
M  V30 6 C 6.9300 4.0011 0.0 0
M  V30 7 C 4.6200 2.6674 0.0 0
M  V30 8 C 7.7000 2.6674 0.0 0 CFG=1
M  V30 9 C 5.3900 1.3338 0.0 0
M  V30 10 C 6.9300 1.3338 0.0 0 CFG=1
M  V30 11 C 3.0800 5.3347 0.0 0
M  V30 12 C 2.3100 6.6685 0.0 0
M  V30 13 C 2.3100 4.0011 0.0 0
M  V30 14 C 0.7700 6.6685 0.0 0
M  V30 15 C 0.7700 4.0011 0.0 0
M  V30 16 C 0.0000 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 1 8 2 CFG=1
M  V30 5 1 10 4 CFG=1
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 8 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 32018-96-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 477600-69-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-7620040
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 5
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (N-Benzyl-4-methyl-piperidin-3-yl)methyl Amine (5). A 640-L reactor was
charged with the toluene solution (103 kg 23%, 23.5 kg 100% 7, 116 mol)
from a second run of the previous step. A solution of methylamine in EtOH
(33% in EtOH, 62 L, 496 mol, 4.3 equiv) was added over a period of 17 min
at 17-18 °C, followed by the addition of HOAc (6.8 L, 116 mol) during 25
min at 18-24 °C. Online IR showed complete consumption of the ketone7
after 54 min. This orange solution was transferred into a feed tank which
had been evacuated beforehand. After the reactor was washed with THF (40
L), NaBH4 (5.74 kg, 150.8 mol, 1.3 equiv) was added, followed by THF (60
L). To this suspension was added HOAc (38 L, 684 mol, 5.9 equiv) under
vigorous stirring over a period of 2.5 h such as to keep the temperature
below 13 °C. The liberated hydrogen was diluted with a nitrogen stream
after the reactor (4.9 m3 N2/h). This was maintained during the following
reduction step. The imine solution was added from the feed tank to the
suspension in the reactor over 2 h so as to keep the temperature below 16
°C and to control foaming. The mixture was stirred for 13 h at 2 °C. IPC
showed complete conversion to the amine (>99%). Water (201 L) was added
over 40 min keeping an IT of 5-8 °C. Subsequently, the pH of the solution
was adjusted to 11 by adding 30% NaOH (35 L). The aqueous layer (ca. 310
L) was extracted with three portions of toluene (3 x 80 L).25 All organic
phases were combined (ca. 423 L) and washed with water (80 L). The
organic phase was concentrated at 50 °C to yield 5 (33.93 kg, 92%) as an
orange solution in toluene. Purity: 86.1% a/a sum of cis-and trans-5
(GC); LOD = 20%. dr 86:14. R f (freebase) = 0.24 (9:1 CH2Cl2-MeOH). 1H
NMR (freebase) (400 MHz, DMSO, 70 °C) δ 7.28 (m, 5H), 3.47 (d, J = 13.27,
1H), 3.40 (d, J = 13.27, 1H), 2.51 (m, 2H), 2.33 (m, 1H), 2.20 (s, 3H),
2.09 (m, 2H), 1.64 (m, 1H), 1.39 (m, 2H), 0.85 (d, J = 7.05, 3H). 13C NMR
(300 MHz, CD3OD) δ 131.5, 130.3, 129.2, 128.7, 60.8, 55.9, 46.8, 46.4,
30.7, 27.5, 26.3, 9.5.
$DTYPE RXN:VAR(1):NOTES
$DATUM anaerobic, stereoselective (86:14 cis:trans), pilot plant
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Development of a Scaleable Route for the Production of
cis-N-Benzyl-3-methylamino-4-methylpiperidine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ripin, David H. Brown; Abele, Stefan; Cai, Weiling; Blumenkopf, Todd;
Casavant, Jeffrey M.; Doty, Jonathan L.; Flanagan, Mark; Koecher,
Christian; Laue, Klaus W.; McCarthy, Keith; Meltz, Cliff; Munchhoff,
Mike; Pouwer, Kees; Shah, Bharat; Sun, Jianmin; Teixeira, John; Vries,
Ton; Whipple, David A.; Wilcox, Glenn
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Process Research & Development (2003), 7(1), 115-120

$RFMT $RIREG SCHEME329 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Methylthio)benzaldehyde
C8H8OS
7022-45-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 4.0010 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 S 4.6201 4.0010 0.0 0
M  V30 4 C 6.1601 4.0010 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.8501 2.6673 0.0 0
M  V30 7 C 1.5400 1.3337 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 2.3101 0.0000 0.0 0
M  V30 10 C 3.8501 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 4
M  V30 4 1 3 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[Isocyano[(4-methylphenyl)sulfonyl]methyl]-1,2,3-trimethoxybenzene
C18H19NO5S
324519-54-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.0801 0.0 0
M  V30 2 S 8.0022 3.8501 0.0 0 VAL=6
M  V30 3 N 6.6685 1.5400 0.0 0 CHG=1 VAL=4
M  V30 4 O 8.7722 2.5164 0.0 0
M  V30 5 O 7.2322 5.1838 0.0 0
M  V30 6 C 6.6685 0.0000 0.0 0 CHG=-1
M  V30 7 O 1.3337 3.0801 0.0 0
M  V30 8 C 1.3337 1.5400 0.0 0
M  V30 9 O 4.0010 7.7002 0.0 0
M  V30 10 C 2.6673 8.4702 0.0 0
M  V30 11 O 1.3337 6.1601 0.0 0
M  V30 12 C 0.0000 5.3901 0.0 0
M  V30 13 C 13.3370 6.9302 0.0 0
M  V30 14 C 5.3348 3.8501 0.0 0
M  V30 15 C 4.0010 3.0801 0.0 0
M  V30 16 C 5.3348 5.3901 0.0 0
M  V30 17 C 2.6673 3.8501 0.0 0
M  V30 18 C 4.0010 6.1601 0.0 0
M  V30 19 C 2.6673 5.3901 0.0 0
M  V30 20 C 9.3360 4.6201 0.0 0
M  V30 21 C 10.6697 3.8501 0.0 0
M  V30 22 C 9.3360 6.1601 0.0 0
M  V30 23 C 12.0033 4.6201 0.0 0
M  V30 24 C 10.6697 6.9302 0.0 0
M  V30 25 C 12.0033 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 14
M  V30 4 2 2 4
M  V30 5 2 2 5
M  V30 6 1 2 20
M  V30 7 3 3 6
M  V30 8 1 7 8
M  V30 9 1 7 17
M  V30 10 1 9 10
M  V30 11 1 9 18
M  V30 12 1 11 12
M  V30 13 1 11 19
M  V30 14 1 13 25
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Methyl-5-[2-(methylthio)phenyl]-4-(3,4,5-trimethoxyphenyl)-1H-imidazole
C20H22N2O3S
1462267-50-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.6372 5.7471 0.0 0
M  V30 2 S 11.0045 3.8118 0.0 0
M  V30 3 C 12.4691 3.3359 0.0 0
M  V30 4 O 1.3336 5.3900 0.0 0
M  V30 5 C 1.3336 6.9300 0.0 0
M  V30 6 O 4.0011 0.7700 0.0 0
M  V30 7 C 2.6673 0.0000 0.0 0
M  V30 8 O 1.3336 2.3100 0.0 0
M  V30 9 C 0.0000 3.0800 0.0 0
M  V30 10 C 6.6684 5.3900 0.0 0
M  V30 11 C 8.0753 4.7635 0.0 0
M  V30 12 N 6.8293 6.9215 0.0 0
M  V30 13 N 9.1057 5.9081 0.0 0
M  V30 14 C 8.3357 7.2417 0.0 0
M  V30 15 C 5.3347 4.6200 0.0 0
M  V30 16 C 4.0011 5.3900 0.0 0
M  V30 17 C 5.3347 3.0800 0.0 0
M  V30 18 C 2.6673 4.6200 0.0 0
M  V30 19 C 4.0011 2.3100 0.0 0
M  V30 20 C 2.6673 3.0800 0.0 0
M  V30 21 C 8.3955 3.2573 0.0 0
M  V30 22 C 9.8600 2.7814 0.0 0
M  V30 23 C 7.2509 2.2268 0.0 0
M  V30 24 C 10.1802 1.2750 0.0 0
M  V30 25 C 7.5711 0.7204 0.0 0
M  V30 26 C 9.0358 0.2446 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 2 3
M  V30 3 1 2 22
M  V30 4 1 4 5
M  V30 5 1 4 18
M  V30 6 1 6 7
M  V30 7 1 6 19
M  V30 8 1 8 9
M  V30 9 1 8 20
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 10 15
M  V30 13 1 11 13
M  V30 14 1 11 21
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 7022-45-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 324519-54-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1462267-50-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-573-CAS-18605134
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 110-71-4
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis, and biological evaluation of novel combretastatin A-4
thio derivatives as microtubule targeting agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Stefanski, Tomasz; Mikstacka, Renata; Kurczab, Rafal; Dutkiewicz,
Zbigniew; Kucinska, Malgorzata; Murias, Marek; Zielinska-Przyjemska,
Malgorzata; Cichocki, Michal; Teubert, Anna; Kaczmarek, Mariusz;
Hogendorf, Adam; Sobiak, Stanislaw
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2018), 144797-816

$RFMT $RIREG SCHEME330 STEP1
$RXN



  3  1
$MOL
Trimethylsilyl cyanide
C4H9NSi
7677-24-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Si 1.5400 1.5400 0.0 0
M  V30 2 C 3.0800 1.5400 0.0 0
M  V30 3 C 0.0000 1.5400 0.0 0
M  V30 4 C 1.5400 0.0000 0.0 0
M  V30 5 C 1.5400 3.0800 0.0 0
M  V30 6 N 4.6200 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 3 2 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Difluorobenzaldehyde
C7H4F2O
34036-07-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 2.6673 0.0 0
M  V30 2 O 6.9302 4.0010 0.0 0
M  V30 3 F 1.5400 0.0000 0.0 0
M  V30 4 F 0.0000 2.6673 0.0 0
M  V30 5 C 4.6201 2.6673 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 3.8501 4.0010 0.0 0
M  V30 8 C 2.3101 1.3337 0.0 0
M  V30 9 C 2.3101 4.0010 0.0 0
M  V30 10 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 8
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Difluoro-α-(methylamino)benzeneacetonitrile
C9H8F2N2
218450-92-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6674 0.0 0
M  V30 2 C 1.5400 1.3338 0.0 0
M  V30 3 N 1.5400 4.0011 0.0 0
M  V30 4 N 0.7700 0.0000 0.0 0
M  V30 5 C 0.0000 4.0011 0.0 0
M  V30 6 F 6.9300 5.3349 0.0 0
M  V30 7 F 8.4700 2.6674 0.0 0
M  V30 8 C 3.8500 2.6674 0.0 0
M  V30 9 C 4.6200 4.0011 0.0 0
M  V30 10 C 4.6200 1.3338 0.0 0
M  V30 11 C 6.1600 4.0011 0.0 0
M  V30 12 C 6.1600 1.3338 0.0 0
M  V30 13 C 6.9300 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 3 2 4
M  V30 5 1 3 5
M  V30 6 1 6 11
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 7677-24-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 34036-07-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 218450-92-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-346-CAS-9248175
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 10139-47-6
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM EXAMPLE 45.
4-(3,4-Difluorophenyl)-3-methyl-1-(3-(4-(2-pyridyl)piperidin-1-yl)propyl)aminocarbonyl-2-imidaxolidons.
a. 2-(3,4-Difluorophenyl)-2-methylamino-acetonitrile: To a mixture of
3,4-difluorobenzaldehyde (4.0 g, 28.0 mmol) and trimethylsilylcyanide
(4.69 mL, 35.1 mmol), catalytic amount of Zinc Iodide was added at 0°C.
After stirring for 15 minutes at room temperature a saturated solution of
methylammonia (15 mL) was added in one lot at 0°C. The reaction mixture
was then stirred for 4 hours at 40°C. After evaporation of the solvent
the residue was purified by column chromatography (hexanes:ethylacetate
3:2). Yield 4.719 g (92%) as a brown syrup.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of oxazolidinones and related compounds as adrenergic α1A
receptor antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lagu, Bharat; Dhar, Tg Murali; Nagarathnam, Dhanapalan; Jeon, Yoon T.;
Marzabadi, Mohammad R.; Wong, Wai C.; Gluchowski, Charles
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US6159990 A 2000-12-12

$RFMT $RIREG SCHEME331 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 3-amino-6-(2-thienyl)-4-(trifluoromethyl)thieno[2,3-b]pyridine-2-carbox...
C15H11F3N2O2S2
340816-56-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.1046 1.5400 0.0 0
M  V30 2 F 3.5646 1.5400 0.0 0
M  V30 3 F 5.1046 0.0000 0.0 0
M  V30 4 F 6.6446 1.5400 0.0 0
M  V30 5 N 8.3788 1.9094 0.0 0
M  V30 6 C 10.3482 4.6200 0.0 0
M  V30 7 O 11.1182 5.9536 0.0 0
M  V30 8 O 11.1182 3.2864 0.0 0
M  V30 9 C 12.6582 5.9536 0.0 0
M  V30 10 C 13.4282 7.2873 0.0 0
M  V30 11 C 6.4384 3.8500 0.0 0
M  V30 12 C 5.1046 3.0800 0.0 0
M  V30 13 C 6.4384 5.3900 0.0 0
M  V30 14 C 7.9030 3.3741 0.0 0
M  V30 15 C 3.7710 3.8500 0.0 0
M  V30 16 S 7.9030 5.8659 0.0 0
M  V30 17 N 5.1046 6.1600 0.0 0
M  V30 18 C 8.8082 4.6200 0.0 0
M  V30 19 C 3.7710 5.3900 0.0 0
M  V30 20 C 2.4374 6.1600 0.0 0
M  V30 21 C 2.2764 7.6915 0.0 0
M  V30 22 S 1.0304 5.5335 0.0 0
M  V30 23 C 0.7700 8.0117 0.0 0
M  V30 24 C 0.0000 6.6781 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 12
M  V30 5 1 5 14
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 18
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 12 15
M  V30 15 1 13 16
M  V30 16 2 13 17
M  V30 17 2 14 18
M  V30 18 2 15 19
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 19 20
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Amino-N-methyl-6-(2-thienyl)-4-(trifluoromethyl)thieno[2,3-b]pyridine-2-car...
C14H10F3N3OS2
2332430-06-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.1046 1.5400 0.0 0
M  V30 2 F 3.5646 1.5400 0.0 0
M  V30 3 F 5.1046 0.0000 0.0 0
M  V30 4 F 6.6446 1.5400 0.0 0
M  V30 5 N 8.3788 1.9094 0.0 0
M  V30 6 C 10.3482 4.6200 0.0 0
M  V30 7 N 11.1182 5.9536 0.0 0
M  V30 8 O 11.1182 3.2864 0.0 0
M  V30 9 C 12.6582 5.9536 0.0 0
M  V30 10 C 6.4384 3.8500 0.0 0
M  V30 11 C 5.1046 3.0800 0.0 0
M  V30 12 C 6.4384 5.3900 0.0 0
M  V30 13 C 7.9030 3.3741 0.0 0
M  V30 14 C 3.7710 3.8500 0.0 0
M  V30 15 S 7.9030 5.8659 0.0 0
M  V30 16 N 5.1046 6.1600 0.0 0
M  V30 17 C 8.8082 4.6200 0.0 0
M  V30 18 C 3.7710 5.3900 0.0 0
M  V30 19 C 2.4374 6.1600 0.0 0
M  V30 20 C 1.0304 5.5335 0.0 0
M  V30 21 S 2.2764 7.6915 0.0 0
M  V30 22 C 0.0000 6.6781 0.0 0
M  V30 23 C 0.7700 8.0117 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 11
M  V30 5 1 5 13
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 17
M  V30 9 1 7 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 11 14
M  V30 14 1 12 15
M  V30 15 2 12 16
M  V30 16 2 13 17
M  V30 17 2 14 18
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 18 19
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 340816-56-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2332430-06-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-20154785
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of Novel Alkyl Amide Functionalized Trifluoromethyl Substituted
Furo/thieno Pyridine Derivatives: Their Anticancer Activity and CoMFA and
CoMSIA Studies
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bhoomandla, Srinu; Gunda, Shravan Kumar; Kotoori, Srawanthi; Kanuparthy,
Phani Raja
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Heterocyclic Chemistry (2019), 56(7), 1986-1998

$RFMT $RIREG SCHEME332 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Methyl-4-oxo-N-phenyl-3-(phenylmethoxy)-4H-pyran-2-carboxamide
C20H17NO4
347393-42-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.7000 5.3347 0.0 0
M  V30 2 N 9.2400 5.3347 0.0 0
M  V30 3 O 6.9300 6.6684 0.0 0
M  V30 4 O 4.6200 5.3347 0.0 0
M  V30 5 C 3.0800 5.3347 0.0 0
M  V30 6 O 3.0800 2.6674 0.0 0
M  V30 7 C 7.7000 0.0000 0.0 0
M  V30 8 C 6.9300 4.0011 0.0 0
M  V30 9 C 5.3900 4.0011 0.0 0
M  V30 10 O 7.7000 2.6674 0.0 0
M  V30 11 C 4.6200 2.6674 0.0 0
M  V30 12 C 6.9300 1.3336 0.0 0
M  V30 13 C 5.3900 1.3336 0.0 0
M  V30 14 C 10.0100 6.6684 0.0 0
M  V30 15 C 9.2400 8.0021 0.0 0
M  V30 16 C 11.5500 6.6684 0.0 0
M  V30 17 C 10.0100 9.3358 0.0 0
M  V30 18 C 12.3200 8.0021 0.0 0
M  V30 19 C 11.5500 9.3358 0.0 0
M  V30 20 C 2.3100 6.6684 0.0 0
M  V30 21 C 3.0800 8.0021 0.0 0
M  V30 22 C 0.7700 6.6684 0.0 0
M  V30 23 C 2.3100 9.3358 0.0 0
M  V30 24 C 0.0000 8.0021 0.0 0
M  V30 25 C 0.7700 9.3358 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 14
M  V30 5 1 4 5
M  V30 6 1 4 9
M  V30 7 1 5 20
M  V30 8 2 6 11
M  V30 9 1 7 12
M  V30 10 2 8 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,4-Dihydro-1,6-dimethyl-4-oxo-N-phenyl-3-(phenylmethoxy)-2-pyridinecarboxamide
C21H20N2O3
347393-46-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 5.3347 0.0 0
M  V30 2 N 3.0800 5.3347 0.0 0
M  V30 3 O 5.3900 6.6684 0.0 0
M  V30 4 O 7.7000 5.3347 0.0 0
M  V30 5 C 9.2400 5.3347 0.0 0
M  V30 6 C 3.0800 2.6674 0.0 0
M  V30 7 O 9.2400 2.6674 0.0 0
M  V30 8 C 4.6200 0.0000 0.0 0
M  V30 9 C 5.3900 4.0011 0.0 0
M  V30 10 C 6.9300 4.0011 0.0 0
M  V30 11 N 4.6200 2.6674 0.0 0
M  V30 12 C 7.7000 2.6674 0.0 0
M  V30 13 C 5.3900 1.3336 0.0 0
M  V30 14 C 6.9300 1.3336 0.0 0
M  V30 15 C 2.3100 6.6684 0.0 0
M  V30 16 C 3.0800 8.0021 0.0 0
M  V30 17 C 0.7700 6.6684 0.0 0
M  V30 18 C 2.3100 9.3358 0.0 0
M  V30 19 C 0.0000 8.0021 0.0 0
M  V30 20 C 0.7700 9.3358 0.0 0
M  V30 21 C 10.0100 6.6684 0.0 0
M  V30 22 C 9.2400 8.0021 0.0 0
M  V30 23 C 11.5500 6.6684 0.0 0
M  V30 24 C 10.0100 9.3358 0.0 0
M  V30 25 C 12.3200 8.0021 0.0 0
M  V30 26 C 11.5500 9.3358 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 15
M  V30 5 1 4 5
M  V30 6 1 4 10
M  V30 7 1 5 21
M  V30 8 1 6 11
M  V30 9 2 7 12
M  V30 10 1 8 13
M  V30 11 2 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 347393-42-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 347393-46-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-2567875
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of 2-amido-3-hydroxypyridin-4(1H)-ones: novel iron chelators
with enhanced pFe3+ values
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liu, Zu D.; Piyamongkol, S.; Liu, Ding Y.; Khodr, Hicham H.; Lu, Shu L.;
Hider, Robert C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2001), 9(3), 563-573

$RFMT $RIREG SCHEME333 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Fluoro-2-hydroxybenzaldehyde
C7H5FO2
347-54-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.3338 0.0 0
M  V30 2 O 2.3100 0.0000 0.0 0
M  V30 3 O 0.0000 4.0011 0.0 0
M  V30 4 F 6.1600 4.0011 0.0 0
M  V30 5 C 2.3100 2.6674 0.0 0
M  V30 6 C 1.5400 4.0011 0.0 0
M  V30 7 C 3.8500 2.6674 0.0 0
M  V30 8 C 2.3100 5.3349 0.0 0
M  V30 9 C 4.6200 4.0011 0.0 0
M  V30 10 C 3.8500 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 6
M  V30 4 1 4 9
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Fluoro-2-[(methylamino)methyl]phenol
C8H10FNO
1363166-05-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 2.6674 0.0 0
M  V30 2 N 5.3900 4.0011 0.0 0
M  V30 3 C 6.9300 4.0011 0.0 0
M  V30 4 O 3.0800 0.0000 0.0 0
M  V30 5 F 0.0000 5.3349 0.0 0
M  V30 6 C 3.0800 2.6674 0.0 0
M  V30 7 C 2.3100 1.3338 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 0.7700 1.3338 0.0 0
M  V30 10 C 0.7700 4.0011 0.0 0
M  V30 11 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 4 7
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 347-54-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1363166-05-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-14602793
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative reaction conditions shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Diaryl macrocycles as modulators of protein kinases and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cui, Jingrong Jean; Li, Yishan; Rogers, Evan W.; Zhai, Dayong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2015112806 A2 2015-07-30

$RFMT $RIREG SCHEME334 STEP1
$RXN



  3  1
$MOL
Sodium thiocyanate
CHNS.Na
540-72-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 N 0.0000 1.5400 0.0 0
M  V30 3 S 3.0800 1.5400 0.0 0
M  V30 4 Na 1.5400 0.0000 0.0 0 VAL=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Methoxyphenyl)benzenecarboximidoyl chloride
C14H12ClNO
34918-74-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3901 2.6673 0.0 0
M  V30 2 C 4.6201 1.3337 0.0 0
M  V30 3 Cl 5.3901 0.0000 0.0 0
M  V30 4 O 11.5503 2.6673 0.0 0
M  V30 5 C 12.3203 4.0010 0.0 0
M  V30 6 C 6.9302 2.6673 0.0 0
M  V30 7 C 7.7002 4.0010 0.0 0
M  V30 8 C 7.7002 1.3337 0.0 0
M  V30 9 C 9.2402 4.0010 0.0 0
M  V30 10 C 9.2402 1.3337 0.0 0
M  V30 11 C 10.0102 2.6673 0.0 0
M  V30 12 C 3.0801 1.3337 0.0 0
M  V30 13 C 2.3101 0.0000 0.0 0
M  V30 14 C 2.3101 2.6673 0.0 0
M  V30 15 C 0.7700 0.0000 0.0 0
M  V30 16 C 0.7700 2.6673 0.0 0
M  V30 17 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 2 12
M  V30 5 1 4 5
M  V30 6 1 4 11
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Methoxyphenyl)-N′-[(methylamino)thioxomethyl]benzenecarboximidamide
C16H17N3OS
666175-09-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.7000 4.0011 0.0 0
M  V30 2 N 6.9300 5.3347 0.0 0
M  V30 3 N 9.2400 4.0011 0.0 0
M  V30 4 C 10.0100 5.3347 0.0 0
M  V30 5 N 11.5500 5.3347 0.0 0
M  V30 6 S 9.2400 6.6685 0.0 0
M  V30 7 C 12.3200 6.6685 0.0 0
M  V30 8 O 0.7700 5.3347 0.0 0
M  V30 9 C 0.0000 6.6685 0.0 0
M  V30 10 C 6.9300 2.6674 0.0 0
M  V30 11 C 5.3900 2.6674 0.0 0
M  V30 12 C 7.7000 1.3338 0.0 0
M  V30 13 C 4.6200 1.3338 0.0 0
M  V30 14 C 6.9300 0.0000 0.0 0
M  V30 15 C 5.3900 0.0000 0.0 0
M  V30 16 C 5.3900 5.3347 0.0 0
M  V30 17 C 4.6200 6.6685 0.0 0
M  V30 18 C 4.6200 4.0011 0.0 0
M  V30 19 C 3.0800 6.6685 0.0 0
M  V30 20 C 3.0800 4.0011 0.0 0
M  V30 21 C 2.3100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 10
M  V30 4 1 2 16
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 2 4 6
M  V30 8 1 5 7
M  V30 9 1 8 9
M  V30 10 1 8 21
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 540-72-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 34918-74-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 666175-09-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24972499
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-64-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for the Preparation of the
Thioureas.12 The appropriate benzimidoyl chloride was dissolved in
acetone p.a. (1 mmol/3 mL). At -15 °C, a solution of NaSCN (1.1 equiv) in
acetone (1 mmol/2 mL) was added dropwise. The mixture was stirred on the
cooling bath until 0 °C was reached. The precipitate (NaCl) was removed
by filtration over a glass filter with Hyflo. The filtrate was stirred on
an ice bath, and appropriate amine (1.1 equiv) was added. After it was
stirred to room temperature, the solvent was removed by evaporation and
the residue was triturated with a diethyl ether/n-pentane (usually 1:4)
mixture, collected on a glass filter, washed once more, and dried in
vacuo to give the thiourea. This product was then used in the next step
without further purification.
1-Methyl-3-(phenyl-4-methoxyphenyliminomethyl)-thiourea (5l). Scale: 9.2
mmol. Yield: 2.52 g (92%) of a yellow solid. 1H NMR (CDCl3): δ 3.27 (d,
3H, J = 4.4 Hz, NCH3); 3.72 (s, 3H, OCH3); 6.64 (m, 4H, arom); 7.27 (m,
5H, arom); 8.05 (s, 1H, NH); 11.94 (broad s, 1H, NH). 13C NMR (CDCl3): δ
31.7, 55.0, 113.7, 123.0, 127.9, 128.4, 130.0, 131.9, 133.0, 139.4,
155.4, 155.7, 180.8
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and biological evaluation of 2,3,5-substituted
[1,2,4]thiadiazoles as allosteric modulators of adenosine receptors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Van den Nieuwendijk, Adrianus M. C. H.; Pietra, Daniele; Heitman, Laura;
Goeblyoes, Aniko; IJzerman, Adriaan P.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2004), 47(3), 663-672

$RFMT $RIREG SCHEME335 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Chromium, pentacarbonyl[methoxy[(4bS,8aS)-4b,5,6,7,8,8a,9,10-octahydro-3-meth...
C24H24CrO7
352233-38-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cr 11.3443 4.7786 0.0 0 CHG=2 VAL=7
M  V30 2 C 7.8952 6.7456 0.0 0 CHG=-2 VAL=4
M  V30 3 C 14.1794 4.7786 0.0 0
M  V30 4 C 8.5053 4.7786 0.0 0
M  V30 5 C 11.3443 1.9396 0.0 0
M  V30 6 C 13.8000 3.3591 0.0 0
M  V30 7 C 11.3443 7.6137 0.0 0
M  V30 8 O 7.8952 8.1611 0.0 0
M  V30 9 O 15.5989 4.7786 0.0 0 VAL=3
M  V30 10 O 7.0858 4.7786 0.0 0 VAL=3
M  V30 11 O 12.7599 1.9396 0.0 0 VAL=3
M  V30 12 O 15.2156 3.3591 0.0 0 VAL=3
M  V30 13 O 12.7599 7.6137 0.0 0 VAL=3
M  V30 14 C 6.2411 9.1192 0.0 0
M  V30 15 O 5.3339 8.2237 0.0 0
M  V30 16 C 3.7228 9.1505 0.0 0
M  V30 17 C 2.6669 5.1462 0.0 0
M  V30 18 C 1.3335 0.0000 0.0 0
M  V30 19 C 6.6673 6.0339 0.0 0
M  V30 20 C 5.3339 6.8042 0.0 0
M  V30 21 C 6.6673 4.4970 0.0 0
M  V30 22 C 4.0004 6.0339 0.0 0
M  V30 23 C 5.3339 3.7267 0.0 0
M  V30 24 C 4.0004 4.4970 0.0 0
M  V30 25 C 5.3339 2.1860 0.0 0
M  V30 26 C 2.6669 3.7267 0.0 0
M  V30 27 C 4.0004 1.4156 0.0 0
M  V30 28 C 2.6669 2.1860 0.0 0
M  V30 29 C 1.3335 4.4970 0.0 0
M  V30 30 C 1.3335 1.4156 0.0 0
M  V30 31 C 0.0000 3.7267 0.0 0
M  V30 32 C 0.0000 2.1860 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 1 6
M  V30 6 1 1 7
M  V30 7 1 2 8
M  V30 8 1 2 19
M  V30 9 3 3 9
M  V30 10 3 4 10
M  V30 11 3 5 11
M  V30 12 3 6 12
M  V30 13 3 7 13
M  V30 14 1 8 14
M  V30 15 1 15 16
M  V30 16 1 15 20
M  V30 17 1 17 26
M  V30 18 2 18 30
M  V30 19 2 19 20
M  V30 20 1 19 21
M  V30 21 1 20 22
M  V30 22 2 21 23
M  V30 23 2 22 24
M  V30 24 1 23 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 1 26 28
M  V30 29 1 26 29
M  V30 30 1 27 28
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Chromium, pentacarbonyl[(methylamino)[(4bS,8aS)-4b,5,6,7,8,8a,9,10-octahydro-...
C24H25CrNO6
352233-55-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cr 11.3443 4.7786 0.0 0 CHG=2 VAL=7
M  V30 2 C 7.8952 6.7456 0.0 0 CHG=-2 VAL=4
M  V30 3 C 14.1794 4.7786 0.0 0
M  V30 4 C 8.5053 4.7786 0.0 0
M  V30 5 C 11.3443 1.9396 0.0 0
M  V30 6 C 13.8000 3.3591 0.0 0
M  V30 7 C 11.3443 7.6137 0.0 0
M  V30 8 N 7.8952 8.1611 0.0 0
M  V30 9 O 15.5989 4.7786 0.0 0 VAL=3
M  V30 10 O 7.0858 4.7786 0.0 0 VAL=3
M  V30 11 O 12.7599 1.9396 0.0 0 VAL=3
M  V30 12 O 15.2156 3.3591 0.0 0 VAL=3
M  V30 13 O 12.7599 7.6137 0.0 0 VAL=3
M  V30 14 C 6.2411 9.1192 0.0 0
M  V30 15 O 5.3339 8.2237 0.0 0
M  V30 16 C 3.7228 9.1505 0.0 0
M  V30 17 C 2.6669 5.1462 0.0 0
M  V30 18 C 1.3335 0.0000 0.0 0
M  V30 19 C 6.6673 6.0339 0.0 0
M  V30 20 C 5.3339 6.8042 0.0 0
M  V30 21 C 6.6673 4.4970 0.0 0
M  V30 22 C 4.0004 6.0339 0.0 0
M  V30 23 C 5.3339 3.7267 0.0 0
M  V30 24 C 4.0004 4.4970 0.0 0
M  V30 25 C 5.3339 2.1860 0.0 0
M  V30 26 C 2.6669 3.7267 0.0 0
M  V30 27 C 4.0004 1.4156 0.0 0
M  V30 28 C 2.6669 2.1860 0.0 0
M  V30 29 C 1.3335 4.4970 0.0 0
M  V30 30 C 1.3335 1.4156 0.0 0
M  V30 31 C 0.0000 3.7267 0.0 0
M  V30 32 C 0.0000 2.1860 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 1 6
M  V30 6 1 1 7
M  V30 7 1 2 8
M  V30 8 1 2 19
M  V30 9 3 3 9
M  V30 10 3 4 10
M  V30 11 3 5 11
M  V30 12 3 6 12
M  V30 13 3 7 13
M  V30 14 1 8 14
M  V30 15 1 15 16
M  V30 16 1 15 20
M  V30 17 1 17 26
M  V30 18 2 18 30
M  V30 19 2 19 20
M  V30 20 1 19 21
M  V30 21 1 20 22
M  V30 22 2 21 23
M  V30 23 2 22 24
M  V30 24 1 23 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 1 26 28
M  V30 29 1 26 29
M  V30 30 1 27 28
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 352233-38-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 352233-55-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-032-CAS-12389564
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of chromium aminocarbene complexes of diterpenoids
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Woodgate, P. D.; Sutherland, H. S.; Rickard, C. E. F.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organometallic Chemistry (2001), 626(1-2), 199-220

$RFMT $RIREG SCHEME336 STEP1
$RXN



  2  1
$MOL
4-(4-Bromophenyl)butanoic acid
C10H11BrO2
35656-89-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 4.0011 0.0 0
M  V30 2 C 6.9300 2.6674 0.0 0
M  V30 3 C 8.4700 2.6674 0.0 0
M  V30 4 C 9.2400 1.3338 0.0 0
M  V30 5 O 10.7800 1.3338 0.0 0
M  V30 6 O 8.4700 0.0000 0.0 0
M  V30 7 Br 0.0000 4.0011 0.0 0
M  V30 8 C 4.6200 4.0011 0.0 0
M  V30 9 C 3.8500 2.6674 0.0 0
M  V30 10 C 3.8500 5.3349 0.0 0
M  V30 11 C 2.3100 2.6674 0.0 0
M  V30 12 C 2.3100 5.3349 0.0 0
M  V30 13 C 1.5400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-N-methylbenzenebutanamide
C11H14BrNO
1033438-98-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0801 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 C 8.0022 3.0801 0.0 0
M  V30 4 C 9.3360 2.3101 0.0 0
M  V30 5 N 10.6697 3.0801 0.0 0
M  V30 6 O 9.3360 0.7700 0.0 0
M  V30 7 C 12.0033 2.3101 0.0 0
M  V30 8 Br 0.0000 0.0000 0.0 0
M  V30 9 C 4.0012 2.3101 0.0 0
M  V30 10 C 4.0012 0.7700 0.0 0
M  V30 11 C 2.6673 3.0801 0.0 0
M  V30 12 C 2.6673 0.0000 0.0 0
M  V30 13 C 1.3337 2.3101 0.0 0
M  V30 14 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 8 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 35656-89-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1033438-98-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-17782629
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Selective α-Oxyamination and Hydroxylation of Aliphatic Amides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Xinwei; Lin, Fengguirong; Huang, Kaimeng; Wei, Jialiang; Li, Xinyao;
Wang, Xiaoyang; Geng, Xiaoyu; Jiao, Ning
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2017), 56(40), 12307-12311

$RFMT $RIREG SCHEME337 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Fmoc-leucine
C21H23NO4
35661-60-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.7534 5.2309 0.0 0
M  V30 2 O 7.0871 4.4608 0.0 0
M  V30 3 C 8.4207 5.2309 0.0 0
M  V30 4 N 9.7544 4.4608 0.0 0
M  V30 5 O 8.4207 6.7709 0.0 0
M  V30 6 C 11.0882 5.2309 0.0 0 CFG=2
M  V30 7 C 11.0882 6.7709 0.0 0
M  V30 8 C 12.4219 4.4608 0.0 0
M  V30 9 C 12.4219 7.5409 0.0 0
M  V30 10 O 12.4219 2.9208 0.0 0
M  V30 11 O 13.7555 5.2309 0.0 0
M  V30 12 C 13.7555 6.7709 0.0 0
M  V30 13 C 12.4219 9.0809 0.0 0
M  V30 14 C 4.4196 4.4608 0.0 0
M  V30 15 C 4.2586 2.9293 0.0 0
M  V30 16 C 3.0128 5.0873 0.0 0
M  V30 17 C 2.7523 2.6091 0.0 0
M  V30 18 C 5.2891 1.7849 0.0 0
M  V30 19 C 1.9823 3.9428 0.0 0
M  V30 20 C 2.5369 6.5519 0.0 0
M  V30 21 C 2.2763 1.1444 0.0 0
M  V30 22 C 4.8132 0.3202 0.0 0
M  V30 23 C 0.4759 4.2630 0.0 0
M  V30 24 C 1.0304 6.8721 0.0 0
M  V30 25 C 3.3069 0.0000 0.0 0
M  V30 26 C 0.0000 5.7277 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7 CFG=1
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 1 9 13
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 15 18
M  V30 18 1 16 19
M  V30 19 2 16 20
M  V30 20 1 17 19
M  V30 21 2 17 21
M  V30 22 1 18 22
M  V30 23 2 19 23
M  V30 24 1 20 24
M  V30 25 1 21 25
M  V30 26 2 22 25
M  V30 27 1 23 26
M  V30 28 2 24 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
9H-Fluoren-9-ylmethyl N-[(1S)-3-methyl-1-[(methylamino)carbonyl]butyl]carbamate
C22H26N2O3
136583-14-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.0022 3.8501 0.0 0
M  V30 2 O 6.6685 4.6201 0.0 0
M  V30 3 C 5.3348 3.8501 0.0 0
M  V30 4 N 4.0012 4.6201 0.0 0
M  V30 5 O 5.3348 2.3101 0.0 0
M  V30 6 C 2.6673 3.8501 0.0 0 CFG=1
M  V30 7 C 1.3337 4.6201 0.0 0
M  V30 8 C 2.6673 2.3101 0.0 0
M  V30 9 N 1.3337 6.1601 0.0 0
M  V30 10 O 0.0000 3.8501 0.0 0
M  V30 11 C 1.3337 1.5400 0.0 0
M  V30 12 C 0.0000 6.9302 0.0 0
M  V30 13 C 0.0000 2.3101 0.0 0
M  V30 14 C 1.3337 0.0000 0.0 0
M  V30 15 C 9.3360 4.6201 0.0 0
M  V30 16 C 9.4969 6.1517 0.0 0
M  V30 17 C 10.7428 3.9936 0.0 0
M  V30 18 C 11.0032 6.4718 0.0 0
M  V30 19 C 8.4665 7.2961 0.0 0
M  V30 20 C 11.7732 5.1382 0.0 0
M  V30 21 C 11.2187 2.5290 0.0 0
M  V30 22 C 11.4793 7.9366 0.0 0
M  V30 23 C 8.9424 8.7608 0.0 0
M  V30 24 C 13.2797 4.8180 0.0 0
M  V30 25 C 12.7251 2.2089 0.0 0
M  V30 26 C 10.4487 9.0810 0.0 0
M  V30 27 C 13.7556 3.3533 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8 CFG=1
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 2 16 19
M  V30 19 1 17 20
M  V30 20 2 17 21
M  V30 21 1 18 20
M  V30 22 2 18 22
M  V30 23 1 19 23
M  V30 24 2 20 24
M  V30 25 1 21 25
M  V30 26 1 22 26
M  V30 27 2 23 26
M  V30 28 1 24 27
M  V30 29 2 25 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(1):AMD
$DATUM resin bound
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 35661-60-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 136583-14-7
$DTYPE RXN:PRO(1):AMD
$DATUM resin-bound
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-6422741
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 128625-52-5
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):NOTES
$DATUM solid-supported reaction, resin-bound
(9H-fluoren-9-yl)methyl-N-[(1S)-3-methyl-1-[(methylamino)carbonyl]butyl]-carbamate
formed, resin-bound methanamine used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A convenient approach to synthesizing peptide C-terminal N-alkyl amides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fang, Wei-Jie; Yakovleva, Tatyana; Aldrich, Jane V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Biopolymers (2011), 96(6), 715-722

$RFMT $RIREG SCHEME338 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Methoxy-2-oxo-2H-1-benzopyran-3-carboxylic acid
C11H8O5
35924-44-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 O 9.3360 1.5400 0.0 0
M  V30 5 C 10.6697 2.3101 0.0 0
M  V30 6 O 1.3337 4.6201 0.0 0
M  V30 7 C 5.3348 2.3101 0.0 0
M  V30 8 C 5.3348 3.8501 0.0 0
M  V30 9 C 4.0012 1.5400 0.0 0
M  V30 10 C 6.6685 1.5400 0.0 0
M  V30 11 O 4.0012 4.6201 0.0 0
M  V30 12 C 6.6685 4.6201 0.0 0
M  V30 13 C 2.6673 2.3101 0.0 0
M  V30 14 C 8.0023 2.3101 0.0 0
M  V30 15 C 2.6673 3.8501 0.0 0
M  V30 16 C 8.0023 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 4 5
M  V30 5 1 4 14
M  V30 6 2 6 15
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Methoxy-N-methyl-2-oxo-2H-1-benzopyran-3-carboxamide
C12H11NO4
827014-06-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.4701 2.6675 0.0 0
M  V30 2 N 9.2401 4.0011 0.0 0
M  V30 3 O 9.2401 1.3338 0.0 0
M  V30 4 C 10.7801 4.0011 0.0 0
M  V30 5 O 1.5400 6.6686 0.0 0
M  V30 6 C 0.0000 6.6686 0.0 0
M  V30 7 O 6.9301 0.0000 0.0 0
M  V30 8 C 4.6201 4.0011 0.0 0
M  V30 9 C 3.8500 2.6675 0.0 0
M  V30 10 C 6.1601 4.0011 0.0 0
M  V30 11 C 3.8500 5.3348 0.0 0
M  V30 12 O 4.6201 1.3338 0.0 0
M  V30 13 C 2.3100 2.6675 0.0 0
M  V30 14 C 6.9301 2.6675 0.0 0
M  V30 15 C 2.3100 5.3348 0.0 0
M  V30 16 C 6.1601 1.3338 0.0 0
M  V30 17 C 1.5400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 15
M  V30 7 2 7 16
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 35924-44-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 827014-06-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-14770392
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM HCl salt of EDC used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Improvement of fluorescence characteristics of coumarins: Syntheses and
fluorescence properties of 6-methoxycoumarin and benzocoumarin
derivatives as novel fluorophores emitting in the longer wavelength
region and their application to analytical reagents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Murata, Chiyomi; Masuda, Toshinobu; Kamochi, Yasuko; Todoroki, Kenichiro;
Yoshida, Hideyuki; Nohta, Hitoshi; Yamaguchi, Masatoshi; Takadate, Akira
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical & Pharmaceutical Bulletin (2005), 53(7), 750-758

$RFMT $RIREG SCHEME339 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Fluoro-5-nitrobenzenamine
C6H5FN2O2
369-36-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 N 5.3901 0.0000 0.0 0
M  V30 5 F 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 9
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N1-Methyl-4-nitro-1,2-benzenediamine
C7H9N3O2
41939-61-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 4.6201 0.0 0 VAL=5
M  V30 2 O 0.0000 3.8500 0.0 0
M  V30 3 O 1.3337 6.1601 0.0 0
M  V30 4 N 4.0011 0.0000 0.0 0
M  V30 5 N 6.6686 1.5400 0.0 0
M  V30 6 C 8.0022 2.3100 0.0 0
M  V30 7 C 2.6675 3.8500 0.0 0
M  V30 8 C 2.6675 2.3100 0.0 0
M  V30 9 C 4.0011 4.6201 0.0 0
M  V30 10 C 4.0011 1.5400 0.0 0
M  V30 11 C 5.3348 3.8500 0.0 0
M  V30 12 C 5.3348 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 10
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 369-36-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 41939-61-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-1541311
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM N-(2-Amino-phenyl)-4-[(l-methyl-1H-benzoimidazol-5-ylamino)-methyl]-benzarnide
(252) Step 1. Nl-Methyl-4-nitro-benzene-1.2-diamine (248): A solution of
fluoride 247 (5.41g, 34.7 mmol) in DMF (4OmL) was treated with 40%w/w
solution of MeNH2 in water (10mL, 128 mmol). The mixture stirred at 90 °C
for 3h, diluted with EtOAc, washed with saturated aqueous NaHCO3. Organic
phase was dried over MgSO4, evaporated and the residue was purified by
flash chromatography (eluent 50% EtOAc in CH2CI2) to afford compound 248,
yield 5.3Ig, 92%. 1H NMR: (CDCI3) δ (ppm): 7.75 (dd, J = 2.6, 8.8 Hz,
1H), 7.53 (d, J = 2.6 Hz, 1H), 6.45 (d, J = 8.8 Hz, 1H), 4.24 (bs, 3H)1
2.91 (s, 3H). LRMS: (calcd.) 167.2; (found) 168.1 (MH)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of N-(2-amino and 2-hydroxy)phenyl carboxamides as inhibitors
of histone deacetylase
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Delorme, Daniel; Vaisburg, Arkadii; Moradei, Oscar; Leit, Silvana;
Raeppel, Stephane; Frechette, Sylvie; Bouchain, Giliane; Zhou, Zhihong;
Paquin, Isabelle; Gaudette, Frederic; Isakovic, Ljubomir
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2005092899 A1 2005-10-06

$RFMT $RIREG SCHEME340 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-Methyl (2R,5R)-5-(acetylamino)-5-methyl-6-oxo-1-(phenylmethyl)-2-piperidi...
C17H22N2O4
370564-79-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.8866 4.0011 0.0 0
M  V30 2 C 8.4266 6.6685 0.0 0
M  V30 3 O 9.1966 8.0021 0.0 0
M  V30 4 O 9.1966 5.3347 0.0 0
M  V30 5 C 10.7366 8.0021 0.0 0
M  V30 6 O 3.8066 4.0011 0.0 0
M  V30 7 N 2.6268 5.6786 0.0 0
M  V30 8 C 1.1798 6.2053 0.0 0
M  V30 9 C 0.0000 5.2154 0.0 0
M  V30 10 O 0.9123 7.7219 0.0 0
M  V30 11 C 2.6268 7.6583 0.0 0
M  V30 12 N 6.1166 5.3347 0.0 0
M  V30 13 C 6.8866 6.6685 0.0 0 CFG=1
M  V30 14 C 4.5766 5.3347 0.0 0
M  V30 15 C 6.1166 8.0021 0.0 0
M  V30 16 C 3.8066 6.6685 0.0 0 CFG=2
M  V30 17 C 4.5766 8.0021 0.0 0
M  V30 18 C 6.1166 2.6674 0.0 0
M  V30 19 C 6.8866 1.3336 0.0 0
M  V30 20 C 4.5766 2.6674 0.0 0
M  V30 21 C 6.1166 0.0000 0.0 0
M  V30 22 C 3.8066 1.3336 0.0 0
M  V30 23 C 4.5766 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 13 2 CFG=3
M  V30 6 1 3 5
M  V30 7 2 6 14
M  V30 8 1 7 8
M  V30 9 1 16 7 CFG=3
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 16 11 CFG=1
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 13 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-(2R,5R)-5-(Acetylamino)-N,5-dimethyl-6-oxo-1-(phenylmethyl)-2-piperidinec...
C17H23N3O3
370564-81-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.8866 4.0011 0.0 0
M  V30 2 C 8.4266 6.6685 0.0 0
M  V30 3 N 9.1966 8.0021 0.0 0
M  V30 4 O 9.1966 5.3347 0.0 0
M  V30 5 C 10.7366 8.0021 0.0 0
M  V30 6 O 3.8066 4.0011 0.0 0
M  V30 7 N 2.6268 5.6786 0.0 0
M  V30 8 C 1.1798 6.2053 0.0 0
M  V30 9 C 0.0000 5.2154 0.0 0
M  V30 10 O 0.9123 7.7219 0.0 0
M  V30 11 C 2.6268 7.6583 0.0 0
M  V30 12 N 6.1166 5.3347 0.0 0
M  V30 13 C 6.8866 6.6685 0.0 0 CFG=1
M  V30 14 C 4.5766 5.3347 0.0 0
M  V30 15 C 6.1166 8.0021 0.0 0
M  V30 16 C 3.8066 6.6685 0.0 0 CFG=2
M  V30 17 C 4.5766 8.0021 0.0 0
M  V30 18 C 6.1166 2.6674 0.0 0
M  V30 19 C 4.5766 2.6674 0.0 0
M  V30 20 C 6.8866 1.3336 0.0 0
M  V30 21 C 3.8066 1.3336 0.0 0
M  V30 22 C 6.1166 0.0000 0.0 0
M  V30 23 C 4.5766 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 13 2 CFG=3
M  V30 6 1 3 5
M  V30 7 2 6 14
M  V30 8 1 7 8
M  V30 9 1 16 7 CFG=3
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 16 11 CFG=1
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 13 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 370564-79-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 370564-81-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-1838636
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of a conformationally restricted dipeptide analogue and its
evaluation as a β-turn mimic
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM De Borggraeve, W. M.; Rombouts, F. J. R.; Van der Eycken, E. V.; Toppet,
S. M.; Hoornaert, G. J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2001), 42(33), 5693-5695

$RFMT $RIREG SCHEME341 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 3-chloro-3-oxopropanoate
C4H5ClO3
37517-81-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 2.6674 2.3100 0.0 0
M  V30 3 O 5.3347 2.3100 0.0 0
M  V30 4 O 4.0011 0.0000 0.0 0
M  V30 5 C 1.3338 1.5400 0.0 0
M  V30 6 C 6.6685 1.5400 0.0 0
M  V30 7 Cl 0.0000 2.3100 0.0 0
M  V30 8 O 1.3338 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 3-(methylamino)-3-oxopropanoate
C5H9NO3
76311-95-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 2.3100 0.0 0
M  V30 2 C 5.3348 1.5400 0.0 0
M  V30 3 C 2.6675 1.5400 0.0 0
M  V30 4 N 6.6686 2.3100 0.0 0
M  V30 5 O 5.3348 0.0000 0.0 0
M  V30 6 O 1.3337 2.3100 0.0 0
M  V30 7 O 2.6675 0.0000 0.0 0
M  V30 8 C 8.0022 1.5400 0.0 0
M  V30 9 C 0.0000 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 1 6 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 37517-81-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 76311-95-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-10537300
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Unsymmetrical vic-Tricarbonyl Compounds for the Total Syntheses of
Cladoniamide G and Cladoniamide F
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Schuette, Julia; Kilgenstein, Frank; Fischer, Michel; Koert, Ulrich
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2014), 2014(24), 5302-5311

$RFMT $RIREG SCHEME342 STEP1
$RXN



  3  1
$MOL
1-[(1E)-2-Nitroethenyl]naphthalene
C12H9NO2
37630-26-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 3.0800 0.0 0
M  V30 2 C 6.6684 2.3100 0.0 0
M  V30 3 N 8.0021 3.0800 0.0 0 VAL=5
M  V30 4 O 8.0021 4.6200 0.0 0
M  V30 5 O 9.3358 2.3100 0.0 0
M  V30 6 C 2.6674 3.0800 0.0 0
M  V30 7 C 4.0011 2.3100 0.0 0
M  V30 8 C 1.3336 2.3100 0.0 0
M  V30 9 C 2.6674 4.6200 0.0 0
M  V30 10 C 4.0011 0.7700 0.0 0
M  V30 11 C 1.3336 0.7700 0.0 0
M  V30 12 C 0.0000 3.0800 0.0 0
M  V30 13 C 1.3336 5.3900 0.0 0
M  V30 14 C 2.6674 0.0000 0.0 0
M  V30 15 C 0.0000 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 2 3 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 2 11 14
M  V30 15 2 12 15
M  V30 16 1 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dimethyl P-(2-phenylacetyl)phosphonate
C10H13O4P
51463-66-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 2.3100 2.3100 0.0 0 VAL=5
M  V30 2 C 3.8500 2.3100 0.0 0
M  V30 3 O 0.7700 2.3100 0.0 0
M  V30 4 O 2.3100 0.7700 0.0 0
M  V30 5 O 2.3100 3.8500 0.0 0
M  V30 6 C 4.6200 3.6436 0.0 0
M  V30 7 O 4.6200 0.9762 0.0 0
M  V30 8 C 0.0000 3.6436 0.0 0
M  V30 9 C 0.9764 0.0000 0.0 0
M  V30 10 C 6.1600 3.6436 0.0 0
M  V30 11 C 6.9300 4.9773 0.0 0
M  V30 12 C 6.9300 2.3100 0.0 0
M  V30 13 C 8.4700 4.9773 0.0 0
M  V30 14 C 8.4700 2.3100 0.0 0
M  V30 15 C 9.2400 3.6436 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 1 5
M  V30 5 1 2 6
M  V30 6 2 2 7
M  V30 7 1 3 8
M  V30 8 1 4 9
M  V30 9 1 6 10
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αR,βS)-N-Methyl-β-(nitromethyl)-α-phenyl-1-naphthalenepropanamide
C21H20N2O3
1457935-45-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.8853 4.6200 0.0 0 CFG=2
M  V30 2 C 5.5516 3.8500 0.0 0 CFG=1
M  V30 3 C 6.8853 6.1601 0.0 0
M  V30 4 C 5.5516 2.3100 0.0 0
M  V30 5 N 8.2189 6.9301 0.0 0
M  V30 6 O 5.5516 6.9301 0.0 0
M  V30 7 N 4.2179 1.5400 0.0 0 VAL=5
M  V30 8 C 8.2189 8.4701 0.0 0
M  V30 9 O 4.2179 0.0000 0.0 0
M  V30 10 O 2.8841 2.3100 0.0 0
M  V30 11 C 8.2189 3.8500 0.0 0
M  V30 12 C 9.5527 4.6200 0.0 0
M  V30 13 C 8.2189 2.3100 0.0 0
M  V30 14 C 10.8864 3.8500 0.0 0
M  V30 15 C 9.5527 1.5400 0.0 0
M  V30 16 C 10.8864 2.3100 0.0 0
M  V30 17 C 4.4627 4.9390 0.0 0
M  V30 18 C 2.9752 4.5404 0.0 0
M  V30 19 C 4.8612 6.4265 0.0 0
M  V30 20 C 1.8862 5.6294 0.0 0
M  V30 21 C 2.5764 3.0529 0.0 0
M  V30 22 C 3.7723 7.5154 0.0 0
M  V30 23 C 2.2848 7.1169 0.0 0
M  V30 24 C 0.3986 5.2308 0.0 0
M  V30 25 C 1.0889 2.6542 0.0 0
M  V30 26 C 0.0000 3.7432 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 11
M  V30 4 1 2 4 CFG=3
M  V30 5 1 2 17
M  V30 6 1 3 5
M  V30 7 2 3 6
M  V30 8 1 4 7
M  V30 9 1 5 8
M  V30 10 2 7 9
M  V30 11 2 7 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 1 17 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 18 21
M  V30 22 1 19 22
M  V30 23 1 20 23
M  V30 24 1 20 24
M  V30 25 2 21 25
M  V30 26 2 22 23
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 37630-26-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 51463-66-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1457935-45-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-7143059
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1457935-39-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, dr=>95:5, 67% ee, Michael addition
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Organocatalyzed asymmetric Michael reaction of β-aryl-α-ketophosphonates
and nitroalkenes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Guang, Jie; Zhao, John Cong-Gui
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2013), 54(42), 5703-5706

$RFMT $RIREG SCHEME343 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 1H-indole-2-carboxylate
C11H11NO2
3770-50-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.0811 1.5400 0.0 0
M  V30 2 O 7.4148 2.3101 0.0 0
M  V30 3 O 6.0811 0.0000 0.0 0
M  V30 4 C 8.7486 1.5400 0.0 0
M  V30 5 C 10.0823 2.3101 0.0 0
M  V30 6 C 2.3101 2.8281 0.0 0
M  V30 7 C 3.0801 4.1618 0.0 0
M  V30 8 C 3.3405 1.6836 0.0 0
M  V30 9 C 0.7700 2.8281 0.0 0
M  V30 10 N 4.5865 3.8416 0.0 0
M  V30 11 C 2.3101 5.4955 0.0 0
M  V30 12 C 4.7475 2.3101 0.0 0
M  V30 13 C 0.0000 4.1618 0.0 0
M  V30 14 C 0.7700 5.4955 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 1 11 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-1H-indole-2-carboxamide
C10H10N2O
69808-71-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.5772 1.5400 0.0 0
M  V30 2 N 7.3472 2.8737 0.0 0
M  V30 3 O 7.3472 0.2064 0.0 0
M  V30 4 C 8.8872 2.8737 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 2.6673 0.7700 0.0 0
M  V30 7 C 4.1321 2.7859 0.0 0
M  V30 8 C 1.3337 3.0801 0.0 0
M  V30 9 N 4.1321 0.2941 0.0 0
M  V30 10 C 1.3337 0.0000 0.0 0
M  V30 11 C 5.0371 1.5400 0.0 0
M  V30 12 C 0.0000 2.3101 0.0 0
M  V30 13 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 1 10 13
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3770-50-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 69808-71-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-8469682
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Preparation 33. Preparation of 2-(methylaminomethyl)-1H-indole. a)
N-Methyl-1H-indol-2-carboxamide. A suspension of ethyl
indole-2-carboxylate (25.30 g, 133.7 mmole) in 40% aqueous CH3NH2 (400
mL) was stirred at RT. The flask was tightly stoppered to keep the
material inside the flask. As the reaction proceeded the product began to
precipitate. The reaction was stirred at RT for 3 days, then was
concentrated to remove approximately 200 mL of the solvent. The remaining
residue was diluted with H2O (500 mL), and the solid was collected by
suction filtration and washed with H2O. Drying under high vacuum left the
title compound. Yield: (21.50 g, 92%) as a light yellow solid. MS (ES)
m/e 175 (M + H)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of N-heteroarylmethyl acrylamides as Fab I inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Miller, William H.; Newlander, Kenneth A.; Seefeld, Mark A.; Uzinskas,
Irene N.; Dewolf, Walter E., Jr.; Jakas, Dalia R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2001027103 A1 2001-04-19

$RFMT $RIREG SCHEME344 STEP1
$RXN



  2  1
$MOL
2-[(1E)-2-(4-Chlorophenyl)ethenyl]benzoic acid
C15H11ClO2
38453-69-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.0011 0.0 0
M  V30 2 C 5.3900 5.3347 0.0 0
M  V30 3 C 3.0800 1.3338 0.0 0
M  V30 4 O 4.6200 1.3338 0.0 0
M  V30 5 O 2.3100 0.0000 0.0 0
M  V30 6 Cl 11.5500 5.3347 0.0 0
M  V30 7 C 3.0800 4.0011 0.0 0
M  V30 8 C 2.3100 2.6674 0.0 0
M  V30 9 C 2.3100 5.3347 0.0 0
M  V30 10 C 0.7700 2.6674 0.0 0
M  V30 11 C 0.7700 5.3347 0.0 0
M  V30 12 C 0.0000 4.0011 0.0 0
M  V30 13 C 6.9300 5.3347 0.0 0
M  V30 14 C 7.7000 6.6685 0.0 0
M  V30 15 C 7.7000 4.0011 0.0 0
M  V30 16 C 9.2400 6.6685 0.0 0
M  V30 17 C 9.2400 4.0011 0.0 0
M  V30 18 C 10.0100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 2 13
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 8
M  V30 7 1 6 18
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[(1E)-2-(4-Chlorophenyl)ethenyl]-N-methylbenzamide
C16H14ClNO
1809194-37-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 5.3347 0.0 0
M  V30 2 C 5.3900 6.6685 0.0 0
M  V30 3 C 3.0800 2.6674 0.0 0
M  V30 4 N 2.3100 1.3336 0.0 0
M  V30 5 O 4.6200 2.6674 0.0 0
M  V30 6 C 3.0800 0.0000 0.0 0
M  V30 7 Cl 11.5500 6.6685 0.0 0
M  V30 8 C 3.0800 5.3347 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 2.3100 6.6685 0.0 0
M  V30 11 C 0.7700 4.0011 0.0 0
M  V30 12 C 0.7700 6.6685 0.0 0
M  V30 13 C 0.0000 5.3347 0.0 0
M  V30 14 C 6.9300 6.6685 0.0 0
M  V30 15 C 7.7000 5.3347 0.0 0
M  V30 16 C 7.7000 8.0021 0.0 0
M  V30 17 C 9.2400 5.3347 0.0 0
M  V30 18 C 9.2400 8.0021 0.0 0
M  V30 19 C 10.0100 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 8
M  V30 3 1 2 14
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 9
M  V30 7 1 4 6
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 38453-69-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1809194-37-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35010584
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM 1.11 mmol scale used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Metal- and Oxidant-Free Electrosynthesis of Heterocycles from
1,2-Diarylalkene Derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yu, Eunsoo; Kim, Hyungguk; Park, Cheol-Min
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Advanced Synthesis & Catalysis (2022), 364(23), 4088-4096

$RFMT $RIREG SCHEME345 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
9H-Purin-2-amine, 6-chloro-9-(2,3-di-O-acetyl-5-S-methyl-5-thio-β-D-ribofuran...
C15H18ClN5O5S
398138-95-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.5542 2.4368 0.0 0
M  V30 2 C 4.3084 1.5317 0.0 0
M  V30 3 C 2.9016 2.1580 0.0 0
M  V30 4 O 4.4695 0.0000 0.0 0
M  V30 5 O 2.6527 4.1120 0.0 0
M  V30 6 C 1.4068 5.0172 0.0 0
M  V30 7 C 0.0000 4.3909 0.0 0
M  V30 8 O 1.5679 6.5488 0.0 0
M  V30 9 C 3.3494 7.3893 0.0 0
M  V30 10 S 3.8253 8.8539 0.0 0
M  V30 11 C 2.7948 9.9984 0.0 0
M  V30 12 Cl 13.1897 4.9392 0.0 0
M  V30 13 N 10.5224 9.5592 0.0 0
M  V30 14 C 6.5379 4.9989 0.0 0 CFG=2
M  V30 15 C 5.3933 3.9685 0.0 0 CFG=2
M  V30 16 O 5.9114 6.4057 0.0 0
M  V30 17 C 4.0597 4.7385 0.0 0 CFG=2
M  V30 18 C 4.3798 6.2448 0.0 0 CFG=2
M  V30 19 N 8.0442 4.6787 0.0 0
M  V30 20 C 9.1885 5.7092 0.0 0
M  V30 21 C 8.6705 3.2718 0.0 0
M  V30 22 C 10.5224 4.9392 0.0 0
M  V30 23 N 9.1885 7.2492 0.0 0
M  V30 24 N 10.2022 3.4329 0.0 0
M  V30 25 C 11.8560 5.7092 0.0 0
M  V30 26 C 10.5224 8.0192 0.0 0
M  V30 27 N 11.8560 7.2492 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 15 1 CFG=3
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 6
M  V30 6 1 17 5 CFG=3
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 9 10
M  V30 10 1 18 9 CFG=1
M  V30 11 1 10 11
M  V30 12 1 12 25
M  V30 13 1 13 26
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 14 19 CFG=1
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 20 23
M  V30 24 2 21 24
M  V30 25 1 22 24
M  V30 26 2 22 25
M  V30 27 1 23 26
M  V30 28 1 25 27
M  V30 29 2 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 14 15 17 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
2-Amino-N-methyl-5′-S-methyl-5′-thioadenosine
C12H18N6O3S
1923818-32-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 4.6201 0.0 0
M  V30 2 C 0.0000 3.8501 0.0 0
M  V30 3 N 4.0010 0.0000 0.0 0
M  V30 4 O 8.9692 7.1223 0.0 0
M  V30 5 C 11.1742 2.1699 0.0 0
M  V30 6 S 12.6805 2.4901 0.0 0
M  V30 7 C 13.7109 1.3457 0.0 0
M  V30 8 O 11.8707 5.4473 0.0 0
M  V30 9 C 5.3348 3.8501 0.0 0
M  V30 10 N 6.4792 4.8805 0.0 0
M  V30 11 C 4.0010 4.6201 0.0 0
M  V30 12 N 5.3348 2.3101 0.0 0
M  V30 13 C 5.8529 6.2873 0.0 0
M  V30 14 C 2.6673 3.8501 0.0 0
M  V30 15 N 4.3213 6.1264 0.0 0
M  V30 16 C 4.0010 1.5400 0.0 0
M  V30 17 N 2.6673 2.3101 0.0 0
M  V30 18 C 7.9857 4.5603 0.0 0 CFG=1
M  V30 19 O 8.6120 3.1534 0.0 0
M  V30 20 C 9.1301 5.5908 0.0 0 CFG=2
M  V30 21 C 10.1436 3.3145 0.0 0 CFG=2
M  V30 22 C 10.4638 4.8208 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 3 16
M  V30 4 1 20 4 CFG=3
M  V30 5 1 5 6
M  V30 6 1 21 5 CFG=1
M  V30 7 1 6 7
M  V30 8 1 22 8 CFG=3
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 2 9 12
M  V30 12 1 10 13
M  V30 13 1 18 10 CFG=1
M  V30 14 2 11 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 2 13 15
M  V30 18 1 14 17
M  V30 19 2 16 17
M  V30 20 1 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 18 20 21 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 398138-95-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1923818-32-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-18760576
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Nucleoside-based anti-bacterial and anti-protozoan drugs
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Back, Thomas G.; Snyder, Floyd F.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20180037601 A1 2018-02-08

$RFMT $RIREG SCHEME345 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
9H-Purin-2-amine, 6-chloro-9-(2,3-di-O-acetyl-5-S-methyl-5-thio-β-D-ribofuran...
C15H18ClN5O5S
398138-95-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.5542 2.4368 0.0 0
M  V30 2 C 4.3084 1.5317 0.0 0
M  V30 3 C 2.9016 2.1580 0.0 0
M  V30 4 O 4.4695 0.0000 0.0 0
M  V30 5 O 2.6527 4.1120 0.0 0
M  V30 6 C 1.4068 5.0172 0.0 0
M  V30 7 C 0.0000 4.3909 0.0 0
M  V30 8 O 1.5679 6.5488 0.0 0
M  V30 9 C 3.3494 7.3893 0.0 0
M  V30 10 S 3.8253 8.8539 0.0 0
M  V30 11 C 2.7948 9.9984 0.0 0
M  V30 12 Cl 13.1897 4.9392 0.0 0
M  V30 13 N 10.5224 9.5592 0.0 0
M  V30 14 C 6.5379 4.9989 0.0 0 CFG=2
M  V30 15 C 5.3933 3.9685 0.0 0 CFG=2
M  V30 16 O 5.9114 6.4057 0.0 0
M  V30 17 C 4.0597 4.7385 0.0 0 CFG=2
M  V30 18 C 4.3798 6.2448 0.0 0 CFG=2
M  V30 19 N 8.0442 4.6787 0.0 0
M  V30 20 C 9.1885 5.7092 0.0 0
M  V30 21 C 8.6705 3.2718 0.0 0
M  V30 22 C 10.5224 4.9392 0.0 0
M  V30 23 N 9.1885 7.2492 0.0 0
M  V30 24 N 10.2022 3.4329 0.0 0
M  V30 25 C 11.8560 5.7092 0.0 0
M  V30 26 C 10.5224 8.0192 0.0 0
M  V30 27 N 11.8560 7.2492 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 15 1 CFG=3
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 6
M  V30 6 1 17 5 CFG=3
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 9 10
M  V30 10 1 18 9 CFG=1
M  V30 11 1 10 11
M  V30 12 1 12 25
M  V30 13 1 13 26
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 14 19 CFG=1
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 20 23
M  V30 24 2 21 24
M  V30 25 1 22 24
M  V30 26 2 22 25
M  V30 27 1 23 26
M  V30 28 1 25 27
M  V30 29 2 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 14 15 17 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
2-Amino-N-methyl-5′-S-methyl-5′-thioadenosine
C12H18N6O3S
1923818-32-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 4.6201 0.0 0
M  V30 2 C 0.0000 3.8501 0.0 0
M  V30 3 N 4.0010 0.0000 0.0 0
M  V30 4 O 8.9692 7.1223 0.0 0
M  V30 5 C 11.1742 2.1699 0.0 0
M  V30 6 S 12.6805 2.4901 0.0 0
M  V30 7 C 13.7109 1.3457 0.0 0
M  V30 8 O 11.8707 5.4473 0.0 0
M  V30 9 C 5.3348 3.8501 0.0 0
M  V30 10 N 6.4792 4.8805 0.0 0
M  V30 11 C 4.0010 4.6201 0.0 0
M  V30 12 N 5.3348 2.3101 0.0 0
M  V30 13 C 5.8529 6.2873 0.0 0
M  V30 14 C 2.6673 3.8501 0.0 0
M  V30 15 N 4.3213 6.1264 0.0 0
M  V30 16 C 4.0010 1.5400 0.0 0
M  V30 17 N 2.6673 2.3101 0.0 0
M  V30 18 C 7.9857 4.5603 0.0 0 CFG=1
M  V30 19 O 8.6120 3.1534 0.0 0
M  V30 20 C 9.1301 5.5908 0.0 0 CFG=2
M  V30 21 C 10.1436 3.3145 0.0 0 CFG=2
M  V30 22 C 10.4638 4.8208 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 3 16
M  V30 4 1 20 4 CFG=3
M  V30 5 1 5 6
M  V30 6 1 21 5 CFG=1
M  V30 7 1 6 7
M  V30 8 1 22 8 CFG=3
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 2 9 12
M  V30 12 1 10 13
M  V30 13 1 18 10 CFG=1
M  V30 14 2 11 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 2 13 15
M  V30 18 1 14 17
M  V30 19 2 16 17
M  V30 20 1 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 18 20 21 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 398138-95-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1923818-32-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-17064678
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and activity of nucleoside-based antiprotozoan compounds
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tran, Huu-Anh; Zheng, Zhaoyan; Wen, Xianghui; Manivannan, Srinivasan;
Pastor, Arnaud; Kaiser, Marcel; Brun, Reto; Snyder, Floyd F.; Back,
Thomas G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2017), 25(7), 2091-2104

$RFMT $RIREG SCHEME345 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
9H-Purin-2-amine, 6-chloro-9-(2,3-di-O-acetyl-5-S-methyl-5-thio-β-D-ribofuran...
C15H18ClN5O5S
398138-95-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.5542 2.4368 0.0 0
M  V30 2 C 4.3084 1.5317 0.0 0
M  V30 3 C 2.9016 2.1580 0.0 0
M  V30 4 O 4.4695 0.0000 0.0 0
M  V30 5 O 2.6527 4.1120 0.0 0
M  V30 6 C 1.4068 5.0172 0.0 0
M  V30 7 C 0.0000 4.3909 0.0 0
M  V30 8 O 1.5679 6.5488 0.0 0
M  V30 9 C 3.3494 7.3893 0.0 0
M  V30 10 S 3.8253 8.8539 0.0 0
M  V30 11 C 2.7948 9.9984 0.0 0
M  V30 12 Cl 13.1897 4.9392 0.0 0
M  V30 13 N 10.5224 9.5592 0.0 0
M  V30 14 C 6.5379 4.9989 0.0 0 CFG=2
M  V30 15 C 5.3933 3.9685 0.0 0 CFG=2
M  V30 16 O 5.9114 6.4057 0.0 0
M  V30 17 C 4.0597 4.7385 0.0 0 CFG=2
M  V30 18 C 4.3798 6.2448 0.0 0 CFG=2
M  V30 19 N 8.0442 4.6787 0.0 0
M  V30 20 C 9.1885 5.7092 0.0 0
M  V30 21 C 8.6705 3.2718 0.0 0
M  V30 22 C 10.5224 4.9392 0.0 0
M  V30 23 N 9.1885 7.2492 0.0 0
M  V30 24 N 10.2022 3.4329 0.0 0
M  V30 25 C 11.8560 5.7092 0.0 0
M  V30 26 C 10.5224 8.0192 0.0 0
M  V30 27 N 11.8560 7.2492 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 15 1 CFG=3
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 6
M  V30 6 1 17 5 CFG=3
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 9 10
M  V30 10 1 18 9 CFG=1
M  V30 11 1 10 11
M  V30 12 1 12 25
M  V30 13 1 13 26
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 14 19 CFG=1
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 20 23
M  V30 24 2 21 24
M  V30 25 1 22 24
M  V30 26 2 22 25
M  V30 27 1 23 26
M  V30 28 1 25 27
M  V30 29 2 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 14 15 17 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
2-Amino-N-methyl-5′-S-methyl-5′-thioadenosine
C12H18N6O3S
1923818-32-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 4.6201 0.0 0
M  V30 2 C 0.0000 3.8501 0.0 0
M  V30 3 N 4.0010 0.0000 0.0 0
M  V30 4 O 8.9692 7.1223 0.0 0
M  V30 5 C 11.1742 2.1699 0.0 0
M  V30 6 S 12.6805 2.4901 0.0 0
M  V30 7 C 13.7109 1.3457 0.0 0
M  V30 8 O 11.8707 5.4473 0.0 0
M  V30 9 C 5.3348 3.8501 0.0 0
M  V30 10 N 6.4792 4.8805 0.0 0
M  V30 11 C 4.0010 4.6201 0.0 0
M  V30 12 N 5.3348 2.3101 0.0 0
M  V30 13 C 5.8529 6.2873 0.0 0
M  V30 14 C 2.6673 3.8501 0.0 0
M  V30 15 N 4.3213 6.1264 0.0 0
M  V30 16 C 4.0010 1.5400 0.0 0
M  V30 17 N 2.6673 2.3101 0.0 0
M  V30 18 C 7.9857 4.5603 0.0 0 CFG=1
M  V30 19 O 8.6120 3.1534 0.0 0
M  V30 20 C 9.1301 5.5908 0.0 0 CFG=2
M  V30 21 C 10.1436 3.3145 0.0 0 CFG=2
M  V30 22 C 10.4638 4.8208 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 3 16
M  V30 4 1 20 4 CFG=3
M  V30 5 1 5 6
M  V30 6 1 21 5 CFG=1
M  V30 7 1 6 7
M  V30 8 1 22 8 CFG=3
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 2 9 12
M  V30 12 1 10 13
M  V30 13 1 18 10 CFG=1
M  V30 14 2 11 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 2 13 15
M  V30 18 1 14 17
M  V30 19 2 16 17
M  V30 20 1 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 18 20 21 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 398138-95-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1923818-32-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-16452682
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of purine nucleoside-based antibacterial and anti-protozoan
drugs
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Back, Thomas G.; Snyder, Floyd F.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2016168911 A1 2016-10-27

$RFMT $RIREG SCHEME345 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
9H-Purin-2-amine, 6-chloro-9-(2,3-di-O-acetyl-5-S-methyl-5-thio-β-D-ribofuran...
C15H18ClN5O5S
398138-95-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.5542 2.4368 0.0 0
M  V30 2 C 4.3084 1.5317 0.0 0
M  V30 3 C 2.9016 2.1580 0.0 0
M  V30 4 O 4.4695 0.0000 0.0 0
M  V30 5 O 2.6527 4.1120 0.0 0
M  V30 6 C 1.4068 5.0172 0.0 0
M  V30 7 C 0.0000 4.3909 0.0 0
M  V30 8 O 1.5679 6.5488 0.0 0
M  V30 9 C 3.3494 7.3893 0.0 0
M  V30 10 S 3.8253 8.8539 0.0 0
M  V30 11 C 2.7948 9.9984 0.0 0
M  V30 12 Cl 13.1897 4.9392 0.0 0
M  V30 13 N 10.5224 9.5592 0.0 0
M  V30 14 C 6.5379 4.9989 0.0 0 CFG=2
M  V30 15 C 5.3933 3.9685 0.0 0 CFG=2
M  V30 16 O 5.9114 6.4057 0.0 0
M  V30 17 C 4.0597 4.7385 0.0 0 CFG=2
M  V30 18 C 4.3798 6.2448 0.0 0 CFG=2
M  V30 19 N 8.0442 4.6787 0.0 0
M  V30 20 C 9.1885 5.7092 0.0 0
M  V30 21 C 8.6705 3.2718 0.0 0
M  V30 22 C 10.5224 4.9392 0.0 0
M  V30 23 N 9.1885 7.2492 0.0 0
M  V30 24 N 10.2022 3.4329 0.0 0
M  V30 25 C 11.8560 5.7092 0.0 0
M  V30 26 C 10.5224 8.0192 0.0 0
M  V30 27 N 11.8560 7.2492 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 15 1 CFG=3
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 6
M  V30 6 1 17 5 CFG=3
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 9 10
M  V30 10 1 18 9 CFG=1
M  V30 11 1 10 11
M  V30 12 1 12 25
M  V30 13 1 13 26
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 14 19 CFG=1
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 20 23
M  V30 24 2 21 24
M  V30 25 1 22 24
M  V30 26 2 22 25
M  V30 27 1 23 26
M  V30 28 1 25 27
M  V30 29 2 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 14 15 17 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
2-Amino-N-methyl-5′-S-methyl-5′-thioadenosine
C12H18N6O3S
1923818-32-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 4.6201 0.0 0
M  V30 2 C 0.0000 3.8501 0.0 0
M  V30 3 N 4.0010 0.0000 0.0 0
M  V30 4 O 8.9692 7.1223 0.0 0
M  V30 5 C 11.1742 2.1699 0.0 0
M  V30 6 S 12.6805 2.4901 0.0 0
M  V30 7 C 13.7109 1.3457 0.0 0
M  V30 8 O 11.8707 5.4473 0.0 0
M  V30 9 C 5.3348 3.8501 0.0 0
M  V30 10 N 6.4792 4.8805 0.0 0
M  V30 11 C 4.0010 4.6201 0.0 0
M  V30 12 N 5.3348 2.3101 0.0 0
M  V30 13 C 5.8529 6.2873 0.0 0
M  V30 14 C 2.6673 3.8501 0.0 0
M  V30 15 N 4.3213 6.1264 0.0 0
M  V30 16 C 4.0010 1.5400 0.0 0
M  V30 17 N 2.6673 2.3101 0.0 0
M  V30 18 C 7.9857 4.5603 0.0 0 CFG=1
M  V30 19 O 8.6120 3.1534 0.0 0
M  V30 20 C 9.1301 5.5908 0.0 0 CFG=2
M  V30 21 C 10.1436 3.3145 0.0 0 CFG=2
M  V30 22 C 10.4638 4.8208 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 3 16
M  V30 4 1 20 4 CFG=3
M  V30 5 1 5 6
M  V30 6 1 21 5 CFG=1
M  V30 7 1 6 7
M  V30 8 1 22 8 CFG=3
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 2 9 12
M  V30 12 1 10 13
M  V30 13 1 18 10 CFG=1
M  V30 14 2 11 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 2 13 15
M  V30 18 1 14 17
M  V30 19 2 16 17
M  V30 20 1 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 18 20 21 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 398138-95-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1923818-32-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-15672612
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel nucleoside-based antimalarial compounds
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zheng, Zhaoyan; Tran, Huu-Anh; Manivannan, Srinivasan; Wen, Xianghui;
Kaiser, Marcel; Brun, Reto; Snyder, Floyd F.; Back, Thomas G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2016), 26(12), 2861-2865

$RFMT $RIREG SCHEME346 STEP1
$RXN



  2  1
$MOL
8-Chloro-10,11-dihydro-5-oxo-5H-dibenzo[a,d]cycloheptene-3-carboxylic acid
C16H11ClO3
40246-96-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.1961 4.9619 0.0 0
M  V30 2 C 1.3337 3.2702 0.0 0
M  V30 3 O 1.3337 4.8102 0.0 0
M  V30 4 O 0.0000 2.5002 0.0 0
M  V30 5 Cl 12.6472 2.7725 0.0 0
M  V30 6 C 5.3348 2.5002 0.0 0
M  V30 7 C 5.3348 0.9602 0.0 0
M  V30 8 C 6.5387 3.4604 0.0 0
M  V30 9 C 4.0010 3.2702 0.0 0
M  V30 10 C 6.5387 0.0000 0.0 0
M  V30 11 C 4.0010 0.1902 0.0 0
M  V30 12 C 8.0401 3.1178 0.0 0
M  V30 13 C 2.6673 2.5002 0.0 0
M  V30 14 C 8.0401 0.3428 0.0 0
M  V30 15 C 2.6673 0.9602 0.0 0
M  V30 16 C 8.7083 1.7302 0.0 0
M  V30 17 C 8.9076 4.3901 0.0 0
M  V30 18 C 10.2440 1.6152 0.0 0
M  V30 19 C 10.4433 4.2751 0.0 0
M  V30 20 C 11.1115 2.8875 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 13
M  V30 5 1 5 20
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 2 12 17
M  V30 17 2 13 15
M  V30 18 1 14 16
M  V30 19 2 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
8-Chloro-10,11-dihydro-N-methyl-5-oxo-5H-dibenzo[a,d]cycloheptene-3-carboxamide
C17H14ClNO2
2133012-77-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.4511 4.9619 0.0 0
M  V30 2 C 11.3135 3.2702 0.0 0
M  V30 3 N 12.6472 2.5002 0.0 0
M  V30 4 O 11.3135 4.8102 0.0 0
M  V30 5 C 13.9809 3.2702 0.0 0
M  V30 6 Cl 0.0000 2.7725 0.0 0
M  V30 7 C 7.3124 2.5002 0.0 0
M  V30 8 C 7.3124 0.9602 0.0 0
M  V30 9 C 6.1085 3.4604 0.0 0
M  V30 10 C 8.6461 3.2702 0.0 0
M  V30 11 C 6.1085 0.0000 0.0 0
M  V30 12 C 8.6461 0.1902 0.0 0
M  V30 13 C 4.6071 3.1178 0.0 0
M  V30 14 C 9.9799 2.5002 0.0 0
M  V30 15 C 4.6071 0.3428 0.0 0
M  V30 16 C 9.9799 0.9602 0.0 0
M  V30 17 C 3.9389 1.7302 0.0 0
M  V30 18 C 3.7395 4.3901 0.0 0
M  V30 19 C 2.4032 1.6152 0.0 0
M  V30 20 C 2.2038 4.2751 0.0 0
M  V30 21 C 1.5357 2.8875 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 14
M  V30 5 1 3 5
M  V30 6 1 6 21
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 2 13 18
M  V30 18 2 14 16
M  V30 19 1 15 17
M  V30 20 2 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 40246-96-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2133012-77-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-17821622
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, Synthesis, and Biological Evaluation of Novel Type I1/2 p38α MAP
Kinase Inhibitors with Excellent Selectivity, High Potency, and Prolonged
Target Residence Time by Interfering with the R-Spine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Walter, Niklas M.; Wentsch, Heike K.; Buehrmann, Mike; Bauer, Silke M.;
Doering, Eva; Mayer-Wrangowski, Svenja; Sievers-Engler, Adrian;
Willemsen-Seegers, Nicole; Zaman, Guido; Buijsman, Rogier; Laemmerhofer,
Michael; Rauh, Daniel; Laufer, Stefan A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2017), 60(19), 8027-8054

$RFMT $RIREG SCHEME347 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Benzofurancarboxaldehyde
C9H6O2
4265-16-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.0811 3.9554 0.0 0
M  V30 2 O 7.4149 3.1854 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 2.3100 2.6673 0.0 0
M  V30 5 C 4.5865 1.6538 0.0 0
M  V30 6 C 2.3100 0.0000 0.0 0
M  V30 7 O 3.3406 3.8119 0.0 0
M  V30 8 C 0.7700 2.6673 0.0 0
M  V30 9 C 4.7474 3.1854 0.0 0
M  V30 10 C 0.7700 0.0000 0.0 0
M  V30 11 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 9
M  V30 11 1 8 11
M  V30 12 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2-benzofuranmethanamine
C10H11NO
74377-46-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.5772 1.5400 0.0 0
M  V30 2 N 7.3472 2.8737 0.0 0
M  V30 3 C 8.8872 2.8737 0.0 0
M  V30 4 C 2.6673 2.3101 0.0 0
M  V30 5 C 2.6673 0.7700 0.0 0
M  V30 6 C 4.1321 2.7859 0.0 0
M  V30 7 C 1.3337 3.0801 0.0 0
M  V30 8 O 4.1321 0.2941 0.0 0
M  V30 9 C 1.3337 0.0000 0.0 0
M  V30 10 C 5.0371 1.5400 0.0 0
M  V30 11 C 0.0000 2.3101 0.0 0
M  V30 12 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 1 9 12
M  V30 13 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4265-16-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 74377-46-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-10824629
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Preparation 67 Preparation of
Methyl-(1-propyl-naphthalen-2-ylmethyl)amine Preparation 93 Preparation
of Benzofuran-2ylmethyl-methylamine [0848] According to the procedure of
Preparation 67, except substituting benzofuran-2-carbaldehyde for
1-propyl-naphthalene-2-carbaldehyde, the title compound (4.98 g, 92%) was
prepared as an orange oil. 1H NMR (300 MHz, DMSO-d6) δ 7.58-7.49 (m, 2H),
7.24-7.19 (m, 2H), 6.70 (s, 1H), 3.77 (s, 2H), 2.17 (s, 3H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20060142265 A1 2006-06-29

$RFMT $RIREG SCHEME347 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Benzofurancarboxaldehyde
C9H6O2
4265-16-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.0811 3.9554 0.0 0
M  V30 2 O 7.4149 3.1854 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 2.3100 2.6673 0.0 0
M  V30 5 C 4.5865 1.6538 0.0 0
M  V30 6 C 2.3100 0.0000 0.0 0
M  V30 7 O 3.3406 3.8119 0.0 0
M  V30 8 C 0.7700 2.6673 0.0 0
M  V30 9 C 4.7474 3.1854 0.0 0
M  V30 10 C 0.7700 0.0000 0.0 0
M  V30 11 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 9
M  V30 11 1 8 11
M  V30 12 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2-benzofuranmethanamine
C10H11NO
74377-46-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.5772 1.5400 0.0 0
M  V30 2 N 7.3472 2.8737 0.0 0
M  V30 3 C 8.8872 2.8737 0.0 0
M  V30 4 C 2.6673 2.3101 0.0 0
M  V30 5 C 2.6673 0.7700 0.0 0
M  V30 6 C 4.1321 2.7859 0.0 0
M  V30 7 C 1.3337 3.0801 0.0 0
M  V30 8 O 4.1321 0.2941 0.0 0
M  V30 9 C 1.3337 0.0000 0.0 0
M  V30 10 C 5.0371 1.5400 0.0 0
M  V30 11 C 0.0000 2.3101 0.0 0
M  V30 12 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 1 9 12
M  V30 13 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4265-16-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 74377-46-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-2415735
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004082586 A2 2004-09-30

$RFMT $RIREG SCHEME347 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Benzofurancarboxaldehyde
C9H6O2
4265-16-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.0811 3.9554 0.0 0
M  V30 2 O 7.4149 3.1854 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 2.3100 2.6673 0.0 0
M  V30 5 C 4.5865 1.6538 0.0 0
M  V30 6 C 2.3100 0.0000 0.0 0
M  V30 7 O 3.3406 3.8119 0.0 0
M  V30 8 C 0.7700 2.6673 0.0 0
M  V30 9 C 4.7474 3.1854 0.0 0
M  V30 10 C 0.7700 0.0000 0.0 0
M  V30 11 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 9
M  V30 11 1 8 11
M  V30 12 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2-benzofuranmethanamine
C10H11NO
74377-46-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.5772 1.5400 0.0 0
M  V30 2 N 7.3472 2.8737 0.0 0
M  V30 3 C 8.8872 2.8737 0.0 0
M  V30 4 C 2.6673 2.3101 0.0 0
M  V30 5 C 2.6673 0.7700 0.0 0
M  V30 6 C 4.1321 2.7859 0.0 0
M  V30 7 C 1.3337 3.0801 0.0 0
M  V30 8 O 4.1321 0.2941 0.0 0
M  V30 9 C 1.3337 0.0000 0.0 0
M  V30 10 C 5.0371 1.5400 0.0 0
M  V30 11 C 0.0000 2.3101 0.0 0
M  V30 12 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 1 9 12
M  V30 13 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4265-16-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 74377-46-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-15030433
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Preparation of
Methyl-(1-propyl-naphthalen-2-ylmethyl)amine A solution of 2.0 M
methylamine in methanol (20 mL) was added to
1-propylnaphthalene-2-carbaldehyde (0.983 g, 4.95 mmol) under N2 and
allowed to stir for 18 h. The solution was concentrated under reduced
pressure. Then the resulting dark yellow oil was solvated in EtOH (20 mL)
under N2. To the solution was added NaBH4 (0.187 g, 4.95 mmol) and the
mixture allowed to stir for 6.5 h. The reaction was concentrated under
reduced pressure, then solvated in 1 N NaOH (20 mL) and extracted with
Et2O (3 x 50 mL). The organics were combined, washed with brine (2 x 100
mL), dried over Na2SO4, filtered and concentrated to yield the title
compound as a yellow oil. Preparation of
Benzofuran-2-ylmethyl-methylamine According to the procedure of
Preparation 1, except substituting benzofuran-2-carbaldehyde for
1-propyl-naphthalene-2-carbaldehyde, the title compound (4.98 g, 92%) was
prepared as an orange oil. 1H NMR (300 MHz, DMSO-d6) δ 7.58-7.49 (m, 2H),
7.24- 7.19 (m, 2H), 6.70 (s, 1H), 3.77 (s, 2H), 2.17 (s, 3H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocyclic compounds as antibacterial agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd; Sampson, Peter; Pauls, Heinz W.; Ramnauth, Jailall;
Manning, David Douglas; Surman, Matthew David; Xie, Dejian; Decornez,
Helene Yvonne
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004052890 A1 2004-06-24

$RFMT $RIREG SCHEME348 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(1S)-1-[[(Diphenylmethyl)amino]carbonyl]-2-methylpropyl (1R,4S,5R)-5-(cyclohe...
C32H40N2O6
431070-11-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 44 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.6620 4.6145 0.0 0
M  V30 2 O 7.9958 5.3845 0.0 0
M  V30 3 O 6.6620 3.0745 0.0 0
M  V30 4 C 9.3295 4.6145 0.0 0 CFG=1
M  V30 5 C 10.6631 5.3845 0.0 0
M  V30 6 C 9.3295 3.0745 0.0 0
M  V30 7 N 11.9968 4.6145 0.0 0
M  V30 8 O 10.6631 6.9245 0.0 0
M  V30 9 C 10.6631 2.3045 0.0 0
M  V30 10 C 7.9958 2.3045 0.0 0
M  V30 11 C 13.3305 5.3845 0.0 0
M  V30 12 O 4.0009 3.0803 0.0 0
M  V30 13 O 6.6588 7.6972 0.0 0
M  V30 14 C 1.3222 7.6857 0.0 0
M  V30 15 C 3.9886 9.2331 0.0 0
M  V30 16 C 5.3284 5.3845 0.0 0 CFG=2
M  V30 17 C 4.0006 4.6203 0.0 0 CFG=2
M  V30 18 O 4.2288 6.5616 0.0 0
M  V30 19 C 5.3262 6.9252 0.0 0
M  V30 20 C 2.6657 5.3882 0.0 0
M  V30 21 C 2.6585 6.9201 0.0 0 CFG=2
M  V30 22 N 3.9914 7.6931 0.0 0
M  V30 23 C 2.6673 2.3102 0.0 0
M  V30 24 C 1.3335 3.0800 0.0 0
M  V30 25 C 2.6676 0.7702 0.0 0
M  V30 26 C 0.0000 2.3097 0.0 0
M  V30 27 C 1.3339 0.0000 0.0 0
M  V30 28 C 0.0002 0.7697 0.0 0
M  V30 29 C 14.6642 4.6145 0.0 0
M  V30 30 C 14.6642 3.0745 0.0 0
M  V30 31 C 15.9978 5.3845 0.0 0
M  V30 32 C 15.9978 2.3045 0.0 0
M  V30 33 C 17.3315 4.6145 0.0 0
M  V30 34 C 17.3315 3.0745 0.0 0
M  V30 35 C 13.3305 6.9245 0.0 0
M  V30 36 C 11.9968 7.6945 0.0 0
M  V30 37 C 14.6642 7.6945 0.0 0
M  V30 38 C 11.9968 9.2345 0.0 0
M  V30 39 C 14.6642 9.2345 0.0 0
M  V30 40 C 13.3305 10.0045 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6 CFG=3
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 6 9
M  V30 10 1 6 10
M  V30 11 1 7 11
M  V30 12 1 11 29
M  V30 13 1 11 35
M  V30 14 1 17 12 CFG=3
M  V30 15 1 12 23
M  V30 16 2 13 19
M  V30 17 1 14 21
M  V30 18 1 15 22
M  V30 19 1 16 17
M  V30 20 1 16 18 CFG=1
M  V30 21 1 16 19
M  V30 22 1 17 20
M  V30 23 1 21 18 CFG=1
M  V30 24 1 19 22
M  V30 25 1 20 21
M  V30 26 1 21 22
M  V30 27 1 23 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 1 27 28
M  V30 33 2 29 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 31 33
M  V30 37 2 32 34
M  V30 38 1 33 34
M  V30 39 2 35 36
M  V30 40 1 35 37
M  V30 41 1 36 38
M  V30 42 2 37 39
M  V30 43 2 38 40
M  V30 44 1 39 40
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 4 16 17 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(1R,4R,5R)-5-(Cyclohexyloxy)-N,1,2-trimethyl-3-oxo-7-oxa-2-azabicyclo[2.2.1]h...
C15H24N2O4
431070-27-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 5.3366 0.0 0
M  V30 2 N 0.7700 5.3366 0.0 0
M  V30 3 O 3.0800 6.6704 0.0 0
M  V30 4 C 0.0000 6.6704 0.0 0
M  V30 5 O 5.3817 5.3346 0.0 0
M  V30 6 O 0.7714 2.6651 0.0 0
M  V30 7 C 5.3988 0.0071 0.0 0
M  V30 8 C 2.3160 0.0000 0.0 0
M  V30 9 C 3.0800 4.0029 0.0 0 CFG=2
M  V30 10 C 4.6120 4.0008 0.0 0 CFG=2
M  V30 11 O 3.4436 2.4338 0.0 0
M  V30 12 C 2.3114 2.6676 0.0 0
M  V30 13 C 5.3841 2.6684 0.0 0
M  V30 14 C 4.6243 1.3381 0.0 0 CFG=2
M  V30 15 N 3.0835 1.3352 0.0 0
M  V30 16 C 6.9217 5.3349 0.0 0
M  V30 17 C 7.6915 6.6687 0.0 0
M  V30 18 C 7.6920 4.0012 0.0 0
M  V30 19 C 9.2315 6.6688 0.0 0
M  V30 20 C 9.2320 4.0015 0.0 0
M  V30 21 C 10.0017 5.3353 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 10 5 CFG=3
M  V30 6 1 5 16
M  V30 7 2 6 12
M  V30 8 1 7 14
M  V30 9 1 8 15
M  V30 10 1 9 10
M  V30 11 1 9 11 CFG=1
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 1 14 11 CFG=1
M  V30 15 1 12 15
M  V30 16 1 13 14
M  V30 17 1 14 15
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 9 10 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 431070-11-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 431070-27-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-15062571
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Cycloadduct (-)-36 (52 mg, 0.105 mmol) was
combined with methylamine (40% wt solution in water, 250 μL)in MeOH (1
mL) and sonicated at room temperature for 30 min until TLC indicated
completion of the reaction. Amide (-)-42 was recovered through silica gel
flash chromatography (50% EtOAc in hexanes).
(1R,4R,5R)-5-Cyclohexyloxy-1,2-dimethyl-3-oxo-7-oxa-2-aza-bicyclo[2.2.1]heptane-4-carboxylic
acid methylamide[(-)-43], yield 92% (32 mg, 0.109 mmol), colorless oil.
[α]23D = - 61.4° (c 2.8, CHCl3); 1H NMR (CDCl3, 300 MHz) δ 1.10-1.30 (m,
6H), 1.44-1.54 (m, 1H), 1.64 (s, 3H), 1.64 (dd, J = 2.5, 12.2 Hz, 1H),
1.64-1.84 (m, 3H), 2.28 (dd, J = 8.2, 12.2 Hz, 1H), 2.84 (s, 3H), 2.93
(d, J = 4.8 Hz, 3H), 3.22-3.33 (m, 1H), 4.54 (dd, J = 2.5,8.2 Hz, 1H),
8.10-8.22 (br m, 1H); 13C NMR (CDCl3, 75 MHz) δ 17.7, 23.9, 24.0, 25.1,
25.6, 26.0, 32.2, 32.3,41.7, 78.6, 79.0, 84.7, 95.1, 165.8, 170.6; FTIR
(CDCl3) 3325, 2933, 2856, 1717, 1683, 1558, 1406, 1159, 1127, 1080 cm-1;
LRMSFAB: 297.2 (M +H+); HRMSFAB calcd for C15H25N2O4 297.1814, found
297.1811.
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, ultrasound
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Modular Evolution of a Chiral Auxiliary for the 1,3-Dipolar Cycloaddition
of Isomuenchnones with Vinyl Ethers
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Savinov, Sergey N.; Austin, David J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2002), 4(9), 1415-1418

$RFMT $RIREG SCHEME349 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Trifluoromethyl)benzaldehyde
C8H5F3O
455-19-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 F 1.5400 0.0000 0.0 0
M  V30 3 F 0.0000 1.5400 0.0 0
M  V30 4 F 1.5400 3.0800 0.0 0
M  V30 5 C 7.7000 1.5400 0.0 0
M  V30 6 O 8.4700 2.8736 0.0 0
M  V30 7 C 3.0800 1.5400 0.0 0
M  V30 8 C 3.8500 2.8736 0.0 0
M  V30 9 C 3.8500 0.2064 0.0 0
M  V30 10 C 5.3900 2.8736 0.0 0
M  V30 11 C 5.3900 0.2064 0.0 0
M  V30 12 C 6.1600 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 7
M  V30 5 2 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C9H9DF3N
3040201-19-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 F 1.5400 3.0800 0.0 0
M  V30 3 F 0.0000 1.5400 0.0 0
M  V30 4 F 1.5400 0.0000 0.0 0
M  V30 5 C 7.7000 1.5400 0.0 0
M  V30 6 N 8.4700 2.8736 0.0 0
M  V30 7 C 10.0100 2.8736 0.0 0
M  V30 8 C 3.0800 1.5400 0.0 0
M  V30 9 C 3.8500 0.2064 0.0 0
M  V30 10 C 3.8500 2.8736 0.0 0
M  V30 11 C 5.3900 0.2064 0.0 0
M  V30 12 C 5.3900 2.8736 0.0 0
M  V30 13 C 6.1600 1.5400 0.0 0
M  V30 14 H 8.4700 0.2064 0.0 0 MASS=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 8
M  V30 5 1 5 6
M  V30 6 1 5 13
M  V30 7 1 5 14
M  V30 8 1 6 7
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 455-19-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3040201-19-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40490672
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 15681-89-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Selective Defluorination of Trifluoromethyl Substituents by
Conformationally Induced Remote Substitution
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jesani, Mehul H.; Schwarz, Maria; Kim, Shiwhu; Evans, Finlay L.; White,
Alexander; Browning, Alex; Abrams, Roman; Clayden, Jonathan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2024), 63(24), e202403477

$RFMT $RIREG SCHEME350 STEP1
$RXN



  6  1
$MOL
Glycine ethyl ester
C4H9NO2
459-73-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 O 4.0011 2.3100 0.0 0
M  V30 3 C 1.3338 2.3100 0.0 0
M  V30 4 O 2.6675 0.0000 0.0 0
M  V30 5 C 5.3348 1.5400 0.0 0
M  V30 6 N 0.0000 1.5400 0.0 0
M  V30 7 C 6.6686 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
p-Tolyl isothiocyanate
C8H7NS
622-59-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 3.0800 0.0 0
M  V30 2 C 6.6686 2.3100 0.0 0
M  V30 3 S 8.0022 1.5400 0.0 0
M  V30 4 C 0.0000 0.0000 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 2.6675 3.0800 0.0 0
M  V30 7 C 4.0011 0.7700 0.0 0
M  V30 8 C 1.3337 2.3100 0.0 0
M  V30 9 C 2.6675 0.0000 0.0 0
M  V30 10 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Hydroxy-1,2-benzenedicarboxaldehyde
C8H6O3
73289-89-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 2.3101 0.0 0
M  V30 2 O 6.6687 3.0801 0.0 0
M  V30 3 C 2.6675 0.7700 0.0 0
M  V30 4 O 1.3338 0.0000 0.0 0
M  V30 5 O 0.0000 2.3101 0.0 0
M  V30 6 C 4.0012 3.0801 0.0 0
M  V30 7 C 2.6675 2.3101 0.0 0
M  V30 8 C 4.0012 4.6201 0.0 0
M  V30 9 C 1.3338 3.0801 0.0 0
M  V30 10 C 2.6675 5.3901 0.0 0
M  V30 11 C 1.3338 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 2 3 4
M  V30 4 1 3 7
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methyl-1-buten-3-yne
C5H6
78-80-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 2.6673 2.3101 0.0 0
M  V30 3 C 0.0000 2.3101 0.0 0
M  V30 4 C 1.3337 0.0000 0.0 0
M  V30 5 C 4.0010 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 3 2 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2′,4′-Dihydroxyacetophenone
C8H8O3
89-84-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 C 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 O 2.3101 0.0000 0.0 0
M  V30 5 O 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
14-Hydroxy-2-(1-methylethenyl)-5-[1-(methylimino)ethyl]-7-[(4-methylphenyl)im...
C32H26N4O3
2754290-00-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 44 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 10.0147 7.7002 0.0 0
M  V30 2 C 8.6810 10.0102 0.0 0
M  V30 3 N 10.0147 10.7802 0.0 0
M  V30 4 O 3.9970 5.5344 0.0 0
M  V30 5 C 8.6810 2.3101 0.0 0
M  V30 6 N 8.6810 0.7700 0.0 0
M  V30 7 C 10.0147 3.0801 0.0 0
M  V30 8 C 10.0147 0.0000 0.0 0
M  V30 9 C 0.7700 3.8501 0.0 0
M  V30 10 C 0.0000 2.5164 0.0 0
M  V30 11 C 0.0000 5.1838 0.0 0
M  V30 12 C 15.3495 4.6201 0.0 0
M  V30 13 C 6.0135 6.9302 0.0 0
M  V30 14 C 6.0135 5.3901 0.0 0
M  V30 15 N 7.3473 7.7002 0.0 0
M  V30 16 C 4.6799 7.7002 0.0 0
M  V30 17 C 7.3473 4.6201 0.0 0
M  V30 18 C 4.6799 4.6201 0.0 0
M  V30 19 C 8.6810 6.9302 0.0 0
M  V30 20 C 7.3473 9.2402 0.0 0
M  V30 21 C 4.6799 9.2402 0.0 0
M  V30 22 C 3.3462 6.9302 0.0 0
M  V30 23 C 7.3473 3.0801 0.0 0
M  V30 24 O 8.6810 5.3901 0.0 0
M  V30 25 C 4.6799 3.0801 0.0 0
M  V30 26 O 3.2153 5.0960 0.0 0
M  V30 27 C 6.0135 10.0102 0.0 0
M  V30 28 C 3.3462 10.0102 0.0 0
M  V30 29 C 2.0125 7.7002 0.0 0
M  V30 30 C 6.0135 2.3101 0.0 0
M  V30 31 C 3.2153 2.6042 0.0 0
M  V30 32 C 2.3101 3.8501 0.0 0
M  V30 33 C 2.0125 9.2402 0.0 0
M  V30 34 C 11.3484 6.9302 0.0 0
M  V30 35 C 11.3484 5.3901 0.0 0
M  V30 36 C 12.6822 7.7002 0.0 0
M  V30 37 C 12.6822 4.6201 0.0 0
M  V30 38 C 14.0158 6.9302 0.0 0
M  V30 39 C 14.0158 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 19 CFG=2
M  V30 2 1 1 34
M  V30 3 3 2 3
M  V30 4 1 2 20
M  V30 5 1 4 22
M  V30 6 2 5 6 CFG=2
M  V30 7 1 5 7
M  V30 8 1 5 23
M  V30 9 1 6 8
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 9 32
M  V30 13 1 12 39
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 13 16
M  V30 17 2 14 17
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 1 15 20
M  V30 21 1 16 21
M  V30 22 2 16 22
M  V30 23 1 17 23
M  V30 24 1 17 24
M  V30 25 2 18 25
M  V30 26 1 18 26
M  V30 27 1 19 24
M  V30 28 2 20 27
M  V30 29 1 21 27
M  V30 30 2 21 28
M  V30 31 1 22 29
M  V30 32 2 23 30
M  V30 33 1 25 30
M  V30 34 1 25 31
M  V30 35 1 26 32
M  V30 36 1 28 33
M  V30 37 2 29 33
M  V30 38 2 31 32
M  V30 39 2 34 35
M  V30 40 1 34 36
M  V30 41 1 35 37
M  V30 42 2 36 38
M  V30 43 2 37 39
M  V30 44 1 38 39
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 459-73-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 622-59-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 73289-89-1
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 78-80-8
$DTYPE RXN:RCT(5):CAS_RN
$DATUM 89-84-9
$DTYPE RXN:RCT(6):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2754290-00-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24903603
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-50-8
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 7789-23-3
$DTYPE RXN:VAR(1):CAT(3):CAS_RN
$DATUM 12173-10-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-catalyst, solid-supported catalyst, catalyst can be
recycled and reused, catalyst prepared and used, MWCNTs nanocomposite
support used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Biosynthesis of Cu/KF/Clinoptilolite@MWCNTs nanocomposite and its
application as a recyclable nanocatalyst for the synthesis of new Schiff
base of benzoxazine derivatives and reduction of organic pollutants
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hamedani, Naghmeh Faal; Hargalani, Fariba Zamani; Rostami-Charati,
Faramarz
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molecular Diversity (2022), 26(4), 2069-2083

$RFMT $RIREG SCHEME351 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 6-(4-iodophenyl)-1-(4-methoxyphenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazo...
C22H20IN3O4
473927-64-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 9.8046 6.8666 0.0 0
M  V30 2 C 4.0738 10.2442 0.0 0
M  V30 3 O 2.6091 9.7684 0.0 0
M  V30 4 O 4.3939 11.7505 0.0 0
M  V30 5 C 1.4647 10.7988 0.0 0
M  V30 6 C 0.0000 10.3229 0.0 0
M  V30 7 O 7.7448 1.0304 0.0 0
M  V30 8 C 6.6003 0.0000 0.0 0
M  V30 9 I 15.9646 9.5340 0.0 0
M  V30 10 C 7.4946 8.2002 0.0 0
M  V30 11 N 6.4640 7.0558 0.0 0
M  V30 12 C 6.7246 9.5340 0.0 0
M  V30 13 C 9.0346 8.2002 0.0 0
M  V30 14 N 5.0572 7.6821 0.0 0
M  V30 15 C 5.2181 9.2138 0.0 0
M  V30 16 C 7.4946 10.8676 0.0 0
M  V30 17 N 9.8046 9.5340 0.0 0
M  V30 18 C 9.0346 10.8676 0.0 0
M  V30 19 C 6.7843 5.5494 0.0 0
M  V30 20 C 5.6398 4.5190 0.0 0
M  V30 21 C 8.2489 5.0735 0.0 0
M  V30 22 C 5.9600 3.0127 0.0 0
M  V30 23 C 8.5690 3.5673 0.0 0
M  V30 24 C 7.4246 2.5367 0.0 0
M  V30 25 C 11.3446 9.5340 0.0 0
M  V30 26 C 12.1146 8.2002 0.0 0
M  V30 27 C 12.1146 10.8676 0.0 0
M  V30 28 C 13.6546 8.2002 0.0 0
M  V30 29 C 13.6546 10.8676 0.0 0
M  V30 30 C 14.4246 9.5340 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 13
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 15
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 1 7 24
M  V30 9 1 9 30
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 13
M  V30 13 1 11 14
M  V30 14 1 11 19
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 2 14 15
M  V30 19 1 16 18
M  V30 20 1 17 18
M  V30 21 1 17 25
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,5,6,7-Tetrahydro-6-(4-iodophenyl)-1-(4-methoxyphenyl)-N-methyl-7-oxo-1H-pyr...
C21H19IN4O3
959426-36-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.3397 6.8666 0.0 0
M  V30 2 C 2.6091 10.2442 0.0 0
M  V30 3 N 1.1444 9.7684 0.0 0
M  V30 4 O 2.9292 11.7505 0.0 0
M  V30 5 C 0.0000 10.7988 0.0 0
M  V30 6 O 6.2801 1.0304 0.0 0
M  V30 7 C 5.1356 0.0000 0.0 0
M  V30 8 I 14.4997 9.5340 0.0 0
M  V30 9 C 6.0297 8.2002 0.0 0
M  V30 10 N 4.9993 7.0558 0.0 0
M  V30 11 C 5.2597 9.5340 0.0 0
M  V30 12 C 7.5697 8.2002 0.0 0
M  V30 13 N 3.5925 7.6821 0.0 0
M  V30 14 C 3.7534 9.2138 0.0 0
M  V30 15 C 6.0297 10.8676 0.0 0
M  V30 16 N 8.3397 9.5340 0.0 0
M  V30 17 C 7.5697 10.8676 0.0 0
M  V30 18 C 5.3195 5.5494 0.0 0
M  V30 19 C 6.7842 5.0735 0.0 0
M  V30 20 C 4.1751 4.5190 0.0 0
M  V30 21 C 7.1043 3.5673 0.0 0
M  V30 22 C 4.4953 3.0127 0.0 0
M  V30 23 C 5.9600 2.5367 0.0 0
M  V30 24 C 9.8797 9.5340 0.0 0
M  V30 25 C 10.6497 10.8676 0.0 0
M  V30 26 C 10.6497 8.2002 0.0 0
M  V30 27 C 12.1897 10.8676 0.0 0
M  V30 28 C 12.1897 8.2002 0.0 0
M  V30 29 C 12.9597 9.5340 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 12
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 14
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 23
M  V30 8 1 8 29
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 1 10 18
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 2 13 14
M  V30 18 1 15 17
M  V30 19 1 16 17
M  V30 20 1 16 24
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 473927-64-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 959426-36-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-14574312
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 75-24-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Preparation of
6-(4-Iodophenyl)-1-(4-methoxyphenyl)-N-methyl-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide
(14b). To a cold (0 °C) solution of methylamine (2 M in THF, 0.64 mL,
1.29 mmol) in CH2Cl2 (10 mL) was added trimethylaluminum (2 M in toluene,
0.64 mL, 1.29 mmol), and the reaction mixture was stirred cold for 0.25
h. To this solution was added compound 9b (0.16 g, 0.32 mmol), and the
reaction mixture was gradually allowed to warm to room temperature and
stirred at this temperature for 72 h. The reaction was quenched with HCl
(1 N, 50 mL), and the mixture was extracted with CH2Cl2 (2 × 50 mL),
washed with brine (50 mL), and dried (Na2SO4). Filtration followed by
purification via silica gel column chromatography (EtOAc/hexanes, 1:4)
afforded compound 14b (53 mg, 92%). 1H NMR (CDCl3) δ : 7.66 (d, J = 8.59
Hz, 2H), 7.45 (d, J = 8.84 Hz, 2H), 7.08 (d, J = 8.59 Hz, 2H), 6.95 (d, J
= 8.84 Hz, 2H), 4.09 (t, J = 6.60 Hz, 2H), 3.82 (s, 3H), 3.40 (t, J =
6.60 Hz, 2H) ppm. ESIMS m/z 518.0 (M + H)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of
1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxo-1-piperidinyl]phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide
(Apixaban, BMS-562247), a Highly Potent, Selective, Efficacious, and
Orally Bioavailable Inhibitor of Blood Coagulation Factor Xa
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pinto, Donald J. P.; Orwat, Michael J.; Koch, Stephanie; Rossi, Karen A.;
Alexander, Richard S.; Smallwood, Angela; Wong, Pancras C.; Rendina, Alan
R.; Luettgen, Joseph M.; Knabb, Robert M.; He, Kan; Xin, Baomin; Wexler,
Ruth R.; Lam, Patrick Y. S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2007), 50(22), 5339-5356

$RFMT $RIREG SCHEME352 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 6-(2-methoxyphenoxy)-1,3-benzodioxole-5-acetate
C17H16O6
476691-09-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6201 6.3710 0.0 0
M  V30 2 C 7.7002 6.3710 0.0 0
M  V30 3 C 9.2402 6.3710 0.0 0
M  V30 4 O 10.0102 7.7046 0.0 0
M  V30 5 O 10.0102 5.0373 0.0 0
M  V30 6 C 11.5503 7.7046 0.0 0
M  V30 7 O 3.0801 9.0385 0.0 0
M  V30 8 C 2.3101 10.3721 0.0 0
M  V30 9 C 5.3901 5.0373 0.0 0
M  V30 10 C 6.9302 5.0373 0.0 0
M  V30 11 C 4.6201 3.7036 0.0 0
M  V30 12 C 7.7002 3.7036 0.0 0
M  V30 13 C 5.3901 2.3698 0.0 0
M  V30 14 C 6.9302 2.3698 0.0 0
M  V30 15 O 4.9142 0.9052 0.0 0
M  V30 16 O 7.4060 0.9052 0.0 0
M  V30 17 C 6.1601 0.0000 0.0 0
M  V30 18 C 3.0801 6.3710 0.0 0
M  V30 19 C 2.3101 7.7046 0.0 0
M  V30 20 C 2.3101 5.0373 0.0 0
M  V30 21 C 0.7700 7.7046 0.0 0
M  V30 22 C 0.7700 5.0373 0.0 0
M  V30 23 C 0.0000 6.3710 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 1 2 10
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 1 4 6
M  V30 8 1 7 8
M  V30 9 1 7 19
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-(2-Methoxyphenoxy)-N-methyl-1,3-benzodioxole-5-acetamide
C17H17NO5
476691-11-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6201 6.3710 0.0 0
M  V30 2 C 7.7002 6.3710 0.0 0
M  V30 3 C 9.2402 6.3710 0.0 0
M  V30 4 N 10.0102 7.7046 0.0 0
M  V30 5 O 10.0102 5.0373 0.0 0
M  V30 6 C 11.5503 7.7046 0.0 0
M  V30 7 O 3.0801 9.0385 0.0 0
M  V30 8 C 2.3101 10.3721 0.0 0
M  V30 9 C 5.3901 5.0373 0.0 0
M  V30 10 C 6.9302 5.0373 0.0 0
M  V30 11 C 4.6201 3.7036 0.0 0
M  V30 12 C 7.7002 3.7036 0.0 0
M  V30 13 C 5.3901 2.3698 0.0 0
M  V30 14 C 6.9302 2.3698 0.0 0
M  V30 15 O 4.9142 0.9052 0.0 0
M  V30 16 O 7.4060 0.9052 0.0 0
M  V30 17 C 6.1601 0.0000 0.0 0
M  V30 18 C 3.0801 6.3710 0.0 0
M  V30 19 C 2.3101 7.7046 0.0 0
M  V30 20 C 2.3101 5.0373 0.0 0
M  V30 21 C 0.7700 7.7046 0.0 0
M  V30 22 C 0.7700 5.0373 0.0 0
M  V30 23 C 0.0000 6.3710 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 1 2 10
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 1 4 6
M  V30 8 1 7 8
M  V30 9 1 7 19
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 476691-09-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 476691-11-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-11361888
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 143-33-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of 3,4-dioxocularine and aristocularine alkaloids in a
convergent route from aryloxyphenyl acetamides involving oxalyl
chloride-Lewis acid
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Suau, Rafael; Rico, Rodrigo; Lopez-Romero, Juan Manuel; Najera,
Francisco; Ruiz, Antonio; Ortiz-Lopez, Francisco Javier
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ARKIVOC (Gainesville, FL, United States) [online computer file] (2002),
(5), 62-72

$RFMT $RIREG SCHEME353 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Chloromethyl)-2-phenylthiazole
C10H8ClNS
4771-31-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.2359 3.0089 0.0 0
M  V30 2 Cl 9.6427 2.3826 0.0 0
M  V30 3 C 4.6201 1.3337 0.0 0
M  V30 4 N 5.5253 2.5795 0.0 0
M  V30 5 S 5.5253 0.0878 0.0 0
M  V30 6 C 6.9898 2.1037 0.0 0
M  V30 7 C 6.9898 0.5636 0.0 0
M  V30 8 C 3.0800 1.3337 0.0 0
M  V30 9 C 2.3100 0.0000 0.0 0
M  V30 10 C 2.3100 2.6673 0.0 0
M  V30 11 C 0.7700 0.0000 0.0 0
M  V30 12 C 0.7700 2.6673 0.0 0
M  V30 13 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 8
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 6 7
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2-phenyl-4-thiazolemethanamine
C11H12N2S
921101-66-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.2357 3.0089 0.0 0
M  V30 2 N 9.6426 2.3824 0.0 0
M  V30 3 C 10.8885 3.2876 0.0 0
M  V30 4 C 4.6200 1.3336 0.0 0
M  V30 5 N 5.5252 2.5795 0.0 0
M  V30 6 S 5.5252 0.0878 0.0 0
M  V30 7 C 6.9898 2.1037 0.0 0
M  V30 8 C 6.9898 0.5636 0.0 0
M  V30 9 C 3.0800 1.3336 0.0 0
M  V30 10 C 2.3100 2.6673 0.0 0
M  V30 11 C 2.3100 0.0000 0.0 0
M  V30 12 C 0.7700 2.6673 0.0 0
M  V30 13 C 0.7700 0.0000 0.0 0
M  V30 14 C 0.0000 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 9
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 8
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4771-31-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 921101-66-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24398641
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structural and Activity Relationships of
6-Sulfonyl-8-Nitrobenzothiazinones as Antitubercular Agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fan, Dongguang; Wang, Bin; Stelitano, Giovanni; Savkova, Karin; Shi, Rui;
Huszar, Stanislav; Han, Quanquan; Mikusova, Katarina; Chiarelli, Laurent
R.; Lu, Yu; Qiao, Chunhua
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2021), 64(19), 14526-14539

$RFMT $RIREG SCHEME354 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[3-Methoxy-4-(5-oxazolyl)phenyl]-N′-(3-methylphenyl)thiourea
C18H17N3O2S
500903-14-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.4374 4.9318 0.0 0
M  V30 2 C 2.4374 6.4718 0.0 0
M  V30 3 N 7.7722 4.9318 0.0 0
M  V30 4 C 9.1059 4.1618 0.0 0
M  V30 5 N 10.4397 4.9318 0.0 0
M  V30 6 S 9.1059 2.6217 0.0 0
M  V30 7 C 15.7745 4.9318 0.0 0
M  V30 8 C 3.7711 2.6217 0.0 0
M  V30 9 C 3.7711 4.1618 0.0 0
M  V30 10 C 5.1049 1.8517 0.0 0
M  V30 11 C 5.1049 4.9318 0.0 0
M  V30 12 C 6.4386 2.6217 0.0 0
M  V30 13 C 6.4386 4.1618 0.0 0
M  V30 14 C 2.4374 1.8517 0.0 0
M  V30 15 C 2.2765 0.3202 0.0 0
M  V30 16 O 1.0306 2.4782 0.0 0
M  V30 17 N 0.7700 0.0000 0.0 0
M  V30 18 C 0.0000 1.3337 0.0 0
M  V30 19 C 11.7734 4.1618 0.0 0
M  V30 20 C 13.1070 4.9318 0.0 0
M  V30 21 C 11.7734 2.6217 0.0 0
M  V30 22 C 14.4407 4.1618 0.0 0
M  V30 23 C 13.1070 1.8517 0.0 0
M  V30 24 C 14.4407 2.6217 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 1 3 13
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 19
M  V30 8 1 7 22
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 8 14
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[3-Methoxy-4-(5-oxazolyl)phenyl]-N′-methyl-N′′-(3-methylphenyl)guanidine
C19H20N4O2
500902-90-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.9098 6.6685 0.0 0
M  V30 2 C 4.6798 8.0022 0.0 0
M  V30 3 N 8.5298 4.0011 0.0 0
M  V30 4 C 9.2998 2.6674 0.0 0
M  V30 5 N 10.8398 2.6674 0.0 0
M  V30 6 N 8.5298 1.3336 0.0 0
M  V30 7 C 9.2998 0.0000 0.0 0
M  V30 8 C 15.4598 5.3347 0.0 0
M  V30 9 C 3.9098 4.0011 0.0 0
M  V30 10 C 4.6798 5.3347 0.0 0
M  V30 11 C 4.6798 2.6674 0.0 0
M  V30 12 C 6.2198 5.3347 0.0 0
M  V30 13 C 6.2198 2.6674 0.0 0
M  V30 14 C 6.9898 4.0011 0.0 0
M  V30 15 C 2.3698 4.0011 0.0 0
M  V30 16 C 1.4645 5.2470 0.0 0
M  V30 17 O 1.4645 2.7552 0.0 0
M  V30 18 N 0.0000 4.7711 0.0 0
M  V30 19 C 0.0000 3.2311 0.0 0
M  V30 20 C 11.6098 4.0011 0.0 0
M  V30 21 C 13.1498 4.0011 0.0 0
M  V30 22 C 10.8398 5.3347 0.0 0
M  V30 23 C 13.9198 5.3347 0.0 0
M  V30 24 C 11.6098 6.6685 0.0 0
M  V30 25 C 13.1498 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 2 3 4 CFG=2
M  V30 4 1 3 14
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 5 20
M  V30 8 1 6 7
M  V30 9 1 8 23
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 9 15
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 500903-14-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 500902-90-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-1163714
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 538-75-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel guanidine-based inhibitors of inosine monophosphate dehydrogenase
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Iwanowicz, Edwin J.; Watterson, Scott H.; Liu, Chunjian; Gu, Henry H.;
Mitt, Toomas; Leftheris, Katerina; Barrish, Joel C.; Fleener, Catherine
A.; Rouleau, Katherine; Sherbina, N. Z.; Hollenbaugh, Diane L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2002), 12(20), 2931-2934

$RFMT $RIREG SCHEME355 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4,6-Trichloro-5-pyrimidinecarboxaldehyde
C5HCl3N2O
50270-27-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6674 0.0 0
M  V30 2 O 0.0000 4.0011 0.0 0
M  V30 3 Cl 2.3100 5.3349 0.0 0
M  V30 4 Cl 2.3100 0.0000 0.0 0
M  V30 5 Cl 6.9300 2.6674 0.0 0
M  V30 6 C 2.3100 2.6674 0.0 0
M  V30 7 C 3.0800 4.0011 0.0 0
M  V30 8 C 3.0800 1.3338 0.0 0
M  V30 9 N 4.6200 4.0011 0.0 0
M  V30 10 N 4.6200 1.3338 0.0 0
M  V30 11 C 5.3900 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 1 3 7
M  V30 4 1 4 8
M  V30 5 1 5 11
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Dichloro-6-(methylamino)-5-pyrimidinecarboxaldehyde
C6H5Cl2N3O
1007197-30-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 C 0.7700 4.0011 0.0 0
M  V30 4 O 0.0000 5.3348 0.0 0
M  V30 5 Cl 2.3100 6.6686 0.0 0
M  V30 6 Cl 6.9301 4.0011 0.0 0
M  V30 7 C 3.0800 2.6675 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 N 4.6201 2.6675 0.0 0
M  V30 10 C 3.0800 5.3348 0.0 0
M  V30 11 C 5.3901 4.0011 0.0 0
M  V30 12 N 4.6201 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 1 3 8
M  V30 5 1 5 10
M  V30 6 1 6 11
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 50270-27-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1007197-30-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-1596957
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 298-14-6
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 311-28-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 2,4-Dichloro-6-(methylamino)pyrimidine-5-carbaldehyde (16) : A mixture of
2,4,6-trichloropyrimidine-5-carbaldehyde (8) (0.52 g, 2.5 mmol), KHCO3
(0.30 g, 3.0 mmol), tetrabutylammonium iodide (46 mg, 0.13 mmol) and
methylamine (0.21 mL, 40 wt % solution in water, 2.5 mmol) in toluene/H2O
(15 mL/15 mL) was stirred at rt for 22 h. The organic layer was then
separated and the aqueous layer was extracted with EtOAc. The combined
organic extracts were washed with brine, dried over anhydrous Na2SO4,
filtered and concentrated in vacuo. The residue was purified by flash
column chromatography on silica gel (5% EtOAc/hexane) to provide 16,
yield 465 mg, 92% as a white solid. Rf = 0.49 (SiO2, 30% EtOAc/hexane).
Mp = 231-232 °C. 1H-NMR (300 MHz, CDCl3)δ (ppm): 10.29 (C5H, s, 1H), 9.25
(NHC6, s, br, 1H), 3.12 (C6H, d, 3J = 5.1 Hz, 3H) . 13C-NMR (75 MHz,
CDCl3) δ (ppm): 190.2 (C5), 165.6 (C2), 162.4 (C1), 161.9 (C4), 106.5
(C3), 28.0 (C6). C6H5Cl2N3O EI-MS: Expected mass for M+/z :
204.98/206.98, Observed: 205/207/209 (M+, 100%), 177/179 ([M-CO]+, 80%).
CI-MS: Expected mass for [M+H+]/z: 205.99/207.99, Observed: 206/208
([M+H+], 100%/64%).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A Regioselective Approach to Trisubstituted 2(or
6)-Arylaminopyrimidine-5-carbaldehydes and Their Application in the
Synthesis of Structurally and Electronically Unique G-C Base Precursors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Beingessner, Rachel L.; Deng, Bo-Liang; Fanwick, Phillip E.; Fenniri,
Hicham
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2008), 73(3), 931-939

$RFMT $RIREG SCHEME356 STEP1
$RXN



  2  1
$MOL
6-Chloro-3-pyridazinecarboxylic acid
C5H3ClN2O2
5096-73-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 Cl 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 N 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 N 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-N-methyl-3-pyridazinecarboxamide
C6H6ClN3O
202135-65-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 N 1.5400 2.6673 0.0 0
M  V30 3 O 1.5400 0.0000 0.0 0
M  V30 4 C 0.0000 2.6673 0.0 0
M  V30 5 Cl 8.4702 1.3337 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 N 4.6201 0.0000 0.0 0
M  V30 9 C 6.1601 2.6673 0.0 0
M  V30 10 N 6.1601 0.0000 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 5096-73-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 202135-65-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34334176
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM SOCl2 also acts as a solvent in stage 1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of
5-{4-[(7-Ethyl-6-oxo-5,6-dihydro-1,5-naphthyridin-3-yl)methyl]piperazin-1-yl}-N-methylpyridine-2-carboxamide
(AZD5305): A PARP1-DNA Trapper with High Selectivity for PARP1 over PARP2
and Other PARPs
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Johannes, Jeffrey W.; Balazs, Amber; Barratt, Derek; Bista, Michal;
Chuba, Matthew D.; Cosulich, Sabina; Critchlow, Susan E.; Degorce,
Sebastien L.; Di Fruscia, Paolo; Edmondson, Scott D.; Embrey, Kevin;
Fawell, Stephen; Ghosh, Avipsa; Gill, Sonja J.; Gunnarsson, Anders;
Hande, Sudhir M.; Heightman, Tom D.; Hemsley, Paul; Illuzzi, Giuditta;
Lane, Jordan; Larner, Carrie; Leo, Elisabetta; Liu, Lina; Madin, Andrew;
Martin, Scott; McWilliams, Lisa; O'Connor, Mark J.; Orme, Jonathan P.;
Pachl, Fiona; Packer, Martin J.; Pei, Xiaohui; Pike, Andrew; Schimpl,
Marianne; She, Hongyao; Staniszewska, Anna D.; Talbot, Verity; Underwood,
Elizabeth; Varnes, Jeffrey G.; Xue, Lin; Yao, Tieguang; Zhang, Ke; Zhang,
Andrew X.; Zheng, Xiaolan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2021), 64(19), 14498-14512

$RFMT $RIREG SCHEME357 STEP1
$RXN



  3  1
$MOL
Methylmalonic acid
C4H6O4
516-05-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 1.5400 0.0 0
M  V30 2 C 4.0011 2.3100 0.0 0
M  V30 3 C 1.3338 2.3100 0.0 0
M  V30 4 C 2.6674 0.0000 0.0 0
M  V30 5 O 4.0011 3.8500 0.0 0
M  V30 6 O 5.3349 1.5400 0.0 0
M  V30 7 O 0.0000 1.5400 0.0 0
M  V30 8 O 1.3338 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Nitrobenzaldehyde
C7H5NO3
555-16-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 C 6.6687 4.6201 0.0 0
M  V30 5 O 8.0023 3.8501 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 1.5400 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 2 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2E)-N,2-Dimethyl-3-(4-nitrophenyl)-2-propenamide
C11H12N2O3
1598408-72-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 4.6201 0.0 0
M  V30 2 C 8.0021 3.8500 0.0 0
M  V30 3 C 9.3359 4.6201 0.0 0
M  V30 4 C 8.0021 2.3100 0.0 0
M  V30 5 N 10.6695 3.8500 0.0 0
M  V30 6 O 9.3359 6.1601 0.0 0
M  V30 7 C 12.0032 4.6201 0.0 0
M  V30 8 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 9 O 0.0000 2.3100 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 5.3348 3.8500 0.0 0
M  V30 12 C 4.0011 4.6201 0.0 0
M  V30 13 C 5.3348 2.3100 0.0 0
M  V30 14 C 2.6673 3.8500 0.0 0
M  V30 15 C 4.0011 1.5400 0.0 0
M  V30 16 C 2.6673 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 2 8 9
M  V30 9 2 8 10
M  V30 10 1 8 16
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 516-05-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 555-16-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1598408-72-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-333-CAS-4310341
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 110-89-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 110-86-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, Knoevenagel condensation (stage 1)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and evaluation of novel diaryl urea derivatives as
potential antitumor agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lu, Chenshu; Tang, Ke; Li, Yan; Li, Peng; Lin, Ziyun; Yin, Dali; Chen,
Xiaoguang; Huang, Haihong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2014), 77351-360

$RFMT $RIREG SCHEME358 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Propanediol, 1-phenyl-, 3-(4-methylbenzenesulfonate)
C16H18O4S
51699-49-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 7.7001 6.6686 0.0 0 VAL=6
M  V30 2 O 6.9301 5.3348 0.0 0
M  V30 3 O 8.4701 8.0022 0.0 0
M  V30 4 O 6.3664 7.4386 0.0 0
M  V30 5 C 5.3901 5.3348 0.0 0
M  V30 6 C 4.6201 4.0011 0.0 0
M  V30 7 C 3.0800 4.0011 0.0 0
M  V30 8 O 2.3100 5.3348 0.0 0
M  V30 9 C 13.0350 3.5885 0.0 0
M  V30 10 C 9.0339 5.8986 0.0 0
M  V30 11 C 10.3675 6.6686 0.0 0
M  V30 12 C 9.0339 4.3586 0.0 0
M  V30 13 C 11.7012 5.8986 0.0 0
M  V30 14 C 10.3675 3.5885 0.0 0
M  V30 15 C 11.7012 4.3586 0.0 0
M  V30 16 C 2.3100 2.6675 0.0 0
M  V30 17 C 0.7700 2.6675 0.0 0
M  V30 18 C 3.0800 1.3337 0.0 0
M  V30 19 C 0.0000 1.3337 0.0 0
M  V30 20 C 2.3100 0.0000 0.0 0
M  V30 21 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 10
M  V30 5 1 2 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 7 16
M  V30 10 1 9 15
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(Methylamino)-1-phenyl-1-propanol
C10H15NO
42142-52-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 5.3348 2.3100 0.0 0
M  V30 3 O 4.0011 0.0000 0.0 0
M  V30 4 C 6.6684 1.5400 0.0 0
M  V30 5 N 8.0022 2.3100 0.0 0
M  V30 6 C 9.3359 1.5400 0.0 0
M  V30 7 C 2.6675 2.3100 0.0 0
M  V30 8 C 1.3337 1.5400 0.0 0
M  V30 9 C 2.6675 3.8500 0.0 0
M  V30 10 C 0.0000 2.3100 0.0 0
M  V30 11 C 1.3337 4.6201 0.0 0
M  V30 12 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 51699-49-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 42142-52-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-4523821
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Remote Hydroxylation through Radical Translocation and Polar Crossover
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hollister, Kyle A.; Conner, Elizabeth S.; Spell, Mark L.; Deveaux,
Kristina; Maneval, Lea; Beal, Michael W.; Ragains, Justin R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2015), 54(27), 7837-7841

$RFMT $RIREG SCHEME359 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Ethyl-1,4-dihydro-7-methyl-4-oxo-1,8-naphthyridine-3-carbonyl chloride
C12H11ClN2O2
52377-28-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 0.7700 0.0 0
M  V30 2 C 2.6675 0.0000 0.0 0
M  V30 3 O 4.0011 6.9301 0.0 0
M  V30 4 C 9.3359 2.3100 0.0 0
M  V30 5 C 1.3337 5.3901 0.0 0
M  V30 6 Cl 0.0000 4.6201 0.0 0
M  V30 7 O 1.3337 6.9301 0.0 0
M  V30 8 C 5.3348 3.0800 0.0 0
M  V30 9 C 5.3348 4.6201 0.0 0
M  V30 10 N 4.0011 2.3100 0.0 0
M  V30 11 N 6.6684 2.3100 0.0 0
M  V30 12 C 4.0011 5.3901 0.0 0
M  V30 13 C 6.6684 5.3901 0.0 0
M  V30 14 C 2.6675 3.0800 0.0 0
M  V30 15 C 8.0022 3.0800 0.0 0
M  V30 16 C 2.6675 4.6201 0.0 0
M  V30 17 C 8.0022 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 2 3 12
M  V30 4 1 4 15
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 16
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Ethyl-1,4-dihydro-N,7-dimethyl-4-oxo-1,8-naphthyridine-3-carboxamide
C13H15N3O2
732986-89-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 1.3338 0.0 0
M  V30 2 C 4.6200 0.0000 0.0 0
M  V30 3 O 6.9300 6.6685 0.0 0
M  V30 4 C 0.0000 5.3347 0.0 0
M  V30 5 C 8.4700 4.0011 0.0 0
M  V30 6 N 9.2400 2.6674 0.0 0
M  V30 7 O 9.2400 5.3347 0.0 0
M  V30 8 C 10.7800 2.6674 0.0 0
M  V30 9 C 3.8500 4.0011 0.0 0
M  V30 10 C 4.6200 5.3347 0.0 0
M  V30 11 N 4.6200 2.6674 0.0 0
M  V30 12 N 2.3100 4.0011 0.0 0
M  V30 13 C 6.1600 5.3347 0.0 0
M  V30 14 C 3.8500 6.6685 0.0 0
M  V30 15 C 6.1600 2.6674 0.0 0
M  V30 16 C 1.5400 5.3347 0.0 0
M  V30 17 C 6.9300 4.0011 0.0 0
M  V30 18 C 2.3100 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 2 3 13
M  V30 4 1 4 16
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 17
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 2 9 12
M  V30 12 1 10 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 52377-28-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 732986-89-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-16443385
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, mt-QSAR studies for predication of antimicrobial activity of
schiff bases, carbohydrazide and anilides/amides derivatives of nalidixic
acid
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Monika; Sucheta; Ruchita; Jain, Shilpa; Paliwal, Meenu; Himanshu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM International Journal of Pharma and Bio Sciences (2015), 6(4), 591-627

$RFMT $RIREG SCHEME360 STEP1
$RXN



  3  1
$MOL
Benzoyl chloride
C7H5ClO
98-88-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 Cl 0.0000 2.6673 0.0 0
M  V30 3 O 0.0000 0.0000 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 0.0000 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 4.6201 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N4-(4-Aminophenyl)-N4,2-dimethylpyrazolo[1,5-a]-1,3,5-triazine-4,8-diamine
C13H15N7
527704-23-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6519 4.6201 0.0 0
M  V30 2 C 6.6519 6.1601 0.0 0
M  V30 3 N 0.0000 4.5603 0.0 0
M  V30 4 C 3.9845 0.0000 0.0 0
M  V30 5 N 11.9867 1.5400 0.0 0
M  V30 6 N 3.9845 4.6201 0.0 0
M  V30 7 C 5.3182 3.8501 0.0 0
M  V30 8 C 2.6509 3.8501 0.0 0
M  V30 9 N 3.6644 6.1264 0.0 0
M  V30 10 N 5.3182 2.3101 0.0 0
M  V30 11 C 1.5063 4.8805 0.0 0
M  V30 12 N 2.6509 2.3101 0.0 0
M  V30 13 C 2.1326 6.2873 0.0 0
M  V30 14 C 3.9845 1.5400 0.0 0
M  V30 15 C 7.9857 3.8501 0.0 0
M  V30 16 C 7.9857 2.3101 0.0 0
M  V30 17 C 9.3194 4.6201 0.0 0
M  V30 18 C 9.3194 1.5400 0.0 0
M  V30 19 C 10.6530 3.8501 0.0 0
M  V30 20 C 10.6530 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 1 15
M  V30 4 1 3 11
M  V30 5 1 4 14
M  V30 6 1 5 20
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 2 7 10
M  V30 11 2 8 11
M  V30 12 1 8 12
M  V30 13 2 9 13
M  V30 14 1 10 14
M  V30 15 1 11 13
M  V30 16 2 12 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[2-Methyl-4-(methylamino)pyrazolo[1,5-a]-1,3,5-triazin-8-yl]benzamide
C14H14N6O
527704-40-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 3.1059 0.0 0
M  V30 2 C 4.0012 3.8760 0.0 0
M  V30 3 O 4.0012 5.4160 0.0 0
M  V30 4 N 11.6428 5.2182 0.0 0
M  V30 5 C 13.1491 4.8981 0.0 0
M  V30 6 C 10.5335 0.0000 0.0 0
M  V30 7 C 8.0755 3.2495 0.0 0
M  V30 8 N 9.1059 4.3940 0.0 0
M  V30 9 C 6.6685 3.8760 0.0 0
M  V30 10 N 8.5513 1.7849 0.0 0
M  V30 11 C 10.6122 4.0739 0.0 0
M  V30 12 N 8.3359 5.7277 0.0 0
M  V30 13 C 6.8294 5.4075 0.0 0
M  V30 14 C 10.0577 1.4647 0.0 0
M  V30 15 N 11.0882 2.6091 0.0 0
M  V30 16 C 2.6673 3.1059 0.0 0
M  V30 17 C 1.3337 3.8760 0.0 0
M  V30 18 C 2.6673 1.5659 0.0 0
M  V30 19 C 0.0000 3.1059 0.0 0
M  V30 20 C 1.3337 0.7959 0.0 0
M  V30 21 C 0.0000 1.5659 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 2 2 3
M  V30 4 1 2 16
M  V30 5 1 4 5
M  V30 6 1 4 11
M  V30 7 1 6 14
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 2 10 14
M  V30 15 2 11 15
M  V30 16 2 12 13
M  V30 17 1 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 98-88-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 527704-23-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 527704-40-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-6546260
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A general approach toward the synthesis of
8-amidopyrazolo[1,5-a]-1,3,5-triazines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Raboisson, Pierre; Schultz, Dominique; Lugnier, Claire; Mathieu, Romain;
Bourguignon, Jean-Jacques
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2003), 44(4), 703-705

$RFMT $RIREG SCHEME361 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,6-Dichloro-5-pyrimidinecarboxaldehyde
C5H2Cl2N2O
5305-40-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6675 0.0 0
M  V30 2 O 5.3901 4.0011 0.0 0
M  V30 3 Cl 3.0800 5.3349 0.0 0
M  V30 4 Cl 3.0800 0.0000 0.0 0
M  V30 5 C 3.0800 2.6675 0.0 0
M  V30 6 C 2.3100 4.0011 0.0 0
M  V30 7 C 2.3100 1.3338 0.0 0
M  V30 8 N 0.7700 4.0011 0.0 0
M  V30 9 N 0.7700 1.3338 0.0 0
M  V30 10 C 0.0000 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 6
M  V30 4 1 4 7
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-6-(methylamino)-5-pyrimidinecarboxaldehyde
C6H6ClN3O
14160-94-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 2.3101 0.0 0
M  V30 2 C 6.6687 3.0801 0.0 0
M  V30 3 C 2.6675 0.7700 0.0 0
M  V30 4 O 1.3338 0.0000 0.0 0
M  V30 5 Cl 0.0000 2.3101 0.0 0
M  V30 6 C 4.0012 3.0801 0.0 0
M  V30 7 C 2.6675 2.3101 0.0 0
M  V30 8 N 4.0012 4.6201 0.0 0
M  V30 9 C 1.3338 3.0801 0.0 0
M  V30 10 C 2.6675 5.3901 0.0 0
M  V30 11 N 1.3338 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 3 4
M  V30 4 1 3 7
M  V30 5 1 5 9
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5305-40-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 14160-94-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-11298164
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 75-50-3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Diverse display of non-covalent interacting elements using
pyrimidine-embedded polyheterocycles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Choi, Yoona; Kim, Heejun; Shin, Young-Hee; Park, Seung Bum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Communications (Cambridge, United Kingdom) (2015), 51(65),
13040-13043

$RFMT $RIREG SCHEME362 STEP1
$RXN



  3  1
$MOL
1,1′-Carbonyldiimidazole
C7H6N4O
530-62-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 O 3.7711 0.0000 0.0 0
M  V30 3 N 2.4374 2.3100 0.0 0
M  V30 4 C 2.2763 3.8416 0.0 0
M  V30 5 C 1.0304 1.6836 0.0 0
M  V30 6 C 0.7700 4.1618 0.0 0
M  V30 7 N 0.0000 2.8281 0.0 0
M  V30 8 N 5.1047 2.3100 0.0 0
M  V30 9 C 5.2658 3.8416 0.0 0
M  V30 10 C 6.5117 1.6836 0.0 0
M  V30 11 C 6.7721 4.1618 0.0 0
M  V30 12 N 7.5421 2.8281 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 2 4 6
M  V30 7 2 5 7
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[2-[6-(Aminomethyl)-2-pyridinyl]ethynyl]-N-[3-chloro-4-[(3-fluorophenyl)met...
C25H19ClFN5O
845658-03-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 14.6708 3.0801 0.0 0
M  V30 2 C 16.0045 3.8501 0.0 0
M  V30 3 N 12.0033 4.6201 0.0 0
M  V30 4 Cl 9.3360 9.2402 0.0 0
M  V30 5 C 21.3393 3.8501 0.0 0
M  V30 6 N 22.6730 4.6201 0.0 0
M  V30 7 O 6.6685 7.7002 0.0 0
M  V30 8 C 5.3348 6.9302 0.0 0
M  V30 9 F 0.0000 6.9302 0.0 0
M  V30 10 C 13.3370 2.3101 0.0 0
M  V30 11 C 12.0033 3.0801 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 13 N 10.6697 2.3101 0.0 0
M  V30 14 N 12.0033 0.0000 0.0 0
M  V30 15 C 10.6697 0.7700 0.0 0
M  V30 16 C 10.6697 5.3901 0.0 0
M  V30 17 C 10.6697 6.9302 0.0 0
M  V30 18 C 9.3360 4.6201 0.0 0
M  V30 19 C 9.3360 7.7002 0.0 0
M  V30 20 C 8.0022 5.3901 0.0 0
M  V30 21 C 8.0022 6.9302 0.0 0
M  V30 22 C 17.3382 4.6201 0.0 0
M  V30 23 N 18.6718 3.8501 0.0 0
M  V30 24 C 17.3382 6.1601 0.0 0
M  V30 25 C 20.0057 4.6201 0.0 0
M  V30 26 C 18.6718 6.9302 0.0 0
M  V30 27 C 20.0057 6.1601 0.0 0
M  V30 28 C 4.0012 7.7002 0.0 0
M  V30 29 C 2.6673 6.9302 0.0 0
M  V30 30 C 4.0012 9.2402 0.0 0
M  V30 31 C 1.3337 7.7002 0.0 0
M  V30 32 C 2.6673 10.0102 0.0 0
M  V30 33 C 1.3337 9.2402 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 10
M  V30 3 1 2 22
M  V30 4 1 3 11
M  V30 5 1 3 16
M  V30 6 1 4 19
M  V30 7 1 5 6
M  V30 8 1 5 25
M  V30 9 1 7 8
M  V30 10 1 7 21
M  V30 11 1 8 28
M  V30 12 1 9 31
M  V30 13 1 10 11
M  V30 14 2 10 12
M  V30 15 2 11 13
M  V30 16 1 12 14
M  V30 17 1 13 15
M  V30 18 2 14 15
M  V30 19 2 16 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 2 18 20
M  V30 23 2 19 21
M  V30 24 1 20 21
M  V30 25 1 22 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 27
M  V30 31 2 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 32
M  V30 35 2 31 33
M  V30 36 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[[6-[2-[4-[[3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl]amino]-5-pyrimidinyl...
C27H22ClFN6O2
845658-12-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 40 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 12.0035 4.6201 0.0 0
M  V30 2 C 14.6708 3.0801 0.0 0
M  V30 3 C 16.0046 3.8501 0.0 0
M  V30 4 Cl 9.3360 9.2402 0.0 0
M  V30 5 O 6.6687 7.7002 0.0 0
M  V30 6 C 5.3348 6.9302 0.0 0
M  V30 7 C 21.3395 3.8501 0.0 0
M  V30 8 N 22.6731 4.6201 0.0 0
M  V30 9 C 24.0068 3.8501 0.0 0
M  V30 10 N 25.3405 4.6201 0.0 0
M  V30 11 O 24.0068 2.3101 0.0 0
M  V30 12 C 26.6743 3.8501 0.0 0
M  V30 13 F 0.0000 6.9302 0.0 0
M  V30 14 C 12.0035 3.0801 0.0 0
M  V30 15 C 13.3372 2.3101 0.0 0
M  V30 16 N 10.6697 2.3101 0.0 0
M  V30 17 C 13.3372 0.7700 0.0 0
M  V30 18 C 10.6697 0.7700 0.0 0
M  V30 19 N 12.0035 0.0000 0.0 0
M  V30 20 C 10.6697 5.3901 0.0 0
M  V30 21 C 10.6697 6.9302 0.0 0
M  V30 22 C 9.3360 4.6201 0.0 0
M  V30 23 C 9.3360 7.7002 0.0 0
M  V30 24 C 8.0023 5.3901 0.0 0
M  V30 25 C 8.0023 6.9302 0.0 0
M  V30 26 C 17.3383 4.6201 0.0 0
M  V30 27 N 18.6720 3.8501 0.0 0
M  V30 28 C 17.3383 6.1601 0.0 0
M  V30 29 C 20.0057 4.6201 0.0 0
M  V30 30 C 18.6720 6.9302 0.0 0
M  V30 31 C 20.0057 6.1601 0.0 0
M  V30 32 C 4.0012 7.7002 0.0 0
M  V30 33 C 2.6675 6.9302 0.0 0
M  V30 34 C 4.0012 9.2402 0.0 0
M  V30 35 C 1.3338 7.7002 0.0 0
M  V30 36 C 2.6675 10.0102 0.0 0
M  V30 37 C 1.3338 9.2402 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 1 20
M  V30 3 3 2 3
M  V30 4 1 2 15
M  V30 5 1 3 26
M  V30 6 1 4 23
M  V30 7 1 5 6
M  V30 8 1 5 25
M  V30 9 1 6 32
M  V30 10 1 7 8
M  V30 11 1 7 29
M  V30 12 1 8 9
M  V30 13 1 9 10
M  V30 14 2 9 11
M  V30 15 1 10 12
M  V30 16 1 13 35
M  V30 17 1 14 15
M  V30 18 2 14 16
M  V30 19 2 15 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 29 1 26 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 31
M  V30 35 2 32 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 2 34 36
M  V30 39 2 35 37
M  V30 40 1 36 37
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 845658-03-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 845658-12-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-14235177
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-66-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 90
N-({6-[(4-{3-Chloro-4-[(3-fluorobenzyl)oxy]anilino}-5-pyrimidinyl)ethynyl]-2-pyridinyl}methyl)-N′-methylurea
1,1′-Carbonyldiimidazole (14 mg, 0.1 mmol) was added to
5-{[6-(aminomethyl)-2-pyridinyl]ethynyl}-N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-4-pyrimidinamine
bis TFA (50 mg, 0.1 mmol) and DIEA (0.063 mL, 0.4 mmol) in CHCl3 at RT.
After stirring for 15 min at RT, methylamine (8 M in ethanol, 0.030 mL,
0.2 mmol) was added. The solution was stirred overnight at RT. Et2O (3
mL) was added to the flask and the mixture was sonicated. The resulting
precipitate was filtered and rinsed with Et2O to give the title compound
as an off-white solid (35 mg, 92%). 1H NMR (300 MHz, DMSO-d6) δ 2.60 (d,
J=4.4 Hz, 3H), 4.33 (d, J=5.9 Hz, 2H), 5.28 (s, 2H), 6.04 (q, J=4.6 Hz,
1H), 6.59 (t, J=5.9 Hz, 1H), 7.18-7.35 (m, 5H), 7.45-7.57 (m, 2H), 7.72
(d, J=7.6 Hz, 1H), 7.77 (d, J=2.4 Hz, 1H), 7.87 (t, J=7.9 Hz, 1H), 8.60
(s, 2H), 9.15 (s, 1H); ESIMS: 517 (M+H)+
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrimidine derivatives as ErbB kinase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Reno, Michael John; Stevens, Kirk Lawrence; Waterson, Alex Gregory;
Zhang, Yuemei
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2005016914 A1 2005-02-24

$RFMT $RIREG SCHEME363 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Iodoaniline
C6H6IN
540-37-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 I 0.0000 1.3337 0.0 0
M  V30 2 N 6.1601 1.3337 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 8
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-p-phenylenediamine
C7H10N2
623-09-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 2.6673 0.0 0
M  V30 3 N 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 540-37-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 623-09-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-339850
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-58-3
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7681-65-4
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 58509-59-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, sealed tube used, alternative preparation shown, oxime
catalyst prepared and used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Room-Temperature Copper-Catalyzed Arylation of Dimethylamine and
Methylamine in Neat Water
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Deping; Kuang, Daizhi; Zhang, Fuxing; Yang, Chunlin; Zhu, Xiaoming
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Advanced Synthesis & Catalysis (2015), 357(4), 714-718

$RFMT $RIREG SCHEME364 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Methylethyl β-oxobenzenepropanoate
C12H14O3
54441-65-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.0801 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 O 4.0012 4.6201 0.0 0
M  V30 4 C 6.6685 3.0801 0.0 0
M  V30 5 O 8.0023 2.3101 0.0 0
M  V30 6 O 6.6685 4.6201 0.0 0
M  V30 7 C 9.3360 3.0801 0.0 0
M  V30 8 C 9.3360 4.6201 0.0 0
M  V30 9 C 10.6697 2.3101 0.0 0
M  V30 10 C 2.6673 2.3101 0.0 0
M  V30 11 C 1.3337 3.0801 0.0 0
M  V30 12 C 2.6673 0.7700 0.0 0
M  V30 13 C 0.0000 2.3101 0.0 0
M  V30 14 C 1.3337 0.0000 0.0 0
M  V30 15 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Methylethyl (2Z)-3-(methylamino)-3-phenyl-2-propenoate
C13H17NO2
2304416-29-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.0800 0.0 0
M  V30 2 C 5.3348 2.3100 0.0 0
M  V30 3 N 4.0011 4.6201 0.0 0
M  V30 4 C 6.6684 3.0800 0.0 0
M  V30 5 C 2.6673 5.3901 0.0 0
M  V30 6 O 8.0022 2.3100 0.0 0
M  V30 7 O 6.6684 4.6201 0.0 0
M  V30 8 C 9.3359 3.0800 0.0 0
M  V30 9 C 9.3359 4.6201 0.0 0
M  V30 10 C 10.6695 2.3100 0.0 0
M  V30 11 C 2.6673 2.3100 0.0 0
M  V30 12 C 1.3337 3.0800 0.0 0
M  V30 13 C 2.6673 0.7700 0.0 0
M  V30 14 C 0.0000 2.3100 0.0 0
M  V30 15 C 1.3337 0.0000 0.0 0
M  V30 16 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 54441-65-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2304416-29-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-19946821
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of Functionalized Imidazolium Salts via Iodine-Mediated
Annulations of Enamines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xia, Biao; Chen, Wenjun; Zhao, Qiongli; Yu, Wenquan; Chang, Junbiao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2019), 21(8), 2583-2587

$RFMT $RIREG SCHEME365 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
9-[(2-Chloroethoxy)methyl]-9H-purin-6-amine
C8H10ClN5O
56004-32-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6519 3.0203 0.0 0
M  V30 2 O 7.6823 4.1648 0.0 0
M  V30 3 C 9.1888 3.8446 0.0 0
M  V30 4 C 10.2192 4.9890 0.0 0
M  V30 5 Cl 11.7256 4.6689 0.0 0
M  V30 6 N 0.0000 3.0800 0.0 0
M  V30 7 C 4.0011 2.3100 0.0 0
M  V30 8 C 2.6675 3.0800 0.0 0
M  V30 9 N 5.1456 3.3404 0.0 0
M  V30 10 N 4.0011 0.7700 0.0 0
M  V30 11 C 1.3338 2.3100 0.0 0
M  V30 12 N 2.9876 4.5863 0.0 0
M  V30 13 C 4.5192 4.7474 0.0 0
M  V30 14 C 2.6675 0.0000 0.0 0
M  V30 15 N 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 6 11
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 2 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 2 12 13
M  V30 16 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
9-[[2-(Methylamino)ethoxy]methyl]-9H-purin-6-amine
C9H14N6O
478161-17-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3078 1.6412 0.0 0
M  V30 2 O 7.6415 2.4111 0.0 0
M  V30 3 C 8.9752 1.6412 0.0 0
M  V30 4 C 10.3088 2.4111 0.0 0
M  V30 5 N 11.6424 1.6412 0.0 0
M  V30 6 C 12.9762 2.4111 0.0 0
M  V30 7 N 0.0000 3.7535 0.0 0
M  V30 8 C 3.5674 1.7848 0.0 0
M  V30 9 C 2.5368 2.9292 0.0 0
M  V30 10 N 4.9741 2.4111 0.0 0
M  V30 11 N 3.0914 0.3202 0.0 0
M  V30 12 C 1.0306 2.6090 0.0 0
M  V30 13 N 3.3068 4.2630 0.0 0
M  V30 14 C 4.8132 3.9428 0.0 0
M  V30 15 C 1.5851 0.0000 0.0 0
M  V30 16 N 0.5547 1.1445 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 7 12
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 2 8 11
M  V30 11 2 9 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 2 13 14
M  V30 17 2 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 56004-32-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 478161-17-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-9317891
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: 5'-Deoxy-5'-methylaminoadenosine (4).
5'-Deoxy-5'-chloroadenosine (2) (5.224 g, 18.3 mmol) was chilled to -70°C
in a metal bomb, and 45 mL of condensed anhydrous methylamine was added.
The bomb was sealed, heated to 55°C for 72 h, and then cooled to -70°C.
The bomb was unsealed and allowed to come slowly to room temperature.
After the excess methylamine had boiled off, the resulting thick oil was
taken up in H2O (50 mL) and allowed to stand for 18 h at room
temperature. The mixture was filtered to remove unreacted 2, and the
filtrate was concentrated in vacuo. The thick oil was then extracted with
EtOAc/H2O (11:1) until TLC (CH2-Cl2/MeOH, 5:1) indicated only product was
present. The thick oil was dried under vacuum to give 4, as ahygroscopic
solid, yield 2.489 g, 49% . 9-(Methylaminoethylmethoxy)adenine (34), as a
white hygroscopic foam, yield 1.116g, 92% . 1H NMR (DMSO-d6): δ2.55 (s,
3H, CH3NH), 3.15 (m, 2H, HNCH2CH2O), 3.85 (m, 2H,HNCH2CH2O), 5.65 (s, 2H,
OCH2-Ad), 8.20 (s, 1H, Ad-H8), and8.30 (s, 1H, Ad-H2).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and Evaluation of Analogs of
5'-([(Z)-4-Amino-2-butenyl]methylamino)-5'-deoxyadenosine as Inhibitors
of Tumor Cell Growth, Trypanosomal Growth, and HIV-1 Infectivity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Marasco, Canio J. Jr.; Kramer, Debora L.; Miller, John; Porter, Carl W.;
Bacchi, Cyrus J.; Rattendi, Donna; Kucera, Louis; Iyer, Nathan; Bernacki,
Ralph; Pera, Paula; Sufrin, Janice R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2002), 45(23), 5112-5122

$RFMT $RIREG SCHEME366 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamimidothioic acid, N-cyano-N′-[[(2S,5R)-tetrahydro-5-(1H-imidazol-4-yl)-...
C11H15N5OS
565455-71-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.5257 4.0009 0.0 0
M  V30 2 N 8.2957 2.6673 0.0 0
M  V30 3 C 9.8357 2.6673 0.0 0
M  V30 4 N 10.6057 4.0009 0.0 0
M  V30 5 S 10.6057 1.3336 0.0 0
M  V30 6 C 12.1457 4.0009 0.0 0
M  V30 7 C 9.8357 0.0000 0.0 0
M  V30 8 N 13.6857 4.0009 0.0 0
M  V30 9 C 3.6158 4.7709 0.0 0 CFG=1
M  V30 10 O 5.0805 5.2469 0.0 0
M  V30 11 C 3.6158 3.2309 0.0 0
M  V30 12 C 5.9857 4.0009 0.0 0 CFG=2
M  V30 13 C 5.0805 2.7551 0.0 0
M  V30 14 C 2.3699 5.6761 0.0 0
M  V30 15 C 0.9052 5.2003 0.0 0
M  V30 16 N 2.3699 7.2161 0.0 0
M  V30 17 N 0.0000 6.4461 0.0 0
M  V30 18 C 0.9052 7.6920 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 12 1 CFG=3
M  V30 3 2 2 3 CFG=2
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 3 6 8
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 14 CFG=3
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 9 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-Cyano-N′-methyl-N′′-[[(2S,5R)-tetrahydro-5-(1H-imidazol-5-yl)-2-furanyl]met...
C11H16N6O
565455-64-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.5257 4.0009 0.0 0
M  V30 2 N 8.2957 2.6673 0.0 0
M  V30 3 C 9.8357 2.6673 0.0 0
M  V30 4 N 10.6057 4.0009 0.0 0
M  V30 5 N 10.6057 1.3336 0.0 0
M  V30 6 C 12.1457 4.0009 0.0 0
M  V30 7 C 9.8357 0.0000 0.0 0
M  V30 8 N 13.6857 4.0009 0.0 0
M  V30 9 C 3.6158 4.7709 0.0 0 CFG=1
M  V30 10 O 5.0805 5.2469 0.0 0
M  V30 11 C 3.6158 3.2309 0.0 0
M  V30 12 C 5.9857 4.0009 0.0 0 CFG=2
M  V30 13 C 5.0805 2.7551 0.0 0
M  V30 14 C 2.3699 5.6761 0.0 0
M  V30 15 C 0.9052 5.2003 0.0 0
M  V30 16 N 2.3699 7.2161 0.0 0
M  V30 17 N 0.0000 6.4461 0.0 0
M  V30 18 C 0.9052 7.6920 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 12 1 CFG=3
M  V30 3 2 2 3 CFG=2
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 3 6 8
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 14 CFG=3
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 9 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 565455-71-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 565455-64-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-4515488
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM The cyanomethylisothiourea 5 was subsequently dissolved in 40% MeNH2 in
MeOH (10 mL). The resulting mixture was stirred for 3 h at room
temperature. The solvent was evaporated to give a residual oil, which was
chromatographed [Chromatrex NH-DM 1210, MeOH-EtOAc (1 :9)] to give 3b
(135 mg, 92%) as a white amorphous product. ORD (c 2.40, EtOH) [a] (nm):
+35.1 (589), +42.6 (550), +57.6 (500), +70.2 (450), +97.7 (400), +142.8
(350), +238.0 (300). IR (neat): 2170 (CN) cm-1. 1H-NMR (CD3OD): 6
1.78-2.28 (m, 4H), 2.73 (s, 3H), 3.29-3.43 (overlapped with CH3OH in
CD3OD), 4.17 (m, 1H), 4.97 (overlapped with H20 in CD3OD), 7.06 (s, 1H),
7.68 (s, 1H). 13C-NMR (CD3OD): 5 28.9, 29.9, 33.0, 47.6, 77.1, 80.2,
117.0, 120.3, 137.2, 162.7. EIMS mlz: 248 (M+). HRMS m/z: 248.1393 (calcd
for CnH16N60: 248.1385).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A Selective Human H4-Receptor Agonist:
(-)-2-Cyano-1-methyl-3-{(2R,5R)-5-[1H-imidazol-4(5)-yl]tetrahydrofuran-2-yl}methylguanidine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hashimoto, Takeshi; Harusawa, Shinya; Araki, Lisa; Zuiderveld, Obbe P.;
Smit, Martine J.; Imazu, Tomonari; Takashima, Seiichiroh; Yamamoto,
Yumiko; Sakamoto, Yasuhiko; Kurihara, Takushi; Leurs, Rob; Bakker, Remko
A.; Yamatodani, Atsushi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2003), 46(14), 3162-3165

$RFMT $RIREG SCHEME367 STEP1
$RXN



  2  1
$MOL
(2α,3β,4α)-2,3,23-Tris(acetyloxy)urs-12-en-28-oic acid
C36H54O8
57688-73-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  47 51 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.5314 3.5255 0.0 0
M  V30 2 C 8.8414 7.8343 0.0 0
M  V30 3 C 5.5243 3.4789 0.0 0
M  V30 4 C 11.2827 3.4964 0.0 0
M  V30 5 O 12.4623 2.5065 0.0 0
M  V30 6 C 12.1948 0.9899 0.0 0
M  V30 7 C 10.7478 0.4632 0.0 0
M  V30 8 O 13.3746 0.0000 0.0 0
M  V30 9 C 12.9971 4.4863 0.0 0
M  V30 10 O 12.3200 9.0141 0.0 0
M  V30 11 C 11.5500 10.3477 0.0 0
M  V30 12 C 12.3200 11.6815 0.0 0
M  V30 13 O 10.0100 10.3477 0.0 0
M  V30 14 O 13.8600 6.3468 0.0 0
M  V30 15 C 14.6300 7.6804 0.0 0
M  V30 16 C 13.8600 9.0141 0.0 0
M  V30 17 O 16.1700 7.6804 0.0 0
M  V30 18 C 1.5400 3.6794 0.0 0
M  V30 19 O 0.0000 3.6794 0.0 0
M  V30 20 O 2.3100 2.3457 0.0 0
M  V30 21 C 3.0800 9.0141 0.0 0
M  V30 22 C 0.0000 9.0141 0.0 0
M  V30 23 C 7.7000 6.3468 0.0 0 CFG=2
M  V30 24 C 6.9300 5.0130 0.0 0 CFG=2
M  V30 25 C 9.2400 6.3468 0.0 0 CFG=2
M  V30 26 C 6.9300 7.6804 0.0 0
M  V30 27 C 5.3900 5.0130 0.0 0 CFG=1
M  V30 28 C 7.7000 3.6794 0.0 0
M  V30 29 C 10.0100 5.0130 0.0 0 CFG=2
M  V30 30 C 10.0100 7.6804 0.0 0
M  V30 31 C 5.3900 7.6804 0.0 0
M  V30 32 C 4.6200 6.3468 0.0 0
M  V30 33 C 4.6200 3.6794 0.0 0
M  V30 34 C 9.2400 3.6794 0.0 0
M  V30 35 C 11.5500 5.0130 0.0 0 CFG=2
M  V30 36 C 11.5500 7.6804 0.0 0 CFG=1
M  V30 37 C 3.0800 6.3468 0.0 0 CFG=2
M  V30 38 C 3.0800 3.6794 0.0 0
M  V30 39 C 12.3200 6.3468 0.0 0 CFG=1
M  V30 40 C 2.3100 5.0130 0.0 0 CFG=1
M  V30 41 C 2.3100 7.6804 0.0 0 CFG=1
M  V30 42 C 0.7700 5.0130 0.0 0
M  V30 43 C 0.7700 7.6804 0.0 0 CFG=2
M  V30 44 C 0.0000 6.3468 0.0 0
M  V30 45 H 7.8343 7.8810 0.0 0
M  V30 46 H 10.7800 3.6794 0.0 0
M  V30 47 H 3.8500 7.6804 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 24 1 CFG=3
M  V30 2 1 25 2 CFG=3
M  V30 3 1 27 3 CFG=1
M  V30 4 1 4 5
M  V30 5 1 35 4 CFG=1
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 35 9 CFG=3
M  V30 10 1 10 11
M  V30 11 1 36 10 CFG=1
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 14 15
M  V30 15 1 39 14 CFG=3
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 1 18 19
M  V30 19 2 18 20
M  V30 20 1 40 18 CFG=3
M  V30 21 1 41 21 CFG=3
M  V30 22 1 43 22 CFG=1
M  V30 23 1 23 24
M  V30 24 1 23 25
M  V30 25 1 23 26
M  V30 26 1 23 45 CFG=1
M  V30 27 1 24 27
M  V30 28 1 24 28
M  V30 29 1 25 29
M  V30 30 1 25 30
M  V30 31 1 26 31
M  V30 32 1 27 32
M  V30 33 1 27 33
M  V30 34 1 28 34
M  V30 35 1 29 34
M  V30 36 1 29 35
M  V30 37 1 29 46 CFG=1
M  V30 38 1 30 36
M  V30 39 2 31 32
M  V30 40 1 32 37
M  V30 41 1 33 38
M  V30 42 1 35 39
M  V30 43 1 36 39
M  V30 44 1 37 40
M  V30 45 1 37 41
M  V30 46 1 37 47 CFG=3
M  V30 47 1 38 40
M  V30 48 1 40 42
M  V30 49 1 41 43
M  V30 50 1 42 44
M  V30 51 1 43 44
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(12 23 24 25 27 29 35 36 37 39 40 41 43)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2α,3β,4α)-2,3,23-Tris(acetyloxy)-N-methylurs-12-en-28-amide
C37H57NO7
1909335-73-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  48 52 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.0176 8.9593 0.0 0
M  V30 2 C 10.2192 6.3022 0.0 0
M  V30 3 C 6.3247 4.0739 0.0 0
M  V30 4 O 5.7980 2.6268 0.0 0
M  V30 5 C 6.7879 1.4471 0.0 0
M  V30 6 C 6.2612 0.0000 0.0 0
M  V30 7 O 8.3045 1.7145 0.0 0
M  V30 8 C 4.3448 4.0739 0.0 0
M  V30 9 O 2.6675 8.3336 0.0 0
M  V30 10 C 2.6675 9.8736 0.0 0
M  V30 11 C 1.3338 10.6436 0.0 0
M  V30 12 O 4.0011 10.6436 0.0 0
M  V30 13 C 11.3205 6.9379 0.0 0
M  V30 14 O 2.6675 5.2536 0.0 0
M  V30 15 C 1.3338 6.0236 0.0 0
M  V30 16 C 0.0000 5.2536 0.0 0
M  V30 17 O 1.3338 7.5636 0.0 0
M  V30 18 C 14.6706 9.1036 0.0 0
M  V30 19 N 16.0043 9.8736 0.0 0
M  V30 20 O 14.6706 7.5636 0.0 0
M  V30 21 C 17.3381 9.1036 0.0 0
M  V30 22 C 10.6695 12.9537 0.0 0
M  V30 23 C 13.3370 14.4937 0.0 0
M  V30 24 C 6.6686 7.5636 0.0 0 CFG=2
M  V30 25 C 8.0022 8.3336 0.0 0 CFG=1
M  V30 26 C 6.6686 6.0236 0.0 0 CFG=1
M  V30 27 C 5.3348 8.3336 0.0 0
M  V30 28 C 9.3359 7.5636 0.0 0 CFG=2
M  V30 29 C 8.0022 9.8736 0.0 0
M  V30 30 C 5.3348 5.2536 0.0 0 CFG=2
M  V30 31 C 8.0022 5.2536 0.0 0
M  V30 32 C 4.0011 7.5636 0.0 0 CFG=1
M  V30 33 C 10.6695 8.3336 0.0 0 CFG=1
M  V30 34 C 9.3359 6.0236 0.0 0
M  V30 35 C 9.3359 10.6436 0.0 0
M  V30 36 C 4.0011 6.0236 0.0 0 CFG=1
M  V30 37 C 10.6695 9.8736 0.0 0
M  V30 38 C 12.0033 7.5636 0.0 0
M  V30 39 C 12.0033 10.6436 0.0 0 CFG=2
M  V30 40 C 13.3370 8.3336 0.0 0
M  V30 41 C 13.3370 9.8736 0.0 0 CFG=1
M  V30 42 C 12.0033 12.1837 0.0 0 CFG=1
M  V30 43 C 14.6706 10.6436 0.0 0
M  V30 44 C 13.3370 12.9537 0.0 0 CFG=2
M  V30 45 C 14.6706 12.1837 0.0 0
M  V30 46 H 7.1189 9.5952 0.0 0
M  V30 47 H 6.6686 4.4836 0.0 0
M  V30 48 H 10.6695 11.4136 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 24 1 CFG=1
M  V30 2 1 28 2 CFG=1
M  V30 3 1 3 4
M  V30 4 1 30 3 CFG=3
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 30 8 CFG=1
M  V30 9 1 9 10
M  V30 10 1 32 9 CFG=3
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 33 13 CFG=3
M  V30 14 1 14 15
M  V30 15 1 36 14 CFG=1
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 1 18 19
M  V30 19 2 18 20
M  V30 20 1 41 18 CFG=1
M  V30 21 1 19 21
M  V30 22 1 42 22 CFG=1
M  V30 23 1 44 23 CFG=3
M  V30 24 1 24 25
M  V30 25 1 24 26
M  V30 26 1 24 27
M  V30 27 1 25 28
M  V30 28 1 25 29
M  V30 29 1 25 46 CFG=3
M  V30 30 1 26 30
M  V30 31 1 26 31
M  V30 32 1 26 47 CFG=3
M  V30 33 1 27 32
M  V30 34 1 28 33
M  V30 35 1 28 34
M  V30 36 1 29 35
M  V30 37 1 30 36
M  V30 38 1 31 34
M  V30 39 1 32 36
M  V30 40 1 33 37
M  V30 41 1 33 38
M  V30 42 2 35 37
M  V30 43 1 37 39
M  V30 44 1 38 40
M  V30 45 1 39 41
M  V30 46 1 39 42
M  V30 47 1 39 48 CFG=1
M  V30 48 1 40 41
M  V30 49 1 41 43
M  V30 50 1 42 44
M  V30 51 1 43 45
M  V30 52 1 44 45
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(12 24 25 26 28 30 32 33 36 39 41 42 44)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 57688-73-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1909335-73-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-15653046
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and anticancer activity of novel fluorinated asiatic acid
derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Goncalves, Bruno M. F.; Salvador, Jorge A. R.; Marin, Silvia; Cascante,
Marta
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2016), 114101-117

$RFMT $RIREG SCHEME368 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
trans-4-[[(2-Methoxybenzoyl)amino]methyl]-4-(2-thienyl)cyclohexyl 4-nitrophen...
C26H26N2O7S
577032-54-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 39 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.5932 6.0559 0.0 0
M  V30 2 N 6.0665 4.6088 0.0 0
M  V30 3 C 4.5499 4.3414 0.0 0
M  V30 4 O 3.5600 5.5211 0.0 0
M  V30 5 O 12.1109 4.0134 0.0 0
M  V30 6 C 13.4445 4.7834 0.0 0
M  V30 7 O 14.7781 4.0134 0.0 0
M  V30 8 O 13.4445 6.3234 0.0 0
M  V30 9 O 1.5167 3.8066 0.0 0
M  V30 10 C 0.0000 3.5391 0.0 0
M  V30 11 N 20.1129 7.0934 0.0 0 VAL=5
M  V30 12 O 20.1129 8.6334 0.0 0
M  V30 13 O 21.4467 6.3234 0.0 0
M  V30 14 C 8.1098 6.3234 0.0 0 CFG=1
M  V30 15 C 8.1098 4.7834 0.0 0
M  V30 16 C 9.4434 7.0934 0.0 0
M  V30 17 C 9.4434 4.0134 0.0 0
M  V30 18 C 10.7772 6.3234 0.0 0
M  V30 19 C 10.7772 4.7834 0.0 0 CFG=2
M  V30 20 C 7.5831 7.7705 0.0 0
M  V30 21 C 8.4443 9.0472 0.0 0
M  V30 22 S 6.1027 8.1950 0.0 0
M  V30 23 C 7.4961 10.2607 0.0 0
M  V30 24 C 6.0490 9.7340 0.0 0
M  V30 25 C 4.0231 2.8943 0.0 0
M  V30 26 C 2.5065 2.6268 0.0 0
M  V30 27 C 5.0130 1.7145 0.0 0
M  V30 28 C 1.9798 1.1796 0.0 0
M  V30 29 C 4.4863 0.2673 0.0 0
M  V30 30 C 2.9697 0.0000 0.0 0
M  V30 31 C 16.1119 4.7834 0.0 0
M  V30 32 C 16.1119 6.3234 0.0 0
M  V30 33 C 17.4456 4.0134 0.0 0
M  V30 34 C 17.4456 7.0934 0.0 0
M  V30 35 C 18.7792 4.7834 0.0 0
M  V30 36 C 18.7792 6.3234 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 14 1 CFG=1
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 1 3 25
M  V30 6 1 5 6
M  V30 7 1 19 5 CFG=1
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 7 31
M  V30 11 1 9 10
M  V30 12 1 9 26
M  V30 13 2 11 12
M  V30 14 2 11 13
M  V30 15 1 11 36
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 14 20 CFG=3
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 1 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 24
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 34 2 31 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 2 33 35
M  V30 38 2 34 36
M  V30 39 1 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 14 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Benzamide, 2-methoxy-N-[[trans-4-[[(methylamino)carbonyl]oxy]-1-(2-thienyl)cy...
C21H26N2O4S
3052323-98-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 3.9841 0.0 0
M  V30 2 N 6.1600 5.3178 0.0 0
M  V30 3 C 4.6200 5.3178 0.0 0
M  V30 4 O 3.8500 3.9841 0.0 0
M  V30 5 O 12.0092 6.9539 0.0 0
M  V30 6 C 13.4562 6.4270 0.0 0
M  V30 7 N 14.6360 7.4169 0.0 0
M  V30 8 O 13.7237 4.9104 0.0 0
M  V30 9 C 16.0831 6.8903 0.0 0
M  V30 10 O 1.5400 5.3178 0.0 0
M  V30 11 C 0.0000 5.3178 0.0 0
M  V30 12 C 8.4700 3.9841 0.0 0 CFG=2
M  V30 13 C 8.2027 5.5007 0.0 0
M  V30 14 C 9.9171 3.4575 0.0 0
M  V30 15 C 9.3823 6.4906 0.0 0
M  V30 16 C 11.0969 4.4474 0.0 0
M  V30 17 C 10.8294 5.9640 0.0 0 CFG=1
M  V30 18 C 8.2027 2.4675 0.0 0
M  V30 19 C 9.2723 1.3597 0.0 0
M  V30 20 S 6.8185 1.7924 0.0 0
M  V30 21 C 8.5495 0.0000 0.0 0
M  V30 22 C 7.0327 0.2673 0.0 0
M  V30 23 C 3.8500 6.6514 0.0 0
M  V30 24 C 2.3100 6.6514 0.0 0
M  V30 25 C 4.6200 7.9852 0.0 0
M  V30 26 C 1.5400 7.9852 0.0 0
M  V30 27 C 3.8500 9.3188 0.0 0
M  V30 28 C 2.3100 9.3188 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 12 1 CFG=1
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 1 3 23
M  V30 6 1 5 6
M  V30 7 1 17 5 CFG=1
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 7 9
M  V30 11 1 10 11
M  V30 12 1 10 24
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 12 18 CFG=3
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 12 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 577032-54-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3052323-98-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37330983
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM overall yield 44% over two steps
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Immunosuppressive effects of new thiophene-based KV1.3 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gubic, Spela; Montalbano, Alberto; Sala, Cesare; Becchetti, Andrea;
Hendrickx, Louise Antonia; Van Theemsche, Kenny M.; Pinheiro-Junior,
Ernesto Lopes; Altadonna, Ginevra Chioccioli; Peigneur, Steve; Ilas,
Janez; Labro, Alain J.; Pardo, Luis A.; Tytgat, Jan; Tomasic, Tihomir;
Arcangeli, Annarosa; Peterlin Masic, Lucija
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2023), 259115561

$RFMT $RIREG SCHEME369 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
16-Hydroxy-3,6,9,14-tetraoxabicyclo[10.2.2]hexadeca-1(15),16-diene-11,13-dione
C12H14O7
577794-94-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.9722 4.3611 0.0 0
M  V30 2 O 2.5189 6.8905 0.0 0
M  V30 3 O 0.0000 4.3443 0.0 0
M  V30 4 C 5.2674 4.5280 0.0 0
M  V30 5 C 4.8020 4.8577 0.0 0
M  V30 6 O 4.1043 5.2993 0.0 0
M  V30 7 C 6.7820 4.7510 0.0 0
M  V30 8 C 3.2211 5.3885 0.0 0
M  V30 9 C 2.5189 5.8331 0.0 0
M  V30 10 O 8.1835 3.9412 0.0 0
M  V30 11 C 1.8288 5.6009 0.0 0
M  V30 12 C 8.5597 2.3484 0.0 0
M  V30 13 C 1.0375 4.1408 0.0 0
M  V30 14 C 7.8174 0.8615 0.0 0
M  V30 15 C 1.2136 2.5403 0.0 0
M  V30 16 O 6.4101 0.0598 0.0 0
M  V30 17 O 2.1192 1.2835 0.0 0
M  V30 18 C 4.8518 0.0000 0.0 0
M  V30 19 C 3.3974 0.4580 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 2 2 9
M  V30 3 2 3 13
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 2 8 11
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
15-Methyl-3,6,9-trioxa-15-azabicyclo[9.3.1]pentadeca-11,14-dien-13-one
C12H17NO4
577794-95-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 2.6674 0.0 0
M  V30 2 O 9.2400 2.6674 0.0 0
M  V30 3 C 5.3900 1.3338 0.0 0
M  V30 4 N 4.6200 2.6674 0.0 0
M  V30 5 C 6.9300 1.3338 0.0 0
M  V30 6 C 4.6200 0.0000 0.0 0
M  V30 7 C 5.3900 4.0011 0.0 0
M  V30 8 C 7.7000 2.6674 0.0 0
M  V30 9 O 3.0800 0.0000 0.0 0
M  V30 10 C 6.9300 4.0011 0.0 0
M  V30 11 C 4.6200 5.3349 0.0 0
M  V30 12 C 2.3100 1.3338 0.0 0
M  V30 13 O 3.0800 5.3349 0.0 0
M  V30 14 C 0.7700 1.3338 0.0 0
M  V30 15 C 2.3100 4.0011 0.0 0
M  V30 16 O 0.0000 2.6674 0.0 0
M  V30 17 C 0.7700 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 2 2 8
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 2 7 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 1 9 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 577794-94-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 577794-95-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-6266143
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A new method for synthesis of crown ether type pyridinophanes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sato, Masayuki; Oda, Tsunehisa; Iwamoto, Ken-Ichi; Fujii, Satoshi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Heterocycles (2003), 60(4), 899-908

$RFMT $RIREG SCHEME370 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Benzimidazole-2-ethanethioamide
C9H9N3S
61689-98-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.5772 2.6673 0.0 0
M  V30 2 C 7.3472 1.3337 0.0 0
M  V30 3 N 6.5772 0.0000 0.0 0
M  V30 4 S 8.8872 1.3337 0.0 0
M  V30 5 C 2.6673 1.8973 0.0 0
M  V30 6 C 2.6673 3.4374 0.0 0
M  V30 7 N 4.1321 1.4215 0.0 0
M  V30 8 C 1.3337 1.1273 0.0 0
M  V30 9 N 4.1321 3.9132 0.0 0
M  V30 10 C 1.3337 4.2074 0.0 0
M  V30 11 C 5.0371 2.6673 0.0 0
M  V30 12 C 0.0000 1.8973 0.0 0
M  V30 13 C 0.0000 3.4374 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 11
M  V30 13 1 10 13
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-1H-benzimidazole-2-ethanethioamide
C10H11N3S
1548829-49-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.0811 3.9554 0.0 0
M  V30 2 C 7.4148 3.1854 0.0 0
M  V30 3 N 8.7486 3.9554 0.0 0
M  V30 4 S 7.4148 1.6454 0.0 0
M  V30 5 C 10.0823 3.1854 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 N 3.3405 3.8119 0.0 0
M  V30 9 C 0.7700 2.6673 0.0 0
M  V30 10 N 4.5865 1.6538 0.0 0
M  V30 11 C 2.3101 0.0000 0.0 0
M  V30 12 C 4.7475 3.1854 0.0 0
M  V30 13 C 0.0000 1.3337 0.0 0
M  V30 14 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 12
M  V30 14 1 11 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 61689-98-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1548829-49-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-033-CAS-12829241
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of a benzimidazole series of ADAMTS-5 (aggrecanase-2)
inhibitors by scaffold hopping
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sogame, Shinya; Suenaga, Yoshihito; Atobe, Masakazu; Kawanishi, Masashi;
Tanaka, Eiichi; Miyoshi, Shiro
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2014), 71250-258

$RFMT $RIREG SCHEME371 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 3-formyl-1-methyl-1H-indole-7-carboxylate
C12H11NO3
620176-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.6825 3.0801 0.0 0
M  V30 2 O 9.0161 2.3101 0.0 0
M  V30 3 O 7.6825 4.6201 0.0 0
M  V30 4 C 10.3500 3.0801 0.0 0
M  V30 5 C 5.7254 5.7308 0.0 0
M  V30 6 C 1.0306 3.0203 0.0 0
M  V30 7 O 0.0000 4.1647 0.0 0
M  V30 8 C 5.0151 3.0801 0.0 0
M  V30 9 C 3.6813 2.3101 0.0 0
M  V30 10 C 6.3488 2.3101 0.0 0
M  V30 11 N 4.6949 4.5864 0.0 0
M  V30 12 C 2.5369 3.3405 0.0 0
M  V30 13 C 3.6813 0.7700 0.0 0
M  V30 14 C 6.3488 0.7700 0.0 0
M  V30 15 C 3.1632 4.7473 0.0 0
M  V30 16 C 5.0151 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 12
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 2 12 15
M  V30 16 1 13 16
M  V30 17 2 14 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Indole-7-carboxylic acid, 1-methyl-3-[(methylamino)methyl]-, methyl ester
C13H16N2O2
620176-13-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 3.0801 0.0 0
M  V30 2 O 1.3337 2.3101 0.0 0
M  V30 3 O 2.6673 4.6201 0.0 0
M  V30 4 C 0.0000 3.0801 0.0 0
M  V30 5 C 4.6244 5.7308 0.0 0
M  V30 6 C 9.3194 3.0203 0.0 0
M  V30 7 N 10.3498 4.1647 0.0 0
M  V30 8 C 11.8561 3.8445 0.0 0
M  V30 9 C 5.3348 3.0801 0.0 0
M  V30 10 C 6.6685 2.3101 0.0 0
M  V30 11 C 4.0010 2.3101 0.0 0
M  V30 12 N 5.6550 4.5864 0.0 0
M  V30 13 C 7.8129 3.3405 0.0 0
M  V30 14 C 6.6685 0.7700 0.0 0
M  V30 15 C 4.0010 0.7700 0.0 0
M  V30 16 C 7.1866 4.7473 0.0 0
M  V30 17 C 5.3348 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 5 12
M  V30 6 1 6 7
M  V30 7 1 6 13
M  V30 8 1 7 8
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 2 13 16
M  V30 17 1 14 17
M  V30 18 2 15 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 620176-12-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 620176-13-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-12939366
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Preparation 12 Preparation of
2-methyl-3-(methylaminomethyl)indole c) Methyl
1-methyl-3-(methylaminomethyl)-1H-indole-7-carboxylate [0798] According
to the procedure of Preparation 12, except substituting
1-methyl-7-methoxycarbonyl-1H-indole 3-carboxaldehyde for the
2-methylindole-3-carboxaldehyde, the title compound (1.7 g, 92%) was
obtained as an oil. MS (ES) m/e 233.2 (M+H)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20060142265 A1 2006-06-29

$RFMT $RIREG SCHEME371 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 3-formyl-1-methyl-1H-indole-7-carboxylate
C12H11NO3
620176-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.6825 3.0801 0.0 0
M  V30 2 O 9.0161 2.3101 0.0 0
M  V30 3 O 7.6825 4.6201 0.0 0
M  V30 4 C 10.3500 3.0801 0.0 0
M  V30 5 C 5.7254 5.7308 0.0 0
M  V30 6 C 1.0306 3.0203 0.0 0
M  V30 7 O 0.0000 4.1647 0.0 0
M  V30 8 C 5.0151 3.0801 0.0 0
M  V30 9 C 3.6813 2.3101 0.0 0
M  V30 10 C 6.3488 2.3101 0.0 0
M  V30 11 N 4.6949 4.5864 0.0 0
M  V30 12 C 2.5369 3.3405 0.0 0
M  V30 13 C 3.6813 0.7700 0.0 0
M  V30 14 C 6.3488 0.7700 0.0 0
M  V30 15 C 3.1632 4.7473 0.0 0
M  V30 16 C 5.0151 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 12
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 2 12 15
M  V30 16 1 13 16
M  V30 17 2 14 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Indole-7-carboxylic acid, 1-methyl-3-[(methylamino)methyl]-, methyl ester
C13H16N2O2
620176-13-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 3.0801 0.0 0
M  V30 2 O 1.3337 2.3101 0.0 0
M  V30 3 O 2.6673 4.6201 0.0 0
M  V30 4 C 0.0000 3.0801 0.0 0
M  V30 5 C 4.6244 5.7308 0.0 0
M  V30 6 C 9.3194 3.0203 0.0 0
M  V30 7 N 10.3498 4.1647 0.0 0
M  V30 8 C 11.8561 3.8445 0.0 0
M  V30 9 C 5.3348 3.0801 0.0 0
M  V30 10 C 6.6685 2.3101 0.0 0
M  V30 11 C 4.0010 2.3101 0.0 0
M  V30 12 N 5.6550 4.5864 0.0 0
M  V30 13 C 7.8129 3.3405 0.0 0
M  V30 14 C 6.6685 0.7700 0.0 0
M  V30 15 C 4.0010 0.7700 0.0 0
M  V30 16 C 7.1866 4.7473 0.0 0
M  V30 17 C 5.3348 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 5 12
M  V30 6 1 6 7
M  V30 7 1 6 13
M  V30 8 1 7 8
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 2 13 16
M  V30 17 1 14 17
M  V30 18 2 15 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 620176-12-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 620176-13-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-4534007
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004082586 A2 2004-09-30

$RFMT $RIREG SCHEME371 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 3-formyl-1-methyl-1H-indole-7-carboxylate
C12H11NO3
620176-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.6825 3.0801 0.0 0
M  V30 2 O 9.0161 2.3101 0.0 0
M  V30 3 O 7.6825 4.6201 0.0 0
M  V30 4 C 10.3500 3.0801 0.0 0
M  V30 5 C 5.7254 5.7308 0.0 0
M  V30 6 C 1.0306 3.0203 0.0 0
M  V30 7 O 0.0000 4.1647 0.0 0
M  V30 8 C 5.0151 3.0801 0.0 0
M  V30 9 C 3.6813 2.3101 0.0 0
M  V30 10 C 6.3488 2.3101 0.0 0
M  V30 11 N 4.6949 4.5864 0.0 0
M  V30 12 C 2.5369 3.3405 0.0 0
M  V30 13 C 3.6813 0.7700 0.0 0
M  V30 14 C 6.3488 0.7700 0.0 0
M  V30 15 C 3.1632 4.7473 0.0 0
M  V30 16 C 5.0151 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 12
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 2 12 15
M  V30 16 1 13 16
M  V30 17 2 14 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Indole-7-carboxylic acid, 1-methyl-3-[(methylamino)methyl]-, methyl ester
C13H16N2O2
620176-13-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 3.0801 0.0 0
M  V30 2 O 1.3337 2.3101 0.0 0
M  V30 3 O 2.6673 4.6201 0.0 0
M  V30 4 C 0.0000 3.0801 0.0 0
M  V30 5 C 4.6244 5.7308 0.0 0
M  V30 6 C 9.3194 3.0203 0.0 0
M  V30 7 N 10.3498 4.1647 0.0 0
M  V30 8 C 11.8561 3.8445 0.0 0
M  V30 9 C 5.3348 3.0801 0.0 0
M  V30 10 C 6.6685 2.3101 0.0 0
M  V30 11 C 4.0010 2.3101 0.0 0
M  V30 12 N 5.6550 4.5864 0.0 0
M  V30 13 C 7.8129 3.3405 0.0 0
M  V30 14 C 6.6685 0.7700 0.0 0
M  V30 15 C 4.0010 0.7700 0.0 0
M  V30 16 C 7.1866 4.7473 0.0 0
M  V30 17 C 5.3348 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 5 12
M  V30 6 1 6 7
M  V30 7 1 6 13
M  V30 8 1 7 8
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 2 13 16
M  V30 17 1 14 17
M  V30 18 2 15 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 620176-12-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 620176-13-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-4317275
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of N-(heteroaryl)methylacrylamides as Fab I inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Burgess, Walter J.; Jakas, Dalia; Huffman, William F.; Miller, William
H.; Newlander, Kenneth A.; Seefeld, Mark A.; Uzinskas, Irene N.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2003088897 A2 2003-10-30

$RFMT $RIREG SCHEME372 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
D-Mannonimidic-15N acid, 2,3:5,6-bis-O-(1-methylethylidene)-N-[(methylsulfony...
C13H21NO8S
620946-79-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 7.7444 4.6687 0.0 0 MASS=15
M  V30 2 O 8.5144 6.0023 0.0 0
M  V30 3 S 10.0544 6.0023 0.0 0 VAL=6
M  V30 4 C 10.0544 4.4623 0.0 0
M  V30 5 O 11.5944 6.0023 0.0 0
M  V30 6 O 10.0544 7.5423 0.0 0
M  V30 7 C 4.4609 0.0000 0.0 0
M  V30 8 C 2.5008 0.6369 0.0 0
M  V30 9 C 0.0000 8.7455 0.0 0
M  V30 10 C 0.0000 6.6845 0.0 0
M  V30 11 C 3.8344 5.4387 0.0 0 CFG=1
M  V30 12 C 3.8344 3.8987 0.0 0 CFG=2
M  V30 13 O 5.2991 5.9145 0.0 0
M  V30 14 C 5.2991 3.4228 0.0 0 CFG=2
M  V30 15 O 2.9292 2.6528 0.0 0
M  V30 16 C 6.2044 4.6687 0.0 0
M  V30 17 O 5.2991 1.8828 0.0 0
M  V30 18 C 3.8344 1.4069 0.0 0
M  V30 19 C 3.5143 6.9451 0.0 0 CFG=1
M  V30 20 O 2.0497 6.4691 0.0 0
M  V30 21 C 3.5143 8.4851 0.0 0
M  V30 22 C 1.1445 7.7151 0.0 0
M  V30 23 O 2.0497 8.9610 0.0 0
M  V30 24 H 2.3029 5.2777 0.0 0
M  V30 25 H 2.3699 4.3745 0.0 0
M  V30 26 H 6.7637 2.9469 0.0 0
M  V30 27 H 5.0458 7.1060 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 16
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 2 3 6
M  V30 7 1 7 18
M  V30 8 1 8 18
M  V30 9 1 9 22
M  V30 10 1 10 22
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 19
M  V30 14 1 11 24 CFG=3
M  V30 15 1 12 14
M  V30 16 1 12 15
M  V30 17 1 12 25 CFG=3
M  V30 18 1 13 16
M  V30 19 1 14 16
M  V30 20 1 14 17
M  V30 21 1 14 26 CFG=3
M  V30 22 1 15 18
M  V30 23 1 17 18
M  V30 24 1 19 20
M  V30 25 1 19 21
M  V30 26 1 19 27 CFG=1
M  V30 27 1 20 22
M  V30 28 1 21 23
M  V30 29 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 11 12 14 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(3R,3′aS,6′R,6′aS)-6′-[(4R)-2,2-Dimethyl-1,3-dioxolan-4-yl]dihydro-1,2′,2′-tr...
C13H22N2O5
620947-00-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.9415 0.0000 0.0 0
M  V30 2 C 1.5315 8.0970 0.0 0
M  V30 3 C 0.0000 6.7179 0.0 0
M  V30 4 C 9.8043 6.2084 0.0 0
M  V30 5 C 8.0194 7.2389 0.0 0
M  V30 6 C 3.1715 2.8738 0.0 0 CFG=1
M  V30 7 C 2.5452 4.2806 0.0 0 CFG=1
M  V30 8 O 4.7030 3.0347 0.0 0
M  V30 9 N 3.1715 1.3338 0.0 0
M  V30 10 N 1.8378 2.1038 0.0 0
M  V30 11 C 3.6895 5.3110 0.0 0 CFG=1
M  V30 12 O 1.2114 5.0506 0.0 0
M  V30 13 C 5.0232 4.5410 0.0 0 CFG=2
M  V30 14 O 3.0632 6.7179 0.0 0
M  V30 15 C 1.5315 6.5570 0.0 0
M  V30 16 C 6.4879 4.0651 0.0 0 CFG=1
M  V30 17 O 6.8080 5.5716 0.0 0
M  V30 18 C 7.8215 3.2951 0.0 0
M  V30 19 C 8.3396 5.7325 0.0 0
M  V30 20 O 8.9660 4.3257 0.0 0
M  V30 21 H 1.4006 3.2502 0.0 0
M  V30 22 H 4.8339 6.3416 0.0 0
M  V30 23 H 5.6496 5.9479 0.0 0
M  V30 24 H 5.8614 2.6583 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 15
M  V30 3 1 3 15
M  V30 4 1 4 19
M  V30 5 1 5 19
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 6 10 CFG=1
M  V30 10 1 7 11
M  V30 11 1 7 12
M  V30 12 1 7 21 CFG=3
M  V30 13 1 8 13
M  V30 14 1 9 10
M  V30 15 1 11 13
M  V30 16 1 11 14
M  V30 17 1 11 22 CFG=3
M  V30 18 1 12 15
M  V30 19 1 13 16
M  V30 20 1 13 23 CFG=3
M  V30 21 1 14 15
M  V30 22 1 16 17
M  V30 23 1 16 18
M  V30 24 1 16 24 CFG=1
M  V30 25 1 17 19
M  V30 26 1 18 20
M  V30 27 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 6 7 11 13 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 620946-79-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 620947-00-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28255015
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM isomer mix.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Glycosylidene carbenes: Part 31: Glycosylidene diaziridines:
Stereoselective addition of ammonia and methylamine to lactone oxime
sulfonates
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bernet, Bruno; Mangholz, Sissi E.; Briner, Karin; Vasella, Andrea
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Helvetica Chimica Acta (2003), 86(5), 1488-1521

$RFMT $RIREG SCHEME373 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,6-Dibromopyridine
C5H3Br2N
626-05-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 0.0000 3.0800 0.0 0
M  V30 2 Br 5.3349 3.0800 0.0 0
M  V30 3 N 2.6675 3.0800 0.0 0
M  V30 4 C 1.3338 2.3100 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 1.3338 0.7700 0.0 0
M  V30 7 C 4.0011 0.7700 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 5
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 2 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromo-N-methyl-2-pyridinamine
C6H7BrN2
89026-79-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 3.0801 0.0 0
M  V30 2 C 6.6687 2.3101 0.0 0
M  V30 3 Br 0.0000 3.0801 0.0 0
M  V30 4 C 4.0012 2.3101 0.0 0
M  V30 5 N 2.6675 3.0801 0.0 0
M  V30 6 C 4.0012 0.7700 0.0 0
M  V30 7 C 1.3338 2.3101 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 9 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 7
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 626-05-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 89026-79-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-13412097
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 6-Bromo-2-methylaminopyridine 2: An autoclave equipped with a magnetic
stir bar was charged with 2,6-dibromopyridine 1 (47.4 g, 200 mmol),
methylamine alcohol solution (27.55g, 27-32%) and 100 mL alcohol. Then it
was heated to 190 °C for 5 h. After the mixture was cooled to room
temperature, the solvent was removed under reduced pressure, and the
residue was dissolved in dichloromethane (400 mL). The organic solution
was washed with saturated Na2CO3 solution (100 mL) and brine (3 × 150mL).
The aqueous phase was re-extracted with dichloromethane (3 × 150mL), and
the combined organic phase was dried over anhydrous Na2SO4. After removal
of solvent, the residue was chromatographed on a silica gel column with a
mixture of petroleum ether and ethyl acetate as the mobile phase to give
pure 2 (34.49g, 92%) as a white solid: mp 62-63 °C; 1H NMR (CDCl3,
300MHz, TMS) δ 7.17 (dd, J = 8.2, 7.4 Hz, 1H), 6.61 (d, J =7.4 Hz, 1H),
6.18 (d, J =8.2Hz, 1H), 5.19 (brs, 1H), 2.8 (s, 3H); 13C NMR (75 MHz,
CDCl3, TMS) δ 160.0, 140.1, 139.6, 115.4, 103.7, 29.1; IR (KBr) 3309,
1596, 1553, 1526 cm-1.
$DTYPE RXN:VAR(1):NOTES
$DATUM autoclave used, products depend on stoichiometry of reactants
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of (NH)m(NMe)4-m-Bridged Calix[4]pyridines and the Effect of NH
Bridge on Structure and Properties
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, En-Xuan; Wang, De-Xian; Huang, Zhi-Tang; Wang, Mei-Xiang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2009), 74(22), 8595-8603

$RFMT $RIREG SCHEME373 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,6-Dibromopyridine
C5H3Br2N
626-05-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 0.0000 3.0800 0.0 0
M  V30 2 Br 5.3349 3.0800 0.0 0
M  V30 3 N 2.6675 3.0800 0.0 0
M  V30 4 C 1.3338 2.3100 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 1.3338 0.7700 0.0 0
M  V30 7 C 4.0011 0.7700 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 5
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 2 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromo-N-methyl-2-pyridinamine
C6H7BrN2
89026-79-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 3.0801 0.0 0
M  V30 2 C 6.6687 2.3101 0.0 0
M  V30 3 Br 0.0000 3.0801 0.0 0
M  V30 4 C 4.0012 2.3101 0.0 0
M  V30 5 N 2.6675 3.0801 0.0 0
M  V30 6 C 4.0012 0.7700 0.0 0
M  V30 7 C 1.3338 2.3101 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 9 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 7
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 626-05-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 89026-79-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-136478
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM An autoclave equipped with a magnetic stir bar was charged with 1 (47.4
g, 200 mmol), methylamine alcohol solution (27.55g, 27-32%) and 100 mL
alcohol. Then it was heated to 190 °C for 5 h. After cooling to room
temperature, the solvent was removed under reduced pressure, and the
residue was dissolved in CH2Cl2 (400 mL). The organic solution was washed
with saturated Na2CO3 solution (100 mL) and brine (3×150 mL). The aqueous
phase was re-extracted with dichloromethane (3×150 mL), and the combined
organic phase was dried over anhydrous Na2SO4. After removal of solvent,
the residue was chromatographed on a silica gel column (100-200) with a
mixture of petroleum ether and ethyl acetate as the mobile phase to give
pure 3 (34.49g, 92%) as a white solid. mp 62-63 °C; IR (KBr) 1526, 1553,
1596, 3309 cm-1; 1H NMR (CDCl3/300MHz) δ 7.17 (dd, J = 8.2, 7.4 Hz, 1H),
6.61 (d, J = 7.4 Hz, 1H), 6.18 (d, J= 8.2Hz, 1H), 5.19 (br.s, 1H), 2.8
(s, 3H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of Large Macrocyclic Azacalix[n]pyridines (n = 6 - 9) and Their
Complexation with Fullerenes C60 and C70
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, En-Xuan; Wang, De-Xian; Zheng, Qi-Yu; Wang, Mei-Xiang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2008), 10(12), 2565-2568

$RFMT $RIREG SCHEME374 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl nitroacetate
C4H7NO4
626-35-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 2.3100 0.0 0
M  V30 2 C 4.0011 1.5400 0.0 0
M  V30 3 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 4 O 5.3348 2.3100 0.0 0
M  V30 5 O 4.0011 0.0000 0.0 0
M  V30 6 O 0.0000 2.3100 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 6.6686 1.5400 0.0 0
M  V30 9 C 8.0022 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 2 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2-nitroacetamide
C3H6N2O3
72078-82-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 2.6674 2.3100 0.0 0
M  V30 3 N 5.3347 2.3100 0.0 0
M  V30 4 O 4.0011 0.0000 0.0 0
M  V30 5 N 1.3338 1.5400 0.0 0 VAL=5
M  V30 6 C 6.6685 1.5400 0.0 0
M  V30 7 O 0.0000 2.3100 0.0 0
M  V30 8 O 1.3338 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 2 5 7
M  V30 7 2 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 626-35-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 72078-82-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-5057074
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 1,4-Diazabicyclo[2.2.2]octane (DABCO) as an efficient reagent for the
synthesis of isoxazole derivatives from primary nitro compounds and
dipolarophiles: the role of the base
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cecchi, Luca; De Sarlo, Francesco; Machetti, Fabrizio
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2006), (21), 4852-4860

$RFMT $RIREG SCHEME375 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-3-nitrobenzoic acid
C7H4BrNO4
6319-40-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3336 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3336 0.0000 0.0 0
M  V30 4 Br 1.3336 4.6200 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 6.6685 0.0000 0.0 0
M  V30 7 O 8.0021 2.3100 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 C 4.0011 1.5400 0.0 0
M  V30 10 C 2.6674 3.8500 0.0 0
M  V30 11 C 5.3347 2.3100 0.0 0
M  V30 12 C 4.0011 4.6200 0.0 0
M  V30 13 C 5.3347 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 10
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Methylamino)-3-nitrobenzoic acid
C8H8N2O4
41263-74-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0012 6.1601 0.0 0 VAL=5
M  V30 2 O 5.3348 6.9302 0.0 0
M  V30 3 O 2.6675 6.9302 0.0 0
M  V30 4 N 6.6687 4.6201 0.0 0
M  V30 5 C 8.0023 3.8501 0.0 0
M  V30 6 C 1.3337 1.5400 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 3.8501 0.0 0
M  V30 11 C 2.6675 3.8501 0.0 0
M  V30 12 C 5.3348 2.3101 0.0 0
M  V30 13 C 2.6675 2.3101 0.0 0
M  V30 14 C 4.0012 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 4 5
M  V30 5 1 4 10
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 13
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 6319-40-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 41263-74-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-20298866
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 534-17-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 87-89-8
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 7440-50-8
$DTYPE RXN:VAR(1):CAT(3):CAS_RN
$DATUM 32503-27-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM aerobic
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM "On Water" promoted N-arylation reactions using Cu(0)/myo-inositol
catalytic system
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhou, Qifan; Du, Fangyu; Chen, Yuanguang; Fu, Yang; Chen, Guoliang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2019), 60(29), 1938-1941

$RFMT $RIREG SCHEME376 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-9-(2,3,5-tri-O-benzoyl-2-C-methyl-β-D-ribofuranosyl)-9H-purin-2-amine
C32H26ClN5O7
641571-44-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  45 50 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.3347 8.8319 0.0 0
M  V30 2 C 4.0011 8.0619 0.0 0
M  V30 3 O 4.0011 6.5219 0.0 0
M  V30 4 C 5.7632 6.8161 0.0 0
M  V30 5 O 7.6520 5.5000 0.0 0
M  V30 6 C 8.8979 4.5948 0.0 0
M  V30 7 O 10.3047 5.2211 0.0 0
M  V30 8 C 10.5535 7.1752 0.0 0
M  V30 9 O 11.7994 8.0804 0.0 0
M  V30 10 C 13.2062 7.4539 0.0 0
M  V30 11 O 13.3671 5.9224 0.0 0
M  V30 12 Cl 5.1824 15.7768 0.0 0
M  V30 13 N 10.4006 14.6675 0.0 0
M  V30 14 C 7.2949 9.4689 0.0 0 CFG=2
M  V30 15 C 6.6684 8.0619 0.0 0 CFG=2
M  V30 16 O 8.8264 9.3080 0.0 0
M  V30 17 C 7.8129 7.0315 0.0 0 CFG=2
M  V30 18 C 9.1466 7.8015 0.0 0 CFG=2
M  V30 19 N 6.5249 10.8025 0.0 0
M  V30 20 C 7.1512 12.2095 0.0 0
M  V30 21 C 4.9932 10.9635 0.0 0
M  V30 22 C 6.0068 13.2399 0.0 0
M  V30 23 N 8.6159 12.6854 0.0 0
M  V30 24 N 4.6730 12.4699 0.0 0
M  V30 25 C 6.3270 14.7462 0.0 0
M  V30 26 C 8.9360 14.1916 0.0 0
M  V30 27 N 7.7915 15.2222 0.0 0
M  V30 28 C 2.6674 8.8319 0.0 0
M  V30 29 C 2.6674 10.3720 0.0 0
M  V30 30 C 1.3336 8.0619 0.0 0
M  V30 31 C 1.3336 11.1420 0.0 0
M  V30 32 C 0.0000 8.8319 0.0 0
M  V30 33 C 0.0000 10.3720 0.0 0
M  V30 34 C 8.7368 3.0632 0.0 0
M  V30 35 C 9.9828 2.1580 0.0 0
M  V30 36 C 7.3300 2.4368 0.0 0
M  V30 37 C 9.8217 0.6265 0.0 0
M  V30 38 C 7.1690 0.9052 0.0 0
M  V30 39 C 8.4149 0.0000 0.0 0
M  V30 40 C 14.4520 8.3592 0.0 0
M  V30 41 C 15.8590 7.7328 0.0 0
M  V30 42 C 14.2911 9.8907 0.0 0
M  V30 43 C 17.1049 8.6381 0.0 0
M  V30 44 C 15.5370 10.7959 0.0 0
M  V30 45 C 16.9439 10.1696 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 15 1 CFG=1
M  V30 3 2 2 3
M  V30 4 1 2 28
M  V30 5 1 15 4 CFG=3
M  V30 6 1 5 6
M  V30 7 1 17 5 CFG=1
M  V30 8 2 6 7
M  V30 9 1 6 34
M  V30 10 1 8 9
M  V30 11 1 18 8 CFG=3
M  V30 12 1 9 10
M  V30 13 2 10 11
M  V30 14 1 10 40
M  V30 15 1 12 25
M  V30 16 1 13 26
M  V30 17 1 14 15
M  V30 18 1 14 16
M  V30 19 1 14 19 CFG=3
M  V30 20 1 15 17
M  V30 21 1 16 18
M  V30 22 1 17 18
M  V30 23 1 19 20
M  V30 24 1 19 21
M  V30 25 1 20 22
M  V30 26 2 20 23
M  V30 27 2 21 24
M  V30 28 1 22 24
M  V30 29 2 22 25
M  V30 30 1 23 26
M  V30 31 1 25 27
M  V30 32 2 26 27
M  V30 33 2 28 29
M  V30 34 1 28 30
M  V30 35 1 29 31
M  V30 36 2 30 32
M  V30 37 2 31 33
M  V30 38 1 32 33
M  V30 39 2 34 35
M  V30 40 1 34 36
M  V30 41 1 35 37
M  V30 42 2 36 38
M  V30 43 2 37 39
M  V30 44 1 38 39
M  V30 45 2 40 41
M  V30 46 1 40 42
M  V30 47 1 41 43
M  V30 48 2 42 44
M  V30 49 2 43 45
M  V30 50 1 44 45
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 14 15 17 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
2-Amino-N-methyl-2′-C-methyladenosine
C12H18N6O4
714249-79-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.8851 6.6212 0.0 0
M  V30 2 O 1.8354 6.8367 0.0 0
M  V30 3 N 10.5368 4.6200 0.0 0
M  V30 4 C 11.8706 3.8500 0.0 0
M  V30 5 N 7.8696 0.0000 0.0 0
M  V30 6 C 0.6967 2.1700 0.0 0
M  V30 7 O 1.1726 0.7053 0.0 0
M  V30 8 O 0.0000 5.4471 0.0 0
M  V30 9 N 5.3914 4.8804 0.0 0
M  V30 10 C 6.5359 3.8500 0.0 0
M  V30 11 C 6.0177 6.2874 0.0 0
M  V30 12 C 7.8696 4.6200 0.0 0
M  V30 13 N 6.5359 2.3100 0.0 0
M  V30 14 N 7.5494 6.1264 0.0 0
M  V30 15 C 9.2032 3.8500 0.0 0
M  V30 16 C 7.8696 1.5400 0.0 0
M  V30 17 N 9.2032 2.3100 0.0 0
M  V30 18 C 3.8851 4.5602 0.0 0 CFG=1
M  V30 19 O 3.2586 3.1535 0.0 0
M  V30 20 C 2.7406 5.5908 0.0 0 CFG=1
M  V30 21 C 1.7271 3.3144 0.0 0 CFG=2
M  V30 22 C 1.4069 4.8208 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 20 1 CFG=3
M  V30 2 1 20 2 CFG=1
M  V30 3 1 3 4
M  V30 4 1 3 15
M  V30 5 1 5 16
M  V30 6 1 6 7
M  V30 7 1 21 6 CFG=3
M  V30 8 1 22 8 CFG=1
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 18 9 CFG=3
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 2 11 14
M  V30 15 1 12 14
M  V30 16 2 12 15
M  V30 17 1 13 16
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 20 1 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 18 20 21 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 641571-44-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 714249-79-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-11229753
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Dual pro-drugs of 2'-C-methyl guanosine monophosphate as potent and
selective inhibitors of hepatitis C virus
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM McGuigan, Christopher; Madela, Karolina; Aljarah, Mohamed; Gilles,
Arnaud; Battina, Srinivas K.; Ramamurty, Changalvala V. S.; Srinivas Rao,
C.; Vernachio, John; Hutchins, Jeff; Hall, Andrea; Kolykhalov, Alexander;
Henson, Geoffrey; Chamberlain, Stanley
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2011), 21(19), 6007-6012

$RFMT $RIREG SCHEME376 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-9-(2,3,5-tri-O-benzoyl-2-C-methyl-β-D-ribofuranosyl)-9H-purin-2-amine
C32H26ClN5O7
641571-44-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  45 50 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.3347 8.8319 0.0 0
M  V30 2 C 4.0011 8.0619 0.0 0
M  V30 3 O 4.0011 6.5219 0.0 0
M  V30 4 C 5.7632 6.8161 0.0 0
M  V30 5 O 7.6520 5.5000 0.0 0
M  V30 6 C 8.8979 4.5948 0.0 0
M  V30 7 O 10.3047 5.2211 0.0 0
M  V30 8 C 10.5535 7.1752 0.0 0
M  V30 9 O 11.7994 8.0804 0.0 0
M  V30 10 C 13.2062 7.4539 0.0 0
M  V30 11 O 13.3671 5.9224 0.0 0
M  V30 12 Cl 5.1824 15.7768 0.0 0
M  V30 13 N 10.4006 14.6675 0.0 0
M  V30 14 C 7.2949 9.4689 0.0 0 CFG=2
M  V30 15 C 6.6684 8.0619 0.0 0 CFG=2
M  V30 16 O 8.8264 9.3080 0.0 0
M  V30 17 C 7.8129 7.0315 0.0 0 CFG=2
M  V30 18 C 9.1466 7.8015 0.0 0 CFG=2
M  V30 19 N 6.5249 10.8025 0.0 0
M  V30 20 C 7.1512 12.2095 0.0 0
M  V30 21 C 4.9932 10.9635 0.0 0
M  V30 22 C 6.0068 13.2399 0.0 0
M  V30 23 N 8.6159 12.6854 0.0 0
M  V30 24 N 4.6730 12.4699 0.0 0
M  V30 25 C 6.3270 14.7462 0.0 0
M  V30 26 C 8.9360 14.1916 0.0 0
M  V30 27 N 7.7915 15.2222 0.0 0
M  V30 28 C 2.6674 8.8319 0.0 0
M  V30 29 C 2.6674 10.3720 0.0 0
M  V30 30 C 1.3336 8.0619 0.0 0
M  V30 31 C 1.3336 11.1420 0.0 0
M  V30 32 C 0.0000 8.8319 0.0 0
M  V30 33 C 0.0000 10.3720 0.0 0
M  V30 34 C 8.7368 3.0632 0.0 0
M  V30 35 C 9.9828 2.1580 0.0 0
M  V30 36 C 7.3300 2.4368 0.0 0
M  V30 37 C 9.8217 0.6265 0.0 0
M  V30 38 C 7.1690 0.9052 0.0 0
M  V30 39 C 8.4149 0.0000 0.0 0
M  V30 40 C 14.4520 8.3592 0.0 0
M  V30 41 C 15.8590 7.7328 0.0 0
M  V30 42 C 14.2911 9.8907 0.0 0
M  V30 43 C 17.1049 8.6381 0.0 0
M  V30 44 C 15.5370 10.7959 0.0 0
M  V30 45 C 16.9439 10.1696 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 15 1 CFG=1
M  V30 3 2 2 3
M  V30 4 1 2 28
M  V30 5 1 15 4 CFG=3
M  V30 6 1 5 6
M  V30 7 1 17 5 CFG=1
M  V30 8 2 6 7
M  V30 9 1 6 34
M  V30 10 1 8 9
M  V30 11 1 18 8 CFG=3
M  V30 12 1 9 10
M  V30 13 2 10 11
M  V30 14 1 10 40
M  V30 15 1 12 25
M  V30 16 1 13 26
M  V30 17 1 14 15
M  V30 18 1 14 16
M  V30 19 1 14 19 CFG=3
M  V30 20 1 15 17
M  V30 21 1 16 18
M  V30 22 1 17 18
M  V30 23 1 19 20
M  V30 24 1 19 21
M  V30 25 1 20 22
M  V30 26 2 20 23
M  V30 27 2 21 24
M  V30 28 1 22 24
M  V30 29 2 22 25
M  V30 30 1 23 26
M  V30 31 1 25 27
M  V30 32 2 26 27
M  V30 33 2 28 29
M  V30 34 1 28 30
M  V30 35 1 29 31
M  V30 36 2 30 32
M  V30 37 2 31 33
M  V30 38 1 32 33
M  V30 39 2 34 35
M  V30 40 1 34 36
M  V30 41 1 35 37
M  V30 42 2 36 38
M  V30 43 2 37 39
M  V30 44 1 38 39
M  V30 45 2 40 41
M  V30 46 1 40 42
M  V30 47 1 41 43
M  V30 48 2 42 44
M  V30 49 2 43 45
M  V30 50 1 44 45
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 14 15 17 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
2-Amino-N-methyl-2′-C-methyladenosine
C12H18N6O4
714249-79-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.8851 6.6212 0.0 0
M  V30 2 O 1.8354 6.8367 0.0 0
M  V30 3 N 10.5368 4.6200 0.0 0
M  V30 4 C 11.8706 3.8500 0.0 0
M  V30 5 N 7.8696 0.0000 0.0 0
M  V30 6 C 0.6967 2.1700 0.0 0
M  V30 7 O 1.1726 0.7053 0.0 0
M  V30 8 O 0.0000 5.4471 0.0 0
M  V30 9 N 5.3914 4.8804 0.0 0
M  V30 10 C 6.5359 3.8500 0.0 0
M  V30 11 C 6.0177 6.2874 0.0 0
M  V30 12 C 7.8696 4.6200 0.0 0
M  V30 13 N 6.5359 2.3100 0.0 0
M  V30 14 N 7.5494 6.1264 0.0 0
M  V30 15 C 9.2032 3.8500 0.0 0
M  V30 16 C 7.8696 1.5400 0.0 0
M  V30 17 N 9.2032 2.3100 0.0 0
M  V30 18 C 3.8851 4.5602 0.0 0 CFG=1
M  V30 19 O 3.2586 3.1535 0.0 0
M  V30 20 C 2.7406 5.5908 0.0 0 CFG=1
M  V30 21 C 1.7271 3.3144 0.0 0 CFG=2
M  V30 22 C 1.4069 4.8208 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 20 1 CFG=3
M  V30 2 1 20 2 CFG=1
M  V30 3 1 3 4
M  V30 4 1 3 15
M  V30 5 1 5 16
M  V30 6 1 6 7
M  V30 7 1 21 6 CFG=3
M  V30 8 1 22 8 CFG=1
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 18 9 CFG=3
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 2 11 14
M  V30 15 1 12 14
M  V30 16 2 12 15
M  V30 17 1 13 16
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 20 1 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 18 20 21 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 641571-44-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 714249-79-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-8738150
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM The
(3R,4R,5R)-2-(2-amino-6-(methylamino)-9H-purin-9-yl)-5-(hydroxymethyl)-3-methyltetrahydrofuran-3,4-diol
was synthesized accordingly: To a solution of
(3R,4R,5R)-2-(2-amino-6-chloro-9H-purin-9-yl)-5-(benzoyloxymethyl)-3-methyltetrahydrofuran-3,4-diyl
dibenzoate (150 mg, 0.239 mmol) in ethanol was added methyl amine (1 mL,
1.2 mmol) and triethyl amine (0.17 mL, 1.2 mmol) and heated to 85 °C
overnight in sealed tube. After cooling and evaporation, the crude
product was purified by column chromatography using
dichloromethane/methanol (93:7) to give 68 mg (92% yield) of
(3R,4R,5R)-2-(2-amino-6-(methylamino)-9H-purin-9-yl)-5-(hydroxymethyl)-3-methyltetrahydrofuran-3,4-diol
as an off white solid. 1H NMR (200 MHz, CD3OD): δ 8.06 (s, 1H), 5.9 (s,
1H), 4.25 (d, J =8.8 Hz, 1H), 4.0 (m, 2H), 3.85 9dd, J =3.2 Hz, J =3.2
Hz, 1H), 3.6 (s, 1H), 3.04 (s, 3H), 0.92 (s, 3H).
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of phosphoramidate derivatives of guanosine nucleoside
compounds for treatment of viral infections
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chamberlain, Stanley; Hutchins, Jeff; Medela, Karolina; Mcguigan,
Christopher; Vernachio, John; Aljarah, Mohamad; Gilles, Arnaud
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010081082 A2 2010-07-15

$RFMT $RIREG SCHEME377 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Bromo-2,4-difluorobenzoic acid
C7H3BrF2O2
651026-98-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 F 2.3101 0.0000 0.0 0
M  V30 5 Br 5.3901 0.0000 0.0 0
M  V30 6 F 6.9302 2.6673 0.0 0
M  V30 7 C 2.3101 2.6673 0.0 0
M  V30 8 C 3.0801 1.3337 0.0 0
M  V30 9 C 3.0801 4.0010 0.0 0
M  V30 10 C 4.6201 1.3337 0.0 0
M  V30 11 C 4.6201 4.0010 0.0 0
M  V30 12 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 8
M  V30 5 1 5 10
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzamide, 3-bromo-2,4-difluoro-N-methyl-
C8H6BrF2NO
1355011-53-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 2.6673 0.0 0
M  V30 2 N 6.9302 4.0010 0.0 0
M  V30 3 O 6.9302 1.3337 0.0 0
M  V30 4 C 8.4702 4.0010 0.0 0
M  V30 5 F 4.6201 0.0000 0.0 0
M  V30 6 Br 1.5400 0.0000 0.0 0
M  V30 7 F 0.0000 2.6673 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 3.8501 1.3337 0.0 0
M  V30 10 C 3.8501 4.0010 0.0 0
M  V30 11 C 2.3101 1.3337 0.0 0
M  V30 12 C 2.3101 4.0010 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 9
M  V30 6 1 6 11
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 651026-98-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1355011-53-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-5933717
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 39968-33-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Synthesis of 3-bromo-2,4-difluoro-N-methylbenzamide [00213] A solution of
methylamine (1.5 equiv.), aza-HOBt (2.0 equiv.),
3-bromo-2,4-difluorobenzoic acid (1.0 equiv.) and EDC (2.0 equiv.) in DMF
(0.30 M) was stirred at RT for 19 h. The reaction mixture was then
diluted with EtOAc and water. The aqueous layer was then separated and
extracted with EtOAc. The organic layer was then dried over MgSO4 and
concentrated in vaccuo to yield a white solid.The crudel was further
purified by column chromatography eluting with 100% heptane to
10%EtOAc:heptane to 30% EtOAc:heptane to yield
3-bromo-2,4-difluoro-N-methylbenzamide. 92% yield. LC/MS (m/z): 249.8
(MH+), Rt= 0.46 min.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of cyclic ether compounds useful as kinase inhibitors for
treatment of cancer or autoimmune diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Burger, Matthew; Ding, Yu; Han, Wooseok; Lindvall, Mika; Nishiguchi,
Gisele A.; Rico, Alice; Smith, Aaron; Tanner, Huw; Wan, Lifeng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012004217 A1 2012-01-12

$RFMT $RIREG SCHEME378 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dibenzo[c,h]xanthylium, 5,6,8,9-tetrahydro-, perchlorate
C21H17O.ClO4
6581-93-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 7.7001 0.0 0
M  V30 2 C 2.6673 6.9301 0.0 0
M  V30 3 C 4.0012 9.2401 0.0 0
M  V30 4 O 5.3348 6.9301 0.0 0 CHG=1 VAL=3
M  V30 5 C 1.3337 7.7001 0.0 0
M  V30 6 C 2.6673 5.3900 0.0 0
M  V30 7 C 5.3348 10.0101 0.0 0
M  V30 8 C 2.6673 10.0101 0.0 0
M  V30 9 C 6.6685 7.7001 0.0 0
M  V30 10 C 1.3337 9.2401 0.0 0
M  V30 11 C 0.0000 6.9301 0.0 0
M  V30 12 C 1.3337 4.6200 0.0 0
M  V30 13 C 6.6685 9.2401 0.0 0
M  V30 14 C 8.0023 6.9301 0.0 0
M  V30 15 C 0.0000 5.3900 0.0 0
M  V30 16 C 8.0023 10.0101 0.0 0
M  V30 17 C 9.3360 7.7001 0.0 0
M  V30 18 C 8.0023 5.3900 0.0 0
M  V30 19 C 9.3360 9.2401 0.0 0
M  V30 20 C 10.6697 6.9301 0.0 0
M  V30 21 C 9.3360 4.6200 0.0 0
M  V30 22 C 10.6697 5.3900 0.0 0
M  V30 23 Cl 5.3348 1.5400 0.0 0 VAL=7
M  V30 24 O 3.7948 1.5400 0.0 0
M  V30 25 O 6.8748 1.5400 0.0 0
M  V30 26 O 5.3348 0.0000 0.0 0
M  V30 27 O 5.3348 3.0800 0.0 0 CHG=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 2 3 7
M  V30 7 1 3 8
M  V30 8 1 4 9
M  V30 9 1 5 10
M  V30 10 2 5 11
M  V30 11 1 6 12
M  V30 12 1 7 13
M  V30 13 1 8 10
M  V30 14 2 9 13
M  V30 15 1 9 14
M  V30 16 1 11 15
M  V30 17 2 12 15
M  V30 18 1 13 16
M  V30 19 1 14 17
M  V30 20 2 14 18
M  V30 21 1 16 19
M  V30 22 1 17 19
M  V30 23 2 17 20
M  V30 24 1 18 21
M  V30 25 1 20 22
M  V30 26 2 21 22
M  V30 27 2 23 24
M  V30 28 2 23 25
M  V30 29 2 23 26
M  V30 30 1 23 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dibenz[c,h]acridinium, 5,6,8,9-tetrahydro-14-methyl-, perchlorate (1:1)
C22H20N.ClO4
2904546-56-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 5.3900 0.0 0
M  V30 2 C 6.6685 7.7001 0.0 0
M  V30 3 C 8.0023 6.9301 0.0 0
M  V30 4 C 6.6685 9.2401 0.0 0
M  V30 5 N 5.3348 6.9301 0.0 0 CHG=1 VAL=4
M  V30 6 C 9.3360 7.7001 0.0 0
M  V30 7 C 8.0023 5.3900 0.0 0
M  V30 8 C 5.3348 10.0101 0.0 0
M  V30 9 C 8.0023 10.0101 0.0 0
M  V30 10 C 4.0012 7.7001 0.0 0
M  V30 11 C 9.3360 9.2401 0.0 0
M  V30 12 C 10.6697 6.9301 0.0 0
M  V30 13 C 9.3360 4.6200 0.0 0
M  V30 14 C 4.0012 9.2401 0.0 0
M  V30 15 C 2.6673 6.9301 0.0 0
M  V30 16 C 10.6697 5.3900 0.0 0
M  V30 17 C 2.6673 10.0101 0.0 0
M  V30 18 C 1.3337 7.7001 0.0 0
M  V30 19 C 2.6673 5.3900 0.0 0
M  V30 20 C 1.3337 9.2401 0.0 0
M  V30 21 C 0.0000 6.9301 0.0 0
M  V30 22 C 1.3337 4.6200 0.0 0
M  V30 23 C 0.0000 5.3900 0.0 0
M  V30 24 Cl 5.3348 1.5400 0.0 0 VAL=7
M  V30 25 O 3.7948 1.5400 0.0 0
M  V30 26 O 6.8748 1.5400 0.0 0
M  V30 27 O 5.3348 0.0000 0.0 0
M  V30 28 O 5.3348 3.0800 0.0 0 CHG=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 2 4 8
M  V30 8 1 4 9
M  V30 9 1 5 10
M  V30 10 1 6 11
M  V30 11 2 6 12
M  V30 12 1 7 13
M  V30 13 1 8 14
M  V30 14 1 9 11
M  V30 15 2 10 14
M  V30 16 1 10 15
M  V30 17 1 12 16
M  V30 18 2 13 16
M  V30 19 1 14 17
M  V30 20 1 15 18
M  V30 21 2 15 19
M  V30 22 1 17 20
M  V30 23 1 18 20
M  V30 24 2 18 21
M  V30 25 1 19 22
M  V30 26 1 21 23
M  V30 27 2 22 23
M  V30 28 2 24 25
M  V30 29 2 24 26
M  V30 30 2 24 27
M  V30 31 1 24 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 6581-93-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2904546-56-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35001823
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM IndiFluors: A New Full-Visible Color-Tunable Donor-Acceptor-Donor
(D1-A-D2) Fluorophore Family for Ratiometric pH Imaging during Mitophagy
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Munan, Subrata; Kottarathil, Shamna; Joseph, Manu M.; Jana, Anal; Ali,
Mudassar; Mapa, Koyeli; Maiti, Kaustabh Kumar; Samanta, Animesh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Sensors (2024), 9(7), 3502-3510

$RFMT $RIREG SCHEME379 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Methyl-1-(phenylmethyl)-1H-1,2,3-triazole-4-carbonyl chloride
C11H10ClN3O
664351-09-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 1.3626 0.0 0
M  V30 2 C 7.0618 0.0000 0.0 0
M  V30 3 C 9.3038 2.4898 0.0 0
M  V30 4 Cl 10.2089 3.7357 0.0 0
M  V30 5 O 9.9301 1.0830 0.0 0
M  V30 6 N 5.3348 2.1326 0.0 0
M  V30 7 C 6.7417 1.5063 0.0 0
M  V30 8 N 5.4958 3.6644 0.0 0
M  V30 9 C 7.7721 2.6509 0.0 0
M  V30 10 N 7.0021 3.9845 0.0 0
M  V30 11 C 2.6673 2.1326 0.0 0
M  V30 12 C 1.3337 1.3626 0.0 0
M  V30 13 C 2.6673 3.6727 0.0 0
M  V30 14 C 0.0000 2.1326 0.0 0
M  V30 15 C 1.3337 4.4427 0.0 0
M  V30 16 C 0.0000 3.6727 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 1 11
M  V30 3 1 2 7
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 9
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,5-Dimethyl-1-(phenylmethyl)-1H-1,2,3-triazole-4-carboxamide
C12H14N4O
664351-10-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.3038 2.4898 0.0 0
M  V30 2 N 10.2090 3.7357 0.0 0
M  V30 3 O 9.9301 1.0830 0.0 0
M  V30 4 C 11.7406 3.5747 0.0 0
M  V30 5 C 7.0620 0.0000 0.0 0
M  V30 6 C 4.0012 1.3626 0.0 0
M  V30 7 C 7.7722 2.6509 0.0 0
M  V30 8 C 6.7417 1.5063 0.0 0
M  V30 9 N 7.0022 3.9845 0.0 0
M  V30 10 N 5.3348 2.1326 0.0 0
M  V30 11 N 5.4958 3.6644 0.0 0
M  V30 12 C 2.6673 2.1326 0.0 0
M  V30 13 C 2.6673 3.6727 0.0 0
M  V30 14 C 1.3337 1.3626 0.0 0
M  V30 15 C 1.3337 4.4427 0.0 0
M  V30 16 C 0.0000 2.1326 0.0 0
M  V30 17 C 0.0000 3.6727 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 8
M  V30 6 1 6 10
M  V30 7 1 6 12
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 664351-09-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 664351-10-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-13819075
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM N6-Cycloalkyl-2-phenyl-3-deaza-8-azaadenines: a new class of A1 adenosine
receptor ligands. A comparison with the corresponding adenines and
8-azaadenines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Biagi, Giuliana; Giorgi, Irene; Livi, Oreste; Nardi, Antonio; Pacchini,
Federica; Scartoni, Valerio; Lucacchini, Antonio
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2003), 38(11-12), 983-990

$RFMT $RIREG SCHEME380 STEP1
$RXN



  2  1
$MOL
1-(Phenylmethyl) 4-[3-bromo-7-[[(4-carboxyphenyl)methyl]amino]pyrazolo[1,5-a]...
C27H26BrN5O4
672317-30-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 41 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 5.7308 0.0 0
M  V30 2 C 6.6685 7.2708 0.0 0
M  V30 3 Br 10.0463 0.0000 0.0 0
M  V30 4 C 16.0045 8.0408 0.0 0
M  V30 5 O 17.3382 7.2708 0.0 0
M  V30 6 O 16.0045 9.5809 0.0 0
M  V30 7 C 18.6718 8.0408 0.0 0
M  V30 8 C 1.3337 10.3509 0.0 0
M  V30 9 O 0.0000 9.5809 0.0 0
M  V30 10 O 1.3337 11.8909 0.0 0
M  V30 11 N 8.0022 3.4207 0.0 0
M  V30 12 C 9.3360 2.6507 0.0 0
M  V30 13 C 8.0022 4.9608 0.0 0
M  V30 14 N 6.8578 2.3903 0.0 0
M  V30 15 N 10.6697 3.4207 0.0 0
M  V30 16 C 9.0158 1.1444 0.0 0
M  V30 17 C 9.3360 5.7308 0.0 0
M  V30 18 C 7.4841 0.9835 0.0 0
M  V30 19 C 10.6697 4.9608 0.0 0
M  V30 20 C 12.0033 5.7308 0.0 0
M  V30 21 C 12.0033 7.2708 0.0 0
M  V30 22 C 13.3370 4.9608 0.0 0
M  V30 23 C 13.3370 8.0408 0.0 0
M  V30 24 C 14.6708 5.7308 0.0 0
M  V30 25 N 14.6708 7.2708 0.0 0
M  V30 26 C 5.3348 8.0408 0.0 0
M  V30 27 C 5.3348 9.5809 0.0 0
M  V30 28 C 4.0012 7.2708 0.0 0
M  V30 29 C 4.0012 10.3509 0.0 0
M  V30 30 C 2.6673 8.0408 0.0 0
M  V30 31 C 2.6673 9.5809 0.0 0
M  V30 32 C 20.0057 7.2708 0.0 0
M  V30 33 C 21.3393 8.0408 0.0 0
M  V30 34 C 20.0057 5.7308 0.0 0
M  V30 35 C 22.6730 7.2708 0.0 0
M  V30 36 C 21.3393 4.9608 0.0 0
M  V30 37 C 22.6730 5.7308 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 26
M  V30 4 1 3 16
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 25
M  V30 8 1 5 7
M  V30 9 1 7 32
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 8 31
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 11 14
M  V30 16 1 12 15
M  V30 17 2 12 16
M  V30 18 2 13 17
M  V30 19 2 14 18
M  V30 20 2 15 19
M  V30 21 1 16 18
M  V30 22 1 17 19
M  V30 23 1 19 20
M  V30 24 1 20 21
M  V30 25 1 20 22
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 1 24 25
M  V30 30 2 26 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 2 28 30
M  V30 34 2 29 31
M  V30 35 1 30 31
M  V30 36 2 32 33
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 2 34 36
M  V30 40 2 35 37
M  V30 41 1 36 37
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylmethyl 4-[3-bromo-7-[[[4-[(methylamino)carbonyl]phenyl]methyl]amino]pyr...
C28H29BrN6O3
672316-16-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 42 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 13.8600 9.3358 0.0 0
M  V30 2 C 14.6300 8.0020 0.0 0
M  V30 3 Br 8.0694 12.6100 0.0 0
M  V30 4 C 6.9300 2.6673 0.0 0
M  V30 5 O 5.3900 2.6673 0.0 0
M  V30 6 O 7.7000 1.3336 0.0 0
M  V30 7 C 4.6200 1.3336 0.0 0
M  V30 8 C 20.7900 8.0020 0.0 0
M  V30 9 N 21.5600 6.6684 0.0 0
M  V30 10 O 21.5600 9.3358 0.0 0
M  V30 11 C 23.1000 6.6684 0.0 0
M  V30 12 N 11.5500 10.6694 0.0 0
M  V30 13 C 10.0100 10.6694 0.0 0
M  V30 14 C 12.3200 9.3358 0.0 0
M  V30 15 N 12.0259 12.1340 0.0 0
M  V30 16 N 9.2400 9.3358 0.0 0
M  V30 17 C 9.5341 12.1340 0.0 0
M  V30 18 C 11.5500 8.0020 0.0 0
M  V30 19 C 10.7800 13.0392 0.0 0
M  V30 20 C 10.0100 8.0020 0.0 0
M  V30 21 C 9.2400 6.6684 0.0 0
M  V30 22 C 10.0100 5.3347 0.0 0
M  V30 23 C 7.7000 6.6684 0.0 0
M  V30 24 C 9.2400 4.0011 0.0 0
M  V30 25 C 6.9300 5.3347 0.0 0
M  V30 26 N 7.7000 4.0011 0.0 0
M  V30 27 C 16.1700 8.0020 0.0 0
M  V30 28 C 16.9400 9.3358 0.0 0
M  V30 29 C 16.9400 6.6684 0.0 0
M  V30 30 C 18.4800 9.3358 0.0 0
M  V30 31 C 18.4800 6.6684 0.0 0
M  V30 32 C 19.2500 8.0020 0.0 0
M  V30 33 C 3.0800 1.3336 0.0 0
M  V30 34 C 2.3100 0.0000 0.0 0
M  V30 35 C 2.3100 2.6673 0.0 0
M  V30 36 C 0.7700 0.0000 0.0 0
M  V30 37 C 0.7700 2.6673 0.0 0
M  V30 38 C 0.0000 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 27
M  V30 4 1 3 17
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 26
M  V30 8 1 5 7
M  V30 9 1 7 33
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 8 32
M  V30 13 1 9 11
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 1 12 15
M  V30 17 1 13 16
M  V30 18 2 13 17
M  V30 19 2 14 18
M  V30 20 2 15 19
M  V30 21 2 16 20
M  V30 22 1 17 19
M  V30 23 1 18 20
M  V30 24 1 20 21
M  V30 25 1 21 22
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 1 25 26
M  V30 31 2 27 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 2 29 31
M  V30 35 2 30 32
M  V30 36 1 31 32
M  V30 37 2 33 34
M  V30 38 1 33 35
M  V30 39 1 34 36
M  V30 40 2 35 37
M  V30 41 2 36 38
M  V30 42 1 37 38
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 672317-30-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 672316-16-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-16149269
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 543-27-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrazolopyrimidines as cyclin-dependent kinase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Guzi, Timothy J.; Paruch, Kamil; Dwyer, Michael P.; Labroli, Marc;
Keertikar, Kartik M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008130569 A1 2008-10-30

$RFMT $RIREG SCHEME381 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Nitromethylene)oxazolidine
C4H6N2O3
67445-78-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 2.6217 0.0 0
M  V30 2 N 5.1049 1.8517 0.0 0 VAL=5
M  V30 3 O 5.1049 0.3117 0.0 0
M  V30 4 O 6.4385 2.6217 0.0 0
M  V30 5 C 2.4374 1.8517 0.0 0
M  V30 6 N 1.0306 2.4782 0.0 0
M  V30 7 O 2.2765 0.3202 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 9 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 5 CFG=2
M  V30 3 2 2 3
M  V30 4 2 2 4
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[[1-(Methylamino)-2-nitroethenyl]amino]ethanol
C5H11N3O3
82653-47-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 3.8500 0.0 0
M  V30 2 N 4.0011 4.6200 0.0 0
M  V30 3 C 2.6674 2.3100 0.0 0
M  V30 4 N 1.3336 4.6200 0.0 0
M  V30 5 C 5.3347 3.8500 0.0 0
M  V30 6 N 1.3336 1.5400 0.0 0 VAL=5
M  V30 7 C 1.3336 6.1600 0.0 0
M  V30 8 C 6.6685 4.6200 0.0 0
M  V30 9 O 1.3336 0.0000 0.0 0
M  V30 10 O 0.0000 2.3100 0.0 0
M  V30 11 O 8.0021 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 2 6 9
M  V30 9 2 6 10
M  V30 10 1 8 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 67445-78-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 82653-47-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-6478853
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A new method for the synthesis of Ranitidine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lipnicka, Urszula; Jasztold-Howorko, Ryszard; Witkiewicz, Krystyna;
Machon, Zdzislaw
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Acta Poloniae Pharmaceutica (2002), 59(2), 121-125

$RFMT $RIREG SCHEME382 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromo-2-(4-fluorophenyl)-5-(1-methylethoxy)-3-benzofurancarboxylic acid
C18H14BrFO4
691857-11-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.0618 6.6519 0.0 0
M  V30 2 O 8.5264 7.1277 0.0 0
M  V30 3 O 5.9173 7.6824 0.0 0
M  V30 4 O 11.6221 2.6674 0.0 0
M  V30 5 C 12.3921 4.0011 0.0 0
M  V30 6 C 11.6221 5.3349 0.0 0
M  V30 7 C 13.9321 4.0011 0.0 0
M  V30 8 Br 10.0821 0.0000 0.0 0
M  V30 9 F 0.0000 7.5991 0.0 0
M  V30 10 C 7.7721 4.0011 0.0 0
M  V30 11 C 6.7417 5.1456 0.0 0
M  V30 12 C 7.0021 2.6674 0.0 0
M  V30 13 C 9.3121 4.0011 0.0 0
M  V30 14 C 5.3347 4.5191 0.0 0
M  V30 15 O 5.4956 2.9876 0.0 0
M  V30 16 C 7.7721 1.3338 0.0 0
M  V30 17 C 10.0821 2.6674 0.0 0
M  V30 18 C 9.3121 1.3338 0.0 0
M  V30 19 C 4.0011 5.2891 0.0 0
M  V30 20 C 4.0011 6.8291 0.0 0
M  V30 21 C 2.6674 4.5191 0.0 0
M  V30 22 C 2.6674 7.5991 0.0 0
M  V30 23 C 1.3336 5.2891 0.0 0
M  V30 24 C 1.3336 6.8291 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 4 5
M  V30 5 1 4 17
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 8 18
M  V30 9 1 9 24
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 2 10 13
M  V30 13 2 11 14
M  V30 14 1 12 15
M  V30 15 2 12 16
M  V30 16 1 13 17
M  V30 17 1 14 15
M  V30 18 1 14 19
M  V30 19 1 16 18
M  V30 20 2 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromo-2-(4-fluorophenyl)-N-methyl-5-(1-methylethoxy)-3-benzofurancarboxamide
C19H17BrFNO3
691853-07-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.8702 6.6519 0.0 0
M  V30 2 N 5.4057 7.1277 0.0 0
M  V30 3 O 8.0148 7.6823 0.0 0
M  V30 4 C 5.0855 8.6342 0.0 0
M  V30 5 O 2.3100 2.6674 0.0 0
M  V30 6 C 1.5400 4.0011 0.0 0
M  V30 7 C 2.3100 5.3347 0.0 0
M  V30 8 C 0.0000 4.0011 0.0 0
M  V30 9 Br 3.8500 0.0000 0.0 0
M  V30 10 F 13.9321 7.5991 0.0 0
M  V30 11 C 6.1600 4.0011 0.0 0
M  V30 12 C 7.1904 5.1456 0.0 0
M  V30 13 C 6.9300 2.6674 0.0 0
M  V30 14 C 4.6200 4.0011 0.0 0
M  V30 15 C 8.5974 4.5191 0.0 0
M  V30 16 O 8.4364 2.9876 0.0 0
M  V30 17 C 6.1600 1.3338 0.0 0
M  V30 18 C 3.8500 2.6674 0.0 0
M  V30 19 C 4.6200 1.3338 0.0 0
M  V30 20 C 9.9310 5.2891 0.0 0
M  V30 21 C 11.2646 4.5191 0.0 0
M  V30 22 C 9.9310 6.8291 0.0 0
M  V30 23 C 12.5984 5.2891 0.0 0
M  V30 24 C 11.2646 7.5991 0.0 0
M  V30 25 C 12.5984 6.8291 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 18
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 9 19
M  V30 10 1 10 25
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 2 11 14
M  V30 14 2 12 15
M  V30 15 1 13 16
M  V30 16 2 13 17
M  V30 17 1 14 18
M  V30 18 1 15 16
M  V30 19 1 15 20
M  V30 20 1 17 19
M  V30 21 2 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 691857-11-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 691853-07-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-11106169
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 128625-52-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzofuran compounds for treatment and prophylaxis of
hepatitis C viral infections and associated diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Burns, Christopher J.; Del Vecchio, Alfred M.; Bailey, Thomas R.;
Kulkarni, Bheemashankar A.; Faitg, Thomas H.; Sherk, Susan R.;
Blackledge, Charles W.; Rys, David J.; Lessen, Thomas A.; Swestock, John;
Deng, Yijun; Nitz, Theodore J.; Reinhardt, Jason A.; Feng, Hao; Saha,
Ashis K.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004041201 A2 2004-05-21

$RFMT $RIREG SCHEME383 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(4-Fluorophenyl)-5-methoxy-6-[(methylsulfonyl)amino]-3-benzofurancarboxylic...
C17H14FNO6S
691857-50-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.4816 7.3306 0.0 0
M  V30 2 O 6.4512 8.4749 0.0 0
M  V30 3 O 8.9879 7.6507 0.0 0
M  V30 4 O 1.5400 6.1600 0.0 0
M  V30 5 C 1.5400 7.7000 0.0 0
M  V30 6 N 1.5400 3.0800 0.0 0
M  V30 7 S 1.5400 1.5400 0.0 0 VAL=6
M  V30 8 C 1.5400 0.0000 0.0 0
M  V30 9 O 3.0800 1.5400 0.0 0
M  V30 10 O 0.0000 1.5400 0.0 0
M  V30 11 F 14.0710 4.6200 0.0 0
M  V30 12 C 5.5411 5.3900 0.0 0
M  V30 13 C 5.5411 3.8500 0.0 0
M  V30 14 C 7.0058 5.8659 0.0 0
M  V30 15 C 4.2074 6.1600 0.0 0
M  V30 16 O 7.0058 3.3741 0.0 0
M  V30 17 C 4.2074 3.0800 0.0 0
M  V30 18 C 7.9110 4.6200 0.0 0
M  V30 19 C 2.8738 5.3900 0.0 0
M  V30 20 C 2.8738 3.8500 0.0 0
M  V30 21 C 9.4510 4.6200 0.0 0
M  V30 22 C 10.2210 3.2864 0.0 0
M  V30 23 C 10.2210 5.9536 0.0 0
M  V30 24 C 11.7610 3.2864 0.0 0
M  V30 25 C 11.7610 5.9536 0.0 0
M  V30 26 C 12.5310 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 4 5
M  V30 5 1 4 19
M  V30 6 1 6 7
M  V30 7 1 6 20
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 2 7 10
M  V30 11 1 11 26
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 2 12 15
M  V30 15 1 13 16
M  V30 16 2 13 17
M  V30 17 2 14 18
M  V30 18 1 15 19
M  V30 19 1 16 18
M  V30 20 1 17 20
M  V30 21 1 18 21
M  V30 22 2 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(4-Fluorophenyl)-5-methoxy-N-methyl-6-[(methylsulfonyl)amino]-3-benzofuranc...
C18H17FN2O5S
691853-37-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.4816 2.6091 0.0 0
M  V30 2 N 6.4512 1.4645 0.0 0
M  V30 3 O 8.9879 2.2889 0.0 0
M  V30 4 C 6.9271 0.0000 0.0 0
M  V30 5 O 1.5400 3.7795 0.0 0
M  V30 6 C 1.5400 2.2395 0.0 0
M  V30 7 N 1.5400 6.8595 0.0 0
M  V30 8 S 1.5400 8.3995 0.0 0 VAL=6
M  V30 9 C 1.5400 9.9395 0.0 0
M  V30 10 O 0.0000 8.3995 0.0 0
M  V30 11 O 3.0800 8.3995 0.0 0
M  V30 12 F 14.0710 5.3195 0.0 0
M  V30 13 C 5.5411 4.5495 0.0 0
M  V30 14 C 7.0058 4.0736 0.0 0
M  V30 15 C 5.5411 6.0895 0.0 0
M  V30 16 C 4.2074 3.7795 0.0 0
M  V30 17 C 7.9110 5.3195 0.0 0
M  V30 18 O 7.0058 6.5655 0.0 0
M  V30 19 C 4.2074 6.8595 0.0 0
M  V30 20 C 2.8738 4.5495 0.0 0
M  V30 21 C 2.8738 6.0895 0.0 0
M  V30 22 C 9.4510 5.3195 0.0 0
M  V30 23 C 10.2210 6.6533 0.0 0
M  V30 24 C 10.2210 3.9858 0.0 0
M  V30 25 C 11.7610 6.6533 0.0 0
M  V30 26 C 11.7610 3.9858 0.0 0
M  V30 27 C 12.5310 5.3195 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 20
M  V30 7 1 7 8
M  V30 8 1 7 21
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 2 8 11
M  V30 12 1 12 27
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 2 13 16
M  V30 16 2 14 17
M  V30 17 1 15 18
M  V30 18 2 15 19
M  V30 19 1 16 20
M  V30 20 1 17 18
M  V30 21 1 17 22
M  V30 22 1 19 21
M  V30 23 2 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 691857-50-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 691853-37-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-1983937
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzofuran compounds for treatment and prophylaxis of
hepatitis C viral infections and associated diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Burns, Christopher J.; Del Vecchio, Alfred M.; Bailey, Thomas R.;
Kulkarni, Bheemashankar A.; Faitg, Thomas H.; Sherk, Susan R.;
Blackledge, Charles W.; Rys, David J.; Lessen, Thomas A.; Swestock, John;
Deng, Yijun; Nitz, Theodore J.; Reinhardt, Jason A.; Feng, Hao; Saha,
Ashis K.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004041201 A2 2004-05-21

$RFMT $RIREG SCHEME384 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Methyl 5-[methyl(methylsulfonyl)amino]-1,3-benzenedicarboxylate
C11H13NO6S
695215-94-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6673 5.3901 0.0 0
M  V30 2 S 1.3337 4.6201 0.0 0 VAL=6
M  V30 3 C 2.6673 6.9302 0.0 0
M  V30 4 C 0.0000 3.8501 0.0 0
M  V30 5 O 0.5637 5.9538 0.0 0
M  V30 6 O 2.1037 3.2864 0.0 0
M  V30 7 C 8.0023 5.3901 0.0 0
M  V30 8 O 9.3360 4.6201 0.0 0
M  V30 9 O 8.0023 6.9302 0.0 0
M  V30 10 C 10.6697 5.3901 0.0 0
M  V30 11 C 5.3348 0.7700 0.0 0
M  V30 12 O 4.0012 0.0000 0.0 0
M  V30 13 O 6.6685 0.0000 0.0 0
M  V30 14 C 4.0012 4.6201 0.0 0
M  V30 15 C 5.3348 5.3901 0.0 0
M  V30 16 C 4.0012 3.0801 0.0 0
M  V30 17 C 6.6685 4.6201 0.0 0
M  V30 18 C 5.3348 2.3101 0.0 0
M  V30 19 C 6.6685 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 2 2 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 17
M  V30 10 1 8 10
M  V30 11 1 11 12
M  V30 12 2 11 13
M  V30 13 1 11 18
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 3-[(methylamino)carbonyl]-5-[methyl(methylsulfonyl)amino]benzoate
C12H16N2O5S
913626-08-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6673 6.9302 0.0 0
M  V30 2 S 1.3337 6.1601 0.0 0 VAL=6
M  V30 3 C 2.6673 8.4702 0.0 0
M  V30 4 C 0.0000 5.3901 0.0 0
M  V30 5 O 0.5637 7.4938 0.0 0
M  V30 6 O 2.1037 4.8265 0.0 0
M  V30 7 C 5.3348 2.3101 0.0 0
M  V30 8 N 6.6685 1.5400 0.0 0
M  V30 9 O 4.0012 1.5400 0.0 0
M  V30 10 C 6.6685 0.0000 0.0 0
M  V30 11 C 8.0023 6.9302 0.0 0
M  V30 12 O 9.3360 6.1601 0.0 0
M  V30 13 O 8.0023 8.4702 0.0 0
M  V30 14 C 10.6697 6.9302 0.0 0
M  V30 15 C 4.0012 6.1601 0.0 0
M  V30 16 C 4.0012 4.6201 0.0 0
M  V30 17 C 5.3348 6.9302 0.0 0
M  V30 18 C 5.3348 3.8501 0.0 0
M  V30 19 C 6.6685 6.1601 0.0 0
M  V30 20 C 6.6685 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 2 2 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 18
M  V30 10 1 8 10
M  V30 11 1 11 12
M  V30 12 2 11 13
M  V30 13 1 11 19
M  V30 14 1 12 14
M  V30 15 2 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 2 17 19
M  V30 19 2 18 20
M  V30 20 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 695215-94-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 913626-08-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-2959408
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 56602-33-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM N-[2-hydroxy-1-(3-methoxybenzyl)ethyl]-N'-methyl-5-[methyl(methylsulfonyl)
amino]isophthalamide (3). Step 1: To a solution of
3-(methoxycarbonyl)-5-[methyl(methylsulfonyl)amino]benzoic acid1 (0.50 g,
1.75 mmol) in CH2Cl2 (20 mL) was added diisopropylethyl amine (0.92 mL,
5.24 mmol), methyl amine (1.75 mL of a 2.0 M THF solution, 3.49 mmol) and
BOP reagent (0.81 g, 1.83 mmol). The resulting mixture was stirred 12 h
at room temperature. The solvent was removed and the residue was purified
by silica gel chromatography (40% EtOAc/Hexane then 100% EtOAc) to
provide methyl 3-[(methylamino)carbonyl]-
5-[methyl(methylsulfonyl)amino]benzoate (1.61 g, 92%).
3-[(methylamino)carbonyl]- 5-[methyl(methylsulfonyl)amino]benzoate, Yield
1.61 g, 92% 1H NMR (400 MHz, DMSOd6) δ 8.74 (d, J = 4.2 Hz, 1H), 8.34 (s,
1H), 8.11 (s, 1H), 8.07 (s, 1H), 3.90 (s, 3H), 3.31 (s, 3H), 3.00 (s,
3H), 2.81 (d, J = 4.4 Hz, 3H). Electrospray Mass Spectrum [M+H] = 301.02
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Macrocyclic inhibitors of β-secretase: functional activity in an animal
model
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Stachel, Shawn J.; Coburn, Craig A.; Sankaranarayanan, Sethu; Price, Eric
A.; Pietrak, Beth L.; Huang, Qian; Lineberger, Janet; Espeseth, Amy S.;
Jin, Lixia; Ellis, Joan; Holloway, M. Katharine; Munshi, Sanjeev;
Allison, Timothy; Hazuda, Daria; Simon, Adam J.; Graham, Samuel L.;
Vacca, Joseph P.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2006), 49(21), 6147-6150

$RFMT $RIREG SCHEME385 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,N′-1,2-Ethanediylbis[N-methyl-L-alanine] 1,1′-dimethyl ester
C12H24N2O4
718605-24-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 17 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 10.6697 2.3101 0.0 0 CFG=1
M  V30 2 N 9.3358 1.5400 0.0 0
M  V30 3 C 12.0033 1.5400 0.0 0
M  V30 4 C 10.6697 3.8501 0.0 0
M  V30 5 C 8.0022 2.3101 0.0 0
M  V30 6 C 9.3358 0.0000 0.0 0
M  V30 7 O 13.3370 2.3101 0.0 0
M  V30 8 O 12.0033 0.0000 0.0 0
M  V30 9 C 6.6685 1.5400 0.0 0
M  V30 10 C 14.6707 1.5400 0.0 0
M  V30 11 N 5.3348 2.3101 0.0 0
M  V30 12 C 4.0010 1.5400 0.0 0 CFG=1
M  V30 13 C 5.3348 3.8501 0.0 0
M  V30 14 C 2.6673 2.3101 0.0 0
M  V30 15 C 4.0010 0.0000 0.0 0
M  V30 16 O 1.3337 1.5400 0.0 0
M  V30 17 O 2.6673 3.8501 0.0 0
M  V30 18 C 0.0000 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 5 9
M  V30 9 1 7 10
M  V30 10 1 9 11
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 12 15 CFG=1
M  V30 15 1 14 16
M  V30 16 2 14 17
M  V30 17 1 16 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(2S,2′S)-2,2′-[1,2-Ethanediylbis(methylimino)]bis[N-methylpropanamide]
C12H26N4O2
718605-26-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 17 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 10.6697 2.3101 0.0 0 CFG=1
M  V30 2 N 9.3358 1.5400 0.0 0
M  V30 3 C 12.0033 1.5400 0.0 0
M  V30 4 C 10.6697 3.8501 0.0 0
M  V30 5 C 8.0022 2.3101 0.0 0
M  V30 6 C 9.3358 0.0000 0.0 0
M  V30 7 N 13.3370 2.3101 0.0 0
M  V30 8 O 12.0033 0.0000 0.0 0
M  V30 9 C 6.6685 1.5400 0.0 0
M  V30 10 C 14.6707 1.5400 0.0 0
M  V30 11 N 5.3348 2.3101 0.0 0
M  V30 12 C 4.0010 1.5400 0.0 0 CFG=1
M  V30 13 C 5.3348 3.8501 0.0 0
M  V30 14 C 2.6673 2.3101 0.0 0
M  V30 15 C 4.0010 0.0000 0.0 0
M  V30 16 N 1.3337 1.5400 0.0 0
M  V30 17 O 2.6673 3.8501 0.0 0
M  V30 18 C 0.0000 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 5 9
M  V30 9 1 7 10
M  V30 10 1 9 11
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 12 15 CFG=1
M  V30 15 1 14 16
M  V30 16 2 14 17
M  V30 17 1 16 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 718605-24-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 718605-26-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-15252091
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM N,N´-Dimethyl-N,N´-ethylene-bis(L-alanine methyl amide) L1. Excess amount
of 40% methylamine solution in methanol (5 ml, ca. 69 mmol) was added to
N,N´-dimethyl-N,N´-ethylene-bis(L-alanine methyl ester) 2 (1.61 g,6.19
mmol), and the solution stirred for 7 days. After evaporation of the
solvent, ligand L1 was isolated as a white powder by chromatography on
silica gel (ca. 70 g) with CHCl3/CH3OH (30/1) eluent (yield 1.5 g, 5.7
mmol, 92%). N,N´-Dimethyl-N,N´-ethylene-bis(L-alanine methyl amide) L1,
yield 1.5 g, 5.7 mmol, 92% Found: C, 55.57; H, 10.22; N, 21.56 %.
C12H26N4O2 requires C, 55.79; H, 10.14; N, 21.69 %. IR; νmax/cm-1 (CDCl3)
1652 (CO). [α]D 20 = +54.3° (c=1.0, CH3CN). Mp=88-93°C. 1H NMR (CDCl3): δ
1.27 (d, 6H, J=7.1, Ala-CH3), 2.27 (d, 2H, J=9.1, ethylene), 2.30 (s, 6H,
N-CH3), 2.56 (d, 2H, J=9.1, ethylene), 2.81 (d, 6H, J=4.9, amide-CH3),
3.29(q, 2H, J=7.1, Ala-αH), 7.87 (bs, 2H, NH). 13C NMR (CDCl3): δ 9.65,
26.21, 39.91, 51.03, 63.87, 174.02. FAB-MS m/z=259 ([M+H]+).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Dynamic Helicity Inversion by Achiral Anion Stimulus in Synthetic Labile
Cobalt(II) Complex
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Miyake, Hiroyuki; Yoshida, Kana; Sugimoto, Hideki; Tsukube, Hiroshi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2004), 126(21), 6524-6525

$RFMT $RIREG SCHEME386 STEP1
$RXN



  4  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Isatin
C8H5NO2
91-56-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6079 0.0000 0.0 0
M  V30 2 O 6.5771 2.7104 0.0 0
M  V30 3 C 2.6673 3.4804 0.0 0
M  V30 4 C 2.6673 1.9404 0.0 0
M  V30 5 N 4.1320 3.9565 0.0 0
M  V30 6 C 1.3337 4.2504 0.0 0
M  V30 7 C 4.1320 1.4646 0.0 0
M  V30 8 C 1.3337 1.1704 0.0 0
M  V30 9 C 5.0371 2.7104 0.0 0
M  V30 10 C 0.0000 3.4804 0.0 0
M  V30 11 C 0.0000 1.9404 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 2 2 9
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 9
M  V30 11 1 8 11
M  V30 12 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 4-ethyl-α,γ-dioxobenzenebutanoate
C14H16O4
741286-35-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 C 8.0022 2.3101 0.0 0
M  V30 3 O 6.6685 0.0000 0.0 0
M  V30 4 C 9.3358 1.5400 0.0 0
M  V30 5 C 10.6697 2.3101 0.0 0
M  V30 6 O 9.3358 0.0000 0.0 0
M  V30 7 O 12.0033 1.5400 0.0 0
M  V30 8 O 10.6697 3.8501 0.0 0
M  V30 9 C 13.3370 2.3101 0.0 0
M  V30 10 C 14.6707 1.5400 0.0 0
M  V30 11 C 1.3337 4.6201 0.0 0
M  V30 12 C 0.0000 3.8501 0.0 0
M  V30 13 C 5.3348 2.3101 0.0 0
M  V30 14 C 4.0010 1.5400 0.0 0
M  V30 15 C 5.3348 3.8501 0.0 0
M  V30 16 C 2.6673 2.3101 0.0 0
M  V30 17 C 4.0010 4.6201 0.0 0
M  V30 18 C 2.6673 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 11 12
M  V30 12 1 11 18
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
tert-Butyl isocyanide
C5H9N
7188-38-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 N 3.0800 1.5400 0.0 0 CHG=1 VAL=4
M  V30 3 C 1.5400 3.0800 0.0 0
M  V30 4 C 0.0000 1.5400 0.0 0
M  V30 5 C 1.5400 0.0000 0.0 0
M  V30 6 C 4.6200 1.5400 0.0 0 CHG=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 3 2 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Spiro[3H-indole-3,5′-[5H]pyrrolo[3,4-d]pyrimidine]-2,7′(1H,6′H)-dione, 3′-(1,...
C26H28N4O3
2925703-88-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3628 3.0917 0.0 0
M  V30 2 O 5.9660 6.0811 0.0 0
M  V30 3 O 5.1840 5.3286 0.0 0
M  V30 4 O 0.0000 6.1525 0.0 0
M  V30 5 C 6.4072 9.4917 0.0 0
M  V30 6 C 7.4962 10.5808 0.0 0
M  V30 7 C 7.4962 8.4028 0.0 0
M  V30 8 C 5.3183 10.5808 0.0 0
M  V30 9 C 11.2684 5.2685 0.0 0
M  V30 10 C 12.3574 6.3575 0.0 0
M  V30 11 C 3.6643 4.5865 0.0 0
M  V30 12 C 3.9845 6.0928 0.0 0
M  V30 13 C 3.3441 3.0800 0.0 0
M  V30 14 N 2.1328 4.4255 0.0 0
M  V30 15 C 5.1960 4.7474 0.0 0
M  V30 16 C 5.3183 6.8628 0.0 0
M  V30 17 C 2.6508 6.8628 0.0 0
M  V30 18 C 4.6778 2.3100 0.0 0
M  V30 19 C 2.0105 2.3100 0.0 0
M  V30 20 C 1.5064 5.8323 0.0 0
M  V30 21 N 5.8223 3.3406 0.0 0
M  V30 22 N 5.3183 8.4028 0.0 0
M  V30 23 N 2.6508 8.4028 0.0 0
M  V30 24 C 4.6778 0.7700 0.0 0
M  V30 25 C 2.0105 0.7700 0.0 0
M  V30 26 C 3.9845 9.1728 0.0 0
M  V30 27 C 3.3441 0.0000 0.0 0
M  V30 28 C 6.8058 6.4642 0.0 0
M  V30 29 C 7.2043 4.9767 0.0 0
M  V30 30 C 7.8947 7.5532 0.0 0
M  V30 31 C 8.6918 4.5782 0.0 0
M  V30 32 C 9.3822 7.1546 0.0 0
M  V30 33 C 9.7808 5.6671 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 2 2 15
M  V30 3 1 3 16
M  V30 4 2 4 20
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 22
M  V30 9 1 9 10
M  V30 10 1 9 33
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 2 12 17
M  V30 17 1 13 18
M  V30 18 2 13 19
M  V30 19 1 14 20
M  V30 20 1 15 21
M  V30 21 1 16 22
M  V30 22 1 16 28
M  V30 23 1 17 20
M  V30 24 1 17 23
M  V30 25 1 18 21
M  V30 26 2 18 24
M  V30 27 1 19 25
M  V30 28 1 22 26
M  V30 29 2 23 26
M  V30 30 1 24 27
M  V30 31 2 25 27
M  V30 32 2 28 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 2 30 32
M  V30 36 2 31 33
M  V30 37 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 91-56-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 741286-35-1
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 7188-38-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2925703-88-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36542803
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 631-61-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 1317-61-9
$DTYPE RXN:VAR(1):CAT(2):AMD
$DATUM coated on titania
$DTYPE RXN:VAR(1):CAT(3):CAS_RN
$DATUM 7440-22-4
$DTYPE RXN:VAR(1):CAT(3):AMD
$DATUM magnetite-coated titania-functionalized carbon nanotube-supported
$DTYPE RXN:VAR(1):CAT(4):CAS_RN
$DATUM 7440-44-0
$DTYPE RXN:VAR(1):CAT(5):CAS_RN
$DATUM 13463-67-7
$DTYPE RXN:VAR(1):CAT(5):AMD
$DATUM magnetite-coated
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, solid-supported catalyst, reusable catalyst, see
experimental details, magnetite-coated titania-functionalized carbon
nanotube-supported silver nanocatalyst prepared and used, stage 1
intermediate in added in stage 3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and Investigation of Biological Activity of New Spiro
Pyrrolo[3,4-d]Pyrimidine Derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tabarsaei, Navisa; Varasteh Moradi, Ali; Sayyed Alangi, S. Zahra;
Hossaini, Zinatossadat; Zafar Mmehrabian, Ramin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Polycyclic Aromatic Compounds (2023), 43(9), 8388-8407

$RFMT $RIREG SCHEME387 STEP1
$RXN



  2  1
$MOL
N-(9-Fluorenylmethoxycarbonyl)-L-glutamic acid γ-tert-butyl ester
C24H27NO6
71989-18-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.7533 5.2309 0.0 0
M  V30 2 O 5.7533 6.7709 0.0 0
M  V30 3 C 7.0871 7.5409 0.0 0
M  V30 4 N 7.0871 9.0810 0.0 0
M  V30 5 O 8.4208 6.7709 0.0 0
M  V30 6 C 8.4208 9.8510 0.0 0 CFG=2
M  V30 7 C 9.7544 9.0810 0.0 0
M  V30 8 C 8.4208 11.3910 0.0 0
M  V30 9 C 11.0881 9.8510 0.0 0
M  V30 10 O 7.0871 12.1610 0.0 0
M  V30 11 O 9.7544 12.1610 0.0 0
M  V30 12 C 12.4219 9.0810 0.0 0
M  V30 13 O 13.7556 9.8510 0.0 0
M  V30 14 O 12.4219 7.5409 0.0 0
M  V30 15 C 15.0893 9.0810 0.0 0
M  V30 16 C 15.8593 10.4146 0.0 0
M  V30 17 C 16.4229 8.3109 0.0 0
M  V30 18 C 14.3192 7.7473 0.0 0
M  V30 19 C 3.0128 5.0873 0.0 0
M  V30 20 C 4.4196 4.4609 0.0 0
M  V30 21 C 1.9822 3.9428 0.0 0
M  V30 22 C 2.5367 6.5519 0.0 0
M  V30 23 C 4.2587 2.9293 0.0 0
M  V30 24 C 2.7522 2.6091 0.0 0
M  V30 25 C 0.4759 4.2630 0.0 0
M  V30 26 C 1.0304 6.8721 0.0 0
M  V30 27 C 5.2891 1.7849 0.0 0
M  V30 28 C 2.2763 1.1444 0.0 0
M  V30 29 C 0.0000 5.7277 0.0 0
M  V30 30 C 4.8132 0.3202 0.0 0
M  V30 31 C 3.3068 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 20
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7 CFG=3
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 1 13 15
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 15 18
M  V30 19 1 19 20
M  V30 20 1 19 21
M  V30 21 2 19 22
M  V30 22 1 20 23
M  V30 23 1 21 24
M  V30 24 2 21 25
M  V30 25 1 22 26
M  V30 26 1 23 24
M  V30 27 2 23 27
M  V30 28 2 24 28
M  V30 29 1 25 29
M  V30 30 2 26 29
M  V30 31 1 27 30
M  V30 32 1 28 31
M  V30 33 2 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (4S)-4-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-5-(methyla...
C25H30N2O5
1147126-39-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.7533 5.2309 0.0 0
M  V30 2 O 5.7533 6.7709 0.0 0
M  V30 3 C 7.0871 7.5409 0.0 0
M  V30 4 N 7.0871 9.0810 0.0 0
M  V30 5 O 8.4208 6.7709 0.0 0
M  V30 6 C 8.4208 9.8510 0.0 0 CFG=2
M  V30 7 C 9.7544 9.0810 0.0 0
M  V30 8 C 8.4208 11.3910 0.0 0
M  V30 9 C 11.0881 9.8510 0.0 0
M  V30 10 N 7.0871 12.1610 0.0 0
M  V30 11 O 9.7544 12.1610 0.0 0
M  V30 12 C 12.4219 9.0810 0.0 0
M  V30 13 C 7.0871 13.7011 0.0 0
M  V30 14 O 13.7556 9.8510 0.0 0
M  V30 15 O 12.4219 7.5409 0.0 0
M  V30 16 C 15.0893 9.0810 0.0 0
M  V30 17 C 15.8593 10.4146 0.0 0
M  V30 18 C 16.4229 8.3109 0.0 0
M  V30 19 C 14.3192 7.7473 0.0 0
M  V30 20 C 4.4196 4.4609 0.0 0
M  V30 21 C 3.0128 5.0873 0.0 0
M  V30 22 C 4.2587 2.9293 0.0 0
M  V30 23 C 1.9822 3.9428 0.0 0
M  V30 24 C 2.5367 6.5519 0.0 0
M  V30 25 C 2.7522 2.6091 0.0 0
M  V30 26 C 5.2891 1.7849 0.0 0
M  V30 27 C 0.4759 4.2630 0.0 0
M  V30 28 C 1.0304 6.8721 0.0 0
M  V30 29 C 2.2763 1.1444 0.0 0
M  V30 30 C 4.8132 0.3202 0.0 0
M  V30 31 C 0.0000 5.7277 0.0 0
M  V30 32 C 3.3068 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 20
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7 CFG=3
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 1 12 14
M  V30 15 2 12 15
M  V30 16 1 14 16
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 16 19
M  V30 20 1 20 21
M  V30 21 1 20 22
M  V30 22 1 21 23
M  V30 23 2 21 24
M  V30 24 1 22 25
M  V30 25 2 22 26
M  V30 26 1 23 25
M  V30 27 2 23 27
M  V30 28 1 24 28
M  V30 29 2 25 29
M  V30 30 1 26 30
M  V30 31 1 27 31
M  V30 32 2 28 31
M  V30 33 1 29 32
M  V30 34 2 30 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 71989-18-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1147126-39-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-10372614
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-02-4
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 543-27-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (S)-tert-Butyl
4-((S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(tert-butoxy)-4-oxobutanamido)-5-(methylamino)-5-oxopentanoate
(37). Fmoc-Glu(OtBu)-OH (637.5 mg, 1.5 mmol) was dissolved in 10 mL THF
and cooled to -15 °C, IBCF (204.9 mg, 1.5 mmol) and NMM (151.7 mg, 1.5
mmol) was added dropwise. After 0.5 h, methylamine (2M, 0.75 mL, 1.5
mmol) was added. The reaction left at -15°C for 4 h. The mixture was
poured into 30 mL ice cold 1M HCl and extracted by ethyl acetate (10 mL x
2). The organic layer was then concentrated and purified by column
chromatography (silica gel, CH2Cl2:methanol = 10:1) to afford product.
White solid, yield 604.4 mg, 92%.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Rational Design of Small-Molecule Inhibitors for β-Catenin/T-Cell Factor
Protein-Protein Interactions by Bioisostere Replacement
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yu, Binxun; Huang, Zheng; Zhang, Min; Dillard, Darren R.; Ji, Haitao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Chemical Biology (2013), 8(3), 524-529

$RFMT $RIREG SCHEME388 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αZ)-2-Amino-α-[(6-phenylimidazo[2,1-b]thiazol-5-yl)methylene]-4-pyrimidineac...
C18H13N5O2S
723341-73-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.8689 5.1779 0.0 0
M  V30 2 C 7.4089 5.1779 0.0 0
M  V30 3 C 8.1789 3.8443 0.0 0
M  V30 4 O 7.4089 2.5105 0.0 0
M  V30 5 O 9.7189 3.8443 0.0 0
M  V30 6 N 12.0289 7.8452 0.0 0
M  V30 7 C 5.0989 3.8443 0.0 0
M  V30 8 C 3.5673 3.6832 0.0 0
M  V30 9 N 5.7253 2.4374 0.0 0
M  V30 10 N 3.2471 2.1769 0.0 0
M  V30 11 C 4.5809 1.4069 0.0 0
M  V30 12 C 7.0589 1.6674 0.0 0
M  V30 13 S 5.2072 0.0000 0.0 0
M  V30 14 C 6.7387 0.1611 0.0 0
M  V30 15 C 2.5368 4.8277 0.0 0
M  V30 16 C 1.0306 4.5076 0.0 0
M  V30 17 C 3.0127 6.2923 0.0 0
M  V30 18 C 0.0000 5.6520 0.0 0
M  V30 19 C 1.9823 7.4368 0.0 0
M  V30 20 C 0.4760 7.1166 0.0 0
M  V30 21 C 8.1789 6.5116 0.0 0
M  V30 22 N 9.7189 6.5116 0.0 0
M  V30 23 C 7.4089 7.8452 0.0 0
M  V30 24 C 10.4889 7.8452 0.0 0
M  V30 25 C 8.1789 9.1790 0.0 0
M  V30 26 N 9.7189 9.1790 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 2 21
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 1 6 24
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 8 15
M  V30 12 1 9 11
M  V30 13 1 9 12
M  V30 14 2 10 11
M  V30 15 1 11 13
M  V30 16 2 12 14
M  V30 17 1 13 14
M  V30 18 2 15 16
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 2 17 19
M  V30 22 2 18 20
M  V30 23 1 19 20
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αZ)-2-Amino-N-methyl-α-[(6-phenylimidazo[2,1-b]thiazol-5-yl)methylene]-4-pyr...
C19H16N6OS
723341-74-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 5.1779 0.0 0
M  V30 2 C 4.6200 5.1779 0.0 0
M  V30 3 C 3.8500 3.8443 0.0 0
M  V30 4 N 2.3100 3.8443 0.0 0
M  V30 5 O 4.6200 2.5105 0.0 0
M  V30 6 C 1.5400 2.5105 0.0 0
M  V30 7 N 0.0000 7.8452 0.0 0
M  V30 8 C 6.9300 3.8443 0.0 0
M  V30 9 C 8.4617 3.6832 0.0 0
M  V30 10 N 6.3037 2.4374 0.0 0
M  V30 11 N 8.7819 2.1769 0.0 0
M  V30 12 C 7.4481 1.4069 0.0 0
M  V30 13 C 4.9700 1.6674 0.0 0
M  V30 14 S 6.8217 0.0000 0.0 0
M  V30 15 C 5.2902 0.1611 0.0 0
M  V30 16 C 9.4921 4.8277 0.0 0
M  V30 17 C 10.9984 4.5076 0.0 0
M  V30 18 C 9.0162 6.2923 0.0 0
M  V30 19 C 12.0289 5.6520 0.0 0
M  V30 20 C 10.0467 7.4368 0.0 0
M  V30 21 C 11.5529 7.1166 0.0 0
M  V30 22 C 3.8500 6.5116 0.0 0
M  V30 23 N 2.3100 6.5116 0.0 0
M  V30 24 C 4.6200 7.8452 0.0 0
M  V30 25 C 1.5400 7.8452 0.0 0
M  V30 26 C 3.8500 9.1790 0.0 0
M  V30 27 N 2.3100 9.1790 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 2 22
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 1 4 6
M  V30 8 1 7 25
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 9 16
M  V30 13 1 10 12
M  V30 14 1 10 13
M  V30 15 2 11 12
M  V30 16 1 12 14
M  V30 17 2 13 15
M  V30 18 1 14 15
M  V30 19 2 16 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 2 18 20
M  V30 23 2 19 21
M  V30 24 1 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 723341-73-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 723341-74-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-1917921
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 127-19-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrimidine derivatives as Tie2 receptor tyrosine kinase
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Luke, Richard William Arthur
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004058776 A1 2004-07-15

$RFMT $RIREG SCHEME389 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Thymidine, 2′,3′-didehydro-3′-deoxy-, 5′-[hydrogen P-(ethoxycarbonyl)phosphon...
C13H17N2O8P
725245-97-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 4.6200 0.0000 0.0 0
M  V30 2 C 9.7758 4.3425 0.0 0
M  V30 3 O 11.1826 3.7162 0.0 0
M  V30 4 P 12.4285 4.6214 0.0 0 VAL=5
M  V30 5 C 13.6745 5.5266 0.0 0
M  V30 6 O 13.3337 3.3755 0.0 0
M  V30 7 O 11.5234 5.8673 0.0 0
M  V30 8 O 15.0813 4.9002 0.0 0
M  V30 9 O 13.5134 7.0582 0.0 0
M  V30 10 C 16.3272 5.8054 0.0 0
M  V30 11 C 17.7341 5.1790 0.0 0
M  V30 12 C 1.5400 5.3347 0.0 0
M  V30 13 O 0.0000 2.6674 0.0 0
M  V30 14 C 6.1600 2.6674 0.0 0 CFG=1
M  V30 15 O 7.0652 3.9133 0.0 0
M  V30 16 C 7.0652 1.4214 0.0 0
M  V30 17 C 8.5299 3.4375 0.0 0 CFG=2
M  V30 18 C 8.5299 1.8974 0.0 0
M  V30 19 N 4.6200 2.6674 0.0 0
M  V30 20 C 3.8500 1.3336 0.0 0
M  V30 21 C 3.8500 4.0011 0.0 0
M  V30 22 N 2.3100 1.3336 0.0 0
M  V30 23 C 2.3100 4.0011 0.0 0
M  V30 24 C 1.5400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 20
M  V30 2 1 2 3
M  V30 3 1 17 2 CFG=3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 12 23
M  V30 13 2 13 24
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 14 19 CFG=3
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 1 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 14 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Thymidine, 2′,3′-didehydro-3′-deoxy-, 5′-[hydrogen [(methylamino)carbonyl]pho...
C12H16N3O7P
725246-04-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 4.6200 0.0000 0.0 0
M  V30 2 C 9.7758 4.3425 0.0 0
M  V30 3 O 11.1826 3.7162 0.0 0
M  V30 4 P 12.4285 4.6214 0.0 0 VAL=5
M  V30 5 C 13.6743 5.5266 0.0 0
M  V30 6 O 13.3337 3.3755 0.0 0
M  V30 7 O 11.5233 5.8673 0.0 0
M  V30 8 N 15.0813 4.9002 0.0 0
M  V30 9 O 13.5134 7.0582 0.0 0
M  V30 10 C 16.3272 5.8054 0.0 0
M  V30 11 C 1.5400 5.3347 0.0 0
M  V30 12 O 0.0000 2.6674 0.0 0
M  V30 13 C 6.1600 2.6674 0.0 0 CFG=1
M  V30 14 O 7.0652 3.9133 0.0 0
M  V30 15 C 7.0652 1.4214 0.0 0
M  V30 16 C 8.5298 3.4375 0.0 0 CFG=2
M  V30 17 C 8.5298 1.8974 0.0 0
M  V30 18 N 4.6200 2.6674 0.0 0
M  V30 19 C 3.8500 1.3336 0.0 0
M  V30 20 C 3.8500 4.0011 0.0 0
M  V30 21 N 2.3100 1.3336 0.0 0
M  V30 22 C 2.3100 4.0011 0.0 0
M  V30 23 C 1.5400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 19
M  V30 2 1 2 3
M  V30 3 1 16 2 CFG=3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 8 10
M  V30 11 1 11 22
M  V30 12 2 12 23
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 18 CFG=3
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 1 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 13 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 725245-97-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 725246-04-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-2004017
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: 3'-Azido-3'-deoxythymidine
5'-(methylaminocarbonyl)phosphonate 14. A solution of phosphonate 9 (80
mg, 0.2 mmol) in 25% aqueous methylamine (3 mL) was kept for 1 h at 20 °C
and evaporated. The residue was dissolved in water and purified on a
DEAE-Toyopearl column in a linear gradient of NH4HCO3 (0-0.2 M).
2',3'-Dideoxy-2',3'-didehydrothymidine
5'-(Methylaminocarbonyl)phosphonate 17, Yield 92%. 1H NMR (D2O): 7.43
(1H, s, H6), 6.85 (1H, m, H1'), 6.35 (1H, m, H2'), 5.86 (1H, m, H3'),
4.97 (1H, m, H4'), 4.03 (2H, m, H5'), 2.61 (3H, s, CH3N), 1.76 (3H, s,
CH3-Thy). 31P NMR (D2O):-1.53 s.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Uncharged AZT and D4T Derivatives of Phosphonoformic and Phosphonoacetic
Acids as Anti-HIV Pronucleosides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shirokova, Elena A.; Jasko, Maxim V.; Khandazhinskaya, Anastasiya L.;
Ivanov, Alexander V.; Yanvarev, Dmitry V.; Skoblov, Yury S.; Mitkevich,
Vladimir A.; Bocharov, Eduard V.; Pronyaeva, Tatyana R.; Fedyuk, Nina V.;
Kukhanova, Marina K.; Pokrovsky, Andrey G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2004), 47(14), 3606-3614

$RFMT $RIREG SCHEME390 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Acetic acid, 2,2′-[(3,5-dibromo-1,2-phenylene)diimino]bis[2-oxo-, diethyl ester
C14H14Br2N2O6
726137-07-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.2400 5.3347 0.0 0
M  V30 2 C 10.7800 5.3347 0.0 0
M  V30 3 C 11.5500 6.6685 0.0 0
M  V30 4 O 11.5500 4.0011 0.0 0
M  V30 5 O 13.0900 6.6685 0.0 0
M  V30 6 O 10.7800 8.0021 0.0 0
M  V30 7 C 13.8600 8.0021 0.0 0
M  V30 8 C 15.4000 8.0021 0.0 0
M  V30 9 N 6.1600 5.3347 0.0 0
M  V30 10 C 4.6200 5.3347 0.0 0
M  V30 11 C 3.8500 6.6685 0.0 0
M  V30 12 O 3.8500 4.0011 0.0 0
M  V30 13 O 2.3100 6.6685 0.0 0
M  V30 14 O 4.6200 8.0021 0.0 0
M  V30 15 C 1.5400 8.0021 0.0 0
M  V30 16 C 0.0000 8.0021 0.0 0
M  V30 17 Br 4.6200 2.6674 0.0 0
M  V30 18 Br 9.2400 0.0000 0.0 0
M  V30 19 C 8.4700 4.0011 0.0 0
M  V30 20 C 6.9300 4.0011 0.0 0
M  V30 21 C 9.2400 2.6674 0.0 0
M  V30 22 C 6.1600 2.6674 0.0 0
M  V30 23 C 8.4700 1.3336 0.0 0
M  V30 24 C 6.9300 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 19
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 9 10
M  V30 10 1 9 20
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 13 15
M  V30 16 1 15 16
M  V30 17 1 17 22
M  V30 18 1 18 23
M  V30 19 2 19 20
M  V30 20 1 19 21
M  V30 21 1 20 22
M  V30 22 2 21 23
M  V30 23 2 22 24
M  V30 24 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethanediamide, N,N′′-(3,5-dibromo-1,2-phenylene)bis[N′-methyl-
C12H12Br2N4O4
726137-11-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 5.3348 0.0 0
M  V30 2 C 3.0800 5.3348 0.0 0
M  V30 3 C 2.3100 6.6686 0.0 0
M  V30 4 O 2.3100 4.0011 0.0 0
M  V30 5 N 0.7700 6.6686 0.0 0
M  V30 6 O 3.0800 8.0022 0.0 0
M  V30 7 C 0.0000 8.0022 0.0 0
M  V30 8 N 7.7001 5.3348 0.0 0
M  V30 9 C 9.2401 5.3348 0.0 0
M  V30 10 C 10.0101 6.6686 0.0 0
M  V30 11 O 10.0101 4.0011 0.0 0
M  V30 12 N 11.5501 6.6686 0.0 0
M  V30 13 O 9.2401 8.0022 0.0 0
M  V30 14 C 12.3201 8.0022 0.0 0
M  V30 15 Br 3.0800 2.6675 0.0 0
M  V30 16 Br 7.7001 0.0000 0.0 0
M  V30 17 C 5.3901 4.0011 0.0 0
M  V30 18 C 6.9301 4.0011 0.0 0
M  V30 19 C 4.6201 2.6675 0.0 0
M  V30 20 C 7.7001 2.6675 0.0 0
M  V30 21 C 5.3901 1.3337 0.0 0
M  V30 22 C 6.9301 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 1 8 9
M  V30 9 1 8 18
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 1 12 14
M  V30 15 1 15 19
M  V30 16 1 16 22
M  V30 17 2 17 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 2 19 21
M  V30 21 2 20 22
M  V30 22 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 726137-07-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 726137-11-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-3541574
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and catalytic activity of square-planar Ni(II) complexes of
bis-N,N'-disubstituted oxamides and related ligands for epoxidation of
olefins
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zheng, G. X.; Wang, Q. F.; Yan, S. L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Polish Journal of Chemistry (2004), 78(1), 19-25

$RFMT $RIREG SCHEME391 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Chloro-2-thiophenecarboxaldehyde
C5H3ClOS
7283-96-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3026 2.6218 0.0 0
M  V30 2 O 6.6363 1.8517 0.0 0
M  V30 3 Cl 0.0000 1.4946 0.0 0
M  V30 4 C 3.9690 1.8517 0.0 0
M  V30 5 S 2.5620 2.4782 0.0 0
M  V30 6 C 3.8079 0.3202 0.0 0
M  V30 7 C 1.5316 1.3337 0.0 0
M  V30 8 C 2.3016 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 7
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(5-Chloro-2-thienyl)methylene]methanamine
C6H6ClNS
2410441-96-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3026 2.6218 0.0 0
M  V30 2 N 6.6363 1.8517 0.0 0
M  V30 3 C 7.9700 2.6218 0.0 0
M  V30 4 Cl 0.0000 1.4946 0.0 0
M  V30 5 C 3.9690 1.8517 0.0 0
M  V30 6 S 2.5620 2.4782 0.0 0
M  V30 7 C 3.8079 0.3202 0.0 0
M  V30 8 C 1.5316 1.3337 0.0 0
M  V30 9 C 2.3016 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 4 8
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 7283-96-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2410441-96-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-21471780
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Hydantoin analogs inhibit the fully assembled ClpXP protease without
affecting the individual peptidase and chaperone domains
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fetzer, Christian; Korotkov, Vadim S.; Sieber, Stephan A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2019), 17(30), 7124-7127

$RFMT $RIREG SCHEME392 STEP1
$RXN



  2  1
$MOL
4′-Nitro[1,1′-biphenyl]-3-carboxylic acid
C13H9NO4
729-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3336 3.8500 0.0 0
M  V30 2 O 0.0000 4.6200 0.0 0
M  V30 3 O 1.3336 2.3100 0.0 0
M  V30 4 N 10.6694 1.5400 0.0 0 VAL=5
M  V30 5 O 10.6694 0.0000 0.0 0
M  V30 6 O 12.0031 2.3100 0.0 0
M  V30 7 C 5.3347 4.6200 0.0 0
M  V30 8 C 4.0011 3.8500 0.0 0
M  V30 9 C 5.3347 6.1600 0.0 0
M  V30 10 C 2.6673 4.6200 0.0 0
M  V30 11 C 4.0011 6.9300 0.0 0
M  V30 12 C 2.6673 6.1600 0.0 0
M  V30 13 C 6.6684 3.8500 0.0 0
M  V30 14 C 8.0020 4.6200 0.0 0
M  V30 15 C 6.6684 2.3100 0.0 0
M  V30 16 C 9.3358 3.8500 0.0 0
M  V30 17 C 8.0020 1.5400 0.0 0
M  V30 18 C 9.3358 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 2 4 5
M  V30 5 2 4 6
M  V30 6 1 4 18
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 13
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4′-nitro[1,1′-biphenyl]-3-carboxamide
C14H12N2O3
1598408-84-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.6695 3.8500 0.0 0
M  V30 2 N 12.0032 4.6201 0.0 0
M  V30 3 O 10.6695 2.3100 0.0 0
M  V30 4 C 13.3369 3.8500 0.0 0
M  V30 5 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 6 O 1.3337 0.0000 0.0 0
M  V30 7 O 0.0000 2.3100 0.0 0
M  V30 8 C 6.6684 4.6201 0.0 0
M  V30 9 C 8.0021 3.8500 0.0 0
M  V30 10 C 6.6684 6.1601 0.0 0
M  V30 11 C 9.3359 4.6201 0.0 0
M  V30 12 C 8.0021 6.9301 0.0 0
M  V30 13 C 9.3359 6.1601 0.0 0
M  V30 14 C 5.3348 3.8500 0.0 0
M  V30 15 C 4.0010 4.6201 0.0 0
M  V30 16 C 5.3348 2.3100 0.0 0
M  V30 17 C 2.6673 3.8500 0.0 0
M  V30 18 C 4.0010 1.5400 0.0 0
M  V30 19 C 2.6673 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 19
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 8 14
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 729-01-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1598408-84-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-13121563
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and evaluation of novel diaryl urea derivatives as
potential antitumor agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lu, Chenshu; Tang, Ke; Li, Yan; Li, Peng; Lin, Ziyun; Yin, Dali; Chen,
Xiaoguang; Huang, Haihong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2014), 77351-360

$RFMT $RIREG SCHEME393 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Acetylbenzenesulfonyl chloride
C8H7ClO3S
73035-16-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.3337 3.0801 0.0 0 VAL=6
M  V30 2 Cl 0.0000 3.8501 0.0 0
M  V30 3 O 0.5637 1.7464 0.0 0
M  V30 4 O 2.1037 4.4137 0.0 0
M  V30 5 C 6.6687 3.0801 0.0 0
M  V30 6 C 6.6687 4.6201 0.0 0
M  V30 7 O 8.0023 2.3101 0.0 0
M  V30 8 C 2.6675 2.3101 0.0 0
M  V30 9 C 4.0012 3.0801 0.0 0
M  V30 10 C 2.6675 0.7700 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 4.0012 0.0000 0.0 0
M  V30 13 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Acetyl-N-methylbenzenesulfonamide
C9H11NO3S
173158-12-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.6685 3.0801 0.0 0 VAL=6
M  V30 2 N 8.0023 3.8501 0.0 0
M  V30 3 O 5.8985 4.4137 0.0 0
M  V30 4 O 7.4385 1.7464 0.0 0
M  V30 5 C 9.3360 3.0801 0.0 0
M  V30 6 C 1.3337 3.0801 0.0 0
M  V30 7 C 1.3337 4.6201 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 3.0801 0.0 0
M  V30 11 C 5.3348 0.7700 0.0 0
M  V30 12 C 2.6675 2.3101 0.0 0
M  V30 13 C 4.0012 0.0000 0.0 0
M  V30 14 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 1 2 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 12
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 73035-16-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 173158-12-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-7681539
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 1. 3-Acetyl-N-methylbenzenesulfonamide To a slurry of
3-acetylbenzene-1-sulfonyl chloride (0.7 g, 3.202 mmol) in acetonitrile
(10mL) and diisopropyl ethyl amine (4.8 mmol, 0.671 mL) was added
methylamine (2M THF, 1.6 mL) at 0° C. The reaction was stirred at 25° C
over 19 hours. Solvent was removed in-vacuo and the resulted oil was
purified by BiotageTM chromatography (cartridge 40s), eluent 1 :2 ethyl
acetate (EtOAc)/hexane to afford 3-acetyl-N-methylbenzenesulfonamide as a
white solid (0.630 g, 92 %). MS (+ESI): 214 [M+H].
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of aminosulfonylphenyl pyrazolo[1,5-a]pyrimidines as Raf
kinase inhibitors.
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berger, Dan Maarten; Levin, Jeremy Ian; Dutia, Minu Dhanjisha; Norton,
Emily Boucher; Diamantidis, George
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009111260 A1 2009-09-11

$RFMT $RIREG SCHEME394 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 5,6-dimethoxy[1,1′-biphenyl]-2-acetate
C17H18O4
736143-49-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 4.6200 0.0 0
M  V30 2 C 8.0021 5.3900 0.0 0
M  V30 3 O 9.3358 4.6200 0.0 0
M  V30 4 O 8.0021 6.9300 0.0 0
M  V30 5 C 10.6694 5.3900 0.0 0
M  V30 6 O 1.3336 4.6200 0.0 0
M  V30 7 C 0.0000 5.3900 0.0 0
M  V30 8 O 1.3336 7.7000 0.0 0
M  V30 9 C 1.3336 9.2400 0.0 0
M  V30 10 C 4.0011 4.6200 0.0 0
M  V30 11 C 5.3347 5.3900 0.0 0
M  V30 12 C 2.6673 5.3900 0.0 0
M  V30 13 C 5.3347 6.9300 0.0 0
M  V30 14 C 2.6673 6.9300 0.0 0
M  V30 15 C 4.0011 7.7000 0.0 0
M  V30 16 C 4.0011 3.0800 0.0 0
M  V30 17 C 2.6673 2.3100 0.0 0
M  V30 18 C 5.3347 2.3100 0.0 0
M  V30 19 C 2.6673 0.7700 0.0 0
M  V30 20 C 5.3347 0.7700 0.0 0
M  V30 21 C 4.0011 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 12
M  V30 8 1 8 9
M  V30 9 1 8 14
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 10 16
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5,6-Dimethoxy-N-methyl[1,1′-biphenyl]-2-acetamide
C17H19NO3
736143-58-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 4.6200 0.0 0
M  V30 2 C 8.0021 5.3900 0.0 0
M  V30 3 N 9.3358 4.6200 0.0 0
M  V30 4 O 8.0021 6.9300 0.0 0
M  V30 5 C 10.6694 5.3900 0.0 0
M  V30 6 O 1.3336 4.6200 0.0 0
M  V30 7 C 0.0000 5.3900 0.0 0
M  V30 8 O 1.3336 7.7000 0.0 0
M  V30 9 C 1.3336 9.2400 0.0 0
M  V30 10 C 4.0011 4.6200 0.0 0
M  V30 11 C 5.3347 5.3900 0.0 0
M  V30 12 C 2.6673 5.3900 0.0 0
M  V30 13 C 5.3347 6.9300 0.0 0
M  V30 14 C 2.6673 6.9300 0.0 0
M  V30 15 C 4.0011 7.7000 0.0 0
M  V30 16 C 4.0011 3.0800 0.0 0
M  V30 17 C 5.3347 2.3100 0.0 0
M  V30 18 C 2.6673 2.3100 0.0 0
M  V30 19 C 5.3347 0.7700 0.0 0
M  V30 20 C 2.6673 0.7700 0.0 0
M  V30 21 C 4.0011 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 12
M  V30 8 1 8 9
M  V30 9 1 8 14
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 10 16
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 736143-49-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 736143-58-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-1099666
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 143-33-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM The palladium(0) Suzuki cross-coupling reaction as the key step in the
synthesis of aporphinoids
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Suau, R.; Rico, R.; Najera, F.; Ortiz-Lopez, F. J.; Lopez-Romero, J. M.;
Moreno-Manas, M.; Roglans, A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2004), 60(27), 5725-5735

$RFMT $RIREG SCHEME395 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Chloro-6-(chloromethyl)-2,4(1H,3H)-pyrimidinedione
C5H4Cl2N2O2
73742-45-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 4.6200 0.0 0
M  V30 2 Cl 6.6685 3.8500 0.0 0
M  V30 3 Cl 2.6674 6.1600 0.0 0
M  V30 4 O 0.0000 4.6200 0.0 0
M  V30 5 O 2.6674 0.0000 0.0 0
M  V30 6 C 4.0011 3.8500 0.0 0
M  V30 7 C 2.6674 4.6200 0.0 0
M  V30 8 N 4.0011 2.3100 0.0 0
M  V30 9 C 1.3338 3.8500 0.0 0
M  V30 10 C 2.6674 1.5400 0.0 0
M  V30 11 N 1.3338 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 3 7
M  V30 4 2 4 9
M  V30 5 2 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Chloro-6-[(methylamino)methyl]-2,4(1H,3H)-pyrimidinedione
C6H8ClN3O2
183205-18-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 4.6200 0.0 0
M  V30 2 N 6.6685 3.8500 0.0 0
M  V30 3 C 8.0021 4.6200 0.0 0
M  V30 4 Cl 2.6674 6.1600 0.0 0
M  V30 5 O 0.0000 4.6200 0.0 0
M  V30 6 O 2.6674 0.0000 0.0 0
M  V30 7 C 4.0011 3.8500 0.0 0
M  V30 8 C 2.6674 4.6200 0.0 0
M  V30 9 N 4.0011 2.3100 0.0 0
M  V30 10 C 1.3336 3.8500 0.0 0
M  V30 11 C 2.6674 1.5400 0.0 0
M  V30 12 N 1.3336 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 4 8
M  V30 5 2 5 10
M  V30 6 2 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 73742-45-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 183205-18-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-9182306
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and evaluation of 6-methylene-bridged uracil derivatives. Part
1: Discovery of novel orally active inhibitors of human thymidine
phosphorylase
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yano, Shingo; Kazuno, Hideki; Suzuki, Norihiko; Emura, Tomohiro; Wierzba,
Konstanty; Yamashita, Jun-Ichi; Tada, Yukio; Yamada, Yuji; Fukushima,
Masakazu; Asao, Tetsuji
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2004), 12(13), 3431-3441

$RFMT $RIREG SCHEME396 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbon disulfide
CS2
75-15-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 0.0000 0.0 0
M  V30 2 S 0.0000 0.0000 0.0 0
M  V30 3 S 3.0800 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Chloroacetyl chloride
C2H2Cl2O
79-04-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 2.6673 2.3101 0.0 0
M  V30 3 Cl 1.3337 0.0000 0.0 0
M  V30 4 O 0.0000 2.3101 0.0 0
M  V30 5 Cl 4.0010 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylrhodanine
C4H5NOS2
4807-55-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.7106 0.0000 0.0 0
M  V30 2 O 0.0000 1.9692 0.0 0
M  V30 3 S 5.4211 1.9692 0.0 0
M  V30 4 N 2.7106 1.5400 0.0 0
M  V30 5 C 1.4647 2.4452 0.0 0
M  V30 6 C 3.9564 2.4452 0.0 0
M  V30 7 C 1.9406 3.9098 0.0 0
M  V30 8 S 3.4806 3.9098 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 2 2 5
M  V30 3 2 3 6
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-15-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 79-04-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 4807-55-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-318-CAS-9447774
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):NOTES
$DATUM no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A novel un-catalyzed and solvent-free method for the synthesis of
2-thioxothiazolidin-4-ones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Moghimi, S.; Heravi, M. M.; Oskooie, H. A.; Beheshtiha, Y. S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Scientia Iranica, Transaction C: Chemistry, Chemical Engineering (2014),
21(3), 748-751

$RFMT $RIREG SCHEME397 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbon disulfide
CS2
75-15-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 0.0000 0.0 0
M  V30 2 S 0.0000 0.0000 0.0 0
M  V30 3 S 3.0800 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl propiolate
C4H4O2
922-67-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 1.3336 0.0 0
M  V30 2 C 3.8500 1.3336 0.0 0
M  V30 3 O 1.5400 2.6673 0.0 0
M  V30 4 O 1.5400 0.0000 0.0 0
M  V30 5 C 5.3900 1.3336 0.0 0
M  V30 6 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 3 2 5
M  V30 5 1 3 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3-Dihydro-3-methyl-2-thioxo-4H-1,3-thiazin-4-one
C5H5NOS2
1193-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 0.0000 0.0 0
M  V30 2 O 0.0000 1.5400 0.0 0
M  V30 3 S 5.3349 1.5400 0.0 0
M  V30 4 N 2.6674 1.5400 0.0 0
M  V30 5 C 1.3338 2.3100 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 1.3338 3.8500 0.0 0
M  V30 8 S 4.0011 3.8500 0.0 0
M  V30 9 C 2.6674 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 2 2 5
M  V30 3 2 3 6
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-15-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 922-67-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1193-58-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-18520257
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, ultrasound
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Ultrasound-mediated three-component reaction "on-water" protocol for the
synthesis of novel mono- and bis-1,3-thiazin-4-one derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Arafa, Wael A. A.; Mohamed, Ashraf M.; Abdel-Magied, Ahmed F.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Heterocycles (2017), 94(8), 1439-1455

$RFMT $RIREG SCHEME398 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbon disulfide
CS2
75-15-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 0.0000 0.0 0
M  V30 2 S 0.0000 0.0000 0.0 0
M  V30 3 S 3.0800 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl isothiocyanate
C2H3NS
556-61-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.7700 0.0 0
M  V30 2 N 2.6673 0.0000 0.0 0
M  V30 3 S 0.0000 1.5400 0.0 0
M  V30 4 C 4.0010 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-15-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 556-61-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-318-CAS-5760061
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7722-84-1
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Synthesis of ITCs General procedure for the preparation of ITCs was
followed the literature method (Li et al., 1997). Carbon disulfide (0.02
mol) was added dropwise to a stirred mixture of aliphatic amine (0.02
mol), triethylamine (0.02 mol), and THF solution (100 mL) at 2-5 °C over
a period of 30 min. Agitation was continued for 30 min, followed by the
drop-wise addition of hydrogen peroxide (30 %, 0.03 mol) with a
controlled reaction temperature of 0-40 °C. Then, hydrochloric acid was
added to the mixture to neutralize the reaction solution. The reaction
mixture was evaporated under reduced pressure and extracted with ethyl
acetate. Then, the ester was removed by evaporation under reduced
pressure. The remaining residue was a yellowish oily liquid. Compounds
were purified by silica gel column chromatography. 1, yield 92% Molecular
formula: C2H3NS; Molecular weight: 73.12; Elemental analysis
(calcd./found): C 32.85/32.81 H 4.14/4.13 N 19.16/19.18; EI-MS [M]+:
72.0; 1H NMR (300 MHz, CDCl3): δ : 3.32 (s, 3 H); IR (KBr) ν/cm-1: 2,983,
2,932 (CH2) 2,108 (NCS) 1,407 (CS)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and structure-activity relationships of aliphatic
isothiocyanate analogs as antibiotic agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Deguang; Shu, Yanan; Li, Pingliang; Zhang, Wenbing; Ni, Hanwen; Cao,
Yongsong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Medicinal Chemistry Research (2013), 22(7), 3119-3125

$RFMT $RIREG SCHEME399 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methylfuro[3,4-c]quinoline-1,3-dione
C12H7NO3
75353-75-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.7105 6.6520 0.0 0
M  V30 2 C 2.6507 0.0000 0.0 0
M  V30 3 O 0.0000 1.9571 0.0 0
M  V30 4 C 3.4207 4.0012 0.0 0
M  V30 5 C 2.6507 2.6675 0.0 0
M  V30 6 C 4.9608 4.0012 0.0 0
M  V30 7 C 2.3903 5.1456 0.0 0
M  V30 8 C 3.4207 1.3337 0.0 0
M  V30 9 C 1.1444 2.9877 0.0 0
M  V30 10 C 5.7308 2.6675 0.0 0
M  V30 11 C 5.7308 5.3348 0.0 0
M  V30 12 O 0.9835 4.5192 0.0 0
M  V30 13 N 4.9608 1.3337 0.0 0
M  V30 14 C 7.2708 2.6675 0.0 0
M  V30 15 C 7.2708 5.3348 0.0 0
M  V30 16 C 8.0408 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 1 2 8
M  V30 3 2 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 2 6 11
M  V30 11 1 7 12
M  V30 12 2 8 13
M  V30 13 1 9 12
M  V30 14 1 10 13
M  V30 15 2 10 14
M  V30 16 1 11 15
M  V30 17 1 14 16
M  V30 18 2 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Dimethyl-1H-pyrrolo[3,4-c]quinoline-1,3(2H)-dione
C13H10N2O2
448190-23-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0608 6.6519 0.0 0
M  V30 2 O 0.3503 1.9570 0.0 0
M  V30 3 C 3.0012 0.0000 0.0 0
M  V30 4 C 0.0000 5.2891 0.0 0
M  V30 5 C 3.7712 4.0011 0.0 0
M  V30 6 C 3.0012 2.6674 0.0 0
M  V30 7 C 5.3112 4.0011 0.0 0
M  V30 8 C 2.7406 5.1454 0.0 0
M  V30 9 C 1.4947 2.9876 0.0 0
M  V30 10 C 3.7712 1.3336 0.0 0
M  V30 11 C 6.0812 2.6674 0.0 0
M  V30 12 C 6.0812 5.3347 0.0 0
M  V30 13 N 1.3338 4.5191 0.0 0
M  V30 14 N 5.3112 1.3336 0.0 0
M  V30 15 C 7.6212 2.6674 0.0 0
M  V30 16 C 7.6212 5.3347 0.0 0
M  V30 17 C 8.3912 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 2 2 9
M  V30 3 1 3 10
M  V30 4 1 4 13
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 2 7 12
M  V30 12 1 8 13
M  V30 13 1 9 13
M  V30 14 2 10 14
M  V30 15 1 11 14
M  V30 16 2 11 15
M  V30 17 1 12 16
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75353-75-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 448190-23-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-366-CAS-12819327
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 110-86-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 1,3-Dioxo-4-methyl-2,3-dihydro-1H-pyrrolo[3,4-c]quinolines as potent
caspase-3 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kravchenko, Dmitri V.; Kysil, Vladimir V.; Ilyn, Alexey P.; Tkachenko,
Sergey E.; Maliarchouk, Sergey; Okun, Ilya M.; Ivachtchenko, Alexandre V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2005), 15(7), 1841-1845

$RFMT $RIREG SCHEME400 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1′-Bis[2-(1-methylethoxy)-3,4-dioxo-1-cyclobuten-1-yl]ferrocene
C24H22FeO6
760998-57-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 42 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 10.8660 15.6150 0.0 0
M  V30 2 C 12.0933 16.3224 0.0 0
M  V30 3 C 13.3206 15.6150 0.0 0
M  V30 4 C 12.0933 17.7413 0.0 0
M  V30 5 O 7.0942 18.8630 0.0 0
M  V30 6 O 6.8088 2.1263 0.0 0
M  V30 7 C 6.8088 0.7114 0.0 0
M  V30 8 C 5.5815 0.0000 0.0 0
M  V30 9 C 8.0361 0.0000 0.0 0
M  V30 10 O 10.5650 5.3978 0.0 0
M  V30 11 O 10.6393 18.8630 0.0 0
M  V30 12 O 10.5650 1.8566 0.0 0
M  V30 13 Fe 3.4435 10.3266 0.0 0 CHG=2 VAL=10
M  V30 14 C 6.8714 15.6150 0.0 0 CHG=-1 VAL=4
M  V30 15 C 6.7971 5.1047 0.0 0 CHG=-1 VAL=4
M  V30 16 C 4.6395 6.3515 0.0 0 VAL=5
M  V30 17 C 3.3692 2.9158 0.0 0 VAL=5
M  V30 18 C 4.7177 14.3681 0.0 0 VAL=5
M  V30 19 C 3.4435 17.7999 0.0 0 VAL=5
M  V30 20 C 0.0782 15.6150 0.0 0 VAL=5
M  V30 21 C 2.2279 14.3681 0.0 0 VAL=5
M  V30 22 C 0.0000 5.1047 0.0 0 VAL=5
M  V30 23 C 2.1458 6.3515 0.0 0 VAL=5
M  V30 24 C 8.0987 16.3224 0.0 0
M  V30 25 C 9.6387 16.3224 0.0 0
M  V30 26 C 8.0987 17.8624 0.0 0
M  V30 27 C 9.6387 17.8624 0.0 0
M  V30 28 C 8.0244 4.3972 0.0 0
M  V30 29 C 8.0244 2.8572 0.0 0
M  V30 30 C 9.5644 4.3972 0.0 0
M  V30 31 C 9.5644 2.8572 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 25
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 2 5 26
M  V30 6 1 6 7
M  V30 7 1 6 29
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 2 10 30
M  V30 11 2 11 27
M  V30 12 2 12 31
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 16 1 13 17
M  V30 17 1 13 18
M  V30 18 1 13 19
M  V30 19 1 13 20
M  V30 20 1 13 21
M  V30 21 1 13 22
M  V30 22 1 13 23
M  V30 23 1 14 18
M  V30 24 1 14 19
M  V30 25 1 14 24
M  V30 26 1 15 16
M  V30 27 1 15 17
M  V30 28 1 15 28
M  V30 29 2 16 23
M  V30 30 2 17 22
M  V30 31 2 18 21
M  V30 32 2 19 20
M  V30 33 1 20 21
M  V30 34 1 22 23
M  V30 35 2 24 25
M  V30 36 1 24 26
M  V30 37 1 25 27
M  V30 38 1 26 27
M  V30 39 2 28 29
M  V30 40 1 28 30
M  V30 41 1 29 31
M  V30 42 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1′-Bis[2-(methylamino)-3,4-dioxo-1-cyclobuten-1-yl]ferrocene
C20H16FeN2O4
1313019-39-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.7380 8.5315 0.0 0
M  V30 2 C 7.5742 9.0139 0.0 0
M  V30 3 O 4.4015 10.5457 0.0 0
M  V30 4 N 4.2149 0.1818 0.0 0
M  V30 5 C 3.2187 0.7562 0.0 0
M  V30 6 O 6.5514 2.1959 0.0 0
M  V30 7 O 6.5974 10.5457 0.0 0
M  V30 8 O 6.5514 0.0000 0.0 0
M  V30 9 Fe 2.1353 5.2522 0.0 0 CHG=2 VAL=10
M  V30 10 C 4.2609 8.5315 0.0 0 CHG=-1 VAL=4
M  V30 11 C 4.2149 2.0141 0.0 0 CHG=-1 VAL=4
M  V30 12 C 2.8770 2.7873 0.0 0 VAL=5
M  V30 13 C 2.0893 0.6568 0.0 0 VAL=5
M  V30 14 C 2.9254 7.7584 0.0 0 VAL=5
M  V30 15 C 2.1353 9.8864 0.0 0 VAL=5
M  V30 16 C 0.0485 8.5315 0.0 0 VAL=5
M  V30 17 C 1.3815 7.7584 0.0 0 VAL=5
M  V30 18 C 0.0000 2.0141 0.0 0 VAL=5
M  V30 19 C 1.3306 2.7873 0.0 0 VAL=5
M  V30 20 C 5.0220 8.9702 0.0 0
M  V30 21 C 5.9769 8.9702 0.0 0
M  V30 22 C 5.0220 9.9252 0.0 0
M  V30 23 C 5.9769 9.9252 0.0 0
M  V30 24 C 4.9759 1.5754 0.0 0
M  V30 25 C 4.9759 0.6205 0.0 0
M  V30 26 C 5.9309 1.5754 0.0 0
M  V30 27 C 5.9309 0.6205 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 21
M  V30 3 2 3 22
M  V30 4 1 4 5
M  V30 5 1 4 25
M  V30 6 2 6 26
M  V30 7 2 7 23
M  V30 8 2 8 27
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 1 9 14
M  V30 14 1 9 15
M  V30 15 1 9 16
M  V30 16 1 9 17
M  V30 17 1 9 18
M  V30 18 1 9 19
M  V30 19 1 10 14
M  V30 20 1 10 15
M  V30 21 1 10 20
M  V30 22 1 11 12
M  V30 23 1 11 13
M  V30 24 1 11 24
M  V30 25 2 12 19
M  V30 26 2 13 18
M  V30 27 2 14 17
M  V30 28 2 15 16
M  V30 29 1 16 17
M  V30 30 1 18 19
M  V30 31 2 20 21
M  V30 32 1 20 22
M  V30 33 1 21 23
M  V30 34 1 22 23
M  V30 35 2 24 25
M  V30 36 1 24 26
M  V30 37 1 25 27
M  V30 38 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 760998-57-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1313019-39-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-9382121
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed vial used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Study of the reactivity of squarylferrocenes. Addition of amines and
aminoesters
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Villanueva-Garcia, Fabian; Reyes, Priscilla; Pannell, Keith H.;
Alvarez-Hernandez, Alejandro; Valois, Ismael; Juarez-Ruiz, Juan M.;
Flores-Rizo, Juan O.; Pena-Cabrera, Eduardo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ARKIVOC (Gainesville, FL, United States) (2011), (9), 105-124

$RFMT $RIREG SCHEME401 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
BOC-D-alanine
C8H15NO4
7764-95-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 12 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 1.5400 0.0 0
M  V30 2 C 4.0012 2.3101 0.0 0
M  V30 3 C 6.6685 2.3101 0.0 0 CFG=2
M  V30 4 O 2.6675 1.5400 0.0 0
M  V30 5 O 4.0012 3.8501 0.0 0
M  V30 6 C 8.0023 1.5400 0.0 0
M  V30 7 C 6.6685 3.8501 0.0 0
M  V30 8 C 1.3337 2.3101 0.0 0
M  V30 9 O 8.0023 0.0000 0.0 0
M  V30 10 O 9.3360 2.3101 0.0 0
M  V30 11 C 0.5637 0.9764 0.0 0
M  V30 12 C 0.0000 3.0801 0.0 0
M  V30 13 C 2.1037 3.6437 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7 CFG=3
M  V30 7 1 4 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 8 13
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Carbamic acid, [1-methyl-2-(methylamino)-2-oxoethyl]-, 1,1-dimethylethyl este...
C9H18N2O3
92208-86-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 13 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 1.5400 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0 CFG=2
M  V30 3 C 4.0012 2.3101 0.0 0
M  V30 4 C 8.0023 1.5400 0.0 0
M  V30 5 C 6.6685 3.8501 0.0 0
M  V30 6 O 2.6673 1.5400 0.0 0
M  V30 7 O 4.0012 3.8501 0.0 0
M  V30 8 N 9.3360 2.3101 0.0 0
M  V30 9 O 8.0023 0.0000 0.0 0
M  V30 10 C 1.3337 2.3101 0.0 0
M  V30 11 C 10.6697 1.5400 0.0 0
M  V30 12 C 2.1037 3.6437 0.0 0
M  V30 13 C 0.0000 3.0801 0.0 0
M  V30 14 C 0.5637 0.9764 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5 CFG=3
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 2 4 9
M  V30 9 1 6 10
M  V30 10 1 8 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 7764-95-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 92208-86-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-23522877
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of [1,2,4]triazolo[1,5-c]quinazolin-5-yl amino acid amides as
well as 3-([1,2,4]triazolo[1,5-c]quinazolin-5-yl)amino azepan-2-ones and
1,4-diazepan-2-ones as aryl hydrocarbon receptor antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lefranc, Julien; Schmees, Norbert; Zorn, Ludwig; Meier, Robin Michael;
Herbert, Simon Anthony; Guenther, Judith; Gutcher, Ilona; Roese, Lars;
Bader, Benjamin; Stoeckigt, Detlef; Gorjanacz, Matyas; Kober, Christina;
Buchmann, Bernd; Boehme, Stephan; Bothe, Ulrich; Platten, Michael;
Baumann, Daniel
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021028382 A1 2021-02-18

$RFMT $RIREG SCHEME402 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3,4-Dimethoxyphenyl)acetone
C11H14O3
776-99-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.7700 4.0011 0.0 0
M  V30 2 C 0.0000 5.3348 0.0 0
M  V30 3 O 2.3100 1.3338 0.0 0
M  V30 4 C 3.0800 0.0000 0.0 0
M  V30 5 C 6.9301 4.0011 0.0 0
M  V30 6 C 7.7001 5.3348 0.0 0
M  V30 7 C 6.9301 6.6686 0.0 0
M  V30 8 O 9.2401 5.3348 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 3.0800 2.6675 0.0 0
M  V30 11 C 3.0800 5.3348 0.0 0
M  V30 12 C 4.6201 2.6675 0.0 0
M  V30 13 C 4.6201 5.3348 0.0 0
M  V30 14 C 5.3901 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 1 5 6
M  V30 6 1 5 14
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Dimethoxy-N-methylamphetamine
C12H19NO2
33236-61-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.7700 4.0011 0.0 0
M  V30 2 C 0.0000 5.3347 0.0 0
M  V30 3 O 2.3100 1.3338 0.0 0
M  V30 4 C 3.0800 0.0000 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 C 7.7000 5.3347 0.0 0
M  V30 7 N 9.2400 5.3347 0.0 0
M  V30 8 C 6.9300 6.6685 0.0 0
M  V30 9 C 10.0100 6.6685 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 3.0800 2.6674 0.0 0
M  V30 12 C 3.0800 5.3347 0.0 0
M  V30 13 C 4.6200 2.6674 0.0 0
M  V30 14 C 4.6200 5.3347 0.0 0
M  V30 15 C 5.3900 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 3 4
M  V30 4 1 3 11
M  V30 5 1 5 6
M  V30 6 1 5 15
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 776-99-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 33236-61-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-10329571
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25895-60-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM 3A Molecular sieves, Na(CN)BH3/3A Mol. sieves, HCl (4.2N)/MeOH, MeOH
(abs), 72 h., Alkylation, Condensation, N-Alkylation, Reduction,
Reductive alkylation
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Reductive aminations of carbonyl compounds with borohydride and borane
reducing agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Baxter, Ellen W.; Reitz, Allen B.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Reactions (Hoboken, NJ, United States) (2002), 59No pp. given

$RFMT $RIREG SCHEME403 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
β-D-Ribofuranuronamide, 3-azido-1,3-dideoxy-1-(2,6-dichloro-9H-purin-9-yl)-N-...
C13H12Cl2N8O4
786665-97-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.3934 2.4368 0.0 0
M  V30 2 C 4.1475 1.5317 0.0 0
M  V30 3 C 4.3085 0.0000 0.0 0
M  V30 4 O 2.7406 2.1580 0.0 0
M  V30 5 N 2.4919 4.1120 0.0 0
M  V30 6 N 1.2460 5.0172 0.0 0 CHG=1 VAL=4
M  V30 7 N 0.0000 5.9224 0.0 0 CHG=-1
M  V30 8 C 3.1884 7.3893 0.0 0
M  V30 9 N 3.6643 8.8538 0.0 0
M  V30 10 O 1.6822 7.0689 0.0 0
M  V30 11 C 2.6339 9.9983 0.0 0
M  V30 12 Cl 13.0288 4.9391 0.0 0
M  V30 13 Cl 10.3613 9.5591 0.0 0
M  V30 14 C 6.3769 4.9989 0.0 0 CFG=2
M  V30 15 C 5.2323 3.9684 0.0 0 CFG=2
M  V30 16 O 5.7505 6.4057 0.0 0
M  V30 17 C 3.8987 4.7385 0.0 0 CFG=2
M  V30 18 C 4.2189 6.2447 0.0 0 CFG=2
M  V30 19 N 7.8831 4.6787 0.0 0
M  V30 20 C 9.0277 5.7091 0.0 0
M  V30 21 C 8.5096 3.2717 0.0 0
M  V30 22 C 10.3613 4.9391 0.0 0
M  V30 23 N 9.0277 7.2491 0.0 0
M  V30 24 N 10.0412 3.4328 0.0 0
M  V30 25 C 11.6950 5.7091 0.0 0
M  V30 26 C 10.3613 8.0191 0.0 0
M  V30 27 N 11.6950 7.2491 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 15 1 CFG=3
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 5 6
M  V30 6 1 17 5 CFG=3
M  V30 7 2 6 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 18 8 CFG=1
M  V30 11 1 9 11
M  V30 12 1 12 25
M  V30 13 1 13 26
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 14 19 CFG=1
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 20 23
M  V30 24 2 21 24
M  V30 25 1 22 24
M  V30 26 2 22 25
M  V30 27 1 23 26
M  V30 28 1 25 27
M  V30 29 2 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 14 15 17 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
3-Azido-1-[2-chloro-6-(methylamino)-9H-purin-9-yl]-1,3-dideoxy-N-methyl-β-D-r...
C12H14ClN9O3
786665-79-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 9.4036 7.9283 0.0 0
M  V30 2 N 11.0788 5.0267 0.0 0
M  V30 3 N 11.9840 6.2726 0.0 0 CHG=1 VAL=4
M  V30 4 N 12.8892 7.5185 0.0 0 CHG=-1
M  V30 5 C 8.8370 2.5369 0.0 0
M  V30 6 N 7.6925 1.5064 0.0 0
M  V30 7 O 10.3016 2.0610 0.0 0
M  V30 8 C 8.0127 0.0000 0.0 0
M  V30 9 N 1.5400 9.5788 0.0 0
M  V30 10 C 0.0000 9.5788 0.0 0
M  V30 11 Cl 1.5400 4.2441 0.0 0
M  V30 12 N 6.1265 7.2316 0.0 0
M  V30 13 C 4.6200 6.9114 0.0 0
M  V30 14 C 6.2874 8.7633 0.0 0
M  V30 15 C 3.8500 8.2452 0.0 0
M  V30 16 N 3.8500 5.5778 0.0 0
M  V30 17 N 4.8806 9.3896 0.0 0
M  V30 18 C 2.3100 8.2452 0.0 0
M  V30 19 C 2.3100 5.5778 0.0 0
M  V30 20 N 1.5400 6.9114 0.0 0
M  V30 21 C 7.2708 6.2011 0.0 0 CFG=2
M  V30 22 C 8.7773 6.5213 0.0 0 CFG=2
M  V30 23 O 7.1099 4.6696 0.0 0
M  V30 24 C 9.5473 5.1877 0.0 0 CFG=2
M  V30 25 C 8.5167 4.0431 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 22 1 CFG=3
M  V30 2 2 2 3
M  V30 3 1 24 2 CFG=3
M  V30 4 2 3 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 25 5 CFG=1
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 18
M  V30 11 1 11 19
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 21 12 CFG=1
M  V30 15 1 13 15
M  V30 16 2 13 16
M  V30 17 2 14 17
M  V30 18 1 15 17
M  V30 19 2 15 18
M  V30 20 1 16 19
M  V30 21 1 18 20
M  V30 22 2 19 20
M  V30 23 1 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 21 22 24 25)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 786665-97-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 786665-79-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-12345313
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and synthesis of 3'-ureidoadenosine-5'-uronamides: effects of the
3'-ureido group on binding to the A3 adenosine receptor
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jeong, Lak Shin; Kim, Myong Jung; Kim, Hea Ok; Gao, Zhan-Guo; Kim,
Soo-Kyung; Jacobson, Kenneth A.; Chun, Moon Woo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2004), 14(19), 4851-4854

$RFMT $RIREG SCHEME404 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 2-amino-5-chloro-3-methyl-, methyl ester
C9H10ClNO2
79101-83-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 4.6200 0.0 0
M  V30 2 O 6.6685 3.8500 0.0 0
M  V30 3 O 5.3347 6.1600 0.0 0
M  V30 4 C 8.0021 4.6200 0.0 0
M  V30 5 N 2.6674 6.1600 0.0 0
M  V30 6 C 0.0000 4.6200 0.0 0
M  V30 7 Cl 2.6674 0.0000 0.0 0
M  V30 8 C 4.0011 3.8500 0.0 0
M  V30 9 C 2.6674 4.6200 0.0 0
M  V30 10 C 4.0011 2.3100 0.0 0
M  V30 11 C 1.3336 3.8500 0.0 0
M  V30 12 C 2.6674 1.5400 0.0 0
M  V30 13 C 1.3336 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 9
M  V30 6 1 6 11
M  V30 7 1 7 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-5-chloro-N,3-dimethylbenzamide
C9H11ClN2O
890707-28-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 4.6200 0.0 0
M  V30 2 N 6.6685 3.8500 0.0 0
M  V30 3 O 5.3347 6.1600 0.0 0
M  V30 4 C 8.0021 4.6200 0.0 0
M  V30 5 N 2.6674 6.1600 0.0 0
M  V30 6 C 0.0000 4.6200 0.0 0
M  V30 7 Cl 2.6674 0.0000 0.0 0
M  V30 8 C 4.0011 3.8500 0.0 0
M  V30 9 C 2.6674 4.6200 0.0 0
M  V30 10 C 4.0011 2.3100 0.0 0
M  V30 11 C 1.3336 3.8500 0.0 0
M  V30 12 C 2.6674 1.5400 0.0 0
M  V30 13 C 1.3336 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 9
M  V30 6 1 6 11
M  V30 7 1 7 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 79101-83-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 890707-28-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-161906
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 111-46-6
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step C: Preparation of 2-amino-5-chloro-N,3-dimethylbenzamide The
solution prepared in Step B (96.2 g, 200 mmol) was diluted with
acetonitrile (60.0 g) and ethylene glycol (180 g) and dried
azeotropically by distilling at atmospheric pressure under a Claisen
distillation head to take off ˜72 mL of volatiles. Then the distillation
head was replaced with a dry-ice-cooled condenser, the remaining solution
was cooled to 0-5° C., and methylamine gas (31.1 g, 1000 mmol) was added
below the surface of the reaction mixture. The mixture was heated at 70°
C. for 17.5 h, and then water (400 mL) was added slowly to precipitate
the product. The mixture was cooled slowly to 5° C., stirred for 15
minutes at this temperature, filtered, and the solids were washed with
water and dried under nitrogen to afford the subject compound (36.36 g,
91.5% yield). HPLC showed 99.3 area % purity.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Method for preparing N-phenylpyrazole-1-carboxamides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shapiro, Rafael; Taylor, Eric de Guyon; Zimmerman, William Thomas
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2006062978 A1 2006-06-15

$RFMT $RIREG SCHEME405 STEP1
$RXN



  2  1
$MOL
4-[2-[4-[5-(4-Fluorophenyl)-4-(4-pyridinyl)-1H-pyrrol-3-yl]-3,6-dihydro-1(2H)...
C29H26FN3O2
811805-08-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 39 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 13.8985 3.8501 0.0 0
M  V30 2 C 15.2322 4.6201 0.0 0
M  V30 3 F 0.0000 6.8043 0.0 0
M  V30 4 C 20.5670 1.5400 0.0 0
M  V30 5 O 20.5670 0.0000 0.0 0
M  V30 6 O 21.9007 2.3100 0.0 0
M  V30 7 C 7.1568 6.3036 0.0 0
M  V30 8 C 8.5638 6.9301 0.0 0
M  V30 9 C 6.1264 7.4482 0.0 0
M  V30 10 C 8.4027 8.4617 0.0 0
M  V30 11 N 6.8964 8.7818 0.0 0
M  V30 12 C 6.8366 4.7973 0.0 0
M  V30 13 C 5.3719 4.3215 0.0 0
M  V30 14 C 7.9810 3.7669 0.0 0
M  V30 15 C 5.0517 2.8150 0.0 0
M  V30 16 C 7.6608 2.2604 0.0 0
M  V30 17 N 6.1963 1.7846 0.0 0
M  V30 18 C 9.8974 6.1601 0.0 0
M  V30 19 C 9.8974 4.6201 0.0 0
M  V30 20 C 11.2311 6.9301 0.0 0
M  V30 21 C 11.2311 3.8501 0.0 0
M  V30 22 C 12.5647 6.1601 0.0 0
M  V30 23 N 12.5647 4.6201 0.0 0
M  V30 24 C 4.5948 7.2872 0.0 0
M  V30 25 C 3.9683 5.8803 0.0 0
M  V30 26 C 3.6896 8.5331 0.0 0
M  V30 27 C 2.4368 5.7193 0.0 0
M  V30 28 C 2.1579 8.3722 0.0 0
M  V30 29 C 1.5316 6.9652 0.0 0
M  V30 30 C 16.5659 3.8501 0.0 0
M  V30 31 C 16.5659 2.3100 0.0 0
M  V30 32 C 17.8995 4.6201 0.0 0
M  V30 33 C 17.8995 1.5400 0.0 0
M  V30 34 C 19.2333 3.8501 0.0 0
M  V30 35 C 19.2333 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 23
M  V30 3 1 2 30
M  V30 4 1 3 29
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 35
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 12
M  V30 11 2 8 10
M  V30 12 1 8 18
M  V30 13 1 9 11
M  V30 14 1 9 24
M  V30 15 1 10 11
M  V30 16 1 12 13
M  V30 17 2 12 14
M  V30 18 2 13 15
M  V30 19 1 14 16
M  V30 20 1 15 17
M  V30 21 2 16 17
M  V30 22 1 18 19
M  V30 23 2 18 20
M  V30 24 1 19 21
M  V30 25 1 20 22
M  V30 26 1 21 23
M  V30 27 1 22 23
M  V30 28 2 24 25
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 2 26 28
M  V30 32 2 27 29
M  V30 33 1 28 29
M  V30 34 2 30 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 2 32 34
M  V30 38 2 33 35
M  V30 39 1 34 35
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[2-[4-[5-(4-Fluorophenyl)-4-(4-pyridinyl)-1H-pyrrol-3-yl]-3,6-dihydro-1(2H)...
C30H29FN4O
811805-21-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 40 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 13.8985 3.8501 0.0 0
M  V30 2 C 15.2323 4.6201 0.0 0
M  V30 3 F 0.0000 6.8043 0.0 0
M  V30 4 C 20.5671 1.5400 0.0 0
M  V30 5 N 21.9008 2.3101 0.0 0
M  V30 6 O 20.5671 0.0000 0.0 0
M  V30 7 C 23.2345 1.5400 0.0 0
M  V30 8 C 7.1568 6.3037 0.0 0
M  V30 9 C 8.5637 6.9302 0.0 0
M  V30 10 C 6.1264 7.4482 0.0 0
M  V30 11 C 8.4027 8.4617 0.0 0
M  V30 12 N 6.8964 8.7819 0.0 0
M  V30 13 C 6.8367 4.7974 0.0 0
M  V30 14 C 5.3719 4.3215 0.0 0
M  V30 15 C 7.9811 3.7669 0.0 0
M  V30 16 C 5.0518 2.8150 0.0 0
M  V30 17 C 7.6609 2.2605 0.0 0
M  V30 18 N 6.1963 1.7846 0.0 0
M  V30 19 C 9.8975 6.1601 0.0 0
M  V30 20 C 9.8975 4.6201 0.0 0
M  V30 21 C 11.2312 6.9302 0.0 0
M  V30 22 C 11.2312 3.8501 0.0 0
M  V30 23 C 12.5648 6.1601 0.0 0
M  V30 24 N 12.5648 4.6201 0.0 0
M  V30 25 C 4.5947 7.2873 0.0 0
M  V30 26 C 3.9684 5.8803 0.0 0
M  V30 27 C 3.6896 8.5332 0.0 0
M  V30 28 C 2.4368 5.7194 0.0 0
M  V30 29 C 2.1579 8.3722 0.0 0
M  V30 30 C 1.5316 6.9653 0.0 0
M  V30 31 C 16.5660 3.8501 0.0 0
M  V30 32 C 16.5660 2.3101 0.0 0
M  V30 33 C 17.8997 4.6201 0.0 0
M  V30 34 C 17.8997 1.5400 0.0 0
M  V30 35 C 19.2333 3.8501 0.0 0
M  V30 36 C 19.2333 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 24
M  V30 3 1 2 31
M  V30 4 1 3 30
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 36
M  V30 8 1 5 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 8 13
M  V30 12 2 9 11
M  V30 13 1 9 19
M  V30 14 1 10 12
M  V30 15 1 10 25
M  V30 16 1 11 12
M  V30 17 1 13 14
M  V30 18 2 13 15
M  V30 19 2 14 16
M  V30 20 1 15 17
M  V30 21 1 16 18
M  V30 22 2 17 18
M  V30 23 1 19 20
M  V30 24 2 19 21
M  V30 25 1 20 22
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 1 23 24
M  V30 29 2 25 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 2 27 29
M  V30 33 2 28 30
M  V30 34 1 29 30
M  V30 35 2 31 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 2 33 35
M  V30 39 2 34 36
M  V30 40 1 35 36
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 811805-08-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 811805-21-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-11120950
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 2-(4-Fluorophenyl)-4-[1-[4-(N-methylcarbamoyl)phenethyl]-1,2,3,6-tetrahydropyridin-4-yl]-3-(pyridin-4-yl)-1H-pyrrole
(Exemplification Compound Number 1-367) To a solution of
4-[1-(4-carboxyphenethyl)-1,2,3,6-tetrahydropyridin-4-yl]-2-(4-fluorophenyl)-3-(pyridin-4-yl)-1H-pyrrole
(500 mg, 1.07 mmol) obtained in Example 4 in dimethylformamide (8 ml) was
added carbonyldiimidazole (347 mg, 2.14 mmol) under stirring, and the
resulting mixture was stirred at room temperature for 30 minutes.
Furthermore, to the reaction mixture was added 2M solution of methylamine
in tetrahydrofuran (1.07 ml, 2.14 mmol) under stirring, and the resulting
mixture was stirred at room temperature for 30 minutes. Subsequently, to
the reaction mixture was added saturated aqueous sodium hydrogencarbonate
solution (10 ml), and the resulting mixture was stirred for a while and
then extracted with ethyl acetate. The separated organic layer containing
the desired compound was washed with water, dried over anhydrous sodium
sulfate and concentrated under reduced pressure. The solid product thus
obtained was washed with a small amount of ethanol to afford the title
compound. Title compound (473 mg) in a yield of 92% as a pale brown
powder. Melting point: 231-233° C. 1H-NMR (400 MHz, DMSO-d6) δppm: 11.37
(1H, s), 8.46 (2H, d, J=6 Hz), 8.34-8.33 (1H, m), 7.74 (2H, d, J=8 Hz),
7.30 (2H, d, J=8 Hz), 7.18-7.09 (6H, m), 6.91 (1H, d, J=2 Hz), 5.25 (1H,
s), 2.92 (2H, s), 2.80-2.73 (5H, m), 2.58-2.53 (4H, m), 2.15 (2H, br.s).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of cyclic tertiary amine compounds that inhibit inflammatory
cytokine production
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kimura, Tomio; Ohkawa, Nobuyuki; Nakao, Akira; Nagasaki, Takayoshi;
Shimozato, Takaichi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20070049620 A1 2007-03-01

$RFMT $RIREG SCHEME406 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (2R,5R)-5-(acetylamino)-5-methyl-6-oxo-1-(phenylmethyl)-2-piperidineca...
C17H22N2O4
817575-49-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.8866 4.0011 0.0 0
M  V30 2 C 8.4266 6.6685 0.0 0
M  V30 3 O 9.1966 8.0021 0.0 0
M  V30 4 O 9.1966 5.3347 0.0 0
M  V30 5 C 10.7366 8.0021 0.0 0
M  V30 6 O 3.8066 4.0011 0.0 0
M  V30 7 N 2.6268 5.6786 0.0 0
M  V30 8 C 1.1798 6.2053 0.0 0
M  V30 9 C 0.0000 5.2154 0.0 0
M  V30 10 O 0.9123 7.7219 0.0 0
M  V30 11 C 2.6268 7.6583 0.0 0
M  V30 12 N 6.1166 5.3347 0.0 0
M  V30 13 C 6.8866 6.6685 0.0 0 CFG=1
M  V30 14 C 4.5766 5.3347 0.0 0
M  V30 15 C 6.1166 8.0021 0.0 0
M  V30 16 C 3.8066 6.6685 0.0 0 CFG=2
M  V30 17 C 4.5766 8.0021 0.0 0
M  V30 18 C 6.1166 2.6674 0.0 0
M  V30 19 C 6.8866 1.3336 0.0 0
M  V30 20 C 4.5766 2.6674 0.0 0
M  V30 21 C 6.1166 0.0000 0.0 0
M  V30 22 C 3.8066 1.3336 0.0 0
M  V30 23 C 4.5766 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 13 2 CFG=3
M  V30 6 1 3 5
M  V30 7 2 6 14
M  V30 8 1 7 8
M  V30 9 1 16 7 CFG=3
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 16 11 CFG=1
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 13 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(2S,5S)-5-(Acetylamino)-N,5-dimethyl-6-oxo-1-(phenylmethyl)-2-piperidinecarbo...
C17H23N3O3
817575-62-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.8866 4.0011 0.0 0
M  V30 2 C 8.4266 6.6685 0.0 0
M  V30 3 N 9.1966 8.0021 0.0 0
M  V30 4 O 9.1966 5.3347 0.0 0
M  V30 5 C 10.7366 8.0021 0.0 0
M  V30 6 O 3.8066 4.0011 0.0 0
M  V30 7 N 2.6268 5.6786 0.0 0
M  V30 8 C 1.1798 6.2053 0.0 0
M  V30 9 C 0.0000 5.2154 0.0 0
M  V30 10 O 0.9123 7.7219 0.0 0
M  V30 11 C 2.6268 7.6583 0.0 0
M  V30 12 N 6.1166 5.3347 0.0 0
M  V30 13 C 6.8866 6.6685 0.0 0 CFG=2
M  V30 14 C 4.5766 5.3347 0.0 0
M  V30 15 C 6.1166 8.0021 0.0 0
M  V30 16 C 3.8066 6.6685 0.0 0 CFG=1
M  V30 17 C 4.5766 8.0021 0.0 0
M  V30 18 C 6.1166 2.6674 0.0 0
M  V30 19 C 4.5766 2.6674 0.0 0
M  V30 20 C 6.8866 1.3336 0.0 0
M  V30 21 C 3.8066 1.3336 0.0 0
M  V30 22 C 6.1166 0.0000 0.0 0
M  V30 23 C 4.5766 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 13 2 CFG=1
M  V30 6 1 3 5
M  V30 7 2 6 14
M  V30 8 1 7 8
M  V30 9 1 16 7 CFG=1
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 16 11 CFG=3
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 13 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 817575-49-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 817575-62-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-2131780
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and synthesis of novel type VI-like β-turn mimetics. Diversity at
the i+1 and the i+2 position
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM De Borggraeve, Wim M.; Verbist, Bie M. P.; Rombouts, Frederik J. R.;
Pawar, Vijaykumar G.; Smets, Wim J.; Kamoune, Laila; Alen, Jo; Van der
Eycken, Erik V.; Compernolle, Frans; Hoornaert, Georges J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2004), 60(50), 11597-11612

$RFMT $RIREG SCHEME407 STEP1
$RXN



  2  1
$MOL
Piperidine-1,4-dicarboxylic acid mono-tert-butyl ester
C11H19NO4
84358-13-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9301 2.8737 0.0 0
M  V30 2 O 7.7001 1.5400 0.0 0
M  V30 3 O 7.7001 4.2073 0.0 0
M  V30 4 C 9.2401 1.5400 0.0 0
M  V30 5 C 9.2401 3.0800 0.0 0
M  V30 6 C 10.7801 1.5400 0.0 0
M  V30 7 C 9.2401 0.0000 0.0 0
M  V30 8 C 0.7700 2.8737 0.0 0
M  V30 9 O 0.0000 4.2073 0.0 0
M  V30 10 O 0.0000 1.5400 0.0 0
M  V30 11 N 5.3901 2.8737 0.0 0
M  V30 12 C 4.6201 4.2073 0.0 0
M  V30 13 C 4.6201 1.5400 0.0 0
M  V30 14 C 3.0800 4.2073 0.0 0
M  V30 15 C 3.0800 1.5400 0.0 0
M  V30 16 C 2.3100 2.8737 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 16
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[(methylamino)carbonyl]-1-piperidinecarboxylate
C12H22N2O3
544696-01-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.8736 0.0 0
M  V30 2 O 3.0800 1.5400 0.0 0
M  V30 3 O 3.0800 4.2073 0.0 0
M  V30 4 C 1.5400 1.5400 0.0 0
M  V30 5 C 1.5400 3.0800 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 1.5400 0.0000 0.0 0
M  V30 8 C 10.0100 2.8736 0.0 0
M  V30 9 N 10.7800 4.2073 0.0 0
M  V30 10 O 10.7800 1.5400 0.0 0
M  V30 11 C 12.3200 4.2073 0.0 0
M  V30 12 N 5.3900 2.8736 0.0 0
M  V30 13 C 6.1600 4.2073 0.0 0
M  V30 14 C 6.1600 1.5400 0.0 0
M  V30 15 C 7.7000 4.2073 0.0 0
M  V30 16 C 7.7000 1.5400 0.0 0
M  V30 17 C 8.4700 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 17
M  V30 11 1 9 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 84358-13-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 544696-01-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-10348039
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 125700-67-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM N-Methyl-N-piperidin-4-ylmethyl-acetamide trifluoroacetate. II.4.a
4-Methylcarbamoyl-piperidine-1-carboxylic acid tert-butyl ester. To a
solution of 6 g (26.17 mmol) piperidine-1,4-dicarboxylic acid
mono-tert-butyl ester in 30ml of dry THF are added 8.477 g (26,4 mmol) of
TBTU and 3.7 ml (26.4 mmol) of triethylamine. The reaction mixture is
stirred at room temperature for one hour. 3.7 ml (26.4 mmol) of
triethylamine and 13.5 ml (26.4 mmol) of methylamine solution (2M) are
added. The reaction mixture is stirred for 48 hours, diluted with water
and extracted with EtOAc. The organic phase is dried over sodium
sulphate.Yield: 5.8 g (92% of theory). C12H22N2O3, EII Mass spectrum: m/z
= 243 [M+H]+
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of new pyridazine derivatives with MCH antagonistic activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lehmann-Lintz, Thorsten; Stenkamp, Dirk; Roth, Gerald Juergen; Mueller,
Stephan Georg; Kley, Joerg; Heckel, Armin; Rudolf, Klaus; Schindler,
Marcus; Lotz, Ralf; Tielmann, Patrick
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008071646 A1 2008-06-19

$RFMT $RIREG SCHEME408 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Azido-N-[(1,1-dimethylethoxy)carbonyl]-L-norleucine
C11H20N4O4
846549-33-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 18 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.9536 2.6674 0.0 0 CFG=2
M  V30 2 N 4.4136 2.6674 0.0 0
M  V30 3 C 6.7236 4.0011 0.0 0
M  V30 4 C 6.7236 1.3338 0.0 0
M  V30 5 C 3.6436 4.0011 0.0 0
M  V30 6 C 8.2636 4.0011 0.0 0
M  V30 7 O 5.9536 0.0000 0.0 0
M  V30 8 O 8.2636 1.3338 0.0 0
M  V30 9 O 2.1036 4.0011 0.0 0
M  V30 10 O 4.4136 5.3347 0.0 0
M  V30 11 C 9.0336 5.3347 0.0 0
M  V30 12 C 1.3336 5.3347 0.0 0
M  V30 13 C 10.5736 5.3347 0.0 0
M  V30 14 C 2.6673 6.1047 0.0 0
M  V30 15 C 0.5636 6.6685 0.0 0
M  V30 16 C 0.0000 4.5647 0.0 0
M  V30 17 N 11.3436 6.6685 0.0 0
M  V30 18 N 12.8836 6.6685 0.0 0 CHG=1 VAL=4
M  V30 19 N 14.4236 6.6685 0.0 0 CHG=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 2 5 10
M  V30 10 1 6 11
M  V30 11 1 9 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 2 17 18
M  V30 18 2 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(1S)-5-azido-1-[(methylamino)carbonyl]pentyl]carbamate
C12H23N5O3
1431217-39-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 19 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.9536 4.0011 0.0 0 CFG=2
M  V30 2 N 4.4136 4.0011 0.0 0
M  V30 3 C 6.7236 5.3347 0.0 0
M  V30 4 C 6.7236 2.6674 0.0 0
M  V30 5 C 3.6436 5.3347 0.0 0
M  V30 6 C 8.2636 5.3347 0.0 0
M  V30 7 N 5.9536 1.3336 0.0 0
M  V30 8 O 8.2636 2.6674 0.0 0
M  V30 9 O 2.1036 5.3347 0.0 0
M  V30 10 O 4.4136 6.6685 0.0 0
M  V30 11 C 9.0336 6.6685 0.0 0
M  V30 12 C 6.7236 0.0000 0.0 0
M  V30 13 C 1.3336 6.6685 0.0 0
M  V30 14 C 10.5736 6.6685 0.0 0
M  V30 15 C 2.6673 7.4385 0.0 0
M  V30 16 C 0.5636 8.0021 0.0 0
M  V30 17 C 0.0000 5.8985 0.0 0
M  V30 18 N 11.3436 8.0021 0.0 0
M  V30 19 N 12.8836 8.0021 0.0 0 CHG=1 VAL=4
M  V30 20 N 14.4236 8.0021 0.0 0 CHG=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 2 5 10
M  V30 10 1 6 11
M  V30 11 1 7 12
M  V30 12 1 9 13
M  V30 13 1 11 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 2 18 19
M  V30 19 2 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 846549-33-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1431217-39-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-2662611
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 833-50-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of 1,5-triazole bridged vancomycin CDE-ring bicyclic mimics
using RuAAC macrocyclization
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Jinqiang; Kemmink, Johan; Rijkers, Dirk T. S.; Liskamp, Rob M. J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Communications (Cambridge, United Kingdom) (2013), 49(40),
4498-4500

$RFMT $RIREG SCHEME409 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Fluoro-3-methoxybenzoyl chloride
C8H6ClFO2
850563-45-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 Cl 1.3337 4.6201 0.0 0
M  V30 3 O 0.0000 2.3100 0.0 0
M  V30 4 F 4.0011 4.6201 0.0 0
M  V30 5 O 6.6686 3.0800 0.0 0
M  V30 6 C 8.0022 2.3100 0.0 0
M  V30 7 C 2.6675 2.3100 0.0 0
M  V30 8 C 4.0011 3.0800 0.0 0
M  V30 9 C 2.6675 0.7700 0.0 0
M  V30 10 C 5.3348 2.3100 0.0 0
M  V30 11 C 4.0011 0.0000 0.0 0
M  V30 12 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 8
M  V30 5 1 5 6
M  V30 6 1 5 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Fluoro-3-methoxy-N-methylbenzamide
C9H10FNO2
1509832-37-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.0801 0.0 0
M  V30 2 N 8.0023 2.3101 0.0 0
M  V30 3 O 6.6685 4.6201 0.0 0
M  V30 4 C 9.3360 3.0801 0.0 0
M  V30 5 F 4.0012 4.6201 0.0 0
M  V30 6 O 1.3337 3.0801 0.0 0
M  V30 7 C 0.0000 2.3101 0.0 0
M  V30 8 C 5.3348 2.3101 0.0 0
M  V30 9 C 4.0012 3.0801 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 11 C 2.6675 2.3101 0.0 0
M  V30 12 C 4.0012 0.0000 0.0 0
M  V30 13 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 9
M  V30 6 1 6 7
M  V30 7 1 6 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 850563-45-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1509832-37-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-20231815
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Chromium-catalyzed para-selective formation of quaternary carbon centers
by alkylation of benzamide derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liu, Pei; Chen, Changpeng; Cong, Xuefeng; Tang, Jinghua; Zeng, Xiaoming
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Nature Communications (2018), 9(1), 1-8

$RFMT $RIREG SCHEME410 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamic acid, [2-[(3-fluoro-4-nitrobenzoyl)amino]ethyl](2-naphthalenylmethyl...
C24H22FN3O5
851075-64-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 8.0020 0.0 0
M  V30 2 N 7.7000 6.6684 0.0 0
M  V30 3 C 6.9300 5.3347 0.0 0
M  V30 4 C 9.2400 6.6684 0.0 0
M  V30 5 O 7.7000 4.0011 0.0 0
M  V30 6 O 5.3900 5.3347 0.0 0
M  V30 7 C 10.0100 8.0020 0.0 0
M  V30 8 C 6.9300 2.6673 0.0 0
M  V30 9 N 11.5500 8.0020 0.0 0
M  V30 10 C 7.7000 1.3336 0.0 0
M  V30 11 C 12.3200 9.3358 0.0 0
M  V30 12 C 6.9300 0.0000 0.0 0
M  V30 13 O 11.5500 10.6694 0.0 0
M  V30 14 F 16.9400 12.0031 0.0 0
M  V30 15 N 18.4800 9.3358 0.0 0 VAL=5
M  V30 16 O 19.2500 10.6694 0.0 0
M  V30 17 O 19.2500 8.0020 0.0 0
M  V30 18 C 3.0800 9.3358 0.0 0
M  V30 19 C 2.3100 8.0020 0.0 0
M  V30 20 C 4.6200 9.3358 0.0 0
M  V30 21 C 2.3100 10.6694 0.0 0
M  V30 22 C 3.0800 6.6684 0.0 0
M  V30 23 C 0.7700 8.0020 0.0 0
M  V30 24 C 5.3900 8.0020 0.0 0
M  V30 25 C 0.7700 10.6694 0.0 0
M  V30 26 C 4.6200 6.6684 0.0 0
M  V30 27 C 0.0000 9.3358 0.0 0
M  V30 28 C 13.8600 9.3358 0.0 0
M  V30 29 C 14.6300 10.6694 0.0 0
M  V30 30 C 14.6300 8.0020 0.0 0
M  V30 31 C 16.1700 10.6694 0.0 0
M  V30 32 C 16.1700 8.0020 0.0 0
M  V30 33 C 16.9400 9.3358 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 24
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 11 28
M  V30 15 1 14 31
M  V30 16 2 15 16
M  V30 17 2 15 17
M  V30 18 1 15 33
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 18 21
M  V30 22 1 19 22
M  V30 23 1 19 23
M  V30 24 2 20 24
M  V30 25 2 21 25
M  V30 26 2 22 26
M  V30 27 2 23 27
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamic acid, [2-[[4-amino-3-(methylamino)benzoyl]amino]ethyl](2-naphthaleny...
C25H28N4O3
851075-66-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 8.0020 0.0 0
M  V30 2 N 7.7000 6.6684 0.0 0
M  V30 3 C 9.2400 6.6684 0.0 0
M  V30 4 C 6.9300 5.3347 0.0 0
M  V30 5 C 10.0100 8.0020 0.0 0
M  V30 6 O 7.7000 4.0011 0.0 0
M  V30 7 O 5.3900 5.3347 0.0 0
M  V30 8 N 11.5500 8.0020 0.0 0
M  V30 9 C 6.9300 2.6673 0.0 0
M  V30 10 C 12.3200 9.3358 0.0 0
M  V30 11 C 7.7000 1.3336 0.0 0
M  V30 12 O 11.5500 10.6694 0.0 0
M  V30 13 C 6.9300 0.0000 0.0 0
M  V30 14 N 16.9400 12.0031 0.0 0
M  V30 15 C 16.1700 13.3367 0.0 0
M  V30 16 N 18.4800 9.3358 0.0 0
M  V30 17 C 2.3100 8.0020 0.0 0
M  V30 18 C 3.0800 9.3358 0.0 0
M  V30 19 C 3.0800 6.6684 0.0 0
M  V30 20 C 0.7700 8.0020 0.0 0
M  V30 21 C 4.6200 9.3358 0.0 0
M  V30 22 C 2.3100 10.6694 0.0 0
M  V30 23 C 4.6200 6.6684 0.0 0
M  V30 24 C 0.0000 9.3358 0.0 0
M  V30 25 C 5.3900 8.0020 0.0 0
M  V30 26 C 0.7700 10.6694 0.0 0
M  V30 27 C 13.8600 9.3358 0.0 0
M  V30 28 C 14.6300 10.6694 0.0 0
M  V30 29 C 14.6300 8.0020 0.0 0
M  V30 30 C 16.1700 10.6694 0.0 0
M  V30 31 C 16.1700 8.0020 0.0 0
M  V30 32 C 16.9400 9.3358 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 25
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 1 10 27
M  V30 14 2 11 13
M  V30 15 1 14 15
M  V30 16 1 14 30
M  V30 17 1 16 32
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 17 20
M  V30 21 1 18 21
M  V30 22 1 18 22
M  V30 23 2 19 23
M  V30 24 2 20 24
M  V30 25 2 21 25
M  V30 26 2 22 26
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 851075-64-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 851075-66-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-10646465
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 10025-69-1
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of potent and selective inhibitors of Candida albicans
N-myristoyltransferase based on the benzothiazole structure
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yamazaki, Kazuo; Kaneko, Yasushi; Suwa, Kie; Ebara, Shinji; Nakazawa,
Kyoko; Yasuno, Kazuhiro
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2005), 13(7), 2509-2522

$RFMT $RIREG SCHEME411 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Difluorobenzyl bromide
C7H5BrF2
85118-01-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 2.6673 0.0 0
M  V30 2 Br 6.9302 4.0010 0.0 0
M  V30 3 F 1.5400 0.0000 0.0 0
M  V30 4 F 0.0000 2.6673 0.0 0
M  V30 5 C 4.6201 2.6673 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 3.8501 4.0010 0.0 0
M  V30 8 C 2.3101 1.3337 0.0 0
M  V30 9 C 2.3101 4.0010 0.0 0
M  V30 10 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 3 8
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Difluoro-N-methylbenzenemethanamine
C8H9F2N
748124-46-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 2.6673 0.0 0
M  V30 2 N 6.9302 4.0010 0.0 0
M  V30 3 C 8.4702 4.0010 0.0 0
M  V30 4 F 1.5400 0.0000 0.0 0
M  V30 5 F 0.0000 2.6673 0.0 0
M  V30 6 C 4.6201 2.6673 0.0 0
M  V30 7 C 3.8501 1.3337 0.0 0
M  V30 8 C 3.8501 4.0010 0.0 0
M  V30 9 C 2.3101 1.3337 0.0 0
M  V30 10 C 2.3101 4.0010 0.0 0
M  V30 11 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 4 9
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 85118-01-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 748124-46-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24312007
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pyrimido[5,4-d]pyrimidine derivatives as ENT inhibitors for the treatment
of cancers, and combination thereof with adenosine receptor antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Deligny, Michael; Crosignani, Stefano; Houthuys, Erica Joke Katelijne
Heleen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021170797 A1 2021-09-02

$RFMT $RIREG SCHEME412 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
8-Fluoro-4-methylfuro[3,4-c]quinoline-1,3-dione
C12H6FNO3
851756-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6948 0.0000 0.0 0
M  V30 2 C 1.3172 5.7308 0.0 0
M  V30 3 O 0.0000 2.7105 0.0 0
M  V30 4 F 9.3194 2.6507 0.0 0
M  V30 5 C 3.9845 2.6507 0.0 0
M  V30 6 C 5.3182 3.4207 0.0 0
M  V30 7 C 2.6509 3.4207 0.0 0
M  V30 8 C 3.6644 1.1444 0.0 0
M  V30 9 C 5.3182 4.9608 0.0 0
M  V30 10 C 6.6520 2.6507 0.0 0
M  V30 11 C 2.6509 4.9608 0.0 0
M  V30 12 C 1.5063 2.3903 0.0 0
M  V30 13 O 2.1328 0.9835 0.0 0
M  V30 14 N 3.9845 5.7308 0.0 0
M  V30 15 C 6.6520 5.7308 0.0 0
M  V30 16 C 7.9857 3.4207 0.0 0
M  V30 17 C 7.9857 4.9608 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 1 2 11
M  V30 3 2 3 12
M  V30 4 1 4 16
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 7 12
M  V30 12 1 8 13
M  V30 13 1 9 14
M  V30 14 2 9 15
M  V30 15 1 10 16
M  V30 16 2 11 14
M  V30 17 1 12 13
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
8-Bromo-2,4-dimethyl-1H-pyrrolo[3,4-c]quinoline-1,3(2H)-dione
C13H9BrN2O2
34505-96-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6948 0.3504 0.0 0
M  V30 2 C 1.3172 6.0813 0.0 0
M  V30 3 O 0.0000 3.0608 0.0 0
M  V30 4 C 1.3628 0.0000 0.0 0
M  V30 5 Br 9.3194 3.0012 0.0 0
M  V30 6 C 3.9845 3.0012 0.0 0
M  V30 7 C 5.3182 3.7712 0.0 0
M  V30 8 C 2.6509 3.7712 0.0 0
M  V30 9 C 3.6644 1.4948 0.0 0
M  V30 10 C 5.3182 5.3113 0.0 0
M  V30 11 C 6.6520 3.0012 0.0 0
M  V30 12 C 2.6509 5.3113 0.0 0
M  V30 13 C 1.5063 2.7406 0.0 0
M  V30 14 N 2.1328 1.3338 0.0 0
M  V30 15 N 3.9845 6.0813 0.0 0
M  V30 16 C 6.6520 6.0811 0.0 0
M  V30 17 C 7.9857 3.7712 0.0 0
M  V30 18 C 7.9857 5.3111 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 1 2 12
M  V30 3 2 3 13
M  V30 4 1 4 14
M  V30 5 1 5 17
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 8 13
M  V30 13 1 9 14
M  V30 14 1 10 15
M  V30 15 2 10 16
M  V30 16 1 11 17
M  V30 17 2 12 15
M  V30 18 1 13 14
M  V30 19 1 16 18
M  V30 20 2 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 851756-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 34505-96-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-174-CAS-10684275
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 110-86-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 1,3-Dioxo-4-methyl-2,3-dihydro-1H-pyrrolo[3,4-c]quinolines as potent
caspase-3 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kravchenko, Dmitri V.; Kysil, Vladimir V.; Ilyn, Alexey P.; Tkachenko,
Sergey E.; Maliarchouk, Sergey; Okun, Ilya M.; Ivachtchenko, Alexandre V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2005), 15(7), 1841-1845

$RFMT $RIREG SCHEME413 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[2-(2-Bromoethoxy)ethyl]-5-nitro-3-(phenylmethoxy)-1H-indazole
C18H18BrN3O4
852378-48-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.2503 5.3348 0.0 0
M  V30 2 C 5.0204 4.0012 0.0 0
M  V30 3 C 8.2791 8.9622 0.0 0
M  V30 4 C 9.5250 8.0571 0.0 0
M  V30 5 O 10.9318 8.6835 0.0 0
M  V30 6 C 12.1778 7.7782 0.0 0
M  V30 7 C 13.5846 8.4046 0.0 0
M  V30 8 Br 14.8305 7.4995 0.0 0
M  V30 9 N 1.1444 10.5337 0.0 0 VAL=5
M  V30 10 O 0.8242 12.0400 0.0 0
M  V30 11 O 0.0000 9.5031 0.0 0
M  V30 12 C 4.3940 8.0755 0.0 0
M  V30 13 C 5.5384 9.1059 0.0 0
M  V30 14 C 5.0204 6.6685 0.0 0
M  V30 15 C 2.9293 8.5513 0.0 0
M  V30 16 N 6.8721 8.3359 0.0 0
M  V30 17 C 5.2183 10.6122 0.0 0
M  V30 18 N 6.5519 6.8296 0.0 0
M  V30 19 C 2.6091 10.0577 0.0 0
M  V30 20 C 3.7535 11.0882 0.0 0
M  V30 21 C 4.2503 2.6673 0.0 0
M  V30 22 C 2.7103 2.6675 0.0 0
M  V30 23 C 5.0204 1.3337 0.0 0
M  V30 24 C 1.9403 1.3337 0.0 0
M  V30 25 C 4.2503 0.0000 0.0 0
M  V30 26 C 2.7103 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 21
M  V30 4 1 3 4
M  V30 5 1 3 16
M  V30 6 1 4 5
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 2 9 10
M  V30 11 2 9 11
M  V30 12 1 9 19
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 2 12 15
M  V30 16 1 13 16
M  V30 17 2 13 17
M  V30 18 2 14 18
M  V30 19 1 15 19
M  V30 20 1 16 18
M  V30 21 1 17 20
M  V30 22 2 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2-[2-[5-nitro-3-(phenylmethoxy)-1H-indazol-1-yl]ethoxy]ethanamine
C19H22N4O4
1575505-08-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.2503 5.3348 0.0 0
M  V30 2 C 5.0204 4.0012 0.0 0
M  V30 3 C 8.2791 8.9622 0.0 0
M  V30 4 C 9.5250 8.0571 0.0 0
M  V30 5 O 10.9319 8.6835 0.0 0
M  V30 6 C 12.1778 7.7782 0.0 0
M  V30 7 C 13.5846 8.4046 0.0 0
M  V30 8 N 14.8305 7.4995 0.0 0
M  V30 9 C 16.2375 8.1258 0.0 0
M  V30 10 N 1.1446 10.5337 0.0 0 VAL=5
M  V30 11 O 0.8242 12.0400 0.0 0
M  V30 12 O 0.0000 9.5031 0.0 0
M  V30 13 C 4.3940 8.0755 0.0 0
M  V30 14 C 5.5384 9.1059 0.0 0
M  V30 15 C 5.0204 6.6685 0.0 0
M  V30 16 C 2.9293 8.5513 0.0 0
M  V30 17 N 6.8722 8.3359 0.0 0
M  V30 18 C 5.2183 10.6122 0.0 0
M  V30 19 N 6.5519 6.8296 0.0 0
M  V30 20 C 2.6091 10.0577 0.0 0
M  V30 21 C 3.7537 11.0882 0.0 0
M  V30 22 C 4.2503 2.6675 0.0 0
M  V30 23 C 2.7103 2.6675 0.0 0
M  V30 24 C 5.0204 1.3337 0.0 0
M  V30 25 C 1.9403 1.3337 0.0 0
M  V30 26 C 4.2503 0.0000 0.0 0
M  V30 27 C 2.7103 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 22
M  V30 4 1 3 4
M  V30 5 1 3 17
M  V30 6 1 4 5
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 2 10 12
M  V30 13 1 10 20
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 2 13 16
M  V30 17 1 14 17
M  V30 18 2 14 18
M  V30 19 2 15 19
M  V30 20 1 16 20
M  V30 21 1 17 19
M  V30 22 1 18 21
M  V30 23 2 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 852378-48-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1575505-08-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-11453666
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM New perspectives on the synthesis and antichagasic activity of
3-alkoxy-1-alkyl-5-nitroindazoles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Muro, Beatriz; Reviriego, Felipe; Navarro, Pilar; Marin, Clotilde;
Ramirez-Macias, Inmaculada; Rosales, Maria Jose; Sanchez-Moreno, Manuel;
Aran, Vicente J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2014), 74124-134

$RFMT $RIREG SCHEME414 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ferrocene, 1-[(1R)-1-(acetyloxy)ethyl]-2-[(S)-1-naphthalenylphenylphosphino]-...
C30H27FeO2P
859839-74-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 46 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 3.3515 5.8419 0.0 0
M  V30 2 C 4.4028 3.5183 0.0 0
M  V30 3 O 4.4028 2.1141 0.0 0
M  V30 4 C 3.1847 4.2243 0.0 0
M  V30 5 C 3.1847 1.4081 0.0 0
M  V30 6 C 1.9667 2.1141 0.0 0
M  V30 7 O 3.1847 0.0000 0.0 0
M  V30 8 Fe 9.0344 9.3952 0.0 0 CHG=2 VAL=10
M  V30 9 C 7.7504 5.4579 0.0 0 VAL=5
M  V30 10 C 5.6208 4.2243 0.0 0 CHG=-1 VAL=4
M  V30 11 C 10.2175 5.4579 0.0 0 VAL=5
M  V30 12 C 8.9607 2.0520 0.0 0 VAL=5
M  V30 13 C 12.3588 4.2243 0.0 0 VAL=5
M  V30 14 C 12.4325 14.6397 0.0 0 CHG=-1 VAL=4
M  V30 15 C 5.6984 14.6397 0.0 0 VAL=5
M  V30 16 C 7.8241 13.4023 0.0 0 VAL=5
M  V30 17 C 10.2951 13.4023 0.0 0 VAL=5
M  V30 18 C 9.0344 16.8081 0.0 0 VAL=5
M  V30 19 C 2.6455 7.0599 0.0 0
M  V30 20 C 3.9644 7.8280 0.0 0
M  V30 21 C 1.3266 7.8280 0.0 0
M  V30 22 C 3.9644 9.3680 0.0 0
M  V30 23 C 5.2833 7.0599 0.0 0
M  V30 24 C 1.3266 9.3680 0.0 0
M  V30 25 C 2.6455 10.1361 0.0 0
M  V30 26 C 5.2833 10.1361 0.0 0
M  V30 27 C 6.6022 7.8280 0.0 0
M  V30 28 C 6.6022 9.3680 0.0 0
M  V30 29 C 2.6455 4.6239 0.0 0
M  V30 30 C 2.6455 3.0955 0.0 0
M  V30 31 C 1.3228 5.3881 0.0 0
M  V30 32 C 1.3228 2.3352 0.0 0
M  V30 33 C 0.0000 4.6239 0.0 0
M  V30 34 C 0.0000 3.0955 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 1 19
M  V30 3 1 1 29
M  V30 4 1 2 3
M  V30 5 1 2 4
M  V30 6 1 2 10
M  V30 7 1 3 5
M  V30 8 1 5 6
M  V30 9 2 5 7
M  V30 10 1 8 9
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 1 8 12
M  V30 14 1 8 13
M  V30 15 1 8 14
M  V30 16 1 8 15
M  V30 17 1 8 16
M  V30 18 1 8 17
M  V30 19 1 8 18
M  V30 20 1 9 10
M  V30 21 2 9 11
M  V30 22 1 10 12
M  V30 23 1 11 13
M  V30 24 2 12 13
M  V30 25 1 14 17
M  V30 26 1 14 18
M  V30 27 1 15 16
M  V30 28 2 15 18
M  V30 29 2 16 17
M  V30 30 1 19 20
M  V30 31 2 19 21
M  V30 32 2 20 22
M  V30 33 1 20 23
M  V30 34 1 21 24
M  V30 35 1 22 25
M  V30 36 1 22 26
M  V30 37 2 23 27
M  V30 38 2 24 25
M  V30 39 2 26 28
M  V30 40 1 27 28
M  V30 41 2 29 30
M  V30 42 1 29 31
M  V30 43 1 30 32
M  V30 44 2 31 33
M  V30 45 2 32 34
M  V30 46 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ferrocene, 1-[(1R)-1-(methylamino)ethyl]-2-[(S)-1-naphthalenylphenylphosphino...
C29H28FeNP
859839-79-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 44 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 3.3440 4.4936 0.0 0
M  V30 2 C 4.3929 2.1752 0.0 0
M  V30 3 N 4.3929 0.7741 0.0 0
M  V30 4 C 3.1776 2.8796 0.0 0
M  V30 5 C 3.0576 0.0000 0.0 0
M  V30 6 Fe 9.0142 8.0389 0.0 0 CHG=2 VAL=10
M  V30 7 C 7.7331 4.1104 0.0 0 VAL=5
M  V30 8 C 5.6082 2.8796 0.0 0 CHG=-1 VAL=4
M  V30 9 C 10.1947 4.1104 0.0 0 VAL=5
M  V30 10 C 8.9407 0.7122 0.0 0 VAL=5
M  V30 11 C 12.3312 2.8796 0.0 0 VAL=5
M  V30 12 C 12.4047 13.2717 0.0 0 CHG=-1 VAL=4
M  V30 13 C 5.6856 13.2717 0.0 0 VAL=5
M  V30 14 C 7.8066 12.0370 0.0 0 VAL=5
M  V30 15 C 10.2721 12.0370 0.0 0 VAL=5
M  V30 16 C 9.0142 15.4352 0.0 0 VAL=5
M  V30 17 C 2.6396 5.7089 0.0 0
M  V30 18 C 3.9556 6.4752 0.0 0
M  V30 19 C 1.3237 6.4752 0.0 0
M  V30 20 C 3.9556 8.0118 0.0 0
M  V30 21 C 5.2715 5.7089 0.0 0
M  V30 22 C 1.3237 8.0118 0.0 0
M  V30 23 C 2.6396 8.7781 0.0 0
M  V30 24 C 5.2715 8.7781 0.0 0
M  V30 25 C 6.5875 6.4752 0.0 0
M  V30 26 C 6.5875 8.0118 0.0 0
M  V30 27 C 2.6396 3.2782 0.0 0
M  V30 28 C 2.6396 1.7533 0.0 0
M  V30 29 C 1.3198 4.0407 0.0 0
M  V30 30 C 1.3198 0.9947 0.0 0
M  V30 31 C 0.0000 3.2782 0.0 0
M  V30 32 C 0.0000 1.7533 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 1 17
M  V30 3 1 1 27
M  V30 4 1 2 3
M  V30 5 1 2 4
M  V30 6 1 2 8
M  V30 7 1 3 5
M  V30 8 1 6 7
M  V30 9 1 6 8
M  V30 10 1 6 9
M  V30 11 1 6 10
M  V30 12 1 6 11
M  V30 13 1 6 12
M  V30 14 1 6 13
M  V30 15 1 6 14
M  V30 16 1 6 15
M  V30 17 1 6 16
M  V30 18 1 7 8
M  V30 19 2 7 9
M  V30 20 1 8 10
M  V30 21 1 9 11
M  V30 22 2 10 11
M  V30 23 1 12 15
M  V30 24 1 12 16
M  V30 25 1 13 14
M  V30 26 2 13 16
M  V30 27 2 14 15
M  V30 28 1 17 18
M  V30 29 2 17 19
M  V30 30 2 18 20
M  V30 31 1 18 21
M  V30 32 1 19 22
M  V30 33 1 20 23
M  V30 34 1 20 24
M  V30 35 2 21 25
M  V30 36 2 22 23
M  V30 37 2 24 26
M  V30 38 1 25 26
M  V30 39 2 27 28
M  V30 40 1 27 29
M  V30 41 1 28 30
M  V30 42 2 29 31
M  V30 43 2 30 32
M  V30 44 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 859839-74-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 859839-79-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-2614968
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (Rc, SFc,
SP)-2-[(1-N-Methylamino)ethyl]-1-[(1-naphthyl)phenylphosphino]ferrocene
[(Rc, SFc, SP)-8b]: A solution of (Rc, SFc, SP)-7b (633 mg, 1.25 mmol)
and 40% methylamine aqueous solution (3.0 mL) in THF (10 mL) and MeOH
(2.5 mL) was stirred for 3 days at 40 °C, and concentrated. The residue
was dissolved in Et2O (20 mL), washed with brine (10 mL), dried (Na2SO4),
and evaporated under reduced pressure. The crude product was purified by
chromatography (SiO2, hexane-EtOAc-Et3N = 85:10:5) to give the title
compound as orange crystals. (Rc, SFc,
SP)-2-[(1-N-Methylamino)ethyl]-1-[(1-naphthyl)phenylphosphino]ferrocene,
yield 549 mg, 92%. 1H NMR (CDCl3, 400.13 MHz): δ 1.49 (d, 3H, J = 6.6
Hz); 2.07 (s, 3H); 3.69 (s, 5H); 3.95 (m, 1H); 4.01 (m, 1H); 4.31 (t, 1H,
J = 2.5 Hz); 4.48 (m, 1H); 7.23 (m, 5H); 7.39 ~ 7.47 (m, 2H); 7.54 (m,
1H); 7.66 (m, 1H); 7.90 (t, 2H, J = 7.9 Hz), 9.25 (dd, 1H, J = 7.9 and
6.7 Hz). 31P NMR (CDCl3, 162 MHz): δ -39.91.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A Very Simple, Highly Stereoselective and Modular Synthesis of
Ferrocene-Based P-Chiral Phosphine Ligands
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chen, Weiping; Mbafor, William; Roberts, Stanley M.; Whittall, John
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2006), 128(12), 3922-3923

$RFMT $RIREG SCHEME414 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ferrocene, 1-[(1R)-1-(acetyloxy)ethyl]-2-[(S)-1-naphthalenylphenylphosphino]-...
C30H27FeO2P
859839-74-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 46 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 3.3515 5.8419 0.0 0
M  V30 2 C 4.4028 3.5183 0.0 0
M  V30 3 O 4.4028 2.1141 0.0 0
M  V30 4 C 3.1847 4.2243 0.0 0
M  V30 5 C 3.1847 1.4081 0.0 0
M  V30 6 C 1.9667 2.1141 0.0 0
M  V30 7 O 3.1847 0.0000 0.0 0
M  V30 8 Fe 9.0344 9.3952 0.0 0 CHG=2 VAL=10
M  V30 9 C 7.7504 5.4579 0.0 0 VAL=5
M  V30 10 C 5.6208 4.2243 0.0 0 CHG=-1 VAL=4
M  V30 11 C 10.2175 5.4579 0.0 0 VAL=5
M  V30 12 C 8.9607 2.0520 0.0 0 VAL=5
M  V30 13 C 12.3588 4.2243 0.0 0 VAL=5
M  V30 14 C 12.4325 14.6397 0.0 0 CHG=-1 VAL=4
M  V30 15 C 5.6984 14.6397 0.0 0 VAL=5
M  V30 16 C 7.8241 13.4023 0.0 0 VAL=5
M  V30 17 C 10.2951 13.4023 0.0 0 VAL=5
M  V30 18 C 9.0344 16.8081 0.0 0 VAL=5
M  V30 19 C 2.6455 7.0599 0.0 0
M  V30 20 C 3.9644 7.8280 0.0 0
M  V30 21 C 1.3266 7.8280 0.0 0
M  V30 22 C 3.9644 9.3680 0.0 0
M  V30 23 C 5.2833 7.0599 0.0 0
M  V30 24 C 1.3266 9.3680 0.0 0
M  V30 25 C 2.6455 10.1361 0.0 0
M  V30 26 C 5.2833 10.1361 0.0 0
M  V30 27 C 6.6022 7.8280 0.0 0
M  V30 28 C 6.6022 9.3680 0.0 0
M  V30 29 C 2.6455 4.6239 0.0 0
M  V30 30 C 2.6455 3.0955 0.0 0
M  V30 31 C 1.3228 5.3881 0.0 0
M  V30 32 C 1.3228 2.3352 0.0 0
M  V30 33 C 0.0000 4.6239 0.0 0
M  V30 34 C 0.0000 3.0955 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 1 19
M  V30 3 1 1 29
M  V30 4 1 2 3
M  V30 5 1 2 4
M  V30 6 1 2 10
M  V30 7 1 3 5
M  V30 8 1 5 6
M  V30 9 2 5 7
M  V30 10 1 8 9
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 1 8 12
M  V30 14 1 8 13
M  V30 15 1 8 14
M  V30 16 1 8 15
M  V30 17 1 8 16
M  V30 18 1 8 17
M  V30 19 1 8 18
M  V30 20 1 9 10
M  V30 21 2 9 11
M  V30 22 1 10 12
M  V30 23 1 11 13
M  V30 24 2 12 13
M  V30 25 1 14 17
M  V30 26 1 14 18
M  V30 27 1 15 16
M  V30 28 2 15 18
M  V30 29 2 16 17
M  V30 30 1 19 20
M  V30 31 2 19 21
M  V30 32 2 20 22
M  V30 33 1 20 23
M  V30 34 1 21 24
M  V30 35 1 22 25
M  V30 36 1 22 26
M  V30 37 2 23 27
M  V30 38 2 24 25
M  V30 39 2 26 28
M  V30 40 1 27 28
M  V30 41 2 29 30
M  V30 42 1 29 31
M  V30 43 1 30 32
M  V30 44 2 31 33
M  V30 45 2 32 34
M  V30 46 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ferrocene, 1-[(1R)-1-(methylamino)ethyl]-2-[(S)-1-naphthalenylphenylphosphino...
C29H28FeNP
859839-79-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 44 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 3.3440 4.4936 0.0 0
M  V30 2 C 4.3929 2.1752 0.0 0
M  V30 3 N 4.3929 0.7741 0.0 0
M  V30 4 C 3.1776 2.8796 0.0 0
M  V30 5 C 3.0576 0.0000 0.0 0
M  V30 6 Fe 9.0142 8.0389 0.0 0 CHG=2 VAL=10
M  V30 7 C 7.7331 4.1104 0.0 0 VAL=5
M  V30 8 C 5.6082 2.8796 0.0 0 CHG=-1 VAL=4
M  V30 9 C 10.1947 4.1104 0.0 0 VAL=5
M  V30 10 C 8.9407 0.7122 0.0 0 VAL=5
M  V30 11 C 12.3312 2.8796 0.0 0 VAL=5
M  V30 12 C 12.4047 13.2717 0.0 0 CHG=-1 VAL=4
M  V30 13 C 5.6856 13.2717 0.0 0 VAL=5
M  V30 14 C 7.8066 12.0370 0.0 0 VAL=5
M  V30 15 C 10.2721 12.0370 0.0 0 VAL=5
M  V30 16 C 9.0142 15.4352 0.0 0 VAL=5
M  V30 17 C 2.6396 5.7089 0.0 0
M  V30 18 C 3.9556 6.4752 0.0 0
M  V30 19 C 1.3237 6.4752 0.0 0
M  V30 20 C 3.9556 8.0118 0.0 0
M  V30 21 C 5.2715 5.7089 0.0 0
M  V30 22 C 1.3237 8.0118 0.0 0
M  V30 23 C 2.6396 8.7781 0.0 0
M  V30 24 C 5.2715 8.7781 0.0 0
M  V30 25 C 6.5875 6.4752 0.0 0
M  V30 26 C 6.5875 8.0118 0.0 0
M  V30 27 C 2.6396 3.2782 0.0 0
M  V30 28 C 2.6396 1.7533 0.0 0
M  V30 29 C 1.3198 4.0407 0.0 0
M  V30 30 C 1.3198 0.9947 0.0 0
M  V30 31 C 0.0000 3.2782 0.0 0
M  V30 32 C 0.0000 1.7533 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 1 17
M  V30 3 1 1 27
M  V30 4 1 2 3
M  V30 5 1 2 4
M  V30 6 1 2 8
M  V30 7 1 3 5
M  V30 8 1 6 7
M  V30 9 1 6 8
M  V30 10 1 6 9
M  V30 11 1 6 10
M  V30 12 1 6 11
M  V30 13 1 6 12
M  V30 14 1 6 13
M  V30 15 1 6 14
M  V30 16 1 6 15
M  V30 17 1 6 16
M  V30 18 1 7 8
M  V30 19 2 7 9
M  V30 20 1 8 10
M  V30 21 1 9 11
M  V30 22 2 10 11
M  V30 23 1 12 15
M  V30 24 1 12 16
M  V30 25 1 13 14
M  V30 26 2 13 16
M  V30 27 2 14 15
M  V30 28 1 17 18
M  V30 29 2 17 19
M  V30 30 2 18 20
M  V30 31 1 18 21
M  V30 32 1 19 22
M  V30 33 1 20 23
M  V30 34 1 20 24
M  V30 35 2 21 25
M  V30 36 2 22 23
M  V30 37 2 24 26
M  V30 38 1 25 26
M  V30 39 2 27 28
M  V30 40 1 27 29
M  V30 41 1 28 30
M  V30 42 2 29 31
M  V30 43 2 30 32
M  V30 44 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 859839-74-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 859839-79-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-10544644
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (Rc,SFe,Sp)-2- [(1- N-Methylamino) ethyl]-1-[(1-naphthyl)
phenylphosphino] ferrocene [(Rc,SFe,Sp)-18]. A solution of (Rc,SFe,Sp)-12
(633 mg, 1.25 mmol) and 40% methylamine aqueous solution (3.0 mL) in THF
(10 mL) and MeOH (2.5 mL) was stirred for 3 days at 40 °C, and
concentrated. The residue was dissolved in Et2O (20 mL), washed with
brine (10 mL), dried (Na2SO4), and evaporated under reduced pressure. The
crude product was purified by chromatography (SiO2, hexane- EtOAc-Et3N =
85: 10: 5) to give the title compound as orange crystals, yield 549 mg,
92%. 1H NMR(CDCl3, 400.13 MHz): δ 1.49 (d, 3H, J = 6. 6 Hz) ; 2.07 (s,
3H); 3.69 (s, 5H); 3.95 (m, 1 H); 4.01 (m, 1 H); 4.31 (t, 1 H, J = 2.5
Hz); 4.48 (m, 1 H); 7. 23 (m, 5H); 7. 39 # 7. 47 (m, 2H); 7.54 (m, 1 H);
7.66 (m, 1 H); 7.90 (t, 2H, J = 7.9 Hz), 9.25 (dd, 1 H, J = 7.9 and 6.7
Hz). 31P NMR (CDCl3, 162 MHz): δ - 39.91.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Metallocene-based chiral phosphine or arsine ligands
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chen, Wei-Ping; Whittall, John
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2005068477 A1 2005-07-28

$RFMT $RIREG SCHEME414 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ferrocene, 1-[(1R)-1-(acetyloxy)ethyl]-2-[(S)-1-naphthalenylphenylphosphino]-...
C30H27FeO2P
859839-74-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 46 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 3.3515 5.8419 0.0 0
M  V30 2 C 4.4028 3.5183 0.0 0
M  V30 3 O 4.4028 2.1141 0.0 0
M  V30 4 C 3.1847 4.2243 0.0 0
M  V30 5 C 3.1847 1.4081 0.0 0
M  V30 6 C 1.9667 2.1141 0.0 0
M  V30 7 O 3.1847 0.0000 0.0 0
M  V30 8 Fe 9.0344 9.3952 0.0 0 CHG=2 VAL=10
M  V30 9 C 7.7504 5.4579 0.0 0 VAL=5
M  V30 10 C 5.6208 4.2243 0.0 0 CHG=-1 VAL=4
M  V30 11 C 10.2175 5.4579 0.0 0 VAL=5
M  V30 12 C 8.9607 2.0520 0.0 0 VAL=5
M  V30 13 C 12.3588 4.2243 0.0 0 VAL=5
M  V30 14 C 12.4325 14.6397 0.0 0 CHG=-1 VAL=4
M  V30 15 C 5.6984 14.6397 0.0 0 VAL=5
M  V30 16 C 7.8241 13.4023 0.0 0 VAL=5
M  V30 17 C 10.2951 13.4023 0.0 0 VAL=5
M  V30 18 C 9.0344 16.8081 0.0 0 VAL=5
M  V30 19 C 2.6455 7.0599 0.0 0
M  V30 20 C 3.9644 7.8280 0.0 0
M  V30 21 C 1.3266 7.8280 0.0 0
M  V30 22 C 3.9644 9.3680 0.0 0
M  V30 23 C 5.2833 7.0599 0.0 0
M  V30 24 C 1.3266 9.3680 0.0 0
M  V30 25 C 2.6455 10.1361 0.0 0
M  V30 26 C 5.2833 10.1361 0.0 0
M  V30 27 C 6.6022 7.8280 0.0 0
M  V30 28 C 6.6022 9.3680 0.0 0
M  V30 29 C 2.6455 4.6239 0.0 0
M  V30 30 C 2.6455 3.0955 0.0 0
M  V30 31 C 1.3228 5.3881 0.0 0
M  V30 32 C 1.3228 2.3352 0.0 0
M  V30 33 C 0.0000 4.6239 0.0 0
M  V30 34 C 0.0000 3.0955 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 1 19
M  V30 3 1 1 29
M  V30 4 1 2 3
M  V30 5 1 2 4
M  V30 6 1 2 10
M  V30 7 1 3 5
M  V30 8 1 5 6
M  V30 9 2 5 7
M  V30 10 1 8 9
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 1 8 12
M  V30 14 1 8 13
M  V30 15 1 8 14
M  V30 16 1 8 15
M  V30 17 1 8 16
M  V30 18 1 8 17
M  V30 19 1 8 18
M  V30 20 1 9 10
M  V30 21 2 9 11
M  V30 22 1 10 12
M  V30 23 1 11 13
M  V30 24 2 12 13
M  V30 25 1 14 17
M  V30 26 1 14 18
M  V30 27 1 15 16
M  V30 28 2 15 18
M  V30 29 2 16 17
M  V30 30 1 19 20
M  V30 31 2 19 21
M  V30 32 2 20 22
M  V30 33 1 20 23
M  V30 34 1 21 24
M  V30 35 1 22 25
M  V30 36 1 22 26
M  V30 37 2 23 27
M  V30 38 2 24 25
M  V30 39 2 26 28
M  V30 40 1 27 28
M  V30 41 2 29 30
M  V30 42 1 29 31
M  V30 43 1 30 32
M  V30 44 2 31 33
M  V30 45 2 32 34
M  V30 46 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ferrocene, 1-[(1R)-1-(methylamino)ethyl]-2-[(S)-1-naphthalenylphenylphosphino...
C29H28FeNP
859839-79-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 44 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 3.3440 4.4936 0.0 0
M  V30 2 C 4.3929 2.1752 0.0 0
M  V30 3 N 4.3929 0.7741 0.0 0
M  V30 4 C 3.1776 2.8796 0.0 0
M  V30 5 C 3.0576 0.0000 0.0 0
M  V30 6 Fe 9.0142 8.0389 0.0 0 CHG=2 VAL=10
M  V30 7 C 7.7331 4.1104 0.0 0 VAL=5
M  V30 8 C 5.6082 2.8796 0.0 0 CHG=-1 VAL=4
M  V30 9 C 10.1947 4.1104 0.0 0 VAL=5
M  V30 10 C 8.9407 0.7122 0.0 0 VAL=5
M  V30 11 C 12.3312 2.8796 0.0 0 VAL=5
M  V30 12 C 12.4047 13.2717 0.0 0 CHG=-1 VAL=4
M  V30 13 C 5.6856 13.2717 0.0 0 VAL=5
M  V30 14 C 7.8066 12.0370 0.0 0 VAL=5
M  V30 15 C 10.2721 12.0370 0.0 0 VAL=5
M  V30 16 C 9.0142 15.4352 0.0 0 VAL=5
M  V30 17 C 2.6396 5.7089 0.0 0
M  V30 18 C 3.9556 6.4752 0.0 0
M  V30 19 C 1.3237 6.4752 0.0 0
M  V30 20 C 3.9556 8.0118 0.0 0
M  V30 21 C 5.2715 5.7089 0.0 0
M  V30 22 C 1.3237 8.0118 0.0 0
M  V30 23 C 2.6396 8.7781 0.0 0
M  V30 24 C 5.2715 8.7781 0.0 0
M  V30 25 C 6.5875 6.4752 0.0 0
M  V30 26 C 6.5875 8.0118 0.0 0
M  V30 27 C 2.6396 3.2782 0.0 0
M  V30 28 C 2.6396 1.7533 0.0 0
M  V30 29 C 1.3198 4.0407 0.0 0
M  V30 30 C 1.3198 0.9947 0.0 0
M  V30 31 C 0.0000 3.2782 0.0 0
M  V30 32 C 0.0000 1.7533 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 1 17
M  V30 3 1 1 27
M  V30 4 1 2 3
M  V30 5 1 2 4
M  V30 6 1 2 8
M  V30 7 1 3 5
M  V30 8 1 6 7
M  V30 9 1 6 8
M  V30 10 1 6 9
M  V30 11 1 6 10
M  V30 12 1 6 11
M  V30 13 1 6 12
M  V30 14 1 6 13
M  V30 15 1 6 14
M  V30 16 1 6 15
M  V30 17 1 6 16
M  V30 18 1 7 8
M  V30 19 2 7 9
M  V30 20 1 8 10
M  V30 21 1 9 11
M  V30 22 2 10 11
M  V30 23 1 12 15
M  V30 24 1 12 16
M  V30 25 1 13 14
M  V30 26 2 13 16
M  V30 27 2 14 15
M  V30 28 1 17 18
M  V30 29 2 17 19
M  V30 30 2 18 20
M  V30 31 1 18 21
M  V30 32 1 19 22
M  V30 33 1 20 23
M  V30 34 1 20 24
M  V30 35 2 21 25
M  V30 36 2 22 23
M  V30 37 2 24 26
M  V30 38 1 25 26
M  V30 39 2 27 28
M  V30 40 1 27 29
M  V30 41 1 28 30
M  V30 42 2 29 31
M  V30 43 2 30 32
M  V30 44 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 859839-74-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 859839-79-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-11859179
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (Rc,Sfe,Sp)-2-[(1-N-Methylamino)ethyl]-1-[(1-naphthyl)phenylphosphino]ferrocene
[(Rc,SFe,Sp)-18]: A solution of (RC, SFe, Sp)-12 (633 mg, 1.25 mmol) and
40% methylamine aqueous solution (3.0 mL) in THF (10 mL) and MeOH (2.5
mL) was stirred for 3 days at 40°C and concentrated. The residue was
dissolved in Et2O (20 mL), washed with brine (10 mL), dried (Na2SO4), and
evaporated under reduced pressure. The crude product was purified by
chromatography (SiO2, hexane- EtOAc-Et3N = 85:10:5) to give the title
compound (549 mg, 92%) as orange crystals.
(Rc,Sfe,Sp)-2-[(1-N-Methylamino)ethyl]-1-[(1-naphthyl)phenylphosphino]ferrocene
[(Rc,SFe,Sp)-18], yield (549 mg, 92%) 1H NMR (CDCl3, 400.13 MHz): δ 1.49
(d, 3H, J= 6.6 Hz); 2.07 (s, 3H); 3.69 (s, 5H); 3.95 (m, 1H); 4.01 (m,
1H); 4.31 (t, 1H, J= 2.5 Hz); 4.48 (m, 1H); 7.23 (m, 5H); 7.39 ~ 7.47 (m,
2H); 7.54 (m, 1H); 7.66 (m, 1H); 7.90 (t, 2H, J= 7.9 Hz), 9.25 (dd, 1H,
J- 7.9 and 6.7 Hz). 31P NMR (CDCl3, 162 MHz): δ - 39.91.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Process for preparation of ferrocene-based chiral phosphines or arsines
as transformation catalysts
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chen, Wei-Ping; Whittall, John
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2005068478 A1 2005-07-28

$RFMT $RIREG SCHEME415 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3R,4R)-1-[[4-[(3-Ethynylphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methy...
C25H26N6O4
859855-20-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 38 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.7471 5.0543 0.0 0
M  V30 2 N 4.5190 4.3939 0.0 0
M  V30 3 C 10.4144 9.6743 0.0 0
M  V30 4 O 9.0808 10.4443 0.0 0
M  V30 5 O 11.7482 10.4443 0.0 0
M  V30 6 C 0.5546 7.9635 0.0 0
M  V30 7 C 0.0787 9.4282 0.0 0
M  V30 8 N 13.0819 8.1343 0.0 0
M  V30 9 C 14.4155 7.3643 0.0 0
M  V30 10 O 15.7493 8.1343 0.0 0
M  V30 11 O 14.4155 5.8243 0.0 0
M  V30 12 C 17.0830 7.3643 0.0 0
M  V30 13 C 18.4166 8.1343 0.0 0
M  V30 14 C 19.7502 7.3643 0.0 0
M  V30 15 C 6.5013 2.6091 0.0 0
M  V30 16 C 7.7471 3.5143 0.0 0
M  V30 17 C 4.9948 2.9292 0.0 0
M  V30 18 N 6.9771 1.1445 0.0 0
M  V30 19 C 8.9930 2.6091 0.0 0
M  V30 20 N 3.9644 1.7849 0.0 0
M  V30 21 C 8.5171 1.1445 0.0 0
M  V30 22 N 5.9467 0.0000 0.0 0
M  V30 23 C 4.4403 0.3202 0.0 0
M  V30 24 N 9.0808 5.8243 0.0 0
M  V30 25 C 9.0808 7.3643 0.0 0
M  V30 26 C 10.4144 5.0543 0.0 0
M  V30 27 C 10.4144 8.1343 0.0 0 CFG=1
M  V30 28 C 11.7482 5.8243 0.0 0
M  V30 29 C 11.7482 7.3643 0.0 0 CFG=2
M  V30 30 C 3.0127 4.7141 0.0 0
M  V30 31 C 2.5368 6.1786 0.0 0
M  V30 32 C 1.9821 3.5696 0.0 0
M  V30 33 C 1.0304 6.4990 0.0 0
M  V30 34 C 0.4759 3.8899 0.0 0
M  V30 35 C 0.0000 5.3544 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 16
M  V30 2 1 1 24
M  V30 3 1 2 17
M  V30 4 1 2 30
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 1 27 3 CFG=1
M  V30 8 3 6 7
M  V30 9 1 6 33
M  V30 10 1 8 9
M  V30 11 1 29 8 CFG=3
M  V30 12 1 9 10
M  V30 13 2 9 11
M  V30 14 1 10 12
M  V30 15 1 12 13
M  V30 16 2 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 15 18
M  V30 20 1 16 19
M  V30 21 2 17 20
M  V30 22 1 18 21
M  V30 23 1 18 22
M  V30 24 2 19 21
M  V30 25 1 20 23
M  V30 26 2 22 23
M  V30 27 1 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 1 28 29
M  V30 33 2 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 2 32 34
M  V30 37 2 33 35
M  V30 38 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 27 29)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
2-Propen-1-yl N-[(3R,4R)-1-[[4-[(3-ethynylphenyl)amino]pyrrolo[2,1-f][1,2,4]t...
C26H29N7O3
1030608-16-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 39 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.7471 6.9300 0.0 0
M  V30 2 N 4.5190 7.5904 0.0 0
M  V30 3 C 10.4144 2.3100 0.0 0
M  V30 4 N 9.0808 1.5400 0.0 0
M  V30 5 O 11.7482 1.5400 0.0 0
M  V30 6 C 9.0808 0.0000 0.0 0
M  V30 7 C 0.5546 4.0208 0.0 0
M  V30 8 C 0.0787 2.5561 0.0 0
M  V30 9 N 13.0818 3.8500 0.0 0
M  V30 10 C 14.4155 4.6200 0.0 0
M  V30 11 O 15.7493 3.8500 0.0 0
M  V30 12 O 14.4155 6.1600 0.0 0
M  V30 13 C 17.0829 4.6200 0.0 0
M  V30 14 C 18.4166 3.8500 0.0 0
M  V30 15 C 19.7502 4.6200 0.0 0
M  V30 16 C 6.5013 9.3752 0.0 0
M  V30 17 C 7.7471 8.4700 0.0 0
M  V30 18 C 4.9948 9.0550 0.0 0
M  V30 19 N 6.9771 10.8398 0.0 0
M  V30 20 C 8.9930 9.3752 0.0 0
M  V30 21 N 3.9644 10.1994 0.0 0
M  V30 22 C 8.5171 10.8398 0.0 0
M  V30 23 N 5.9467 11.9843 0.0 0
M  V30 24 C 4.4403 11.6641 0.0 0
M  V30 25 N 9.0808 6.1600 0.0 0
M  V30 26 C 9.0808 4.6200 0.0 0
M  V30 27 C 10.4144 6.9300 0.0 0
M  V30 28 C 10.4144 3.8500 0.0 0 CFG=1
M  V30 29 C 11.7482 6.1600 0.0 0
M  V30 30 C 11.7482 4.6200 0.0 0 CFG=2
M  V30 31 C 3.0127 7.2702 0.0 0
M  V30 32 C 2.5368 5.8056 0.0 0
M  V30 33 C 1.9821 8.4147 0.0 0
M  V30 34 C 1.0304 5.4853 0.0 0
M  V30 35 C 0.4759 8.0944 0.0 0
M  V30 36 C 0.0000 6.6299 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 17
M  V30 2 1 1 25
M  V30 3 1 2 18
M  V30 4 1 2 31
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 1 28 3 CFG=3
M  V30 8 1 4 6
M  V30 9 3 7 8
M  V30 10 1 7 34
M  V30 11 1 9 10
M  V30 12 1 30 9 CFG=1
M  V30 13 1 10 11
M  V30 14 2 10 12
M  V30 15 1 11 13
M  V30 16 1 13 14
M  V30 17 2 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 16 19
M  V30 21 1 17 20
M  V30 22 2 18 21
M  V30 23 1 19 22
M  V30 24 1 19 23
M  V30 25 2 20 22
M  V30 26 1 21 24
M  V30 27 2 23 24
M  V30 28 1 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 1 29 30
M  V30 34 2 31 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 2 33 35
M  V30 38 2 34 36
M  V30 39 1 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 28 30)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 859855-20-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1030608-16-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-15531591
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 56602-33-6
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM p253C. Preparation of allyl
(3R,4R)-1-((4-(3-ethynylphenylamino)pyrrolo[1,2-f][1,2,4]-triazin-5-yl)methyl)-3-(methylcarbamoyl)piperidin-4-ylcarbamate
A solution of 253B (0.22 g, 0.46 mmol) in MeCN (4.6 mL) was treated with
diisopropylethylamine (59 mg, 0.46 mmol),
benzotriazol-1-yloxy-tris(dimethylamino)phosphonium hexafluorophosphate
(hereinafter referred to as the "Bop Reagenr") (036 g, 0.69 mmol), and 2
N methylamine in THF (0.70 mL, 138 mmol). The reaction mixture was
stirred for two hours, quenched with water, and concentrated. The
resulting slurry was dissolved in MeOH and purified by preparative HPLC
(YMC ODS-A 5um, 20 × 100 mm, solvent A 10% MeOH-90% H2O-0.1% TFA, solvent
B 90% MeOH-10% H2O-0.1% TFA, gradient 0-100%B. 12 minutes). The desired
fractions were concentrated, neutralized by saturated aqueous NaHCO3 to
pH =10, and extracted with EtOAc (2 × 50 mL). The combined organic layers
wem dried (Na2SO4) and concentrated in vacuo to give 0.21 g (yield: 92%)
of Compound 253C as a solid. allyl
(3R,4R)-1-((4-(3-ethynylphenylamino)pyrrolo[1,2-f][1,2,4]-triazin-5-yl)methyl)-3-(methylcarbamoyl)piperidin-4-ylcarbamate,
yield 0.21 g (yield: 92%)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrrolo[2,1-f][1,2,4]triazine derivatives as HER1, HER2,
and HER4 kinase inhibitors, and antiproliferative agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fink, Brian E.; Gavai, Ashvinikumar V.; Vite, Gregory D.; Chen, Ping;
Mastalerz, Harold; Norris, Derek J.; Tokarski, John S.; Zhao, Yufen; Han,
Wen-Ching
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2005066176 A1 2005-07-21

$RFMT $RIREG SCHEME416 STEP1
$RXN



  2  1
$MOL
4-Amino-3-bromo-5-methylbenzoic acid
C8H8BrNO2
860787-42-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6675 0.0 0
M  V30 2 O 0.0000 4.0011 0.0 0
M  V30 3 O 0.0000 1.3338 0.0 0
M  V30 4 Br 5.3901 0.0000 0.0 0
M  V30 5 C 5.3901 5.3349 0.0 0
M  V30 6 N 6.9301 2.6675 0.0 0
M  V30 7 C 2.3100 2.6675 0.0 0
M  V30 8 C 3.0800 1.3338 0.0 0
M  V30 9 C 3.0800 4.0011 0.0 0
M  V30 10 C 4.6201 1.3338 0.0 0
M  V30 11 C 4.6201 4.0011 0.0 0
M  V30 12 C 5.3901 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 10
M  V30 5 1 5 11
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Amino-3-bromo-N,5-dimethylbenzamide
C9H11BrN2O
1610419-19-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 2.6674 0.0 0
M  V30 2 N 6.9300 4.0011 0.0 0
M  V30 3 O 6.9300 1.3338 0.0 0
M  V30 4 C 8.4700 4.0011 0.0 0
M  V30 5 Br 1.5400 0.0000 0.0 0
M  V30 6 C 1.5400 5.3349 0.0 0
M  V30 7 N 0.0000 2.6674 0.0 0
M  V30 8 C 4.6200 2.6674 0.0 0
M  V30 9 C 3.8500 1.3338 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3338 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 1 6 12
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 860787-42-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1610419-19-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-3370494
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General method for preparing intermediates
8a-8i. To 4-amino-3-halo-5-methylbenzoic acid 7 (10 mmol) was added
thionyl chloride (30 mmol) and the mixture was refluxed for 3 h to give
acid chloride. A solution of isopropylamine (20 mmol) in THF (20 ml) was
dropwised and this mixture was vigorously stirred at room temperature for
overnight. Subsequently, the reaction mixture was diluted with water and
extracted several times with ethyl acetate. The combined organic phases
were dried over MgSO4 and evaporated. The residue was purified by
chromatography on a silica gel using petroleum ether and ethyl acetate as
the eluent to afford the compounds 8a-8i.
4-amino-3-bromo-N-5-dimethylbenzamide 8i, 91.8 % yield, white solid. m.p.
220-225 °C; 1H NMR (400 MHz, d6) δ: 2.17 (s, 3H, CH3), 2.72 (d, 3H, J =
4.4 Hz, NHCH3), 5.47 (s, 2H, NH2), 7.50 (s, 1H, Ar-H), 7.77 (s, 1H,
Ar-H), 8.12 (br, 1H, NH).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, structure and insecticidal activity of some novel amides
containing N-pyridylpyrazole
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dong, Wei-Li; Xu, Jun-Ying; Xiong, Li-Xia; Li, Zheng-Ming
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the Iranian Chemical Society (2013), 10(3), 429-437

$RFMT $RIREG SCHEME417 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Dichloro-N-(phenylmethyl)-5-pyrimidinamine
C11H9Cl2N3
867151-49-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3900 2.6674 0.0 0
M  V30 2 C 4.6200 4.0011 0.0 0
M  V30 3 Cl 6.9300 0.0000 0.0 0
M  V30 4 Cl 11.5500 2.6674 0.0 0
M  V30 5 C 6.9300 2.6674 0.0 0
M  V30 6 C 7.7000 1.3338 0.0 0
M  V30 7 C 7.7000 4.0011 0.0 0
M  V30 8 N 9.2400 1.3338 0.0 0
M  V30 9 N 9.2400 4.0011 0.0 0
M  V30 10 C 10.0100 2.6674 0.0 0
M  V30 11 C 3.0800 4.0011 0.0 0
M  V30 12 C 2.3100 2.6674 0.0 0
M  V30 13 C 2.3100 5.3349 0.0 0
M  V30 14 C 0.7700 2.6674 0.0 0
M  V30 15 C 0.7700 5.3349 0.0 0
M  V30 16 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 2 11
M  V30 4 1 3 6
M  V30 5 1 4 10
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N4-methyl-N5-(phenylmethyl)-4,5-pyrimidinediamine
C12H13ClN4
867151-54-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3900 4.0011 0.0 0
M  V30 2 C 4.6200 5.3347 0.0 0
M  V30 3 N 6.9300 1.3338 0.0 0
M  V30 4 C 7.7000 0.0000 0.0 0
M  V30 5 Cl 11.5500 4.0011 0.0 0
M  V30 6 C 6.9300 4.0011 0.0 0
M  V30 7 C 7.7000 2.6674 0.0 0
M  V30 8 C 7.7000 5.3347 0.0 0
M  V30 9 N 9.2400 2.6674 0.0 0
M  V30 10 N 9.2400 5.3347 0.0 0
M  V30 11 C 10.0100 4.0011 0.0 0
M  V30 12 C 3.0800 5.3347 0.0 0
M  V30 13 C 2.3100 6.6685 0.0 0
M  V30 14 C 2.3100 4.0011 0.0 0
M  V30 15 C 0.7700 6.6685 0.0 0
M  V30 16 C 0.7700 4.0011 0.0 0
M  V30 17 C 0.0000 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 12
M  V30 4 1 3 4
M  V30 5 1 3 7
M  V30 6 1 5 11
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 867151-49-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 867151-54-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-8492707
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM N5-Benzyl-2-chloro-N4-methylpyrimidine-4,5-diamine (4a); Typical
Procedure To a solution of 3a (200 mg, 0.79 mmol) in EtOH (3 mL) were
added 0.1 M aq HCl (5 mL) and methylamine (33 weight% in EtOH, 1 mL, 7.9
mmol). The mixture was heated at reflux for 1 h and concentrated under
reduced pressure until crystals appeared in the flask (2 mL). The
crystals were collected by filtration and washed with water to afford 4a.
Off-white solid, yield (180 mg, 92%). 1H NMR (250 MHz, DMSO-d6): δ = 2.86
(d, J = 4.5 Hz, 3 H, CH3), 4.27 (d, J = 5.4 Hz, 2 H, CH2), 5.44 (t, J =
5.4 Hz, 1 H, NHCH2), 7.18 (s, 1 H, H-6), 7.25-7.40 (m, 6 H, Ph, NHCH3).
13C NMR (62.5 MHz, DMSO-d6): δ = 27.5 (CH3), 46.4 (CH2), 127.0 (C-5,
p-Ph), 127.5 (o-Ph), 128.3 (m-Ph), 131.7 (C-6), 138.4 (n-Ph), 147.2
(C-2), 154.3 (C-4).
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A general and facile route to new trisubstituted purin-8-ones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gaulon, Catherine; Dijkstra, Harmen P.; Springer, Caroline J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2005), (13), 2227-2233

$RFMT $RIREG SCHEME418 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 3-(2-methylphenyl)-4-oxo-1-piperidinecarboxylate
C17H23NO3
869720-03-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6673 0.0000 0.0 0
M  V30 2 C 4.0012 5.3901 0.0 0
M  V30 3 C 8.0022 3.0801 0.0 0
M  V30 4 O 9.3360 2.3101 0.0 0
M  V30 5 O 8.0022 4.6201 0.0 0
M  V30 6 C 10.6697 3.0801 0.0 0
M  V30 7 C 9.8996 4.4137 0.0 0
M  V30 8 C 12.0033 3.8501 0.0 0
M  V30 9 C 11.4397 1.7464 0.0 0
M  V30 10 C 4.0012 2.3101 0.0 0
M  V30 11 C 5.3348 3.0801 0.0 0
M  V30 12 C 4.0012 0.7700 0.0 0
M  V30 13 N 6.6685 2.3101 0.0 0
M  V30 14 C 5.3348 0.0000 0.0 0
M  V30 15 C 6.6685 0.7700 0.0 0
M  V30 16 C 2.6673 3.0801 0.0 0
M  V30 17 C 2.6673 4.6201 0.0 0
M  V30 18 C 1.3337 2.3101 0.0 0
M  V30 19 C 1.3337 5.3901 0.0 0
M  V30 20 C 0.0000 3.0801 0.0 0
M  V30 21 C 0.0000 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 12
M  V30 2 1 2 17
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 13
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 16
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-(methylamino)-3-(2-methylphenyl)-1-piperidinecarboxylate
C18H28N2O2
2375772-83-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6673 1.5400 0.0 0
M  V30 2 C 2.6673 0.0000 0.0 0
M  V30 3 C 4.0012 6.9302 0.0 0
M  V30 4 C 8.0022 4.6201 0.0 0
M  V30 5 O 9.3360 3.8501 0.0 0
M  V30 6 O 8.0022 6.1601 0.0 0
M  V30 7 C 10.6697 4.6201 0.0 0
M  V30 8 C 9.8996 5.9538 0.0 0
M  V30 9 C 12.0033 5.3901 0.0 0
M  V30 10 C 11.4397 3.2864 0.0 0
M  V30 11 C 4.0012 3.8501 0.0 0
M  V30 12 C 4.0012 2.3101 0.0 0
M  V30 13 C 5.3348 4.6201 0.0 0
M  V30 14 C 5.3348 1.5400 0.0 0
M  V30 15 N 6.6685 3.8501 0.0 0
M  V30 16 C 6.6685 2.3101 0.0 0
M  V30 17 C 2.6673 4.6201 0.0 0
M  V30 18 C 2.6673 6.1601 0.0 0
M  V30 19 C 1.3337 3.8501 0.0 0
M  V30 20 C 1.3337 6.9302 0.0 0
M  V30 21 C 0.0000 4.6201 0.0 0
M  V30 22 C 0.0000 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 3 18
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 15
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 17
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 869720-03-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2375772-83-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-21603566
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 56553-60-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of piperidinyl 3-(aryloxy)propanamides and
3-(aryloxy)propanoates as SSTR4 modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cheruvallath, Zacharia; Green, Jason; Johnson, Ben; Schleicher, Kristin;
Sun, Huikai; Tang, Mingnam
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019169153 A1 2019-09-06

$RFMT $RIREG SCHEME419 STEP1
$RXN



  2  1
$MOL
2-Chlorobenzonitrile
C7H4ClN
873-32-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 N 6.1601 2.6673 0.0 0
M  V30 3 Cl 3.0801 0.0000 0.0 0
M  V30 4 C 3.0801 2.6673 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 2.3101 4.0010 0.0 0
M  V30 7 C 0.7700 1.3337 0.0 0
M  V30 8 C 0.7700 4.0010 0.0 0
M  V30 9 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 4
M  V30 3 1 3 5
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N-methylbenzenecarbothioamide
C8H8ClNS
73280-30-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 N 5.3901 4.0010 0.0 0
M  V30 3 S 5.3901 1.3337 0.0 0
M  V30 4 C 6.9302 4.0010 0.0 0
M  V30 5 Cl 3.0801 0.0000 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 2.3101 1.3337 0.0 0
M  V30 8 C 2.3101 4.0010 0.0 0
M  V30 9 C 0.7700 1.3337 0.0 0
M  V30 10 C 0.7700 4.0010 0.0 0
M  V30 11 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 873-32-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 73280-30-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25070617
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 12135-76-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 349081-21-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 349081-21-6
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: To a mixture of nitrile (1 mmol) in
C6(mim)2Cl2 (1.1 mmol), ammonium sulfide (1.2 mmol) was added. The
resulting mixture was stirred at 70 °C for the appropriate time shown in
Table 2. After the completion of the reaction, as indicated by TLC, amine
(5 mmol) was added to the reaction and stirred at 70 °C for 10 min to 5 h
(Table 3). Then the reaction took place, was quenched with ice-water (10
ml) and stirred at room temperature for 10 min. The above mixture was
extracted with ethyl acetate (3 × 5 ml) and the organic layers were
combined. When the residue was dried and concentrated in vacuo, it was
chromatographied on silica gel (n-heptane/ethyl acetate as eluent) to
afford the pure products in 70-95% yields. Compound: 3b, Yield (%): 92,
Time (min): 10.
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, no solvent, ionic liquid used (catalytic media)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Efficient and green protocol for the synthesis of thioamides in
C6(mim)2Cl2 as a dicationic ionic liquid
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Khosropour, A. R.; Noei, J.; Mirjafari, A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the Iranian Chemical Society (2010), 7(3), 752-758

$RFMT $RIREG SCHEME420 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 4-chloro-2,5-difluorobenzoate
C9H7ClF2O2
879093-03-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 4.6200 0.0 0
M  V30 2 O 6.6684 3.8500 0.0 0
M  V30 3 O 5.3347 6.1600 0.0 0
M  V30 4 C 8.0021 4.6200 0.0 0
M  V30 5 C 9.3358 3.8500 0.0 0
M  V30 6 F 2.6674 6.1600 0.0 0
M  V30 7 F 2.6674 0.0000 0.0 0
M  V30 8 Cl 0.0000 1.5400 0.0 0
M  V30 9 C 4.0011 3.8500 0.0 0
M  V30 10 C 2.6674 4.6200 0.0 0
M  V30 11 C 4.0011 2.3100 0.0 0
M  V30 12 C 1.3336 3.8500 0.0 0
M  V30 13 C 2.6674 1.5400 0.0 0
M  V30 14 C 1.3336 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 10
M  V30 7 1 7 13
M  V30 8 1 8 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-2,5-difluoro-N-methylbenzamide
C8H6ClF2NO
921213-29-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 2.6674 0.0 0
M  V30 2 N 6.9300 4.0011 0.0 0
M  V30 3 O 6.9300 1.3338 0.0 0
M  V30 4 C 8.4700 4.0011 0.0 0
M  V30 5 F 4.6200 0.0000 0.0 0
M  V30 6 F 1.5400 5.3349 0.0 0
M  V30 7 Cl 0.0000 2.6674 0.0 0
M  V30 8 C 4.6200 2.6674 0.0 0
M  V30 9 C 3.8500 1.3338 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3338 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 9
M  V30 6 1 6 12
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 879093-03-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 921213-29-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-14442217
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM N-Methyl 2,5-difluoro-4-chloro-benzamide (10), from 3 on lab scale. Ethyl
2,5-difluoro-4-chloro-benzoate 3 (154 g, 0.70 mol) was dissolved in THF
(250 mL). Water (250 mL) was added, followed by methylamine (303 mL, 3.5
mol, 40 wt % in water). The mixture was stirred at 20 °C for 2 h. Water
(500 mL) was added, and most of THF was distilled off under vacuum (<30
°C, 0.05 bar). The resulting slurry was stirred at 20 °C for 1 h and
filtered. The cake was washed with water (500 mL) and dried in a vacuum
oven (40 °C) for 16 h to obtain 10. White powder, yield. 92% (132.6 g,
0.64 mol).
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A Scalable Synthesis of CE-157119 HCl Salt, an SRI/5-HT2A Antagonist
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tao, Yong; Widlicka, Daniel W.; Hill, Paul D.; Couturier, Michel; Young,
Gregory R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Process Research & Development (2012), 16(11), 1805-1810

$RFMT $RIREG SCHEME420 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 4-chloro-2,5-difluorobenzoate
C9H7ClF2O2
879093-03-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 4.6200 0.0 0
M  V30 2 O 6.6684 3.8500 0.0 0
M  V30 3 O 5.3347 6.1600 0.0 0
M  V30 4 C 8.0021 4.6200 0.0 0
M  V30 5 C 9.3358 3.8500 0.0 0
M  V30 6 F 2.6674 6.1600 0.0 0
M  V30 7 F 2.6674 0.0000 0.0 0
M  V30 8 Cl 0.0000 1.5400 0.0 0
M  V30 9 C 4.0011 3.8500 0.0 0
M  V30 10 C 2.6674 4.6200 0.0 0
M  V30 11 C 4.0011 2.3100 0.0 0
M  V30 12 C 1.3336 3.8500 0.0 0
M  V30 13 C 2.6674 1.5400 0.0 0
M  V30 14 C 1.3336 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 10
M  V30 7 1 7 13
M  V30 8 1 8 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-2,5-difluoro-N-methylbenzamide
C8H6ClF2NO
921213-29-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 2.6674 0.0 0
M  V30 2 N 6.9300 4.0011 0.0 0
M  V30 3 O 6.9300 1.3338 0.0 0
M  V30 4 C 8.4700 4.0011 0.0 0
M  V30 5 F 4.6200 0.0000 0.0 0
M  V30 6 F 1.5400 5.3349 0.0 0
M  V30 7 Cl 0.0000 2.6674 0.0 0
M  V30 8 C 4.6200 2.6674 0.0 0
M  V30 9 C 3.8500 1.3338 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3338 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 9
M  V30 6 1 6 12
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 879093-03-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 921213-29-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-5925563
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 3 N-methyl 2,5-difluoro-4-chloro-benzamide (Two Steps): 40%
methylamine in water (303 ml, 3.5 moles) was added to a mixture of ethyl
2,5-difluoro-4-chloro-benzoate (154 g, 0.7 moles) (prepared from Example
2) in THF (250 ml) and water (250 ml). The mixture was stirred at room
temperature for 2 hours. Water (500 ml) was added and most of the THF was
distilled off. The resulting slurry was stirred at room temperature for 1
hour and filtered. The cake was washed with water and dried in a vacuum
oven at 40°C for 16 hours. N-methyl 2,5-difluoro-4-chloro-benzamide
(132.6 g) was obtained at 92.4% yield. Mp: 127.5-127.6°C 1H NMR (in
CDCl3): δ 7.88 (dd, J=9.5/7.0. 1H), 7.20 (dd, J=10.4/5.4, 1H), 6.67
(brs), 1H), 3.00 (d, J=4.5, 3H). GC-MS: 205 (M+).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of diphenyl ethers
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tao, Yong; Widlicka, Daniel William
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2007010350 A1 2007-01-25

$RFMT $RIREG SCHEME421 STEP1
$RXN



  2  1
$MOL
5-[[[(4-Fluorophenyl)methyl]amino]carbonyl]-3-methoxy-4-(phenylmethoxy)-2-pyr...
C22H19FN2O5
880261-52-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6200 6.6684 0.0 0
M  V30 2 C 3.0800 6.6684 0.0 0
M  V30 3 C 7.7000 6.6684 0.0 0
M  V30 4 N 9.2400 6.6684 0.0 0
M  V30 5 O 6.9300 8.0021 0.0 0
M  V30 6 C 10.0100 8.0021 0.0 0
M  V30 7 O 3.0800 4.0011 0.0 0
M  V30 8 C 2.3100 2.6673 0.0 0
M  V30 9 C 4.6200 1.3336 0.0 0
M  V30 10 O 5.3900 0.0000 0.0 0
M  V30 11 O 3.0800 1.3336 0.0 0
M  V30 12 F 16.1700 8.0021 0.0 0
M  V30 13 C 5.3900 5.3347 0.0 0
M  V30 14 C 6.9300 5.3347 0.0 0
M  V30 15 C 4.6200 4.0011 0.0 0
M  V30 16 C 7.7000 4.0011 0.0 0
M  V30 17 C 5.3900 2.6673 0.0 0
M  V30 18 N 6.9300 2.6673 0.0 0
M  V30 19 C 2.3100 8.0021 0.0 0
M  V30 20 C 0.7700 8.0021 0.0 0
M  V30 21 C 3.0800 9.3358 0.0 0
M  V30 22 C 0.0000 9.3358 0.0 0
M  V30 23 C 2.3100 10.6694 0.0 0
M  V30 24 C 0.7700 10.6694 0.0 0
M  V30 25 C 11.5500 8.0021 0.0 0
M  V30 26 C 12.3200 6.6684 0.0 0
M  V30 27 C 12.3200 9.3358 0.0 0
M  V30 28 C 13.8600 6.6684 0.0 0
M  V30 29 C 13.8600 9.3358 0.0 0
M  V30 30 C 14.6300 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 19
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 14
M  V30 7 1 4 6
M  V30 8 1 6 25
M  V30 9 1 7 8
M  V30 10 1 7 15
M  V30 11 1 9 10
M  V30 12 2 9 11
M  V30 13 1 9 17
M  V30 14 1 12 30
M  V30 15 1 13 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N5-[(4-Fluorophenyl)methyl]-1,4-dihydro-3-hydroxy-N2-methyl-4-oxo-2,5-pyridin...
C15H14FN3O4
880261-29-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 5.3901 0.0 0
M  V30 2 N 8.0022 4.6201 0.0 0
M  V30 3 O 6.6685 6.9302 0.0 0
M  V30 4 C 9.3358 5.3901 0.0 0
M  V30 5 O 4.0010 6.9302 0.0 0
M  V30 6 O 1.3337 5.3901 0.0 0
M  V30 7 C 1.3337 2.3101 0.0 0
M  V30 8 N 1.3337 0.7700 0.0 0
M  V30 9 O 0.0000 3.0801 0.0 0
M  V30 10 C 0.0000 0.0000 0.0 0
M  V30 11 F 14.6707 2.3101 0.0 0
M  V30 12 C 5.3348 4.6201 0.0 0
M  V30 13 C 4.0010 5.3901 0.0 0
M  V30 14 C 5.3348 3.0801 0.0 0
M  V30 15 C 2.6673 4.6201 0.0 0
M  V30 16 N 4.0010 2.3101 0.0 0
M  V30 17 C 2.6673 3.0801 0.0 0
M  V30 18 C 10.6697 4.6201 0.0 0
M  V30 19 C 12.0033 5.3901 0.0 0
M  V30 20 C 10.6697 3.0801 0.0 0
M  V30 21 C 13.3370 4.6201 0.0 0
M  V30 22 C 12.0033 2.3101 0.0 0
M  V30 23 C 13.3370 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 4 18
M  V30 6 2 5 13
M  V30 7 1 6 15
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 17
M  V30 11 1 8 10
M  V30 12 1 11 23
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 880261-52-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 880261-29-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-049-CAS-9332125
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 628-13-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure:
3-Hydroxy-4-oxo-1,4-dihydropyridine-2,5-dicarboxylic Acid 2-Amide
5-(4-fluorobenzyl)amide (19). The compound 15 (155 mg, 0.378 mmol),
2-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (87 mg, 0.453
mmol), and 1-hydroxybenzotriazole (61 mg, 0.453 mmol) were dissolved in
DMF (2 mL), and the solution was stirred at room temperature for 30 min.
Thereafter, ammonium chloride (40 mg, 0.756 mmol) and
diisopropylethylamine (198 μL, 1.13 mmol) were added. The reaction
solution was stirred at room temperature for 1 h. Water was added to the
solution, and precipitate was collected by filtration and washed with
Et2O to give crude product 16 of 127 mg. Directly to 16 pyridine-HCl
(1.27 g) was added and then heated at 180 °C for 5 min. After cooling the
reaction mixture to room temperature, water was added. Precipitate was
collected by filtration and washed with Et2O to give the product.
3-Hydroxy-4-oxo-1,4-dihydropyridine-2,5-dicarboxylic Acid
5-(4-Fluorobenzyl)amide 2-methylamide (20). This compound was prepared in
a similar manner to that described for 19 (colorless crystals 89 mg, 92%
yield for two steps). Mp higher than 300 °C. 1H NMR (DMSO-d6) δ 2.91 (d,
J = 4.7 Hz, 3H), 4.53 (d, J = 5.8 Hz, 2H), 7.14-7.20 (m, 2H), 7.35-7.40
(m, 2H), 8.23-8.25 (m, 1H), 8.35 (d, J = 5.0 Hz, 1H), 10.35 (t, J = 5.8
Hz, 1H), 12.23 (d, J = 6.3 Hz, 1H). Anal. Calcd for C15H14FN3O4: C,
56.43; H, 4.42; F, 5.95; N, 13.16. Found: C, 56.18; H, 4.36; F, 5.63; N,
12.96.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Carbamoyl Pyridone HIV-1 Integrase Inhibitors. 1. Molecular Design and
Establishment of an Advanced Two-Metal Binding Pharmacophore
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kawasuji, Takashi; Johns, Brian A.; Yoshida, Hiroshi; Taishi, Teruhiko;
Taoda, Yoshiyuki; Murai, Hitoshi; Kiyama, Ryuichi; Fuji, Masahiro;
Yoshinaga, Tomokazu; Seki, Takahiro; Kobayashi, Masanori; Sato, Akihiko;
Fujiwara, Tamio
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2012), 55(20), 8735-8744

$RFMT $RIREG SCHEME422 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phthaloylamlodipine
C28H27ClN2O7
88150-62-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 41 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 7.7687 0.0 0
M  V30 2 O 6.6685 8.5387 0.0 0
M  V30 3 O 4.0011 8.5387 0.0 0
M  V30 4 C 6.6685 10.0787 0.0 0
M  V30 5 C 8.0021 10.8487 0.0 0
M  V30 6 C 3.1177 2.6573 0.0 0
M  V30 7 O 3.7687 1.2614 0.0 0
M  V30 8 O 1.5836 2.7914 0.0 0
M  V30 9 C 2.8853 0.0000 0.0 0
M  V30 10 C 8.0021 6.2287 0.0 0
M  V30 11 O 9.3358 5.4587 0.0 0
M  V30 12 C 10.6694 6.2287 0.0 0
M  V30 13 C 12.0032 5.4587 0.0 0
M  V30 14 C 5.3347 1.6087 0.0 0
M  V30 15 Cl 1.3338 3.9187 0.0 0
M  V30 16 O 15.0638 4.0959 0.0 0
M  V30 17 O 12.3534 8.7908 0.0 0
M  V30 18 C 4.0011 5.4587 0.0 0
M  V30 19 C 5.3347 6.2287 0.0 0
M  V30 20 C 4.0011 3.9187 0.0 0
M  V30 21 C 6.6685 5.4587 0.0 0
M  V30 22 C 5.3347 3.1487 0.0 0
M  V30 23 N 6.6685 3.9187 0.0 0
M  V30 24 C 2.6674 6.2287 0.0 0
M  V30 25 C 1.3338 5.4587 0.0 0
M  V30 26 C 2.6674 7.7687 0.0 0
M  V30 27 C 0.0000 6.2287 0.0 0
M  V30 28 C 1.3338 8.5387 0.0 0
M  V30 29 C 0.0000 7.7687 0.0 0
M  V30 30 N 13.3369 6.2287 0.0 0
M  V30 31 C 14.7437 5.6024 0.0 0
M  V30 32 C 13.4978 7.7602 0.0 0
M  V30 33 C 15.7742 6.7467 0.0 0
M  V30 34 C 15.0042 8.0804 0.0 0
M  V30 35 C 17.3142 6.7467 0.0 0
M  V30 36 C 15.7742 9.4142 0.0 0
M  V30 37 C 18.0842 8.0804 0.0 0
M  V30 38 C 17.3142 9.4142 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 20
M  V30 9 1 7 9
M  V30 10 1 10 11
M  V30 11 1 10 21
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 1 13 30
M  V30 15 1 14 22
M  V30 16 1 15 25
M  V30 17 2 16 31
M  V30 18 2 17 32
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 18 24
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 1 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 1 32 34
M  V30 36 1 33 34
M  V30 37 2 33 35
M  V30 38 2 34 36
M  V30 39 1 35 37
M  V30 40 1 36 38
M  V30 41 2 37 38
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Ethyl 3-methyl 4-(2-chlorophenyl)-1,4-dihydro-2-methyl-6-[[2-[[2-[(methylam...
C29H32ClN3O7
721958-72-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 42 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 7.9529 0.0 0
M  V30 2 O 5.3901 9.2866 0.0 0
M  V30 3 O 3.0801 7.9529 0.0 0
M  V30 4 C 4.6201 10.6202 0.0 0
M  V30 5 C 5.3901 11.9539 0.0 0
M  V30 6 C 5.2558 2.4175 0.0 0
M  V30 7 O 6.5174 1.5342 0.0 0
M  V30 8 O 3.8601 1.7667 0.0 0
M  V30 9 C 6.3831 0.0000 0.0 0
M  V30 10 C 7.7002 7.9529 0.0 0
M  V30 11 O 9.2402 7.9529 0.0 0
M  V30 12 C 10.0102 9.2866 0.0 0
M  V30 13 C 11.5503 9.2866 0.0 0
M  V30 14 N 12.3203 10.6202 0.0 0
M  V30 15 C 13.8603 10.6202 0.0 0
M  V30 16 O 14.6303 9.2866 0.0 0
M  V30 17 C 7.7002 2.6181 0.0 0
M  V30 18 Cl 3.0801 2.6181 0.0 0
M  V30 19 C 16.9404 10.6202 0.0 0
M  V30 20 N 18.4804 10.6202 0.0 0
M  V30 21 O 16.1704 9.2866 0.0 0
M  V30 22 C 19.2504 9.2866 0.0 0
M  V30 23 C 4.6201 5.2854 0.0 0
M  V30 24 C 5.3901 6.6191 0.0 0
M  V30 25 C 5.3901 3.9517 0.0 0
M  V30 26 C 6.9302 6.6191 0.0 0
M  V30 27 C 6.9302 3.9517 0.0 0
M  V30 28 N 7.7002 5.2854 0.0 0
M  V30 29 C 3.0801 5.2854 0.0 0
M  V30 30 C 2.3101 3.9517 0.0 0
M  V30 31 C 2.3101 6.6191 0.0 0
M  V30 32 C 0.7700 3.9517 0.0 0
M  V30 33 C 0.7700 6.6191 0.0 0
M  V30 34 C 0.0000 5.2854 0.0 0
M  V30 35 C 14.6303 11.9539 0.0 0
M  V30 36 C 16.1704 11.9539 0.0 0
M  V30 37 C 13.8603 13.2877 0.0 0
M  V30 38 C 16.9404 13.2877 0.0 0
M  V30 39 C 14.6303 14.6214 0.0 0
M  V30 40 C 16.1704 14.6214 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 24
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 25
M  V30 9 1 7 9
M  V30 10 1 10 11
M  V30 11 1 10 26
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 14 15
M  V30 16 2 15 16
M  V30 17 1 15 35
M  V30 18 1 17 27
M  V30 19 1 18 30
M  V30 20 1 19 20
M  V30 21 2 19 21
M  V30 22 1 19 36
M  V30 23 1 20 22
M  V30 24 1 23 24
M  V30 25 1 23 25
M  V30 26 1 23 29
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 28
M  V30 30 1 27 28
M  V30 31 2 29 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 2 31 33
M  V30 35 2 32 34
M  V30 36 1 33 34
M  V30 37 2 35 36
M  V30 38 1 35 37
M  V30 39 1 36 38
M  V30 40 2 37 39
M  V30 41 2 38 40
M  V30 42 1 39 40
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 88150-62-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 721958-72-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-363-CAS-8107650
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 3-Ethyl 5-methyl
(4RS)-4-(2-chlorophenyl)-6-[[2-[[2-methylcarbamoyl)benzoy]]amino]
ethoxy]methyl]-1,4-dihydropyridine-3,5-dicarboxylate (VII) A 250 mL
one-necked flask, equipped with a magnetic stirrer was charged with 10 g
phthaloyl amlodipine in 25 mL of THF. To this solution was added 3 mL of
methyamine (40%). The solution was stirred at it for 30 minutes. The
solvent was evaporated in vacuo. The residue was precipitated by adding
diethylether to give the title compound as a white solid 9.72 g (92%,
with a relative purity> 96% based on area%). 3-Ethyl 5-methyl
(4RS)-4-(2-chlorophenyl)-6-[[2-[[2-methylcarbamoyl)benzoy]]amino]ethoxy]methyl]-1,4-dihydropyridine-3,5-dicarboxylate
(VII), yield 9.72 g (92%, IR (cm-1): 3340, 2341, 1699, 1670, 1636, 1540,
1487, 1286, 1205, 1100, 870, 668. EI-MS (70 eV): 569 [M]+ (3), 538 [M-
C2H5]+ (12), 458 [M-C6H5Cl]+ (45), 427 [M-C6H4Cl-OMe]+ (91), 347
[C18H18ClNO4]+ (100), 297 (66), 280 (7), 260 (13), 254 (18), 236
[C12H15N2O7]+ (10), 223 [C11H14N2O3]+ (28), 208 (57), 174 (61), 162 (71),
148 (12), 130 (14), 105 (10), 76 (8). 1H-NMR (CDCl3) δ 7.83 (d, 1H),
7.63-7.67 (m, 2H), 7.41-7.45 (m, 2H), 7.36 (d, 1H), 7.20 (d, 1H), 7.10
(q, 1H), 7.00 (q, 1H), 6.90 (q, 1H), 5.37 (s, 1H), 4.77 (d, 1H), 4.67 (d,
1H), 4.03 (q, 2H), 3.80-3.82 (m, 2H), 3.61 - 3.66 (m, 2H), 3.57 (s, 3H),
2.91 (d, 3H), 2.30 (s, 3H), 1.16 (t, 3H). 13C-NMR(CDCl3) δ 170.9, 168.9,
168.3, 167.4, 146.1, 145.2, 145.1, 134.8, 134.2, 132.4, 131.6, 130.3,
129.5, 129.4, 127.9, 127.5, 127.0, 103.7, 101.9, 70.4, 70.3, 60.0, 50.9,
39.8, 37.2, 27.2, 19.2, 14.4.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A process for the preparation of amlodipine and its salts
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Aslan, Tuncer; Adiyaman, Mustafa; Yurdakul, Aycil; Sahpaz, Filiz;
Ozarslan, Evren A.; Guner, Didem; Ridvanoglu, Nurten
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004058711 A1 2004-07-15

$RFMT $RIREG SCHEME423 STEP1
$RXN



  2  1
$MOL
trans-4-Nitrocinnamic acid
C9H7NO4
882-06-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 C 6.6684 4.6201 0.0 0
M  V30 5 C 8.0022 3.8500 0.0 0
M  V30 6 C 9.3359 4.6201 0.0 0
M  V30 7 O 10.6695 3.8500 0.0 0
M  V30 8 O 9.3359 6.1601 0.0 0
M  V30 9 C 2.6673 2.3100 0.0 0
M  V30 10 C 2.6673 3.8500 0.0 0
M  V30 11 C 4.0011 1.5400 0.0 0
M  V30 12 C 4.0011 4.6201 0.0 0
M  V30 13 C 5.3348 2.3100 0.0 0
M  V30 14 C 5.3348 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 2 4 5
M  V30 5 1 4 14
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2E)-N-Methyl-3-(4-nitrophenyl)-2-propenamide
C10H10N2O3
141544-16-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 4.6201 0.0 0
M  V30 2 C 8.0022 3.8501 0.0 0
M  V30 3 C 9.3360 4.6201 0.0 0
M  V30 4 N 10.6697 3.8501 0.0 0
M  V30 5 O 9.3360 6.1601 0.0 0
M  V30 6 C 12.0033 4.6201 0.0 0
M  V30 7 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 O 1.3337 0.0000 0.0 0
M  V30 10 C 5.3348 3.8501 0.0 0
M  V30 11 C 4.0012 4.6201 0.0 0
M  V30 12 C 5.3348 2.3101 0.0 0
M  V30 13 C 2.6673 3.8501 0.0 0
M  V30 14 C 4.0012 1.5400 0.0 0
M  V30 15 C 2.6673 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 2 7 8
M  V30 8 2 7 9
M  V30 9 1 7 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 882-06-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 141544-16-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-13000119
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and evaluation of novel diaryl urea derivatives as
potential antitumor agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lu, Chenshu; Tang, Ke; Li, Yan; Li, Peng; Lin, Ziyun; Yin, Dali; Chen,
Xiaoguang; Huang, Haihong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2014), 77351-360

$RFMT $RIREG SCHEME424 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(1,1,2,2,2-Pentafluoroethyl)benzaldehyde
C9H5F5O
884602-82-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.3337 0.0 0
M  V30 2 C 1.3337 2.1037 0.0 0
M  V30 3 F 3.4375 0.0000 0.0 0
M  V30 4 F 1.8975 0.0000 0.0 0
M  V30 5 F 0.5637 0.7700 0.0 0
M  V30 6 F 0.0000 2.8737 0.0 0
M  V30 7 F 2.1037 3.4374 0.0 0
M  V30 8 C 8.0023 4.4137 0.0 0
M  V30 9 O 9.3360 3.6437 0.0 0
M  V30 10 C 4.0012 2.1037 0.0 0
M  V30 11 C 4.0012 3.6437 0.0 0
M  V30 12 C 5.3348 1.3337 0.0 0
M  V30 13 C 5.3348 4.4137 0.0 0
M  V30 14 C 6.6685 2.1037 0.0 0
M  V30 15 C 6.6685 3.6437 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 10
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 2 7
M  V30 8 2 8 9
M  V30 9 1 8 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-(1,1,2,2,2-pentafluoroethyl)benzenemethanamine
C10H10F5N
1783359-04-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 1.3337 0.0 0
M  V30 2 C 1.3337 2.1037 0.0 0
M  V30 3 F 3.4374 0.0000 0.0 0
M  V30 4 F 1.8973 0.0000 0.0 0
M  V30 5 F 2.1037 3.4374 0.0 0
M  V30 6 F 0.0000 2.8737 0.0 0
M  V30 7 F 0.5637 0.7700 0.0 0
M  V30 8 C 8.0023 4.4137 0.0 0
M  V30 9 N 9.3360 3.6437 0.0 0
M  V30 10 C 10.6697 4.4137 0.0 0
M  V30 11 C 4.0012 2.1037 0.0 0
M  V30 12 C 5.3348 1.3337 0.0 0
M  V30 13 C 4.0012 3.6437 0.0 0
M  V30 14 C 6.6685 2.1037 0.0 0
M  V30 15 C 5.3348 4.4137 0.0 0
M  V30 16 C 6.6685 3.6437 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 11
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 2 7
M  V30 8 1 8 9
M  V30 9 1 8 16
M  V30 10 1 9 10
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 884602-82-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1783359-04-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40490533
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Selective Defluorination of Trifluoromethyl Substituents by
Conformationally Induced Remote Substitution
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jesani, Mehul H.; Schwarz, Maria; Kim, Shiwhu; Evans, Finlay L.; White,
Alexander; Browning, Alex; Abrams, Roman; Clayden, Jonathan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2024), 63(24), e202403477

$RFMT $RIREG SCHEME425 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-3-[(3,5-dimethylphenyl)methyl]-1-(phenylmethyl)-2,4(1H,3H)-pyrimidin...
C20H19ClN2O2
890525-16-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.3358 4.6201 0.0 0
M  V30 2 O 6.6685 6.1601 0.0 0
M  V30 3 O 9.3358 1.5400 0.0 0
M  V30 4 C 4.0010 4.6201 0.0 0
M  V30 5 Cl 4.0010 1.5400 0.0 0
M  V30 6 C 12.0033 0.0000 0.0 0
M  V30 7 C 14.6707 4.6201 0.0 0
M  V30 8 N 8.0022 3.8501 0.0 0
M  V30 9 C 6.6685 4.6201 0.0 0
M  V30 10 C 8.0022 2.3101 0.0 0
M  V30 11 N 5.3348 3.8501 0.0 0
M  V30 12 C 6.6685 1.5400 0.0 0
M  V30 13 C 5.3348 2.3101 0.0 0
M  V30 14 C 10.6697 3.8501 0.0 0
M  V30 15 C 10.6697 2.3101 0.0 0
M  V30 16 C 12.0033 4.6201 0.0 0
M  V30 17 C 12.0033 1.5400 0.0 0
M  V30 18 C 13.3370 3.8501 0.0 0
M  V30 19 C 13.3370 2.3101 0.0 0
M  V30 20 C 2.6673 3.8501 0.0 0
M  V30 21 C 2.6673 2.3101 0.0 0
M  V30 22 C 1.3337 4.6201 0.0 0
M  V30 23 C 1.3337 1.5400 0.0 0
M  V30 24 C 0.0000 3.8501 0.0 0
M  V30 25 C 0.0000 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 1 14
M  V30 3 2 2 9
M  V30 4 2 3 10
M  V30 5 1 4 11
M  V30 6 1 4 20
M  V30 7 1 5 13
M  V30 8 1 6 17
M  V30 9 1 7 18
M  V30 10 1 8 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[(3,5-Dimethylphenyl)methyl]-6-(methylamino)-1-(phenylmethyl)-2,4(1H,3H)-py...
C21H23N3O2
1453172-29-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.2401 4.0011 0.0 0
M  V30 2 N 7.7001 1.3337 0.0 0
M  V30 3 C 6.9301 0.0000 0.0 0
M  V30 4 O 7.7001 6.6684 0.0 0
M  V30 5 C 4.6201 6.6684 0.0 0
M  V30 6 O 3.0800 4.0011 0.0 0
M  V30 7 C 0.0000 9.3359 0.0 0
M  V30 8 C 0.0000 4.0011 0.0 0
M  V30 9 N 7.7001 4.0011 0.0 0
M  V30 10 C 6.9301 2.6675 0.0 0
M  V30 11 C 6.9301 5.3348 0.0 0
M  V30 12 C 5.3901 2.6675 0.0 0
M  V30 13 N 5.3901 5.3348 0.0 0
M  V30 14 C 4.6201 4.0011 0.0 0
M  V30 15 C 10.0101 5.3348 0.0 0
M  V30 16 C 9.2401 6.6684 0.0 0
M  V30 17 C 11.5501 5.3348 0.0 0
M  V30 18 C 10.0101 8.0022 0.0 0
M  V30 19 C 12.3201 6.6684 0.0 0
M  V30 20 C 11.5501 8.0022 0.0 0
M  V30 21 C 3.0800 6.6684 0.0 0
M  V30 22 C 2.3100 8.0022 0.0 0
M  V30 23 C 2.3100 5.3348 0.0 0
M  V30 24 C 0.7700 8.0022 0.0 0
M  V30 25 C 0.7700 5.3348 0.0 0
M  V30 26 C 0.0000 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 1 2 10
M  V30 5 2 4 11
M  V30 6 1 5 13
M  V30 7 1 5 21
M  V30 8 2 6 14
M  V30 9 1 7 24
M  V30 10 1 8 25
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 890525-16-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1453172-29-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-9111309
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 497-19-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and evaluation of novel 3-(3,5-dimethylbenzyl)uracil analogs as
potential anti-HIV-1 agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sakakibara, Norikazu; Hamasaki, Takayuki; Baba, Masanori; Demizu, Yosuke;
Kurihara, Masaaki; Irie, Kohji; Iwai, Masatoshi; Asada, Eriko; Kato,
Yoshihisa; Maruyama, Tokumi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2013), 21(18), 5900-5906

